<SEC-DOCUMENT>0000917520-23-000030.txt : 20230426
<SEC-HEADER>0000917520-23-000030.hdr.sgml : 20230426
<ACCEPTANCE-DATETIME>20230426162611
ACCESSION NUMBER:		0000917520-23-000030
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		93
CONFORMED PERIOD OF REPORT:	20230331
FILED AS OF DATE:		20230426
DATE AS OF CHANGE:		20230426

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			INTEGRA LIFESCIENCES HOLDINGS CORP
		CENTRAL INDEX KEY:			0000917520
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				510317849
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-26224
		FILM NUMBER:		23850131

	BUSINESS ADDRESS:	
		STREET 1:		1100 CAMPUS ROAD
		CITY:			PRINCETON
		STATE:			NJ
		ZIP:			08540
		BUSINESS PHONE:		6092750500

	MAIL ADDRESS:	
		STREET 1:		1100 CAMPUS ROAD
		CITY:			PRINCETON
		STATE:			NJ
		ZIP:			08540

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	INTEGRA LIFESCIENCES CORP
		DATE OF NAME CHANGE:	19950614
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>iart-20230331.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2023 Workiva--><!--r:0e3cd8f8-520d-473a-a9d1-16bfb1ec7d66,g:2b3f0039-4147-46cc-8b95-ac89c1bf8f8d,d:5f1eb1bd01d541c3aa0777712077c048--><html xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns="http://www.w3.org/1999/xhtml" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:srt="http://fasb.org/srt/2022" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:iart="http://integralife.com/20230331" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:link="http://www.xbrl.org/2003/linkbase" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>iart-20230331</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80L2ZyYWc6YTBmMjczMWU4MzRhNGY0ODhiZmZhZDkzZmMxMmNiZTMvdGFibGU6MTUyODM2MmRjY2QyNDBkZGFkMjcxZTVhYWVjMTg4NmIvdGFibGVyYW5nZToxNTI4MzYyZGNjZDI0MGRkYWQyNzFlNWFhZWMxODg2Yl80LTEtMS0xLTE4NjgyMQ_1a7e1092-9252-4431-acb6-68b517c82d6c">false</ix:nonNumeric><ix:nonNumeric contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80L2ZyYWc6YTBmMjczMWU4MzRhNGY0ODhiZmZhZDkzZmMxMmNiZTMvdGFibGU6MTUyODM2MmRjY2QyNDBkZGFkMjcxZTVhYWVjMTg4NmIvdGFibGVyYW5nZToxNTI4MzYyZGNjZDI0MGRkYWQyNzFlNWFhZWMxODg2Yl82LTEtMS0xLTE4NjgyMQ_53f46d55-ff36-4b2a-8c4a-ed7414c27776">2023</ix:nonNumeric><ix:nonNumeric contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80L2ZyYWc6YTBmMjczMWU4MzRhNGY0ODhiZmZhZDkzZmMxMmNiZTMvdGFibGU6MTUyODM2MmRjY2QyNDBkZGFkMjcxZTVhYWVjMTg4NmIvdGFibGVyYW5nZToxNTI4MzYyZGNjZDI0MGRkYWQyNzFlNWFhZWMxODg2Yl83LTEtMS0xLTE4NjgyMQ_96a1325e-61fa-424b-9931-ac3267752316">Q1</ix:nonNumeric><ix:nonNumeric contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" name="dei:DocumentPeriodEndDate" format="ixt:date-month-day-year" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80L2ZyYWc6YTBmMjczMWU4MzRhNGY0ODhiZmZhZDkzZmMxMmNiZTMvdGFibGU6MTUyODM2MmRjY2QyNDBkZGFkMjcxZTVhYWVjMTg4NmIvdGFibGVyYW5nZToxNTI4MzYyZGNjZDI0MGRkYWQyNzFlNWFhZWMxODg2Yl8xMC0xLTEtMS0xOTU4Mjg_e0b7504c-1e2c-4902-bebc-ecfcde588b0e">3/31/2023</ix:nonNumeric><ix:nonNumeric contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80L2ZyYWc6YTBmMjczMWU4MzRhNGY0ODhiZmZhZDkzZmMxMmNiZTMvdGFibGU6MTUyODM2MmRjY2QyNDBkZGFkMjcxZTVhYWVjMTg4NmIvdGFibGVyYW5nZToxNTI4MzYyZGNjZDI0MGRkYWQyNzFlNWFhZWMxODg2Yl8xMC0xLTEtMS0xODY4MjE_438c6881-7b6f-47fb-bbfb-5d7d584ab757">0000917520</ix:nonNumeric><ix:nonNumeric contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" name="dei:CurrentFiscalYearEndDate" format="ixt:date-monthname-day-en" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80L2ZyYWc6YTBmMjczMWU4MzRhNGY0ODhiZmZhZDkzZmMxMmNiZTMvdGFibGU6MTUyODM2MmRjY2QyNDBkZGFkMjcxZTVhYWVjMTg4NmIvdGFibGVyYW5nZToxNTI4MzYyZGNjZDI0MGRkYWQyNzFlNWFhZWMxODg2Yl8xMS0xLTEtMS0xODY4MjE_53c81632-6145-471d-bfec-d0f2bac75980">December 31</ix:nonNumeric><ix:nonFraction unitRef="number" contextRef="i3027f2cbc7194fc49391e18cf6122617_D20200204-20200204" decimals="7" name="us-gaap:DebtInstrumentConvertibleConversionRatio1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81NS9mcmFnOjk1N2M0MWY1YjhjMDRlZTc4NzNlOThlMWY2M2YzMDE1L3RleHRyZWdpb246OTU3YzQxZjViOGMwNGVlNzg3M2U5OGUxZjYzZjMwMTVfNA_f11d9e7d-0a4f-414b-a0fa-b0f65a60efd6">0.0135739</ix:nonFraction><ix:nonNumeric contextRef="ia54d728bf30d440cab41cf9be0182655_D20230101-20230331" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82MS9mcmFnOmVjZjA3OTliODczNTQ2MjFhODNlMzFlYWUxZWEyOTMxL3RleHRyZWdpb246ZWNmMDc5OWI4NzM1NDYyMWE4M2UzMWVhZTFlYTI5MzFfNzIx_2efd93e6-4b81-4ecd-a888-8a73dfd19f51">P6Y</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="iart-20230331.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9d6e2966991d4fe6b8a46d9c30f8b61d_I20230425"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-04-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="ica4b4c17b7db4efd96016f438f3fc36e_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i50dcc39eee364391aeb0073e75dcfb4f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i635d765ec67b4491a13addb3d7bc40cd_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8b664c70cda046d684b591844ea4bde4_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i18a51afa82d740fbbdf6665bed1d8a09_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia60ef6361a9e4be48bde714624b18a33_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia54b6095ce1949b680fbf6e3777f0cd1_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie9da7c98e7334b2b98f63a2448e31bd5_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5a86b99b663a4de7bdb689dab96e1f70_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4b3ce7fe6f5d47549cce8165b587a1d0_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia95f80b5f4b8491b8974cc31b9e4bcd7_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0fb8907de52a4781af049b3a4064bcdf_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8a149e1d463f4cca8d2969ce8c1e4a84_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaf1259e8da8a41d8874851f04fa9e5d6_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3e47e80bbb2040c7a084e52b255b0d28_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifd938a82772142df82f2a578295bcd9a_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ied07d9963f9d439fb1ad815102c390d4_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia9645160354f47929ed32876cc704c86_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5173bceb1ba843f5b9ba6fac4ca9b4ca_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i366dba347b9f46848ca7d06dec81acb5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6e56583327fe4abe82cb79ace79055aa_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia84198cc189e4e0f8778dab882b9d737_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5712711f454141d18540576f0d8ead64_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6cfa05b583da44ddab7edd770f9bd953_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia48c06fa8e984f2682cf6945ce8d6a84_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7887839e434d4a3eaa3b791ba3071cd7_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i12b2bd10a7124b6b8b76ec49059b3fda_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iec34d4ae56714939a2ae0fcab654c01c_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1be1849f53b94167a15b3f9045e8f051_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i73947427cc2b499ab016969c72081ee0_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idb0fcc9c413d41d28bf9655bcf94a392_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2313f3e834a34925a9399b4f10d82fd7_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3e56c025683743ddb68924e934a1c045_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2aee20b22d6c4af1adc9943efb3a200b_D20221206-20221206"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:SurgicalInnovationAssociatesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-12-06</xbrli:startDate><xbrli:endDate>2022-12-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="payment"><xbrli:measure>iart:payment</xbrli:measure></xbrli:unit><xbrli:context id="ic77f745d6f9e48afadfcda799fcc3235_I20221206"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:SurgicalInnovationAssociatesIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">iart:RevenueBasedPerformanceMilestonesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4a4cd86df7eb418cb65f718c0f4e4dbd_I20221206"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">iart:FDAApprovalOfPremarketApprovalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:SurgicalInnovationAssociatesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9562f5f76a11487db81f0d5c50e212ba_I20221206"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:SurgicalInnovationAssociatesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i5b74908fc42a482b9a714af70be67c23_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:SurgicalInnovationAssociatesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i945ecb5f56064998992427ac8c2997e7_I20220831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">iart:TraditionalWoundCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i04a8a39a1e704ddfa67a4702f8617631_D20220831-20220831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">iart:TraditionalWoundCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-08-31</xbrli:startDate><xbrli:endDate>2022-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i36c1f405b82c4668bb563f8b0467fa90_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">iart:TraditionalWoundCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i07f57ce44af74eeb8d954e3a7fb7f1bc_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">iart:TraditionalWoundCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i770b51dde44c4f0f852868d1b571cf9e_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2023-04-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i41cd523bdedf46cc95670faedd457b46_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:CodmanSpecialtySurgicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">iart:NeurosurgeryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieb2f835f7aba47f8b013ef0af01dc9fa_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:CodmanSpecialtySurgicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">iart:NeurosurgeryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1f536ce18eba4aa1b760c5c3107d3a2a_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:CodmanSpecialtySurgicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">iart:InstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia5280886888b459382b2676a7723925f_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:CodmanSpecialtySurgicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">iart:InstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifd59456ea9aa4f04b19628e881f264f6_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:CodmanSpecialtySurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6524a64fd30c42eca0a31257f157eeec_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:CodmanSpecialtySurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5b9610cb297e4cb9a4dacf782076fbbb_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:TissueTechnologiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">iart:RegenerativeSkinAndWoundMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iac40b4f9e2254c7da7351d7d272012dd_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:TissueTechnologiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">iart:RegenerativeSkinAndWoundMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i90fa502ea15741368ebd39ece562c20f_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">iart:PrivateLabelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:TissueTechnologiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0fd180115b9642178d42038efe2b2776_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">iart:PrivateLabelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:TissueTechnologiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibcfddd0c2c684ea4acbf2b9ae4cd8527_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:TissueTechnologiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i842208849e5d47b588209f3a26f3a724_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:TissueTechnologiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib712dcb2854f46f28657fb649d2220db_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:CodmanSpecialtySurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i542245b54ecf4d72b1024950a433c9af_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:TissueTechnologiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1841156103084935b575ef1c38b8e26c_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:CodmanSpecialtySurgicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:SurgicalInnovationAssociatesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib0ddadf2f33d42e18b362897b2b47f30_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:TissueTechnologiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:SurgicalInnovationAssociatesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9796a6882ba147419345a7d80b8e97d0_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:SurgicalInnovationAssociatesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id96439be0e9c43bc9bdb59971d641299_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:CodmanSpecialtySurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ida3b360960f84ba791b9beca0ffbeacd_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:TissueTechnologiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i97cf8c18c01245a3b5878b1a70debb09_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:CompletedTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id52aed2cbf2644509a8d761ee366e14e_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:CompletedTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0c74c93593f04e0a8c727b1e6224e815_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5dc82ac4ce464f4da5b9c83153642d32_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i42d7a82bf02941cfa73330ae1871acf1_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:TrademarksBrandNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0660f35837f94b01a3733519c74443b0_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:TrademarksBrandNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib6126f6a52e94c36bb96da081cbfd6a2_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6b0ff551735c45b7bfe3c18fdbb4e9b2_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:SupplierRelationShipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8efb348618694eb0b761b917a80af933_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:SupplierRelationShipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i15371427605f42a2a6b646f1911d4b0f_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:AllOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i300eb0465a16418db26404ea8b152196_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:AllOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib10821a2be0a4a9cb44ee7405d2e3b3b_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:CompletedTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5161e2ebe90148f3a9f6b6b4d290dbe4_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:CompletedTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9ec130bce102400abaa3a20544f9f36f_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaf15e0a25a2341c0b2b8d2b4ee0f2751_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i64d8a19482454a3586c748993f1474c6_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:TrademarksBrandNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4d1a3397e8cd4decab44bcff39bb8345_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:TrademarksBrandNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i45871e5e03c54676a898558774ed322e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i79d3d15982c14927ab9ed833406b2dc2_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:SupplierRelationShipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5182401e0e9b451db9f13c85d749b4b1_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:SupplierRelationShipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4bd0685df71b4334baf2049236ad65c1_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:AllOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i111c837e553e4c579da41292d97ec939_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:AllOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5f1abf32d8ec43f3a621a5448c21a7a1_I20230324"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:SeniorCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icd0dbd7f9cc3475488e71805c8369830_I20230324"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:TermLoanFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0d1f785d88d94ee08e66c1b385dc0f1d_I20230324"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2925166e860d464e857eec9b85318b66_I20230324"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:StandbyLettersOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3a69c660cc994e3e89f928d370becf48_I20230324"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">iart:SwinglineLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i29c495bb726f416f92c438401600a765_I20230324"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="iart:DebtCovenantPeriodAxis">iart:DebtCovenantPeriod1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:SeniorCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0a99dd10d5ee423cb63f788fb7285962_I20230324"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="iart:DebtCovenantPeriodAxis">iart:DebtCovenantPeriod2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:SeniorCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7f83b1b30bad4b0abf661670d1135229_I20230324"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="iart:DebtCovenantPeriodAxis">iart:DebtCovenantPeriod3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:SeniorCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i14a19f77eafb4116aa1875402c21a6ac_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:SeniorCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i96878a4e0354445fa679e461e52e913e_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:SeniorCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7d6d16e6e0d9418c82c2bdc6fe950a0b_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:SeniorCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i82965aae546f4e83a526730570a1e256_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:SeniorCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:FederalFundsEffectiveSwapRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3f2fb631c5ee4c2fa49138cf5e6235e8_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:SeniorCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i75b239dc572a41de8d6401d6434fe2fa_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:SeniorCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i99b8d45450b94b73be890ff82ddfc718_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3cf8dd5a6f664b3d8b55fc2f763a1d0e_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0fc6705bbac14c0a8a85244af899d39c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3b6f2ca5a0ff4bcf9931d0f74490b27a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:TermLoanFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6ace526dcf2e4bd7b1d416abfd600915_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:TermLoanFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i113a67b9524a40fdb5f84333cb215b19_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:TermLoanFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i33d9a2beed6845289ab811beceaf918e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:StandbyLettersOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:SeniorCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2fcddd5311424f18bf9d0ea34cf199ce_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:StandbyLettersOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:SeniorCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4d85c23c3dd4486a8c0cad316eeb498d_I20200204"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:TwoThousandTwentyFiveSeniorConvertibleNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-02-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3027f2cbc7194fc49391e18cf6122617_D20200204-20200204"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:TwoThousandTwentyFiveSeniorConvertibleNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-02-04</xbrli:startDate><xbrli:endDate>2020-02-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i296f2de4222e4edd96bf4c0e1aa8b562_I20201209"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:TwoThousandTwentyFiveSeniorConvertibleNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2a88a3ee579649698c7a806c20baf329_D20200204-20200204"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityEquityAxis">us-gaap:CallOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:TwoThousandTwentyFiveSeniorConvertibleNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-02-04</xbrli:startDate><xbrli:endDate>2020-02-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0028dc2843f2423f8f300edeb35aa725_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:TwoThousandTwentyFiveSeniorConvertibleNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if38b10df1e9e4c7bbece89c49285e3f3_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i660d9b3823f743b9bb93a4c91c601967_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember132017Tranche2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if90a05dc42874d4c91a7b0d2cd282433_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember132017Tranche3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic80e820d18594abbb087fa7ea6c97b34_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedOctober102018Tranche1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i242cbbb364f64c76abce2babdef87734_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedOctober102018Tranche2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1df01832fdb04d5687ddfbc85bd04c29_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedOctober102018Tranche3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id7f35814aec144359ed4a1f6aca5ff44_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember182018Tranche1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if455fa2d39f24cf59e0ca350ce4174ae_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember182018Tranche2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i68d02b4ce6b442a39ee633b1a9c0c689_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember152020Tranche1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4611de47ca424f2880fb6c66abf4c864_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember152020Tranche2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id3e91944e1f34523a944e5c31a1dcfb8_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedMarch312023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1b244a95ae9e496fa6a76dbb19e5a1ff_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibaa12b7418534a0f9c95d84d9ad6b1bb_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9f5aaca61a204337a8cdf280d2e2d8d1_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember132017Tranche2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i110563708a344d13b6ba6837a8ffdaff_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember132017Tranche3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib8d564f8afa4405eac0fdd8215345e13_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedOctober102018Tranche1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i453cd89c33ef48c7bdfc3ff3788502d2_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedOctober102018Tranche2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iefae8c9c545043389530b336eede02b7_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedOctober102018Tranche3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idb9a8e940c7a42eb987c4c32a8bdb139_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember182018Tranche1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i107d35b94cbf4cafb70558b912de87a9_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember182018Tranche2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1063bf6f331744358ce9892d6b046199_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember152020Tranche1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i69349b63e94749f680a73aa85071a4f3_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember152020Tranche2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic0e31fe1684f414cbac936fef047cdc0_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8f1a2f6132444776b0b916c3ec4d150a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id6f12805ce8f48c2a0fbeec9e8c8a8dc_I20220926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:CodmanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="chf"><xbrli:measure>iso4217:CHF</xbrli:measure></xbrli:unit><xbrli:context id="if875fdad2a23408d9d0ed3e81db4e7ee_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:CodmanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0d2cb496f6d34578a914d07e7359d877_I20201221"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7e2dbfd7e64c4a058f61e6ddbb174ba2_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i64420e77a1cf469498e2ca2af1883f9f_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:CodmanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia25949993bc54e31b057302d171fccae_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:CodmanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6e76d40129eb4fceb7e3cbae9e1a5025_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:CodmanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i12840888426f47f0bfab4c48ba3fa8c5_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:CodmanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4c73f19cfa39458dbce322781befa454_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:CodmanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icfc6c257ec264f86b565dfd0902ba5f6_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:CodmanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3703f1657e1c4322924cfd69bfd51ed2_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:CodmanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id9839714200e436fb715c8e97dc0b9e1_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:CodmanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4facc35f040e40778807e0ec5945fd96_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:CodmanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia9d15227403d47bda86034e4464a9675_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:CodmanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia4d70da53f2e443b81f302d5bc88197c_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:CodmanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i69b25e2065b74ec9b2d6fc10d48a3919_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:CodmanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if68feb9648554b258a953ab0b3cf1b44_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:CodmanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7aa8838f170544bca9b1f95ebe3e1329_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:CodmanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9d0c5e4a255d4bed9a9758f0390707d2_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6cc6a5aaf59940698e0bc2bd4666b5dc_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iebf426920d4e4859b85ce6e6e41cd500_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i17088e89ea1f43888ce939b60c045452_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if1daaefdc2464e3cb18c32c6114de13b_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="eur"><xbrli:measure>iso4217:EUR</xbrli:measure></xbrli:unit><xbrli:context id="i8e00ac098d0d4a64b488a0c17ae543cc_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i71266e4583bc437f92273bca0ecbadeb_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idd51fbcf77834a9e9093fdb6e8cc4af5_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i84d05810f465447c8eee056a6ea0a040_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9044d98efacd431b815b8b6162aa3841_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id8fc9bc6fbc8473e98a29ae421b261cb_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i67cb9870e2ce452f89c2a1478634a794_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if26ad90eefe4415185190203179a9d0a_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9ea815ac7be1481cbb1e19dc878ef6a2_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i91ef1532274e495ca14298a177ea1acc_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i36f4034c904b4615a9bc452fe0768b20_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i29d096aee8e64b748938c9c63aacf5f5_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9118200971f14bd8b119346ba9f7bff3_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic7c538eff08b4fd6b79f7f5500bdfbfd_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i10a6a1852b544a5986e489c72e4c44c8_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i681f0e0ed1b448caa21fee3e2b8496bd_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i24c7d1057dba44f88ef1cbe078d56c52_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i58f139fbd41647c48c9057f1580cdac4_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i09796f9df77e48bca077728e4c8ae491_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0fed5dd652c740a78c23127d0779d0ba_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5eff930bd16f443f9ec4ab5edde345f2_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3e5ef68fc663402486e8a4e07e50b256_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i05dafd738acc468dba86e7bafd1510f0_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i57a5868b001f4d67935cf17c02a3c1ef_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9a4696f581d04cb586ec819e32f565b4_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icf74fb8aa39848049e1301eb02d39d82_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i99aa6d57dd04424181e96f7c91cc61ec_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9f5e216cf841484db3c4b4c6a4d7360a_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ida7dd09e252d4494a378fddc92937759_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7f8fb64f3560438aa95a28deccc11b4c_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5470f9ecb06a401e92323ccc20c80c85_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2be277f4f7ed4c18b787daf8a062f6c9_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib322bd99c183409fae8ee9d54c859608_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i74d46a8f5e78435b89e68529ae10f606_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9c9770e2724246d49b05399c4fbab21b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5fcf3db2e33e4516bb7de79733b0c0d0_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia1b37fecaa804375ad71d7e5bcdde933_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i71915794f65d4c91bc088e849a5fc799_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">iart:AccruedExpensesAndOtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7620e47d0bf84bce859b3bad2a16f684_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">iart:AccruedExpensesAndOtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaec22d28ecc94c71b2b12a038b76b4e4_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">iart:AccruedExpensesAndOtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i996b0ea6443441c4aaaf1bd24cc0bee4_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">iart:AccruedExpensesAndOtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic6da3ccfb9a34aabbeeb47220c6e49ff_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">iart:AccruedExpensesAndOtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieeb15fbf63ab4f469961445718c86de4_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">iart:AccruedExpensesAndOtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0072310af3d241efafdaf988459146fa_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">iart:AccruedExpensesAndOtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5aae5383e5894e1282dce76c96936d34_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">iart:AccruedExpensesAndOtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id498dc6dfe534a538bd4b76e7d332cb4_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i69e2392f36f44936a75ae231876a5027_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1b2593474fd840ba8291d49024330993_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2c7c8157157e4ecd949d6ac6cb41b21c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f574ae0feba45f79e1abe5b7ec3d086_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icddae4bb16a64dea817870f7632c24e2_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i56846d631dbe49b18b07a654b7e1ce4d_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2492f43b74614fcab458b7ed60d99fc2_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8ee9771bb95e427193ef400f91e7f20e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3e6c0e609ad149bdbbfc158b0e5fd68a_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic4eb84f89dad4116bceeb45741f9a641_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib3fe4a582ccd4061a97fd0b9da7c7f0d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i178b4152981345408498c8dfbee4cbc7_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9d6a89764db9416587bce17f35871a44_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if6fb80266a304dc5be9547704ed56286_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i92388a95dedc4a34a9f55ffd26aca363_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i810224786fad497790a97ede68b59f5f_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2b3f564951d04d5e92ce288f73dcb9b4_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i560720c3abc24f638935549d00ddf679_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaf1bbb7d552b43bc97be79bd949d01ce_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i545e60a320824ebca08bfa1384c3f0f0_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3c8bc030a0e84d8884ff38380b57a524_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie8763013b51645d9b4f267faa1bc585c_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6f53e0e076bd414e80ef7c0bf8a3584f_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id2ee30afd022428e9770584749497e62_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id8ccc5370489410a8499e0a9e3753b87_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2b2554dad56a4166a558274eed8d4fbb_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i579d645e131641bfa09602eb64db21f3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i63c6bd493f22494e9df49e5e6f48e027_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4b8fe8c3c3e2433a8f7cd9487fff6fef_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iae8885f4db32466ab5102315e110644a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i837380b9b55a43d9a21479305539ed99_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iac14ca05a7c84129889affd66eddd064_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib5284fa32e194b4887c09b3bd11c5196_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2c763dd699df40f7994d4bd081a81d5b_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2ee28a1877fb49278defab1977e4dfed_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i64221cccd9784e23b84697c3a6cae83e_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6b9673d1d44547fabe1719aef8ec54e2_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7cae2dbfb6a5475491033e353f69120b_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i60372d5d4c714e66a7f44c71f2d47770_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id118186cdcc643509f813c46ce8000ba_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if7a8dd366e654da081146a5b25db1c1b_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i399d8f6d881640bb810eee6e1458f2ba_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">iart:EmployeeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia54d728bf30d440cab41cf9be0182655_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">iart:DirectorsandCertainExecutiveOfficersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if710322947774a689663db2f525eeb6b_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">iart:DirectorsandCertainExecutiveOfficersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3bc994fc34b64d4cb7c684fd6244bac3_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6c69b026d57d423eb79ebbdfa493c6b3_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib4f03ffd86fa4e22af66c496e06ac9ec_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4989d4c8ef004834bf2980d2722cccaf_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iart:PerformanceStockAndRestrictedStockAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3046bc1317c642afb36b924feec16501_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i663c47912e30448682d1e675fc6bf6fd_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="renewal_option"><xbrli:measure>iart:renewal_option</xbrli:measure></xbrli:unit><xbrli:context id="i0312bf3fc4c644b5a90beedc5b117be5_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibb2818c35582446bb26bb336b6909032_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ief22d29946704881b53879628a3b3a03_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i77b6f580f27a43fa87d99324c7d3333c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i858dd34246b34029ba59dcfd73afff17_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iac36470e6fcb4453b97db73bbce55586_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i81703db4530142f4a19d6c5342dd660a_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">iart:RelatedPartiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i96ad5df3ea584444876af27fc107fa44_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">iart:ThirdPartiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i01e32628066d40fc8d8037b63a6a88b0_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">iart:FiveYearOptionLeasePeriodOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iccf8172c44f8418299899a406aff6ff5_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">iart:FiveYearOptionLeasePeriodOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idb728fa94349423cada113737d6ec277_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">iart:FiveYearOptionLeasePeriodTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6657623349984d07affcf737d966245b_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">iart:FiveYearOptionLeasePeriodTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i142beeb645c448e9b1d164dc7254fd2f_D20230331-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-03-31</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia47e8fa146ee495e917d3a8854512649_D20221231-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-12-31</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i05fc75ff93f849f6b97ee88d5015c23a_I20230126"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-01-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6eb2c396ee604c4493e35d50b9e4ab46_D20230126-20230126"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-26</xbrli:startDate><xbrli:endDate>2023-01-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4a535ba6db064ba5a22bf28443b5a825_I20220112"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-01-12</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic6638393ed5a47c19e1abcc6dca5d5d6_D20220112-20220112"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-12</xbrli:startDate><xbrli:endDate>2022-01-12</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1e7a618c6acb4e27a31c0800c72f5336_I20220324"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-03-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i646bea5fed00426299f8098e7755c18a_D20220331-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-31</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id48bc317ce8e43efa6fa6cdb7b8520e9_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i290c54e5ab7c451886f952e89f0d495a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iec175f17c95341d18708296b15afd58d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if10648f7e149447883c792b44180c76c_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i24ac1f0514474ac28f44980dc2f162ce_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9130414215c54f04be9fcc0ddd7ed89c_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i13b04fba956e41bc8127fdc101213375_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i805ec6ae450148b0aa6ec4a436b8b09e_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6afed391e44e4f1f965479a68ca6dcb5_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icf3a5e50a53a4b55a3ef05b821846b94_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if45e5d60245d47f7835ea2adf65836fa_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>iart:Segment</xbrli:measure></xbrli:unit><xbrli:unit id="product"><xbrli:measure>iart:product</xbrli:measure></xbrli:unit><xbrli:context id="i9189a78d31fb4c448c4078f016f511fb_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:CodmanSpecialtySurgicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i21203583e6274aefacecda4e30af7977_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:CodmanSpecialtySurgicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibb29c4fb3257468aba668e88d86534f1_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:TissueTechnologiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i66b66534a77f456aaf743a7fb2ed1e05_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:TissueTechnologiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia720faaba52b43d2be21584d13ecec2a_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib1c1895e254b42068cd689b2d2e0cb17_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iecf751356922485386ff472a954f4b37_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if9b97ade31164041b7058022a9eb48a9_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8ec4e98c494d4152959a7ad4e62f2cdc_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5c11bb731e264ce287a9ba4be5cf11c6_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i07f997c575a845b49f6c85d88adbf303_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic7f5c4fd7cee463ca7ad0e86dbcbc6b6_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id8b5c9cc0fb140aaa998a0d5849918a1_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5f5d773def504f108c920a0391f44968_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idceeee4c12c44c50b93f23c34fdf4267_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iart:RestOfWorldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaa37c54d794549a99aea38389a6d9606_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iart:RestOfWorldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifcaf924eb8b044b5959cc99978a303a7_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8389bf8a7d824c2980154809fed6d74d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i87b4b1d7730e401b9ab2ced0eb01926f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:DermaSciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib2ebabea23ce4ed1b68823b3506d6cee_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ACellMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i35632a429f994b4c93a6bf032cf1dab3_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:SurgicalInnovationAssociatesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i28c09119df4d46479f028692c5abc6c9_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:SurgicalInnovationAssociatesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iebe056bf287c49189659a150fa4bb005_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie94f070e4ad14a71bbd6d5a287488485_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic5212f8a1bee4dc6ba5f12945bceefac_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:DermaSciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5b996d3591a14f7b8ad05792e133d08b_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ACellMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i76cdb8918dd040ca80187c0cd9780d22_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:SurgicalInnovationAssociatesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4a2f319447e54f4da01d7985e4319c02_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:SurgicalInnovationAssociatesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibc5039e063bb4575a7f706baf7647a99_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3a5ab664d800458296dd51aa0092a73a_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifbf2b5d3f97042bdbb5011c85b4e62ff_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:DermaSciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifda9aebeb4fc4e828e24ac81907aa5d7_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ACellMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic6f8fb897f9041c8ba230423d37c9561_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:SurgicalInnovationAssociatesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i04a72655453e4dc799f5272ab6e4c43f_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:SurgicalInnovationAssociatesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i03382ae93c3949428c4641c300c15cf5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i63bd28aa464048d382efdc354e8d30ef_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if1f1f28f2ace4bbebc59d26841e82a9c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:DermaSciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id31fe52cb24f4c5d8a546c61e9306f16_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ACellMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ida5433fc38b34f3d80d99d0b3ae06943_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ACellMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7ad7e73cd2384933bcc0486859965b91_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8d4ac64501714cd8b27e0d99a3bc50f1_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i744d6e80b2d2438caf54348f35691d3c_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:DermaSciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2dff9a5632b143f6bcc0a2d0430fc736_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ACellMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i57a65d2fe6b445379851b358047cd045_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ACellMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i57d1bb45844549318bf527ab1d455e38_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i26ba6bc78b3a4d95b2893e8f8c7ad8a8_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i843804a3b389484b948c99a44059b0c4_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:DermaSciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if2bb2185bf654d9fa8253aa6e70cdc7a_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ACellMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4ac142c72a864f468e0436fe327c0980_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ACellMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5d9c6f2f864e40aea1985e58d5f1a41e_I20190729"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-07-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifbe9986f6bcd4de881c523419a2fb725_I20190729"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">iart:MilestonePaymentOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-07-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id780b85560324a2b8af98ff6056e8d1f_I20190729"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">iart:MilestonePaymentTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-07-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaba62da9aab3440ab34c023a05b0b605_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i28c3ebc588a3437abfe6a86e8e38ae70_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia93dbf54c16a4910aa3b24636e104e30_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">iart:AccruedExpensesAndOtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i03c41c6e3db74ceab9f18b88621af236_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">iart:AccruedExpensesAndOtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5b8b02acfe4a4006ba624b2aa4272aa9_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">iart:BioDEarnoutPaymentsandMedihoneyEarnoutPaymentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:DermaSciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i86b0bf361fcc48fcb96359b69ccfd113_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:DermaSciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="liability"><xbrli:measure>iart:liability</xbrli:measure></xbrli:unit><xbrli:context id="i1a0930d1120745c0909b0d6a10d930ff_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:DermaSciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i51cb03d8a5ea47b9bf04b0cbd6cd4e2e_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:DermaSciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id9e1f135607c446e87244607e8e7fb74_I20210120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ACellIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-01-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i52c4ec9dcdbe44349b2eb5a85c04baae_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ACellIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic09564d0848d46c79b0dbcb1d9f96df9_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ACellIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i5f1eb1bd01d541c3aa0777712077c048_1"></div><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">WASHINGTON, DC 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xL2ZyYWc6ZGUzM2JhODhmNTZjNGIxZDhjNzMzZTQyYWE2N2ZhZmEvdGV4dHJlZ2lvbjpkZTMzYmE4OGY1NmM0YjFkOGM3MzNlNDJhYTY3ZmFmYV8yMDc2_807614df-8d77-46c7-9824-cfa665276cc6">10-Q</ix:nonNumeric> </span></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(Mark One)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.756%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.044%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" name="dei:DocumentQuarterlyReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xL2ZyYWc6ZGUzM2JhODhmNTZjNGIxZDhjNzMzZTQyYWE2N2ZhZmEvdGFibGU6NTEwZjUzMDUzN2U3NDdhYjkyNmIzMzdhZDAxOTUzODgvdGFibGVyYW5nZTo1MTBmNTMwNTM3ZTc0N2FiOTI2YjMzN2FkMDE5NTM4OF8wLTAtMS0xLTE4NjgyMQ_cb97ad3e-60b8-47a2-82d5-036f93835091">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">For the quarterly period ended March&#160;31, 2023</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">or</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.756%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.044%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" name="dei:DocumentTransitionReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xL2ZyYWc6ZGUzM2JhODhmNTZjNGIxZDhjNzMzZTQyYWE2N2ZhZmEvdGFibGU6MGU5OWYzMTQ5MzAxNDMzZmI3NGQ0MWFkMGJhZDM2MzYvdGFibGVyYW5nZTowZTk5ZjMxNDkzMDE0MzNmYjc0ZDQxYWQwYmFkMzYzNl8wLTAtMS0xLTE4NjgyMQ_91f7c819-40b6-4112-953d-b2d26e359af0">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">For the transition period from &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; to &#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">COMMISSION FILE NO. <ix:nonNumeric contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xL2ZyYWc6ZGUzM2JhODhmNTZjNGIxZDhjNzMzZTQyYWE2N2ZhZmEvdGV4dHJlZ2lvbjpkZTMzYmE4OGY1NmM0YjFkOGM3MzNlNDJhYTY3ZmFmYV8yMDcy_832d0ac9-471a-4972-9876-bca450966a68">000-26224</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xL2ZyYWc6ZGUzM2JhODhmNTZjNGIxZDhjNzMzZTQyYWE2N2ZhZmEvdGV4dHJlZ2lvbjpkZTMzYmE4OGY1NmM0YjFkOGM3MzNlNDJhYTY3ZmFmYV8yMDc3_0bdd231a-5f5e-4656-a16e-b3199a27009c">INTEGRA LIFESCIENCES HOLDINGS CORP</ix:nonNumeric>ORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.391%"><tr><td style="width:1.0%"></td><td style="width:22.228%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.137%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.417%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.326%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.192%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xL2ZyYWc6ZGUzM2JhODhmNTZjNGIxZDhjNzMzZTQyYWE2N2ZhZmEvdGFibGU6ZGJkY2NkODliMDJjNGE4NmIyNjRmZTY1ZGQxODlmZjEvdGFibGVyYW5nZTpkYmRjY2Q4OWIwMmM0YTg2YjI2NGZlNjVkZDE4OWZmMV8wLTAtMS0xLTE4NjgyMQ_11c06cea-3647-460d-b18f-56fba00f0612">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xL2ZyYWc6ZGUzM2JhODhmNTZjNGIxZDhjNzMzZTQyYWE2N2ZhZmEvdGFibGU6ZGJkY2NkODliMDJjNGE4NmIyNjRmZTY1ZGQxODlmZjEvdGFibGVyYW5nZTpkYmRjY2Q4OWIwMmM0YTg2YjI2NGZlNjVkZDE4OWZmMV8wLTQtMS0xLTE4NjgyMQ_f1d0adeb-dd2a-4624-b8ec-c4af808aabda">51-0317849</ix:nonNumeric></span></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(STATE OR OTHER JURISDICTION OF<br/>INCORPORATION OR ORGANIZATION)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(I.R.S. EMPLOYER<br/>IDENTIFICATION NO.)</span></td></tr><tr style="height:15pt"><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xL2ZyYWc6ZGUzM2JhODhmNTZjNGIxZDhjNzMzZTQyYWE2N2ZhZmEvdGFibGU6ZGJkY2NkODliMDJjNGE4NmIyNjRmZTY1ZGQxODlmZjEvdGFibGVyYW5nZTpkYmRjY2Q4OWIwMmM0YTg2YjI2NGZlNjVkZDE4OWZmMV8zLTAtMS0xLTE4NjgyMQ_dddb6037-fec3-40cb-a85a-9cb75b7f3f26">1100 Campus Road</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xL2ZyYWc6ZGUzM2JhODhmNTZjNGIxZDhjNzMzZTQyYWE2N2ZhZmEvdGFibGU6ZGJkY2NkODliMDJjNGE4NmIyNjRmZTY1ZGQxODlmZjEvdGFibGVyYW5nZTpkYmRjY2Q4OWIwMmM0YTg2YjI2NGZlNjVkZDE4OWZmMV8zLTQtMS0xLTE4NjgyMQ_876dde7a-b5ce-4fc0-9ee4-1f6d2ff95c71">08540</ix:nonNumeric></span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xL2ZyYWc6ZGUzM2JhODhmNTZjNGIxZDhjNzMzZTQyYWE2N2ZhZmEvdGFibGU6ZGJkY2NkODliMDJjNGE4NmIyNjRmZTY1ZGQxODlmZjEvdGFibGVyYW5nZTpkYmRjY2Q4OWIwMmM0YTg2YjI2NGZlNjVkZDE4OWZmMV80LTAtMS0xLTE4NjgyMQ_980c49df-4fe4-448f-b63a-cd09c3803182">Princeton</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">,</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xL2ZyYWc6ZGUzM2JhODhmNTZjNGIxZDhjNzMzZTQyYWE2N2ZhZmEvdGFibGU6ZGJkY2NkODliMDJjNGE4NmIyNjRmZTY1ZGQxODlmZjEvdGFibGVyYW5nZTpkYmRjY2Q4OWIwMmM0YTg2YjI2NGZlNjVkZDE4OWZmMV80LTItMS0xLTE4NjgyMQ_a7707718-5960-4b97-9fe4-b86bf9f83885">New Jersey</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(ZIP CODE)</span></td></tr><tr style="height:12pt"><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(ADDRESS OF PRINCIPAL EXECUTIVE OFFICES)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Registrant's Telephone Number, Including Area Code: (<ix:nonNumeric contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xL2ZyYWc6ZGUzM2JhODhmNTZjNGIxZDhjNzMzZTQyYWE2N2ZhZmEvdGV4dHJlZ2lvbjpkZTMzYmE4OGY1NmM0YjFkOGM3MzNlNDJhYTY3ZmFmYV8yMDcz_092a637d-395b-488a-ad73-6c40216701ac">609</ix:nonNumeric>)&#160;<ix:nonNumeric contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xL2ZyYWc6ZGUzM2JhODhmNTZjNGIxZDhjNzMzZTQyYWE2N2ZhZmEvdGV4dHJlZ2lvbjpkZTMzYmE4OGY1NmM0YjFkOGM3MzNlNDJhYTY3ZmFmYV8yMDc0_200d59eb-4dac-4ac8-b54b-46b5112d6f9e">275-0500</ix:nonNumeric> </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Former Name, Former Address and Former Fiscal Year, if Changed Since Last Report: </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:30.718%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.841%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.141%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">TITLE OF EACH CLASS</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">TRADING SYMBOL</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">NAME OF EACH EXCHANGE ON WHICH REGISTERED</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xL2ZyYWc6ZGUzM2JhODhmNTZjNGIxZDhjNzMzZTQyYWE2N2ZhZmEvdGFibGU6MGFlNTdhZWFmZGI3NDhkNmI0NGNmM2RjNDk4MjU0NmIvdGFibGVyYW5nZTowYWU1N2FlYWZkYjc0OGQ2YjQ0Y2YzZGM0OTgyNTQ2Yl8xLTAtMS0xLTE4NjgyMQ_4fbab122-b29c-4791-ab69-efa7634d627c">Common Stock, Par Value $.01 Per Share</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xL2ZyYWc6ZGUzM2JhODhmNTZjNGIxZDhjNzMzZTQyYWE2N2ZhZmEvdGFibGU6MGFlNTdhZWFmZGI3NDhkNmI0NGNmM2RjNDk4MjU0NmIvdGFibGVyYW5nZTowYWU1N2FlYWZkYjc0OGQ2YjQ0Y2YzZGM0OTgyNTQ2Yl8xLTEtMS0xLTE4NjgyMQ_a7648b75-857c-4fc7-92ba-1e3c09226fee">IART</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xL2ZyYWc6ZGUzM2JhODhmNTZjNGIxZDhjNzMzZTQyYWE2N2ZhZmEvdGFibGU6MGFlNTdhZWFmZGI3NDhkNmI0NGNmM2RjNDk4MjU0NmIvdGFibGVyYW5nZTowYWU1N2FlYWZkYjc0OGQ2YjQ0Y2YzZGM0OTgyNTQ2Yl8xLTItMS0xLTE4NjgyMQ_62af41d0-3d35-4b1c-934f-47ac5e0822ad">Nasdaq Global Select Market</ix:nonNumeric></span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. &#160;&#160;&#160;<ix:nonNumeric contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xL2ZyYWc6ZGUzM2JhODhmNTZjNGIxZDhjNzMzZTQyYWE2N2ZhZmEvdGV4dHJlZ2lvbjpkZTMzYmE4OGY1NmM0YjFkOGM3MzNlNDJhYTY3ZmFmYV8yMDc4_2eb50966-8d7c-4b70-8fea-b23b06ad5f04">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). &#160;&#160;<ix:nonNumeric contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xL2ZyYWc6ZGUzM2JhODhmNTZjNGIxZDhjNzMzZTQyYWE2N2ZhZmEvdGV4dHJlZ2lvbjpkZTMzYmE4OGY1NmM0YjFkOGM3MzNlNDJhYTY3ZmFmYV8yMDcx_152e2554-6e8d-40d7-94d3-9a51551143ad">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of large accelerated filer, accelerated filer, smaller reporting company, and "emerging growth company" in Rule 12b-2 of the Exchange Act. </span></div><div><span><br/></span></div><div style="margin-top:9pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:23.936%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.008%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.733%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xL2ZyYWc6ZGUzM2JhODhmNTZjNGIxZDhjNzMzZTQyYWE2N2ZhZmEvdGFibGU6ZWRjOWYwOWZjYWMzNGI5ZmI3ZjY3MjQxOTg5Mzk1NTEvdGFibGVyYW5nZTplZGM5ZjA5ZmNhYzM0YjlmYjdmNjcyNDE5ODkzOTU1MV8wLTAtMS0xLTE4NjgyMQ_0aeaa668-a549-40ff-bf6f-b7009f7622e3">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9746;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accelerated&#160;filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Smaller&#160;reporting&#160;company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" name="dei:EntitySmallBusiness" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xL2ZyYWc6ZGUzM2JhODhmNTZjNGIxZDhjNzMzZTQyYWE2N2ZhZmEvdGFibGU6ZWRjOWYwOWZjYWMzNGI5ZmI3ZjY3MjQxOTg5Mzk1NTEvdGFibGVyYW5nZTplZGM5ZjA5ZmNhYzM0YjlmYjdmNjcyNDE5ODkzOTU1MV8yLTMtMS0xLTE4NjgyMQ_063c1788-d0ad-41a9-bfea-442ccf8ff0bd">&#9744;</ix:nonNumeric></span></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xL2ZyYWc6ZGUzM2JhODhmNTZjNGIxZDhjNzMzZTQyYWE2N2ZhZmEvdGFibGU6ZWRjOWYwOWZjYWMzNGI5ZmI3ZjY3MjQxOTg5Mzk1NTEvdGFibGVyYW5nZTplZGM5ZjA5ZmNhYzM0YjlmYjdmNjcyNDE5ODkzOTU1MV80LTEtMS0xLTE4NjgyMQ_117e69cc-d9fc-450f-ab1f-93115ba7f9a2">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).&#160;&#160;&#160;&#160;Yes&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" name="dei:EntityShellCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xL2ZyYWc6ZGUzM2JhODhmNTZjNGIxZDhjNzMzZTQyYWE2N2ZhZmEvdGV4dHJlZ2lvbjpkZTMzYmE4OGY1NmM0YjFkOGM3MzNlNDJhYTY3ZmFmYV8yMDc1_478ce679-31a2-4a49-96de-02914d69b393">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The number of shares of the registrant&#8217;s Common Stock, $0.01 par value, outstanding as of April&#160;25, 2023 was <ix:nonFraction unitRef="shares" contextRef="i9d6e2966991d4fe6b8a46d9c30f8b61d_I20230425" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xL2ZyYWc6ZGUzM2JhODhmNTZjNGIxZDhjNzMzZTQyYWE2N2ZhZmEvdGV4dHJlZ2lvbjpkZTMzYmE4OGY1NmM0YjFkOGM3MzNlNDJhYTY3ZmFmYV8yMDY5_1c7445a5-9ff0-4f45-821a-c3a744efb9f8">81,904,442</ix:nonFraction>.</span></div><div id="i5f1eb1bd01d541c3aa0777712077c048_7"></div><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i5f1eb1bd01d541c3aa0777712077c048_7">Table of Contents</a></span></div></div><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INDEX</span></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:87.584%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.216%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Page<br/>Number</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5f1eb1bd01d541c3aa0777712077c048_10">PART&#160;I.&#160;FINANCIAL&#160;INFORMATION</a></span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5f1eb1bd01d541c3aa0777712077c048_13">Item&#160;1. Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5f1eb1bd01d541c3aa0777712077c048_13">4</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5f1eb1bd01d541c3aa0777712077c048_16">Condensed Consolidated Statements of Operations and Comprehensive Income for the three months ended March 31, 202</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5f1eb1bd01d541c3aa0777712077c048_16">3</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5f1eb1bd01d541c3aa0777712077c048_16"> and 202</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5f1eb1bd01d541c3aa0777712077c048_16">2</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5f1eb1bd01d541c3aa0777712077c048_16"> (Unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5f1eb1bd01d541c3aa0777712077c048_16">4</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5f1eb1bd01d541c3aa0777712077c048_22">Condensed Consolidated Balance Sheets as of March 31, 202</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5f1eb1bd01d541c3aa0777712077c048_22">3</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5f1eb1bd01d541c3aa0777712077c048_22"> and December 31, 202</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5f1eb1bd01d541c3aa0777712077c048_22">2</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5f1eb1bd01d541c3aa0777712077c048_22"> (Unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5f1eb1bd01d541c3aa0777712077c048_19">5</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5f1eb1bd01d541c3aa0777712077c048_25">Condensed Consolidated Statements of Cash Flows for the three months ended March 31, 202</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5f1eb1bd01d541c3aa0777712077c048_25">3</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5f1eb1bd01d541c3aa0777712077c048_25"> and 202</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5f1eb1bd01d541c3aa0777712077c048_25">2</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5f1eb1bd01d541c3aa0777712077c048_25"> (Unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5f1eb1bd01d541c3aa0777712077c048_25">6</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5f1eb1bd01d541c3aa0777712077c048_28">Condensed Consolidated Statements of Changes in Shareholders' Equity for the three months ended March 31, 202</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5f1eb1bd01d541c3aa0777712077c048_28">3</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5f1eb1bd01d541c3aa0777712077c048_28"> and 202</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5f1eb1bd01d541c3aa0777712077c048_28">2</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5f1eb1bd01d541c3aa0777712077c048_28"> (Unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5f1eb1bd01d541c3aa0777712077c048_28">7</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5f1eb1bd01d541c3aa0777712077c048_31">Notes to Unaudited Condensed Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5f1eb1bd01d541c3aa0777712077c048_31">8</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5f1eb1bd01d541c3aa0777712077c048_88">Item&#160;2. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5f1eb1bd01d541c3aa0777712077c048_88">30</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5f1eb1bd01d541c3aa0777712077c048_112">Item&#160;3. Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5f1eb1bd01d541c3aa0777712077c048_112">40</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5f1eb1bd01d541c3aa0777712077c048_115">Item&#160;4. Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5f1eb1bd01d541c3aa0777712077c048_115">40</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5f1eb1bd01d541c3aa0777712077c048_118">PART II. OTHER INFORMATION</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5f1eb1bd01d541c3aa0777712077c048_121">Item&#160;1. Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5f1eb1bd01d541c3aa0777712077c048_121">41</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5f1eb1bd01d541c3aa0777712077c048_124">Item&#160;1A. Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5f1eb1bd01d541c3aa0777712077c048_124">41</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5f1eb1bd01d541c3aa0777712077c048_127">Item&#160;2. Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5f1eb1bd01d541c3aa0777712077c048_127">41</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5f1eb1bd01d541c3aa0777712077c048_130">Item&#160;4. Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5f1eb1bd01d541c3aa0777712077c048_130">41</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5f1eb1bd01d541c3aa0777712077c048_133">Item 5. Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5f1eb1bd01d541c3aa0777712077c048_133">41</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5f1eb1bd01d541c3aa0777712077c048_136">Item&#160;6. Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5f1eb1bd01d541c3aa0777712077c048_136">42</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5f1eb1bd01d541c3aa0777712077c048_139">SIGNATURES</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5f1eb1bd01d541c3aa0777712077c048_139">44</a></span></div></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i5f1eb1bd01d541c3aa0777712077c048_10"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i5f1eb1bd01d541c3aa0777712077c048_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I. FINANCIAL INFORMATION</span></div><div><span><br/></span></div><div id="i5f1eb1bd01d541c3aa0777712077c048_13"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1. Financial Statements</span></div><div><span><br/></span></div><div id="i5f1eb1bd01d541c3aa0777712077c048_16"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AND COMPREHENSIVE INCOME</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div><div style="margin-bottom:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Dollars in thousands, except per share amounts)</span></div><div style="margin-bottom:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total revenue, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xNi9mcmFnOjc1OTNhNzRmMzFkMDQ5YjliNDY0ZTMyMTQwMDI5MzAyL3RhYmxlOjlmM2VjZTc1N2VlYTRmMzNiYTk0Nzc4NDllYjNmZWM0L3RhYmxlcmFuZ2U6OWYzZWNlNzU3ZWVhNGYzM2JhOTQ3Nzg0OWViM2ZlYzRfMi0xLTEtMS0xODY4MjE_fcd18600-9b20-4604-abff-7e3da8ada507">380,846</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xNi9mcmFnOjc1OTNhNzRmMzFkMDQ5YjliNDY0ZTMyMTQwMDI5MzAyL3RhYmxlOjlmM2VjZTc1N2VlYTRmMzNiYTk0Nzc4NDllYjNmZWM0L3RhYmxlcmFuZ2U6OWYzZWNlNzU3ZWVhNGYzM2JhOTQ3Nzg0OWViM2ZlYzRfMi0zLTEtMS0xODY4MjE_ba1b1aab-8757-475d-b9ea-23e7e83a0a10">376,638</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Costs and expenses:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of goods sold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xNi9mcmFnOjc1OTNhNzRmMzFkMDQ5YjliNDY0ZTMyMTQwMDI5MzAyL3RhYmxlOjlmM2VjZTc1N2VlYTRmMzNiYTk0Nzc4NDllYjNmZWM0L3RhYmxlcmFuZ2U6OWYzZWNlNzU3ZWVhNGYzM2JhOTQ3Nzg0OWViM2ZlYzRfNS0xLTEtMS0xODY4MjE_9d3832ab-0dd8-4527-9869-358fc9cd21b3">147,975</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xNi9mcmFnOjc1OTNhNzRmMzFkMDQ5YjliNDY0ZTMyMTQwMDI5MzAyL3RhYmxlOjlmM2VjZTc1N2VlYTRmMzNiYTk0Nzc4NDllYjNmZWM0L3RhYmxlcmFuZ2U6OWYzZWNlNzU3ZWVhNGYzM2JhOTQ3Nzg0OWViM2ZlYzRfNS0zLTEtMS0xODY4MjE_71f0a599-700e-4a03-b472-6d59b3fbd70f">142,569</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xNi9mcmFnOjc1OTNhNzRmMzFkMDQ5YjliNDY0ZTMyMTQwMDI5MzAyL3RhYmxlOjlmM2VjZTc1N2VlYTRmMzNiYTk0Nzc4NDllYjNmZWM0L3RhYmxlcmFuZ2U6OWYzZWNlNzU3ZWVhNGYzM2JhOTQ3Nzg0OWViM2ZlYzRfNi0xLTEtMS0xODY4MjE_fd677d7d-4169-480d-a43e-83361dd72141">26,724</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xNi9mcmFnOjc1OTNhNzRmMzFkMDQ5YjliNDY0ZTMyMTQwMDI5MzAyL3RhYmxlOjlmM2VjZTc1N2VlYTRmMzNiYTk0Nzc4NDllYjNmZWM0L3RhYmxlcmFuZ2U6OWYzZWNlNzU3ZWVhNGYzM2JhOTQ3Nzg0OWViM2ZlYzRfNi0zLTEtMS0xODY4MjE_5e06bee5-cfbd-4640-b6ff-0170135b7ff5">24,085</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xNi9mcmFnOjc1OTNhNzRmMzFkMDQ5YjliNDY0ZTMyMTQwMDI5MzAyL3RhYmxlOjlmM2VjZTc1N2VlYTRmMzNiYTk0Nzc4NDllYjNmZWM0L3RhYmxlcmFuZ2U6OWYzZWNlNzU3ZWVhNGYzM2JhOTQ3Nzg0OWViM2ZlYzRfNy0xLTEtMS0xODY4MjE_6985d2bb-a23b-450f-8c3a-38b423048306">166,657</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xNi9mcmFnOjc1OTNhNzRmMzFkMDQ5YjliNDY0ZTMyMTQwMDI5MzAyL3RhYmxlOjlmM2VjZTc1N2VlYTRmMzNiYTk0Nzc4NDllYjNmZWM0L3RhYmxlcmFuZ2U6OWYzZWNlNzU3ZWVhNGYzM2JhOTQ3Nzg0OWViM2ZlYzRfNy0zLTEtMS0xODY4MjE_0f52e3cd-4fec-498d-8c41-b4f0d00686ec">159,926</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible asset amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xNi9mcmFnOjc1OTNhNzRmMzFkMDQ5YjliNDY0ZTMyMTQwMDI5MzAyL3RhYmxlOjlmM2VjZTc1N2VlYTRmMzNiYTk0Nzc4NDllYjNmZWM0L3RhYmxlcmFuZ2U6OWYzZWNlNzU3ZWVhNGYzM2JhOTQ3Nzg0OWViM2ZlYzRfOC0xLTEtMS0xODY4MjE_eec168f4-d4b2-4d6f-96b4-06eebe7085fd">3,108</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xNi9mcmFnOjc1OTNhNzRmMzFkMDQ5YjliNDY0ZTMyMTQwMDI5MzAyL3RhYmxlOjlmM2VjZTc1N2VlYTRmMzNiYTk0Nzc4NDllYjNmZWM0L3RhYmxlcmFuZ2U6OWYzZWNlNzU3ZWVhNGYzM2JhOTQ3Nzg0OWViM2ZlYzRfOC0zLTEtMS0xODY4MjE_20d732a3-f760-4668-a24c-da8668ed9833">3,894</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total costs and expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xNi9mcmFnOjc1OTNhNzRmMzFkMDQ5YjliNDY0ZTMyMTQwMDI5MzAyL3RhYmxlOjlmM2VjZTc1N2VlYTRmMzNiYTk0Nzc4NDllYjNmZWM0L3RhYmxlcmFuZ2U6OWYzZWNlNzU3ZWVhNGYzM2JhOTQ3Nzg0OWViM2ZlYzRfOS0xLTEtMS0xODY4MjE_565c249c-c210-44b7-a3b4-ab7de11292af">344,464</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xNi9mcmFnOjc1OTNhNzRmMzFkMDQ5YjliNDY0ZTMyMTQwMDI5MzAyL3RhYmxlOjlmM2VjZTc1N2VlYTRmMzNiYTk0Nzc4NDllYjNmZWM0L3RhYmxlcmFuZ2U6OWYzZWNlNzU3ZWVhNGYzM2JhOTQ3Nzg0OWViM2ZlYzRfOS0zLTEtMS0xODY4MjE_a189b0d0-0314-4176-9640-91dbac02f9f9">330,474</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xNi9mcmFnOjc1OTNhNzRmMzFkMDQ5YjliNDY0ZTMyMTQwMDI5MzAyL3RhYmxlOjlmM2VjZTc1N2VlYTRmMzNiYTk0Nzc4NDllYjNmZWM0L3RhYmxlcmFuZ2U6OWYzZWNlNzU3ZWVhNGYzM2JhOTQ3Nzg0OWViM2ZlYzRfMTAtMS0xLTEtMTg2ODIx_7c9920f5-663a-461d-9f63-0735ec83da4f">36,382</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xNi9mcmFnOjc1OTNhNzRmMzFkMDQ5YjliNDY0ZTMyMTQwMDI5MzAyL3RhYmxlOjlmM2VjZTc1N2VlYTRmMzNiYTk0Nzc4NDllYjNmZWM0L3RhYmxlcmFuZ2U6OWYzZWNlNzU3ZWVhNGYzM2JhOTQ3Nzg0OWViM2ZlYzRfMTAtMy0xLTEtMTg2ODIx_4a6e2da6-3334-4e19-a833-5ca3e726b65e">46,164</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" decimals="-3" name="us-gaap:InvestmentIncomeInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xNi9mcmFnOjc1OTNhNzRmMzFkMDQ5YjliNDY0ZTMyMTQwMDI5MzAyL3RhYmxlOjlmM2VjZTc1N2VlYTRmMzNiYTk0Nzc4NDllYjNmZWM0L3RhYmxlcmFuZ2U6OWYzZWNlNzU3ZWVhNGYzM2JhOTQ3Nzg0OWViM2ZlYzRfMTEtMS0xLTEtMTg2ODIx_8ae08901-6ecf-453d-abd6-99713f4a6742">4,107</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331" decimals="-3" name="us-gaap:InvestmentIncomeInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xNi9mcmFnOjc1OTNhNzRmMzFkMDQ5YjliNDY0ZTMyMTQwMDI5MzAyL3RhYmxlOjlmM2VjZTc1N2VlYTRmMzNiYTk0Nzc4NDllYjNmZWM0L3RhYmxlcmFuZ2U6OWYzZWNlNzU3ZWVhNGYzM2JhOTQ3Nzg0OWViM2ZlYzRfMTEtMy0xLTEtMTg2ODIx_d5ff4f1a-3070-4ac5-b6ff-a3e65a57add2">1,377</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xNi9mcmFnOjc1OTNhNzRmMzFkMDQ5YjliNDY0ZTMyMTQwMDI5MzAyL3RhYmxlOjlmM2VjZTc1N2VlYTRmMzNiYTk0Nzc4NDllYjNmZWM0L3RhYmxlcmFuZ2U6OWYzZWNlNzU3ZWVhNGYzM2JhOTQ3Nzg0OWViM2ZlYzRfMTItMS0xLTEtMTg2ODIx_53ac4565-c128-42da-a453-bcc343701269">12,100</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xNi9mcmFnOjc1OTNhNzRmMzFkMDQ5YjliNDY0ZTMyMTQwMDI5MzAyL3RhYmxlOjlmM2VjZTc1N2VlYTRmMzNiYTk0Nzc4NDllYjNmZWM0L3RhYmxlcmFuZ2U6OWYzZWNlNzU3ZWVhNGYzM2JhOTQ3Nzg0OWViM2ZlYzRfMTItMy0xLTEtMTg2ODIx_986ed14c-a525-4850-87fc-88b201d6e77a">11,655</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xNi9mcmFnOjc1OTNhNzRmMzFkMDQ5YjliNDY0ZTMyMTQwMDI5MzAyL3RhYmxlOjlmM2VjZTc1N2VlYTRmMzNiYTk0Nzc4NDllYjNmZWM0L3RhYmxlcmFuZ2U6OWYzZWNlNzU3ZWVhNGYzM2JhOTQ3Nzg0OWViM2ZlYzRfMTQtMS0xLTEtMTg2ODIx_ceebe536-9f41-4631-ad9f-459a0f7a25f6">1,389</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xNi9mcmFnOjc1OTNhNzRmMzFkMDQ5YjliNDY0ZTMyMTQwMDI5MzAyL3RhYmxlOjlmM2VjZTc1N2VlYTRmMzNiYTk0Nzc4NDllYjNmZWM0L3RhYmxlcmFuZ2U6OWYzZWNlNzU3ZWVhNGYzM2JhOTQ3Nzg0OWViM2ZlYzRfMTQtMy0xLTEtMTg2ODIx_7992e67f-fad3-4696-98d7-f4e3efcdb3c0">3,429</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Income before income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xNi9mcmFnOjc1OTNhNzRmMzFkMDQ5YjliNDY0ZTMyMTQwMDI5MzAyL3RhYmxlOjlmM2VjZTc1N2VlYTRmMzNiYTk0Nzc4NDllYjNmZWM0L3RhYmxlcmFuZ2U6OWYzZWNlNzU3ZWVhNGYzM2JhOTQ3Nzg0OWViM2ZlYzRfMTUtMS0xLTEtMTg2ODIx_6d4a4d8b-9c2c-4193-8cf2-20c660e835c3">29,778</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xNi9mcmFnOjc1OTNhNzRmMzFkMDQ5YjliNDY0ZTMyMTQwMDI5MzAyL3RhYmxlOjlmM2VjZTc1N2VlYTRmMzNiYTk0Nzc4NDllYjNmZWM0L3RhYmxlcmFuZ2U6OWYzZWNlNzU3ZWVhNGYzM2JhOTQ3Nzg0OWViM2ZlYzRfMTUtMy0xLTEtMTg2ODIx_3c47b850-7871-40e5-96b7-2c747713284f">39,315</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xNi9mcmFnOjc1OTNhNzRmMzFkMDQ5YjliNDY0ZTMyMTQwMDI5MzAyL3RhYmxlOjlmM2VjZTc1N2VlYTRmMzNiYTk0Nzc4NDllYjNmZWM0L3RhYmxlcmFuZ2U6OWYzZWNlNzU3ZWVhNGYzM2JhOTQ3Nzg0OWViM2ZlYzRfMTYtMS0xLTEtMTg2ODIx_270cf846-94f1-4e4a-a36b-3bbf901924a0">5,552</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xNi9mcmFnOjc1OTNhNzRmMzFkMDQ5YjliNDY0ZTMyMTQwMDI5MzAyL3RhYmxlOjlmM2VjZTc1N2VlYTRmMzNiYTk0Nzc4NDllYjNmZWM0L3RhYmxlcmFuZ2U6OWYzZWNlNzU3ZWVhNGYzM2JhOTQ3Nzg0OWViM2ZlYzRfMTYtMy0xLTEtMTg2ODIx_3d22cd58-8194-48d1-a7e6-da592f0b4e13">6,414</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net income </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xNi9mcmFnOjc1OTNhNzRmMzFkMDQ5YjliNDY0ZTMyMTQwMDI5MzAyL3RhYmxlOjlmM2VjZTc1N2VlYTRmMzNiYTk0Nzc4NDllYjNmZWM0L3RhYmxlcmFuZ2U6OWYzZWNlNzU3ZWVhNGYzM2JhOTQ3Nzg0OWViM2ZlYzRfMTctMS0xLTEtMTg2ODIx_6cc18cff-506d-4fac-9073-8525c9af8405">24,226</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xNi9mcmFnOjc1OTNhNzRmMzFkMDQ5YjliNDY0ZTMyMTQwMDI5MzAyL3RhYmxlOjlmM2VjZTc1N2VlYTRmMzNiYTk0Nzc4NDllYjNmZWM0L3RhYmxlcmFuZ2U6OWYzZWNlNzU3ZWVhNGYzM2JhOTQ3Nzg0OWViM2ZlYzRfMTctMy0xLTEtMTg2ODIx_be9f118e-5b06-417f-a7c2-4a1d3e4ded5a">32,901</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net income per share</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xNi9mcmFnOjc1OTNhNzRmMzFkMDQ5YjliNDY0ZTMyMTQwMDI5MzAyL3RhYmxlOjlmM2VjZTc1N2VlYTRmMzNiYTk0Nzc4NDllYjNmZWM0L3RhYmxlcmFuZ2U6OWYzZWNlNzU3ZWVhNGYzM2JhOTQ3Nzg0OWViM2ZlYzRfMjAtMS0xLTEtMTg2ODIx_68b5aff7-a358-4d98-9bce-68dce14f75b2">0.30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xNi9mcmFnOjc1OTNhNzRmMzFkMDQ5YjliNDY0ZTMyMTQwMDI5MzAyL3RhYmxlOjlmM2VjZTc1N2VlYTRmMzNiYTk0Nzc4NDllYjNmZWM0L3RhYmxlcmFuZ2U6OWYzZWNlNzU3ZWVhNGYzM2JhOTQ3Nzg0OWViM2ZlYzRfMjAtMy0xLTEtMTg2ODIx_fc2a538e-0314-47ba-9ca5-7eabf9e688f4">0.39</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xNi9mcmFnOjc1OTNhNzRmMzFkMDQ5YjliNDY0ZTMyMTQwMDI5MzAyL3RhYmxlOjlmM2VjZTc1N2VlYTRmMzNiYTk0Nzc4NDllYjNmZWM0L3RhYmxlcmFuZ2U6OWYzZWNlNzU3ZWVhNGYzM2JhOTQ3Nzg0OWViM2ZlYzRfMjEtMS0xLTEtMTg2ODIx_bbcd90d0-d9cc-4edb-b716-aab81394db9a">0.29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xNi9mcmFnOjc1OTNhNzRmMzFkMDQ5YjliNDY0ZTMyMTQwMDI5MzAyL3RhYmxlOjlmM2VjZTc1N2VlYTRmMzNiYTk0Nzc4NDllYjNmZWM0L3RhYmxlcmFuZ2U6OWYzZWNlNzU3ZWVhNGYzM2JhOTQ3Nzg0OWViM2ZlYzRfMjEtMy0xLTEtMTg2ODIx_7f74969a-e23c-4971-b0c8-84ce3b4e2ecd">0.39</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted average common shares outstanding (See Note 13):</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xNi9mcmFnOjc1OTNhNzRmMzFkMDQ5YjliNDY0ZTMyMTQwMDI5MzAyL3RhYmxlOjlmM2VjZTc1N2VlYTRmMzNiYTk0Nzc4NDllYjNmZWM0L3RhYmxlcmFuZ2U6OWYzZWNlNzU3ZWVhNGYzM2JhOTQ3Nzg0OWViM2ZlYzRfMjQtMS0xLTEtMTg2ODIx_7cd35af2-d74f-421a-b9b9-aac858d1d0bf">81,871</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xNi9mcmFnOjc1OTNhNzRmMzFkMDQ5YjliNDY0ZTMyMTQwMDI5MzAyL3RhYmxlOjlmM2VjZTc1N2VlYTRmMzNiYTk0Nzc4NDllYjNmZWM0L3RhYmxlcmFuZ2U6OWYzZWNlNzU3ZWVhNGYzM2JhOTQ3Nzg0OWViM2ZlYzRfMjQtMy0xLTEtMTg2ODIx_52493370-e153-47f7-9c82-4fc488e1db36">83,632</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xNi9mcmFnOjc1OTNhNzRmMzFkMDQ5YjliNDY0ZTMyMTQwMDI5MzAyL3RhYmxlOjlmM2VjZTc1N2VlYTRmMzNiYTk0Nzc4NDllYjNmZWM0L3RhYmxlcmFuZ2U6OWYzZWNlNzU3ZWVhNGYzM2JhOTQ3Nzg0OWViM2ZlYzRfMjUtMS0xLTEtMTg2ODIx_7f168f21-956f-4052-b61b-df9c6bc74ce8">82,323</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xNi9mcmFnOjc1OTNhNzRmMzFkMDQ5YjliNDY0ZTMyMTQwMDI5MzAyL3RhYmxlOjlmM2VjZTc1N2VlYTRmMzNiYTk0Nzc4NDllYjNmZWM0L3RhYmxlcmFuZ2U6OWYzZWNlNzU3ZWVhNGYzM2JhOTQ3Nzg0OWViM2ZlYzRfMjUtMy0xLTEtMTg2ODIx_2d915101-d088-4c26-b975-9354d30aa7a9">84,276</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Comprehensive income (See Note 14)</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xNi9mcmFnOjc1OTNhNzRmMzFkMDQ5YjliNDY0ZTMyMTQwMDI5MzAyL3RhYmxlOjlmM2VjZTc1N2VlYTRmMzNiYTk0Nzc4NDllYjNmZWM0L3RhYmxlcmFuZ2U6OWYzZWNlNzU3ZWVhNGYzM2JhOTQ3Nzg0OWViM2ZlYzRfMjYtMS0xLTEtMTg2ODIx_4c8e3f33-8757-40a6-9e22-fcd38601b618">21,028</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xNi9mcmFnOjc1OTNhNzRmMzFkMDQ5YjliNDY0ZTMyMTQwMDI5MzAyL3RhYmxlOjlmM2VjZTc1N2VlYTRmMzNiYTk0Nzc4NDllYjNmZWM0L3RhYmxlcmFuZ2U6OWYzZWNlNzU3ZWVhNGYzM2JhOTQ3Nzg0OWViM2ZlYzRfMjYtMy0xLTEtMTg2ODIx_bcf54f0b-51c0-4f29-a1bd-360adf42b686">57,031</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="i5f1eb1bd01d541c3aa0777712077c048_19"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i5f1eb1bd01d541c3aa0777712077c048_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)</span></div><div style="margin-bottom:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Dollars in thousands, except per share amounts)</span></div><div style="margin-bottom:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.537%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.539%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMy0xLTEtMS0xODY4MjE_8776edeb-dba4-4998-b20b-bee49f30faef">307,367</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMy0zLTEtMS0xODY4MjE_5152eecd-53ca-4b0e-8057-f57c15f04ef8">456,661</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trade accounts receivable, net of allowances of $<ix:nonFraction unitRef="usd" contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfNC0wLTEtMS0xODY4MjEvdGV4dHJlZ2lvbjo3YWRkY2JiZWVjY2E0YmFjOGMzY2VhNWQ4MTA2MDIzZF81Mg_be7b55cc-cfea-4fc8-8d69-677cac5ba9c4">3,544</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfNC0wLTEtMS0xODY4MjEvdGV4dHJlZ2lvbjo3YWRkY2JiZWVjY2E0YmFjOGMzY2VhNWQ4MTA2MDIzZF81OQ_0c62f383-bc94-4b23-a463-e26b29d157a1">4,304</ix:nonFraction></span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfNC0xLTEtMS0xODY4MjE_deecbf8e-35cf-4479-a187-8c7a1e397188">253,995</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfNC0zLTEtMS0xODY4MjE_472279aa-79e6-40a0-95c5-c1e3a8c97577">263,465</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventories, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfNS0xLTEtMS0xODY4MjE_e2805340-46b7-4ffe-a349-820d073a8e8b">351,275</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfNS0zLTEtMS0xODY4MjE_2e51d810-cade-4234-8d39-8b072772dbbf">324,583</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfNi0xLTEtMS0xODY4MjE_9d024351-9b30-4cff-a7bd-30af9de8bcad">116,845</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfNi0zLTEtMS0xODY4MjE_4bd5b912-538f-4724-85f7-1b22bc854a0b">116,789</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfNy0xLTEtMS0xODY4MjE_f5c5ad2c-88f6-4f80-9e44-ea3411d447c6">1,029,482</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfNy0zLTEtMS0xODY4MjE_4fca8052-02f0-4ad8-962c-66624a137f21">1,161,498</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfOC0xLTEtMS0xODY4MjE_df79f148-3d1f-4fcd-919b-bdfc127872b9">315,175</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfOC0zLTEtMS0xODY4MjE_91835406-9997-41e1-ab68-2f3661a75cad">311,302</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Right of use asset - operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfOS0xLTEtMS0xODY4MjE_671bcbaa-bef4-4e2c-9c75-1f8c3c6d1b60">146,514</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfOS0zLTEtMS0xODY4MjE_02aaf061-585c-493d-a83b-af69af2af208">148,284</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMTAtMS0xLTEtMTg2ODIx_f20a0203-015a-4f9e-9f4e-69345f1a5a6b">1,108,759</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMTAtMy0xLTEtMTg2ODIx_72ebef04-0ee8-4c6b-8585-8cf9a56fb1af">1,126,609</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMTEtMS0xLTEtMTg2ODIx_22ee83bb-abd1-4409-a68c-f4a8113f0c5d">1,041,606</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMTEtMy0xLTEtMTg2ODIx_19a25be0-5432-4184-b66e-1708fb8f1d0e">1,038,881</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331" decimals="-3" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMTItMS0xLTEtMTg2ODIx_e66ce578-7984-4dad-a2ee-a173de963a38">44,680</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231" decimals="-3" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMTItMy0xLTEtMTg2ODIx_b9a8740e-5819-40ca-b597-e1648890695f">45,994</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMTMtMS0xLTEtMTg2ODIx_f58bfd47-53f8-487a-a29b-5fe33e45c08f">56,183</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMTMtMy0xLTEtMTg2ODIx_66e9fceb-2c4a-4d29-8175-bb2467e21842">57,190</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMTQtMS0xLTEtMTg2ODIx_39380f6e-7ea1-496e-8be7-42452e689ef6">3,742,399</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMTQtMy0xLTEtMTg2ODIx_e07730fe-d76c-4bd1-9610-5441da21c1e7">3,889,758</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current portion of borrowings under senior credit facility</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331" decimals="-3" name="us-gaap:SecuredDebtCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMTctMS0xLTEtMTg2ODIx_e4b36da7-ba4c-49bd-83d9-ba82a8586d0c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231" decimals="-3" name="us-gaap:SecuredDebtCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMTctMy0xLTEtMTg2ODIx_b8461577-9a69-4166-8d5a-c2ee39c7441a">38,125</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current portion of lease liability - operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMTgtMS0xLTEtMTg2ODIx_ef5cb82b-805d-4bb7-bb32-3ebb2aece2d3">14,792</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMTgtMy0xLTEtMTg2ODIx_5c0001ef-bce6-487d-8a92-927eafb0cd1c">14,624</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable, trade</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331" decimals="-3" name="us-gaap:AccountsPayableTradeCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMTktMS0xLTEtMTg2ODIx_65b048e0-2d3f-4d50-bd92-e6b24b63f49d">112,785</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231" decimals="-3" name="us-gaap:AccountsPayableTradeCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMTktMy0xLTEtMTg2ODIx_e1cbc470-2f14-4431-b627-d02d3e37e7ed">102,100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contract liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMjAtMS0xLTEtMTg2ODIx_65ce2192-872d-43c6-8cde-0dbafa2f7711">7,743</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMjAtMy0xLTEtMTg2ODIx_f6060f6f-9fba-477a-bd6b-cb690f5e1d39">7,253</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMjEtMS0xLTEtMTg2ODIx_f555536f-6977-4b9e-af8d-d2fd30a77db0">53,611</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMjEtMy0xLTEtMTg2ODIx_afdc402c-3312-48c7-bcf7-4af9e4b1112f">78,771</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMjItMS0xLTEtMTg2ODIx_da7dafd7-d836-4410-a73e-e7897b03ae68">93,362</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMjItMy0xLTEtMTg2ODIx_45ec3811-d0ed-4dac-a55b-8a044ad140e5">80,033</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMjMtMS0xLTEtMTg2ODIx_c4945710-1c4e-436e-ac96-887d891c2a4c">282,293</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMjMtMy0xLTEtMTg2ODIx_a580cf97-5fe0-4f8e-9994-2bed31362d5d">320,906</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term borrowings under senior credit facility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331" decimals="-3" name="us-gaap:SecuredLongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMjQtMS0xLTEtMTg2ODIx_3748f0d6-143c-4912-8efc-29dd379feb9d">769,143</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231" decimals="-3" name="us-gaap:SecuredLongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMjQtMy0xLTEtMTg2ODIx_41933348-43ac-4bd3-b753-297368d28efb">733,149</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term borrowings under securitization facility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331" decimals="-3" name="iart:SecuredLongTermDebtSecuritizationProgramNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMjUtMS0xLTEtMTg2ODIx_fd9bdf9f-4f7e-457a-8d16-c314d1a6a819">102,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231" decimals="-3" name="iart:SecuredLongTermDebtSecuritizationProgramNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMjUtMy0xLTEtMTg2ODIx_e5d41deb-5a9b-4053-b198-eb3359ecf045">104,700</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term convertible securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331" decimals="-3" name="us-gaap:ConvertibleDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMjYtMS0xLTEtMTg2ODIx_7c1ec781-ffdd-48fd-928b-7ff9b7782c2b">568,069</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231" decimals="-3" name="us-gaap:ConvertibleDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMjYtMy0xLTEtMTg2ODIx_b720e0c1-47f5-4d3f-b036-768e60753f45">567,341</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Lease liability - operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMjctMS0xLTEtMTg2ODIx_f61678ae-d4ba-42c8-a078-8336f0160378">156,910</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMjctMy0xLTEtMTg2ODIx_029e0d0f-58f5-4154-aa25-f939e19dba21">157,420</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMjgtMS0xLTEtMTg2ODIx_fecf4281-6b50-4c00-936b-bbd7fc2a91e7">61,693</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMjgtMy0xLTEtMTg2ODIx_cbf35baa-fce8-4008-bacb-174658f560be">63,338</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMjktMS0xLTEtMTg2ODIx_302d1a46-d180-4b9b-b5ba-f51a457746b4">126,853</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMjktMy0xLTEtMTg2ODIx_152856d7-ae80-4d67-8f40-b30601b71d5f">138,501</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMzAtMS0xLTEtMTg2ODIx_f719cca5-cf3a-425f-a16d-3b17705ca64a">2,067,461</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMzAtMy0xLTEtMTg2ODIx_dd8637ff-0231-4d45-8e10-90df1ad737b0">2,085,355</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stockholders&#8217; equity:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Preferred stock; <ix:nonFraction unitRef="usdPerShare" contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMzItMC0xLTEtMTg2ODIxL3RleHRyZWdpb246ODU4ZTU2ZDY1MGJmNDc2YmJiODM2M2VlMjc0MTlmMjJfMjE_0a09cb4c-e3b0-430c-a009-844940411f96"><ix:nonFraction unitRef="usdPerShare" contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMzItMC0xLTEtMTg2ODIxL3RleHRyZWdpb246ODU4ZTU2ZDY1MGJmNDc2YmJiODM2M2VlMjc0MTlmMjJfMjE_c5320404-beb0-4a1a-af13-130ecb310379">no</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction unitRef="shares" contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMzItMC0xLTEtMTg2ODIxL3RleHRyZWdpb246ODU4ZTU2ZDY1MGJmNDc2YmJiODM2M2VlMjc0MTlmMjJfMzU_8455fcac-2f4f-4949-9e49-90ed08dbf791"><ix:nonFraction unitRef="shares" contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMzItMC0xLTEtMTg2ODIxL3RleHRyZWdpb246ODU4ZTU2ZDY1MGJmNDc2YmJiODM2M2VlMjc0MTlmMjJfMzU_e8f2e9ab-9e39-49b4-8a49-f32d8cd1dbc9">15,000</ix:nonFraction></ix:nonFraction> authorized shares; <ix:nonFraction unitRef="shares" contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMzItMC0xLTEtMTg2ODIxL3RleHRyZWdpb246ODU4ZTU2ZDY1MGJmNDc2YmJiODM2M2VlMjc0MTlmMjJfNTc_712022d9-4ea0-4621-a7c1-5a93f089001d"><ix:nonFraction unitRef="shares" contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMzItMC0xLTEtMTg2ODIxL3RleHRyZWdpb246ODU4ZTU2ZDY1MGJmNDc2YmJiODM2M2VlMjc0MTlmMjJfNTc_ced7ab21-4fc0-4fcd-9fad-6fbd03615d83">none</ix:nonFraction></ix:nonFraction> outstanding</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMzItMS0xLTEtMTg2ODIx_7cfedd20-c8c8-40f8-8d43-52ceec611f75">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMzItMy0xLTEtMTg2ODIx_d6faa034-c695-4de7-9244-d69bce9da387">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock; $<ix:nonFraction unitRef="usdPerShare" contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMzMtMC0xLTEtMTg2ODIxL3RleHRyZWdpb246MDI0MzJmYmY1ZDExNGM4OWEwNGVkNmZlNWM3NzA3NGJfMTg_040d8ceb-3fc1-4535-b265-3d4a7f226c36"><ix:nonFraction unitRef="usdPerShare" contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMzMtMC0xLTEtMTg2ODIxL3RleHRyZWdpb246MDI0MzJmYmY1ZDExNGM4OWEwNGVkNmZlNWM3NzA3NGJfMTg_20b0c789-ab6a-4f7b-99b5-578188aed9e7">0.01</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction unitRef="shares" contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMzMtMC0xLTEtMTg2ODIxL3RleHRyZWdpb246MDI0MzJmYmY1ZDExNGM4OWEwNGVkNmZlNWM3NzA3NGJfMzI_7acd5135-f00c-4953-9939-52c7914b8268"><ix:nonFraction unitRef="shares" contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMzMtMC0xLTEtMTg2ODIxL3RleHRyZWdpb246MDI0MzJmYmY1ZDExNGM4OWEwNGVkNmZlNWM3NzA3NGJfMzI_857cae0c-910d-4cf0-a11d-88992c3f6032">240,000</ix:nonFraction></ix:nonFraction> authorized shares; <ix:nonFraction unitRef="shares" contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMzMtMC0xLTEtMTg2ODIxL3RleHRyZWdpb246MDI0MzJmYmY1ZDExNGM4OWEwNGVkNmZlNWM3NzA3NGJfNTQ_2099c5b2-d499-4921-85a7-70de5edae001">90,813</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMzMtMC0xLTEtMTg2ODIxL3RleHRyZWdpb246MDI0MzJmYmY1ZDExNGM4OWEwNGVkNmZlNWM3NzA3NGJfNjE_1a5c72ea-dcb0-4a2e-9cb3-0e26f86aa71b">90,477</ix:nonFraction> issued at March&#160;31, 2023 and December&#160;31, 2022, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMzMtMS0xLTEtMTg2ODIx_b3063621-baf7-4f59-bd40-292d5ea2c0e6">908</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMzMtMy0xLTEtMTg2ODIx_2e8e03b7-67d3-4ac5-887b-fe9fd45b4a3d">905</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMzQtMS0xLTEtMTg2ODIx_c092c433-5243-4aa7-b73d-2b787dde7e19">1,245,297</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMzQtMy0xLTEtMTg2ODIx_e9b4da75-c197-49e5-b89b-ee7a2af76175">1,276,977</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Treasury stock, at cost; <ix:nonFraction unitRef="shares" contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331" decimals="INF" name="us-gaap:TreasuryStockShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMzUtMC0xLTEtMTg2ODIxL3RleHRyZWdpb246YzgzY2I0MDM0MDc2NGY3YmE1Y2ViZjljMWJmYzdmOWJfMjk_242c3766-283b-4ba1-b281-a4223d88be4c">8,918</ix:nonFraction> shares and <ix:nonFraction unitRef="shares" contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231" decimals="INF" name="us-gaap:TreasuryStockShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMzUtMC0xLTEtMTg2ODIxL3RleHRyZWdpb246YzgzY2I0MDM0MDc2NGY3YmE1Y2ViZjljMWJmYzdmOWJfNDM_f96fd7b5-4a13-4cb9-a332-d3a5f878278d">6,823</ix:nonFraction> shares at March&#160;31, 2023 and December&#160;31, 2022, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331" decimals="-3" name="us-gaap:TreasuryStockValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMzUtMS0xLTEtMTg2ODIx_feaded01-777e-49f9-8350-52ed1d85850f">481,678</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231" decimals="-3" name="us-gaap:TreasuryStockValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMzUtMy0xLTEtMTg2ODIx_445c1f05-5cc9-43ac-bbaf-5345020d20c7">362,862</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMzYtMS0xLTEtMTg2ODIx_a5419d63-a5f5-4e68-8070-e722f1cdf444">7,067</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMzYtMy0xLTEtMTg2ODIx_39552300-8332-45e3-beac-b49ec6026318">10,265</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331" decimals="-3" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMzctMS0xLTEtMTg2ODIx_373e6c7b-c78e-4f76-9023-e2f52af45b73">903,344</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231" decimals="-3" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMzctMy0xLTEtMTg2ODIx_fac272f2-e50f-45cd-b20e-c6befc52a5e6">879,118</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total stockholders&#8217; equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMzgtMS0xLTEtMTg2ODIx_86027962-eace-4f8d-8e5d-e614f4ca1626">1,674,938</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMzgtMy0xLTEtMTg2ODIx_3f35cd80-6a3d-4d0b-9213-08586b47995e">1,804,403</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total liabilities and stockholders&#8217; equity</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMzktMS0xLTEtMTg2ODIx_31008bd4-cd0c-4bfa-b8b8-e20c51e42266">3,742,399</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMzktMy0xLTEtMTg2ODIx_f0dc237b-52cb-452a-90d7-250645d8598e">3,889,758</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="i5f1eb1bd01d541c3aa0777712077c048_25"></div><hr style="page-break-after:always"/><div style="min-height:31.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i5f1eb1bd01d541c3aa0777712077c048_7">Table of Contents</a></span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div><div style="margin-bottom:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Dollars in thousands)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.929%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.522%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">OPERATING ACTIVITIES:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yNS9mcmFnOjRmMjUxYWRiMWQxZjQ2ZDBiMzRhODQ0ZjY2ZjEwYjRiL3RhYmxlOjU2NzNlN2QxMWIzZjRiMzhiNTYyMDgwNjAwNGJlOWEyL3RhYmxlcmFuZ2U6NTY3M2U3ZDExYjNmNGIzOGI1NjIwODA2MDA0YmU5YTJfMy0xLTEtMS0xODY4MjE_09514bda-0062-45f8-97dd-35bb51e1257d">24,226</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yNS9mcmFnOjRmMjUxYWRiMWQxZjQ2ZDBiMzRhODQ0ZjY2ZjEwYjRiL3RhYmxlOjU2NzNlN2QxMWIzZjRiMzhiNTYyMDgwNjAwNGJlOWEyL3RhYmxlcmFuZ2U6NTY3M2U3ZDExYjNmNGIzOGI1NjIwODA2MDA0YmU5YTJfMy0zLTEtMS0xODY4MjE_3f2475ad-1526-4af8-8807-c88363ca8fdb">32,901</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments to reconcile net income to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" decimals="-3" name="us-gaap:OtherDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yNS9mcmFnOjRmMjUxYWRiMWQxZjQ2ZDBiMzRhODQ0ZjY2ZjEwYjRiL3RhYmxlOjU2NzNlN2QxMWIzZjRiMzhiNTYyMDgwNjAwNGJlOWEyL3RhYmxlcmFuZ2U6NTY3M2U3ZDExYjNmNGIzOGI1NjIwODA2MDA0YmU5YTJfNS0xLTEtMS0xODY4MjE_db084cc2-36d2-454a-8f02-ea52f10082a3">31,143</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331" decimals="-3" name="us-gaap:OtherDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yNS9mcmFnOjRmMjUxYWRiMWQxZjQ2ZDBiMzRhODQ0ZjY2ZjEwYjRiL3RhYmxlOjU2NzNlN2QxMWIzZjRiMzhiNTYyMDgwNjAwNGJlOWEyL3RhYmxlcmFuZ2U6NTY3M2U3ZDExYjNmNGIzOGI1NjIwODA2MDA0YmU5YTJfNS0zLTEtMS0xODY4MjE_497cc367-9fb8-42bb-9d25-f017313cc7a2">29,724</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred income tax provision</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" decimals="-3" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yNS9mcmFnOjRmMjUxYWRiMWQxZjQ2ZDBiMzRhODQ0ZjY2ZjEwYjRiL3RhYmxlOjU2NzNlN2QxMWIzZjRiMzhiNTYyMDgwNjAwNGJlOWEyL3RhYmxlcmFuZ2U6NTY3M2U3ZDExYjNmNGIzOGI1NjIwODA2MDA0YmU5YTJfNy0xLTEtMS0xODY4MjE_1574eaa2-d203-4fc1-9aba-40ec5ddfb983">1,953</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331" decimals="-3" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yNS9mcmFnOjRmMjUxYWRiMWQxZjQ2ZDBiMzRhODQ0ZjY2ZjEwYjRiL3RhYmxlOjU2NzNlN2QxMWIzZjRiMzhiNTYyMDgwNjAwNGJlOWEyL3RhYmxlcmFuZ2U6NTY3M2U3ZDExYjNmNGIzOGI1NjIwODA2MDA0YmU5YTJfNy0zLTEtMS0xODY4MjE_4439965a-f5ab-43a1-9a8e-ba8c5459ec68">3,544</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yNS9mcmFnOjRmMjUxYWRiMWQxZjQ2ZDBiMzRhODQ0ZjY2ZjEwYjRiL3RhYmxlOjU2NzNlN2QxMWIzZjRiMzhiNTYyMDgwNjAwNGJlOWEyL3RhYmxlcmFuZ2U6NTY3M2U3ZDExYjNmNGIzOGI1NjIwODA2MDA0YmU5YTJfOC0xLTEtMS0xODY4MjE_03f00572-c754-4ae5-958d-4cca2eed2aae">3,620</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yNS9mcmFnOjRmMjUxYWRiMWQxZjQ2ZDBiMzRhODQ0ZjY2ZjEwYjRiL3RhYmxlOjU2NzNlN2QxMWIzZjRiMzhiNTYyMDgwNjAwNGJlOWEyL3RhYmxlcmFuZ2U6NTY3M2U3ZDExYjNmNGIzOGI1NjIwODA2MDA0YmU5YTJfOC0zLTEtMS0xODY4MjE_20b01be8-3bf4-4bb3-90a7-5f624b923d55">6,291</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of debt issuance costs and expenses associated with debt refinancing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" decimals="-3" name="iart:AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yNS9mcmFnOjRmMjUxYWRiMWQxZjQ2ZDBiMzRhODQ0ZjY2ZjEwYjRiL3RhYmxlOjU2NzNlN2QxMWIzZjRiMzhiNTYyMDgwNjAwNGJlOWEyL3RhYmxlcmFuZ2U6NTY3M2U3ZDExYjNmNGIzOGI1NjIwODA2MDA0YmU5YTJfOS0xLTEtMS0xODY4MjE_eafa5f64-df9c-428c-9720-800112d96aed">1,890</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331" decimals="-3" name="iart:AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yNS9mcmFnOjRmMjUxYWRiMWQxZjQ2ZDBiMzRhODQ0ZjY2ZjEwYjRiL3RhYmxlOjU2NzNlN2QxMWIzZjRiMzhiNTYyMDgwNjAwNGJlOWEyL3RhYmxlcmFuZ2U6NTY3M2U3ZDExYjNmNGIzOGI1NjIwODA2MDA0YmU5YTJfOS0zLTEtMS0xODY4MjE_abc24b7e-bda4-4e62-9ef0-b0ffeec74fab">1,724</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-cash lease expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" decimals="-3" name="iart:NoncashLeaseExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yNS9mcmFnOjRmMjUxYWRiMWQxZjQ2ZDBiMzRhODQ0ZjY2ZjEwYjRiL3RhYmxlOjU2NzNlN2QxMWIzZjRiMzhiNTYyMDgwNjAwNGJlOWEyL3RhYmxlcmFuZ2U6NTY3M2U3ZDExYjNmNGIzOGI1NjIwODA2MDA0YmU5YTJfMTAtMS0xLTEtMTg2ODIx_2d9567a9-6e2f-4876-a65e-a50f4155ee66">1,260</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331" decimals="-3" sign="-" name="iart:NoncashLeaseExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yNS9mcmFnOjRmMjUxYWRiMWQxZjQ2ZDBiMzRhODQ0ZjY2ZjEwYjRiL3RhYmxlOjU2NzNlN2QxMWIzZjRiMzhiNTYyMDgwNjAwNGJlOWEyL3RhYmxlcmFuZ2U6NTY3M2U3ZDExYjNmNGIzOGI1NjIwODA2MDA0YmU5YTJfMTAtMy0xLTEtMTg2ODIx_a8478968-bf94-40d4-8f59-5baa4af4e454">17</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss (gain) on disposal of property and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" decimals="-3" name="us-gaap:GainLossOnDispositionOfAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yNS9mcmFnOjRmMjUxYWRiMWQxZjQ2ZDBiMzRhODQ0ZjY2ZjEwYjRiL3RhYmxlOjU2NzNlN2QxMWIzZjRiMzhiNTYyMDgwNjAwNGJlOWEyL3RhYmxlcmFuZ2U6NTY3M2U3ZDExYjNmNGIzOGI1NjIwODA2MDA0YmU5YTJfMTEtMS0xLTEtMTg2ODIx_e6f96db8-1f57-4af4-9039-2f2501a8ce42">23</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:GainLossOnDispositionOfAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yNS9mcmFnOjRmMjUxYWRiMWQxZjQ2ZDBiMzRhODQ0ZjY2ZjEwYjRiL3RhYmxlOjU2NzNlN2QxMWIzZjRiMzhiNTYyMDgwNjAwNGJlOWEyL3RhYmxlcmFuZ2U6NTY3M2U3ZDExYjNmNGIzOGI1NjIwODA2MDA0YmU5YTJfMTEtMy0xLTEtMTg2ODIx_c54b9873-7deb-4bf5-93cc-9b2bb9ae69db">712</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in fair value of contingent consideration and others</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yNS9mcmFnOjRmMjUxYWRiMWQxZjQ2ZDBiMzRhODQ0ZjY2ZjEwYjRiL3RhYmxlOjU2NzNlN2QxMWIzZjRiMzhiNTYyMDgwNjAwNGJlOWEyL3RhYmxlcmFuZ2U6NTY3M2U3ZDExYjNmNGIzOGI1NjIwODA2MDA0YmU5YTJfMTMtMS0xLTEtMTg2ODIx_8e687750-fb45-4d68-81c7-6672f101f56c">4,699</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yNS9mcmFnOjRmMjUxYWRiMWQxZjQ2ZDBiMzRhODQ0ZjY2ZjEwYjRiL3RhYmxlOjU2NzNlN2QxMWIzZjRiMzhiNTYyMDgwNjAwNGJlOWEyL3RhYmxlcmFuZ2U6NTY3M2U3ZDExYjNmNGIzOGI1NjIwODA2MDA0YmU5YTJfMTMtMy0xLTEtMTg2ODIx_d0eaa635-57c6-49ce-8516-ee96328b2206">765</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Changes in assets and liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yNS9mcmFnOjRmMjUxYWRiMWQxZjQ2ZDBiMzRhODQ0ZjY2ZjEwYjRiL3RhYmxlOjU2NzNlN2QxMWIzZjRiMzhiNTYyMDgwNjAwNGJlOWEyL3RhYmxlcmFuZ2U6NTY3M2U3ZDExYjNmNGIzOGI1NjIwODA2MDA0YmU5YTJfMTUtMS0xLTEtMTg2ODIx_1320928a-5563-4cb8-9bca-9c4e0bec0f41">10,041</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yNS9mcmFnOjRmMjUxYWRiMWQxZjQ2ZDBiMzRhODQ0ZjY2ZjEwYjRiL3RhYmxlOjU2NzNlN2QxMWIzZjRiMzhiNTYyMDgwNjAwNGJlOWEyL3RhYmxlcmFuZ2U6NTY3M2U3ZDExYjNmNGIzOGI1NjIwODA2MDA0YmU5YTJfMTUtMy0xLTEtMTg2ODIx_d7643f92-34f3-481b-8146-fab2a91d8cdf">3,116</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" decimals="-3" name="us-gaap:IncreaseDecreaseInInventories" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yNS9mcmFnOjRmMjUxYWRiMWQxZjQ2ZDBiMzRhODQ0ZjY2ZjEwYjRiL3RhYmxlOjU2NzNlN2QxMWIzZjRiMzhiNTYyMDgwNjAwNGJlOWEyL3RhYmxlcmFuZ2U6NTY3M2U3ZDExYjNmNGIzOGI1NjIwODA2MDA0YmU5YTJfMTYtMS0xLTEtMTg2ODIx_44d3cf68-a7e2-4a58-8d98-539230bace5d">25,423</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331" decimals="-3" name="us-gaap:IncreaseDecreaseInInventories" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yNS9mcmFnOjRmMjUxYWRiMWQxZjQ2ZDBiMzRhODQ0ZjY2ZjEwYjRiL3RhYmxlOjU2NzNlN2QxMWIzZjRiMzhiNTYyMDgwNjAwNGJlOWEyL3RhYmxlcmFuZ2U6NTY3M2U3ZDExYjNmNGIzOGI1NjIwODA2MDA0YmU5YTJfMTYtMy0xLTEtMTg2ODIx_378ebb42-ba78-43b0-8fc9-bd51059cf6f0">11,561</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" decimals="-3" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yNS9mcmFnOjRmMjUxYWRiMWQxZjQ2ZDBiMzRhODQ0ZjY2ZjEwYjRiL3RhYmxlOjU2NzNlN2QxMWIzZjRiMzhiNTYyMDgwNjAwNGJlOWEyL3RhYmxlcmFuZ2U6NTY3M2U3ZDExYjNmNGIzOGI1NjIwODA2MDA0YmU5YTJfMTctMS0xLTEtMTg2ODIx_b243ca78-c108-45e0-af01-7f3843a473d6">2,164</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331" decimals="-3" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yNS9mcmFnOjRmMjUxYWRiMWQxZjQ2ZDBiMzRhODQ0ZjY2ZjEwYjRiL3RhYmxlOjU2NzNlN2QxMWIzZjRiMzhiNTYyMDgwNjAwNGJlOWEyL3RhYmxlcmFuZ2U6NTY3M2U3ZDExYjNmNGIzOGI1NjIwODA2MDA0YmU5YTJfMTctMy0xLTEtMTg2ODIx_4ed59d6b-93d2-43c5-a577-c8987161fc0c">5,046</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yNS9mcmFnOjRmMjUxYWRiMWQxZjQ2ZDBiMzRhODQ0ZjY2ZjEwYjRiL3RhYmxlOjU2NzNlN2QxMWIzZjRiMzhiNTYyMDgwNjAwNGJlOWEyL3RhYmxlcmFuZ2U6NTY3M2U3ZDExYjNmNGIzOGI1NjIwODA2MDA0YmU5YTJfMTgtMS0xLTEtMTg2ODIx_833d900e-9cc0-44fb-9c74-3b90979c0646">6,009</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yNS9mcmFnOjRmMjUxYWRiMWQxZjQ2ZDBiMzRhODQ0ZjY2ZjEwYjRiL3RhYmxlOjU2NzNlN2QxMWIzZjRiMzhiNTYyMDgwNjAwNGJlOWEyL3RhYmxlcmFuZ2U6NTY3M2U3ZDExYjNmNGIzOGI1NjIwODA2MDA0YmU5YTJfMTgtMy0xLTEtMTg2ODIx_c689ea77-f8d7-4809-88a7-c6371d958c8f">2,283</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable, accrued expenses and other current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yNS9mcmFnOjRmMjUxYWRiMWQxZjQ2ZDBiMzRhODQ0ZjY2ZjEwYjRiL3RhYmxlOjU2NzNlN2QxMWIzZjRiMzhiNTYyMDgwNjAwNGJlOWEyL3RhYmxlcmFuZ2U6NTY3M2U3ZDExYjNmNGIzOGI1NjIwODA2MDA0YmU5YTJfMTktMS0xLTEtMTg2ODIx_831b83a9-4e2d-4283-9adc-cca9818890dd">4,984</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yNS9mcmFnOjRmMjUxYWRiMWQxZjQ2ZDBiMzRhODQ0ZjY2ZjEwYjRiL3RhYmxlOjU2NzNlN2QxMWIzZjRiMzhiNTYyMDgwNjAwNGJlOWEyL3RhYmxlcmFuZ2U6NTY3M2U3ZDExYjNmNGIzOGI1NjIwODA2MDA0YmU5YTJfMTktMy0xLTEtMTg2ODIx_fce5efba-09bc-41d4-b3c3-c92edbd00fb3">9,754</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yNS9mcmFnOjRmMjUxYWRiMWQxZjQ2ZDBiMzRhODQ0ZjY2ZjEwYjRiL3RhYmxlOjU2NzNlN2QxMWIzZjRiMzhiNTYyMDgwNjAwNGJlOWEyL3RhYmxlcmFuZ2U6NTY3M2U3ZDExYjNmNGIzOGI1NjIwODA2MDA0YmU5YTJfMjEtMS0xLTEtMTg2ODIx_ca776998-bfd7-4683-8fd5-88c2b1592e3f">14,073</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yNS9mcmFnOjRmMjUxYWRiMWQxZjQ2ZDBiMzRhODQ0ZjY2ZjEwYjRiL3RhYmxlOjU2NzNlN2QxMWIzZjRiMzhiNTYyMDgwNjAwNGJlOWEyL3RhYmxlcmFuZ2U6NTY3M2U3ZDExYjNmNGIzOGI1NjIwODA2MDA0YmU5YTJfMjEtMy0xLTEtMTg2ODIx_189aad3c-46b6-428c-9877-b472d743ecd4">2,576</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net cash provided by operating activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yNS9mcmFnOjRmMjUxYWRiMWQxZjQ2ZDBiMzRhODQ0ZjY2ZjEwYjRiL3RhYmxlOjU2NzNlN2QxMWIzZjRiMzhiNTYyMDgwNjAwNGJlOWEyL3RhYmxlcmFuZ2U6NTY3M2U3ZDExYjNmNGIzOGI1NjIwODA2MDA0YmU5YTJfMjItMS0xLTEtMTg2ODIx_ae1dec02-7766-4e3a-a581-8b0d01f7d264">26,156</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yNS9mcmFnOjRmMjUxYWRiMWQxZjQ2ZDBiMzRhODQ0ZjY2ZjEwYjRiL3RhYmxlOjU2NzNlN2QxMWIzZjRiMzhiNTYyMDgwNjAwNGJlOWEyL3RhYmxlcmFuZ2U6NTY3M2U3ZDExYjNmNGIzOGI1NjIwODA2MDA0YmU5YTJfMjItMy0xLTEtMTg2ODIx_bffbbda1-9b43-44bf-9212-dfcb19876d1d">44,344</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">INVESTING ACTIVITIES:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases of property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yNS9mcmFnOjRmMjUxYWRiMWQxZjQ2ZDBiMzRhODQ0ZjY2ZjEwYjRiL3RhYmxlOjU2NzNlN2QxMWIzZjRiMzhiNTYyMDgwNjAwNGJlOWEyL3RhYmxlcmFuZ2U6NTY3M2U3ZDExYjNmNGIzOGI1NjIwODA2MDA0YmU5YTJfMjQtMS0xLTEtMTg2ODIx_85449f30-0603-4e43-909a-eafbbf8926bc">13,704</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yNS9mcmFnOjRmMjUxYWRiMWQxZjQ2ZDBiMzRhODQ0ZjY2ZjEwYjRiL3RhYmxlOjU2NzNlN2QxMWIzZjRiMzhiNTYyMDgwNjAwNGJlOWEyL3RhYmxlcmFuZ2U6NTY3M2U3ZDExYjNmNGIzOGI1NjIwODA2MDA0YmU5YTJfMjQtMy0xLTEtMTg2ODIx_81dd8832-cd98-46b2-9e85-ba3ba37459da">9,325</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquired in-process research and development milestone</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" decimals="-3" name="us-gaap:PaymentsToAcquireInProcessResearchAndDevelopment" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yNS9mcmFnOjRmMjUxYWRiMWQxZjQ2ZDBiMzRhODQ0ZjY2ZjEwYjRiL3RhYmxlOjU2NzNlN2QxMWIzZjRiMzhiNTYyMDgwNjAwNGJlOWEyL3RhYmxlcmFuZ2U6NTY3M2U3ZDExYjNmNGIzOGI1NjIwODA2MDA0YmU5YTJfMjYtMS0xLTEtMTg2ODIx_dcabd490-9509-46c0-93fb-d6135b0e693b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331" decimals="-3" name="us-gaap:PaymentsToAcquireInProcessResearchAndDevelopment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yNS9mcmFnOjRmMjUxYWRiMWQxZjQ2ZDBiMzRhODQ0ZjY2ZjEwYjRiL3RhYmxlOjU2NzNlN2QxMWIzZjRiMzhiNTYyMDgwNjAwNGJlOWEyL3RhYmxlcmFuZ2U6NTY3M2U3ZDExYjNmNGIzOGI1NjIwODA2MDA0YmU5YTJfMjYtMy0xLTEtMTg2ODIx_14308c01-a4fc-48d8-bd9d-b12415177d35">4,742</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yNS9mcmFnOjRmMjUxYWRiMWQxZjQ2ZDBiMzRhODQ0ZjY2ZjEwYjRiL3RhYmxlOjU2NzNlN2QxMWIzZjRiMzhiNTYyMDgwNjAwNGJlOWEyL3RhYmxlcmFuZ2U6NTY3M2U3ZDExYjNmNGIzOGI1NjIwODA2MDA0YmU5YTJfMjgtMS0xLTEtMTg2ODIx_a3c45aba-6420-4f53-8e90-4b6e618b2f47">13,704</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yNS9mcmFnOjRmMjUxYWRiMWQxZjQ2ZDBiMzRhODQ0ZjY2ZjEwYjRiL3RhYmxlOjU2NzNlN2QxMWIzZjRiMzhiNTYyMDgwNjAwNGJlOWEyL3RhYmxlcmFuZ2U6NTY3M2U3ZDExYjNmNGIzOGI1NjIwODA2MDA0YmU5YTJfMjgtMy0xLTEtMTg2ODIx_d2e73e65-f8e9-4a4c-a30b-353c48202668">14,067</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">FINANCING ACTIVITIES:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from borrowings of long-term indebtedness</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfSecuredDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yNS9mcmFnOjRmMjUxYWRiMWQxZjQ2ZDBiMzRhODQ0ZjY2ZjEwYjRiL3RhYmxlOjU2NzNlN2QxMWIzZjRiMzhiNTYyMDgwNjAwNGJlOWEyL3RhYmxlcmFuZ2U6NTY3M2U3ZDExYjNmNGIzOGI1NjIwODA2MDA0YmU5YTJfMzAtMS0xLTEtMTg2ODIx_0b126cd8-cfdc-4a88-9e59-878ecb0a343e">10,200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfSecuredDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yNS9mcmFnOjRmMjUxYWRiMWQxZjQ2ZDBiMzRhODQ0ZjY2ZjEwYjRiL3RhYmxlOjU2NzNlN2QxMWIzZjRiMzhiNTYyMDgwNjAwNGJlOWEyL3RhYmxlcmFuZ2U6NTY3M2U3ZDExYjNmNGIzOGI1NjIwODA2MDA0YmU5YTJfMzAtMy0xLTEtMTg2ODIx_55340ee9-0885-43a0-878d-2405799f48ee">11,250</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments on debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" decimals="-3" name="us-gaap:RepaymentsOfSecuredDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yNS9mcmFnOjRmMjUxYWRiMWQxZjQ2ZDBiMzRhODQ0ZjY2ZjEwYjRiL3RhYmxlOjU2NzNlN2QxMWIzZjRiMzhiNTYyMDgwNjAwNGJlOWEyL3RhYmxlcmFuZ2U6NTY3M2U3ZDExYjNmNGIzOGI1NjIwODA2MDA0YmU5YTJfMzEtMS0xLTEtMTg2ODIx_448767de-6a2e-4bd2-be2c-034e6addd1c7">12,400</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331" decimals="-3" name="us-gaap:RepaymentsOfSecuredDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yNS9mcmFnOjRmMjUxYWRiMWQxZjQ2ZDBiMzRhODQ0ZjY2ZjEwYjRiL3RhYmxlOjU2NzNlN2QxMWIzZjRiMzhiNTYyMDgwNjAwNGJlOWEyL3RhYmxlcmFuZ2U6NTY3M2U3ZDExYjNmNGIzOGI1NjIwODA2MDA0YmU5YTJfMzEtMy0xLTEtMTg2ODIx_688e4c63-ca67-4a4c-a7c9-76f0dfbca909">11,750</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payment of debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" decimals="-3" name="us-gaap:PaymentsOfDebtIssuanceCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yNS9mcmFnOjRmMjUxYWRiMWQxZjQ2ZDBiMzRhODQ0ZjY2ZjEwYjRiL3RhYmxlOjU2NzNlN2QxMWIzZjRiMzhiNTYyMDgwNjAwNGJlOWEyL3RhYmxlcmFuZ2U6NTY3M2U3ZDExYjNmNGIzOGI1NjIwODA2MDA0YmU5YTJfMjktMS0xLTEtMTk5MDky_78004c4f-cdad-4869-aa6e-10e540aed6bf">7,578</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331" decimals="-3" name="us-gaap:PaymentsOfDebtIssuanceCosts" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yNS9mcmFnOjRmMjUxYWRiMWQxZjQ2ZDBiMzRhODQ0ZjY2ZjEwYjRiL3RhYmxlOjU2NzNlN2QxMWIzZjRiMzhiNTYyMDgwNjAwNGJlOWEyL3RhYmxlcmFuZ2U6NTY3M2U3ZDExYjNmNGIzOGI1NjIwODA2MDA0YmU5YTJfMjktMy0xLTEtMTk5MTAx_bde35bac-a6b0-4fcd-87cd-85148b1eee39">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases of treasury stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yNS9mcmFnOjRmMjUxYWRiMWQxZjQ2ZDBiMzRhODQ0ZjY2ZjEwYjRiL3RhYmxlOjU2NzNlN2QxMWIzZjRiMzhiNTYyMDgwNjAwNGJlOWEyL3RhYmxlcmFuZ2U6NTY3M2U3ZDExYjNmNGIzOGI1NjIwODA2MDA0YmU5YTJfMzItMS0xLTEtMTg2ODIx_a9285c85-32bd-415f-a5c9-e5dafe46fefa">150,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yNS9mcmFnOjRmMjUxYWRiMWQxZjQ2ZDBiMzRhODQ0ZjY2ZjEwYjRiL3RhYmxlOjU2NzNlN2QxMWIzZjRiMzhiNTYyMDgwNjAwNGJlOWEyL3RhYmxlcmFuZ2U6NTY3M2U3ZDExYjNmNGIzOGI1NjIwODA2MDA0YmU5YTJfMzItMy0xLTEtMTg2ODIx_68009483-9101-4dd0-ac76-dc6968414b84">125,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from exercised stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yNS9mcmFnOjRmMjUxYWRiMWQxZjQ2ZDBiMzRhODQ0ZjY2ZjEwYjRiL3RhYmxlOjU2NzNlN2QxMWIzZjRiMzhiNTYyMDgwNjAwNGJlOWEyL3RhYmxlcmFuZ2U6NTY3M2U3ZDExYjNmNGIzOGI1NjIwODA2MDA0YmU5YTJfMzMtMS0xLTEtMTg2ODIx_58c6d868-8ffc-4233-a12b-8de86dbd145b">2,326</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yNS9mcmFnOjRmMjUxYWRiMWQxZjQ2ZDBiMzRhODQ0ZjY2ZjEwYjRiL3RhYmxlOjU2NzNlN2QxMWIzZjRiMzhiNTYyMDgwNjAwNGJlOWEyL3RhYmxlcmFuZ2U6NTY3M2U3ZDExYjNmNGIzOGI1NjIwODA2MDA0YmU5YTJfMzMtMy0xLTEtMTg2ODIx_76628ca5-9544-4868-a5ec-d7e55eb4404c">1,239</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash taxes paid in net equity settlement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" decimals="-3" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yNS9mcmFnOjRmMjUxYWRiMWQxZjQ2ZDBiMzRhODQ0ZjY2ZjEwYjRiL3RhYmxlOjU2NzNlN2QxMWIzZjRiMzhiNTYyMDgwNjAwNGJlOWEyL3RhYmxlcmFuZ2U6NTY3M2U3ZDExYjNmNGIzOGI1NjIwODA2MDA0YmU5YTJfMzQtMS0xLTEtMTg2ODIx_2fdd6d8a-a18d-4f83-ac92-6e58e19ccae4">5,231</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331" decimals="-3" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yNS9mcmFnOjRmMjUxYWRiMWQxZjQ2ZDBiMzRhODQ0ZjY2ZjEwYjRiL3RhYmxlOjU2NzNlN2QxMWIzZjRiMzhiNTYyMDgwNjAwNGJlOWEyL3RhYmxlcmFuZ2U6NTY3M2U3ZDExYjNmNGIzOGI1NjIwODA2MDA0YmU5YTJfMzQtMy0xLTEtMTg2ODIx_67bcf198-0c51-4192-b6dc-9c3d16d4e0a4">9,204</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net cash used in financing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yNS9mcmFnOjRmMjUxYWRiMWQxZjQ2ZDBiMzRhODQ0ZjY2ZjEwYjRiL3RhYmxlOjU2NzNlN2QxMWIzZjRiMzhiNTYyMDgwNjAwNGJlOWEyL3RhYmxlcmFuZ2U6NTY3M2U3ZDExYjNmNGIzOGI1NjIwODA2MDA0YmU5YTJfMzUtMS0xLTEtMTg2ODIx_d9339c05-809d-457a-b0c9-bae7b57e36ba">162,683</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yNS9mcmFnOjRmMjUxYWRiMWQxZjQ2ZDBiMzRhODQ0ZjY2ZjEwYjRiL3RhYmxlOjU2NzNlN2QxMWIzZjRiMzhiNTYyMDgwNjAwNGJlOWEyL3RhYmxlcmFuZ2U6NTY3M2U3ZDExYjNmNGIzOGI1NjIwODA2MDA0YmU5YTJfMzUtMy0xLTEtMTg2ODIx_a9a742d4-38fe-40b9-8f17-0e15e2e6e542">133,465</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" decimals="-3" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yNS9mcmFnOjRmMjUxYWRiMWQxZjQ2ZDBiMzRhODQ0ZjY2ZjEwYjRiL3RhYmxlOjU2NzNlN2QxMWIzZjRiMzhiNTYyMDgwNjAwNGJlOWEyL3RhYmxlcmFuZ2U6NTY3M2U3ZDExYjNmNGIzOGI1NjIwODA2MDA0YmU5YTJfMzYtMS0xLTEtMTg2ODIx_70452226-c426-48b3-8b53-be2ce5e3eb4d">937</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yNS9mcmFnOjRmMjUxYWRiMWQxZjQ2ZDBiMzRhODQ0ZjY2ZjEwYjRiL3RhYmxlOjU2NzNlN2QxMWIzZjRiMzhiNTYyMDgwNjAwNGJlOWEyL3RhYmxlcmFuZ2U6NTY3M2U3ZDExYjNmNGIzOGI1NjIwODA2MDA0YmU5YTJfMzYtMy0xLTEtMTg2ODIx_f2641063-57a0-4f92-9e3d-6a7b2784d7e5">3,168</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net decrease in cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yNS9mcmFnOjRmMjUxYWRiMWQxZjQ2ZDBiMzRhODQ0ZjY2ZjEwYjRiL3RhYmxlOjU2NzNlN2QxMWIzZjRiMzhiNTYyMDgwNjAwNGJlOWEyL3RhYmxlcmFuZ2U6NTY3M2U3ZDExYjNmNGIzOGI1NjIwODA2MDA0YmU5YTJfMzctMS0xLTEtMTg2ODIx_bed609ca-ff3a-4c8b-bb35-216fc45bd01c">149,294</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yNS9mcmFnOjRmMjUxYWRiMWQxZjQ2ZDBiMzRhODQ0ZjY2ZjEwYjRiL3RhYmxlOjU2NzNlN2QxMWIzZjRiMzhiNTYyMDgwNjAwNGJlOWEyL3RhYmxlcmFuZ2U6NTY3M2U3ZDExYjNmNGIzOGI1NjIwODA2MDA0YmU5YTJfMzctMy0xLTEtMTg2ODIx_f9c3b8c0-4339-464e-9926-604f9a1c7949">106,356</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash and cash equivalents at beginning of period</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yNS9mcmFnOjRmMjUxYWRiMWQxZjQ2ZDBiMzRhODQ0ZjY2ZjEwYjRiL3RhYmxlOjU2NzNlN2QxMWIzZjRiMzhiNTYyMDgwNjAwNGJlOWEyL3RhYmxlcmFuZ2U6NTY3M2U3ZDExYjNmNGIzOGI1NjIwODA2MDA0YmU5YTJfMzgtMS0xLTEtMTg2ODIx_27091781-aef0-4f50-8faf-808785e49636">456,661</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50dcc39eee364391aeb0073e75dcfb4f_I20211231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yNS9mcmFnOjRmMjUxYWRiMWQxZjQ2ZDBiMzRhODQ0ZjY2ZjEwYjRiL3RhYmxlOjU2NzNlN2QxMWIzZjRiMzhiNTYyMDgwNjAwNGJlOWEyL3RhYmxlcmFuZ2U6NTY3M2U3ZDExYjNmNGIzOGI1NjIwODA2MDA0YmU5YTJfMzgtMy0xLTEtMTg2ODIx_eb647b82-ed68-4669-9559-82ba7cbc998e">513,448</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash and cash equivalents at end of period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yNS9mcmFnOjRmMjUxYWRiMWQxZjQ2ZDBiMzRhODQ0ZjY2ZjEwYjRiL3RhYmxlOjU2NzNlN2QxMWIzZjRiMzhiNTYyMDgwNjAwNGJlOWEyL3RhYmxlcmFuZ2U6NTY3M2U3ZDExYjNmNGIzOGI1NjIwODA2MDA0YmU5YTJfMzktMS0xLTEtMTg2ODIx_20fdec2a-71bd-4866-83ad-365eba309e98">307,367</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635d765ec67b4491a13addb3d7bc40cd_I20220331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yNS9mcmFnOjRmMjUxYWRiMWQxZjQ2ZDBiMzRhODQ0ZjY2ZjEwYjRiL3RhYmxlOjU2NzNlN2QxMWIzZjRiMzhiNTYyMDgwNjAwNGJlOWEyL3RhYmxlcmFuZ2U6NTY3M2U3ZDExYjNmNGIzOGI1NjIwODA2MDA0YmU5YTJfMzktMy0xLTEtMTg2ODIx_b5a48213-a948-4164-b571-1c15f8d491b7">407,092</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><div id="i5f1eb1bd01d541c3aa0777712077c048_28"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i5f1eb1bd01d541c3aa0777712077c048_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div><div style="margin-bottom:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Dollars in thousands)</span></div><div style="margin-bottom:20pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:27.885%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.711%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.379%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.015%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.379%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.711%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.379%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.015%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.379%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.030%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.379%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.349%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.379%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.001%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.379%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.330%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="45" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2023</span></td></tr><tr style="height:23pt"><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury Stock</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional Paid-In Capital</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Loss</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Equity</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance, January 1, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8b664c70cda046d684b591844ea4bde4_I20221231" decimals="INF" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjk0ZDEyNDBkN2YwMzQ0NTdiOGI0YmJhNDM1ZGQzMGMyL3RhYmxlcmFuZ2U6OTRkMTI0MGQ3ZjAzNDQ1N2I4YjRiYmE0MzVkZDMwYzJfMy0xLTEtMS0xODY4MjE_777cede6-ff9b-4612-bcea-087221a804f0">90,476</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b664c70cda046d684b591844ea4bde4_I20221231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjk0ZDEyNDBkN2YwMzQ0NTdiOGI0YmJhNDM1ZGQzMGMyL3RhYmxlcmFuZ2U6OTRkMTI0MGQ3ZjAzNDQ1N2I4YjRiYmE0MzVkZDMwYzJfMy0zLTEtMS0xODY4MjE_71529c0d-78e3-4402-b3d5-325d00136b98">905</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i18a51afa82d740fbbdf6665bed1d8a09_I20221231" decimals="INF" name="us-gaap:TreasuryStockShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjk0ZDEyNDBkN2YwMzQ0NTdiOGI0YmJhNDM1ZGQzMGMyL3RhYmxlcmFuZ2U6OTRkMTI0MGQ3ZjAzNDQ1N2I4YjRiYmE0MzVkZDMwYzJfMy01LTEtMS0xODY4MjE_10eca361-9dab-4099-a06f-64f959aaadde">6,823</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i18a51afa82d740fbbdf6665bed1d8a09_I20221231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjk0ZDEyNDBkN2YwMzQ0NTdiOGI0YmJhNDM1ZGQzMGMyL3RhYmxlcmFuZ2U6OTRkMTI0MGQ3ZjAzNDQ1N2I4YjRiYmE0MzVkZDMwYzJfMy03LTEtMS0xODY4MjE_8157e100-b332-4bbd-adf1-abd0435ed211">362,862</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia60ef6361a9e4be48bde714624b18a33_I20221231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjk0ZDEyNDBkN2YwMzQ0NTdiOGI0YmJhNDM1ZGQzMGMyL3RhYmxlcmFuZ2U6OTRkMTI0MGQ3ZjAzNDQ1N2I4YjRiYmE0MzVkZDMwYzJfMy05LTEtMS0xODY4MjE_8d2a96de-d692-4a71-9b10-f16a4a184fd7">1,276,977</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia54b6095ce1949b680fbf6e3777f0cd1_I20221231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjk0ZDEyNDBkN2YwMzQ0NTdiOGI0YmJhNDM1ZGQzMGMyL3RhYmxlcmFuZ2U6OTRkMTI0MGQ3ZjAzNDQ1N2I4YjRiYmE0MzVkZDMwYzJfMy0xMS0xLTEtMTg2ODIx_b605a912-1188-458c-81c6-4a26766e0f70">10,265</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9da7c98e7334b2b98f63a2448e31bd5_I20221231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjk0ZDEyNDBkN2YwMzQ0NTdiOGI0YmJhNDM1ZGQzMGMyL3RhYmxlcmFuZ2U6OTRkMTI0MGQ3ZjAzNDQ1N2I4YjRiYmE0MzVkZDMwYzJfMy0xMy0xLTEtMTg2ODIx_160fb882-38cf-4e08-9982-d7c7cfe90bbe">879,118</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjk0ZDEyNDBkN2YwMzQ0NTdiOGI0YmJhNDM1ZGQzMGMyL3RhYmxlcmFuZ2U6OTRkMTI0MGQ3ZjAzNDQ1N2I4YjRiYmE0MzVkZDMwYzJfMy0xNS0xLTEtMTg2ODIx_8d65af6e-dd02-451e-99fd-acb306078553">1,804,403</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a86b99b663a4de7bdb689dab96e1f70_D20230101-20230331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjk0ZDEyNDBkN2YwMzQ0NTdiOGI0YmJhNDM1ZGQzMGMyL3RhYmxlcmFuZ2U6OTRkMTI0MGQ3ZjAzNDQ1N2I4YjRiYmE0MzVkZDMwYzJfNC0xMy0xLTEtMTg2ODIx_fc8bedcc-37bc-456e-ad98-34c5d332708d">24,226</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjk0ZDEyNDBkN2YwMzQ0NTdiOGI0YmJhNDM1ZGQzMGMyL3RhYmxlcmFuZ2U6OTRkMTI0MGQ3ZjAzNDQ1N2I4YjRiYmE0MzVkZDMwYzJfNC0xNS0xLTEtMTg2ODIx_c23ed918-699f-4aa0-bee1-a0ccfd292adc">24,226</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income (loss), net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4b3ce7fe6f5d47549cce8165b587a1d0_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjk0ZDEyNDBkN2YwMzQ0NTdiOGI0YmJhNDM1ZGQzMGMyL3RhYmxlcmFuZ2U6OTRkMTI0MGQ3ZjAzNDQ1N2I4YjRiYmE0MzVkZDMwYzJfNS0xMS0xLTEtMTg2ODIx_ab79abf8-f21a-4824-90ff-f440fbc96bb4">3,198</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjk0ZDEyNDBkN2YwMzQ0NTdiOGI0YmJhNDM1ZGQzMGMyL3RhYmxlcmFuZ2U6OTRkMTI0MGQ3ZjAzNDQ1N2I4YjRiYmE0MzVkZDMwYzJfNS0xNS0xLTEtMTg2ODIx_2b0a0e70-f103-4108-b588-d4c95bd6324a">3,198</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock through employee stock purchase plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia95f80b5f4b8491b8974cc31b9e4bcd7_D20230101-20230331" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjk0ZDEyNDBkN2YwMzQ0NTdiOGI0YmJhNDM1ZGQzMGMyL3RhYmxlcmFuZ2U6OTRkMTI0MGQ3ZjAzNDQ1N2I4YjRiYmE0MzVkZDMwYzJfNi0xLTEtMS0xODY4MjE_c25fb0cf-ca5d-42db-aa38-1c7292260ddd">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0fb8907de52a4781af049b3a4064bcdf_D20230101-20230331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjk0ZDEyNDBkN2YwMzQ0NTdiOGI0YmJhNDM1ZGQzMGMyL3RhYmxlcmFuZ2U6OTRkMTI0MGQ3ZjAzNDQ1N2I4YjRiYmE0MzVkZDMwYzJfNi05LTEtMS0xODY4MjE_57905c3e-8fba-41b1-92f4-e331d256bcc7">1,107</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjk0ZDEyNDBkN2YwMzQ0NTdiOGI0YmJhNDM1ZGQzMGMyL3RhYmxlcmFuZ2U6OTRkMTI0MGQ3ZjAzNDQ1N2I4YjRiYmE0MzVkZDMwYzJfNi0xNS0xLTEtMTg2ODIx_560c7080-13f4-4819-94d2-6300288ffa4b">1,107</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock for vesting of share based awards, net of shares withheld for taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia95f80b5f4b8491b8974cc31b9e4bcd7_D20230101-20230331" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjk0ZDEyNDBkN2YwMzQ0NTdiOGI0YmJhNDM1ZGQzMGMyL3RhYmxlcmFuZ2U6OTRkMTI0MGQ3ZjAzNDQ1N2I4YjRiYmE0MzVkZDMwYzJfNy0xLTEtMS0xODY4MjE_a9b06a9d-255d-4ce2-86ba-c05153297bdb">316</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia95f80b5f4b8491b8974cc31b9e4bcd7_D20230101-20230331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjk0ZDEyNDBkN2YwMzQ0NTdiOGI0YmJhNDM1ZGQzMGMyL3RhYmxlcmFuZ2U6OTRkMTI0MGQ3ZjAzNDQ1N2I4YjRiYmE0MzVkZDMwYzJfNy0zLTEtMS0xODY4MjE_94d87afc-d1b5-428b-a7e4-7bfc1b4d41f7">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8a149e1d463f4cca8d2969ce8c1e4a84_D20230101-20230331" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjk0ZDEyNDBkN2YwMzQ0NTdiOGI0YmJhNDM1ZGQzMGMyL3RhYmxlcmFuZ2U6OTRkMTI0MGQ3ZjAzNDQ1N2I4YjRiYmE0MzVkZDMwYzJfNy01LTEtMS0xODY4MjE_5bc88d71-bba0-46d6-891f-98e89e046ed3">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a149e1d463f4cca8d2969ce8c1e4a84_D20230101-20230331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjk0ZDEyNDBkN2YwMzQ0NTdiOGI0YmJhNDM1ZGQzMGMyL3RhYmxlcmFuZ2U6OTRkMTI0MGQ3ZjAzNDQ1N2I4YjRiYmE0MzVkZDMwYzJfNy03LTEtMS0xODY4MjE_76614765-c1e9-4069-a8f4-8d7cb7a8712c">846</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0fb8907de52a4781af049b3a4064bcdf_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjk0ZDEyNDBkN2YwMzQ0NTdiOGI0YmJhNDM1ZGQzMGMyL3RhYmxlcmFuZ2U6OTRkMTI0MGQ3ZjAzNDQ1N2I4YjRiYmE0MzVkZDMwYzJfNy05LTEtMS0xODY4MjE_247b1cc5-7077-4a1e-bbf6-52292d8bf84d">4,858</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjk0ZDEyNDBkN2YwMzQ0NTdiOGI0YmJhNDM1ZGQzMGMyL3RhYmxlcmFuZ2U6OTRkMTI0MGQ3ZjAzNDQ1N2I4YjRiYmE0MzVkZDMwYzJfNy0xNS0xLTEtMTg2ODIx_32f90f5a-ce7d-4956-b251-623e015a6188">4,011</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia95f80b5f4b8491b8974cc31b9e4bcd7_D20230101-20230331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjk0ZDEyNDBkN2YwMzQ0NTdiOGI0YmJhNDM1ZGQzMGMyL3RhYmxlcmFuZ2U6OTRkMTI0MGQ3ZjAzNDQ1N2I4YjRiYmE0MzVkZDMwYzJfOC0zLTEtMS0xODY4MjE_f93444d9-883a-4614-a9a3-84e7c434489a">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0fb8907de52a4781af049b3a4064bcdf_D20230101-20230331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjk0ZDEyNDBkN2YwMzQ0NTdiOGI0YmJhNDM1ZGQzMGMyL3RhYmxlcmFuZ2U6OTRkMTI0MGQ3ZjAzNDQ1N2I4YjRiYmE0MzVkZDMwYzJfOC05LTEtMS0xODY4MjE_90073cfd-2e3e-4b0d-aa15-524b795f5549">3,609</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjk0ZDEyNDBkN2YwMzQ0NTdiOGI0YmJhNDM1ZGQzMGMyL3RhYmxlcmFuZ2U6OTRkMTI0MGQ3ZjAzNDQ1N2I4YjRiYmE0MzVkZDMwYzJfOC0xNS0xLTEtMTg2ODIx_53c9d6aa-1641-4cd4-b07f-19cee013d635">3,611</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accelerated shares repurchased</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i8a149e1d463f4cca8d2969ce8c1e4a84_D20230101-20230331" decimals="INF" name="us-gaap:StockRepurchasedDuringPeriodShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjk0ZDEyNDBkN2YwMzQ0NTdiOGI0YmJhNDM1ZGQzMGMyL3RhYmxlcmFuZ2U6OTRkMTI0MGQ3ZjAzNDQ1N2I4YjRiYmE0MzVkZDMwYzJfOS01LTEtMS0xODY4MjE_26ebae56-9d9e-4897-985a-254b7ee54f4d">2,111</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8a149e1d463f4cca8d2969ce8c1e4a84_D20230101-20230331" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjk0ZDEyNDBkN2YwMzQ0NTdiOGI0YmJhNDM1ZGQzMGMyL3RhYmxlcmFuZ2U6OTRkMTI0MGQ3ZjAzNDQ1N2I4YjRiYmE0MzVkZDMwYzJfOS03LTEtMS0xODY4MjE_6073cefe-19bf-48c4-a943-ff6cf6dc633b">119,662</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0fb8907de52a4781af049b3a4064bcdf_D20230101-20230331" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjk0ZDEyNDBkN2YwMzQ0NTdiOGI0YmJhNDM1ZGQzMGMyL3RhYmxlcmFuZ2U6OTRkMTI0MGQ3ZjAzNDQ1N2I4YjRiYmE0MzVkZDMwYzJfOS05LTEtMS0xODY4MjE_53fd621a-67a0-41f7-8db1-ee1dd653ca2e">31,538</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjk0ZDEyNDBkN2YwMzQ0NTdiOGI0YmJhNDM1ZGQzMGMyL3RhYmxlcmFuZ2U6OTRkMTI0MGQ3ZjAzNDQ1N2I4YjRiYmE0MzVkZDMwYzJfOS0xNS0xLTEtMTg2ODIx_f6522247-f6fa-47c9-88f6-9740be55698c">151,200</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance, March 31, 2023</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iaf1259e8da8a41d8874851f04fa9e5d6_I20230331" decimals="INF" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjk0ZDEyNDBkN2YwMzQ0NTdiOGI0YmJhNDM1ZGQzMGMyL3RhYmxlcmFuZ2U6OTRkMTI0MGQ3ZjAzNDQ1N2I4YjRiYmE0MzVkZDMwYzJfMTAtMS0xLTEtMTg2ODIx_97f4d778-6963-4fd9-9462-3235988e8f43">90,813</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf1259e8da8a41d8874851f04fa9e5d6_I20230331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjk0ZDEyNDBkN2YwMzQ0NTdiOGI0YmJhNDM1ZGQzMGMyL3RhYmxlcmFuZ2U6OTRkMTI0MGQ3ZjAzNDQ1N2I4YjRiYmE0MzVkZDMwYzJfMTAtMy0xLTEtMTg2ODIx_e6d1d5d2-307b-4170-bd3f-b2fc2874cbe7">908</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i3e47e80bbb2040c7a084e52b255b0d28_I20230331" decimals="INF" name="us-gaap:TreasuryStockShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjk0ZDEyNDBkN2YwMzQ0NTdiOGI0YmJhNDM1ZGQzMGMyL3RhYmxlcmFuZ2U6OTRkMTI0MGQ3ZjAzNDQ1N2I4YjRiYmE0MzVkZDMwYzJfMTAtNS0xLTEtMTg2ODIx_35712a77-825e-417c-b5d4-f5f82b685ab7">8,918</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3e47e80bbb2040c7a084e52b255b0d28_I20230331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjk0ZDEyNDBkN2YwMzQ0NTdiOGI0YmJhNDM1ZGQzMGMyL3RhYmxlcmFuZ2U6OTRkMTI0MGQ3ZjAzNDQ1N2I4YjRiYmE0MzVkZDMwYzJfMTAtNy0xLTEtMTg2ODIx_d27ad072-50af-496c-91a7-8924eed370e8">481,678</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd938a82772142df82f2a578295bcd9a_I20230331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjk0ZDEyNDBkN2YwMzQ0NTdiOGI0YmJhNDM1ZGQzMGMyL3RhYmxlcmFuZ2U6OTRkMTI0MGQ3ZjAzNDQ1N2I4YjRiYmE0MzVkZDMwYzJfMTAtOS0xLTEtMTg2ODIx_2e4b66e0-e338-4047-8a34-915c3581516e">1,245,297</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied07d9963f9d439fb1ad815102c390d4_I20230331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjk0ZDEyNDBkN2YwMzQ0NTdiOGI0YmJhNDM1ZGQzMGMyL3RhYmxlcmFuZ2U6OTRkMTI0MGQ3ZjAzNDQ1N2I4YjRiYmE0MzVkZDMwYzJfMTAtMTEtMS0xLTE4NjgyMQ_bc8d5165-0d1c-4072-8a25-0380f53805a1">7,067</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9645160354f47929ed32876cc704c86_I20230331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjk0ZDEyNDBkN2YwMzQ0NTdiOGI0YmJhNDM1ZGQzMGMyL3RhYmxlcmFuZ2U6OTRkMTI0MGQ3ZjAzNDQ1N2I4YjRiYmE0MzVkZDMwYzJfMTAtMTMtMS0xLTE4NjgyMQ_5a8105e9-99a2-4466-9378-c73475e3d6c7">903,344</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjk0ZDEyNDBkN2YwMzQ0NTdiOGI0YmJhNDM1ZGQzMGMyL3RhYmxlcmFuZ2U6OTRkMTI0MGQ3ZjAzNDQ1N2I4YjRiYmE0MzVkZDMwYzJfMTAtMTUtMS0xLTE4NjgyMQ_d9b06a86-e7a7-4415-86c7-4b3a99968c6d">1,674,938</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:27.885%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.711%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.379%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.015%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.379%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.711%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.379%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.015%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.379%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.030%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.379%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.349%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.379%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.001%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.379%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.330%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="45" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2022</span></td></tr><tr style="height:23pt"><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury Stock</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional Paid-In Capital</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Loss</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Equity</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance, January 1, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5173bceb1ba843f5b9ba6fac4ca9b4ca_I20211231" decimals="INF" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjQ5MWRkZTMzMGVlYjQwNzQ5MGNiOWY0ZDA4NmMyMjJlL3RhYmxlcmFuZ2U6NDkxZGRlMzMwZWViNDA3NDkwY2I5ZjRkMDg2YzIyMmVfMy0xLTEtMS0xODY4MjE_9eff08f4-ded6-4a1e-9f61-f2e5537c6c15">89,600</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5173bceb1ba843f5b9ba6fac4ca9b4ca_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjQ5MWRkZTMzMGVlYjQwNzQ5MGNiOWY0ZDA4NmMyMjJlL3RhYmxlcmFuZ2U6NDkxZGRlMzMwZWViNDA3NDkwY2I5ZjRkMDg2YzIyMmVfMy0zLTEtMS0xODY4MjE_bc4eec02-9e4e-4514-8d6f-381158d65650">896</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i366dba347b9f46848ca7d06dec81acb5_I20211231" decimals="INF" name="us-gaap:TreasuryStockShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjQ5MWRkZTMzMGVlYjQwNzQ5MGNiOWY0ZDA4NmMyMjJlL3RhYmxlcmFuZ2U6NDkxZGRlMzMwZWViNDA3NDkwY2I5ZjRkMDg2YzIyMmVfMy01LTEtMS0xODY4MjE_1ff6c900-d517-4033-9a5f-47d839e2c7ec">4,899</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i366dba347b9f46848ca7d06dec81acb5_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjQ5MWRkZTMzMGVlYjQwNzQ5MGNiOWY0ZDA4NmMyMjJlL3RhYmxlcmFuZ2U6NDkxZGRlMzMwZWViNDA3NDkwY2I5ZjRkMDg2YzIyMmVfMy03LTEtMS0xODY4MjE_1b657607-d874-4462-90fa-843f6a8b6c43">234,448</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e56583327fe4abe82cb79ace79055aa_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjQ5MWRkZTMzMGVlYjQwNzQ5MGNiOWY0ZDA4NmMyMjJlL3RhYmxlcmFuZ2U6NDkxZGRlMzMwZWViNDA3NDkwY2I5ZjRkMDg2YzIyMmVfMy05LTEtMS0xODY4MjE_2b5fe720-b3b0-4efb-9fd1-139f0bd3dcfb">1,264,943</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia84198cc189e4e0f8778dab882b9d737_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjQ5MWRkZTMzMGVlYjQwNzQ5MGNiOWY0ZDA4NmMyMjJlL3RhYmxlcmFuZ2U6NDkxZGRlMzMwZWViNDA3NDkwY2I5ZjRkMDg2YzIyMmVfMy0xMS0xLTEtMTg2ODIx_94ac12a6-d267-49b9-942d-db1eccbc28c8">45,155</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5712711f454141d18540576f0d8ead64_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjQ5MWRkZTMzMGVlYjQwNzQ5MGNiOWY0ZDA4NmMyMjJlL3RhYmxlcmFuZ2U6NDkxZGRlMzMwZWViNDA3NDkwY2I5ZjRkMDg2YzIyMmVfMy0xMy0xLTEtMTg2ODIx_6232f838-8a80-468d-88bf-1937b6f32751">698,568</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50dcc39eee364391aeb0073e75dcfb4f_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjQ5MWRkZTMzMGVlYjQwNzQ5MGNiOWY0ZDA4NmMyMjJlL3RhYmxlcmFuZ2U6NDkxZGRlMzMwZWViNDA3NDkwY2I5ZjRkMDg2YzIyMmVfMy0xNS0xLTEtMTg2ODIx_c08c1772-7b86-4d10-8452-3de4ec4007a3">1,684,804</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6cfa05b583da44ddab7edd770f9bd953_D20220101-20220331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjQ5MWRkZTMzMGVlYjQwNzQ5MGNiOWY0ZDA4NmMyMjJlL3RhYmxlcmFuZ2U6NDkxZGRlMzMwZWViNDA3NDkwY2I5ZjRkMDg2YzIyMmVfNC0xMy0xLTEtMTg2ODIx_98dd766e-e475-45b1-8595-2cda07c87bac">32,901</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjQ5MWRkZTMzMGVlYjQwNzQ5MGNiOWY0ZDA4NmMyMjJlL3RhYmxlcmFuZ2U6NDkxZGRlMzMwZWViNDA3NDkwY2I5ZjRkMDg2YzIyMmVfNC0xNS0xLTEtMTg2ODIx_4c37efca-2f0a-49dd-966a-9ad354e8077f">32,901</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income (loss), net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia48c06fa8e984f2682cf6945ce8d6a84_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjQ5MWRkZTMzMGVlYjQwNzQ5MGNiOWY0ZDA4NmMyMjJlL3RhYmxlcmFuZ2U6NDkxZGRlMzMwZWViNDA3NDkwY2I5ZjRkMDg2YzIyMmVfNS0xMS0xLTEtMTg2ODIx_cfe0e45d-8b71-4c76-bd02-38a37819d88d">24,130</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjQ5MWRkZTMzMGVlYjQwNzQ5MGNiOWY0ZDA4NmMyMjJlL3RhYmxlcmFuZ2U6NDkxZGRlMzMwZWViNDA3NDkwY2I5ZjRkMDg2YzIyMmVfNS0xNS0xLTEtMTg2ODIx_529a1461-6d17-4dd5-bd2c-70f28145d15e">24,130</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock through employee stock purchase plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7887839e434d4a3eaa3b791ba3071cd7_D20220101-20220331" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjQ5MWRkZTMzMGVlYjQwNzQ5MGNiOWY0ZDA4NmMyMjJlL3RhYmxlcmFuZ2U6NDkxZGRlMzMwZWViNDA3NDkwY2I5ZjRkMDg2YzIyMmVfNi0xLTEtMS0xODY4MjE_1bdd0ebf-db5d-4ac3-a883-e553ac5c9032">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12b2bd10a7124b6b8b76ec49059b3fda_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjQ5MWRkZTMzMGVlYjQwNzQ5MGNiOWY0ZDA4NmMyMjJlL3RhYmxlcmFuZ2U6NDkxZGRlMzMwZWViNDA3NDkwY2I5ZjRkMDg2YzIyMmVfNi05LTEtMS0xODY4MjE_1067cf0b-2103-40d2-b848-e22ab3515c1b">1,078</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjQ5MWRkZTMzMGVlYjQwNzQ5MGNiOWY0ZDA4NmMyMjJlL3RhYmxlcmFuZ2U6NDkxZGRlMzMwZWViNDA3NDkwY2I5ZjRkMDg2YzIyMmVfNi0xNS0xLTEtMTg2ODIx_62593402-92f1-4377-b846-f3bce9e02b51">1,078</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock for vesting of share based awards, net of shares withheld for taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7887839e434d4a3eaa3b791ba3071cd7_D20220101-20220331" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjQ5MWRkZTMzMGVlYjQwNzQ5MGNiOWY0ZDA4NmMyMjJlL3RhYmxlcmFuZ2U6NDkxZGRlMzMwZWViNDA3NDkwY2I5ZjRkMDg2YzIyMmVfNy0xLTEtMS0xODY4MjE_633c65d1-bc73-4b4a-ab32-9d55caa0734b">339</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7887839e434d4a3eaa3b791ba3071cd7_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjQ5MWRkZTMzMGVlYjQwNzQ5MGNiOWY0ZDA4NmMyMjJlL3RhYmxlcmFuZ2U6NDkxZGRlMzMwZWViNDA3NDkwY2I5ZjRkMDg2YzIyMmVfNy0zLTEtMS0xODY4MjE_f6c77850-0d7d-4c10-9c63-3a6d51a50e33">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iec34d4ae56714939a2ae0fcab654c01c_D20220101-20220331" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjQ5MWRkZTMzMGVlYjQwNzQ5MGNiOWY0ZDA4NmMyMjJlL3RhYmxlcmFuZ2U6NDkxZGRlMzMwZWViNDA3NDkwY2I5ZjRkMDg2YzIyMmVfNy01LTEtMS0xODY4MjE_c074b4d6-ac9f-47c0-b4fe-af49b7640fe3">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec34d4ae56714939a2ae0fcab654c01c_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjQ5MWRkZTMzMGVlYjQwNzQ5MGNiOWY0ZDA4NmMyMjJlL3RhYmxlcmFuZ2U6NDkxZGRlMzMwZWViNDA3NDkwY2I5ZjRkMDg2YzIyMmVfNy03LTEtMS0xODY4MjE_db0a42eb-179c-4a2b-a326-727572388e63">714</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i12b2bd10a7124b6b8b76ec49059b3fda_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjQ5MWRkZTMzMGVlYjQwNzQ5MGNiOWY0ZDA4NmMyMjJlL3RhYmxlcmFuZ2U6NDkxZGRlMzMwZWViNDA3NDkwY2I5ZjRkMDg2YzIyMmVfNy05LTEtMS0xODY4MjE_35bb658a-2a90-4a6d-9eaa-376f4d05ef05">9,758</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjQ5MWRkZTMzMGVlYjQwNzQ5MGNiOWY0ZDA4NmMyMjJlL3RhYmxlcmFuZ2U6NDkxZGRlMzMwZWViNDA3NDkwY2I5ZjRkMDg2YzIyMmVfNy0xNS0xLTEtMTg2ODIx_3fd8bff4-ce5a-4927-aa07-f6ee676ac6c3">9,040</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12b2bd10a7124b6b8b76ec49059b3fda_D20220101-20220331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjQ5MWRkZTMzMGVlYjQwNzQ5MGNiOWY0ZDA4NmMyMjJlL3RhYmxlcmFuZ2U6NDkxZGRlMzMwZWViNDA3NDkwY2I5ZjRkMDg2YzIyMmVfOC05LTEtMS0xODY4MjE_e4fb9f1c-a024-4d36-858a-e81a80b2ec7a">6,324</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjQ5MWRkZTMzMGVlYjQwNzQ5MGNiOWY0ZDA4NmMyMjJlL3RhYmxlcmFuZ2U6NDkxZGRlMzMwZWViNDA3NDkwY2I5ZjRkMDg2YzIyMmVfOC0xNS0xLTEtMTg2ODIx_360a9180-b4b3-42a1-9724-d8728a89aae5">6,324</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accelerated shares repurchased</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="iec34d4ae56714939a2ae0fcab654c01c_D20220101-20220331" decimals="INF" name="us-gaap:StockRepurchasedDuringPeriodShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjQ5MWRkZTMzMGVlYjQwNzQ5MGNiOWY0ZDA4NmMyMjJlL3RhYmxlcmFuZ2U6NDkxZGRlMzMwZWViNDA3NDkwY2I5ZjRkMDg2YzIyMmVfOS01LTEtMS0xODY4MjE_936dede5-890d-433d-8282-509adb084e65">1,938</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec34d4ae56714939a2ae0fcab654c01c_D20220101-20220331" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjQ5MWRkZTMzMGVlYjQwNzQ5MGNiOWY0ZDA4NmMyMjJlL3RhYmxlcmFuZ2U6NDkxZGRlMzMwZWViNDA3NDkwY2I5ZjRkMDg2YzIyMmVfOS03LTEtMS0xODY4MjE_f9672cb7-9e6f-40e8-ac10-545669512eb7">129,152</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12b2bd10a7124b6b8b76ec49059b3fda_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjQ5MWRkZTMzMGVlYjQwNzQ5MGNiOWY0ZDA4NmMyMjJlL3RhYmxlcmFuZ2U6NDkxZGRlMzMwZWViNDA3NDkwY2I5ZjRkMDg2YzIyMmVfOS05LTEtMS0xODY4MjE_1cffe2f9-88c1-4c83-91cb-6fb876a2fa50">4,152</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjQ5MWRkZTMzMGVlYjQwNzQ5MGNiOWY0ZDA4NmMyMjJlL3RhYmxlcmFuZ2U6NDkxZGRlMzMwZWViNDA3NDkwY2I5ZjRkMDg2YzIyMmVfOS0xNS0xLTEtMTg2ODIx_0106cb77-cd25-4c28-82f0-7a5f7c526a22">125,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance, March 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1be1849f53b94167a15b3f9045e8f051_I20220331" decimals="INF" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjQ5MWRkZTMzMGVlYjQwNzQ5MGNiOWY0ZDA4NmMyMjJlL3RhYmxlcmFuZ2U6NDkxZGRlMzMwZWViNDA3NDkwY2I5ZjRkMDg2YzIyMmVfMTAtMS0xLTEtMTg2ODIx_b8b96325-02b0-4567-ab97-0513167070c7">89,956</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1be1849f53b94167a15b3f9045e8f051_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjQ5MWRkZTMzMGVlYjQwNzQ5MGNiOWY0ZDA4NmMyMjJlL3RhYmxlcmFuZ2U6NDkxZGRlMzMwZWViNDA3NDkwY2I5ZjRkMDg2YzIyMmVfMTAtMy0xLTEtMTg2ODIx_dcf249fc-1d47-4919-aab3-6b419a349a9b">900</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i73947427cc2b499ab016969c72081ee0_I20220331" decimals="INF" name="us-gaap:TreasuryStockShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjQ5MWRkZTMzMGVlYjQwNzQ5MGNiOWY0ZDA4NmMyMjJlL3RhYmxlcmFuZ2U6NDkxZGRlMzMwZWViNDA3NDkwY2I5ZjRkMDg2YzIyMmVfMTAtNS0xLTEtMTg2ODIx_f2457eb6-26a1-4968-b328-74f80454ad27">6,823</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i73947427cc2b499ab016969c72081ee0_I20220331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjQ5MWRkZTMzMGVlYjQwNzQ5MGNiOWY0ZDA4NmMyMjJlL3RhYmxlcmFuZ2U6NDkxZGRlMzMwZWViNDA3NDkwY2I5ZjRkMDg2YzIyMmVfMTAtNy0xLTEtMTg2ODIx_4da11726-1feb-4656-a855-b78802dc1d68">362,886</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb0fcc9c413d41d28bf9655bcf94a392_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjQ5MWRkZTMzMGVlYjQwNzQ5MGNiOWY0ZDA4NmMyMjJlL3RhYmxlcmFuZ2U6NDkxZGRlMzMwZWViNDA3NDkwY2I5ZjRkMDg2YzIyMmVfMTAtOS0xLTEtMTg2ODIx_eab402c3-57ed-4cd1-b52b-8656e9cde288">1,266,739</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2313f3e834a34925a9399b4f10d82fd7_I20220331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjQ5MWRkZTMzMGVlYjQwNzQ5MGNiOWY0ZDA4NmMyMjJlL3RhYmxlcmFuZ2U6NDkxZGRlMzMwZWViNDA3NDkwY2I5ZjRkMDg2YzIyMmVfMTAtMTEtMS0xLTE4NjgyMQ_6bdd3a09-00ca-4413-8fb7-954bc5b68890">21,025</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e56c025683743ddb68924e934a1c045_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjQ5MWRkZTMzMGVlYjQwNzQ5MGNiOWY0ZDA4NmMyMjJlL3RhYmxlcmFuZ2U6NDkxZGRlMzMwZWViNDA3NDkwY2I5ZjRkMDg2YzIyMmVfMTAtMTMtMS0xLTE4NjgyMQ_a55a3bbe-2560-414c-93f2-2d92c68c2b52">731,469</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635d765ec67b4491a13addb3d7bc40cd_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjQ5MWRkZTMzMGVlYjQwNzQ5MGNiOWY0ZDA4NmMyMjJlL3RhYmxlcmFuZ2U6NDkxZGRlMzMwZWViNDA3NDkwY2I5ZjRkMDg2YzIyMmVfMTAtMTUtMS0xLTE4NjgyMQ_9b0eaa28-101a-494c-bdeb-30ef50dbb224">1,615,197</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><div id="i5f1eb1bd01d541c3aa0777712077c048_31"></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i5f1eb1bd01d541c3aa0777712077c048_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)</span></div><div style="text-align:center"><span><br/></span></div><div id="i5f1eb1bd01d541c3aa0777712077c048_34"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.&#160;<ix:nonNumeric contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8zNC9mcmFnOjlhMDA5ODY5OGJiZDRlZDdiNGIwNjBiOTRhYzdiNDJiL3RleHRyZWdpb246OWEwMDk4Njk4YmJkNGVkN2I0YjA2MGI5NGFjN2I0MmJfMTE1MzU_9a271c17-48d3-433c-a001-3e0abf5f1725" continuedAt="i11ea7fbf375644928db817d4f4d3182f" escape="true"><ix:nonNumeric contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8zNC9mcmFnOjlhMDA5ODY5OGJiZDRlZDdiNGIwNjBiOTRhYzdiNDJiL3RleHRyZWdpb246OWEwMDk4Njk4YmJkNGVkN2I0YjA2MGI5NGFjN2I0MmJfMTE1NTg_ea1029b2-f949-44ff-b5bf-d9661e8abd29" continuedAt="i3993f508d3b243b1bf0edf163452c695" escape="true">BASIS OF PRESENTATION</ix:nonNumeric></ix:nonNumeric></span></div><ix:continuation id="i3993f508d3b243b1bf0edf163452c695"><ix:continuation id="i11ea7fbf375644928db817d4f4d3182f" continuedAt="i8ce04931d4c1400285ef40c16ac2753b"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">General</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The terms &#8220;we,&#8221; &#8220;our,&#8221; &#8220;us,&#8221; &#8220;Company&#8221; and &#8220;Integra&#8221; refer to Integra LifeSciences Holdings Corporation, a Delaware corporation, and its subsidiaries unless the context suggests otherwise.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the opinion of management, the March&#160;31, 2023 unaudited condensed consolidated financial statements contain all adjustments (consisting only of normal recurring adjustments) necessary for a fair statement of the financial position, statement of changes in shareholders' equity, results of operations and cash flows of the Company. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States ("GAAP") have been condensed or omitted in accordance with the instructions to Form 10-Q and Rule&#160;10-01 of Regulation&#160;S-X. These unaudited condensed consolidated financial statements should be read in conjunction with the Company&#8217;s consolidated financial statements for the year ended December&#160;31, 2022 included in the Company&#8217;s Annual Report on Form 10-K. The December&#160;31, 2022 consolidated balance sheet was derived from audited financial statements, but does not include all disclosures required by GAAP. Operating results for the three-month period ended March&#160;31, 2023 are not necessarily indicative of the results to be expected for the entire year.</span></div></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i8ce04931d4c1400285ef40c16ac2753b">The preparation of consolidated financial statements is in conformity with GAAP, which requires management to make estimates and assumptions that affect the reported amount of assets and liabilities, the disclosure of contingent liabilities, and the reported amounts of revenues and expenses. Significant estimates affecting amounts reported or disclosed in the condensed consolidated financial statements include allowances for doubtful accounts receivable and sales returns and allowances, net realizable value of inventories, valuation of intangible assets including amortization periods for acquired intangible assets, discount rates and estimated projected cash flows used to value and test impairments of long-lived assets and goodwill, estimates of projected cash flows and depreciation and amortization periods for long-lived assets, computation of taxes, valuation allowances recorded against deferred tax assets, the valuation of stock-based compensation, valuation of derivative instruments, valuation of contingent liabilities, the fair value of debt instruments and loss contingencies. These estimates are based on historical experience and on various other assumptions that are believed to be reasonable under the current circumstances. Actual results could differ from these estimates.</ix:continuation> </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8zNC9mcmFnOjlhMDA5ODY5OGJiZDRlZDdiNGIwNjBiOTRhYzdiNDJiL3RleHRyZWdpb246OWEwMDk4Njk4YmJkNGVkN2I0YjA2MGI5NGFjN2I0MmJfMTE1NTQ_de73ae4c-95ff-4b47-8c3e-c6b91fb57eef" escape="true"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In March 2020, the FASB issued ASU 2020-04,&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Reference Rate Reform </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(Topic 848), and subsequent amendment to the initial guidance: ASU 2021-01, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Reference Rate Reform</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> (Topic 848): Scope (collectively, &#8220;Topic 848&#8221;). Topic 848 provides optional expedients and exceptions for applying GAAP to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. The amendments apply only to contracts, hedging relationships, and other transactions that reference London Inter-Bank Offered Rate ("LIBOR") or another reference rate expected to be discontinued because of reference rate reform. The guidance generally can be applied through December 31, 2024. The Alternative Reference Rates Committee, a group of private-market participants convened by the U.S. Federal Reserve Board and the New York Federal Reserve, has recommended the use of the Secured Overnight Financing Rate ("SOFR") as a more robust reference rate alternative to LIBOR. The use of SOFR as a substitute for LIBOR is, however, voluntary and may not be suitable for all market participants. There can be no assurance that the replacement rate will be economically equivalent to LIBOR, which could result in higher interest rates for us under our debt facilities. There is no guarantee that a transition from LIBOR to SOFR will not result in financial market disruptions, significant increases in benchmark rates, or our borrowing costs, any of which could have an adverse effect on our business, results of operations and financial condition. On March 24, 2023, the Company entered into the seventh amendment and restatement (the "March 2023 Amendment") of its Senior Credit Facility (the &#8220;Senior Credit Facility&#8221;) with a syndicate of lending banks with Bank of America, N.A., as Administrative Agent. In connection with the March 2023 Amendment the Company replaced all LIBOR-based contracts with SOFR, which is calculated based on overnight transactions under repurchase agreements backed by Treasury securities (See Note 6).  In March 2023, the Company entered into a basis swap where the Company receives Term SOFR and pays LIBOR to convert the portfolio of interest rate swaps from LIBOR to SOFR. Integra has elected to adopt the optional expedient under ASC 848, which will allow the interest rate swap hedging relationship to continue, without de-designation, due to the change in the indexed rate from LIBOR to SOFR. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are no other recently issued accounting pronouncements that are expected to have any significant effect on the Company's financial position, results of operations or cash flows.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><div id="i5f1eb1bd01d541c3aa0777712077c048_37"></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (continued) </span></div></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.&#160;<ix:nonNumeric contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" name="us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8zNy9mcmFnOjM1MjU5OWQwYjU5ODQxYmM5ZjY0N2MxNGMzOWRkYjVjL3RleHRyZWdpb246MzUyNTk5ZDBiNTk4NDFiYzlmNjQ3YzE0YzM5ZGRiNWNfNjkwNg_a655664e-e315-4c8c-844e-95dc6243a1d5" continuedAt="i5261ad5805c343f1981da123bb061c9b" escape="true">ACQUISITIONS AND DIVESTITURES</ix:nonNumeric></span></div><ix:continuation id="i5261ad5805c343f1981da123bb061c9b" continuedAt="idd2aec97be2c42efaead2dcf896e1219"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:107%">Surgical Innovation Associates, Inc. Acquisition</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">On December 6, 2022, the Company completed its acquisition of Surgical Innovation Associates, Inc. ("SIA") for an acquisition purchase price of $<ix:nonFraction unitRef="usd" contextRef="i2aee20b22d6c4af1adc9943efb3a200b_D20221206-20221206" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8zNy9mcmFnOjM1MjU5OWQwYjU5ODQxYmM5ZjY0N2MxNGMzOWRkYjVjL3RleHRyZWdpb246MzUyNTk5ZDBiNTk4NDFiYzlmNjQ3YzE0YzM5ZGRiNWNfNDM5ODA0NjUyMzcyMw_9c0722b6-5475-421f-b6c0-00a0d97e7d88">51.5</ix:nonFraction>&#160;million (the "SIA Acquisition"). In addition to the purchase price, the acquisition includes <ix:nonFraction unitRef="payment" contextRef="i2aee20b22d6c4af1adc9943efb3a200b_D20221206-20221206" decimals="INF" name="iart:BusinessAcquisitionNumberOfContingentLiabilities" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8zNy9mcmFnOjM1MjU5OWQwYjU5ODQxYmM5ZjY0N2MxNGMzOWRkYjVjL3RleHRyZWdpb246MzUyNTk5ZDBiNTk4NDFiYzlmNjQ3YzE0YzM5ZGRiNWNfOTg5NTYwNDY4MTgyOA_de5a27c8-8186-4083-a077-e39fa4492032">two</ix:nonFraction> separate contingent considerations payments, which are dependent on 1) achieving certain revenue-based performance milestones in 2023, 2024, and 2025 (up to $<ix:nonFraction unitRef="usd" contextRef="ic77f745d6f9e48afadfcda799fcc3235_I20221206" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8zNy9mcmFnOjM1MjU5OWQwYjU5ODQxYmM5ZjY0N2MxNGMzOWRkYjVjL3RleHRyZWdpb246MzUyNTk5ZDBiNTk4NDFiYzlmNjQ3YzE0YzM5ZGRiNWNfNDM5ODA0NjUyMzczOQ_c525274d-d38f-42ef-8d48-ffe8b9aa7853">50.0</ix:nonFraction>&#160;million in additional payments), as well as 2) the approval by the FDA of the Premarket Approval (&#8220;PMA&#8221;) Application for DuraSorb for certain uses by certain timing targets (up to $<ix:nonFraction unitRef="usd" contextRef="i4a4cd86df7eb418cb65f718c0f4e4dbd_I20221206" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8zNy9mcmFnOjM1MjU5OWQwYjU5ODQxYmM5ZjY0N2MxNGMzOWRkYjVjL3RleHRyZWdpb246MzUyNTk5ZDBiNTk4NDFiYzlmNjQ3YzE0YzM5ZGRiNWNfNjA0NzMxMzk2NTQxNg_b617409d-b05a-4571-9351-851b8581d758">40.0</ix:nonFraction>&#160;million in additional payments).  SIA's core technology, DuraSorb, is a fully resorbable scaffold of a globally accepted polymer, which is cleared for use in hernia repair, abdominal wall, and other soft tissue reinforcement. DuraSorb sales will be reported within Integra&#8217;s Tissue Technologies ("TT") segment as part of its Wound Reconstruction and Care franchise.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%">Assets Acquired and Liabilities Assumed at Fair Value</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The SIA Acquisition has been accounted for using the acquisition method of accounting. This method requires that assets acquired, and liabilities assumed in a business combination to be recognized at their fair values as of the acquisition date. </span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><ix:nonNumeric contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" name="us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8zNy9mcmFnOjM1MjU5OWQwYjU5ODQxYmM5ZjY0N2MxNGMzOWRkYjVjL3RleHRyZWdpb246MzUyNTk5ZDBiNTk4NDFiYzlmNjQ3YzE0YzM5ZGRiNWNfOTg5NTYwNDY4MTgyMQ_d58679db-b9e4-42a3-8c02-0a4b88965711" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The following table summarizes the fair values of the assets acquired and liabilities assumed at the acquisition date:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.543%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.028%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.545%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Preliminary Valuation</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Life</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9562f5f76a11487db81f0d5c50e212ba_I20221206" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8zNy9mcmFnOjM1MjU5OWQwYjU5ODQxYmM5ZjY0N2MxNGMzOWRkYjVjL3RhYmxlOjUyN2VlYzkyMzFjYTQyNjY5OTVjN2U2Nzc1MDI2Yzk0L3RhYmxlcmFuZ2U6NTI3ZWVjOTIzMWNhNDI2Njk5NWM3ZTY3NzUwMjZjOTRfMi0xLTEtMS0xOTA0NTI_e1eb70e5-1bde-481a-bd9c-d59110064992">4,438</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trade accounts receivable, net </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9562f5f76a11487db81f0d5c50e212ba_I20221206" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8zNy9mcmFnOjM1MjU5OWQwYjU5ODQxYmM5ZjY0N2MxNGMzOWRkYjVjL3RhYmxlOjUyN2VlYzkyMzFjYTQyNjY5OTVjN2U2Nzc1MDI2Yzk0L3RhYmxlcmFuZ2U6NTI3ZWVjOTIzMWNhNDI2Njk5NWM3ZTY3NzUwMjZjOTRfMy0xLTEtMS0xOTA0NTI_c7c5c069-9947-49c5-8833-356918bc9419">1,551</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventories, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9562f5f76a11487db81f0d5c50e212ba_I20221206" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8zNy9mcmFnOjM1MjU5OWQwYjU5ODQxYmM5ZjY0N2MxNGMzOWRkYjVjL3RhYmxlOjUyN2VlYzkyMzFjYTQyNjY5OTVjN2U2Nzc1MDI2Yzk0L3RhYmxlcmFuZ2U6NTI3ZWVjOTIzMWNhNDI2Njk5NWM3ZTY3NzUwMjZjOTRfNC0xLTEtMS0xOTA0NTI_39ef4e9e-226d-4c1d-87be-92b6f7ca046d">2,900</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9562f5f76a11487db81f0d5c50e212ba_I20221206" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8zNy9mcmFnOjM1MjU5OWQwYjU5ODQxYmM5ZjY0N2MxNGMzOWRkYjVjL3RhYmxlOjUyN2VlYzkyMzFjYTQyNjY5OTVjN2U2Nzc1MDI2Yzk0L3RhYmxlcmFuZ2U6NTI3ZWVjOTIzMWNhNDI2Njk5NWM3ZTY3NzUwMjZjOTRfNS0xLTEtMS0xOTA0NTI_9c29e468-4f2d-4fc1-8a34-a54507ae88f8">1,654</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9562f5f76a11487db81f0d5c50e212ba_I20221206" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8zNy9mcmFnOjM1MjU5OWQwYjU5ODQxYmM5ZjY0N2MxNGMzOWRkYjVjL3RhYmxlOjUyN2VlYzkyMzFjYTQyNjY5OTVjN2U2Nzc1MDI2Yzk0L3RhYmxlcmFuZ2U6NTI3ZWVjOTIzMWNhNDI2Njk5NWM3ZTY3NzUwMjZjOTRfNi0xLTEtMS0yMDMyNjY_e82e506e-4888-4e14-b847-668410f96da8">10,543</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9562f5f76a11487db81f0d5c50e212ba_I20221206" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8zNy9mcmFnOjM1MjU5OWQwYjU5ODQxYmM5ZjY0N2MxNGMzOWRkYjVjL3RhYmxlOjUyN2VlYzkyMzFjYTQyNjY5OTVjN2U2Nzc1MDI2Yzk0L3RhYmxlcmFuZ2U6NTI3ZWVjOTIzMWNhNDI2Njk5NWM3ZTY3NzUwMjZjOTRfNy0xLTEtMS0xOTA0NTI_637acf7a-ec85-40a4-a671-96743095dbf2">75,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i2aee20b22d6c4af1adc9943efb3a200b_D20221206-20221206" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8zNy9mcmFnOjM1MjU5OWQwYjU5ODQxYmM5ZjY0N2MxNGMzOWRkYjVjL3RhYmxlOjUyN2VlYzkyMzFjYTQyNjY5OTVjN2U2Nzc1MDI2Yzk0L3RhYmxlcmFuZ2U6NTI3ZWVjOTIzMWNhNDI2Njk5NWM3ZTY3NzUwMjZjOTRfNy0zLTEtMS0xOTA0NTI_1b05cf1f-1723-4094-97ba-795c456c6e49">14</ix:nonNumeric> years</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9562f5f76a11487db81f0d5c50e212ba_I20221206" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8zNy9mcmFnOjM1MjU5OWQwYjU5ODQxYmM5ZjY0N2MxNGMzOWRkYjVjL3RhYmxlOjUyN2VlYzkyMzFjYTQyNjY5OTVjN2U2Nzc1MDI2Yzk0L3RhYmxlcmFuZ2U6NTI3ZWVjOTIzMWNhNDI2Njk5NWM3ZTY3NzUwMjZjOTRfOC0xLTEtMS0xOTA0NTI_9a05d3ba-9e0d-4f5b-9645-e915b6a3aff2">41,854</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total assets acquired</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9562f5f76a11487db81f0d5c50e212ba_I20221206" decimals="-3" name="iart:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8zNy9mcmFnOjM1MjU5OWQwYjU5ODQxYmM5ZjY0N2MxNGMzOWRkYjVjL3RhYmxlOjUyN2VlYzkyMzFjYTQyNjY5OTVjN2U2Nzc1MDI2Yzk0L3RhYmxlcmFuZ2U6NTI3ZWVjOTIzMWNhNDI2Njk5NWM3ZTY3NzUwMjZjOTRfOS0xLTEtMS0yMDMyNjY_96e51be7-5023-4097-b343-f019057ffbd6">127,397</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9562f5f76a11487db81f0d5c50e212ba_I20221206" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8zNy9mcmFnOjM1MjU5OWQwYjU5ODQxYmM5ZjY0N2MxNGMzOWRkYjVjL3RhYmxlOjUyN2VlYzkyMzFjYTQyNjY5OTVjN2U2Nzc1MDI2Yzk0L3RhYmxlcmFuZ2U6NTI3ZWVjOTIzMWNhNDI2Njk5NWM3ZTY3NzUwMjZjOTRfMTItMS0xLTEtMTkwNDUy_d522c00a-25c6-42fc-9423-68d697f131db">2,044</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9562f5f76a11487db81f0d5c50e212ba_I20221206" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8zNy9mcmFnOjM1MjU5OWQwYjU5ODQxYmM5ZjY0N2MxNGMzOWRkYjVjL3RhYmxlOjUyN2VlYzkyMzFjYTQyNjY5OTVjN2U2Nzc1MDI2Yzk0L3RhYmxlcmFuZ2U6NTI3ZWVjOTIzMWNhNDI2Njk5NWM3ZTY3NzUwMjZjOTRfMTMtMS0xLTEtMjAzMjY2_57cfc8de-99ce-4dca-8948-3f95ae766511">2,044</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred Tax Liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9562f5f76a11487db81f0d5c50e212ba_I20221206" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8zNy9mcmFnOjM1MjU5OWQwYjU5ODQxYmM5ZjY0N2MxNGMzOWRkYjVjL3RhYmxlOjUyN2VlYzkyMzFjYTQyNjY5OTVjN2U2Nzc1MDI2Yzk0L3RhYmxlcmFuZ2U6NTI3ZWVjOTIzMWNhNDI2Njk5NWM3ZTY3NzUwMjZjOTRfMTQtMS0xLTEtMTkwNDUy_b28b28f5-e40b-4ea0-9519-e320ebeafbeb">11,799</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9562f5f76a11487db81f0d5c50e212ba_I20221206" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8zNy9mcmFnOjM1MjU5OWQwYjU5ODQxYmM5ZjY0N2MxNGMzOWRkYjVjL3RhYmxlOjUyN2VlYzkyMzFjYTQyNjY5OTVjN2U2Nzc1MDI2Yzk0L3RhYmxlcmFuZ2U6NTI3ZWVjOTIzMWNhNDI2Njk5NWM3ZTY3NzUwMjZjOTRfMTUtMS0xLTEtMTkwNDUy_d1a29d6a-9376-4638-800f-0b08c827efda">57,607</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total liabilities assumed</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9562f5f76a11487db81f0d5c50e212ba_I20221206" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8zNy9mcmFnOjM1MjU5OWQwYjU5ODQxYmM5ZjY0N2MxNGMzOWRkYjVjL3RhYmxlOjUyN2VlYzkyMzFjYTQyNjY5OTVjN2U2Nzc1MDI2Yzk0L3RhYmxlcmFuZ2U6NTI3ZWVjOTIzMWNhNDI2Njk5NWM3ZTY3NzUwMjZjOTRfMTYtMS0xLTEtMjAzMjY2_54f10150-c76d-440e-b902-398ff21b8d72">71,450</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net assets acquired</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9562f5f76a11487db81f0d5c50e212ba_I20221206" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8zNy9mcmFnOjM1MjU5OWQwYjU5ODQxYmM5ZjY0N2MxNGMzOWRkYjVjL3RhYmxlOjUyN2VlYzkyMzFjYTQyNjY5OTVjN2U2Nzc1MDI2Yzk0L3RhYmxlcmFuZ2U6NTI3ZWVjOTIzMWNhNDI2Njk5NWM3ZTY3NzUwMjZjOTRfMTgtMS0xLTEtMjAzMjY2_cef8e103-5a43-433f-8933-277d6d0c667c">55,947</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%">Developed Technology</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The estimated fair value of the developed technology was determined using the multi-period excess earnings method of the income approach, which estimates value based on the present value of future economic benefits. Some of the more significant assumptions inherent in the development of those asset valuations include the estimated net cash flows for each year for each product including net revenues, cost of sales, R&amp;D costs, selling and marketing costs, working capital, and contributory asset charges, the appropriate discount rate to select in order to measure the risk inherent in each future cash flow stream, the assessment of the asset&#8217;s life cycle, and competitive trends impacting the asset and the cash flow stream.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The Company used a discount rate of <ix:nonFraction unitRef="number" contextRef="i9562f5f76a11487db81f0d5c50e212ba_I20221206" decimals="INF" name="iart:BusinessCombinationIntangibleAssetAcquiredDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8zNy9mcmFnOjM1MjU5OWQwYjU5ODQxYmM5ZjY0N2MxNGMzOWRkYjVjL3RleHRyZWdpb246MzUyNTk5ZDBiNTk4NDFiYzlmNjQ3YzE0YzM5ZGRiNWNfNDM5ODA0NjUyMDIxMQ_febe47d2-bf07-4388-aca2-5ebc4f2996b0">18</ix:nonFraction>% to arrive at the present value for the acquired intangible assets to reflect the rate of return a market participant would expect to earn and incremental commercial uncertainty in the cash flow projections. No assurances can be given that the underlying assumptions used to prepare the discounted cash flow analysis will not change. For these and other reasons, actual results may vary significantly from estimated results.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (continued) </span></div></div><ix:continuation id="idd2aec97be2c42efaead2dcf896e1219" continuedAt="ic4d58cd4a8b54f9c86426ac1627efab0"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%">Goodwill</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The Company allocated goodwill related to the SIA Acquisition to the TT segment. Goodwill is the excess of the consideration transferred over the net assets recognized and represents the expected revenue and cost synergies of the combined company and assembled workforce. A key factor that contributes to the recognition of goodwill, and a driver for the Company&#8217;s acquisition of SIA, is the attractive growth opportunities presented by the surgical matrix business in the breast reconstruction market. Goodwill recognized as a result of this acquisition is non-deductible for income tax purposes.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%">Contingent Consideration</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The Company determines the acquisition date fair value of contingent consideration obligations based on a probability-weighted income approach derived from revenue estimates and a probability assessment with respect to the likelihood of achieving contingent obligations. The fair value measurement is based on significant inputs not observable in the market and thus represents a Level 3 measurement as defined using the fair value concepts in ASC 820. The resulting most likely payouts are discounted using an appropriate effective annual interest rate. At each reporting date, the contingent consideration obligation will be revalued to estimated fair value and changes in fair value will be reflected as income or expense in the consolidated statement of operations. Changes in the fair value of the contingent considerations may result from changes in discount periods and rates and changes in the timing and amount of revenue estimates. Changes in assumptions utilized in the contingent consideration fair value estimates could result in an increase in the contingent consideration obligation and a corresponding charge to operating results.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">As part of the SIA Acquisition, the Company is required to pay to the shareholder of SIA up to $<ix:nonFraction unitRef="usd" contextRef="i9562f5f76a11487db81f0d5c50e212ba_I20221206" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8zNy9mcmFnOjM1MjU5OWQwYjU5ODQxYmM5ZjY0N2MxNGMzOWRkYjVjL3RleHRyZWdpb246MzUyNTk5ZDBiNTk4NDFiYzlmNjQ3YzE0YzM5ZGRiNWNfMTQyOTM2NTExOTE2NTg_8adf2133-e35e-4e11-92ef-21c5c48d648e">90.0</ix:nonFraction>&#160;million for <ix:nonFraction unitRef="payment" contextRef="i2aee20b22d6c4af1adc9943efb3a200b_D20221206-20221206" decimals="INF" name="iart:BusinessAcquisitionNumberOfContingentLiabilities" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8zNy9mcmFnOjM1MjU5OWQwYjU5ODQxYmM5ZjY0N2MxNGMzOWRkYjVjL3RleHRyZWdpb246MzUyNTk5ZDBiNTk4NDFiYzlmNjQ3YzE0YzM5ZGRiNWNfMTQyOTM2NTExOTE2NjY_de5a27c8-8186-4083-a077-e39fa4492032">two</ix:nonFraction> separate payments, which are dependent on 1) achieving certain revenue-based performance milestones in 2023, 2024, and 2025 (up to $<ix:nonFraction unitRef="usd" contextRef="ic77f745d6f9e48afadfcda799fcc3235_I20221206" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8zNy9mcmFnOjM1MjU5OWQwYjU5ODQxYmM5ZjY0N2MxNGMzOWRkYjVjL3RleHRyZWdpb246MzUyNTk5ZDBiNTk4NDFiYzlmNjQ3YzE0YzM5ZGRiNWNfMTQyOTM2NTExOTE4MDE_c525274d-d38f-42ef-8d48-ffe8b9aa7853">50.0</ix:nonFraction>&#160;million in additional payments), as well as 2) the approval by the FDA of the PMA for DuraSorb for certain uses by certain timing targets (up to $<ix:nonFraction unitRef="usd" contextRef="i4a4cd86df7eb418cb65f718c0f4e4dbd_I20221206" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8zNy9mcmFnOjM1MjU5OWQwYjU5ODQxYmM5ZjY0N2MxNGMzOWRkYjVjL3RleHRyZWdpb246MzUyNTk5ZDBiNTk4NDFiYzlmNjQ3YzE0YzM5ZGRiNWNfMTQyOTM2NTExOTE5NDI_3dfa4e95-35a6-48c9-bb5a-14d8cf59db11">40.0</ix:nonFraction>&#160;million in additional payments).  The Company used iterations of the Monte Carlo simulation to calculate the fair value of the contingent consideration for the revenue-based milestone that considered the possible outcomes of scenarios related to each specific milestone for the revenue based performance milestone. The Company used probabilities of achieving the conditions to calculate the fair value of the contingent consideration for the PMA approval milestone.  The Company estimated the fair value of the contingent consideration for the revenue based milestone to be $<ix:nonFraction unitRef="usd" contextRef="ic77f745d6f9e48afadfcda799fcc3235_I20221206" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8zNy9mcmFnOjM1MjU5OWQwYjU5ODQxYmM5ZjY0N2MxNGMzOWRkYjVjL3RleHRyZWdpb246MzUyNTk5ZDBiNTk4NDFiYzlmNjQ3YzE0YzM5ZGRiNWNfMTQyOTM2NTExOTI1MTI_da5ede24-cd13-4b88-809b-5ec5e03823e3">32.6</ix:nonFraction>&#160;million at the acquisition date and $<ix:nonFraction unitRef="usd" contextRef="i4a4cd86df7eb418cb65f718c0f4e4dbd_I20221206" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8zNy9mcmFnOjM1MjU5OWQwYjU5ODQxYmM5ZjY0N2MxNGMzOWRkYjVjL3RleHRyZWdpb246MzUyNTk5ZDBiNTk4NDFiYzlmNjQ3YzE0YzM5ZGRiNWNfMTQyOTM2NTExOTI1NDQ_f6b3dbf3-463d-4c3c-bc3f-efd7371ae4db">25.0</ix:nonFraction>&#160;million for the PMA approval milestone as of December 31, 2022. The company recorded a total of $<ix:nonFraction unitRef="usd" contextRef="i5b74908fc42a482b9a714af70be67c23_I20230331" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8zNy9mcmFnOjM1MjU5OWQwYjU5ODQxYmM5ZjY0N2MxNGMzOWRkYjVjL3RleHRyZWdpb246MzUyNTk5ZDBiNTk4NDFiYzlmNjQ3YzE0YzM5ZGRiNWNfNTQ5NzU1ODQ1OTg3_616bf53a-f7da-4049-9d3c-d5c326d48a98">48.7</ix:nonFraction>&#160;million in other liabilities as of March 31, 2023 and $<ix:nonFraction unitRef="usd" contextRef="i5b74908fc42a482b9a714af70be67c23_I20230331" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8zNy9mcmFnOjM1MjU5OWQwYjU5ODQxYmM5ZjY0N2MxNGMzOWRkYjVjL3RleHRyZWdpb246MzUyNTk5ZDBiNTk4NDFiYzlmNjQ3YzE0YzM5ZGRiNWNfNTQ5NzU1ODQ2MDA0_b5fd02fa-be57-4736-b220-d243bba0ac64">12.5</ix:nonFraction>&#160;million in accrued expenses and other current liabilities at March 31, 2023 in the consolidated balance sheet of the company.  </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The change in the fair value of the contingent obligation was primarily as a result of changes in the timing.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%">Deferred Tax Liabilities</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Deferred tax liabilities result from identifiable intangible assets&#8217; fair value adjustments. These adjustments create excess book basis over tax basis which is tax-effected by the statutory tax rates of applicable jurisdictions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:107%">Sale of non-core traditional wound care business</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 31, 2022, the Company completed its sale of its non-core traditional wound care ("TWC") business to Gentell, LLC ("Gentell") for $<ix:nonFraction unitRef="usd" contextRef="i945ecb5f56064998992427ac8c2997e7_I20220831" decimals="-5" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8zNy9mcmFnOjM1MjU5OWQwYjU5ODQxYmM5ZjY0N2MxNGMzOWRkYjVjL3RleHRyZWdpb246MzUyNTk5ZDBiNTk4NDFiYzlmNjQ3YzE0YzM5ZGRiNWNfNjA0NzMxMzk2Nzc4MA_2b50af60-c258-4636-82f7-aa0798848164">28.8</ix:nonFraction> million, which consists of $<ix:nonFraction unitRef="usd" contextRef="i04a8a39a1e704ddfa67a4702f8617631_D20220831-20220831" decimals="-5" name="us-gaap:ProceedsFromDivestitureOfBusinesses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8zNy9mcmFnOjM1MjU5OWQwYjU5ODQxYmM5ZjY0N2MxNGMzOWRkYjVjL3RleHRyZWdpb246MzUyNTk5ZDBiNTk4NDFiYzlmNjQ3YzE0YzM5ZGRiNWNfNjA0NzMxMzk2Nzc4NQ_8af016e9-fa26-4926-9ee7-af67aaca5464">27.8</ix:nonFraction> million in cash plus $<ix:nonFraction unitRef="usd" contextRef="i945ecb5f56064998992427ac8c2997e7_I20220831" decimals="-5" name="iart:DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsideration" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8zNy9mcmFnOjM1MjU5OWQwYjU5ODQxYmM5ZjY0N2MxNGMzOWRkYjVjL3RleHRyZWdpb246MzUyNTk5ZDBiNTk4NDFiYzlmNjQ3YzE0YzM5ZGRiNWNfNjA0NzMxMzk2Nzc5Mw_d3a65443-7ff2-4c6a-8d5d-33d5b3ab5792">1.0</ix:nonFraction> million in contingent consideration which may be received upon achieving certain revenue-based performance milestones <ix:nonNumeric contextRef="i945ecb5f56064998992427ac8c2997e7_I20220831" name="iart:DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsiderationPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8zNy9mcmFnOjM1MjU5OWQwYjU5ODQxYmM5ZjY0N2MxNGMzOWRkYjVjL3RleHRyZWdpb246MzUyNTk5ZDBiNTk4NDFiYzlmNjQ3YzE0YzM5ZGRiNWNfNjA0NzMxMzk2Nzc5OA_2881b6fc-fdcc-4cc6-a7de-31377fbdf01b">two years</ix:nonNumeric> after the closing date. The proceeds from the sale of the TWC business of $<ix:nonFraction unitRef="usd" contextRef="i04a8a39a1e704ddfa67a4702f8617631_D20220831-20220831" decimals="-5" name="us-gaap:ProceedsFromDivestitureOfBusinesses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8zNy9mcmFnOjM1MjU5OWQwYjU5ODQxYmM5ZjY0N2MxNGMzOWRkYjVjL3RleHRyZWdpb246MzUyNTk5ZDBiNTk4NDFiYzlmNjQ3YzE0YzM5ZGRiNWNfNjA0NzMxMzk2NzgwMw_8af016e9-fa26-4926-9ee7-af67aaca5464">27.8</ix:nonFraction> million is presented in the consolidated statement of cash flows net of cash transferred of $<ix:nonFraction unitRef="usd" contextRef="i04a8a39a1e704ddfa67a4702f8617631_D20220831-20220831" decimals="-5" name="us-gaap:CashDivestedFromDeconsolidation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8zNy9mcmFnOjM1MjU5OWQwYjU5ODQxYmM5ZjY0N2MxNGMzOWRkYjVjL3RleHRyZWdpb246MzUyNTk5ZDBiNTk4NDFiYzlmNjQ3YzE0YzM5ZGRiNWNfNjA0NzMxMzk2NzgwNw_5f778ce6-0816-4b6e-ba3d-3e6cdf7e003c">3.5</ix:nonFraction> million and other transaction fees. The transaction included the sale of the Company's TWC products, such as sponges, gauze and conforming bandages, and certain advanced wound care dressings, such as supportive, calcium alginate, hydrogel, and foam dressings.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (continued) </span></div></div><ix:continuation id="ic4d58cd4a8b54f9c86426ac1627efab0"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The divestiture did not represent a strategic shift that had a major effect on the Company's operations and financial statements. Goodwill was allocated to the assets and liabilities divested using the relative fair value method of the TWC business to the Company's TT reportable business segment. In connection with the sale, the Company recognized $<ix:nonFraction unitRef="usd" contextRef="i36c1f405b82c4668bb563f8b0467fa90_D20220101-20221231" decimals="-5" name="us-gaap:GainLossOnSaleOfBusiness" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8zNy9mcmFnOjM1MjU5OWQwYjU5ODQxYmM5ZjY0N2MxNGMzOWRkYjVjL3RleHRyZWdpb246MzUyNTk5ZDBiNTk4NDFiYzlmNjQ3YzE0YzM5ZGRiNWNfNDM5ODA0NjUyNjIyMg_22cf0418-7546-4ea5-af45-99503f5ff795">0.6</ix:nonFraction> million as a gain from the sale of the business in the condensed consolidated statement of operations for the year ended December&#160;31, 2022. The transaction is subject to final working capital adjustments.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the purchase and sale agreement, the Company also entered into a contract manufacturing agreement with Gentell. Under the terms of the agreement, Gentell received inventory, equipment, and tooling to manufacture certain MediHoney&#174; and TCC-EZ&#174; products on behalf of the Company. On the close date of this transaction, the Company transferred all inventory associated with these products to Gentell and recognized an asset of $<ix:nonFraction unitRef="usd" contextRef="i945ecb5f56064998992427ac8c2997e7_I20220831" decimals="-5" name="iart:DiscontinuedOperationContinuingInvolvementPrepaidAsset" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8zNy9mcmFnOjM1MjU5OWQwYjU5ODQxYmM5ZjY0N2MxNGMzOWRkYjVjL3RleHRyZWdpb246MzUyNTk5ZDBiNTk4NDFiYzlmNjQ3YzE0YzM5ZGRiNWNfNDM5ODA0NjUyNjIyNw_2e28ba02-e86d-4102-a8c7-63d84806aa57">11.1</ix:nonFraction> million, as a form of a deposit for the inventory transferred, which based on the expected timing of inventory purchases, was primarily included within prepaid expenses and other current assets in the consolidated balance sheet. This deposit will be utilized by the Company on future orders placed to Gentell for such products. As of March&#160;31, 2023, the Company had a deposit remaining of $<ix:nonFraction unitRef="usd" contextRef="i07f57ce44af74eeb8d954e3a7fb7f1bc_I20230331" decimals="-5" name="iart:DiscontinuedOperationContinuingInvolvementPrepaidAssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8zNy9mcmFnOjM1MjU5OWQwYjU5ODQxYmM5ZjY0N2MxNGMzOWRkYjVjL3RleHRyZWdpb246MzUyNTk5ZDBiNTk4NDFiYzlmNjQ3YzE0YzM5ZGRiNWNfNDM5ODA0NjUyNjI3Mw_7df05f0e-d4e0-4671-8636-bc0184185035">7.3</ix:nonFraction> million which is included in prepaid assets and recognized a payable due to Gentell of $<ix:nonFraction unitRef="usd" contextRef="i07f57ce44af74eeb8d954e3a7fb7f1bc_I20230331" decimals="-5" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8zNy9mcmFnOjM1MjU5OWQwYjU5ODQxYmM5ZjY0N2MxNGMzOWRkYjVjL3RleHRyZWdpb246MzUyNTk5ZDBiNTk4NDFiYzlmNjQ3YzE0YzM5ZGRiNWNfNDM5ODA0NjUyNjI4OA_ebef7be1-ba6d-4d1f-bb61-904a5902887b">0.7</ix:nonFraction> million, which is included in the condensed consolidated balance sheet within accrued expenses and other current liabilities.</span></div></ix:continuation><div id="i5f1eb1bd01d541c3aa0777712077c048_40"></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.&#160;<ix:nonNumeric contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80MC9mcmFnOjM5ODIzMTE1ZWIyYTQ0ZTI5NmEwOGZmNTVmZWQ5NjU3L3RleHRyZWdpb246Mzk4MjMxMTVlYjJhNDRlMjk2YTA4ZmY1NWZlZDk2NTdfNDk4Ng_7aa48cc9-816a-465c-8b21-7400a901fd02" continuedAt="iea73d9db2c50420983f6999c54dbd90f" escape="true">REVENUES FROM CONTRACTS WITH CUSTOMERS </ix:nonNumeric></span></div><ix:continuation id="iea73d9db2c50420983f6999c54dbd90f" continuedAt="i412ecfbed6d24998b34c7af014bbc0ca"><ix:nonNumeric contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80MC9mcmFnOjM5ODIzMTE1ZWIyYTQ0ZTI5NmEwOGZmNTVmZWQ5NjU3L3RleHRyZWdpb246Mzk4MjMxMTVlYjJhNDRlMjk2YTA4ZmY1NWZlZDk2NTdfNTAwMA_fd2b8488-39de-4aaa-b957-3d30ccb75091" continuedAt="i9a9bff6203534edd9a52b3d9c19ca833" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Summary of Accounting Policies on Revenue Recognition</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized upon the transfer of control of promised products or services to the customers in an amount that reflects the consideration the Company expects to receive in exchange for those products and services.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Performance Obligations</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's performance obligations consist mainly of transferring control of goods and services identified in the contracts, purchase orders, or invoices. The Company has no significant multi-element contracts with customers.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Significant Estimates</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Usage-based royalties and licenses are estimated based on the provisions of contracts with customers and recognized in the same period that the royalty-based products are sold by the Company's strategic partners. The Company estimates and recognizes royalty revenue based upon communication with licensees, historical information, and expected sales trends. Differences between actual reported licensee sales and those that were estimated are adjusted in the period in which they become known, which is typically the following quarter. Historically, such adjustments have not been significant.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company estimates returns, price concessions, and discount allowances using the expected value method based on historical trends and other known factors. Rebate allowances are estimated using the most likely method based on each customer contract.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's return policy, as set forth in its product catalogs and sales invoices, requires review and authorization in advance prior to the return of product. Upon the authorization, a credit will be issued for the goods returned within a set amount of days from the shipment, which is generally <ix:nonNumeric contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" name="iart:ReturnPolicyIssueOfCreditNumberOfDaysFromShipment" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80MC9mcmFnOjM5ODIzMTE1ZWIyYTQ0ZTI5NmEwOGZmNTVmZWQ5NjU3L3RleHRyZWdpb246Mzk4MjMxMTVlYjJhNDRlMjk2YTA4ZmY1NWZlZDk2NTdfMTc0NQ_9c577405-c679-4006-a076-e5db00ae3dea">90</ix:nonNumeric> days.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company disregards the effects of a financing component if the Company expects, at contract inception, that the period between the transfer and customer payment for the goods or services will be one year or less. The Company has no significant revenues recognized on payments expected to be received more than one year after the transfer of control of products or services to customers.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contract Asset and Liability</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues recognized from the Company's private label business that are not invoiced to the customers as a result of recognizing revenue over time are recorded as a contract asset included in the prepaid expenses and other current assets account in the consolidated balance sheets.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other operating revenues may include fees received under service agreements. Non-refundable fees received under multiple-period service agreements are recognized as revenue as the Company satisfies the performance obligations to the other party. A portion of the transaction price allocated to the performance obligations to be satisfied in the future periods is recognized as contract liability.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (continued) </span></div></div><ix:continuation id="i412ecfbed6d24998b34c7af014bbc0ca" continuedAt="i8f89dfdb884c4e0c849ca8172d4f04e7"><ix:nonNumeric contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" name="us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80MC9mcmFnOjM5ODIzMTE1ZWIyYTQ0ZTI5NmEwOGZmNTVmZWQ5NjU3L3RleHRyZWdpb246Mzk4MjMxMTVlYjJhNDRlMjk2YTA4ZmY1NWZlZDk2NTdfNDk5Mw_9e3755f4-e76a-49b6-8506-558a126e958a" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarized the changes in the contract asset and liability balances for the three months ended March 31, 2023:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:79.747%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:18.053%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Contract Asset</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contract asset, January 1, 2023</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231" decimals="-3" name="us-gaap:ContractWithCustomerAssetNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80MC9mcmFnOjM5ODIzMTE1ZWIyYTQ0ZTI5NmEwOGZmNTVmZWQ5NjU3L3RhYmxlOmU3M2M5NjU5MzIxNzRjMTk4MGM1ZWEwM2Y0ZjQ4MjE3L3RhYmxlcmFuZ2U6ZTczYzk2NTkzMjE3NGMxOTgwYzVlYTAzZjRmNDgyMTdfNC01LTEtMS0xODY4MjE_60e4e016-da0d-4ee5-90ff-23942a65b5fa">10,122</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transferred to trade receivable from contract asset included in beginning of the year contract asset</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" decimals="-3" name="us-gaap:ContractWithCustomerAssetReclassifiedToReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80MC9mcmFnOjM5ODIzMTE1ZWIyYTQ0ZTI5NmEwOGZmNTVmZWQ5NjU3L3RhYmxlOmU3M2M5NjU5MzIxNzRjMTk4MGM1ZWEwM2Y0ZjQ4MjE3L3RhYmxlcmFuZ2U6ZTczYzk2NTkzMjE3NGMxOTgwYzVlYTAzZjRmNDgyMTdfNS01LTEtMS0xODY4MjE_59d7cee0-3ceb-419d-b6ae-8c7469dc02d3">9,765</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contract asset, net of transferred to trade receivables on contracts during the period</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" decimals="-3" name="iart:ContractWithCustomerAssetNetOfReclassifiedToReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80MC9mcmFnOjM5ODIzMTE1ZWIyYTQ0ZTI5NmEwOGZmNTVmZWQ5NjU3L3RhYmxlOmU3M2M5NjU5MzIxNzRjMTk4MGM1ZWEwM2Y0ZjQ4MjE3L3RhYmxlcmFuZ2U6ZTczYzk2NTkzMjE3NGMxOTgwYzVlYTAzZjRmNDgyMTdfNi01LTEtMS0xODY4MjE_1fdb35de-3dd7-4d2b-b592-345bf7de49b3">9,713</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contract asset, March&#160;31, 2023</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331" decimals="-3" name="us-gaap:ContractWithCustomerAssetNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80MC9mcmFnOjM5ODIzMTE1ZWIyYTQ0ZTI5NmEwOGZmNTVmZWQ5NjU3L3RhYmxlOmU3M2M5NjU5MzIxNzRjMTk4MGM1ZWEwM2Y0ZjQ4MjE3L3RhYmxlcmFuZ2U6ZTczYzk2NTkzMjE3NGMxOTgwYzVlYTAzZjRmNDgyMTdfNy01LTEtMS0xODY4MjE_a2900e7b-c5bd-44a9-8bd7-8a46d4faba44">10,070</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Contract Liability</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contract liability, January 1, 2023</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231" decimals="-3" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80MC9mcmFnOjM5ODIzMTE1ZWIyYTQ0ZTI5NmEwOGZmNTVmZWQ5NjU3L3RhYmxlOmU3M2M5NjU5MzIxNzRjMTk4MGM1ZWEwM2Y0ZjQ4MjE3L3RhYmxlcmFuZ2U6ZTczYzk2NTkzMjE3NGMxOTgwYzVlYTAzZjRmNDgyMTdfMTAtNS0xLTEtMTg2ODIx_262f0474-d1e2-4cca-a88b-66b827589250">16,127</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Recognition of revenue included in beginning of year contract liability</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" decimals="-3" sign="-" name="iart:ContractWithCustomerLiabilityNetOfRevenueRecognized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80MC9mcmFnOjM5ODIzMTE1ZWIyYTQ0ZTI5NmEwOGZmNTVmZWQ5NjU3L3RhYmxlOmU3M2M5NjU5MzIxNzRjMTk4MGM1ZWEwM2Y0ZjQ4MjE3L3RhYmxlcmFuZ2U6ZTczYzk2NTkzMjE3NGMxOTgwYzVlYTAzZjRmNDgyMTdfMTEtNS0xLTEtMTg2ODIx_5e7be706-eeae-4990-b152-926ba14e5063">2,492</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contract liability, net of revenue recognized on contracts during the period</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80MC9mcmFnOjM5ODIzMTE1ZWIyYTQ0ZTI5NmEwOGZmNTVmZWQ5NjU3L3RhYmxlOmU3M2M5NjU5MzIxNzRjMTk4MGM1ZWEwM2Y0ZjQ4MjE3L3RhYmxlcmFuZ2U6ZTczYzk2NTkzMjE3NGMxOTgwYzVlYTAzZjRmNDgyMTdfMTItNS0xLTEtMTg2ODIx_22ccca8e-b5e8-4f5d-bf34-03d923fa435c">2,921</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" decimals="-3" name="iart:ContractWithCustomerLiabilityIncreaseDecreaseFromForeignCurrencyTranslation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80MC9mcmFnOjM5ODIzMTE1ZWIyYTQ0ZTI5NmEwOGZmNTVmZWQ5NjU3L3RhYmxlOmU3M2M5NjU5MzIxNzRjMTk4MGM1ZWEwM2Y0ZjQ4MjE3L3RhYmxlcmFuZ2U6ZTczYzk2NTkzMjE3NGMxOTgwYzVlYTAzZjRmNDgyMTdfMTMtNS0xLTEtMTg2ODIx_763a5207-af8a-40f5-b836-da9e21012e4e">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contract liability, March&#160;31, 2023</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331" decimals="-3" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80MC9mcmFnOjM5ODIzMTE1ZWIyYTQ0ZTI5NmEwOGZmNTVmZWQ5NjU3L3RhYmxlOmU3M2M5NjU5MzIxNzRjMTk4MGM1ZWEwM2Y0ZjQ4MjE3L3RhYmxlcmFuZ2U6ZTczYzk2NTkzMjE3NGMxOTgwYzVlYTAzZjRmNDgyMTdfMTQtNS0xLTEtMTg2ODIx_c324b4d5-6efc-4a52-b40e-c8784aa2daa2">16,559</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2023, the short-term portion of the contract liability of $<ix:nonFraction unitRef="usd" contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80MC9mcmFnOjM5ODIzMTE1ZWIyYTQ0ZTI5NmEwOGZmNTVmZWQ5NjU3L3RleHRyZWdpb246Mzk4MjMxMTVlYjJhNDRlMjk2YTA4ZmY1NWZlZDk2NTdfMzAwNw_a26e267e-6bff-4317-b575-4235d996a62a">7.7</ix:nonFraction> million and the long-term portion of $<ix:nonFraction unitRef="usd" contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80MC9mcmFnOjM5ODIzMTE1ZWIyYTQ0ZTI5NmEwOGZmNTVmZWQ5NjU3L3RleHRyZWdpb246Mzk4MjMxMTVlYjJhNDRlMjk2YTA4ZmY1NWZlZDk2NTdfMzAzOQ_f3721919-fc3c-4a58-b470-ea0fd056685f">8.8</ix:nonFraction> million is included in current liabilities and other liabilities, respectively, in the consolidated balance sheets.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023, the Company is expected to recognize revenue of approximately <ix:nonFraction unitRef="number" contextRef="i770b51dde44c4f0f852868d1b571cf9e_I20230331" decimals="2" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80MC9mcmFnOjM5ODIzMTE1ZWIyYTQ0ZTI5NmEwOGZmNTVmZWQ5NjU3L3RleHRyZWdpb246Mzk4MjMxMTVlYjJhNDRlMjk2YTA4ZmY1NWZlZDk2NTdfMzIyMg_faba3370-4033-4831-9e63-5dfe4dd3d6ef">47</ix:nonFraction>% of unsatisfied (or partially unsatisfied) performance obligations as revenue within <ix:nonNumeric contextRef="i770b51dde44c4f0f852868d1b571cf9e_I20230331" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80MC9mcmFnOjM5ODIzMTE1ZWIyYTQ0ZTI5NmEwOGZmNTVmZWQ5NjU3L3RleHRyZWdpb246Mzk4MjMxMTVlYjJhNDRlMjk2YTA4ZmY1NWZlZDk2NTdfMzMwOQ_85345b83-ad3e-417b-b173-d8357f1b2324">12</ix:nonNumeric> months, with the remaining balance to be recognized thereafter.</span></div><ix:continuation id="i9a9bff6203534edd9a52b3d9c19ca833"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Shipping and Handling Fees</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company elected to account for shipping and handling activities as a fulfillment cost rather than a separate performance obligation. Amounts billed to customers for shipping and handling are included as part of the transaction price and recognized as revenue when control of underlying products is transferred to the customer. The related shipping and freight charges incurred by the Company are included in the cost of goods sold.</span></div></ix:continuation><ix:nonNumeric contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" name="us-gaap:ExtendedProductWarrantyPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80MC9mcmFnOjM5ODIzMTE1ZWIyYTQ0ZTI5NmEwOGZmNTVmZWQ5NjU3L3RleHRyZWdpb246Mzk4MjMxMTVlYjJhNDRlMjk2YTA4ZmY1NWZlZDk2NTdfNDk4Mg_daf016d9-8435-4ce1-8aac-e541b1ef1e11" escape="true"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Product Warranties</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of the Company's medical devices, including monitoring systems and neurosurgical systems, are designed to operate over long periods of time. These products are sold with warranties which may extend for up to <ix:nonNumeric contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" name="iart:RevenueProductWarrantyPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80MC9mcmFnOjM5ODIzMTE1ZWIyYTQ0ZTI5NmEwOGZmNTVmZWQ5NjU3L3RleHRyZWdpb246Mzk4MjMxMTVlYjJhNDRlMjk2YTA4ZmY1NWZlZDk2NTdfNDA2Nw_a5b37686-a444-4976-8e7f-d551433c7eba">two years</ix:nonNumeric> from the date of purchase. The warranties are not considered a separate performance obligation. The Company estimates its product warranties using the expected value method based on historical trends and other known factors. The Company includes them in accrued expenses and other current liabilities in the consolidated balance sheet.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" name="us-gaap:RevenueTransactionPriceMeasurementTaxExclusionPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80MC9mcmFnOjM5ODIzMTE1ZWIyYTQ0ZTI5NmEwOGZmNTVmZWQ5NjU3L3RleHRyZWdpb246Mzk4MjMxMTVlYjJhNDRlMjk2YTA4ZmY1NWZlZDk2NTdfNTAwMQ_39f5251a-8d05-438a-922a-1fa22f60c242" escape="true"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Taxes Collected from Customers</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company elected to exclude from the measurement of the transaction price all taxes assessed by a governmental authority that are both imposed on and concurrent with a specific revenue-producing transaction and collected by the entity from a customer.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (continued) </span></div></div><ix:continuation id="i8f89dfdb884c4e0c849ca8172d4f04e7"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Disaggregated Revenue</span></div><ix:nonNumeric contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80MC9mcmFnOjM5ODIzMTE1ZWIyYTQ0ZTI5NmEwOGZmNTVmZWQ5NjU3L3RleHRyZWdpb246Mzk4MjMxMTVlYjJhNDRlMjk2YTA4ZmY1NWZlZDk2NTdfNTAwNA_4eee4e43-6a12-427c-8e4a-0d214d86c88e" escape="true"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents revenues disaggregated by the major sources of revenues for the three months ended March&#160;31, 2023 and 2022 (dollar amounts in thousands):</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.028%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.545%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Neurosurgery</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41cd523bdedf46cc95670faedd457b46_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80MC9mcmFnOjM5ODIzMTE1ZWIyYTQ0ZTI5NmEwOGZmNTVmZWQ5NjU3L3RhYmxlOmI2ZTM5OWI4MzFmZjQ4YTNhOWI4YWU4M2FiNDg0MjAxL3RhYmxlcmFuZ2U6YjZlMzk5YjgzMWZmNDhhM2E5YjhhZTgzYWI0ODQyMDFfMS0xLTEtMS0xODY4MjE_902c8a00-bf2a-416e-9577-d57122a7d0f0">192,870</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb2f835f7aba47f8b013ef0af01dc9fa_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80MC9mcmFnOjM5ODIzMTE1ZWIyYTQ0ZTI5NmEwOGZmNTVmZWQ5NjU3L3RhYmxlOmI2ZTM5OWI4MzFmZjQ4YTNhOWI4YWU4M2FiNDg0MjAxL3RhYmxlcmFuZ2U6YjZlMzk5YjgzMWZmNDhhM2E5YjhhZTgzYWI0ODQyMDFfMS0zLTEtMS0xODY4MjE_13424041-7c48-42a6-99f8-46b4035acdd4">194,675</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Instruments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f536ce18eba4aa1b760c5c3107d3a2a_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80MC9mcmFnOjM5ODIzMTE1ZWIyYTQ0ZTI5NmEwOGZmNTVmZWQ5NjU3L3RhYmxlOmI2ZTM5OWI4MzFmZjQ4YTNhOWI4YWU4M2FiNDg0MjAxL3RhYmxlcmFuZ2U6YjZlMzk5YjgzMWZmNDhhM2E5YjhhZTgzYWI0ODQyMDFfMi0xLTEtMS0xODY4MjE_8185fb7e-dc1c-4c18-90b4-22b131e443da">55,266</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5280886888b459382b2676a7723925f_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80MC9mcmFnOjM5ODIzMTE1ZWIyYTQ0ZTI5NmEwOGZmNTVmZWQ5NjU3L3RhYmxlOmI2ZTM5OWI4MzFmZjQ4YTNhOWI4YWU4M2FiNDg0MjAxL3RhYmxlcmFuZ2U6YjZlMzk5YjgzMWZmNDhhM2E5YjhhZTgzYWI0ODQyMDFfMi0zLTEtMS0xODY4MjE_a243e3a7-0f73-4bb3-b7ea-4ed8544d4bca">52,633</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Codman Specialty Surgical</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd59456ea9aa4f04b19628e881f264f6_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80MC9mcmFnOjM5ODIzMTE1ZWIyYTQ0ZTI5NmEwOGZmNTVmZWQ5NjU3L3RhYmxlOmI2ZTM5OWI4MzFmZjQ4YTNhOWI4YWU4M2FiNDg0MjAxL3RhYmxlcmFuZ2U6YjZlMzk5YjgzMWZmNDhhM2E5YjhhZTgzYWI0ODQyMDFfMy0xLTEtMS0xODY4MjE_799fc8ee-8554-428c-af38-8b8b098274d5">248,136</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6524a64fd30c42eca0a31257f157eeec_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80MC9mcmFnOjM5ODIzMTE1ZWIyYTQ0ZTI5NmEwOGZmNTVmZWQ5NjU3L3RhYmxlOmI2ZTM5OWI4MzFmZjQ4YTNhOWI4YWU4M2FiNDg0MjAxL3RhYmxlcmFuZ2U6YjZlMzk5YjgzMWZmNDhhM2E5YjhhZTgzYWI0ODQyMDFfMy0zLTEtMS0xODY4MjE_6749f577-5d90-4c28-9d6c-5ba77add67ab">247,308</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Wound Reconstruction and Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b9610cb297e4cb9a4dacf782076fbbb_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80MC9mcmFnOjM5ODIzMTE1ZWIyYTQ0ZTI5NmEwOGZmNTVmZWQ5NjU3L3RhYmxlOmI2ZTM5OWI4MzFmZjQ4YTNhOWI4YWU4M2FiNDg0MjAxL3RhYmxlcmFuZ2U6YjZlMzk5YjgzMWZmNDhhM2E5YjhhZTgzYWI0ODQyMDFfNS0xLTEtMS0xODY4MjE_e0993c47-596f-4a9f-a88a-3579cd73696f">100,940</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac40b4f9e2254c7da7351d7d272012dd_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80MC9mcmFnOjM5ODIzMTE1ZWIyYTQ0ZTI5NmEwOGZmNTVmZWQ5NjU3L3RhYmxlOmI2ZTM5OWI4MzFmZjQ4YTNhOWI4YWU4M2FiNDg0MjAxL3RhYmxlcmFuZ2U6YjZlMzk5YjgzMWZmNDhhM2E5YjhhZTgzYWI0ODQyMDFfNS0zLTEtMS0xODY4MjE_245b9b67-0d0c-4acf-85da-1ea7e49e03b9">94,630</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Private Label</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90fa502ea15741368ebd39ece562c20f_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80MC9mcmFnOjM5ODIzMTE1ZWIyYTQ0ZTI5NmEwOGZmNTVmZWQ5NjU3L3RhYmxlOmI2ZTM5OWI4MzFmZjQ4YTNhOWI4YWU4M2FiNDg0MjAxL3RhYmxlcmFuZ2U6YjZlMzk5YjgzMWZmNDhhM2E5YjhhZTgzYWI0ODQyMDFfNi0xLTEtMS0xODY4MjE_97f546c3-c3ea-4eaa-a534-9282519afb79">31,770</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0fd180115b9642178d42038efe2b2776_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80MC9mcmFnOjM5ODIzMTE1ZWIyYTQ0ZTI5NmEwOGZmNTVmZWQ5NjU3L3RhYmxlOmI2ZTM5OWI4MzFmZjQ4YTNhOWI4YWU4M2FiNDg0MjAxL3RhYmxlcmFuZ2U6YjZlMzk5YjgzMWZmNDhhM2E5YjhhZTgzYWI0ODQyMDFfNi0zLTEtMS0xODY4MjE_7a549352-6036-4c54-a67f-75c11961ac3b">34,700</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Tissue Technologies</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcfddd0c2c684ea4acbf2b9ae4cd8527_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80MC9mcmFnOjM5ODIzMTE1ZWIyYTQ0ZTI5NmEwOGZmNTVmZWQ5NjU3L3RhYmxlOmI2ZTM5OWI4MzFmZjQ4YTNhOWI4YWU4M2FiNDg0MjAxL3RhYmxlcmFuZ2U6YjZlMzk5YjgzMWZmNDhhM2E5YjhhZTgzYWI0ODQyMDFfNy0xLTEtMS0xODY4MjE_a747fd4b-d608-4be5-b7f7-f2ac29317188">132,710</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i842208849e5d47b588209f3a26f3a724_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80MC9mcmFnOjM5ODIzMTE1ZWIyYTQ0ZTI5NmEwOGZmNTVmZWQ5NjU3L3RhYmxlOmI2ZTM5OWI4MzFmZjQ4YTNhOWI4YWU4M2FiNDg0MjAxL3RhYmxlcmFuZ2U6YjZlMzk5YjgzMWZmNDhhM2E5YjhhZTgzYWI0ODQyMDFfNy0zLTEtMS0xODY4MjE_ca0818ee-56c0-4744-8488-b1501934e561">129,330</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80MC9mcmFnOjM5ODIzMTE1ZWIyYTQ0ZTI5NmEwOGZmNTVmZWQ5NjU3L3RhYmxlOmI2ZTM5OWI4MzFmZjQ4YTNhOWI4YWU4M2FiNDg0MjAxL3RhYmxlcmFuZ2U6YjZlMzk5YjgzMWZmNDhhM2E5YjhhZTgzYWI0ODQyMDFfOC0xLTEtMS0xODY4MjE_888fcd10-59ed-4193-9f40-ad60ccd5500a">380,846</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80MC9mcmFnOjM5ODIzMTE1ZWIyYTQ0ZTI5NmEwOGZmNTVmZWQ5NjU3L3RhYmxlOmI2ZTM5OWI4MzFmZjQ4YTNhOWI4YWU4M2FiNDg0MjAxL3RhYmxlcmFuZ2U6YjZlMzk5YjgzMWZmNDhhM2E5YjhhZTgzYWI0ODQyMDFfOC0zLTEtMS0xODY4MjE_77221196-dfb1-4b9e-854c-25aa48f934e8">376,638</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 15, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment and Geographical Information</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for details of revenues based on the location of the customer.</span></div></ix:continuation><div id="i5f1eb1bd01d541c3aa0777712077c048_43"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.&#160;<ix:nonNumeric contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" name="us-gaap:InventoryDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80My9mcmFnOmRkMzJhNzA2ZWM5ZTRiMzJhMjc2MDlkYTBhM2QwOTMwL3RleHRyZWdpb246ZGQzMmE3MDZlYzllNGIzMmEyNzYwOWRhMGEzZDA5MzBfODQ_b4f35900-1b6a-4ee9-89a0-f0ad217e127e" continuedAt="if4fe2e8c13c54233bb5c7b758f95f08a" escape="true">INVENTORIES</ix:nonNumeric></span></div><ix:continuation id="if4fe2e8c13c54233bb5c7b758f95f08a"><ix:nonNumeric contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80My9mcmFnOmRkMzJhNzA2ZWM5ZTRiMzJhMjc2MDlkYTBhM2QwOTMwL3RleHRyZWdpb246ZGQzMmE3MDZlYzllNGIzMmEyNzYwOWRhMGEzZDA5MzBfNjU_8c9738bb-3da7-41b7-8a50-7416a48e206d" escape="true"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories, net consisted of the following:</span></div><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.882%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.545%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finished goods</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331" decimals="-3" name="us-gaap:InventoryFinishedGoodsNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80My9mcmFnOmRkMzJhNzA2ZWM5ZTRiMzJhMjc2MDlkYTBhM2QwOTMwL3RhYmxlOjlkZWUxNWMwNjFjZjRmOTFhYTFkOWM5ZjgxYWRmMzVhL3RhYmxlcmFuZ2U6OWRlZTE1YzA2MWNmNGY5MWFhMWQ5YzlmODFhZGYzNWFfMS0xLTEtMS0xODY4MjE_ac4a8038-7551-4c58-91b8-3e2b5e61f0f9">178,626</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231" decimals="-3" name="us-gaap:InventoryFinishedGoodsNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80My9mcmFnOmRkMzJhNzA2ZWM5ZTRiMzJhMjc2MDlkYTBhM2QwOTMwL3RhYmxlOjlkZWUxNWMwNjFjZjRmOTFhYTFkOWM5ZjgxYWRmMzVhL3RhYmxlcmFuZ2U6OWRlZTE1YzA2MWNmNGY5MWFhMWQ5YzlmODFhZGYzNWFfMS0zLTEtMS0xODY4MjE_94e06ff1-f405-4916-849b-d67141aff7f6">172,088</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331" decimals="-3" name="us-gaap:InventoryWorkInProcessNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80My9mcmFnOmRkMzJhNzA2ZWM5ZTRiMzJhMjc2MDlkYTBhM2QwOTMwL3RhYmxlOjlkZWUxNWMwNjFjZjRmOTFhYTFkOWM5ZjgxYWRmMzVhL3RhYmxlcmFuZ2U6OWRlZTE1YzA2MWNmNGY5MWFhMWQ5YzlmODFhZGYzNWFfMi0xLTEtMS0xODY4MjE_0b3da39b-f3db-4c4b-8b03-5fff44f4f046">80,532</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231" decimals="-3" name="us-gaap:InventoryWorkInProcessNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80My9mcmFnOmRkMzJhNzA2ZWM5ZTRiMzJhMjc2MDlkYTBhM2QwOTMwL3RhYmxlOjlkZWUxNWMwNjFjZjRmOTFhYTFkOWM5ZjgxYWRmMzVhL3RhYmxlcmFuZ2U6OWRlZTE1YzA2MWNmNGY5MWFhMWQ5YzlmODFhZGYzNWFfMi0zLTEtMS0xODY4MjE_2ec2897e-04a6-4bac-96fa-a062eb73e7d1">70,598</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331" decimals="-3" name="us-gaap:InventoryRawMaterialsAndPurchasedPartsNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80My9mcmFnOmRkMzJhNzA2ZWM5ZTRiMzJhMjc2MDlkYTBhM2QwOTMwL3RhYmxlOjlkZWUxNWMwNjFjZjRmOTFhYTFkOWM5ZjgxYWRmMzVhL3RhYmxlcmFuZ2U6OWRlZTE1YzA2MWNmNGY5MWFhMWQ5YzlmODFhZGYzNWFfMy0xLTEtMS0xODY4MjE_11ab22d2-9756-4e20-b730-2caa0b6e8fd5">92,117</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231" decimals="-3" name="us-gaap:InventoryRawMaterialsAndPurchasedPartsNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80My9mcmFnOmRkMzJhNzA2ZWM5ZTRiMzJhMjc2MDlkYTBhM2QwOTMwL3RhYmxlOjlkZWUxNWMwNjFjZjRmOTFhYTFkOWM5ZjgxYWRmMzVhL3RhYmxlcmFuZ2U6OWRlZTE1YzA2MWNmNGY5MWFhMWQ5YzlmODFhZGYzNWFfMy0zLTEtMS0xODY4MjE_187ddef1-9d38-4ae2-8d7b-e8f3db1d2a45">81,897</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total inventories, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80My9mcmFnOmRkMzJhNzA2ZWM5ZTRiMzJhMjc2MDlkYTBhM2QwOTMwL3RhYmxlOjlkZWUxNWMwNjFjZjRmOTFhYTFkOWM5ZjgxYWRmMzVhL3RhYmxlcmFuZ2U6OWRlZTE1YzA2MWNmNGY5MWFhMWQ5YzlmODFhZGYzNWFfNC0xLTEtMS0xODY4MjE_0561d775-b972-4683-9f41-85f3b88614f6">351,275</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80My9mcmFnOmRkMzJhNzA2ZWM5ZTRiMzJhMjc2MDlkYTBhM2QwOTMwL3RhYmxlOjlkZWUxNWMwNjFjZjRmOTFhYTFkOWM5ZjgxYWRmMzVhL3RhYmxlcmFuZ2U6OWRlZTE1YzA2MWNmNGY5MWFhMWQ5YzlmODFhZGYzNWFfNC0zLTEtMS0xODY4MjE_4dc724ec-4bdf-48bc-8c5a-ab8295e88def">324,583</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="i5f1eb1bd01d541c3aa0777712077c048_46"></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.&#160;<ix:nonNumeric contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RleHRyZWdpb246YTI1ZmIwNDQ3ODBlNGQ4NWI5ZTBlMDY5YjFmOGE1NDNfNTA2_36b42a5f-dd34-4085-9127-ca8a87ec13d7" continuedAt="ia153d9c46e814297bb0fc427955e661b" escape="true">GOODWILL AND OTHER INTANGIBLE ASSETS</ix:nonNumeric></span></div><ix:continuation id="ia153d9c46e814297bb0fc427955e661b" continuedAt="i90ebda8ee6e6454f8552e04429b14a2e"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill</span></div><ix:nonNumeric contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RleHRyZWdpb246YTI1ZmIwNDQ3ODBlNGQ4NWI5ZTBlMDY5YjFmOGE1NDNfNTE4_6b0ea34f-d7ad-4a28-8b51-1a607c8de003" escape="true"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the carrying amount of goodwill for the three-month period ended March&#160;31, 2023 were as follows:</span></div><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:55.389%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.911%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.911%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.915%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Codman Specialty <br/>Surgical</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Tissue Technologies</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill at December 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib712dcb2854f46f28657fb649d2220db_I20221231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjEwZmU1ZmMzZTY3ZjRlNTU4NGFjNmY5OWRjZjMwZWE3L3RhYmxlcmFuZ2U6MTBmZTVmYzNlNjdmNGU1NTg0YWM2Zjk5ZGNmMzBlYTdfMS0xLTEtMS0xODY4MjE_fa771ed0-9865-4940-afc5-e7e1144fdedd">656,219</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i542245b54ecf4d72b1024950a433c9af_I20221231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjEwZmU1ZmMzZTY3ZjRlNTU4NGFjNmY5OWRjZjMwZWE3L3RhYmxlcmFuZ2U6MTBmZTVmYzNlNjdmNGU1NTg0YWM2Zjk5ZGNmMzBlYTdfMS0zLTEtMS0xODY4MjE_1271648b-f709-41d4-8f77-b3cbdb7fcc31">382,662</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjEwZmU1ZmMzZTY3ZjRlNTU4NGFjNmY5OWRjZjMwZWE3L3RhYmxlcmFuZ2U6MTBmZTVmYzNlNjdmNGU1NTg0YWM2Zjk5ZGNmMzBlYTdfMS01LTEtMS0xODY4MjE_f25a98a0-bffd-4725-80b1-0d6be2fa27d7">1,038,881</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">SIA Acquisition Working Capital Adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1841156103084935b575ef1c38b8e26c_D20230101-20230331" decimals="-3" name="us-gaap:GoodwillPurchaseAccountingAdjustments" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjEwZmU1ZmMzZTY3ZjRlNTU4NGFjNmY5OWRjZjMwZWE3L3RhYmxlcmFuZ2U6MTBmZTVmYzNlNjdmNGU1NTg0YWM2Zjk5ZGNmMzBlYTdfMi0xLTEtMS0xOTc2MjU_bc6def11-9d2c-4225-8c34-98d438979380">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0ddadf2f33d42e18b362897b2b47f30_D20230101-20230331" decimals="-3" name="us-gaap:GoodwillPurchaseAccountingAdjustments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjEwZmU1ZmMzZTY3ZjRlNTU4NGFjNmY5OWRjZjMwZWE3L3RhYmxlcmFuZ2U6MTBmZTVmYzNlNjdmNGU1NTg0YWM2Zjk5ZGNmMzBlYTdfMi0zLTEtMS0xOTc1Nzg_5102d1c1-4c03-44bb-9130-373ba2f6f736">129</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9796a6882ba147419345a7d80b8e97d0_D20230101-20230331" decimals="-3" name="us-gaap:GoodwillPurchaseAccountingAdjustments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjEwZmU1ZmMzZTY3ZjRlNTU4NGFjNmY5OWRjZjMwZWE3L3RhYmxlcmFuZ2U6MTBmZTVmYzNlNjdmNGU1NTg0YWM2Zjk5ZGNmMzBlYTdfMi01LTEtMS0xOTc2MjU_0e83aec1-9f8e-4e69-a270-91173b856316">129</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd59456ea9aa4f04b19628e881f264f6_D20230101-20230331" decimals="-3" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjEwZmU1ZmMzZTY3ZjRlNTU4NGFjNmY5OWRjZjMwZWE3L3RhYmxlcmFuZ2U6MTBmZTVmYzNlNjdmNGU1NTg0YWM2Zjk5ZGNmMzBlYTdfMi0xLTEtMS0xODY4MjE_f86ea784-1846-441a-a8ac-4a1bb22f64a6">1,639</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcfddd0c2c684ea4acbf2b9ae4cd8527_D20230101-20230331" decimals="-3" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjEwZmU1ZmMzZTY3ZjRlNTU4NGFjNmY5OWRjZjMwZWE3L3RhYmxlcmFuZ2U6MTBmZTVmYzNlNjdmNGU1NTg0YWM2Zjk5ZGNmMzBlYTdfMi0zLTEtMS0xODY4MjE_2468a2ee-3c72-49f7-9537-2dcab61f907c">957</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" decimals="-3" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjEwZmU1ZmMzZTY3ZjRlNTU4NGFjNmY5OWRjZjMwZWE3L3RhYmxlcmFuZ2U6MTBmZTVmYzNlNjdmNGU1NTg0YWM2Zjk5ZGNmMzBlYTdfMi01LTEtMS0xODY4MjE_c77f2431-c398-4830-bb7b-4d240b29aa74">2,596</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill at March&#160;31, 2023</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id96439be0e9c43bc9bdb59971d641299_I20230331" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjEwZmU1ZmMzZTY3ZjRlNTU4NGFjNmY5OWRjZjMwZWE3L3RhYmxlcmFuZ2U6MTBmZTVmYzNlNjdmNGU1NTg0YWM2Zjk5ZGNmMzBlYTdfMy0xLTEtMS0xODY4MjE_75a40376-8473-4abb-8bfb-4843c1822d24">657,858</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida3b360960f84ba791b9beca0ffbeacd_I20230331" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjEwZmU1ZmMzZTY3ZjRlNTU4NGFjNmY5OWRjZjMwZWE3L3RhYmxlcmFuZ2U6MTBmZTVmYzNlNjdmNGU1NTg0YWM2Zjk5ZGNmMzBlYTdfMy0zLTEtMS0xODY4MjE_7f69268c-a0b7-4f21-84e3-fc08bd9e53a5">383,748</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjEwZmU1ZmMzZTY3ZjRlNTU4NGFjNmY5OWRjZjMwZWE3L3RhYmxlcmFuZ2U6MTBmZTVmYzNlNjdmNGU1NTg0YWM2Zjk5ZGNmMzBlYTdfMy01LTEtMS0xODY4MjE_a1d1d12e-9d07-4f7c-a536-29daf5faf790">1,041,606</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (continued) </span></div></div><ix:continuation id="i90ebda8ee6e6454f8552e04429b14a2e"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Intangible Assets</span></div><ix:nonNumeric contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" name="us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RleHRyZWdpb246YTI1ZmIwNDQ3ODBlNGQ4NWI5ZTBlMDY5YjFmOGE1NDNfNTA5_fc41183d-bb19-4829-a9cb-64e1918e2c3d" escape="true"><ix:nonNumeric contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RleHRyZWdpb246YTI1ZmIwNDQ3ODBlNGQ4NWI5ZTBlMDY5YjFmOGE1NDNfNTE3_1e656ca2-b5a1-4e45-8f46-fd849ccc6066" escape="true"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of the Company&#8217;s identifiable intangible assets were as follows:</span></div><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.367%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.331%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Life</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Completed technology</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i97cf8c18c01245a3b5878b1a70debb09_D20230101-20230331" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjdmNTVhNWU3NTQ1MTRmM2U4YzI2OTgxMDA1YzhmYjNkL3RhYmxlcmFuZ2U6N2Y1NWE1ZTc1NDUxNGYzZThjMjY5ODEwMDVjOGZiM2RfMi0xLTEtMS0xODY4MjE_3ae434fc-e126-4ea9-b000-8f287e24b78e">18</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id52aed2cbf2644509a8d761ee366e14e_I20230331" decimals="-3" name="iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjdmNTVhNWU3NTQ1MTRmM2U4YzI2OTgxMDA1YzhmYjNkL3RhYmxlcmFuZ2U6N2Y1NWE1ZTc1NDUxNGYzZThjMjY5ODEwMDVjOGZiM2RfMi0zLTEtMS0xODY4MjE_ab4d13eb-82c6-4103-b5ca-96bc476f0c70">1,206,748</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id52aed2cbf2644509a8d761ee366e14e_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjdmNTVhNWU3NTQ1MTRmM2U4YzI2OTgxMDA1YzhmYjNkL3RhYmxlcmFuZ2U6N2Y1NWE1ZTc1NDUxNGYzZThjMjY5ODEwMDVjOGZiM2RfMi01LTEtMS0xODY4MjE_3cddca0a-030c-462f-ac14-55d8905a377c">389,297</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id52aed2cbf2644509a8d761ee366e14e_I20230331" decimals="-3" name="iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjdmNTVhNWU3NTQ1MTRmM2U4YzI2OTgxMDA1YzhmYjNkL3RhYmxlcmFuZ2U6N2Y1NWE1ZTc1NDUxNGYzZThjMjY5ODEwMDVjOGZiM2RfMi03LTEtMS0xODY4MjE_d2298a3a-249a-49b4-bf90-70fbbb7d6829">817,451</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0c74c93593f04e0a8c727b1e6224e815_D20230101-20230331" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjdmNTVhNWU3NTQ1MTRmM2U4YzI2OTgxMDA1YzhmYjNkL3RhYmxlcmFuZ2U6N2Y1NWE1ZTc1NDUxNGYzZThjMjY5ODEwMDVjOGZiM2RfMy0xLTEtMS0xODY4MjE_9d12e343-f85e-4f04-8af5-8027a3443607">12</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc82ac4ce464f4da5b9c83153642d32_I20230331" decimals="-3" name="iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjdmNTVhNWU3NTQ1MTRmM2U4YzI2OTgxMDA1YzhmYjNkL3RhYmxlcmFuZ2U6N2Y1NWE1ZTc1NDUxNGYzZThjMjY5ODEwMDVjOGZiM2RfMy0zLTEtMS0xODY4MjE_f26d72f1-93c2-4002-856d-7adf986f0b23">193,297</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5dc82ac4ce464f4da5b9c83153642d32_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjdmNTVhNWU3NTQ1MTRmM2U4YzI2OTgxMDA1YzhmYjNkL3RhYmxlcmFuZ2U6N2Y1NWE1ZTc1NDUxNGYzZThjMjY5ODEwMDVjOGZiM2RfMy01LTEtMS0xODY4MjE_e14b8b53-59dc-4cc0-8731-d5c9c5a3c923">146,098</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc82ac4ce464f4da5b9c83153642d32_I20230331" decimals="-3" name="iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjdmNTVhNWU3NTQ1MTRmM2U4YzI2OTgxMDA1YzhmYjNkL3RhYmxlcmFuZ2U6N2Y1NWE1ZTc1NDUxNGYzZThjMjY5ODEwMDVjOGZiM2RfMy03LTEtMS0xODY4MjE_2de6f260-6d76-4418-a902-eb5efd8f9578">47,199</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trademarks/brand names</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i42d7a82bf02941cfa73330ae1871acf1_D20230101-20230331" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjdmNTVhNWU3NTQ1MTRmM2U4YzI2OTgxMDA1YzhmYjNkL3RhYmxlcmFuZ2U6N2Y1NWE1ZTc1NDUxNGYzZThjMjY5ODEwMDVjOGZiM2RfNC0xLTEtMS0xODY4MjE_a83d9b71-70ba-4dae-b17e-d5e5079c7f08">28</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0660f35837f94b01a3733519c74443b0_I20230331" decimals="-3" name="iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjdmNTVhNWU3NTQ1MTRmM2U4YzI2OTgxMDA1YzhmYjNkL3RhYmxlcmFuZ2U6N2Y1NWE1ZTc1NDUxNGYzZThjMjY5ODEwMDVjOGZiM2RfNC0zLTEtMS0xODY4MjE_e1ec28ad-1594-4a4c-b7f5-5c3f5c734c65">97,554</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0660f35837f94b01a3733519c74443b0_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjdmNTVhNWU3NTQ1MTRmM2U4YzI2OTgxMDA1YzhmYjNkL3RhYmxlcmFuZ2U6N2Y1NWE1ZTc1NDUxNGYzZThjMjY5ODEwMDVjOGZiM2RfNC01LTEtMS0xODY4MjE_cfdeea13-1ce0-4105-9155-a18a62c05cd2">35,665</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0660f35837f94b01a3733519c74443b0_I20230331" decimals="-3" name="iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjdmNTVhNWU3NTQ1MTRmM2U4YzI2OTgxMDA1YzhmYjNkL3RhYmxlcmFuZ2U6N2Y1NWE1ZTc1NDUxNGYzZThjMjY5ODEwMDVjOGZiM2RfNC03LTEtMS0xODY4MjE_c9490e35-2fa2-4532-b662-19d1e962f3b2">61,889</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Codman tradename</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Indefinite</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6126f6a52e94c36bb96da081cbfd6a2_I20230331" decimals="-3" name="iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjdmNTVhNWU3NTQ1MTRmM2U4YzI2OTgxMDA1YzhmYjNkL3RhYmxlcmFuZ2U6N2Y1NWE1ZTc1NDUxNGYzZThjMjY5ODEwMDVjOGZiM2RfNS0zLTEtMS0xODY4MjE_aa68bd52-93dc-4baa-bf49-8dddfedde7ea">167,529</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6126f6a52e94c36bb96da081cbfd6a2_I20230331" decimals="-3" name="iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjdmNTVhNWU3NTQ1MTRmM2U4YzI2OTgxMDA1YzhmYjNkL3RhYmxlcmFuZ2U6N2Y1NWE1ZTc1NDUxNGYzZThjMjY5ODEwMDVjOGZiM2RfNS03LTEtMS0xODY4MjE_dd11e368-98a8-40fb-b97c-8fb2d6c7f312">167,529</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Supplier relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i6b0ff551735c45b7bfe3c18fdbb4e9b2_D20230101-20230331" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjdmNTVhNWU3NTQ1MTRmM2U4YzI2OTgxMDA1YzhmYjNkL3RhYmxlcmFuZ2U6N2Y1NWE1ZTc1NDUxNGYzZThjMjY5ODEwMDVjOGZiM2RfNi0xLTEtMS0xODY4MjE_c4082953-c47d-48de-90ff-72cf6b036777">30</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8efb348618694eb0b761b917a80af933_I20230331" decimals="-3" name="iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjdmNTVhNWU3NTQ1MTRmM2U4YzI2OTgxMDA1YzhmYjNkL3RhYmxlcmFuZ2U6N2Y1NWE1ZTc1NDUxNGYzZThjMjY5ODEwMDVjOGZiM2RfNi0zLTEtMS0xODY4MjE_adfe1a5a-b91b-44b4-9407-ef1991d78fe2">30,211</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8efb348618694eb0b761b917a80af933_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjdmNTVhNWU3NTQ1MTRmM2U4YzI2OTgxMDA1YzhmYjNkL3RhYmxlcmFuZ2U6N2Y1NWE1ZTc1NDUxNGYzZThjMjY5ODEwMDVjOGZiM2RfNi01LTEtMS0xODY4MjE_30e47d71-6bd7-46ce-8c12-5dc423833ac4">17,415</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8efb348618694eb0b761b917a80af933_I20230331" decimals="-3" name="iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjdmNTVhNWU3NTQ1MTRmM2U4YzI2OTgxMDA1YzhmYjNkL3RhYmxlcmFuZ2U6N2Y1NWE1ZTc1NDUxNGYzZThjMjY5ODEwMDVjOGZiM2RfNi03LTEtMS0xODY4MjE_3edbc00d-3c05-45ee-8ba8-a2db321b84a4">12,796</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">All other</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i15371427605f42a2a6b646f1911d4b0f_D20230101-20230331" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjdmNTVhNWU3NTQ1MTRmM2U4YzI2OTgxMDA1YzhmYjNkL3RhYmxlcmFuZ2U6N2Y1NWE1ZTc1NDUxNGYzZThjMjY5ODEwMDVjOGZiM2RfNy0xLTEtMS0xODY4MjE_60a107ee-f9b0-4be4-8c96-ccda94ccc4e1">11</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i300eb0465a16418db26404ea8b152196_I20230331" decimals="-3" name="iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjdmNTVhNWU3NTQ1MTRmM2U4YzI2OTgxMDA1YzhmYjNkL3RhYmxlcmFuZ2U6N2Y1NWE1ZTc1NDUxNGYzZThjMjY5ODEwMDVjOGZiM2RfNy0zLTEtMS0xODY4MjE_3ab7ab8e-a339-4237-8c49-b5c3d5d73e9e">6,024</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i300eb0465a16418db26404ea8b152196_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjdmNTVhNWU3NTQ1MTRmM2U4YzI2OTgxMDA1YzhmYjNkL3RhYmxlcmFuZ2U6N2Y1NWE1ZTc1NDUxNGYzZThjMjY5ODEwMDVjOGZiM2RfNy01LTEtMS0xODY4MjE_d714fef5-ad4b-4ee9-ad80-e73d83a9358f">4,129</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i300eb0465a16418db26404ea8b152196_I20230331" decimals="-3" name="iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjdmNTVhNWU3NTQ1MTRmM2U4YzI2OTgxMDA1YzhmYjNkL3RhYmxlcmFuZ2U6N2Y1NWE1ZTc1NDUxNGYzZThjMjY5ODEwMDVjOGZiM2RfNy03LTEtMS0xODY4MjE_bb5c06ec-0be2-4915-b214-6b7f87511cec">1,895</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331" decimals="-3" name="iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjdmNTVhNWU3NTQ1MTRmM2U4YzI2OTgxMDA1YzhmYjNkL3RhYmxlcmFuZ2U6N2Y1NWE1ZTc1NDUxNGYzZThjMjY5ODEwMDVjOGZiM2RfOC0zLTEtMS0xODY4MjE_afd1d3e1-370c-45d0-88a3-71b4004d0581">1,701,363</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjdmNTVhNWU3NTQ1MTRmM2U4YzI2OTgxMDA1YzhmYjNkL3RhYmxlcmFuZ2U6N2Y1NWE1ZTc1NDUxNGYzZThjMjY5ODEwMDVjOGZiM2RfOC01LTEtMS0xODY4MjE_81fcc8d2-3972-414a-b1d6-2b6bc18044bd">592,604</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331" decimals="-3" name="iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjdmNTVhNWU3NTQ1MTRmM2U4YzI2OTgxMDA1YzhmYjNkL3RhYmxlcmFuZ2U6N2Y1NWE1ZTc1NDUxNGYzZThjMjY5ODEwMDVjOGZiM2RfOC03LTEtMS0xODY4MjE_8fe1f3e3-5fd6-41e3-857a-6e56a54d9bde">1,108,759</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.783%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.554%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.331%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Life</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Completed technology</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib10821a2be0a4a9cb44ee7405d2e3b3b_D20220101-20221231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjUyODBhMGIwYjc4NzQzNzFiYzI4ZDc0OTJhMTEzNjQxL3RhYmxlcmFuZ2U6NTI4MGEwYjBiNzg3NDM3MWJjMjhkNzQ5MmExMTM2NDFfMi0xLTEtMS0xODY4MjE_54ac8aeb-23f1-4e51-9142-8b226ba4e361">18</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5161e2ebe90148f3a9f6b6b4d290dbe4_I20221231" decimals="-3" name="iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjUyODBhMGIwYjc4NzQzNzFiYzI4ZDc0OTJhMTEzNjQxL3RhYmxlcmFuZ2U6NTI4MGEwYjBiNzg3NDM3MWJjMjhkNzQ5MmExMTM2NDFfMi0zLTEtMS0xODY4MjE_2324fee8-a3b1-4798-9bde-b7f6cec14982">1,204,325</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5161e2ebe90148f3a9f6b6b4d290dbe4_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjUyODBhMGIwYjc4NzQzNzFiYzI4ZDc0OTJhMTEzNjQxL3RhYmxlcmFuZ2U6NTI4MGEwYjBiNzg3NDM3MWJjMjhkNzQ5MmExMTM2NDFfMi01LTEtMS0xODY4MjE_ccce4fc8-9216-4683-b5ce-3c1206571cff">370,968</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5161e2ebe90148f3a9f6b6b4d290dbe4_I20221231" decimals="-3" name="iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjUyODBhMGIwYjc4NzQzNzFiYzI4ZDc0OTJhMTEzNjQxL3RhYmxlcmFuZ2U6NTI4MGEwYjBiNzg3NDM3MWJjMjhkNzQ5MmExMTM2NDFfMi03LTEtMS0xODY4MjE_317da237-8f57-4dc1-aa83-63f3cb2fd079">833,357</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9ec130bce102400abaa3a20544f9f36f_D20220101-20221231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjUyODBhMGIwYjc4NzQzNzFiYzI4ZDc0OTJhMTEzNjQxL3RhYmxlcmFuZ2U6NTI4MGEwYjBiNzg3NDM3MWJjMjhkNzQ5MmExMTM2NDFfMy0xLTEtMS0xODY4MjE_5f22aa91-c161-4d13-9963-5a72068b69d3">12</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf15e0a25a2341c0b2b8d2b4ee0f2751_I20221231" decimals="-3" name="iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjUyODBhMGIwYjc4NzQzNzFiYzI4ZDc0OTJhMTEzNjQxL3RhYmxlcmFuZ2U6NTI4MGEwYjBiNzg3NDM3MWJjMjhkNzQ5MmExMTM2NDFfMy0zLTEtMS0xODY4MjE_0e52c95c-5e9c-419d-b362-37261498c654">193,081</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf15e0a25a2341c0b2b8d2b4ee0f2751_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjUyODBhMGIwYjc4NzQzNzFiYzI4ZDc0OTJhMTEzNjQxL3RhYmxlcmFuZ2U6NTI4MGEwYjBiNzg3NDM3MWJjMjhkNzQ5MmExMTM2NDFfMy01LTEtMS0xODY4MjE_c591a22e-33f9-4e02-9884-ab623e8512c9">144,040</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf15e0a25a2341c0b2b8d2b4ee0f2751_I20221231" decimals="-3" name="iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjUyODBhMGIwYjc4NzQzNzFiYzI4ZDc0OTJhMTEzNjQxL3RhYmxlcmFuZ2U6NTI4MGEwYjBiNzg3NDM3MWJjMjhkNzQ5MmExMTM2NDFfMy03LTEtMS0xODY4MjE_9cb02c91-b0ec-4095-b188-3dc2428da7be">49,041</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trademarks/brand names</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i64d8a19482454a3586c748993f1474c6_D20220101-20221231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjUyODBhMGIwYjc4NzQzNzFiYzI4ZDc0OTJhMTEzNjQxL3RhYmxlcmFuZ2U6NTI4MGEwYjBiNzg3NDM3MWJjMjhkNzQ5MmExMTM2NDFfNC0xLTEtMS0xODY4MjE_53bf784e-3127-42bd-90f4-d913127af600">28</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d1a3397e8cd4decab44bcff39bb8345_I20221231" decimals="-3" name="iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjUyODBhMGIwYjc4NzQzNzFiYzI4ZDc0OTJhMTEzNjQxL3RhYmxlcmFuZ2U6NTI4MGEwYjBiNzg3NDM3MWJjMjhkNzQ5MmExMTM2NDFfNC0zLTEtMS0xODY4MjE_b8f52789-e716-4574-9d01-a8ac18961a52">97,265</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4d1a3397e8cd4decab44bcff39bb8345_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjUyODBhMGIwYjc4NzQzNzFiYzI4ZDc0OTJhMTEzNjQxL3RhYmxlcmFuZ2U6NTI4MGEwYjBiNzg3NDM3MWJjMjhkNzQ5MmExMTM2NDFfNC01LTEtMS0xODY4MjE_0de04f54-da64-47ca-b151-6875d1532ccf">34,674</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d1a3397e8cd4decab44bcff39bb8345_I20221231" decimals="-3" name="iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjUyODBhMGIwYjc4NzQzNzFiYzI4ZDc0OTJhMTEzNjQxL3RhYmxlcmFuZ2U6NTI4MGEwYjBiNzg3NDM3MWJjMjhkNzQ5MmExMTM2NDFfNC03LTEtMS0xODY4MjE_cd068fbc-e8db-42a7-bb3c-115772131abe">62,591</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Codman tradename</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Indefinite</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45871e5e03c54676a898558774ed322e_I20221231" decimals="-3" name="iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjUyODBhMGIwYjc4NzQzNzFiYzI4ZDc0OTJhMTEzNjQxL3RhYmxlcmFuZ2U6NTI4MGEwYjBiNzg3NDM3MWJjMjhkNzQ5MmExMTM2NDFfNS0zLTEtMS0xODY4MjE_0c8ffc80-b1d1-4525-95aa-f5dfab081d33">166,693</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45871e5e03c54676a898558774ed322e_I20221231" decimals="-3" name="iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjUyODBhMGIwYjc4NzQzNzFiYzI4ZDc0OTJhMTEzNjQxL3RhYmxlcmFuZ2U6NTI4MGEwYjBiNzg3NDM3MWJjMjhkNzQ5MmExMTM2NDFfNS03LTEtMS0xODY4MjE_0547249e-a637-402d-a037-4218c6ccaf18">166,693</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Supplier relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i79d3d15982c14927ab9ed833406b2dc2_D20220101-20221231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjUyODBhMGIwYjc4NzQzNzFiYzI4ZDc0OTJhMTEzNjQxL3RhYmxlcmFuZ2U6NTI4MGEwYjBiNzg3NDM3MWJjMjhkNzQ5MmExMTM2NDFfNi0xLTEtMS0xODY4MjE_593e77d4-472b-4951-8d3b-ae0536907bc4">30</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5182401e0e9b451db9f13c85d749b4b1_I20221231" decimals="-3" name="iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjUyODBhMGIwYjc4NzQzNzFiYzI4ZDc0OTJhMTEzNjQxL3RhYmxlcmFuZ2U6NTI4MGEwYjBiNzg3NDM3MWJjMjhkNzQ5MmExMTM2NDFfNi0zLTEtMS0xODY4MjE_a5caa854-8e8d-4de5-a9ca-8709a1cf8460">30,211</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5182401e0e9b451db9f13c85d749b4b1_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjUyODBhMGIwYjc4NzQzNzFiYzI4ZDc0OTJhMTEzNjQxL3RhYmxlcmFuZ2U6NTI4MGEwYjBiNzg3NDM3MWJjMjhkNzQ5MmExMTM2NDFfNi01LTEtMS0xODY4MjE_d8e1abc2-066a-47ea-b7f7-60e396ca9d66">17,170</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5182401e0e9b451db9f13c85d749b4b1_I20221231" decimals="-3" name="iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjUyODBhMGIwYjc4NzQzNzFiYzI4ZDc0OTJhMTEzNjQxL3RhYmxlcmFuZ2U6NTI4MGEwYjBiNzg3NDM3MWJjMjhkNzQ5MmExMTM2NDFfNi03LTEtMS0xODY4MjE_e1e8f2b1-2856-4a7e-9920-c6aa8f4491b2">13,041</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">All other</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4bd0685df71b4334baf2049236ad65c1_D20220101-20221231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjUyODBhMGIwYjc4NzQzNzFiYzI4ZDc0OTJhMTEzNjQxL3RhYmxlcmFuZ2U6NTI4MGEwYjBiNzg3NDM3MWJjMjhkNzQ5MmExMTM2NDFfNy0xLTEtMS0xODY4MjE_b628a7ea-ac00-4d5f-83c8-3295f9cd4cb2">11</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i111c837e553e4c579da41292d97ec939_I20221231" decimals="-3" name="iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjUyODBhMGIwYjc4NzQzNzFiYzI4ZDc0OTJhMTEzNjQxL3RhYmxlcmFuZ2U6NTI4MGEwYjBiNzg3NDM3MWJjMjhkNzQ5MmExMTM2NDFfNy0zLTEtMS0xODY4MjE_49f8276d-ce37-4df7-ac3d-336447986f19">5,957</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i111c837e553e4c579da41292d97ec939_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjUyODBhMGIwYjc4NzQzNzFiYzI4ZDc0OTJhMTEzNjQxL3RhYmxlcmFuZ2U6NTI4MGEwYjBiNzg3NDM3MWJjMjhkNzQ5MmExMTM2NDFfNy01LTEtMS0xODY4MjE_c56a8046-b468-43ba-a8fc-8081fc2760a6">4,071</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i111c837e553e4c579da41292d97ec939_I20221231" decimals="-3" name="iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjUyODBhMGIwYjc4NzQzNzFiYzI4ZDc0OTJhMTEzNjQxL3RhYmxlcmFuZ2U6NTI4MGEwYjBiNzg3NDM3MWJjMjhkNzQ5MmExMTM2NDFfNy03LTEtMS0xODY4MjE_1c1c6aaa-26d0-42b2-a9e9-0559a28302d4">1,886</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231" decimals="-3" name="iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjUyODBhMGIwYjc4NzQzNzFiYzI4ZDc0OTJhMTEzNjQxL3RhYmxlcmFuZ2U6NTI4MGEwYjBiNzg3NDM3MWJjMjhkNzQ5MmExMTM2NDFfOC0zLTEtMS0xODY4MjE_ba05b311-38b9-4aea-a768-d6af090dda4c">1,697,532</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjUyODBhMGIwYjc4NzQzNzFiYzI4ZDc0OTJhMTEzNjQxL3RhYmxlcmFuZ2U6NTI4MGEwYjBiNzg3NDM3MWJjMjhkNzQ5MmExMTM2NDFfOC01LTEtMS0xODY4MjE_a52ff3e4-9929-477c-bdcb-a5f231a4a9d3">570,923</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231" decimals="-3" name="iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjUyODBhMGIwYjc4NzQzNzFiYzI4ZDc0OTJhMTEzNjQxL3RhYmxlcmFuZ2U6NTI4MGEwYjBiNzg3NDM3MWJjMjhkNzQ5MmExMTM2NDFfOC03LTEtMS0xODY4MjE_a3973bde-444a-4cfa-8133-a5bda86713aa">1,126,609</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div></ix:nonNumeric></ix:nonNumeric><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on quarter-end exchange rates, amortization expense (including amounts reported in cost of goods sold) is expected to be approximately $<ix:nonFraction unitRef="usd" contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RleHRyZWdpb246YTI1ZmIwNDQ3ODBlNGQ4NWI5ZTBlMDY5YjFmOGE1NDNfMzk4_e1c22f8b-cb81-489e-8773-ea5dde2ef79f">61.8</ix:nonFraction> million for the remainder of 2023, $<ix:nonFraction unitRef="usd" contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RleHRyZWdpb246YTI1ZmIwNDQ3ODBlNGQ4NWI5ZTBlMDY5YjFmOGE1NDNfNDI2_7523a6a6-effe-4ab9-80a9-f90560a276ce">81.8</ix:nonFraction> million in 2024, $<ix:nonFraction unitRef="usd" contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RleHRyZWdpb246YTI1ZmIwNDQ3ODBlNGQ4NWI5ZTBlMDY5YjFmOGE1NDNfNDM2_eb1a158b-42e9-42bd-8512-b9d96a9bf323">81.8</ix:nonFraction> million in 2025, $<ix:nonFraction unitRef="usd" contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RleHRyZWdpb246YTI1ZmIwNDQ3ODBlNGQ4NWI5ZTBlMDY5YjFmOGE1NDNfNDQ2_92726a24-af0f-45ca-baab-03916d79c673">81.6</ix:nonFraction> million in 2026, $<ix:nonFraction unitRef="usd" contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RleHRyZWdpb246YTI1ZmIwNDQ3ODBlNGQ4NWI5ZTBlMDY5YjFmOGE1NDNfNDU2_b46230dc-3639-4c7f-a7ff-89781e5ffb6f">79.7</ix:nonFraction> million in 2027, $<ix:nonFraction unitRef="usd" contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RleHRyZWdpb246YTI1ZmIwNDQ3ODBlNGQ4NWI5ZTBlMDY5YjFmOGE1NDNfNDY2_b279b1a9-a4ca-46b4-8aa2-143f1fd9db7e">78.1</ix:nonFraction> million in 2028 and $<ix:nonFraction unitRef="usd" contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RleHRyZWdpb246YTI1ZmIwNDQ3ODBlNGQ4NWI5ZTBlMDY5YjFmOGE1NDNfNDg3_e656f731-e04c-4818-929d-a6fbfaaca262">474.4</ix:nonFraction> million thereafter.</span></div></ix:continuation><div id="i5f1eb1bd01d541c3aa0777712077c048_49"></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6. <ix:nonNumeric contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RleHRyZWdpb246OGU2Njc2MjUzNThjNDkxODk1YWE2M2E2YmMwOGI2ODBfMTEzODU_780ae0f2-c731-4f56-9dd3-e2b5c9bbc42c" continuedAt="ibc133537c8a24a2295f583bf843be0b0" escape="true">DEBT </ix:nonNumeric></span></div><ix:continuation id="ibc133537c8a24a2295f583bf843be0b0" continuedAt="ic8e0dc4b7c294e28838dde71195efdeb"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Amendment to the Seventh Amended and Restated Senior Credit Agreement</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 24, 2023, the Company entered into the March 2023 Amendment of the Senior Credit Facility with a syndicate of lending banks with Bank of America, N.A., as Administrative Agent. The March 2023 Amendment extended the maturity date to March&#160;24, 2028, amended the contractual repayments of Term loan A, and amended the interest rate from LIBOR to SOFR-indexed interest. The Company continues to have the aggregate principal amount of up to approximately $<ix:nonFraction unitRef="usd" contextRef="i5f1abf32d8ec43f3a621a5448c21a7a1_I20230324" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RleHRyZWdpb246OGU2Njc2MjUzNThjNDkxODk1YWE2M2E2YmMwOGI2ODBfNTA0_0ab8bba5-6439-4b86-812e-2c53645c5319">2.1</ix:nonFraction> billion available to it through the following facilities: (i) a $<ix:nonFraction unitRef="usd" contextRef="icd0dbd7f9cc3475488e71805c8369830_I20230324" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RleHRyZWdpb246OGU2Njc2MjUzNThjNDkxODk1YWE2M2E2YmMwOGI2ODBfNTYz_13d44367-6c06-43e5-980b-899d11256cca">775.0</ix:nonFraction> million term loan facility, and (ii) a $<ix:nonFraction unitRef="usd" contextRef="i0d1f785d88d94ee08e66c1b385dc0f1d_I20230324" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RleHRyZWdpb246OGU2Njc2MjUzNThjNDkxODk1YWE2M2E2YmMwOGI2ODBfNTk3_8a93ae9e-c409-4866-8d1d-a2fca706a143">1.3</ix:nonFraction> billion revolving credit facility, which includes a $<ix:nonFraction unitRef="usd" contextRef="i2925166e860d464e857eec9b85318b66_I20230324" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RleHRyZWdpb246OGU2Njc2MjUzNThjNDkxODk1YWE2M2E2YmMwOGI2ODBfNjQ0_4bb52d25-2461-419a-b766-d945b817f1cb">60</ix:nonFraction> million sublimit for the issuance of standby letters of credit and a $<ix:nonFraction unitRef="usd" contextRef="i3a69c660cc994e3e89f928d370becf48_I20230324" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RleHRyZWdpb246OGU2Njc2MjUzNThjNDkxODk1YWE2M2E2YmMwOGI2ODBfNzA4_e81a7911-ed0a-4c1c-8afc-c4b8e2123a6a">60</ix:nonFraction> million sublimit for swingline loans.  </span></div><ix:nonNumeric contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" name="us-gaap:ScheduleOfDebtInstrumentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RleHRyZWdpb246OGU2Njc2MjUzNThjNDkxODk1YWE2M2E2YmMwOGI2ODBfMTEzNjk_035270fd-b7f0-4e21-8731-aa612c6c4671" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s maximum consolidated total leverage ratio in the financial covenants (as defined in the Senior Credit Facility) was modified to the following:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:513.00pt"><tr><td style="width:1.0pt"></td><td style="width:394.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:111.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Quarter</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maximum Consolidated Total Leverage Ratio</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 31, 2023 through December 31, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i29c495bb726f416f92c438401600a765_I20230324" decimals="INF" name="iart:DebtInstrumentCovenantMaximumLeverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RhYmxlOjgwYzBmMTczZmFlYTRiYWY5YmMyY2MwYmQ2MzNlNjE0L3RhYmxlcmFuZ2U6ODBjMGYxNzNmYWVhNGJhZjliYzJjYzBiZDYzM2U2MTRfMS0yLTEtMS0xODY4MjEvdGV4dHJlZ2lvbjphODhmMzJiZjEwZjg0Yzk5YjhmMGJlMGQ0MzRhYTI0Zl80Mzk4MDQ2NTExMTI0_b39a4d35-9df4-4f62-90c4-8dad7c4d436e">4.50</ix:nonFraction> to 1.00</span></div></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 31, 2025 through June 30, 2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0a99dd10d5ee423cb63f788fb7285962_I20230324" decimals="INF" name="iart:DebtInstrumentCovenantMaximumLeverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RhYmxlOjgwYzBmMTczZmFlYTRiYWY5YmMyY2MwYmQ2MzNlNjE0L3RhYmxlcmFuZ2U6ODBjMGYxNzNmYWVhNGJhZjliYzJjYzBiZDYzM2U2MTRfMi0yLTEtMS0xODY4MjEvdGV4dHJlZ2lvbjpjYTcwMzQxYzBmNzM0YzlmYjZmNjY1ZTBjNDQ5YTk3Yl80Mzk4MDQ2NTExMTI0_a667cd81-0a25-41e7-8f44-7d93ec0f830c">4.25</ix:nonFraction> to 1.00</span></div></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 30, 2026 and the last day of each fiscal quarter thereafter</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7f83b1b30bad4b0abf661670d1135229_I20230324" decimals="INF" name="iart:DebtInstrumentCovenantMaximumLeverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RhYmxlOjgwYzBmMTczZmFlYTRiYWY5YmMyY2MwYmQ2MzNlNjE0L3RhYmxlcmFuZ2U6ODBjMGYxNzNmYWVhNGJhZjliYzJjYzBiZDYzM2U2MTRfMy0yLTEtMS0xODY4MjEvdGV4dHJlZ2lvbjo0M2U3NTJhYmU5OWE0N2JiYTE5YTU5MjhjNWVmOTdhZF80Mzk4MDQ2NTExMTI0_fa2b1833-cf69-4c8f-a8eb-3b485b586fe9">4.00</ix:nonFraction> to 1.00</span></div></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Borrowings under the Senior Credit Facility bear interest, at the Company&#8217;s option, at a rate equal to the following:</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.73pt">term SOFR in effect from time to time plus <ix:nonFraction unitRef="number" contextRef="i14a19f77eafb4116aa1875402c21a6ac_D20230101-20230331" decimals="INF" name="iart:DebtInstrumentBasisSpreadAdjustmentOnVariableRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RleHRyZWdpb246OGU2Njc2MjUzNThjNDkxODk1YWE2M2E2YmMwOGI2ODBfNDM5ODA0NjUyMzk3OQ_a64a61b6-500a-45fc-a951-bfd65c90c225">0.10</ix:nonFraction>%  plus the applicable rate (ranging from <ix:nonFraction unitRef="number" contextRef="i96878a4e0354445fa679e461e52e913e_D20230101-20230331" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RleHRyZWdpb246OGU2Njc2MjUzNThjNDkxODk1YWE2M2E2YmMwOGI2ODBfMTU3NA_f1a068c2-770a-4e50-aff1-c0a264244332">1.00</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i7d6d16e6e0d9418c82c2bdc6fe950a0b_D20230101-20230331" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RleHRyZWdpb246OGU2Njc2MjUzNThjNDkxODk1YWE2M2E2YmMwOGI2ODBfMTU4MA_cdc72ef8-a68d-4f43-a61e-1740dd011f91">1.75</ix:nonFraction>%), or </span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ii.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.96pt">the highest of: </span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">the weighted average overnight Federal funds rate, as published by the Federal Reserve Bank of New York, plus <ix:nonFraction unitRef="number" contextRef="i82965aae546f4e83a526730570a1e256_D20230101-20230331" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RleHRyZWdpb246OGU2Njc2MjUzNThjNDkxODk1YWE2M2E2YmMwOGI2ODBfMTcxNw_991e35fd-a586-43ff-99c0-e8514f774097">0.50</ix:nonFraction>% </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (continued) </span></div></div><ix:continuation id="ic8e0dc4b7c294e28838dde71195efdeb" continuedAt="i7e2353c8e5364635a02f53d42a85617c"><div style="margin-bottom:6pt;margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">the prime lending rate of Bank of America, N.A. or</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">the one-month Term SOFR plus <ix:nonFraction unitRef="number" contextRef="i14a19f77eafb4116aa1875402c21a6ac_D20230101-20230331" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RleHRyZWdpb246OGU2Njc2MjUzNThjNDkxODk1YWE2M2E2YmMwOGI2ODBfMTgwNw_7758deea-74e2-47f2-a703-bc4ea0f5fa97">1.00</ix:nonFraction>% </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The applicable rates are based on the Company&#8217;s consolidated total leverage ratio (defined as the ratio of (a)&#160;consolidated funded indebtedness as of such date less cash that is not subject to any restriction on the use or investment thereof to (b) consolidated EBITDA (as defined by the amended Seventh Amended and Restated Credit Agreement (the "Credit Agreement")), for the period of four consecutive fiscal quarters ending on such date).</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company will pay an annual commitment fee (ranging from <ix:nonFraction unitRef="number" contextRef="i3f2fb631c5ee4c2fa49138cf5e6235e8_D20230101-20230331" decimals="INF" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RleHRyZWdpb246OGU2Njc2MjUzNThjNDkxODk1YWE2M2E2YmMwOGI2ODBfMjI1NA_79e7288a-1e45-4eb6-9f7d-8bb47abf8163">0.15</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i75b239dc572a41de8d6401d6434fe2fa_D20230101-20230331" decimals="INF" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RleHRyZWdpb246OGU2Njc2MjUzNThjNDkxODk1YWE2M2E2YmMwOGI2ODBfMjI2MA_7b649b0f-f292-4831-9a62-97c42e25727d">0.30</ix:nonFraction>%), based on the Company's consolidated total leverage ratio, on the amount available for borrowing under the revolving credit facility.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Senior Credit Facility is collateralized by substantially all of the assets of the Company&#8217;s U.S. subsidiaries, excluding intangible assets. The Senior Credit Facility is subject to various financial and negative covenants and at March&#160;31, 2023, the Company was in compliance with all such covenants. The Company capitalized $<ix:nonFraction unitRef="usd" contextRef="i99b8d45450b94b73be890ff82ddfc718_I20230331" decimals="-5" name="us-gaap:DeferredFinanceCostsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RleHRyZWdpb246OGU2Njc2MjUzNThjNDkxODk1YWE2M2E2YmMwOGI2ODBfNzY5NjU4MTQxMTY3Mw_cd68367a-e869-48ce-8102-48ccee609804">7.6</ix:nonFraction>&#160;million in deferred financing costs in connection with the modification of the Senior Credit Facility and wrote off $<ix:nonFraction unitRef="usd" contextRef="i3cf8dd5a6f664b3d8b55fc2f763a1d0e_D20230101-20230331" decimals="-5" name="us-gaap:WriteOffOfDeferredDebtIssuanceCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RleHRyZWdpb246OGU2Njc2MjUzNThjNDkxODk1YWE2M2E2YmMwOGI2ODBfNzY5NjU4MTQxMTY4Nw_7512b54a-e412-41d5-897a-4e69c87c59f3">0.2</ix:nonFraction>&#160;million of previously capitalized financing costs during the first quarter of 2023.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2023 and December&#160;31, 2022 there wa</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s <ix:nonFraction unitRef="usd" contextRef="i0fc6705bbac14c0a8a85244af899d39c_I20221231" decimals="INF" name="us-gaap:LineOfCredit" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RleHRyZWdpb246OGU2Njc2MjUzNThjNDkxODk1YWE2M2E2YmMwOGI2ODBfMjcxNQ_26cd12bf-20a4-496a-835d-5316de350ea0"><ix:nonFraction unitRef="usd" contextRef="i99b8d45450b94b73be890ff82ddfc718_I20230331" decimals="INF" name="us-gaap:LineOfCredit" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RleHRyZWdpb246OGU2Njc2MjUzNThjNDkxODk1YWE2M2E2YmMwOGI2ODBfMjcxNQ_f66c635f-eb0f-49e4-b04d-864dd0b4ca0b">no</ix:nonFraction></ix:nonFraction> balance ou</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">tstanding under the revolving portion of the Senior Credit Facility. At March&#160;31, 2023 and December&#160;31, 2022, there was $<ix:nonFraction unitRef="usd" contextRef="i3b6f2ca5a0ff4bcf9931d0f74490b27a_I20221231" decimals="-5" name="us-gaap:LineOfCredit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RleHRyZWdpb246OGU2Njc2MjUzNThjNDkxODk1YWE2M2E2YmMwOGI2ODBfMjg5Nw_14fb55c3-892e-474c-b363-d5cc73212194"><ix:nonFraction unitRef="usd" contextRef="i6ace526dcf2e4bd7b1d416abfd600915_I20230331" decimals="-5" name="us-gaap:LineOfCredit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RleHRyZWdpb246OGU2Njc2MjUzNThjNDkxODk1YWE2M2E2YmMwOGI2ODBfMjg5Nw_a69985e2-7664-47fc-90cd-395fa31d8ba9">775.0</ix:nonFraction></ix:nonFraction> million outstanding under the term loan component of the Senior Credit Facility at a weighted average interest rate of <ix:nonFraction unitRef="number" contextRef="i6ace526dcf2e4bd7b1d416abfd600915_I20230331" decimals="3" name="us-gaap:DebtWeightedAverageInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RleHRyZWdpb246OGU2Njc2MjUzNThjNDkxODk1YWE2M2E2YmMwOGI2ODBfMzAzMw_d1281682-3745-43b6-bd47-165d2a0e703c">6.3</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i3b6f2ca5a0ff4bcf9931d0f74490b27a_I20221231" decimals="3" name="us-gaap:DebtWeightedAverageInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RleHRyZWdpb246OGU2Njc2MjUzNThjNDkxODk1YWE2M2E2YmMwOGI2ODBfNDM5ODA0NjUyODEwNA_09e2c261-6936-49f6-84c7-049887ec2445">5.6</ix:nonFraction>%, respectively. As of  March&#160;31, 2023 there was <ix:nonFraction unitRef="usd" contextRef="i6ace526dcf2e4bd7b1d416abfd600915_I20230331" decimals="INF" name="us-gaap:SecuredDebtCurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RleHRyZWdpb246OGU2Njc2MjUzNThjNDkxODk1YWE2M2E2YmMwOGI2ODBfNDM5ODA0NjUyNDMwOQ_ebadcf01-b894-4a18-94d1-de9c081bc35b">no</ix:nonFraction> portion of the Term Loan component of the Senior Credit Facility classified as current on the condensed consolidated balance sheet. As of  December&#160;31, 2022, there was $<ix:nonFraction unitRef="usd" contextRef="i3b6f2ca5a0ff4bcf9931d0f74490b27a_I20221231" decimals="-5" name="us-gaap:SecuredDebtCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RleHRyZWdpb246OGU2Njc2MjUzNThjNDkxODk1YWE2M2E2YmMwOGI2ODBfMzA4Nw_c94839cb-3358-4328-a48a-eec111f3888c">38.1</ix:nonFraction> million of the Term Loan component of the Senior Credit Facility classified as current on the consolidated balance sheets under the prior terms of the agreement.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of outstanding borrowings of the Senior Credit Facility's Term Loan component at March&#160;31, 2023</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> $<ix:nonFraction unitRef="usd" contextRef="i113a67b9524a40fdb5f84333cb215b19_I20230331" decimals="-5" name="us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RleHRyZWdpb246OGU2Njc2MjUzNThjNDkxODk1YWE2M2E2YmMwOGI2ODBfMzMzOQ_c21e02b9-07c5-45a3-97a2-7b5cced0faac">750.9</ix:nonFraction> million. This fair value was determined by using a discounted cash flow model based on current market interest rates available to the Company. These inputs are corroborated by observable market data for similar liabilities and therefore classified within Level 2 of the fair value hierarchy. Level 2 inputs represent inputs that are observable for the asset or liability, either directly or indirectly, and are other than active market observable i</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nputs that reflect unadjusted quoted prices for identical assets or liabilities.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Letters of credit outstanding as of March&#160;31, 2023 and December&#160;31, 2022 to</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">taled $<ix:nonFraction unitRef="usd" contextRef="i33d9a2beed6845289ab811beceaf918e_I20221231" decimals="-5" name="us-gaap:LettersOfCreditOutstandingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RleHRyZWdpb246OGU2Njc2MjUzNThjNDkxODk1YWE2M2E2YmMwOGI2ODBfMzkzNA_10c6f890-cc7d-4c0e-a979-1c704ae976f6"><ix:nonFraction unitRef="usd" contextRef="i2fcddd5311424f18bf9d0ea34cf199ce_I20230331" decimals="-5" name="us-gaap:LettersOfCreditOutstandingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RleHRyZWdpb246OGU2Njc2MjUzNThjNDkxODk1YWE2M2E2YmMwOGI2ODBfMzkzNA_a2806eed-62c4-43b3-99cd-b41c0bcfe0a9">1.6</ix:nonFraction></ix:nonFraction> million. There were <ix:nonFraction unitRef="usd" contextRef="i2fcddd5311424f18bf9d0ea34cf199ce_I20230331" decimals="INF" name="us-gaap:LineOfCredit" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RleHRyZWdpb246OGU2Njc2MjUzNThjNDkxODk1YWE2M2E2YmMwOGI2ODBfMzk0OQ_be04ebcc-e764-4e04-9d34-083595156a1d">no</ix:nonFraction> amounts drawn as of March&#160;31, 2023.</span></div><ix:nonNumeric contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" name="us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RleHRyZWdpb246OGU2Njc2MjUzNThjNDkxODk1YWE2M2E2YmMwOGI2ODBfMTEzNzY_d0de4ecf-8eb5-4460-91dd-54ecea52675c" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contractual repayments of the Term Loan component of the Senior Credit Facility are due as follows:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.432%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.784%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quarter Ended March&#160;31, 2023</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Principal Repayment</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Remainder of 2023</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RhYmxlOjQ3NGI4NDAwOWMyYzQ1OGZiODdmYTU4M2E1NTU1M2U4L3RhYmxlcmFuZ2U6NDc0Yjg0MDA5YzJjNDU4ZmI4N2ZhNTgzYTU1NTUzZThfMi0yLTEtMS0xODY4MjE_a35ea265-4026-4334-8ae5-cedf8ae941ac">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RhYmxlOjQ3NGI4NDAwOWMyYzQ1OGZiODdmYTU4M2E1NTU1M2U4L3RhYmxlcmFuZ2U6NDc0Yjg0MDA5YzJjNDU4ZmI4N2ZhNTgzYTU1NTUzZThfMy0yLTEtMS0xODY4MjE_a01b6ecc-fb5c-4a49-9750-80ff2e8da359">14,531</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RhYmxlOjQ3NGI4NDAwOWMyYzQ1OGZiODdmYTU4M2E1NTU1M2U4L3RhYmxlcmFuZ2U6NDc0Yjg0MDA5YzJjNDU4ZmI4N2ZhNTgzYTU1NTUzZThfNC0yLTEtMS0xODY4MjE_ccb3e29a-b2ab-4182-9ad8-7c81a3726fa6">33,906</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RhYmxlOjQ3NGI4NDAwOWMyYzQ1OGZiODdmYTU4M2E1NTU1M2U4L3RhYmxlcmFuZ2U6NDc0Yjg0MDA5YzJjNDU4ZmI4N2ZhNTgzYTU1NTUzZThfNS0yLTEtMS0xODY4MjE_6b00777e-8d2c-402f-8169-c5628c85b613">38,750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331" decimals="-3" name="iart:LongTermDebtMaturityAfterYearThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RhYmxlOjQ3NGI4NDAwOWMyYzQ1OGZiODdmYTU4M2E1NTU1M2U4L3RhYmxlcmFuZ2U6NDc0Yjg0MDA5YzJjNDU4ZmI4N2ZhNTgzYTU1NTUzZThfNi0yLTEtMS0xOTcyOTk_76466298-638e-418e-9935-5bff3897c74f">687,813</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RhYmxlOjQ3NGI4NDAwOWMyYzQ1OGZiODdmYTU4M2E1NTU1M2U4L3RhYmxlcmFuZ2U6NDc0Yjg0MDA5YzJjNDU4ZmI4N2ZhNTgzYTU1NTUzZThfNi0yLTEtMS0xODY4MjE_23de0699-b23e-4a18-bc19-faf015ab4b21">775,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future interest payments on the term loan component of the Senior Credit Facility based on current interest rates are expected to approximate $<ix:nonFraction unitRef="usd" contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331" decimals="-5" name="iart:InterestPaymentsReminderOfFiscalYear" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RleHRyZWdpb246OGU2Njc2MjUzNThjNDkxODk1YWE2M2E2YmMwOGI2ODBfNDIyMA_ed13df71-0aba-4cb8-8aa9-3de9d8c6c049">35.9</ix:nonFraction> million for remainder of 2023, $<ix:nonFraction unitRef="usd" contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331" decimals="-5" name="iart:InterestPaymentsYearOne" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RleHRyZWdpb246OGU2Njc2MjUzNThjNDkxODk1YWE2M2E2YmMwOGI2ODBfNDI0Ng_1d8e5ebd-9636-41d3-a67f-d12807b13ee8">38.1</ix:nonFraction> million in 2024,  $<ix:nonFraction unitRef="usd" contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331" decimals="-5" name="iart:InterestPaymentsYearTwo" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RleHRyZWdpb246OGU2Njc2MjUzNThjNDkxODk1YWE2M2E2YmMwOGI2ODBfNDI1OA_b342a0c5-a400-4c32-9f53-fcf827c22156">32.6</ix:nonFraction> million in 2025, $<ix:nonFraction unitRef="usd" contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331" decimals="-5" name="iart:InterestPaymentsYearThree" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RleHRyZWdpb246OGU2Njc2MjUzNThjNDkxODk1YWE2M2E2YmMwOGI2ODBfNjA0NzMxMzk2ODUzNg_c39020b3-f6fd-4364-8f7a-4b25cb53adbc">30.0</ix:nonFraction> million in  2026, and $<ix:nonFraction unitRef="usd" contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331" decimals="-5" name="iart:InterestPaymentsAfterYearThree" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RleHRyZWdpb246OGU2Njc2MjUzNThjNDkxODk1YWE2M2E2YmMwOGI2ODBfNjA0NzMxMzk2ODU1Nw_eea8d2a1-9d32-4c3a-b7af-690008f9fb12">34.5</ix:nonFraction> million thereafter . Interest is calculated on the term loan portion of the Senior Credit Facility based on SOFR plus the certain amounts set forth in the Credit Agreement. As the revolving credit facility and Securitization Facility can be repaid at any time, no interest has been included in the calculation.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any outstanding borrowings on the revolving credit component of the Senior Credit Facility is due on March 24, 2028.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Convertible Senior Notes</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 4, 2020, the Company issued $<ix:nonFraction unitRef="usd" contextRef="i4d85c23c3dd4486a8c0cad316eeb498d_I20200204" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RleHRyZWdpb246OGU2Njc2MjUzNThjNDkxODk1YWE2M2E2YmMwOGI2ODBfNDc4NQ_c57d14da-2208-47d0-856c-ac620a3b7c88">575.0</ix:nonFraction> million aggregate principal amount of its <ix:nonFraction unitRef="number" contextRef="i4d85c23c3dd4486a8c0cad316eeb498d_I20200204" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RleHRyZWdpb246OGU2Njc2MjUzNThjNDkxODk1YWE2M2E2YmMwOGI2ODBfNDgyMg_d9644e3a-3b1b-421e-a5cc-7d6179c3d112">0.5</ix:nonFraction>% Convertible Senior Notes due 2025 (the "2025 Notes"). The 2025 Notes will mature on August 15, 2025 and bear interest at a rate of <ix:nonFraction unitRef="number" contextRef="i4d85c23c3dd4486a8c0cad316eeb498d_I20200204" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RleHRyZWdpb246OGU2Njc2MjUzNThjNDkxODk1YWE2M2E2YmMwOGI2ODBfNDk1Ng_d9644e3a-3b1b-421e-a5cc-7d6179c3d112">0.5</ix:nonFraction>% per annum payable semi-annually in arrears, unless earlier converted, repurchased or redeemed in accordance with the terms of the 2025 Notes. In connection with this offering, the Company capitalized $<ix:nonFraction unitRef="usd" contextRef="i4d85c23c3dd4486a8c0cad316eeb498d_I20200204" decimals="-5" name="us-gaap:DeferredFinanceCostsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RleHRyZWdpb246OGU2Njc2MjUzNThjNDkxODk1YWE2M2E2YmMwOGI2ODBfNTMyNg_d7590dce-3a25-4544-99bf-71403914a694">13.2</ix:nonFraction> million of financing fees.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (continued) </span></div></div><ix:continuation id="i7e2353c8e5364635a02f53d42a85617c"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2025 Notes are senior, unsecured obligations of the Company, and are convertible into cash and shares of its common stock based on initial conversion rate, subject to adjustment of 13.5739 shares per $1,000 principal amounts of the 2025 Notes (which represents an initial conversion price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i4d85c23c3dd4486a8c0cad316eeb498d_I20200204" decimals="INF" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RleHRyZWdpb246OGU2Njc2MjUzNThjNDkxODk1YWE2M2E2YmMwOGI2ODBfNTYzNQ_d4195120-2ab0-4c6b-a749-a1ee2bd54d84">73.67</ix:nonFraction> per share). The 2025 Notes convert only in the following circumstances: (1) if the closing price of the Company's common stock has been at least <ix:nonFraction unitRef="number" contextRef="i3027f2cbc7194fc49391e18cf6122617_D20200204-20200204" decimals="INF" name="iart:DebtInstrumentMaximumSellingPriceOfCommonStockOfTheConversionPriceDuringPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RleHRyZWdpb246OGU2Njc2MjUzNThjNDkxODk1YWE2M2E2YmMwOGI2ODBfNTc4Mw_40e46432-8c4f-4606-ae97-882afaecf5b1">130</ix:nonFraction>% of the conversion price during the period; (2) if the average trading price per $1,000 principal amount of the 2025 Notes is less than or equal to <ix:nonFraction unitRef="number" contextRef="i3027f2cbc7194fc49391e18cf6122617_D20200204-20200204" decimals="INF" name="iart:DebtInstrumentMaximumAverageConversionValueOfNotes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RleHRyZWdpb246OGU2Njc2MjUzNThjNDkxODk1YWE2M2E2YmMwOGI2ODBfNTkzMw_72c24f0a-a239-4b7d-92a4-76f0c7d3f8f0">98</ix:nonFraction>% of the average conversion value of the 2025 Notes during a period as defined in the indenture; (3) at any time on or after February 20, 2023; or (4) if specified corporate transactions occur. As of March&#160;31, 2023, none of these conditions existed with respect to the 2025 Notes and as a result the 2025 Notes are classified as long term.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 9, 2020, the Company entered into the First Supplemental Indenture to the original agreement dated as of February 4, 2020 between the Company and Citibank, N.A., as trustee, governing the Company&#8217;s outstanding 2025 Notes. The Company irrevocably elected (1) to eliminate the Company&#8217;s option to choose physical settlement on any conversion of the 2025 Notes that occurs on or after the date of the First Supplemental Indenture and (2) with respect to any Combination Settlement for a conversion of the 2025 Notes, the Specified Dollar Amount that will be settled in cash per $1,000 principal amount of the 2025 Notes shall be no lower than $<ix:nonFraction unitRef="usd" contextRef="i296f2de4222e4edd96bf4c0e1aa8b562_I20201209" decimals="INF" name="iart:DebtInstrumentCombinationSettlementForDebtConversionMinimumSettledInCashPerPrincipalAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RleHRyZWdpb246OGU2Njc2MjUzNThjNDkxODk1YWE2M2E2YmMwOGI2ODBfNDk0NzgwMjMzNzk1OQ_da04dec9-d07b-4ffd-8fef-06f662635979">1,000</ix:nonFraction>.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of the Notes will have the right to require the Company to repurchase for cash all or a portion of their Notes at <ix:nonFraction unitRef="number" contextRef="i3027f2cbc7194fc49391e18cf6122617_D20200204-20200204" decimals="INF" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RleHRyZWdpb246OGU2Njc2MjUzNThjNDkxODk1YWE2M2E2YmMwOGI2ODBfNzA0NA_160452af-7760-4bab-b46b-2869b50a728a">100</ix:nonFraction>% of their principal amount, plus any accrued and unpaid interest, upon the occurrence of a fundamental change (as defined in the indenture relating to the Notes). The Company will also be required to increase the conversion rate for holders who convert their Notes in connection with certain fundamental changes occurring prior to the maturity date or following delivery by the Company of a notice of redemption.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the issuance of the 2025 Notes, the Company entered into call transactions and warrant transactions, primarily with affiliates of the initial purchasers of the 2025 Notes (the &#8220;hedge participants&#8221;). The cost of the call transactions was $<ix:nonFraction unitRef="usd" contextRef="i2a88a3ee579649698c7a806c20baf329_D20200204-20200204" decimals="-5" name="iart:PaymentsForOptionIndexToIssuersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RleHRyZWdpb246OGU2Njc2MjUzNThjNDkxODk1YWE2M2E2YmMwOGI2ODBfNzcxNQ_afb637a3-34bb-40df-883b-5d0387a51bbb">104.2</ix:nonFraction> million for the 2025 Notes. The Company received $<ix:nonFraction unitRef="usd" contextRef="i2a88a3ee579649698c7a806c20baf329_D20200204-20200204" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfWarrants" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RleHRyZWdpb246OGU2Njc2MjUzNThjNDkxODk1YWE2M2E2YmMwOGI2ODBfNzc1OQ_d23698b3-0a07-4674-af87-cc4ba38ba984">44.5</ix:nonFraction> million of proceeds from the warrant transactions for the 2025 Notes. The call transactions involved purchasing call options from the hedge participants, and the warrant transactions involved selling call options to the hedge participants with a higher strike price than the purchased call options. The initial strike price of the call transactions was $<ix:nonFraction unitRef="usdPerShare" contextRef="i2a88a3ee579649698c7a806c20baf329_D20200204-20200204" decimals="INF" name="us-gaap:OptionIndexedToIssuersEquityStrikePrice1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RleHRyZWdpb246OGU2Njc2MjUzNThjNDkxODk1YWE2M2E2YmMwOGI2ODBfODEwNw_3f3fabb1-2ab2-4d0f-82c0-01a7fe0038da">73.67</ix:nonFraction>, subject to anti-dilution adjustments substantially similar to those in the 2025 Notes. The initial strike price of the warrant transactions was $<ix:nonFraction unitRef="usdPerShare" contextRef="i4d85c23c3dd4486a8c0cad316eeb498d_I20200204" decimals="INF" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RleHRyZWdpb246OGU2Njc2MjUzNThjNDkxODk1YWE2M2E2YmMwOGI2ODBfODI1NQ_fd7cd350-bc74-4774-9924-c90af1350f81">113.34</ix:nonFraction> for the 2025 Notes, subject to customary anti-dilution adjustments.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March&#160;31, 2023</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the carrying amount of the liability w</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">as $<ix:nonFraction unitRef="usd" contextRef="i0028dc2843f2423f8f300edeb35aa725_I20230331" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RleHRyZWdpb246OGU2Njc2MjUzNThjNDkxODk1YWE2M2E2YmMwOGI2ODBfODY4OA_00e446a7-320f-46fd-94f5-dfe39cf8b17c">575.0</ix:nonFraction> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">million. The fair value of the 2025 Notes at March&#160;31, 2023 was </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="i0028dc2843f2423f8f300edeb35aa725_I20230331" decimals="-5" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RleHRyZWdpb246OGU2Njc2MjUzNThjNDkxODk1YWE2M2E2YmMwOGI2ODBfODc0Mw_1b49b169-25c1-4707-b4dc-58635d403d40">561.7</ix:nonFraction></span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> million. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Factors that the Company considered when estimating the fair value of the 2025 Notes included recent quoted market prices or dealer quote. The level of the 2025 Notes is considered as Level 1.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Securitization Facility</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2018, the Company entered into an accounts receivable securitization facility (the "Securitization Facility") under which accounts receivable of certain domestic subsidiaries are sold on a non-recourse basis to a special purpose entity (&#8220;SPE&#8221;), which is a bankruptcy-remote, consolidated subsidiary of the Company. Accordingly, the assets of the SPE are not available to satisfy the obligations of the Company or any of its subsidiaries. From time to time, the SPE may finance such accounts receivable with a revolving loan facility secured by a pledge of such accounts receivable. The amount of outstanding borrowings on the Securitization Facility at any one time is limited to&#160;$<ix:nonFraction unitRef="usd" contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331" decimals="INF" name="iart:TransferorsInterestsInTransferredFinancialAssetsMaximumInvestmentLimit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RleHRyZWdpb246OGU2Njc2MjUzNThjNDkxODk1YWE2M2E2YmMwOGI2ODBfOTg3Ng_c76e3620-9564-4b24-81be-0a168fd56f40">150.0</ix:nonFraction> million. The Securitization Facility Agreement ("Securitization Agreement") governing the Securitization Facility contains certain covenants and termination events. An occurrence of an event of default or a termination event under this Securitization Agreement may give rise to the right of its counterparty to terminate this facility. As of March&#160;31, 2023, the Company was in compliance with the covenants and none of the termination events had occurred.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 28, 2021, the Company entered into an amendment (the "May 2021 Amendment") of the Securitization Facility which extended the maturity date from December 21, 2021 to May 28, 2024. The May 2021 Amendment does not increase the Company&#8217;s total indebtedness.  </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Securitization Facility is currently indexed to LIBOR. At March&#160;31, 2023 and December&#160;31, 2022, the Company had $<ix:nonFraction unitRef="usd" contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331" decimals="-5" name="iart:SecuredLongTermDebtSecuritizationProgram" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RleHRyZWdpb246OGU2Njc2MjUzNThjNDkxODk1YWE2M2E2YmMwOGI2ODBfMTA2MDY_861597f0-2ee1-41f0-b758-ade0f9e3b14e">102.5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231" decimals="-5" name="iart:SecuredLongTermDebtSecuritizationProgram" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RleHRyZWdpb246OGU2Njc2MjUzNThjNDkxODk1YWE2M2E2YmMwOGI2ODBfMTA2MTM_043b4fea-8c44-4c50-8470-712aeb8aacb2">104.7</ix:nonFraction> million, respectively, of outstanding borrowings under its Securitization Facility at a weighted average interest rate of&#160;<ix:nonFraction unitRef="number" contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331" decimals="3" name="iart:DebtWeightedAverageInterestRateFromSecuritization" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RleHRyZWdpb246OGU2Njc2MjUzNThjNDkxODk1YWE2M2E2YmMwOGI2ODBfMTA3MzA_b3dc7dfc-8a68-49dd-9690-be9524ea9295">5.8</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231" decimals="3" name="iart:DebtWeightedAverageInterestRateFromSecuritization" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RleHRyZWdpb246OGU2Njc2MjUzNThjNDkxODk1YWE2M2E2YmMwOGI2ODBfMTA3Mzc_f2d807f2-f657-4839-8cdc-8372b2715ca3">5.0</ix:nonFraction>%, respectively. In April 2023, we amended the facility to replace LIBOR with SOFR-indexed interest. The fair value of the outstanding borrowing of the Securitization Facility at&#160;March&#160;31, 2023&#160;was&#160;$<ix:nonFraction unitRef="usd" contextRef="if38b10df1e9e4c7bbece89c49285e3f3_I20230331" decimals="-5" name="iart:SecuritizationFacilityFairValueOfAmountOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RleHRyZWdpb246OGU2Njc2MjUzNThjNDkxODk1YWE2M2E2YmMwOGI2ODBfMTA4NDA_fcfee696-566a-4210-9e2d-267e2d875e92">102.2</ix:nonFraction> million. These fair values were determined by using a discounted cash flow model based on current market interest rates available to the Company. These inputs are corroborated by observable market data for similar liabilities and therefore classified within Level 2 of the fair value hierarchy. Level 2 inputs represent inputs that are observable for the asset or liability, either directly or indirectly, and are other than active market observable i</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nputs that reflect unadjusted quoted prices for identical assets or liabilities.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><div id="i5f1eb1bd01d541c3aa0777712077c048_58"></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (continued) </span></div></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.&#160;<ix:nonNumeric contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" name="us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RleHRyZWdpb246ODA4MTIyY2E0NzEyNDJhN2I5MzExOGQ4ZTEyNmQ4NjBfMTA4NTM_a9634748-8fb4-4614-a871-fa4dd8e358f9" continuedAt="i26ae90696b9948d3acf40fb875071b9a" escape="true">DERIVATIVE INSTRUMENTS </ix:nonNumeric></span></div><ix:continuation id="i26ae90696b9948d3acf40fb875071b9a" continuedAt="ib5d3e0d6d98a4c31a56f999bf1b3e598"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Hedging</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s interest rate risk relates to U.S. dollar denominated variable interest rate borrowings. The Company uses interest rate swap derivative instruments to manage earnings and cash flow exposure resulting from changes in interest rates. These interest rate swaps apply a fixed interest rate on a portion of the Company's expected SOFR-indexed borrowings. In connection with the March 2023 Amendment to the Senior Credit Facility, the Company amended its interest rate from LIBOR to SOFR-indexed interest. In March 2023, the Company entered into a basis swap where the Company receives Term SOFR and pays LIBOR to convert the portfolio of swaps from LIBOR to SOFR. </span></div><ix:nonNumeric contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" name="us-gaap:ScheduleOfDerivativeInstrumentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RleHRyZWdpb246ODA4MTIyY2E0NzEyNDJhN2I5MzExOGQ4ZTEyNmQ4NjBfMTA4NjU_320c3d40-81d0-420c-af1a-fdc0640c440c" continuedAt="ibafbda57447f468490c1925cd53ad296" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company held the following interest rate swaps as of March&#160;31, 2023 and December&#160;31, 2022 (dollar amounts in thousands):</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:center;text-indent:-9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.783%"><tr><td style="width:1.0%"></td><td style="width:15.667%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.555%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:10.833%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.404%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:12.646%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.404%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.646%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.404%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.646%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.404%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.625%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.404%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.462%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Hedged Item</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional Amount</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Designation Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Termination Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fixed Interest Rate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated Fair Value</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asset (Liability)</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1-month Term SOFR Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i660d9b3823f743b9bb93a4c91c601967_I20230331" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjQzZjZiNzkxMTY0YjRlMzRiZGQxNzM1OTYxODIwMWM0L3RhYmxlcmFuZ2U6NDNmNmI3OTExNjRiNGUzNGJkZDE3MzU5NjE4MjAxYzRfNC00LTEtMS0xODY4MjE_216a4106-6fa2-4c83-8543-cf1b48546f37">150,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 13, 2017</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">July 1, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">June 30, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i660d9b3823f743b9bb93a4c91c601967_I20230331" decimals="5" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjQzZjZiNzkxMTY0YjRlMzRiZGQxNzM1OTYxODIwMWM0L3RhYmxlcmFuZ2U6NDNmNmI3OTExNjRiNGUzNGJkZDE3MzU5NjE4MjAxYzRfNC0xNC0xLTEtMTg2ODIx_de395d36-c93c-4d41-8a0a-d6e60af2c8ba">2.423</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i660d9b3823f743b9bb93a4c91c601967_I20230331" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjQzZjZiNzkxMTY0YjRlMzRiZGQxNzM1OTYxODIwMWM0L3RhYmxlcmFuZ2U6NDNmNmI3OTExNjRiNGUzNGJkZDE3MzU5NjE4MjAxYzRfNC0xNi0xLTEtMTg2ODIx_9b166945-f88b-417a-8e78-93bca18c19a8">4,022</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1-month Term SOFR Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if90a05dc42874d4c91a7b0d2cd282433_I20230331" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjQzZjZiNzkxMTY0YjRlMzRiZGQxNzM1OTYxODIwMWM0L3RhYmxlcmFuZ2U6NDNmNmI3OTExNjRiNGUzNGJkZDE3MzU5NjE4MjAxYzRfNS00LTEtMS0xODY4MjE_da12b221-c104-4a1e-af5c-81ee69ad112b">200,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 13, 2017</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">January 1, 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if90a05dc42874d4c91a7b0d2cd282433_I20230331" decimals="5" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjQzZjZiNzkxMTY0YjRlMzRiZGQxNzM1OTYxODIwMWM0L3RhYmxlcmFuZ2U6NDNmNmI3OTExNjRiNGUzNGJkZDE3MzU5NjE4MjAxYzRfNS0xNC0xLTEtMTg2ODIx_f52d7b49-a9af-41a7-89a5-8e5d4a2aeee8">2.313</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if90a05dc42874d4c91a7b0d2cd282433_I20230331" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjQzZjZiNzkxMTY0YjRlMzRiZGQxNzM1OTYxODIwMWM0L3RhYmxlcmFuZ2U6NDNmNmI3OTExNjRiNGUzNGJkZDE3MzU5NjE4MjAxYzRfNS0xNi0xLTEtMTg2ODIx_aa7ccc4b-7f91-4d98-bcd5-641203c50405">6,738</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1-month Term SOFR Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic80e820d18594abbb087fa7ea6c97b34_I20230331" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjQzZjZiNzkxMTY0YjRlMzRiZGQxNzM1OTYxODIwMWM0L3RhYmxlcmFuZ2U6NDNmNmI3OTExNjRiNGUzNGJkZDE3MzU5NjE4MjAxYzRfNi00LTEtMS0xODY4MjE_ec58acfa-4019-43b1-8748-125dffd48fcd">75,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">October 10, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">July 1, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">June 30, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic80e820d18594abbb087fa7ea6c97b34_I20230331" decimals="5" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjQzZjZiNzkxMTY0YjRlMzRiZGQxNzM1OTYxODIwMWM0L3RhYmxlcmFuZ2U6NDNmNmI3OTExNjRiNGUzNGJkZDE3MzU5NjE4MjAxYzRfNi0xNC0xLTEtMTg2ODIx_2e1fb448-91c6-4b95-b44f-100b6b21b792">3.220</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic80e820d18594abbb087fa7ea6c97b34_I20230331" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjQzZjZiNzkxMTY0YjRlMzRiZGQxNzM1OTYxODIwMWM0L3RhYmxlcmFuZ2U6NDNmNmI3OTExNjRiNGUzNGJkZDE3MzU5NjE4MjAxYzRfNi0xNi0xLTEtMTg2ODIx_1e12f50f-9b96-4898-8168-5de71166c659">1,329</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1-month Term SOFR Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i242cbbb364f64c76abce2babdef87734_I20230331" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjQzZjZiNzkxMTY0YjRlMzRiZGQxNzM1OTYxODIwMWM0L3RhYmxlcmFuZ2U6NDNmNmI3OTExNjRiNGUzNGJkZDE3MzU5NjE4MjAxYzRfNy00LTEtMS0xODY4MjE_9b984b57-074e-41d5-910c-04a638174f16">75,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">October 10, 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">July 1, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">June 30, 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i242cbbb364f64c76abce2babdef87734_I20230331" decimals="5" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjQzZjZiNzkxMTY0YjRlMzRiZGQxNzM1OTYxODIwMWM0L3RhYmxlcmFuZ2U6NDNmNmI3OTExNjRiNGUzNGJkZDE3MzU5NjE4MjAxYzRfNy0xNC0xLTEtMTg2ODIx_0750fbec-b081-4690-b2c6-90bc211f95f6">3.199</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i242cbbb364f64c76abce2babdef87734_I20230331" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjQzZjZiNzkxMTY0YjRlMzRiZGQxNzM1OTYxODIwMWM0L3RhYmxlcmFuZ2U6NDNmNmI3OTExNjRiNGUzNGJkZDE3MzU5NjE4MjAxYzRfNy0xNi0xLTEtMTg2ODIx_8656ddb1-d67b-4abc-90db-dda577dbfa43">1,539</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1-month Term SOFR Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1df01832fdb04d5687ddfbc85bd04c29_I20230331" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjQzZjZiNzkxMTY0YjRlMzRiZGQxNzM1OTYxODIwMWM0L3RhYmxlcmFuZ2U6NDNmNmI3OTExNjRiNGUzNGJkZDE3MzU5NjE4MjAxYzRfOC00LTEtMS0xODY4MjE_374317d6-b6ee-4e8c-81e2-51dbdac7f277">75,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">October 10, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">July 1, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">June 30, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1df01832fdb04d5687ddfbc85bd04c29_I20230331" decimals="5" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjQzZjZiNzkxMTY0YjRlMzRiZGQxNzM1OTYxODIwMWM0L3RhYmxlcmFuZ2U6NDNmNmI3OTExNjRiNGUzNGJkZDE3MzU5NjE4MjAxYzRfOC0xNC0xLTEtMTg2ODIx_22800d73-bafe-4e77-92a9-344a87e91ae5">3.209</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1df01832fdb04d5687ddfbc85bd04c29_I20230331" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjQzZjZiNzkxMTY0YjRlMzRiZGQxNzM1OTYxODIwMWM0L3RhYmxlcmFuZ2U6NDNmNmI3OTExNjRiNGUzNGJkZDE3MzU5NjE4MjAxYzRfOC0xNi0xLTEtMTg2ODIx_4433c76c-18eb-47cf-b711-b41a9b2376c9">1,441</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1-month Term SOFR Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7f35814aec144359ed4a1f6aca5ff44_I20230331" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjQzZjZiNzkxMTY0YjRlMzRiZGQxNzM1OTYxODIwMWM0L3RhYmxlcmFuZ2U6NDNmNmI3OTExNjRiNGUzNGJkZDE3MzU5NjE4MjAxYzRfOS00LTEtMS0xODY4MjE_64b5846a-9a76-41b6-a78c-795b5b739b04">100,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 18, 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 30, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31, 2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id7f35814aec144359ed4a1f6aca5ff44_I20230331" decimals="5" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjQzZjZiNzkxMTY0YjRlMzRiZGQxNzM1OTYxODIwMWM0L3RhYmxlcmFuZ2U6NDNmNmI3OTExNjRiNGUzNGJkZDE3MzU5NjE4MjAxYzRfOS0xNC0xLTEtMTg2ODIx_59edc221-60e4-4ccc-abf9-f8817a58f71e">2.885</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7f35814aec144359ed4a1f6aca5ff44_I20230331" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjQzZjZiNzkxMTY0YjRlMzRiZGQxNzM1OTYxODIwMWM0L3RhYmxlcmFuZ2U6NDNmNmI3OTExNjRiNGUzNGJkZDE3MzU5NjE4MjAxYzRfOS0xNi0xLTEtMTg2ODIx_05e34df7-1808-4ec3-8123-3504184aeb4a">2,770</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1-month Term SOFR Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if455fa2d39f24cf59e0ca350ce4174ae_I20230331" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjQzZjZiNzkxMTY0YjRlMzRiZGQxNzM1OTYxODIwMWM0L3RhYmxlcmFuZ2U6NDNmNmI3OTExNjRiNGUzNGJkZDE3MzU5NjE4MjAxYzRfMTAtNC0xLTEtMTg2ODIx_3f122ec7-9120-4445-a510-bd16fd4818a4">100,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 18, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31, 2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if455fa2d39f24cf59e0ca350ce4174ae_I20230331" decimals="5" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjQzZjZiNzkxMTY0YjRlMzRiZGQxNzM1OTYxODIwMWM0L3RhYmxlcmFuZ2U6NDNmNmI3OTExNjRiNGUzNGJkZDE3MzU5NjE4MjAxYzRfMTAtMTQtMS0xLTE4NjgyMQ_77aed230-4c9e-469a-95c8-539fef299250">2.867</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if455fa2d39f24cf59e0ca350ce4174ae_I20230331" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjQzZjZiNzkxMTY0YjRlMzRiZGQxNzM1OTYxODIwMWM0L3RhYmxlcmFuZ2U6NDNmNmI3OTExNjRiNGUzNGJkZDE3MzU5NjE4MjAxYzRfMTAtMTYtMS0xLTE4NjgyMQ_453ddbf2-bbce-4d73-a61a-a226e8c90755">2,708</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1-month Term SOFR Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68d02b4ce6b442a39ee633b1a9c0c689_I20230331" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjQzZjZiNzkxMTY0YjRlMzRiZGQxNzM1OTYxODIwMWM0L3RhYmxlcmFuZ2U6NDNmNmI3OTExNjRiNGUzNGJkZDE3MzU5NjE4MjAxYzRfMTEtNC0xLTEtMTg2ODIx_c320db32-82d5-425d-9199-9f3365f0df81">575,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 15, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">July 31, 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31, 2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i68d02b4ce6b442a39ee633b1a9c0c689_I20230331" decimals="5" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjQzZjZiNzkxMTY0YjRlMzRiZGQxNzM1OTYxODIwMWM0L3RhYmxlcmFuZ2U6NDNmNmI3OTExNjRiNGUzNGJkZDE3MzU5NjE4MjAxYzRfMTEtMTQtMS0xLTE4NjgyMQ_0d7c8757-0dc1-411a-ae5d-924eec2c4423">1.415</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68d02b4ce6b442a39ee633b1a9c0c689_I20230331" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjQzZjZiNzkxMTY0YjRlMzRiZGQxNzM1OTYxODIwMWM0L3RhYmxlcmFuZ2U6NDNmNmI3OTExNjRiNGUzNGJkZDE3MzU5NjE4MjAxYzRfMTEtMTYtMS0xLTE4NjgyMQ_12b7b1d5-e239-4436-8560-24249f634755">19,406</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1-month Term SOFR Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4611de47ca424f2880fb6c66abf4c864_I20230331" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjQzZjZiNzkxMTY0YjRlMzRiZGQxNzM1OTYxODIwMWM0L3RhYmxlcmFuZ2U6NDNmNmI3OTExNjRiNGUzNGJkZDE3MzU5NjE4MjAxYzRfMTItNC0xLTEtMTg2ODIx_355c0b93-698b-4908-ade8-147cbdf8da84">125,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 15, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">July 1, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31, 2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4611de47ca424f2880fb6c66abf4c864_I20230331" decimals="5" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjQzZjZiNzkxMTY0YjRlMzRiZGQxNzM1OTYxODIwMWM0L3RhYmxlcmFuZ2U6NDNmNmI3OTExNjRiNGUzNGJkZDE3MzU5NjE4MjAxYzRfMTItMTQtMS0xLTE4NjgyMQ_c9b10ed4-5e90-49fc-8cfc-3dc0afbf686e">1.404</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4611de47ca424f2880fb6c66abf4c864_I20230331" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjQzZjZiNzkxMTY0YjRlMzRiZGQxNzM1OTYxODIwMWM0L3RhYmxlcmFuZ2U6NDNmNmI3OTExNjRiNGUzNGJkZDE3MzU5NjE4MjAxYzRfMTItMTYtMS0xLTE4NjgyMQ_0e29ee73-0bf5-4ca7-9e1b-28f52762a973">4,567</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Basis Swap </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3e91944e1f34523a944e5c31a1dcfb8_I20230331" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjQzZjZiNzkxMTY0YjRlMzRiZGQxNzM1OTYxODIwMWM0L3RhYmxlcmFuZ2U6NDNmNmI3OTExNjRiNGUzNGJkZDE3MzU5NjE4MjAxYzRfMTMtNC0xLTEtMjAzMTc3_5d15dc19-721e-4ee0-8a68-86b6d6c927f4">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">March 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">March 24, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31, 2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id3e91944e1f34523a944e5c31a1dcfb8_I20230331" decimals="-3" sign="-" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjQzZjZiNzkxMTY0YjRlMzRiZGQxNzM1OTYxODIwMWM0L3RhYmxlcmFuZ2U6NDNmNmI3OTExNjRiNGUzNGJkZDE3MzU5NjE4MjAxYzRfMTMtMTYtMS0xLTIwMzE3Nw_c3d56ec9-1898-434c-b7c5-4f24b0712a88">1,842</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b244a95ae9e496fa6a76dbb19e5a1ff_I20230331" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjQzZjZiNzkxMTY0YjRlMzRiZGQxNzM1OTYxODIwMWM0L3RhYmxlcmFuZ2U6NDNmNmI3OTExNjRiNGUzNGJkZDE3MzU5NjE4MjAxYzRfMTMtNC0xLTEtMTg2ODIx_2dcbb149-c9b6-4c33-bb1a-54dcb3fd1ea0">1,475,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibaa12b7418534a0f9c95d84d9ad6b1bb_I20230331" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjQzZjZiNzkxMTY0YjRlMzRiZGQxNzM1OTYxODIwMWM0L3RhYmxlcmFuZ2U6NDNmNmI3OTExNjRiNGUzNGJkZDE3MzU5NjE4MjAxYzRfMTMtMTYtMS0xLTE4NjgyMQ_19c51b4a-206f-479a-9c49-af0ef9f03f58">42,678</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="39" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> The notional of the basis swap amortizes to match the total notional of the interest rate swap portfolio over time</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:12pt;margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:center;text-indent:-9pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (continued) </span></div></div><ix:continuation id="ib5d3e0d6d98a4c31a56f999bf1b3e598" continuedAt="i9814d18431ed4caf85c90cb79562fce3"><div style="margin-bottom:12pt;margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:center;text-indent:-9pt"><ix:continuation id="ibafbda57447f468490c1925cd53ad296" continuedAt="i9e3888f6f4fe41d9b7cf2153548bdd36"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.684%"><tr><td style="width:1.0%"></td><td style="width:21.122%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.392%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.392%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.381%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.392%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.381%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.392%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.381%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.392%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.677%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.392%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:13.573%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Hedged Item</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Designation Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Termination Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fixed Interest Rate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated Fair Value</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asset (Liability)</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f5aaca61a204337a8cdf280d2e2d8d1_I20221231" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjFmNjIwMGUxYzIyOTQ0ZjY4YmQ0MGEzYjcyM2Q5ZmYxL3RhYmxlcmFuZ2U6MWY2MjAwZTFjMjI5NDRmNjhiZDQwYTNiNzIzZDlmZjFfNC02LTEtMS0yMDAyODU_f92a6a66-fe56-4977-bcd2-b9f79af96718">150,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 13, 2017</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">July 1, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">June 30, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9f5aaca61a204337a8cdf280d2e2d8d1_I20221231" decimals="5" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjFmNjIwMGUxYzIyOTQ0ZjY4YmQ0MGEzYjcyM2Q5ZmYxL3RhYmxlcmFuZ2U6MWY2MjAwZTFjMjI5NDRmNjhiZDQwYTNiNzIzZDlmZjFfNC0xNC0xLTEtMjAwMjg1_611efb8a-c336-442b-a002-c71d5a1f1ab7">2.423</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f5aaca61a204337a8cdf280d2e2d8d1_I20221231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjFmNjIwMGUxYzIyOTQ0ZjY4YmQ0MGEzYjcyM2Q5ZmYxL3RhYmxlcmFuZ2U6MWY2MjAwZTFjMjI5NDRmNjhiZDQwYTNiNzIzZDlmZjFfNC0xOC0xLTEtMjAwMjg1_a91e5aa3-668c-4a38-b3fc-83e39cb65db6">5,012</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i110563708a344d13b6ba6837a8ffdaff_I20221231" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjFmNjIwMGUxYzIyOTQ0ZjY4YmQ0MGEzYjcyM2Q5ZmYxL3RhYmxlcmFuZ2U6MWY2MjAwZTFjMjI5NDRmNjhiZDQwYTNiNzIzZDlmZjFfNS02LTEtMS0yMDAyODU_1fc0e455-20af-4f24-a7c1-f9997d7e8f0f">200,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 13, 2017</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">January 1, 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i110563708a344d13b6ba6837a8ffdaff_I20221231" decimals="5" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjFmNjIwMGUxYzIyOTQ0ZjY4YmQ0MGEzYjcyM2Q5ZmYxL3RhYmxlcmFuZ2U6MWY2MjAwZTFjMjI5NDRmNjhiZDQwYTNiNzIzZDlmZjFfNS0xNC0xLTEtMjAwMjg1_a4ac4b06-3190-4c47-ab9a-c3874eb75f46">2.313</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i110563708a344d13b6ba6837a8ffdaff_I20221231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjFmNjIwMGUxYzIyOTQ0ZjY4YmQ0MGEzYjcyM2Q5ZmYxL3RhYmxlcmFuZ2U6MWY2MjAwZTFjMjI5NDRmNjhiZDQwYTNiNzIzZDlmZjFfNS0xOC0xLTEtMjAwMjg1_bb427c29-d062-4598-ad52-8904683adcad">8,380</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8d564f8afa4405eac0fdd8215345e13_I20221231" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjFmNjIwMGUxYzIyOTQ0ZjY4YmQ0MGEzYjcyM2Q5ZmYxL3RhYmxlcmFuZ2U6MWY2MjAwZTFjMjI5NDRmNjhiZDQwYTNiNzIzZDlmZjFfNi02LTEtMS0yMDAyODU_723cf53d-08f4-49ef-82e9-60cb3eaea02c">75,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">October 10, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">July 1, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">June 30, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib8d564f8afa4405eac0fdd8215345e13_I20221231" decimals="5" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjFmNjIwMGUxYzIyOTQ0ZjY4YmQ0MGEzYjcyM2Q5ZmYxL3RhYmxlcmFuZ2U6MWY2MjAwZTFjMjI5NDRmNjhiZDQwYTNiNzIzZDlmZjFfNi0xNC0xLTEtMjAwMjg1_66063123-9a56-400b-81e2-a00351509a64">3.220</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8d564f8afa4405eac0fdd8215345e13_I20221231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjFmNjIwMGUxYzIyOTQ0ZjY4YmQ0MGEzYjcyM2Q5ZmYxL3RhYmxlcmFuZ2U6MWY2MjAwZTFjMjI5NDRmNjhiZDQwYTNiNzIzZDlmZjFfNi0xOC0xLTEtMjAwMjg1_1bfa5de9-9b38-4990-ab8c-d14eae587472">1,831</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i453cd89c33ef48c7bdfc3ff3788502d2_I20221231" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjFmNjIwMGUxYzIyOTQ0ZjY4YmQ0MGEzYjcyM2Q5ZmYxL3RhYmxlcmFuZ2U6MWY2MjAwZTFjMjI5NDRmNjhiZDQwYTNiNzIzZDlmZjFfNy02LTEtMS0yMDAyODU_08eecccd-bdb5-4fcd-ad31-98127b815f12">75,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">October 10, 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">July 1, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">June 30, 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i453cd89c33ef48c7bdfc3ff3788502d2_I20221231" decimals="5" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjFmNjIwMGUxYzIyOTQ0ZjY4YmQ0MGEzYjcyM2Q5ZmYxL3RhYmxlcmFuZ2U6MWY2MjAwZTFjMjI5NDRmNjhiZDQwYTNiNzIzZDlmZjFfNy0xNC0xLTEtMjAwMjg1_ad9cb1b7-113a-4e9d-b003-ce8cdde79e5c">3.199</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i453cd89c33ef48c7bdfc3ff3788502d2_I20221231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjFmNjIwMGUxYzIyOTQ0ZjY4YmQ0MGEzYjcyM2Q5ZmYxL3RhYmxlcmFuZ2U6MWY2MjAwZTFjMjI5NDRmNjhiZDQwYTNiNzIzZDlmZjFfNy0xOC0xLTEtMjAwMjg1_285d7a24-b97d-4020-affc-b40cb4bcf2ee">1,905</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iefae8c9c545043389530b336eede02b7_I20221231" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjFmNjIwMGUxYzIyOTQ0ZjY4YmQ0MGEzYjcyM2Q5ZmYxL3RhYmxlcmFuZ2U6MWY2MjAwZTFjMjI5NDRmNjhiZDQwYTNiNzIzZDlmZjFfOC02LTEtMS0yMDAyODU_2718cb0b-9e85-4a09-9d58-98a58ffe7297">75,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">October 10, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">July 1, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">June 30, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iefae8c9c545043389530b336eede02b7_I20221231" decimals="5" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjFmNjIwMGUxYzIyOTQ0ZjY4YmQ0MGEzYjcyM2Q5ZmYxL3RhYmxlcmFuZ2U6MWY2MjAwZTFjMjI5NDRmNjhiZDQwYTNiNzIzZDlmZjFfOC0xNC0xLTEtMjAwMjg1_9dbf8381-9e09-4d05-8004-5a333c74461d">3.209</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iefae8c9c545043389530b336eede02b7_I20221231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjFmNjIwMGUxYzIyOTQ0ZjY4YmQ0MGEzYjcyM2Q5ZmYxL3RhYmxlcmFuZ2U6MWY2MjAwZTFjMjI5NDRmNjhiZDQwYTNiNzIzZDlmZjFfOC0xOC0xLTEtMjAwMjg1_c1c4ffba-0fa3-4ebc-931d-707b046de78a">1,970</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb9a8e940c7a42eb987c4c32a8bdb139_I20221231" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjFmNjIwMGUxYzIyOTQ0ZjY4YmQ0MGEzYjcyM2Q5ZmYxL3RhYmxlcmFuZ2U6MWY2MjAwZTFjMjI5NDRmNjhiZDQwYTNiNzIzZDlmZjFfOS02LTEtMS0yMDAyODU_646b4082-dc6d-40d3-97cc-a526d5eca71a">100,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 18, 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 30, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31, 2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idb9a8e940c7a42eb987c4c32a8bdb139_I20221231" decimals="5" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjFmNjIwMGUxYzIyOTQ0ZjY4YmQ0MGEzYjcyM2Q5ZmYxL3RhYmxlcmFuZ2U6MWY2MjAwZTFjMjI5NDRmNjhiZDQwYTNiNzIzZDlmZjFfOS0xNC0xLTEtMjAwMjg1_68e7d5b6-dfdd-4aba-8323-283560528f77">2.885</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb9a8e940c7a42eb987c4c32a8bdb139_I20221231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjFmNjIwMGUxYzIyOTQ0ZjY4YmQ0MGEzYjcyM2Q5ZmYxL3RhYmxlcmFuZ2U6MWY2MjAwZTFjMjI5NDRmNjhiZDQwYTNiNzIzZDlmZjFfOS0xOC0xLTEtMjAwMjg1_155388d8-966b-45e7-8597-25142fe824b4">4,252</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i107d35b94cbf4cafb70558b912de87a9_I20221231" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjFmNjIwMGUxYzIyOTQ0ZjY4YmQ0MGEzYjcyM2Q5ZmYxL3RhYmxlcmFuZ2U6MWY2MjAwZTFjMjI5NDRmNjhiZDQwYTNiNzIzZDlmZjFfMTAtNi0xLTEtMjAwMjg1_1b153e82-d222-4f8b-8616-7786b4363f10">100,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 18, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31, 2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i107d35b94cbf4cafb70558b912de87a9_I20221231" decimals="5" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjFmNjIwMGUxYzIyOTQ0ZjY4YmQ0MGEzYjcyM2Q5ZmYxL3RhYmxlcmFuZ2U6MWY2MjAwZTFjMjI5NDRmNjhiZDQwYTNiNzIzZDlmZjFfMTAtMTQtMS0xLTIwMDI4NQ_54a9a19d-ac6e-4cec-9139-9d4e403096df">2.867</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i107d35b94cbf4cafb70558b912de87a9_I20221231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjFmNjIwMGUxYzIyOTQ0ZjY4YmQ0MGEzYjcyM2Q5ZmYxL3RhYmxlcmFuZ2U6MWY2MjAwZTFjMjI5NDRmNjhiZDQwYTNiNzIzZDlmZjFfMTAtMTgtMS0xLTIwMDI4NQ_11fbcd1b-8547-46bb-90ee-fb4a832dee4c">4,153</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1063bf6f331744358ce9892d6b046199_I20221231" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjFmNjIwMGUxYzIyOTQ0ZjY4YmQ0MGEzYjcyM2Q5ZmYxL3RhYmxlcmFuZ2U6MWY2MjAwZTFjMjI5NDRmNjhiZDQwYTNiNzIzZDlmZjFfMTEtNi0xLTEtMjAwMjg1_95ee5dba-6bc8-45f2-a629-336e3f3b17d9">575,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 15, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">July 31, 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31, 2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1063bf6f331744358ce9892d6b046199_I20221231" decimals="5" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjFmNjIwMGUxYzIyOTQ0ZjY4YmQ0MGEzYjcyM2Q5ZmYxL3RhYmxlcmFuZ2U6MWY2MjAwZTFjMjI5NDRmNjhiZDQwYTNiNzIzZDlmZjFfMTEtMTQtMS0xLTIwMDI4NQ_083c1660-6480-44b2-bd1c-888b885615ab">1.415</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1063bf6f331744358ce9892d6b046199_I20221231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjFmNjIwMGUxYzIyOTQ0ZjY4YmQ0MGEzYjcyM2Q5ZmYxL3RhYmxlcmFuZ2U6MWY2MjAwZTFjMjI5NDRmNjhiZDQwYTNiNzIzZDlmZjFfMTEtMTgtMS0xLTIwMDI4NQ_10feda83-0c18-4446-9749-000bf5634258">23,742</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69349b63e94749f680a73aa85071a4f3_I20221231" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjFmNjIwMGUxYzIyOTQ0ZjY4YmQ0MGEzYjcyM2Q5ZmYxL3RhYmxlcmFuZ2U6MWY2MjAwZTFjMjI5NDRmNjhiZDQwYTNiNzIzZDlmZjFfMTItNi0xLTEtMjAwMjg1_54a42e23-bbcb-4a99-97ac-0e38c2317309">125,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 15, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">July 1, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31, 2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i69349b63e94749f680a73aa85071a4f3_I20221231" decimals="5" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjFmNjIwMGUxYzIyOTQ0ZjY4YmQ0MGEzYjcyM2Q5ZmYxL3RhYmxlcmFuZ2U6MWY2MjAwZTFjMjI5NDRmNjhiZDQwYTNiNzIzZDlmZjFfMTItMTQtMS0xLTIwMDI4NQ_fe3815cb-c155-44e6-87d1-5673c94988e7">1.404</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69349b63e94749f680a73aa85071a4f3_I20221231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjFmNjIwMGUxYzIyOTQ0ZjY4YmQ0MGEzYjcyM2Q5ZmYxL3RhYmxlcmFuZ2U6MWY2MjAwZTFjMjI5NDRmNjhiZDQwYTNiNzIzZDlmZjFfMTItMTgtMS0xLTIwMDI4NQ_3e634f9b-bb76-4095-b22f-9cb8fdd5c446">5,467</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0e31fe1684f414cbac936fef047cdc0_I20221231" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjFmNjIwMGUxYzIyOTQ0ZjY4YmQ0MGEzYjcyM2Q5ZmYxL3RhYmxlcmFuZ2U6MWY2MjAwZTFjMjI5NDRmNjhiZDQwYTNiNzIzZDlmZjFfMTQtNi0xLTEtMjAzMTEx_4f34927d-313f-4d7b-b2ee-51ad9dcc572f">1,475,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f1a2f6132444776b0b916c3ec4d150a_I20221231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjFmNjIwMGUxYzIyOTQ0ZjY4YmQ0MGEzYjcyM2Q5ZmYxL3RhYmxlcmFuZ2U6MWY2MjAwZTFjMjI5NDRmNjhiZDQwYTNiNzIzZDlmZjFfMTQtMTgtMS0xLTIwMzExMQ_fa14686a-d802-45d2-ab20-f1063c6105c1">56,712</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></ix:continuation></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has designated these derivative instruments as cash flow hedges. The Company assesses the effectiveness of these derivative instruments and has recorded the changes in the fair value of the derivative instrument designated as a cash flow hedge as unrealized gains or losses in accumulated other comprehensive loss (&#8220;AOCL&#8221;), net of tax, until the hedged item affected earnings, at which point any gain or loss was reclassified to earnings. If the hedged cash flow does not occur, or if it becomes probable that it will not occur, the Company will reclassify the remaining amount of any gain or loss on the related cash flow hedge recorded in AOCL to interest expense at that time.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Hedging</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company enters into foreign currency hedge contracts intended to protect the U.S. dollar value of certain forecasted foreign currency denominated transactions. The Company assesses the effectiveness of the contracts that are designated as hedging instruments. The changes in fair value of foreign currency cash flow hedges are recorded in AOCL, net of tax. Those amounts are subsequently reclassified to earnings from AOCL as impacted by the hedged item when the hedged item affects earnings. If the hedged forecasted transaction does not occur or if it becomes probable that it will not occur, the Company will reclassify the amount of any gain or loss on the related cash flow hedge to earnings at that time. For contracts not designated as hedging instruments, the changes in fair value of the contracts are recognized in other income, net in the consolidated statements of operation, along with the offsetting foreign currency gain or loss on the underlying assets or liabilities.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The success of the Company&#8217;s hedging anticipated currency exchange gains or losses to the extent that there are differences between forecasted and actual activities during periods of currency volatility. In addition, changes in currency exchange rates related to any unhedged transactions may affect earnings and cash flows.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cross-Currency Rate Swaps</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 26, 2022, the Company amended the CHF-denominated intercompany loan to extend the termination date to September 2023 and as a result, the Company early terminated the cross-currency swap designated as cash flow hedge of an intercompany loan with aggregate notional amount of <ix:nonFraction unitRef="usd" contextRef="id6f12805ce8f48c2a0fbeec9e8c8a8dc_I20220926" decimals="-5" name="iart:DerivativeNotionalAmountTerminated" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RleHRyZWdpb246ODA4MTIyY2E0NzEyNDJhN2I5MzExOGQ4ZTEyNmQ4NjBfNDM5ODA0NjUyNDQ0Mg_89854c52-957d-400f-847b-389904002e4a">50.0</ix:nonFraction> million. Simultaneously, the Company entered into a cross-currency swap agreement to convert a notional amount of CHF <ix:nonFraction unitRef="chf" contextRef="id6f12805ce8f48c2a0fbeec9e8c8a8dc_I20220926" decimals="-5" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RleHRyZWdpb246ODA4MTIyY2E0NzEyNDJhN2I5MzExOGQ4ZTEyNmQ4NjBfNDM5ODA0NjUyNDQ0OA_03b51077-2aba-4faa-8022-cc832265b2ff">48.5</ix:nonFraction> million equivalent to <ix:nonFraction unitRef="usd" contextRef="if875fdad2a23408d9d0ed3e81db4e7ee_I20230331" decimals="-5" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RleHRyZWdpb246ODA4MTIyY2E0NzEyNDJhN2I5MzExOGQ4ZTEyNmQ4NjBfNDM5ODA0NjUyNDQ1NA_f7b088ae-2b65-4ab6-8535-6188cb8e5eb5">49.1</ix:nonFraction> million of this amended intercompany loan into U.S. dollars. The loss recorded by the Company upon the settlement of the swap was not material for the period.  </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 21, 2020, the Company entered into cross-currency swap agreements to convert a notional amount of $<ix:nonFraction unitRef="usd" contextRef="i0d2cb496f6d34578a914d07e7359d877_I20201221" decimals="INF" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RleHRyZWdpb246ODA4MTIyY2E0NzEyNDJhN2I5MzExOGQ4ZTEyNmQ4NjBfNDc2MA_9c9bd94e-662d-48da-870c-cc5f70e0738e">471.6</ix:nonFraction>&#160;million equivalent to <ix:nonFraction unitRef="chf" contextRef="i0d2cb496f6d34578a914d07e7359d877_I20201221" decimals="-5" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RleHRyZWdpb246ODA4MTIyY2E0NzEyNDJhN2I5MzExOGQ4ZTEyNmQ4NjBfNDc3Nw_20dee34a-26c0-432c-a96e-c685068ddac7">420.1</ix:nonFraction>&#160;million of a CHF-denominated intercompany loan into U.S. dollars. The CHF-denominated intercompany loan was the result of an intra-entity transfer of certain intellectual property rights to a subsidiary in Switzerland completed during the fourth quarter of 2020. The intercompany loan requires quarterly payments of CHF <ix:nonFraction unitRef="chf" contextRef="i7e2dbfd7e64c4a058f61e6ddbb174ba2_D20230101-20230331" decimals="-5" name="iart:IntercompanyLoanQuarterlyPayment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RleHRyZWdpb246ODA4MTIyY2E0NzEyNDJhN2I5MzExOGQ4ZTEyNmQ4NjBfNTA5Mg_f79da5fe-f894-427d-bd74-ed8b6effb4d5">5.8</ix:nonFraction>&#160;million plus accrued interest. As a result, the aggregate notional amount of the related cross-currency swaps will decrease by a corresponding amount. </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (continued) </span></div></div><ix:continuation id="i9814d18431ed4caf85c90cb79562fce3" continuedAt="i35b80620688a4bdea2d747ed1ad97bf6"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The objective of these cross-currency swaps is to reduce volatility of earnings and cash flows associated with changes in the foreign currency exchange rate. Under the terms of these contracts, which have been designated as cash flow hedges, the Company will make interest payments in Swiss Francs and receive interest in U.S. dollars. Upon the maturity of these contracts, the Company will pay the principal amount of the loans in Swiss Francs and receive U.S. dollars from the counterparties.</span></div><ix:continuation id="i9e3888f6f4fe41d9b7cf2153548bdd36" continuedAt="i49ed42ac0a614941bf351960341288e1"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company held the following cross-currency rate swaps as of March&#160;31, 2023 and December&#160;31, 2022 (dollar amounts in thousands):</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.747%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.020%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Termination Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fixed Rate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate Notional Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value<br/>Asset (Liability)</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pay CHF</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">December 21, 2020</span></td><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">December 22, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i64420e77a1cf469498e2ca2af1883f9f_I20230331" decimals="INF" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjdkNDBiYTQ5NDY4YTRjMTk4YzQzNjRjY2Y5ZTliNzZjL3RhYmxlcmFuZ2U6N2Q0MGJhNDk0NjhhNGMxOThjNDM2NGNjZjllOWI3NmNfNi02LTEtMS0xODY4MjE_6cefdc0f-99e6-4e4a-a663-fd1c947ef5cd">3.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CHF</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="chf" contextRef="i64420e77a1cf469498e2ca2af1883f9f_I20230331" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjdkNDBiYTQ5NDY4YTRjMTk4YzQzNjRjY2Y5ZTliNzZjL3RhYmxlcmFuZ2U6N2Q0MGJhNDk0NjhhNGMxOThjNDM2NGNjZjllOWI3NmNfNi05LTEtMS0xODY4MjE_ac1c2e76-dda9-4806-a206-ef5d564db029">373,227</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="chf" contextRef="ia25949993bc54e31b057302d171fccae_I20221231" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjdkNDBiYTQ5NDY4YTRjMTk4YzQzNjRjY2Y5ZTliNzZjL3RhYmxlcmFuZ2U6N2Q0MGJhNDk0NjhhNGMxOThjNDM2NGNjZjllOWI3NmNfNi0xMC0xLTEtMTg2ODIx_d3d05a7d-58e2-445e-8455-127226a18213">397,137</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6e76d40129eb4fceb7e3cbae9e1a5025_I20230331" decimals="-3" sign="-" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjdkNDBiYTQ5NDY4YTRjMTk4YzQzNjRjY2Y5ZTliNzZjL3RhYmxlcmFuZ2U6N2Q0MGJhNDk0NjhhNGMxOThjNDM2NGNjZjllOWI3NmNfNi0xMi0yLTEtMTg2ODIx_c230272e-1f09-409e-8825-4324d31aa34e">3,033</ix:nonFraction>)</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i12840888426f47f0bfab4c48ba3fa8c5_I20221231" decimals="-3" sign="-" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjdkNDBiYTQ5NDY4YTRjMTk4YzQzNjRjY2Y5ZTliNzZjL3RhYmxlcmFuZ2U6N2Q0MGJhNDk0NjhhNGMxOThjNDM2NGNjZjllOWI3NmNfNi0xNC0xLTEtMTg2ODIx_6da3e335-9c29-4589-b1be-964640b1df74">4,241</ix:nonFraction>)</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Receive U.S.$</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4c73f19cfa39458dbce322781befa454_I20230331" decimals="INF" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjdkNDBiYTQ5NDY4YTRjMTk4YzQzNjRjY2Y5ZTliNzZjL3RhYmxlcmFuZ2U6N2Q0MGJhNDk0NjhhNGMxOThjNDM2NGNjZjllOWI3NmNfNy02LTEtMS0xODY4MjE_8519c737-ec9a-4da8-9ac2-9784e2797caa">3.98</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c73f19cfa39458dbce322781befa454_I20230331" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjdkNDBiYTQ5NDY4YTRjMTk4YzQzNjRjY2Y5ZTliNzZjL3RhYmxlcmFuZ2U6N2Q0MGJhNDk0NjhhNGMxOThjNDM2NGNjZjllOWI3NmNfNy05LTEtMS0xODY4MjE_236c25b3-33bf-4ab2-9a77-239044808de8">418,980</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfc6c257ec264f86b565dfd0902ba5f6_I20221231" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjdkNDBiYTQ5NDY4YTRjMTk4YzQzNjRjY2Y5ZTliNzZjL3RhYmxlcmFuZ2U6N2Q0MGJhNDk0NjhhNGMxOThjNDM2NGNjZjllOWI3NmNfNy0xMC0xLTEtMTg2ODIx_f97f6d67-714e-47bd-9f31-cd5af7528aca">445,821</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pay CHF</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 28, 2022</span></td><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 29, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3703f1657e1c4322924cfd69bfd51ed2_I20230331" decimals="INF" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjdkNDBiYTQ5NDY4YTRjMTk4YzQzNjRjY2Y5ZTliNzZjL3RhYmxlcmFuZ2U6N2Q0MGJhNDk0NjhhNGMxOThjNDM2NGNjZjllOWI3NmNfOS02LTEtMS0xOTE0Nzk_f9e2343c-9d79-4328-9820-dc8ac647109f">1.95</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CHF</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="chf" contextRef="i3703f1657e1c4322924cfd69bfd51ed2_I20230331" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjdkNDBiYTQ5NDY4YTRjMTk4YzQzNjRjY2Y5ZTliNzZjL3RhYmxlcmFuZ2U6N2Q0MGJhNDk0NjhhNGMxOThjNDM2NGNjZjllOWI3NmNfOS05LTEtMS0xOTE0ODY_985cedd8-c90b-4879-bb66-4c9d3ad76c2a">48,533</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="chf" contextRef="id9839714200e436fb715c8e97dc0b9e1_I20221231" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjdkNDBiYTQ5NDY4YTRjMTk4YzQzNjRjY2Y5ZTliNzZjL3RhYmxlcmFuZ2U6N2Q0MGJhNDk0NjhhNGMxOThjNDM2NGNjZjllOWI3NmNfOS0xMC0xLTEtMTkxNDkz_58659d5d-f67f-400c-8fb9-1cf292a9566a">48,532</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4facc35f040e40778807e0ec5945fd96_I20230331" decimals="-3" sign="-" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjdkNDBiYTQ5NDY4YTRjMTk4YzQzNjRjY2Y5ZTliNzZjL3RhYmxlcmFuZ2U6N2Q0MGJhNDk0NjhhNGMxOThjNDM2NGNjZjllOWI3NmNfNi0xMi0yLTEtMTk1Nzg3_99f547b5-1b61-4b7b-8999-b33a3c06b661">4,011</ix:nonFraction>)</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia9d15227403d47bda86034e4464a9675_I20221231" decimals="-3" sign="-" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjdkNDBiYTQ5NDY4YTRjMTk4YzQzNjRjY2Y5ZTliNzZjL3RhYmxlcmFuZ2U6N2Q0MGJhNDk0NjhhNGMxOThjNDM2NGNjZjllOWI3NmNfNi0xNC0yLTEtMTk1Nzg3_f902eb08-981e-4441-ae84-1c2113f4f2ea">3,528</ix:nonFraction>)</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Receive U.S.$</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia4d70da53f2e443b81f302d5bc88197c_I20230331" decimals="INF" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjdkNDBiYTQ5NDY4YTRjMTk4YzQzNjRjY2Y5ZTliNzZjL3RhYmxlcmFuZ2U6N2Q0MGJhNDk0NjhhNGMxOThjNDM2NGNjZjllOWI3NmNfMTAtNi0xLTEtMTkxNDc5_d1c1a7b2-2fd9-414a-b284-a02a0e9e4241">5.32</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4d70da53f2e443b81f302d5bc88197c_I20230331" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjdkNDBiYTQ5NDY4YTRjMTk4YzQzNjRjY2Y5ZTliNzZjL3RhYmxlcmFuZ2U6N2Q0MGJhNDk0NjhhNGMxOThjNDM2NGNjZjllOWI3NmNfMTAtOS0xLTEtMTkxNDg2_ae4cfca2-4577-40d0-8cd5-2ad99ef029fe">49,142</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69b25e2065b74ec9b2d6fc10d48a3919_I20221231" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjdkNDBiYTQ5NDY4YTRjMTk4YzQzNjRjY2Y5ZTliNzZjL3RhYmxlcmFuZ2U6N2Q0MGJhNDk0NjhhNGMxOThjNDM2NGNjZjllOWI3NmNfMTAtMTAtMS0xLTE5MTQ5Mw_1c87be97-5c47-4577-8dd8-8ac151d01ec0">49,142</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if68feb9648554b258a953ab0b3cf1b44_I20230331" decimals="-3" sign="-" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjdkNDBiYTQ5NDY4YTRjMTk4YzQzNjRjY2Y5ZTliNzZjL3RhYmxlcmFuZ2U6N2Q0MGJhNDk0NjhhNGMxOThjNDM2NGNjZjllOWI3NmNfOS0xMi0xLTEtMTg2ODIx_5b5f51b8-e818-4e7e-9825-f139b5cd005d">7,044</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7aa8838f170544bca9b1f95ebe3e1329_I20221231" decimals="-3" sign="-" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjdkNDBiYTQ5NDY4YTRjMTk4YzQzNjRjY2Y5ZTliNzZjL3RhYmxlcmFuZ2U6N2Q0MGJhNDk0NjhhNGMxOThjNDM2NGNjZjllOWI3NmNfOS0xNC0xLTEtMTg2ODIx_5a853c4f-ad86-4bca-b27d-6fae5079d0bc">7,769</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cross-currency swaps are carried on the consolidated balance sheet at fair value, and changes in the fair values are recorded as unrealized gains or losses in AOCL. For the three months ended March&#160;31, 2023, and 2022, the Company recorded a loss of $<ix:nonFraction unitRef="usd" contextRef="i9d0c5e4a255d4bed9a9758f0390707d2_D20230101-20230331" decimals="-5" sign="-" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RleHRyZWdpb246ODA4MTIyY2E0NzEyNDJhN2I5MzExOGQ4ZTEyNmQ4NjBfNjM3Mg_43344a63-8153-4076-849b-997b72ea2dd6">4.9</ix:nonFraction> million and a gain $<ix:nonFraction unitRef="usd" contextRef="i6cc6a5aaf59940698e0bc2bd4666b5dc_D20220101-20220331" decimals="-5" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RleHRyZWdpb246ODA4MTIyY2E0NzEyNDJhN2I5MzExOGQ4ZTEyNmQ4NjBfNjM3OQ_4d8c212c-e807-4541-b9fa-97ab6b78836f">6.5</ix:nonFraction> million, respectively, in other income, net related to change in fair value related to the foreign currency rate translation to offset the losses recognized on the intercompany loans.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March&#160;31, 2023, and 2022, the Company recorded a gain of $<ix:nonFraction unitRef="usd" contextRef="i7e2dbfd7e64c4a058f61e6ddbb174ba2_D20230101-20230331" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RleHRyZWdpb246ODA4MTIyY2E0NzEyNDJhN2I5MzExOGQ4ZTEyNmQ4NjBfNjYyNQ_0152b364-3a07-429e-8f8e-a878fd2461a0">7.5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="iebf426920d4e4859b85ce6e6e41cd500_D20220101-20220331" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RleHRyZWdpb246ODA4MTIyY2E0NzEyNDJhN2I5MzExOGQ4ZTEyNmQ4NjBfNjYzMg_6241d23b-881e-43ad-8a4e-58c0574c3505">7.9</ix:nonFraction> million in AOCL, respectively, related to change in fair value of the cross-currency swaps.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March&#160;31, 2023, and 2022, the Company recorded a gain of $<ix:nonFraction unitRef="usd" contextRef="i7e2dbfd7e64c4a058f61e6ddbb174ba2_D20230101-20230331" decimals="-5" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RleHRyZWdpb246ODA4MTIyY2E0NzEyNDJhN2I5MzExOGQ4ZTEyNmQ4NjBfNjc4Ng_60ed6968-664a-4ccf-85b9-a4293d0e7edb">1.5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="iebf426920d4e4859b85ce6e6e41cd500_D20220101-20220331" decimals="-5" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RleHRyZWdpb246ODA4MTIyY2E0NzEyNDJhN2I5MzExOGQ4ZTEyNmQ4NjBfNjc5Mw_939d7a11-ccd3-4b24-8f16-7b8c743c305e">1.8</ix:nonFraction> million, respectively, in other income, net included in the consolidated statements of operations related to the interest rate differential of the cross-currency swaps.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated gain that is expected to be reclassified to other income (expense), net from AOCL as of March&#160;31, 2023 within the next twelve months is $<ix:nonFraction unitRef="usd" contextRef="i17088e89ea1f43888ce939b60c045452_I20230331" decimals="-5" name="us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RleHRyZWdpb246ODA4MTIyY2E0NzEyNDJhN2I5MzExOGQ4ZTEyNmQ4NjBfNzA5NQ_cbb9e51a-66d7-4917-9bc7-b2aa62f5287b">0.1</ix:nonFraction> million. As of March&#160;31, 2023, the Company does not expect any gains or losses will be reclassified into earnings as a result of the discontinuance of these cash flow hedges because the original forecasted transaction will not occur.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Investment Hedges</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company manages certain foreign exchange risks through a variety of strategies, including hedging. The Company is exposed to foreign exchange risk from its international operations through foreign currency purchases, net investments in foreign subsidiaries, and foreign currency assets and liabilities created in the normal course of business. On October 1, 2018 and December 16, 2020, the Company entered into cross-currency swap agreements designated as net investment hedges to partially offset the effects of foreign currency on foreign subsidiaries.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (continued) </span></div></div><ix:continuation id="i35b80620688a4bdea2d747ed1ad97bf6" continuedAt="i0001b42f337e40208cb864f943771516"><ix:continuation id="i49ed42ac0a614941bf351960341288e1"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company held the following cross-currency rate swaps designated as net investment hedges as of March&#160;31, 2023 and December&#160;31, 2022, respectively (dollar amounts in thousands):</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"><tr><td style="width:1.0%"></td><td style="width:14.705%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.390%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.159%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.390%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.390%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.319%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.390%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.660%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.205%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.390%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.614%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.390%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.387%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.390%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.284%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March&#160;31, 2023</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31, 2022</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Termination Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fixed Rate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate Notional Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value<br/>Asset (Liability)</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pay EUR</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">October 3, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 30, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if1daaefdc2464e3cb18c32c6114de13b_I20230331" decimals="INF" name="us-gaap:DerivativeFixedInterestRate" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjQzMWQwYzhhMjVmYTQ0OTM5YzU3YTJmNDcxZTE2MGY4L3RhYmxlcmFuZ2U6NDMxZDBjOGEyNWZhNDQ5MzljNTdhMmY0NzFlMTYwZjhfMy02LTEtMS0xODY4MjE_993d117a-7094-4fdb-a2ec-2b0d75f798d4">&#8212;</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">EUR</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if1daaefdc2464e3cb18c32c6114de13b_I20230331" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjQzMWQwYzhhMjVmYTQ0OTM5YzU3YTJmNDcxZTE2MGY4L3RhYmxlcmFuZ2U6NDMxZDBjOGEyNWZhNDQ5MzljNTdhMmY0NzFlMTYwZjhfMy05LTEtMS0xODY4MjE_2cbcbc4c-6e63-4987-9b2d-fed3a232175c">51,760</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i8e00ac098d0d4a64b488a0c17ae543cc_I20221231" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjQzMWQwYzhhMjVmYTQ0OTM5YzU3YTJmNDcxZTE2MGY4L3RhYmxlcmFuZ2U6NDMxZDBjOGEyNWZhNDQ5MzljNTdhMmY0NzFlMTYwZjhfMy0xMS0xLTEtMTkyOTA3_c2f5ebc7-f5e5-43a7-9497-d3d2912f0ca4">51,760</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71266e4583bc437f92273bca0ecbadeb_I20230331" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjQzMWQwYzhhMjVmYTQ0OTM5YzU3YTJmNDcxZTE2MGY4L3RhYmxlcmFuZ2U6NDMxZDBjOGEyNWZhNDQ5MzljNTdhMmY0NzFlMTYwZjhfMy0xMS0xLTEtMTg2ODIx_83c4c056-6dec-423f-9d54-de2129453e86">3,989</ix:nonFraction>&#160;</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd51fbcf77834a9e9093fdb6e8cc4af5_I20221231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjQzMWQwYzhhMjVmYTQ0OTM5YzU3YTJmNDcxZTE2MGY4L3RhYmxlcmFuZ2U6NDMxZDBjOGEyNWZhNDQ5MzljNTdhMmY0NzFlMTYwZjhfMy0xMy0xLTEtMTg2ODIx_5375880a-784b-4e13-a04f-7b226f853973">4,713</ix:nonFraction>&#160;</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Receive U.S.$</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i84d05810f465447c8eee056a6ea0a040_I20230331" decimals="4" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjQzMWQwYzhhMjVmYTQ0OTM5YzU3YTJmNDcxZTE2MGY4L3RhYmxlcmFuZ2U6NDMxZDBjOGEyNWZhNDQ5MzljNTdhMmY0NzFlMTYwZjhfNC02LTEtMS0xODY4MjE_ae8f157d-24df-4078-ab64-82083c34d2b4">2.57</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84d05810f465447c8eee056a6ea0a040_I20230331" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjQzMWQwYzhhMjVmYTQ0OTM5YzU3YTJmNDcxZTE2MGY4L3RhYmxlcmFuZ2U6NDMxZDBjOGEyNWZhNDQ5MzljNTdhMmY0NzFlMTYwZjhfNC05LTEtMS0xODY4MjE_3a47504f-53bb-4af1-81f2-c3fb9485d456">60,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9044d98efacd431b815b8b6162aa3841_I20221231" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjQzMWQwYzhhMjVmYTQ0OTM5YzU3YTJmNDcxZTE2MGY4L3RhYmxlcmFuZ2U6NDMxZDBjOGEyNWZhNDQ5MzljNTdhMmY0NzFlMTYwZjhfNC0xMS0xLTEtMTkyOTA3_5e96af97-f3a1-480a-9085-abf54e19bff9">60,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pay EUR</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">October 3, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 30, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id8fc9bc6fbc8473e98a29ae421b261cb_I20230331" decimals="INF" name="us-gaap:DerivativeFixedInterestRate" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjQzMWQwYzhhMjVmYTQ0OTM5YzU3YTJmNDcxZTE2MGY4L3RhYmxlcmFuZ2U6NDMxZDBjOGEyNWZhNDQ5MzljNTdhMmY0NzFlMTYwZjhfNi02LTEtMS0xODY4MjE_14fb292c-cc1d-46ea-8d9f-03f2b81347f5">&#8212;</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">EUR</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="id8fc9bc6fbc8473e98a29ae421b261cb_I20230331" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjQzMWQwYzhhMjVmYTQ0OTM5YzU3YTJmNDcxZTE2MGY4L3RhYmxlcmFuZ2U6NDMxZDBjOGEyNWZhNDQ5MzljNTdhMmY0NzFlMTYwZjhfNi05LTEtMS0xODY4MjE_ce2ea82e-e47a-4e37-8c4f-a5c5d28f6988">38,820</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i67cb9870e2ce452f89c2a1478634a794_I20221231" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjQzMWQwYzhhMjVmYTQ0OTM5YzU3YTJmNDcxZTE2MGY4L3RhYmxlcmFuZ2U6NDMxZDBjOGEyNWZhNDQ5MzljNTdhMmY0NzFlMTYwZjhfNi0xMS0xLTEtMTkyOTE0_4056a015-3b5f-44b0-9732-0ee514a38801">38,820</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if26ad90eefe4415185190203179a9d0a_I20230331" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjQzMWQwYzhhMjVmYTQ0OTM5YzU3YTJmNDcxZTE2MGY4L3RhYmxlcmFuZ2U6NDMxZDBjOGEyNWZhNDQ5MzljNTdhMmY0NzFlMTYwZjhfNi0xMS0xLTEtMTg2ODIx_f9879289-60cb-4d3e-a6f6-92e4a3d1dcf3">3,932</ix:nonFraction>&#160;</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ea815ac7be1481cbb1e19dc878ef6a2_I20221231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjQzMWQwYzhhMjVmYTQ0OTM5YzU3YTJmNDcxZTE2MGY4L3RhYmxlcmFuZ2U6NDMxZDBjOGEyNWZhNDQ5MzljNTdhMmY0NzFlMTYwZjhfNi0xMy0xLTEtMTg2ODIx_16dde0ef-61a0-4de3-9a43-22ced663d50f">4,307</ix:nonFraction>&#160;</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Receive U.S.$</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i91ef1532274e495ca14298a177ea1acc_I20230331" decimals="4" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjQzMWQwYzhhMjVmYTQ0OTM5YzU3YTJmNDcxZTE2MGY4L3RhYmxlcmFuZ2U6NDMxZDBjOGEyNWZhNDQ5MzljNTdhMmY0NzFlMTYwZjhfNy02LTEtMS0xODY4MjE_16639c0e-82b2-45c8-903f-2895a87f2ef1">2.19</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91ef1532274e495ca14298a177ea1acc_I20230331" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjQzMWQwYzhhMjVmYTQ0OTM5YzU3YTJmNDcxZTE2MGY4L3RhYmxlcmFuZ2U6NDMxZDBjOGEyNWZhNDQ5MzljNTdhMmY0NzFlMTYwZjhfNy05LTEtMS0xODY4MjE_eb97ac63-459d-4f61-8e96-c26a69c9157b">45,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36f4034c904b4615a9bc452fe0768b20_I20221231" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjQzMWQwYzhhMjVmYTQ0OTM5YzU3YTJmNDcxZTE2MGY4L3RhYmxlcmFuZ2U6NDMxZDBjOGEyNWZhNDQ5MzljNTdhMmY0NzFlMTYwZjhfNy0xMS0xLTEtMTkyOTE0_2450a6d9-1bc5-456f-b78e-bf6144519267">45,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pay CHF</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 26, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">December 16, 2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i29d096aee8e64b748938c9c63aacf5f5_I20230331" decimals="INF" name="us-gaap:DerivativeFixedInterestRate" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjQzMWQwYzhhMjVmYTQ0OTM5YzU3YTJmNDcxZTE2MGY4L3RhYmxlcmFuZ2U6NDMxZDBjOGEyNWZhNDQ5MzljNTdhMmY0NzFlMTYwZjhfOS02LTEtMS0xODY4MjE_bbbfce70-25f5-406b-a34b-6681a7962206">&#8212;</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CHF</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="chf" contextRef="i29d096aee8e64b748938c9c63aacf5f5_I20230331" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjQzMWQwYzhhMjVmYTQ0OTM5YzU3YTJmNDcxZTE2MGY4L3RhYmxlcmFuZ2U6NDMxZDBjOGEyNWZhNDQ5MzljNTdhMmY0NzFlMTYwZjhfOS05LTEtMS0xODY4MjE_0ca94e58-f645-400f-ac1e-81a17e6b29d7">288,210</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="chf" contextRef="i9118200971f14bd8b119346ba9f7bff3_I20221231" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjQzMWQwYzhhMjVmYTQ0OTM5YzU3YTJmNDcxZTE2MGY4L3RhYmxlcmFuZ2U6NDMxZDBjOGEyNWZhNDQ5MzljNTdhMmY0NzFlMTYwZjhfOS0xMS0xLTEtMTkyOTIx_86998207-c561-4a53-bbde-12ef02dd96d3">288,210</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic7c538eff08b4fd6b79f7f5500bdfbfd_I20230331" decimals="-3" sign="-" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjQzMWQwYzhhMjVmYTQ0OTM5YzU3YTJmNDcxZTE2MGY4L3RhYmxlcmFuZ2U6NDMxZDBjOGEyNWZhNDQ5MzljNTdhMmY0NzFlMTYwZjhfOS0xMy0yLTEtMTk4NTQ2_fcf35211-d2af-4d34-8dc3-16530421ec83">14,711</ix:nonFraction>)</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i10a6a1852b544a5986e489c72e4c44c8_I20221231" decimals="-3" sign="-" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjQzMWQwYzhhMjVmYTQ0OTM5YzU3YTJmNDcxZTE2MGY4L3RhYmxlcmFuZ2U6NDMxZDBjOGEyNWZhNDQ5MzljNTdhMmY0NzFlMTYwZjhfOS0xMy0xLTEtMTg2ODIx_9ce426c3-f13e-4a5a-8f0c-d64102b3c393">14,663</ix:nonFraction>)</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Receive U.S.$</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i681f0e0ed1b448caa21fee3e2b8496bd_I20230331" decimals="4" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjQzMWQwYzhhMjVmYTQ0OTM5YzU3YTJmNDcxZTE2MGY4L3RhYmxlcmFuZ2U6NDMxZDBjOGEyNWZhNDQ5MzljNTdhMmY0NzFlMTYwZjhfMTAtNi0xLTEtMTg2ODIx_6e00bb4e-5930-403b-bb41-e33f1522d6da">1.94</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i681f0e0ed1b448caa21fee3e2b8496bd_I20230331" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjQzMWQwYzhhMjVmYTQ0OTM5YzU3YTJmNDcxZTE2MGY4L3RhYmxlcmFuZ2U6NDMxZDBjOGEyNWZhNDQ5MzljNTdhMmY0NzFlMTYwZjhfMTAtOS0xLTEtMTg2ODIx_8a9244a5-297f-4013-96c4-8f0583dabe2d">300,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24c7d1057dba44f88ef1cbe078d56c52_I20221231" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjQzMWQwYzhhMjVmYTQ0OTM5YzU3YTJmNDcxZTE2MGY4L3RhYmxlcmFuZ2U6NDMxZDBjOGEyNWZhNDQ5MzljNTdhMmY0NzFlMTYwZjhfMTAtMTEtMS0xLTE5MjkyMQ_87e826b5-d049-449a-ba60-32bb45242362">300,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i58f139fbd41647c48c9057f1580cdac4_I20230331" decimals="-3" sign="-" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjQzMWQwYzhhMjVmYTQ0OTM5YzU3YTJmNDcxZTE2MGY4L3RhYmxlcmFuZ2U6NDMxZDBjOGEyNWZhNDQ5MzljNTdhMmY0NzFlMTYwZjhfMTItMTEtMS0xLTE4NjgyMQ_81ad4921-041d-4fa5-a610-f338cfefb0f9">6,790</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09796f9df77e48bca077728e4c8ae491_I20221231" decimals="-3" sign="-" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjQzMWQwYzhhMjVmYTQ0OTM5YzU3YTJmNDcxZTE2MGY4L3RhYmxlcmFuZ2U6NDMxZDBjOGEyNWZhNDQ5MzljNTdhMmY0NzFlMTYwZjhfMTItMTMtMS0xLTE4NjgyMQ_e92904bb-dbfd-4021-878e-ff482fabee5a">5,643</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cross-currency swaps were carried on the consolidated balance sheet at fair value and changes in the fair values were recorded as unrealized gains or losses in AOCL. For the three months ended March&#160;31, 2023 and 2022, the Company recorded a loss of $<ix:nonFraction unitRef="usd" contextRef="i0fed5dd652c740a78c23127d0779d0ba_D20230101-20230331" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RleHRyZWdpb246ODA4MTIyY2E0NzEyNDJhN2I5MzExOGQ4ZTEyNmQ4NjBfNDM5ODA0NjUyNTQyNQ_309187b7-844f-46e1-a21a-bfb2b0eb12a3">1.1</ix:nonFraction> million and a gain $<ix:nonFraction unitRef="usd" contextRef="i5eff930bd16f443f9ec4ab5edde345f2_D20220101-20220331" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RleHRyZWdpb246ODA4MTIyY2E0NzEyNDJhN2I5MzExOGQ4ZTEyNmQ4NjBfNDM5ODA0NjUyNTQwNw_12bf3d54-fafb-48ca-9010-598d932e0d2a">1.3</ix:nonFraction> million, respectively, in AOCL related to the change in fair value of the cross-currency swaps.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March&#160;31, 2023, and 2022, the Company recorded gains of $<ix:nonFraction unitRef="usd" contextRef="i0fed5dd652c740a78c23127d0779d0ba_D20230101-20230331" decimals="-5" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RleHRyZWdpb246ODA4MTIyY2E0NzEyNDJhN2I5MzExOGQ4ZTEyNmQ4NjBfNDM5ODA0NjUyNTQzMg_5ea7b9c6-df47-4094-9944-effcaf9ce02b">2.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i5eff930bd16f443f9ec4ab5edde345f2_D20220101-20220331" decimals="-5" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RleHRyZWdpb246ODA4MTIyY2E0NzEyNDJhN2I5MzExOGQ4ZTEyNmQ4NjBfNDM5ODA0NjUyNTQxMg_8d1ac80c-c237-4ad5-b102-fef63d36d4bf">1.3</ix:nonFraction> million, respectively, in interest income included in the consolidated statements of operations related to the interest rate differential of the cross-currency swaps.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated gain that is expected to be reclassified to interest income from AOCL as of March&#160;31, 2023 within the next twelve months is $<ix:nonFraction unitRef="usd" contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331" decimals="-5" name="us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RleHRyZWdpb246ODA4MTIyY2E0NzEyNDJhN2I5MzExOGQ4ZTEyNmQ4NjBfNDM5ODA0NjUyNTQxOA_38fa313a-0509-47be-ab96-e7dd2586fbeb">10.9</ix:nonFraction> million.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Forward Contract</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has entered into a hedge for forecasted intercompany purchases denominated in foreign currencies through the use of forward contracts designated as cash flow hedges. To the extent these forward contracts meet hedge accounting criteria, changes in their fair value are not included in accumulated comprehensive loss. These changes in fair value will be recognized into earnings as a component of cost of sales when the forecasted-transaction occurs. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2023 the Company entered into Foreign Currency Forward Contracts with a notional amount of $<ix:nonFraction unitRef="usd" contextRef="i3e5ef68fc663402486e8a4e07e50b256_I20230331" decimals="-5" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RleHRyZWdpb246ODA4MTIyY2E0NzEyNDJhN2I5MzExOGQ4ZTEyNmQ4NjBfNjA0NzMxMzk3MjYyMQ_f60b6b67-4bb5-4a62-98d8-d74ca7a77001">10.8</ix:nonFraction> million to mitigate the risk of foreign currency on intercompany purchases in CHF.  During the three months ended March&#160;31, 2023 the Company recorded an <ix:nonFraction unitRef="usd" contextRef="i05dafd738acc468dba86e7bafd1510f0_D20230101-20230331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RleHRyZWdpb246ODA4MTIyY2E0NzEyNDJhN2I5MzExOGQ4ZTEyNmQ4NjBfNTQ5NzU1ODE2MjgwNQ_dd55b6d3-a940-4e25-81ab-02cf8b4ee40b">immaterial</ix:nonFraction>  loss in AOCL related to the change in fair value of the Foreign Currency Forward Contracts.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Counterparty Credit Risk</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company manages its concentration of counterparty credit risk on its derivative instruments by limiting acceptable counterparties to a group of major financial institutions with investment grade credit ratings, and by actively monitoring their credit ratings and outstanding positions on an ongoing basis. Therefore, the Company considers the credit risk of the counterparties to be low. Furthermore, none of the Company&#8217;s derivative transactions are subject to collateral or other security arrangements, and none contain provisions that depend upon the Company&#8217;s credit ratings from any credit rating agency.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value of Derivative Instruments</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has classified all of its derivative instruments within Level 2 of the fair value hierarchy because observable inputs are available for substantially the full term of the derivative instruments. The fair values of the interest rate swaps and cross-currency swaps were developed using a market approach based on publicly available market yield curves and the terms of the swap. The Company performs ongoing assessments of counterparty credit risk.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (continued) </span></div></div><ix:continuation id="i0001b42f337e40208cb864f943771516" continuedAt="i8881d2af7f2b48fbb4c996517bbd4e2f"><ix:nonNumeric contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" name="us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RleHRyZWdpb246ODA4MTIyY2E0NzEyNDJhN2I5MzExOGQ4ZTEyNmQ4NjBfMTA4NTU_1e0e4d4c-5d65-491e-8862-811b46e9ffaf" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the fair value for derivatives designated as hedging instruments in the condensed consolidated balance sheets as of March&#160;31, 2023 and December&#160;31, 2022:</span></div><div style="margin-bottom:3pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:67.181%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.024%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.174%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value as of</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location on Balance Sheet </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">:</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivatives designated as hedges &#8212; Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Cash Flow Hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swap</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57a5868b001f4d67935cf17c02a3c1ef_I20230331" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjFkZGQ3MTgwOWI4NDRhZmM4MDViMzVmNzVhZWMzYzAxL3RhYmxlcmFuZ2U6MWRkZDcxODA5Yjg0NGFmYzgwNWIzNWY3NWFlYzNjMDFfNi0yLTEtMS0xODY4MjE_71a0c049-471e-4835-aa3b-9a2d1bb15e0c">15,659</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a4696f581d04cb586ec819e32f565b4_I20221231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjFkZGQ3MTgwOWI4NDRhZmM4MDViMzVmNzVhZWMzYzAxL3RhYmxlcmFuZ2U6MWRkZDcxODA5Yjg0NGFmYzgwNWIzNWY3NWFlYzNjMDFfNi00LTEtMS0xODY4MjE_47282269-8de1-4dfa-a1bd-bef43dcf2eef">16,682</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf74fb8aa39848049e1301eb02d39d82_I20230331" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjFkZGQ3MTgwOWI4NDRhZmM4MDViMzVmNzVhZWMzYzAxL3RhYmxlcmFuZ2U6MWRkZDcxODA5Yjg0NGFmYzgwNWIzNWY3NWFlYzNjMDFfNy0yLTEtMS0xOTY5MDQ_d591ba65-8151-498f-afc4-68524f8a2349">4,139</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99aa6d57dd04424181e96f7c91cc61ec_I20221231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjFkZGQ3MTgwOWI4NDRhZmM4MDViMzVmNzVhZWMzYzAxL3RhYmxlcmFuZ2U6MWRkZDcxODA5Yjg0NGFmYzgwNWIzNWY3NWFlYzNjMDFfNy00LTEtMS0xOTY5MDQ_6cb42eda-be59-4934-9264-ca84b4248ae3">4,497</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Net Investment Hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f5e216cf841484db3c4b4c6a4d7360a_I20230331" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjFkZGQ3MTgwOWI4NDRhZmM4MDViMzVmNzVhZWMzYzAxL3RhYmxlcmFuZ2U6MWRkZDcxODA5Yjg0NGFmYzgwNWIzNWY3NWFlYzNjMDFfOC0yLTEtMS0xODY4MjE_41ed0188-63f9-498e-8d40-1b9fa5c6a399">10,942</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida7dd09e252d4494a378fddc92937759_I20221231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjFkZGQ3MTgwOWI4NDRhZmM4MDViMzVmNzVhZWMzYzAxL3RhYmxlcmFuZ2U6MWRkZDcxODA5Yjg0NGFmYzgwNWIzNWY3NWFlYzNjMDFfOC00LTEtMS0xODY4MjE_4fafcc96-ef31-412f-a080-13384a23ab0f">11,653</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Cash Flow Hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swap</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f8fb64f3560438aa95a28deccc11b4c_I20230331" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjFkZGQ3MTgwOWI4NDRhZmM4MDViMzVmNzVhZWMzYzAxL3RhYmxlcmFuZ2U6MWRkZDcxODA5Yjg0NGFmYzgwNWIzNWY3NWFlYzNjMDFfMTEtMi0xLTEtMTg2ODIx_438b2587-217c-4dfc-ac04-57c726a1a8c8">28,861</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5470f9ecb06a401e92323ccc20c80c85_I20221231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjFkZGQ3MTgwOWI4NDRhZmM4MDViMzVmNzVhZWMzYzAxL3RhYmxlcmFuZ2U6MWRkZDcxODA5Yjg0NGFmYzgwNWIzNWY3NWFlYzNjMDFfMTEtNC0xLTEtMTg2ODIx_ed83f792-8c34-42e6-8543-48b71e1ac748">40,030</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2be277f4f7ed4c18b787daf8a062f6c9_I20230331" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjFkZGQ3MTgwOWI4NDRhZmM4MDViMzVmNzVhZWMzYzAxL3RhYmxlcmFuZ2U6MWRkZDcxODA5Yjg0NGFmYzgwNWIzNWY3NWFlYzNjMDFfMTItMi0xLTEtMTg2ODIx_c1e80ee4-9032-43c6-af8b-f6b9a64f2274">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib322bd99c183409fae8ee9d54c859608_I20221231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjFkZGQ3MTgwOWI4NDRhZmM4MDViMzVmNzVhZWMzYzAxL3RhYmxlcmFuZ2U6MWRkZDcxODA5Yjg0NGFmYzgwNWIzNWY3NWFlYzNjMDFfMTItNC0xLTEtMTg2ODIx_fb99422f-fdcf-4c5d-84e5-e66e5ac4cd9b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Net Investment Hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74d46a8f5e78435b89e68529ae10f606_I20230331" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjFkZGQ3MTgwOWI4NDRhZmM4MDViMzVmNzVhZWMzYzAxL3RhYmxlcmFuZ2U6MWRkZDcxODA5Yjg0NGFmYzgwNWIzNWY3NWFlYzNjMDFfMTQtMi0xLTEtMTg2ODIx_1febd7f5-6dd9-4d03-8942-f1758486ef3a">2,940</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c9770e2724246d49b05399c4fbab21b_I20221231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjFkZGQ3MTgwOWI4NDRhZmM4MDViMzVmNzVhZWMzYzAxL3RhYmxlcmFuZ2U6MWRkZDcxODA5Yjg0NGFmYzgwNWIzNWY3NWFlYzNjMDFfMTQtNC0xLTEtMTg2ODIx_764fea7c-1845-40b4-bddd-f90011ebced8">3,311</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total derivatives designated as hedges &#8212; Assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fcf3db2e33e4516bb7de79733b0c0d0_I20230331" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjFkZGQ3MTgwOWI4NDRhZmM4MDViMzVmNzVhZWMzYzAxL3RhYmxlcmFuZ2U6MWRkZDcxODA5Yjg0NGFmYzgwNWIzNWY3NWFlYzNjMDFfMTUtMi0xLTEtMTg2ODIx_73d7f753-7286-49c7-8ab4-62acba4ae336">62,541</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1b37fecaa804375ad71d7e5bcdde933_I20221231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjFkZGQ3MTgwOWI4NDRhZmM4MDViMzVmNzVhZWMzYzAxL3RhYmxlcmFuZ2U6MWRkZDcxODA5Yjg0NGFmYzgwNWIzNWY3NWFlYzNjMDFfMTUtNC0xLTEtMTg2ODIx_a7da6f84-f01b-4bbf-b7ef-844096339a50">76,173</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivatives designated as hedges &#8212; Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Cash Flow Hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swap</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71915794f65d4c91bc088e849a5fc799_I20230331" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjFkZGQ3MTgwOWI4NDRhZmM4MDViMzVmNzVhZWMzYzAxL3RhYmxlcmFuZ2U6MWRkZDcxODA5Yjg0NGFmYzgwNWIzNWY3NWFlYzNjMDFfMjAtMi0xLTEtMTg2ODIx_a1c068ac-e4e5-4fe7-8818-2595d0dc5fd5">762</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7620e47d0bf84bce859b3bad2a16f684_I20221231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjFkZGQ3MTgwOWI4NDRhZmM4MDViMzVmNzVhZWMzYzAxL3RhYmxlcmFuZ2U6MWRkZDcxODA5Yjg0NGFmYzgwNWIzNWY3NWFlYzNjMDFfMjAtNC0xLTEtMTg2ODIx_8dd593b6-deea-4061-b8de-af096faca159">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec22d28ecc94c71b2b12a038b76b4e4_I20230331" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjFkZGQ3MTgwOWI4NDRhZmM4MDViMzVmNzVhZWMzYzAxL3RhYmxlcmFuZ2U6MWRkZDcxODA5Yjg0NGFmYzgwNWIzNWY3NWFlYzNjMDFfMjEtMi0xLTEtMTg2ODIx_4df64afe-a003-447c-a0ba-f01369435286">4,011</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i996b0ea6443441c4aaaf1bd24cc0bee4_I20221231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjFkZGQ3MTgwOWI4NDRhZmM4MDViMzVmNzVhZWMzYzAxL3RhYmxlcmFuZ2U6MWRkZDcxODA5Yjg0NGFmYzgwNWIzNWY3NWFlYzNjMDFfMjEtNC0xLTEtMTg2ODIx_b89660e4-4eb6-4d9d-ba1d-643ff3ec6099">3,528</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6da3ccfb9a34aabbeeb47220c6e49ff_I20230331" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjFkZGQ3MTgwOWI4NDRhZmM4MDViMzVmNzVhZWMzYzAxL3RhYmxlcmFuZ2U6MWRkZDcxODA5Yjg0NGFmYzgwNWIzNWY3NWFlYzNjMDFfMjMtMi0xLTEtMTk5NzA3_faab8d13-eb5e-44d8-8509-b8523fa2fbb9">69</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="ieeb15fbf63ab4f469961445718c86de4_I20221231" xsi:nil="true" name="us-gaap:DerivativeFairValueOfDerivativeLiability" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjFkZGQ3MTgwOWI4NDRhZmM4MDViMzVmNzVhZWMzYzAxL3RhYmxlcmFuZ2U6MWRkZDcxODA5Yjg0NGFmYzgwNWIzNWY3NWFlYzNjMDFfMjMtNC0xLTEtMjAzMTYx_695f6299-2d31-485c-aa49-009a392ce3a4"></ix:nonFraction></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Net Investment Hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0072310af3d241efafdaf988459146fa_I20230331" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjFkZGQ3MTgwOWI4NDRhZmM4MDViMzVmNzVhZWMzYzAxL3RhYmxlcmFuZ2U6MWRkZDcxODA5Yjg0NGFmYzgwNWIzNWY3NWFlYzNjMDFfMjMtMi0xLTEtMTg2ODIx_de794642-d4de-4a92-96e9-ca265bad95db">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5aae5383e5894e1282dce76c96936d34_I20221231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjFkZGQ3MTgwOWI4NDRhZmM4MDViMzVmNzVhZWMzYzAxL3RhYmxlcmFuZ2U6MWRkZDcxODA5Yjg0NGFmYzgwNWIzNWY3NWFlYzNjMDFfMjMtNC0xLTEtMTg2ODIx_965acdeb-96ca-4873-9967-43ace6f80f64">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Cash Flow Hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swap</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id498dc6dfe534a538bd4b76e7d332cb4_I20230331" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjFkZGQ3MTgwOWI4NDRhZmM4MDViMzVmNzVhZWMzYzAxL3RhYmxlcmFuZ2U6MWRkZDcxODA5Yjg0NGFmYzgwNWIzNWY3NWFlYzNjMDFfMjYtMi0xLTEtMTg2ODIx_9496145e-ec13-44ae-9f88-2cb0b29e711b">1,080</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69e2392f36f44936a75ae231876a5027_I20221231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjFkZGQ3MTgwOWI4NDRhZmM4MDViMzVmNzVhZWMzYzAxL3RhYmxlcmFuZ2U6MWRkZDcxODA5Yjg0NGFmYzgwNWIzNWY3NWFlYzNjMDFfMjYtNC0xLTEtMTg2ODIx_0dc13483-1c9a-4543-a492-b4e0bc549578">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b2593474fd840ba8291d49024330993_I20230331" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjFkZGQ3MTgwOWI4NDRhZmM4MDViMzVmNzVhZWMzYzAxL3RhYmxlcmFuZ2U6MWRkZDcxODA5Yjg0NGFmYzgwNWIzNWY3NWFlYzNjMDFfMjctMi0xLTEtMTg2ODIx_f2343750-10dc-40b0-b254-105a051d5b6b">7,172</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c7c8157157e4ecd949d6ac6cb41b21c_I20221231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjFkZGQ3MTgwOWI4NDRhZmM4MDViMzVmNzVhZWMzYzAxL3RhYmxlcmFuZ2U6MWRkZDcxODA5Yjg0NGFmYzgwNWIzNWY3NWFlYzNjMDFfMjctNC0xLTEtMTg2ODIx_47618516-8bf4-4b6a-9c57-de685487dc13">8,738</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Net Investment Hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f574ae0feba45f79e1abe5b7ec3d086_I20230331" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjFkZGQ3MTgwOWI4NDRhZmM4MDViMzVmNzVhZWMzYzAxL3RhYmxlcmFuZ2U6MWRkZDcxODA5Yjg0NGFmYzgwNWIzNWY3NWFlYzNjMDFfMjktMi0xLTEtMTg2ODIx_49ec171a-35fc-4821-b90e-9fb1e3eea2c8">20,672</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icddae4bb16a64dea817870f7632c24e2_I20221231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjFkZGQ3MTgwOWI4NDRhZmM4MDViMzVmNzVhZWMzYzAxL3RhYmxlcmFuZ2U6MWRkZDcxODA5Yjg0NGFmYzgwNWIzNWY3NWFlYzNjMDFfMjktNC0xLTEtMTg2ODIx_546993fc-0f92-4741-8d54-8c7ffab4b515">20,608</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total derivatives designated as hedges &#8212; Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fcf3db2e33e4516bb7de79733b0c0d0_I20230331" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjFkZGQ3MTgwOWI4NDRhZmM4MDViMzVmNzVhZWMzYzAxL3RhYmxlcmFuZ2U6MWRkZDcxODA5Yjg0NGFmYzgwNWIzNWY3NWFlYzNjMDFfMzAtMi0xLTEtMTg2ODIx_8e6ba630-8e69-43e1-b029-46888b4f8119">33,766</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1b37fecaa804375ad71d7e5bcdde933_I20221231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjFkZGQ3MTgwOWI4NDRhZmM4MDViMzVmNzVhZWMzYzAxL3RhYmxlcmFuZ2U6MWRkZDcxODA5Yjg0NGFmYzgwNWIzNWY3NWFlYzNjMDFfMzAtNC0xLTEtMTg2ODIx_19bbbec1-4027-4081-90d2-3fa5c2b0af5c">32,874</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:3pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company classifies derivative assets and liabilities as current based on the cash flows expected to be incurred within the following 12&#160;months.</span></div><div style="margin-bottom:12pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> At March&#160;31, 2023 and December&#160;31, 2022, the total notional amounts related to the Company&#8217;s interest rate swaps were both $<ix:nonFraction unitRef="usd" contextRef="i56846d631dbe49b18b07a654b7e1ce4d_I20230331" decimals="-8" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RleHRyZWdpb246ODA4MTIyY2E0NzEyNDJhN2I5MzExOGQ4ZTEyNmQ4NjBfMTA2MDY_24f55ab8-0e0c-4551-af6b-215d4ba3227c"><ix:nonFraction unitRef="usd" contextRef="i2492f43b74614fcab458b7ed60d99fc2_I20221231" decimals="-8" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RleHRyZWdpb246ODA4MTIyY2E0NzEyNDJhN2I5MzExOGQ4ZTEyNmQ4NjBfMTA2MDY_e6ed3272-e18f-4554-a963-8705fbe10d08">1.5</ix:nonFraction></ix:nonFraction> billion, respectively.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (continued) </span></div></div><ix:continuation id="i8881d2af7f2b48fbb4c996517bbd4e2f"><ix:nonNumeric contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" name="us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RleHRyZWdpb246ODA4MTIyY2E0NzEyNDJhN2I5MzExOGQ4ZTEyNmQ4NjBfMTA4Njk_e8c8c22e-f7d1-41e0-8933-11f0e967d96a" escape="true"><div style="margin-bottom:10pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following presents the effect of derivative instruments designated as cash flow hedges and net investment hedges on the accompanying condensed consolidated statement of operations during the three months ended March&#160;31, 2023 and 2022:</span></div><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:30.917%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.911%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.057%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.597%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;in&#160;AOCL<br/>Beginning of<br/>Quarter</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount&#160;of<br/>Gain (Loss)<br/>Recognized&#160;in<br/>AOCL</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount&#160;of&#160;Gain (Loss)<br/>Reclassified from<br/>AOCL into<br/>Earnings</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;in&#160;AOCL<br/>End of Quarter</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location in<br/>Statements&#160;of<br/>Operations</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Cash Flow Hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swap</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ee9771bb95e427193ef400f91e7f20e_I20221231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOmI0YWRkYWE5NTM0MDQwZmViMzNiOTU1YzE0MjU1ODAyL3RhYmxlcmFuZ2U6YjRhZGRhYTk1MzQwNDBmZWIzM2I5NTVjMTQyNTU4MDJfMy0xLTEtMS0xODY4MjE_e1eb2d69-cba9-4b3f-940b-4518ab6c5558">56,712</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3e6c0e609ad149bdbbfc158b0e5fd68a_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOmI0YWRkYWE5NTM0MDQwZmViMzNiOTU1YzE0MjU1ODAyL3RhYmxlcmFuZ2U6YjRhZGRhYTk1MzQwNDBmZWIzM2I5NTVjMTQyNTU4MDJfMy0zLTEtMS0xODY4MjE_019f5e2d-f95c-47d1-ac5b-4ef72786707a">10,534</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e6c0e609ad149bdbbfc158b0e5fd68a_D20230101-20230331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOmI0YWRkYWE5NTM0MDQwZmViMzNiOTU1YzE0MjU1ODAyL3RhYmxlcmFuZ2U6YjRhZGRhYTk1MzQwNDBmZWIzM2I5NTVjMTQyNTU4MDJfMy01LTEtMS0xODY4MjE_859a42f0-3bc3-4fc5-9eb9-dddceffa9aea">3,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4eb84f89dad4116bceeb45741f9a641_I20230331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOmI0YWRkYWE5NTM0MDQwZmViMzNiOTU1YzE0MjU1ODAyL3RhYmxlcmFuZ2U6YjRhZGRhYTk1MzQwNDBmZWIzM2I5NTVjMTQyNTU4MDJfMy03LTEtMS0xODY4MjE_4810f200-2eff-4eb0-909f-9fb1b71877ae">42,678</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib3fe4a582ccd4061a97fd0b9da7c7f0d_I20221231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOmI0YWRkYWE5NTM0MDQwZmViMzNiOTU1YzE0MjU1ODAyL3RhYmxlcmFuZ2U6YjRhZGRhYTk1MzQwNDBmZWIzM2I5NTVjMTQyNTU4MDJfNC0xLTEtMS0xODY4MjE_f96a994e-60ac-496e-ad45-a6f80360f83f">20,271</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i178b4152981345408498c8dfbee4cbc7_D20230101-20230331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOmI0YWRkYWE5NTM0MDQwZmViMzNiOTU1YzE0MjU1ODAyL3RhYmxlcmFuZ2U6YjRhZGRhYTk1MzQwNDBmZWIzM2I5NTVjMTQyNTU4MDJfNC0zLTEtMS0xODY4MjE_1ffc2929-d5c5-4d7f-9308-b92af245c4a6">2,191</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i178b4152981345408498c8dfbee4cbc7_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOmI0YWRkYWE5NTM0MDQwZmViMzNiOTU1YzE0MjU1ODAyL3RhYmxlcmFuZ2U6YjRhZGRhYTk1MzQwNDBmZWIzM2I5NTVjMTQyNTU4MDJfNC01LTEtMS0xODY4MjE_28fb0c99-513b-4b0f-8bfb-40d7cec131af">3,504</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9d6a89764db9416587bce17f35871a44_I20230331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOmI0YWRkYWE5NTM0MDQwZmViMzNiOTU1YzE0MjU1ODAyL3RhYmxlcmFuZ2U6YjRhZGRhYTk1MzQwNDBmZWIzM2I5NTVjMTQyNTU4MDJfNC03LTEtMS0xODY4MjE_60b0687d-30a2-4617-bbba-ee69954d03df">14,576</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other income, net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign Currency Forward Contract</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6fb80266a304dc5be9547704ed56286_I20221231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOmI0YWRkYWE5NTM0MDQwZmViMzNiOTU1YzE0MjU1ODAyL3RhYmxlcmFuZ2U6YjRhZGRhYTk1MzQwNDBmZWIzM2I5NTVjMTQyNTU4MDJfNS0xLTEtMS0xOTgxMTU_ba6a9fe4-b8ac-4a91-a4a3-56088c140987">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i92388a95dedc4a34a9f55ffd26aca363_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOmI0YWRkYWE5NTM0MDQwZmViMzNiOTU1YzE0MjU1ODAyL3RhYmxlcmFuZ2U6YjRhZGRhYTk1MzQwNDBmZWIzM2I5NTVjMTQyNTU4MDJfNS0zLTEtMS0xOTgxMjM_e92de1b0-bc26-4824-ad0c-42d87d19ca00">69</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i810224786fad497790a97ede68b59f5f_D20230101-20230331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOmI0YWRkYWE5NTM0MDQwZmViMzNiOTU1YzE0MjU1ODAyL3RhYmxlcmFuZ2U6YjRhZGRhYTk1MzQwNDBmZWIzM2I5NTVjMTQyNTU4MDJfNS01LTEtMS0xOTgxMzE_4f119c2d-d28b-4298-a9fd-4175a742a469">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2b3f564951d04d5e92ce288f73dcb9b4_I20230331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOmI0YWRkYWE5NTM0MDQwZmViMzNiOTU1YzE0MjU1ODAyL3RhYmxlcmFuZ2U6YjRhZGRhYTk1MzQwNDBmZWIzM2I5NTVjMTQyNTU4MDJfNS03LTEtMS0xOTgxMzg_ee294034-c596-4296-9879-2694d3d84e9b">69</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of Sales</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Net Investment Hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i560720c3abc24f638935549d00ddf679_I20221231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOmI0YWRkYWE5NTM0MDQwZmViMzNiOTU1YzE0MjU1ODAyL3RhYmxlcmFuZ2U6YjRhZGRhYTk1MzQwNDBmZWIzM2I5NTVjMTQyNTU4MDJfNi0xLTEtMS0xODY4MjE_e84b8a9d-6136-496a-8157-e4e769498c7b">6,914</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf1bbb7d552b43bc97be79bd949d01ce_D20230101-20230331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOmI0YWRkYWE5NTM0MDQwZmViMzNiOTU1YzE0MjU1ODAyL3RhYmxlcmFuZ2U6YjRhZGRhYTk1MzQwNDBmZWIzM2I5NTVjMTQyNTU4MDJfNi0zLTEtMS0xODY4MjE_f984f628-75c8-4829-be2f-fed8ecb4e3ee">950</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf1bbb7d552b43bc97be79bd949d01ce_D20230101-20230331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOmI0YWRkYWE5NTM0MDQwZmViMzNiOTU1YzE0MjU1ODAyL3RhYmxlcmFuZ2U6YjRhZGRhYTk1MzQwNDBmZWIzM2I5NTVjMTQyNTU4MDJfNi01LTEtMS0xODY4MjE_fb33fa4f-1665-4846-949d-c3ee5dd0f093">2,096</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i545e60a320824ebca08bfa1384c3f0f0_I20230331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOmI0YWRkYWE5NTM0MDQwZmViMzNiOTU1YzE0MjU1ODAyL3RhYmxlcmFuZ2U6YjRhZGRhYTk1MzQwNDBmZWIzM2I5NTVjMTQyNTU4MDJfNi03LTEtMS0xODY4MjE_cb507e0d-df89-4a14-9dc6-0241abcba3bb">8,060</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest income</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c8bc030a0e84d8884ff38380b57a524_I20221231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOmI0YWRkYWE5NTM0MDQwZmViMzNiOTU1YzE0MjU1ODAyL3RhYmxlcmFuZ2U6YjRhZGRhYTk1MzQwNDBmZWIzM2I5NTVjMTQyNTU4MDJfNy0xLTEtMS0xODY4MjE_2863b95c-4b6c-42c4-a864-c82dbedc542a">29,527</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie8763013b51645d9b4f267faa1bc585c_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOmI0YWRkYWE5NTM0MDQwZmViMzNiOTU1YzE0MjU1ODAyL3RhYmxlcmFuZ2U6YjRhZGRhYTk1MzQwNDBmZWIzM2I5NTVjMTQyNTU4MDJfNy0zLTEtMS0xODY4MjE_e1a56a08-f3d3-4d87-a51f-7b3e30bdbbd1">7,462</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8763013b51645d9b4f267faa1bc585c_D20230101-20230331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOmI0YWRkYWE5NTM0MDQwZmViMzNiOTU1YzE0MjU1ODAyL3RhYmxlcmFuZ2U6YjRhZGRhYTk1MzQwNDBmZWIzM2I5NTVjMTQyNTU4MDJfNy01LTEtMS0xODY4MjE_f9391dc9-533c-45f0-bd3e-89f577980bc0">2,092</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f53e0e076bd414e80ef7c0bf8a3584f_I20230331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOmI0YWRkYWE5NTM0MDQwZmViMzNiOTU1YzE0MjU1ODAyL3RhYmxlcmFuZ2U6YjRhZGRhYTk1MzQwNDBmZWIzM2I5NTVjMTQyNTU4MDJfNy03LTEtMS0xODY4MjE_50dc5b3b-7824-4b4b-9653-792c2559451d">19,973</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Cash Flow Hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swap</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id2ee30afd022428e9770584749497e62_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOmI0YWRkYWE5NTM0MDQwZmViMzNiOTU1YzE0MjU1ODAyL3RhYmxlcmFuZ2U6YjRhZGRhYTk1MzQwNDBmZWIzM2I5NTVjMTQyNTU4MDJfMTAtMS0xLTEtMTg2ODIx_9ff5c70d-1189-4ca8-abc6-4f9e70d0a830">43,956</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8ccc5370489410a8499e0a9e3753b87_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOmI0YWRkYWE5NTM0MDQwZmViMzNiOTU1YzE0MjU1ODAyL3RhYmxlcmFuZ2U6YjRhZGRhYTk1MzQwNDBmZWIzM2I5NTVjMTQyNTU4MDJfMTAtMy0xLTEtMTg2ODIx_eaeedd4d-3b97-47ea-a24f-9a45a7814c31">41,675</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id8ccc5370489410a8499e0a9e3753b87_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOmI0YWRkYWE5NTM0MDQwZmViMzNiOTU1YzE0MjU1ODAyL3RhYmxlcmFuZ2U6YjRhZGRhYTk1MzQwNDBmZWIzM2I5NTVjMTQyNTU4MDJfMTAtNS0xLTEtMTg2ODIx_b92a52d3-1697-4d01-a164-54cfeb848d6e">5,213</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b2554dad56a4166a558274eed8d4fbb_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOmI0YWRkYWE5NTM0MDQwZmViMzNiOTU1YzE0MjU1ODAyL3RhYmxlcmFuZ2U6YjRhZGRhYTk1MzQwNDBmZWIzM2I5NTVjMTQyNTU4MDJfMTAtNy0xLTEtMTg2ODIx_2c6a9a14-f70b-4ce8-9f06-ac709b033c2d">2,932</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i579d645e131641bfa09602eb64db21f3_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOmI0YWRkYWE5NTM0MDQwZmViMzNiOTU1YzE0MjU1ODAyL3RhYmxlcmFuZ2U6YjRhZGRhYTk1MzQwNDBmZWIzM2I5NTVjMTQyNTU4MDJfMTEtMS0xLTEtMTg2ODIx_eb14b20e-2fbb-4c0c-8ddc-8008d1ccdc69">9,688</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63c6bd493f22494e9df49e5e6f48e027_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOmI0YWRkYWE5NTM0MDQwZmViMzNiOTU1YzE0MjU1ODAyL3RhYmxlcmFuZ2U6YjRhZGRhYTk1MzQwNDBmZWIzM2I5NTVjMTQyNTU4MDJfMTEtMy0xLTEtMTg2ODIx_637592fd-6341-4e1e-941c-4716575aa054">316</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63c6bd493f22494e9df49e5e6f48e027_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOmI0YWRkYWE5NTM0MDQwZmViMzNiOTU1YzE0MjU1ODAyL3RhYmxlcmFuZ2U6YjRhZGRhYTk1MzQwNDBmZWIzM2I5NTVjMTQyNTU4MDJfMTEtNS0xLTEtMTg2ODIx_680f0334-49c2-45c7-9a88-6a30d32e6952">8,331</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4b8fe8c3c3e2433a8f7cd9487fff6fef_I20220331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOmI0YWRkYWE5NTM0MDQwZmViMzNiOTU1YzE0MjU1ODAyL3RhYmxlcmFuZ2U6YjRhZGRhYTk1MzQwNDBmZWIzM2I5NTVjMTQyNTU4MDJfMTEtNy0xLTEtMTg2ODIx_5d23b912-aaaf-4f1e-ac33-b6749cdcf214">17,703</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other income, net</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Net Investment Hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae8885f4db32466ab5102315e110644a_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOmI0YWRkYWE5NTM0MDQwZmViMzNiOTU1YzE0MjU1ODAyL3RhYmxlcmFuZ2U6YjRhZGRhYTk1MzQwNDBmZWIzM2I5NTVjMTQyNTU4MDJfMTMtMS0xLTEtMTg2ODIx_06120420-9891-4883-918e-7aa5a244e4cb">2,312</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i837380b9b55a43d9a21479305539ed99_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOmI0YWRkYWE5NTM0MDQwZmViMzNiOTU1YzE0MjU1ODAyL3RhYmxlcmFuZ2U6YjRhZGRhYTk1MzQwNDBmZWIzM2I5NTVjMTQyNTU4MDJfMTMtMy0xLTEtMTg2ODIx_c5a4b60b-0528-4f95-be9e-2643010839d9">1,309</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i837380b9b55a43d9a21479305539ed99_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOmI0YWRkYWE5NTM0MDQwZmViMzNiOTU1YzE0MjU1ODAyL3RhYmxlcmFuZ2U6YjRhZGRhYTk1MzQwNDBmZWIzM2I5NTVjMTQyNTU4MDJfMTMtNS0xLTEtMTg2ODIx_8df39807-dc8f-477f-9529-2e884d42cfa7">1,320</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iac14ca05a7c84129889affd66eddd064_I20220331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOmI0YWRkYWE5NTM0MDQwZmViMzNiOTU1YzE0MjU1ODAyL3RhYmxlcmFuZ2U6YjRhZGRhYTk1MzQwNDBmZWIzM2I5NTVjMTQyNTU4MDJfMTMtNy0xLTEtMTg2ODIx_9ba3530e-af0e-4acd-bbf4-96bd65e28111">2,323</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest income</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib5284fa32e194b4887c09b3bd11c5196_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOmI0YWRkYWE5NTM0MDQwZmViMzNiOTU1YzE0MjU1ODAyL3RhYmxlcmFuZ2U6YjRhZGRhYTk1MzQwNDBmZWIzM2I5NTVjMTQyNTU4MDJfMTQtMS0xLTEtMTg2ODIx_c7452925-236d-4afb-a0ed-d7ff8ede069d">55,956</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c763dd699df40f7994d4bd081a81d5b_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOmI0YWRkYWE5NTM0MDQwZmViMzNiOTU1YzE0MjU1ODAyL3RhYmxlcmFuZ2U6YjRhZGRhYTk1MzQwNDBmZWIzM2I5NTVjMTQyNTU4MDJfMTQtMy0xLTEtMTg2ODIx_463b43b3-d52e-4bf9-abf9-19b8ba667dc7">43,300</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c763dd699df40f7994d4bd081a81d5b_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOmI0YWRkYWE5NTM0MDQwZmViMzNiOTU1YzE0MjU1ODAyL3RhYmxlcmFuZ2U6YjRhZGRhYTk1MzQwNDBmZWIzM2I5NTVjMTQyNTU4MDJfMTQtNS0xLTEtMTg2ODIx_57b85ba3-f65f-4633-9ff2-697599b236db">4,438</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2ee28a1877fb49278defab1977e4dfed_I20220331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOmI0YWRkYWE5NTM0MDQwZmViMzNiOTU1YzE0MjU1ODAyL3RhYmxlcmFuZ2U6YjRhZGRhYTk1MzQwNDBmZWIzM2I5NTVjMTQyNTU4MDJfMTQtNy0xLTEtMTg2ODIx_05e61f26-4511-4c4f-af04-5102b5b7000c">17,094</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Derivative Instruments not designated hedges:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the second quarter of 2021, the Company entered into a foreign currency swap, with a notional amount of $<ix:nonFraction unitRef="usd" contextRef="i64221cccd9784e23b84697c3a6cae83e_I20210630" decimals="-5" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RleHRyZWdpb246ODA4MTIyY2E0NzEyNDJhN2I5MzExOGQ4ZTEyNmQ4NjBfNDM5ODA0NjUyNzM3Mw_2ed27060-7ae6-4cbe-ae3e-18ce3a1199e2">7.3</ix:nonFraction> million to mitigate the risk from fluctuations in foreign currency exchange rates associated with an intercompany loan denominated in JPY. In a foreign currency swap transaction, the Company agrees with another party to exchange, at specified intervals, the difference between one currency and another currency at a fixed exchange rate, generally set at inception, calculated by reference to an agreed upon notional amount. The notional amount of each currency is exchanged at the inception and termination of the currency swap by each party. The Company subsequently paid down a portion of this swap, bringing the notional amount down to $<ix:nonFraction unitRef="usd" contextRef="i6b9673d1d44547fabe1719aef8ec54e2_I20210930" decimals="-5" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RleHRyZWdpb246ODA4MTIyY2E0NzEyNDJhN2I5MzExOGQ4ZTEyNmQ4NjBfNDM5ODA0NjUyODAwOA_5b9cb4fb-3371-4550-9815-95344bf64f7e">6.4</ix:nonFraction> million. </span></div><ix:nonNumeric contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" name="us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RleHRyZWdpb246ODA4MTIyY2E0NzEyNDJhN2I5MzExOGQ4ZTEyNmQ4NjBfODI0NjMzNzIyNjc0Ng_f814dd41-728f-48ba-85d4-d767af84381f" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the gains (losses) of derivative instruments not designated as hedges on the condensed consolidated statements of income, which was included in other income:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.736%"><tr><td style="width:1.0%"></td><td style="width:64.640%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.417%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:15.412%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.417%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.414%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7cae2dbfb6a5475491033e353f69120b_D20230101-20230331" decimals="-3" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjI2M2ZhY2NlNDE5NjRkMDU5MjM1N2RkMjNjOGUzZThkL3RhYmxlcmFuZ2U6MjYzZmFjY2U0MTk2NGQwNTkyMzU3ZGQyM2M4ZTNlOGRfMy02LTEtMS0xOTc5NTI_1dd82e9f-9081-4d35-9210-fb61f2895549">55</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60372d5d4c714e66a7f44c71f2d47770_D20220101-20220331" decimals="-3" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjI2M2ZhY2NlNDE5NjRkMDU5MjM1N2RkMjNjOGUzZThkL3RhYmxlcmFuZ2U6MjYzZmFjY2U0MTk2NGQwNTkyMzU3ZGQyM2M4ZTNlOGRfMy04LTEtMS0xOTc5NTI_cdf1a342-63e5-47c5-b176-b767fa3d23e6">360</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" decimals="-3" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjI2M2ZhY2NlNDE5NjRkMDU5MjM1N2RkMjNjOGUzZThkL3RhYmxlcmFuZ2U6MjYzZmFjY2U0MTk2NGQwNTkyMzU3ZGQyM2M4ZTNlOGRfNC02LTEtMS0xOTg1Mjg_aa551f27-f084-4355-9c7a-bce6ee7d04ee">55</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331" decimals="-3" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjI2M2ZhY2NlNDE5NjRkMDU5MjM1N2RkMjNjOGUzZThkL3RhYmxlcmFuZ2U6MjYzZmFjY2U0MTk2NGQwNTkyMzU3ZGQyM2M4ZTNlOGRfNC04LTEtMS0xOTg1Mjg_57eae17e-f2ab-43bb-a400-e9d7d1dc9ea5">360</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="i5f1eb1bd01d541c3aa0777712077c048_61"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8. <ix:nonNumeric contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82MS9mcmFnOmVjZjA3OTliODczNTQ2MjFhODNlMzFlYWUxZWEyOTMxL3RleHRyZWdpb246ZWNmMDc5OWI4NzM1NDYyMWE4M2UzMWVhZTFlYTI5MzFfMjk0Mw_2e758e20-6217-45a1-b3ef-45cf6bf37acf" continuedAt="ic6e9fb47e7574e4baf90f0875ecc5d0b" escape="true">STOCK-BASED COMPENSATION </ix:nonNumeric></span></div><ix:continuation id="ic6e9fb47e7574e4baf90f0875ecc5d0b" continuedAt="ib6fe327c6d1d41088438a0cec6bc4105"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023, the Company had stock options, restricted stock awards, performance stock awards, contract stock awards and restricted stock unit awards outstanding under the Integra LifeSciences Holdings Corporation Fifth Amended and Restated 2003 Equity Incentive Plan (the &#8220;2003 Plan&#8221;). The 2000 and 2001 Equity Incentive Plans were terminated as of February 19, 2021, and no further awards may be issued under the plans.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock options issued under the 2003 Plan become exercisable over specified periods, generally within <ix:nonNumeric contextRef="id118186cdcc643509f813c46ce8000ba_D20230101-20230331" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82MS9mcmFnOmVjZjA3OTliODczNTQ2MjFhODNlMzFlYWUxZWEyOTMxL3RleHRyZWdpb246ZWNmMDc5OWI4NzM1NDYyMWE4M2UzMWVhZTFlYTI5MzFfNTU0_7e16f240-86d3-4a9e-a2b8-449f605044aa">four years</ix:nonNumeric> from the date of grant for officers and employees, within <ix:nonNumeric contextRef="if7a8dd366e654da081146a5b25db1c1b_D20230101-20230331" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82MS9mcmFnOmVjZjA3OTliODczNTQ2MjFhODNlMzFlYWUxZWEyOTMxL3RleHRyZWdpb246ZWNmMDc5OWI4NzM1NDYyMWE4M2UzMWVhZTFlYTI5MzFfNjE1_d500d141-2e03-46c3-9c09-024486426d6e">one year</ix:nonNumeric> from date of grant for directors which generally expire <ix:nonNumeric contextRef="i399d8f6d881640bb810eee6e1458f2ba_D20230101-20230331" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82MS9mcmFnOmVjZjA3OTliODczNTQ2MjFhODNlMzFlYWUxZWEyOTMxL3RleHRyZWdpb246ZWNmMDc5OWI4NzM1NDYyMWE4M2UzMWVhZTFlYTI5MzFfNjc0_83652e31-2204-4a79-9862-45b18da39041">eight years</ix:nonNumeric> from the grant date for employees, and from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82MS9mcmFnOmVjZjA3OTliODczNTQ2MjFhODNlMzFlYWUxZWEyOTMxL3RleHRyZWdpb246ZWNmMDc5OWI4NzM1NDYyMWE4M2UzMWVhZTFlYTI5MzFfNzIx_2efd93e6-4b81-4ecd-a888-8a73dfd19f51">six</span> to <ix:nonNumeric contextRef="if710322947774a689663db2f525eeb6b_D20230101-20230331" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82MS9mcmFnOmVjZjA3OTliODczNTQ2MjFhODNlMzFlYWUxZWEyOTMxL3RleHRyZWdpb246ZWNmMDc5OWI4NzM1NDYyMWE4M2UzMWVhZTFlYTI5MzFfNzI3_c5a8a229-0471-4cc8-968c-e80978a2e949">ten years</ix:nonNumeric> for directors and certain executive officers, except in certain instances that result in accelerated vesting due to death, disability, retirement age or change in-control provisions within their grant agreements. The Company values stock option grants using the binomial distribution model. Restricted stock issued under the Plans vests over specified periods, generally <ix:nonNumeric contextRef="i3bc994fc34b64d4cb7c684fd6244bac3_D20230101-20230331" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82MS9mcmFnOmVjZjA3OTliODczNTQ2MjFhODNlMzFlYWUxZWEyOTMxL3RleHRyZWdpb246ZWNmMDc5OWI4NzM1NDYyMWE4M2UzMWVhZTFlYTI5MzFfMTEwMQ_01a76cc5-267b-46af-bf20-feb3229b32db">three years</ix:nonNumeric> after the date of grant. The vesting of performance stock issued under the Plans is subject to service and performance conditions.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (continued) </span></div></div><ix:continuation id="ib6fe327c6d1d41088438a0cec6bc4105"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Options</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023, there were approximately $<ix:nonFraction unitRef="usd" contextRef="i6c69b026d57d423eb79ebbdfa493c6b3_I20230331" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82MS9mcmFnOmVjZjA3OTliODczNTQ2MjFhODNlMzFlYWUxZWEyOTMxL3RleHRyZWdpb246ZWNmMDc5OWI4NzM1NDYyMWE4M2UzMWVhZTFlYTI5MzFfMTI4NA_abdc7088-3c9d-459f-ba74-403adb94d14e">5.6</ix:nonFraction> million of total unrecognized compensation costs related to unvested stock options. These costs are expected to be recognized over a weighted-average period of approximately <ix:nonNumeric contextRef="ib4f03ffd86fa4e22af66c496e06ac9ec_D20230101-20230331" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82MS9mcmFnOmVjZjA3OTliODczNTQ2MjFhODNlMzFlYWUxZWEyOTMxL3RleHRyZWdpb246ZWNmMDc5OWI4NzM1NDYyMWE4M2UzMWVhZTFlYTI5MzFfMTQ1Mw_fcf00cb7-f82f-4a30-8e0a-40544fb880ba">three years</ix:nonNumeric>. There were <ix:nonFraction unitRef="shares" contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82MS9mcmFnOmVjZjA3OTliODczNTQ2MjFhODNlMzFlYWUxZWEyOTMxL3RleHRyZWdpb246ZWNmMDc5OWI4NzM1NDYyMWE4M2UzMWVhZTFlYTI5MzFfMTQ2OA_8869a51f-349f-4d3a-ac6f-4797f5577373">151,293</ix:nonFraction> stock options granted during the three months ended March&#160;31, 2023. For the three months ended March&#160;31, 2023, the weighted average grant date fair value for stock options granted was $<ix:nonFraction unitRef="usdPerShare" contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82MS9mcmFnOmVjZjA3OTliODczNTQ2MjFhODNlMzFlYWUxZWEyOTMxL3RleHRyZWdpb246ZWNmMDc5OWI4NzM1NDYyMWE4M2UzMWVhZTFlYTI5MzFfMTYxNw_2e4ce816-8628-4428-bd78-405c3705fde0">21.58</ix:nonFraction> per option.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Awards of Restricted Stock and Performance Stock</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Performance stock and restricted stock awards generally have requisite service periods of <ix:nonNumeric contextRef="i4989d4c8ef004834bf2980d2722cccaf_D20230101-20230331" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82MS9mcmFnOmVjZjA3OTliODczNTQ2MjFhODNlMzFlYWUxZWEyOTMxL3RleHRyZWdpb246ZWNmMDc5OWI4NzM1NDYyMWE4M2UzMWVhZTFlYTI5MzFfMTc3MQ_2546bb17-ed9d-4a37-8faf-98a957aabc7c">three years</ix:nonNumeric>, except in certain instances that result in accelerated vesting due to death, disability, retirement age provision or change in-control provisions in their grant agreements. Performance stock units are subject to graded vesting conditions based on revenue goals of the Company. The Company expenses the fair value of restricted stock awards on a straight-line basis over the requisite service period. As of March&#160;31, 2023, there was approximately $<ix:nonFraction unitRef="usd" contextRef="i3046bc1317c642afb36b924feec16501_I20230331" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82MS9mcmFnOmVjZjA3OTliODczNTQ2MjFhODNlMzFlYWUxZWEyOTMxL3RleHRyZWdpb246ZWNmMDc5OWI4NzM1NDYyMWE4M2UzMWVhZTFlYTI5MzFfMjIwOQ_352d92e4-f0ca-43cf-a481-5222ebc06630">48.6</ix:nonFraction> million of total unrecognized compensation costs related to these unvested awards. The Company expects to recognize these costs over a weighted-average period of approximately <ix:nonNumeric contextRef="i3bc994fc34b64d4cb7c684fd6244bac3_D20230101-20230331" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82MS9mcmFnOmVjZjA3OTliODczNTQ2MjFhODNlMzFlYWUxZWEyOTMxL3RleHRyZWdpb246ZWNmMDc5OWI4NzM1NDYyMWE4M2UzMWVhZTFlYTI5MzFfMjM4MA_51baa7f7-14d2-4ff8-93aa-b4a34ae8bb32">two years</ix:nonNumeric>. The Company granted <ix:nonFraction unitRef="shares" contextRef="i3bc994fc34b64d4cb7c684fd6244bac3_D20230101-20230331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82MS9mcmFnOmVjZjA3OTliODczNTQ2MjFhODNlMzFlYWUxZWEyOTMxL3RleHRyZWdpb246ZWNmMDc5OWI4NzM1NDYyMWE4M2UzMWVhZTFlYTI5MzFfMjQwNA_e9eb2397-1af0-49f7-b8ea-6159c052536b">346,745</ix:nonFraction> restricted stock awards and <ix:nonFraction unitRef="shares" contextRef="i663c47912e30448682d1e675fc6bf6fd_D20230101-20230331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82MS9mcmFnOmVjZjA3OTliODczNTQ2MjFhODNlMzFlYWUxZWEyOTMxL3RleHRyZWdpb246ZWNmMDc5OWI4NzM1NDYyMWE4M2UzMWVhZTFlYTI5MzFfMjQzNQ_2d7538fc-3dba-4fda-a250-a3236e5bf5d1">161,218</ix:nonFraction> performance stock awards during the three months ended March&#160;31, 2023. For the three months ended March&#160;31, 2023, the weighted average grant date fair value for restricted stock awards and performance stock units granted was $<ix:nonFraction unitRef="usdPerShare" contextRef="i3bc994fc34b64d4cb7c684fd6244bac3_D20230101-20230331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82MS9mcmFnOmVjZjA3OTliODczNTQ2MjFhODNlMzFlYWUxZWEyOTMxL3RleHRyZWdpb246ZWNmMDc5OWI4NzM1NDYyMWE4M2UzMWVhZTFlYTI5MzFfMjYyNQ_39247259-dd71-4cb2-81ac-e16afe5fa33d">53.37</ix:nonFraction> and $<ix:nonFraction unitRef="usdPerShare" contextRef="i663c47912e30448682d1e675fc6bf6fd_D20230101-20230331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82MS9mcmFnOmVjZjA3OTliODczNTQ2MjFhODNlMzFlYWUxZWEyOTMxL3RleHRyZWdpb246ZWNmMDc5OWI4NzM1NDYyMWE4M2UzMWVhZTFlYTI5MzFfMjYzMg_cb327df4-acea-4893-bce3-43b5e0d6e9bb">52.87</ix:nonFraction> per award, respectively.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also maintains an Employee Stock Purchase Plan (the &#8220;ESPP&#8221;), which provides eligible employees with the opportunity to acquire shares of common stock at periodic intervals by means of accumulated payroll deductions. The ESPP is a non-compensatory plan based on its terms.</span></div></ix:continuation><div id="i5f1eb1bd01d541c3aa0777712077c048_64"></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9. <ix:nonNumeric contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" name="us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82NC9mcmFnOjdhZTU2MzUyMWE3MzQwZmU5MDZjZDEzMDdlZTE5MGE0L3RleHRyZWdpb246N2FlNTYzNTIxYTczNDBmZTkwNmNkMTMwN2VlMTkwYTRfMjIzNA_42c8702e-0214-4aeb-983f-ed749e468adb" continuedAt="i9fe1cff5183d49aba7324eb31d9175c0" escape="true">RETIREMENT PLANS</ix:nonNumeric></span></div><ix:continuation id="i9fe1cff5183d49aba7324eb31d9175c0"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains defined benefit pension plans that cover certain employees in France, Japan, Germany and Switzerland.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net periodic benefit costs for the Company&#8217;s defined benefit pension plans for the three months ended March 31, 2023 were $<ix:nonFraction unitRef="usd" contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" decimals="-5" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82NC9mcmFnOjdhZTU2MzUyMWE3MzQwZmU5MDZjZDEzMDdlZTE5MGE0L3RleHRyZWdpb246N2FlNTYzNTIxYTczNDBmZTkwNmNkMTMwN2VlMTkwYTRfMjQw_402cfdd2-5711-4ae6-bb6f-36ed3e0f42ba">0.3</ix:nonFraction> million. The components of the net periodic benefit costs other than the service cost component of $<ix:nonFraction unitRef="usd" contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" decimals="-5" name="us-gaap:DefinedBenefitPlanServiceCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82NC9mcmFnOjdhZTU2MzUyMWE3MzQwZmU5MDZjZDEzMDdlZTE5MGE0L3RleHRyZWdpb246N2FlNTYzNTIxYTczNDBmZTkwNmNkMTMwN2VlMTkwYTRfMzM0_7e06dbb9-6a87-4545-8e3f-c6e2f55804ef">0.5</ix:nonFraction> million for the three months ended March&#160;31, 2023 are included in other income, net in the consolidated statements of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net periodic benefit costs for the Company&#8217;s defined benefit pension plans for the three months ended March 31, 2022 were $<ix:nonFraction unitRef="usd" contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331" decimals="-5" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82NC9mcmFnOjdhZTU2MzUyMWE3MzQwZmU5MDZjZDEzMDdlZTE5MGE0L3RleHRyZWdpb246N2FlNTYzNTIxYTczNDBmZTkwNmNkMTMwN2VlMTkwYTRfNTM1_f0729d2f-9b21-46cd-9659-32aeb5a58ab7">0.3</ix:nonFraction> million. The components of the net periodic benefit costs other than the service cost component of $<ix:nonFraction unitRef="usd" contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331" decimals="-5" name="us-gaap:DefinedBenefitPlanServiceCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82NC9mcmFnOjdhZTU2MzUyMWE3MzQwZmU5MDZjZDEzMDdlZTE5MGE0L3RleHRyZWdpb246N2FlNTYzNTIxYTczNDBmZTkwNmNkMTMwN2VlMTkwYTRfNjI5_5405a25c-eda1-46ce-ba85-5b4c07175630">0.7</ix:nonFraction> million for the three months ended March&#160;31, 2022 are included in other income, net in the consolidated statements of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair values of plan assets were $<ix:nonFraction unitRef="usd" contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82NC9mcmFnOjdhZTU2MzUyMWE3MzQwZmU5MDZjZDEzMDdlZTE5MGE0L3RleHRyZWdpb246N2FlNTYzNTIxYTczNDBmZTkwNmNkMTMwN2VlMTkwYTRfNzg1_73c78124-4d46-41f5-abc3-1a002c3eb010">36.4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82NC9mcmFnOjdhZTU2MzUyMWE3MzQwZmU5MDZjZDEzMDdlZTE5MGE0L3RleHRyZWdpb246N2FlNTYzNTIxYTczNDBmZTkwNmNkMTMwN2VlMTkwYTRfNzky_435b4c9a-43ec-4dd5-8a93-7bec96f3c194">38.1</ix:nonFraction> million as of March&#160;31, 2023 and December&#160;31, 2022, respectively. The net plan assets of the pension plans are invested in common trusts as of March&#160;31, 2023 and December&#160;31, 2022. Common trusts are classified as Level 2 in the fair value hierarchy. The fair value of common trusts is valued at the net asset value based on the fair values of the underlying investments of the trusts as determined by the sponsor of the trusts. The investment strategy of the Company's defined benefit plans is both to meet the liabilities of the plans as they fall due and to maximize the return on invested assets within an appropriate risk profile.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Deferred Compensation Plan</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains a Deferred Compensation Plan in which certain employees of the Company may defer the payment and taxation of up to <ix:nonFraction unitRef="number" contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" decimals="INF" name="iart:DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82NC9mcmFnOjdhZTU2MzUyMWE3MzQwZmU5MDZjZDEzMDdlZTE5MGE0L3RleHRyZWdpb246N2FlNTYzNTIxYTczNDBmZTkwNmNkMTMwN2VlMTkwYTRfMTUzMg_60c662b6-dddb-45c0-a7f1-abac14ac12f0">75</ix:nonFraction>% of their base salary and up to <ix:nonFraction unitRef="number" contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" decimals="INF" name="iart:DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82NC9mcmFnOjdhZTU2MzUyMWE3MzQwZmU5MDZjZDEzMDdlZTE5MGE0L3RleHRyZWdpb246N2FlNTYzNTIxYTczNDBmZTkwNmNkMTMwN2VlMTkwYTRfMTU2Ng_72a6b32d-ba62-41c0-bb9d-8fa877a90dc2">100</ix:nonFraction>% of bonus amounts and other eligible cash compensation.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This deferred compensation is invested in funds offered under this plan and is valued based on Level 1 measurements in the fair value hierarchy. Assets of the Company's deferred compensation plan are included in other current assets and recorded at fair value based on their quoted market prices. The fair value of these assets were $<ix:nonFraction unitRef="usd" contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331" decimals="-5" name="us-gaap:DeferredCompensationPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82NC9mcmFnOjdhZTU2MzUyMWE3MzQwZmU5MDZjZDEzMDdlZTE5MGE0L3RleHRyZWdpb246N2FlNTYzNTIxYTczNDBmZTkwNmNkMTMwN2VlMTkwYTRfMjEwMA_2a5cd152-e39f-424c-92b6-d93a583dd3cb">5.0</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231" decimals="-5" name="us-gaap:DeferredCompensationPlanAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82NC9mcmFnOjdhZTU2MzUyMWE3MzQwZmU5MDZjZDEzMDdlZTE5MGE0L3RleHRyZWdpb246N2FlNTYzNTIxYTczNDBmZTkwNmNkMTMwN2VlMTkwYTRfMjExNQ_0abcc7b0-325e-44b0-8bd2-9f3e48873e37">4.7</ix:nonFraction> million as of March&#160;31, 2023 and December&#160;31, 2022, respectively. Offsetting liabilities relating to the deferred compensation plan are included in Other liabilities.</span></div></ix:continuation><div id="i5f1eb1bd01d541c3aa0777712077c048_67"></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10. <ix:nonNumeric contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" name="us-gaap:LesseeOperatingLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RleHRyZWdpb246MzQ4MGRhZmY0OTEzNGYxNzhjZDkzNGM2ZTExNWU0NThfMjQzMA_aea4982f-303d-4aac-a701-76af0ed69065" continuedAt="if1ad78e70c474baa94c3a343ee0daea3" escape="true">LEASES AND RELATED PARTY LEASES</ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="if1ad78e70c474baa94c3a343ee0daea3" continuedAt="ic6fd7b96fbae404f830cc631b5b4f156">The Company leases administrative, manufacturing, research and distribution facilities and vehicles through operating lease agreements. The Company has no finance leases as of March&#160;31, 2023. Many of the Company's leases include both lease (e.g., fixed payments including rent) and non-lease components (e.g., common-area or other maintenance costs). For vehicles, the Company has elected the practical expedient to group lease and non-lease components.</ix:continuation></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (continued) </span></div></div><ix:continuation id="ic6fd7b96fbae404f830cc631b5b4f156" continuedAt="i790ac155445341b2a2cc5e9fd268b7f8"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Most facility leases include <ix:nonFraction unitRef="renewal_option" contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" decimals="INF" name="iart:LesseeOperatingLeaseNumberOfRenewalOptions" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RleHRyZWdpb246MzQ4MGRhZmY0OTEzNGYxNzhjZDkzNGM2ZTExNWU0NThfNTEy_430c3387-e050-4472-ac16-5d797da9d461">one</ix:nonFraction> or more options to renew. The exercise of lease renewal options is typically at the Company's sole discretion, therefore, the majority of renewals to extend the lease terms are not included in the Right of Use ("ROU") assets and lease liabilities as they are not reasonably certain of exercise. The Company regularly evaluates renewal options and when they are reasonably certain of exercise, the renewal period is included in the lease term.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As most of the Company's leases do not provide an implicit rate, the Company uses a collateralized incremental borrowing rate based on the information available at the lease commencement date in determining the present value of the lease payments.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total operating lease expense for the three months ended March 31, 2023 and March&#160;31, 2022 was $<ix:nonFraction unitRef="usd" contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" decimals="-5" name="us-gaap:OperatingLeaseExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RleHRyZWdpb246MzQ4MGRhZmY0OTEzNGYxNzhjZDkzNGM2ZTExNWU0NThfMTI1OA_e8d48e05-028a-4f0d-9a5c-0717b16ead9d">6.0</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331" decimals="-5" name="us-gaap:OperatingLeaseExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RleHRyZWdpb246MzQ4MGRhZmY0OTEzNGYxNzhjZDkzNGM2ZTExNWU0NThfMTI2NQ_fde76868-e1e8-422e-ab19-11b7e728c77c">4.9</ix:nonFraction> million respectively, which includes $<ix:nonFraction unitRef="usd" contextRef="i0312bf3fc4c644b5a90beedc5b117be5_D20220101-20220331" decimals="-5" name="us-gaap:OperatingLeaseExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RleHRyZWdpb246MzQ4MGRhZmY0OTEzNGYxNzhjZDkzNGM2ZTExNWU0NThfMTI5Nw_2991498d-8bc4-4588-b161-f18ef97bc033"><ix:nonFraction unitRef="usd" contextRef="ibb2818c35582446bb26bb336b6909032_D20230101-20230331" decimals="-5" name="us-gaap:OperatingLeaseExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RleHRyZWdpb246MzQ4MGRhZmY0OTEzNGYxNzhjZDkzNGM2ZTExNWU0NThfMTI5Nw_5aac7976-d3bb-45bb-aa87-104b8a78fc6a">0.1</ix:nonFraction></ix:nonFraction> million, in related party operating lease expense.</span></div><ix:nonNumeric contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" name="iart:AssetsAndLiabilitiesLesseeTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RleHRyZWdpb246MzQ4MGRhZmY0OTEzNGYxNzhjZDkzNGM2ZTExNWU0NThfMjQ0Mw_c25e3832-81d0-44d0-be49-3c0f007421e5" escape="true"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental balance sheet information related to operating leases were as follows:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.718%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:18.198%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.200%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands, except lease term and discount rate</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31, 2022</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ROU assets</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RhYmxlOmQwZGI0MTJkNGE2YzQzOWM5ZGU0OTY1YzRmOGQ5YTBmL3RhYmxlcmFuZ2U6ZDBkYjQxMmQ0YTZjNDM5YzlkZTQ5NjVjNGY4ZDlhMGZfMS01LTEtMS0xODY4MjE_2a1298fe-4a12-4db1-899c-90b0b5021da4">146,514</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RhYmxlOmQwZGI0MTJkNGE2YzQzOWM5ZGU0OTY1YzRmOGQ5YTBmL3RhYmxlcmFuZ2U6ZDBkYjQxMmQ0YTZjNDM5YzlkZTQ5NjVjNGY4ZDlhMGZfMS03LTEtMS0xODY4MjE_c46b1c8d-5947-4401-97db-970453a94d31">148,284</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current lease liabilities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RhYmxlOmQwZGI0MTJkNGE2YzQzOWM5ZGU0OTY1YzRmOGQ5YTBmL3RhYmxlcmFuZ2U6ZDBkYjQxMmQ0YTZjNDM5YzlkZTQ5NjVjNGY4ZDlhMGZfMy01LTEtMS0xODY4MjE_ace5b1df-2094-4330-ac78-6cb66bed9a25">14,792</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RhYmxlOmQwZGI0MTJkNGE2YzQzOWM5ZGU0OTY1YzRmOGQ5YTBmL3RhYmxlcmFuZ2U6ZDBkYjQxMmQ0YTZjNDM5YzlkZTQ5NjVjNGY4ZDlhMGZfMy03LTEtMS0xODY4MjE_5569f44d-a369-4e76-80a5-a925cee32d13">14,624</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-current lease liabilities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RhYmxlOmQwZGI0MTJkNGE2YzQzOWM5ZGU0OTY1YzRmOGQ5YTBmL3RhYmxlcmFuZ2U6ZDBkYjQxMmQ0YTZjNDM5YzlkZTQ5NjVjNGY4ZDlhMGZfNC01LTEtMS0xODY4MjE_4b21e858-3ce1-42cb-833f-366a20e57341">156,910</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RhYmxlOmQwZGI0MTJkNGE2YzQzOWM5ZGU0OTY1YzRmOGQ5YTBmL3RhYmxlcmFuZ2U6ZDBkYjQxMmQ0YTZjNDM5YzlkZTQ5NjVjNGY4ZDlhMGZfNC03LTEtMS0xODY4MjE_368f0c1c-5145-4c1a-af54-4b679b8b13ad">157,420</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RhYmxlOmQwZGI0MTJkNGE2YzQzOWM5ZGU0OTY1YzRmOGQ5YTBmL3RhYmxlcmFuZ2U6ZDBkYjQxMmQ0YTZjNDM5YzlkZTQ5NjVjNGY4ZDlhMGZfNS01LTEtMS0xODY4MjE_2ac58911-8957-41ea-8ceb-071983784936">171,702</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RhYmxlOmQwZGI0MTJkNGE2YzQzOWM5ZGU0OTY1YzRmOGQ5YTBmL3RhYmxlcmFuZ2U6ZDBkYjQxMmQ0YTZjNDM5YzlkZTQ5NjVjNGY4ZDlhMGZfNS03LTEtMS0xODY4MjE_a60d0986-a219-484b-acf1-b1cf100d0e76">172,044</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average remaining lease term (in years):</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Leased facilities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ief22d29946704881b53879628a3b3a03_I20230331" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RhYmxlOmQwZGI0MTJkNGE2YzQzOWM5ZGU0OTY1YzRmOGQ5YTBmL3RhYmxlcmFuZ2U6ZDBkYjQxMmQ0YTZjNDM5YzlkZTQ5NjVjNGY4ZDlhMGZfOC01LTEtMS0xODY4MjE_7515fcb3-0220-41c2-9a02-1698999a7cc6">17.1</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i77b6f580f27a43fa87d99324c7d3333c_I20221231" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RhYmxlOmQwZGI0MTJkNGE2YzQzOWM5ZGU0OTY1YzRmOGQ5YTBmL3RhYmxlcmFuZ2U6ZDBkYjQxMmQ0YTZjNDM5YzlkZTQ5NjVjNGY4ZDlhMGZfOC03LTEtMS0xODY4MjE_8c7b7046-97df-4d08-ac5b-3a08246c71c3">16.9</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Leased vehicles</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i858dd34246b34029ba59dcfd73afff17_I20230331" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RhYmxlOmQwZGI0MTJkNGE2YzQzOWM5ZGU0OTY1YzRmOGQ5YTBmL3RhYmxlcmFuZ2U6ZDBkYjQxMmQ0YTZjNDM5YzlkZTQ5NjVjNGY4ZDlhMGZfOS01LTEtMS0xODY4MjE_5bea49fd-8188-4c37-884d-0c32eda8b083">2.0</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iac36470e6fcb4453b97db73bbce55586_I20221231" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RhYmxlOmQwZGI0MTJkNGE2YzQzOWM5ZGU0OTY1YzRmOGQ5YTBmL3RhYmxlcmFuZ2U6ZDBkYjQxMmQ0YTZjNDM5YzlkZTQ5NjVjNGY4ZDlhMGZfOS03LTEtMS0xODY4MjE_bd41025e-fb79-40a5-8239-7e7e3e87a0be">2.0</ix:nonNumeric> years</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average discount rate:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Leased facilities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ief22d29946704881b53879628a3b3a03_I20230331" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RhYmxlOmQwZGI0MTJkNGE2YzQzOWM5ZGU0OTY1YzRmOGQ5YTBmL3RhYmxlcmFuZ2U6ZDBkYjQxMmQ0YTZjNDM5YzlkZTQ5NjVjNGY4ZDlhMGZfMTItNS0xLTEtMTg2ODIx_0b2df3e7-accb-4d0a-a87d-1ea4a3418d0e">5.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i77b6f580f27a43fa87d99324c7d3333c_I20221231" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RhYmxlOmQwZGI0MTJkNGE2YzQzOWM5ZGU0OTY1YzRmOGQ5YTBmL3RhYmxlcmFuZ2U6ZDBkYjQxMmQ0YTZjNDM5YzlkZTQ5NjVjNGY4ZDlhMGZfMTItNy0xLTEtMTg2ODIx_73852bef-31cd-4b59-9919-1ebad8b46b37">5.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Leased vehicles</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i858dd34246b34029ba59dcfd73afff17_I20230331" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RhYmxlOmQwZGI0MTJkNGE2YzQzOWM5ZGU0OTY1YzRmOGQ5YTBmL3RhYmxlcmFuZ2U6ZDBkYjQxMmQ0YTZjNDM5YzlkZTQ5NjVjNGY4ZDlhMGZfMTMtNS0xLTEtMTg2ODIx_64272e17-0f15-4b01-a4eb-66c910125ec8">2.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iac36470e6fcb4453b97db73bbce55586_I20221231" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RhYmxlOmQwZGI0MTJkNGE2YzQzOWM5ZGU0OTY1YzRmOGQ5YTBmL3RhYmxlcmFuZ2U6ZDBkYjQxMmQ0YTZjNDM5YzlkZTQ5NjVjNGY4ZDlhMGZfMTMtNy0xLTEtMTg2ODIx_0f68f6df-a7fb-40e1-be51-07169cf27c0e">2.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" name="iart:CashFlowLesseeTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RleHRyZWdpb246MzQ4MGRhZmY0OTEzNGYxNzhjZDkzNGM2ZTExNWU0NThfMjQzMg_0054dfca-75d6-46f1-9dee-2b41f0cb9535" escape="true"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to leases for the three months ended March 31, 2023 and 2022 were as follows:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.075%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.522%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March&#160;31, 2022</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" decimals="-3" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RhYmxlOjhkN2YyMDY4ZmZlNDRhODM5OGYzMmMzMzU1ZTFlM2ZiL3RhYmxlcmFuZ2U6OGQ3ZjIwNjhmZmU0NGE4Mzk4ZjMyYzMzNTVlMWUzZmJfMi0xLTEtMS0xODY4MjE_d6bbfbce-bf9d-442b-8fda-8f7a71cd4201">4,319</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331" decimals="-3" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RhYmxlOjhkN2YyMDY4ZmZlNDRhODM5OGYzMmMzMzU1ZTFlM2ZiL3RhYmxlcmFuZ2U6OGQ3ZjIwNjhmZmU0NGE4Mzk4ZjMyYzMzNTVlMWUzZmJfMi0zLTEtMS0xODY4MjE_ee1798db-9e87-478a-84ae-56da5d02949b">4,696</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ROU assets obtained in exchange for lease liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating leases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RhYmxlOjhkN2YyMDY4ZmZlNDRhODM5OGYzMmMzMzU1ZTFlM2ZiL3RhYmxlcmFuZ2U6OGQ3ZjIwNjhmZmU0NGE4Mzk4ZjMyYzMzNTVlMWUzZmJfNS0xLTEtMS0xODY4MjE_4a33fc87-4dbe-4a85-9bec-25327fd7b1ed">1,721</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RhYmxlOjhkN2YyMDY4ZmZlNDRhODM5OGYzMmMzMzU1ZTFlM2ZiL3RhYmxlcmFuZ2U6OGQ3ZjIwNjhmZmU0NGE4Mzk4ZjMyYzMzNTVlMWUzZmJfNS0zLTEtMS0xODY4MjE_cc83bdd7-6d29-48dd-874c-4cb5f803cd83">507</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RleHRyZWdpb246MzQ4MGRhZmY0OTEzNGYxNzhjZDkzNGM2ZTExNWU0NThfMjQ0NA_2c8e62b7-595d-476b-b46b-ad7a9626ec38" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future minimum lease payments under operating leases at March&#160;31, 2023 were as follows:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:56.940%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.500%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Related Parties</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Third Parties</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Remainder of 2023</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81703db4530142f4a19d6c5342dd660a_I20230331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RhYmxlOjk4NzgyNjg2MWI4NjQ5N2Y5MDkzMTJlOGRjYmNmMmNlL3RhYmxlcmFuZ2U6OTg3ODI2ODYxYjg2NDk3ZjkwOTMxMmU4ZGNiY2YyY2VfMS0xLTEtMS0xODY4MjE_2f20c0b8-38b1-4284-8f66-c3b43f5ef04b">222</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96ad5df3ea584444876af27fc107fa44_I20230331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RhYmxlOjk4NzgyNjg2MWI4NjQ5N2Y5MDkzMTJlOGRjYmNmMmNlL3RhYmxlcmFuZ2U6OTg3ODI2ODYxYjg2NDk3ZjkwOTMxMmU4ZGNiY2YyY2VfMS0zLTEtMS0xODY4MjE_b9aa7f28-bd42-4de8-9d40-e0006237f567">15,870</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RhYmxlOjk4NzgyNjg2MWI4NjQ5N2Y5MDkzMTJlOGRjYmNmMmNlL3RhYmxlcmFuZ2U6OTg3ODI2ODYxYjg2NDk3ZjkwOTMxMmU4ZGNiY2YyY2VfMS01LTEtMS0xODY4MjE_b76a74c4-71e8-4ab6-bafa-ad4b2a6c9b19">16,092</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81703db4530142f4a19d6c5342dd660a_I20230331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RhYmxlOjk4NzgyNjg2MWI4NjQ5N2Y5MDkzMTJlOGRjYmNmMmNlL3RhYmxlcmFuZ2U6OTg3ODI2ODYxYjg2NDk3ZjkwOTMxMmU4ZGNiY2YyY2VfMi0xLTEtMS0xODY4MjE_c5e52115-2220-4d93-9cfd-649350cedce5">296</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96ad5df3ea584444876af27fc107fa44_I20230331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RhYmxlOjk4NzgyNjg2MWI4NjQ5N2Y5MDkzMTJlOGRjYmNmMmNlL3RhYmxlcmFuZ2U6OTg3ODI2ODYxYjg2NDk3ZjkwOTMxMmU4ZGNiY2YyY2VfMi0zLTEtMS0xODY4MjE_59e0b73c-b056-4ac3-9551-cd6690cc32e8">21,086</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RhYmxlOjk4NzgyNjg2MWI4NjQ5N2Y5MDkzMTJlOGRjYmNmMmNlL3RhYmxlcmFuZ2U6OTg3ODI2ODYxYjg2NDk3ZjkwOTMxMmU4ZGNiY2YyY2VfMi01LTEtMS0xODY4MjE_32a7b28d-0663-4776-b1a5-bfb276e4996c">21,382</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81703db4530142f4a19d6c5342dd660a_I20230331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RhYmxlOjk4NzgyNjg2MWI4NjQ5N2Y5MDkzMTJlOGRjYmNmMmNlL3RhYmxlcmFuZ2U6OTg3ODI2ODYxYjg2NDk3ZjkwOTMxMmU4ZGNiY2YyY2VfMy0xLTEtMS0xODY4MjE_6285ff71-8e6c-4585-858f-d4020552a1f5">296</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96ad5df3ea584444876af27fc107fa44_I20230331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RhYmxlOjk4NzgyNjg2MWI4NjQ5N2Y5MDkzMTJlOGRjYmNmMmNlL3RhYmxlcmFuZ2U6OTg3ODI2ODYxYjg2NDk3ZjkwOTMxMmU4ZGNiY2YyY2VfMy0zLTEtMS0xODY4MjE_bf8c4c24-b140-452a-ada8-a27488fe370c">19,753</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RhYmxlOjk4NzgyNjg2MWI4NjQ5N2Y5MDkzMTJlOGRjYmNmMmNlL3RhYmxlcmFuZ2U6OTg3ODI2ODYxYjg2NDk3ZjkwOTMxMmU4ZGNiY2YyY2VfMy01LTEtMS0xODY4MjE_4dab2bbe-0b83-41c3-a605-335d202fdc82">20,049</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81703db4530142f4a19d6c5342dd660a_I20230331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RhYmxlOjk4NzgyNjg2MWI4NjQ5N2Y5MDkzMTJlOGRjYmNmMmNlL3RhYmxlcmFuZ2U6OTg3ODI2ODYxYjg2NDk3ZjkwOTMxMmU4ZGNiY2YyY2VfNC0xLTEtMS0xODY4MjE_c6864cce-1c33-48e9-b8b4-e730c3f49872">296</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96ad5df3ea584444876af27fc107fa44_I20230331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RhYmxlOjk4NzgyNjg2MWI4NjQ5N2Y5MDkzMTJlOGRjYmNmMmNlL3RhYmxlcmFuZ2U6OTg3ODI2ODYxYjg2NDk3ZjkwOTMxMmU4ZGNiY2YyY2VfNC0zLTEtMS0xODY4MjE_cc0a4ad1-7456-4a6e-8070-5eb65406a45b">17,148</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RhYmxlOjk4NzgyNjg2MWI4NjQ5N2Y5MDkzMTJlOGRjYmNmMmNlL3RhYmxlcmFuZ2U6OTg3ODI2ODYxYjg2NDk3ZjkwOTMxMmU4ZGNiY2YyY2VfNC01LTEtMS0xODY4MjE_3614aff7-ce32-4842-9a66-d7a3435b4f80">17,444</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81703db4530142f4a19d6c5342dd660a_I20230331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RhYmxlOjk4NzgyNjg2MWI4NjQ5N2Y5MDkzMTJlOGRjYmNmMmNlL3RhYmxlcmFuZ2U6OTg3ODI2ODYxYjg2NDk3ZjkwOTMxMmU4ZGNiY2YyY2VfNS0xLTEtMS0xODY4MjE_6294ef52-b651-4230-b9eb-d7aa5deb4464">296</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96ad5df3ea584444876af27fc107fa44_I20230331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RhYmxlOjk4NzgyNjg2MWI4NjQ5N2Y5MDkzMTJlOGRjYmNmMmNlL3RhYmxlcmFuZ2U6OTg3ODI2ODYxYjg2NDk3ZjkwOTMxMmU4ZGNiY2YyY2VfNS0zLTEtMS0xODY4MjE_9a0f1a2b-8c3a-4376-b553-6961b372d82f">16,205</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RhYmxlOjk4NzgyNjg2MWI4NjQ5N2Y5MDkzMTJlOGRjYmNmMmNlL3RhYmxlcmFuZ2U6OTg3ODI2ODYxYjg2NDk3ZjkwOTMxMmU4ZGNiY2YyY2VfNS01LTEtMS0xODY4MjE_239af2c2-13e7-43b1-b5f5-f7811e2130f1">16,501</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2028</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81703db4530142f4a19d6c5342dd660a_I20230331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RhYmxlOjk4NzgyNjg2MWI4NjQ5N2Y5MDkzMTJlOGRjYmNmMmNlL3RhYmxlcmFuZ2U6OTg3ODI2ODYxYjg2NDk3ZjkwOTMxMmU4ZGNiY2YyY2VfNi0xLTEtMS0xODY4MjE_fbd35104-5a09-4a40-bb87-eec0ae4a6e80">296</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96ad5df3ea584444876af27fc107fa44_I20230331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RhYmxlOjk4NzgyNjg2MWI4NjQ5N2Y5MDkzMTJlOGRjYmNmMmNlL3RhYmxlcmFuZ2U6OTg3ODI2ODYxYjg2NDk3ZjkwOTMxMmU4ZGNiY2YyY2VfNi0zLTEtMS0xODY4MjE_3ee78d2b-621d-43d5-99c4-6763cd3423f4">13,951</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RhYmxlOjk4NzgyNjg2MWI4NjQ5N2Y5MDkzMTJlOGRjYmNmMmNlL3RhYmxlcmFuZ2U6OTg3ODI2ODYxYjg2NDk3ZjkwOTMxMmU4ZGNiY2YyY2VfNi01LTEtMS0xODY4MjE_57d4a5a4-8507-4e6d-976d-253719752fba">14,247</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81703db4530142f4a19d6c5342dd660a_I20230331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RhYmxlOjk4NzgyNjg2MWI4NjQ5N2Y5MDkzMTJlOGRjYmNmMmNlL3RhYmxlcmFuZ2U6OTg3ODI2ODYxYjg2NDk3ZjkwOTMxMmU4ZGNiY2YyY2VfNy0xLTEtMS0xODY4MjE_f3f6f592-0396-4c00-b3fa-89272f8fa69c">246</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96ad5df3ea584444876af27fc107fa44_I20230331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RhYmxlOjk4NzgyNjg2MWI4NjQ5N2Y5MDkzMTJlOGRjYmNmMmNlL3RhYmxlcmFuZ2U6OTg3ODI2ODYxYjg2NDk3ZjkwOTMxMmU4ZGNiY2YyY2VfNy0zLTEtMS0xODY4MjE_f750a281-73ef-4fee-9a61-7e14bf1dac04">151,206</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RhYmxlOjk4NzgyNjg2MWI4NjQ5N2Y5MDkzMTJlOGRjYmNmMmNlL3RhYmxlcmFuZ2U6OTg3ODI2ODYxYjg2NDk3ZjkwOTMxMmU4ZGNiY2YyY2VfNy01LTEtMS0xODY4MjE_284a1307-a0f8-45c1-81ea-0db96f948a2c">151,452</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total minimum lease payments</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81703db4530142f4a19d6c5342dd660a_I20230331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RhYmxlOjk4NzgyNjg2MWI4NjQ5N2Y5MDkzMTJlOGRjYmNmMmNlL3RhYmxlcmFuZ2U6OTg3ODI2ODYxYjg2NDk3ZjkwOTMxMmU4ZGNiY2YyY2VfOC0xLTEtMS0xODY4MjE_d045e340-f9e1-42ea-97b8-07e5d4fe6acb">1,948</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96ad5df3ea584444876af27fc107fa44_I20230331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RhYmxlOjk4NzgyNjg2MWI4NjQ5N2Y5MDkzMTJlOGRjYmNmMmNlL3RhYmxlcmFuZ2U6OTg3ODI2ODYxYjg2NDk3ZjkwOTMxMmU4ZGNiY2YyY2VfOC0zLTEtMS0xODY4MjE_61f6f545-aa37-461e-849f-2d768e38074b">255,219</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RhYmxlOjk4NzgyNjg2MWI4NjQ5N2Y5MDkzMTJlOGRjYmNmMmNlL3RhYmxlcmFuZ2U6OTg3ODI2ODYxYjg2NDk3ZjkwOTMxMmU4ZGNiY2YyY2VfOC01LTEtMS0xODY4MjE_20b815cc-f9a1-4bde-9cfc-58beb9b022d9">257,167</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Imputed interest</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RhYmxlOjk4NzgyNjg2MWI4NjQ5N2Y5MDkzMTJlOGRjYmNmMmNlL3RhYmxlcmFuZ2U6OTg3ODI2ODYxYjg2NDk3ZjkwOTMxMmU4ZGNiY2YyY2VfOS01LTEtMS0xODY4MjE_a8bc2b77-30be-412f-b052-9d0d8d941d4c">85,465</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RhYmxlOjk4NzgyNjg2MWI4NjQ5N2Y5MDkzMTJlOGRjYmNmMmNlL3RhYmxlcmFuZ2U6OTg3ODI2ODYxYjg2NDk3ZjkwOTMxMmU4ZGNiY2YyY2VfMTAtNS0xLTEtMTg2ODIx_846b2f9e-e2a1-4247-91b1-a650792e9a04">171,702</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Current lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RhYmxlOjk4NzgyNjg2MWI4NjQ5N2Y5MDkzMTJlOGRjYmNmMmNlL3RhYmxlcmFuZ2U6OTg3ODI2ODYxYjg2NDk3ZjkwOTMxMmU4ZGNiY2YyY2VfMTEtNS0xLTEtMTg2ODIx_8fcb7ca7-248b-4c8a-a05e-0ad7ffe8d41c">14,792</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RhYmxlOjk4NzgyNjg2MWI4NjQ5N2Y5MDkzMTJlOGRjYmNmMmNlL3RhYmxlcmFuZ2U6OTg3ODI2ODYxYjg2NDk3ZjkwOTMxMmU4ZGNiY2YyY2VfMTItNS0xLTEtMTg2ODIx_a46dcfe2-8f21-4cd7-900f-e7917be86f30">156,910</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (continued) </span></div></div><ix:continuation id="i790ac155445341b2a2cc5e9fd268b7f8"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no future minimum lease payments under finance leases at March&#160;31, 2023.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Related Party Leases</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company leases its manufacturing facility in Plainsboro, New Jersey, from Plainsboro Associates, a New Jersey general partnership. Ocirne, Inc., a subsidiary of Provco Industries, owns a <ix:nonFraction unitRef="number" contextRef="ibb2818c35582446bb26bb336b6909032_D20230101-20230331" decimals="2" name="iart:PercentOfManufacturingFacilityOwnedByCorporationWhoseShareholdersAreTrustsWhoseBeneficiariesIncludeFamilyMembersOfCompanysFormerDirector" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RleHRyZWdpb246MzQ4MGRhZmY0OTEzNGYxNzhjZDkzNGM2ZTExNWU0NThfMTc5OA_ff0aedaf-5959-4c56-8034-8795f5d4d784">50</ix:nonFraction>% % interest in Plainsboro Associates. Provco Industries is the corporate general partner of Tru St. Partnership LLP, a principal stockholder of the Company. The term of the current lease agreement is through October&#160;31, 2029 at an annual rate of approximately $<ix:nonFraction unitRef="usd" contextRef="ibb2818c35582446bb26bb336b6909032_D20230101-20230331" decimals="-5" name="iart:AnnualRateOfLeaseAgreement" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RleHRyZWdpb246MzQ4MGRhZmY0OTEzNGYxNzhjZDkzNGM2ZTExNWU0NThfMjA2MQ_84849d97-f54b-4d51-87f2-8dc3f67b3707">0.3</ix:nonFraction> million per year. The current lease agreement also provides (i) a <ix:nonNumeric contextRef="i01e32628066d40fc8d8037b63a6a88b0_I20230331" name="us-gaap:LesseeOperatingLeaseRenewalTerm" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RleHRyZWdpb246MzQ4MGRhZmY0OTEzNGYxNzhjZDkzNGM2ZTExNWU0NThfMjEyMg_88ffe392-2971-4372-bd9e-9c75cb607289">5</ix:nonNumeric>-year renewal option for the Company to extend the lease from <ix:nonNumeric contextRef="iccf8172c44f8418299899a406aff6ff5_D20230101-20230331" name="us-gaap:LesseeOperatingLeaseOptionToExtend" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RleHRyZWdpb246MzQ4MGRhZmY0OTEzNGYxNzhjZDkzNGM2ZTExNWU0NThfMjQzNA_5469ad99-cfcd-47e2-bab0-25f44eac0e9d">November 1, 2029 through October 31, 2034</ix:nonNumeric> at the fair market rental rate of the premises, and (ii) another <ix:nonNumeric contextRef="idb728fa94349423cada113737d6ec277_I20230331" name="us-gaap:LesseeOperatingLeaseRenewalTerm" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RleHRyZWdpb246MzQ4MGRhZmY0OTEzNGYxNzhjZDkzNGM2ZTExNWU0NThfMjI5Mw_6209948c-23f4-4861-b640-2d592f361f94">5</ix:nonNumeric>-year renewal option to extend the lease from <ix:nonNumeric contextRef="i6657623349984d07affcf737d966245b_D20230101-20230331" name="us-gaap:LesseeOperatingLeaseOptionToExtend" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RleHRyZWdpb246MzQ4MGRhZmY0OTEzNGYxNzhjZDkzNGM2ZTExNWU0NThfMjQ0Ng_720dbea1-c38e-48c9-b555-90b406219d6d">November 1, 2034 through October 31, 2039</ix:nonNumeric> at the fair market rental rate of the premises.</span></div></ix:continuation><div id="i5f1eb1bd01d541c3aa0777712077c048_70"></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11.&#160;<ix:nonNumeric contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" name="us-gaap:TreasuryStockTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83MC9mcmFnOmY1MDdjODljMGQyMTQzZWZiZGJiODNkN2VlZTlhNmIxL3RleHRyZWdpb246ZjUwN2M4OWMwZDIxNDNlZmJkYmI4M2Q3ZWVlOWE2YjFfMjA1Ng_edc7ec0c-6f4a-490a-9a57-ccac35498e6b" continuedAt="i745a8cb5ac534feda3a6adbc0f5e7422" escape="true">TREASURY STOCK</ix:nonNumeric></span></div><ix:continuation id="i745a8cb5ac534feda3a6adbc0f5e7422"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023 and December&#160;31, 2022, there were <ix:nonFraction unitRef="shares" contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331" decimals="-5" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83MC9mcmFnOmY1MDdjODljMGQyMTQzZWZiZGJiODNkN2VlZTlhNmIxL3RleHRyZWdpb246ZjUwN2M4OWMwZDIxNDNlZmJkYmI4M2Q3ZWVlOWE2YjFfNTI_7d3aa839-0970-464c-b37f-6f194c62a9b1">8.9</ix:nonFraction> million and <ix:nonFraction unitRef="shares" contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231" decimals="-5" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83MC9mcmFnOmY1MDdjODljMGQyMTQzZWZiZGJiODNkN2VlZTlhNmIxL3RleHRyZWdpb246ZjUwN2M4OWMwZDIxNDNlZmJkYmI4M2Q3ZWVlOWE2YjFfNTk_4f88eb72-d501-4e59-b98f-fb57bd9d287c">6.8</ix:nonFraction> million shares of treasury stock outstanding with a cost of $<ix:nonFraction unitRef="usd" contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331" decimals="-5" name="us-gaap:TreasuryStockCommonValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83MC9mcmFnOmY1MDdjODljMGQyMTQzZWZiZGJiODNkN2VlZTlhNmIxL3RleHRyZWdpb246ZjUwN2M4OWMwZDIxNDNlZmJkYmI4M2Q3ZWVlOWE2YjFfMTE0_cd0d19a6-aebb-49fd-8b35-ce858767dfbd">481.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231" decimals="-5" name="us-gaap:TreasuryStockCommonValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83MC9mcmFnOmY1MDdjODljMGQyMTQzZWZiZGJiODNkN2VlZTlhNmIxL3RleHRyZWdpb246ZjUwN2M4OWMwZDIxNDNlZmJkYmI4M2Q3ZWVlOWE2YjFfMTIx_01c6de6c-fd62-4aea-958a-cfbfc54e22db">362.9</ix:nonFraction> million, at a weighted average cost per share of $<ix:nonFraction unitRef="usdPerShare" contextRef="i142beeb645c448e9b1d164dc7254fd2f_D20230331-20230331" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83MC9mcmFnOmY1MDdjODljMGQyMTQzZWZiZGJiODNkN2VlZTlhNmIxL3RleHRyZWdpb246ZjUwN2M4OWMwZDIxNDNlZmJkYmI4M2Q3ZWVlOWE2YjFfMTY1_e3d46f3d-5038-4f1e-82c5-cdeda9603443">54.01</ix:nonFraction> and $<ix:nonFraction unitRef="usdPerShare" contextRef="ia47e8fa146ee495e917d3a8854512649_D20221231-20221231" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83MC9mcmFnOmY1MDdjODljMGQyMTQzZWZiZGJiODNkN2VlZTlhNmIxL3RleHRyZWdpb246ZjUwN2M4OWMwZDIxNDNlZmJkYmI4M2Q3ZWVlOWE2YjFfMTcy_12294275-3dbb-4bd4-bd16-aa14bf917c41">53.18</ix:nonFraction>, respectively.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On January 26, 2023, the Company entered into a $<ix:nonFraction unitRef="usd" contextRef="i05fc75ff93f849f6b97ee88d5015c23a_I20230126" decimals="-6" name="us-gaap:AcceleratedShareRepurchasesSettlementPaymentOrReceipt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83MC9mcmFnOmY1MDdjODljMGQyMTQzZWZiZGJiODNkN2VlZTlhNmIxL3RleHRyZWdpb246ZjUwN2M4OWMwZDIxNDNlZmJkYmI4M2Q3ZWVlOWE2YjFfNTQ5NzU1ODE4NTcz_f0fdd222-79b4-4ca0-af12-96be3775c5f9">150</ix:nonFraction> million accelerated share repurchase ("2023 ASR") and received <ix:nonFraction unitRef="shares" contextRef="i05fc75ff93f849f6b97ee88d5015c23a_I20230126" decimals="-5" name="iart:AcceleratedShareRepurchasesSharesReceivedAtInception" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83MC9mcmFnOmY1MDdjODljMGQyMTQzZWZiZGJiODNkN2VlZTlhNmIxL3RleHRyZWdpb246ZjUwN2M4OWMwZDIxNDNlZmJkYmI4M2Q3ZWVlOWE2YjFfNDk0NzgwMjMzMjMxNQ_84184a26-dcf1-406e-baa7-b3cb49dc2610">2.1</ix:nonFraction>&#160;million shares of the Company common stock at inception of the 2023 ASR, which represented approximately <ix:nonFraction unitRef="number" contextRef="i6eb2c396ee604c4493e35d50b9e4ab46_D20230126-20230126" decimals="2" name="iart:AcceleratedShareRepurchasesPercentageOfExpectedTotalRepurchased" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83MC9mcmFnOmY1MDdjODljMGQyMTQzZWZiZGJiODNkN2VlZTlhNmIxL3RleHRyZWdpb246ZjUwN2M4OWMwZDIxNDNlZmJkYmI4M2Q3ZWVlOWE2YjFfNTQ5NzU1ODE4NTk0_d1995710-06a9-4538-97c6-bdcd1b64442e">80</ix:nonFraction>% of the expected total shares under the 2023 ASR.  The remaining repurchase transactions are expected to be completed in the second quarter of 2023.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On August 16, 2022, the Inflation Reduction Act of 2022 (the &#8220;Act&#8221;) was signed into law. The Act implements a new excise tax of 1% on the net share repurchases made by the company effective for share repurchases performed January 1, 2023, or after. The company accrued $<ix:nonFraction unitRef="usd" contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" decimals="-5" name="iart:ExciseTaxPayableOnShareRepurchases" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83MC9mcmFnOmY1MDdjODljMGQyMTQzZWZiZGJiODNkN2VlZTlhNmIxL3RleHRyZWdpb246ZjUwN2M4OWMwZDIxNDNlZmJkYmI4M2Q3ZWVlOWE2YjFfNTQ5NzU1ODIxNTg0_61407b1f-738a-4862-a7ed-77ba1bb17422">1.2</ix:nonFraction> million regarding the excise tax in Q-1 related to the ASR mentioned above.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 12, 2022, the Company entered into a $<ix:nonFraction unitRef="usd" contextRef="i4a535ba6db064ba5a22bf28443b5a825_I20220112" decimals="-4" name="us-gaap:AcceleratedShareRepurchasesSettlementPaymentOrReceipt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83MC9mcmFnOmY1MDdjODljMGQyMTQzZWZiZGJiODNkN2VlZTlhNmIxL3RleHRyZWdpb246ZjUwN2M4OWMwZDIxNDNlZmJkYmI4M2Q3ZWVlOWE2YjFfODM2_ed1c3977-cca2-4362-8f6b-1670eb1e4bb2">125</ix:nonFraction>&#160;million accelerated share repurchase ("2022 ASR") and received <ix:nonFraction unitRef="shares" contextRef="i4a535ba6db064ba5a22bf28443b5a825_I20220112" decimals="-4" name="iart:AcceleratedShareRepurchasesSharesReceivedAtInception" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83MC9mcmFnOmY1MDdjODljMGQyMTQzZWZiZGJiODNkN2VlZTlhNmIxL3RleHRyZWdpb246ZjUwN2M4OWMwZDIxNDNlZmJkYmI4M2Q3ZWVlOWE2YjFfODk0_bfec6390-01c3-45d3-8a6f-ee9df75890ab">1.48</ix:nonFraction>&#160;million shares of Company common stock at inception of the 2022 ASR, which represented approximately <ix:nonFraction unitRef="number" contextRef="ic6638393ed5a47c19e1abcc6dca5d5d6_D20220112-20220112" decimals="2" name="iart:AcceleratedShareRepurchasesPercentageOfExpectedTotalRepurchased" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83MC9mcmFnOmY1MDdjODljMGQyMTQzZWZiZGJiODNkN2VlZTlhNmIxL3RleHRyZWdpb246ZjUwN2M4OWMwZDIxNDNlZmJkYmI4M2Q3ZWVlOWE2YjFfOTkw_ccd2aeaa-3488-4b6a-9f50-00ab23529856">80</ix:nonFraction>% of the expected total shares under the 2022 ASR. On March 24, 2022, the early exercise provision under the 2022 ASR was exercised by 2022 ASR counterparty. Upon settlement on March 24, 2022, the Company received an additional <ix:nonFraction unitRef="shares" contextRef="i1e7a618c6acb4e27a31c0800c72f5336_I20220324" decimals="-4" name="iart:AcceleratedShareRepurchasesAdditionalSharesReceived" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83MC9mcmFnOmY1MDdjODljMGQyMTQzZWZiZGJiODNkN2VlZTlhNmIxL3RleHRyZWdpb246ZjUwN2M4OWMwZDIxNDNlZmJkYmI4M2Q3ZWVlOWE2YjFfNTQ5NzU1ODIwMDg5_772fa5f2-d6fd-46b2-8b49-6b86fc1c46ca">0.46</ix:nonFraction>&#160;million shares determined using the volume-weighted average price of the Company's common stock during the term of the 2022 ASR.</span></div></ix:continuation><div id="i5f1eb1bd01d541c3aa0777712077c048_73"></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12. <ix:nonNumeric contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83My9mcmFnOmMyOTg4NzRmZTY0MTRjMjdhMDEwNWRhODBiYzRjYmQ3L3RleHRyZWdpb246YzI5ODg3NGZlNjQxNGMyN2EwMTA1ZGE4MGJjNGNiZDdfMjE2OA_42642d3b-5a33-4c9b-9885-ce565157adc4" continuedAt="ic28bb25ddb824b069624858b1b7bf7f4" escape="true">INCOME TAXES</ix:nonNumeric></span></div><ix:continuation id="ic28bb25ddb824b069624858b1b7bf7f4"><ix:nonNumeric contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83My9mcmFnOmMyOTg4NzRmZTY0MTRjMjdhMDEwNWRhODBiYzRjYmQ3L3RleHRyZWdpb246YzI5ODg3NGZlNjQxNGMyN2EwMTA1ZGE4MGJjNGNiZDdfMjE4Ng_ac1002a4-5cd1-4877-8381-fa1ba8cd515f" escape="true"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a summary of the Company's effective tax rate:</span></div><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.075%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.522%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Reported tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83My9mcmFnOmMyOTg4NzRmZTY0MTRjMjdhMDEwNWRhODBiYzRjYmQ3L3RhYmxlOmM2ZmJlZGJmN2ExYTRjZjg5MjJlYzczZTk0Njg0MjAyL3RhYmxlcmFuZ2U6YzZmYmVkYmY3YTFhNGNmODkyMmVjNzNlOTQ2ODQyMDJfMi0xLTEtMS0xODY4MjE_c28aa383-6099-416d-98c6-3c9d51e3c8da">18.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83My9mcmFnOmMyOTg4NzRmZTY0MTRjMjdhMDEwNWRhODBiYzRjYmQ3L3RhYmxlOmM2ZmJlZGJmN2ExYTRjZjg5MjJlYzczZTk0Njg0MjAyL3RhYmxlcmFuZ2U6YzZmYmVkYmY3YTFhNGNmODkyMmVjNzNlOTQ2ODQyMDJfMi0zLTEtMS0xODY4MjE_e5bb285f-9612-488c-9629-426a6c35db73">16.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company&#8217;s effective income tax rates for the three months ended March 31, 2023 and 2022 w</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">ere <ix:nonFraction unitRef="number" contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83My9mcmFnOmMyOTg4NzRmZTY0MTRjMjdhMDEwNWRhODBiYzRjYmQ3L3RleHRyZWdpb246YzI5ODg3NGZlNjQxNGMyN2EwMTA1ZGE4MGJjNGNiZDdfMTY1_c28aa383-6099-416d-98c6-3c9d51e3c8da">18.6</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83My9mcmFnOmMyOTg4NzRmZTY0MTRjMjdhMDEwNWRhODBiYzRjYmQ3L3RleHRyZWdpb246YzI5ODg3NGZlNjQxNGMyN2EwMTA1ZGE4MGJjNGNiZDdfMTcy_e5bb285f-9612-488c-9629-426a6c35db73">16.3</ix:nonFraction>%, respectively. For the three months ended March 31, 2023, the primary driver of the higher tax rate relates to a reduction of excess tax benefits from stock compensation.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Changes to income tax laws and regulations, in any of the tax jurisdictions in which the Company operates, could impact the effective tax rate. Various governments, both U.S. and non-U.S., are increasingly focused on tax reform and revenue-raising legislation. Further, legislation in foreign jurisdictions may be enacted, in response to the base erosion and profit-sharing project begun by the Organization for Economic Cooperation and Development ("OECD"). The OECD recently finalized major reform of the international tax system with respect to a global minimum tax rate. Such changes in U.S. and non-U.S. jurisdictions could have an adverse effect on the Company&#8217;s effective tax rate.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As of March&#160;31, 2023, the Company has not provided deferred income taxes on unrepatriated earnings from foreign subsidiaries as they are deemed to be indefinitely reinvested unless there is a manner under which to remit the earnings with no material tax cost. Material taxes would primarily be attributable to foreign withholding taxes and local income taxes when such earnings are distributed. The Company will repatriate foreign earnings when there is no need for reinvestment overseas and there is no material cost to bring the earnings back to the United States. Reinvestment considerations would include future acquisitions, transactions, and capital expenditure plans.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><div id="i5f1eb1bd01d541c3aa0777712077c048_76"></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (continued) </span></div></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13. <ix:nonNumeric contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83Ni9mcmFnOjg5YzNkMDI5ODdiODQzNTY5MzMwMTdhYzEwNjlhNzkwL3RleHRyZWdpb246ODljM2QwMjk4N2I4NDM1NjkzMzAxN2FjMTA2OWE3OTBfOTYx_5a1918fa-48fc-4a89-81cc-3d4dfb227e8c" continuedAt="i6d784f536480496b91a28239972d7bc6" escape="true">NET INCOME PER SHARE</ix:nonNumeric></span></div><ix:continuation id="i6d784f536480496b91a28239972d7bc6"><ix:nonNumeric contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83Ni9mcmFnOjg5YzNkMDI5ODdiODQzNTY5MzMwMTdhYzEwNjlhNzkwL3RleHRyZWdpb246ODljM2QwMjk4N2I4NDM1NjkzMzAxN2FjMTA2OWE3OTBfOTY2_c42a2ade-7e36-4077-8778-d99ffd90f4c3" escape="true"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic and diluted net income per share was as follows:</span></div><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.169%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.473%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.474%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;Dollars in thousands, except per share amounts</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Basic net income per share:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83Ni9mcmFnOjg5YzNkMDI5ODdiODQzNTY5MzMwMTdhYzEwNjlhNzkwL3RhYmxlOmFiZmFhN2Q3YTg4ZTRhZDliMWFlMThiYjAxZWM2MWFhL3RhYmxlcmFuZ2U6YWJmYWE3ZDdhODhlNGFkOWIxYWUxOGJiMDFlYzYxYWFfMy0xLTEtMS0xODY4MjE_5c065027-8056-4d84-8ced-d6fcc7ba5aa2">24,226</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83Ni9mcmFnOjg5YzNkMDI5ODdiODQzNTY5MzMwMTdhYzEwNjlhNzkwL3RhYmxlOmFiZmFhN2Q3YTg4ZTRhZDliMWFlMThiYjAxZWM2MWFhL3RhYmxlcmFuZ2U6YWJmYWE3ZDdhODhlNGFkOWIxYWUxOGJiMDFlYzYxYWFfMy0zLTEtMS0xODY4MjE_57c5b32d-b333-48e8-b801-93ef93d9dfcd">32,901</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83Ni9mcmFnOjg5YzNkMDI5ODdiODQzNTY5MzMwMTdhYzEwNjlhNzkwL3RhYmxlOmFiZmFhN2Q3YTg4ZTRhZDliMWFlMThiYjAxZWM2MWFhL3RhYmxlcmFuZ2U6YWJmYWE3ZDdhODhlNGFkOWIxYWUxOGJiMDFlYzYxYWFfNC0xLTEtMS0xODY4MjE_e214a68c-96a7-4ffd-9126-cb1e347407cd">81,871</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83Ni9mcmFnOjg5YzNkMDI5ODdiODQzNTY5MzMwMTdhYzEwNjlhNzkwL3RhYmxlOmFiZmFhN2Q3YTg4ZTRhZDliMWFlMThiYjAxZWM2MWFhL3RhYmxlcmFuZ2U6YWJmYWE3ZDdhODhlNGFkOWIxYWUxOGJiMDFlYzYxYWFfNC0zLTEtMS0xODY4MjE_281bd6c5-e2ab-4181-8ef4-0e8767238f84">83,632</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic net income per common share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83Ni9mcmFnOjg5YzNkMDI5ODdiODQzNTY5MzMwMTdhYzEwNjlhNzkwL3RhYmxlOmFiZmFhN2Q3YTg4ZTRhZDliMWFlMThiYjAxZWM2MWFhL3RhYmxlcmFuZ2U6YWJmYWE3ZDdhODhlNGFkOWIxYWUxOGJiMDFlYzYxYWFfNi0xLTEtMS0xODY4MjE_974ffd0d-b916-4bbe-b1ff-5f3246780cdc">0.30</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83Ni9mcmFnOjg5YzNkMDI5ODdiODQzNTY5MzMwMTdhYzEwNjlhNzkwL3RhYmxlOmFiZmFhN2Q3YTg4ZTRhZDliMWFlMThiYjAxZWM2MWFhL3RhYmxlcmFuZ2U6YWJmYWE3ZDdhODhlNGFkOWIxYWUxOGJiMDFlYzYxYWFfNi0zLTEtMS0xODY4MjE_73e0f3bd-6510-461e-9de9-b53f8664dff3">0.39</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Diluted net income per share:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83Ni9mcmFnOjg5YzNkMDI5ODdiODQzNTY5MzMwMTdhYzEwNjlhNzkwL3RhYmxlOmFiZmFhN2Q3YTg4ZTRhZDliMWFlMThiYjAxZWM2MWFhL3RhYmxlcmFuZ2U6YWJmYWE3ZDdhODhlNGFkOWIxYWUxOGJiMDFlYzYxYWFfOS0xLTEtMS0xODY4MjE_e655bcd0-0dc3-4778-9fa1-5cd823fb88a5">24,226</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83Ni9mcmFnOjg5YzNkMDI5ODdiODQzNTY5MzMwMTdhYzEwNjlhNzkwL3RhYmxlOmFiZmFhN2Q3YTg4ZTRhZDliMWFlMThiYjAxZWM2MWFhL3RhYmxlcmFuZ2U6YWJmYWE3ZDdhODhlNGFkOWIxYWUxOGJiMDFlYzYxYWFfOS0zLTEtMS0xODY4MjE_8f9c8009-7179-4e7c-8cd3-cba930a4d6d1">32,901</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average common shares outstanding &#8212; Basic</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83Ni9mcmFnOjg5YzNkMDI5ODdiODQzNTY5MzMwMTdhYzEwNjlhNzkwL3RhYmxlOmFiZmFhN2Q3YTg4ZTRhZDliMWFlMThiYjAxZWM2MWFhL3RhYmxlcmFuZ2U6YWJmYWE3ZDdhODhlNGFkOWIxYWUxOGJiMDFlYzYxYWFfMTEtMS0xLTEtMTg2ODIx_39a2c038-05b8-4dcb-ab50-cc8338210015">81,871</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83Ni9mcmFnOjg5YzNkMDI5ODdiODQzNTY5MzMwMTdhYzEwNjlhNzkwL3RhYmxlOmFiZmFhN2Q3YTg4ZTRhZDliMWFlMThiYjAxZWM2MWFhL3RhYmxlcmFuZ2U6YWJmYWE3ZDdhODhlNGFkOWIxYWUxOGJiMDFlYzYxYWFfMTEtMy0xLTEtMTg2ODIx_5d1de476-9484-4acf-b877-e9ee2802fbdd">83,632</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect of dilutive securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock options and restricted stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83Ni9mcmFnOjg5YzNkMDI5ODdiODQzNTY5MzMwMTdhYzEwNjlhNzkwL3RhYmxlOmFiZmFhN2Q3YTg4ZTRhZDliMWFlMThiYjAxZWM2MWFhL3RhYmxlcmFuZ2U6YWJmYWE3ZDdhODhlNGFkOWIxYWUxOGJiMDFlYzYxYWFfMTMtMS0xLTEtMTg2ODIx_868bdff7-a5e4-406b-a838-20ae2e21807e">452</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83Ni9mcmFnOjg5YzNkMDI5ODdiODQzNTY5MzMwMTdhYzEwNjlhNzkwL3RhYmxlOmFiZmFhN2Q3YTg4ZTRhZDliMWFlMThiYjAxZWM2MWFhL3RhYmxlcmFuZ2U6YWJmYWE3ZDdhODhlNGFkOWIxYWUxOGJiMDFlYzYxYWFfMTMtMy0xLTEtMTg2ODIx_c8284742-b3fd-40d8-90d1-bb7ce4b9f2a5">644</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average common shares for diluted earnings per share</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83Ni9mcmFnOjg5YzNkMDI5ODdiODQzNTY5MzMwMTdhYzEwNjlhNzkwL3RhYmxlOmFiZmFhN2Q3YTg4ZTRhZDliMWFlMThiYjAxZWM2MWFhL3RhYmxlcmFuZ2U6YWJmYWE3ZDdhODhlNGFkOWIxYWUxOGJiMDFlYzYxYWFfMTQtMS0xLTEtMTg2ODIx_291bed3d-2543-4419-ae27-fa896cf63f3c">82,323</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83Ni9mcmFnOjg5YzNkMDI5ODdiODQzNTY5MzMwMTdhYzEwNjlhNzkwL3RhYmxlOmFiZmFhN2Q3YTg4ZTRhZDliMWFlMThiYjAxZWM2MWFhL3RhYmxlcmFuZ2U6YWJmYWE3ZDdhODhlNGFkOWIxYWUxOGJiMDFlYzYxYWFfMTQtMy0xLTEtMTg2ODIx_9136cde3-2af8-44df-873c-1d3f39e86842">84,276</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted net income per common share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83Ni9mcmFnOjg5YzNkMDI5ODdiODQzNTY5MzMwMTdhYzEwNjlhNzkwL3RhYmxlOmFiZmFhN2Q3YTg4ZTRhZDliMWFlMThiYjAxZWM2MWFhL3RhYmxlcmFuZ2U6YWJmYWE3ZDdhODhlNGFkOWIxYWUxOGJiMDFlYzYxYWFfMTYtMS0xLTEtMTg2ODIx_9e60f02f-9478-4395-bf7c-333ca5915460">0.29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83Ni9mcmFnOjg5YzNkMDI5ODdiODQzNTY5MzMwMTdhYzEwNjlhNzkwL3RhYmxlOmFiZmFhN2Q3YTg4ZTRhZDliMWFlMThiYjAxZWM2MWFhL3RhYmxlcmFuZ2U6YWJmYWE3ZDdhODhlNGFkOWIxYWUxOGJiMDFlYzYxYWFfMTYtMy0xLTEtMTg2ODIx_c92e6e64-8a3e-432d-92ef-6bed697e2e43">0.39</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Common stock of approximately <ix:nonFraction unitRef="shares" contextRef="i142beeb645c448e9b1d164dc7254fd2f_D20230331-20230331" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83Ni9mcmFnOjg5YzNkMDI5ODdiODQzNTY5MzMwMTdhYzEwNjlhNzkwL3RleHRyZWdpb246ODljM2QwMjk4N2I4NDM1NjkzMzAxN2FjMTA2OWE3OTBfMTE3_4ad27a12-8b15-4103-8482-b388ddc03b03">0.3</ix:nonFraction> million an</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d <ix:nonFraction unitRef="shares" contextRef="i646bea5fed00426299f8098e7755c18a_D20220331-20220331" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83Ni9mcmFnOjg5YzNkMDI5ODdiODQzNTY5MzMwMTdhYzEwNjlhNzkwL3RleHRyZWdpb246ODljM2QwMjk4N2I4NDM1NjkzMzAxN2FjMTA2OWE3OTBfMTI0_97e60589-3b23-42f9-9f00-5bdad57db242">0.2</ix:nonFraction> million shares at March&#160;31, 2023, and 2022, res</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">pectively that are issuable through exercise of dilutive securities were not included in the computation of diluted net income per share because their effect would have been anti-dilutive.</span></div></ix:continuation><div id="i5f1eb1bd01d541c3aa0777712077c048_79"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">14. <ix:nonNumeric contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" name="us-gaap:ComprehensiveIncomeNoteTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83OS9mcmFnOmFiMjU2ZTA0OTdmYTRiMjU5MmEwMTE1ZTE1MTY1YzA0L3RleHRyZWdpb246YWIyNTZlMDQ5N2ZhNGIyNTkyYTAxMTVlMTUxNjVjMDRfNDEz_adae3c85-5df9-40a5-86b0-494095d33a02" continuedAt="ie723ce88e4fd4e299c44636f099254f7" escape="true">ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)</ix:nonNumeric></span></div><ix:continuation id="ie723ce88e4fd4e299c44636f099254f7"><ix:nonNumeric contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" name="us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83OS9mcmFnOmFiMjU2ZTA0OTdmYTRiMjU5MmEwMTE1ZTE1MTY1YzA0L3RleHRyZWdpb246YWIyNTZlMDQ5N2ZhNGIyNTkyYTAxMTVlMTUxNjVjMDRfNDE1_98c28588-c1e8-4973-b65b-7563da2a4de1" escape="true"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Comprehensive income for the three months ended March 31, 2023 and 2022 was as follows:</span></div><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.122%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.498%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83OS9mcmFnOmFiMjU2ZTA0OTdmYTRiMjU5MmEwMTE1ZTE1MTY1YzA0L3RhYmxlOjMxYWVmZmJkNDIwNDRkMGNiNmE4ODg0MmI1YzNkMDAyL3RhYmxlcmFuZ2U6MzFhZWZmYmQ0MjA0NGQwY2I2YTg4ODQyYjVjM2QwMDJfMi0xLTEtMS0xODY4MjE_bdb73f57-cd2b-48a9-a402-d7f0cba3f18c">24,226</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83OS9mcmFnOmFiMjU2ZTA0OTdmYTRiMjU5MmEwMTE1ZTE1MTY1YzA0L3RhYmxlOjMxYWVmZmJkNDIwNDRkMGNiNmE4ODg0MmI1YzNkMDAyL3RhYmxlcmFuZ2U6MzFhZWZmYmQ0MjA0NGQwY2I2YTg4ODQyYjVjM2QwMDJfMi0zLTEtMS0xODY4MjE_0682ec87-f039-491b-920d-3aba1b1e136b">32,901</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83OS9mcmFnOmFiMjU2ZTA0OTdmYTRiMjU5MmEwMTE1ZTE1MTY1YzA0L3RhYmxlOjMxYWVmZmJkNDIwNDRkMGNiNmE4ODg0MmI1YzNkMDAyL3RhYmxlcmFuZ2U6MzFhZWZmYmQ0MjA0NGQwY2I2YTg4ODQyYjVjM2QwMDJfMy0xLTEtMS0xODY4MjE_c8fee2ed-da4d-4064-acc8-19f397efa9b9">4,076</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83OS9mcmFnOmFiMjU2ZTA0OTdmYTRiMjU5MmEwMTE1ZTE1MTY1YzA0L3RhYmxlOjMxYWVmZmJkNDIwNDRkMGNiNmE4ODg0MmI1YzNkMDAyL3RhYmxlcmFuZ2U6MzFhZWZmYmQ0MjA0NGQwY2I2YTg4ODQyYjVjM2QwMDJfMy0zLTEtMS0xODY4MjE_35050aa3-307a-4f23-908b-3abbabc8fa3f">5,683</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in unrealized loss/(gain) on derivatives, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83OS9mcmFnOmFiMjU2ZTA0OTdmYTRiMjU5MmEwMTE1ZTE1MTY1YzA0L3RhYmxlOjMxYWVmZmJkNDIwNDRkMGNiNmE4ODg0MmI1YzNkMDAyL3RhYmxlcmFuZ2U6MzFhZWZmYmQ0MjA0NGQwY2I2YTg4ODQyYjVjM2QwMDJfNC0xLTEtMS0xODY4MjE_e9dfa56a-d42d-49ee-8227-9cb094602195">7,377</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83OS9mcmFnOmFiMjU2ZTA0OTdmYTRiMjU5MmEwMTE1ZTE1MTY1YzA0L3RhYmxlOjMxYWVmZmJkNDIwNDRkMGNiNmE4ODg0MmI1YzNkMDAyL3RhYmxlcmFuZ2U6MzFhZWZmYmQ0MjA0NGQwY2I2YTg4ODQyYjVjM2QwMDJfNC0zLTEtMS0xODY4MjE_43b9d40f-8077-4c64-b1f9-83ca6a380d15">29,822</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pension liability adjustment, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83OS9mcmFnOmFiMjU2ZTA0OTdmYTRiMjU5MmEwMTE1ZTE1MTY1YzA0L3RhYmxlOjMxYWVmZmJkNDIwNDRkMGNiNmE4ODg0MmI1YzNkMDAyL3RhYmxlcmFuZ2U6MzFhZWZmYmQ0MjA0NGQwY2I2YTg4ODQyYjVjM2QwMDJfNS0xLTEtMS0xODY4MjE_92b64f0e-36a9-4b79-9dc3-e263eb36a2a7">103</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83OS9mcmFnOmFiMjU2ZTA0OTdmYTRiMjU5MmEwMTE1ZTE1MTY1YzA0L3RhYmxlOjMxYWVmZmJkNDIwNDRkMGNiNmE4ODg0MmI1YzNkMDAyL3RhYmxlcmFuZ2U6MzFhZWZmYmQ0MjA0NGQwY2I2YTg4ODQyYjVjM2QwMDJfNS0zLTEtMS0xODY4MjE_feeabd06-32e3-4d1a-9ba3-0602b5523541">9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Comprehensive income, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83OS9mcmFnOmFiMjU2ZTA0OTdmYTRiMjU5MmEwMTE1ZTE1MTY1YzA0L3RhYmxlOjMxYWVmZmJkNDIwNDRkMGNiNmE4ODg0MmI1YzNkMDAyL3RhYmxlcmFuZ2U6MzFhZWZmYmQ0MjA0NGQwY2I2YTg4ODQyYjVjM2QwMDJfNi0xLTEtMS0xODY4MjE_dc463c9c-f774-4a20-96f1-ab55f0f14c72">21,028</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83OS9mcmFnOmFiMjU2ZTA0OTdmYTRiMjU5MmEwMTE1ZTE1MTY1YzA0L3RhYmxlOjMxYWVmZmJkNDIwNDRkMGNiNmE4ODg0MmI1YzNkMDAyL3RhYmxlcmFuZ2U6MzFhZWZmYmQ0MjA0NGQwY2I2YTg4ODQyYjVjM2QwMDJfNi0zLTEtMS0xODY4MjE_6fec9c23-2c67-4d80-9e3a-90232a89ded3">57,031</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83OS9mcmFnOmFiMjU2ZTA0OTdmYTRiMjU5MmEwMTE1ZTE1MTY1YzA0L3RleHRyZWdpb246YWIyNTZlMDQ5N2ZhNGIyNTkyYTAxMTVlMTUxNjVjMDRfMzkz_f2f9c52b-6b0e-43a0-b1e3-8681edbaaf5e" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in accumulated other comprehensive income by component between December&#160;31, 2022 and March&#160;31, 2023 are presented in the table below, net of tax:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.747%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.287%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains and Losses on Derivatives</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Defined Benefit Pension Items</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Items</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at January 1, 2023</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id48bc317ce8e43efa6fa6cdb7b8520e9_I20221231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83OS9mcmFnOmFiMjU2ZTA0OTdmYTRiMjU5MmEwMTE1ZTE1MTY1YzA0L3RhYmxlOjJlMWNiM2FiMGVlMjQzMTBhMzJmNzFiMzAyZjM4NzdhL3RhYmxlcmFuZ2U6MmUxY2IzYWIwZWUyNDMxMGEzMmY3MWIzMDJmMzg3N2FfMS0yLTEtMS0xODY4MjE_51106af8-5ad0-4fe9-bc02-b909c926280a">22,817</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i290c54e5ab7c451886f952e89f0d495a_I20221231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83OS9mcmFnOmFiMjU2ZTA0OTdmYTRiMjU5MmEwMTE1ZTE1MTY1YzA0L3RhYmxlOjJlMWNiM2FiMGVlMjQzMTBhMzJmNzFiMzAyZjM4NzdhL3RhYmxlcmFuZ2U6MmUxY2IzYWIwZWUyNDMxMGEzMmY3MWIzMDJmMzg3N2FfMS00LTEtMS0xODY4MjE_18c90081-0453-4190-9a33-c06db0437980">9,322</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec175f17c95341d18708296b15afd58d_I20221231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83OS9mcmFnOmFiMjU2ZTA0OTdmYTRiMjU5MmEwMTE1ZTE1MTY1YzA0L3RhYmxlOjJlMWNiM2FiMGVlMjQzMTBhMzJmNzFiMzAyZjM4NzdhL3RhYmxlcmFuZ2U6MmUxY2IzYWIwZWUyNDMxMGEzMmY3MWIzMDJmMzg3N2FfMS02LTEtMS0xODY4MjE_c3989bd2-65e2-4f5c-9bb9-ea596246aa14">21,874</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia54b6095ce1949b680fbf6e3777f0cd1_I20221231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83OS9mcmFnOmFiMjU2ZTA0OTdmYTRiMjU5MmEwMTE1ZTE1MTY1YzA0L3RhYmxlOjJlMWNiM2FiMGVlMjQzMTBhMzJmNzFiMzAyZjM4NzdhL3RhYmxlcmFuZ2U6MmUxY2IzYWIwZWUyNDMxMGEzMmY3MWIzMDJmMzg3N2FfMS04LTEtMS0xODY4MjE_32dfc6b7-dbc0-47ff-b193-6fbbf92f9542">10,265</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive gain (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if10648f7e149447883c792b44180c76c_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83OS9mcmFnOmFiMjU2ZTA0OTdmYTRiMjU5MmEwMTE1ZTE1MTY1YzA0L3RhYmxlOjJlMWNiM2FiMGVlMjQzMTBhMzJmNzFiMzAyZjM4NzdhL3RhYmxlcmFuZ2U6MmUxY2IzYWIwZWUyNDMxMGEzMmY3MWIzMDJmMzg3N2FfMi0yLTEtMS0xODY4MjE_d1a2b1e3-6d1a-4d68-97d2-123021ef55d8">5,754</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24ac1f0514474ac28f44980dc2f162ce_D20230101-20230331" decimals="-3" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83OS9mcmFnOmFiMjU2ZTA0OTdmYTRiMjU5MmEwMTE1ZTE1MTY1YzA0L3RhYmxlOjJlMWNiM2FiMGVlMjQzMTBhMzJmNzFiMzAyZjM4NzdhL3RhYmxlcmFuZ2U6MmUxY2IzYWIwZWUyNDMxMGEzMmY3MWIzMDJmMzg3N2FfMi00LTEtMS0xODY4MjE_0c3972a2-6f47-4ba1-91bd-cfacf9f451b7">103</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9130414215c54f04be9fcc0ddd7ed89c_D20230101-20230331" decimals="-3" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83OS9mcmFnOmFiMjU2ZTA0OTdmYTRiMjU5MmEwMTE1ZTE1MTY1YzA0L3RhYmxlOjJlMWNiM2FiMGVlMjQzMTBhMzJmNzFiMzAyZjM4NzdhL3RhYmxlcmFuZ2U6MmUxY2IzYWIwZWUyNDMxMGEzMmY3MWIzMDJmMzg3N2FfMi02LTEtMS0xODY4MjE_b40abab9-00b2-43e6-8495-21ce7dbd0621">4,076</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83OS9mcmFnOmFiMjU2ZTA0OTdmYTRiMjU5MmEwMTE1ZTE1MTY1YzA0L3RhYmxlOjJlMWNiM2FiMGVlMjQzMTBhMzJmNzFiMzAyZjM4NzdhL3RhYmxlcmFuZ2U6MmUxY2IzYWIwZWUyNDMxMGEzMmY3MWIzMDJmMzg3N2FfMi04LTEtMS0xODY4MjE_5cc92d2c-c531-4a92-83b6-525ee3ed5ae8">1,575</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 21.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Amounts reclassified from accumulated other comprehensive income, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if10648f7e149447883c792b44180c76c_D20230101-20230331" decimals="-3" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83OS9mcmFnOmFiMjU2ZTA0OTdmYTRiMjU5MmEwMTE1ZTE1MTY1YzA0L3RhYmxlOjJlMWNiM2FiMGVlMjQzMTBhMzJmNzFiMzAyZjM4NzdhL3RhYmxlcmFuZ2U6MmUxY2IzYWIwZWUyNDMxMGEzMmY3MWIzMDJmMzg3N2FfMy0yLTEtMS0xODY4MjE_578ce76f-ba17-47b0-91cc-1a946e77c119">1,623</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24ac1f0514474ac28f44980dc2f162ce_D20230101-20230331" decimals="-3" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83OS9mcmFnOmFiMjU2ZTA0OTdmYTRiMjU5MmEwMTE1ZTE1MTY1YzA0L3RhYmxlOjJlMWNiM2FiMGVlMjQzMTBhMzJmNzFiMzAyZjM4NzdhL3RhYmxlcmFuZ2U6MmUxY2IzYWIwZWUyNDMxMGEzMmY3MWIzMDJmMzg3N2FfMy00LTEtMS0xODY4MjE_e2f37ba8-f34b-454f-93f7-5e10a767c41c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9130414215c54f04be9fcc0ddd7ed89c_D20230101-20230331" decimals="-3" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83OS9mcmFnOmFiMjU2ZTA0OTdmYTRiMjU5MmEwMTE1ZTE1MTY1YzA0L3RhYmxlOjJlMWNiM2FiMGVlMjQzMTBhMzJmNzFiMzAyZjM4NzdhL3RhYmxlcmFuZ2U6MmUxY2IzYWIwZWUyNDMxMGEzMmY3MWIzMDJmMzg3N2FfMy02LTEtMS0xODY4MjE_7adde660-3c28-4454-ac3f-5636681308e8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" decimals="-3" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83OS9mcmFnOmFiMjU2ZTA0OTdmYTRiMjU5MmEwMTE1ZTE1MTY1YzA0L3RhYmxlOjJlMWNiM2FiMGVlMjQzMTBhMzJmNzFiMzAyZjM4NzdhL3RhYmxlcmFuZ2U6MmUxY2IzYWIwZWUyNDMxMGEzMmY3MWIzMDJmMzg3N2FfMy04LTEtMS0xODY4MjE_9e39eff4-33fd-4749-a3e7-0c1eed440895">1,623</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 21.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net current-period other comprehensive gain (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if10648f7e149447883c792b44180c76c_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83OS9mcmFnOmFiMjU2ZTA0OTdmYTRiMjU5MmEwMTE1ZTE1MTY1YzA0L3RhYmxlOjJlMWNiM2FiMGVlMjQzMTBhMzJmNzFiMzAyZjM4NzdhL3RhYmxlcmFuZ2U6MmUxY2IzYWIwZWUyNDMxMGEzMmY3MWIzMDJmMzg3N2FfNC0yLTEtMS0xODY4MjE_152385fe-942c-4826-9000-76f258f3b06f">7,377</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24ac1f0514474ac28f44980dc2f162ce_D20230101-20230331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83OS9mcmFnOmFiMjU2ZTA0OTdmYTRiMjU5MmEwMTE1ZTE1MTY1YzA0L3RhYmxlOjJlMWNiM2FiMGVlMjQzMTBhMzJmNzFiMzAyZjM4NzdhL3RhYmxlcmFuZ2U6MmUxY2IzYWIwZWUyNDMxMGEzMmY3MWIzMDJmMzg3N2FfNC00LTEtMS0xODY4MjE_acff5440-a07c-4d87-b38f-6ab2e1347b50">103</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9130414215c54f04be9fcc0ddd7ed89c_D20230101-20230331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83OS9mcmFnOmFiMjU2ZTA0OTdmYTRiMjU5MmEwMTE1ZTE1MTY1YzA0L3RhYmxlOjJlMWNiM2FiMGVlMjQzMTBhMzJmNzFiMzAyZjM4NzdhL3RhYmxlcmFuZ2U6MmUxY2IzYWIwZWUyNDMxMGEzMmY3MWIzMDJmMzg3N2FfNC02LTEtMS0xODY4MjE_81425d53-0977-417f-83f6-3006aa809b18">4,076</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83OS9mcmFnOmFiMjU2ZTA0OTdmYTRiMjU5MmEwMTE1ZTE1MTY1YzA0L3RhYmxlOjJlMWNiM2FiMGVlMjQzMTBhMzJmNzFiMzAyZjM4NzdhL3RhYmxlcmFuZ2U6MmUxY2IzYWIwZWUyNDMxMGEzMmY3MWIzMDJmMzg3N2FfNC04LTEtMS0xODY4MjE_0d1914df-022e-4452-b713-5fc9663bef37">3,198</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at March&#160;31, 2023</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13b04fba956e41bc8127fdc101213375_I20230331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83OS9mcmFnOmFiMjU2ZTA0OTdmYTRiMjU5MmEwMTE1ZTE1MTY1YzA0L3RhYmxlOjJlMWNiM2FiMGVlMjQzMTBhMzJmNzFiMzAyZjM4NzdhL3RhYmxlcmFuZ2U6MmUxY2IzYWIwZWUyNDMxMGEzMmY3MWIzMDJmMzg3N2FfNS0yLTEtMS0xODY4MjE_3a9958b1-ceab-4961-a74c-27edde27f33f">15,440</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i805ec6ae450148b0aa6ec4a436b8b09e_I20230331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83OS9mcmFnOmFiMjU2ZTA0OTdmYTRiMjU5MmEwMTE1ZTE1MTY1YzA0L3RhYmxlOjJlMWNiM2FiMGVlMjQzMTBhMzJmNzFiMzAyZjM4NzdhL3RhYmxlcmFuZ2U6MmUxY2IzYWIwZWUyNDMxMGEzMmY3MWIzMDJmMzg3N2FfNS00LTEtMS0xODY4MjE_4dca5ff0-c2bc-401d-ade0-a5e1b393e778">9,425</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6afed391e44e4f1f965479a68ca6dcb5_I20230331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83OS9mcmFnOmFiMjU2ZTA0OTdmYTRiMjU5MmEwMTE1ZTE1MTY1YzA0L3RhYmxlOjJlMWNiM2FiMGVlMjQzMTBhMzJmNzFiMzAyZjM4NzdhL3RhYmxlcmFuZ2U6MmUxY2IzYWIwZWUyNDMxMGEzMmY3MWIzMDJmMzg3N2FfNS02LTEtMS0xODY4MjE_59030dd8-52fb-41eb-811d-f9108937b2ef">17,798</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied07d9963f9d439fb1ad815102c390d4_I20230331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83OS9mcmFnOmFiMjU2ZTA0OTdmYTRiMjU5MmEwMTE1ZTE1MTY1YzA0L3RhYmxlOjJlMWNiM2FiMGVlMjQzMTBhMzJmNzFiMzAyZjM4NzdhL3RhYmxlcmFuZ2U6MmUxY2IzYWIwZWUyNDMxMGEzMmY3MWIzMDJmMzg3N2FfNS04LTEtMS0xODY4MjE_c4215315-1970-4bc7-8d84-59df88f1c6f1">7,067</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March 31, 2023, the Company reclassified a gain of $<ix:nonFraction unitRef="usd" contextRef="icf3a5e50a53a4b55a3ef05b821846b94_D20230101-20230331" decimals="-5" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83OS9mcmFnOmFiMjU2ZTA0OTdmYTRiMjU5MmEwMTE1ZTE1MTY1YzA0L3RleHRyZWdpb246YWIyNTZlMDQ5N2ZhNGIyNTkyYTAxMTVlMTUxNjVjMDRfMjc3_03ccb4eb-0ad6-412d-9704-2227554f8af3">4.3</ix:nonFraction> million and a loss of $<ix:nonFraction unitRef="usd" contextRef="if45e5d60245d47f7835ea2adf65836fa_D20230101-20230331" decimals="-5" sign="-" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83OS9mcmFnOmFiMjU2ZTA0OTdmYTRiMjU5MmEwMTE1ZTE1MTY1YzA0L3RleHRyZWdpb246YWIyNTZlMDQ5N2ZhNGIyNTkyYTAxMTVlMTUxNjVjMDRfMjk0_db2cf03b-e06c-4f7b-afd5-85d23e4ffcb1">2.7</ix:nonFraction> million from accumulated other comprehensive income to other income, net and interest income, respectively.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><div id="i5f1eb1bd01d541c3aa0777712077c048_82"></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (continued) </span></div></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">15. <ix:nonNumeric contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84Mi9mcmFnOjIwZmFlOTU4ZjI1MTQ4NGRhOWY1YjY1YWM4NDcwM2JkL3RleHRyZWdpb246MjBmYWU5NThmMjUxNDg0ZGE5ZjViNjVhYzg0NzAzYmRfMjQ3Mg_8d118a4f-6fd6-4a42-99a1-1fb654f6c015" continuedAt="i0fc967f9cade4d8f9c5f0b17b15e43ae" escape="true">SEGMENT AND GEOGRAPHIC INFORMATION</ix:nonNumeric></span></div><ix:continuation id="i0fc967f9cade4d8f9c5f0b17b15e43ae"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company internally manages&#160;<ix:nonFraction unitRef="segment" contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84Mi9mcmFnOjIwZmFlOTU4ZjI1MTQ4NGRhOWY1YjY1YWM4NDcwM2JkL3RleHRyZWdpb246MjBmYWU5NThmMjUxNDg0ZGE5ZjViNjVhYzg0NzAzYmRfNzU_23e59eac-ac3e-4e4e-853d-93d1860389f5">two</ix:nonFraction>&#160;global reportable segments and reports the results of its businesses to its chief operating decision maker. The&#160;<ix:nonFraction unitRef="segment" contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84Mi9mcmFnOjIwZmFlOTU4ZjI1MTQ4NGRhOWY1YjY1YWM4NDcwM2JkL3RleHRyZWdpb246MjBmYWU5NThmMjUxNDg0ZGE5ZjViNjVhYzg0NzAzYmRfMTkw_41735c44-41e4-44e5-990c-f37176f5ee1d">two</ix:nonFraction>&#160;reportable segments and their activities are described below.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Codman Specialty Surgical segment includes (i) the Neurosurgery business, which sells a full line of products for neurosurgery and neuro critical care such as tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment and (ii) the Instruments business, which sells more than <ix:nonFraction unitRef="product" contextRef="ifd59456ea9aa4f04b19628e881f264f6_D20230101-20230331" decimals="INF" name="iart:SegmentReportingInformationNumberOfProductsOffered" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84Mi9mcmFnOjIwZmFlOTU4ZjI1MTQ4NGRhOWY1YjY1YWM4NDcwM2JkL3RleHRyZWdpb246MjBmYWU5NThmMjUxNDg0ZGE5ZjViNjVhYzg0NzAzYmRfNzQ0_3647e991-e7c3-469e-876d-93f2ac84569a">40,000</ix:nonFraction> instrument patterns and surgical and lighting products to hospitals, surgery centers, dental, podiatry, and veterinary offices.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.15pt">The TT segment includes such offerings as skin and wound repair, plastics &amp; surgical reconstruction products, bone grafts, and nerve and tendon repair products.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Corporate and other category includes (i) various executive, finance, human resource, information systems and legal functions, (ii) brand management, and (iii) share-based compensation costs.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The operating results of the various reportable segments as presented are not comparable to one another because (i)&#160;certain operating segments are more dependent than others on corporate functions for unallocated general and administrative and/or operational manufacturing functions, and (ii)&#160;the Company does not allocate certain manufacturing costs and general and administrative costs to the operating segment results. <ix:nonNumeric contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84Mi9mcmFnOjIwZmFlOTU4ZjI1MTQ4NGRhOWY1YjY1YWM4NDcwM2JkL3RleHRyZWdpb246MjBmYWU5NThmMjUxNDg0ZGE5ZjViNjVhYzg0NzAzYmRfMjQ2OA_b4e87798-556d-41df-96d6-c4fa11582248" continuedAt="i9eb8cd6cedfc4a10be23e3045d6a474a" escape="true">Net sales and profit by each reportable segment for the three months ended March&#160;31, 2023 and 2022 are as follows:</ix:nonNumeric></span></div><div style="margin-bottom:12pt;margin-top:12pt"><ix:continuation id="i9eb8cd6cedfc4a10be23e3045d6a474a" continuedAt="i3e999f7fdfc84af887b0902af9bf9af5"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.859%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.128%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.129%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Segment Net Sales</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Codman Specialty Surgical</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd59456ea9aa4f04b19628e881f264f6_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84Mi9mcmFnOjIwZmFlOTU4ZjI1MTQ4NGRhOWY1YjY1YWM4NDcwM2JkL3RhYmxlOmE4NmYxMDZkMmQ2MjQ2Y2Y4MjJiY2M5ZmQ5MzExYTY0L3RhYmxlcmFuZ2U6YTg2ZjEwNmQyZDYyNDZjZjgyMmJjYzlmZDkzMTFhNjRfMy0xLTEtMS0xODY4MjE_d8080fb1-e443-4930-a9c6-c6c718ccde1d">248,136</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6524a64fd30c42eca0a31257f157eeec_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84Mi9mcmFnOjIwZmFlOTU4ZjI1MTQ4NGRhOWY1YjY1YWM4NDcwM2JkL3RhYmxlOmE4NmYxMDZkMmQ2MjQ2Y2Y4MjJiY2M5ZmQ5MzExYTY0L3RhYmxlcmFuZ2U6YTg2ZjEwNmQyZDYyNDZjZjgyMmJjYzlmZDkzMTFhNjRfMy0zLTEtMS0xODY4MjE_070940e3-54e8-4ce1-b221-c6472aeedf4b">247,308</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Tissue Technologies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"> </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcfddd0c2c684ea4acbf2b9ae4cd8527_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84Mi9mcmFnOjIwZmFlOTU4ZjI1MTQ4NGRhOWY1YjY1YWM4NDcwM2JkL3RhYmxlOmE4NmYxMDZkMmQ2MjQ2Y2Y4MjJiY2M5ZmQ5MzExYTY0L3RhYmxlcmFuZ2U6YTg2ZjEwNmQyZDYyNDZjZjgyMmJjYzlmZDkzMTFhNjRfNC0xLTEtMS0xODY4MjE_cbfd9dd7-fa66-4c78-9c0b-a5294628ae9d">132,710</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i842208849e5d47b588209f3a26f3a724_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84Mi9mcmFnOjIwZmFlOTU4ZjI1MTQ4NGRhOWY1YjY1YWM4NDcwM2JkL3RhYmxlOmE4NmYxMDZkMmQ2MjQ2Y2Y4MjJiY2M5ZmQ5MzExYTY0L3RhYmxlcmFuZ2U6YTg2ZjEwNmQyZDYyNDZjZjgyMmJjYzlmZDkzMTFhNjRfNC0zLTEtMS0xODY4MjE_866b5287-e7b4-4967-8133-daf47c78c540">129,330</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84Mi9mcmFnOjIwZmFlOTU4ZjI1MTQ4NGRhOWY1YjY1YWM4NDcwM2JkL3RhYmxlOmE4NmYxMDZkMmQ2MjQ2Y2Y4MjJiY2M5ZmQ5MzExYTY0L3RhYmxlcmFuZ2U6YTg2ZjEwNmQyZDYyNDZjZjgyMmJjYzlmZDkzMTFhNjRfNS0xLTEtMS0xODY4MjE_dc6fe96c-c11e-48be-aace-6231dc9930ba">380,846</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84Mi9mcmFnOjIwZmFlOTU4ZjI1MTQ4NGRhOWY1YjY1YWM4NDcwM2JkL3RhYmxlOmE4NmYxMDZkMmQ2MjQ2Y2Y4MjJiY2M5ZmQ5MzExYTY0L3RhYmxlcmFuZ2U6YTg2ZjEwNmQyZDYyNDZjZjgyMmJjYzlmZDkzMTFhNjRfNS0zLTEtMS0xODY4MjE_dfde4fd0-baee-4968-8216-254defb8602e">376,638</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Segment Profit </span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Codman Specialty Surgical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9189a78d31fb4c448c4078f016f511fb_D20230101-20230331" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84Mi9mcmFnOjIwZmFlOTU4ZjI1MTQ4NGRhOWY1YjY1YWM4NDcwM2JkL3RhYmxlOmE4NmYxMDZkMmQ2MjQ2Y2Y4MjJiY2M5ZmQ5MzExYTY0L3RhYmxlcmFuZ2U6YTg2ZjEwNmQyZDYyNDZjZjgyMmJjYzlmZDkzMTFhNjRfNy0xLTEtMS0xODY4MjE_2c1d384c-ba45-4b7b-9782-b2149f9cd8a2">110,933</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21203583e6274aefacecda4e30af7977_D20220101-20220331" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84Mi9mcmFnOjIwZmFlOTU4ZjI1MTQ4NGRhOWY1YjY1YWM4NDcwM2JkL3RhYmxlOmE4NmYxMDZkMmQ2MjQ2Y2Y4MjJiY2M5ZmQ5MzExYTY0L3RhYmxlcmFuZ2U6YTg2ZjEwNmQyZDYyNDZjZjgyMmJjYzlmZDkzMTFhNjRfNy0zLTEtMS0xODY4MjE_ca5a4c21-0931-4c0a-939f-cfbb60fd846f">110,160</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Tissue Technologies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"> </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb29c4fb3257468aba668e88d86534f1_D20230101-20230331" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84Mi9mcmFnOjIwZmFlOTU4ZjI1MTQ4NGRhOWY1YjY1YWM4NDcwM2JkL3RhYmxlOmE4NmYxMDZkMmQ2MjQ2Y2Y4MjJiY2M5ZmQ5MzExYTY0L3RhYmxlcmFuZ2U6YTg2ZjEwNmQyZDYyNDZjZjgyMmJjYzlmZDkzMTFhNjRfOC0xLTEtMS0xODY4MjE_d72b2895-5edb-4075-981a-f851e1947f39">52,281</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66b66534a77f456aaf743a7fb2ed1e05_D20220101-20220331" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84Mi9mcmFnOjIwZmFlOTU4ZjI1MTQ4NGRhOWY1YjY1YWM4NDcwM2JkL3RhYmxlOmE4NmYxMDZkMmQ2MjQ2Y2Y4MjJiY2M5ZmQ5MzExYTY0L3RhYmxlcmFuZ2U6YTg2ZjEwNmQyZDYyNDZjZjgyMmJjYzlmZDkzMTFhNjRfOC0zLTEtMS0xODY4MjE_8d621c48-c277-485a-a5de-5d6dbd976138">53,893</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Segment profit</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia720faaba52b43d2be21584d13ecec2a_D20230101-20230331" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84Mi9mcmFnOjIwZmFlOTU4ZjI1MTQ4NGRhOWY1YjY1YWM4NDcwM2JkL3RhYmxlOmE4NmYxMDZkMmQ2MjQ2Y2Y4MjJiY2M5ZmQ5MzExYTY0L3RhYmxlcmFuZ2U6YTg2ZjEwNmQyZDYyNDZjZjgyMmJjYzlmZDkzMTFhNjRfOS0xLTEtMS0xODY4MjE_4a2cbf05-71a2-40b9-be72-35d989fe0efb">163,214</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1c1895e254b42068cd689b2d2e0cb17_D20220101-20220331" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84Mi9mcmFnOjIwZmFlOTU4ZjI1MTQ4NGRhOWY1YjY1YWM4NDcwM2JkL3RhYmxlOmE4NmYxMDZkMmQ2MjQ2Y2Y4MjJiY2M5ZmQ5MzExYTY0L3RhYmxlcmFuZ2U6YTg2ZjEwNmQyZDYyNDZjZjgyMmJjYzlmZDkzMTFhNjRfOS0zLTEtMS0xODY4MjE_1f26489c-6860-4dc1-9141-66aaca29ebdc">164,053</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84Mi9mcmFnOjIwZmFlOTU4ZjI1MTQ4NGRhOWY1YjY1YWM4NDcwM2JkL3RhYmxlOmE4NmYxMDZkMmQ2MjQ2Y2Y4MjJiY2M5ZmQ5MzExYTY0L3RhYmxlcmFuZ2U6YTg2ZjEwNmQyZDYyNDZjZjgyMmJjYzlmZDkzMTFhNjRfMTAtMS0xLTEtMTg2ODIx_f10897a0-5864-4866-abcd-c640e6c5bcb5">3,108</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84Mi9mcmFnOjIwZmFlOTU4ZjI1MTQ4NGRhOWY1YjY1YWM4NDcwM2JkL3RhYmxlOmE4NmYxMDZkMmQ2MjQ2Y2Y4MjJiY2M5ZmQ5MzExYTY0L3RhYmxlcmFuZ2U6YTg2ZjEwNmQyZDYyNDZjZjgyMmJjYzlmZDkzMTFhNjRfMTAtMy0xLTEtMTg2ODIx_a858fe3f-3ab6-466a-b7db-f0928325010a">3,894</ix:nonFraction>)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iecf751356922485386ff472a954f4b37_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84Mi9mcmFnOjIwZmFlOTU4ZjI1MTQ4NGRhOWY1YjY1YWM4NDcwM2JkL3RhYmxlOmE4NmYxMDZkMmQ2MjQ2Y2Y4MjJiY2M5ZmQ5MzExYTY0L3RhYmxlcmFuZ2U6YTg2ZjEwNmQyZDYyNDZjZjgyMmJjYzlmZDkzMTFhNjRfMTEtMS0xLTEtMTg2ODIx_ca8a4b04-e389-4d34-90f5-586a47cba7d9">123,724</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if9b97ade31164041b7058022a9eb48a9_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84Mi9mcmFnOjIwZmFlOTU4ZjI1MTQ4NGRhOWY1YjY1YWM4NDcwM2JkL3RhYmxlOmE4NmYxMDZkMmQ2MjQ2Y2Y4MjJiY2M5ZmQ5MzExYTY0L3RhYmxlcmFuZ2U6YTg2ZjEwNmQyZDYyNDZjZjgyMmJjYzlmZDkzMTFhNjRfMTEtMy0xLTEtMTg2ODIx_48281b35-94e6-4ee3-9756-897accacbd80">113,995</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating income</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84Mi9mcmFnOjIwZmFlOTU4ZjI1MTQ4NGRhOWY1YjY1YWM4NDcwM2JkL3RhYmxlOmE4NmYxMDZkMmQ2MjQ2Y2Y4MjJiY2M5ZmQ5MzExYTY0L3RhYmxlcmFuZ2U6YTg2ZjEwNmQyZDYyNDZjZjgyMmJjYzlmZDkzMTFhNjRfMTItMS0xLTEtMTg2ODIx_84dddb45-7303-4a40-847a-c9e5940848db">36,382</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84Mi9mcmFnOjIwZmFlOTU4ZjI1MTQ4NGRhOWY1YjY1YWM4NDcwM2JkL3RhYmxlOmE4NmYxMDZkMmQ2MjQ2Y2Y4MjJiY2M5ZmQ5MzExYTY0L3RhYmxlcmFuZ2U6YTg2ZjEwNmQyZDYyNDZjZjgyMmJjYzlmZDkzMTFhNjRfMTItMy0xLTEtMTg2ODIx_9097b613-aacd-4c25-9b39-cf1606027088">46,164</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company does not allocate any assets to the reportable segments. No asset information is reported to the chief operating decision maker and disclosed in the financial information for each segment. The Company attributes revenues to geographic areas based on the location of the customer. <ix:continuation id="i3e999f7fdfc84af887b0902af9bf9af5" continuedAt="if9ab65eb4d5e411da2d355c553e235e9">Total revenue by major geographic area consisted of the following:</ix:continuation></span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><ix:continuation id="if9ab65eb4d5e411da2d355c553e235e9"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.274%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.420%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.422%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ec4e98c494d4152959a7ad4e62f2cdc_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84Mi9mcmFnOjIwZmFlOTU4ZjI1MTQ4NGRhOWY1YjY1YWM4NDcwM2JkL3RhYmxlOjA2MjY5MTc2NWU1ODRlNDA4M2M5ZDBjNzY4NDFlMzRjL3RhYmxlcmFuZ2U6MDYyNjkxNzY1ZTU4NGU0MDgzYzlkMGM3Njg0MWUzNGNfMi0xLTEtMS0xODY4MjE_7e0a5c43-e4d1-4439-b6a3-18f77c114b7d">271,002</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c11bb731e264ce287a9ba4be5cf11c6_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84Mi9mcmFnOjIwZmFlOTU4ZjI1MTQ4NGRhOWY1YjY1YWM4NDcwM2JkL3RhYmxlOjA2MjY5MTc2NWU1ODRlNDA4M2M5ZDBjNzY4NDFlMzRjL3RhYmxlcmFuZ2U6MDYyNjkxNzY1ZTU4NGU0MDgzYzlkMGM3Njg0MWUzNGNfMi0zLTEtMS0xODY4MjE_546a01bb-d423-497d-ae74-114a1b76e77b">263,351</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07f997c575a845b49f6c85d88adbf303_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84Mi9mcmFnOjIwZmFlOTU4ZjI1MTQ4NGRhOWY1YjY1YWM4NDcwM2JkL3RhYmxlOjA2MjY5MTc2NWU1ODRlNDA4M2M5ZDBjNzY4NDFlMzRjL3RhYmxlcmFuZ2U6MDYyNjkxNzY1ZTU4NGU0MDgzYzlkMGM3Njg0MWUzNGNfMy0xLTEtMS0xODY4MjE_9b1797fd-29b8-42f1-b49d-0ae18b102f20">41,064</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7f5c4fd7cee463ca7ad0e86dbcbc6b6_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84Mi9mcmFnOjIwZmFlOTU4ZjI1MTQ4NGRhOWY1YjY1YWM4NDcwM2JkL3RhYmxlOjA2MjY5MTc2NWU1ODRlNDA4M2M5ZDBjNzY4NDFlMzRjL3RhYmxlcmFuZ2U6MDYyNjkxNzY1ZTU4NGU0MDgzYzlkMGM3Njg0MWUzNGNfMy0zLTEtMS0xODY4MjE_60337cd7-ca27-4117-93c7-623f5e7c9249">43,744</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Asia Pacific</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8b5c9cc0fb140aaa998a0d5849918a1_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84Mi9mcmFnOjIwZmFlOTU4ZjI1MTQ4NGRhOWY1YjY1YWM4NDcwM2JkL3RhYmxlOjA2MjY5MTc2NWU1ODRlNDA4M2M5ZDBjNzY4NDFlMzRjL3RhYmxlcmFuZ2U6MDYyNjkxNzY1ZTU4NGU0MDgzYzlkMGM3Njg0MWUzNGNfNC0xLTEtMS0xODY4MjE_ee077826-40e4-439c-875c-994925397438">50,473</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f5d773def504f108c920a0391f44968_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84Mi9mcmFnOjIwZmFlOTU4ZjI1MTQ4NGRhOWY1YjY1YWM4NDcwM2JkL3RhYmxlOjA2MjY5MTc2NWU1ODRlNDA4M2M5ZDBjNzY4NDFlMzRjL3RhYmxlcmFuZ2U6MDYyNjkxNzY1ZTU4NGU0MDgzYzlkMGM3Njg0MWUzNGNfNC0zLTEtMS0xODY4MjE_41a6624c-53d1-461b-9450-56d31b872c38">47,717</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idceeee4c12c44c50b93f23c34fdf4267_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84Mi9mcmFnOjIwZmFlOTU4ZjI1MTQ4NGRhOWY1YjY1YWM4NDcwM2JkL3RhYmxlOjA2MjY5MTc2NWU1ODRlNDA4M2M5ZDBjNzY4NDFlMzRjL3RhYmxlcmFuZ2U6MDYyNjkxNzY1ZTU4NGU0MDgzYzlkMGM3Njg0MWUzNGNfNS0xLTEtMS0xODY4MjE_b3fdd581-e22e-42cb-bf7f-2d8f4edfd5c4">18,307</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa37c54d794549a99aea38389a6d9606_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84Mi9mcmFnOjIwZmFlOTU4ZjI1MTQ4NGRhOWY1YjY1YWM4NDcwM2JkL3RhYmxlOjA2MjY5MTc2NWU1ODRlNDA4M2M5ZDBjNzY4NDFlMzRjL3RhYmxlcmFuZ2U6MDYyNjkxNzY1ZTU4NGU0MDgzYzlkMGM3Njg0MWUzNGNfNS0zLTEtMS0xODY4MjE_89ad6541-2d76-4aec-bb0f-ad62d44875eb">21,826</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84Mi9mcmFnOjIwZmFlOTU4ZjI1MTQ4NGRhOWY1YjY1YWM4NDcwM2JkL3RhYmxlOjA2MjY5MTc2NWU1ODRlNDA4M2M5ZDBjNzY4NDFlMzRjL3RhYmxlcmFuZ2U6MDYyNjkxNzY1ZTU4NGU0MDgzYzlkMGM3Njg0MWUzNGNfNi0xLTEtMS0xODY4MjE_4c61499d-099e-4186-b8f4-939b6e2fd413">380,846</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84Mi9mcmFnOjIwZmFlOTU4ZjI1MTQ4NGRhOWY1YjY1YWM4NDcwM2JkL3RhYmxlOjA2MjY5MTc2NWU1ODRlNDA4M2M5ZDBjNzY4NDFlMzRjL3RhYmxlcmFuZ2U6MDYyNjkxNzY1ZTU4NGU0MDgzYzlkMGM3Njg0MWUzNGNfNi0zLTEtMS0xODY4MjE_069d9676-8dd5-427a-8c52-8259fba88ffa">376,638</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div></ix:continuation><div id="i5f1eb1bd01d541c3aa0777712077c048_85"></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">16.&#160;<ix:nonNumeric contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RleHRyZWdpb246NDU3ZTAzOThiNGM2NDJjZGFhNGU3M2I3N2E2NGEyZjJfNDE2OA_da3fcce8-e1f7-4f36-a081-cc2458a09e75" continuedAt="ia6c13ce31c0c461384e983a8166a465c" escape="true">COMMITMENTS AND CONTINGENCIES</ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ia6c13ce31c0c461384e983a8166a465c" continuedAt="i42541f08b7fe4d28925669be93b257f1">In consideration for certain technology, manufacturing, distribution, and selling rights and licenses granted to the Company, the Company has agreed to pay royalties on sales of certain products that it sells. The royalty payments that the Company made under these agreements were not significant for any of the periods presented.</ix:continuation></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (continued) </span></div></div><ix:continuation id="i42541f08b7fe4d28925669be93b257f1" continuedAt="ieb274f93954e417ea161bf87f2e7b080"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to various claims, lawsuits and proceedings in the ordinary course of the Company's business, including claims by current or former employees, distributors and competitors and with respect to its products and product liability claims, lawsuits and proceedings, some of which have been settled by the Company. In the opinion of management, such claims are either adequately covered by insurance or otherwise indemnified, or are not expected, individually or in the aggregate, to result in a material, adverse effect on the Company's financial condition. However, it is possible that the Company's results of operations, financial position and cash flows in a particular period could be materially affected by these contingencies.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accrues for loss contingencies when it is deemed probable that a loss has been incurred and that loss is estimable. The amounts accrued are based on the full amount of the estimated loss before considering insurance proceeds and do not include an estimate for legal fees expected to be incurred in connection with the loss contingency. The Company consistently accrues legal fees expected to be incurred in connection with loss contingencies as those fees are incurred by outside counsel as a period cost.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contingent Consideration</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determined the fair value of contingent consideration during the three month period ended March&#160;31, 2023 and March&#160;31, 2022 to reflect the change in estimate, additions, payments, transfers and the time value of money during the period.</span></div><ix:nonNumeric contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RleHRyZWdpb246NDU3ZTAzOThiNGM2NDJjZGFhNGU3M2I3N2E2NGEyZjJfNDE3OQ_e02cecfe-6caf-4891-b1d2-ee99d66cbf28" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the opening balances to the closing balances of these Level 3 measurements for the three months ended March 31, 2023 and March&#160;31, 2022 is as follows (in thousands):</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"><tr><td style="width:1.0%"></td><td style="width:18.988%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.390%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.319%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.390%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.876%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.390%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.535%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.390%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.024%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.390%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:7.319%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.390%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.319%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.390%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.319%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.390%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.681%"></td><td style="width:0.1%"></td></tr><tr style="height:29pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Contingent Consideration Liability Related to Acquisition of:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:29pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Arkis</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location in Financial Statements</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derma Sciences</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ACell</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Surgical Innovations Associates, Inc. (FN 2)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location in Financial Statements</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Short-term</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Short-term</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of January 1, 2023</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifcaf924eb8b044b5959cc99978a303a7_I20221231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RhYmxlOjcyZmViOGYzOWI0ZjQzMjE4YmJlYWIxNjE3OGJlNTU2L3RhYmxlcmFuZ2U6NzJmZWI4ZjM5YjRmNDMyMThiYmVhYjE2MTc4YmU1NTZfMy0yLTEtMS0xODY4MjE_c620a907-84c6-4a3d-b230-f4efe78f3bd9">2,845</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8389bf8a7d824c2980154809fed6d74d_I20221231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RhYmxlOjcyZmViOGYzOWI0ZjQzMjE4YmJlYWIxNjE3OGJlNTU2L3RhYmxlcmFuZ2U6NzJmZWI4ZjM5YjRmNDMyMThiYmVhYjE2MTc4YmU1NTZfMy00LTEtMS0xODY4MjE_41024449-62a0-413a-9007-a2ec3869a067">10,050</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87b4b1d7730e401b9ab2ced0eb01926f_I20221231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RhYmxlOjcyZmViOGYzOWI0ZjQzMjE4YmJlYWIxNjE3OGJlNTU2L3RhYmxlcmFuZ2U6NzJmZWI4ZjM5YjRmNDMyMThiYmVhYjE2MTc4YmU1NTZfMy04LTEtMS0xODY4MjE_7249e3c2-f391-4e33-b01b-820f3fcc9ddf">230</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2ebabea23ce4ed1b68823b3506d6cee_I20221231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RhYmxlOjcyZmViOGYzOWI0ZjQzMjE4YmJlYWIxNjE3OGJlNTU2L3RhYmxlcmFuZ2U6NzJmZWI4ZjM5YjRmNDMyMThiYmVhYjE2MTc4YmU1NTZfMy0xMi0xLTEtMTg2ODIx_63463b9f-5813-48b6-aed3-8cffc19bb5a4">3,700</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35632a429f994b4c93a6bf032cf1dab3_I20221231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RhYmxlOjcyZmViOGYzOWI0ZjQzMjE4YmJlYWIxNjE3OGJlNTU2L3RhYmxlcmFuZ2U6NzJmZWI4ZjM5YjRmNDMyMThiYmVhYjE2MTc4YmU1NTZfMy0xMy0xLTEtMjAzOTIy_572bb328-61d3-4384-80ab-470c870dd1ac">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28c09119df4d46479f028692c5abc6c9_I20221231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RhYmxlOjcyZmViOGYzOWI0ZjQzMjE4YmJlYWIxNjE3OGJlNTU2L3RhYmxlcmFuZ2U6NzJmZWI4ZjM5YjRmNDMyMThiYmVhYjE2MTc4YmU1NTZfMy0xMy0xLTEtMTkyNDc4_d21cd14d-99a1-458a-a603-a4eab8097405">57,607</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transfers</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebe056bf287c49189659a150fa4bb005_D20230101-20230331" decimals="-3" name="iart:FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RhYmxlOjcyZmViOGYzOWI0ZjQzMjE4YmJlYWIxNjE3OGJlNTU2L3RhYmxlcmFuZ2U6NzJmZWI4ZjM5YjRmNDMyMThiYmVhYjE2MTc4YmU1NTZfNC0yLTEtMS0xODY4MjE_6b830650-4227-43d5-b686-37a2d8260e46">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie94f070e4ad14a71bbd6d5a287488485_D20230101-20230331" decimals="-3" name="iart:FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RhYmxlOjcyZmViOGYzOWI0ZjQzMjE4YmJlYWIxNjE3OGJlNTU2L3RhYmxlcmFuZ2U6NzJmZWI4ZjM5YjRmNDMyMThiYmVhYjE2MTc4YmU1NTZfNC00LTEtMS0xODY4MjE_40cf116d-1c54-48bb-b7cd-1c35465460fb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5212f8a1bee4dc6ba5f12945bceefac_D20230101-20230331" decimals="-3" name="iart:FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RhYmxlOjcyZmViOGYzOWI0ZjQzMjE4YmJlYWIxNjE3OGJlNTU2L3RhYmxlcmFuZ2U6NzJmZWI4ZjM5YjRmNDMyMThiYmVhYjE2MTc4YmU1NTZfNC04LTEtMS0xODY4MjE_36261f63-cd80-4ebb-8770-d3fa58703c0b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b996d3591a14f7b8ad05792e133d08b_D20230101-20230331" decimals="-3" name="iart:FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RhYmxlOjcyZmViOGYzOWI0ZjQzMjE4YmJlYWIxNjE3OGJlNTU2L3RhYmxlcmFuZ2U6NzJmZWI4ZjM5YjRmNDMyMThiYmVhYjE2MTc4YmU1NTZfNC0xMi0xLTEtMTg2ODIx_81189c6e-a0de-4eba-a1ba-30eae0e15b94">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76cdb8918dd040ca80187c0cd9780d22_D20230101-20230331" decimals="-3" name="iart:FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RhYmxlOjcyZmViOGYzOWI0ZjQzMjE4YmJlYWIxNjE3OGJlNTU2L3RhYmxlcmFuZ2U6NzJmZWI4ZjM5YjRmNDMyMThiYmVhYjE2MTc4YmU1NTZfNC0xMy0xLTEtMjAwNzk0_2ee2bd8e-35b0-41a7-ac83-e000c20e5d49">12,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a2f319447e54f4da01d7985e4319c02_D20230101-20230331" decimals="-3" sign="-" name="iart:FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RhYmxlOjcyZmViOGYzOWI0ZjQzMjE4YmJlYWIxNjE3OGJlNTU2L3RhYmxlcmFuZ2U6NzJmZWI4ZjM5YjRmNDMyMThiYmVhYjE2MTc4YmU1NTZfNC0xMy0xLTEtMTkyNDc4_e7785cfe-7ea7-400f-8829-5c3a1d2b6c85">12,500</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in fair value of contingent consideration liabilities </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebe056bf287c49189659a150fa4bb005_D20230101-20230331" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RhYmxlOjcyZmViOGYzOWI0ZjQzMjE4YmJlYWIxNjE3OGJlNTU2L3RhYmxlcmFuZ2U6NzJmZWI4ZjM5YjRmNDMyMThiYmVhYjE2MTc4YmU1NTZfNS0yLTEtMS0xODY4MjE_c1697de3-9d8d-4fef-98d0-35641c0e0695">1,543</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie94f070e4ad14a71bbd6d5a287488485_D20230101-20230331" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RhYmxlOjcyZmViOGYzOWI0ZjQzMjE4YmJlYWIxNjE3OGJlNTU2L3RhYmxlcmFuZ2U6NzJmZWI4ZjM5YjRmNDMyMThiYmVhYjE2MTc4YmU1NTZfNS00LTEtMS0xODY4MjE_842a86c0-29b6-4f23-a772-05558df6cdd8">1,756</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5212f8a1bee4dc6ba5f12945bceefac_D20230101-20230331" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RhYmxlOjcyZmViOGYzOWI0ZjQzMjE4YmJlYWIxNjE3OGJlNTU2L3RhYmxlcmFuZ2U6NzJmZWI4ZjM5YjRmNDMyMThiYmVhYjE2MTc4YmU1NTZfNS04LTEtMS0xODY4MjE_a9513def-f681-41b7-89ff-ba661b6aa54f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5b996d3591a14f7b8ad05792e133d08b_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RhYmxlOjcyZmViOGYzOWI0ZjQzMjE4YmJlYWIxNjE3OGJlNTU2L3RhYmxlcmFuZ2U6NzJmZWI4ZjM5YjRmNDMyMThiYmVhYjE2MTc4YmU1NTZfNS0xMi0xLTEtMTg2ODIx_5c57779d-c5a4-48f6-b84f-9eb844195e43">2,200</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76cdb8918dd040ca80187c0cd9780d22_D20230101-20230331" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RhYmxlOjcyZmViOGYzOWI0ZjQzMjE4YmJlYWIxNjE3OGJlNTU2L3RhYmxlcmFuZ2U6NzJmZWI4ZjM5YjRmNDMyMThiYmVhYjE2MTc4YmU1NTZfNS0xMy0xLTEtMjAwODA1_0f14cada-df2d-4037-b6f6-0f7520588390">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a2f319447e54f4da01d7985e4319c02_D20230101-20230331" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RhYmxlOjcyZmViOGYzOWI0ZjQzMjE4YmJlYWIxNjE3OGJlNTU2L3RhYmxlcmFuZ2U6NzJmZWI4ZjM5YjRmNDMyMThiYmVhYjE2MTc4YmU1NTZfNi0xMy0xLTEtMTkyNDc4_ec43da9a-4f69-4cf5-b559-a29ba0448487">3,600</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of March 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc5039e063bb4575a7f706baf7647a99_I20230331" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RhYmxlOjcyZmViOGYzOWI0ZjQzMjE4YmJlYWIxNjE3OGJlNTU2L3RhYmxlcmFuZ2U6NzJmZWI4ZjM5YjRmNDMyMThiYmVhYjE2MTc4YmU1NTZfNi0yLTEtMS0xODY4MjE_4cb678b1-5f4c-4724-8089-c2aafbf6d969">4,388</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a5ab664d800458296dd51aa0092a73a_I20230331" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RhYmxlOjcyZmViOGYzOWI0ZjQzMjE4YmJlYWIxNjE3OGJlNTU2L3RhYmxlcmFuZ2U6NzJmZWI4ZjM5YjRmNDMyMThiYmVhYjE2MTc4YmU1NTZfNi00LTEtMS0xODY4MjE_89e8caf1-7a5c-498c-95da-ac86823f4991">11,806</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbf2b5d3f97042bdbb5011c85b4e62ff_I20230331" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RhYmxlOjcyZmViOGYzOWI0ZjQzMjE4YmJlYWIxNjE3OGJlNTU2L3RhYmxlcmFuZ2U6NzJmZWI4ZjM5YjRmNDMyMThiYmVhYjE2MTc4YmU1NTZfNi04LTEtMS0xODY4MjE_b73692cc-1dd6-4491-8bb1-59903b789f9c">230</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifda9aebeb4fc4e828e24ac81907aa5d7_I20230331" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RhYmxlOjcyZmViOGYzOWI0ZjQzMjE4YmJlYWIxNjE3OGJlNTU2L3RhYmxlcmFuZ2U6NzJmZWI4ZjM5YjRmNDMyMThiYmVhYjE2MTc4YmU1NTZfNi0xMi0xLTEtMTg2ODIx_a62f0bae-2e93-4e18-9378-7e4b24f61ac0">1,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6f8fb897f9041c8ba230423d37c9561_I20230331" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RhYmxlOjcyZmViOGYzOWI0ZjQzMjE4YmJlYWIxNjE3OGJlNTU2L3RhYmxlcmFuZ2U6NzJmZWI4ZjM5YjRmNDMyMThiYmVhYjE2MTc4YmU1NTZfNi0xMy0xLTEtMjAzOTIy_09c537ea-99f1-4d50-b155-293242aab4f6">12,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04a72655453e4dc799f5272ab6e4c43f_I20230331" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RhYmxlOjcyZmViOGYzOWI0ZjQzMjE4YmJlYWIxNjE3OGJlNTU2L3RhYmxlcmFuZ2U6NzJmZWI4ZjM5YjRmNDMyMThiYmVhYjE2MTc4YmU1NTZfNy0xMy0xLTEtMTkyNDc4_56bc341d-05cb-4e02-8076-85be6afeddbe">48,707</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:28.036%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.831%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.245%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:9.295%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.245%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.684%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.099%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:13.255%"></td><td style="width:0.1%"></td></tr><tr style="height:29pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Contingent Consideration Liability Related to Acquisition of:</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:29pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Arkis </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location in Financial Statements</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derma Sciences</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ACell Inc.</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location in Financial Statements</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Short-term</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Short-term</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of January 1, 2022</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03382ae93c3949428c4641c300c15cf5_I20211231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RhYmxlOmE0ZmVhZjA0OTQ1ZjQzMmZiYTVhMDZhYzVkOTg3ZWU5L3RhYmxlcmFuZ2U6YTRmZWFmMDQ5NDVmNDMyZmJhNWEwNmFjNWQ5ODdlZTlfMy0yLTEtMS0xODY4MjE_70efa5fc-f7cb-44f2-a5cd-11dfa9a90850">3,691</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63bd28aa464048d382efdc354e8d30ef_I20211231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RhYmxlOmE0ZmVhZjA0OTQ1ZjQzMmZiYTVhMDZhYzVkOTg3ZWU5L3RhYmxlcmFuZ2U6YTRmZWFmMDQ5NDVmNDMyZmJhNWEwNmFjNWQ5ODdlZTlfMy00LTEtMS0xODY4MjE_76031cd0-ded3-476f-a3f7-cdc908f7223e">11,408</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1f1f28f2ace4bbebc59d26841e82a9c_I20211231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RhYmxlOmE0ZmVhZjA0OTQ1ZjQzMmZiYTVhMDZhYzVkOTg3ZWU5L3RhYmxlcmFuZ2U6YTRmZWFmMDQ5NDVmNDMyZmJhNWEwNmFjNWQ5ODdlZTlfMy04LTEtMS0xODY4MjE_e024e8f8-23db-4a1e-a1e7-67bb39cd4626">230</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id31fe52cb24f4c5d8a546c61e9306f16_I20211231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RhYmxlOmE0ZmVhZjA0OTQ1ZjQzMmZiYTVhMDZhYzVkOTg3ZWU5L3RhYmxlcmFuZ2U6YTRmZWFmMDQ5NDVmNDMyZmJhNWEwNmFjNWQ5ODdlZTlfMy0xMC0xLTEtMTg2ODIx_53c68479-2c8e-4233-9a4e-64af34bc8047">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida5433fc38b34f3d80d99d0b3ae06943_I20211231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RhYmxlOmE0ZmVhZjA0OTQ1ZjQzMmZiYTVhMDZhYzVkOTg3ZWU5L3RhYmxlcmFuZ2U6YTRmZWFmMDQ5NDVmNDMyZmJhNWEwNmFjNWQ5ODdlZTlfMy0xNC0xLTEtMTkyMTM3_aec373f2-8bdb-4d9c-9a76-0fac42d0d15b">21,800</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transfers</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ad7e73cd2384933bcc0486859965b91_D20220101-20220331" decimals="-3" name="iart:FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RhYmxlOmE0ZmVhZjA0OTQ1ZjQzMmZiYTVhMDZhYzVkOTg3ZWU5L3RhYmxlcmFuZ2U6YTRmZWFmMDQ5NDVmNDMyZmJhNWEwNmFjNWQ5ODdlZTlfNS0yLTEtMS0xODY4MjE_13d91bd7-df6b-4c80-bc4d-38a81167039f">59</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8d4ac64501714cd8b27e0d99a3bc50f1_D20220101-20220331" decimals="-3" sign="-" name="iart:FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RhYmxlOmE0ZmVhZjA0OTQ1ZjQzMmZiYTVhMDZhYzVkOTg3ZWU5L3RhYmxlcmFuZ2U6YTRmZWFmMDQ5NDVmNDMyZmJhNWEwNmFjNWQ5ODdlZTlfNS00LTEtMS0xODY4MjE_745834df-a658-4ef7-94c1-fe765308d5ca">59</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i744d6e80b2d2438caf54348f35691d3c_D20220101-20220331" decimals="-3" name="iart:FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RhYmxlOmE0ZmVhZjA0OTQ1ZjQzMmZiYTVhMDZhYzVkOTg3ZWU5L3RhYmxlcmFuZ2U6YTRmZWFmMDQ5NDVmNDMyZmJhNWEwNmFjNWQ5ODdlZTlfNS04LTEtMS0xODY4MjE_bcb404a3-3d6b-4f4f-a73b-fe71bdeb9f18">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2dff9a5632b143f6bcc0a2d0430fc736_D20220101-20220331" decimals="-3" name="iart:FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RhYmxlOmE0ZmVhZjA0OTQ1ZjQzMmZiYTVhMDZhYzVkOTg3ZWU5L3RhYmxlcmFuZ2U6YTRmZWFmMDQ5NDVmNDMyZmJhNWEwNmFjNWQ5ODdlZTlfNS0xMC0xLTEtMTg2ODIx_85971897-c5eb-4a60-b5dd-68f422eba3f2">4,885</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i57a65d2fe6b445379851b358047cd045_D20220101-20220331" decimals="-3" sign="-" name="iart:FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RhYmxlOmE0ZmVhZjA0OTQ1ZjQzMmZiYTVhMDZhYzVkOTg3ZWU5L3RhYmxlcmFuZ2U6YTRmZWFmMDQ5NDVmNDMyZmJhNWEwNmFjNWQ5ODdlZTlfNS0xNC0xLTEtMTkyMTM3_1c0fb2a5-c83b-4b2c-ac66-3516c366664c">4,885</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in fair value of contingent consideration liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ad7e73cd2384933bcc0486859965b91_D20220101-20220331" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RhYmxlOmE0ZmVhZjA0OTQ1ZjQzMmZiYTVhMDZhYzVkOTg3ZWU5L3RhYmxlcmFuZ2U6YTRmZWFmMDQ5NDVmNDMyZmJhNWEwNmFjNWQ5ODdlZTlfNi0yLTEtMS0xODY4MjE_36451adf-af71-4040-9dfa-2bc9a68ac5c9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8d4ac64501714cd8b27e0d99a3bc50f1_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RhYmxlOmE0ZmVhZjA0OTQ1ZjQzMmZiYTVhMDZhYzVkOTg3ZWU5L3RhYmxlcmFuZ2U6YTRmZWFmMDQ5NDVmNDMyZmJhNWEwNmFjNWQ5ODdlZTlfNi00LTEtMS0xODY4MjE_f12988df-aaa0-422c-b2ae-038f8a090dc8">1,065</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i744d6e80b2d2438caf54348f35691d3c_D20220101-20220331" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RhYmxlOmE0ZmVhZjA0OTQ1ZjQzMmZiYTVhMDZhYzVkOTg3ZWU5L3RhYmxlcmFuZ2U6YTRmZWFmMDQ5NDVmNDMyZmJhNWEwNmFjNWQ5ODdlZTlfNi04LTEtMS0xODY4MjE_b7571590-d17f-4587-87f4-ae7a84ff5589">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2dff9a5632b143f6bcc0a2d0430fc736_D20220101-20220331" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RhYmxlOmE0ZmVhZjA0OTQ1ZjQzMmZiYTVhMDZhYzVkOTg3ZWU5L3RhYmxlcmFuZ2U6YTRmZWFmMDQ5NDVmNDMyZmJhNWEwNmFjNWQ5ODdlZTlfNi0xMC0xLTEtMTg2ODIx_894a9091-89b9-45bb-b903-8c027aa6fcd2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57a65d2fe6b445379851b358047cd045_D20220101-20220331" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RhYmxlOmE0ZmVhZjA0OTQ1ZjQzMmZiYTVhMDZhYzVkOTg3ZWU5L3RhYmxlcmFuZ2U6YTRmZWFmMDQ5NDVmNDMyZmJhNWEwNmFjNWQ5ODdlZTlfNi0xNC0xLTEtMTkyMTM3_2a9dc401-bedd-4a43-b2d5-2bdc1c3a0137">300</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of March&#160;31, 2022</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57d1bb45844549318bf527ab1d455e38_I20220331" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RhYmxlOmE0ZmVhZjA0OTQ1ZjQzMmZiYTVhMDZhYzVkOTg3ZWU5L3RhYmxlcmFuZ2U6YTRmZWFmMDQ5NDVmNDMyZmJhNWEwNmFjNWQ5ODdlZTlfNy0yLTEtMS0xODY4MjE_6cf86ee6-813e-4df4-aa4a-2de9b03ce9c9">3,750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26ba6bc78b3a4d95b2893e8f8c7ad8a8_I20220331" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RhYmxlOmE0ZmVhZjA0OTQ1ZjQzMmZiYTVhMDZhYzVkOTg3ZWU5L3RhYmxlcmFuZ2U6YTRmZWFmMDQ5NDVmNDMyZmJhNWEwNmFjNWQ5ODdlZTlfNy00LTEtMS0xODY4MjE_e4cc71b8-2cdf-4fef-bcc0-3382aaf245ec">10,284</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843804a3b389484b948c99a44059b0c4_I20220331" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RhYmxlOmE0ZmVhZjA0OTQ1ZjQzMmZiYTVhMDZhYzVkOTg3ZWU5L3RhYmxlcmFuZ2U6YTRmZWFmMDQ5NDVmNDMyZmJhNWEwNmFjNWQ5ODdlZTlfNy04LTEtMS0xODY4MjE_f8eb9e14-6937-4ab8-949b-41031fc84618">230</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2bb2185bf654d9fa8253aa6e70cdc7a_I20220331" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RhYmxlOmE0ZmVhZjA0OTQ1ZjQzMmZiYTVhMDZhYzVkOTg3ZWU5L3RhYmxlcmFuZ2U6YTRmZWFmMDQ5NDVmNDMyZmJhNWEwNmFjNWQ5ODdlZTlfNy0xMC0xLTEtMTg2ODIx_d647f0c8-1a52-48ff-baeb-4bf6f6eda33b">4,885</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ac142c72a864f468e0436fe327c0980_I20220331" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RhYmxlOmE0ZmVhZjA0OTQ1ZjQzMmZiYTVhMDZhYzVkOTg3ZWU5L3RhYmxlcmFuZ2U6YTRmZWFmMDQ5NDVmNDMyZmJhNWEwNmFjNWQ5ODdlZTlfNy0xNC0xLTEtMTkyMTM3_94f03fff-be99-4e35-b4d1-72c459b00c20">17,215</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (continued) </span></div></div><ix:continuation id="ieb274f93954e417ea161bf87f2e7b080"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Arkis BioSciences Inc.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the acquisition of Arkis BioSciences Inc. ("Arkis"), the Company is required to pay the former shareholders of Arkis up to $<ix:nonFraction unitRef="usd" contextRef="i5d9c6f2f864e40aea1985e58d5f1a41e_I20190729" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RleHRyZWdpb246NDU3ZTAzOThiNGM2NDJjZGFhNGU3M2I3N2E2NGEyZjJfMjY5Mg_b3de1bd0-f3db-41d2-b07a-92a99b38311e">25.5</ix:nonFraction> million&#160;based on the timing of certain development milestones of $<ix:nonFraction unitRef="usd" contextRef="ifbe9986f6bcd4de881c523419a2fb725_I20190729" decimals="INF" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RleHRyZWdpb246NDU3ZTAzOThiNGM2NDJjZGFhNGU3M2I3N2E2NGEyZjJfMjc2MA_a3f04fbb-9abe-47ed-acf6-e2c721b3867f">10.0</ix:nonFraction> million and commercial sales milestones of $<ix:nonFraction unitRef="usd" contextRef="id780b85560324a2b8af98ff6056e8d1f_I20190729" decimals="INF" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RleHRyZWdpb246NDU3ZTAzOThiNGM2NDJjZGFhNGU3M2I3N2E2NGEyZjJfMjgwNg_19b1fd77-45a5-4f24-abd2-7ccd9d868658">15.5</ix:nonFraction> million, respectively.&#160;The Company used a probability weighted income approach to calculate the fair value of the contingent consideration that considered the possible outcomes of scenarios related to each specified milestone. The Company estimated the fair value of the contingent consideration to be $<ix:nonFraction unitRef="usd" contextRef="i5d9c6f2f864e40aea1985e58d5f1a41e_I20190729" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RleHRyZWdpb246NDU3ZTAzOThiNGM2NDJjZGFhNGU3M2I3N2E2NGEyZjJfMzExMQ_31a64e3c-2ca7-4853-a61a-90f86c5f000a">13.1</ix:nonFraction> million at the acquisition date. The estimated fair value as of March&#160;31, 2023 and March&#160;31, 2022 was $<ix:nonFraction unitRef="usd" contextRef="iaba62da9aab3440ab34c023a05b0b605_I20230331" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RleHRyZWdpb246NDU3ZTAzOThiNGM2NDJjZGFhNGU3M2I3N2E2NGEyZjJfMzE4NA_8df4559b-e80f-48ae-9ee7-25e8a2e79969">16.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i28c3ebc588a3437abfe6a86e8e38ae70_I20220331" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RleHRyZWdpb246NDU3ZTAzOThiNGM2NDJjZGFhNGU3M2I3N2E2NGEyZjJfMzE5MQ_e6a54d69-76cb-44ec-8780-7b154ddcbf9a">14.0</ix:nonFraction> million, respectively. The Company recorded $<ix:nonFraction unitRef="usd" contextRef="i3a5ab664d800458296dd51aa0092a73a_I20230331" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RleHRyZWdpb246NDU3ZTAzOThiNGM2NDJjZGFhNGU3M2I3N2E2NGEyZjJfMzIzMA_c6fc052b-4138-4677-b01d-a6eb83cee55b">11.8</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i26ba6bc78b3a4d95b2893e8f8c7ad8a8_I20220331" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RleHRyZWdpb246NDU3ZTAzOThiNGM2NDJjZGFhNGU3M2I3N2E2NGEyZjJfMzIzNw_0e72dbb0-f607-47ce-a98c-45b53f36ed95">10.3</ix:nonFraction> million in other liabilities at March&#160;31, 2023 and March&#160;31, 2022, respectively, and $<ix:nonFraction unitRef="usd" contextRef="ia93dbf54c16a4910aa3b24636e104e30_I20230331" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RleHRyZWdpb246NDU3ZTAzOThiNGM2NDJjZGFhNGU3M2I3N2E2NGEyZjJfMzI5Mw_9f96738a-1933-4cea-ae5b-0f233e4dbdd1">4.4</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i03c41c6e3db74ceab9f18b88621af236_I20220331" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RleHRyZWdpb246NDU3ZTAzOThiNGM2NDJjZGFhNGU3M2I3N2E2NGEyZjJfNDM5ODA0NjUxNTMwNg_7d85f563-5dc2-4e21-a2fc-582c2bcb9971">3.8</ix:nonFraction>&#160;million in accrued expenses and other current liabilities at March&#160;31, 2023 and March&#160;31, 2022, respectively, in the consolidated balance sheet of the Company.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Derma Sciences</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assumed contingent consideration incurred by Derma Sciences, Inc. ("Derma Sciences")&#160;related to its acquisitions of BioD and the intellectual property related to Medihoney products. The Company accounted for the contingent liabilities by recording their fair value on the date of the acquisition based on a probability weighted income approach. The Company has already paid $<ix:nonFraction unitRef="usd" contextRef="i5b8b02acfe4a4006ba624b2aa4272aa9_D20230101-20230331" decimals="-5" name="us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RleHRyZWdpb246NDU3ZTAzOThiNGM2NDJjZGFhNGU3M2I3N2E2NGEyZjJfMzgzMg_0b8ffe2e-118d-4239-90ab-987510f864e4">33.3</ix:nonFraction> million related to the aforementioned contingent liabilities. <ix:nonFraction unitRef="liability" contextRef="i86b0bf361fcc48fcb96359b69ccfd113_I20230331" decimals="INF" name="iart:BusinessCombinationContingentConsiderationNumberOfLiabilities" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RleHRyZWdpb246NDU3ZTAzOThiNGM2NDJjZGFhNGU3M2I3N2E2NGEyZjJfMzg4OQ_274971c6-980c-4903-9e6f-9b9ff0a411f5">One</ix:nonFraction> contingent milestone remains which relates to net sales of Medihoney&#8482; products exceeding certain amounts defined in the agreement between the Company and Derma Sciences. The potential maximum undiscounted payment amounts to $<ix:nonFraction unitRef="usd" contextRef="i86b0bf361fcc48fcb96359b69ccfd113_I20230331" decimals="INF" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RleHRyZWdpb246NDU3ZTAzOThiNGM2NDJjZGFhNGU3M2I3N2E2NGEyZjJfNDExNg_5b10d81f-e262-45b1-a606-c8e7aa519fb6">3.0</ix:nonFraction> million. The estimated fair value as of March&#160;31, 2023 and March&#160;31, 2022 was $<ix:nonFraction unitRef="usd" contextRef="i1a0930d1120745c0909b0d6a10d930ff_I20230331" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RleHRyZWdpb246NDU3ZTAzOThiNGM2NDJjZGFhNGU3M2I3N2E2NGEyZjJfNDE2NQ_5a584e3d-26fb-42b3-a788-d799687e84e0"><ix:nonFraction unitRef="usd" contextRef="i51cb03d8a5ea47b9bf04b0cbd6cd4e2e_I20220331" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RleHRyZWdpb246NDU3ZTAzOThiNGM2NDJjZGFhNGU3M2I3N2E2NGEyZjJfNDE2NQ_7d5561de-6949-4aeb-9dc7-62c73a249bb1">0.2</ix:nonFraction></ix:nonFraction> million. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">ACell Inc.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the ACell Acquisition, the Company is required to make payments to the former shareholders of ACell up to $<ix:nonFraction unitRef="usd" contextRef="id9e1f135607c446e87244607e8e7fb74_I20210120" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RleHRyZWdpb246NDU3ZTAzOThiNGM2NDJjZGFhNGU3M2I3N2E2NGEyZjJfMTA5OTUxMTYyODg3NDQ_2a635a3d-5f0b-4c97-a0a9-297b9c2ee5f6">100</ix:nonFraction>&#160;million based on the achievement by the Company of certain revenue-based performance milestones in 2023 and 2025. The Company used iterations of the Monte Carlo simulation to calculate the fair value of the contingent consideration that considered the possible outcomes of scenarios related to each specific milestone. The Company estimated the fair value of the contingent consideration to be $<ix:nonFraction unitRef="usd" contextRef="id9e1f135607c446e87244607e8e7fb74_I20210120" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RleHRyZWdpb246NDU3ZTAzOThiNGM2NDJjZGFhNGU3M2I3N2E2NGEyZjJfMTA5OTUxMTYyODkxNDE_c8e1054d-35bd-46cd-97d6-308ac71bc3ca">23.9</ix:nonFraction>&#160;million at the acquisition date. The estimated fair value as of March 31, 2023 was </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="i52c4ec9dcdbe44349b2eb5a85c04baae_I20230331" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RleHRyZWdpb246NDU3ZTAzOThiNGM2NDJjZGFhNGU3M2I3N2E2NGEyZjJfNTQ5NzU1ODI1ODc1_9488e0a4-bbf6-4ed2-bd87-ac146b3fd4d9">1.5</ix:nonFraction> million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company recorded </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="i52c4ec9dcdbe44349b2eb5a85c04baae_I20230331" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RleHRyZWdpb246NDU3ZTAzOThiNGM2NDJjZGFhNGU3M2I3N2E2NGEyZjJfNTQ5NzU1ODI1ODk1_9488e0a4-bbf6-4ed2-bd87-ac146b3fd4d9">1.5</ix:nonFraction> million </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="ic09564d0848d46c79b0dbcb1d9f96df9_I20220331" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RleHRyZWdpb246NDU3ZTAzOThiNGM2NDJjZGFhNGU3M2I3N2E2NGEyZjJfNTQ5NzU1ODI1OTEz_3c75e6e2-bea8-45f8-865b-6fcc876a0550">17.2</ix:nonFraction> million </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in other liabilities at March 31, 2023 and March 31, 2022, respectively, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and $<ix:nonFraction unitRef="usd" contextRef="ic09564d0848d46c79b0dbcb1d9f96df9_I20220331" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RleHRyZWdpb246NDU3ZTAzOThiNGM2NDJjZGFhNGU3M2I3N2E2NGEyZjJfNTQ5NzU1ODI1OTQ0_8b3a8cca-8ab1-4d91-abfc-c3d3639602b1">4.9</ix:nonFraction> million in accrued expenses and other current liabilities at March&#160;31, 2022</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the consolidated balance sheets of the Company. The change in the fair value of the contingent obligation was primarily as a result of changes in the timing and amount of revenue estimates.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><div id="i5f1eb1bd01d541c3aa0777712077c048_88"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i5f1eb1bd01d541c3aa0777712077c048_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">"</span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160;2. MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following discussion and analysis of the Company's financial condition and results of operations should be read in conjunction with our condensed consolidated financial statements and the related notes thereto appearing elsewhere in this report and our consolidated financial statements for the year ended December&#160;31, 2022 included in our Annual Report on Form 10-K.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We have made statements in this report that constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934 (the &#8220;Exchange Act&#8221;). All statements other than statements of historical fact contained in this Quarterly Report on Form 10-Q (this &#8220;Quarterly Report&#8221;), including statements regarding our future results of operations and financial position, business strategy and plans, objectives of management for future operations and current expectations or forecasts of future results, are forward-looking statements. These forward-looking statements are subject to a number of risks, uncertainties and assumptions about the Company and other matters that may cause our actual results, performance, or achievements to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">These statements involve known and unknown risks, uncertainties, and other important factors that may cause our actual results, performance, or achievements to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements. Our forward-looking statements may include statements related to our growth and growth strategies, developments in the markets for our products and services, financial results, development launches and effectiveness, research and development strategy, regulatory approvals, competitive strengths, the potential or anticipated direct or indirect impact of the Coronavirus pandemic on our business, results of operations, and/or financial condition, restructuring and cost-saving initiatives, intellectual property rights, litigation and tax matters, governmental proceedings and investigations, mergers and acquisitions, divestitures, market acceptance of our products and services, accounting estimates, financing activities, ongoing contractual obligations, working capital adequacy, value of our investments, our effective tax rate, our expected returns to shareholders, and sales efforts.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In some cases, these forward-looking statements may be identified by forward-looking words such as &#8220;believe,&#8221; &#8220;may,&#8221; &#8220;might,&#8221; &#8220;could,&#8221; &#8220;will,&#8221; &#8220;estimate,&#8221; &#8220;continue,&#8221; &#8220;anticipate,&#8221; &#8220;intend,&#8221; &#8220;seek,&#8221; &#8220;plan,&#8221; &#8220;expect,&#8221; &#8220;should,&#8221; &#8220;would&#8221; and similar words and expressions in this report. Forward-looking statements in this Quarterly Report include, but are not limited to, statements regarding our ability to drive long-term shareholder value, development and future launches of products and continued or future acceptance of products and services in our segments; our ability to navigate and mitigate any on-going or future impact associated with economic disruptions, including supply chain constraints and inflation; expected timing for completion of research studies relating to our products; market positioning and performance of our products; divestitures and the potential benefits thereof; the costs and benefits of integrating previous acquisitions; anticipated timing for Food and Drug Administration (&#8220;FDA&#8221;) in the U.S., as well as for non-U.S. regulatory approval of new products; increased presence in new markets, including markets outside the U.S.; changes in the market and our market share; acquisitions and investment initiatives, including the timing of regulatory approvals as well as integration of acquired companies into our operations; the resolution of tax matters; the effectiveness of our development activities in reducing patient care costs and hospital stay lengths; our approach towards cost containment; our expectations regarding healthcare costs; general economic conditions; and the potential impact of our compliance with governmental regulations and accounting guidance.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our business, results of operations, financial condition, and/or cash flows. These forward-looking statements speak only as of the date of this Quarterly Report and are subject to a number of risks, uncertainties and assumptions described in the &#8220;Risk Factors&#8221; section and elsewhere in our Annual Report on Form 10-K for the year ended December&#160;31, 2022. As forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified, you should not rely on these forward-looking statements as predictions of future events. One must carefully consider forward-looking statements and understand that such forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified, and involve a variety of risks and uncertainties, known and unknown, including, among others, those discussed in the sections entitled &#8220;Government Regulation&#8221; within &#8220;Item 1. Business&#8221; and &#8220;Item 1A. Risk Factors&#8221; in our Annual Report on Form 10-K for the year ended December 31, 2022. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except to the extent required by applicable law.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><div id="i5f1eb1bd01d541c3aa0777712077c048_91"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i5f1eb1bd01d541c3aa0777712077c048_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">"</span></div></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">GENERAL</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Integra, headquartered in Princeton, New Jersey, is a world leader in neurosurgical solutions and regenerative tissue technologies. The Company was founded in 1989 with the acquisition of an engineered collagen technology platform used to repair and regenerate tissue. Integra has developed numerous product lines from this technology for applications ranging from burn and deep tissue wounds to the repair of dura mater in the brain, as well as nerves and tendons. We have expanded our base regenerative technology business to include surgical instruments, neurosurgical products and advanced wound care through global acquisitions and product development to meet the evolving needs of its customers and enhance patient care. Integra LifeSciences Holdings Corporation common stock trades on the Nasdaq Global Select Market (&#8220;Nasdaq&#8221;) under the symbol &#8220;IART.&#8221;</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We manufacture and sell medical technologies and products in two reportable business segments: Codman Specialty Surgical ("CSS") and Tissue Technologies ("TT"). The CSS segment, which represents approximately two-thirds of our total revenue, consists of market-leading technologies and instrumentation used for a wide range of specialties, such as neurosurgery, neurocritical care and otolaryngology. We are the world leader in neurosurgery and one of the top three providers in instruments used in precision, specialty, and general surgical procedures. Our TT segment generates about one-third of our overall revenue and focuses on three main areas: complex wound surgery, surgical reconstruction, and peripheral nerve repair.</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have key manufacturing and research facilities located in California, Indiana, Maryland, Massachusetts, New Jersey, Ohio, Puerto Rico, Tennessee, Utah, France, Germany, Ireland and Switzerland. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We source most of our handheld surgical instruments and sealant products through specialized third-party vendors.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Integra is committed to restoring patients&#8217; lives through transformative technologies and products in the segments in which we compete. Our mission is to innovate treatment pathways to advance patient outcomes and set new standards of care. We refocused our strategies around five pillars, specifically three core growth drivers -- innovating for outcomes, growing internationally, broadening our impact on care pathways &#8211; enabled by two key levers: driving operational and customer excellence and cultivating a high-performance culture. These five pillars drive how and where we aim to accelerate in 2023 and in the coming years. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Innovating for Outcomes.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> An important part of Integra&#8217;s growth strategy is introducing new products to strengthen and expand our portfolio. Additionally, we seek clinical evidence to support regulatory approval and strong reimbursement of our product portfolio around the world, including new indications for existing technologies. On December 6, 2022, we completed the acquisition of Surgical Innovation Associates, Inc. (&#8220;SIA&#8221;), which develops, markets and sells DuraSorb, a resorbable synthetic matrix for plastic and reconstructive surgery. This acquisition advances our global strategy in breast reconstruction, expanding plans to access the U.S. market where SIA is pursuing pre-market approval for use in implant-based breast reconstruction ("IBBR"). We also continued to advance the development of pioneering neurosurgical technologies with the expansion of our product offerings. In early 2023, the CUSA&#174; Clarity Bone Tip was launched in U.S., which is used when controlled fragmentation, emulsification and aspiration of bone is necessary. This follows the CUSA&#174; Clarity extended laparoscopic tip, launched in the U.S. in late 2022 to enhance the benefits of ultrasonic ablation to minimally invasive laparoscopic liver surgery.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Growing International.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">  Over the years, we have been significantly expanding our global footprint through investments in our commercial organization, expansion and development of international markets and new product introductions. Several new products were introduced in 2023, including MicroMatrix&#174; and Certas Plus&#174; Programmable Valve which were launched in Europe, and CUSA Clarity Laparoscopic ("Lap") tip which was launched in Australia and New Zealand. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Broadening Impact on Care Pathways.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Integra seeks ways to develop products and technologies that impact the lives of patients, starting with the journey that a patient takes from diagnosis and treatment planning to surgery and postoperative care. Integra is well-established in acute care in the hospital setting and plans to leverage that strong position to grow in this segment and shape treatment pathways into preoperative care and additional sites of care. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Driving Operations and Customer Excellence.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Integra has been making investments to build more responsive and scalable processes, enhance the reliability of our supply chain, and drive productivity initiatives to further supply and lower costs. Additionally, we continue to invest in technologies, systems and processes to enhance the customer experience. In 2022, certain transactional back-office finance and customer service activities were outsourced to enhance customer quality, build scale for future growth, and capture cost efficiencies. </span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Cultivating a High-Performance Culture.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">  Creating a culture focused on empowerment and agility and building a diverse and inclusive workplace are cornerstones of our people strategy. These efforts resulted in Integra being named in several best workplace lists globally in 2022. Most recently, Integra China was recognized as a Great Place to Work in Greater China. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i5f1eb1bd01d541c3aa0777712077c048_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">"</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Additionally, we have been making great strides in advancing our environmental, social and governance ("ESG") agenda to drive sustainability across the organization and recently published our first ESG report in late 2022.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Clinical and Product Development Activities</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Integra continues to invest in collecting clinical evidence to support our existing products and new product launches, and to ensure that we obtain market access for broader and more cost-effective solutions</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In  2022, we made progress to several enhancements to our CUSA Clarity Tissue Ablation System. The extended laparoscopic tip was launched in the U.S. to enhance laparoscopic liver procedures. In addition, a single-sided bone tip received 510(k) clearance. In early 2023, we had our commercial launch with initial surgeries successfully completed.  We continue to update our CUSA Clarity platform by incorporating new ultrasonic handpiece and integrated electrosurgical capabilities.</span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In 2022, we continued to advance the early-stage technology platforms we acquired in 2019. Through the acquisition of Arkis Biosciences, Inc. ("Arkis") we added a platform technology, CerebroFlo&#174; external ventricular drainage ("EVD"), catheter with Endexo&#174; technology, a permanent additive designed to reduce the potential for catheter obstruction due to thrombus formation. The CerebroFlo EVD Catheter has demonstrated an average of 99% less thrombus accumulation onto its surface, in vitro, compared to a market leading EVD catheter. Our work to combine our bactiseal antimicrobial technology with the Endexo anti-occlusive technology obtained through our 2019 acquisition of Arkis continues to progress for both a silicone-based hydrocephalus and EVD project.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In 2019, we also acquired Rebound Therapeutics Corporation ("Rebound Therapeutics"), a company that specialized in single-use medical device, known as Aurora Surgiscope, which is the only tubular retractor system designed for cranial surgery with an integrated access channel, camera and lighting. In the third quarter of 2021, we conducted a limited clinical launch of the Aurora Surgiscope for use in minimally invasive neurosurgery as well as initiated a registry called MIRROR to collect data on early surgical intervention using this same technology platform for the treatment of ICH. In 2022, we launched the Aurora&#174; Evacuator with Coagulation device in the U.S., designed to be used in conjunction with our Aurora Surgiscope to safely address and evacuate blood in the brain caused by hemorrhagic stroke.&#8239;</span></div><div style="margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are focused on the development of core clinical applications in our electromechanical technologies portfolio. In June 2022, we launched the Neutus&#174; EVD system, our first EVD in China. The Neutus EVD system is manufactured in China by Shanghai Haoju Medical Technology Co., Ltd. under an exclusive distribution arrangement. The device is used in the management of CSF and is highly complementary to our Bactiseal&#174; catheter and advanced intercranial pressure monitoring products. In 2021, we launched our CereLink ICP Monitor System in the U.S. and Europe direct markets and continued the global rollout in the first half of 2022. CereLink provides enhanced accuracy, usability and advanced data presentation that provides clinicians with uncompromised, advanced continuous ICP monitoring that until now, has not been available when treating patients with traumatic brain injuries. Refer below to the information appearing in the "FDA Matters" section for additional information on the voluntary recall of the CereLink ICP Monitor System. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Within our TT segment, in 2022, we launched NeuraGen 3D Nerve Guide Matrix, a resorbable implant for repair of peripheral nerve discontinuities and engineered to create an optimized environment for nerve regeneration.  In the third quarter of 2021, we filed the PMA application for a specific indication for SurgiMend in the use of post-mastectomy breast reconstruction, for which we hope to obtain FDA approval in 2024. On December 6, 2022, we completed the acquisition of SIA, which develops, markets and sells DuraSorb&#174;, a resorbable synthetic matrix for plastic and reconstructive surgery. This acquisition advances our global strategy in breast reconstruction, expanding plans to access the U.S. market where SIA is pursuing pre-market approval for use in IBBR. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FDA Matters</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 18, 2022, we, after consultation with the FDA and other regulatory authorities outside of the United States, initiated an immediate voluntary global product removal of all CereLink intracranial pressure monitors as a result of customer reports about monitors whose pressure readings were out of range. We believe that the out-of-range readings are principally caused by electrical interference from the external environment and/or interference from a component on the circuit board of the monitor. These out-of-range readings have occurred at a low incidence rate and at a limited number of sites; however, out of an abundance of caution, we removed all CereLink monitors from the field.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are continuing our investigation into the matter in order to remedy the observed issue and plans to resume shipment of the CereLink monitors as soon as any such issues have been resolved and required regulatory reviews have been completed. Based on the outlook for returning the product to market and feedback from customers, we recorded a $1.9 million provision for product returns, as a reduction of net revenue, and a $0.8 million rework accrual in cost of goods sold in 2022.  In the first quarter of 2023 we recorded an additional $0.8M in provision for product returns as a reduction of net revenue, and no additional rework costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i5f1eb1bd01d541c3aa0777712077c048_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">"</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On March 7, 2019, TEI Biosciences, Inc. ("TEI"), one of our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">wholly-owned subsidiaries , received a Warning Letter (the &#8220;Warning Letter&#8221;), dated March 6, 2019, from the FDA. The warning letter related to quality systems issues at TEI's manufacturing facility located in Boston, Massachusetts. The letter resulted from an inspection held at that facility in October and November 2018 and did not identify any new observations that were not already provided in the Form 483 that followed the inspection. We submitted our initial response to the FDA Warning Letter on March 28, 2019 and provide regular progress reports to the FDA as to its corrective actions and, since the conclusion of the inspection, we have undertaken significant efforts to remediate the observations and continue to do so. On October 28, 2021 the FDA initiated an inspection of the facility and at the conclusion of the inspection issued a FDA Form 483 on November 12, 2021 (the "2021 Form 483"). We provided an initial response to the inspection observations and will continue to provide responses to the FDA. On March 1, 2023, the FDA commenced an inspection of the facility, and we anticipate that the FDA will issue an FDA Form 483 at the conclusion of this inspection. The Warning Letter and the 2021 FDA Form 483 do not restrict our ability to manufacture or ship products or require the recall of any products, nor do they restrict our ability to seek FDA 510(k) clearance of products. Additionally, premarket approval applications for Class III devices to which the Quality System regulation violations are reasonably related will not be approved until the violations have been corrected. The TEI Boston facility manufactures extracellular bovine matrix products. We cannot give any assurances that the FDA will be satisfied with our response to the Warning Letter or as to the expected date of the resolution of the matters included in the letter. Until the issues cited in the letter are resolved to the FDA&#8217;s satisfaction, the FDA may initiate additional regulatory action without further notice. Any adverse regulatory action, depending on its magnitude, may restrict us from effectively manufacturing, marketing and selling our products and could have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues of products manufactured in the TEI Boston facility for the three months ended March 31, 2023 were approximately 4.4% of consolidated revenues. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OPTIMIZATION AND INTEGRATION ACTIVITIES</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of our ongoing acquisition strategy and significant growth in recent years, we have undertaken cost-saving initiatives to consolidate manufacturing operations, distribution facilities and transfer activities, eliminate duplicative positions, realign various sales and marketing activities, and expand and upgrade production capacity for our regenerative technology products. These efforts are expected to continue and while we expect a positive impact from ongoing restructuring, integration, and manufacturing transfer and expansion activities, such results remain uncertain.  In support of our continued focus on product margins during 2022, we closed a manufacturing facility located in France and transferred production to our existing Switzerland facility</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In 2022, we outsourced certain transactional back-office finance and customer service activities to enhance customer quality, build scale for future growth, and capture cost efficiencies. </span></div><div id="i5f1eb1bd01d541c3aa0777712077c048_94"></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RESULTS OF OPERATIONS</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Executive Summary</span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Net income for the three months ended March&#160;31, 2023 was $24.2 million, or $0.29 per diluted share, as compared to $32.9 million or $0.39 per diluted share for the three months ended March&#160;31, 2022. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The decrease in net income for the three months ended March&#160;31, 2023, was primarily driven by impacts from the SIA acquisition, including additional amortization, research and development, and other costs.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i5f1eb1bd01d541c3aa0777712077c048_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">"</span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Special Charges</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income before taxes includes the following </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">special charges</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">:</span></div><div style="margin-bottom:3pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisition, divestiture and integration-related charges</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,776&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">574&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Structural optimization charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,335&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,320&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">EU medical device regulation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,404&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,513&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,515&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,407&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The items reported above are reflected in the condensed consolidated statements of operations as follows:</span></div><div style="margin-bottom:3pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.075%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.522%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of goods sold </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,066&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,530&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,218&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,267&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,730&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,902&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(499)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,292)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,515&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,407&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:12pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We typically define special charges as items for which the amounts and/or timing of such expenses may vary significantly from period to period, depending upon our acquisition, divestiture, integration and restructuring activities, and for which the amounts are non-cash in nature, and for which the amounts are not expected to recur at the same magnitude. We believe that given our ongoing strategy of seeking acquisitions, our continuing focus on rationalizing our existing manufacturing and distribution infrastructure and our continuing review of various product lines in relation to our current business strategy, some of the special charges discussed above could recur with similar materiality in the future.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that the separate identification of these special charges provides important supplemental information to investors regarding financial and business trends relating to our financial condition and results of operations. Investors may find this information useful in assessing comparability of our operating performance from period to period, against the business model objectives that management has established, and against other companies in our industry. We provide this information to investors so that they can analyze our operating results in the same way that management does and to use this information in their assessment of our core business and valuation of Integra.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenues and Gross Margin</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's revenues and gross margin on product revenues were as follows:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.075%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.522%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Segment Net Sales</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Codman Specialty Surgical</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">248,136</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">247,308</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Tissue Technologies</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">132,710</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">129,330</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">380,846</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">376,638</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of goods sold</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">147,975</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">142,569</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross margin on total revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">232,871</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">234,069</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross margin as a percentage of total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">61.1&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62.1&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div id="i5f1eb1bd01d541c3aa0777712077c048_97"></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Three Months Ended March 31, 2023 as Compared to Three Months Ended March 31, 2022</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenues </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March&#160;31, 2023, total revenues increased by $4.2 million to $380.8 million from $376.6 million for the same period in 2022, inclusive of a unfavorable foreign currency impact of $7.0 million on revenues, as well as a $4.5 million decrease that impacts both domestic and international revenues related to the divestiture of the TWC business. This also includes an increase of $1.8 million related to the SIA acquisition.  Excluding the impacts of these items, domestic revenues increased by $6.8 million, or 2.6% as compared to the prior year period. International revenues increased by $7.1 million or 6.5% as compared to the prior period.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The increase in domestic revenues was primarily driven by strong sales in our TT segment.  The increase in international revenues was primarily driven by Advanced Energy.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i5f1eb1bd01d541c3aa0777712077c048_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">"</span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the CSS segment, revenues were $248.1 million which was an increase of $0.8 million, or 0.3% as compared to the prior-year period, inclusive of a</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> $6.4 million </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">unfavorable foreign currency impact on revenue. Excluding the impact of foreign exchange, Neurosurgery portfolio grew low</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> single digits</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> primarily due to sales in Advanced Energy. Sales in our instruments portfolio increased mid-</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">single digits </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">as compared to the same period in the prior year.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the TT segment, revenues were $132.7 million which was an increase of $3.4 million, or 2.6% from the prior-year period, inclusive of a $0.6 million unfavorable foreign currency impact on revenue, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">as well as a $4.5 million decrease that impacts both domestic and international revenues related to the divestiture of the TWC business. This also includes an increase of $1.8 million related to the SIA acquisition. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Excluding the impact of these items, our sales increased mid single digits, driven by strong customer demand and increased burn cases. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Gross Margin</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross margin was $232.9 million for the three months ended March&#160;31, 2023, a decrease of $1.2 million from $234.1 million for the sa</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">me period in 2022. Gross margin as a percentage of revenues was 61.1% </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for the three months ended March&#160;31, 2023</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and 62.1% f</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">or the sa</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">me period in 2022.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This decrease in gross margin is a result of unfavorable product mix and an increase in manufacturing costs.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operating Expenses</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of operating expenses as a percent of total revenues:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.028%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.545%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible asset amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total operating expenses, which consist of research and development, selling, general and administrative, and amortization expenses, increased by $8.6 million, or 4.6% to $196.5 million in the three months ended March&#160;31, 2023, compared to $187.9</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> million </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in the same period in 2022. The increase in operating expenses compared to the prior year is primarily a result of the SIA acquisition combined with increases in selling costs associated with higher revenue.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and Development</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expenses for the three months ended March&#160;31, 2023 increased by $2.6 million as compared to the same period in the prior year. This increase in spending resulted from additional spending related to the SIA acquisition, new product development and clinical studies.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Selling, General and Administrative</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling, general and administrative costs for the three months ended March&#160;31, 2023 increased by $6.7 million as compared to the same period in the prior year driven primarily due to increased selling costs associated with SIA acquisition and costs associated with consulting activities.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intangible Asset Amortization</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense (exclu</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">din</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">g amounts reported in cost of product revenues for technology-based intangible assets) for the three months ended March&#160;31, 2023 was $3.1 million compared to $3.9 million for the same period in the prior year.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i5f1eb1bd01d541c3aa0777712077c048_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">"</span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Non-Operating Income and Expenses</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of non-operating income and expenses:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.443%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.835%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.838%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,107&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,377&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12,100)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11,655)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,389&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,429&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total non-operating income and expense</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,604)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,849)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Income</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest income for the three months ended March&#160;31, 2023 increased by $2.7 million as compared to the same period in the prior year due to higher interest rates.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Expense</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense for the three months ended March&#160;31, 2023 decreased by $0.4 million as compared to the same period in the prior year.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Income, net</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income, net for the three months ended March&#160;31, 2023 decreased by $2.0 million compared to the same period in the prior year.  The decrease is primarily driven by lower Transition Service Agreement ("TSA") income from the sale of our Extremity orthopedics business, offset by additional TSA income from the sale of our TWC business.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes </span></div><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.443%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.835%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.838%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,778&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39,315&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax (benefit) expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,552&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,414&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effective tax rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our  effective income tax rates for the three months ended March&#160;31, 2023 and 2022 were 18.6% and 16.3%, respectively.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March 31, 2023, the primary driver of the higher tax rate relates to a reduction of excess tax benefits from stock compensation.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effective tax rate may vary from period to period depending on, among other factors, the geographic and business mix of taxable earnings and losses, tax planning and settlements with various taxing authorities. We consider these factors and others, including the Company's history of generating taxable earnings, in assessing our ability to realize tax assets on a quarterly basis.</span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, changes to income tax laws and regulations, in any of the tax jurisdictions in which we operate, could impact the effective tax rate. Various governments, both U.S. and non-U.S., are increasingly focused on tax reform and revenue-raising legislation. Further, legislation in foreign jurisdictions may be enacted, in response to the base erosion and profit-shifting project begun by the Organization for Economic Cooperation and Development ("OECD"). The OECD recently finalized major reform of the international tax system with respect to implementing a global minimum tax rate. Such changes in U.S. and non-U.S. jurisdictions could have an adverse effect on the Company&#8217;s effective tax rate.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While it is often difficult to predict the outcome or the timing of the resolution of a particular matter with the various federal, state, and foreign tax authorities, we believe that our reserves reflect the most probable outcome of known tax contingencies. Settlement of a particular issue would usually require the use of cash. A favorable resolution would be recognized as a reduction to our annual effective tax rate in the year of resolution. Our tax reserves are presented in the balance sheet within other liabilities, except for amounts relating to items that we expect to pay in the coming year, which would be classified as current income taxes payable.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><div id="i5f1eb1bd01d541c3aa0777712077c048_103"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i5f1eb1bd01d541c3aa0777712077c048_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">"</span></div></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">GEOGRAPHIC PRODUCT REVENUES AND OPERATIONS</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We attribute revenues to geographic areas based on the location of the customer. Total revenue by major geographic area consisted of the following:</span></div><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.075%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.522%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">271,002&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">263,351&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41,064&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43,744&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Asia Pacific</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50,473&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47,717&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,307&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,826&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">380,846&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">376,638&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generate significant revenues outside the U.S., a portion of which are U.S. dollar-denominated transactions conducted with customers that generate revenue in currencies other than the U.S. dollar. As a result, currency fluctuations between the U.S. dollar and the currencies in which those customers do business could have an impact on the demand for our products in foreign countries. Local economic conditions, regulatory compliance or political considerations, the effectiveness of our sales representatives and distributors, local competition and changes in local medical practice all may combine to affect our sales into markets outside the U.S.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Domestic revenues increased by $7.7 million for the three months ended March&#160;31, 2023 compared to the same period last year. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">European sales decreased by $2.7 million for the three months ended March&#160;31, 2023 compared to the same period last year. Sales to customers in Asia Pacific increased by $2.8 million for the three months ended March&#160;31, 2023. The Rest of World for the three months ended March&#160;31, 2023 decreased by $3.5 million compared to the same period last year. The international revenues were impacted by $7.0 million of unfavorable foreign exchange impact, with the larger impact in Europe. The increase in global revenues, inclusive of a $7.0 million unfavorable foreign exchange impact on revenue, is a result of strong sales in our TT division and our international businesses.  Sales in Japan, China, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Europe</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Canada and our indirect markets continue to drive international growth. </span></div><div id="i5f1eb1bd01d541c3aa0777712077c048_106"></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LIQUIDITY AND CAPITAL RESOURCES</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Working Capital</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's working capital as of March&#160;31, 2023 and December&#160;31, 2022 was $747.2 million and $840.6 million, respectively. Working capital consists of total current assets less total current liabilities as presented in the consolidated balance sheets.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash and Marketable Securities</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had cash and cash equivalents totaling approximately $307.4 million and $456.7 million at March&#160;31, 2023 and December&#160;31, 2022 respectively, which are valued based on Level 1 measurements in the fair value hierarchy. At March&#160;31, 2023, our non-U.S. subsidiaries held approximately $242.2 million of cash and cash equivalents that are available for use outside the U.S. The Company asserts that it has the ability and intends to indefinitely reinvest the undistributed earnings from its foreign operations unless there is no material tax cost to remit the earnings into the U.S..</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash Flows</span></div><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.443%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.835%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.838%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,156&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44,344&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(13,704)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14,067)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash used in financing activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(162,683)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(133,465)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect of exchange rate fluctuations on cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">937&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,168)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flows Provided by Operating Activities </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating cash flows for the three months ended March&#160;31, 2023 decreased by $18.2 million compared to the same period in 2022. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income after removing the non-cash adjustments decreased for the three months ended </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March&#160;31, 2023</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> by approximately $5.3&#160;million as compared to the same period in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2022</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> primarily due to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">higher product costs and expenses related to support for key growth initiatives in research and development, selling and marketing areas. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i5f1eb1bd01d541c3aa0777712077c048_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">"</span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in assets and liabilities in the first quarter of 2023, net of business acquisitions, decreased cash flows by $42.6 million, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">mainly attributable to increases in inventory to support increased sales and decreases in accrued expenses and other current liabilities due to increased payments processed in the quarter. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in assets and liabilities in the first quarter of 2022, net of business acquisitions, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">decreased</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> cash flows by </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$29.8 million, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">primarily due to increases in inventory to support increased sales and decreases in accounts payable, accrued expenses and other current liabilities due to increased payments processed in the quarter.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flows Used in Investing Activities</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2023, we paid $13.7 million for capital expenditures to support operations improvement initiatives at a number of our manufacturing facilities and other information technology investments.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2022, we paid $9.3 million for capital expenditures to support operations improvement initiatives at a number of our manufacturing facilities and other information technology investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> as well as the final $4.7&#160;million payment related to the final developmental milestone for Rebound Therapeutics Corporation.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flows Used in Financing Activities</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Uses of cash from financing activities in the three months ended March&#160;31, 2023 related to the repurchase of treasury stock of $150.0 million under the 2023 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">accelerated share repurchase agreement, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">repayments of $12.4 million under our Senior Credit Facility and Securitization Facility. We also had $7.6 million in payment of debt issuance costs.  In addition, the Company had $5.2 million in cash taxes paid for net equity settlements. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sources of cash from financing activities for the three months ended March 31, 2023 were $10.2 million borrowing under our Senior Credit Facility and Securitization Facility and $2.3 million proceeds from the exercise of stock options.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Uses of cash from financing activities in the three months ended March&#160;31, 2022 related to the repurchase of treasury stock of $125.0&#160;million under the 2022 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">accelerated share repurchase agreement, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">repayments of $11.8 million under our Senior Credit Facility and Securitization Facility. In addition, we had $9.2 million in cash taxes paid for net equity settlements. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sources of cash from financing activities for the three months ended March 31, 2022 were $11.3 million borrowing under our Senior Credit Facility and Securitization Facility and $1.2 million proceeds from the exercise of stock options.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Amended and Restated Senior Credit Agreement, Convertible Senior Notes, Securitization and Related Hedging Activities</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 6.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Debt</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to the Notes to Consolidated Financial Statements (Part I, Item 1 of this Quarterly Report) for a discussion of our Amended and Restated Senior Credit Agreement, the 2025 Notes and Securitization Facility and Note 7, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivative Instruments</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to the Notes to Consolidated Financial Statements (Part I, Item 1 of this Quarterly Report) for discussion of our hedging activities. We are forecasting that sales and earnings for the next twelve months will be sufficient to remain in compliance with our financial covenants under the terms of the March 2023 Amendment to the Senior Credit Facility. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Share Repurchase Plan</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On January 26, 2023, we entered into ("the 2023 ASR") and received 2.1&#160;million shares of our common stock at inception of the 2023 ASR, which represented approximately 80% of the expected total shares under the 2023 ASR.  The remaining repurchase transactions are expected to be completed in the second quarter of 2023.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 12, 2022, we entered into a $125.0&#160;million </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">accelerated share repurchase ("2022 </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASR") and received </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.48&#160;million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> shares of our common stock at inception of the 2022 ASR, which represented approximately 80% of the expected total shares under the 2022 ASR. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 24, 2022, the early exercise provision under the 2022 ASR was exercised by 2022 ASR counterparty. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon settlement of the 2022 ASR on March 24, 2022, we received an additional 0.46 million shares determined using the volume-weighted average price of our common stock during the term of the 2022 ASR.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 11. Treasury Stock, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to the Notes to Consolidated Financial Statements (Part I, Item 1 of this Quarterly Report) for further details.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Dividend Policy</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have not paid any cash dividends on our common stock since our formation. Our Senior Credit Facility limits the amount of dividends that we may pay. Any future determinations to pay cash dividends on our common stock will be at the discretion of the Board and will depend upon our financial condition, results of operations, cash flows and other factors deemed relevant by the Board.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i5f1eb1bd01d541c3aa0777712077c048_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">"</span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Capital Resources</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our cash and available borrowings under the Senior Credit Facility are sufficient to finance our operations and capital expenditures for the foreseeable future. Our future capital requirements will depend on many factors, including the growth of our business, the timing and introduction of new products and investments, strategic plans and acquisitions, among others. Additional sources of liquidity available to us include short term borrowings and the issuance of long term debt and equity securities.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Off-Balance Sheet Arrangements</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not have any off&#8211;balance sheet financing arrangements during the three months ended March&#160;31, 2023 that have or are reasonably likely to have, a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that are material to our interests.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contractual Obligations and Commitments</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We will continue to have cash requirements to support seasonal working capital needs and capital expenditures, to pay interest, to service debt, and to fund acquisitions. As part of our ongoing operations, we enter into contractual arrangements that obligate us to make future cash payments.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our primary obligations include principal and interest payments on revolving portion and </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Term Loan component of the Senior Credit Facility, Securitization Facility and Convertible Securities. See </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 6. Debt</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to the Notes to Consolidated Financial Statements (Part I, Item 1 of this Quarterly Report) for details. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also lease some of our manufacturing facilities and office buildings which have future minimum lease payments associated. See </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 10. Leases and Related Party Leases</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to the Notes to Consolidated Financial Statements (Part I, Item 1 of this Quarterly Report) </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for a schedule of our future minimum lease payments. Amounts related to our other obligations, including employment agreements and purchase obligations were not material.</span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has contingent consideration obligation related to prior and current year acquisitions and future pension contribution obligations. See </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 9. Retirement Plans</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 16. Commitments and Contingencies</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to the Notes to Consolidated Financial Statements (Part I, Item 1 of this Quarterly Report) for details. The associated obligations are not fixed. We also have a liability for uncertain tax benefits including interest and penalties. We cannot make a reliable estimate of the period in which the uncertain tax benefits may be realized.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div id="i5f1eb1bd01d541c3aa0777712077c048_109"></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OTHER MATTERS</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Estimates</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The critical accounting estimates included in our Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2022 have not materially changed. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently Issued Accounting Standards</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Information regarding new accounting pronouncements is included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Note 1. Basis of Presentation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, to the Notes to Consolidated Financial Statements (Part I, Item 1 of this Quarterly Report)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">to the current period&#8217;s condensed consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><div id="i5f1eb1bd01d541c3aa0777712077c048_112"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i5f1eb1bd01d541c3aa0777712077c048_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">"</span></div></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160;3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are exposed to various market risks, including changes in foreign currency exchange rates and interest rates that could adversely affect our results of operations and financial condition. To manage the volatility relating to these typical business exposures, we may enter into various derivative transactions when appropriate. We do not hold or issue derivative instruments for trading or other speculative purposes.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Foreign Currency Exchange and Other Rate Risks</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate on a global basis and are exposed to the risk that changes in foreign currency exchange rates could adversely affect our financial condition, results of operations and cash flows. We are primarily exposed to foreign currency exchange rate risk with respect to transactions and net assets denominated in Euros, British pounds, Swiss francs, Canadian dollars, Japanese yen, Mexican pesos, Brazilian reais, Australian dollars and Chinese yuan. We manage the foreign currency exposure centrally, on a combined basis, which allows us to net exposures and to take advantage of any natural offsets. To mitigate the impact of currency fluctuations on transactions denominated in nonfunctional currencies, we periodically enter into derivative financial instruments in the form of foreign currency exchange forward contracts with major financial institutions. We temporarily record realized and unrealized gains and losses on these contracts that qualify as cash flow hedges in other comprehensive income, and then recognize them in other income or expense when the hedged item affects net earnings.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">From time to time, we enter into foreign currency forward exchange contracts to manage currency exposures for transactions denominated in a currency other than an entity&#8217;s functional currency. As a result, the impact of foreign currency gains/losses recognized in earnings are partially offset by gains/losses on the related foreign currency forward exchange contracts in the same reporting period. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Note 7. Derivative Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, to Notes to Consolidated Financial Statements (Part I, Item 1 of this Quarterly Report) for further information.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain written policies and procedures governing our risk management activities. With respect to derivatives, changes in hedged items are generally expected to be completely offset by changes in the fair value of hedge instruments. Consequently, foreign currency exchange contracts would not subject us to material risk due to exchange rate movements, because gains and losses on these contracts offset gains and losses on the assets, liabilities or transactions being hedged.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The results of operations discussed herein have not been materially affected by inflation.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Interest Rate Risk</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Cash and Cash Equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - We are exposed to the risk of interest rate fluctuations on the interest income earned on our cash and cash equivalents. A hypothetical 100 basis points movement in interest rates applicable to our cash and cash equivalents outstanding at March&#160;31, 2023 would impact interest income by approximately $3.1&#160;million on an annual basis. We are subject to foreign currency exchange risk with respect to cash balances maintained in foreign currencies.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%;text-decoration:underline">Debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> - Our interest rate risk relates primarily to U.S. dollar SOFR-indexed borrowings. We use interest rate swap derivative instruments to manage our earnings and cash flow exposure to changes in interest rates. These interest rate swaps fix the interest rate on a portion of our expected SOFR-indexed floating-rate borrowings. These interest rate swaps were designated as cash flow hedges as of March&#160;31, 2023. The total notional amounts related to the Company&#8217;s interest rate swaps were $1.5 billion with $775.0 million effective as of March&#160;31, 2023. Based on our outstanding borrowings at March&#160;31, 2023, a 100 basis points change in interest rates would have impacted interest expense on the unhedged portion of the debt by $1.0 million on an annualized basis. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Note 7. Derivative Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, to the Notes to Consolidated Financial Statements (Part I, Item 1 of this Quarterly Report) for further information regarding interest rate swaps.</span></div><div id="i5f1eb1bd01d541c3aa0777712077c048_115"></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160;4. CONTROLS AND PROCEDURES</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Evaluation of Disclosure Controls and Procedures</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain disclosure controls and procedures that are designed to provide reasonable assurance that information required to be disclosed in our Exchange Act report is recorded, processed, summarized and reported within the time periods specified in the SEC&#8217;s rules and forms and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosure. Disclosure controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management is required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Management has designed our disclosure controls and procedures to provide reasonable assurance of achieving the desired control objectives.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i5f1eb1bd01d541c3aa0777712077c048_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">"</span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As required by Exchange Act Rule&#160;13a-15(b), we have carried out an evaluation, under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, of the effectiveness of the design and operation of our disclosure controls and procedures as of March&#160;31, 2023. Based upon this evaluation, our principal executive officer and principal financial officer concluded that our disclosure controls and procedures were effective as of March&#160;31, 2023 to provide such reasonable assurance.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Changes in Internal Control Over Financial Reporting</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no changes in our internal control over financial reporting (as defined in Rule&#160;13a-15(f) under the Exchange Act) that occurred during the quarter ended March&#160;31, 2023&#160;that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In response to business integration activities, we have and will continue to further align and streamline the design and operation of the financial control environment to be responsive to the changing business model. </span></div><div id="i5f1eb1bd01d541c3aa0777712077c048_118"></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II. OTHER INFORMATION</span></div><div id="i5f1eb1bd01d541c3aa0777712077c048_121"></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160;1. LEGAL PROCEEDINGS</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information pertaining to legal proceedings can be found in Note 16, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commitment and Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to the Notes to Consolidated Financial Statements (Part I, Item 1 of this Quarterly Report).</span></div><div id="i5f1eb1bd01d541c3aa0777712077c048_124"></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160;1A. RISK FACTORS </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no material changes in our risk factors included in our Annual Report on Form 10-K for the fiscal year ended </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2022</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and subsequent periodic reports filed with the Securities and Exchange Commission pursuant to the Securities Exchange Act of 1934, as amended (the "Exchange Act").</span></div><div id="i5f1eb1bd01d541c3aa0777712077c048_127"></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160;2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information about purchases by us during the quarter ended March&#160;31, 2023 of equity securities that are registered by us pursuant to Section 12 of the Exchange Act. Subject to applicable law, share repurchases may be made from time to time in open market transactions, privately negotiated transactions including accelerated share repurchase agreements, or pursuant to instruments and plans complying with Rule 10b5-1 under the Exchange Act, among other types of transactions and arrangements.</span></div><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:13.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.420%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.724%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.613%"></td><td style="width:0.1%"></td></tr><tr><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Issuer purchases of equity securities</span></td></tr><tr style="height:15pt"><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Period</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total number of shares purchased by month</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average price paid per share</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total number of shares purchased by month as part of publicly announced repurchase programs</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Approximate dollar value of shares that may yet be purchased under the plans or program</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">01/01/23 - 01/31/23</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,111,189&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">56.68&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,111,189&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,000,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">02/01/23 - 02/28/23</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">03/01/23 - 03/31/23</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,111,189&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">56.68&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,111,189&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,000,000&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 26, 2023, the Company entered into the 2023 ASR and received 2.1 million shares of our common stock at inception of the 2023 ASR, which represented approximately 80% of the expected total shares under the 2023 ASR.  The remaining repurchase transactions are expected to be completed in the second quarter of 2023. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 11, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Treasury Stock, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to the Notes to Consolidated Financial Statements (Part I, Item 1 of this Quarterly Report) for additional information regarding our share repurchase program and the 2023 ASR. </span></div><div id="i5f1eb1bd01d541c3aa0777712077c048_130"></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160;4. MINE SAFETY DISCLOSURES </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div id="i5f1eb1bd01d541c3aa0777712077c048_133"></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 5. OTHER INFORMATION</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><div id="i5f1eb1bd01d541c3aa0777712077c048_136"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i5f1eb1bd01d541c3aa0777712077c048_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">"</span></div></div><div style="-sec-extract:summary;margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 6. EXHIBITS</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:10.240%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.714%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.646%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 12.25pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibits</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 12.25pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1(a)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752006000066/ex3-1aform10k031406.txt">Amended and Restated Certificate of Incorporation of the Company dated February 16, 1993 (Incorporated by reference to Exhibit 3.1(a) to the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December 31, 2005)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 12.25pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1(b)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/0000889812-99-001063.txt">Certificate of Amendment to Amended and Restated Certificate of Incorporation of the Company dated May 22, 1998 (Incorporated by reference to Exhibit 3.1(b) to the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December 31, 1998)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 12.25pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1(c)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/917520/000095012305003217/y06769exv3w1wc.txt">Certificate of Amendment to Amended and Restated Certificate of Incorporation of the Company dated May 17, 1999 (Incorporated by reference to Exhibit 3.1(c) to the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December 31, 2004)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 12.25pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1(d)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/917520/000091752016000107/ex_3x1xfileddecember22x2016.htm">Certificate of Amendment to Amended and Restated Certificate of Incorporation of the Company dated December 21, 2016 (Incorporated by reference to Exhibit 3.1 to the Company&#8217;s Current Report on Form 8-K filed on December 22, 2016)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 12.25pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/917520/000091752018000042/ex3_1xsecondarbylawsxdec20.htm">Second Amended and Restated Bylaws of Integra LifeSciences Holdings Corporation, effective as of December 11, 2018 (Incorporated by reference to Exhibit 3.2 to the Company&#8217;s Current Report on Form 8-k filed on December 12, 2018)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 12.25pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/917520/000091752023000015/iart-20221231xexx33.htm">Third Amended and Restated Bylaws of Integra LifeSciences Holdings Corporation, effective as of February 21, 2023 (Incorporated by reference to Exhibit 3.3 to the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December 31, 2022 filed on February 22, 2023)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 12.25pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/917520/000091752023000017/integra-7tharcreditagree.htm">Seventh Amended and Restated Credit Agreement, dated as of March 24, 2023, among Integra LifeSciences Holdings Corporation, the lenders party thereto, Bank of America, N.A., as Administrative Agent, Swing Line Lender and L/C Issuer, Citibank N.A., JPMorgan Chase Bank, N.A., Morgan Stanley MUFG Loan Partners, LLC, PNC Bank, N.A., Truist Securities, Inc. and Wells Fargo Bank, N.A., as Co-Syndication Agents, and The Bank of Nova Scotia, BMO Harris Bank N.A., BNP Paribas, Capital One, National Association, Citizens Bank, N.A., DNB Bank ASA, New York Branch, Santander Bank, N.A. and TD Bank, N.A., as Co-Documentation Agents (Incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on March 24, 2023).</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 12.25pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/917520/000091752023000017/integraratificationagree.htm">Ratification Agreement, dated as of March 24, 2023, between Integra LifeSciences Holdings Corporation, the Subsidiary Guarantors of Integra LifeSciences Holdings Corporation and Bank of America, N.A., as Administrative Agent (Incorporated by reference to Exhibit 10.2 to the Company&#8217;s Current Report on Form 8-K filed on March 24, 2023).</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 12.25pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3(a)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/917520/000091752023000015/iart-20221231xexx103h.htm">Form of Integra LifeSciences Holdings Corporation Fifth Amended and Restated 2003 Equity Incentive Plan Restricted Stock Award Agreement &#8211; Directors (Incorporated by reference to Exhibit 10.3(h) to the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December 31, 2022 filed on February 22, 2023) #</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 12.25pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3(b)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/917520/000091752023000015/iart-20221231xexx103i.htm">Form of Integra LifeSciences Holdings Corporation Fifth Amended and Restated 2003 Equity Incentive Plan Restricted Stock Agreement &#8211; Executive Officers (Incorporated by reference to Exhibit 10.3(i) to the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December 31, 2022 filed on February 22, 2023) #</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 12.25pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3(c)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/917520/000091752023000015/iart-20221231xexx103j.htm">Form of Integra LifeSciences Holdings Corporation Fifth Amended and Restated 2003 Equity Incentive Plan Performance Stock Unit Award Agreement (Incorporated by reference to Exhibit 10.3(j) to the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December 31, 2022 filed on February 22, 2023) +</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 12.25pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3(d)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/917520/000091752023000015/iart-20221231xexx103k.htm">Form of Integra LifeSciences Holdings Corporation Fifth Amended and Restated 2003 Equity Incentive Plan Non-Qualified Stock Option Award Agreement (Incorporated by reference to Exhibit 10.3(k) to the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December 31, 2022 filed on February 22, 2023) +</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 12.25pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3(e)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/917520/000091752023000015/iart-20221231xexx103l.htm">Form of Integra LifeSciences Holdings Corporation Fifth Amended and Restated 2003 Equity Incentive Plan Restricted Stock Award Agreement &#8211; OUS (Incorporated by reference to Exhibit 10.3(l) to the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December 31, 2022 filed on February 22, 2023) +</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i5f1eb1bd01d541c3aa0777712077c048_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">"</span></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:10.240%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.714%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.646%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 12.25pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*10.4</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="iart-20230331xexx104.htm">Amendment No. 4 to Receivables Financing Agreement and Reaffirmation of Performance Guaranty, dated as of April 17, 2023, by and among, Integra Receivables LLC, Integra LifeSciences Sales LLC, as Servicer, PNC Bank, National Associations, as Administrative Agent, PNC Capital Markets LLC, as Structuring Agent, Committed Lender and Group Agent, and certain lenders and group agents that are parties thereto from time to time</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 12.25pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*31.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="iart-20230331xexx311.htm">Certification of Principal Executive Officer Pursuant to Section&#160;302 of the Sarbanes-Oxley Act of 2002</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 12.25pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*31.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="iart-20230331xexx312.htm">Certification of Principal Financial Officer Pursuant to Section&#160;302 of the Sarbanes-Oxley Act of 2002</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 12.25pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*32.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="iart-20230331xexx321.htm">Certification of Principal Executive Officer Pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 12.25pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*32.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="iart-20230331xexx322.htm">Certification of Principal Financial Officer Pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*&#8224;101.INS</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*&#8224;101.SCH</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Schema Document</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*&#8224;101.CAL</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Calculation Linkbase Document</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*&#8224;101.DEF</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Definition Linkbase Document</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*&#8224;101.LAB</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Labels Linkbase Document</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*&#8224;101.PRE</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Presentation Linkbase Document</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)</span></td></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:4.635%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.165%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Filed herewith</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">#</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indicates a management contract or compensatory plan or arrangement.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8224;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The financial information of Integra LifeSciences Holdings Corporation Quarterly Report on Form 10-Q for the quarter ended March&#160;31, 2023 filed on April&#160;26, 2023 formatted in XBRL (Extensible Business Reporting Language): (i)&#160;the Condensed Consolidated Statements of Operations and Comprehensive Income, (ii)&#160;the Condensed Consolidated Balance Sheets, (iii)&#160;Parenthetical Data to the Condensed Consolidated Balance Sheets, (iv)&#160;the Condensed Consolidated Statements of Cash Flows, and (v)&#160;Notes to Condensed Consolidated Financial Statements, is furnished electronically herewith.</span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><div id="i5f1eb1bd01d541c3aa0777712077c048_139"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i5f1eb1bd01d541c3aa0777712077c048_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">"</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.906%"><tr><td style="width:1.0%"></td><td style="width:4.845%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.430%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.015%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.310%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 26, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Jan De Witte</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jan De Witte</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President and Chief Executive Officer</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Executive Officer)</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 26, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Jeffrey A. Mosebrook</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jeffrey A. Mosebrook</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Vice President, Finance</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial Officer and Principal Accounting Officer)</span></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.4
<SEQUENCE>2
<FILENAME>iart-20230331xexx104.htm
<DESCRIPTION>EX-10.4
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i29d3ee780415406894d01c68f622cdf1_58"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exhibit 10.4</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">AMENDMENT NO. 4 TO RECEIVABLES FINANCING AGREEMENT</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">AND</font></div><div style="margin-bottom:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">REAFFIRMATION OF PERFORMANCE GUARANTY </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">This AMENDMENT NO. 4 TO RECEIVABLES FINANCING AGREEMENT AND REAFFIRMATION OF PERFORMANCE GUARANTY (this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Amendment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), dated as of April 17, 2023 is entered into by and among INTEGRA RECEIVABLES LLC (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Integra</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), as borrower under the Receivables Financing Agreement (as defined below) (in such capacity, together with its successors and permitted assigns in such capacity, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Borrower</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), INTEGRA LIFESCIENCES SALES LLC (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Integra Sales</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), as initial servicer under the Receivables Financing Agreement (in such capacity, together with its successors and permitted assigns in such capacity, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Servicer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), PNC BANK, NATIONAL ASSOCIATION (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">PNC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), as administrative agent under the Receivables Financing Agreement (in such capacity, together with its successors and permitted assigns in such capacity, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Administrative Agent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), as a committed lender under the Receivables Financing Agreement (in such capacity, together with its successors and permitted assigns in such capacity, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Committed Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), and as group agent for the PNC Group under the Receivables Financing Agreement (in such capacity, together with its successors and permitted assigns in such capacity, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Group Agent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), and the various other Lenders and Group Agents from time to time party to the Receivables Financing Agreement, and acknowledged and agreed to by PNC CAPITAL MARKETS LLC, as structuring agent (in such capacity, together with its successors and permitted assigns in such capacity, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Structuring Agent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), and is reaffirmed by, with respect to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> hereof, INTEGRA LIFESCIENCES HOLDINGS CORPORATION (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Integra Holdings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), as performance guarantor (in such capacity, together with its successors and permitted assigns in such capacity, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Performance Guarantor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">BACKGROUND</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">WHEREAS, the Borrower, the Servicer, the Persons from time to time party thereto as Lenders and as Group Agents, the Administrative Agent, and, solely with respect to Section 10.10 thereof, the Structuring Agent, entered into the Receivables Financing Agreement, dated as of December 21, 2018 (as amended, restated, supplemented or otherwise modified prior to the date hereof, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Original Receivables Financing Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;&#59; and as amended by this Amendment and as may be further amended, restated, supplemented or otherwise modified from time to time, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Receivables Financing Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;)&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">WHEREAS, the Performance Guarantor entered into the Performance Guaranty as of December 21, 2018 (as may be further amended, restated, supplemented or otherwise modified from time to time, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Performance Guaranty</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) in favor of, and as accepted by, the Administrative Agent&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">WHEREAS, the parties hereto wish to further amend the Original Receivables Financing Agreement pursuant to the terms and conditions set forth herein.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">NOW, THEREFORE, in consideration of the foregoing and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto hereby agree as follows&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9.36pt">Definitions.  Capitalized terms used but not defined in this Amendment shall have the meanings assigned to them in the Receivables Financing Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9.36pt">Amendments to Original Receivables Financing Agreement.  Effective as of the date hereof and subject to the satisfaction of the conditions precedent set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">123470162&#92;V-4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">hereof, the Original Receivables Financing Agreement is hereby amended to add or delete such text as may be necessary to conform the Original Receivables Purchase Agreement to the agreement attached as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9.36pt">Representations, Warranties and Enforceability.  Each of the Borrower and the Servicer hereby represents and warrants to the Administrative Agent, the Group Agents and the Lenders, as applicable, as of the date hereof with respect to itself, as follows&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">the representations and warranties of it contained in Section 6.01 and Section 6.02, as applicable, of the Receivables Financing Agreement are true and correct in all material respects (unless such representations and warranties contain a materiality qualification, in which case, such representations and warranties shall be true and correct as made) on and as of the date hereof as though made on and as of such date unless such representations and warranties by their terms refer to an earlier date, in which case they shall be true and correct in all material respects (unless such representations and warranties contain a materiality qualification, in which case such representations and warranties shall be true and correct as made) on and as of such earlier date&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">(i) the execution and delivery by it of this Amendment, and the performance of its obligations under this Amendment and the Receivables Financing Agreement are within its organizational powers and have been duly authorized by all necessary action on its part and (ii) this Amendment and the Receivables Financing Agreement are its valid and legally binding obligations, enforceable in accordance with their respective terms.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9.36pt">Conditions Precedent.  The effectiveness of this Amendment is subject to the satisfaction of all of the following conditions precedent&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">The Administrative Agent shall have received a fully executed counterpart of this Amendment.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:22.02pt">(i) PNC, as the Administrative Agent, as a Committed Lender and as the Group Agent for the PNC Group under the Receivables Financing Agreement, as applicable, shall have received all fees and other amounts due and payable to it under the Transaction Documents and in connection with this Amendment on or prior to the date hereof, including, to the extent invoiced, payment or reimbursement of all fees and expenses (including reasonable and documented out-of-pocket fees, charges and disbursements of counsel) required to be paid or reimbursed on or prior to the date hereof and (ii) PNC Capital Markets LLC, as Structuring Agent under the Receivables Financing Agreement, shall have received a one-time fee (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Amendment Fee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;) in an amount equal to Fifty Thousand Dollars ($50,000), which Amendment Fee shall accrue and be due and payable on the date hereof .  To the extent such fees and other amounts have not yet been invoiced, the Borrower agrees to remit payment to the applicable party promptly upon receipt of such invoice.</font></div><div style="text-indent:54pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">No Event of Default or Unmatured Event of Default, as set forth in Section 9.01 of the Receivables Financing Agreement, shall have occurred and be continuing.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9.36pt">Amendment.  The Borrower, the Servicer, the Administrative Agent, the Group Agents, the Lenders, and, with respect to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> hereof, the Performance Guarantor, hereby agree that the provisions and effectiveness of this Amendment shall apply to the Receivables Financing Agreement as of the date hereof.  Except as amended by this Amendment, the Original Receivables Financing Agreement remains unchanged and in full force and effect.  This Amendment is a Transaction Document.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">123470162&#92;V-4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9.36pt">Counterparts.  This Amendment may be executed in any number of counterparts, each of which when so executed shall be deemed to be an original and all of which when taken together shall constitute one and the same agreement.  Delivery of an executed counterpart hereof by facsimile or other electronic means shall be equally effective as delivery of an originally executed counterpart.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9.36pt">Captions.  The headings of the Sections of this Amendment are provided solely for convenience of reference and shall not modify, define, expand or limit any of the terms or provisions of this Amendment.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9.36pt">Successors and permitted assigns.  The terms of this Amendment shall be binding upon, and shall inure to the benefit of, the Borrower, the Servicer, the Administrative Agent, the Group Agents, the Lenders, and, with respect to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> hereof, the Performance Guarantor and their respective successors and permitted assigns.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9.36pt">Severability.  Any provision of this Amendment which is prohibited or unenforceable in any jurisdiction shall, as to such jurisdiction, be ineffective to the extent of such prohibition or unenforceability without invalidating the remaining provisions hereof, and any such prohibition or unenforceability in any jurisdiction shall not invalidate or render unenforceable such provision in any other jurisdiction.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:3.36pt">Governing Law and Jurisdiction.  The provisions of the Receivables Financing Agreement with respect to governing law, jurisdiction, and agent for service of process are incorporated in this Amendment by reference as if such provisions were set forth herein.</font></div><div style="margin-bottom:18pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:3.36pt">Ratification of Performance Guarantee.  After giving effect to this Amendment, all of the provisions of the Performance Guaranty shall remain in full force and effect and the Performance Guarantor hereby ratifies and affirms the Performance Guaranty and acknowledges that the Performance Guaranty has continued and shall continue in full force and effect in accordance with its terms.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#91;REMAINDER OF PAGE INTENTIONALLY LEFT BLANK&#93;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">123470162&#92;V-4</font></div></div></div><div id="i29d3ee780415406894d01c68f622cdf1_61"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:30pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">IN WITNESS WHEREOF, the parties hereto have executed this Amendment by their duly authorized officers as of the date first above written.</font></div><div style="padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">INTEGRA RECEIVABLES LLC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">,</font></div><div style="margin-bottom:30pt;padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">as the Borrower</font></div><div style="padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;&#47;s&#47; Matthieu Aussermeier&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> Matthieu Aussermeier&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:30pt;padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title&#58;  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;Treasurer&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">INTEGRA LIFESCIENCES SALES LLC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">,</font></div><div style="margin-bottom:12pt;padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">as the Servicer </font></div><div style="margin-bottom:30pt;padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58; Integra LifeSciences Corporation, its sole member</font></div><div style="padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;&#47;s&#47; Matthieu Aussermeier&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> Matthieu Aussermeier&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:30pt;padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title&#58;  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;Treasurer&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="padding-left:216pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Amendment No. 4 to RFA (Integra)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">S-1</font></div></div></div><div id="i29d3ee780415406894d01c68f622cdf1_64"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:30pt;padding-right:252pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Acknowledged and reaffirmed by, with respect to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> hereof, as of the date first written above&#58;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="padding-right:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font></div><div style="margin-bottom:30pt;padding-right:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">as the Performance Guarantor</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;&#47;s&#47; Matthieu Aussermeier&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58;   </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Matthieu Aussermeier&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:30pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title&#58;  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160; Treasurer&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="padding-left:216pt;text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Amendment No. 4 to RFA (Integra)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">S-2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">PNC BANK, NATIONAL ASSOCIATION</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">,</font></div><div style="margin-bottom:30pt;padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">as the Administrative Agent</font></div><div style="padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> &#47;s&#47; Eric Bruno&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58;  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> Eric Bruno&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:30pt;padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title&#58;  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;Senior Vice President&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">PNC BANK, NATIONAL ASSOCIATION</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">,</font></div><div style="margin-bottom:30pt;padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">as the Group Agent for the PNC Group</font></div><div style="padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> &#47;s&#47; Eric Bruno&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58;  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> Eric Bruno&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:30pt;padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title&#58;  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;Senior Vice President&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">PNC BANK, NATIONAL ASSOCIATION</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">,</font></div><div style="margin-bottom:30pt;padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">as a Committed Lender</font></div><div style="padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> &#47;s&#47; Eric Bruno&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58;  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> Eric Bruno&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:30pt;padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title&#58;  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;Senior Vice President&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:30pt;padding-right:252pt;text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Amendment No. 4 to RFA (Integra)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">S-3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:30pt;padding-right:252pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Acknowledged and agreed to by, as of the date first written above&#58;&#160;&#160;&#160;&#160;</font></div><div style="padding-right:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">PNC CAPITAL MARKETS LLC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font></div><div style="margin-bottom:30pt;padding-right:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">as the Structuring Agent</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> &#47;s&#47; Eric Bruno&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">  Eric Bruno&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title&#58;  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;Managing Director&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Amendment No. 4 to RFA (Integra)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">S-4</font></div></div></div><div id="i29d3ee780415406894d01c68f622cdf1_67"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:18pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit A to Amendment No. 4 to RFA</font></div><div style="margin-bottom:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">CONFORMED RECEIVABLES FINANCING AGREEMENT</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Exhibit A</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">123470162&#92;V-4</font></div></div></div><div id="i29d3ee780415406894d01c68f622cdf1_70"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Exhibit A to Amendment No. 4</font></div></div><div style="margin-bottom:12pt;margin-top:140pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">RECEIVABLES FINANCING AGREEMENT</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Dated as of December 21, 2018</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">by and among</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">INTEGRA RECEIVABLES LLC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">,</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">as Borrower,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">THE PERSONS FROM TIME TO TIME PARTY HERETO</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">,</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">as Lenders and as Group Agents,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">PNC BANK, NATIONAL ASSOCIATION</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">,</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">as Administrative Agent,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">INTEGRA LIFESCIENCES SALES LLC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">as initial Servicer,<br></font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">and</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">PNC CAPITAL MARKETS LLC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">, </font></div><div style="margin-bottom:60pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">as Structuring Agent</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><div id="i29d3ee780415406894d01c68f622cdf1_73"></div><hr style="page-break-after:always"><div style="min-height:118.08pt;width:100%"><div style="margin-bottom:12pt;padding-left:5.75pt;padding-right:5.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">TABLE OF CONTENTS</font></div><div style="margin-bottom:22pt;padding-left:5.75pt;padding-right:5.75pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Page</font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.300%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:52.500%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">ARTICLE I DEFINITIONS</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">SECTION 1.01.</a></font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a></font><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Certain Defined Terms</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">1</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">SECTION 1.02.</a></font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a></font><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Other Interpretative Matters</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">39</a></font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">ARTICLE II TERMS OF THE LOANS</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">SECTION 2.01.</a></font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a></font><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Loan Facility</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">39</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">SECTION 2.02.</a></font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a></font><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Making Loans&#59; Repayment of Loans</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">40</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">SECTION 2.03.</a></font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a></font><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Interest and Fees</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">42</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">SECTION 2.04.</a></font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a></font><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Records of Loans</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">42</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">SECTION 2.05.</a></font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a></font><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Selection of Interest Rates</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">43</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">SECTION 2.06.</a></font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a></font><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Defaulting Lenders</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">43</a></font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">ARTICLE III SETTLEMENT PROCEDURES AND PAYMENT PROVISIONS</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">SECTION 3.01.</a></font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a></font><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Settlement Procedures</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">44</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">SECTION 3.02.</a></font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a></font><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Payments and Computations, Etc</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">47</a></font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">ARTICLE IV INCREASED COSTS&#59; FUNDING LOSSES&#59; TAXES&#59; ILLEGALITY AND SECURITY INTEREST</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">SECTION 4.01.</a></font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a></font><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Increased Costs</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">47</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">SECTION 4.02.</a></font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a></font><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Funding Losses</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">49</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">SECTION 4.03.</a></font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a></font><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Taxes</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">49</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">SECTION 4.04.</a></font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a></font><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Conforming Changes Relating to Term SOFR or Daily 1M SOFR</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">53</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">SECTION 4.05.</a></font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a></font><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Security Interest</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">54</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">SECTION 4.06.</a></font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a></font><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Rate Unascertainable&#59; Illegality&#59; Benchmark Replacement Setting.</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">55</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">SECTION 4.07.</a></font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a></font><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Benchmark Replacement Notification</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">57</a></font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-left:1.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"><tr><td style="width:1.0%"></td><td style="width:43.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.832%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.435%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">-i-</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:118.08pt;width:100%"><div style="padding-left:5.75pt;padding-right:5.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">TABLE OF CONTENTS</font></div><div style="padding-left:5.75pt;padding-right:5.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(continued)</font></div><div style="margin-bottom:22pt;padding-left:5.75pt;padding-right:5.75pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Page</font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.300%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:52.500%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">ARTICLE V CONDITIONS to Effectiveness and CREDIT EXTENSIONS</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">SECTION 5.01.</a></font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a></font><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Conditions Precedent to Effectiveness and the Initial Credit Extension</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">58</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">SECTION 5.02.</a></font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a></font><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Conditions Precedent to All Credit Extensions</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">58</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">SECTION 5.03.</a></font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a></font><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Conditions Precedent to All Releases</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">59</a></font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">ARTICLE VI REPRESENTATIONS AND WARRANTIES</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">SECTION 6.01.</a></font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a></font><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Representations and Warranties of the Borrower</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">60</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">SECTION 6.02.</a></font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a></font><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Representations and Warranties of the Servicer</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">65</a></font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">ARTICLE VII COVENANTS</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">SECTION 7.01.</a></font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a></font><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Covenants of the Borrower</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">69</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">SECTION 7.02.</a></font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a></font><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Covenants of the Servicer</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">78</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">SECTION 7.03.</a></font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a></font><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Separate Existence of the Borrower</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">84</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">SECTION 7.04.</a></font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a></font><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Financial Covenant</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">87</a></font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">ARTICLE VIII ADMINISTRATION AND COLLECTION OF RECEIVABLES</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">SECTION 8.01.</a></font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a></font><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Appointment of the Servicer</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">88</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">SECTION 8.02.</a></font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a></font><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Duties of the Servicer</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">89</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">SECTION 8.03.</a></font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a></font><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Collection Account Arrangements</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">90</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">SECTION 8.04.</a></font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a></font><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Enforcement Rights</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">91</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">SECTION 8.05.</a></font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a></font><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Responsibilities of the Borrower</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">92</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">SECTION 8.06.</a></font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a></font><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Servicing Fee</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">93</a></font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">ARTICLE IX EVENTS OF DEFAULT</a></font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-left:1.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"><tr><td style="width:1.0%"></td><td style="width:43.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.832%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.435%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">-ii-</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:118.08pt;width:100%"><div style="padding-left:5.75pt;padding-right:5.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">TABLE OF CONTENTS</font></div><div style="padding-left:5.75pt;padding-right:5.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(continued)</font></div><div style="margin-bottom:22pt;padding-left:5.75pt;padding-right:5.75pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Page</font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.300%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:52.500%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">SECTION 9.01.</a></font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a></font><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Events of Default</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">93</a></font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">ARTICLE X THE ADMINISTRATIVE AGENT</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">SECTION 10.01.</a></font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a></font><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Authorization and Action</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">97</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">SECTION 10.02.</a></font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a></font><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Administrative Agent&#8217;s Reliance, Etc</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">97</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">SECTION 10.03.</a></font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a></font><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Administrative Agent and Affiliates</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">97</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">SECTION 10.04.</a></font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a></font><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Indemnification of Administrative Agent</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">98</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">SECTION 10.05.</a></font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a></font><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Delegation of Duties</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">98</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">SECTION 10.06.</a></font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a></font><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Action or Inaction by Administrative Agent</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">98</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">SECTION 10.07.</a></font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a></font><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Notice of Events of Default&#59; Action by Administrative Agent</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">98</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">SECTION 10.08.</a></font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a></font><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Non-Reliance on Administrative Agent and Other Parties</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">99</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">SECTION 10.09.</a></font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a></font><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Successor Administrative Agent</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">99</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">SECTION 10.10.</a></font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a></font><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Structuring Agent</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">99</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">SECTION 10.11.</a></font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a></font><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Erroneous Payment</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">100</a></font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">ARTICLE XI THE GROUP AGENTS</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">SECTION 11.01.</a></font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a></font><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Authorization and Action</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">101</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">SECTION 11.02.</a></font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a></font><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Group Agent&#8217;s Reliance, Etc</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">101</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">SECTION 11.03.</a></font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a></font><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Group Agent and Affiliates</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">102</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">SECTION 11.04.</a></font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a></font><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Indemnification of Group Agents</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">102</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">SECTION 11.05.</a></font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a></font><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Delegation of Duties</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">102</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">SECTION 11.06.</a></font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a></font><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Notice of Events of Default</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">102</a></font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-left:1.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"><tr><td style="width:1.0%"></td><td style="width:43.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.832%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.435%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">-iii-</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:118.08pt;width:100%"><div style="padding-left:5.75pt;padding-right:5.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">TABLE OF CONTENTS</font></div><div style="padding-left:5.75pt;padding-right:5.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(continued)</font></div><div style="margin-bottom:22pt;padding-left:5.75pt;padding-right:5.75pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Page</font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.300%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:52.500%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">SECTION 11.07.</a></font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a></font><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Non-Reliance on Group Agent and Other Parties</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">103</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">SECTION 11.08.</a></font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a></font><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Successor Group Agent</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">103</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">SECTION 11.09.</a></font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a></font><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Reliance on Group Agent</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">103</a></font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">ARTICLE XII INDEMNIFICATION</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">SECTION 12.01.</a></font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a></font><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Indemnities by the Borrower</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">103</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">SECTION 12.02.</a></font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a></font><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Indemnification by the Servicer</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">107</a></font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">ARTICLE XIII MISCELLANEOUS</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">SECTION 13.01.</a></font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a></font><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Amendments, Etc</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">108</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">SECTION 13.02.</a></font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a></font><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Notices, Etc</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">109</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">SECTION 13.03.</a></font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a></font><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Assignability&#59; Addition of Lenders&#59; Removal of Lenders</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">109</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">SECTION 13.04.</a></font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a></font><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Costs and Expenses</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">113</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">SECTION 13.05.</a></font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a></font><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">No Proceedings&#59; Limitation on Payments</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">113</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">SECTION 13.06.</a></font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a></font><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Confidentiality</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">114</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">SECTION 13.07.</a></font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a></font><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">GOVERNING LAW</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">116</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">SECTION 13.08.</a></font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a></font><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Execution in Counterparts</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">116</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">SECTION 13.09.</a></font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a></font><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Integration&#59; Binding Effect&#59; Survival of Termination</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">116</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">SECTION 13.10.</a></font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a></font><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">CONSENT TO JURISDICTION</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">116</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">SECTION 13.11.</a></font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a></font><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">WAIVER OF JURY TRIAL</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">117</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">SECTION 13.12.</a></font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a></font><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Ratable Payments</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">117</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">SECTION 13.13.</a></font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a></font><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Limitation of Liability</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">117</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">SECTION 13.14.</a></font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a></font><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Intent of the Parties</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">118</a></font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-left:1.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"><tr><td style="width:1.0%"></td><td style="width:43.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.832%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.435%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">-iv-</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:118.08pt;width:100%"><div style="padding-left:5.75pt;padding-right:5.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">TABLE OF CONTENTS</font></div><div style="padding-left:5.75pt;padding-right:5.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(continued)</font></div><div style="margin-bottom:22pt;padding-left:5.75pt;padding-right:5.75pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Page</font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.300%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:52.500%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">SECTION 13.15.</a></font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a></font><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">USA Patriot Act</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">118</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">SECTION 13.16.</a></font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a></font><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Right of Setoff</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">118</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">SECTION 13.17.</a></font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a></font><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Severability</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">119</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">SECTION 13.18.</a></font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a></font><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Mutual Negotiations</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">119</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">SECTION 13.19.</a></font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">&#160;&#160;&#160;&#160;</a></font><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Captions and Cross References</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#i29d3ee780415406894d01c68f622cdf1_76" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">119</a></font></div></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div style="margin-bottom:12pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-left:1.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"><tr><td style="width:1.0%"></td><td style="width:43.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.832%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.435%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">-v-</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:118.08pt;width:100%"><div style="padding-left:5.75pt;padding-right:5.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">TABLE OF CONTENTS</font></div><div style="padding-left:5.75pt;padding-right:5.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(continued)</font></div><div style="margin-bottom:22pt;padding-left:5.75pt;padding-right:5.75pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Page</font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">EXHIBITS</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">EXHIBIT A&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8211;&#160;&#160;&#160;&#160;Form of Loan Request</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">EXHIBIT B&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8211;&#160;&#160;&#160;&#160;Form of Reduction Notice</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">EXHIBIT C&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Form of Assignment and Acceptance Agreement</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">EXHIBIT D&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8211;&#160;&#160;&#160;&#160;Form of Assumption Agreement</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">EXHIBIT E&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8211;&#160;&#160;&#160;&#160;Credit and Collection Procedures</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">EXHIBIT F&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8211;&#160;&#160;&#160;&#160;Form of Information Package</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">EXHIBIT G&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8211;&#160;&#160;&#160;&#160;Form of Compliance Certificate</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">EXHIBIT H&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8211;&#160;&#160;&#160;&#160;Closing Memorandum</font></div><div style="margin-bottom:24pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">EXHIBIT I&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Form of Interim Report</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">SCHEDULES</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SCHEDULE I&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8211;&#160;&#160;&#160;&#160;Commitments</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SCHEDULE II&#160;&#160;&#160;&#160;&#8211;&#160;&#160;&#160;&#160;Lock-Boxes, Collection Accounts and Collection Account Banks</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SCHEDULE III&#160;&#160;&#160;&#160;&#8211;&#160;&#160;&#160;&#160;Notice Addresses</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SCHEDULE IV&#160;&#160;&#160;&#160;&#8211;&#160;&#160;&#160;&#160;Excluded Obligors and Originators</font></div><div style="margin-bottom:96pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-left:1.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"><tr><td style="width:1.0%"></td><td style="width:43.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.832%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.435%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">-vi-</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><div id="i29d3ee780415406894d01c68f622cdf1_76"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">This RECEIVABLES FINANCING AGREEMENT (as amended, restated, supplemented or otherwise modified from time to time, this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) is entered into as of December 21, 2018 by and among the following parties&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)&#160;&#160;&#160;&#160;INTEGRA RECEIVABLES LLC, a Delaware limited liability company, as Borrower (together with its successors and assigns, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Borrower</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;)&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii)&#160;&#160;&#160;&#160;the Persons from time to time party hereto as Lenders and as Group Agents&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iii)&#160;&#160;&#160;&#160;PNC BANK, NATIONAL ASSOCIATION (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">PNC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> as Administrative Agent&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iv)&#160;&#160;&#160;&#160;INTEGRA LIFESCIENCES SALES LLC, a Delaware limited liability company, in its individual capacity (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Integra Sales</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) and as initial servicer (in such capacity, together with its successors and assigns in such capacity, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Servicer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;)&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(v)&#160;&#160;&#160;&#160;PNC CAPITAL MARKETS LLC, a Pennsylvania limited liability company, as Structuring Agent.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">PRELIMINARY STATEMENTS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Borrower has acquired, and will acquire from time to time, Receivables from the Originator(s) pursuant to the Purchase and Sale Agreement.  The Borrower has requested that the Lenders make Loans from time to time to the Borrower, on the terms, and subject to the conditions set forth herein, secured by, among other things, the Receivables.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">In consideration of the mutual agreements, provisions and covenants contained herein, the sufficiency of which is hereby acknowledged, the parties hereto agree as follows&#58;</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ARTICLE 1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:8.36pt"><br><br>DEFINITIONS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1.0a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:31.04pt">Certain Defined Terms.  As used in this Agreement, the following terms shall have the following meanings (such meanings to be equally applicable to both the singular and plural forms of the terms defined)&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Account Control Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means each agreement, in form and substance satisfactory to the Administrative Agent, among the Borrower, the Servicer (if applicable), the Administrative Agent and a Collection Account Bank, governing the terms of the related Collection Accounts that (i) provides the Administrative Agent with control within the meaning of the UCC over the deposit accounts subject to such agreement and (ii) by its terms, may not be terminated or canceled by the related Collection Account Bank without the written consent of the Administrative Agent or upon no less than sixty (60) calendar days&#8217; prior written notice to the Administrative Agent, as the same may be amended, restated, supplemented or otherwise modified from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Adjusted Net Receivables Pool Balance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means an amount equal to (a) the Net Receivables Pool Balance minus (b) the greater of (i) the Specifically Reserved Dilution Amount and (ii) zero.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Administrative Agent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means PNC, in its capacity as contractual representative for the Credit Parties, and any successor thereto in such capacity appointed pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Article X or Section 13.03(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Adverse Claim</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any ownership interest or claim, mortgage, deed of trust, pledge, lien, security interest, hypothecation, charge or other encumbrance or security arrangement of any nature whatsoever, whether voluntarily or involuntarily given, including, but not limited to, any conditional sale or title retention arrangement, and any assignment, deposit arrangement or lease intended as, or having the effect of, security and any filed financing statement or other notice of any of the foregoing (whether or not a lien or other encumbrance is created or exists at the time of the filing)&#59; it being understood that any of the foregoing in favor of, or assigned to, the Administrative Agent (for the benefit of the Secured Parties) shall not constitute an Adverse Claim.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Advisors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 13.06(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Affected Person</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means each Credit Party, each Program Support Provider, each Liquidity Agent and each of their respective Affiliates.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Affiliate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, as to any Person&#58; (a) any Person that, directly or indirectly, is in control of, is controlled by or is under common control with such Person or (b) who is a director or officer&#58;  (i) of such Person or (ii) of any Person described in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">clause (a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, except that, in the case of each Conduit Lender, Affiliate shall mean the holder(s) of its Capital Stock or membership interests, as the case may be.  For purposes of this definition, control of a Person shall mean the power, direct or indirect, whether or not exercised&#58;  (x) to vote 25% or more of the securities having ordinary voting power for the election of directors or managers of such Person or (y) to direct or cause the direction of the management and policies of such Person, in either case whether by ownership of securities, contract, proxy or otherwise.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Aggregate Capital</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, at any time of determination, the aggregate outstanding Capital of all Lenders at such time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Aggregate Interest</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, at any time of determination, the aggregate accrued and unpaid Interest on the Loans of all Lenders at such time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">preamble</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> to this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Alternative Currency</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means each of Euro and GBP.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Anti-Terrorism Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any Applicable Law relating to terrorism financing, trade sanctions programs and embargoes, import&#47;export licensing, money laundering or bribery, and any regulation, order, or directive promulgated, issued or enforced pursuant to such Applicable Laws, all as amended, supplemented or replaced from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Applicable Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Person, (x) all provisions of law, statute, treaty, constitution, ordinance, rule, regulation, ordinance, requirement, restriction, permit, executive order, certificate, decision, directive or order of any Governmental Authority applicable to such Person or any of its property and (y) all judgments, injunctions, orders, writs, decrees and awards of all courts and arbitrators in proceedings or actions in which such Person is a party or by which any of its property is bound.  For the avoidance of doubt, FATCA shall constitute an &#8220;Applicable Law&#8221; for all purposes of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Assignment and Acceptance Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means an assignment and acceptance agreement entered into by a Committed Lender, an Eligible Assignee, such Committed Lender&#8217;s </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Group Agent and the Administrative Agent, and, if required, the Borrower, pursuant to which such Eligible Assignee may become a party to this Agreement, in substantially the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit C</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> hereto.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Assumption Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 13.03(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Attorney Costs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means and includes all fees, costs, expenses and disbursements of any law firm or other external counsel and all disbursements of internal counsel.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Available Tenor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, as of any date of determination and with respect to the then-current Benchmark, as applicable, if such Benchmark (a) is Term SOFR or Daily 1M SOFR, one (1) month, and (b) is a term rate, any tenor for such Benchmark (or component thereof) that is or may be used for determining the length of an interest period pursuant to this Agreement as of such date and not including, for the avoidance of doubt, any tenor of such Benchmark that is then-removed from the definition of &#8220;Interest Period&#8221; pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 4.06(d)(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Bankruptcy Code</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the United States Bankruptcy Reform Act of 1978 (11 U.S.C. &#167; 101, et seq.), as amended from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Base Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, for any day and any Lender, a fluctuating interest rate </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">per annum</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> as shall be in effect from time to time, which rate shall be at all times equal to the greater of&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">the rate of interest in effect for such day as publicly announced from time to time by the applicable Group Agent or its Affiliate as its &#8220;reference rate&#8221; or &#8220;prime rate&#8221;, as applicable.  Such &#8220;reference rate&#8221; or &#8220;prime rate&#8221; is set by the applicable Group Agent or its Affiliate based upon various factors, including such Person&#8217;s costs and desired return, general economic conditions and other factors, and is used as a reference point for pricing some loans, which may be priced at, above or below such announced rate, and is not necessarily the lowest rate charged to any customer&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">a half percent (0.50%) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">per annum</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> above the latest Overnight Bank Funding Rate.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Base Rate Loan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means a Loan bearing interest at the Base Rate.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Benchmark</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, initially, the Term SOFR Rate or the Daily SOFR Rate, as applicable&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that if a Benchmark Transition Event has occurred with respect to the then-current Benchmark, then &#8220;Benchmark&#8221; means the applicable Benchmark Replacement to the extent that such Benchmark Replacement has replaced such prior benchmark rate pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 4.06</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Benchmark Replacement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Benchmark Transition Event, the first alternative set forth in the order below that can be determined by the Administrative Agent for the applicable Benchmark Replacement Date&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(1)&#160;&#160;&#160;&#160;the sum of&#58; (A) Daily Simple SOFR, and (B) the SOFR Adjustment&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(2)&#160;&#160;&#160;&#160;the sum of (A) the alternate benchmark rate that has been selected by the Administrative Agent and the Borrower, giving due consideration to (x) any selection or recommendation of a replacement benchmark rate or the mechanism for determining such a rate by the Relevant Governmental Body or (y) any evolving or then-prevailing market convention for determining a benchmark rate as a replacement to the then-current Benchmark for U.S. dollar-denominated syndicated credit facilities at such time and (B) the related Benchmark Replacement Adjustment&#59; </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that if the Benchmark Replacement as determined pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">clause (2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> above would be less than the Floor, the Benchmark Replacement will be deemed to be the Floor for the purposes of this Agreement and the other Transaction Documents.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Benchmark Replacement Adjustment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, with respect to any replacement of the then-current Benchmark with an Unadjusted Benchmark Replacement, the spread adjustment, or method for calculating or determining such spread adjustment, (which may be a positive or negative value or zero) that has been selected by the Administrative Agent and the Borrower, giving due consideration to (A) any selection or recommendation of a spread adjustment, or method for calculating or determining such spread adjustment, for the replacement of such Benchmark with the applicable Unadjusted Benchmark Replacement by the Relevant Governmental Body or (B) any evolving or then-prevailing market convention for determining a spread adjustment, or method for calculating or determining such spread adjustment, for the replacement of such Benchmark with the applicable Unadjusted Benchmark Replacement for U.S. dollar-denominated syndicated credit facilities at such time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Benchmark Replacement Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means a date and time determined by the Administrative Agent, which date shall be no later than the earliest to occur of the following events with respect to the then-current Benchmark&#58;  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(1) in the case of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">clause (1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> of the definition of &#8220;Benchmark Transition Event,&#8221; the later of (A) the date of the public statement or publication of information referenced therein and (B) the date on which the administrator of such Benchmark (or the published component used in the calculation thereof) permanently or indefinitely ceases to provide such Benchmark (or such component thereof) or, if such Benchmark is a term rate or is based on a term rate, all Available Tenors of such Benchmark (or such component thereof)&#59; or</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(2) in the case of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">clause (3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> of the definition of &#8220;Benchmark Transition Event,&#8221; the date determined by the Administrative Agent, which date shall promptly follow the date of the public statement or publication of information referenced therein&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">For the avoidance of doubt, if such Benchmark is a term rate or is based on a term rate, the &#8220;Benchmark Replacement Date&#8221; will be deemed to have occurred in the case of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">clause (1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> with respect to any Benchmark upon the occurrence of the applicable event or events set forth therein with respect to all then-current Available Tenors of such Benchmark (or the published component used in the calculation thereof).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Benchmark Transition Event</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, the occurrence of one or more of the following events, with respect to the then-current Benchmark&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(1)&#160;&#160;&#160;&#160;a public statement or publication of information by or on behalf of the administrator of such Benchmark (or the published component used in the calculation thereof) announcing that such administrator has ceased or will cease to provide such Benchmark (or such component thereof) or, if such Benchmark is a term rate or is based on a term rate, all Available Tenors of such Benchmark (or such component thereof), permanently or indefinitely&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that, at the time of such statement or publication, there is no successor administrator that will continue to provide any Available Tenor of such Benchmark (or such component thereof)&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(2)&#160;&#160;&#160;&#160;a public statement or publication of information by a Governmental Authority having jurisdiction over the Administrative Agent, the regulatory supervisor for the administrator of such Benchmark (or the published component used in the calculation thereof), the Federal Reserve Board, the Federal Reserve Bank of New York, an insolvency official with jurisdiction over the administrator for such Benchmark (or such component), a resolution authority with jurisdiction over the administrator for such Benchmark (or such component) or a court or an </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">entity with similar insolvency or resolution authority over the administrator for such Benchmark (or such component), which states that the administrator of such Benchmark (or such component) has ceased or will cease to provide such Benchmark (or such component thereof) or, if such Benchmark is a term rate or is based on a term rate, all Available Tenors of such Benchmark (or such component thereof) permanently or indefinitely, provided that, at the time of such statement or publication, there is no successor administrator that will continue to provide such Benchmark (or such component thereof) or, if such Benchmark is a term rate or is based on a term rate, any Available Tenor of such Benchmark (or such component thereof)&#59; or</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(3)&#160;&#160;&#160;&#160;a public statement or publication of information by the regulatory supervisor for the administrator of such Benchmark (or the published component used in the calculation thereof) or a Governmental Authority having jurisdiction over the Administrative Agent announcing that such Benchmark (or such component thereof) or, if such Benchmark is a term rate or is based on a term rate, all Available Tenors of such Benchmark (or such component thereof) are not, or as of a specified future date will not be, representative.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">For the avoidance of doubt, if such Benchmark is a term rate or is based on a term rate, a &#8220;Benchmark Transition Event&#8221; will be deemed to have occurred with respect to any Benchmark if a public statement or publication of information set forth above has occurred with respect to each then-current Available Tenor of such Benchmark (or the published component used in the calculation thereof).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Benchmark Unavailability Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the period (if any) (x) beginning at the time that a Benchmark Replacement Date has occurred if, at such time, no Benchmark Replacement has replaced the then-current Benchmark for all purposes hereunder and under any Transaction Document in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 4.06(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> and (y) ending at the time that a Benchmark Replacement has replaced the then-current Benchmark for all purposes hereunder and under any Transaction Document in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 4.06(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Borrower</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning specified in the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">preamble to this Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Borrower Indemnified Amounts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 12.01(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Borrower Indemnified Party</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 12.01(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Borrower Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means all present and future indebtedness, reimbursement obligations, and other liabilities and obligations (howsoever created, arising or evidenced, whether direct or indirect, absolute or contingent, or due or to become due) of the Borrower to any Credit Party, Borrower Indemnified Party and&#47;or any Affected Person, arising under or in connection with this Agreement or any other Transaction Document or the transactions contemplated hereby or thereby, and shall include, without limitation, all Capital and Interest on the Loans, all Fees and all other amounts due or to become due under the Transaction Documents (whether in respect of fees, costs, expenses, indemnifications or otherwise), including, without limitation, interest, fees and other obligations that accrue after the commencement of any Insolvency Proceeding with respect to the Borrower (in each case whether or not allowed as a claim in such proceeding).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Borrower&#8217;s Net Worth</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, at any time of determination, an amount equal to (i) the Outstanding Balance of all Pool Receivables at such time, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">minus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (ii) the sum of (A) the Aggregate Capital at such time, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (B) the Aggregate Interest at such time, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (C) the aggregate accrued and unpaid Fees at such time, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (D) the aggregate outstanding principal balance of all Subordinated Notes at such time, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (E) the aggregate accrued and unpaid interest on all Subordinated Notes at such time, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (F) without duplication, the aggregate accrued and unpaid other Borrower Obligations at such time.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Borrowing Base</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, at any time of determination, the amount equal to the lesser of (a) the Facility Limit and (b) an amount equal to (i) the Adjusted Net Receivables Pool Balance at such time, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">minus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (ii) the Total Reserves at such time. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Borrowing Base Deficit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, at any time of determination, the amount, if any, by which (a) the Aggregate Capital at such time, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">exceeds</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (b) the Borrowing Base at such time, or, in each case, if such day is not a Business Day, then the immediately preceding Business Day. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Breakage Fee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means (i) for any Interest Period for which Interest is computed by reference to the CP Rate, the Term SOFR Rate or the Daily SOFR Rate, as applicable, and a reduction of Capital is made for any reason on any day other than a Settlement Date or (ii) to the extent that the Borrower shall for any reason, fail to borrow on the date specified by the Borrower in connection with any request for funding pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Article II</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> of this Agreement, the amount, if any, by which (A) the additional Interest (calculated without taking into account any Breakage Fee or any shortened duration of such Interest Period pursuant to the definition thereof) which would have accrued during such Interest Period (or, in the case of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">clause (i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> above, until the maturity of the underlying Note) on the reductions of Capital relating to such Interest Period had such reductions not been made (or, in the case of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">clause (ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> above, the amounts so failed to be borrowed or accepted in connection with any such request for funding by the Borrower), exceeds (B) the income, if any, received by the applicable Lender from the investment of the proceeds of such reductions of Capital (or such amounts failed to be borrowed by the Borrower).  A certificate as to the amount of any Breakage Fee (including the computation of such amount) shall be submitted by the affected Lender (or applicable Group Agent on its behalf) to the Borrower and shall be conclusive and binding for all purposes, absent manifest error.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#8220;Business Day&#8221; means any day other than a Saturday or Sunday or a legal holiday on which commercial banks are authorized or required to be closed, or are in fact closed, for business in Pittsburgh, Pennsylvania or New York, New York (or, if otherwise, any day other than a Saturday or Sunday or a legal holiday on which the lending office of the Administrative Agent is authorized or required to be closed, or is in fact closed, for business)&#59; provided, that, when used in connection with an amount that bears interest at a rate based on SOFR or any direct or indirect calculation or determination of SOFR, the term &#8220;Business Day&#8221; means any such day that is also a U.S. Government Securities Business Day.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Capital</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Lender, without duplication, the aggregate amounts paid to, or on behalf of, the Borrower in connection with all Loans made by such Lender pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Article II</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, as reduced from time to time by Collections distributed and applied on account of such Capital pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that if such Capital shall have been reduced by any distribution and thereafter all or a portion of such distribution is rescinded or must otherwise be returned for any reason, such Capital shall be increased by the amount of such rescinded or returned distribution as though it had not been made.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Capital Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Person, any and all common shares, preferred shares, interests, participations, rights in or other equivalents (however designated) of such Person&#8217;s capital stock, partnership interests, limited liability company interests, membership interests or other equivalent interests and any rights (other than debt securities convertible into or exchangeable for capital stock), warrants or options exchangeable for or convertible into such capital stock or other equity interests.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Change in Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the occurrence of any of the following&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">Integra LifeSciences Corporation ceases to own, directly, 100% of the issued and outstanding Capital Stock and all other equity interests of the Borrower free and clear of all Adverse Claims&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">the Parent ceases to own, directly or indirectly, 100% of the issued and outstanding Capital Stock, membership interests or other equity interests of any Originator free and clear of all Adverse Claims&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">any Subordinated Note shall at any time cease to be owned by an Originator, free and clear of all Adverse Claims&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(4)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">with respect to the Parent&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">any Person (or two or more Persons acting in concert) shall have acquired by contract or otherwise, or shall have entered into a contract or arrangement that, upon consummation thereof, will result in its or their acquisition of control over Voting Securities of the Borrower on a fully-diluted basis assuming the conversion and&#47;or exercise of all outstanding Equity Interests of the Parent owned by such Person or Persons representing thirty percent (30%) or more of the combined voting power of all Voting Securities of the Parent&#59; or</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">during any period of twenty four (24) consecutive months, a majority of the members of the board of directors or other equivalent governing body of the Parent cease to be composed of individuals (i) who were members of that board or equivalent governing body on the first day of such period, (ii) whose election or nomination to that board or equivalent governing body was approved by individuals referred to in clause (i) above constituting at the time of such election or nomination at least a majority of that board or equivalent governing body or (iii) whose election or nomination to that board or equivalent governing body was approved by individuals referred to in clauses (i) and (ii) above constituting at the time of such election or nomination at least a majority of that board or equivalent governing body.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Change in Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the occurrence, after the Closing Date (or with respect to any Lender, if later, the date on which such Lender becomes a Lender), of any of the following&#58; (a) the adoption or taking effect of any law, rule, regulation or treaty, (b) any change in any law, rule, regulation or treaty or in the administration, interpretation, implementation or application thereof by any Governmental Authority or (c) the making or issuance of any request, rule, guideline or directive (whether or not having the force of law) by any Governmental Authority&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that notwithstanding anything herein to the contrary, (w) the final rule titled </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Risk-Based Capital Guidelines&#59; Capital Adequacy Guidelines&#59; Capital Maintenance&#58; Regulatory Capital&#59; Impact of Modifications to Generally Accepted Accounting Principles&#59; Consolidation of Asset-Backed Commercial Paper Programs&#59; and Other Related Issues</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, adopted by the United States bank regulatory agencies on December 15, 2009, (x) the Dodd-Frank Wall Street Reform and Consumer Protection Act and all requests, rules, guidelines or directives thereunder or issued in connection therewith and (y) all requests, rules, guidelines or directives promulgated by the Bank for International Settlements, the Basel Committee on Banking Supervision (or any successor or similar authority) or the United States or foreign regulatory authorities, in each case pursuant to the agreements reached by the Basel Committee on Banking Supervision in &#8220;Basel III&#58; A Global Regulatory Framework for More Resilient Banks and Banking Systems&#8221; (as amended, supplemented or otherwise modified or replaced from time to time), shall in each case be deemed to be a &#8220;Change in Law&#8221;, regardless of the date enacted, adopted or issued.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Closing Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means December 21, 2018.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Code</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the Internal Revenue Code of 1986, as amended, reformed or otherwise modified from time to time.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Collateral</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 4.05(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Collection Account</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means each account listed on Schedule II to this Agreement (as such schedule may be modified from time to time in connection with the closing or opening of any Collection Account in accordance with the terms hereof), in each case, in the name of the Borrower and maintained at a bank or other financial institution acting as a Collection Account Bank pursuant to an Account Control Agreement for the purpose of receiving Collections.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Collection Account Bank</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any of the banks or other financial institutions holding one or more Collection Accounts.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Collections</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Pool Receivable&#58;  (a) all funds that are received by any Integra Party or any other Person on their behalf in payment of any amounts owed in respect of such Pool Receivable (including purchase price, finance charges, interest and all other charges), or applied to amounts owed in respect of such Pool Receivable (including insurance payments and net proceeds of the sale or other disposition of repossessed goods or other collateral or property of the related Obligor or any other Person directly or indirectly liable for the payment of such Pool Receivable and available to be applied thereon), (b) all Deemed Collections, (c) all proceeds of all Related Security with respect to such Pool Receivable and (d) all other proceeds of such Pool Receivable.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Commitment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Committed Lender (including a Related Committed Lender), the maximum aggregate amount which such Person is obligated to lend or pay hereunder on account of all Loans, on a combined basis, as set forth on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule I</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> or in the Assumption Agreement or other agreement pursuant to which it became a Lender, as such amount may be modified in connection with any subsequent assignment pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 13.03</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> or in connection with a reduction in the Facility Limit pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.02(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  If the context so requires, &#8220;Commitment&#8221; also refers to a Committed Lender&#8217;s obligation to make Loans hereunder in accordance with this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Committed Lenders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means PNC and each other Person that is or becomes a party to this Agreement in the capacity of a &#8220;Committed Lender&#8221;.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Concentration Percentage</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means (a) for any Group A Obligor, twenty percent (20.00%), (b) for any Group B Obligor, fifteen percent (15.00%), (c) for any Group C Obligor, ten percent (10.00%), (d) for the largest Group D Obligor, five percent (5.00%) and (e) for any Group D Obligor (excluding the largest Group D Obligor), three percent (3.00%).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Concentration Reserve Percentage</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, at any time of determination, the largest of&#58; (a) the sum of the four (4) largest Obligor Percentages of the Group D Obligors, (b) the sum of the two (2) largest Obligor Percentages of the Group C Obligors, (c) the largest Obligor Percentage of the Group B Obligors and (d) twelve percent (12.00%).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Conduit Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means each commercial paper conduit that is or becomes a party to this Agreement in the capacity of a &#8220;Conduit Lender&#8221;.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Conforming Changes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, with respect to Term SOFR or Daily 1M SOFR, as applicable, or any Benchmark Replacement in relation thereto, any technical, administrative or operational changes (including changes to the definition of &#8220;Base Rate,&#8221; the definition of &#8220;Business Day,&#8221; the definition of &#8220;Interest Period,&#8221; the definition of &#8220;U.S. Government Securities Business Day,&#8221; timing and frequency of determining rates and making payments of interest, timing of borrowing requests or prepayment, conversion or continuation notices, the applicability and length of lookback periods, the applicability of breakage provisions, and other technical, administrative or operational matters) that the Administrative Agent decides may be </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">8</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">appropriate to reflect the adoption and implementation of any such rate and to permit the administration thereof by the Administrative Agent in a manner substantially consistent with market practice (or, if the Administrative Agent decides that adoption of any portion of such market practice is not administratively feasible or if the Administrative Agent determines that no market practice for the administration of any such rate exists, in such other manner of administration as the Administrative Agent decides is reasonably necessary in connection with the administration of this Agreement and the other Transaction Documents).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Connection Income Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means Other Connection Taxes that are imposed on or measured by net income (however denominated) or that are franchise Taxes or branch profits Taxes.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Consolidated Total Leverage Ratio</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; shall have the same meaning attributed to such term in the Credit Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Contract</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Receivable, any and all contracts, instruments, agreements, leases, invoices, notes or other writings pursuant to which such Receivable arises or that evidence such Receivable or under which an Obligor becomes or is obligated to make payment in respect of such Receivable.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Controlled Group</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means all members of a controlled group of corporations or other business entities and all trades or businesses (whether or not incorporated) under common control which, together with Parent or any of its Subsidiaries, are treated as a single employer under Section 414 of the Code.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Covered Entity</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means (a) each Integra Party, the Parent and each of Parent&#8217;s Subsidiaries and (b) each Person that, directly or indirectly, is in control of a Person described in clause (a) above.  For purposes of this definition, control of a Person shall mean the direct or indirect (x) ownership of, or power to vote, 25% or more of the issued and outstanding equity interests having ordinary voting power for the election of directors of such Person or other Persons performing similar functions for such Person, or (y) power to direct or cause the direction of the management and policies of such Person whether by ownership of equity interests, contract or otherwise.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">CP Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, for any Conduit Lender and for any Interest Period for any Portion of Capital (a) the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">per annum</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> rate equivalent to the weighted average cost (as determined by the applicable Group Agent and which shall include commissions of placement agents and dealers, incremental carrying costs incurred with respect to Notes of such Person maturing on dates other than those on which corresponding funds are received by such Conduit Lender, other borrowings by such Conduit Lender (other than under any Program Support Agreement) and any other costs associated with the issuance of Notes) of or related to the issuance of Notes that are allocated, in whole or in part, by the applicable Conduit Lender to fund or maintain such Portion of Capital (and which may be also allocated in part to the funding of other assets of such Conduit Lender)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that if any component of such rate is a discount rate, in calculating the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">CP Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; for such Portion of Capital for such Interest Period, the applicable Group Agent shall for such component use the rate resulting from converting such discount rate to an interest bearing equivalent rate </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">per annum</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that notwithstanding anything in this Agreement or the other Transaction Documents to the contrary, the Borrower agrees that any amounts payable to Conduit Lenders in respect of Interest for any Interest Period with respect to any Portion of Capital funded by such Conduit Lenders at the CP Rate shall include an amount equal to the portion of the face amount of the outstanding Notes issued to fund or maintain such Portion of Capital that corresponds to the portion of the proceeds of such Notes that was used to pay the interest component of maturing Notes issued to fund or maintain such Portion of Capital, to the extent that such Conduit Lenders had not received payments of interest in respect of such interest </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">9</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">component prior to the maturity date of such maturing Notes (for purposes of the foregoing, the &#8220;interest component&#8221; of Notes equals the excess of the face amount thereof over the net proceeds received by such Conduit Lender from the issuance of Notes, except that if such Notes are issued on an interest-bearing basis its &#8220;interest component&#8221; will equal the amount of interest accruing on such Notes through maturity) or (b) any other rate designated as the &#8220;CP Rate&#8221; for such Conduit Lender in the Assumption Agreement or other document pursuant to which such Person becomes a party as a Conduit Lender to this Agreement, or any other writing or agreement provided by such Conduit Lender to the Borrower, the Servicer and the applicable Agent from time to time.  The &#8220;CP Rate&#8221; for any Conduit Lender for any day while an Event of Default has occurred and is continuing shall be an interest rate equal to the greater of (i) 2.50% </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">per annum</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> above the Base Rate and (ii) 2.50% </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">per annum</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> above the &#8220;CP Rate&#8221; calculated without giving effect to such Event of Default. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Credit Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means that certain Sixth Amended and Restated Credit Agreement, dated as of February 3, 2020, by and among the Parent, as the borrower thereunder, each lender and issuing bank from time to time party thereto, Bank of America, N.A., as administrative agent, swing line lender and an L&#47;C issuer thereunder, Citibank N.A., Morgan Stanley MUFG Loan Partners, LLC and Wells Fargo Bank, N.A., as co-syndication agents thereunder, and the various other co-documentation agents, joint lead arrangers and joint book managers party thereto, and so long as PNC and Mizuho Bank, Ltd. are each a lender under the Credit Agreement as amended, restated, supplemented or otherwise modified from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Credit and Collection Procedures</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, as the context may require, those receivables credit and collection policies and historical practices of the Originators and&#47;or Servicer in effect on the Closing Date and described in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit E</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, as modified in compliance with this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Credit Extension</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the making of any Loan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Credit Party</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means each Lender, the Administrative Agent and each Group Agent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Currency Reserve Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, at any time of determination, the sum of (a) the Euro Volatility Reserve, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (b) the GBP Volatility Reserve, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (c) the excess (if any) of (i) the U.S. Dollar Equivalent of the aggregate Outstanding Balance of all Pool Receivables denominated in an Alternative Currency, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">over</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (ii) the product of (x) two and a half percent (2.5%), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">multiplied by</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (y) the U.S. Dollar Equivalent of the aggregate Outstanding Balance of all Pool Receivables.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Daily 1M SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, for any day, the rate </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">per annum</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> determined by the Administrative Agent (rounded upwards, at the Administrative Agent&#8217;s discretion, to the nearest 1&#47;100th of 1%) equal to the Term SOFR Reference Rate for such day for a one (1) month period, as published by the Term SOFR Administrator&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that if Daily 1M SOFR, determined as provided above, would be less than the Floor, then Daily 1M SOFR shall be deemed to be the Floor.  The rate of interest will be adjusted automatically as of each Business Day based on changes in Daily 1M SOFR without notice to the Borrower.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Daily Simple SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, for any day (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">SOFR Rate Day</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), the interest rate </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">per annum</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> determined by the Administrative Agent (rounded upwards, at the Administrative Agent&#8217;s discretion, to the nearest 1&#47;100th of 1%) equal to SOFR for the day (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">SOFR Determination Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) that is two (2) Business Days prior to (i) such SOFR Rate Day if such SOFR Rate Day is a Business Day or (ii) the Business Day immediately preceding such SOFR Rate Day if such SOFR Rate Day is not a Business Day, in each case, as such SOFR is published by the Federal Reserve Bank of New York (or a successor administrator of the secured overnight financing rate) on the website of the Federal Reserve Bank of New York, currently at http&#58;&#47;&#47;www.newyorkfed.org, or any successor source identified by the Federal Reserve Bank of New York or its successor administrator for the secured overnight financing rate from time to time.  If </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Daily Simple SOFR as determined above would be less than the Floor, then Daily Simple SOFR shall be deemed to be the Floor.  If SOFR for any SOFR Determination Date has not been so published or replaced with a Benchmark Replacement by 5&#58;00 p.m. (Pittsburgh, Pennsylvania time) on the second Business Day immediately following such SOFR Determination Date, then SOFR for such SOFR Determination Date will be SOFR for the first Business Day preceding such SOFR Determination Date for which SOFR was published as described above&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that SOFR determined pursuant to this sentence shall be used for purposes of calculating Daily Simple SOFR for no more than three (3) consecutive SOFR Rate Days.  If and when Daily Simple SOFR as determined above changes, any applicable rate of interest based on Daily Simple SOFR will change automatically without notice to the Borrower, effective on the date of any such change.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Daily SOFR Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the option of the Borrower to have Loans bearing interest at the rate and under the terms specified in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.05(a)(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Daily SOFR Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means with respect to Loans to which the Daily SOFR Option applies, a fluctuating interest rate </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">per annum</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> as shall be in effect from time to time equal to (a) Daily 1M SOFR, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (b) the SOFR Adjustment.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Daily SOFR Rate Loan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means a Loan that bears interest based on the Daily SOFR Rate.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Days&#8217; Sales Outstanding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, for any Fiscal Month, an amount computed as of the last day of such Fiscal Month equal to&#58;  (a) the average of the Outstanding Balance of all Pool Receivables as of the last day of each of the three (3) most recent Fiscal Months ended on the last day of such Fiscal Month, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">divided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">by</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (b) (i) the aggregate initial Outstanding Balance of all Pool Receivables generated by the Originators during the three (3) most recent Fiscal Months ended on the last day of such Fiscal Month, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">divided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">by</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (ii) ninety (90).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Debt</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, as to any Person at any time of determination, any and all indebtedness, obligations or liabilities (whether matured or unmatured, liquidated or unliquidated, direct or indirect, absolute or contingent, or joint or several) of such Person for or in respect of&#58;  (i) borrowed money, (ii) amounts raised under or liabilities in respect of any bonds, debentures, notes, note purchase, acceptance or credit facility, or other similar instruments or facilities, (iii) reimbursement obligations (contingent or otherwise) under any letter of credit, (iv) any other transaction (including production payments (excluding royalties), installment purchase agreements, forward sale or purchase agreements, capitalized leases and conditional sales agreements) having the commercial effect of a borrowing of money entered into by such Person to finance its operations or capital requirements (but not including accounts payable incurred in the ordinary course of such Person&#8217;s business payable on terms customary in the trade), (v) all net obligations of such Person in respect of interest rate on currency hedges or (vi) any Guaranty of any such Debt.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Deemed Collections</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.01(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Defaulting Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any Lender that (a) has failed, within one (1) Business Day of the date required to be funded or paid, to (i) fund any portion of its Loans or (ii) pay over to any Credit Party any other amount required to be paid by it hereunder, unless, in the case of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">clause (i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> above, such Lender notifies the Administrative Agent in writing that such failure is the result of such Lender&#8217;s good faith determination that a condition precedent to funding (specifically identified and including the particular default, if any) has not been satisfied, (b) has notified the Borrower or any Credit Party in writing, or has made a public statement to the effect, that it does not intend or expect to comply with any of its funding obligations under this Agreement (unless such writing or public statement indicates that such position is based on such Lender&#8217;s good faith </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">determination that a condition precedent (specifically identified and including the particular default, if any) to funding a Loan under this Agreement cannot be satisfied) or generally under other agreements in which it commits to extend credit, (c) has failed, within three (3) Business Days after request by a Credit Party, acting in good faith, to provide a certification in writing from an authorized officer of such Lender that it will comply with its obligations (and is financially able to meet such obligations) to fund prospective Loans under this Agreement, provided that such Lender shall cease to be a Defaulting Lender pursuant to this clause (c) upon such Credit Party&#8217;s receipt of such certification in form and substance satisfactory to it and the Administrative Agent, or (d) has become the subject of an Insolvency Proceeding. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Default Ratio</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the ratio (expressed as a percentage and rounded to the nearest 1&#47;100 of 1%, with 5&#47;1000th of 1% rounded upward) computed as of the last day of each Fiscal Month by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">dividing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#58;  (a) the aggregate Outstanding Balance of all Pool Receivables that became Defaulted Receivables during such Fiscal Month, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">by</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (b) the aggregate initial Outstanding Balance of all Pool Receivables generated by the Originators during the month that is six (6) Fiscal Months before such Fiscal Month.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Defaulted Receivable</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means a Receivable&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">as to which any payment, or part thereof, remains unpaid for one hundred fifty one (151) calendar days or more from the original due date for such payment&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">without duplication, as to which any payment, or part thereof, remains unpaid for less than or equal to one hundred fifty one (151) calendar days from the original due date for such payment and, consistent with the Credit and Collection Procedures, is or should be written off the applicable Originator&#8217;s or the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Borrower</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8217;s books as uncollectible&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">without duplication, as to which an Insolvency Proceeding shall have occurred with respect to the Obligor thereof or any other Person obligated thereon or owning any Related Security with respect thereto&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that in each case above such amount shall be calculated without giving effect to any netting of credits that have not been matched to a particular Receivable for the purposes of aged trial balance reporting.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Delinquency Ratio</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the ratio (expressed as a percentage and rounded to the nearest 1&#47;100 of 1%, with 5&#47;1000th of 1% rounded upward) computed as of the last day of each Fiscal Month by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">dividing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#58;  (a) the sum of (I) the aggregate Outstanding Balance of all Pool Receivables that were Delinquent Receivables on such day, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (II) the aggregate amount of Deemed Collections as of such date with respect to such Delinquent Receivables, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">by</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (b) the aggregate Outstanding Balance of all Pool Receivables on such day. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Delinquent Receivable</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means a Receivable as to which any payment, or part thereof, remains unpaid for ninety one (91) calendar days or more from the original due date for such payment&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that such amount shall be calculated without giving effect to any netting of credits that have not been matched to a particular Receivable for the purposes of aged trial balance reporting.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Dilution Horizon Ratio</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, for any Fiscal Month, the ratio (expressed as a percentage and rounded to the nearest 1&#47;100th of 1%, with 5&#47;1000th of 1% rounded upward) computed as of the last day of such Fiscal Month by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">dividing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#58;  (a) the sum of (i) the aggregate initial Outstanding Balance of all Pool Receivables (other than Unbilled Receivables) generated by the Originators during such Fiscal Month, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (ii) fifty percent (50%) of the aggregate initial </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">12</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Outstanding Balance of all Pool Receivables generated by the Originators during the preceding Fiscal Month, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">by</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (b) the Net Receivables Pool Balance as of the last day of such Fiscal Month.  Within thirty (30) calendar days of the completion and the receipt by the Administrative Agent of the results of any annual audit or field exam of the Receivables and the servicing and origination practices of the Servicer and the Originators, the numerator of the Dilution Horizon Ratio may be adjusted by the Administrative Agent upon not less than five (5) Business Days&#8217; notice to the Borrower to reflect such number of Fiscal Months as the Administrative Agent and the Borrower agree best reflects the business practices of the Servicer and the Originators and the actual amount of dilution and Deemed Collections that occur with respect to Pool Receivables based on the weighted average dilution lag calculation completed as part of such audit or field exam.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Dilution Ratio</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the ratio (expressed as a percentage and rounded to the nearest 1&#47;100th of 1%, with 5&#47;1000th of 1% rounded upward), computed as of the last day of each Fiscal Month by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">dividing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#58;  (a) the aggregate amount of Deemed Collections during such Fiscal Month (other than amounts related to the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Specifically Reserved Dilution Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">by</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (b) the aggregate initial Outstanding Balance of all Pool Receivables generated by the Originators during the prior Fiscal Month.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Dilution Reserve Percentage</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, on any day, the product of (a) the Dilution Horizon Ratio </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">multiplied</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">by</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (b) the sum of (i) 2.00 times the average of the Dilution Ratios for the twelve (12) most recent Fiscal Months and (ii) the Dilution Volatility Component. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Dilution Volatility Component</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, for any Fiscal Month, the product (expressed as a percentage and rounded to the nearest 1&#47;100 of 1%, with 5&#47;1000th of 1% rounded upward) of (a) the positive difference, if any, between&#58;  (i) the highest Dilution Ratio for any Fiscal Month during the twelve (12) most recent Fiscal Months and (ii) the arithmetic average of the Dilution Ratios for such twelve (12) Fiscal Months </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">times</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (b) the quotient of (i) the highest Dilution Ratio for any Fiscal Month during the twelve (12) most recent consecutive Fiscal Months </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">divided by</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (ii) the arithmetic average of the Dilution Ratios for such twelve (12) consecutive Fiscal Months.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Dollars</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; and &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">$</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; each mean the lawful currency of the United States of America.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Earned Milestone Receivable</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means a Receivable earned, notwithstanding the fact that the Originator thereof has not recognized the related revenue on its financial books and records under GAAP, paid in accordance with the milestones set forth in the Contract giving rise to such Receivable, and is not subject to the performance of additional services by the Originator thereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Eligible Assignee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means (a) any Committed Lender or any of its Affiliates, (b) any Person managed by a Committed Lender or any of its Affiliates and (c) any other financial or other institution.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Eligible Foreign Currency Receivable</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, at any time, any Foreign Currency Receivable that is denominated and payable in an Alternative Currency.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Eligible Foreign Obligor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; an Obligor that is a corporation or other business organization that is organized in or that has a head office (domicile), registered office, and chief executive office located in a country other than (a) the United States or (b) a Sanctioned Country.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Eligible In-Transit Receivable</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, at any time, any In-Transit Receivable if (a) the related goods have been shipped not more than thirty (30) calendar days prior to such date, (b) the related Originator has not pledged inventory as collateral for any Debt and (c) no inventory of such Originator is encumbered in any way.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Eligible Receivable</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, at any time of determination, a Pool Receivable&#58;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">13</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">the Obligor of which&#58; (i) is either a U.S. Obligor or an Eligible Foreign Obligor&#59; (ii) is not a Sanctioned Person&#59; (iii) is not subject to any Insolvency Proceeding&#59; (iv) is not an Affiliate of an Integra Party or the Parent&#59; (v) does not have an aggregate Outstanding Balance of Pool Receivables as to which any payment, or part thereof, remains unpaid for one hundred twenty one (121) calendar days or more from the original due date for such payment that exceeds fifty percent (50%) of the aggregate Outstanding Balance of all of such Obligor&#8217;s Pool Receivables&#59; (vi) is not a natural person&#59; (vii) is not a material supplier to any Originator or an Affiliate of a material supplier&#59; and (viii) is not a Temporarily Ineligible Obligor&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">for which an Insolvency Proceeding shall not have occurred with respect to the Obligor thereof or any other Person obligated thereon or owning any Related Security with respect thereto&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">that is denominated and payable only in Dollars in the United States of America or an Alternative Currency payable in the United States of America, and the Obligor with respect to which has been instructed to remit Collections in respect thereof directly to a Lock-Box or Collection Account in the United States of America&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(4)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">that does not have a due date which is more than one hundred eighty (180) calendar days after the original invoice date of such Receivable&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(5)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">that arises under a Contract for the sale of goods or services on an arm&#8217;s-length basis in the ordinary course of the applicable Originator&#8217;s business&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(6)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">that arises under a duly authorized Contract that is in full force and effect and that is a legal, valid and binding obligation of the related Obligor, enforceable against such Obligor in accordance with its terms, except as such enforceability may be limited by applicable bankruptcy, insolvency, reorganization or other similar laws affecting the enforcement of creditors&#8217; rights generally and by general principles of equity regardless of whether enforceability is considered in a proceeding in equity or at law&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(7)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">that has been transferred by an Originator to the Borrower pursuant to the Purchase and Sale Agreement with respect to which transfer all conditions precedent under the Purchase and Sale Agreement have been met&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(8)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">that, together with the Contract related thereto, conforms in all material respects with all Applicable Laws (including any Applicable Laws relating to usury, truth in lending, fair credit billing, fair credit reporting, equal credit opportunity, fair debt collection practices and privacy)&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(9)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">with respect to which all consents, licenses, approvals or authorizations of, or registrations or declarations with or notices to, any Governmental Authority or other Person required to be obtained, effected or given by an Originator in connection with the creation of such Receivable, the execution, delivery and performance by such Originator of the related Contract or the assignment thereof under the Purchase and Sale Agreement have been duly obtained, effected or given and are in full force and effect&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(10)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:16.02pt">that is not subject to any existing dispute, litigation, right of rescission, set-off (including, customer deposits, advance payments (including payments related to unearned revenues, but at any time prior to the occurrence of a Specific Reporting Event not including Earned Milestone Receivables), etc.), counterclaim, hold back defense, any other defense against the applicable Originator (or any assignee of such Originator) or Adverse Claim, and the Obligor of which holds no right as against the applicable </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">14</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Originator to cause such Originator to repurchase the goods or merchandise, the sale of which shall have given rise to such Receivable&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(11)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:16.02pt">that satisfies all applicable requirements of the Credit and Collection Procedures&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(12)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:16.02pt">that, together with the Contract related thereto, has not been modified, waived or restructured since its creation, except as permitted pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 8.02(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> of this Agreement&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(13)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:16.02pt">in</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">which the Borrower owns good and marketable title, free and clear of any Adverse Claims, and that is freely assignable (including without any consent of the related Obligor or any Governmental Authority)&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(14)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:16.02pt">for which the Administrative Agent (on behalf of the Secured Parties) shall have a valid and enforceable first priority perfected security interest therein and in the Related Security and Collections with respect thereto, in each case free and clear of any Adverse Claim&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(15)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:16.02pt">that (i) constitutes an &#8220;account&#8221; or &#8220;payment intangible&#8221; (as defined in the UCC), (ii) is not evidenced by instruments or chattel paper and (iii) does not constitute, or arise from the sale of, as extracted collateral (as defined in the UCC)&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(16)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:16.02pt">that is neither a Defaulted Receivable nor a Delinquent Receivable&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(17)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:16.02pt">for which no Integra Party has established any offset or netting arrangements with the related Obligor in connection with the ordinary course of payment of such Receivable&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(18)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:16.02pt">that, other than for Eligible In-Transit Receivables, represents amounts earned and payable by the Obligor that are not subject to the performance of additional services by the Originator thereof or by the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Borrower</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> and the related goods or merchandise shall have been shipped and&#47;or services performed&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that if such Receivable is subject to the performance of additional services, only the portion of such Receivables attributable to such additional services shall be excluded&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(19)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:16.02pt">which (i) does not arise from a sale of accounts made as part of a sale of a business or constitute an assignment for the purpose of collection only, (ii) is not a transfer of a single account made in whole or partial satisfaction of a preexisting indebtedness or an assignment of a right to payment under a contract to an assignee that is also obligated to perform under the contract and (iii) is not a transfer of an interest in or an assignment of a claim under a policy of insurance&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(20)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:16.02pt">which does not relate to the sale of any consigned goods or finished goods which have incorporated any consigned goods into such finished goods&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(21)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:16.02pt">that represents amounts earned by the Originator thereof and payable by the related Obligor in accordance with the Contract related thereto that are not subject to the performance of any additional services by the Originator thereof or by the Borrower, other than, (i) the billing or invoicing of such Receivable in the case of an Eligible Unbilled Receivable and (ii) the obligation of the applicable Originator with respect to standard warranties and indemnities related to the goods or services sold that gave rise to such Receivable&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that if such Receivable is subject to the performance of </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">15</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">additional services, only the portion of such Receivable attributable to such additional services shall be ineligible&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(22)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:16.02pt">that, if such Receivable is an In-Transit Receivable, is an Eligible In-Transit Receivable&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(23)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:16.02pt">that, if such Receivable is a Foreign Currency Receivable, is an Eligible Foreign Currency Receivable.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Eligible Unbilled Receivable</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, at any time, any Unbilled Receivable if (a) the related Originator has recognized the related revenue on its financial books and records under GAAP, and (b) not more than thirty (30) calendar days have expired since the date such Unbilled Receivable arose.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Equity Interests</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Person, all of the shares of capital stock of (or other ownership or profit interests in) such Person, all of the warrants, options or other rights for the purchase or acquisition from such Person of shares of capital stock of (or other ownership or profit interest in) such Person, all of the securities convertible into or exchangeable for shares of capital stock of (or other ownership or profit interests in) such Person or warrants, rights or options for the purchase or acquisition from such Person of such shares (or such other interests), and all of the other ownership or profit interests in such Person (including partnership, member or trust interests therein), whether voting or nonvoting, and whether or not such shares, warrants, options, rights or other interests are outstanding on any date of determination, not including debt securities convertible into or exchangeable for capital stock.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">ERISA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the Employee Retirement Income Security Act of 1974, as amended from time to time, and any rule or regulation issued thereunder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">ERISA Affiliate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Person, any corporation, trade or business which together with the Person is a member of a controlled group of corporations or a controlled group of trades or businesses and would be deemed a &#8220;single employer&#8221; within the meaning of Sections 414(b), (c), (m) of the Code or Section 4001(b) of ERISA.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Erroneous Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 10.11(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Erroneous Payment Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 10.11(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Euro</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; and &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#8364;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; each mean the single currency of participating member states of the European Monetary Union.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Euro VaR Percentage</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means six percent (6.00%), or such other percentage designated as such by the Administrative Agent from time to time upon ten (10) Business Days&#8217; written notice to the Borrower.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Euro Volatility Reserve</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, at any time of determination, the product of (a) the U.S. Dollar Equivalent of the aggregate Outstanding Balance of all Pool Receivables denominated in Euro at such time, times (b) the Euro VaR Percentage at such time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Event of Default</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning specified in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 9.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  For the avoidance of doubt, any Event of Default that occurs shall be deemed to be continuing at all times thereafter unless and until waived in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 13.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Excess Concentration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the sum of the following amounts, without duplication&#58;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">16</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">the sum of the amounts calculated for each of the Obligors equal to the excess (if any) of (i) the aggregate Outstanding Balance of the Eligible Receivables of such Obligor, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">over</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (ii) the product of (x) such Obligor&#8217;s Concentration Percentage, multiplied by (y) the aggregate Outstanding Balance of all Eligible Receivables then in the Receivables Pool&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">the excess (if any) of (i) the aggregate Outstanding Balance of all Eligible Receivables, the Obligors of which are Eligible Foreign Obligors, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">over</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (ii) the product of (x) thirty percent (30.00%), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">multiplied by</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (y) the aggregate Outstanding Balance of all Eligible Receivables then in the Receivables Pool&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that the aggregate Outstanding Balance of all Eligible Receivables, the Obligors of which are Eligible Foreign Obligors (A) organized in, and whose principal place of business is in, a country that has a long-term sovereign foreign-currency rating from and including &#8220;A&#8221; to and including &#8220;BBB-&#8221; by S&#38;P or from and including &#8220;A2&#8221; to and including &#8220;Baa3&#8221; by Moody&#8217;s, shall not exceed twenty percent (20.00%) of the aggregate Outstanding Balance of all Eligible Receivables, (B) organized in, and whose principal place of business is in, a country that has a long-term sovereign foreign-currency rating equal to or less than &#8220;BB+&#8221; by S&#38;P or &#8220;Ba1&#8221; by Moody&#8217;s, shall not exceed five percent (5.00%) of the aggregate Outstanding Balance of all Eligible Receivables, (C) organized in, and whose principal place of business is in, the People&#8217;s Republic of China, shall not exceed seven and one half percent (7.50%) of the aggregate Outstanding Balance of all Eligible Receivables and (D) organized in, and whose principal place of business is in, a country other than the People&#8217;s Republic of China, shall not exceed five percent (5.00%) of the aggregate Outstanding Balance of all Eligible Receivables&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">the excess (if any) of (i) the aggregate Outstanding Balance of all Eligible Receivables as to which any payment, or part thereof, remain unpaid for sixty one (61) to ninety (90) calendar days from the original due date for such payment, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">over</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (ii) the product of (x) five percent (5.00%), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">multiplied by</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (y) the aggregate Outstanding Balance of all Eligible Receivables then in the Receivables Pool&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(4)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">the excess (if any) of (i) the aggregate Outstanding Balance of all Eligible Receivables that have a due date which is between ninety one (91) to one hundred twenty (120) calendar days after the original invoice date of such Receivable, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">over</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (ii) the product of (x) ten percent (10.00%), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">multiplied by</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (y) the aggregate Outstanding Balance of all Eligible Receivables then in the Receivables Pool&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(5)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">the excess (if any) of (i) the aggregate Outstanding Balance of all Eligible Receivables that have a due date which is between one hundred twenty one (121) to one hundred eighty (180) calendar days after the original invoice date of such Receivable, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">over</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (ii) the product of (x) five percent (5.00%), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">multiplied by</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (y) the aggregate Outstanding Balance of all Eligible Receivables then in the Receivables Pool&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(6)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">the excess (if any) of (i) the aggregate Outstanding Balance of all Eligible In-Transit Receivables, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">over</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (ii) the product of (x) two and a half percent (2.50%), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">multiplied by</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (y) the aggregate Outstanding Balance of all Eligible Receivables then in the Receivables Pool&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(7)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">the excess (if any) of (i) the aggregate Outstanding Balance of all Eligible Receivables, the Obligors of which are the federal government of the United States of America or any political subdivision, department, affiliate, agency or other entity thereof (which, for the avoidance of doubt, does not include any state or local government body or any political subdivision, department, affiliate, agency or other entity thereof), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">over</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (ii) </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">17</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">the product of (x) one percent (1.00%), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">multiplied by</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (y) the aggregate Outstanding Balance of all Eligible Receivables then in the Receivables Pool&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(8)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">the excess (if any) of (i) the aggregate Outstanding Balance of all Eligible Receivables owing from the four (4) Group D Obligors with the four (4) largest Obligor Percentages of all Group D Obligors, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">over</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (ii) the product of (x) twelve percent (12.00%), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">multiplied by</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (y) the aggregate Outstanding Balance of all Eligible Receivables then in the Receivables Pool.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exchange Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the Securities Exchange Act of 1934, as amended or otherwise modified from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Excluded Obligor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means each Obligor listed on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule IV</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, which schedule may be amended, modified, restated, supplemented or replaced from time to time with the consent of the Administrative Agent, the Majority Group Agents and the Borrower.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Excluded Originator</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means each Originator (or sub-division or business unit or other similar entity thereof) listed on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule IV</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, which schedule may be amended, modified, restated, supplemented or replaced from time to time with the consent of the Administrative Agent, the Majority Group Agents and the Borrower.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Excluded Receivable</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any Receivable, (a) the Obligor of which is an Excluded Obligor or (b) the Originator of which is an Excluded Originator.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Excluded Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any of the following Taxes imposed on or with respect to an Affected Person or required to be withheld or deducted from a payment to an Affected Person&#58;  (a) Taxes imposed on or measured by net income (however denominated), franchise Taxes and branch profits Taxes, in each case, (i) imposed as a result of such Affected Person being organized under the laws of, or having its principal office or, in the case of any Lender, its applicable lending office located in, the jurisdiction imposing such Tax (or any political subdivision thereof) or (ii) that are Other Connection Taxes, (b) in the case of a Lender, U.S. federal withholding Taxes imposed on amounts payable to or for the account of such Lender with respect to an applicable interest in the Loans or Commitment pursuant to a law in effect on the date on which (i) such Lender makes a Loan or its Commitment or (ii) such Lender changes its lending office, except in each case to the extent that, pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 4.03</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, amounts with respect to such Taxes were payable either to such Lender&#8217;s assignor immediately before such Lender became a party hereto or to such Lender immediately before it changed its lending office, (c) Taxes attributable to such Affected Person&#8217;s failure to comply with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 4.03(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 4.03(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> and (d) any withholding Taxes imposed pursuant to FATCA.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Facility Limit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means one hundred fifty million dollars ($150,000,000) as reduced or increased from time to time pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.02(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  References to the unused portion of the Facility Limit shall mean, at any time of determination, an amount equal to (x) the Facility Limit at such time, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">minus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (y) the Aggregate Capital.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">FATCA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means Sections 1471 through 1474 of the Code, as of the date of this Agreement (or any amended or successor version that is substantively comparable and not materially more onerous to comply with) and any current or future regulations or official interpretations thereof, any agreements entered into pursuant to Section 1471(b)(1) of the Code and any fiscal or regulatory legislation, rules or practices adopted pursuant to any intergovernmental agreement, treaty or convention among Governmental Authorities entered into in connection with the implementation of the foregoing.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">18</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Federal Reserve Board</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the Board of Governors of the Federal Reserve System, or any entity succeeding to any of its principal functions.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Fee Letter</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning specified in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.03(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Fees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning specified in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.03(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Final Maturity Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the date that (i) is thirty (30) calendar days following the Scheduled Termination Date or (ii) such earlier date on which the Loans become due and payable pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 9.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Final Payout Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the date on or after the Termination Date when (i) the Aggregate Capital and Aggregate Interest have been paid in full, (ii) all Borrower Obligations shall have been paid in full, (iii) all other amounts owing to the Credit Parties and any other Borrower Indemnified Party or Affected Person hereunder and under the other Transaction Documents have been paid in full and (iv) all accrued Servicing Fees have been paid in full.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Financial Officer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; of any Person means, the chief executive officer, the chief financial officer, the chief accounting officer, the principal accounting officer, the controller, the treasurer or the assistant treasurer of such Person.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Fiscal Month</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means each calendar month.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Fitch</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means Fitch, Inc. and any successor thereto that is a nationally recognized statistical rating organization.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Floor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the benchmark rate floor, if any, provided in this Agreement initially (as of the execution of this Agreement, the modification, amendment or renewal of this Agreement or otherwise) with respect to Term SOFR, Daily 1M SOFR or Daily Simple SOFR, as applicable, or, if no floor is specified, zero.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Foreign Currency Receivable</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, at any time, any Receivable that is denominated and payable in a lawful currency of a country other than the United States of America.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">GAAP</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means generally accepted accounting principles in the United States of America, consistently applied.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">GBP</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Pounds Sterling</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; and &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#163;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; each mean the lawful currency of the United Kingdom.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">GBP VaR Percentage</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means seven percent (7.00%), or such other percentage designated as such by the Administrative Agent from time to time upon ten (10) Business Days&#8217; written notice to the Borrower.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">GBP Volatility Reserve</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, at any time of determination, the product of (a) the U.S. Dollar Equivalent of the aggregate Outstanding Balance of all Pool Receivables denominated in GBP at such time, times (b) the GBP VaR Percentage at such time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Governmental Authority</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the government of the United States of America or any other nation, or any political subdivision thereof, whether state or local, and any agency, authority, instrumentality, regulatory body, court, central bank or other entity exercising executive, legislative, judicial, taxing, regulatory or administrative powers or functions of or pertaining to government (including any supra-national bodies such as the European Union or the European Central Bank) and any group or body charged with setting financial accounting or </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">19</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">regulatory capital rules or standards (including the Financial Accounting Standards Board, the Bank for International Settlements or the Basel Committee on Banking Supervision or any successor or similar authority to any of the foregoing).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Group</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, (i) for any Conduit Lender, such Conduit Lender, together with such Conduit Lender&#8217;s Related Committed Lenders and related Group Agent, (ii) for PNC, PNC as a Committed Lender and as a Group Agent, (iii) for any other Lender that does not have a Related Conduit Lender, such Lender, together with such Lender&#8217;s related Group Agent and each other Lender for which such Group Agent acts as a Group Agent hereunder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Group A Obligor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any Obligor (or its parent or majority owner, as applicable, if such Obligor is not rated) with a short-term rating of at least&#58;  (a) &#8220;A-1&#8221; by S&#38;P, or if such Obligor does not have a short-term rating from S&#38;P, a rating of &#8220;A+&#8221; or better by S&#38;P on such Obligor&#8217;s, its parent&#8217;s, or its majority owner&#8217;s (as applicable) long-term senior unsecured and uncredit-enhanced debt securities, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">or</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (b) &#8220;P 1&#8221; by Moody&#8217;s, or if such Obligor does not have a short-term rating from Moody&#8217;s, &#8220;Al&#8221; or better by Moody&#8217;s on such Obligor&#8217;s, its parent&#8217;s or its majority owner&#8217;s (as applicable) long-term senior unsecured and uncredit-enhanced debt securities&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that if an Obligor (or its parent or majority owner, as applicable, if such Obligor is not rated) receives a split rating from S&#38;P and Moody&#8217;s, then such Obligor (or its parent or majority owner, as applicable) shall be deemed to have the higher rating, and such deemed rating shall be used for the purposes of whether such rating satisfies </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">clauses (a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> above.  Notwithstanding the foregoing, any Obligor that is a Subsidiary of an Obligor that satisfies the definition of &#8220;Group A Obligor&#8221; shall be deemed to be a Group A Obligor and shall be aggregated with the Obligor that satisfies such definition for the purposes of determining the &#8220;Concentration Reserve Percentage&#8221;, the &#8220;Concentration Reserve&#8221; and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">clause (i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> of the definition of &#8220;Excess Concentration&#8221; for such Obligors, unless such deemed Obligor separately satisfies the definition of &#8220;Group A Obligor&#8221;, &#8220;Group B Obligor&#8221;, or &#8220;Group C Obligor&#8221;, in which case such Obligor shall be separately treated as a Group A Obligor, a Group B Obligor or a Group C Obligor, as the case may be, and shall be aggregated and combined for such purposes with any of its Subsidiaries that are Obligors.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Group Agent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means each Person acting as agent on behalf of a Group and designated as the Group Agent for such Group on the signature pages to this Agreement or any other Person who becomes a party to this Agreement as a Group Agent for any Group pursuant to an Assumption Agreement, an Assignment and Acceptance Agreement or otherwise in accordance with this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Group Agent&#8217;s Account</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Group, the account(s) from time to time designated in writing by the applicable Group Agent to the Borrower and the Servicer for purposes of receiving payments to or for the account of the members of such Group hereunder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Group B Obligor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means an Obligor (or its parent or majority owner, as applicable, if such Obligor is not rated) that is not a Group A Obligor, with a short-term rating of at least&#58;  (a) &#8220;A-2&#8221; by S&#38;P, or if such Obligor does not have a short-term rating from S&#38;P, a rating of &#8220;BBB+&#8221; to &#8220;A&#8221; by S&#38;P on such Obligor&#8217;s, its parent&#8217;s or its majority owner&#8217;s (as applicable) long-term senior unsecured and uncredit-enhanced debt securities, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">or</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (b) &#8220;P 2&#8221; by Moody&#8217;s, or if such Obligor does not have a short-term rating from Moody&#8217;s, &#8220;Baal&#8221; to &#8220;A2&#8221; by Moody&#8217;s on such Obligor&#8217;s, its parent&#8217;s or its majority owner&#8217;s (as applicable) long-term senior unsecured and uncredit-enhanced debt securities&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that if an Obligor (or its parent or majority owner, as applicable, if such Obligor is not rated) receives a split rating from S&#38;P and Moody&#8217;s, then such Obligor (or its parent or majority owner, as applicable) shall be deemed to have the higher rating, and such deemed rating shall be used for the purposes of whether such rating satisfies </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">clauses (a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> above.  Notwithstanding the foregoing, any Obligor that is a Subsidiary of an Obligor that satisfies the definition of &#8220;Group B Obligor&#8221; shall be deemed to be </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">20</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">a Group B Obligor and shall be aggregated with the Obligor that satisfies such definition for the purposes of determining the &#8220;Concentration Reserve Percentage&#8221;, the &#8220;Concentration Reserve&#8221; and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">clause (i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> of the definition of &#8220;Excess Concentration&#8221; for such Obligors, unless such deemed Obligor separately satisfies the definition of &#8220;Group A Obligor&#8221;, &#8220;Group B Obligor&#8221;, or &#8220;Group C Obligor&#8221;, in which case such Obligor shall be separately treated as a Group A Obligor, a Group B Obligor or a Group C Obligor, as the case may be, and shall be aggregated and combined for such purposes with any of its Subsidiaries that are Obligors.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Group C Obligor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means an Obligor (or its parent or majority owner, as applicable, if such Obligor is not rated) that is not a Group A Obligor or a Group B Obligor, with a short-term rating of at least&#58;  (a) &#8220;A-3&#8221; by S&#38;P, or if such Obligor does not have a short-term rating from S&#38;P, a rating of &#8220;BBB-&#8221; to &#8220;BBB&#8221; by S&#38;P on such Obligor&#8217;s, its parent&#8217;s or its majority owner&#8217;s (as applicable) long-term senior unsecured and uncredit-enhanced debt securities, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">or</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (b) &#8220;P 3&#8221; by Moody&#8217;s, or if such Obligor does not have a short-term rating from Moody&#8217;s, &#8220;Baa3&#8221; to &#8220;Baa2&#8221; by Moody&#8217;s on such Obligor&#8217;s, its parent&#8217;s or its majority owner&#8217;s (as applicable) long-term senior unsecured and uncredit-enhanced debt securities&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that if an Obligor (or its parent or majority owner, as applicable, if such Obligor is not rated) receives a split rating from S&#38;P and Moody&#8217;s, then such Obligor (or its parent or majority owner, as applicable) shall be deemed to have the higher rating, and such deemed rating shall be used for the purposes of whether such rating satisfies </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">clauses (a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> above.  Notwithstanding the foregoing, any Obligor that is a Subsidiary of an Obligor that satisfies the definition of &#8220;Group C Obligor&#8221; shall be deemed to be a Group C Obligor and shall be aggregated with the Obligor that satisfies such definition for the purposes of determining the &#8220;Concentration Reserve Percentage&#8221;, the &#8220;Concentration Reserve&#8221; and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">clause (i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> of the definition of &#8220;Excess Concentration&#8221; for such Obligors, unless such deemed Obligor separately satisfies the definition of &#8220;Group A Obligor&#8221;, &#8220;Group B Obligor&#8221;, or &#8220;Group C Obligor&#8221;, in which case such Obligor shall be separately treated as a Group A Obligor, a Group B Obligor or a Group C Obligor, as the case may be, and shall be aggregated and combined for such purposes with any of its Subsidiaries that are Obligors.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Group Commitment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Group, at any time of determination, the aggregate Commitments of all Committed Lenders within such Group.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Group D Obligor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any Obligor that is not a Group A Obligor, Group B Obligor or Group C Obligor&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that any Obligor (or its parent or majority owner, as applicable, if such Obligor is unrated) that is not rated by both Moody&#8217;s and S&#38;P shall be a Group D Obligor.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Guaranty</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; of any Person means any obligation of such Person guarantying or in effect guarantying any Debt, liability or obligation of any other Person in any manner, whether directly or indirectly, including any such liability arising by virtue of partnership agreements, including any agreement to indemnify or hold harmless any other Person, any performance bond or other surety ship arrangement and any other form of assurance against loss, except endorsement of negotiable or other instruments for deposit or collection in the ordinary course of business.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Indemnified Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means (a) Taxes, other than Excluded Taxes, imposed on or with respect to any payment made by or on account of any obligation of the Borrower or any of its Affiliates under any Transaction Document and (b) to the extent not otherwise described in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">clause (a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> above, Other Taxes.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Independent Director</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.03(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Information Package</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means a report, in substantially the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit F</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Insolvency Proceeding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means (a) any case, action or proceeding before any court or other Governmental Authority relating to bankruptcy, reorganization, insolvency, liquidation, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">21</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">receivership, dissolution, winding-up or relief of debtors or (b) any general assignment for the benefit of creditors of a Person, composition, marshaling of assets for creditors of a Person, or other, similar arrangement in respect of its creditors generally or any substantial portion of its creditors, in each of clauses (a) and (b) undertaken under U.S. Federal, state or foreign law, including the Bankruptcy Code.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Integra Party</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, the Borrower, the Servicer, each Originator and the Performance Guarantor, either individually or collectively as the context may require.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Integra Sales</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in the preamble to this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Intended Tax Treatment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 13.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Interest</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, for each Loan for any day during any Interest Period (or portion thereof), the amount of interest accrued on the Capital of such Loan during such Interest Period (or portion thereof) in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.03(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Interest Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, with respect to each Loan, (a) before the Termination Date&#58;  (i) initially, the period commencing on the date such Loan is made pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (or in the case of any fees payable hereunder, commencing on the Closing Date) and ending on (but not including) the next Monthly Settlement Date and (ii) thereafter, each period commencing on such Monthly Settlement Date and ending on (but not including) the next Monthly Settlement Date and (b) on and after the Termination Date, such period (including a period of one day) as shall be selected from time to time by the Administrative Agent (with the consent or at the direction of the Majority Group Agents) or, in the absence of any such selection, each period of thirty (30) calendar days from the last day of the preceding Interest Period.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Interest Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, for any day in any Interest Period for any Loan (or any portion of Capital thereof)&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">if such Loan (or such portion of Capital thereof) is being funded by a Conduit Lender on such day through the issuance of Notes, the applicable CP Rate&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">if such Loan (or such portion of Capital thereof) is being funded by any Lender on such day other than through the issuance of Notes (including, without limitation, if a Conduit Lender is then funding such Loan (or such portion of Capital thereof) under a Program Support Agreement, or if a Committed Lender is then funding such Loan (or such portion of Capital thereof)), then the Base Rate, the Term SOFR Rate or the Daily SOFR Rate as determined pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.05</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that the Interest Rate applicable to any Loan that is not advanced on a Monthly Settlement Date shall be the Daily SOFR Rate for each day during the initial Interest Period applicable to such Loan from the date such Loan is made pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> until the next occurring Monthly Settlement Date.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that the &#8220;Interest Rate&#8221; for each Loan and any day while an Event of Default has occurred and is continuing shall be an interest rate </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">per annum</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> equal the sum of two and a half percent (2.50)% </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">per annum</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> plus the greater of (i) the interest rate </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">per annum</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> determined for such Loan and such day pursuant to clause (a) or (b) above, as applicable, and (ii) the Base Rate in effect on such day&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that no provision of this Agreement shall require the payment or permit the collection of Interest in excess of the maximum permitted by Applicable Law&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that Interest for any Loan shall not be considered paid by any distribution to the extent that at any time all or a portion of such distribution is rescinded or must otherwise be returned for any reason.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">22</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Interim Report</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means a report, in substantially the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit I</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">In-Transit Receivable</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, at any time, any Receivable arising in connection with the sale of any goods or merchandise that as of such time, have been shipped but not delivered to the related Obligor.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Investment Company Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the Investment Company Act of 1940, as amended or otherwise modified from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Lenders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the Conduit Lenders and the Committed Lenders.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Linked Account</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any deposit account which is or could be linked to a Collection Account by a controlled balance arrangement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Liquidity Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, on any date of determination, the sum of (a) the amount of borrowing availability under the Credit Agreement, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (b) unrestricted cash balances and liquid investments held by the Parent and its Affiliates.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Liquidity Agent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any bank or other financial institution acting as agent for the various Liquidity Providers under each Liquidity Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Liquidity Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any agreement entered into in connection with this Agreement pursuant to which a Liquidity Provider agrees to make purchases or advances to, or purchase assets from, any Conduit Lender in order to provide liquidity for such Conduit Lender&#8217;s Loans.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Liquidity Provider</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means each bank or other financial institution that provides liquidity support to any Conduit Lender pursuant to the terms of a Liquidity Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Loan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any loan made by a Lender pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Loan Request</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means a letter in substantially the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> hereto executed and delivered by the Borrower to the Administrative Agent and the Group Agents pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.02(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Lock-Box</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means each locked postal box with respect to which a Collection Account Bank has executed an Account Control Agreement pursuant to which it has been granted exclusive access for the purpose of retrieving and processing payments made on the Receivables and which is listed on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule II</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (as such schedule may be modified from time to time in connection with the addition or removal of any Lock-Box in accordance with the terms hereof).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Loss Horizon Ratio</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, for any Fiscal Month, the ratio (expressed as a percentage and rounded to the nearest 1&#47;100 of 1%, with 5&#47;1000th of 1% rounded upward) computed, as of the last day of such Fiscal Month, by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">dividing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#58; (a) the sum of (i) the aggregate initial Outstanding Balance of all Pool Receivables (other than Unbilled Receivables) generated by the Originators during the five (5) most recent Fiscal Months, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (ii) the product of (x) the sum of the Loss Horizon Terms Component, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> five percent (5.00%), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">and</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (y) the aggregate initial Outstanding Balance of all Pool Receivables originated by the Originators during the sixth (6th) most recent Fiscal Month&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">by</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (b) the Net Receivables Pool Balance as of such date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Loss Horizon Terms Component</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means (a) the Weighted Average Remaining Credit Terms of the most recent Fiscal Month minus thirty (30) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">divided by</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (b) thirty (30).</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">23</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Loss Reserve Percentage</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, at any time of determination, the product of (a) 2.00, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">times</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (b) the highest average of the Default Ratios for any three consecutive Fiscal Months during the twelve (12) most recent Fiscal Months, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">times</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (c) the Loss Horizon Ratio.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Majority Group Agents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means one or more Group Agents which in its Group, or their combined Groups, as the case may be, have Committed Lenders representing more than fifty percent (50%) of the aggregate Commitments of all Committed Lenders in all Groups (or, if the Commitments have been terminated, have Lenders representing more than fifty percent (50%) of the aggregate outstanding Capital held by all the Lenders in all Groups)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that in no event shall the Majority Group Agents include fewer than two (2) Group Agents at any time when there are two (2) or more Groups. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Material Adverse Effect</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means relative to any Person (provided that if no particular Person is specified, &#8220;Material Adverse Effect&#8221; shall be deemed to be relative to the Borrower, the Servicer, the Performance Guarantor and the Originators, individually and in the aggregate) with respect to any event or circumstance, a material adverse effect on any of the following&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">the assets, operations, business or financial condition of such Person&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">the ability of such Person to perform its obligations under this Agreement or any other Transaction Document to which it is a party&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">the validity or enforceability of this Agreement or any other Transaction Document, or the validity, enforceability, value or collectibility of any material portion of the Pool Receivables&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(4)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">the status, perfection, enforceability or priority of the Administrative Agent&#8217;s security interest in the Collateral&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(5)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">the rights and remedies of any Credit Party under the Transaction Documents or associated with its respective interest in the Collateral.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Minimum Dilution Reserve Percentage</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, on any day, the product (expressed as a percentage and rounded to the nearest 1&#47;100 of 1%, with 5&#47;1000th of 1% rounded upward) of (a) the average of the Dilution Ratios for the twelve (12) most recent Fiscal Months, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">multiplied by</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (b) the Dilution Horizon Ratio.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Minimum Funding Threshold</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means an amount equal to the lesser of (a) seventy five percent (75%) of the Facility Limit and (b) the Borrowing Base. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Minimum Liquidity Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means a Liquidity Amount that is equal to or greater than three hundred million dollars ($300,000,000).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Monthly Settlement Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the twenty-fifth (25th) calendar day of each calendar month (or if such day is not a Business Day, the next occurring Business Day).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Moody&#8217;s</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means Moody&#8217;s Investors Service, Inc. and any successor thereto that is a nationally recognized statistical rating organization.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Multiemployer Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means a multiemployer plan as defined in Section 4001(a)(3) of ERISA to which the Borrower, the Servicer, any Originator, the Parent or any of their respective ERISA Affiliates (other than one considered an ERISA Affiliate only pursuant to subsection (m) or (o) of Section 414 of the Code) is making or accruing an obligation to make contributions, or </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">24</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">has within any of the preceding five plan years made or accrued an obligation to make contributions.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Net Receivables Pool Balance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, at any time of determination&#58;  (a) the aggregate Outstanding Balance of Eligible Receivables then in the Receivables Pool, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">minus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (b) the Excess Concentration.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Notes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means short-term promissory notes issued, or to be issued, by any Conduit Lender to fund its investments in accounts receivable or other financial assets.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Obligor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Receivable, the Person obligated to make payments pursuant to the Contract relating to such Receivable.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Obligor Percentage</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, at any time of determination, for each Obligor, a fraction, expressed as a percentage, (a) the numerator of which is the aggregate Outstanding Balance of the Eligible Receivables of such Obligor less the amount (if any) then included in the calculation of the Excess Concentration with respect to such Obligor and (b) the denominator of which is the aggregate Outstanding Balance of all Eligible Receivables at such time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">OFAC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the U.S. Department of Treasury&#8217;s Office of Foreign Assets Control.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Originator</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; and &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Originators</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; have the meaning set forth in the Purchase and Sale Agreement, as the same may be modified from time to time by adding new Originators or removing Originators, in each case with the prior written consent of the Administrative Agent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Other Connection Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Affected Person, Taxes imposed as a result of a present or former connection between such Affected Person and the jurisdiction imposing such Tax (other than connections arising from such Affected Person having executed, delivered, become a party to, performed its obligations under, received payments under, received or perfected a security interest under, engaged in any other transaction pursuant to or enforced any Transaction Document, or sold or assigned an interest in any Loan or Transaction Document).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Other Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any and all present or future stamp or documentary Taxes or any other excise or property Taxes, charges or similar levies or fees arising from any payment made hereunder or from the execution, delivery, filing, recording or enforcement of, or otherwise in respect of, this Agreement, the other Transaction Documents and the other documents or agreements to be delivered hereunder or thereunder, except any such Taxes that are Other Connection Taxes imposed with respect to an assignment.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Outstanding Balance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, at any time of determination, with respect to any Receivable, the then outstanding principal balance thereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Overnight Bank Funding Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means for any day, the rate comprised of both overnight federal funds and overnight eurocurrency borrowings by U.S.-managed banking offices of depository institutions, as such composite rate shall be determined by the Federal Reserve Bank of New York, as set forth on its public website from time to time, and as published on the next succeeding Business Day as the overnight bank funding rate by the Federal Reserve Bank of New York (or by such other recognized electronic source (such as Bloomberg) selected by the Administrative Agent for the purpose of displaying such rate)&#59; provided, that if such day is not a Business Day, the Overnight Bank Funding Rate for such day shall be such rate on the immediately preceding Business Day&#59; provided, further, that if such rate shall at any time, for any reason, no longer exist, a comparable replacement rate determined by the Administrative Agent at such time (which determination shall be conclusive absent manifest error). If the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">25</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Overnight Bank Funding Rate determined as above would be less than zero, then such rate shall be deemed to be zero. The rate of interest charged shall be adjusted as of each Business Day based on changes in the Overnight Bank Funding Rate without notice to the Borrower.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Parent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means Integra LifeSciences Holdings Corporation, a Delaware corporation.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Parent Group</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.03(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Participant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 13.03(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Participant Register</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 13.03(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">PATRIOT Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 13.15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">PBGC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the Pension Benefit Guaranty Corporation, or any successor thereto.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Pension Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means a pension plan (other than a Multiemployer Plan) as defined in Section 3(2) of ERISA that is subject to Title IV of ERISA which any Originator, the Borrower or any other member of the Controlled Group has an obligation to contribute to or maintain or has made contributions within the preceding five (5) years.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Percentage</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, at any time of determination, with respect to any Committed Lender, a fraction (expressed as a percentage), (a) the numerator of which is (i) prior to the termination of all Commitments hereunder, its Commitment at such time or (ii) if all Commitments hereunder have been terminated, the aggregate outstanding Capital of all Loans being funded by the Lenders in such Committed Lender&#8217;s Group at such time and (b) the denominator of which is (i) prior to the termination of all Commitments hereunder, the aggregate Commitments of all Committed Lenders at such time or (ii) if all Commitments hereunder have been terminated, the aggregate outstanding Capital of all Loans at such time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Performance Guarantor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means Integra LifeSciences Holdings Corporation, a Delaware corporation.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Performance Guaranty</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the Performance Guaranty, dated as of the Closing Date, by the Performance Guarantor in favor of the Administrative Agent for the benefit of the Secured Parties, as such agreement may be amended, restated, supplemented or otherwise modified from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Person</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means an individual, partnership, corporation (including a business trust), joint stock company, trust, unincorporated association, joint venture, limited liability company or other entity, or a government or any political subdivision or agency thereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">PNC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">preamble</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> to this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Pool Receivable</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means a Receivable in the Receivables Pool.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Portion of Capital</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Lender and its related Capital, the portion of such Capital being funded or maintained by such Lender by reference to a particular interest rate basis.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Program Support Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means and includes any Liquidity Agreement and any other agreement entered into by any Program Support Provider providing for&#58;  (a) the issuance of one or more letters of credit for the account of any Conduit Lender, (b) the issuance of one or more surety bonds for which any Conduit Lender is obligated to reimburse the applicable </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">26</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Program Support Provider for any drawings thereunder, (c) the sale by any Conduit Lender to any Program Support Provider of any Loan (or portions thereof or participation interest therein) maintained by such Conduit Lender and&#47;or (d) the making of loans and&#47;or other extensions of credit to any Conduit Lender in connection with such Conduit Lender&#8217;s receivables-securitization program contemplated in this Agreement, together with any letter of credit, surety bond or other instrument issued thereunder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Program Support Provider</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means and includes, with respect to any Conduit Lender, any Liquidity Provider and any other Person (other than any customer of such Conduit Lender) now or hereafter extending credit or having a commitment to extend credit to or for the account of, or to make purchases from, such Conduit Lender pursuant to any Program Support Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Purchase and Sale Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the Purchase and Sale Agreement, dated as of the Closing Date, among the Servicer, the Originators and the Borrower, as such agreement may be amended, supplemented or otherwise modified from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Purchase and Sale Termination Event</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in the Purchase and Sale Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Rating Agency</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; mean each of S&#38;P, Fitch and Moody&#8217;s (and&#47;or each other rating agency then rating the Notes of any Conduit Lender).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Receivable</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any right to payment of a monetary obligation, whether or not earned by performance, owed to any Originator or the Borrower (as assignee of an Originator), whether constituting an account, chattel paper, payment intangible, instrument or general intangible, in each instance arising in connection with the sale of goods that have been or are to be sold or for services rendered or to be rendered, and includes, without limitation, the obligation to pay any finance charges, fees and other charges with respect thereto.  Any such right to payment arising from any one transaction, including, without limitation, any such right to payment represented by an individual invoice or agreement, shall constitute a Receivable separate from a Receivable consisting of any such right to payment arising from any other transaction.  Notwithstanding the foregoing, &#8220;Receivable&#8221; shall not include any Excluded Receivables.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Receivables Pool</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, at any time of determination, all of the then outstanding Receivables transferred (or purported to be transferred) to the Borrower pursuant to the Purchase and Sale Agreement prior to the Termination Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Register</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 13.03(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Related Committed Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means with respect to any Conduit Lender, each Committed Lender listed as such for each Conduit Lender as set forth on the signature pages of this Agreement or in any Assumption Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Related Conduit Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Committed Lender, each Conduit Lender which is, or pursuant to any Assignment and Acceptance Agreement or Assumption Agreement or otherwise pursuant to this Agreement becomes, included as a Conduit Lender in such Committed Lender&#8217;s Group, as designated on its signature page hereto or in such Assignment and Acceptance Agreement, Assumption Agreement or other agreement executed by such Committed Lender, as the case may be.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Related Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 1.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> of the Purchase and Sale Agreement.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">27</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Related Security</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Receivable&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">all of the Borrower&#8217;s and each Originator&#8217;s interest in any goods (including returned goods), and documentation of title evidencing the shipment or storage of any goods (including returned goods), the sale of which gave rise to such Receivable&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">all instruments and chattel paper that may evidence such Receivable&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">all other security interests or liens and property subject thereto from time to time purporting to secure payment of such Receivable, whether pursuant to the Contract related to such Receivable or otherwise, together with all UCC financing statements or similar filings relating thereto&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(4)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">all of the Borrower&#8217;s and each Originator&#8217;s rights, interests and claims under the related Contracts and all guaranties, indemnities, insurance and other agreements (including the related Contract) or arrangements of whatever character from time to time supporting or securing payment of such Receivable or otherwise relating to such Receivable, whether pursuant to the Contract related to such Receivable or otherwise&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(5)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">all of the Borrower&#8217;s rights, interests and claims under the Purchase and Sale Agreement and the other Transaction Documents.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Release</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.01(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Relevant Governmental Body</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the Board of Governors of the Federal Reserve System or the Federal Reserve Bank of New York, or a committee officially endorsed or convened by the Board of Governors of the Federal Reserve System or the Federal Reserve Bank of New York, or any successor thereto.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Relief Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the Fiscal Months beginning and including March 2023 through and including December 2023.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Reportable Compliance Event</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means that any Covered Entity becomes a Sanctioned Person, or is charged by indictment, criminal complaint or similar charging instrument, arraigned, or custodially detained in connection with any Anti-Terrorism Law or any predicate crime to any Anti-Terrorism Law, or has knowledge of facts or circumstances to the effect that it is reasonably likely that any aspect of its operations is in actual or probable violation of any Anti-Terrorism Law.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Reportable Event</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any reportable event as defined in Section 4043(c) of ERISA for which the notice provision has not been waived under the applicable regulations issued thereunder with respect to a Pension Plan (other than a Pension Plan maintained by an ERISA Affiliate which is considered an ERISA Affiliate only pursuant to subsection (m) or (o) of Section 414 of the Code).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Representatives</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 13.06(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Required Capital Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, as of any date of determination, an amount equal to the product of (a) the Loss Reserve Percentage at such time times, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">multiplied</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">by</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (b) the aggregate Outstanding Balance of all Eligible Receivables then in the Receivables Pool.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Restricted Payments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.01(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">28</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">S&#38;P</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means Standard &#38; Poor&#8217;s Rating Services, a Standard &#38; Poor&#8217;s Financial Services LLC business, and any successor thereto that is a nationally recognized statistical rating organization.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Sanctioned Country</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means a country or territory that is the subject or target of a sanctions program maintained under any Anti-Terrorism Law, including any such country identified on the list maintained by OFAC and available at&#58; </font><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">http&#58;&#47;&#47;www.treasury.gov&#47;resource-center&#47;sanctions&#47;Programs&#47;Pages&#47;Programs.aspx</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, or as otherwise published from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Sanctioned Person</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means (a) a person named on the list of &#8220;Specially Designated Nationals&#8221; or &#8220;Blocked Persons&#8221; maintained by OFAC available at&#58;  </font><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">https&#58;&#47;&#47;www.treasury.gov&#47;resource-center&#47;sanctions&#47;SDN-List&#47;Pages&#47;default.aspx</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, or as otherwise published from time to time, (b) (i) an agency of the government of a Sanctioned Country, (ii) an organization controlled by a Sanctioned Country or (iii) a person resident in a Sanctioned Country, to the extent subject to a sanctions program administered by OFAC, or (c) any individual person, group, regime, entity or thing listed or otherwise recognized as a specially designated, prohibited, sanctioned or debarred person, group, regime, entity or thing, or subject to any limitations or prohibitions (including but not limited to the blocking of property or rejection of transactions), under any Anti-Terrorism Law.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Scheduled Termination Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means May 28, 2024.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">SEC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the U.S. Securities and Exchange Commission or any governmental agencies substituted therefor.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Secured Parties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means each Credit Party, each Borrower Indemnified Party and each Affected Person.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Securities Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the Securities Act of 1933, as amended or otherwise modified from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Servicer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">preamble</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> to this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Servicer Indemnified Amounts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 12.02(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Servicer Indemnified Party</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 12.02(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Servicing Fee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the fee referred to in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 8.06(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Servicing Fee Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the rate referred to in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 8.06(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Settlement Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means with respect to any Portion of Capital for any Interest Period or any Interest or Fees, (i) so long as no Event of Default has occurred and is continuing and the Termination Date has not occurred, the Monthly Settlement Date and (ii) on and after the Termination Date or if an Event of Default has occurred and is continuing, each day selected from time to time by the Administrative Agent (with the consent or at the direction of the Majority Group Agents) (it being understood that the Administrative Agent (with the consent or at the direction of the Majority Group Agents) may select such Settlement Date to occur as frequently as daily), or, in the absence of such selection, the Monthly Settlement Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, for any day, a rate equal to the secured overnight financing rate as administered by the Federal Reserve Bank of New York (or a successor administrator of the secured overnight financing rate).</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">29</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">SOFR Adjustment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means ten (10) basis points (0.10%) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">per annum</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">SOFR Determination Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; shall have the meaning set forth in the definition of &#8220;Daily Simple SOFR&#8221;.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">SOFR Rate Day</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; shall have the meaning set forth in the definition of &#8220;Daily Simple SOFR&#8221;.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Solvent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Person and as of any particular date, (i) the present fair market value (or present fair saleable value) of the assets of such Person is not less than the total amount required to pay the probable liabilities of such Person on its total existing debts and liabilities (including contingent liabilities) as they become absolute and matured, (ii) such Person is able to realize upon its assets and pay its debts and other liabilities, contingent obligations and commitments as they mature and become due in the normal course of business, (iii) such Person is not incurring debts or liabilities beyond its ability to pay such debts and liabilities as they mature and (iv) such Person is not engaged in any business or transaction, and is not about to engage in any business or transaction, for which its property would constitute unreasonably small capital after giving due consideration to the prevailing practice in the industry in which such Person is engaged.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Specifically Reserved Dilution Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means for any Fiscal Month, an amount computed on the last day of such Fiscal Month, equal to the greater of&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">the product of (i) the U.S. Dollar Equivalent of the aggregate amount of dilution or similar adjustments arising out of volume rebates, terms discounts, indirect rebates, direct rebates (net of any direct rebate recovery), key promotional programs or similar arrangements which are customary for the Originators and specified in the related Contract or applicable marketing program related to the applicable Receivable and Obligor thereof that are expected by the Servicer to be made or otherwise incurred with respect to the then outstanding Pool Receivables as such expected dilution and similar adjustments are reflected on the books and records of the Originators and their Affiliates and reserved for by the Originator and their Affiliates (GL Account # 231230), as determined in consultation with the external accountants of the Originators and in accordance with the customary procedures established by the Originators and such accountants and (ii) one hundred percent (100.00%) (or such lesser percentage specified by the Administrative Agent upon not less than five (5) Business Days&#8217; notice to the Borrower to reflect such percentage as the Administrative Agent reasonably believes best reflects the reserve coverage relative to Pool Receivables based on the observed historical information and&#47;or the results of any audit or field exam of the Originators&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">the product of (i) the aggregate credit sales made by each Originator, as applicable, during the most recent Fiscal Month and (ii) three percent (3.00%) (or such other percentage specified by the Administrative Agent upon not less than five (5) Business Days&#8217; notice to the Borrower to reflect such percentage as the Administrative Agent reasonably believes best reflects the dilution activity described in section (a) herein based on the observed historical information and&#47;or the results of any audit or field exam of the Originators.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Specific Reporting Event</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; shall occur when the Minimum Liquidity Amount has not been maintained for a period of five (5) consecutive Business Days&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that such Specific Reporting Event shall cease to occur once the Minimum Liquidity Amount has been maintained for a period of thirty (30) consecutive calendar days.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">30</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Spot Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, on any day, (a) for the purpose of exchanging U.S. Dollars to Alternative Currency or Alternative Currency to U.S. Dollars in connection with applying funds to pay amounts owing hereunder or under the Transaction Documents in accordance with this Agreement, the actual rate used by the Administrative Agent&#8217;s principal foreign exchange trading office for the purchase by the Administrative Agent of the applicable currency with the other currency through its principal foreign exchange trading office, and (b) for the purpose of making any calculation hereunder that does not require the actual exchange of U.S. Dollars for Alternative Currency or Alternative Currency for U.S. Dollars to make a payment of amounts owing hereunder or under the Transaction Documents, (i) with respect to the determination of the U.S. Dollar Equivalent of any amount denominated in Alternative Currency, the exchange rate at which such Alternative Currency may be exchanged into U.S. Dollars as set forth at approximately 11&#58;00 a.m. New York City time, on such day as published on the Bloomberg Key Cross-Currency Rates Page for such Alternative Currency or (ii) with respect to the determination of the Alternative Currency equivalent of any amount denominated in U.S. Dollars, the exchange rate at which U.S. Dollars may be exchanged into Alternative Currency as set forth at approximately 11&#58;00 a.m. New York City time, on such day as published on the Bloomberg Key Cross-Currency Rates Page for U.S. Dollars.  In the event that such rate does not appear on any Bloomberg Key Cross Currency Rates Page, the Spot Rate shall be determined by reference to such other publicly available service for displaying exchange rates as may be selected by the Administrative Agent and is reasonably satisfactory to the Servicer, or, in the absence of such an agreement, such Spot Rate shall instead be the arithmetic average of the spot rates of exchange of the Administrative Agent in the market where its foreign currency exchange operations in respect of such currency are then being conducted, at or about 11&#58;00 a.m. New York time, on such date for the purchase of U.S. Dollars with the applicable Alternative Currency for delivery two (2) Business Days later&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">that if at the time of any such determination, for any reason, no such spot rate is being quoted, the Administrative Agent may use any reasonable method it deems appropriate to determine such rate, and such determination shall be conclusive absent manifest error.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Structuring Agent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means PNC Capital Markets LLC, a Pennsylvania limited liability company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Subordinated Note</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in the Purchase and Sale Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Sub-Servicer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 8.01(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Subsidiary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, as to any Person, a corporation, partnership, limited liability company or other entity of which shares of stock of each class or other interests having ordinary voting power (other than stock or other interests having such power only by reason of the happening of a contingency) to elect a majority of the Board of Directors or other managers of such entity are at the time owned, or management of which is otherwise controlled&#58;  (a) by such Person, (b) by one or more Subsidiaries of such Person or (c) by such Person and one or more Subsidiaries of such Person.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any and all present or future taxes, levies, imposts, duties, deductions, charges or withholdings (including backup withholding), assessments, fees or other charges imposed by any Governmental Authority and all interest, penalties, additions to tax and any similar liabilities with respect thereto.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Temporarily Ineligible Obligor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means Promedon Do Brazil or any other Obligor requested by the Borrower and consented to in writing by the Majority Group Agents in their sole discretion until such time that the Majority Group Agents and the Borrower mutually agree that such Obligor is no longer deemed ineligible (including, for the avoidance of doubt, Promedon Do Brazil).</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">31</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Temporarily Ineligible Receivable</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any Receivable the Obligor of which is a Temporarily Ineligible Obligor.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; shall mean, with respect to any Loan (or portion thereof) to which the Term SOFR Option applies, for any Interest Period, the interest rate </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">per annum</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> determined by the Administrative Agent (rounded upwards, at the Administrative Agent&#8217;s discretion, to the nearest 1&#47;100th of 1%) equal to the Term SOFR Reference Rate for a tenor comparable to such Interest Period, as such rate is published by the Term SOFR Administrator on the day (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR Determination Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) that is two (2) Business Days prior to the first day of such Interest Period.  If the Term SOFR Reference Rate for the applicable tenor has not been published or replaced with a Benchmark Replacement by 5&#58;00 p.m. (Pittsburgh, Pennsylvania time) on the Term SOFR Determination Date, then the Term SOFR Reference Rate shall be the Term SOFR Reference Rate for such tenor on the first Business Day preceding such Term SOFR Determination Date for which such Term SOFR Reference Rate for such tenor was published by the Term SOFR Administrator in accordance herewith, so long as such first preceding Business Day is not more than three (3) Business Days prior to such Term SOFR Determination Date.  If Term SOFR, determined as provided above, would be less than the Floor, then Term SOFR shall be deemed to be the Floor.  Term SOFR shall be adjusted automatically without notice to the Borrower on and as of the first day of each Interest Period.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR Administrator</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means CME Group Benchmark Administration Limited (CBA) (or a successor administrator of the Term SOFR Reference Rate selected by the Administrative Agent in its reasonable discretion).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR Determination Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; shall have the meaning set forth in the definition of &#8220;Term SOFR&#8221;.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the option of the Borrower to have Loans bearing interest at the rate and under the terms specified in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.05(a)(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means with respect to Loans to which the Term SOFR Option applies, a fluctuating interest rate </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">per annum</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> as shall be in effect from time to time equal to (a) Term SOFR, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (b) the SOFR Adjustment.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR Rate Loan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means a Loan that bears interest based on the Term SOFR Rate.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR Reference Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; shall mean the forward-looking term rate based on SOFR.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Termination Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the earliest to occur of (a) the Scheduled Termination Date, (b) the date on which the &#8220;Termination Date&#8221; is declared or deemed to have occurred under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 9.01 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c) the date selected by the Borrower on which all Commitments have been reduced to zero pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.02(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> and (d) the date as determined pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.01(z)(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Total Reserves</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, at any time of determination, an amount equal to the sum of (a) the product of (i) the sum of&#58;  (A) the Yield Reserve Percentage, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (B) the greatest of (I) the sum of the Concentration Reserve Percentage </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> the Minimum Dilution Reserve Percentage and (II) the sum of the Loss Reserve Percentage </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> the Dilution Reserve Percentage, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">multiplied by</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (ii) the Adjusted Net Receivables Pool Balance at such time, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (b) the Currency Reserve Amount&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">that</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> Temporarily Ineligible Receivables shall be excluded from each component of the calculations used to determine Total Reserves.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Transaction Documents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means this Agreement, the Purchase and Sale Agreement, the Account Control Agreement(s), the Fee Letter, each Subordinated Note, the Performance </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">32</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Guaranty and all other certificates, instruments, UCC financing statements, reports, notices, agreements and documents executed or delivered under or in connection with this Agreement, in each case as the same may be amended, supplemented or otherwise modified from time to time in accordance with this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Transaction Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any information provided to any Rating Agency, in each case, to the extent related to such Rating Agency providing or proposing to provide a rating of any Notes or monitoring such rating including, without limitation, information in connection with the Borrower, the Originator, the Servicer or the Receivables.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">UCC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the Uniform Commercial Code as from time to time in effect in the applicable jurisdiction.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Unadjusted Benchmark Replacement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the applicable Benchmark Replacement excluding the related Benchmark Replacement Adjustment.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Unbilled Receivable</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, at any time, any Receivable as to which the invoice or bill with respect thereto has not yet been sent to the Obligor thereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Unmatured Event of Default</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means an event that but for notice or lapse of time or both would constitute an Event of Default.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Unmatured Purchase and Sale Termination Event</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in the Purchase and Sale Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">U.S. Dollar Equivalent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, on any date on which a determination thereof is to be made, with respect to (a) any amount denominated in U.S. Dollars, such amount and (b) any amount denominated in an Alternative Currency, the U.S. Dollar equivalent of such amount of such Alternative Currency determined by reference to the Spot Rate determined as of such determination date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">U.S. Government Securities Business Day</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any day except for (a) a Saturday or Sunday or (b) a day on which the Securities Industry and Financial Markets Association recommends that the fixed income departments of its members be closed for the entire day for purposes of trading in United States government securities.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">U.S. Obligor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means an Obligor that is (a) a corporation or other business organization and is organized under the laws of the United States of America (or of a United States of America territory, district, state, commonwealth, or possession, including, without limitation, Puerto Rico and the U.S. Virgin Islands) or any political subdivision thereof, (b) the federal government of the United States of America or any political subdivision, department, affiliate, agency or other entity thereof, and (c) any state or local government body in the United States of America or any political subdivision, department, affiliate, agency or other entity thereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">U.S. Tax Compliance Certificate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 4.03(f)(ii)(B)(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Volcker Rule</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means Section 13 of the U.S. Bank Holding Company Act of 1956, as amended, and the applicable rules and regulations thereunder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Voting Securities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Person, securities or other ownership interests having by the terms thereof ordinary voting power to elect the board of directors or other persons performing similar functions of such Person (irrespective of whether or not at such time securities or other ownership interests of any other class or classes of such Person shall have or might have voting power by reason of the happening of any contingency).</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">33</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Weighted Average Remaining Credit Terms</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, for any Fiscal Month, the weighted average (weighted based on the Outstanding Balance of all Pool Receivables) remaining payment period (computed in days and calculated based on the difference between the date of determination and the stated due date for payment) of invoices for all Pool Receivables (for which the related stated due date for payment has not occurred as of such date of determination) as of the last day of such Fiscal Month. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Withdrawal Liability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means liability to a Multiemployer Plan as a result of a complete or partial withdrawal from such Multiemployer Plan, as such terms are defined in Part I of Subtitle E of Title IV of ERISA.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Yield Reserve Percentage</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means at any time of determination&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">1.50 x DSO x (BR + SFR)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><br>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;360</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">where&#58;</font></div><div style="margin-bottom:12pt;padding-left:144pt;text-align:justify;text-indent:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">BR&#160;&#160;&#160;&#160;&#61;&#160;&#160;&#160;&#160;the Base Rate&#59;</font></div><div style="margin-bottom:12pt;padding-left:144pt;text-align:justify;text-indent:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">DSO&#160;&#160;&#160;&#160;&#61;&#160;&#160;&#160;&#160;the Days&#8217; Sales Outstanding for the most recently ended Fiscal Month&#59; and</font></div><div style="margin-bottom:12pt;padding-left:144pt;text-align:justify;text-indent:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SFR&#160;&#160;&#160;&#160;&#61;&#160;&#160;&#160;&#160;the Servicing Fee Rate.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1.0b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:30.36pt">Other Interpretative Matters.  All accounting terms not specifically defined herein shall be construed in accordance with GAAP.  All terms used in Article 9 of the UCC in the State of New York and not specifically defined herein, are used herein as defined in such Article 9.  Unless otherwise expressly indicated, all references herein to &#8220;Article,&#8221; &#8220;Section,&#8221; &#8220;Schedule&#8221;, &#8220;Exhibit&#8221; or &#8220;Annex&#8221; shall mean articles and sections of, and schedules, exhibits and annexes to, this Agreement.  For purposes of this Agreement, the other Transaction Documents and all such certificates and other documents, unless the context otherwise requires&#58; (a) references to any amount as on deposit or outstanding on any particular date means such amount at the close of business on such day&#59; (b) the words &#8220;hereof,&#8221; &#8220;herein&#8221; and &#8220;hereunder&#8221; and words of similar import refer to such agreement (or the certificate or other document in which they are used) as a whole and not to any particular provision of such agreement (or such certificate or document)&#59; (c) references to any Section, Schedule or Exhibit are references to Sections, Schedules and Exhibits in or to such agreement (or the certificate or other document in which the reference is made), and references to any paragraph, subsection, clause or other subdivision within any Section or definition refer to such paragraph, subsection, clause or other subdivision of such Section or definition&#59; (d) the term &#8220;including&#8221; means &#8220;including without limitation&#8221;&#59; (e) references to any Applicable Law refer to that Applicable Law as amended from time to time and include any successor Applicable Law&#59; (f) references to any agreement refer to that agreement as from time to time amended, restated or supplemented or as the terms of such agreement are waived or modified in accordance with its terms&#59; (g) references to any Person include that Person&#8217;s permitted successors and assigns&#59; (h) headings are for purposes of reference only and shall not otherwise affect the meaning or interpretation of any provision hereof&#59; (i) unless otherwise provided, in the calculation of time from a specified date to a later specified date, the term &#8220;from&#8221; means &#8220;from and including&#8221;, and the terms &#8220;to&#8221; and &#8220;until&#8221; each means &#8220;to but excluding&#8221;&#59; (j) terms in one gender include the parallel terms in the neuter and opposite gender&#59; (k) references to any amount as on deposit or outstanding on any particular date means such amount at the close of business on such day and (l) the term &#8220;or&#8221; is not exclusive.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">34</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ARTICLE 2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:8.36pt"><br><br>TERMS OF THE LOANS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1.0a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:31.04pt">Loan Facility.  Upon a request by the Borrower pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, and on the terms and subject to the conditions hereinafter set forth, the Conduit Lenders, ratably, in accordance with the aggregate of the Commitments of the Related Committed Lenders with respect to each such Conduit Lender, severally and not jointly, may, in their sole discretion, make Loans to the Borrower on a revolving basis, and if and to the extent any Conduit Lender does not make any such requested Loan or if any Group does not include a Conduit Lender, the Related Committed Lender(s) for such Conduit Lender or the Committed Lender for such Group, as the case may be, shall, ratably in accordance with their respective Commitments, severally and not jointly, make such Loans to the Borrower, in either case, from time to time during the period from the Closing Date to the Termination Date.  Under no circumstances shall any Lender be obligated to make any such Loan if, after giving effect to such Loan&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:65.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">i.the Aggregate Capital would exceed the Facility Limit at such time&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:62.34pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ii.the sum of (A) the Capital of such Lender, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (B) the aggregate outstanding Capital of each other Lender in its Group, would exceed the Group Commitment of such Lender&#8217;s Group&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:59.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">iii.if such Lender is a Committed Lender, the aggregate outstanding Capital of such Committed Lender would exceed its Commitment&#59; or</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:59.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">iv.the Aggregate Capital would exceed the Borrowing Base at such time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1.0b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:30.36pt">Making Loans&#59; Repayment of Loans. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:65.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">i.Each Loan hereunder shall be made on at least one (1) Business Day&#8217;s prior written request from the Borrower to the Administrative Agent and each Group Agent in the form of a Loan Request attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Each such request for a Loan shall be made no later than 1&#58;00 p.m. (New York City time) on a Business Day (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">it being understood</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that any such request made after such time shall be deemed to have been made on the following Business Day) and shall specify (i) the amount of the Loan(s) requested (which shall not be less than one million dollars ($1,000,000) and shall be an integral multiple of one hundred thousand dollars ($100,000)), (ii) the allocation of such amount among the Groups (which shall be ratable based on the Group Commitments), (iii) the account to which the proceeds of such Loan shall be distributed and (iv) the date such requested Loan is to be made (which shall be a Business Day).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:62.34pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ii.On the date of each Loan specified in the applicable Loan Request, the Lenders shall, upon satisfaction of the applicable conditions set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Article V</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> and pursuant to the other conditions set forth in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Article II</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, make available to the Borrower in same day funds an aggregate amount equal to the amount of such Loans requested, at the account set forth in the related Loan Request.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:59.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">iii.Each Committed Lender&#8217;s obligation shall be several, such that the failure of any Committed Lender to make available to the Borrower any funds in connection with any Loan shall not relieve any other Committed Lender of its obligation, if any, hereunder to make funds available on the date such Loans are requested (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">it</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">being</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">understood</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that no Committed Lender shall be responsible for the failure of any other Committed Lender (other than a Committed Lender in its Group) to make funds available to the Borrower in connection with any Loan hereunder).</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">35</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:59.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">iv.The Borrower shall repay in full the outstanding Capital of each Lender on the Final Maturity Date.  Prior thereto, the Borrower shall, on each Settlement Date, make a prepayment of the outstanding Capital of the Lenders to the extent required under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> and otherwise in accordance therewith.  Notwithstanding the foregoing, the Borrower, in its discretion, shall have the right to make a prepayment, in whole or in part, of the outstanding Capital of the Lenders on any Business Day upon at least (x) with respect to any Base Rate Loan, one (1) Business Day&#8217;s prior written notice thereof to the Administrative Agent and each Group Agent, and (y) with respect to any Term SOFR Rate Loan or Daily SOFR Rate Loan, three (3) Business Days prior written notice thereof to the Administrative Agent and each Group Agent, in any case in the form of a Reduction Notice attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit B</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that (i) each such prepayment shall be in a minimum aggregate amount of one hundred thousand dollars ($100,000) and shall be an integral multiple of one hundred thousand dollars ($100,000)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that notwithstanding the foregoing, a prepayment may be in an amount necessary to reduce any Borrowing Base Deficit existing at such time or the outstanding Capital of the Lenders to zero ($0), and (ii) any accrued Interest and Fees in respect of such prepaid Capital shall be paid on the immediately following Settlement Date&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that the Borrower shall not provide any Reduction Notice, and no such Reduction Notice shall be effective, if after giving effect thereto, the Aggregate Capital at such time would be less than the Minimum Funding Threshold.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:63pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">v.All prepayments required pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> shall be applied first to Base Rate Loans, then to Daily SOFR Rate Loans, then to Term SOFR Rate Loans. In accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 12.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, the Borrower shall indemnify the Lenders for any loss or expense, including loss of margin, incurred with respect to any such prepayments applied against Loans subject to a Term SOFR Option or Daily SOFR Option on any day other than the last day of the applicable Interest Period.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:59.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">vi.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Decreases or Increases in Commitments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">The Borrower may, at any time upon at least thirty (30) calendar days&#8217; prior written notice to the Administrative Agent and each Group Agent, terminate the Facility Limit in whole or ratably reduce the Facility Limit in part.  Each partial reduction in the Facility Limit shall be in a minimum aggregate amount of five million dollars ($5,000,000) or integral multiples of one million dollars ($1,000,000) in excess thereof, and no such partial reduction shall reduce the Facility Limit to an amount less than one hundred million dollars ($100,000,000).  In connection with any partial reduction in the Facility Limit, the Commitment of each Committed Lender shall be ratably reduced.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">So long as no Event of Default or Unmatured Event of Default has occurred and is continuing, the Borrower may, with the prior written consent of the Majority Group Agents (in their sole discretion), upon thirty (30) calendar days&#8217; prior written notice to the Administrative Agent and the Majority Group Agents, from time to time, request an increase in the Commitment with respect to one or more Lenders (and a related increase in the Facility Limit) or cause additional Persons to become parties to this Agreement, as lenders, at any time following the Closing Date and prior to the Termination Date&#59; it being understood and agreed that the Administrative Agent, any Majority Group Agent or any Lender increasing its Commitment pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.02(e)(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> may request any of (A) resolutions of the Board of Managers of the Borrower approving or consenting to such Commitment increase and authorizing the execution, delivery and performance of any amendment to this Agreement, (B) a corporate and enforceability opinion of counsel of the Borrower and (C) such other documents, agreements and opinions reasonably requested by the Administrative Agent, such Majority Group Agent or such Lender.  For the avoidance of doubt, Any such Person not </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">36</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">responding within such time period shall be deemed to have declined to consent to an increase in such Lender&#8217;s Commitment.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:56.34pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">vii.In connection with any reduction of the Commitments, the Borrower shall remit to the Administrative Agent (i) instructions regarding such reduction and (ii) for payment to the Lenders, cash in an amount sufficient to pay (A) Capital of Lenders in each Group in excess of the Group Commitment of such Group and (B) all other outstanding Borrower Obligations with respect to such reduction (determined based on the ratio of the reduction of the Commitments being effected to the amount of the Commitments prior to such reduction or, if the Administrative Agent reasonably determines that any portion of the outstanding Borrower Obligations is allocable solely to that portion of the Commitments being reduced or has arisen solely as a result of such reduction, all of such portion) including, without duplication, any associated Breakage Fees.  Upon receipt of any such amounts, the Administrative Agent shall apply such amounts first to the reduction of the outstanding Capital, and second to the payment of the remaining outstanding Borrower Obligations with respect to such reduction, including any Breakage Fees, by paying such amounts to the Lenders.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:53.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">viii.The Borrower hereby covenants and agrees from time to time to request Loans pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.02(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> in amounts and at such times such that the Aggregate Capital at all times is no less than the Minimum Funding Threshold at such time&#59; it being understood and agreed that each Credit Extension pursuant to this Agreement is subject to the applicable conditions set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Article V</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> and the other conditions set forth in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Article II</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1.0c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:31.04pt">Interest and Fees.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:65.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">i.On each Settlement Date, the Borrower shall, in accordance with the terms and priorities for payment set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, pay to each Group Agent, each Lender, the Administrative Agent and the Structuring Agent certain fees (collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Fees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) in the amounts set forth in the fee letter agreements from time to time entered into, among the Borrower, the members of the applicable Group (or their Group Agent on their behalf) and&#47;or the Administrative Agent (each such fee letter agreement, as amended, restated, supplemented or otherwise modified from time to time, collectively being referred to herein as the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Fee Letter</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).  Undrawn Fees (as defined in the Fee Letter) shall cease to accrue on the unfunded portion of the Commitment of such Defaulting Lender as provided in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.06</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:62.34pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ii.Each Loan of each Lender and the Capital thereof shall accrue interest on each day when such Capital remains outstanding at the then applicable Interest Rate for such Loan.  The Borrower shall pay all Interest (including, for the avoidance of doubt, all Interest accrued on Loans during an Interest Period regardless of whether the applicable Interest Period has ended), Fees and Breakage Fees accrued during each Interest Period on each Settlement Date in accordance with the terms and priorities for payment set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1.0d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:30.36pt">Records of Loans.  Each Group Agent shall record in its records, the date and amount of each Loan made by the Lenders in its Group hereunder, the interest rate with respect thereto, the Interest accrued thereon and each repayment and payment thereof.  Subject to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 13.03(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, such records shall be conclusive and binding absent manifest error.  The failure to so record any such information or any error in so recording any such information shall not, however, limit or otherwise affect the obligations of the Borrower hereunder or under the other Transaction Documents to repay the Capital of each Lender, together with all Interest accruing thereon and all other Borrower Obligations.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1.0e.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:31.04pt">Selection of Interest Rates.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">37</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:65.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">i.The Borrower shall have the right to select from the following types of Interest Rate applicable to a Loan&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Base Rate Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#58;  the Base Rate (computed on the basis of a year of 365 or 366 days, as the case may be, and actual days elapsed), subject to change automatically from time to time effective as of the effective date of each change in the Base Rate&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Term SOFR Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#58;  the Term SOFR Rate (computed on the basis of a year of 360 days and actual days elapsed) as determined for each applicable Interest Period&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Daily SOFR Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#58;  the Daily SOFR Rate (computed on the basis of a year of 360 days and actual days elapsed) as determined for each applicable Interest Period.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:62.34pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ii.So long as no Event of Default has occurred and is continuing, the Borrower may from time to time elect to change or continue the type of Interest Rate borne by each Loan or, subject to the minimum amount requirement for each outstanding Loan set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, a portion thereof by notice to the Administrative Agent not later than 11&#58;00 a.m. (New York City time), one (1) Business Day prior to the expiration of the applicable Interest Period, as applicable&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that there shall not be more than three (3) Loans accruing interest at any Interest Rate and outstanding hereunder at any one time&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that for the avoidance of doubt, any change to the Interest Rate applicable to a Loan shall not be effective until the Monthly Settlement Date occurring after the date of such request.  Any such notices requesting the continuation or conversion of a Loan to the Administrative Agent may be given by telephone, telecopy, or other telecommunication device acceptable to the Administrative Agent (which notice shall be irrevocable once given and, if by telephone, shall be promptly confirmed in writing in a manner acceptable to the Administrative Agent).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:59.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">iii.If, by the time required in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.05(a),</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> the Borrower fails to select an Interest Rate for any Loan, such Loan shall automatically accrue Interest at the Daily SOFR Rate for the next occurring Interest Period.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1.0f.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:32.37pt">Defaulting Lenders.  Notwithstanding any provision of this Agreement to the contrary, if any Lender becomes a Defaulting Lender, then the following provisions shall apply for so long as such Lender is a Defaulting Lender&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:65.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">i.Undrawn Fees (as defined in the Fee Letter) shall cease to accrue on the unfunded portion of the Commitment of such Defaulting Lender.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:62.34pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ii.The Commitment and Capital of such Defaulting Lender shall not be included in determining whether the Majority Group Agents have taken or may take any action hereunder (including any consent to any amendment, waiver or other modification pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 13.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that, except as otherwise provided in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 13.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">clause (b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> shall not apply to the vote of a Defaulting Lender in the case of an amendment, waiver or other modification requiring the consent of such Lender or each Lender directly affected thereby (if such Lender is directly affected thereby).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:59.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">iii.In the event that the Administrative Agent, the Borrower and the Servicer each agrees in writing that a Defaulting Lender has adequately remedied all matters that caused such Lender to be a Defaulting Lender, then on such date such Lender shall purchase at par such of the Loans of the other Lenders as the Administrative Agent shall determine may be necessary in order for such Lender to hold such Loans in accordance with its Pro Rata Percentage&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that no adjustments shall be made retroactively with respect to fees accrued or payments made by </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">38</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">or on behalf of the Borrower while such Lender was a Defaulting Lender, and provided, further, that except to the extent otherwise agreed by the affected parties, no change hereunder from Defaulting Lender to Lender that is not a Defaulting Lender will constitute a waiver or release of any claim of any party hereunder arising from that Lender having been a Defaulting Lender.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ARTICLE 3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:8.36pt"><br><br>SETTLEMENT PROCEDURES AND PAYMENT PROVISIONS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1.0a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:31.04pt">Settlement Procedures.</font></div><div style="margin-bottom:12pt;padding-left:13.5pt;text-align:justify;text-indent:65.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.5pt">The Servicer shall set aside and hold in trust for the benefit of the Secured Parties (or, upon the occurrence and during the continuation of a Specific Reporting Event or at any time Days&#8217; Sales Outstanding exceeds fifty-five (55) calendar days, if so requested by the Administrative Agent, promptly upon (but in no event later than one (1) Business Day after) receipt of such request, segregate in a separate account approved by the Administrative Agent, which shall be an account maintained and controlled by the Administrative Agent unless the Administrative Agent otherwise instructs in its sole discretion, for application in accordance with the priority of payments set forth below, all Collections on Pool Receivables that are received by the Servicer or the Borrower or received in any Lock-Box or Collection Account&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that so long as each of the conditions precedent set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5.03</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> are satisfied on such date, the Servicer may release to the Borrower from such Collections the amount (if any) necessary to pay (i) the purchase price for Receivables purchased by the Borrower on such date in accordance with the terms of the Purchase and Sale Agreement or (ii) amounts owing by the Borrower to the Originators under the Subordinated Notes (each such release, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Release</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).  On each Settlement Date, the Servicer (or, following its assumption of control of the Collection Accounts, the Administrative Agent) shall, distribute such Collections in the following order of priority&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">first</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, to the Servicer for the payment of the accrued Servicing Fees payable for the immediately preceding Interest Period (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, if applicable, the amount of Servicing Fees payable for any prior Interest Period to the extent such amount has not been distributed to the Servicer)&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">second</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, to each Lender and other Credit Party (ratably, based on the amount then due and owing), all accrued and unpaid Interest, Fees and Breakage Fees due to such Lender and other Credit Party for the immediately preceding Interest Period (including any additional amounts or indemnified amounts payable under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Sections 4.03</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">12.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> in respect of such payments), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, if applicable, the amount of any such Interest, Fees and Breakage Fees (including any additional amounts or indemnified amounts payable under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Sections 4.03</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">12.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> in respect of such payments) payable for any prior Interest Period to the extent such amount has not been distributed to such Lender or Credit Party&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">third</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, as set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">clause (A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> below, as applicable&#58;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27.68pt">prior to the occurrence of the Termination Date, to the extent that a Borrowing Base Deficit exists on such date or the Aggregate Capital on such date exceeds the Facility Limit, to the Lenders (ratably, based on the aggregate outstanding Capital of each Lender at such time) for the payment of a portion of the outstanding Aggregate Capital at such time, in an aggregate amount equal to the amount necessary to reduce the Borrowing Base Deficit to zero ($0) or the amount necessary to reduce the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">39</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Aggregate Capital to an amount equal to or less than the Facility Limit, as applicable&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">on and after the occurrence of the Termination Date, to each Lender (ratably, based on the aggregate outstanding Capital of each Lender at such time) for the payment in full of the aggregate outstanding Capital of such Lender at such time&#59; or</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27.68pt">prior to the occurrence of the Termination Date, at the election of the Borrower from time to time and in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.02(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, to the payment of all or any portion of the outstanding Capital of the Lenders at such time (ratably, based on the aggregate outstanding Capital of each Lender at such time)&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">fourth</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, to the Credit Parties, the Affected Persons and the Borrower Indemnified Parties (ratably, based on the amount due and owing at such time), for the payment of all other Borrower Obligations then due and owing by the Borrower to the Credit Parties, the Affected Persons and the Borrower Indemnified Parties&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">fifth</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, the balance, if any, to be paid to the Borrower for its own account.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:62.34pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ii.All payments or distributions to be made by the Servicer, the Borrower and any other Person to the Lenders (or their respective related Affected Persons and the Borrower Indemnified Parties) shall be paid or distributed to the related Group Agent at its Group Agent&#8217;s Account.  Each Group Agent, upon its receipt in the applicable Group Agent&#8217;s Account of any such payments or distributions, shall distribute such amounts to the applicable Lenders, Affected Persons and the Borrower Indemnified Parties within its Group ratably&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that if such Group Agent shall have received insufficient funds to pay all of the above amounts in full on any such date, such Group Agent shall pay such amounts to the applicable Lenders, Affected Persons and the Borrower Indemnified Parties within its Group in accordance with the priority of payments set forth above, and with respect to any such category above for which there are insufficient funds to pay all amounts owing on such date, ratably (based on the amounts in such categories owing to each such Person in such Group) among all such Persons in such Group entitled to payment thereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:59.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">iii.If and to the extent the Administrative Agent, any Credit Party, any Affected Person or any Borrower Indemnified Party shall be required, for any reason relating to any act or omission of any Integra Party or any Insolvency Event relating to any Integra Party, to pay over to any Person any amount received on its behalf hereunder, such amount shall be deemed not to have been so received but rather to have been retained by the Borrower and, accordingly, the Administrative Agent, such Credit Party, such Affected Person or such Borrower Indemnified Party, as the case may be, shall have a claim against the Borrower for such amount.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:59.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">iv.For the purposes of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">If, on any day, the Outstanding Balance of any Pool Receivable is reduced or adjusted as a result of any defective, rejected, returned, repossessed or foreclosed goods or services, or any revision, cancellation, allowance, rebate, credit memo, discount or other adjustment made by the Borrower, any Originator, the Servicer or any Affiliate of the Servicer, or any setoff, counterclaim or dispute between the Borrower or any Affiliate of the Borrower, an Originator or any Affiliate of an Originator, or the Servicer or any Affiliate of the Servicer, and an Obligor, the Borrower shall be deemed to have received on such day a Collection of such Pool Receivable in the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">40</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">amount of such reduction or adjustment and shall immediately pay any and all such amounts in respect thereof to a Collection Account (or as otherwise directed by the Administrative Agent at such time) for the benefit of the Credit Parties for application pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.01(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">if on any day any of the representations or warranties in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 6.01(o)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 6.01(w)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> is not true with respect to any Pool Receivable, the Borrower shall be deemed to have received on such day a Collection of such Pool Receivable in full and shall immediately pay the amount of such deemed Collection to a Collection Account (or as otherwise directed by the Administrative Agent at such time) for the benefit of the Credit Parties for application pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.01(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (Collections deemed to have been received pursuant this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.01(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> are hereinafter sometimes referred to as &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Deemed Collections</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;)&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">except as provided in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">clauses (i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> above or otherwise required by Applicable Law or the relevant Contract, all Collections received from an Obligor of any Receivable shall be applied to the Receivables of such Obligor in the order of the age of such Receivables, starting with the oldest such Receivable, unless such Obligor designates in writing its payment for application to specific Receivables&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">if and to the extent the Administrative Agent, any Credit Party, any Affected Person or any Borrower Indemnified Party shall be required for any reason to pay over to an Obligor (or any trustee, receiver, custodian or similar official in any Insolvency Proceeding) any amount received by it hereunder, such amount shall be deemed not to have been so received by such Person but rather to have been retained by the Borrower and, accordingly, such Person shall have a claim against the Borrower for such amount, payable when and to the extent that any distribution from or on behalf of such Obligor is made in respect thereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1.0b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:30.36pt">Payments and Computations, Etc.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:65.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">i.All amounts to be paid by the Borrower or the Servicer to the Administrative Agent, any Credit Party, any Affected Person or any Borrower Indemnified Party hereunder shall be paid no later than noon (12&#58;00 p.m.) (New York City time) on the day when due in same day funds to the applicable Group Agent&#8217;s Account.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:62.34pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ii.Each of the Borrower and the Servicer shall, to the extent permitted by Applicable Law, pay interest on any amount not paid or deposited by it when due hereunder, at an interest rate </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">per annum</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> equal to 2.50% </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">per annum</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> above the Base Rate, payable on demand. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:59.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">iii.All computations of interest under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">subsection (b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> above and all computations of Interest, Fees and other amounts hereunder shall be made on the basis of a year of 360 days (or, in the case of amounts determined by reference to the Base Rate, 365 or 366 days, as applicable) for the actual number of days (including the first but excluding the last day) elapsed.  Whenever any payment or deposit to be made hereunder shall be due on a day other than a Business Day, such payment or deposit shall be made on the next succeeding Business Day and such extension of time shall be included in the computation of such payment or deposit.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ARTICLE 4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:8.36pt"><br><br>INCREASED COSTS&#59; FUNDING LOSSES&#59; TAXES&#59; ILLEGALITY AND SECURITY INTEREST</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1.0a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:31.04pt">Increased Costs.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">41</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:65.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Increased Costs Generally</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  If any Change in Law shall&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">impose, modify or deem applicable any reserve, special deposit, compulsory loan, insurance charge or similar requirement against assets of, deposits with or for the account of, or credit extended or participated in by, any Affected Person&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">subject any Affected Person to any Taxes (other than (A) Indemnified Taxes, (B) Taxes described in clauses (b) through (d) of the definition of Excluded Taxes and (C) Connection Income Taxes) on its loans, loan principal, commitments or other obligations, or its deposits, reserves, other liabilities or capital attributable thereto&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">impose on any Affected Person any other condition, cost or expense (other than Taxes) (A) affecting the Collateral, this Agreement, any other Transaction Document, any Program Support Agreement, any Loan or (B) affecting its obligations or rights to make Loans&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">and the result of any of the foregoing shall be to increase the cost to such Affected Person of making, converting to, continuing or maintaining any Loan or of maintaining its obligation to make any such Loan, or to increase the cost to such Affected Person of participating in, converting to, continuing or maintaining any Loan, or to reduce the amount of any sum received or receivable by such Affected Person hereunder (whether of principal, interest or any other amount) then, upon request of such Affected Person, the Borrower will pay to such Affected Person, as the case may be, such additional amount or amounts as will compensate such Affected Person, as the case may be, for such additional costs incurred or reduction suffered&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that upon the occurrence of any Change in Law imposing a reserve percentage on any interest rate based on SOFR, the Administrative Agent, in its reasonable discretion, may modify the calculation of each such SOFR-based interest rate to add (or otherwise account for) such reserve percentage.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:62.34pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Capital and Liquidity Requirements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  If any Affected Person determines that any Change in Law affecting such Affected Person or any lending office of such Affected Person or such Affected Person&#8217;s holding company, if any, regarding capital or liquidity requirements, has or would have the effect of (x) increasing the amount of capital required to be maintained by such Affected Person or Affected Person&#8217;s holding company, if any, (y) reducing the rate of return on such Affected Person&#8217;s capital or on the capital of such Affected Person&#8217;s holding company, if any, or (z) causing an internal capital or liquidity charge or other imputed cost to be assessed upon such Affected Person or Affected Person&#8217;s holding company, if any, in each case, as a consequence of (A) this Agreement or any other Transaction Document, (B) the commitments of such Affected Person hereunder or under any other Transaction Document or related Program Support Agreement, (C) the Loans made by such Affected Person or (D) any Capital (or portion thereof), to a level below that which such Affected Person or such Affected Person&#8217;s holding company could have achieved but for such Change in Law (taking into consideration such Affected Person&#8217;s policies and the policies of such Affected Person&#8217;s holding company with respect to capital adequacy and liquidity), then from time to time, upon request of such Affected Person (or its Group Agent), the Borrower will pay to such Affected Person such additional amount or amounts as will compensate such Affected Person or such Affected Person&#8217;s holding company for any such increase, reduction or charge.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:59.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">iii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Adoption of Changes in Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Borrower acknowledges that any Affected Person may institute measures in anticipation of a Change in Law (including, without limitation, the imposition of internal charges on such Affected Person&#8217;s interests or obligations under any Transaction Document or Program Support Agreement), and may commence allocating charges to or seeking compensation from the Borrower under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 4.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> in connection with such </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">42</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">measures, in advance of the effective date of such Change in Law, and the Borrower agrees to pay such charges or compensation to such Affected Person, following demand therefor in accordance with the terms of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 4.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, without regard to whether such effective date has occurred.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:59.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">iv.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Certificates for Reimbursement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  A certificate of an Affected Person (or its Group Agent on its behalf) setting forth the amount or amounts necessary to compensate such Affected Person or its holding company, as the case may be, as specified in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">clause (a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 4.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> and delivered to the Borrower, shall be conclusive absent manifest error.  The Borrower shall, subject to the priorities of payment set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, pay such Affected Person the amount shown as due on any such certificate on the first Settlement Date occurring after the Borrower&#8217;s receipt of such certificate.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:63pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">v.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Delay in Requests</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Failure or delay on the part of any Affected Person to demand compensation pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 4.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> shall not constitute a waiver of such Affected Person&#8217;s right to demand such compensation.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:59.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">vi.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Replacement of Lenders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  If any Lender requests compensation under this Section 4.01, or if the Borrower is required to pay any additional amount to any Lender or any Governmental Authority for the account of any Lender pursuant to Section 4.03, the Borrower may replace such Lender in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 13.03(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1.0b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:30.36pt">Funding Losses.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:65.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">i.The Borrower will pay each Lender its ratable portion of Breakage Fees in accordance herewith.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:62.34pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ii.A certificate of a Lender (or its Group Agent on its behalf) setting forth the amount or amounts necessary to compensate such Lender, as specified in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">clause (a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> above and delivered to the Borrower, shall be conclusive absent manifest error.  The Borrower shall, subject to the priorities of payment set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, pay such Lender the amount shown as due on any such certificate on the first Settlement Date occurring after the Borrower&#8217;s receipt of such certificate.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1.0c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:31.04pt">Taxes.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:65.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Payments Free of Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Any and all payments by or on account of any obligation of the Borrower under any Transaction Document shall be made without deduction or withholding for any Taxes, except as required by Applicable Law.  If any Applicable Law (as determined in the good faith discretion of the applicable Credit Party, Affected Person or Borrower Indemnified Party) requires the deduction or withholding of any Tax from any such payment by a Credit Party, Affected Person or Borrower Indemnified Party, then the applicable Credit Party, Affected Person or Borrower Indemnified Party shall be entitled to make such deduction or withholding and shall timely pay the full amount deducted or withheld to the relevant Governmental Authority in accordance with Applicable Law, and, if such Tax is an Indemnified Tax, then the sum payable by the Borrower shall be increased as necessary so that after such deduction or withholding has been made (including such deductions and withholdings applicable to additional sums payable under this Section), the applicable Credit Party, Affected Person or Borrower Indemnified Party receives an amount equal to the sum it would have received had no such deduction or withholding been made.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:62.34pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Payment of Other Taxes by the Borrower</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Borrower shall timely pay to the relevant Governmental Authority in accordance with Applicable Law, or, at the option of the Administrative Agent, timely reimburse it for the payment of, any Other Taxes.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">43</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:59.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">iii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Indemnification by the Borrower</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Borrower shall indemnify each Affected Person, within ten (10) calendar days after demand therefor, for the full amount of any Indemnified Taxes (including Indemnified Taxes imposed or asserted on or attributable to amounts payable under this Section) payable or paid by such Affected Person or required to be withheld or deducted from a payment to such Affected Person and any penalties, interest and reasonable expenses arising therefrom or with respect thereto, whether or not such Indemnified Taxes were correctly or legally imposed or asserted by the relevant Governmental Authority and a certificate as to the amount of such payment or liability, as well as the payee and other information necessary for the Borrower to make such payment, delivered to the Borrower by an Affected Person (with a copy to the Administrative Agent), or by the Administrative Agent on its own behalf or on behalf of an Affected Person, shall be conclusive absent manifest error.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:59.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">iv.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Indemnification by the Lenders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Each Lender (other than the Conduit Lenders) shall severally indemnify the Administrative Agent, within ten (10) calendar days after demand therefor, for (i) any Indemnified Taxes attributable to such Lender, its Related Conduit Lender or any of their respective Affiliates that are Affected Persons (but only to the extent that the Borrower and its Affiliates have not already indemnified the Administrative Agent for such Indemnified Taxes and without limiting any obligation of the Borrower, the Servicer or their Affiliates to do so), (ii) any Taxes attributable to the failure of such Lender, its Related Conduit Lender or any of their respective Affiliates that are Affected Persons to comply with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 13.03(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> relating to the maintenance of a Participant Register and (iii) any Excluded Taxes attributable to such Lender, its Related Conduit Lender or any of their respective Affiliates that are Affected Persons, in each case, that are payable or paid by the Administrative Agent in connection with any Transaction Document, and any reasonable expenses arising therefrom or with respect thereto, whether or not such Taxes were correctly or legally imposed or asserted by the relevant Governmental Authority.  A certificate as to the amount of such payment or liability delivered to any Lender (or its Group Agent) by the Administrative Agent shall be conclusive absent manifest error.  Each Lender (other than the Conduit Lenders) hereby authorizes the Administrative Agent to set off and apply any and all amounts at any time owing to such Lender, its Related Conduit Lender or any of their respective Affiliates that are Affected Persons under any Transaction Document or otherwise payable by the Administrative Agent to such Lender, its Related Conduit Lender or any of their respective Affiliates that are Affected Persons from any other source against any amount due to the Administrative Agent under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">clause (d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:63pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">v.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Evidence of Payments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  As soon as practicable after any payment of Taxes by the Borrower to a Governmental Authority pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 4.03</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, the Borrower shall deliver to the Administrative Agent the original or a certified copy of a receipt issued by such Governmental Authority evidencing such payment, a copy of the return reporting such payment or other evidence of such payment reasonably satisfactory to the Administrative Agent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:59.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">vi.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Status of Affected Persons</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">Any Affected Person that is entitled to an exemption from or reduction of withholding Tax with respect to payments made under any Transaction Document shall deliver to the Borrower and the Administrative Agent, at the time or times reasonably requested by the Borrower or the Administrative Agent, such properly completed and executed documentation reasonably requested by the Borrower or the Administrative Agent as will permit such payments to be made without withholding or at a reduced rate of withholding.  In addition, any Affected Person, if reasonably requested by the Borrower or the Administrative Agent, shall deliver such other documentation prescribed by Applicable Law or reasonably requested by the Borrower or the Administrative Agent as will enable the Borrower or the Administrative Agent to determine whether or not such Affected Person is subject to backup withholding or information reporting requirements.  Notwithstanding anything to the contrary in the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">44</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">preceding two sentences, the completion, execution and submission of such documentation (other than such documentation set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Sections 4.03(f)(ii)(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, 4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">.03(f)(ii)(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">4.03(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">) shall not be required if, in the Affected Person&#8217;s reasonable judgment, such completion, execution or submission would subject such Affected Person to any material unreimbursed cost or expense or would materially prejudice the legal or commercial position of such Affected Person</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">Without limiting the generality of the foregoing&#58;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27.68pt">an Affected Person that is a U.S. Person shall deliver to the Borrower and the Administrative Agent on or prior to the date on which such Affected Person becomes a party to this Agreement and from time to time thereafter upon the reasonable request of the Borrower or the Administrative Agent, executed originals of Internal Revenue Service Form W-9 certifying that such Affected Person is exempt from U.S. federal backup withholding tax&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">any Affected Person that is not a U.S. Person shall, to the extent it is legally entitled to do so, deliver to the Borrower and the Administrative Agent (in such number of copies as shall be requested by the recipient) on or prior to the date on which such Affected Person becomes a party to this Agreement and from time to time thereafter upon the reasonable request of the Borrower or the Administrative Agent, whichever of the following is applicable&#58;</font></div><div style="margin-bottom:12pt;padding-left:144pt;text-align:justify;text-indent:29.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">i.in the case of such an Affected Person claiming the benefits of an income tax treaty to which the United States is a party, (x) with respect to payments of interest under any Transaction Document, executed originals of Internal Revenue Service Form W-8BEN establishing an exemption from, or reduction of, U.S. federal withholding Tax pursuant to the &#8220;interest&#8221; article of such tax treaty and (y) with respect to any other applicable payments under any Transaction Document, Internal Revenue Service Form W-8BEN establishing an exemption from, or reduction of, U.S. federal withholding Tax pursuant to the &#8220;business profits&#8221; or &#8220;other income&#8221; article of such tax treaty&#59;</font></div><div style="margin-bottom:12pt;padding-left:144pt;text-align:justify;text-indent:26.34pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ii.executed originals of Internal Revenue Service Form W-8ECI&#59;</font></div><div style="margin-bottom:12pt;padding-left:144pt;text-align:justify;text-indent:23.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">iii.in the case of such an Affected Person claiming the benefits of the exemption for portfolio interest under Section 881(c) of the Code, (x) a certificate to the effect that such Affected Person is not a &#8220;bank&#8221; within the meaning of Section 881(c)(3)(A) of the Code, a &#8220;10 percent shareholder&#8221; of the Borrower within the meaning of Section 881(c)(3)(B) of the Code, or a &#8220;controlled foreign corporation&#8221; described in Section 881(c)(3)(C) of the Code (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">U.S. Tax Compliance Certificate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) and (y) executed originals of Internal Revenue Service Form W-8BEN&#59; or</font></div><div style="margin-bottom:12pt;padding-left:144pt;text-align:justify;text-indent:23.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">iv.to the extent such Affected Person is not the beneficial owner, executed originals of Internal Revenue Service Form W-8IMY, accompanied by Internal Revenue Service Form W-8ECI, Internal Revenue Service Form W-8BEN, a U.S. Tax </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">45</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:144pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Compliance Certificate, Internal Revenue Service Form W-9, and&#47;or other certification documents from each beneficial owner, as applicable&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that, if such Affected Person is a partnership and one or more direct or indirect partners of such Affected Person are claiming the portfolio interest exemption, such Affected Person may provide a U.S. Tax Compliance Certificate on behalf of each such direct and indirect partner&#59; and</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27.68pt">any Affected Person that is not a U.S. Person shall, to the extent it is legally entitled to do so, deliver to the Borrower and the Administrative Agent (in such number of copies as shall be requested by the recipient) on or prior to the date on which such Affected Person becomes a party to this Agreement and from time to time thereafter upon the reasonable request of the Borrower or the Administrative Agent, executed originals of any other form prescribed by Applicable Law as a basis for claiming exemption from or a reduction in U.S. federal withholding Tax, duly completed, together with such supplementary documentation as may be prescribed by Applicable Law to permit the Borrower or the Administrative Agent to determine the withholding or deduction required to be made.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:56.34pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">vii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Documentation Required by FATCA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  If a payment made to an Affected Person under any Transaction Document would be subject to U.S. federal withholding Tax imposed by FATCA if such Affected Person were to fail to comply with the applicable reporting requirements of FATCA (including those contained in Section 1471(b) or 1472(b) of the Code, as applicable), such Affected Person shall deliver to the Borrower and the Administrative Agent at the time or times prescribed by Applicable Law and at such time or times reasonably requested by the Borrower or the Administrative Agent such documentation prescribed by Applicable Law (including as prescribed by Section 1471(b)(3)(C)(i) of the Code) and such additional documentation reasonably requested by the Borrower or the Administrative Agent as may be necessary for the Borrower and the Administrative Agent to comply with their obligations under FATCA and to determine that such Affected Person has complied with such Affected Person&#8217;s obligations under FATCA or to determine the amount to deduct and withhold from such payment.  Solely for purposes of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">clause (g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">FATCA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; shall include any amendments made to FATCA after the date of this Agreement and any fiscal or regulatory legislation, rules or practices adopted pursuant to any intergovernmental agreement entered into in connection with FATCA.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:53.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">viii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Survival</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Each party&#8217;s obligations under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 4.03</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> shall survive the resignation or replacement of the Administrative Agent or any assignment of rights by, or the replacement of, a Credit Party or any other Affected person, the termination of the Commitments and the repayment, satisfaction or discharge of all the Borrower Obligations and the Servicer&#8217;s obligations hereunder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:59.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ix.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Updates</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Each Affected Person agrees that if any form or certification it previously delivered pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 4.03</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> expires or becomes obsolete or inaccurate in any respect, it shall update such form or certification or promptly notify the Borrower and the Administrative Agent in writing of its legal inability to do so.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:63pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">x.If any party determines, in its sole discretion exercised in good faith, that it has received a refund of any Taxes as to which it has been indemnified pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 4.03</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (including by the payment of additional amounts pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 4.03</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">), it shall pay to the indemnifying party an amount equal to such refund (but only to the extent of indemnity payments made under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 4.03</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> with respect to the Taxes giving rise to such refund), net </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">46</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">of all out-of-pocket expenses (including Taxes) of such indemnified party and without interest (other than any interest paid by the relevant Governmental Authority with respect to such refund).  Such indemnifying party, upon the request of such indemnified party, shall repay to such indemnified party the amount paid over pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">clause (j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (plus any penalties, interest or other charges imposed by the relevant Governmental Authority) in the event that such indemnified party is required to repay such refund to such Governmental Authority.  Notwithstanding anything to the contrary in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">clause (j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, in no event will the indemnified party be required to pay any amount to an indemnifying party pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">clause (j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> the payment of which would place the indemnified party in a less favorable net after-Tax position than the indemnified party would have been in if the Tax subject to indemnification and giving rise to such refund had not been deducted, withheld or otherwise imposed and the indemnification payments or additional amounts with respect to such Tax had never been paid.  This paragraph shall not be construed to require any indemnified party to make available its Tax returns (or any other information relating to its Taxes that it deems confidential) to the indemnifying party or any other Person.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1.0d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:30.36pt">Conforming Changes Relating to Term SOFR or Daily 1M SOFR.  With respect to Term SOFR or Daily 1M SOFR, the Administrative Agent will have the right to make Conforming Changes from time to time and, notwithstanding anything to the contrary herein or in any other Transaction Document, any amendments implementing such Conforming Changes will become effective without any further action or consent of any other party to this Agreement or any other Transaction Document&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that,  the Administrative Agent shall provide notice to the Borrower and the Lenders of each such amendment implementing such Conforming Changes reasonably promptly after such amendment becomes effective.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1.0e.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:31.04pt">Security Interest.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:65.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">i.As security for the performance by the Borrower of all the terms, covenants and agreements on the part of the Borrower to be performed under this Agreement or any other Transaction Document, including the punctual payment when due of the Aggregate Capital and all Interest in respect of the Loans and all other Borrower Obligations, the Borrower hereby grants to the Administrative Agent for its benefit and the ratable benefit of the Secured Parties, a valid, continuing and perfected first priority security interest in, all of the Borrower&#8217;s right, title and interest in, to and under all of the following, whether now or hereafter owned, existing or arising (collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Collateral</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;)&#58; (i) all Pool Receivables, (ii) all Related Security with respect to such Pool Receivables, (iii) all Collections with respect to such Pool Receivables, (iv) the Lock-Boxes and Collection Accounts and all amounts on deposit therein, and all certificates and instruments, if any, from time to time evidencing such Lock-Boxes and Collection Accounts and amounts on deposit therein, (v) all rights (but none of the obligations) of the Borrower under the Purchase and Sale Agreement, (vi) all other personal and fixture property or assets of the Borrower of every kind and nature including, without limitation, all goods (including inventory, equipment and any accessions thereto), instruments (including promissory notes), documents, accounts, chattel paper (whether tangible or electronic), deposit accounts, securities accounts, securities entitlements, letter of credit rights, commercial tort claims, securities and all other investment property, supporting obligations, money, any other contract rights or rights to the payment of money, insurance claims and proceeds, and all general intangibles (including all payment intangibles) (each as defined in the UCC) and (vii) all proceeds of, and all amounts received or receivable under any or all of, the foregoing.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:62.34pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ii.The Administrative Agent (for the benefit of the Secured Parties) shall have, with respect to all the Collateral, and in addition to all the other rights and remedies available to the Administrative Agent (for the benefit of the Secured Parties), all the rights and remedies of a secured party under any applicable UCC.  The Borrower hereby authorizes the Administrative Agent to file financing statements describing as the collateral covered thereby as &#8220;all of the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">47</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">debtor&#8217;s personal property or assets&#8221; or words to that effect, notwithstanding that such wording may be broader in scope than the collateral described in this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:59.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">iii.Immediately upon the occurrence of the Final Payout Date, the Collateral shall be automatically released from the lien created hereby, and this Agreement and all obligations (other than those expressly stated to survive such termination) of the Administrative Agent, the Lenders and the other Credit Parties hereunder shall terminate, all without delivery of any instrument or performance of any act by any party, and all rights to the Collateral shall revert to the Borrower&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that promptly following written request therefor by the Borrower delivered to the Administrative Agent following any such termination, and at the expense of the Borrower, the Administrative Agent shall execute (if applicable) and deliver to the Borrower UCC-3 termination statements and such other documents as the Borrower shall reasonably request to evidence such termination.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1.0f.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:32.37pt">Rate Unascertainable&#59; Illegality&#59; Benchmark Replacement Setting.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:65.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">Rate Unascertainable</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  If at any time&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">the Administrative Agent shall have determined (which determination shall be conclusive and binding absent manifest error) that the Term SOFR Rate or the Daily SOFR Rate, as applicable, cannot be determined pursuant to the definition thereof&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">the Majority Group Agents determine that for any reason in connection with any request for a Term SOFR Rate Loan or a Daily SOFR Rate Loan or conversion thereto or continuation thereof that the Term SOFR Rate does not adequately and fairly reflect the cost to the Lenders of funding, establishing or maintaining such Term SOFR Rate Loan during the applicable Interest Period, or the Daily SOFR Rate does not adequately and fairly reflect the cost to the Lenders of funding, establishing or maintaining such Daily SOFR Rate Loan, as applicable, and the Majority Group Agents have provided notice of such determination to the Administrative Agent,</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">then the Administrative Agent shall have the rights specified in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 4.06(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:62.34pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">Illegality</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  If at any time any Lender shall have determined, or any Governmental Authority shall have asserted, that the making, maintenance or funding of any Term SOFR Rate Loan or Daily SOFR Rate Loan, or the determination or charging of interest rates based on the Term SOFR Rate or the Daily SOFR Rate, has been made impracticable or unlawful by compliance by such Lender in good faith with any Applicable Law or any interpretation or application thereof by any Governmental Authority or with any request or directive of any such Governmental Authority (whether or not having the force of Applicable Law), then the Administrative Agent shall have the rights specified in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 4.06(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:59.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">iii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">Administrative Agent&#8217;s and Lender&#8217;s Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  In the case of any event specified in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 4.06(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> above, the Administrative Agent shall promptly notify the Group Agents and the Borrower thereof, and in the case of an event specified in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 4.06(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> above, the Majority Group Agents shall promptly so notify the Administrative Agent and endorse a certificate to such notice as to the specific circumstances of such notice, and the Administrative Agent shall promptly send copies of such notice and certificate to the other Group Agents and the Borrower.  Upon such date as shall be specified in such notice (which shall not be earlier than the date such notice is given), the obligation of (i) the Lenders, in the case of such notice given by the Administrative Agent, or (ii) the relevant Group Agents, in the case of such notice given by the Majority Group Agents, to allow the Borrower to select, convert to, renew or continue a Term SOFR Rate Loan or a Daily SOFR Rate Loan, as applicable, shall be suspended (to the extent of </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">48</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">the affected Term SOFR Rate Loan, Daily SOFR Rate Loan or Interest Periods) until the Administrative Agent shall have later notified the Borrower, or the Majority Group Agents shall have later notified the Administrative Agent, of the Administrative Agent&#8217;s or the Majority Group Agents&#8217;, as the case may be, determination that the circumstances giving rise to such previous determination no longer exist.  Upon a determination by Administrative Agent under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 4.06(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, (i) if the Borrower has previously notified the Administrative Agent of its selection of, conversion to or renewal of a Term SOFR Rate Loan or a Daily SOFR Rate Loan and the Term SOFR Option or the Daily SOFR Option, as applicable, has not yet gone into effect, such notification shall be deemed to provide for selection of, conversion to or renewal of a Base Rate Loan, (ii) any outstanding affected Daily SOFR Rate Loans will be deemed to have been converted into Base Rate Loans immediately, and (iii) any outstanding affected Term SOFR Rate Loans will be deemed to have been converted into Base Rate Loans at the end of the applicable Interest Period.  If the Majority Group Agents notify the Administrative Agent of a determination under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 4.06(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, the Borrower shall, subject to the Borrower&#8217;s indemnification obligations under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 12.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, as to any Loan of a Lender to which a Term SOFR Option or a Daily SOFR Option applies, on the date specified in such notice either convert such Loan to a Base Rate Loan otherwise available with respect to such Loan or prepay such Loan in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Absent due notice from the Borrower of conversion or prepayment, such Loan shall automatically be converted to a Base Rate Loan upon such specified date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:59.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">iv.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">Benchmark Replacement Setting</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Benchmark Replacement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Notwithstanding anything to the contrary herein or in any other Transaction Document, if a Benchmark Transition Event and its related Benchmark Replacement Date have occurred prior to any setting of the then-current Benchmark, then (A) if a Benchmark Replacement is determined in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">clause (1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> of the definition of &#8220;Benchmark Replacement&#8221; for such Benchmark Replacement Date, such Benchmark Replacement will replace such Benchmark for all purposes hereunder and under any Transaction Document in respect of such Benchmark setting and subsequent Benchmark settings without any amendment to, or further action or consent of any other party to, this Agreement or any other Transaction Document and (B) if a Benchmark Replacement is determined in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">clause (2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> of the definition of &#8220;Benchmark Replacement&#8221; for such Benchmark Replacement Date, such Benchmark Replacement will replace such Benchmark for all purposes hereunder and under any Transaction Document in respect of any Benchmark setting at or after 5&#58;00 p.m. (New York City time) on the fifth (5th) Business Day after the date notice of such Benchmark Replacement is provided to the Group Agents without any amendment to, or further action or consent of any other party to, this Agreement or any other Transaction Document so long as the Administrative Agent has not received, by such time, written notice of objection to such Benchmark Replacement from the Majority Group Agents.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Benchmark Replacement Conforming Changes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  In connection with the use, administration, adoption or implementation of a Benchmark Replacement, the Administrative Agent will have the right to make Conforming Changes from time to time and, notwithstanding anything to the contrary herein or in any other Transaction Document, any amendments implementing such Conforming Changes will become effective without any further action or consent of any other party to this Agreement or any other Transaction Document.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Notices&#59; Standards for Decisions and Determinations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Administrative Agent will promptly notify the Borrower and the Group Agents of  (A) the implementation of any Benchmark Replacement, and (B) the effectiveness of any Conforming Changes in connection with the use, administration, adoption or </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">49</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">implementation of a Benchmark Replacement.  The Administrative Agent will notify the Borrower of (x) the removal or reinstatement of any tenor of a Benchmark pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">clause (iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> below and (y) the commencement of any Benchmark Unavailability Period.  Any determination, decision or election that may be made by the Administrative Agent or, if applicable, any Lender (or group of Lenders) pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 4.06</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, including any determination with respect to a tenor, rate or adjustment or of the occurrence or non-occurrence of an event, circumstance or date and any decision to take or refrain from taking any action or any selection, will be conclusive and binding absent manifest error and may be made in its or their sole discretion and without consent from any other party to this Agreement or any other Transaction Document except, in each case, as expressly required pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 4.06</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Unavailability of Tenor of Benchmark</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Notwithstanding anything to the contrary herein or in any other Transaction Document, at any time (including in connection with the implementation of a Benchmark Replacement), (A) if the then-current Benchmark is a term rate or based on a term rate and either (I) any tenor for such Benchmark is not displayed on a screen or other information service that publishes such rate from time to time as selected by the Administrative Agent in its reasonable discretion or (II) the regulatory supervisor for the administrator of such Benchmark has provided a public statement or publication of information announcing that any tenor for such Benchmark is not or will not be representative, then the Administrative Agent may modify the definition of &#8220;Interest Period&#8221; (or any similar or analogous definition) for any Benchmark settings at or after such time to remove such unavailable or non-representative tenor&#59; and (B) if a tenor that was removed pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">clause (A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> above either (I) is subsequently displayed on a screen or information service for a Benchmark (including a Benchmark Replacement) or (II) is not, or is no longer, subject to an announcement that it is not or will not be representative for a Benchmark (including a Benchmark Replacement), then the Administrative Agent may modify the definition of &#8220;Interest Period&#8221; (or any similar or analogous definition) for all Benchmark settings at or after such time to reinstate such previously removed tenor.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Benchmark Unavailability Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Upon the Borrower&#8217;s receipt of notice of the commencement of a Benchmark Unavailability Period with respect to the Term SOFR Rate or the Daily SOFR Rate, as applicable, the Borrower may revoke any pending request for a Loan bearing interest based on such rate or conversion to or continuation of Loans bearing interest based on such rate to be made, converted or continued during any Benchmark Unavailability Period and, failing that, the Borrower will be deemed to have converted any such request into a request for a Base Rate Loan or conversion to a Base Rate Loan.  During a Benchmark Unavailability Period or at any time that a tenor for the then-current Benchmark is not an Available Tenor, the component of the Base Rate based upon the then-current Benchmark or such tenor for such Benchmark, as applicable, will not be used in any determination of the Base Rate.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1.0g.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:30.36pt">Benchmark Replacement Notification.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 4.06(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> of this Agreement provides a mechanism for determining an alternative rate of interest in the event that the Term SOFR Rate or the Daily SOFR Rate, as applicable, is no longer available or in certain other circumstances.  The Administrative Agent does not warrant or accept any responsibility for and shall not have any liability with respect to, the administration, submission or any other matter related to the Term SOFR Rate or the Daily SOFR Rate, as applicable, or with respect to any alternative or successor rate thereto, or replacement rate therefor.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">50</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ARTICLE 5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:8.36pt"><br><br>CONDITIONS TO EFFECTIVENESS AND CREDIT EXTENSIONS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1.0a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:31.04pt">Conditions Precedent to Effectiveness and the Initial Credit Extension.  This Agreement shall become effective as of the Closing Date when (a) the Administrative Agent shall have received each of the documents, agreements (in fully executed form), opinions of counsel, lien search results, UCC filings, certificates and other deliverables listed on the closing memorandum attached as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit H</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> hereto, in each case, in form and substance acceptable to the Administrative Agent and (b) all fees and expenses payable by the Borrower on the Closing Date to the Credit Parties have been paid in full in accordance with the terms of the Transaction Documents.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1.0b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:30.36pt">Conditions Precedent to All Credit Extensions.  Each Credit Extension hereunder on or after the Closing Date shall be subject to the conditions precedent that&#58; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:65.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">i.in the case of a Loan, the Borrower shall have delivered to the Administrative Agent and each Group Agent a Loan Request for such Loan, in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.02(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:62.34pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ii.the Servicer shall have delivered to the Administrative Agent and each Group Agent all Information Packages required to be delivered hereunder&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:59.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">iii.the conditions precedent to such Credit Extension specified in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.01(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> through </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> shall be satisfied&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:59.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">iv.on the date of such Credit Extension the following statements shall be true and correct (and upon the occurrence of such Credit Extension, the Borrower and the Servicer shall be deemed to have represented and warranted that such statements are then true and correct)&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">the representations and warranties of the Borrower and the Servicer contained in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Sections 6.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">6.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> are true and correct in all material respects (unless such representations and warranties contain a materiality qualifier, in which case such representations and warranties shall be true and correct as made) on and as of the date of such Credit Extension as though made on and as of such date unless such representations and warranties by their terms refer to an earlier date, in which case they shall be true and correct in all material respects (unless such representations and warranties contain a materiality qualifier, in which case such representations and warranties shall be true and correct as made) on and as of such earlier date&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">no Event of Default or Unmatured Event of Default has occurred and is continuing, and no Event of Default or Unmatured Event of Default would result from such Credit Extension&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">no Borrowing Base Deficit exists or would exist after giving effect to such Credit Extension&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">the Aggregate Capital would not equal an amount less than the Minimum Funding Threshold after giving effect to such Credit Extension&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">the Termination Date has not occurred.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1.0c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:31.04pt">Conditions Precedent to All Releases.  Each Release hereunder on or after the Closing Date shall be subject to the conditions precedent that&#58;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">51</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:65.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">i.after giving effect to such Release, the Servicer shall be holding in trust for the benefit of the Secured Parties an amount of Collections sufficient to pay the sum of (x) all accrued and unpaid Servicing Fees, Interest, Fees and Breakage Fees, in each case, through the date of such Release, (y) the amount of any Borrowing Base Deficit and (z) the amount of all other accrued and unpaid Borrower Obligations through the date of such Release&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:62.34pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ii.the Borrower shall use the proceeds of such Release solely to pay (x) the purchase price for Receivables purchased by the Borrower in accordance with the terms of the Purchase and Sale Agreement and (y) any amounts owing by the Borrower to the Originators under the Subordinated Notes&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:59.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">iii.on the date of such Release the following statements shall be true and correct (and upon the occurrence of such Release, the Borrower and the Servicer shall be deemed to have represented and warranted that such statements are then true and correct)&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">the representations and warranties of the Borrower and the Servicer contained in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Sections 6.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">6.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> are true and correct in all material respects (unless such representations and warranties contain a materiality qualifier, in which case such representations and warranties shall be true and correct as made) on and as of the date of such Release as though made on and as of such date unless such representations and warranties by their terms refer to an earlier date, in which case they shall be true and correct in all material respects (unless such representations and warranties contain a materiality qualifier, in which case such representations and warranties shall be true and correct as made) on and as of such earlier date&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">no Event of Default has occurred and is continuing, and no Event of Default would result from such Release&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">no Borrowing Base Deficit exists or would exist after giving effect to such Release&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">the Termination Date has not occurred.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ARTICLE 6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:8.36pt"><br><br>REPRESENTATIONS AND WARRANTIES</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1.0a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:31.04pt">Representations and Warranties of the Borrower.  The Borrower represents and warrants to each Credit Party as of the Closing Date, on each Settlement Date and on each day on which a Credit Extension shall have occurred&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:65.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Formation and Good Standing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Borrower is a duly formed and validly existing limited liability company in good standing under the laws of the State of Delaware and has full power and authority under its organizational documents and under the laws of the State of Delaware to own its properties and to conduct its business as such properties are currently owned and such business is presently conducted.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:62.34pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Due Qualification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Borrower is duly qualified to do business, is in good standing as a foreign entity and has obtained all necessary licenses and approvals in all jurisdictions in which the conduct of its business requires such qualification, licenses or approvals, except where the failure to do so could not reasonably be expected to have a Material Adverse Effect.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">52</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:59.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">iii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Power and Authority&#59; Due Authorization</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Borrower (i) has all necessary power and authority to (A) execute and deliver this Agreement and the other Transaction Documents to which it is a party, (B) perform its obligations under this Agreement and the other Transaction Documents to which it is a party and (C) grant a security interest in the Collateral to the Administrative Agent on the terms and subject to the conditions herein provided and (ii) has duly authorized by all necessary action such grant and the execution, delivery and performance of, and the consummation of the transactions provided for in, this Agreement and the other Transaction Documents to which it is a party.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:59.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">iv.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Binding Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  This Agreement and each of the other Transaction Documents to which the Borrower is a party constitutes legal, valid and binding obligations of the Borrower, enforceable against the Borrower in accordance with their respective terms, except (i) as such enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium or other similar laws affecting the enforcement of creditors&#8217; rights generally and (ii) as such enforceability may be limited by general principles of equity, regardless of whether such enforceability is considered in a proceeding in equity or at law.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:63pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">v.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">No Conflict or Violation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The execution, delivery and performance of, and the consummation of the transactions contemplated by, this Agreement and the other Transaction Documents to which the Borrower is a party, and the fulfillment of the terms hereof and thereof, will not (i) conflict with, result in any breach of any of the terms or provisions of, or constitute (with or without notice or lapse of time or both) a default under its organizational documents or any indenture, sale agreement, credit agreement, loan agreement, security agreement, mortgage, deed of trust or other agreement or instrument to which the Borrower is a party or by which it or any of its properties is bound, (ii) result in the creation or imposition of any Adverse Claim upon any of the Collateral or any of its properties pursuant to the terms of any such indenture, credit agreement, loan agreement, security agreement, mortgage, deed of trust or other agreement or instrument, other than this Agreement and the other Transaction Documents or (iii) conflict with or violate any Applicable Law, except to the extent that any such conflict, breach, default, Adverse Claim or violation could not reasonably be expected to have a Material Adverse Effect.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:59.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">vi.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Litigation and Other Proceedings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  (i)  There is no action, suit, proceeding or investigation pending or, to the best knowledge of the Borrower, threatened, against the Borrower before any Governmental Authority and (ii) the Borrower is not subject to any order, judgment, decree, injunction, stipulation or consent order of or with any Governmental Authority that, in the case of either of the foregoing </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">clauses (i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, (A) asserts the invalidity of this Agreement or any other Transaction Document, (B) seeks to prevent the grant of a security interest in any Collateral by the Borrower to the Administrative Agent, the ownership or acquisition by the Borrower of any Pool Receivables or other Collateral or the consummation of any of the transactions contemplated by this Agreement or any other Transaction Document, (C) seeks any determination or ruling that could materially and adversely affect the performance by the Borrower of its obligations under, or the validity or enforceability of, this Agreement or any other Transaction Document or (D) individually or in the aggregate for all such actions, suits, proceedings and investigations could reasonably be expected to have a Material Adverse Effect.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:56.34pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">vii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">No Consents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Borrower is not required to obtain the consent of any other party or any consent, order, license, approval, registration, authorization, action or declaration of or with any Governmental Authority in connection with the grant of a security interest in the Collateral by the Borrower to the Administrative Agent hereunder or the due execution, delivery, or performance by the Borrower of this Agreement or any other Transaction Document to which it is a party or the consummation by the Borrower of the transactions contemplated by this Agreement or any other Transaction Documents to which it is a party that has not already been obtained and are in full force and effect or the failure of which to obtain could not reasonably be expected to have a Material Adverse Effect. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">53</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:53.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">viii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Offices&#59; Legal Name</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Borrower&#8217;s sole jurisdiction of organization is the State of Delaware and such jurisdiction has not changed within four (4) months prior to the date of this Agreement.  The office of the Borrower is located at 311 Enterprise Drive, Plainsboro, New Jersey 08536.  The legal name of the Borrower is Integra Receivables LLC.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:59.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ix.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Investment Company Act&#59; Volcker Rule</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Borrower (i) is not, and is not controlled by, an &#8220;investment company&#8221; registered or required to be registered under the Investment Company Act and (ii) is not a &#8220;covered fund&#8221; under the Volcker Rule.  In determining that the Borrower is not a &#8220;covered fund&#8221; under the Volcker Rule, the Borrower relies on, and is entitled to rely on, the exemption from the definition of &#8220;investment company&#8221; set forth in Section 3(c)(5) of the Investment Company Act.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:63pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">x.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">No Material Adverse Effect</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Since the date of formation of the Borrower there has been no Material Adverse Effect with respect to the Borrower.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:59.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">xi.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Accuracy of Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  All Information Packages, Interim Reports, Loan Requests, certificates, reports, statements, documents and other information, other than financial projections, furnished to the Administrative Agent or any other Credit Party by or on behalf of the Borrower pursuant to any provision of this Agreement or any other Transaction Document, or in connection with or pursuant to any amendment or modification of, or waiver under, this Agreement or any other Transaction Document, are, at the time the same are so furnished, complete and correct in all material respects on the date the same are furnished to the Administrative Agent or such other Credit Party, and do not contain any material misstatement of fact or omit to state a material fact or any fact necessary to make the statements contained therein not misleading.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:56.34pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">xii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Anti-Money Laundering&#47;International Trade Law Compliance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  No Covered Entity is a Sanctioned Person.  No Covered Entity, either in its own right or through any third party, (i) has any of its assets in a Sanctioned Country or in the possession, custody or control of a Sanctioned Person in violation of any Anti-Terrorism Law&#59; (ii) does business in or with, or derives any of its income from investments in or transactions with, any Sanctioned Country or Sanctioned Person in violation of any Anti-Terrorism Law&#59; or (iii) engages in any dealings or transactions prohibited by any Anti-Terrorism Law.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:53.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">xiii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Transaction Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  None of the Borrower, any Affiliate of the Borrower or any third party with which the Borrower or any Affiliate thereof has contracted, has delivered, in writing or orally, to any Rating Agency, any Transaction Information without providing such Transaction Information to the applicable Group Agent prior to delivery to such Rating Agency and has not participated in any oral communications with respect to Transaction Information with any Rating Agency without the participation of such Group Agent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:53.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">xiv.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Compliance with Law.  The Borrower has complied in all respects with all Applicable Laws to which it may be subject, except to the extent that any such noncompliance could not reasonably be expected to have a Material Adverse Effect.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:57pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">xv.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Eligible Receivables</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Each Receivable included as an Eligible Receivable in the calculation of the Net Receivables Pool Balance as of any date is an Eligible Receivable as of such date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:53.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">xvi.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Bulk Sales Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  No transaction contemplated by this Agreement requires compliance by it with any bulk sales act or similar law.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:50.34pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">xvii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Borrower has (i) timely filed all tax returns (federal, state and local) required to be filed by it and (ii) paid, or caused to be paid, all taxes, assessments and other </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">54</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">governmental charges, if any, other than taxes, assessments and other governmental charges being contested in good faith by appropriate proceedings and as to which adequate reserves have been provided in accordance with GAAP, except to the extent that any such non-filing or non-payment could not reasonably be expected to have a Material Adverse Effect.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:47.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">xviii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Opinions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The facts regarding the Borrower, the Receivables, the Related Security and the related matters set forth or assumed in each of the opinions of counsel delivered in connection with this Agreement and the Transaction Documents are true and correct in all material respects.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:53.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">xix.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Other Transaction Documents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Each representation and warranty made by the Borrower under each other Transaction Document to which it is a party is true and correct in all material respects (unless such representation and warranty contains a materiality qualifier, in which case such representation and warranty shall be true and correct as made) as of the date when made, except for any such representation and warranty that applies as to an earlier date (in which case, such representation and warranty shall be true and correct in all material respects (unless such representation and warranty contains a materiality qualifier, in which case such representation and warranty shall be true and correct as made) as of such earlier date).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:57pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">xx.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">No Linked Accounts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  There are no Linked Accounts with respect to any Collection Account.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:53.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">xxi.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Margin Regulations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Borrower is not engaged, principally or as one of its important activities, in the business of extending credit for the purpose of purchasing or carrying margin stock (within the meanings of Regulations T, U and X of the Board of Governors of the Federal Reserve System).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:50.34pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">xxii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Solvency</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  After giving effect to the transactions contemplated by this Agreement and the other Transaction Documents, the Borrower is Solvent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:47.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">xxiii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Perfection Representations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">This Agreement creates a valid and continuing security interest (as defined in the applicable UCC) in the Borrower&#8217;s right, title and interest in, to and under the Collateral which (A) security interest has been perfected and is enforceable against creditors of and purchasers from the Borrower and (B) will be free of all Adverse Claims in such Collateral.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">The Receivables constitute &#8220;accounts&#8221; or &#8220;payment intangibles&#8221; within the meaning of Section 9-102 of the UCC.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">The Borrower owns and has good and marketable title to the Collateral free and clear of any Adverse Claim of any Person.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">All appropriate financing statements, financing statement amendments and continuation statements have been filed in the proper filing office in the appropriate jurisdictions under Applicable Law in order to perfect (and continue the perfection of) the sale or contribution of the Receivables and Related Security from each Originator to the Borrower pursuant to the Purchase and Sale Agreement and the grant by the Borrower of a security interest in the Collateral to the Administrative Agent pursuant to this Agreement.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">Other than the security interest granted to the Administrative Agent pursuant to this Agreement, the Borrower has not pledged, assigned, sold, granted </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">55</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">a security interest in, or otherwise conveyed any of the Collateral except as permitted by this Agreement and the other Transaction Documents.  The Borrower has not authorized the filing of and is not aware of any financing statements filed against the Borrower that include a description of collateral covering the Collateral other than any financing statement (i) in favor of the Administrative Agent or (ii) that has been terminated or amended to reflect the release of any security interest in the Collateral.  The Borrower is not aware of any judgment lien, ERISA lien or tax lien filings against the Borrower.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">Notwithstanding any other provision of this Agreement or any other Transaction Document, the representations contained in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 6.01(w)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> shall be continuing and remain in full force and effect until the Final Payout Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:47.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">xxiv.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">The Lock-Boxes and Collection Accounts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Nature of Collection Accounts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Each Collection Account constitutes a &#8220;deposit account&#8221; within the meaning of the applicable UCC.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Ownership</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Each Lock-Box and Collection Account is in the name of the Borrower, and the Borrower owns and has good and marketable title to the Collection Accounts free and clear of any Adverse Claim.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Perfection</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Borrower has delivered to the Administrative Agent a fully executed Account Control Agreement relating to each Lock-Box and Collection Account, pursuant to which each applicable Collection Account Bank has agreed to comply with the instructions originated by the Administrative Agent directing the disposition of funds in such Lock-Box and Collection Account without further consent by the Borrower, the Servicer or any other Person.  The Administrative Agent has &#8220;control&#8221; (as defined in Section 9-104 of the UCC) over each Collection Account.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Instructions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Neither the Lock-Boxes nor the Collection Accounts are in the name of any Person other than the Borrower.  Neither the Borrower nor the Servicer has consented to the applicable Collection Account Bank complying with instructions of any Person other than the Administrative Agent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:51pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">xxv.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Ordinary Course of Business.  Each remittance of Collections by or on behalf of the Borrower to the Credit Parties under this Agreement will have been (i) in payment of a debt incurred by the Borrower in the ordinary course of business or financial affairs of the Borrower and (ii) made in the ordinary course of business or financial affairs of the Borrower.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:47.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">xxvi.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Tax Status</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Borrower (i) is, and shall at all relevant times continue to be, a &#8220;disregarded entity&#8221; within the meaning of U.S. Treasury Regulation &#167; 301.7701-3 for U.S. federal income tax purposes and (ii) is not and will not at any relevant time become an association (or publicly traded partnership) taxable as an association for U.S. federal income tax purposes.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:44.34pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">xxvii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Liquidity Coverage Ratio</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Borrower has not, does not and will not during this Agreement (x) issue any obligations that (A) constitute asset-backed commercial paper, or (B) are securities required to be registered under the Securities Act or that may be offered for sale under Rule 144A or a similar exemption from registration under the Securities Act or the rules promulgated thereunder, or (y) issue any other debt obligations or equity interest other than debt obligations substantially similar to the obligations of the Borrower under this Agreement that are (A) issued to other banks or asset-backed commercial paper conduits in privately negotiated transactions, and (B) subject to transfer restrictions substantially similar to the transfer restrictions set forth in this Agreement.  The Borrower further represents and warrants that its </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">56</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">assets and liabilities are consolidated with the assets and liabilities of Parent for purposes of generally accepted accounting principles.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:41.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">xxviii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Reaffirmation of Representations and Warranties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">On the date of each Credit Extension, on the date of each Release, on each Settlement Date and on the date each Information Package, Interim Report or other report is delivered to the Administrative Agent or any Group Agent hereunder, the Borrower shall be deemed to have certified that (i) all representations and warranties of the Borrower hereunder are true and correct in all material respects (unless such representations and warranties contain a materiality qualifier, in which case such representations and warranties shall be true and correct as made) on and as of such day as though made on and as of such day, except for representations and warranties which apply as to an earlier date (in which case such representations and warranties shall be true and correct in all material respects (unless such representations and warranties contain a materiality qualifier, in which case such representations and warranties shall be true and correct as made) as of such date) and (ii) no Event of Default or an Unmatured Event of Default has occurred and is continuing or will result from such Credit Extension or Release.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Notwithstanding any other provision of this Agreement or any other Transaction Document, the representations and warranties contained in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 6.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> shall be continuing, and remain in full force and effect until the Final Payout Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1.0b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:30.36pt">Representations and Warranties of the Servicer.  The Servicer represents and warrants to each Credit Party as of the Closing Date, on each Settlement Date and on each day on which a Credit Extension shall have occurred&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:65.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Organization and Good Standing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Servicer is a duly organized and validly existing limited liability company in good standing under the laws of the State of Delaware and has full power and authority under its organizational documents and under the laws of the State of Delaware to own its properties and to conduct its business as such properties are currently owned and such business is presently conducted.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:62.34pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Due Qualification.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  The Servicer is duly qualified to do business, is in good standing as a foreign entity and has obtained all necessary licenses and approvals in all jurisdictions in which the conduct of its business or the servicing of the Pool Receivables as required by this Agreement requires such qualification, licenses or approvals, except where the failure to do so could not reasonably be expected to have a Material Adverse Effect.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:59.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">iii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Power and Authority&#59; Due Authorization.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  The Servicer (i) has all necessary power and authority to (A) execute and deliver this Agreement and the other Transaction Documents to which it is a party and (B) perform its obligations under this Agreement and the other Transaction Documents to which it is a party and (ii) has duly authorized by all necessary action the execution, delivery and performance of, and the consummation of the transactions provided for in, this Agreement and the other Transaction Documents to which it is a party.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:59.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">iv.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Binding Obligations.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  This Agreement and each of the other Transaction Documents to which the Servicer is a party constitutes legal, valid and binding obligations of the Servicer, enforceable against the Servicer in accordance with their respective terms, except (i) as such enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium or other similar laws affecting the enforcement of creditors&#8217; rights generally and (ii) as such enforceability may be limited by general principles of equity, regardless of whether such enforceability is considered in a proceeding in equity or at law.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:63pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">v.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">No Conflict or Violation.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  The execution, delivery and performance of, and the consummation of the transactions contemplated by, this Agreement and the other Transaction </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">57</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Documents to which the Servicer is a party, and the fulfillment of the terms hereof and thereof, will not (i) conflict with, result in any breach of any of the terms or provisions of, or constitute (with or without notice or lapse of time or both) a default under its organizational documents or any indenture, sale agreement, credit agreement, loan agreement, security agreement, mortgage, deed of trust or other agreement or instrument to which the Servicer is a party or by which it or any of its properties is bound, (ii) result in the creation or imposition of any Adverse Claim upon any of its properties pursuant to the terms of any such indenture, credit agreement, loan agreement, security agreement, mortgage, deed of trust or other agreement or instrument, other than this Agreement and the other Transaction Documents or (iii) conflict with or violate any Applicable Law, except to the extent that any such conflict, breach, default, Adverse Claim or violation could not reasonably be expected to have a Material Adverse Effect.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:59.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">vi.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Litigation and Other Proceedings.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  (i)  There is no action, suit, proceeding or investigation pending or, to the best knowledge of the Servicer, threatened, against the Borrower before any Governmental Authority and (ii) the Servicer is not subject to any order, judgment, decree, injunction, stipulation or consent order of or with any Governmental Authority that, in the case of either of the foregoing </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">clauses (i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, (A) asserts the invalidity of this Agreement or any other Transaction Document, (B) seeks to prevent the consummation of any of the transactions contemplated by this Agreement or any other Transaction Document, (C) seeks any determination or ruling that could materially and adversely affect the performance by the Servicer of its obligations under, or the validity or enforceability of, this Agreement or any other Transaction Document or (D) individually or in the aggregate for all such actions, suits, proceedings and investigations could reasonably be expected to have a Material Adverse Effect.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:56.34pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">vii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">No Consents.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  The Servicer is not required to obtain the consent of any other party or any consent, order, license, approval, registration, authorization, action or declaration of or with any Governmental Authority in connection with the due execution, delivery, or performance by the Servicer of this Agreement or any other Transaction Documents to which it is a party or the consummation by the Servicer of the transactions contemplated by this Agreement or any other Transaction Document to which it is a party that has not already been obtained and are in full force and effect or the failure of which to obtain could not reasonably be expected to have a Material Adverse Effect.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:53.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">viii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Location of Records.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  The offices where the initial Servicer keeps all of its records relating to the servicing of the Pool Receivables are located at 311 Enterprise Drive, Plainsboro, New Jersey 08536.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:59.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ix.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Investment Company Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Servicer is not, and is not controlled by, an &#8220;investment company&#8221; registered or required to be registered under the Investment Company Act.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:63pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">x.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">No Material Adverse Effect</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Since September 30, 2018, there has been no Material Adverse Effect with respect to the Servicer. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:59.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">xi.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Accuracy of Information.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  All Information Packages, Interim Reports, Loan Requests, certificates, reports, statements, documents and other information, other than financial projections, furnished to the Administrative Agent or any other Credit Party by or on behalf of the Servicer pursuant to any provision of this Agreement or any other Transaction Document, or in connection with or pursuant to any amendment or modification of, or waiver under, this Agreement or any other Transaction Document, are, at the time the same are so furnished, complete and correct in all material respects on the date the same are furnished to the Administrative Agent or such other Credit Party, and do not contain any material misstatement of fact or omit to state a material fact or any fact necessary to make the statements contained therein not misleading.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">58</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:56.34pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">xii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Anti-Money Laundering&#47;International Trade Law Compliance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  No Covered Entity is a Sanctioned Person.  No Covered Entity, either in its own right or through any third party, (i) has any of its assets in a Sanctioned Country or in the possession, custody or control of a Sanctioned Person in violation of any Anti-Terrorism Law&#59; (ii) does business in or with, or derives any of its income from investments in or transactions with, any Sanctioned Country or Sanctioned Person in violation of any Anti-Terrorism Law&#59; or (iii) engages in any dealings or transactions prohibited by any Anti-Terrorism Law.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:53.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">xiii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Transaction Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  None of the Servicer, any Affiliate of the Servicer or any third party with which the Servicer or any Affiliate thereof has contracted, has delivered, in writing or orally, to any Rating Agency, or monitoring a rating of, any Notes, any Transaction Information without providing such Transaction Information to the applicable Group Agent prior to delivery to such Rating Agency and has not participated in any oral communications with respect to Transaction Information with any Rating Agency without the participation of such Group Agent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:53.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">xiv.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Compliance with Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Servicer (i) has duly satisfied all obligations on its part to be fulfilled under or in connection with the Pool Receivables and the related Contracts, (ii) has maintained in effect all qualifications required under Applicable Law in order to properly service the Pool Receivables and (iii) has complied in all respects with all Applicable Laws in connection with servicing the Pool Receivables, except to the extent that any such non-satisfaction, non-maintenance or noncompliance could not reasonably be expected to have a Material Adverse Effect.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:57pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">xv.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Eligible Receivables</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Each Receivable included as an Eligible Receivable in the calculation of the Net Receivables Pool Balance as of any date is an Eligible Receivable as of such date.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:53.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">xvi.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Servicer has (i) timely filed all tax returns (federal, state and local) required to be filed by it and (ii) paid, or caused to be paid, all taxes, assessments and other governmental charges, if any, other than taxes, assessments and other governmental charges being contested in good faith by appropriate proceedings and as to which adequate reserves have been provided in accordance with GAAP, except to the extent that any such non-filing or non-payment could not reasonably be expected to have a Material Adverse Effect.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:50.34pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">xvii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Opinions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The facts regarding the Servicer, the Receivables, the Related Security and the related matters set forth or assumed in each of the opinions of counsel delivered in connection with this Agreement and the Transaction Documents are true and correct in all material respects.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:47.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">xviii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Other Transaction Documents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Each representation and warranty made by the Servicer under each other Transaction Document to which it is a party (including, without limitation, the Purchase and Sale Agreement) is true and correct in all material respects (unless such representation and warranty contains a materiality qualifier, in which case such representation and warranty shall be true and correct as made) as of the date when made, except for any such representation and warranty that applies as to an earlier date (in which case, such representation and warranty shall be true and correct in all material respects (unless such representation and warranty contains a materiality qualifier, in which case such representation and warranty shall be true and correct as made) as of such earlier date).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:53.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">xix.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">No Linked Accounts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  There are no Linked Accounts with respect to any Collection Account.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">59</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:57pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">xx.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Credit and Collection Procedures.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  The Servicer has complied in all material respects with the Credit and Collection Procedures (or, prior to the existence thereof in documented form, the substance thereof) with regard to each Pool Receivable and the related Contracts.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:53.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">xxi.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Servicing Programs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  No license or approval is required for the Administrative Agent&#8217;s use of any software or other computer program used by the Servicer, any Originator or any Sub-Servicer in the servicing of the Pool Receivables, other than those which have been obtained and are in full force and effect.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:50.34pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">xxii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Servicing of Pool Receivables</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Since the Closing Date, there has been no material adverse change in the ability of the Servicer or any Sub-Servicer to service and collect the Pool Receivables and the Related Security.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:47.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">xxiii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Financial Condition</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The consolidated balance sheets of the Servicer and its consolidated Subsidiaries as of September 30, 2018 and the related statements of income and shareholders&#8217; equity of the Servicer and its consolidated Subsidiaries for the fiscal quarter then ended, copies of which have been furnished to the Administrative Agent and the Group Agents, present fairly in all material respects the consolidated financial position of the Servicer and its consolidated Subsidiaries for the period ended on such date, all in accordance with GAAP.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:47.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">xxiv.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Reaffirmation of Representations and Warranties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">On the date of each Credit Extension, on the date of each Release, on each Settlement Date and on the date each Information Package, Interim Report or other report is delivered to the Administrative Agent or any Group Agent hereunder, the Servicer shall be deemed to have certified that (i) all representations and warranties of the Servicer hereunder are true and correct in all material respects (unless such representations and warranties contain a materiality qualifier, in which case such representations and warranties shall be true and correct as made) on and as of such day as though made on and as of such day, except for representations and warranties which apply as to an earlier date (in which case such representations and warranties shall be true and correct in all material respects (unless such representations and warranties contain a materiality qualifier, in which case such representations and warranties shall be true and correct as made) as of such date) and (ii) no Event of Default or an Unmatured Event of Default has occurred and is continuing or will result from such Credit Extension or Release.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Notwithstanding any other provision of this Agreement or any other Transaction Document, the representations and warranties contained in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 6.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> shall be continuing, and remain in full force and effect until the Final Payout Date.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ARTICLE 7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:8.36pt"><br><br>COVENANTS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1.0a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:31.04pt">Covenants of the Borrower.  At all times from the Closing Date until the Final Payout Date&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:65.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Payment of Principal and Interest</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Borrower shall duly and punctually pay Capital, Interest, Fees and all other amounts payable by the Borrower hereunder in accordance with the terms of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:62.34pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Existence</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Borrower shall keep in full force and effect its existence and rights as a limited liability company under the laws of the State of Delaware, and shall obtain and preserve its qualification to do business in each jurisdiction in which such qualification is or shall </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">60</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">be necessary to protect the validity and enforceability of this Agreement, the other Transaction Documents and the Collateral.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:59.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">iii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Financial Reporting</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Borrower will maintain a system of accounting established and administered in accordance with GAAP, and the Borrower (or the Servicer on its behalf) shall furnish to the Administrative Agent and each Group Agent&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Annual Financial Statements of the Borrower</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Promptly upon completion and in no event later than ninety (90) calendar days after the close of each fiscal year of the Borrower (or, if applicable, the date on which the financial statements describe in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.01(c)(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> are delivered), annual unaudited financial statements of the Borrower certified by a Financial Officer of the Borrower that they fairly present in all material respects, in accordance with GAAP, the financial condition of the Borrower as of the date indicated and the results of its operations for the periods indicated.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Information Packages and Interim Reports</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  As soon as available and in any event not later than two (2) Business Days prior to each Settlement Date, an Information Package as of the most recently completed Fiscal Month&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that, upon the occurrence of a Specific Reporting Event and ten (10) Business Days&#8217; prior written notice from the Administrative Agent, the Borrower shall furnish or cause to be furnished to the Administrative Agent and each Group Agent a weekly (or on a more frequent basis as indicated in the written notice from the Administrative Agent) Interim Report with respect to the Pool Receivables with data as of the close of business on the Business Day preceding the date on which such Interim Report is delivered&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that, at any time after the occurrence and during the continuance of an Event of Default, the Administrative Agent may specify in such notice that such Interim Report be furnished to the Administrative Agent and each Group Agent on a more frequent basis until the Administrative Agent gives notices otherwise.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Other Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Such other information relating to the Borrower or the Pool Receivables (including non-financial information) as the Administrative Agent or any Group Agent may from time to time reasonably request.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Quarterly Financial Statements of Parent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  As soon as available and in no event later than forty five (45) calendar days following the end of each of the first three fiscal quarters in each of Parent&#8217;s fiscal years (or, if applicable, the date on which such financial statements are required to be filed with the SEC), (i) the unaudited consolidated balance sheet and statements of income of Parent and its consolidated Subsidiaries as at the end of such fiscal quarter and the related unaudited consolidated statements of earnings and cash flows for such fiscal quarter and for the elapsed portion of the fiscal year ended with the last day of such fiscal quarter, in each case setting forth comparative figures for the corresponding fiscal quarter in the prior fiscal year, all of which shall be certified by a Financial Officer of Parent that they fairly present in all material respects, in accordance with GAAP, the financial condition of Parent and its consolidated Subsidiaries as of the dates indicated and the results of their operations for the periods indicated, subject to normal year-end audit adjustments and the absence of footnotes and (ii) management&#8217;s discussion and analysis of the important operational and financial developments during such fiscal quarter.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Annual Financial Statements of Parent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Within ninety (90) calendar days after the close of each of Parent&#8217;s fiscal years (or, if applicable, the date on which such financial statements are required to be filed with the SEC), the consolidated balance sheet of Parent and its consolidated Subsidiaries as at the end of such fiscal year and the related consolidated statements of earnings and cash flows for such fiscal year </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">61</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">setting forth comparative figures for the preceding fiscal year, all reported on by independent certified public accountants of recognized national standing (without a &#8220;going concern&#8221; or like qualification or exception) to the effect that such consolidated financial statements present fairly in all material respects, in accordance with GAAP, the financial condition of Parent and its consolidated Subsidiaries as of the dates indicated and the results of their operations for the periods indicated.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Other Reports and Filings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Promptly (but in any event within ten (10) calendar days) after the filing or delivery thereof, copies of all financial information, proxy materials and reports not otherwise delivered pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Sections 7.01(c)(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> through </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> above, if any, which Parent or any of its consolidated Subsidiaries shall publicly file with the SEC or deliver to holders (or any trustee, agent or other representative therefor) of any of its material Debt pursuant to the terms of the documentation governing the same. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">Notwithstanding anything herein to the contrary, any financial information, proxy statements or other material required to be delivered pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.01(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> shall be deemed to have been furnished to each of the Administrative Agent and each Group Agent on the date that such report, proxy statement or other material is posted on the SEC&#8217;s website at www.sec.gov.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:59.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">iv.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Notices</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Borrower (or the Servicer on its behalf) will notify the Administrative Agent and each Group Agent in writing of any of the following events promptly upon (but in no event later than five (5) Business Days after) a Financial Officer or other officer learning of the occurrence thereof, with such notice describing the same, and if applicable, the steps being taken by the Person(s) affected with respect thereto&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Notice of Events of Default or Unmatured Events of Default</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  A statement of a Financial Officer of the Borrower setting forth details of any Event of Default or Unmatured Event of Default that has occurred and is continuing and the action which the Borrower proposes to take with respect thereto.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Representations and Warranties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The failure of any representation or warranty made or deemed to be made by the Borrower under this Agreement or any other Transaction Document to be true and correct in any material respect when made.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Litigation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The institution of any litigation, arbitration proceeding or governmental proceeding on any Integra Party, which with respect to any Person other than the Borrower, could reasonably be expected to have a Material Adverse Effect.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Adverse Claim</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(A) Any Person shall obtain an Adverse Claim upon the Collateral or any portion thereof, (B) any Person other than the Borrower, the Servicer or the Administrative Agent shall obtain any rights or direct any action with respect to any Collection Account (or related Lock-Box) or (C) any Obligor shall receive any change in payment instructions with respect to Pool Receivable(s) from a Person other than the Servicer or the Administrative Agent.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Name Changes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  At least ten (10) Business Days before any change in any Originator&#8217;s or the Borrower&#8217;s name, jurisdiction of organization or any other change requiring the amendment of UCC financing statements, a notice setting forth such changes and the effective date thereof.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Change in Accountants or Accounting Policy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Any change in (i) the external accountants of any Integra Party, (ii) any accounting policy of the Borrower </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">62</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">or (iii) any material accounting policy of any Originator that is relevant to the transactions contemplated by this Agreement or any other Transaction Document (it being understood that any change to the manner in which any Originator accounts for the Pool Receivables shall be deemed &#8220;material&#8221; for such purpose).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Notice of Purchase and Sale Termination Event or Unmatured Purchase and Sale Termination Event</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The occurrence of a Purchase and Sale Termination Event or an Unmatured Purchase and Sale Termination Event under the Purchase and Sale Agreement.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Material Adverse Change.  Promptly after the occurrence thereof, notice of any material adverse change in the business, operations, property or financial or other condition of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">any Integra Party</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> (including, without limitation, a change to the Credit and Collection </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Procedures</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:63pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">v.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Conduct of Business</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Borrower will carry on and conduct its business in substantially the same manner and in substantially the same fields of enterprise as it is presently conducted, and will do all things necessary to remain duly organized, validly existing and in good standing as a domestic organization in its jurisdiction of organization and maintain all requisite authority to conduct its business in each jurisdiction in which its business is conducted.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:59.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">vi.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Compliance with Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Borrower will comply with all Applicable Laws to which it may be subject if the failure to comply could reasonably be expected to have a Material Adverse Effect.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:56.34pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">vii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Furnishing of Information and Inspection of Receivables</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Borrower will furnish or cause to be furnished to the Administrative Agent and each Group Agent from time to time such information with respect to the Pool Receivables and the other Collateral as the Administrative Agent or any Group Agent may reasonably request.  The Borrower will, (i) at the Borrower&#8217;s expense, during regular business hours with prior written notice, permit the Administrative Agent and each Group Agent or their respective agents or representatives to (A) examine and make copies of and abstracts from all books and records relating to the Pool Receivables or other Collateral, (B) visit the offices and properties of the Borrower for the purpose of examining such books and records and (C) discuss matters relating to the Pool Receivables, the other Collateral or the Borrower&#8217;s performance hereunder or under the other Transaction Documents to which it is a party with any of the officers, directors, employees or independent public accountants of the Borrower having knowledge of such matters and (ii) without limiting the provisions of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">clause (i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> above, during regular business hours, at the Borrower&#8217;s expense, upon prior written notice from the Administrative Agent, permit certified public accountants or other auditors acceptable to the Administrative Agent to conduct a review of its books and records with respect to the Pool Receivables and other Collateral&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that the Borrower shall be required to reimburse the Administrative Agent for only one (1) such review pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">clause (ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> above in any twelve-month period, unless an Event of Default has occurred and is continuing.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:53.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">viii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Payments on Receivables, Collection Accounts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Borrower (or the Servicer on its behalf) will, and will cause each Originator to, at all times, instruct all Obligors to deliver payments on the Pool Receivables to a Collection Account or a Lock-Box.  The Borrower (or the Servicer on its behalf) will, and will cause each Originator to, at all times, maintain such books and records as are necessary to identify Collections received from time to time on Pool Receivables and to segregate such Collections from other property of the Servicer and the Originators.  If any payments on the Pool Receivables or other Collections are received by the Borrower, the Servicer or an Originator, it shall hold such payments in trust for the benefit of the Administrative Agent, the Group Agents and the other Secured Parties and promptly (but in any </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">63</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">event within two (2) Business Days after receipt) remit such funds into a Collection Account.  The Borrower (or the Servicer on its behalf) will cause each Collection Account Bank to comply with the terms of each applicable Account Control Agreement.  The Borrower shall not permit funds other than Collections on Pool Receivables and other Collateral to be deposited into any Collection Account.  If such funds are nevertheless deposited into any Collection Account, the Borrower (or the Servicer on its behalf) shall, within two (2) Business Days, (x) identify and transfer such funds to the appropriate Person entitled to such funds and (y) instruct such Person to no longer deposit any such funds into any such Collection Account.  The Borrower will not, and will not permit the Servicer, any Originator or any other Person to commingle Collections or other funds to which the Administrative Agent, any Group Agent or any other Secured Party is entitled, with any other funds.  The Borrower shall only add a Collection Account (or a related Lock-Box) or a Collection Account Bank to those listed on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule II</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> to this Agreement, if the Administrative Agent has received notice of such addition and an executed and acknowledged copy of an Account Control Agreement (or an amendment thereto) in form and substance acceptable to the Administrative Agent from the applicable Collection Account Bank.  The Borrower shall only terminate a Collection Account Bank or close a Collection Account (or a related Lock-Box) with the prior written consent of the Administrative Agent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:59.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ix.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Sales, Liens, etc.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  Except as otherwise provided herein, the Borrower will not sell, assign (by operation of law or otherwise) or otherwise dispose of, or create or suffer to exist any Adverse Claim upon (including, without limitation, the filing of any financing statement) or with respect to, any Pool Receivable or other Collateral, or assign any right to receive income in respect thereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:63pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">x.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Extension or Amendment of Pool Receivables</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Except as otherwise permitted in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 8.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, the Borrower will not, and will not permit the Servicer to, alter the delinquency status or adjust the Outstanding Balance or otherwise modify the terms of any Pool Receivable in any respect, or amend, modify or waive, in any respect, any term or condition of any related Contract that could have a Material Adverse Effect.  The Borrower shall at its expense, timely and fully perform and comply in all material respects with all provisions, covenants and other promises required to be observed by it under the Contracts related to the Pool Receivables, and timely and fully comply with the Credit and Collection Procedures with regard to each Pool Receivable and the related Contract.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:59.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">xi.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Change in Credit and Collection </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Procedures.  The Borrower will not make any change that could be reasonably expected to have a Material Adverse Effect in the Credit and Collection Procedures without the prior written consent of the Administrative Agent and the Majority Group Agents.  Promptly following any change in the Credit and Collection Procedures, the Borrower will deliver a copy of the updated Credit and Collection Procedures to the Administrative Agent and each Lender.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:56.34pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">xii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Books and Records</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Borrower shall maintain and implement (or cause the Servicer to maintain and implement) administrative and operating procedures (including an ability to recreate records evidencing Pool Receivables and related Contracts in the event of the destruction of the originals thereof), and keep and maintain (or cause the Servicer to keep and maintain) all documents, books, records, computer tapes and disks and other information reasonably necessary or advisable for the collection of all Pool Receivables (including records adequate to permit the daily identification of each Pool Receivable and all Collections of and adjustments to each existing Pool Receivable).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:53.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">xiii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Identifying of Records</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Borrower shall&#58; (i) identify (or cause the Servicer to identify) its master data processing records relating to Pool Receivables and related Contracts with a legend that indicates that the Pool Receivables have been pledged in accordance with this </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">64</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Agreement and (ii) cause each Originator so to identify its master data processing records with such a legend.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:53.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">xiv.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Change in Payment Instructions to Obligors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Borrower shall not (and shall not permit the Servicer or any Sub-Servicer to) add, replace or terminate any Collection Account (or any related Lock-Box) or make any change in its (or their) instructions to the Obligors regarding payments to be made to the Collection Accounts (or any related Lock-Box), other than any instruction to remit payments to a different Collection Account (or any related Lock-Box), unless the Administrative Agent shall have received (i) prior written notice of such addition, termination or change and (ii) a signed and acknowledged Account Control Agreement (or an amendment thereto) with respect to such new Collection Accounts (or any related Lock-Box), and the Administrative Agent shall have consented to such change in writing.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:57pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">xv.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Security Interest, Etc.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  The Borrower shall (and shall cause the Servicer to), at its expense, take all action necessary or reasonably desirable to establish and maintain a valid and enforceable first priority perfected security interest in the Collateral, in each case free and clear of any Adverse Claim, in favor of the Administrative Agent (on behalf of the Secured Parties), including taking such action to perfect, protect or more fully evidence the security interest of the Administrative Agent (on behalf of the Secured Parties) as the Administrative Agent or any Secured Party may reasonably request.  In order to evidence the security interests of the Administrative Agent under this Agreement, the Borrower shall, from time to time take such action, or execute and deliver such instruments as may be necessary (including, without limitation, such actions as are reasonably requested by the Administrative Agent) to maintain and perfect, as a first-priority interest, the Administrative Agent&#8217;s security interest in the Receivables, Related Security and Collections.  The Borrower shall, from time to time and within the time limits established by law, prepare and present to the Administrative Agent for the Administrative Agent&#8217;s authorization and approval, all financing statements, amendments, continuations or initial financing statements in lieu of a continuation statement, or other filings necessary to continue, maintain and perfect the Administrative Agent&#8217;s security interest as a first-priority interest.  The Administrative Agent&#8217;s approval of such filings shall authorize the Borrower to file such financing statements under the UCC without the signature of the Borrower, any Originator or the Administrative Agent where allowed by Applicable Law.  Notwithstanding anything else in the Transaction Documents to the contrary, the Borrower shall not have any authority to file a termination, partial termination, release, partial release, or any amendment that deletes the name of a debtor or excludes collateral of any such financing statements filed in connection with the Transaction Documents, without the prior written consent of the Administrative Agent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:53.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">xvi.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Further Assurances&#59; Change in Name or Jurisdiction of Origination, etc.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">The Borrower hereby authorizes and hereby agrees from time to time, at its own expense, promptly to execute (if necessary) and deliver all further instruments and documents, and to take all further actions, that may be necessary or desirable, or that the Administrative Agent may reasonably request, to perfect, protect or more fully evidence the security interest granted pursuant to this Agreement or any other Transaction Document, or to enable the Administrative Agent (on behalf of the Secured Parties) to exercise and enforce the Secured Parties&#8217; rights and remedies under this Agreement or any other Transaction Document.  Without limiting the foregoing, the Borrower hereby authorizes, and will, upon the request of the Administrative Agent, at the Borrower&#8217;s own expense, execute (if necessary) and file such financing statements or continuation statements, or amendments thereto, and such other instruments and documents, that may be necessary or desirable, or that the Administrative Agent may reasonably request, to perfect, protect or evidence any of the foregoing.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">65</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">The Borrower authorizes the Administrative Agent to file financing statements, continuation statements and amendments thereto and assignments thereof, relating to the Receivables, the Related Security, the related Contracts, Collections with respect thereto and the other Collateral without the signature of the Borrower.  A photocopy or other reproduction of this Agreement shall be sufficient as a financing statement where permitted by law.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">The Borrower shall at all times be organized under the laws of the State of Delaware and shall not take any action to change its jurisdiction of organization.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">The Borrower will not change its name, location, identity or corporate structure unless (x) the Borrower, at its own expense, shall have taken all action necessary or appropriate to perfect or maintain the perfection of the security interest under this Agreement (including, without limitation, the filing of all financing statements and the taking of such other action as the Administrative Agent may request in connection with such change or relocation) and (y) if requested by the Administrative Agent, the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Borrower</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> shall cause to be delivered to the Administrative Agent, an opinion, in form and substance satisfactory to the Administrative Agent as to such UCC perfection and priority matters as the Administrative Agent may request at such time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:50.34pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">xvii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Transaction Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  None of the Borrower, any Affiliate of the Borrower or any third party with which the Borrower or any Affiliate thereof has contracted, shall deliver, in writing or orally, to any Rating Agency, any Transaction Information without providing such Transaction Information to the applicable Group Agent prior to delivery to such Rating Agency and will not participate in any oral communications with respect to Transaction Information with any Rating Agency without the participation of such Group Agent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:47.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">xviii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Anti-Money Laundering&#47;International Trade Law Compliance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Borrower will not become a Sanctioned Person.  No Covered Entity, either in its own right or through any third party, will (a) have any of its assets in a Sanctioned Country or in the possession, custody or control of a Sanctioned Person in violation of any Anti-Terrorism Law&#59; (b) do business in or with, or derive any of its income from investments in or transactions with, any Sanctioned Country or Sanctioned Person in violation of any Anti-Terrorism Law&#59; (c) engage in any dealings or transactions prohibited by any Anti-Terrorism Law or (d) use the proceeds of any Credit Extension to fund any operations in, finance any investments or activities in, or, make any payments to, a Sanctioned Country or Sanctioned Person in violation of any Anti-Terrorism Law.  The funds used to repay each Credit Extension will not be derived from any unlawful activity.  The Borrower shall comply with all Anti-Terrorism Laws.  The Borrower shall promptly notify the Administrative Agent and each Lender in writing upon the occurrence of a Reportable Compliance Event.  The Borrower has not used and will not use the proceeds of any Credit Extension to fund any operations in, finance any investments or activities in or make any payments to, a Sanctioned Person or a Sanctioned Country.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:53.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">xix.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Borrower&#8217;s Tax Status</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Borrower will remain a wholly-owned subsidiary of a United States person (within the meaning of Section 7701(a)(30) of the Code) and not be subject to withholding under Section 1446 of the Code.  The Borrower shall not take or cause any action to be taken that could result in the Borrower (i) being treated other than as a &#8220;disregarded entity&#8221; within the meaning of U.S. Treasury Regulation &#167; 301.7701-3 for U.S. federal income tax purposes or (ii) becoming an association taxable as a corporation or a publicly traded partnership taxable as a corporation for U.S. federal income tax purposes.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:57pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">xx.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Fundamental Changes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Borrower shall not, without the prior written consent of the Administrative Agent and the Majority Group Agents, permit (i) itself to merge, divide or consolidate with or into, or convey, transfer, lease or otherwise dispose of (whether in one </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">66</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">transaction or in a series of transactions) all or substantially all of its assets (whether now owned or hereafter acquired) to, any Person or (ii) itself to be directly owned by any Person other than an Originator or (iii) any of its issued and outstanding Capital Stock or any of its other equity interests to become subject to any Adverse Claims.  The Borrower shall provide the Administrative Agent with at least ten (10) Business Days&#8217; prior written notice before making any change in the Borrower&#8217;s name or location or making any other change in the Borrower&#8217;s identity or corporate structure that could impair or otherwise render any UCC financing statement filed in connection with this Agreement or any other Transaction Document &#8220;seriously misleading&#8221; as such term (or similar term) is used in the applicable UCC&#59; each notice to the Administrative Agent and the Group Agents pursuant to this sentence shall set forth the applicable change and the proposed effective date thereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:53.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">xxi.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Certain Agreements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Without the prior written consent of the Administrative Agent and the Majority Group Agents, the Borrower will not (and will not permit any Originator or the Servicer to) amend, modify, waive, revoke or terminate any Transaction Document to which it is a party or any provision of the Borrower&#8217;s organizational documents which requires the consent of the &#8220;Independent Director&#8221; (as such term is used in the Borrower&#8217;s Certificate of Formation and Limited Liability Company Agreement).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:50.34pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">xxii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Restricted Payments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">Except pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">clause (ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> below, the Borrower will not&#58; (A) purchase or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">redeem</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> any of its membership interests, (B)&#160;declare or pay any dividend or set aside any funds for any such purpose, (C) prepay, purchase or redeem any Debt, (D) lend or advance any funds or (E) repay any loans or advances to, for or from any of its Affiliates (the amounts described in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">clauses (A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> through </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">(E)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> being referred to as &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Restricted Payments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">Subject to the limitations set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">clause (iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> below, the Borrower may make Restricted Payments so long as such Restricted Payments are made only in one or more of the following ways&#58; (A) the Borrower may make cash payments (including prepayments) on the Subordinated Notes in accordance with their respective terms and (B) the Borrower may declare and pay dividends if, in both cases, both immediately before and immediately after giving effect thereto, the Borrower&#8217;s Net Worth is not less than the Required Capital Amount.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">The Borrower may make Restricted Payments only out of the funds, if any, it receives pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Sections 3.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> of this Agreement&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that the Borrower shall not pay, make or declare any Restricted Payment (including any dividend) if, after giving effect thereto, any Event of Default or Unmatured Event of Default shall have occurred and be continuing.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:47.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">xxiii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Other Business</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Borrower will not&#58; (i) engage in any business other than the transactions contemplated by the Transaction Documents, (ii) create, incur or permit to exist any Debt of any kind (or cause or permit to be issued for its account any letters of credit) or bankers&#8217; acceptances, in the aggregate in excess of fifteen thousand dollars ($15,000), other than pursuant to this Agreement or the Subordinated Notes or (iii) form any Subsidiary or make any investments in any other Person.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:47.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">xxiv.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Use of Collections Available to the Borrower</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Borrower shall apply the Collections available to the Borrower to make payments in the following order of priority&#58; (i) the payment of its obligations under this Agreement and each of the other Transaction Documents (other than the Subordinated Notes), (ii) the payment of accrued and unpaid interest on the Subordinated Notes and (iii) other legal and valid purposes.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">67</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:51pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">xxv.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Borrower&#8217;s Net Worth</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Borrower shall not permit the Borrower&#8217;s Net Worth to be less than the Required Capital Amount.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:47.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">xxvi.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Post-Closing Actions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">At any time on or after the Closing Date and within five (5) Business Days after receipt of the initial field examination report from CBIZ, Inc. by the Administrative Agent, the Administrative Agent may propose one or more amendments to this Agreement in order to (A) amend or otherwise modify, or change (directly or indirectly) the definitions of Defaulted Receivable, Delinquent Receivable, Eligible Receivable, Excess Concentration, Net Receivables Pool Balance, Adjusted Net Receivables Pool Balance, or Total Reserves, or any other term referenced in such definitions but not expressly listed hereunder&#59; (B) increase the then existing Concentration Percentage for any Obligor&#59; or (C) change the calculation of the Borrowing Base, in each case to reflect the findings of the initial field examination (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Proposed Amendments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).  The parties shall use commercially reasonable efforts to agree on the form and substance of any such Proposed Amendments, and to enter into a written amendment to this Agreement giving effect to the Proposed Amendments, not later than ten (10) Business Days following the Administrative Agent&#8217;s proposal.  The Borrower shall not be entitled to submit any new Loan Requests until the Proposed Amendments, if requested, are entered into. If the parties are unable to agree on all or any part of the Proposed Amendments, then a Termination Date shall automatically occur on the earlier of (A) the eleventh (11th) Business Day following the Administrative Agent&#8217;s proposal or (B) the date the Borrower notifies the Administrative Agent in writing that it will not agree to the Proposed Amendments.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">On or prior to January 31, 2019 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Post Closing Due Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), the Borrower shall (A) enter into and deliver an executed copy of the applicable Account Control Agreement with respect to each Collection Account Bank and (B) take all further actions, that may be necessary or desirable, or that the Administrative Agent may reasonably request in connection with the immediately preceding clause (A) (including, but not limited to the delivery of executed copies of the opinions of counsel that would have been required had any such Account Control Agreement been executed and delivered on the Closing Date), in each case, in form and substance satisfactory to the Administrative Agent and the Majority Group Agents&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that the Post-Closing Due Date may be extended upon the written consent of the Administrative Agent (which may be via e-mail).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1.0b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:30.36pt">Covenants of the Servicer.  At all times from the Closing Date until the Final Payout Date&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:65.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Existence</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Servicer shall keep in full force and effect its existence and rights as a limited liability company under the laws of the State of Delaware, and shall obtain and preserve its qualification to do business in each jurisdiction in which such qualification is or shall be necessary for the conduct of its business or the servicing of the Pool Receivables as required by this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:62.34pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Financial Reporting</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Servicer will maintain a system of accounting established and administered in accordance with GAAP, and the Servicer shall furnish to the Administrative Agent and each Group Agent&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Compliance Certificates</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  (A) A compliance certificate promptly upon completion of the annual report of the Parent and in no event later than ninety (90) calendar days after the close of each fiscal year of the Parent, in form and substance </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">68</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">substantially similar to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit G</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> signed by a Financial Officer of the Servicer stating that no Event of Default or Unmatured Event of Default has occurred and is continuing, or if any Event of Default or Unmatured Event of Default has occurred and is continuing, stating the nature and status thereof and setting forth the current Consolidated Total Leverage Ratio and (B) within thirty (30) calendar days after the close of each fiscal quarter of the Servicer, a compliance certificate in form and substance substantially similar to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit G</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> signed by a Financial Officer of the Servicer stating that no Event of Default or Unmatured Event of Default has occurred and is continuing, or if any Event of Default or Unmatured Event of Default has occurred and is continuing, stating the nature and status thereof and setting forth the current Consolidated Total Leverage Ratio.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Information Packages and Interim Reports</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  As soon as available and in any event not later than two (2) Business Days prior to each Settlement Date, an Information Package as of the most recently completed Fiscal Month&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that, upon the occurrence of a Specific Reporting Event and ten (10) Business Days&#8217; prior written notice from the Administrative Agent, the Servicer shall furnish or cause to be furnished to the Administrative Agent and each Group Agent a weekly (or on a more frequent basis as indicated in the written notice from the Administrative Agent) Interim Report with respect to the Pool Receivables with data as of the close of business on the Business Day preceding the date on which such Interim Report is delivered&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that, at any time after the occurrence and during the continuance of an Event of Default, the Administrative Agent may specify in such notice that such Interim Report be furnished to the Administrative Agent and each Group Agent on a more frequent basis until the Administrative Agent gives notices otherwise. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Other Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Such other information (including non-financial information) as the Administrative Agent or any Group Agent may from time to time reasonably request relating to any of the Servicer, the Borrower, any Originator, any Obligor or the Pool Receivables. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">Notwithstanding anything herein to the contrary, any financial information, proxy statements or other material required to be delivered pursuant to this Section 7.02(b) shall be deemed to have been furnished to each of the Administrative Agent and each Group Agent on the date that such report, proxy statement or other material is posted on the SEC&#8217;s website at www.sec.gov.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:59.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">iii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Notices</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Servicer will notify the Administrative Agent and each Group Agent in writing of any of the following events promptly upon (but in no event later than three (3) Business Days after) a Financial Officer or other officer learning of the occurrence thereof, with such notice describing the same, and if applicable, the steps being taken by the Person(s) affected with respect thereto&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Notice of Events of Default or Unmatured Events of Default</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  A statement of a Financial Officer of the Servicer setting forth details of any Event of Default or Unmatured Event of Default that has occurred and is continuing and the action which the Servicer proposes to take with respect thereto.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Representations and Warranties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The failure of any representation or warranty made or deemed to be made by the Servicer under this Agreement or any other Transaction Document to be true and correct in any material respect when made.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Litigation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The institution of any litigation, arbitration proceeding or governmental proceeding which could reasonably be expected to have a Material Adverse Effect.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">69</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Adverse Claim</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(A) Any Person shall obtain an Adverse Claim upon the Collateral or any portion thereof, (B) any Person other than the Borrower, the Servicer or the Administrative Agent shall obtain any rights or direct any action with respect to any Collection Account (or related Lock-Box) or (C) any Obligor shall receive any change in payment instructions with respect to Pool Receivable(s) from a Person other than the Servicer or the Administrative Agent.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Name Changes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  At least ten (10) Business Days before any change in any Originator&#8217;s or the Borrower&#8217;s name, jurisdiction of organization or any other change requiring the amendment of UCC financing statements, a notice setting forth such changes and the effective date thereof.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Change in Accountants or Accounting Policy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Any change in (i) the external accountants of any Integra Party, (ii) any accounting policy of the Borrower or (iii) any material accounting policy of any Originator that is relevant to the transactions contemplated by this Agreement or any other Transaction Document (it being understood that any change to the manner in which any Originator accounts for the Pool Receivables shall be deemed &#8220;material&#8221; for such purpose).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Notice of Purchase and Sale Termination Event or Unmatured Purchase and Sale Termination Event.  The occurrence of a Purchase and Sale Termination Event or an Unmatured Purchase and Sale Termination Event under the Purchase and Sale Agreement.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Material Adverse Change</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Promptly after the occurrence thereof, notice of any</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> material adverse change in the business, operations, property or financial or other condition of any Integra Party </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">(including, without limitation, a change to the Credit and Collection </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Procedures</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:59.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">iv.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Conduct of Business</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Servicer will do all things necessary to remain duly organized, validly existing and in good standing as a domestic limited liability company in its jurisdiction of organization and maintain all requisite authority to conduct its business in each jurisdiction in which its business is conducted if the failure to have such authority could reasonably be expected to have a Material Adverse Effect.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:63pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">v.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Compliance with Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Servicer will comply with all Applicable Laws to which it may be subject if the failure to comply could reasonably be expected to have a Material Adverse Effect.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:59.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">vi.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Furnishing of Information and Inspection of Receivables</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Servicer will furnish or cause to be furnished to the Administrative Agent and each Group Agent from time to time such information with respect to the Pool Receivables and the other Collateral as the Administrative Agent or any Group Agent may reasonably request.  The Servicer will, (i) at the Servicer&#8217;s expense, during regular business hours with prior written notice, permit the Administrative Agent and each Group Agent or their respective agents or representatives to (A) examine and make copies of and abstracts from all books and records relating to the Pool Receivables or other Collateral, (B) visit the offices and properties of the Servicer for the purpose of examining such books and records and (C) discuss matters relating to the Pool Receivables, the other Collateral or the Servicer&#8217;s performance hereunder or under the other Transaction Documents to which it is a party with any of the officers, directors, employees or independent public accountants of the Servicer (provided that representatives of the Servicer are present during such discussions) having knowledge of such matters and (ii) without limiting the provisions of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">clause (i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> above, during regular business hours, at the Servicer&#8217;s expense, upon prior written notice from the Administrative Agent, permit certified public accountants or other </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">70</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">auditors acceptable to the Administrative Agent to conduct a review of its books and records with respect to the Pool Receivables and other Collateral&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that the Servicer shall be required to reimburse the Administrative Agent for only one (1) such review pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">clause (ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> above in any twelve-month period unless an Event of Default has occurred and is continuing.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:56.34pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">vii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Payments on Receivables, Collection Accounts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Servicer will at all times, instruct all Obligors to deliver payments on the Pool Receivables to a Collection Account or a Lock-Box.  The Servicer will, at all times, maintain such books and records as are necessary to identify Collections received from time to time on Pool Receivables and to segregate such Collections from other property of the Servicer and the Originators.  If any payments on the Pool Receivables or other Collections are received by the Borrower, the Servicer or an Originator, it shall hold such payments in trust for the benefit of the Administrative Agent, the Group Agents and the other Secured Parties and promptly (but in any event within two (2) Business Days after receipt) remit such funds into a Collection Account.  The Servicer shall not permit funds other than Collections on Pool Receivables and other Collateral to be deposited into any Collection Account.  If such funds are nevertheless deposited into any Collection Account, the Servicer shall, within two (2) Business Days, (x) identify and transfer such funds to the appropriate Person entitled to such funds and (y) instruct such Person to no longer deposit any such funds into any such Collection Account.  The Servicer will not, and will not permit the Borrower, any Originator or any other Person to commingle Collections or other funds to which the Administrative Agent, any Group Agent or any other Secured Party is entitled, with any other funds.  The Servicer shall only add a Collection Account (or a related Lock-Box) or a Collection Account Bank to those listed on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule II</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> to this Agreement, if the Administrative Agent has received notice of such addition and an executed and acknowledged copy of an Account Control Agreement (or an amendment thereto) in form and substance acceptable to the Administrative Agent from the applicable Collection Account Bank.  The Servicer shall only terminate a Collection Account Bank or close a Collection Account (or a related Lock-Box) with the prior written consent of the Administrative Agent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:53.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">viii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Extension or Amendment of Pool Receivables</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Except as otherwise permitted in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 8.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, the Servicer will not alter the delinquency status or adjust the Outstanding Balance or otherwise modify the terms of any Pool Receivable in any respect that could have a Material Adverse Effect, or amend, modify or waive, in any material respect, any term or condition of any related Contract.  The Servicer shall at its expense, timely and fully perform and comply in all material respects with all provisions, covenants and other promises required to be observed by it under the Contracts related to the Pool Receivables, and timely and fully comply with the Credit and Collection Procedures with regard to each Pool Receivable and the related Contract.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:59.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ix.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Change in Credit and Collection Procedures</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Servicer will comply in all respects with the Credit and Collection Procedures with regard to each Pool Receivable and the related Contracts, except where such noncompliance could reasonably expected to have a Material Adverse Effect.  The Servicer will not make any material change in the Credit and Collection Procedures without the prior written consent of the Administrative Agent and the Majority Group Agents.  Promptly following any change in the Credit and Collection Procedures, the Servicer will deliver a copy of the updated Credit and Collection Procedures to the Administrative Agent and each Lender.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:63pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">x.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Books and Records</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Servicer will maintain and implement administrative and operating procedures (including an ability to recreate records evidencing Pool Receivables and related Contracts in the event of the destruction of the originals thereof), and keep and maintain all documents, books, records, computer tapes and disks and other information reasonably necessary or advisable for the collection of all Pool Receivables (including records adequate to permit the daily identification of each Pool Receivable and all Collections of and adjustments to each existing Pool Receivable).</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">71</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:59.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">xi.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Identifying of Records</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Servicer shall identify its master data processing records relating to Pool Receivables and related Contracts with a legend that indicates that the Pool Receivables have been pledged in accordance with this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:56.34pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">xii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Change in Payment Instructions to Obligors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Servicer shall not (and shall not permit any Sub-Servicer to) add, replace or terminate any Collection Account (or any related Lock-Box) or make any change in its instructions to the Obligors regarding payments to be made to the Collection Accounts (or any related Lock-Box), other than any instruction to remit payments to a different Collection Account (or any related Lock-Box), unless the Administrative Agent shall have received (i) prior written notice of such addition, termination or change and (ii) a signed and acknowledged Account Control Agreement (or an amendment thereto) with respect to such new Collection Accounts (or any related Lock-Box) and the Administrative Agent shall have consented to such change in writing.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:53.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">xiii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Security Interest, Etc.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  The Servicer shall, at its expense, take all action necessary or reasonably desirable to establish and maintain a valid and enforceable first priority perfected security interest in the Collateral, in each case free and clear of any Adverse Claim in favor of the Administrative Agent (on behalf of the Secured Parties), including taking such action to perfect, protect or more fully evidence the security interest of the Administrative Agent (on behalf of the Secured Parties) as the Administrative Agent or any Secured Party may reasonably request.  In order to evidence the security interests of the Administrative Agent under this Agreement, the Servicer shall, from time to time take such action, or execute and deliver such instruments as may be necessary (including, without limitation, such actions as are reasonably requested by the Administrative Agent) to maintain and perfect, as a first-priority interest, the Administrative Agent&#8217;s security interest in the Receivables, Related Security and Collections.  The Servicer shall, from time to time and within the time limits established by law, prepare and present to the Administrative Agent for the Administrative Agent&#8217;s authorization and approval, all financing statements, amendments, continuations or initial financing statements in lieu of a continuation statement, or other filings necessary to continue, maintain and perfect the Administrative Agent&#8217;s security interest as a first-priority interest.  The Administrative Agent&#8217;s approval of such filings shall authorize the Servicer to file such financing statements under the UCC without the signature of the Borrower, any Originator or the Administrative Agent where allowed by Applicable Law.  Notwithstanding anything else in the Transaction Documents to the contrary, the Servicer shall not have any authority to file a termination, partial termination, release, partial release, or any amendment that deletes the name of a debtor or excludes collateral of any such financing statements filed in connection with the Transaction Documents, without the prior written consent of the Administrative Agent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:53.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">xiv.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Further Assurances&#59; Change in Name or Jurisdiction of Origination, etc.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  The Servicer hereby authorizes and hereby agrees from time to time, at its own expense, promptly to execute (if necessary) and deliver all further instruments and documents, and to take all further actions, that may be necessary or desirable, or that the Administrative Agent may reasonably request, to perfect, protect or more fully evidence the security interest granted pursuant to this Agreement or any other Transaction Document, or to enable the Administrative Agent (on behalf of the Secured Parties) to exercise and enforce the Secured Parties&#8217; rights and remedies under this Agreement or any other Transaction Document.  Without limiting the foregoing, the Servicer hereby authorizes, and will, upon the request of the Administrative Agent, at the Servicer&#8217;s own expense, execute (if necessary) and file such financing statements or continuation statements, or amendments thereto, and such other instruments and documents, that may be necessary or desirable, or that the Administrative Agent may reasonably request, to perfect, protect or evidence any of the foregoing.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:57pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">xv.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Transaction Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  None of the Servicer, any Affiliate of the Servicer or any third party with which the Servicer or any Affiliate thereof has contracted, shall deliver, in </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">72</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">writing or orally, to any Rating Agency, any Transaction Information without providing such Transaction Information to the applicable Group Agent prior to delivery to such Rating Agency, and will not participate in any oral communications with respect to Transaction Information with any Rating Agency without the participation of such Group Agent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:53.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">xvi.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Anti-Money Laundering&#47;International Trade Law Compliance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Servicer will not become a Sanctioned Person.  No Covered Entity, either in its own right or through any third party, will (a) have any of its assets in a Sanctioned Country or in the possession, custody or control of a Sanctioned Person in violation of any Anti-Terrorism Law&#59; (b) do business in or with, or derive any of its income from investments in or transactions with, any Sanctioned Country or Sanctioned Person in violation of any Anti-Terrorism Law&#59; (c) engage in any dealings or transactions prohibited by any Anti-Terrorism Law or (d) use the proceeds of any Credit Extension to fund any operations in, finance any investments or activities in, or, make any payments to, a Sanctioned Country or Sanctioned Person in violation of any Anti-Terrorism Law.  The funds used to repay each Credit Extension will not be derived from any unlawful activity.  The Servicer shall comply with all Anti-Terrorism Laws.  The Servicer shall promptly notify the Administrative Agent and each Lender in writing upon the occurrence of a Reportable Compliance Event.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:50.34pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">xvii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Borrower&#8217;s Tax Status</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Servicer shall not take or cause any action to be taken that could result in the Borrower (i) being treated other than as a &#8220;disregarded entity&#8221; within the meaning of U.S. Treasury Regulation &#167; 301.7701-3 for U.S. federal income tax purposes or (ii) becoming an association taxable as a corporation or a publicly traded partnership taxable as a corporation for U.S. federal income tax purposes.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1.0c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:31.04pt">Separate Existence of the Borrower.  Each of the Borrower and the Servicer hereby acknowledges that the Secured Parties, the Group Agents and the Administrative Agent are entering into the transactions contemplated by this Agreement and the other Transaction Documents in reliance upon the Borrower&#8217;s identity as a legal entity separate from any Originator, the Servicer, the Performance Guarantor and their Affiliates.  Therefore, each of the Borrower and Servicer shall take all steps specifically required by this Agreement or reasonably required by the Administrative Agent or any Group Agent to continue the Borrower&#8217;s identity as a separate legal entity and to make it apparent to third Persons that the Borrower is an entity with assets and liabilities distinct from those of the Performance Guarantor, the Originators, the Servicer and any other Person, and is not a division of the Performance Guarantor, the Originators, the Servicer, its Affiliates or any other Person. Without limiting the generality of the foregoing and in addition to and consistent with the other covenants set forth herein, each of the Borrower and the Servicer shall take such actions as shall be required in order that&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:65.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Special Purpose Entity</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Borrower will be a special purpose company whose primary activities are restricted in its Certificate of Formation or Limited Liability Company Agreement to&#58; (i) purchasing or otherwise acquiring from the Originators, owning, holding, collecting, granting security interests or selling interests in, the Collateral, (ii) entering into agreements for the selling, servicing and financing of the Receivables Pool (including the Transaction Documents) and (iii) conducting such other activities as it deems necessary or appropriate to carry out its primary activities.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:62.34pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">No Other Business or Debt</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Borrower shall not engage in any business or activity except as set forth in this Agreement nor, incur any indebtedness or liability other than as expressly permitted by the Transaction Documents.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:59.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">iii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Independent Director</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Not fewer than one member of the Borrower&#8217;s board of directors (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Independent Director</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) shall be a natural person who (i) has never been, and shall </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">73</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">at no time be, an equityholder, director, officer, manager, member, partner, officer, employee or associate, or any relative of the foregoing, of any member of the Parent Group (as hereinafter defined) (other than his or her service as an Independent Director of the Borrower or an independent director of any other bankruptcy-remote special purpose entity formed for the sole purpose of securitizing, or facilitating the securitization of, financial assets of any member or members of the Parent Group), (ii) is not a customer or supplier of any member of the Parent Group (other than his or her service as an Independent Director of the Borrower or an independent director of any other bankruptcy-remote special purpose entity formed for the sole purpose of securitizing, or facilitating the securitization of, financial assets of any member or members of the Parent Group), (iii) is not any member of the immediate family of a person described in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> above, and (iv) has (x) prior experience as an independent director for a corporation or limited liability company whose organizational or charter documents required the unanimous consent of all independent directors thereof before such corporation or limited liability company could consent to the institution of bankruptcy or insolvency proceedings against it or could file a petition seeking relief under any applicable federal or state law relating to bankruptcy and (y) at least three years of employment experience with one or more entities that provide, in the ordinary course of their respective businesses, advisory, management or placement services to issuers of securitization or structured finance instruments, agreements or securities.  For purposes of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">clause (c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Parent Group</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; shall mean (i) the Parent, the Servicer, the Performance Guarantor and each Originator, (ii) each person that directly or indirectly, owns or controls, whether beneficially, or as a trustee, guardian or other fiduciary, five percent (5%) or more of the membership interests in the Parent, (iii) each person that controls, is controlled by or is under common control with the Parent and (iv) each of such person&#8217;s officers, directors, managers, joint venturers and partners.  For the purposes of this definition, &#8220;control&#8221; of a person means the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies of a person or entity, whether through the ownership of voting securities, by contract or otherwise.  A person shall be deemed to be an &#8220;associate&#8221; of (A) a corporation or organization of which such person is an officer, director, partner or manager or is, directly or indirectly, the beneficial owner of ten percent (10%) or more of any class of equity securities, (B) any trust or other estate in which such person serves as trustee or in a similar capacity and (C) any relative or spouse of a person described in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">clause (A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> of this sentence, or any relative of such spouse.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Borrower shall (A) give written notice to the Administrative Agent of the election or appointment, or proposed election or appointment, of a new Independent Director of the Borrower, which notice shall be given not later than five (5) Business Days prior to the date such appointment or election would be effective (except when such election or appointment is necessary to fill a vacancy caused by the death, disability, or incapacity of the existing Independent Director, or the failure of such Independent Director to satisfy the criteria for an Independent Director set forth in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">clause (c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, in which case the Borrower shall provide written notice of such election or appointment within one (1) Business Day) and (B) with any such written notice, certify to the Administrative Agent that the Independent Director satis</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:100%;position:relative;top:1.69pt;vertical-align:baseline">f</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ies the criteria for an Independent Director set forth in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">clause (c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Borrower&#8217;s Limited Liability Company Agreement shall provide that&#58; (A) the Borrower&#8217;s board of directors shall not approve, or take any other action to cause the filing of, a voluntary bankruptcy petition with respect to the Borrower unless the Independent Director shall approve the taking of such action in writing before the taking of such action and (B) such provision and each other provision requiring an Independent Director cannot be amended without the prior written consent of the Independent Director.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Independent Director shall not at any time serve as a trustee in bankruptcy for any Integra Party or any of their Affiliates.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">74</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:59.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">iv.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Organizational Documents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Borrower shall maintain its organizational documents in conformity with this Agreement, such that it does not amend, restate, supplement or otherwise modify its ability to comply with the terms and provisions of any of the Transaction Documents, including, without limitation, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.01(o)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:63pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">v.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Conduct of Business</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Borrower shall conduct its affairs strictly in accordance with its organizational documents and observe all necessary, appropriate and customary company formalities, including, but not limited to, holding all regular and special members&#8217; and board of directors&#8217; meetings appropriate to authorize all company action, keeping separate and accurate minutes of its meetings, passing all resolutions or consents necessary to authorize actions taken or to be taken, and maintaining accurate and separate books, records and accounts, including, but not limited to, payroll and intercompany transaction accounts.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:59.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">vi.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Compensation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Any employee, consultant or agent of the Borrower will be compensated from the Borrower&#8217;s funds for services provided to the Borrower, and to the extent that Borrower shares the same officers or other employees as the Servicer (or any other Affiliate thereof), the salaries and expenses relating to providing benefits to such officers and other employees shall be fairly allocated among such entities, and each such entity shall bear its fair share of the salary and benefit costs associated with such common officers and employees.  The Borrower will not engage any agents other than its attorneys, auditors and other professionals, and a servicer and any other agent contemplated by the Transaction Documents for the Receivables Pool, which servicer will be fully compensated for its services by payment of the Servicing Fee.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:56.34pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">vii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Servicing and Costs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Borrower will contract with the Servicer to perform for the Borrower all operations required on a daily basis to service the Receivables Pool.  The Borrower will not incur any indirect or overhead expenses for items shared with the Servicer (or any other Affiliate thereof) that are not reflected in the Servicing Fee.  To the extent, if any, that the Borrower (or any Affiliate thereof) shares items of expenses not reflected in the Servicing Fee, such as legal, auditing and other professional services, such expenses will be allocated to the extent practical on the basis of actual use or the value of services rendered, and otherwise on a basis reasonably related to the actual use or the value of services rendered.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:53.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">viii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Operating Expenses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Borrower&#8217;s operating expenses will not be paid by any Integra Party or any Affiliate thereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:59.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ix.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Stationery</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Borrower will have its own separate stationery.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:63pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">x.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Books and Records</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Borrower&#8217;s books and records will be maintained separately from those of the Parent, each other Integra Party and any of their Affiliates and in a manner such that it will not be difficult or costly to segregate, ascertain or otherwise identify the assets and liabilities of the Borrower.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:59.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">xi.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Disclosure of Transactions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  All financial statements of the Parent, each other Integra Party or any Affiliate thereof that are consolidated to include the Borrower will disclose that (i) the Borrower&#8217;s sole business consists of the purchase or acceptance through capital contributions of the Receivables and Related Rights from the Originators and the subsequent retransfer of or granting of a security interest in such Receivables and Related Rights to the Administrative Agent pursuant to this Agreement, (ii) the Borrower is a separate legal entity with its own separate creditors who will be entitled, upon its liquidation, to be satisfied out of the Borrower&#8217;s assets prior to any assets or value in the Borrower becoming available to the Borrower&#8217;s equity holders and (iii) the assets of the Borrower are not available to pay creditors of the Parent, each other Integra Party or any Affiliate thereof.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">75</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:56.34pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">xii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Segregation of Assets</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Borrower&#8217;s assets will be maintained in a manner that facilitates their identification and segregation from those of the Parent, each other Integra Party or any Affiliates thereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:53.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">xiii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Corporate Formalities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Borrower will strictly observe limited liability company formalities in its dealings with the Parent, each other Integra Party or any Affiliates thereof, and funds or other assets of the Borrower will not be commingled with those of the Parent, each other Integra Party or any Affiliates thereof except as permitted by this Agreement in connection with servicing the Pool Receivables.  The Borrower shall not maintain joint bank accounts or other depository accounts to which the Parent, each other Integra Party or any Affiliate thereof (other than the Servicer solely in its capacity as such) has independent access.  The Borrower is not named, and has not entered into any agreement to be named, directly or indirectly, as a direct or contingent beneficiary or loss payee on any insurance policy with respect to any loss relating to the property of the Parent, each other Integra Party or any Subsidiaries or other Affiliates thereof.  The Borrower will pay to the appropriate Affiliate the marginal increase or, in the absence of such increase, the market amount of its portion of the premium payable with respect to any insurance policy that covers the Borrower and such Affiliate.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:53.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">xiv.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Arm&#8217;s-Length Relationships</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Borrower will maintain arm&#8217;s-length relationships with the Parent, each other Integra Party and any Affiliates thereof.  Any Person that renders or otherwise furnishes services to the Borrower will be compensated by the Borrower at market rates for such services it renders or otherwise furnishes to the Borrower.  Neither the Borrower on the one hand, nor the Parent, each other Integra Party or any Affiliate thereof, on the other hand, will be or will hold itself out to be responsible for the debts of the other or the decisions or actions respecting the daily business and affairs of the other.  The Parent, each Integra Party and their respective Affiliates will immediately correct any known misrepresentation with respect to the foregoing, and they will not operate or purport to operate as an integrated single economic unit with respect to each other or in their dealing with any other entity.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:57pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">xv.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Allocation of Overhead</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  To the extent that Borrower, on the one hand, and the Parent, each other Integra Party or any Affiliate thereof, on the other hand, have offices in the same location, there shall be a fair and appropriate allocation of overhead costs between them, and the Borrower shall bear its fair share of such expenses, which may be paid through the Servicing Fee or otherwise.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1.0d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:30.36pt">Financial Covenant.  The Borrower shall not, directly or indirectly, nor shall it permit any Integra Party or the Parent to, directly or indirectly, permit the Consolidated Total Leverage Ratio of the Parent and its consolidated Subsidiaries as of the last day of any consecutive four fiscal quarter period ending on the dates identified below to be greater than the ratio set forth below opposite such date (and so long as PNC and Mizuho Bank, Ltd. are each a lender under the Credit Agreement, or such other ratio for such related period as specified in the Credit Agreement from time to time)&#58; </font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">76</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="padding-left:42.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:81.730%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Four Fiscal Quarters Ending</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Maximum Consolidated Total Leverage Ratio</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:3.32pt;padding-right:3.32pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">First fiscal quarter ending after the Effective Date through June 30, 2022</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5.00 to 1.00</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">September 30, 2022 through June 30, 2023</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.50 to 1.00</font></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">September 30, 2023 and the last day of each fiscal quarter thereafter</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.00 to 1.00</font></td></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Notwithstanding the foregoing, at the election of the Parent, up to two times during the term of this Agreement, the maximum Consolidated Total Leverage Ratio set forth in this grid above may be increased to accommodate a Permitted Acquisition (as defined in the Credit Agreement), as determined by the Parent and as designated in the Compliance Certificate (as defined in the Credit Agreement, a copy of which shall be promptly provided to the Administrative Agent hereunder) or earlier notice given by the Parent in connection with such Permitted Acquisition (as defined in the Credit Agreement) (including for determining any ratios, baskets, representations and warranties or test any Event of Default (as defined in the Credit Agreement,) or Default (as defined in the Credit Agreement) blocker pursuant to Section 1.08 of the Credit Agreement)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, such increase will not otherwise go into effect until the closing of such Permitted Acquisition (as defined in the Credit Agreement)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that (a) such increase shall only apply for a period of twelve months from and after such Permitted Acquisition and immediately upon the expiration of such twelve month period, the required maximum Consolidated Total Leverage Ratio shall revert to the level set forth above for the measurement period in which such step down occurs&#59; (b) in no event shall the maximum Consolidated Total Leverage Ratio after giving effect to any such step-up exceed 5.00 to 1.00&#59; and (c) the maximum amount that any Consolidated Total Leverage Ratio covenant level may step-up during any Consolidated Total Leverage Ratio measurement period is 0.50.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ARTICLE 8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:8.36pt"><br><br>ADMINISTRATION AND COLLECTION<br>OF RECEIVABLES</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1.0a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:31.04pt">Appointment of the Servicer.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:65.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">i.The servicing, administering and collection of the Pool Receivables shall be conducted by the Person so designated from time to time as the Servicer in accordance with this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 8.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Until the Administrative Agent gives notice to the Servicer (in accordance with this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 8.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">) of the designation of a new Servicer following an Event of Default, Integra Sales is hereby designated as, and hereby agrees to perform the duties and obligations of, the Servicer pursuant to the terms hereof.  Upon the occurrence of an Event of Default, the Administrative Agent may (with the consent of the Majority Group Agents) and shall (at the direction of the Majority Group Agents) designate as Servicer any Person (including itself) to succeed Integra Sales or any successor Servicer, on the condition in each case that any such Person so designated shall agree to perform the duties and obligations of the Servicer pursuant to the terms hereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:62.34pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ii.Upon the designation of a successor Servicer as set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">clause (a) above</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, Integra Sales agrees that it will terminate its activities as Servicer hereunder in a manner that the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">77</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Administrative Agent reasonably determines will facilitate the transition of the performance of such activities to the new Servicer, and Integra Sales shall cooperate with and assist such new Servicer.  Such cooperation shall include access to and transfer of records (including all Contracts) related to Pool Receivables and use by the new Servicer of all licenses (or the obtaining of new licenses), hardware or software necessary or reasonably desirable to collect the Pool Receivables and the Related Security.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:59.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">iii.Integra Sales acknowledges that, in making its decision to execute and deliver this Agreement, the Administrative Agent and each member in each Group have relied on Integra Sales&#8217;s agreement to act as Servicer hereunder.  Accordingly, Integra Sales agrees that it will not voluntarily resign as Servicer without the prior written consent of the Administrative Agent and the Majority Group Agents, except if such activity is no longer permitted by Applicable Law, as confirmed by an opinion of counsel reasonably satisfactory to the Administrative Agent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:59.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">iv.The Servicer may delegate its duties and obligations hereunder to any subservicer (each a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Sub-Servicer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that, in each such delegation&#58; (i) such Sub-Servicer shall agree in writing to perform the delegated duties and obligations of the Servicer pursuant to the terms hereof, (ii) the Servicer shall remain liable for the performance of the duties and obligations so delegated, (iii) the Borrower, the Administrative Agent, each Lender and each Group Agent shall have the right to look solely to the Servicer for performance, (iv) the terms of any agreement with any Sub-Servicer shall provide that the Administrative Agent may terminate such agreement upon the termination of the Servicer hereunder by giving notice of its desire to terminate such agreement to the Servicer (and the Servicer shall provide appropriate notice to each such Sub-Servicer) and (v) if such Sub-Servicer is not an Affiliate of the Parent, the Administrative Agent and the Majority Group Agents shall have consented in writing in advance to such delegation.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:63pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">v.For so long as an Integra Party or an Affiliate of an Integra Party is the Servicer, the Servicer may assign its duties hereunder to any Affiliate without the consent of the Administrative Agent or any Lender.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1.0b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:30.36pt">Duties of the Servicer.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:65.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">i.The Servicer shall take or cause to be taken all such action as may be necessary or reasonably advisable to service, administer and collect each Pool Receivable from time to time, all in accordance with this Agreement and all Applicable Laws, with reasonable care and diligence, and in accordance with the Credit and Collection Procedures and consistent with the past practices of the Originators.  The Servicer shall set aside, for the accounts of each Group, the amount of Collections to which each such Group is entitled in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Article III</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> hereof.  The Servicer may, in accordance with the Credit and Collection Procedures and consistent with past practices of the Originators, take such action, including modifications, waivers or restructurings of Pool Receivables and related Contracts, as the Servicer may reasonably determine to be appropriate to maximize Collections thereof or reflect adjustments expressly permitted under the Credit and Collection Procedures or as expressly required under Applicable Laws or the applicable Contract&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that for purposes of this Agreement&#58; (i) such action shall not, and shall not be deemed to, change the number of days such Pool Receivable has remained unpaid from the date of the original due date related to such Pool Receivable, (ii) such action shall not alter the status of such Pool Receivable as a Delinquent Receivable or a Defaulted Receivable or limit the rights of any Secured Party under this Agreement or any other Transaction Document and (iii) if an Event of Default has occurred and is continuing, the Servicer may take such action only upon the prior written consent of the Administrative Agent.  The Borrower shall deliver to the Servicer and the Servicer shall hold for the benefit of the Administrative Agent (individually and for the benefit of each Group), in accordance with their respective interests, all records and documents (including computer tapes </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">78</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">or disks) with respect to each Pool Receivable. Notwithstanding anything to the contrary contained herein, if an Event of Default has occurred and is continuing, the Administrative Agent may direct the Servicer to commence or settle any legal action to enforce collection of any Pool Receivable that is a Defaulted Receivable or to foreclose upon or repossess any Related Security with respect to any such Defaulted Receivable.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:62.34pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ii.The Servicer shall, as soon as practicable following actual receipt of collected funds, turn over to the Borrower the collections of any indebtedness that is not a Pool Receivable, less, if Integra Sales or an Affiliate thereof is not the Servicer, all reasonable and appropriate out-of-pocket costs and expenses of such Servicer of servicing, collecting and administering such collections.  The Servicer, if other than Integra Sales or an Affiliate thereof, shall, as soon as practicable upon demand, deliver to the Borrower all records in its possession that evidence or relate to any indebtedness that is not a Pool Receivable, and copies of records in its possession that evidence or relate to any indebtedness that is a Pool Receivable.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:59.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">iii.The Servicer&#8217;s obligations hereunder shall terminate on the Final Payout Date.  Promptly following the Final Payout Date, the Servicer shall deliver to the Borrower all books, records and related materials that the Borrower previously provided to the Servicer, or that have been obtained by the Servicer, in connection with this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1.0c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:31.04pt">Collection Account Arrangements.  On or prior to the date set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.01(z)(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, the Borrower shall have entered into Account Control Agreements with all of the Collection Account Banks and delivered executed counterparts of each to the Administrative Agent.  Upon the occurrence and during the continuance of an Event of Default, the Administrative Agent may (with the consent of the Majority Group Agents) and shall (upon the direction of the Majority Group Agents) at any time thereafter give notice to each Collection Account Bank that the Administrative Agent is exercising its rights under the Account Control Agreements to do any or all of the following&#58; (a) to have the exclusive ownership and control of the Collection Accounts transferred to the Administrative Agent (for the benefit of the Secured Parties) and to exercise exclusive dominion and control over the funds deposited therein, (b) to have the proceeds that are sent to the respective Collection Accounts redirected pursuant to the Administrative Agent&#8217;s instructions rather than deposited in the applicable Collection Account and (c) to take any or all other actions permitted under the applicable Account Control Agreement.  The Borrower hereby agrees that if the Administrative Agent at any time takes any action set forth in the preceding sentence, the Administrative Agent shall have exclusive control (for the benefit of the Secured Parties) of the proceeds (including Collections) of all Pool Receivables and the Borrower hereby further agrees to take any other action that the Administrative Agent may reasonably request to transfer such control.  Any proceeds of Pool Receivables received by the Borrower or the Servicer thereafter shall be sent immediately to, or as otherwise instructed by, the Administrative Agent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1.0d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:30.36pt">Enforcement Rights.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:65.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">i.At any time following the occurrence and during the continuation of an Event of Default&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">the Administrative Agent (at the Borrower&#8217;s expense) may direct the Obligors that payment of all amounts payable under any Pool Receivable is to be made directly to the Administrative Agent or its designee&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">the Administrative Agent may instruct the Borrower or the Servicer to give notice of the Secured Parties&#8217; interest in Pool Receivables to each Obligor, which notice shall direct that payments be made directly to the Administrative Agent or its designee (on behalf of the Secured Parties), and the Borrower or the Servicer, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">79</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">as the case may be, shall give such notice at the expense of the Borrower or the Servicer, as the case may be&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that if the Borrower or the Servicer, as the case may be, fails to so notify each Obligor within two (2) Business Days following instruction by the Administrative Agent, the Administrative Agent (at the Borrower&#8217;s or the Servicer&#8217;s, as the case may be, expense) may so notify the Obligors&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">the Administrative Agent may request the Servicer to, and upon such request the Servicer shall&#58; (A) assemble all of the records necessary or desirable to collect the Pool Receivables and the Related Security, and transfer or license to a successor Servicer the use of all software necessary or desirable to collect the Pool Receivables and the Related Security, and make the same available to the Administrative Agent or its designee (for the benefit of the Secured Parties) at a place selected by the Administrative Agent and (B) segregate all cash, checks and other instruments received by it from time to time constituting Collections in a manner reasonably acceptable to the Administrative Agent and, promptly upon receipt, remit all such cash, checks and instruments, duly endorsed or with duly executed instruments of transfer, to the Administrative Agent or its designee&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">the Administrative Agent may notify the Collection Account Banks that the Borrower and the Servicer will no longer have any access to the Collection Accounts&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">the Administrative Agent may (or, at the direction of the Majority Group Agents shall) replace the Person then acting as Servicer&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">the Administrative Agent may collect any amounts due from an Originator under the Purchase and Sale Agreement or the Performance Guarantor under the Performance Guaranty.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:62.34pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ii.The Borrower hereby authorizes the Administrative Agent (on behalf of the Secured Parties), and irrevocably appoints the Administrative Agent as its attorney-in-fact with full power of substitution and with full authority in the place and stead of the Borrower, which appointment is coupled with an interest, to take any and all steps in the name of the Borrower and on behalf of the Borrower necessary or desirable, in the reasonable determination of the Administrative Agent, after the occurrence and during the continuation of an Event of Default, to collect any and all amounts or portions thereof due under any and all Collateral, including endorsing the name of the Borrower on checks and other instruments representing Collections and enforcing such Collateral.  Notwithstanding anything to the contrary contained in this subsection, none of the powers conferred upon such attorney-in-fact pursuant to the preceding sentence shall subject such attorney-in-fact to any liability if any action taken by it shall prove to be inadequate or invalid, nor shall they confer any obligations upon such attorney-in-fact in any manner whatsoever.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:59.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">iii.The Servicer hereby authorizes the Administrative Agent (on behalf of the Secured Parties), and irrevocably appoints the Administrative Agent as its attorney-in-fact with full power of substitution and with full authority in the place and stead of the Servicer, which appointment is coupled with an interest, to take any and all steps in the name of the Servicer and on behalf of the Servicer necessary or desirable, in the reasonable determination of the Administrative Agent, after the occurrence and during the continuation of an Event of Default, to collect any and all amounts or portions thereof due under any and all Collateral, including endorsing the name of the Servicer on checks and other instruments representing Collections and enforcing such Collateral.  Notwithstanding anything to the contrary contained in this subsection, none of the powers conferred upon such attorney-in-fact pursuant to the preceding sentence shall subject such attorney-in-fact to any liability if any action taken by it shall prove to be inadequate </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">80</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">or invalid, nor shall they confer any obligations upon such attorney-in-fact in any manner whatsoever.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1.0e.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:31.04pt">Responsibilities of the Borrower.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:65.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">i.Anything herein to the contrary notwithstanding, the Borrower shall&#58; (i) perform all of its obligations, if any, under the Contracts related to the Pool Receivables to the same extent as if interests in such Pool Receivables had not been transferred hereunder, and the exercise by the Administrative Agent, or any other Credit Party of their respective rights hereunder shall not relieve the Borrower from such obligations and (ii) pay when due any taxes, including any sales taxes payable in connection with the Pool Receivables and their creation and satisfaction. None of the Credit Parties shall have any obligation or liability with respect to any Collateral, nor shall any of them be obligated to perform any of the obligations of the Borrower, the Servicer or any Originator thereunder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:62.34pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ii.Integra Sales hereby irrevocably agrees that if at any time it shall cease to be the Servicer hereunder, it shall act (if the then-current Servicer so requests) as the data-processing agent of the Servicer and, in such capacity, Integra Sales shall conduct the data-processing functions (including but not limited to compiling and inputting data regarding the Receivables and Collections thereon and producing reports based on such data) of the administration of the Receivables and the Collections thereon in substantially the same way that Integra Sales conducted such data-processing functions while it acted as the Servicer.  In connection with any such processing functions, the Borrower shall pay to Integra Sales its reasonable out-of-pocket costs and expenses from the Borrower&#8217;s own funds (subject to the priority of payments set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1.0f.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:32.37pt">Servicing Fee.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:65.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">i.Subject to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">clause (b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> below, the Borrower shall pay the Servicer a fee (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Servicing Fee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) equal to 1.00% </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">per annum</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Servicing Fee Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) of the daily average aggregate Outstanding Balance of the Pool Receivables.  Accrued Servicing Fees shall be payable from Collections to the extent of available funds in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:62.34pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ii.If the Servicer ceases to be Integra Sales or an Affiliate thereof, the Servicing Fee shall be the greater of&#58; (i) the amount calculated pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">clause (a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> above and (ii) an alternative amount specified by the successor Servicer not to exceed 110% of the aggregate reasonable costs and expenses incurred by such successor Servicer in connection with the performance of its obligations as Servicer hereunder.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ARTICLE 9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:8.36pt"><br><br>EVENTS OF DEFAULT</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1.0a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:31.04pt">Events of Default.  If any of the following events (each an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Event of Default</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) shall occur&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:65.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">i.(i) any Integra Party shall fail to perform or observe any term, covenant or agreement under this Agreement or any other Transaction Document (other than any such failure which would constitute an Event of Default under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">clause (ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 9.01(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">), and such failure, solely to the extent capable of cure, shall continue unremedied for thirty (30) calendar days solely to the extent (A) such failure is capable of being cured (as determined by the Administrative Agent) and (B) an Integra Party provides written notice to the Administrative Agent detailing the action which it is taking in order to cure such failure, (ii) any Integra Party shall fail to make when due any payment or deposit to be made by it under this Agreement or any </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">81</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">other Transaction Document and such failure shall continue unremedied for two (2) Business Days (unless such failure is related to an Event of Default set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 9.01(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">), (iii) Integra Sales shall resign as Servicer, and no successor Servicer reasonably satisfactory to the Administrative Agent shall have been appointed or (iv) immediately upon the breach of any covenant set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.04</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> of this Agreement&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:62.34pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ii.any representation or warranty made or deemed made by an Integra Party (or any of their respective officers) under or in connection with this Agreement or any other Transaction Document or any information or report delivered by an Integra Party pursuant to this Agreement or any other Transaction Document, shall prove to have been incorrect or untrue in any material respect when made or deemed made or delivered, and, solely to the extent such breach is capable of being cured (as determined by the Administrative Agent), such breach shall continue unremedied for fifteen (15) calendar days following the earlier of (A) any Integra Party&#8217;s actual knowledge of such breach and (B) the Administrative Agent&#8217;s written notice to any Integra Party of such breach&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:59.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">iii.the Borrower or the Servicer shall fail to deliver an Information Package or Interim Report pursuant to this Agreement, and such failure shall remain unremedied for two (2) Business Days with respect to an Information Package or two (2) Business Days with respect to an Interim Report&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:59.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">iv.this Agreement or any security interest granted pursuant to this Agreement or any other Transaction Document shall for any reason cease to create, or for any reason cease to be, a valid and enforceable first priority perfected security interest in favor of the Administrative Agent with respect to the Collateral, free and clear of any Adverse Claim&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:63pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">v.any Integra Party shall generally not pay its debts as such debts become due, or shall admit in writing its inability to pay its debts generally, or shall make a general assignment for the benefit of creditors&#59; or any Insolvency Proceeding shall be instituted by or against any Integra Party and, in the case of any such proceeding instituted against such Person (but not instituted by such Person), either such proceeding shall remain undismissed or unstayed for a period of sixty (60) consecutive calendar days, or any of the actions sought in such proceeding (including the entry of an order for relief against, or the appointment of a receiver, trustee, custodian or other similar official for, it or for any substantial part of its property) shall occur&#59; or any Integra Party shall take any corporate or organizational action to authorize any of the actions set forth above in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 9.01(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:59.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">vi.(i) the average for three (3) consecutive Fiscal Months of&#58;  (A) the Default Ratio shall exceed four percent (4.00%), (B) the Delinquency Ratio shall exceed (x) during the Relief Period, eighteen percent (18.00%), and (y) at all other times, twelve percent (12.00%) or (C) the Dilution Ratio shall exceed six percent (6.00%) or (ii) the Days&#8217; Sales Outstanding shall exceed sixty five (65) calendar days&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">that</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> solely for purposes of this clause (f), Temporarily Ineligible Receivables shall be excluded from each component of the calculations used to determine compliance with the tests relating to the Default Ratio, the Delinquency Ratio, the Dilution Ratio and Days&#8217; Sales Outstanding set forth in this clause (f)&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:56.34pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">vii.a Change in Control shall occur&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:53.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">viii.a Borrowing Base Deficit shall occur, and shall not have been cured within two (2) Business Days&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:59.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ix.(i) the Borrower shall fail to pay any principal of or premium or interest on any of its Debt when the same becomes due and payable (whether by scheduled maturity, required prepayment, acceleration, demand or otherwise), and such failure shall continue after the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">82</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">applicable grace period (not to exceed thirty (30) calendar days), if any, specified in the agreement, mortgage, indenture or instrument relating to such Debt (whether or not such failure shall have been waived under the related agreement)&#59; (ii) any other Integra Party or any of their respective Subsidiaries, individually or in the aggregate, shall fail to pay any principal of or premium or interest on any of its Debt that is outstanding in a principal amount of at least fifty million dollars (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">$50,000,000) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">in the aggregate when the same becomes due and payable (whether by scheduled maturity, required prepayment, acceleration, demand or otherwise), and such failure shall continue after the applicable grace period (not to exceed thirty (30) calendar days), if any, specified in the agreement, mortgage, indenture or instrument relating to such Debt (whether or not such failure shall have been waived under the related agreement)&#59; (iii) any other event shall occur or condition shall exist under any agreement, mortgage, indenture or instrument relating to any such Debt (as referred to in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">clause (i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 9.01(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">) and shall continue after the applicable grace period (not to exceed thirty (30) calendar days), if any, specified in such agreement, mortgage, indenture or instrument (whether or not such failure shall have been waived under the related agreement), if the effect of such event or condition is to give the applicable debtholders the right (whether acted upon or not) to accelerate or permit the acceleration of the maturity of such Debt (as referred to in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">clause (i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 9.01(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">) or to terminate the commitment of any lender thereunder, or (iv) any such Debt (as referred to in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">clause (i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 9.01(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">) shall be declared to be due and payable, or required to be prepaid (other than by a regularly scheduled required prepayment), redeemed, purchased or defeased, or an offer to repay, redeem, purchase or defease such Debt shall be required to be made or the commitment of any lender thereunder terminated, in each case before the stated maturity thereof&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:63pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">x.the Performance Guarantor shall fail to perform any of its obligations under the Performance Guaranty&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:59.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">xi.the Borrower shall fail (x) at any time (other than for ten (10) Business Days following notice of the death or resignation of any Independent Director) to have an Independent Director who satisfies each requirement and qualification specified in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.03(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> of this Agreement for Independent Directors, on the Borrower&#8217;s board of directors or (y) to timely notify the Administrative Agent of any replacement or appointment of any director that is to serve as an Independent Director on the Borrower&#8217;s board of directors as required pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.03(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> of this Agreement&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:56.34pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">xii.there shall have occurred any event which materially adversely impairs, the collectibility of the Pool Receivables generally or any material portion thereof&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:53.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">xiii.either (i) the Internal Revenue Service shall file notice of a lien pursuant to Section 6323 of the Code with regard to any assets of the Borrower, any Originator or the Parent or (ii) the PBGC shall, or shall indicate its intention to, file notice of a lien pursuant to Section 4068 of ERISA with regard to any of the assets of the Borrower, the Servicer, any Originator or the Parent, and in either case with respect to any Originator or Parent, such lien shall not have been released within thirty (30) calendar days&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:53.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">xiv.(i) the occurrence of a Reportable Event with respect to a Pension Plan&#59; (ii) the adoption of an amendment to a Pension Plan that would require the provision of security pursuant to Section 401(a)(29) of the Code&#59; (iii) the existence with respect to any Multiemployer Plan of an &#8220;accumulated funding deficiency&#8221; (as defined in Section 431 of the Code or Section 304 of ERISA), whether or not waived&#59; (iv) the failure to satisfy the minimum funding standard under Section 412 of the Code with respect to any Pension Plan (v) the incurrence of any liability under Title IV of ERISA with respect to the termination of any Pension Plan or the withdrawal or partial withdrawal of any of the Borrower, any Originator, the Servicer, the Parent or any of their respective ERISA Affiliates from any Multiemployer Plan&#59; (vi) the receipt by any of the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">83</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Borrower, any Originator, the Servicer, the Parent or any of their respective ERISA Affiliates from the PBGC or any plan administrator of any notice relating to the intention to terminate any Pension Plan or Multiemployer Plan or to appoint a trustee to administer any Pension Plan or Multiemployer Plan&#59; (vii) with respect to the Borrower, any Originator, the Servicer, the Parent or any of their respective ERISA Affiliates, the imposition of Withdrawal Liability or a determination that a Multiemployer Plan is insolvent or in reorganization, within the meaning of Title IV of ERISA&#59; or (viii) the occurrence of a prohibited transaction with respect to any of the Borrower, any Originator, the Servicer, the Parent or any of their respective ERISA Affiliates (pursuant to Section 4975 of the Code)&#59; provided that, the occurrence or existence of any event or condition described in each of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">clause (i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> through (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">viii</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">) will only constitute an Event of Default if either individually or in the aggregate, it could reasonably be expected to result in a Material Adverse Effect&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:57pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">xv.a Purchase and Sale Termination Event shall occur under the Purchase and Sale Agreement&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:53.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">xvi.the Borrower shall be required to register as an &#8220;investment company&#8221; within the meaning of the Investment Company Act&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:50.34pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">xvii.any material provision of this Agreement or any other Transaction Document shall cease to be in full force and effect or any Integra Party (or any of their respective Affiliates) shall so state in writing&#59; or</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:47.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">xviii.one or more judgments or decrees shall be entered against any Integra Party or any Affiliate of any of the foregoing involving in the aggregate a liability (not paid or to the extent not covered by a reputable and solvent insurance company) and such judgments and decrees either shall be final and non-appealable or shall not be vacated, discharged or stayed or bonded pending appeal for any period of thirty (30) consecutive calendar days, and the aggregate amount of all such judgments equals or exceeds fifty million dollars ($50,000,000) (or solely with respect to the Borrower, fifteen thousand dollars ($15,000))&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">then, and in any such event, the Administrative Agent may (or, at the direction of the Majority Group Agents shall) by notice to the Borrower (x) declare the Termination Date to have occurred (in which case the Termination Date shall be deemed to have occurred), (y) declare the Final Maturity Date to have occurred (in which case the Final Maturity Date shall be deemed to have occurred) and (z) declare the Aggregate Capital and all other Borrower Obligations to be immediately due and payable (in which case the Aggregate Capital and all other Borrower Obligations shall be immediately due and payable)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that, automatically upon the occurrence of any event (without any requirement for the giving of notice) described in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">subsection (e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 9.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, the Termination Date shall occur and the Aggregate Capital and all other Borrower Obligations shall be immediately due and payable.  Upon any such declaration or designation or upon such automatic termination, the Administrative Agent and the other Secured Parties shall have, in addition to the rights and remedies which they may have under this Agreement and the other Transaction Documents, all other rights and remedies provided after default under the UCC and under other Applicable Law, which rights and remedies shall be cumulative.  Any proceeds from liquidation of the Collateral shall be applied in the order of priority set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ARTICLE 10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:2.36pt"><br><br>THE ADMINISTRATIVE AGENT</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1.0a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:31.04pt">Authorization and Action.  Each Credit Party hereby appoints and authorizes the Administrative Agent to take such action as agent on its behalf and to exercise </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">84</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">such powers under this Agreement as are delegated to the Administrative Agent by the terms hereof, together with such powers as are reasonably incidental thereto.  The Administrative Agent shall not have any duties other than those expressly set forth in the Transaction Documents, and no implied obligations or liabilities shall be read into any Transaction Document, or otherwise exist, against the Administrative Agent.  The Administrative Agent does not assume, nor shall it be deemed to have assumed, any obligation to, or relationship of trust or agency with, the Borrower or any Affiliate thereof or any Credit Party except for any obligations expressly set forth herein.  Notwithstanding any provision of this Agreement or any other Transaction Document, in no event shall the Administrative Agent ever be required to take any action which exposes the Administrative Agent to personal liability or which is contrary to any provision of any Transaction Document or Applicable Law.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1.0b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:30.36pt">Administrative Agent&#8217;s Reliance, Etc.  Neither the Administrative Agent nor any of its directors, officers, agents or employees shall be liable for any action taken or omitted to be taken by it or them as Administrative Agent under or in connection with this Agreement (including, without limitation, the Administrative Agent&#8217;s servicing, administering or collecting Pool Receivables in the event it replaces the Servicer in such capacity pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 8.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">), in the absence of its or their own gross negligence or willful misconduct.  Without limiting the generality of the foregoing, the Administrative Agent&#58; (a) may consult with legal counsel (including counsel for any Credit Party or the Servicer), independent certified public accountants and other experts selected by it and shall not be liable for any action taken or omitted to be taken in good faith by it in accordance with the advice of such counsel, accountants or experts&#59; (b) makes no warranty or representation to any Credit Party (whether written or oral) and shall not be responsible to any Credit Party for any statements, warranties or representations (whether written or oral) made by any other party in or in connection with this Agreement&#59; (c) shall not have any duty to ascertain or to inquire as to the performance or observance of any of the terms, covenants or conditions of this Agreement on the part of any Credit Party or to inspect the property (including the books and records) of any Credit Party&#59; (d) shall not be responsible to any Credit Party for the due execution, legality, validity, enforceability, genuineness, sufficiency or value of this Agreement or any other instrument or document furnished pursuant hereto&#59; and (e) shall be entitled to rely, and shall be fully protected in so relying, upon any notice (including notice by telephone), consent, certificate or other instrument or writing (which may be by facsimile) believed by it to be genuine and signed or sent by the proper party or parties.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1.0c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:31.04pt">Administrative Agent and Affiliates.  With respect to any Credit Extension or interests therein owned by any Credit Party that is also the Administrative Agent, such Credit Party shall have the same rights and powers under this Agreement as any other Credit Party and may exercise the same as though it were not the Administrative Agent.  The Administrative Agent and any of its Affiliates may generally engage in any kind of business with the Borrower or any Affiliate thereof and any Person who may do business with or own securities of the Borrower or any Affiliate thereof, all as if the Administrative Agent were not the Administrative Agent hereunder and without any duty to account therefor to any other Secured Party.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1.0d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:30.36pt">Indemnification of Administrative Agent.  Each Committed Lender agrees to indemnify the Administrative Agent (to the extent not reimbursed by the Borrower or any Affiliate thereof), ratably according to the respective Percentage of such Committed Lender, from and against any and all liabilities, obligations, losses, damages, penalties, actions, judgments, suits, costs, expenses or disbursements of any kind or nature whatsoever which may be imposed on, incurred by, or asserted against the Administrative Agent in any way relating to or arising out of this Agreement or any other Transaction Document or any action taken or omitted by the Administrative Agent under this Agreement or any other Transaction Document&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that no Committed Lender shall be liable for any portion of such liabilities, obligations, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">85</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">losses, damages, penalties, actions, judgments, suits, costs, expenses or disbursements resulting from the Administrative Agent&#8217;s gross negligence or willful misconduct.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1.0e.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:31.04pt">Delegation of Duties.  The Administrative Agent may execute any of its duties through agents or attorneys-in-fact and shall be entitled to advice of counsel concerning all matters pertaining to such duties.  The Administrative Agent shall not be responsible for the negligence or misconduct of any agents or attorneys-in-fact selected by it with reasonable care.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1.0f.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:32.37pt">Action or Inaction by Administrative Agent.  The Administrative Agent shall in all cases be fully justified in failing or refusing to take action under any Transaction Document unless it shall first receive such advice or concurrence of the Group Agents or the Majority Group Agents, as the case may be, and assurance of its indemnification by the Committed Lenders, as it deems appropriate.  The Administrative Agent shall in all cases be fully protected in acting, or in refraining from acting, under this Agreement or any other Transaction Document in accordance with a request or at the direction of the Group Agents or the Majority Group Agents, as the case may be, and such request or direction and any action taken or failure to act pursuant thereto shall be binding upon all Credit Parties.  The Credit Parties and the Administrative Agent agree that unless any action to be taken by the Administrative Agent under a Transaction Document (i) specifically requires the advice or concurrence of all Group Agents or (ii) may be taken by the Administrative Agent alone or without any advice or concurrence of any Group Agent, then the Administrative Agent may take action based upon the advice or concurrence of the Majority Group Agents.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1.0g.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:30.36pt">Notice of Events of Default&#59; Action by Administrative Agent.  The Administrative Agent shall not be deemed to have knowledge or notice of the occurrence of any Unmatured Event of Default or Event of Default unless the Administrative Agent has received notice from any Credit Party or the Borrower stating that an Unmatured Event of Default or Event of Default has occurred hereunder and describing such Unmatured Event of Default or Event of Default.  If the Administrative Agent receives such a notice, it shall promptly give notice thereof to each Group Agent, whereupon each Group Agent shall promptly give notice thereof to its respective Conduit Lender(s) and Related Committed Lender(s).  The Administrative Agent may (but shall not be obligated to) take such action, or refrain from taking such action, concerning an Unmatured Event of Default or Event of Default or any other matter hereunder as the Administrative Agent deems advisable and in the best interests of the Secured Parties.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1.0h.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:30.36pt">Non-Reliance on Administrative Agent and Other Parties.  Each Credit Party expressly acknowledges that neither the Administrative Agent nor any of its directors, officers, agents or employees has made any representations or warranties to it and that no act by the Administrative Agent hereafter taken, including any review of the affairs of the Borrower or any Affiliate thereof, shall be deemed to constitute any representation or warranty by the Administrative Agent.  Each Credit Party represents and warrants to the Administrative Agent that, independently and without reliance upon the Administrative Agent or any other Credit Party and based on such documents and information as it has deemed appropriate, it has made and will continue to make its own appraisal of, and investigation into, the business, operations, property, prospects, financial and other conditions and creditworthiness of each Integra Party and the Pool Receivables and its own decision to enter into this Agreement and to take, or omit, action under any Transaction Document.  Except for items expressly required to be delivered under any Transaction Document by the Administrative Agent to any Credit Party, the Administrative Agent shall not have any duty or responsibility to provide any Credit Party with any information concerning any Integra Party that comes into the possession of the Administrative Agent or any of its directors, officers, agents, employees, attorneys-in-fact or Affiliates.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">86</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1.0i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:33.03pt">Successor Administrative Agent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:65.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">i.The Administrative Agent may, upon at least thirty (30) calendar days&#8217; notice to the Borrower, the Servicer and each Group Agent, resign as Administrative Agent.  Except as provided below, such resignation shall not become effective until a successor Administrative Agent is appointed by the Majority Group Agents as a successor Administrative Agent and has accepted such appointment.  If no successor Administrative Agent shall have been so appointed by the Majority Group Agents, within thirty (30) calendar days after the departing Administrative Agent&#8217;s giving of notice of resignation, the departing Administrative Agent may, on behalf of the Secured Parties, appoint a successor Administrative Agent as successor Administrative Agent.  If no successor Administrative Agent shall have been so appointed by the Majority Group Agents within sixty (60) calendar days after the departing Administrative Agent&#8217;s giving of notice of resignation, the departing Administrative Agent may, on behalf of the Secured Parties, petition a court of competent jurisdiction to appoint a successor Administrative Agent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:62.34pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ii.Upon such acceptance of its appointment as Administrative Agent hereunder by a successor Administrative Agent, such successor Administrative Agent shall succeed to and become vested with all the rights and duties of the resigning Administrative Agent, and the resigning Administrative Agent shall be discharged from its duties and obligations under the Transaction Documents.  After any resigning Administrative Agent&#8217;s resignation hereunder, the provisions of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Article X</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Article XII</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> shall inure to its benefit as to any actions taken or omitted to be taken by it while it was the Administrative Agent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1.j.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:3.03pt">Structuring Agent.  Each of the parties hereto hereby acknowledges and agrees that the Structuring Agent shall not have any right, power, obligation, liability, responsibility or duty under this Agreement, other than the Structuring Agent&#8217;s right to receive fees pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.03</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> and expenses (if any) pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 13.04</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Each Credit Party acknowledges that it has not relied, and will not rely, on the Structuring Agent in deciding to enter into this Agreement and to take, or omit to take, any action under any Transaction Document.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1.k.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:0.36pt">Erroneous Payment.</font></div><div style="margin-bottom:12pt;padding-left:13.5pt;text-align:justify;text-indent:65.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.5pt">Each Lender hereby agrees that (i) if the Administrative Agent notifies such Lender that the Administrative Agent has determined in its sole discretion that any funds received by such Lender from the Administrative Agent or any of its Affiliates were erroneously transmitted to, or otherwise erroneously or mistakenly received by, such Lender (whether or not known to such Lender (whether as a payment, prepayment or repayment of principal, interest, fees or otherwise), individually and collectively, an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Erroneous Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) and demands the return of such Erroneous Payment (or a portion thereof), such Lender shall promptly, but in no event later than one Business Day thereafter, return to the Administrative Agent the amount of any such Erroneous Payment (or portion thereof) as to which such a demand was made, in same day funds (in the currency so received), together with interest thereon in respect of each day from and including the date such Erroneous Payment (or portion thereof) was received by such Lender to the date such amount is repaid to the Administrative Agent in same day funds at the greater of the Overnight Bank Funding Rate and a rate determined by the Administrative Agent in accordance with banking industry rules on interbank compensation from time to time in effect, and (ii) such Lender shall not assert any right or claim to the Erroneous Payment, and hereby waives any claim, counterclaim, defense or right of set-off or recoupment with respect to any demand, claim or counterclaim by the Administrative Agent for the return of any Erroneous Payments received, including without limitation waiver of any defense based on &#8220;discharge for value&#8221; or any similar </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">87</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:13.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">doctrine.  A notice of the Administrative Agent to any Lender under this clause (a) shall be conclusive, absent manifest error.</font></div><div style="margin-bottom:12pt;padding-left:13.5pt;text-align:justify;text-indent:62.34pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.5pt">Without limiting immediately preceding clause (a), each Lender hereby further agrees that if it receives an Erroneous Payment from the Administrative Agent (or any of its Affiliates) (i) that is in an amount different than (other than a de minimis difference), or on a different date from, that specified in a notice of payment sent by the Administrative Agent (or any of its Affiliates) with respect to such Erroneous Payment (an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Erroneous Payment Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), or (ii) that was not preceded or accompanied by an Erroneous Payment Notice, it shall be on notice that, in each such case, an error has been made with respect to such Erroneous Payment.  Each Lender further agrees that, in each such case, or if it otherwise becomes aware an Erroneous Payment (or portion thereof) may have been sent in error, such Lender shall promptly notify the Administrative Agent of such occurrence and, upon demand from the Administrative Agent, it shall promptly, but in no event later than one (1) Business Day thereafter, return to the Administrative Agent the amount of any such Erroneous Payment (or portion thereof) that was received by such Lender to the date such amount is repaid to the Administrative Agent in same day funds at the greater of the Overnight Bank Funding Rate and a rate determined by the Administrative Agent in accordance with banking industry rules on interbank compensation from time to time in effect.</font></div><div style="margin-bottom:12pt;padding-left:13.5pt;text-align:justify;text-indent:59.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">iii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.5pt">The Borrower and the Servicer hereby agree that (i) in the event an Erroneous Payment (or portion thereof) is not recovered from any Lender that has received such Erroneous Payment (or portion thereof) for any reason, the Administrative Agent shall be subrogated to all the rights of such Lender with respect to such amount and (ii) an Erroneous Payment shall not pay, prepay, repay, discharge or otherwise satisfy any Obligations owed by the Borrower or the Servicer.</font></div><div style="margin-bottom:12pt;padding-left:13.5pt;text-align:justify;text-indent:59.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">iv.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.5pt">Each party&#8217;s obligations under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 10.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> shall survive the resignation or replacement of the Administrative Agent or any transfer of rights or obligations by, or the replacement of, a Lender, the termination of the Commitments or the repayment, satisfaction or discharge of all Borrower Obligations (or any portion thereof) and the Servicer&#8217;s obligations (or any portion thereof) under any Transaction Document.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ARTICLE 11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:2.36pt"><br><br>THE GROUP AGENTS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1.0a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:31.04pt">Authorization and Action.  Each Credit Party that belongs to a Group hereby appoints and authorizes the Group Agent for such Group to take such action as agent on its behalf and to exercise such powers under this Agreement as are delegated to such Group Agent by the terms hereof, together with such powers as are reasonably incidental thereto.  No Group Agent shall have any duties other than those expressly set forth in the Transaction Documents, and no implied obligations or liabilities shall be read into any Transaction Document, or otherwise exist, against any Group Agent.  No Group Agent assumes, nor shall it be deemed to have assumed, any obligation to, or relationship of trust or agency with the Borrower or any Affiliate thereof, any Lender except for any obligations expressly set forth herein.  Notwithstanding any provision of this Agreement or any other Transaction Document, in no event shall any Group Agent ever be required to take any action which exposes such Group Agent to personal liability or which is contrary to any provision of any Transaction Document or Applicable Law.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1.0b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:30.36pt">Group Agent&#8217;s Reliance, Etc.  No Group Agent nor any of its directors, officers, agents or employees shall be liable for any action taken or omitted to be taken by it or them as a Group Agent under or in connection with this Agreement or any other </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">88</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Transaction Documents in the absence of its or their own gross negligence or willful misconduct.  Without limiting the generality of the foregoing, a Group Agent&#58; (a) may consult with legal counsel (including counsel for the Administrative Agent, the Borrower or the Servicer), independent certified public accountants and other experts selected by it and shall not be liable for any action taken or omitted to be taken in good faith by it in accordance with the advice of such counsel, accountants or experts&#59; (b) makes no warranty or representation to any Credit Party (whether written or oral) and shall not be responsible to any Credit Party for any statements, warranties or representations (whether written or oral) made by any other party in or in connection with this Agreement or any other Transaction Document&#59; (c) shall not have any duty to ascertain or to inquire as to the performance or observance of any of the terms, covenants or conditions of this Agreement or any other Transaction Document on the part of the Borrower or any Affiliate thereof or any other Person or to inspect the property (including the books and records) of the Borrower or any Affiliate thereof&#59; (d) shall not be responsible to any Credit Party for the due execution, legality, validity, enforceability, genuineness, sufficiency or value of this Agreement, any other Transaction Documents or any other instrument or document furnished pursuant hereto&#59; and (e)&#160;shall be entitled to rely, and shall be fully protected in so relying, upon any notice (including notice by telephone), consent, certificate or other instrument or writing (which may be by facsimile) believed by it to be genuine and signed or sent by the proper party or parties.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1.0c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:31.04pt">Group Agent and Affiliates.  With respect to any Credit Extension or interests therein owned by any Credit Party that is also a Group Agent, such Credit Party shall have the same rights and powers under this Agreement as any other Lender and may exercise the same as though it were not a Group Agent.  A Group Agent and any of its Affiliates may generally engage in any kind of business with the Borrower or any Affiliate thereof and any Person who may do business with or own securities of the Borrower or any Affiliate thereof or any of their respective Affiliates, all as if such Group Agent were not a Group Agent hereunder and without any duty to account therefor to any other Secured Party.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1.0d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:30.36pt">Indemnification of Group Agents.  Each Committed Lender in any Group agrees to indemnify the Group Agent for such Group (to the extent not reimbursed by the Borrower or any Affiliate thereof), ratably according to the proportion of the Percentage of such Committed Lender to the aggregate Percentages of all Committed Lenders in such Group, from and against any and all liabilities, obligations, losses, damages, penalties, actions, judgments, suits, costs, expenses or disbursements of any kind or nature whatsoever which may be imposed on, incurred by, or asserted against such Group Agent in any way relating to or arising out of this Agreement or any other Transaction Document or any action taken or omitted by such Group Agent under this Agreement or any other Transaction Document&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that no Committed Lender shall be liable for any portion of such liabilities, obligations, losses, damages, penalties, actions, judgments, suits, costs, expenses or disbursements resulting from such Group Agent&#8217;s gross negligence or willful misconduct.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1.0e.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:31.04pt">Delegation of Duties.  Each Group Agent may execute any of its duties through agents or attorneys-in-fact and shall be entitled to advice of counsel concerning all matters pertaining to such duties.  No Group Agent shall be responsible for the negligence or misconduct of any agents or attorneys-in-fact selected by it with reasonable care.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1.0f.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:32.37pt">Notice of Events of Default.  No Group Agent shall be deemed to have knowledge or notice of the occurrence of any Unmatured Event of Default or Event of Default unless such Group Agent has received notice from the Administrative Agent, any other Group Agent, any other Credit Party, the Servicer or the Borrower stating that an Unmatured Event of Default or Event of Default has occurred hereunder and describing such Unmatured Event of Default or Event of Default.  If a Group Agent receives such a notice, it shall promptly give notice thereof to the Credit Parties in its Group and to the Administrative Agent (but only if </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">89</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">such notice received by such Group Agent was not sent by the Administrative Agent).  A Group Agent may take such action concerning an Unmatured Event of Default or Event of Default as may be directed by Committed Lenders in its Group representing a majority of the Commitments in such Group (subject to the other provisions of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Article XI</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">), but until such Group Agent receives such directions, such Group Agent may (but shall not be obligated to) take such action, or refrain from taking such action, as such Group Agent deems advisable and in the best interests of the Conduit Lenders and Committed Lenders in its Group.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1.0g.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:30.36pt">Non-Reliance on Group Agent and Other Parties.  Each Credit Party expressly acknowledges that neither the Group Agent for its Group nor any of such Group Agent&#8217;s directors, officers, agents or employees has made any representations or warranties to it and that no act by such Group Agent hereafter taken, including any review of the affairs of the Borrower or any Affiliate thereof, shall be deemed to constitute any representation or warranty by such Group Agent.  Each Credit Party represents and warrants to the Group Agent for its Group that, independently and without reliance upon such Group Agent, any other Group Agent, the Administrative Agent or any other Credit Party and based on such documents and information as it has deemed appropriate, it has made and will continue to make its own appraisal of, and investigation into, the business, operations, property, prospects, financial and other conditions and creditworthiness of the Borrower or any Affiliate thereof and the Receivables and its own decision to enter into this Agreement and to take, or omit, action under any Transaction Document.  Except for items expressly required to be delivered under any Transaction Document by a Group Agent to any Credit Party in its Group, no Group Agent shall have any duty or responsibility to provide any Credit Party in its Group with any information concerning the Borrower or any Affiliate thereof that comes into the possession of such Group Agent or any of its directors, officers, agents, employees, attorneys-in-fact or Affiliates.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1.0h.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:30.36pt">Successor Group Agent.  Any Group Agent may, upon at least thirty (30) days&#8217; notice to the Administrative Agent, the Borrower, the Servicer and the Credit Parties in its Group, resign as Group Agent for its Group.  Such resignation shall not become effective until a successor Group Agent is appointed by the Lender(s) in such Group.  Upon such acceptance of its appointment as Group Agent for such Group hereunder by a successor Group Agent, such successor Group Agent shall succeed to and become vested with all the rights and duties of the resigning Group Agent, and the resigning Group Agent shall be discharged from its duties and obligations under the Transaction Documents.  After any resigning Group Agent&#8217;s resignation hereunder, the provisions of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Article XI</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Article XII</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> shall inure to its benefit as to any actions taken or omitted to be taken by it while it was a Group Agent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1.0i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:33.03pt">Reliance on Group Agent.  Unless otherwise advised in writing by a Group Agent or by any Credit Party in such Group Agent&#8217;s Group, each party to this Agreement may assume that (i) such Group Agent is acting for the benefit and on behalf of each of the Credit Parties in its Group, as well as for the benefit of each assignee or other transferee from any such Person and (ii) each action taken by such Group Agent has been duly authorized and approved by all necessary action on the part of the Credit Parties in its Group.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ARTICLE 12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:2.36pt"><br><br>INDEMNIFICATION</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1.0a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:31.04pt">Indemnities by the Borrower.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:65.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">i.Without limiting any other rights that the Administrative Agent, the Credit Parties, the Affected Persons and their respective assigns, officers, directors, agents and employees (each, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Borrower Indemnified Party</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) may have hereunder or under Applicable Law, the Borrower hereby agrees to indemnify each Borrower Indemnified Party from and </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">90</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">against any and all claims, expenses, damages, losses and liabilities suffered or sustained (including Attorney Costs) (all of the foregoing being collectively referred to as &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Borrower Indemnified Amounts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) arising out of, relating to or in connection this Agreement or any other Transaction Document or the use of proceeds of the Credit Extensions or the security interest in respect of any Pool Receivable or any other Collateral&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">excluding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, (x) Borrower Indemnified Amounts to the extent a final non-appealable judgment of a court of competent jurisdiction holds that such Borrower Indemnified Amounts resulted solely from the gross negligence, bad faith, willful misconduct by the Borrower Indemnified Party seeking indemnification, (y) Borrower Indemnified Amounts to the extent a final non-appealable judgment of a court of competent jurisdiction holds that such Borrower Indemnified Amounts resulted solely from a material breach of a Transaction Document by the Borrower Indemnified Party seeking indemnification and (z) Taxes that are covered by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 4.03</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Without limiting or being limited by the foregoing, the Borrower shall pay on demand (it being understood that if any portion of such payment obligation is made from Collections, such payment will be made at the time and in the order of priority set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">), to each Borrower Indemnified Party any and all amounts necessary to indemnify such Borrower Indemnified Party from and against any and all Borrower Indemnified Amounts relating to or resulting from any of the following (but excluding Borrower Indemnified Amounts and Taxes described in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">clauses (x)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">(y)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">(z)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> above)&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">any Pool Receivable which the Borrower or the Servicer includes as an Eligible Receivable as part of the Net Receivables Pool Balance but which is not an Eligible Receivable at such time&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">any representation, warranty or statement made or deemed made by the Borrower (or any of its respective officers) under or in connection with this Agreement, any of the other Transaction Documents, any Information Package, Interim Report or any other information or report delivered by or on behalf of the Borrower pursuant hereto which shall have been untrue or incorrect when made or deemed made&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">the failure by the Borrower to comply with any Applicable Law with respect to any Pool Receivable or the related Contract&#59; or the failure of any Pool Receivable or the related Contract to conform to any such Applicable Law&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">the failure to vest in the Administrative Agent a first priority perfected security interest in all or any portion of the Collateral, in each case free and clear of any Adverse Claim&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">the failure to have filed, or any delay in filing, financing statements, financing statement amendments, continuation statements or other similar instruments or documents under the UCC of any applicable jurisdiction or other Applicable Laws with respect to any Pool Receivable and the other Collateral and Collections in respect thereof, whether at the time of any Credit Extension or at any subsequent time&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">any dispute, claim or defense (other than discharge in bankruptcy), of an Obligor to the payment of any Pool Receivable (including, without limitation, a defense based on such Pool Receivable or the related Contract not being a legal, valid and binding obligation of such Obligor enforceable against it in accordance with its terms), or any other claim resulting from or relating to collection activities with respect to such Pool Receivable&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">any failure of the Borrower to perform any of its duties or obligations in accordance with the provisions hereof and of each other Transaction </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">91</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Document related to Pool Receivables or to timely and fully comply with the Credit and Collection Procedures in regard to each Pool Receivable&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">any products liability, environmental or other claim arising out of or in connection with any Pool Receivable or other merchandise, goods or services which are the subject of or related to any Pool Receivable&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">the commingling of Collections of Pool Receivables at any time with other funds&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt">any investigation, litigation or proceeding (actual or threatened) related to this Agreement or any other Transaction Document or the use of proceeds of any Credit Extensions or in respect of any Pool Receivable or other Collateral or any related Contract&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt">any failure of the Borrower to comply with its covenants, obligations and agreements contained in this Agreement or any other Transaction Document&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">12.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt">any offset, setoff, adjustment, or other non-cash reduction of any Pool Receivable (including Deemed Collections) not arising from the bankruptcy or insolvency, lack of creditworthiness or other financial default or inability to pay of the related Obligor any undisputed indebtedness&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">13.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt">any claim brought by any Person other than a Borrower Indemnified Party arising from any activity by the Borrower or any Affiliate of the Borrower in servicing, administering or collecting any Pool Receivable&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">14.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt">the failure by the Borrower to pay when due any taxes, including, without limitation, sales, excise or personal property taxes&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">15.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt">any failure of a Collection Account Bank to comply with the terms of the applicable Account Control Agreement, the termination by a Collection Account Bank prior to the appointment of a successor collection account bank or any amounts payable by the Administrative Agent to a Collection Account Bank under any Account Control Agreement&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">16.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt">any dispute, claim, offset or defense (other than discharge in bankruptcy of the Obligor) of the Obligor to the payment of any Pool Receivable (including, without limitation, a defense based on such Pool Receivable or the related Contract not being a legal, valid and binding obligation of such Obligor enforceable against it in accordance with its terms), or any other claim resulting from the sale of goods or the rendering of services related to such Pool Receivable or the furnishing or failure to furnish any such goods or services or other similar claim or defense not arising from the financial inability of any Obligor to pay undisputed indebtedness&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">17.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt">any action taken by the Administrative Agent as attorney-in-fact for the Borrower, any Originator or the Servicer pursuant to this Agreement or any other Transaction Document&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">18.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt">the use of proceeds of any Credit Extension&#59; </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">92</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">19.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt">any reduction in Capital as a result of the distribution of Collections if all or a portion of such distributions shall thereafter be rescinded or otherwise must be returned for any reason&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">20.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt">any failure by any Originator to provide an Obligor with an invoice evidencing indebtedness related to a Pool Receivable&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">21.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt">payment, prepayment, conversion or renewal of any Loan to which a Term SOFR Option or Daily SOFR Option applies on a day other than the last day of the corresponding Interest Period (whether or not any such payment or prepayment is mandatory, voluntary or automatic and whether or not any such payment or prepayment is then due)&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">22.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt">any assignment of a Loan under the Term SOFR Option or the Daily SOFR Rate Option on a day other than the last day of the Interest Period therefor as a result of a request by the Borrower pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 4.01(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:62.34pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ii.Notwithstanding anything to the contrary in this Agreement, solely for purposes of the Borrower&#8217;s indemnification obligations in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">clauses (ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">(vii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">(xi)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Article XII</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, any representation, warranty or covenant qualified by the occurrence or non-occurrence of a material adverse effect or similar concepts of materiality shall be deemed to be not so qualified.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:59.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">iii.If for any reason the foregoing indemnification is unavailable to any Borrower Indemnified Party or insufficient to hold it harmless, then the Borrower shall contribute to such Borrower Indemnified Party the amount paid or payable by such Borrower Indemnified Party as a result of such loss, claim, damage or liability in such proportion as is appropriate to reflect the relative economic interests of the Borrower and its Affiliates on the one hand and such Borrower Indemnified Party on the other hand in the matters contemplated by this Agreement as well as the relative fault of the Borrower and its Affiliates and such Borrower Indemnified Party with respect to such loss, claim, damage or liability and any other relevant equitable considerations.  The reimbursement, indemnity and contribution obligations of the Borrower under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 12.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> shall be in addition to any liability which the Borrower may otherwise have, shall extend upon the same terms and conditions to each Borrower Indemnified Party, and shall be binding upon and inure to the benefit of any successors, assigns, heirs and personal representatives of the Borrower and the Borrower Indemnified Parties.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:59.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">iv.Any indemnification or contribution under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 12.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> shall survive the termination of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1.0b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:30.36pt">Indemnification by the Servicer.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:65.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">i.The Servicer hereby agrees to indemnify and hold harmless the Borrower, the Administrative Agent, the Credit Parties, the Affected Persons and their respective assigns, officers, directors, agents and employees (each, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Servicer Indemnified Party</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), from and against any and all claims, expenses, damages, losses and liabilities suffered or sustained by reason of any acts, omissions or alleged acts or omissions arising out of activities of the Servicer pursuant to this Agreement or any other Transaction Document, including any judgment, award, settlement, Attorney Costs and other costs or expenses incurred in connection with the defense of any actual or threatened action, proceeding or claim (all of the foregoing being collectively referred to as, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Servicer Indemnified Amounts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;)&#59; excluding (w) Servicer Indemnified Amounts to the extent a final non-appealable judgment of a court of competent jurisdiction holds that such Servicer Indemnified Amounts resulted solely from the gross negligence, bad faith or willful misconduct by the Servicer Indemnified Party seeking indemnification, (x) Servicer Indemnified Amounts to the extent a final non-appealable judgment of a court of competent jurisdiction holds </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">93</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">that such Servicer Indemnified Amounts resulted solely from a material breach of a Transaction Document by the Servicer Indemnified Party seeking indemnification, (y) Taxes that are covered by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 4.03</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> and (z) Servicer Indemnified Amounts to the extent the same includes losses in respect of Pool Receivables that are uncollectible solely on account of the insolvency, bankruptcy, lack of creditworthiness or other financial inability to pay of the related Obligor.  Without limiting or being limited by the foregoing, the Servicer shall pay on demand, to each Servicer Indemnified Party any and all amounts necessary to indemnify such Servicer Indemnified Party from and against any and all Servicer Indemnified Amounts relating to or resulting from any of the following (but excluding Servicer Indemnified Amounts described in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">clauses (z)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">(y)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">(z)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> above)&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">any representation, warranty or statement made or deemed made by the Servicer (or any of its respective officers) under or in connection with this Agreement, any of the other Transaction Documents, any Information Package, Interim Report or any other information or report delivered by or on behalf of the Servicer pursuant hereto which shall have been untrue or incorrect when made or deemed made&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">the failure by the Servicer to comply with any Applicable Law with respect to any Pool Receivable or the related Contract&#59; or the failure of any Pool Receivable or the related Contract to conform to any such Applicable Law&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">the commingling of Collections of Pool Receivables at any time with other funds&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">any failure of the Servicer to comply with its covenants, obligations and agreements contained in this Agreement or any other Transaction Document (including, without limitation, the failure or delay by the Servicer to provide, or cause the applicable Originator to provide, any Obligor with an invoice or other evidence of Indebtedness related to a Pool Receivable). </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:62.34pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ii.If for any reason the foregoing indemnification is unavailable to any Servicer Indemnified Party or insufficient to hold it harmless, then the Servicer shall contribute to the amount paid or payable by such Servicer Indemnified Party as a result of such loss, claim, damage or liability in such proportion as is appropriate to reflect the relative economic interests of the Servicer and its Affiliates on the one hand and such Servicer Indemnified Party on the other hand in the matters contemplated by this Agreement as well as the relative fault of the Servicer and its Affiliates and such Servicer Indemnified Party with respect to such loss, claim, damage or liability and any other relevant equitable considerations.  The reimbursement, indemnity and contribution obligations of the Servicer under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 12.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> shall be in addition to any liability which the Servicer may otherwise have, shall extend upon the same terms and conditions to Servicer Indemnified Party, and shall be binding upon and inure to the benefit of any successors, assigns, heirs and personal representatives of the Servicer and the Servicer Indemnified Parties.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:59.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">iii.Any indemnification or contribution under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 12.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> shall survive the termination of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ARTICLE 13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:2.36pt"><br><br>MISCELLANEOUS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1.0a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:31.04pt">Amendments, Etc.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">94</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No failure on the part of any Credit Party to exercise, and no delay in exercising, any right hereunder shall operate as a waiver thereof&#59; nor shall any single or partial exercise of any right hereunder preclude any other or further exercise thereof or the exercise of any other right.  No amendment or waiver of any provision of this Agreement or consent to any departure by any of the Borrower or any Affiliate thereof shall be effective unless in a writing signed by the Administrative Agent and the Majority Group Agents (and, in the case of any amendment, also signed by the Borrower), and then such amendment, waiver or consent shall be effective only in the specific instance and for the specific purpose for which given&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that (A) no amendment, waiver or consent shall, unless in writing and signed by the Servicer, affect the rights or duties of the Servicer under this Agreement&#59; (B) no amendment, waiver or consent shall, unless in writing and signed by the Administrative Agent and each Group Agent&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:65.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">i.change (directly or indirectly) the definitions of, Borrowing Base Deficit, Defaulted Receivable, Delinquent Receivable, Eligible Receivable, Facility Limit, Final Maturity Date, Net Receivables Pool Balance, Adjusted Net Receivables Pool Balance or Total Reserves contained in this Agreement, or increase the then existing Concentration Percentage for any Obligor or change the calculation of the Borrowing Base&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:62.34pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ii.reduce the amount of Capital or Interest or any Fee that is payable on account of any Loan or with respect to any other Credit Extension or delay any scheduled date for payment thereof&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:59.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">iii.change any Event of Default&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:59.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">iv.release all or a material portion of the Collateral from the Administrative Agent&#8217;s security interest created hereunder&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:63pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">v.release the Performance Guarantor from any of its obligations under the Performance Guaranty or terminate the Performance Guaranty&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:59.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">vi.change any of the provisions of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 13.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> or the definition of &#8220;Majority Group Agents&#8221;&#59; or</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:56.34pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">vii.change the order of priority in which Collections are applied pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Notwithstanding the foregoing, (i) no amendment, waiver or consent shall increase any Committed Lender&#8217;s Commitment hereunder without the consent of such Committed Lender and (ii) no amendment, waiver or consent shall reduce any Fees payable by the Borrower to any member of any Group or delay the dates on which any such Fees are payable, in either case, without the consent of the Group Agent for such Group and (iii) no consent with respect to any amendment, waiver or other modification of this Agreement shall be required of any Defaulting Lender, except with respect to any amendment, waiver or other modification referred to in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">clauses (i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> through </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">(vii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> above and then only in the event such Defaulting Lender shall be directly affected by such amendment, waiver or other modification.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1.0b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:34.86pt">Notices, Etc.  All notices and other communications hereunder shall, unless otherwise stated herein, be in writing (which shall include facsimile communication) and faxed or delivered, to each party hereto, at its address set forth under its name on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule III</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> hereto or at such other address as shall be designated by such party in a written notice to the other parties hereto.  Notices and communications by facsimile shall be effective when sent (and shall be followed by hard copy sent by regular mail), and notices and communications sent by other means shall be effective when received.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">95</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1.0c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:35.54pt">Assignability&#59; Addition of Lenders&#59; Removal of Lenders.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:65.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Assignment by Conduit Lenders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  This Agreement and the rights of each Conduit Lender hereunder (including each Loan made by it hereunder) shall be assignable by such Conduit Lender and its successors and permitted assigns (i) to any Program Support Provider of such Conduit Lender without prior notice to or consent from the Borrower or any other party, or any other condition or restriction of any kind, (ii)  to any other Lender with prior notice to the Borrower but without consent from the Borrower or (iii) with the prior written consent of the Borrower (such consent not to be unreasonably withheld, conditioned or delayed&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that such consent shall not be required if an Event of Default or Unmatured Event of Default has occurred and is continuing), to any other Eligible Assignee.  Each assignor of a Loan or any interest therein may, in connection with the assignment or participation, disclose to the assignee or Participant any information relating to the Borrower and its Affiliates, including the Receivables, furnished to such assignor by or on behalf of the Borrower and its Affiliates or by the Administrative Agent&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that, prior to any such disclosure, the assignee or Participant agrees to preserve the confidentiality of any confidential information relating to the Borrower and its Affiliates received by it from any of the foregoing entities in a manner consistent with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 13.06(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:62.34pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Assignment by Committed Lenders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Each Committed Lender may assign to any Eligible Assignee or to any other Committed Lender all or a portion of its rights and obligations under this Agreement (including, without limitation, all or a portion of its Commitment and any Loan or interests therein owned by it)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">except for an assignment by a Committed Lender to either an Affiliate of such Committed Lender or any other Committed Lender, each such assignment shall require the prior written consent of the Borrower (such consent not to be unreasonably withheld, conditioned or delayed&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that such consent shall not be required if an Event of Default or an Unmatured Event of Default has occurred and is continuing)&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">each such assignment shall be of a constant, and not a varying, percentage of all rights and obligations under this Agreement&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">the amount being assigned pursuant to each such assignment (determined as of the date of the Assignment and Acceptance Agreement with respect to such assignment) shall in no event be less than the lesser of (x) five million dollars ($5,000,000) and (y) all of the assigning Committed Lender&#8217;s Commitment&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">the parties to each such assignment shall execute and deliver to the Administrative Agent, for its acceptance and recording in the Register, an Assignment and Acceptance Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Upon such execution, delivery, acceptance and recording from and after the effective date specified in such Assignment and Acceptance Agreement, (x) the assignee thereunder shall be a party to this Agreement, and to the extent that rights and obligations under this Agreement have been assigned to it pursuant to such Assignment and Acceptance Agreement, have the rights and obligations of a Committed Lender hereunder and (y) the assigning Committed Lender shall, to the extent that rights and obligations have been assigned by it pursuant to such Assignment and Acceptance Agreement, relinquish such rights and be released from such obligations under this Agreement (and, in the case of an Assignment and Acceptance Agreement covering all or the remaining portion of an assigning Committed Lender&#8217;s rights and obligations under this Agreement, such Committed Lender shall cease to be a party hereto).</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">96</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:59.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">iii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Register</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Administrative Agent shall, acting solely for this purpose as an agent of the Borrower, maintain at its address referred to on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule III</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> of this Agreement (or such other address of the Administrative Agent notified by the Administrative Agent to the other parties hereto) a copy of each Assignment and Acceptance Agreement delivered to and accepted by it and a register for the recordation of the names and addresses of the Committed Lenders and the Conduit Lenders, the Commitment of each Committed Lender and the aggregate outstanding Capital (and stated interest) of the Loans of each Conduit Lender and Committed Lender from time to time (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Register</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).  The entries in the Register shall be conclusive and binding for all purposes, absent manifest error, and the Borrower, the Servicer, the Administrative Agent, the Group Agents, and the other Credit Parties may treat each Person whose name is recorded in the Register as a Committed Lender or Conduit Lender, as the case may be, under this Agreement for all purposes of this Agreement.  The Register shall be available for inspection by the Borrower, the Servicer, any Group Agent, any Conduit Lender or any Committed Lender at any reasonable time and from time to time upon reasonable prior notice.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:59.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">iv.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Procedure</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Upon its receipt of an Assignment and Acceptance Agreement executed and delivered by an assigning Committed Lender and an Eligible Assignee or assignee Committed Lender, the Administrative Agent shall, if such Assignment and Acceptance Agreement has been duly completed, (i) accept such Assignment and Acceptance Agreement, (ii) record the information contained therein in the Register and (iii) give prompt notice thereof to the Borrower and the Servicer.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:63pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">v.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Participations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Each Committed Lender may sell participations to one or more Eligible Assignees (each, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Participant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) in or to all or a portion of its rights and&#47;or obligations under this Agreement (including, without limitation, all or a portion of its Commitment and the interests in the Loans owned by it)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">such Committed Lender&#8217;s obligations under this Agreement (including, without limitation, its Commitment to the Borrower hereunder) shall remain unchanged, and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">such Committed Lender shall remain solely responsible to the other parties to this Agreement for the performance of such obligations.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Administrative Agent, the Group Agents, the Conduit Lenders, the other Committed Lenders, the Borrower and the Servicer shall have the right to continue to deal solely and directly with such Committed Lender in connection with such Committed Lender&#8217;s rights and obligations under this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:59.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">vi.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Participant Register.  Each Committed Lender that sells a participation shall, acting solely for this purpose as an agent of the Borrower, maintain a register on which it enters the name and address of each Participant and the principal amounts (and stated interest) of each Participant&#8217;s interest in the Loans or other obligations under this Agreement (the &#8220;Participant Register&#8221;)&#59; provided that no Committed Lender shall have any obligation to disclose all or any portion of the Participant Register (including the identity of any Participant or any information relating to a Participant&#8217;s interest in any Commitments, Loans or its other obligations under any this Agreement) to any Person except to the extent that such disclosure is necessary to establish that such Commitment, Loan or other obligation is in registered form under Section 5f.103-1(c) of the United States Treasury Regulations.  The entries in the Participant Register shall be conclusive absent manifest error, and such Committed Lender shall treat each Person whose name is recorded in the Participant Register as the owner of such participation for all purposes of this Agreement notwithstanding any notice to the contrary.  For the avoidance of doubt, the Administrative Agent (in its capacity as Administrative Agent) shall have no responsibility for maintaining a Participant Register.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">97</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:56.34pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">vii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Assignments by Agents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  This Agreement and the rights and obligations of the Administrative Agent and each Group Agent herein shall be assignable by the Administrative Agent or such Group Agent, as the case may be, and its successors and assigns&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that in the case of an assignment to a Person that is not an Affiliate of the Administrative Agent or such Group Agent, so long as no Event of Default or Unmatured Event of Default has occurred and is continuing, such assignment shall require the Borrower&#8217;s consent (not to be unreasonably withheld, conditioned or delayed).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:53.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">viii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Assignments by the Borrower or the Servicer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Neither the Borrower nor, except as provided in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 8.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, the Servicer may assign any of its respective rights or obligations hereunder or any interest herein without the prior written consent of the Administrative Agent and each Group Agent (such consent to be provided or withheld in the sole discretion of such Person).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:59.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ix.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Addition of Lenders or Groups</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Borrower may, with written consent of the Administrative Agent and the Majority Group Agents, add additional Persons as Lenders (by creating a new Group) or cause an existing Lender to increase its Commitment&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that the Commitment of any existing Lender may only be increased with the prior written consent of such Lender.  Each new Lender (or Group) shall become a party hereto, by executing and delivering to the Administrative Agent and the Borrower, an assumption agreement (each, an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Assumption Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) in the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit D</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> hereto (which Assumption Agreement shall, in the case of any new Lender, be executed by each Person in such new Lender&#8217;s Group).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:63pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">x.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Removal of Lenders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  If (i) any Lender requests compensation under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 4.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, or if the Borrower is required to pay any additional amount to any Lender or any Governmental Authority for the account of any Lender pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 4.03</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, (iv) any Lender is a Defaulting Lender, or (v) any other circumstance exists hereunder that gives the Borrower the right to replace a Lender as a party hereto, then the Borrower may, at its sole expense and effort, upon notice to such Lender and the Administrative Agent, require such Lender to assign and delegate, without recourse (in accordance with and subject to the restrictions contained in, and consents required by, this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 13.03</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">), all of its interests, rights (other than its existing rights to payments pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Sections 4.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">4.03</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">) and obligations under this Agreement and the related Transaction Documents to an assignee that shall assume such obligations (which assignee may be another Lender, if a Lender accepts such assignment), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">such Lender shall have received payment of an amount equal to 100% of the outstanding Capital, accrued interest thereon, accrued fees and all other amounts payable to it hereunder and under the other Transaction Documents from the assignee (to the extent of such outstanding Capital and accrued interest and fees)&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">in the case of any such assignment resulting from a claim for compensation under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 4.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> or payments required to be made pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 4.03</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, such assignment will result in a reduction in such compensation or payments thereafter&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">such assignment does not conflict with Applicable Law.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">A Lender shall not be required to make any such assignment or delegation if, prior thereto, as a result of a waiver by such Lender or otherwise, the circumstances entitling the Borrower to require such assignment and delegation cease to apply.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:59.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">xi.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Pledge to a Federal Reserve Bank</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Notwithstanding anything to the contrary set forth herein, (i) any Lender, Program Support Provider or any of their respective Affiliates may </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">98</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">at any time pledge or grant a security interest in all or any portion of its interest in, to and under this Agreement (including, without limitation, rights to payment of Capital and Interest) and any other Transaction Document to secure its obligations to a Federal Reserve Bank, without notice to or the consent of the Borrower, the Servicer, any Affiliate thereof or any Credit Party&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that that no such pledge shall relieve such assignor of its obligations under this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:56.34pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">xii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Pledge to a Security Trustee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Notwithstanding anything to the contrary set forth herein, (i) any Lender, Program Support Provider or any of their respective Affiliates may at any time pledge or grant a security interest in all or any portion of its interest in, to and under this Agreement (including, without limitation, rights to payment of Capital and Interest) and any other Transaction Document to a security trustee in connection with the funding by such Person of Loans, without notice to or the consent of the Borrower, the Servicer, any Affiliate thereof or any Credit Party&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that that no such pledge shall relieve such assignor of its obligations under this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1.0d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:30.36pt">Costs and Expenses.  In addition to the rights of indemnification granted under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 12.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> hereof, the Borrower agrees to pay on demand all reasonable and documented out-of-pocket costs and expenses in connection with the preparation, negotiation, execution, delivery and administration of this Agreement, any Program Support Agreement (or any supplement or amendment thereof) related to this Agreement and the other Transaction Documents (together with all amendments, restatements, supplements, consents and waivers, if any, from time to time hereto and thereto), including, without limitation, (i) the reasonable Attorney Costs for the Administrative Agent, the Structuring Agent and the other Credit Parties and any of their respective Affiliates with respect thereto and with respect to advising the Administrative Agent, the Structuring Agent and the other Credit Parties and their respective Affiliates as to their rights and remedies under this Agreement and the other Transaction Documents and (ii) reasonable accountants&#8217;, auditors&#8217; and consultants&#8217; fees and expenses for the Administrative Agent, the Structuring Agent and the other Credit Parties and any of their respective Affiliates and the fees and charges of any nationally recognized statistical rating agency incurred in connection with the administration and maintenance of this Agreement or advising the Administrative Agent or any other Credit Party as to their rights and remedies under this Agreement or as to any actual or reasonably claimed breach of this Agreement or any other Transaction Document.  In addition, the Borrower agrees to pay on demand all reasonable out-of-pocket costs and expenses (including reasonable Attorney Costs), of the Administrative Agent, the Structuring Agent and the other Credit Parties and their respective Affiliates, incurred in connection with the enforcement of any of their respective rights or remedies under the provisions of this Agreement and the other Transaction Documents.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1.0e.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:31.04pt">No Proceedings&#59; Limitation on Payments.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:65.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">i.Each of the Borrower, the Administrative Agent, the Servicer, each Group Agent, each Lender and each assignee of a Loan or any interest agrees that it will not institute against, or join any other Person in instituting against, any Conduit Lender any Insolvency Proceeding so long as any Notes or other senior indebtedness issued by such Conduit Lender shall be outstanding or there shall not have elapsed one year plus one day since the last day on which any such Notes or other senior indebtedness shall have been outstanding.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:62.34pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ii.Each of the Servicer, each Group Agent, each Lender and each assignee of a Loan or any interest therein, hereby covenants and agrees that it will not institute against, or join any other Person in instituting against, the Borrower any Insolvency Proceeding until one year and one day after the Final Payout Date&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that the Administrative Agent may take any such action in its sole discretion following the occurrence of an Event of Default.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">99</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:59.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">iii.Notwithstanding any provisions contained in this Agreement to the contrary, a Conduit Lender shall not, and shall be under no obligation to, pay any amount, if any, payable by it pursuant to this Agreement or any other Transaction Document unless (i) such Conduit Lender has received funds which may be used to make such payment and which funds are not required to repay such Conduit Lender&#8217;s Notes when due and (ii) after giving effect to such payment, either (x) such Conduit Lender could issue Notes to refinance all of its outstanding Notes (assuming such outstanding Notes matured at such time) in accordance with the program documents governing such Conduit Lender&#8217;s securitization program or (y) all of such Conduit Lender&#8217;s Notes are paid in full.  Any amount which any Conduit Lender does not pay pursuant to the operation of the preceding sentence shall not constitute a claim (as defined in Section 101 of the Bankruptcy Code) against or company obligation of such Conduit Lender for any such insufficiency unless and until such Conduit Lender satisfies the provisions of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">clauses (i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> above.  The provisions of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 13.05</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> shall survive any termination of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1.0f.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:0.87pt">Confidentiality.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:65.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">i.Each of the Borrower and the Servicer covenants and agrees to hold in confidence, and not disclose to any Person, the terms of this Agreement or any Fee Letter (including any fees payable in connection with this Agreement, such Fee Letter or any other Transaction Document or the identity of the Administrative Agent or any other Credit Party), except as the Administrative Agent and each Group Agent may have consented to in writing prior to any proposed disclosure&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that it may disclose such information (i) to its Advisors and Representatives, (ii) to the extent such information has become available to the public other than as a result of a disclosure by or through the Borrower, the Servicer or their Advisors and Representatives or (iii) to the extent it should be (A) required by Applicable Law, or in connection with any legal or regulatory proceeding or (B) requested by any Governmental Authority to disclose such information&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that, in the case of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">clause (iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> above, the Borrower and the Servicer will use reasonable efforts to maintain confidentiality and will (unless otherwise prohibited by Applicable Law) notify the Administrative Agent and the affected Credit Party of its intention to make any such disclosure prior to making such disclosure.  Each of the Borrower and the Servicer agrees to be responsible for any breach of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 13.06</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> by its Representatives and Advisors and agrees that its Representatives and Advisors will be advised by it of the confidential nature of such information and shall agree to comply with this Section.  Notwithstanding the foregoing, it is expressly agreed that each of the Borrower, the Servicer and their respective Affiliates may publish a press release or otherwise publicly announce the existence and principal amount of the Commitments under this Agreement and the transactions contemplated hereby&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that the Administrative Agent shall be provided a reasonable opportunity to review such press release or other public announcement prior to its release and provide comment thereon&#59; and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that no such press release shall name or otherwise identify the Administrative Agent, any other Credit Party or any of their respective Affiliates without such Person&#8217;s prior written consent (such consent not to be unreasonably withheld, conditioned or delayed).  Notwithstanding the foregoing, the Borrower consents to the publication by the Administrative Agent or any other Credit Party of a tombstone or similar advertising material relating to the financing transactions contemplated by this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:62.34pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ii.Each of the Administrative Agent and each other Credit Party, severally and with respect to itself only, agrees to hold in confidence, and not disclose to any Person, any confidential and proprietary information concerning the Borrower, the Servicer and their respective Affiliates and their businesses or the terms of this Agreement (including any fees payable in connection with this Agreement or the other Transaction Documents), except as the Borrower or the Servicer may have consented to in writing prior to any proposed disclosure&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that it may disclose such information (i) to its Advisors and Representatives and to any related Program Support Provider, (ii) to its assignees and Participants and potential assignees and Participants and their respective counsel if they agree in writing to hold it </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">100</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">confidential, (iii) to the extent such information has become available to the public other than as a result of a disclosure by or through it or its Representatives or Advisors or any related Program Support Provider, (iv) to any nationally recognized statistical rating organization in connection with obtaining or maintaining the rating of any Conduit Lender&#8217;s Notes or as contemplated by 17 CFR 240.17g-5(a)(3), (v) at the request of a bank examiner or other regulatory authority or in connection with an examination of any of the Administrative Agent, any Group Agent or any Lender or their respective Affiliates or Program Support Providers or (vi) to the extent it should be (A) required by Applicable Law, or in connection with any legal or regulatory proceeding or (B) requested by any Governmental Authority to disclose such information&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that, in the case of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">clause (vi)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> above, the Administrative Agent, each Group Agent and each Lender will use reasonable efforts to maintain confidentiality and will (unless otherwise prohibited by Applicable Law) notify the Borrower and the Servicer of its making any such disclosure as promptly as reasonably practicable thereafter.  Each of the Administrative Agent, each Group Agent and each Lender, severally and with respect to itself only, agrees to be responsible for any breach of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 13.06</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> by its Representatives, Advisors and Program Support Providers and agrees that its Representatives, Advisors and Program Support Providers will be advised by it of the confidential nature of such information and shall agree to comply with this Section.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:59.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">iii.As used in this Section, (i) &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Advisors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Person, such Person&#8217;s accountants, attorneys and other confidential advisors and (ii) &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Representatives</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Person, such Person&#8217;s Affiliates, and its and their Subsidiaries, directors, managers, officers, employees, members, investors, financing sources, insurers, professional advisors, representatives and agents&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that such Persons shall not be deemed to Representatives of a Person unless (and solely to the extent that) confidential information is furnished to such Person.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:59.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">iv.Notwithstanding the foregoing, to the extent not inconsistent with applicable securities laws, each party hereto (and each of its employees, representatives or other agents) may disclose to any and all persons, without limitation of any kind, the tax treatment and tax structure (as defined in Section 1.6011-4 of the Treasury Regulations) of the transactions contemplated by the Transaction Documents and all materials of any kind (including opinions or other tax analyses) that are provided to such Person relating to such tax treatment and tax structure.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1.0g.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:30.36pt">GOVERNING LAW.  THIS AGREEMENT, INCLUDING THE RIGHTS AND DUTIES OF THE PARTIES HERETO, SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK (INCLUDING SECTIONS 5-1401 AND 5-1402 OF THE GENERAL OBLIGATIONS LAW OF THE STATE OF NEW YORK, BUT WITHOUT REGARD TO ANY OTHER CONFLICTS OF LAW PROVISIONS THEREOF, EXCEPT TO THE EXTENT THAT THE PERFECTION, THE EFFECT OF PERFECTION OR PRIORITY OF THE INTERESTS OF ADMINISTRATIVE AGENT OR ANY LENDER IN THE COLLATERAL IS GOVERNED BY THE LAWS OF A JURISDICTION OTHER THAN THE STATE OF NEW YORK).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1.0h.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:30.36pt">Execution in Counterparts.  This Agreement may be executed in any number of counterparts, each of which when so executed shall be deemed to be an original and all of which when taken together shall constitute one and the same agreement.  Delivery of an executed counterpart hereof by facsimile or other electronic means shall be equally effective as delivery of an originally executed counterpart.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1.0i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:33.03pt">Integration&#59; Binding Effect&#59; Survival of Termination.  This Agreement and the other Transaction Documents contain the final and complete integration of all prior expressions by the parties hereto with respect to the subject matter hereof and shall constitute the entire agreement among the parties hereto with respect to the subject matter hereof </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">101</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">superseding all prior oral or written understandings.  This Agreement shall be binding upon and inure to the benefit of the parties hereto and their respective successors and permitted assigns.  This Agreement shall create and constitute the continuing obligations of the parties hereto in accordance with its terms and shall remain in full force and effect until the Final Payout Date&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that the provisions of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Sections 4.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">4.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">4.03</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">10.04</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">10.06</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">11.04</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">12.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">12.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">13.04</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">13.05</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">13.06</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">13.09</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">13.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">13.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> shall survive any termination of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1.j.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:3.03pt">CONSENT TO JURISDICTION.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:65.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">i.EACH PARTY HERETO HEREBY IRREVOCABLY SUBMITS TO (I) WITH RESPECT TO THE BORROWER AND THE SERVICER, THE EXCLUSIVE JURISDICTION, AND (II) WITH RESPECT TO EACH OF THE OTHER PARTIES HERETO, THE NON-EXCLUSIVE JURISDICTION, IN EACH CASE, OF ANY NEW YORK STATE OR FEDERAL COURT SITTING IN NEW YORK CITY, NEW YORK IN ANY ACTION OR PROCEEDING ARISING OUT OF OR RELATING TO THIS AGREEMENT OR ANY OTHER TRANSACTION DOCUMENT, AND EACH PARTY HERETO HEREBY IRREVOCABLY AGREES THAT ALL CLAIMS IN RESPECT OF SUCH ACTION OR PROCEEDING (I) IF BROUGHT BY THE BORROWER, THE SERVICER OR ANY AFFILIATE THEREOF, SHALL BE HEARD AND DETERMINED, AND (II) IF BROUGHT BY ANY OTHER PARTY TO THIS AGREEMENT OR ANY OTHER TRANSACTION DOCUMENT, MAY BE HEARD AND DETERMINED, IN EACH CASE, IN SUCH NEW YORK STATE COURT OR, TO THE EXTENT PERMITTED BY LAW, IN SUCH FEDERAL COURT.  NOTHING IN THIS </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">SECTION 13.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> SHALL AFFECT THE RIGHT OF THE ADMINISTRATIVE AGENT OR ANY OTHER CREDIT PARTY TO BRING ANY ACTION OR PROCEEDING AGAINST THE BORROWER OR THE SERVICER OR ANY OF THEIR RESPECTIVE PROPERTY IN THE COURTS OF OTHER JURISDICTIONS.  EACH OF THE BORROWER AND THE SERVICER HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT IT MAY EFFECTIVELY DO SO, THE DEFENSE OF AN INCONVENIENT FORUM TO THE MAINTENANCE OF SUCH ACTION OR PROCEEDING.  THE PARTIES HERETO AGREE THAT A FINAL JUDGMENT IN ANY SUCH ACTION OR PROCEEDING SHALL BE CONCLUSIVE AND MAY BE ENFORCED IN OTHER JURISDICTIONS BY SUIT ON THE JUDGMENT OR IN ANY OTHER MANNER PROVIDED BY LAW.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:62.34pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">EACH OF THE BORROWER AND THE SERVICER CONSENTS TO THE SERVICE OF ANY AND ALL PROCESS IN ANY SUCH ACTION OR PROCEEDING BY THE MAILING OF COPIES OF SUCH PROCESS TO IT AT ITS ADDRESS SPECIFIED IN </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">SECTION 13.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">.  NOTHING IN THIS </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">SECTION 13.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> SHALL AFFECT THE RIGHT OF THE ADMINISTRATIVE AGENT OR ANY OTHER CREDIT PARTY TO SERVE LEGAL PROCESS IN ANY OTHER MANNER PERMITTED BY LAW.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1.k.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:0.36pt">WAIVER OF JURY TRIAL.  EACH PARTY HERETO HEREBY WAIVES, TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW, TRIAL BY JURY IN ANY JUDICIAL PROCEEDING INVOLVING, DIRECTLY OR INDIRECTLY, ANY MATTER (WHETHER SOUNDING IN TORT, CONTRACT OR OTHERWISE) IN ANY WAY ARISING OUT OF, RELATED TO, OR CONNECTED WITH THIS AGREEMENT OR ANY OTHER TRANSACTION DOCUMENT.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1.l.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:3.03pt">Ratable Payments.  If any Credit Party, whether by setoff or otherwise, has payment made to it with respect to any Borrower Obligations in a greater proportion than that received by any other Credit Party entitled to receive a ratable share of such Borrower Obligations, such Credit Party agrees, promptly upon demand, to purchase for cash without </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">102</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">recourse or warranty a portion of such Borrower Obligations held by the other Credit Parties so that after such purchase each Credit Party will hold its ratable proportion of such Borrower Obligations&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that if all or any portion of such excess amount is thereafter recovered from such Credit Party, such purchase shall be rescinded and the purchase price restored to the extent of such recovery, but without interest.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1.m.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:33.03pt">Limitation of Liability.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:65.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">i.No claim may be made by the Borrower or any Affiliate thereof or any other Person against any Credit Party or their respective Affiliates, members, directors, officers, employees, incorporators, attorneys or agents for any special, indirect, consequential or punitive damages in respect of any claim for breach of contract or any other theory of liability arising out of or related to the transactions contemplated by this Agreement or any other Transaction Document, or any act, omission or event occurring in connection herewith or therewith&#59; and each of the Borrower and the Servicer hereby waives, releases, and agrees not to sue upon any claim for any such damages, whether or not accrued and whether or not known or suspected to exist in its favor.  None of the Credit Parties and their respective Affiliates shall have any liability to the Borrower or any Affiliate thereof or any other Person asserting claims on behalf of or in right of the Borrower or any Affiliate thereof in connection with or as a result of this Agreement or any other Transaction Document or the transactions contemplated hereby or thereby, except to the extent that any losses, claims, damages, liabilities or expenses incurred by the Borrower or any Affiliate thereof result from the breach of contract, gross negligence or willful misconduct of such Credit Party in performing its duties and obligations hereunder and under the other Transaction Documents to which it is a party.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:62.34pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ii.The obligations of the Administrative Agent and each of the other Credit Parties under this Agreement and each of the Transaction Documents are solely the corporate obligations of such Person.  No recourse shall be had for any obligation or claim arising out of or based upon this Agreement or any other Transaction Document against any member, director, officer, employee or incorporator of any such Person.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1.n.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:0.36pt">Intent of the Parties.  The Borrower has structured this Agreement with the intention that the Loans and the obligations of the Borrower hereunder will be treated under United States federal, and applicable state, local and foreign tax law as debt (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Intended Tax Treatment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).  The Borrower, the Servicer, the Administrative Agent and the other Credit Parties agree to file no tax return, or take any action, inconsistent with the Intended Tax Treatment unless required by law.  Each assignee and each Participant acquiring an interest in a Credit Extension, by its acceptance of such assignment or participation, agrees to comply with the immediately preceding sentence.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1.o.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:0.36pt">USA Patriot Act.  Each of the Administrative Agent and each of the other Credit Parties hereby notifies the Borrower and the Servicer that pursuant to the requirements of the USA PATRIOT Act, Title III of Pub. L. 107-56 (signed into law October 26, 2001) (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">PATRIOT Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), the Administrative Agent and the other Credit Parties may be required to obtain, verify and record information that identifies any Integra Party, which information includes the name, address, tax identification number and other information regarding any Integra Party that will allow the Administrative Agent and the other Credit Parties to identify such Integra Party in accordance with the PATRIOT Act.  This notice is given in accordance with the requirements of the PATRIOT Act.  Each of the Borrower and the Servicer agrees to provide the Administrative Agent and each other Credit Parties such information and documentation as may reasonably be requested by the Administrative Agent or any Credit Party, from time to time, for purposes of compliance by the Administrative Agent or such Credit Party with Applicable Laws (including without limitation the PATRIOT Act and other &#8220;know your </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">103</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">customer&#8221; and anti-money laundering rules and regulations) and any policy or procedure implemented by the Administrative Agent or such Credit Party to comply therewith.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1.p.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:0.36pt">Right of Setoff.  Each Credit Party is hereby authorized (in addition to any other rights it may have), at any time during the continuance of an Event of Default, to setoff, appropriate and apply (without presentment, demand, protest or other notice which are hereby expressly waived) any deposits and any other indebtedness held or owing by such Credit Party (including by any branches or agencies of such Credit Party) to, or for the account of, the Borrower or the Servicer against amounts owing by the Borrower or the Servicer hereunder (even if contingent or unmatured)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that such Credit Party shall notify the Borrower or the Servicer, as applicable, promptly following such setoff.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1.q.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:0.36pt">Severability.  Any provisions of this Agreement which are prohibited or unenforceable in any jurisdiction shall, as to such jurisdiction, be ineffective to the extent of such prohibition or unenforceability without invalidating the remaining provisions hereof, and any such prohibition or unenforceability in any jurisdiction shall not invalidate or render unenforceable such provision in any other jurisdiction.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1.r.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:2.37pt">Mutual Negotiations.  This Agreement and the other Transaction Documents are the product of mutual negotiations by the parties thereto and their counsel, and no party shall be deemed the draftsperson of this Agreement or any other Transaction Document or any provision hereof or thereof or to have provided the same.  Accordingly, in the event of any inconsistency or ambiguity of any provision of this Agreement or any other Transaction Document, such inconsistency or ambiguity shall not be interpreted against any party because of such party&#8217;s involvement in the drafting thereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1.s.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:1.7pt">Captions and Cross References.  The various captions (including the table of contents) in this Agreement are provided solely for convenience of reference and shall not affect the meaning or interpretation of any provision of this Agreement.  Unless otherwise indicated, references in this Agreement to any Section, Schedule or Exhibit are to such Section Schedule or Exhibit to this Agreement, as the case may be, and references in any Section, subsection, or clause to any subsection, clause or subclause are to such subsection, clause or subclause of such Section, subsection or clause.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">&#91;Signature Pages Follow&#93;</font></div><div style="margin-bottom:48pt;text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">104</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><div id="i29d3ee780415406894d01c68f622cdf1_79"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:30pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">IN WITNESS WHEREOF, the parties have caused this Agreement to be executed by their respective officers thereunto duly authorized, as of the date first above written.</font></div><div style="padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">INTEGRA RECEIVABLES LLC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">,</font></div><div style="margin-bottom:30pt;padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">as the Borrower</font></div><div style="padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58;  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:30pt;padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title&#58;  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">INTEGRA LIFESCIENCES SALES LLC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">,</font></div><div style="margin-bottom:30pt;padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">as the Servicer </font></div><div style="padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58;  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:18pt;padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title&#58;  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:30pt;padding-left:216pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.912%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.874%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.914%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">S-1</font></div></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Receivables Financing Agreement (Integra)</font></td></tr></table></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">PNC BANK, NATIONAL ASSOCIATION</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">,</font></div><div style="margin-bottom:30pt;padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">as the Administrative Agent</font></div><div style="padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58;  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:30pt;padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title&#58;  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">PNC BANK, NATIONAL ASSOCIATION</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">,</font></div><div style="margin-bottom:30pt;padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">as the Group Agent for the PNC Group</font></div><div style="padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58;  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:30pt;padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title&#58;  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">PNC BANK, NATIONAL ASSOCIATION</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">,</font></div><div style="margin-bottom:30pt;padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">as a Committed Lender</font></div><div style="padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58;  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:30pt;padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title&#58;  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:30pt;padding-left:216pt;text-align:justify"><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.912%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.874%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.914%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">S-2</font></div></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Receivables Financing Agreement (Integra)</font></td></tr></table></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:18pt;padding-right:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ACCEPTED AND ACKNOWLEDGED SOLELY WITH RESPECT TO SECTION 10.10 HEREOF&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">PNC CAPITAL MARKETS LLC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">,</font></div><div style="margin-bottom:30pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">as the Structuring Agent</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><br>Name&#58;  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><br>Title&#58;  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.912%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.874%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.914%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">S-3</font></div></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Receivables Financing Agreement (Integra)</font></td></tr></table></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.912%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.874%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.914%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">S-4</font></div></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Receivables Financing Agreement (Integra)</font></td></tr></table></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><div id="i29d3ee780415406894d01c68f622cdf1_82"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">EXHIBIT A</font></div><div style="margin-bottom:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Form of Loan Request</font></div><div style="margin-bottom:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#91;Letterhead of Borrower&#93;</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#91;Date&#93;<br><br>&#91;Administrative Agent&#93;</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#91;Group Agents&#93;</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Re&#58;&#160;&#160;&#160;&#160;Loan Request</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Ladies and Gentlemen&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Reference is hereby made to that certain Receivables Financing Agreement, dated as of December 21, 2018, by and among Integra Receivables LLC (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Borrower</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), Integra LifeSciences Sales LLC, as Servicer (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Servicer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), the Lenders party thereto, the Group Agents party thereto, PNC Bank, National Association, as Administrative Agent (in such capacity, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Administrative Agent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) and PNC Capital Markets LLC, as Structuring Agent (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Structuring Agent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) (as amended, supplemented or otherwise modified from time to time, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).  Capitalized terms used in this Loan Request and not otherwise defined herein shall have the meanings assigned thereto in the Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">This letter constitutes a Loan Request pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.02(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> of the Agreement.  The Borrower hereby request a Loan in the amount of &#91;$_______&#93; to be made on &#91;_____, 20__&#93; (of which $&#91;___&#93; will be funded by the PNC Group &#91;and $&#91;___&#93; will be funded by the &#91;___&#93; Group&#93;.  The proceeds of such Loan should be deposited to &#91;Account number&#93;, at &#91;Name, Address and ABA Number of Bank&#93;.  After giving effect to such Loan, the Aggregate Capital will be &#91;$_______&#93;.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Borrower hereby represents and warrants as of the date hereof, and after giving effect to such Credit Extension, as follows&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">the representations and warranties of the Borrower and the Servicer contained in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Sections 6.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">6.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> of the Agreement are true and correct in all material respects (unless such representations and warranties contain a materiality qualifier, in which case such representations and warranties shall be true and correct as made) on and as of the date of such Credit Extension as though made on and as of such date unless such representations and warranties by their terms refer to an earlier date, in which case they shall be true and correct in all material respects (unless such representations and warranties contain a materiality qualifier, in which case such representations and warranties shall be true and correct as made) on and as of such earlier date&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">no Event of Default or Unmatured Event of Default has occurred and is continuing, and no Event of Default or Unmatured Event of Default would result from such Credit Extension&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">no Borrowing Base Deficit exists or would exist after giving effect to such Credit Extension&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(4)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">the Aggregate Capital will not exceed the Facility Limit&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.912%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.874%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.914%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Exhibit A-1</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(5)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">the sum of (A) the Capital of the applicable Lender, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (B) the aggregate outstanding Capital of each other Lender in its Group, would not exceed the Group Commitment of such Lender&#8217;s Group&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(6)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">if the applicable Lender is a Committed Lender, the aggregate outstanding Capital of such Committed Lender would not exceed its Commitment&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(7)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">the Aggregate Capital would not exceed the Borrowing Base at such time&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(8)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">the Termination Date has not occurred.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.912%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.874%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.914%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Exhibit A-2</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">IN WITNESS WHEREOF, the undersigned has executed this letter by its duly authorized officer as of the date first above written.</font></div><div style="margin-bottom:30pt;padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Very truly yours,</font></div><div style="margin-bottom:30pt;padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">INTEGRA RECEIVABLES LLC</font></div><div style="margin-bottom:72pt;padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;  &#160;&#160;&#160;&#160;<br>Name&#58;  &#160;&#160;&#160;&#160;<br>Title&#58;  &#160;&#160;&#160;&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.912%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.874%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.914%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Exhibit A-3</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><div id="i29d3ee780415406894d01c68f622cdf1_85"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">EXHIBIT B</font></div><div style="margin-bottom:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Form of Reduction Notice</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">&#91;Letterhead of Borrower&#93;</font></div><div style="margin-top:14pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:117%">&#91;Date&#93;</font></div><div style="margin-top:14pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:117%">&#91;Administrative Agent&#93;</font></div><div style="margin-top:14pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:117%">&#91;Group Agents&#93;</font></div><div style="margin-bottom:24pt;margin-top:20pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:117%">Re&#58;&#160;&#160;&#160;&#160;Reduction Notice</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Ladies and Gentlemen&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Reference is hereby made to that certain Receivables Financing Agreement, dated as of </font><font style="color:#000000;font-family:'Times',sans-serif;font-size:12pt;font-weight:400;line-height:100%">December 21, 2018, by and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">among Integra Receivables LLC (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Borrower</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), </font><font style="color:#000000;font-family:'Times',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Integra LifeSciences Sales LLC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, as Servicer (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Servicer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), the Lenders party thereto, the Group Agents party thereto, PNC Bank, National Association, as Administrative Agent (in such capacity, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Administrative Agent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) </font><font style="color:#000000;font-family:'Times',sans-serif;font-size:12pt;font-weight:400;line-height:100%">and PNC Capital Markets LLC, as Structuring Agent (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">the &#8220;</font><font style="color:#000000;font-family:'Times',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Structuring</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> Agent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) (as amended, supplemented or otherwise modified from time to time, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).  Capitalized terms used in this Reduction Notice and not otherwise defined herein shall have the meanings assigned thereto in the Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">This letter constitutes a Reduction Notice pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.02(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> of the Agreement.  The Borrower hereby notifies the Administrative Agent and the Lenders that it shall prepay the outstanding Capital of the Lenders in the amount of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">&#91;$_______&#93;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> to be made on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">&#91;_____, 201_&#93;.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">After giving effect to such prepayment, the Aggregate Capital will be</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> &#91;$_______&#93;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Borrower hereby represents and warrants as of the date hereof, and after giving effect to such reduction, as follows&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">the representations and warranties of the Borrower and the Servicer contained in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Sections 6.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">6.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> of the Agreement are true and correct in all material respects (unless such representations and warranties contain a materiality qualifier, in which case such representations and warranties shall be true and correct as made) on and as of the date of such prepayment as though made on and as of such date unless such representations and warranties by their terms refer to an earlier date, in which case they shall be true and correct in all material respects (unless such representations and warranties contain a materiality qualifier, in which case such representations and warranties shall be true and correct as made)  on and as of such earlier date&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">no Event of Default or Unmatured Event of Default has occurred and is continuing, and no Event of Default or Unmatured Event of Default would result from such prepayment&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">no Borrowing Base Deficit exists or would exist after giving effect to such prepayment&#59; </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Exhibit B-1</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(4)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">the Aggregate Capital would not equal an amount less than the Minimum Funding Threshold&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(5)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">the Termination Date has not occurred.</font></div><div style="margin-bottom:12pt;margin-top:14pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Exhibit B-2</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:117%">In Witness Whereof, the undersigned has executed this letter by its duly authorized officer as of the date first above written.</font></div><div style="margin-bottom:30pt;padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Very truly yours,</font></div><div style="margin-bottom:30pt;padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">INTEGRA RECEIVABLES LLC</font></div><div style="margin-bottom:72pt;padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;  &#160;&#160;&#160;&#160;<br>Name&#58;  &#160;&#160;&#160;&#160;<br>Title&#58;  &#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:60pt"><font><br></font></div><div style="margin-bottom:60pt;text-align:center;text-indent:242.25pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Exhibit B-3</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><div id="i29d3ee780415406894d01c68f622cdf1_88"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">EXHIBIT C</font></div><div style="margin-bottom:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Form of Assignment and Acceptance Agreement</font></div><div style="margin-bottom:24pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Dated as of ___________, 20__</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.100%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 39.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Commitment assigned&#58;</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">$&#91;_____&#93;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 39.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Assignor&#8217;s remaining Commitment&#58;</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">$&#91;_____&#93;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 39.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Capital allocable to Commitment assigned&#58;</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">$&#91;_____&#93;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 39.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Assignor&#8217;s remaining Capital&#58;</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">$&#91;_____&#93;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 39.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Interest (if any) allocable to Capital assigned&#58;</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">$&#91;_____&#93;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 39.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Interest (if any) allocable to Assignor&#8217;s remaining Capital&#58;</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">$&#91;_____&#93;</font></td></tr></table></div><div><font><br></font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-indent:28.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Effective Date of this Assignment and Acceptance Agreement&#58;   &#91;__________&#93;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Upon execution and delivery of this Assignment and Acceptance Agreement by the assignee and the assignor and the satisfaction of the other conditions to assignment specified in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 13.03(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> of the Agreement (as defined below), from and after the effective date specified above, the assignee shall become a party to, and, to the extent of the rights and obligations thereunder being assigned to it pursuant to this Assignment and Acceptance Agreement, shall have the rights and obligations of a Committed Lender under that certain Receivables Financing Agreement, dated as of December 21, 2018, by and among Integra Receivables LLC (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Borrower</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), Integra LifeSciences Sales LLC, as Servicer (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Servicer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), the Lenders party thereto, the Group Agents party thereto, PNC Bank, National Association, as Administrative Agent (in such capacity, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Administrative Agent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) and PNC Capital Markets LLC, as Structuring Agent (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Structuring Agent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) (as amended, supplemented or otherwise modified from time to time, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(Signature Pages Follow)</font></div><div style="margin-bottom:24pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Exhibit C-1</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:24pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ASSIGNOR&#58;  &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">&#91;_________&#93;</font></div><div style="margin-bottom:36pt;padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><br>Name&#58;<br>Title</font></div><div style="margin-bottom:24pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ASSIGNEE&#58;  &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">&#91;_________&#93;</font></div><div style="margin-bottom:12pt;padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58;<br>Title&#58;</font></div><div style="margin-bottom:48pt;padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#91;Address&#93;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Accepted as of date first above</font></div><div style="margin-bottom:24pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">written&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">PNC BANK, NATIONAL ASSOCIATION</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">,</font></div><div style="margin-bottom:30pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">as Administrative Agent</font></div><div style="margin-bottom:30pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;<br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58;<br>Title&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">INTEGRA RECEIVABLES LLC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">,</font></div><div style="margin-bottom:30pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">as Borrower</font></div><div style="margin-bottom:30pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;<br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58;<br>Title&#58;</font></div><div style="margin-bottom:30pt"><font><br></font></div><div style="margin-bottom:30pt"><font><br></font></div><div id="i29d3ee780415406894d01c68f622cdf1_91"></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">EXHIBIT D</font></div><div style="margin-bottom:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Form of Assumption Agreement</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Exhibit C-2</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">THIS ASSUMPTION AGREEMENT (this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), dated as of &#91;______ __, ____&#93;, is among ____________________ (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Borrower</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), &#91;________&#93;, as conduit lender (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#91;_____&#93; Conduit Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), &#91;________&#93;, as the Related Committed Lender (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#91;______&#93; Committed Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; and together with the Conduit Lender, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#91;_____&#93; Lenders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), and &#91;________&#93;, as group agent for the &#91;_____&#93; Lenders (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#91;______&#93; Group Agent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; and together with the &#91;_____&#93; Lenders, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#91;_______&#93; Group</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">BACKGROUND</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Borrower and various others are parties to a certain Receivables Financing Agreement, dated as of December 21, 2018 (as amended through the date hereof and as the same may be amended, amended and restated, supplemented or otherwise modified from time to time, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Receivables Financing Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).  Capitalized terms used and not otherwise defined herein have the respective meaning assigned to such terms in the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Receivables Financing Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">NOW, THEREFORE, the parties hereto hereby agree as follows&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1.&#160;&#160;&#160;&#160;This letter constitutes an Assumption Agreement pursuant to Section</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> 13.03(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> of the Receivables Financing Agreement.  The Borrower desires &#91;the &#91;_____&#93; Lenders&#93; &#91;the &#91;______&#93; Committed Lender&#93; to &#91;become a Group&#93; &#91;increase its existing Commitment&#93; under the Receivables Financing Agreement, and upon the terms and subject to the conditions set forth in the Receivables Financing Agreement, the &#91;the &#91;_____&#93; Lenders&#93; &#91;the &#91;______&#93; Committed Lender&#93; agree&#91;s&#93; to &#91;become Lenders within a Group thereunder&#93; &#91;increase its Commitment to the amount set forth as its &#8220;Commitment&#8221; under the signature of such &#91;______&#93; Committed Lender hereto&#93;.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Borrower hereby represents and warrants to the &#91;the &#91;_____&#93; Lenders&#93; &#91;the &#91;______&#93; Committed Lender&#93; &#91;and the &#91;_________&#93; Group Agent&#93; as of the date hereof, as follows&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">the representations and warranties of the Borrower contained in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 6.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> of the Receivables Financing Agreement are true and correct on and as of such date as though made on and as of such date&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">no Event of Default or Unmatured Event of Default has occurred and is continuing, or would result from the assumption contemplated hereby&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Termination Date shall not have occurred.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 2.&#160;&#160;&#160;&#160;Upon execution and delivery of this Agreement by the Borrower and &#91;each member of the &#91;______&#93; Group&#93; &#91;the &#91;_____&#93; Lenders&#93; &#91;the &#91;______&#93; Committed Lender&#93;, satisfaction of the other conditions with respect to the addition of a Group specified in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 13.03(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> of the Receivables Financing Agreement (including the written consent of the Administrative Agent and the Majority Group Agents) and receipt by the Administrative Agent of counterparts of this Agreement (whether by facsimile or otherwise) executed by each of the parties hereto, &#91;the &#91;_____&#93; Lenders shall become a party to, and have the rights and obligations of Lenders under, the Receivables Financing Agreement and the &#8220;Commitment&#8221; with respect to the Committed Lenders in such Group as shall be as set forth under the signature of each such Committed Lender hereto&#93; &#91;the &#91;______&#93; Committed Lender shall increase its Commitment to the amount set forth as the &#8220;Commitment&#8221; under the signature of the &#91;______&#93; Committed Lender hereto&#93;.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 3.&#160;&#160;&#160;&#160;Each party hereto hereby covenants and agrees that it will not institute against, or join any other Person in instituting against, any Conduit Lender, any bankruptcy, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Exhibit D-1</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">reorganization, arrangement, insolvency or liquidation proceeding, or other proceeding under any federal or state bankruptcy or similar law, for one year and one day after the latest maturing commercial paper notes or other senior indebtedness issued by such Conduit Lender is paid in full. The covenant contained in this paragraph shall survive any termination of the Receivables Financing Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 4.&#160;&#160;&#160;&#160;THIS AGREEMENT, INCLUDING THE RIGHTS AND DUTIES OF THE PARTIES HERETO, SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK (INCLUDING SECTIONS 5-1401 AND 5-1402 OF THE GENERAL OBLIGATIONS LAW OF THE STATE OF NEW YORK, BUT WITHOUT REGARD TO ANY OTHER CONFLICTS OF LAW PROVISIONS THEREOF).  This Agreement may not be amended or supplemented except pursuant to a writing signed be each of the parties hereto and may not be waived except pursuant to a writing signed by the party to be charged.  This Agreement may be executed in counterparts, and by the different parties on different counterparts, each of which shall constitute an original, but all together shall constitute one and the same agreement.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(Signature Pages Follow)</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Exhibit D-2</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">IN WITNESS WHEREOF, the parties hereto have executed this Agreement by their duly authorized officers as of the date first above written.</font></div><div style="padding-left:194.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#91;___________&#93;, as a Conduit Lender<br><br><br>By&#58;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name Printed&#58;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title&#58;</font></div><div style="margin-bottom:24pt;padding-left:194.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#91;Address&#93;</font></div><div style="padding-left:194.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#91;___________&#93;, as a Committed Lender<br><br>By&#58;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name Printed&#58;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title&#58;</font></div><div style="padding-left:194.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#91;Address&#93;</font></div><div style="margin-bottom:24pt;padding-left:194.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#91;Commitment&#93;</font></div><div style="padding-left:194.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#91;_____________&#93;, as Group Agent for &#91;_________&#93;<br><br>By&#58;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name Printed&#58;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title&#58;</font></div><div style="padding-left:194.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#91;Address&#93;</font></div><div style="margin-bottom:30pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Exhibit D-3</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:30pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">INTEGRA RECEIVABLES LLC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">,<br>as Borrower</font></div><div style="margin-bottom:144pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;&#160;&#160;&#160;&#160;<br>Name Printed&#58;&#160;&#160;&#160;&#160;<br>Title&#58;&#160;&#160;&#160;&#160;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Exhibit D-4</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><div id="i29d3ee780415406894d01c68f622cdf1_94"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">EXHIBIT E</font></div><div style="margin-bottom:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Credit and Collection Procedures</font></div><div style="margin-bottom:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(Attached)</font></div><div><font><br></font></div><div style="margin-bottom:24pt;text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Exhibit E-1</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><div id="i29d3ee780415406894d01c68f622cdf1_97"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">EXHIBIT F</font></div><div style="margin-bottom:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Form of Information Package</font></div><div style="margin-bottom:24pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(Attached)</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Exhibit F-1</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><div id="i29d3ee780415406894d01c68f622cdf1_100"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">EXHIBIT G</font></div><div style="margin-bottom:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Form of Compliance Certificate</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">To&#58; PNC Bank, National Association, as Administrative Agent</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">This Compliance Certificate is furnished pursuant to that certain Receivables Financing Agreement, dated as of December 21, 2018, by and among Integra Receivables LLC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Borrower</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), Integra LifeSciences Sales LLC, as Servicer (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Servicer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), the Lenders party thereto, the Group Agents party thereto, PNC Bank, National Association, as Administrative Agent (in such capacity, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Administrative Agent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) and PNC Capital Markets LLC, as Structuring Agent (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Structuring Agent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) (as amended, supplemented or otherwise modified from time to time, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).  Capitalized terms used herein and not otherwise defined herein shall have the meanings assigned to them in the Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">THE UNDERSIGNED HEREBY CERTIFIES THAT&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.&#160;&#160;&#160;&#160;I am the duly elected ________________of the Servicer.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.&#160;&#160;&#160;&#160;I have reviewed the terms of the Agreement and each of the other Transaction Documents and I have made, or have caused to be made under my supervision, a detailed review of the transactions and condition of the Borrower during the accounting period covered by the attached financial statements.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.&#160;&#160;&#160;&#160;The examinations described in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">paragraph 2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> above did not disclose, and I have no knowledge of, the existence of any condition or event which constitutes an Event of Default or an Unmatured Event of Default, as each such term is defined under the Agreement, during or at the end of the accounting period covered by the attached financial statements or as of the date of this Certificate&#91;, except as set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">paragraph 5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> below&#93;.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule I</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> attached hereto sets forth financial statements of the Parent and its Subsidiaries for the period referenced on such </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule I</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#91;5.&#160;&#160;&#160;&#160;Described below are the exceptions, if any, to paragraph 3 above by listing, in detail, the nature of the condition or event, the period during which it has existed and the action which Borrower has taken, is taking, or proposes to take with respect to each such condition or event&#58;&#93;</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Exhibit G-1</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:24pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The foregoing certifications are made and delivered this ______ day of ___________________, 20___.</font></div><div style="margin-bottom:24pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#91;_________&#93;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:84pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Exhibit G-2</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><div id="i29d3ee780415406894d01c68f622cdf1_103"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SCHEDULE I TO COMPLIANCE CERTIFICATE</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">Schedule of Compliance as of&#160;&#160;&#160;&#160; ___________________, 20__ with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.02(b)(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> of the Agreement.  Unless otherwise defined herein, the terms used in this Compliance Certificate have the meanings ascribed thereto in the Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">This schedule relates to the month ended&#58; __________________.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">The following financial statements of the Parent and its Subsidiaries for the period ending on ______________, 20__, are attached hereto&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">Consolidated Total Leverage Ratio _____________ for the four consecutive fiscal quarter period ending&#58;  _________________.</font></div><div style="margin-bottom:72pt;text-align:justify;text-indent:72pt"><font><br></font></div><div id="i29d3ee780415406894d01c68f622cdf1_106"></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Exhibit G-3</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><div id="i29d3ee780415406894d01c68f622cdf1_109"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">EXHIBIT H</font></div><div style="margin-bottom:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Closing Memorandum</font></div><div style="margin-bottom:24pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(Attached)</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Exhibit H-1</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><div id="i29d3ee780415406894d01c68f622cdf1_112"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">EXHIBIT I</font></div><div style="margin-bottom:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Form of Interim Report</font></div><div style="margin-bottom:24pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(Attached)</font></div><div style="margin-bottom:48pt;text-align:center"><font><br></font></div><div style="margin-bottom:48pt;text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Exhibit I-1</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><div id="i29d3ee780415406894d01c68f622cdf1_115"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SCHEDULE I</font></div><div style="margin-bottom:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Commitments</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.710%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.824%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.166%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">PNC Group</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Party</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Capacity</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Maximum Commitment</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">PNC</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Committed Lender</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">$150,000,000</font></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">PNC</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Group Agent</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">N&#47;A</font></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Schedule I-1</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><div id="i29d3ee780415406894d01c68f622cdf1_118"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SCHEDULE II</font></div><div style="margin-bottom:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Lock-Boxes, Collection Accounts and Collection Account Banks</font></div><div style="padding-left:46.13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:80.448%"><tr><td style="width:1.0%"></td><td style="width:40.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.792%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.375%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Collection Account Bank</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Lock-Box</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Collection Account</font></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Bank of America, N.A.</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3756327238</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3756327238</font></td></tr></table></div><div style="margin-bottom:18pt"><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Schedule II-1</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><div id="i29d3ee780415406894d01c68f622cdf1_121"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SCHEDULE III</font></div><div style="margin-bottom:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Notice Addresses</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(A)&#160;&#160;&#160;&#160;in the case of the Borrower, at the following address&#58;</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Integra Receivables LLC</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1100 Campus Road</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Princeton, New Jersey 08540</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Attention&#58;  Timothy Swiss</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Telephone&#58;  609-936-6969</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Email&#58;  timothy.swiss&#64;integralife.com</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(B)&#160;&#160;&#160;&#160;in the case of the Servicer, at the following address&#58;</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Integra LifeSciences Sales LLC</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1100 Campus Road</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Princeton, New Jersey 08540</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Attention&#58;  Timothy Swiss</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Telephone&#58;  609-936-6969</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Email&#58;  timothy.swiss&#64;integralife.com </font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(C)&#160;&#160;&#160;&#160;in the case of PNC or the Administrative Agent, at the following address&#58;</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">PNC Bank, National Association</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">300 Fifth Avenue</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Pittsburgh, PA 15222</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Attention&#58;  Brian Stanley</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Telephone&#58;  (412) 768-2001</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Facsimile&#58;  (412) 803-7142</font></div><div style="margin-bottom:12pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Email&#58;  brian.stanley&#64;pnc.com</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(D)&#160;&#160;&#160;&#160;in the case of any other Person, at the address for such Person specified in the other Transaction Documents&#59; in each case, or at such other address as shall be designated by such Person in a written notice to the other parties to this Agreement.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Schedule III-1</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div><div id="i29d3ee780415406894d01c68f622cdf1_124"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SCHEDULE IV</font></div><div style="margin-bottom:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Excluded Obligors and Originators</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Excluded Obligors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#58;</font></div><div style="margin-bottom:30pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">None</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Excluded Originators (or sub-division or business unit thereof)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#58;</font></div><div style="margin-bottom:48pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">Integra Pain Management, a business unit or division of Integra LifeSciences Corporation</font></div><div style="margin-bottom:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Schedule IV-1</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Error! Unknown document property name.</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>3
<FILENAME>iart-20230331xexx311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ib596b94bcba8478ebc19e8b0899e95bb_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1 </font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certification of Principal Executive Officer </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to Section&#160;302 of the Sarbanes-Oxley Act of 2002 </font></div><div style="margin-top:9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Jan De Witte, certify that&#58;</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this quarterly report on Form 10-Q of Integra LifeSciences Holdings Corporation&#59;</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules&#160;13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and we have&#58;</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting&#59; and</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt"> The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.228%"><tr><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.694%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.613%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 26, 2023</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Jan De Witte</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jan De Witte</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">President and Chief Executive Officer</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>4
<FILENAME>iart-20230331xexx312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i11eaee5012ed4c09aa0f3e731f127283_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2 </font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certification of Principal Financial Officer </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to Section&#160;302 of the Sarbanes-Oxley Act of 2002 </font></div><div style="margin-top:9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Jeffrey A. Mosebrook, certify that&#58;</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this quarterly report on Form 10-Q of Integra LifeSciences Holdings Corporation&#59;</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules&#160;13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and we have&#58;</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting&#59; and</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt"> The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div><div><font><br></font></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.081%"><tr><td style="width:1.0%"></td><td style="width:7.246%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.769%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.685%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 26, 2023</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Jeffrey A. Mosebrook</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jeffrey A. Mosebrook</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Senior Vice President, Finance</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>5
<FILENAME>iart-20230331xexx321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i82efa29dec5643fbbba982b08e017166_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.1 </font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certification of Principal Executive Officer </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002 </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Quarterly Report of Integra LifeSciences Holdings Corporation (the &#8220;Company&#8221;) on Form 10-Q for the quarter ended March&#160;31, 2023 as filed with the Securities Exchange Commission on the date hereof (the &#8220;Report&#8221;), I, Jan De Witte, President and Chief Executive Officer of the Company, hereby certify, pursuant to 18 U.S.C. &#167;1350, as adopted pursuant to &#167;906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge&#58;</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The Report fully complies with the requirement of Section&#160;13(a) or Section&#160;15(d), as applicable, of the Securities Exchange Act of 1934, as amended&#59; and</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.473%"><tr><td style="width:1.0%"></td><td style="width:5.599%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.612%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.489%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 26, 2023</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Jan De Witte</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jan De Witte</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">President and Chief Executive Officer</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>6
<FILENAME>iart-20230331xexx322.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i6cd29815647d45fd9f2277e619d474dc_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.2 </font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certification of Principal Financial Officer </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002 </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Quarterly Report of Integra LifeSciences Holdings Corporation (the &#8220;Company&#8221;) on Form 10-Q for the quarter ended March&#160;31, 2023 as filed with the Securities Exchange Commission on the date hereof (the &#8220;Report&#8221;), I, Jeffrey A. Mosebrook, Senior Vice President, Finance of the Company, hereby certify, pursuant to 18 U.S.C. &#167;1350, as adopted pursuant to &#167;906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge&#58; </font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The Report fully complies with the requirement of Section&#160;13(a) or Section&#160;15(d), as applicable, of the Securities Exchange Act of 1934, as amended&#59; and</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.766%"><tr><td style="width:1.0%"></td><td style="width:5.903%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.457%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.340%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 26, 2023</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Jeffrey A. Mosebrook</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jeffrey A. Mosebrook</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Senior Vice President, Finance</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>7
<FILENAME>iart-20230331.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:0e3cd8f8-520d-473a-a9d1-16bfb1ec7d66,g:2b3f0039-4147-46cc-8b95-ac89c1bf8f8d-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:iart="http://integralife.com/20230331" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://integralife.com/20230331">
  <xs:import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2022" schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="iart-20230331_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="iart-20230331_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="iart-20230331_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="iart-20230331_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://integralife.com/role/Cover">
        <link:definition>0000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED" roleURI="http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED">
        <link:definition>0000002 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (UNAUDITED)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" roleURI="http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED">
        <link:definition>0000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITEDParenthetical" roleURI="http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITEDParenthetical">
        <link:definition>0000004 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" roleURI="http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED">
        <link:definition>0000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUNAUDITED" roleURI="http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUNAUDITED">
        <link:definition>0000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (UNAUDITED)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BASISOFPRESENTATION" roleURI="http://integralife.com/role/BASISOFPRESENTATION">
        <link:definition>0000007 - Disclosure - BASIS OF PRESENTATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACQUISITIONSANDDIVESTITURES" roleURI="http://integralife.com/role/ACQUISITIONSANDDIVESTITURES">
        <link:definition>0000008 - Disclosure - ACQUISITIONS AND DIVESTITURES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUESFROMCONTRACTSWITHCUSTOMERS" roleURI="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERS">
        <link:definition>0000009 - Disclosure - REVENUES FROM CONTRACTS WITH CUSTOMERS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVENTORIES" roleURI="http://integralife.com/role/INVENTORIES">
        <link:definition>0000010 - Disclosure - INVENTORIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDOTHERINTANGIBLEASSETS" roleURI="http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETS">
        <link:definition>0000011 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBT" roleURI="http://integralife.com/role/DEBT">
        <link:definition>0000012 - Disclosure - DEBT</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DERIVATIVEINSTRUMENTS" roleURI="http://integralife.com/role/DERIVATIVEINSTRUMENTS">
        <link:definition>0000013 - Disclosure - DERIVATIVE INSTRUMENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKBASEDCOMPENSATION" roleURI="http://integralife.com/role/STOCKBASEDCOMPENSATION">
        <link:definition>0000014 - Disclosure - STOCK-BASED COMPENSATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RETIREMENTPLANS" roleURI="http://integralife.com/role/RETIREMENTPLANS">
        <link:definition>0000015 - Disclosure - RETIREMENT PLANS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESANDRELATEDPARTYLEASES" roleURI="http://integralife.com/role/LEASESANDRELATEDPARTYLEASES">
        <link:definition>0000016 - Disclosure - LEASES AND RELATED PARTY LEASES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="TREASURYSTOCK" roleURI="http://integralife.com/role/TREASURYSTOCK">
        <link:definition>0000017 - Disclosure - TREASURY STOCK</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXES" roleURI="http://integralife.com/role/INCOMETAXES">
        <link:definition>0000018 - Disclosure - INCOME TAXES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NETINCOMEPERSHARE" roleURI="http://integralife.com/role/NETINCOMEPERSHARE">
        <link:definition>0000019 - Disclosure - NET INCOME PER SHARE</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSS" roleURI="http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSS">
        <link:definition>0000020 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTANDGEOGRAPHICINFORMATION" roleURI="http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATION">
        <link:definition>0000021 - Disclosure - SEGMENT AND GEOGRAPHIC INFORMATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COMMITMENTSANDCONTINGENCIES" roleURI="http://integralife.com/role/COMMITMENTSANDCONTINGENCIES">
        <link:definition>0000022 - Disclosure - COMMITMENTS AND CONTINGENCIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BASISOFPRESENTATIONPolicies" roleURI="http://integralife.com/role/BASISOFPRESENTATIONPolicies">
        <link:definition>0000023 - Disclosure - BASIS OF PRESENTATION (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACQUISITIONSANDDIVESTITURESTables" roleURI="http://integralife.com/role/ACQUISITIONSANDDIVESTITURESTables">
        <link:definition>0000024 - Disclosure - ACQUISITIONS AND DIVESTITURES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUESFROMCONTRACTSWITHCUSTOMERSTables" roleURI="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSTables">
        <link:definition>0000025 - Disclosure - REVENUES FROM CONTRACTS WITH CUSTOMERS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVENTORIESTables" roleURI="http://integralife.com/role/INVENTORIESTables">
        <link:definition>0000026 - Disclosure - INVENTORIES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDOTHERINTANGIBLEASSETSTables" roleURI="http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables">
        <link:definition>0000027 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBTTables" roleURI="http://integralife.com/role/DEBTTables">
        <link:definition>0000028 - Disclosure - DEBT (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DERIVATIVEINSTRUMENTSTables" roleURI="http://integralife.com/role/DERIVATIVEINSTRUMENTSTables">
        <link:definition>0000029 - Disclosure - DERIVATIVE INSTRUMENTS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESANDRELATEDPARTYLEASESTables" roleURI="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESTables">
        <link:definition>0000030 - Disclosure - LEASES AND RELATED PARTY LEASES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESTables" roleURI="http://integralife.com/role/INCOMETAXESTables">
        <link:definition>0000031 - Disclosure - INCOME TAXES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NETINCOMEPERSHARETables" roleURI="http://integralife.com/role/NETINCOMEPERSHARETables">
        <link:definition>0000032 - Disclosure - NET INCOME PER SHARE (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSTables" roleURI="http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSTables">
        <link:definition>0000033 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTANDGEOGRAPHICINFORMATIONTables" roleURI="http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTables">
        <link:definition>0000034 - Disclosure - SEGMENT AND GEOGRAPHIC INFORMATION (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COMMITMENTSANDCONTINGENCIESTables" roleURI="http://integralife.com/role/COMMITMENTSANDCONTINGENCIESTables">
        <link:definition>0000035 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACQUISITIONSANDDIVESTITURESBusinessCombinationNarrativeDetails" roleURI="http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationNarrativeDetails">
        <link:definition>0000036 - Disclosure - ACQUISITIONS AND DIVESTITURES- Business Combination, Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails" roleURI="http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails">
        <link:definition>0000037 - Disclosure - ACQUISITIONS AND DIVESTITURES - Business Combination, Schedule of Purchase Price Allocation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACQUISITIONSANDDIVESTITURESDivestituresNarrativeDetails" roleURI="http://integralife.com/role/ACQUISITIONSANDDIVESTITURESDivestituresNarrativeDetails">
        <link:definition>0000038 - Disclosure - ACQUISITIONS AND DIVESTITURES - Divestitures, Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeDetails" roleURI="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeDetails">
        <link:definition>0000039 - Disclosure - REVENUES FROM CONTRACTS WITH CUSTOMERS - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeRevenueRemainingPerformanceObligationDetails" roleURI="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeRevenueRemainingPerformanceObligationDetails">
        <link:definition>0000040 - Disclosure - REVENUES FROM CONTRACTS WITH CUSTOMERS - Narrative, Revenue Remaining Performance Obligation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeRevenueRemainingPerformanceObligationDetails_1" roleURI="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeRevenueRemainingPerformanceObligationDetails_1">
        <link:definition>0000040 - Disclosure - REVENUES FROM CONTRACTS WITH CUSTOMERS - Narrative, Revenue Remaining Performance Obligation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofChangesinContractAssetsandLiabilitiesDetails" roleURI="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofChangesinContractAssetsandLiabilitiesDetails">
        <link:definition>0000041 - Disclosure - REVENUES FROM CONTRACTS WITH CUSTOMERS - Schedule of Changes in Contract Assets and Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofRevenuesDisaggregatedbyMajorSourceDetails" roleURI="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofRevenuesDisaggregatedbyMajorSourceDetails">
        <link:definition>0000042 - Disclosure - REVENUES FROM CONTRACTS WITH CUSTOMERS - Schedule of Revenues Disaggregated by Major Source (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVENTORIESScheduleofNetInventoriesDetails" roleURI="http://integralife.com/role/INVENTORIESScheduleofNetInventoriesDetails">
        <link:definition>0000043 - Disclosure - INVENTORIES - Schedule of Net Inventories (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesinCarryingAmountofGoodwillDetails" roleURI="http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesinCarryingAmountofGoodwillDetails">
        <link:definition>0000044 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Schedule of Changes in Carrying Amount of Goodwill (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails" roleURI="http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails">
        <link:definition>0000045 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Components of Company's Identifiable Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails" roleURI="http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails">
        <link:definition>0000046 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBTNarrativeDetails" roleURI="http://integralife.com/role/DEBTNarrativeDetails">
        <link:definition>0000047 - Disclosure - DEBT - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBTMaximumTotalLeverageRatioTableDetails" roleURI="http://integralife.com/role/DEBTMaximumTotalLeverageRatioTableDetails">
        <link:definition>0000048 - Disclosure - DEBT - Maximum Total Leverage Ratio Table (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBTContractualMaturityTableDetails" roleURI="http://integralife.com/role/DEBTContractualMaturityTableDetails">
        <link:definition>0000049 - Disclosure - DEBT - Contractual Maturity Table (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DERIVATIVEINSTRUMENTSScheduleofDerivativeInstrumentsDetails" roleURI="http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofDerivativeInstrumentsDetails">
        <link:definition>0000050 - Disclosure - DERIVATIVE INSTRUMENTS - Schedule of Derivative Instruments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DERIVATIVEINSTRUMENTSNarrativeDetails" roleURI="http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails">
        <link:definition>0000051 - Disclosure - DERIVATIVE INSTRUMENTS - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails" roleURI="http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails">
        <link:definition>0000052 - Disclosure - DERIVATIVE INSTRUMENTS - Schedule of Cross Currency Swap Derivatives (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails" roleURI="http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails">
        <link:definition>0000053 - Disclosure - DERIVATIVE INSTRUMENTS - Schedule of Net Investment Hedges Derivatives (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails" roleURI="http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails">
        <link:definition>0000054 - Disclosure - DERIVATIVE INSTRUMENTS - Fair Value of Derivative Instruments By Balance Sheet Location (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails" roleURI="http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails">
        <link:definition>0000055 - Disclosure - DERIVATIVE INSTRUMENTS - Effect of Derivative Instruments Designated Cash Flow Hedges on Statements of Operations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DERIVATIVEINSTRUMENTSScheduleofDerivativesNotDesignatedasHedgingInstrumentsDetails" roleURI="http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofDerivativesNotDesignatedasHedgingInstrumentsDetails">
        <link:definition>0000056 - Disclosure - DERIVATIVE INSTRUMENTS - Schedule of Derivatives Not Designated as Hedging Instruments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKBASEDCOMPENSATIONNarrativeDetails" roleURI="http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails">
        <link:definition>0000057 - Disclosure - STOCK-BASED COMPENSATION - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RETIREMENTPLANSNarrativeDetails" roleURI="http://integralife.com/role/RETIREMENTPLANSNarrativeDetails">
        <link:definition>0000058 - Disclosure - RETIREMENT PLANS - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESANDRELATEDPARTYLEASESNarrativeDetails" roleURI="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESNarrativeDetails">
        <link:definition>0000059 - Disclosure - LEASES AND RELATED PARTY LEASES - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESANDRELATEDPARTYLEASESSupplementalBalanceSheetInformationDetails" roleURI="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalBalanceSheetInformationDetails">
        <link:definition>0000060 - Disclosure - LEASES AND RELATED PARTY LEASES - Supplemental Balance Sheet Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESANDRELATEDPARTYLEASESSupplementalCashFlowInformationDetails" roleURI="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalCashFlowInformationDetails">
        <link:definition>0000061 - Disclosure - LEASES AND RELATED PARTY LEASES - Supplemental Cash Flow Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesDetails" roleURI="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesDetails">
        <link:definition>0000062 - Disclosure - LEASES AND RELATED PARTY LEASES - Future Minimum Lease Payment Under Operating Leases (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesDetails_1" roleURI="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesDetails_1">
        <link:definition>0000062 - Disclosure - LEASES AND RELATED PARTY LEASES - Future Minimum Lease Payment Under Operating Leases (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="TREASURYSTOCKNarrativeDetails" roleURI="http://integralife.com/role/TREASURYSTOCKNarrativeDetails">
        <link:definition>0000063 - Disclosure - TREASURY STOCK - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESSummaryofEffectiveTaxRateDetails" roleURI="http://integralife.com/role/INCOMETAXESSummaryofEffectiveTaxRateDetails">
        <link:definition>0000064 - Disclosure - INCOME TAXES - Summary of Effective Tax Rate (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESNarrativeDetails" roleURI="http://integralife.com/role/INCOMETAXESNarrativeDetails">
        <link:definition>0000065 - Disclosure - INCOME TAXES - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NETINCOMEPERSHAREBasicandDilutedNetIncomePerShareDetails" roleURI="http://integralife.com/role/NETINCOMEPERSHAREBasicandDilutedNetIncomePerShareDetails">
        <link:definition>0000066 - Disclosure - NET INCOME PER SHARE - Basic and Diluted Net Income Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NETINCOMEPERSHARENarrativeDetails" roleURI="http://integralife.com/role/NETINCOMEPERSHARENarrativeDetails">
        <link:definition>0000067 - Disclosure - NET INCOME PER SHARE - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSScheduleofComprehensiveIncomeDetails" roleURI="http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSScheduleofComprehensiveIncomeDetails">
        <link:definition>0000068 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) - Schedule of Comprehensive Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails" roleURI="http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails">
        <link:definition>0000069 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) - Schedule of Changes in Accumulated Other Comprehensive Income by Component (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSNarrativeDetails" roleURI="http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSNarrativeDetails">
        <link:definition>0000070 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTANDGEOGRAPHICINFORMATIONNarrativeDetails" roleURI="http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNarrativeDetails">
        <link:definition>0000071 - Disclosure - SEGMENT AND GEOGRAPHIC INFORMATION - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails" roleURI="http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails">
        <link:definition>0000072 - Disclosure - SEGMENT AND GEOGRAPHIC INFORMATION - Net Sales and Profit by Reportable Segment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTANDGEOGRAPHICINFORMATIONTotalRevenuebyMajorGeographicAreaDetails" roleURI="http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTotalRevenuebyMajorGeographicAreaDetails">
        <link:definition>0000073 - Disclosure - SEGMENT AND GEOGRAPHIC INFORMATION - Total Revenue by Major Geographic Area (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails" roleURI="http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails">
        <link:definition>0000074 - Disclosure - COMMITMENTS AND CONTINGENCIES - Fair Value Contingent Consideration, Balance Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COMMITMENTSANDCONTINGENCIESNarrativeDetails" roleURI="http://integralife.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails">
        <link:definition>0000075 - Disclosure - COMMITMENTS AND CONTINGENCIES - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="iart_DebtCovenantPeriodDomain" abstract="true" name="DebtCovenantPeriodDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_PrivateLabelMember" abstract="true" name="PrivateLabelMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_CashFlowLesseeAbstract" abstract="true" name="CashFlowLesseeAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="iart_TermLoanFacilityMember" abstract="true" name="TermLoanFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_InterestPaymentsYearOne" abstract="false" name="InterestPaymentsYearOne" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_ExciseTaxPayableOnShareRepurchases" abstract="false" name="ExciseTaxPayableOnShareRepurchases" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_SecuredLongTermDebtSecuritizationProgramNoncurrent" abstract="false" name="SecuredLongTermDebtSecuritizationProgramNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_BusinessCombinationIntangibleAssetAcquiredDiscountRate" abstract="false" name="BusinessCombinationIntangibleAssetAcquiredDiscountRate" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="iart_ContractWithCustomerLiabilityIncreaseDecreaseFromForeignCurrencyTranslation" abstract="false" name="ContractWithCustomerLiabilityIncreaseDecreaseFromForeignCurrencyTranslation" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_SecuritizationFacilityFairValueOfAmountOutstanding" abstract="false" name="SecuritizationFacilityFairValueOfAmountOutstanding" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract" abstract="true" name="RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="iart_CodmanMember" abstract="true" name="CodmanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_EmployeeMember" abstract="true" name="EmployeeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_CrossCurrencyInterestRateContractThreeMember" abstract="true" name="CrossCurrencyInterestRateContractThreeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_InterestRateSwapDesignatedMarch312023Member" abstract="true" name="InterestRateSwapDesignatedMarch312023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_DebtInstrumentCombinationSettlementForDebtConversionMinimumSettledInCashPerPrincipalAmount" abstract="false" name="DebtInstrumentCombinationSettlementForDebtConversionMinimumSettledInCashPerPrincipalAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_SurgicalInnovationAssociatesIncMember" abstract="true" name="SurgicalInnovationAssociatesIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_IntercompanyLoanQuarterlyPayment" abstract="false" name="IntercompanyLoanQuarterlyPayment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_ACellIncMember" abstract="true" name="ACellIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_ArkisBioSciencesInc.Member" abstract="true" name="ArkisBioSciencesInc.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_AllOtherMember" abstract="true" name="AllOtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_BusinessCombinationContingentConsiderationNumberOfLiabilities" abstract="false" name="BusinessCombinationContingentConsiderationNumberOfLiabilities" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="iart_BusinessAcquisitionNumberOfContingentLiabilities" abstract="false" name="BusinessAcquisitionNumberOfContingentLiabilities" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="iart_AcceleratedShareRepurchasesAdditionalSharesReceived" abstract="false" name="AcceleratedShareRepurchasesAdditionalSharesReceived" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="iart_PercentOfManufacturingFacilityOwnedByCorporationWhoseShareholdersAreTrustsWhoseBeneficiariesIncludeFamilyMembersOfCompanysFormerDirector" abstract="false" name="PercentOfManufacturingFacilityOwnedByCorporationWhoseShareholdersAreTrustsWhoseBeneficiariesIncludeFamilyMembersOfCompanysFormerDirector" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="iart_FiveYearOptionLeasePeriodTwoMember" abstract="true" name="FiveYearOptionLeasePeriodTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage" abstract="false" name="DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="iart_SecuredLongTermDebtSecuritizationProgram" abstract="false" name="SecuredLongTermDebtSecuritizationProgram" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_InterestRateSwapDesignatedDecember182018Tranche2Member" abstract="true" name="InterestRateSwapDesignatedDecember182018Tranche2Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_DebtInstrumentMaximumSellingPriceOfCommonStockOfTheConversionPriceDuringPeriod" abstract="false" name="DebtInstrumentMaximumSellingPriceOfCommonStockOfTheConversionPriceDuringPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="iart_TrademarksBrandNamesMember" abstract="true" name="TrademarksBrandNamesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_DirectorsandCertainExecutiveOfficersMember" abstract="true" name="DirectorsandCertainExecutiveOfficersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_RestOfWorldMember" abstract="true" name="RestOfWorldMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_AnnualRateOfLeaseAgreement" abstract="false" name="AnnualRateOfLeaseAgreement" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_BioDEarnoutPaymentsandMedihoneyEarnoutPaymentsMember" abstract="true" name="BioDEarnoutPaymentsandMedihoneyEarnoutPaymentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_DebtInstrumentBasisSpreadAdjustmentOnVariableRate" abstract="false" name="DebtInstrumentBasisSpreadAdjustmentOnVariableRate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="iart_TransferorsInterestsInTransferredFinancialAssetsMaximumInvestmentLimit" abstract="false" name="TransferorsInterestsInTransferredFinancialAssetsMaximumInvestmentLimit" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_PaymentsForOptionIndexToIssuersEquity" abstract="false" name="PaymentsForOptionIndexToIssuersEquity" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_AcceleratedShareRepurchasesPercentageOfExpectedTotalRepurchased" abstract="false" name="AcceleratedShareRepurchasesPercentageOfExpectedTotalRepurchased" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="iart_FiveYearOptionLeasePeriodOneMember" abstract="true" name="FiveYearOptionLeasePeriodOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_AccruedExpensesAndOtherCurrentLiabilitiesMember" abstract="true" name="AccruedExpensesAndOtherCurrentLiabilitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_InterestRateSwapDesignatedDecember132017Tranche3Member" abstract="true" name="InterestRateSwapDesignatedDecember132017Tranche3Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_SegmentReportingInformationNumberOfProductsOffered" abstract="false" name="SegmentReportingInformationNumberOfProductsOffered" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="iart_ThirdPartiesMember" abstract="true" name="ThirdPartiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill" abstract="false" name="DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_InterestRateSwapDesignatedDecember152020Tranche2Member" abstract="true" name="InterestRateSwapDesignatedDecember152020Tranche2Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_RelatedPartiesMember" abstract="true" name="RelatedPartiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_InstrumentsMember" abstract="true" name="InstrumentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_ACellMember" abstract="true" name="ACellMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_InterestRateSwapDesignatedDecember182018Tranche1Member" abstract="true" name="InterestRateSwapDesignatedDecember182018Tranche1Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_DebtCovenantPeriod1Member" abstract="true" name="DebtCovenantPeriod1Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_CashFlowLesseeTableTextBlock" abstract="false" name="CashFlowLesseeTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="iart_AssetsAndLiabilitiesLesseeTableTextBlock" abstract="false" name="AssetsAndLiabilitiesLesseeTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="iart_DebtCovenantPeriod3Member" abstract="true" name="DebtCovenantPeriod3Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_InterestPaymentsYearTwo" abstract="false" name="InterestPaymentsYearTwo" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_InterestPaymentsReminderOfFiscalYear" abstract="false" name="InterestPaymentsReminderOfFiscalYear" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_ContractWithCustomerLiabilityNetOfRevenueRecognized" abstract="false" name="ContractWithCustomerLiabilityNetOfRevenueRecognized" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_LesseeOperatingLeaseNumberOfRenewalOptions" abstract="false" name="LesseeOperatingLeaseNumberOfRenewalOptions" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="iart_MilestonePaymentTwoMember" abstract="true" name="MilestonePaymentTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_DebtCovenantPeriod2Member" abstract="true" name="DebtCovenantPeriod2Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_DebtInstrumentCovenantMaximumLeverageRatio" abstract="false" name="DebtInstrumentCovenantMaximumLeverageRatio" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="iart_RegenerativeSkinAndWoundMember" abstract="true" name="RegenerativeSkinAndWoundMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_DiscontinuedOperationContinuingInvolvementPrepaidAssetsCurrent" abstract="false" name="DiscontinuedOperationContinuingInvolvementPrepaidAssetsCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_CompletedTechnologyMember" abstract="true" name="CompletedTechnologyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_LongTermDebtMaturityAfterYearThree" abstract="false" name="LongTermDebtMaturityAfterYearThree" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_InterestRateSwapDesignatedOctober102018Tranche1Member" abstract="true" name="InterestRateSwapDesignatedOctober102018Tranche1Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_AcceleratedShareRepurchasesSharesReceivedAtInception" abstract="false" name="AcceleratedShareRepurchasesSharesReceivedAtInception" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="iart_TissueTechnologiesMember" abstract="true" name="TissueTechnologiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_DebtCovenantPeriodAxis" abstract="true" name="DebtCovenantPeriodAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="iart_InterestPaymentsAfterYearThree" abstract="false" name="InterestPaymentsAfterYearThree" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_TwoThousandTwentyFiveSeniorConvertibleNotesMember" abstract="true" name="TwoThousandTwentyFiveSeniorConvertibleNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_ContractWithCustomerAssetNetOfReclassifiedToReceivable" abstract="false" name="ContractWithCustomerAssetNetOfReclassifiedToReceivable" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage" abstract="false" name="DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="iart_CrossCurrencyInterestRateContractOneMember" abstract="true" name="CrossCurrencyInterestRateContractOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_SupplierRelationShipsMember" abstract="true" name="SupplierRelationShipsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_DerivativeNotionalAmountTerminated" abstract="false" name="DerivativeNotionalAmountTerminated" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_SwinglineLoanMember" abstract="true" name="SwinglineLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_TraditionalWoundCareMember" abstract="true" name="TraditionalWoundCareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsideration" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsideration" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_RevenueProductWarrantyPeriod" abstract="false" name="RevenueProductWarrantyPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="iart_DiscontinuedOperationContinuingInvolvementPrepaidAsset" abstract="false" name="DiscontinuedOperationContinuingInvolvementPrepaidAsset" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_DermaSciencesMember" abstract="true" name="DermaSciencesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_FDAApprovalOfPremarketApprovalMember" abstract="true" name="FDAApprovalOfPremarketApprovalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_CodmanSpecialtySurgicalMember" abstract="true" name="CodmanSpecialtySurgicalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_ChangeInContractWithCustomerAssetRollForward" abstract="true" name="ChangeInContractWithCustomerAssetRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="iart_DebtInstrumentMaximumAverageConversionValueOfNotes" abstract="false" name="DebtInstrumentMaximumAverageConversionValueOfNotes" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="iart_ChangeInContractWithCustomerLiabilityRollForward" abstract="true" name="ChangeInContractWithCustomerLiabilityRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="iart_FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent" abstract="false" name="FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_InterestRateSwapDesignatedDecember152020Tranche1Member" abstract="true" name="InterestRateSwapDesignatedDecember152020Tranche1Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_MilestonePaymentOneMember" abstract="true" name="MilestonePaymentOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_NoncashLeaseExpense" abstract="false" name="NoncashLeaseExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_InterestRateSwapDesignatedOctober102018Tranche2Member" abstract="true" name="InterestRateSwapDesignatedOctober102018Tranche2Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_DebtWeightedAverageInterestRateFromSecuritization" abstract="false" name="DebtWeightedAverageInterestRateFromSecuritization" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="iart_AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees" abstract="false" name="AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_InterestPaymentsYearThree" abstract="false" name="InterestPaymentsYearThree" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iart_ReturnPolicyIssueOfCreditNumberOfDaysFromShipment" abstract="false" name="ReturnPolicyIssueOfCreditNumberOfDaysFromShipment" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="iart_SeniorCreditFacilityMember" abstract="true" name="SeniorCreditFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_ChangesInAssetsAndLiabilitiesAbstract" abstract="true" name="ChangesInAssetsAndLiabilitiesAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="iart_ContingentConsiderationLiabilityMember" abstract="true" name="ContingentConsiderationLiabilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_PerformanceStockAndRestrictedStockAwardsMember" abstract="true" name="PerformanceStockAndRestrictedStockAwardsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_InterestRateSwapDesignatedDecember132017Tranche2Member" abstract="true" name="InterestRateSwapDesignatedDecember132017Tranche2Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_CrossCurrencyInterestRateContractTwoMember" abstract="true" name="CrossCurrencyInterestRateContractTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_InterestRateSwapDesignatedOctober102018Tranche3Member" abstract="true" name="InterestRateSwapDesignatedOctober102018Tranche3Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsiderationPeriod" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsiderationPeriod" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="iart_NeurosurgeryMember" abstract="true" name="NeurosurgeryMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_RevenueBasedPerformanceMilestonesMember" abstract="true" name="RevenueBasedPerformanceMilestonesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iart_MergersAcquisitionsAndDispositionsAbstract" abstract="true" name="MergersAcquisitionsAndDispositionsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill" abstract="false" name="CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>8
<FILENAME>iart-20230331_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:0e3cd8f8-520d-473a-a9d1-16bfb1ec7d66,g:2b3f0039-4147-46cc-8b95-ac89c1bf8f8d-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED" xlink:type="simple" xlink:href="iart-20230331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED"/>
  <link:calculationLink xlink:role="http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_b0b222c9-ec7a-40c5-9844-bc4742ba2e74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_8e668210-4661-46fe-9d29-99a58dae4572" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_b0b222c9-ec7a-40c5-9844-bc4742ba2e74" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_8e668210-4661-46fe-9d29-99a58dae4572" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_61fa6085-d427-40b4-9fd3-7a0741855cd5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_b0b222c9-ec7a-40c5-9844-bc4742ba2e74" xlink:to="loc_us-gaap_CostsAndExpenses_61fa6085-d427-40b4-9fd3-7a0741855cd5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_af81f968-29d7-4f53-b0b0-b98b05fbb3e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_a5b8e145-7d14-45a8-b95f-ac0df8df033c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_af81f968-29d7-4f53-b0b0-b98b05fbb3e1" xlink:to="loc_us-gaap_OperatingIncomeLoss_a5b8e145-7d14-45a8-b95f-ac0df8df033c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_44a477e5-5989-4132-92de-8166236167cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_af81f968-29d7-4f53-b0b0-b98b05fbb3e1" xlink:to="loc_us-gaap_InvestmentIncomeInterest_44a477e5-5989-4132-92de-8166236167cd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_10e7d223-996d-42ca-bec6-87b270493746" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_af81f968-29d7-4f53-b0b0-b98b05fbb3e1" xlink:to="loc_us-gaap_InterestExpense_10e7d223-996d-42ca-bec6-87b270493746" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_e37b0484-3a67-4637-949f-fc86659a39a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_af81f968-29d7-4f53-b0b0-b98b05fbb3e1" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_e37b0484-3a67-4637-949f-fc86659a39a1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_62f5def6-561f-41e9-991f-daf873f2cd71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_75cebc7b-ecc1-4fdf-8a95-dc529495bc60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_62f5def6-561f-41e9-991f-daf873f2cd71" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_75cebc7b-ecc1-4fdf-8a95-dc529495bc60" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_39abf5d0-399e-457f-b1c8-2f908d266db3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_62f5def6-561f-41e9-991f-daf873f2cd71" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_39abf5d0-399e-457f-b1c8-2f908d266db3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_f4f00c7a-9a9a-453d-916f-352fa2fc4009" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_4176e5ef-2325-4e14-9f55-3be5b2d8e560" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_f4f00c7a-9a9a-453d-916f-352fa2fc4009" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_4176e5ef-2325-4e14-9f55-3be5b2d8e560" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_14df5b8a-9663-4910-b609-1f4f8ed0d5d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_f4f00c7a-9a9a-453d-916f-352fa2fc4009" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_14df5b8a-9663-4910-b609-1f4f8ed0d5d5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_b077356b-bf5d-4132-8ed1-7a2216f13c2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_f4f00c7a-9a9a-453d-916f-352fa2fc4009" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_b077356b-bf5d-4132-8ed1-7a2216f13c2d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_7e174099-3f3d-4927-8f20-115f8969b551" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_f4f00c7a-9a9a-453d-916f-352fa2fc4009" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_7e174099-3f3d-4927-8f20-115f8969b551" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" xlink:type="simple" xlink:href="iart-20230331.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"/>
  <link:calculationLink xlink:role="http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_4237e49b-0f43-4bec-9783-bd0d8dd34f54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtCurrent_73ee0297-7e7a-4289-bb17-91bd3c72dba4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebtCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_4237e49b-0f43-4bec-9783-bd0d8dd34f54" xlink:to="loc_us-gaap_SecuredDebtCurrent_73ee0297-7e7a-4289-bb17-91bd3c72dba4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_78d0c0c4-e033-48dc-bdd8-9edde473202f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_4237e49b-0f43-4bec-9783-bd0d8dd34f54" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_78d0c0c4-e033-48dc-bdd8-9edde473202f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableTradeCurrent_f8fad8fd-78f9-4c33-beaa-77721197002c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_4237e49b-0f43-4bec-9783-bd0d8dd34f54" xlink:to="loc_us-gaap_AccountsPayableTradeCurrent_f8fad8fd-78f9-4c33-beaa-77721197002c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_5f5650ec-3786-40cd-a432-5c0c632a2f64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_4237e49b-0f43-4bec-9783-bd0d8dd34f54" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_5f5650ec-3786-40cd-a432-5c0c632a2f64" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_5e7ad4f6-9dd4-4fff-80f5-e9035b930915" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_4237e49b-0f43-4bec-9783-bd0d8dd34f54" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_5e7ad4f6-9dd4-4fff-80f5-e9035b930915" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_f3cafdeb-f7d8-43b7-88fc-ce8d9ba580c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_4237e49b-0f43-4bec-9783-bd0d8dd34f54" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_f3cafdeb-f7d8-43b7-88fc-ce8d9ba580c6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_02c78b2a-fbfb-45b1-a609-50f57e877648" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_170431c9-b87c-4a03-a0f9-5459549f669f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_02c78b2a-fbfb-45b1-a609-50f57e877648" xlink:to="loc_us-gaap_LiabilitiesCurrent_170431c9-b87c-4a03-a0f9-5459549f669f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredLongTermDebt_e5e7462e-8958-49b7-b206-778e017e166d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredLongTermDebt"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_02c78b2a-fbfb-45b1-a609-50f57e877648" xlink:to="loc_us-gaap_SecuredLongTermDebt_e5e7462e-8958-49b7-b206-778e017e166d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SecuredLongTermDebtSecuritizationProgramNoncurrent_fd76707f-ba15-475b-ac05-89feb3e241e5" xlink:href="iart-20230331.xsd#iart_SecuredLongTermDebtSecuritizationProgramNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_02c78b2a-fbfb-45b1-a609-50f57e877648" xlink:to="loc_iart_SecuredLongTermDebtSecuritizationProgramNoncurrent_fd76707f-ba15-475b-ac05-89feb3e241e5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtNoncurrent_753c5111-a3b6-411c-86d6-b9af267450d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_02c78b2a-fbfb-45b1-a609-50f57e877648" xlink:to="loc_us-gaap_ConvertibleDebtNoncurrent_753c5111-a3b6-411c-86d6-b9af267450d8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_1f868df0-cd79-4ef7-9af3-4b9d03c9656d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_02c78b2a-fbfb-45b1-a609-50f57e877648" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_1f868df0-cd79-4ef7-9af3-4b9d03c9656d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_29bdd659-ac40-4967-8108-8b59c38412ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_02c78b2a-fbfb-45b1-a609-50f57e877648" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_29bdd659-ac40-4967-8108-8b59c38412ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_80603511-9ee6-43e2-a8e5-3caca4e2d4d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_02c78b2a-fbfb-45b1-a609-50f57e877648" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_80603511-9ee6-43e2-a8e5-3caca4e2d4d4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_48b6f0e6-c0f4-418e-9b3a-cd322a11f6a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_1c324190-1203-4c7d-bd59-7ab70cebf0c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_48b6f0e6-c0f4-418e-9b3a-cd322a11f6a3" xlink:to="loc_us-gaap_PreferredStockValue_1c324190-1203-4c7d-bd59-7ab70cebf0c8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_5a00bb21-e422-4c88-963d-1d7765fbc382" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_48b6f0e6-c0f4-418e-9b3a-cd322a11f6a3" xlink:to="loc_us-gaap_CommonStockValue_5a00bb21-e422-4c88-963d-1d7765fbc382" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_97df50c0-d841-4a27-91dd-fca3ffccf19d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_48b6f0e6-c0f4-418e-9b3a-cd322a11f6a3" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_97df50c0-d841-4a27-91dd-fca3ffccf19d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_f6ac3c92-527e-4f4a-8c29-dbdcc408f3ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValue"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_48b6f0e6-c0f4-418e-9b3a-cd322a11f6a3" xlink:to="loc_us-gaap_TreasuryStockValue_f6ac3c92-527e-4f4a-8c29-dbdcc408f3ec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_36b733f2-ef8b-4dd9-9b71-a19bb0d048e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_48b6f0e6-c0f4-418e-9b3a-cd322a11f6a3" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_36b733f2-ef8b-4dd9-9b71-a19bb0d048e5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_82e4d453-d487-46aa-b85c-b7ef66a0d8f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_48b6f0e6-c0f4-418e-9b3a-cd322a11f6a3" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_82e4d453-d487-46aa-b85c-b7ef66a0d8f2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_1a7b098c-74ea-4247-810e-f536ff85ce2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_73f455f6-0e61-481b-ab4f-e520d92b8267" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_1a7b098c-74ea-4247-810e-f536ff85ce2a" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_73f455f6-0e61-481b-ab4f-e520d92b8267" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_03dadd1d-7de6-46a4-be93-ccbf81c72647" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_1a7b098c-74ea-4247-810e-f536ff85ce2a" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_03dadd1d-7de6-46a4-be93-ccbf81c72647" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_9825dfea-b951-4231-9e79-94ee656d8ce9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_1a7b098c-74ea-4247-810e-f536ff85ce2a" xlink:to="loc_us-gaap_InventoryNet_9825dfea-b951-4231-9e79-94ee656d8ce9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_a02f28f1-a29d-4cbb-b099-324bae89a6c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_1a7b098c-74ea-4247-810e-f536ff85ce2a" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_a02f28f1-a29d-4cbb-b099-324bae89a6c8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_3bd1311e-5236-43ae-8c4a-f82e5bb52e79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_bf3d3008-c57f-4a52-bdb5-2c88ca136d0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_3bd1311e-5236-43ae-8c4a-f82e5bb52e79" xlink:to="loc_us-gaap_Liabilities_bf3d3008-c57f-4a52-bdb5-2c88ca136d0e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_e5565ed2-26dc-46aa-89dd-835c3e0274d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_3bd1311e-5236-43ae-8c4a-f82e5bb52e79" xlink:to="loc_us-gaap_StockholdersEquity_e5565ed2-26dc-46aa-89dd-835c3e0274d8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_96cbcf45-4bec-454f-a155-1d6c2cde4b83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_3aeb5915-7cfc-4dd4-be7d-665301e29452" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_96cbcf45-4bec-454f-a155-1d6c2cde4b83" xlink:to="loc_us-gaap_AssetsCurrent_3aeb5915-7cfc-4dd4-be7d-665301e29452" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_fee5dbed-9a25-4db2-8cc7-9b45065c83ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_96cbcf45-4bec-454f-a155-1d6c2cde4b83" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_fee5dbed-9a25-4db2-8cc7-9b45065c83ec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_2eb51cef-1303-4321-a950-be1bed87e43e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_96cbcf45-4bec-454f-a155-1d6c2cde4b83" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_2eb51cef-1303-4321-a950-be1bed87e43e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_6f05ff0e-29ba-4866-ac71-40f2b7e6e22e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_96cbcf45-4bec-454f-a155-1d6c2cde4b83" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_6f05ff0e-29ba-4866-ac71-40f2b7e6e22e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_b9008ff2-e14a-4c5f-b58c-d889a1a4423b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_96cbcf45-4bec-454f-a155-1d6c2cde4b83" xlink:to="loc_us-gaap_Goodwill_b9008ff2-e14a-4c5f-b58c-d889a1a4423b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_b636b3a7-7669-40f4-8f72-b7e265ff555d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_96cbcf45-4bec-454f-a155-1d6c2cde4b83" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_b636b3a7-7669-40f4-8f72-b7e265ff555d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_6739d091-7e18-4094-b15f-8f49224c6edf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_96cbcf45-4bec-454f-a155-1d6c2cde4b83" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_6739d091-7e18-4094-b15f-8f49224c6edf" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" xlink:type="simple" xlink:href="iart-20230331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"/>
  <link:calculationLink xlink:role="http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_65b173c3-3f2e-4de2-8a9c-7c943b64b688" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSecuredDebt_b523f8c2-66d6-4beb-ad6b-be9d5b32972d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSecuredDebt"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_65b173c3-3f2e-4de2-8a9c-7c943b64b688" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSecuredDebt_b523f8c2-66d6-4beb-ad6b-be9d5b32972d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSecuredDebt_e61b34de-a4d8-47ef-8d8b-c4cd73ab0966" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfSecuredDebt"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_65b173c3-3f2e-4de2-8a9c-7c943b64b688" xlink:to="loc_us-gaap_RepaymentsOfSecuredDebt_e61b34de-a4d8-47ef-8d8b-c4cd73ab0966" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_dde206a9-7871-42b3-ad7e-15fd46439a74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_65b173c3-3f2e-4de2-8a9c-7c943b64b688" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_dde206a9-7871-42b3-ad7e-15fd46439a74" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_cbea036b-be05-4499-b1e2-2409f750945f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_65b173c3-3f2e-4de2-8a9c-7c943b64b688" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_cbea036b-be05-4499-b1e2-2409f750945f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_06337789-daa7-4cf2-86bc-3f20a026e0eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_65b173c3-3f2e-4de2-8a9c-7c943b64b688" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_06337789-daa7-4cf2-86bc-3f20a026e0eb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_c0fc7ce3-87ff-4650-92c7-74ad0c563741" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_65b173c3-3f2e-4de2-8a9c-7c943b64b688" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_c0fc7ce3-87ff-4650-92c7-74ad0c563741" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_8f428e09-4ca8-4bee-bbc1-37bf86400172" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_bdc681fd-cca7-4add-a730-0a9903c90f0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_8f428e09-4ca8-4bee-bbc1-37bf86400172" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_bdc681fd-cca7-4add-a730-0a9903c90f0d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment_12021fec-9afb-470b-b858-8c681208521a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_8f428e09-4ca8-4bee-bbc1-37bf86400172" xlink:to="loc_us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment_12021fec-9afb-470b-b858-8c681208521a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_78969b5f-7ef4-4673-aa6d-76d507465682" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_05a2ae43-d9da-443c-86db-6a66f82e3dd9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_78969b5f-7ef4-4673-aa6d-76d507465682" xlink:to="loc_us-gaap_NetIncomeLoss_05a2ae43-d9da-443c-86db-6a66f82e3dd9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDepreciationAndAmortization_0f2bd523-db1b-4a1f-8f30-45b6ac05927f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherDepreciationAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_78969b5f-7ef4-4673-aa6d-76d507465682" xlink:to="loc_us-gaap_OtherDepreciationAndAmortization_0f2bd523-db1b-4a1f-8f30-45b6ac05927f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_5def4e2c-2267-481b-a0c7-a4868296bec0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_78969b5f-7ef4-4673-aa6d-76d507465682" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_5def4e2c-2267-481b-a0c7-a4868296bec0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_af81cf30-2101-4ba3-8131-ef0185bdf459" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_78969b5f-7ef4-4673-aa6d-76d507465682" xlink:to="loc_us-gaap_ShareBasedCompensation_af81cf30-2101-4ba3-8131-ef0185bdf459" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees_33a7fd87-8df1-4077-9605-b13455dc7118" xlink:href="iart-20230331.xsd#iart_AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_78969b5f-7ef4-4673-aa6d-76d507465682" xlink:to="loc_iart_AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees_33a7fd87-8df1-4077-9605-b13455dc7118" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_NoncashLeaseExpense_7c2f896a-fa92-4d5e-aec1-569675699935" xlink:href="iart-20230331.xsd#iart_NoncashLeaseExpense"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_78969b5f-7ef4-4673-aa6d-76d507465682" xlink:to="loc_iart_NoncashLeaseExpense_7c2f896a-fa92-4d5e-aec1-569675699935" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets_52c5a81f-6ed4-433d-97ec-0e8c8a38bec5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnDispositionOfAssets"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_78969b5f-7ef4-4673-aa6d-76d507465682" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets_52c5a81f-6ed4-433d-97ec-0e8c8a38bec5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_ceba225f-9932-4ca0-ad81-344f72e2f0c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_78969b5f-7ef4-4673-aa6d-76d507465682" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_ceba225f-9932-4ca0-ad81-344f72e2f0c9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_1504af29-1d1c-4f45-a289-69bce94e51c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_78969b5f-7ef4-4673-aa6d-76d507465682" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_1504af29-1d1c-4f45-a289-69bce94e51c6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_f8c8bde7-a0c3-4b1e-ae85-a5cb407e56d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_78969b5f-7ef4-4673-aa6d-76d507465682" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_f8c8bde7-a0c3-4b1e-ae85-a5cb407e56d8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_33953d9b-f60a-40eb-97c0-a50749af3da5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_78969b5f-7ef4-4673-aa6d-76d507465682" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_33953d9b-f60a-40eb-97c0-a50749af3da5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_69003421-1712-4a5b-8479-09d3ada1bf44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_78969b5f-7ef4-4673-aa6d-76d507465682" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_69003421-1712-4a5b-8479-09d3ada1bf44" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_45ed5fc8-a3cd-470c-98a7-9aedb882b539" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_78969b5f-7ef4-4673-aa6d-76d507465682" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_45ed5fc8-a3cd-470c-98a7-9aedb882b539" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_e6657023-3ec4-47a1-a840-95b1331edf24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_78969b5f-7ef4-4673-aa6d-76d507465682" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_e6657023-3ec4-47a1-a840-95b1331edf24" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_e73b8878-f034-4a57-91d7-538f07147c6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4c909c61-95bf-4f95-bc1e-ce4519c119b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_e73b8878-f034-4a57-91d7-538f07147c6f" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4c909c61-95bf-4f95-bc1e-ce4519c119b2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_905d12d1-6fb3-44bf-8f7c-b86b5d85b746" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_e73b8878-f034-4a57-91d7-538f07147c6f" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_905d12d1-6fb3-44bf-8f7c-b86b5d85b746" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d7e934fd-d950-4638-805e-1753f06ad663" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_e73b8878-f034-4a57-91d7-538f07147c6f" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d7e934fd-d950-4638-805e-1753f06ad663" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_db6e024f-f2ff-4ab0-8b80-f2851f31c967" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_e73b8878-f034-4a57-91d7-538f07147c6f" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_db6e024f-f2ff-4ab0-8b80-f2851f31c967" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails" xlink:type="simple" xlink:href="iart-20230331.xsd#ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails"/>
  <link:calculationLink xlink:role="http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_df142d21-0f6e-41e4-8326-1c1f795b413f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_17b1a112-de42-4173-b8c1-0e2254d6f538" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_df142d21-0f6e-41e4-8326-1c1f795b413f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_17b1a112-de42-4173-b8c1-0e2254d6f538" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_a545f594-37bf-45ec-a16a-a01f723b7643" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_997a846f-e244-4927-983a-91e663de8902" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_a545f594-37bf-45ec-a16a-a01f723b7643" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_997a846f-e244-4927-983a-91e663de8902" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability_651ee237-dfcb-48cd-8043-20fa74c80005" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_a545f594-37bf-45ec-a16a-a01f723b7643" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability_651ee237-dfcb-48cd-8043-20fa74c80005" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_90a9fa8a-9e74-4785-93c7-8266d7a9888d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_a545f594-37bf-45ec-a16a-a01f723b7643" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_90a9fa8a-9e74-4785-93c7-8266d7a9888d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_3fe58ccc-0e0d-434f-baf4-234115698731" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_5249233a-2912-4363-971b-1c8bef0d46ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_3fe58ccc-0e0d-434f-baf4-234115698731" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_5249233a-2912-4363-971b-1c8bef0d46ed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_8d1802d4-9317-4f22-9d7b-56e552af4f08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_3fe58ccc-0e0d-434f-baf4-234115698731" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_8d1802d4-9317-4f22-9d7b-56e552af4f08" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_f26adc18-a7aa-44e2-be55-0a36f133c43a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_3fe58ccc-0e0d-434f-baf4-234115698731" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_f26adc18-a7aa-44e2-be55-0a36f133c43a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_6908d4b7-763d-4733-9c1b-180edc41ff43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_3fe58ccc-0e0d-434f-baf4-234115698731" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_6908d4b7-763d-4733-9c1b-180edc41ff43" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_2c27c94d-e255-4302-baa4-3f770639b52a" xlink:href="iart-20230331.xsd#iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_1b2c7850-8586-4a4a-90a9-14f86cab58cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_2c27c94d-e255-4302-baa4-3f770639b52a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_1b2c7850-8586-4a4a-90a9-14f86cab58cb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_b36ad43e-909b-41e3-b1cd-0f09ae366113" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_2c27c94d-e255-4302-baa4-3f770639b52a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_b36ad43e-909b-41e3-b1cd-0f09ae366113" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_cdcc7d2a-4da3-4f8f-84a4-981be46bb1a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_2c27c94d-e255-4302-baa4-3f770639b52a" xlink:to="loc_us-gaap_Goodwill_cdcc7d2a-4da3-4f8f-84a4-981be46bb1a0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_e789f85f-4428-437e-839f-9fe0ab65ed1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_463d4005-ec3c-4b09-97d0-3677a39441db" xlink:href="iart-20230331.xsd#iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_e789f85f-4428-437e-839f-9fe0ab65ed1d" xlink:to="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_463d4005-ec3c-4b09-97d0-3677a39441db" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_f0233e48-ad3d-4efd-8c03-8ee7ae351bce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_e789f85f-4428-437e-839f-9fe0ab65ed1d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_f0233e48-ad3d-4efd-8c03-8ee7ae351bce" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://integralife.com/role/INVENTORIESScheduleofNetInventoriesDetails" xlink:type="simple" xlink:href="iart-20230331.xsd#INVENTORIESScheduleofNetInventoriesDetails"/>
  <link:calculationLink xlink:role="http://integralife.com/role/INVENTORIESScheduleofNetInventoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_459d2120-6591-4e0a-b0eb-465e10ad10d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_84c34414-b71b-44c0-95f7-b06c3880951f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_459d2120-6591-4e0a-b0eb-465e10ad10d8" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_84c34414-b71b-44c0-95f7-b06c3880951f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_e7272305-5fa0-41fd-b725-d2633afb374f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_459d2120-6591-4e0a-b0eb-465e10ad10d8" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_e7272305-5fa0-41fd-b725-d2633afb374f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsAndPurchasedPartsNetOfReserves_41f3428d-4032-4c05-b19a-b42bfa1aae93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterialsAndPurchasedPartsNetOfReserves"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_459d2120-6591-4e0a-b0eb-465e10ad10d8" xlink:to="loc_us-gaap_InventoryRawMaterialsAndPurchasedPartsNetOfReserves_41f3428d-4032-4c05-b19a-b42bfa1aae93" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails" xlink:type="simple" xlink:href="iart-20230331.xsd#GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails"/>
  <link:calculationLink xlink:role="http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill_12d1c9a4-3940-482a-a646-52563764a530" xlink:href="iart-20230331.xsd#iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill_c45cc3cb-04e0-4728-9d98-0dafe207237c" xlink:href="iart-20230331.xsd#iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill_12d1c9a4-3940-482a-a646-52563764a530" xlink:to="loc_iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill_c45cc3cb-04e0-4728-9d98-0dafe207237c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_d12ff2e5-bfa7-4ddc-9708-2a72c73592ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill_12d1c9a4-3940-482a-a646-52563764a530" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_d12ff2e5-bfa7-4ddc-9708-2a72c73592ad" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://integralife.com/role/DEBTContractualMaturityTableDetails" xlink:type="simple" xlink:href="iart-20230331.xsd#DEBTContractualMaturityTableDetails"/>
  <link:calculationLink xlink:role="http://integralife.com/role/DEBTContractualMaturityTableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_7f4a3b2d-9c27-4d62-8df6-e87ee18cd18a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_e9a3cb92-c8a7-45b4-81d0-52b424676ffe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_7f4a3b2d-9c27-4d62-8df6-e87ee18cd18a" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_e9a3cb92-c8a7-45b4-81d0-52b424676ffe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_a2f30ae0-2c88-4999-9aef-ff1a1fd71141" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_7f4a3b2d-9c27-4d62-8df6-e87ee18cd18a" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_a2f30ae0-2c88-4999-9aef-ff1a1fd71141" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_15fee7b7-8c69-42fe-b29a-369fbde3229d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_7f4a3b2d-9c27-4d62-8df6-e87ee18cd18a" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_15fee7b7-8c69-42fe-b29a-369fbde3229d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_14593c20-e4fb-4c86-9f56-b3f60d0d176e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_7f4a3b2d-9c27-4d62-8df6-e87ee18cd18a" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_14593c20-e4fb-4c86-9f56-b3f60d0d176e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_LongTermDebtMaturityAfterYearThree_f1f5cb24-e8e5-4aeb-ab87-e0029a4fec85" xlink:href="iart-20230331.xsd#iart_LongTermDebtMaturityAfterYearThree"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_7f4a3b2d-9c27-4d62-8df6-e87ee18cd18a" xlink:to="loc_iart_LongTermDebtMaturityAfterYearThree_f1f5cb24-e8e5-4aeb-ab87-e0029a4fec85" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesDetails" xlink:type="simple" xlink:href="iart-20230331.xsd#LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesDetails"/>
  <link:calculationLink xlink:role="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_bf05715f-e86b-4b0a-9a7b-3bc4d7688a9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_f21be5de-a995-4056-b82f-85f2cda6366e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_bf05715f-e86b-4b0a-9a7b-3bc4d7688a9a" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_f21be5de-a995-4056-b82f-85f2cda6366e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_0321267a-21e4-45f7-9a1e-d85705962066" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_bf05715f-e86b-4b0a-9a7b-3bc4d7688a9a" xlink:to="loc_us-gaap_OperatingLeaseLiability_0321267a-21e4-45f7-9a1e-d85705962066" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_491b95a9-4ca5-4d31-9210-3591b484bc49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_396568e8-439b-4eaa-9a55-abcd3bd20fff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_491b95a9-4ca5-4d31-9210-3591b484bc49" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_396568e8-439b-4eaa-9a55-abcd3bd20fff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_6398099c-1430-4d38-944c-0c9fba332568" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_491b95a9-4ca5-4d31-9210-3591b484bc49" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_6398099c-1430-4d38-944c-0c9fba332568" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesDetails_1" xlink:type="simple" xlink:href="iart-20230331.xsd#LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesDetails_1"/>
  <link:calculationLink xlink:role="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_e135f72a-d9c4-423a-bed0-074ad42e7c9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_d2842a08-f86b-42b5-ad70-44058a614b6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_e135f72a-d9c4-423a-bed0-074ad42e7c9c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_d2842a08-f86b-42b5-ad70-44058a614b6f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_1e0e6536-3d07-4fd6-bd1a-1afefd7cbf71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_e135f72a-d9c4-423a-bed0-074ad42e7c9c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_1e0e6536-3d07-4fd6-bd1a-1afefd7cbf71" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_2a6ae266-0abf-4c3f-9aed-1ec5b80ac2f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_e135f72a-d9c4-423a-bed0-074ad42e7c9c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_2a6ae266-0abf-4c3f-9aed-1ec5b80ac2f7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_216415d5-90e3-4d91-8b67-cc7ca671177f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_e135f72a-d9c4-423a-bed0-074ad42e7c9c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_216415d5-90e3-4d91-8b67-cc7ca671177f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_312a3812-5e7d-4e63-9006-e2ddb31122bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_e135f72a-d9c4-423a-bed0-074ad42e7c9c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_312a3812-5e7d-4e63-9006-e2ddb31122bd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_df5514df-7427-45a3-b377-cc1509ef0ea7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_e135f72a-d9c4-423a-bed0-074ad42e7c9c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_df5514df-7427-45a3-b377-cc1509ef0ea7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_cfc4cacc-eaf2-4e49-aa93-d336b685ca6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_e135f72a-d9c4-423a-bed0-074ad42e7c9c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_cfc4cacc-eaf2-4e49-aa93-d336b685ca6d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://integralife.com/role/NETINCOMEPERSHAREBasicandDilutedNetIncomePerShareDetails" xlink:type="simple" xlink:href="iart-20230331.xsd#NETINCOMEPERSHAREBasicandDilutedNetIncomePerShareDetails"/>
  <link:calculationLink xlink:role="http://integralife.com/role/NETINCOMEPERSHAREBasicandDilutedNetIncomePerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_c3a3e377-830d-47b2-9212-09e080c2aad7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_e7d70e86-94f0-42f5-9aa2-fa25e1027f3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_c3a3e377-830d-47b2-9212-09e080c2aad7" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_e7d70e86-94f0-42f5-9aa2-fa25e1027f3e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_fe75fcf2-22ee-4f35-a6b3-8daf733032b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_c3a3e377-830d-47b2-9212-09e080c2aad7" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_fe75fcf2-22ee-4f35-a6b3-8daf733032b1" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSScheduleofComprehensiveIncomeDetails" xlink:type="simple" xlink:href="iart-20230331.xsd#ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSScheduleofComprehensiveIncomeDetails"/>
  <link:calculationLink xlink:role="http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSScheduleofComprehensiveIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_aed54645-0c77-4382-a7c1-48b140fdad79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_d4fb7414-a714-489c-ab57-7e3f461b6bd2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_aed54645-0c77-4382-a7c1-48b140fdad79" xlink:to="loc_us-gaap_NetIncomeLoss_d4fb7414-a714-489c-ab57-7e3f461b6bd2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_7d0dbf37-79b4-49fd-b53b-2abd4f878a30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_aed54645-0c77-4382-a7c1-48b140fdad79" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_7d0dbf37-79b4-49fd-b53b-2abd4f878a30" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent_ec99544e-9511-474e-b883-fc1a311b5e55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_aed54645-0c77-4382-a7c1-48b140fdad79" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent_ec99544e-9511-474e-b883-fc1a311b5e55" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_9d9692f7-f62b-4d7c-b142-9c897cd1623e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_aed54645-0c77-4382-a7c1-48b140fdad79" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_9d9692f7-f62b-4d7c-b142-9c897cd1623e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails" xlink:type="simple" xlink:href="iart-20230331.xsd#ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails"/>
  <link:calculationLink xlink:role="http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_af39bca2-fa87-4a78-94fb-6285ca3d7d19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_ab9f3e46-8172-436c-a9ac-2535e1ac4562" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_af39bca2-fa87-4a78-94fb-6285ca3d7d19" xlink:to="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_ab9f3e46-8172-436c-a9ac-2535e1ac4562" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_822c1924-ca41-4943-9019-4c085cd56398" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_af39bca2-fa87-4a78-94fb-6285ca3d7d19" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_822c1924-ca41-4943-9019-4c085cd56398" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>9
<FILENAME>iart-20230331_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:0e3cd8f8-520d-473a-a9d1-16bfb1ec7d66,g:2b3f0039-4147-46cc-8b95-ac89c1bf8f8d-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUNAUDITED" xlink:type="simple" xlink:href="iart-20230331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUNAUDITED"/>
  <link:definitionLink xlink:role="http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUNAUDITED" xlink:type="extended" id="i80702d731590436194d9a5f19c92169a_CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUNAUDITED">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_ea89147b-d050-4400-9cd2-bbe332551498" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_84444d4a-08bc-41cc-8fc5-8478f10075e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ea89147b-d050-4400-9cd2-bbe332551498" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_84444d4a-08bc-41cc-8fc5-8478f10075e9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_aa8a8ca8-c862-4f5d-916d-809218d78496" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_84444d4a-08bc-41cc-8fc5-8478f10075e9" xlink:to="loc_us-gaap_SharesIssued_aa8a8ca8-c862-4f5d-916d-809218d78496" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_bdd0578f-cf0d-402e-b35b-68dab7391d29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_84444d4a-08bc-41cc-8fc5-8478f10075e9" xlink:to="loc_us-gaap_StockholdersEquity_bdd0578f-cf0d-402e-b35b-68dab7391d29" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_4a25069c-be6e-4691-9576-4f9ad48e9313" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_84444d4a-08bc-41cc-8fc5-8478f10075e9" xlink:to="loc_us-gaap_TreasuryStockShares_4a25069c-be6e-4691-9576-4f9ad48e9313" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_551bd3de-ffab-4415-bb8d-a225f59bffbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_84444d4a-08bc-41cc-8fc5-8478f10075e9" xlink:to="loc_us-gaap_NetIncomeLoss_551bd3de-ffab-4415-bb8d-a225f59bffbd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_9c01a171-ff58-4220-a194-8c9b77133025" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_84444d4a-08bc-41cc-8fc5-8478f10075e9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_9c01a171-ff58-4220-a194-8c9b77133025" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_b3269622-8c75-4ec7-93b8-a4266b9d3466" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_84444d4a-08bc-41cc-8fc5-8478f10075e9" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_b3269622-8c75-4ec7-93b8-a4266b9d3466" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_a6237c5f-2163-4f47-ac23-3257e51ba00f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_84444d4a-08bc-41cc-8fc5-8478f10075e9" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_a6237c5f-2163-4f47-ac23-3257e51ba00f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_2f21c9de-d624-4a2d-a4e8-16b7acec57c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_84444d4a-08bc-41cc-8fc5-8478f10075e9" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_2f21c9de-d624-4a2d-a4e8-16b7acec57c5" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_09939b38-a818-42bc-8e96-5a04688eab66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_84444d4a-08bc-41cc-8fc5-8478f10075e9" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_09939b38-a818-42bc-8e96-5a04688eab66" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_b628c90e-a581-45d0-ac68-bdd1eccf37dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_84444d4a-08bc-41cc-8fc5-8478f10075e9" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_b628c90e-a581-45d0-ac68-bdd1eccf37dc" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_18663ec6-47f5-4ff5-935a-ce529e0ea99f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_84444d4a-08bc-41cc-8fc5-8478f10075e9" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_18663ec6-47f5-4ff5-935a-ce529e0ea99f" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_ef92b9a8-f8c0-4cf2-90d2-5efd8bcd62a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_84444d4a-08bc-41cc-8fc5-8478f10075e9" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_ef92b9a8-f8c0-4cf2-90d2-5efd8bcd62a0" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_e059c8b6-b45e-4b89-a8ff-2aef3544f7cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssued"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_f07b5163-dd19-49a3-8f0b-121643c74e7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_ee2c8f69-7374-4fb0-b963-f66a1ffec991" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockShares"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_ef97a230-a586-41bf-92fb-aa05afb9321b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_ea89147b-d050-4400-9cd2-bbe332551498" xlink:to="loc_us-gaap_StatementTable_ef97a230-a586-41bf-92fb-aa05afb9321b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_35cba81b-6606-475d-875a-223d5e248ef2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_ef97a230-a586-41bf-92fb-aa05afb9321b" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_35cba81b-6606-475d-875a-223d5e248ef2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_35cba81b-6606-475d-875a-223d5e248ef2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_35cba81b-6606-475d-875a-223d5e248ef2" xlink:to="loc_us-gaap_EquityComponentDomain_35cba81b-6606-475d-875a-223d5e248ef2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_a046491c-3532-4af1-89d4-14294a458803" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_35cba81b-6606-475d-875a-223d5e248ef2" xlink:to="loc_us-gaap_EquityComponentDomain_a046491c-3532-4af1-89d4-14294a458803" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_b0829400-d678-4781-a8e0-63431e80bffc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_a046491c-3532-4af1-89d4-14294a458803" xlink:to="loc_us-gaap_CommonStockMember_b0829400-d678-4781-a8e0-63431e80bffc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_8733ef3a-c31e-40fb-af85-d497e5fd2595" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_a046491c-3532-4af1-89d4-14294a458803" xlink:to="loc_us-gaap_TreasuryStockMember_8733ef3a-c31e-40fb-af85-d497e5fd2595" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_095dd3c5-8435-4841-9df3-00db061ccb61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_a046491c-3532-4af1-89d4-14294a458803" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_095dd3c5-8435-4841-9df3-00db061ccb61" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_c9c6cddf-c959-4f22-8f22-5a4cf529f857" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_a046491c-3532-4af1-89d4-14294a458803" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_c9c6cddf-c959-4f22-8f22-5a4cf529f857" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_57dd2bb8-6da0-4c6b-b2fe-eec44354b41b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_a046491c-3532-4af1-89d4-14294a458803" xlink:to="loc_us-gaap_RetainedEarningsMember_57dd2bb8-6da0-4c6b-b2fe-eec44354b41b" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationNarrativeDetails" xlink:type="simple" xlink:href="iart-20230331.xsd#ACQUISITIONSANDDIVESTITURESBusinessCombinationNarrativeDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationNarrativeDetails" xlink:type="extended" id="ia670227bc55e4a4ba7dc80db53874b40_ACQUISITIONSANDDIVESTITURESBusinessCombinationNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_e550aa6e-a1fb-4c18-9fce-d507f125b030" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_0804ae04-a64b-4533-980f-60a9c2825503" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e550aa6e-a1fb-4c18-9fce-d507f125b030" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_0804ae04-a64b-4533-980f-60a9c2825503" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_BusinessAcquisitionNumberOfContingentLiabilities_82536f50-8992-4bc6-be4c-141a0cfd2370" xlink:href="iart-20230331.xsd#iart_BusinessAcquisitionNumberOfContingentLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e550aa6e-a1fb-4c18-9fce-d507f125b030" xlink:to="loc_iart_BusinessAcquisitionNumberOfContingentLiabilities_82536f50-8992-4bc6-be4c-141a0cfd2370" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_7f89a141-24d6-46ab-8a04-77a4c45e2685" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e550aa6e-a1fb-4c18-9fce-d507f125b030" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_7f89a141-24d6-46ab-8a04-77a4c45e2685" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_BusinessCombinationIntangibleAssetAcquiredDiscountRate_b4b29c64-575f-4d8d-b18d-49ff7b84d03f" xlink:href="iart-20230331.xsd#iart_BusinessCombinationIntangibleAssetAcquiredDiscountRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e550aa6e-a1fb-4c18-9fce-d507f125b030" xlink:to="loc_iart_BusinessCombinationIntangibleAssetAcquiredDiscountRate_b4b29c64-575f-4d8d-b18d-49ff7b84d03f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_b78ab744-c01e-4edb-9551-94178537fac8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e550aa6e-a1fb-4c18-9fce-d507f125b030" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_b78ab744-c01e-4edb-9551-94178537fac8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_8fdd789c-0a35-4b66-8dfa-f7b5b28b5756" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e550aa6e-a1fb-4c18-9fce-d507f125b030" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_8fdd789c-0a35-4b66-8dfa-f7b5b28b5756" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_b1ed6389-719e-4eda-a091-34e6a51f42bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e550aa6e-a1fb-4c18-9fce-d507f125b030" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_b1ed6389-719e-4eda-a091-34e6a51f42bd" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_caf8a69d-b700-4267-b3d2-27919c840f50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e550aa6e-a1fb-4c18-9fce-d507f125b030" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_caf8a69d-b700-4267-b3d2-27919c840f50" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_356e3d5b-13f6-4c0d-80e1-bc4c646c73c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_caf8a69d-b700-4267-b3d2-27919c840f50" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_356e3d5b-13f6-4c0d-80e1-bc4c646c73c9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_356e3d5b-13f6-4c0d-80e1-bc4c646c73c9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_356e3d5b-13f6-4c0d-80e1-bc4c646c73c9" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_356e3d5b-13f6-4c0d-80e1-bc4c646c73c9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9442030e-f7df-4582-9ab4-e34b18b98225" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_356e3d5b-13f6-4c0d-80e1-bc4c646c73c9" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9442030e-f7df-4582-9ab4-e34b18b98225" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SurgicalInnovationAssociatesIncMember_4d4b967c-ba06-48b6-abd2-7658dfdf81bc" xlink:href="iart-20230331.xsd#iart_SurgicalInnovationAssociatesIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9442030e-f7df-4582-9ab4-e34b18b98225" xlink:to="loc_iart_SurgicalInnovationAssociatesIncMember_4d4b967c-ba06-48b6-abd2-7658dfdf81bc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_206def7f-6d62-4def-866f-c7269fa672a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_caf8a69d-b700-4267-b3d2-27919c840f50" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_206def7f-6d62-4def-866f-c7269fa672a5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_206def7f-6d62-4def-866f-c7269fa672a5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_206def7f-6d62-4def-866f-c7269fa672a5" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_206def7f-6d62-4def-866f-c7269fa672a5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_226dcaa9-9490-487f-9b11-ef6e93235bda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_206def7f-6d62-4def-866f-c7269fa672a5" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_226dcaa9-9490-487f-9b11-ef6e93235bda" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_RevenueBasedPerformanceMilestonesMember_fab407a8-b675-45b4-8ca2-50a3411d1e56" xlink:href="iart-20230331.xsd#iart_RevenueBasedPerformanceMilestonesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_226dcaa9-9490-487f-9b11-ef6e93235bda" xlink:to="loc_iart_RevenueBasedPerformanceMilestonesMember_fab407a8-b675-45b4-8ca2-50a3411d1e56" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_FDAApprovalOfPremarketApprovalMember_a48fc723-88b1-46e8-93c4-42295957a86e" xlink:href="iart-20230331.xsd#iart_FDAApprovalOfPremarketApprovalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_226dcaa9-9490-487f-9b11-ef6e93235bda" xlink:to="loc_iart_FDAApprovalOfPremarketApprovalMember_a48fc723-88b1-46e8-93c4-42295957a86e" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails" xlink:type="simple" xlink:href="iart-20230331.xsd#ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails" xlink:type="extended" id="i83334161dc974ff6972e66b449512e55_ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_a5c8c27e-a3f4-4d78-9b25-54f8be4f98e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract_e7642665-6c04-4d1b-b43b-1b6c5ca44684" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a5c8c27e-a3f4-4d78-9b25-54f8be4f98e0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract_e7642665-6c04-4d1b-b43b-1b6c5ca44684" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_30095b7d-b15f-4848-9d10-fada50371c34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract_e7642665-6c04-4d1b-b43b-1b6c5ca44684" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_30095b7d-b15f-4848-9d10-fada50371c34" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_57d75cf3-4873-4d25-ba02-d971abed8782" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract_e7642665-6c04-4d1b-b43b-1b6c5ca44684" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_57d75cf3-4873-4d25-ba02-d971abed8782" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_9714310a-0856-4a1e-9bca-e1a28f7ca517" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract_e7642665-6c04-4d1b-b43b-1b6c5ca44684" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_9714310a-0856-4a1e-9bca-e1a28f7ca517" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_bed41a78-085f-4cf4-a92b-939f96b0bb4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract_e7642665-6c04-4d1b-b43b-1b6c5ca44684" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_bed41a78-085f-4cf4-a92b-939f96b0bb4c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_e3edbec1-355b-46ad-b9e3-5261acdf4832" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract_e7642665-6c04-4d1b-b43b-1b6c5ca44684" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_e3edbec1-355b-46ad-b9e3-5261acdf4832" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_91cd697e-7a57-4481-9281-4f25d098fe98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a5c8c27e-a3f4-4d78-9b25-54f8be4f98e0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_91cd697e-7a57-4481-9281-4f25d098fe98" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_9144a366-51e3-4de8-a88f-4c2abd7ab5e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a5c8c27e-a3f4-4d78-9b25-54f8be4f98e0" xlink:to="loc_us-gaap_Goodwill_9144a366-51e3-4de8-a88f-4c2abd7ab5e0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_26b8fec2-7737-4c27-be23-d277c4cb393f" xlink:href="iart-20230331.xsd#iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a5c8c27e-a3f4-4d78-9b25-54f8be4f98e0" xlink:to="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_26b8fec2-7737-4c27-be23-d277c4cb393f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract_c475b5b5-bdc9-4282-a20d-b998d773227f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a5c8c27e-a3f4-4d78-9b25-54f8be4f98e0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract_c475b5b5-bdc9-4282-a20d-b998d773227f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_c6529aa8-1e1b-42b3-9efc-49924128db71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract_c475b5b5-bdc9-4282-a20d-b998d773227f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_c6529aa8-1e1b-42b3-9efc-49924128db71" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_d4869ecd-caea-440a-ac08-0c659f14b7c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract_c475b5b5-bdc9-4282-a20d-b998d773227f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_d4869ecd-caea-440a-ac08-0c659f14b7c2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_de53b5bc-bd7e-4fb6-9b37-1ae1c26b672c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a5c8c27e-a3f4-4d78-9b25-54f8be4f98e0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_de53b5bc-bd7e-4fb6-9b37-1ae1c26b672c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability_0b957452-9a64-4f6c-905c-18f69ada6c57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a5c8c27e-a3f4-4d78-9b25-54f8be4f98e0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability_0b957452-9a64-4f6c-905c-18f69ada6c57" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_7879cbd6-fb5d-41d2-bd4b-18c1c86aa51a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a5c8c27e-a3f4-4d78-9b25-54f8be4f98e0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_7879cbd6-fb5d-41d2-bd4b-18c1c86aa51a" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_ffd3ed21-a903-4d27-95f2-b0acfbf81cfa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a5c8c27e-a3f4-4d78-9b25-54f8be4f98e0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_ffd3ed21-a903-4d27-95f2-b0acfbf81cfa" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_2df815c4-401f-4b09-8be4-bff12f883956" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a5c8c27e-a3f4-4d78-9b25-54f8be4f98e0" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_2df815c4-401f-4b09-8be4-bff12f883956" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_932b19f2-d841-4895-b22c-4a52d101fe2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a5c8c27e-a3f4-4d78-9b25-54f8be4f98e0" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_932b19f2-d841-4895-b22c-4a52d101fe2c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_5da3a72d-de8d-42ce-b95c-ce488a3cd1e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_932b19f2-d841-4895-b22c-4a52d101fe2c" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_5da3a72d-de8d-42ce-b95c-ce488a3cd1e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5da3a72d-de8d-42ce-b95c-ce488a3cd1e6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_5da3a72d-de8d-42ce-b95c-ce488a3cd1e6" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5da3a72d-de8d-42ce-b95c-ce488a3cd1e6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1ae69d75-587c-4621-b48e-85603390f8e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_5da3a72d-de8d-42ce-b95c-ce488a3cd1e6" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1ae69d75-587c-4621-b48e-85603390f8e0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SurgicalInnovationAssociatesIncMember_a0a7e938-6b4f-4f36-9d4c-15b9fa59a7b4" xlink:href="iart-20230331.xsd#iart_SurgicalInnovationAssociatesIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1ae69d75-587c-4621-b48e-85603390f8e0" xlink:to="loc_iart_SurgicalInnovationAssociatesIncMember_a0a7e938-6b4f-4f36-9d4c-15b9fa59a7b4" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/ACQUISITIONSANDDIVESTITURESDivestituresNarrativeDetails" xlink:type="simple" xlink:href="iart-20230331.xsd#ACQUISITIONSANDDIVESTITURESDivestituresNarrativeDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/ACQUISITIONSANDDIVESTITURESDivestituresNarrativeDetails" xlink:type="extended" id="if99728eb28b14249902da895214ff7ec_ACQUISITIONSANDDIVESTITURESDivestituresNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7b71ed3e-3f64-4f7b-9ff5-2858b47f21fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_bda4a3fe-3b76-4a60-9cd2-7eedda485ed8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7b71ed3e-3f64-4f7b-9ff5-2858b47f21fc" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_bda4a3fe-3b76-4a60-9cd2-7eedda485ed8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_3cf11cdf-2b76-4ee3-ae8a-db0a7f3b52a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7b71ed3e-3f64-4f7b-9ff5-2858b47f21fc" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_3cf11cdf-2b76-4ee3-ae8a-db0a7f3b52a4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsideration_38f94f40-fbf0-4ee9-99c8-f26d2584656e" xlink:href="iart-20230331.xsd#iart_DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsideration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7b71ed3e-3f64-4f7b-9ff5-2858b47f21fc" xlink:to="loc_iart_DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsideration_38f94f40-fbf0-4ee9-99c8-f26d2584656e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsiderationPeriod_74ee45d1-a9cf-45b3-9518-5474d3463e7f" xlink:href="iart-20230331.xsd#iart_DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsiderationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7b71ed3e-3f64-4f7b-9ff5-2858b47f21fc" xlink:to="loc_iart_DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsiderationPeriod_74ee45d1-a9cf-45b3-9518-5474d3463e7f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashDivestedFromDeconsolidation_813b7324-dc08-4c97-a2ea-b5c59de8ab56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashDivestedFromDeconsolidation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7b71ed3e-3f64-4f7b-9ff5-2858b47f21fc" xlink:to="loc_us-gaap_CashDivestedFromDeconsolidation_813b7324-dc08-4c97-a2ea-b5c59de8ab56" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_362881b0-509e-4166-9148-603d70af206e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7b71ed3e-3f64-4f7b-9ff5-2858b47f21fc" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_362881b0-509e-4166-9148-603d70af206e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DiscontinuedOperationContinuingInvolvementPrepaidAsset_f2288ee4-1a9e-4514-a6c7-bc5e884b8c27" xlink:href="iart-20230331.xsd#iart_DiscontinuedOperationContinuingInvolvementPrepaidAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7b71ed3e-3f64-4f7b-9ff5-2858b47f21fc" xlink:to="loc_iart_DiscontinuedOperationContinuingInvolvementPrepaidAsset_f2288ee4-1a9e-4514-a6c7-bc5e884b8c27" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DiscontinuedOperationContinuingInvolvementPrepaidAssetsCurrent_c723d8a9-80d2-4b1c-b239-60fe9ace261a" xlink:href="iart-20230331.xsd#iart_DiscontinuedOperationContinuingInvolvementPrepaidAssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7b71ed3e-3f64-4f7b-9ff5-2858b47f21fc" xlink:to="loc_iart_DiscontinuedOperationContinuingInvolvementPrepaidAssetsCurrent_c723d8a9-80d2-4b1c-b239-60fe9ace261a" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable_8f381c50-526c-40e9-932d-6353ed9c94b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7b71ed3e-3f64-4f7b-9ff5-2858b47f21fc" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable_8f381c50-526c-40e9-932d-6353ed9c94b1" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_d724d567-8f58-45f8-9ed3-f4a252af0239" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7b71ed3e-3f64-4f7b-9ff5-2858b47f21fc" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_d724d567-8f58-45f8-9ed3-f4a252af0239" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_7b35d0e3-f769-4b02-bf87-36f587942da8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_d724d567-8f58-45f8-9ed3-f4a252af0239" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_7b35d0e3-f769-4b02-bf87-36f587942da8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_7b35d0e3-f769-4b02-bf87-36f587942da8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_7b35d0e3-f769-4b02-bf87-36f587942da8" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_7b35d0e3-f769-4b02-bf87-36f587942da8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_8fef1017-0368-4f50-8df4-e8bcdaad7ef5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_7b35d0e3-f769-4b02-bf87-36f587942da8" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_8fef1017-0368-4f50-8df4-e8bcdaad7ef5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_c7ae5181-103e-42a8-8d14-2d2d2f3bf1f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_8fef1017-0368-4f50-8df4-e8bcdaad7ef5" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_c7ae5181-103e-42a8-8d14-2d2d2f3bf1f7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_22434595-2c3e-4af9-9e3c-64e3aa4462c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_d724d567-8f58-45f8-9ed3-f4a252af0239" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_22434595-2c3e-4af9-9e3c-64e3aa4462c8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_22434595-2c3e-4af9-9e3c-64e3aa4462c8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_22434595-2c3e-4af9-9e3c-64e3aa4462c8" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_22434595-2c3e-4af9-9e3c-64e3aa4462c8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_5b90646e-f75e-4605-a862-7b82939a5a23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_22434595-2c3e-4af9-9e3c-64e3aa4462c8" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_5b90646e-f75e-4605-a862-7b82939a5a23" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_TraditionalWoundCareMember_01976f8c-80d1-4dc8-97d4-790179441315" xlink:href="iart-20230331.xsd#iart_TraditionalWoundCareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_5b90646e-f75e-4605-a862-7b82939a5a23" xlink:to="loc_iart_TraditionalWoundCareMember_01976f8c-80d1-4dc8-97d4-790179441315" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeRevenueRemainingPerformanceObligationDetails" xlink:type="simple" xlink:href="iart-20230331.xsd#REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeRevenueRemainingPerformanceObligationDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeRevenueRemainingPerformanceObligationDetails" xlink:type="extended" id="i46f69189397f48ac8a1f66659e78589c_REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeRevenueRemainingPerformanceObligationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_4c26d446-c6b2-4372-aa35-b8992a17d2ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_47f152d3-f36f-4783-9c61-0347c77933ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_4c26d446-c6b2-4372-aa35-b8992a17d2ad" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_47f152d3-f36f-4783-9c61-0347c77933ec" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_d8a3f3c8-afe6-46ac-bc24-7bae5f2916ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_4c26d446-c6b2-4372-aa35-b8992a17d2ad" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_d8a3f3c8-afe6-46ac-bc24-7bae5f2916ca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_b89f3dc2-6c70-4e07-aa3e-8a12592dc32f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_4c26d446-c6b2-4372-aa35-b8992a17d2ad" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_b89f3dc2-6c70-4e07-aa3e-8a12592dc32f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_23f649ac-406a-4b43-8b57-21f3676b1c05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_b89f3dc2-6c70-4e07-aa3e-8a12592dc32f" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_23f649ac-406a-4b43-8b57-21f3676b1c05" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeRevenueRemainingPerformanceObligationDetails_1" xlink:type="simple" xlink:href="iart-20230331.xsd#REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeRevenueRemainingPerformanceObligationDetails_1"/>
  <link:definitionLink xlink:role="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeRevenueRemainingPerformanceObligationDetails_1" xlink:type="extended" id="i2c762e8d692a413e9b9a888cf34c7bc8_REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeRevenueRemainingPerformanceObligationDetails_1">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_4c26d446-c6b2-4372-aa35-b8992a17d2ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_47f152d3-f36f-4783-9c61-0347c77933ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_4c26d446-c6b2-4372-aa35-b8992a17d2ad" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_47f152d3-f36f-4783-9c61-0347c77933ec" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_d8a3f3c8-afe6-46ac-bc24-7bae5f2916ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_4c26d446-c6b2-4372-aa35-b8992a17d2ad" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_d8a3f3c8-afe6-46ac-bc24-7bae5f2916ca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_b89f3dc2-6c70-4e07-aa3e-8a12592dc32f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_4c26d446-c6b2-4372-aa35-b8992a17d2ad" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_b89f3dc2-6c70-4e07-aa3e-8a12592dc32f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofRevenuesDisaggregatedbyMajorSourceDetails" xlink:type="simple" xlink:href="iart-20230331.xsd#REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofRevenuesDisaggregatedbyMajorSourceDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofRevenuesDisaggregatedbyMajorSourceDetails" xlink:type="extended" id="i39c4b7422ee94d848212f939eadee890_REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofRevenuesDisaggregatedbyMajorSourceDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_9d9ffd07-7e51-4d20-958c-c16e0e0dbf18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_85969e9c-930a-4891-8e1d-1e332bae921a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_9d9ffd07-7e51-4d20-958c-c16e0e0dbf18" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_85969e9c-930a-4891-8e1d-1e332bae921a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_e00aabf0-a9d2-4a89-b569-705ecd3473d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_9d9ffd07-7e51-4d20-958c-c16e0e0dbf18" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_e00aabf0-a9d2-4a89-b569-705ecd3473d7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_7129b1a7-9ec6-422b-a374-8836d0b5b83f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_e00aabf0-a9d2-4a89-b569-705ecd3473d7" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_7129b1a7-9ec6-422b-a374-8836d0b5b83f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_7129b1a7-9ec6-422b-a374-8836d0b5b83f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_7129b1a7-9ec6-422b-a374-8836d0b5b83f" xlink:to="loc_us-gaap_SegmentDomain_7129b1a7-9ec6-422b-a374-8836d0b5b83f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_6d2e378f-802f-4d56-a3e6-490a1648c3f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_7129b1a7-9ec6-422b-a374-8836d0b5b83f" xlink:to="loc_us-gaap_SegmentDomain_6d2e378f-802f-4d56-a3e6-490a1648c3f1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CodmanSpecialtySurgicalMember_8d485526-748a-461a-8b74-1f5852c18f2c" xlink:href="iart-20230331.xsd#iart_CodmanSpecialtySurgicalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_6d2e378f-802f-4d56-a3e6-490a1648c3f1" xlink:to="loc_iart_CodmanSpecialtySurgicalMember_8d485526-748a-461a-8b74-1f5852c18f2c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_TissueTechnologiesMember_c1c025a6-9d99-40da-9cd8-49d532dee698" xlink:href="iart-20230331.xsd#iart_TissueTechnologiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_6d2e378f-802f-4d56-a3e6-490a1648c3f1" xlink:to="loc_iart_TissueTechnologiesMember_c1c025a6-9d99-40da-9cd8-49d532dee698" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_765c641b-4246-4d40-a9f9-a0f4bf9c12ef" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_e00aabf0-a9d2-4a89-b569-705ecd3473d7" xlink:to="loc_srt_ProductOrServiceAxis_765c641b-4246-4d40-a9f9-a0f4bf9c12ef" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_765c641b-4246-4d40-a9f9-a0f4bf9c12ef_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_765c641b-4246-4d40-a9f9-a0f4bf9c12ef" xlink:to="loc_srt_ProductsAndServicesDomain_765c641b-4246-4d40-a9f9-a0f4bf9c12ef_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_90473350-e4d1-4677-bdfb-2479735b6cec" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_765c641b-4246-4d40-a9f9-a0f4bf9c12ef" xlink:to="loc_srt_ProductsAndServicesDomain_90473350-e4d1-4677-bdfb-2479735b6cec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_NeurosurgeryMember_06b9c620-c694-48fc-8736-4a7b410d9300" xlink:href="iart-20230331.xsd#iart_NeurosurgeryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_90473350-e4d1-4677-bdfb-2479735b6cec" xlink:to="loc_iart_NeurosurgeryMember_06b9c620-c694-48fc-8736-4a7b410d9300" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InstrumentsMember_956468f2-f0e1-4626-aa85-dabd4511a4fe" xlink:href="iart-20230331.xsd#iart_InstrumentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_90473350-e4d1-4677-bdfb-2479735b6cec" xlink:to="loc_iart_InstrumentsMember_956468f2-f0e1-4626-aa85-dabd4511a4fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_RegenerativeSkinAndWoundMember_69e2e633-22a4-4b8e-b62a-062da26dc3e2" xlink:href="iart-20230331.xsd#iart_RegenerativeSkinAndWoundMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_90473350-e4d1-4677-bdfb-2479735b6cec" xlink:to="loc_iart_RegenerativeSkinAndWoundMember_69e2e633-22a4-4b8e-b62a-062da26dc3e2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_PrivateLabelMember_c73dde0e-6576-4c6b-9d7e-c7f5d57836ae" xlink:href="iart-20230331.xsd#iart_PrivateLabelMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_90473350-e4d1-4677-bdfb-2479735b6cec" xlink:to="loc_iart_PrivateLabelMember_c73dde0e-6576-4c6b-9d7e-c7f5d57836ae" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesinCarryingAmountofGoodwillDetails" xlink:type="simple" xlink:href="iart-20230331.xsd#GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesinCarryingAmountofGoodwillDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesinCarryingAmountofGoodwillDetails" xlink:type="extended" id="ia19c1ebde9c84237a2116a9b50af6946_GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesinCarryingAmountofGoodwillDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_2a1f4198-c20f-4015-a7a7-432faa52ce90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_93c15dbe-3302-413b-9b12-9dad669d6459" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_2a1f4198-c20f-4015-a7a7-432faa52ce90" xlink:to="loc_us-gaap_GoodwillRollForward_93c15dbe-3302-413b-9b12-9dad669d6459" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_f914df1e-9ad0-49c6-aa99-023ef087de7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_93c15dbe-3302-413b-9b12-9dad669d6459" xlink:to="loc_us-gaap_Goodwill_f914df1e-9ad0-49c6-aa99-023ef087de7b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_fcb8e6e8-e120-48a7-af4a-b986b5be4cc1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_93c15dbe-3302-413b-9b12-9dad669d6459" xlink:to="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_fcb8e6e8-e120-48a7-af4a-b986b5be4cc1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_a6c1a7d6-1cbd-461b-91ba-780b56deeeb2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_93c15dbe-3302-413b-9b12-9dad669d6459" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_a6c1a7d6-1cbd-461b-91ba-780b56deeeb2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_cd92dcd2-6395-4446-bc80-57dadfd0bf3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_84ca9a29-e8f4-4f65-b29f-6b6dcb0cde5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_2a1f4198-c20f-4015-a7a7-432faa52ce90" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_84ca9a29-e8f4-4f65-b29f-6b6dcb0cde5b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_b78c84fb-91ec-4062-b2a5-314110729066" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_84ca9a29-e8f4-4f65-b29f-6b6dcb0cde5b" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_b78c84fb-91ec-4062-b2a5-314110729066" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_b78c84fb-91ec-4062-b2a5-314110729066_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_b78c84fb-91ec-4062-b2a5-314110729066" xlink:to="loc_us-gaap_SegmentDomain_b78c84fb-91ec-4062-b2a5-314110729066_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_c47b3753-c304-446d-8448-7bb88560f732" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_b78c84fb-91ec-4062-b2a5-314110729066" xlink:to="loc_us-gaap_SegmentDomain_c47b3753-c304-446d-8448-7bb88560f732" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CodmanSpecialtySurgicalMember_a12615db-6896-426b-8740-fa3f2871143b" xlink:href="iart-20230331.xsd#iart_CodmanSpecialtySurgicalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_c47b3753-c304-446d-8448-7bb88560f732" xlink:to="loc_iart_CodmanSpecialtySurgicalMember_a12615db-6896-426b-8740-fa3f2871143b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_TissueTechnologiesMember_dda9b2f2-ae58-4c27-8d71-6cec6c2c2854" xlink:href="iart-20230331.xsd#iart_TissueTechnologiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_c47b3753-c304-446d-8448-7bb88560f732" xlink:to="loc_iart_TissueTechnologiesMember_dda9b2f2-ae58-4c27-8d71-6cec6c2c2854" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_899d57a0-9ca3-4e30-8aee-08ee3857bf9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_84ca9a29-e8f4-4f65-b29f-6b6dcb0cde5b" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_899d57a0-9ca3-4e30-8aee-08ee3857bf9f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_899d57a0-9ca3-4e30-8aee-08ee3857bf9f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_899d57a0-9ca3-4e30-8aee-08ee3857bf9f" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_899d57a0-9ca3-4e30-8aee-08ee3857bf9f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b226b924-66cd-493c-a1ee-89fb55ca05a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_899d57a0-9ca3-4e30-8aee-08ee3857bf9f" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b226b924-66cd-493c-a1ee-89fb55ca05a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SurgicalInnovationAssociatesIncMember_85e9784c-5833-4753-a45c-de05dbe44ecc" xlink:href="iart-20230331.xsd#iart_SurgicalInnovationAssociatesIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b226b924-66cd-493c-a1ee-89fb55ca05a3" xlink:to="loc_iart_SurgicalInnovationAssociatesIncMember_85e9784c-5833-4753-a45c-de05dbe44ecc" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails" xlink:type="simple" xlink:href="iart-20230331.xsd#GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails" xlink:type="extended" id="ie9996bcaa98e486fb32fdd19227f994c_GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_50c8654a-f945-49e4-bede-c85229e2bcab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_c1c31aeb-4f90-4a5f-a52d-ed8cad6a4405" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_50c8654a-f945-49e4-bede-c85229e2bcab" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_c1c31aeb-4f90-4a5f-a52d-ed8cad6a4405" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill_c97a5675-a197-4985-8a90-ffa9a44d16af" xlink:href="iart-20230331.xsd#iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_50c8654a-f945-49e4-bede-c85229e2bcab" xlink:to="loc_iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill_c97a5675-a197-4985-8a90-ffa9a44d16af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_d44b5188-d652-4252-a79b-7d95c1e939de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_50c8654a-f945-49e4-bede-c85229e2bcab" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_d44b5188-d652-4252-a79b-7d95c1e939de" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill_11e1dd9c-e2db-43d3-be95-042a36eabfce" xlink:href="iart-20230331.xsd#iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_50c8654a-f945-49e4-bede-c85229e2bcab" xlink:to="loc_iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill_11e1dd9c-e2db-43d3-be95-042a36eabfce" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_e44c9e22-7896-45e7-aa12-f501c4630b6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_50c8654a-f945-49e4-bede-c85229e2bcab" xlink:to="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_e44c9e22-7896-45e7-aa12-f501c4630b6c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_fe91f3ad-3a0f-4b3f-8aee-8df29980862d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_e44c9e22-7896-45e7-aa12-f501c4630b6c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_fe91f3ad-3a0f-4b3f-8aee-8df29980862d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_fe91f3ad-3a0f-4b3f-8aee-8df29980862d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_fe91f3ad-3a0f-4b3f-8aee-8df29980862d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_fe91f3ad-3a0f-4b3f-8aee-8df29980862d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_59c2886c-c18f-4186-9c41-3a3f385307f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_fe91f3ad-3a0f-4b3f-8aee-8df29980862d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_59c2886c-c18f-4186-9c41-3a3f385307f9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CompletedTechnologyMember_854c4088-ec0e-40cf-8343-0db2f9431770" xlink:href="iart-20230331.xsd#iart_CompletedTechnologyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_59c2886c-c18f-4186-9c41-3a3f385307f9" xlink:to="loc_iart_CompletedTechnologyMember_854c4088-ec0e-40cf-8343-0db2f9431770" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_d032c2b4-00ec-4f03-b44a-0c93e3127357" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_59c2886c-c18f-4186-9c41-3a3f385307f9" xlink:to="loc_us-gaap_CustomerRelationshipsMember_d032c2b4-00ec-4f03-b44a-0c93e3127357" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_TrademarksBrandNamesMember_db984733-69e5-4842-9eb5-d30593909e31" xlink:href="iart-20230331.xsd#iart_TrademarksBrandNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_59c2886c-c18f-4186-9c41-3a3f385307f9" xlink:to="loc_iart_TrademarksBrandNamesMember_db984733-69e5-4842-9eb5-d30593909e31" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SupplierRelationShipsMember_56d2c71c-a978-48f5-a241-86fb278d44db" xlink:href="iart-20230331.xsd#iart_SupplierRelationShipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_59c2886c-c18f-4186-9c41-3a3f385307f9" xlink:to="loc_iart_SupplierRelationShipsMember_56d2c71c-a978-48f5-a241-86fb278d44db" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AllOtherMember_64d18f05-55f6-45b4-a741-fda5c7e165ed" xlink:href="iart-20230331.xsd#iart_AllOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_59c2886c-c18f-4186-9c41-3a3f385307f9" xlink:to="loc_iart_AllOtherMember_64d18f05-55f6-45b4-a741-fda5c7e165ed" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_cb53cf1c-e4ee-42fd-9f8c-3b54135fb092" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_e44c9e22-7896-45e7-aa12-f501c4630b6c" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_cb53cf1c-e4ee-42fd-9f8c-3b54135fb092" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_cb53cf1c-e4ee-42fd-9f8c-3b54135fb092_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_cb53cf1c-e4ee-42fd-9f8c-3b54135fb092" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_cb53cf1c-e4ee-42fd-9f8c-3b54135fb092_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_02b824da-d371-4e7e-9d6d-9356e3a7617a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_cb53cf1c-e4ee-42fd-9f8c-3b54135fb092" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_02b824da-d371-4e7e-9d6d-9356e3a7617a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_baad7e57-10cb-4660-a2ea-23fcdd23a8a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_02b824da-d371-4e7e-9d6d-9356e3a7617a" xlink:to="loc_us-gaap_TradeNamesMember_baad7e57-10cb-4660-a2ea-23fcdd23a8a7" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/DEBTNarrativeDetails" xlink:type="simple" xlink:href="iart-20230331.xsd#DEBTNarrativeDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/DEBTNarrativeDetails" xlink:type="extended" id="if7674ed0e5ad4e4a93b9cd5aa646bada_DEBTNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_89acf97d-962c-44f3-981e-6b2dd514710b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_03775543-4e69-4a65-8126-c8cf538da08a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_89acf97d-962c-44f3-981e-6b2dd514710b" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_03775543-4e69-4a65-8126-c8cf538da08a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtInstrumentBasisSpreadAdjustmentOnVariableRate_2fa9a697-2925-45c2-a19f-6d2b565f0db6" xlink:href="iart-20230331.xsd#iart_DebtInstrumentBasisSpreadAdjustmentOnVariableRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_89acf97d-962c-44f3-981e-6b2dd514710b" xlink:to="loc_iart_DebtInstrumentBasisSpreadAdjustmentOnVariableRate_2fa9a697-2925-45c2-a19f-6d2b565f0db6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_906df256-f952-4beb-92bb-8dd0b98f2842" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_89acf97d-962c-44f3-981e-6b2dd514710b" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_906df256-f952-4beb-92bb-8dd0b98f2842" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_790061cb-191e-4c4f-8fad-d975caa84517" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_89acf97d-962c-44f3-981e-6b2dd514710b" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_790061cb-191e-4c4f-8fad-d975caa84517" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_e6db4e60-8a00-457d-a35e-cefc9138be2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_89acf97d-962c-44f3-981e-6b2dd514710b" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_e6db4e60-8a00-457d-a35e-cefc9138be2f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost_e1f94f54-c640-492d-82b4-d676cc9de622" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WriteOffOfDeferredDebtIssuanceCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_89acf97d-962c-44f3-981e-6b2dd514710b" xlink:to="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost_e1f94f54-c640-492d-82b4-d676cc9de622" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_51f88868-2d1c-4b69-8390-705aea30af24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_89acf97d-962c-44f3-981e-6b2dd514710b" xlink:to="loc_us-gaap_LineOfCredit_51f88868-2d1c-4b69-8390-705aea30af24" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtWeightedAverageInterestRate_22ea94b6-a636-41e9-8228-df730ade3d08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtWeightedAverageInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_89acf97d-962c-44f3-981e-6b2dd514710b" xlink:to="loc_us-gaap_DebtWeightedAverageInterestRate_22ea94b6-a636-41e9-8228-df730ade3d08" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtCurrent_fe3dffbb-ac11-42f3-aad6-5e52f515855a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_89acf97d-962c-44f3-981e-6b2dd514710b" xlink:to="loc_us-gaap_SecuredDebtCurrent_fe3dffbb-ac11-42f3-aad6-5e52f515855a" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_ca861275-74d6-4520-8565-86c131d77519" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_89acf97d-962c-44f3-981e-6b2dd514710b" xlink:to="loc_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_ca861275-74d6-4520-8565-86c131d77519" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_6de6d491-c46d-4007-b4d4-287fb5a5999e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_89acf97d-962c-44f3-981e-6b2dd514710b" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_6de6d491-c46d-4007-b4d4-287fb5a5999e" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestPaymentsReminderOfFiscalYear_e70affb5-75d0-4ffe-93ae-f3a435167432" xlink:href="iart-20230331.xsd#iart_InterestPaymentsReminderOfFiscalYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_89acf97d-962c-44f3-981e-6b2dd514710b" xlink:to="loc_iart_InterestPaymentsReminderOfFiscalYear_e70affb5-75d0-4ffe-93ae-f3a435167432" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestPaymentsYearOne_82f9fc87-5d1f-4108-8d62-157e43aaef00" xlink:href="iart-20230331.xsd#iart_InterestPaymentsYearOne"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_89acf97d-962c-44f3-981e-6b2dd514710b" xlink:to="loc_iart_InterestPaymentsYearOne_82f9fc87-5d1f-4108-8d62-157e43aaef00" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestPaymentsYearTwo_ee0bf564-bfb4-4a39-a769-7ae9a469a486" xlink:href="iart-20230331.xsd#iart_InterestPaymentsYearTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_89acf97d-962c-44f3-981e-6b2dd514710b" xlink:to="loc_iart_InterestPaymentsYearTwo_ee0bf564-bfb4-4a39-a769-7ae9a469a486" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestPaymentsYearThree_196ca44d-1c57-4bd2-bbdb-e55c6e38accc" xlink:href="iart-20230331.xsd#iart_InterestPaymentsYearThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_89acf97d-962c-44f3-981e-6b2dd514710b" xlink:to="loc_iart_InterestPaymentsYearThree_196ca44d-1c57-4bd2-bbdb-e55c6e38accc" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestPaymentsAfterYearThree_fb142a74-14a6-46bc-8488-3ca9916fc567" xlink:href="iart-20230331.xsd#iart_InterestPaymentsAfterYearThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_89acf97d-962c-44f3-981e-6b2dd514710b" xlink:to="loc_iart_InterestPaymentsAfterYearThree_fb142a74-14a6-46bc-8488-3ca9916fc567" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_f2d23b92-ab2e-4df9-8f18-cd1f18fff597" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_89acf97d-962c-44f3-981e-6b2dd514710b" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_f2d23b92-ab2e-4df9-8f18-cd1f18fff597" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_b9465f2e-1582-4c7c-8acc-983abd159c43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_89acf97d-962c-44f3-981e-6b2dd514710b" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_b9465f2e-1582-4c7c-8acc-983abd159c43" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross_5023aa9a-5bcb-47cc-8978-e6c82883fb2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_89acf97d-962c-44f3-981e-6b2dd514710b" xlink:to="loc_us-gaap_DeferredFinanceCostsGross_5023aa9a-5bcb-47cc-8978-e6c82883fb2e" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_3bc70e56-530c-4364-ac06-97129c6c280c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_89acf97d-962c-44f3-981e-6b2dd514710b" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_3bc70e56-530c-4364-ac06-97129c6c280c" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_246849f4-45f2-42a7-915b-c2580716cafb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_89acf97d-962c-44f3-981e-6b2dd514710b" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_246849f4-45f2-42a7-915b-c2580716cafb" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtInstrumentMaximumSellingPriceOfCommonStockOfTheConversionPriceDuringPeriod_b6886e61-6b95-4551-8cb8-d3990718e132" xlink:href="iart-20230331.xsd#iart_DebtInstrumentMaximumSellingPriceOfCommonStockOfTheConversionPriceDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_89acf97d-962c-44f3-981e-6b2dd514710b" xlink:to="loc_iart_DebtInstrumentMaximumSellingPriceOfCommonStockOfTheConversionPriceDuringPeriod_b6886e61-6b95-4551-8cb8-d3990718e132" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtInstrumentMaximumAverageConversionValueOfNotes_d77b2f47-558a-416b-b933-370390b2b26e" xlink:href="iart-20230331.xsd#iart_DebtInstrumentMaximumAverageConversionValueOfNotes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_89acf97d-962c-44f3-981e-6b2dd514710b" xlink:to="loc_iart_DebtInstrumentMaximumAverageConversionValueOfNotes_d77b2f47-558a-416b-b933-370390b2b26e" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtInstrumentCombinationSettlementForDebtConversionMinimumSettledInCashPerPrincipalAmount_0e988cad-2201-4745-85bd-e8c009fc8b31" xlink:href="iart-20230331.xsd#iart_DebtInstrumentCombinationSettlementForDebtConversionMinimumSettledInCashPerPrincipalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_89acf97d-962c-44f3-981e-6b2dd514710b" xlink:to="loc_iart_DebtInstrumentCombinationSettlementForDebtConversionMinimumSettledInCashPerPrincipalAmount_0e988cad-2201-4745-85bd-e8c009fc8b31" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_b68f2d30-fc23-4cb6-800f-76961453076d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_89acf97d-962c-44f3-981e-6b2dd514710b" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_b68f2d30-fc23-4cb6-800f-76961453076d" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_PaymentsForOptionIndexToIssuersEquity_edad462c-c3da-459a-a881-6a7c05341c96" xlink:href="iart-20230331.xsd#iart_PaymentsForOptionIndexToIssuersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_89acf97d-962c-44f3-981e-6b2dd514710b" xlink:to="loc_iart_PaymentsForOptionIndexToIssuersEquity_edad462c-c3da-459a-a881-6a7c05341c96" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfWarrants_becb5d37-3d66-4bd7-8205-ec286f8c5256" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_89acf97d-962c-44f3-981e-6b2dd514710b" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfWarrants_becb5d37-3d66-4bd7-8205-ec286f8c5256" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityStrikePrice1_5a3bd9e6-a0a9-42e2-835d-843f9c99be82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OptionIndexedToIssuersEquityStrikePrice1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_89acf97d-962c-44f3-981e-6b2dd514710b" xlink:to="loc_us-gaap_OptionIndexedToIssuersEquityStrikePrice1_5a3bd9e6-a0a9-42e2-835d-843f9c99be82" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_51ce8bc1-1a9d-450b-afe4-d9bda0cf564e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_89acf97d-962c-44f3-981e-6b2dd514710b" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_51ce8bc1-1a9d-450b-afe4-d9bda0cf564e" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_bfb0f70a-175a-4b4f-b249-d8e9b9a3d488" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_89acf97d-962c-44f3-981e-6b2dd514710b" xlink:to="loc_us-gaap_DebtInstrumentFairValue_bfb0f70a-175a-4b4f-b249-d8e9b9a3d488" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_TransferorsInterestsInTransferredFinancialAssetsMaximumInvestmentLimit_ab41d701-1b9e-424e-8352-dfdf28559f8b" xlink:href="iart-20230331.xsd#iart_TransferorsInterestsInTransferredFinancialAssetsMaximumInvestmentLimit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_89acf97d-962c-44f3-981e-6b2dd514710b" xlink:to="loc_iart_TransferorsInterestsInTransferredFinancialAssetsMaximumInvestmentLimit_ab41d701-1b9e-424e-8352-dfdf28559f8b" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SecuredLongTermDebtSecuritizationProgram_0cc32fc1-9db7-426f-8136-3a19a1482dfa" xlink:href="iart-20230331.xsd#iart_SecuredLongTermDebtSecuritizationProgram"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_89acf97d-962c-44f3-981e-6b2dd514710b" xlink:to="loc_iart_SecuredLongTermDebtSecuritizationProgram_0cc32fc1-9db7-426f-8136-3a19a1482dfa" xlink:type="arc" order="31"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtWeightedAverageInterestRateFromSecuritization_264cd339-b89f-467a-b2f4-cd66a623d71c" xlink:href="iart-20230331.xsd#iart_DebtWeightedAverageInterestRateFromSecuritization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_89acf97d-962c-44f3-981e-6b2dd514710b" xlink:to="loc_iart_DebtWeightedAverageInterestRateFromSecuritization_264cd339-b89f-467a-b2f4-cd66a623d71c" xlink:type="arc" order="32"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SecuritizationFacilityFairValueOfAmountOutstanding_a76c1e17-2c81-4ed8-b5fa-ab74e11ca53b" xlink:href="iart-20230331.xsd#iart_SecuritizationFacilityFairValueOfAmountOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_89acf97d-962c-44f3-981e-6b2dd514710b" xlink:to="loc_iart_SecuritizationFacilityFairValueOfAmountOutstanding_a76c1e17-2c81-4ed8-b5fa-ab74e11ca53b" xlink:type="arc" order="33"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_b048e5a0-0dd5-4727-87f8-5345d11b0599" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_89acf97d-962c-44f3-981e-6b2dd514710b" xlink:to="loc_us-gaap_DebtInstrumentTable_b048e5a0-0dd5-4727-87f8-5345d11b0599" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_23ee7a46-6dfd-4c86-beb8-d779ea6c4bdc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_b048e5a0-0dd5-4727-87f8-5345d11b0599" xlink:to="loc_us-gaap_DebtInstrumentAxis_23ee7a46-6dfd-4c86-beb8-d779ea6c4bdc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_23ee7a46-6dfd-4c86-beb8-d779ea6c4bdc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_23ee7a46-6dfd-4c86-beb8-d779ea6c4bdc" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_23ee7a46-6dfd-4c86-beb8-d779ea6c4bdc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_3e1b2792-f19f-4cc4-889c-76c8b2aebc5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_23ee7a46-6dfd-4c86-beb8-d779ea6c4bdc" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_3e1b2792-f19f-4cc4-889c-76c8b2aebc5d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SeniorCreditFacilityMember_67e66495-732f-4db8-8124-f5693c2e6810" xlink:href="iart-20230331.xsd#iart_SeniorCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3e1b2792-f19f-4cc4-889c-76c8b2aebc5d" xlink:to="loc_iart_SeniorCreditFacilityMember_67e66495-732f-4db8-8124-f5693c2e6810" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_TermLoanFacilityMember_6c3e38c9-635b-4893-b680-2526b01eb1d5" xlink:href="iart-20230331.xsd#iart_TermLoanFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3e1b2792-f19f-4cc4-889c-76c8b2aebc5d" xlink:to="loc_iart_TermLoanFacilityMember_6c3e38c9-635b-4893-b680-2526b01eb1d5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_TwoThousandTwentyFiveSeniorConvertibleNotesMember_7f571709-8979-4ef6-804c-244f9281672a" xlink:href="iart-20230331.xsd#iart_TwoThousandTwentyFiveSeniorConvertibleNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3e1b2792-f19f-4cc4-889c-76c8b2aebc5d" xlink:to="loc_iart_TwoThousandTwentyFiveSeniorConvertibleNotesMember_7f571709-8979-4ef6-804c-244f9281672a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_c3a45898-8f97-4934-bf49-4fa558b9260a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_b048e5a0-0dd5-4727-87f8-5345d11b0599" xlink:to="loc_us-gaap_CreditFacilityAxis_c3a45898-8f97-4934-bf49-4fa558b9260a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_c3a45898-8f97-4934-bf49-4fa558b9260a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_c3a45898-8f97-4934-bf49-4fa558b9260a" xlink:to="loc_us-gaap_CreditFacilityDomain_c3a45898-8f97-4934-bf49-4fa558b9260a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_6eb23496-aac1-41e7-81e8-1f5af9177f5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_c3a45898-8f97-4934-bf49-4fa558b9260a" xlink:to="loc_us-gaap_CreditFacilityDomain_6eb23496-aac1-41e7-81e8-1f5af9177f5b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_e38d4b41-b7b7-4bf2-a2d4-b9270eb1a129" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_6eb23496-aac1-41e7-81e8-1f5af9177f5b" xlink:to="loc_us-gaap_SecuredDebtMember_e38d4b41-b7b7-4bf2-a2d4-b9270eb1a129" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_7d5261d7-1a06-43f1-a23c-baba2e59d224" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_6eb23496-aac1-41e7-81e8-1f5af9177f5b" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_7d5261d7-1a06-43f1-a23c-baba2e59d224" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandbyLettersOfCreditMember_337ce48d-29df-4549-bfa8-cf7e007606b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StandbyLettersOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_6eb23496-aac1-41e7-81e8-1f5af9177f5b" xlink:to="loc_us-gaap_StandbyLettersOfCreditMember_337ce48d-29df-4549-bfa8-cf7e007606b4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SwinglineLoanMember_448c6f9f-1ce6-4490-8a1f-30cf60610569" xlink:href="iart-20230331.xsd#iart_SwinglineLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_6eb23496-aac1-41e7-81e8-1f5af9177f5b" xlink:to="loc_iart_SwinglineLoanMember_448c6f9f-1ce6-4490-8a1f-30cf60610569" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_a4a0278a-e472-430c-a512-ccbf262cf146" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_b048e5a0-0dd5-4727-87f8-5345d11b0599" xlink:to="loc_srt_RangeAxis_a4a0278a-e472-430c-a512-ccbf262cf146" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a4a0278a-e472-430c-a512-ccbf262cf146_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_a4a0278a-e472-430c-a512-ccbf262cf146" xlink:to="loc_srt_RangeMember_a4a0278a-e472-430c-a512-ccbf262cf146_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_0152b1e8-6fe9-432b-9399-687367a1aea7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_a4a0278a-e472-430c-a512-ccbf262cf146" xlink:to="loc_srt_RangeMember_0152b1e8-6fe9-432b-9399-687367a1aea7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_bde1040d-24de-4942-b19e-de42cef6b484" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_0152b1e8-6fe9-432b-9399-687367a1aea7" xlink:to="loc_srt_MinimumMember_bde1040d-24de-4942-b19e-de42cef6b484" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_6b5ad471-da3d-405d-8a94-e329ef5d464e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_0152b1e8-6fe9-432b-9399-687367a1aea7" xlink:to="loc_srt_MaximumMember_6b5ad471-da3d-405d-8a94-e329ef5d464e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_cc5e43a0-4360-41d6-ad92-7c80aa32b609" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_b048e5a0-0dd5-4727-87f8-5345d11b0599" xlink:to="loc_us-gaap_VariableRateAxis_cc5e43a0-4360-41d6-ad92-7c80aa32b609" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_cc5e43a0-4360-41d6-ad92-7c80aa32b609_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_cc5e43a0-4360-41d6-ad92-7c80aa32b609" xlink:to="loc_us-gaap_VariableRateDomain_cc5e43a0-4360-41d6-ad92-7c80aa32b609_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_da0bcba1-8546-4e10-b8fe-a346c07a66a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_cc5e43a0-4360-41d6-ad92-7c80aa32b609" xlink:to="loc_us-gaap_VariableRateDomain_da0bcba1-8546-4e10-b8fe-a346c07a66a7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalFundsEffectiveSwapRateMember_0dc01a5b-fcb1-4809-bf43-4cb8d36667c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FederalFundsEffectiveSwapRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_da0bcba1-8546-4e10-b8fe-a346c07a66a7" xlink:to="loc_us-gaap_FederalFundsEffectiveSwapRateMember_0dc01a5b-fcb1-4809-bf43-4cb8d36667c3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_bec59897-f2be-4f26-80c8-90b69aad0a6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_da0bcba1-8546-4e10-b8fe-a346c07a66a7" xlink:to="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_bec59897-f2be-4f26-80c8-90b69aad0a6d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_fcfadb19-db45-464f-87eb-8ee1f00fa497" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_b048e5a0-0dd5-4727-87f8-5345d11b0599" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_fcfadb19-db45-464f-87eb-8ee1f00fa497" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_fcfadb19-db45-464f-87eb-8ee1f00fa497_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_fcfadb19-db45-464f-87eb-8ee1f00fa497" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_fcfadb19-db45-464f-87eb-8ee1f00fa497_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_da33ebec-b956-4f20-b21b-1344e127f157" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_fcfadb19-db45-464f-87eb-8ee1f00fa497" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_da33ebec-b956-4f20-b21b-1344e127f157" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_69314569-30eb-453d-a195-2b93a9394974" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_da33ebec-b956-4f20-b21b-1344e127f157" xlink:to="loc_us-gaap_ConvertibleDebtMember_69314569-30eb-453d-a195-2b93a9394974" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityEquityAxis_ad084951-bdc4-41c4-a516-801b36bdd685" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OptionIndexedToIssuersEquityEquityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_b048e5a0-0dd5-4727-87f8-5345d11b0599" xlink:to="loc_us-gaap_OptionIndexedToIssuersEquityEquityAxis_ad084951-bdc4-41c4-a516-801b36bdd685" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_ad084951-bdc4-41c4-a516-801b36bdd685_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OptionIndexedToIssuersEquityTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_OptionIndexedToIssuersEquityEquityAxis_ad084951-bdc4-41c4-a516-801b36bdd685" xlink:to="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_ad084951-bdc4-41c4-a516-801b36bdd685_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_3f2a7d58-302c-42d4-a956-1ed5bc578436" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OptionIndexedToIssuersEquityTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_OptionIndexedToIssuersEquityEquityAxis_ad084951-bdc4-41c4-a516-801b36bdd685" xlink:to="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_3f2a7d58-302c-42d4-a956-1ed5bc578436" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CallOptionMember_027de236-77e0-4ef5-bbcc-c1dcb62f02f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CallOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_3f2a7d58-302c-42d4-a956-1ed5bc578436" xlink:to="loc_us-gaap_CallOptionMember_027de236-77e0-4ef5-bbcc-c1dcb62f02f2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_2e9a4710-3212-4ae8-992e-62daba7182c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_b048e5a0-0dd5-4727-87f8-5345d11b0599" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_2e9a4710-3212-4ae8-992e-62daba7182c4" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2e9a4710-3212-4ae8-992e-62daba7182c4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_2e9a4710-3212-4ae8-992e-62daba7182c4" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2e9a4710-3212-4ae8-992e-62daba7182c4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_bc8888d6-7916-4de3-a284-7016cff7bfc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_2e9a4710-3212-4ae8-992e-62daba7182c4" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_bc8888d6-7916-4de3-a284-7016cff7bfc0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_c9d23430-b8f4-4f71-b8f3-3f2ae23a3d7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_bc8888d6-7916-4de3-a284-7016cff7bfc0" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_c9d23430-b8f4-4f71-b8f3-3f2ae23a3d7c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/DEBTMaximumTotalLeverageRatioTableDetails" xlink:type="simple" xlink:href="iart-20230331.xsd#DEBTMaximumTotalLeverageRatioTableDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/DEBTMaximumTotalLeverageRatioTableDetails" xlink:type="extended" id="i74ec56a4f1904c778520ee5405f296cc_DEBTMaximumTotalLeverageRatioTableDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_3b1e9af6-77fd-4b57-87ab-6f6eb123db79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtInstrumentCovenantMaximumLeverageRatio_60f6f440-2cbe-4432-a42d-949999a7d9a7" xlink:href="iart-20230331.xsd#iart_DebtInstrumentCovenantMaximumLeverageRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3b1e9af6-77fd-4b57-87ab-6f6eb123db79" xlink:to="loc_iart_DebtInstrumentCovenantMaximumLeverageRatio_60f6f440-2cbe-4432-a42d-949999a7d9a7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_658506b5-d289-4118-9dec-3331752ce36d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3b1e9af6-77fd-4b57-87ab-6f6eb123db79" xlink:to="loc_us-gaap_DebtInstrumentTable_658506b5-d289-4118-9dec-3331752ce36d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtCovenantPeriodAxis_050c46b2-cdbf-4c96-aa80-4112a647eed8" xlink:href="iart-20230331.xsd#iart_DebtCovenantPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_658506b5-d289-4118-9dec-3331752ce36d" xlink:to="loc_iart_DebtCovenantPeriodAxis_050c46b2-cdbf-4c96-aa80-4112a647eed8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtCovenantPeriodDomain_050c46b2-cdbf-4c96-aa80-4112a647eed8_default" xlink:href="iart-20230331.xsd#iart_DebtCovenantPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_iart_DebtCovenantPeriodAxis_050c46b2-cdbf-4c96-aa80-4112a647eed8" xlink:to="loc_iart_DebtCovenantPeriodDomain_050c46b2-cdbf-4c96-aa80-4112a647eed8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtCovenantPeriodDomain_1263928b-dddc-4a94-b4d7-c6a1a74e5d88" xlink:href="iart-20230331.xsd#iart_DebtCovenantPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_iart_DebtCovenantPeriodAxis_050c46b2-cdbf-4c96-aa80-4112a647eed8" xlink:to="loc_iart_DebtCovenantPeriodDomain_1263928b-dddc-4a94-b4d7-c6a1a74e5d88" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtCovenantPeriod1Member_415eeb2d-6422-4fbe-bda0-c9d820838350" xlink:href="iart-20230331.xsd#iart_DebtCovenantPeriod1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_DebtCovenantPeriodDomain_1263928b-dddc-4a94-b4d7-c6a1a74e5d88" xlink:to="loc_iart_DebtCovenantPeriod1Member_415eeb2d-6422-4fbe-bda0-c9d820838350" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtCovenantPeriod2Member_32b1f9fa-ef02-4a30-b77f-692a54a505de" xlink:href="iart-20230331.xsd#iart_DebtCovenantPeriod2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_DebtCovenantPeriodDomain_1263928b-dddc-4a94-b4d7-c6a1a74e5d88" xlink:to="loc_iart_DebtCovenantPeriod2Member_32b1f9fa-ef02-4a30-b77f-692a54a505de" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtCovenantPeriod3Member_0ff2162e-09ea-459b-a264-7cf80c6afcaf" xlink:href="iart-20230331.xsd#iart_DebtCovenantPeriod3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iart_DebtCovenantPeriodDomain_1263928b-dddc-4a94-b4d7-c6a1a74e5d88" xlink:to="loc_iart_DebtCovenantPeriod3Member_0ff2162e-09ea-459b-a264-7cf80c6afcaf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_14f6379c-0d1c-4226-b2a4-13e126a6e5e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_658506b5-d289-4118-9dec-3331752ce36d" xlink:to="loc_us-gaap_DebtInstrumentAxis_14f6379c-0d1c-4226-b2a4-13e126a6e5e7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_14f6379c-0d1c-4226-b2a4-13e126a6e5e7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_14f6379c-0d1c-4226-b2a4-13e126a6e5e7" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_14f6379c-0d1c-4226-b2a4-13e126a6e5e7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_8c108e8d-0c52-4da7-af63-655019508c5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_14f6379c-0d1c-4226-b2a4-13e126a6e5e7" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_8c108e8d-0c52-4da7-af63-655019508c5e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SeniorCreditFacilityMember_3f8f7c3e-2fc2-4f93-8e1e-cf7fb7426872" xlink:href="iart-20230331.xsd#iart_SeniorCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8c108e8d-0c52-4da7-af63-655019508c5e" xlink:to="loc_iart_SeniorCreditFacilityMember_3f8f7c3e-2fc2-4f93-8e1e-cf7fb7426872" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofDerivativeInstrumentsDetails" xlink:type="simple" xlink:href="iart-20230331.xsd#DERIVATIVEINSTRUMENTSScheduleofDerivativeInstrumentsDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofDerivativeInstrumentsDetails" xlink:type="extended" id="i604eaf8f9e2d4937be2514ab7e5bb03b_DERIVATIVEINSTRUMENTSScheduleofDerivativeInstrumentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_c96ca175-5a43-41b0-94bb-83f60f95ba4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_e844bea0-31c6-4be3-b76a-c14aab89b68b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_c96ca175-5a43-41b0-94bb-83f60f95ba4a" xlink:to="loc_us-gaap_DerivativeNotionalAmount_e844bea0-31c6-4be3-b76a-c14aab89b68b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFixedInterestRate_b230e8db-3a65-4af7-b7f4-41b71a650554" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFixedInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_c96ca175-5a43-41b0-94bb-83f60f95ba4a" xlink:to="loc_us-gaap_DerivativeFixedInterestRate_b230e8db-3a65-4af7-b7f4-41b71a650554" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeNet_d480cf2b-6eed-4721-b301-0cd24aa4d77c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_c96ca175-5a43-41b0-94bb-83f60f95ba4a" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeNet_d480cf2b-6eed-4721-b301-0cd24aa4d77c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_5ee183e1-2582-49ff-99b9-dbaa92ab2d30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_c96ca175-5a43-41b0-94bb-83f60f95ba4a" xlink:to="loc_us-gaap_DerivativeTable_5ee183e1-2582-49ff-99b9-dbaa92ab2d30" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_2e007487-290b-43ab-aec4-45787949abfd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_5ee183e1-2582-49ff-99b9-dbaa92ab2d30" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_2e007487-290b-43ab-aec4-45787949abfd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_2e007487-290b-43ab-aec4-45787949abfd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_2e007487-290b-43ab-aec4-45787949abfd" xlink:to="loc_us-gaap_HedgingRelationshipDomain_2e007487-290b-43ab-aec4-45787949abfd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_5fe1dda6-0275-4594-96ac-f4aa9d0c3080" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_2e007487-290b-43ab-aec4-45787949abfd" xlink:to="loc_us-gaap_HedgingRelationshipDomain_5fe1dda6-0275-4594-96ac-f4aa9d0c3080" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_2a89b3df-56bb-4def-adcb-7751993664f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_5fe1dda6-0275-4594-96ac-f4aa9d0c3080" xlink:to="loc_us-gaap_CashFlowHedgingMember_2a89b3df-56bb-4def-adcb-7751993664f0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_2dce7095-309d-4ebd-9817-6dda55020a92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_5ee183e1-2582-49ff-99b9-dbaa92ab2d30" xlink:to="loc_us-gaap_HedgingDesignationAxis_2dce7095-309d-4ebd-9817-6dda55020a92" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_2dce7095-309d-4ebd-9817-6dda55020a92_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_2dce7095-309d-4ebd-9817-6dda55020a92" xlink:to="loc_us-gaap_HedgingDesignationDomain_2dce7095-309d-4ebd-9817-6dda55020a92_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_8a213e35-53dc-4af4-89a7-429022bf579a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_2dce7095-309d-4ebd-9817-6dda55020a92" xlink:to="loc_us-gaap_HedgingDesignationDomain_8a213e35-53dc-4af4-89a7-429022bf579a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_7bd609dc-3f38-4413-a5b1-1a8054cec3ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_8a213e35-53dc-4af4-89a7-429022bf579a" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_7bd609dc-3f38-4413-a5b1-1a8054cec3ca" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_fad2fbaf-6dc0-4d78-bab0-f78a1fdffb5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_5ee183e1-2582-49ff-99b9-dbaa92ab2d30" xlink:to="loc_us-gaap_VariableRateAxis_fad2fbaf-6dc0-4d78-bab0-f78a1fdffb5d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_fad2fbaf-6dc0-4d78-bab0-f78a1fdffb5d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_fad2fbaf-6dc0-4d78-bab0-f78a1fdffb5d" xlink:to="loc_us-gaap_VariableRateDomain_fad2fbaf-6dc0-4d78-bab0-f78a1fdffb5d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_015fa07b-7783-46e5-ba07-8a7c97383584" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_fad2fbaf-6dc0-4d78-bab0-f78a1fdffb5d" xlink:to="loc_us-gaap_VariableRateDomain_015fa07b-7783-46e5-ba07-8a7c97383584" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_e0cddb89-fff5-4206-86c9-c79dd17bdded" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_015fa07b-7783-46e5-ba07-8a7c97383584" xlink:to="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_e0cddb89-fff5-4206-86c9-c79dd17bdded" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_74333183-ec67-4a25-9373-98cc3b0b9326" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_5ee183e1-2582-49ff-99b9-dbaa92ab2d30" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_74333183-ec67-4a25-9373-98cc3b0b9326" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_74333183-ec67-4a25-9373-98cc3b0b9326_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_74333183-ec67-4a25-9373-98cc3b0b9326" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_74333183-ec67-4a25-9373-98cc3b0b9326_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_8d03f8b4-c119-4681-ba8e-8046f9aa14e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_74333183-ec67-4a25-9373-98cc3b0b9326" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_8d03f8b4-c119-4681-ba8e-8046f9aa14e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedDecember132017Tranche2Member_f21973c4-5594-404a-ae36-dca16fc63422" xlink:href="iart-20230331.xsd#iart_InterestRateSwapDesignatedDecember132017Tranche2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_8d03f8b4-c119-4681-ba8e-8046f9aa14e6" xlink:to="loc_iart_InterestRateSwapDesignatedDecember132017Tranche2Member_f21973c4-5594-404a-ae36-dca16fc63422" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedDecember132017Tranche3Member_ab3e0c22-5a82-4460-8090-0421926fa7ce" xlink:href="iart-20230331.xsd#iart_InterestRateSwapDesignatedDecember132017Tranche3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_8d03f8b4-c119-4681-ba8e-8046f9aa14e6" xlink:to="loc_iart_InterestRateSwapDesignatedDecember132017Tranche3Member_ab3e0c22-5a82-4460-8090-0421926fa7ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedOctober102018Tranche1Member_85e4057e-d4a7-4ba3-89d0-3e02ac1862d7" xlink:href="iart-20230331.xsd#iart_InterestRateSwapDesignatedOctober102018Tranche1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_8d03f8b4-c119-4681-ba8e-8046f9aa14e6" xlink:to="loc_iart_InterestRateSwapDesignatedOctober102018Tranche1Member_85e4057e-d4a7-4ba3-89d0-3e02ac1862d7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedOctober102018Tranche2Member_11bb151f-71a8-4f1e-9f80-2c664e0c56b0" xlink:href="iart-20230331.xsd#iart_InterestRateSwapDesignatedOctober102018Tranche2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_8d03f8b4-c119-4681-ba8e-8046f9aa14e6" xlink:to="loc_iart_InterestRateSwapDesignatedOctober102018Tranche2Member_11bb151f-71a8-4f1e-9f80-2c664e0c56b0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedOctober102018Tranche3Member_46162cf2-68a2-436f-944f-22c773762e0c" xlink:href="iart-20230331.xsd#iart_InterestRateSwapDesignatedOctober102018Tranche3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_8d03f8b4-c119-4681-ba8e-8046f9aa14e6" xlink:to="loc_iart_InterestRateSwapDesignatedOctober102018Tranche3Member_46162cf2-68a2-436f-944f-22c773762e0c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedDecember182018Tranche1Member_5ba67a47-d162-4bb5-87fc-260e0992d72e" xlink:href="iart-20230331.xsd#iart_InterestRateSwapDesignatedDecember182018Tranche1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_8d03f8b4-c119-4681-ba8e-8046f9aa14e6" xlink:to="loc_iart_InterestRateSwapDesignatedDecember182018Tranche1Member_5ba67a47-d162-4bb5-87fc-260e0992d72e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedDecember182018Tranche2Member_fa9eff82-5e67-4774-b3d7-9ebab1cc56ec" xlink:href="iart-20230331.xsd#iart_InterestRateSwapDesignatedDecember182018Tranche2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_8d03f8b4-c119-4681-ba8e-8046f9aa14e6" xlink:to="loc_iart_InterestRateSwapDesignatedDecember182018Tranche2Member_fa9eff82-5e67-4774-b3d7-9ebab1cc56ec" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedDecember152020Tranche1Member_727cafad-1a30-4812-87e1-cd7314d208cd" xlink:href="iart-20230331.xsd#iart_InterestRateSwapDesignatedDecember152020Tranche1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_8d03f8b4-c119-4681-ba8e-8046f9aa14e6" xlink:to="loc_iart_InterestRateSwapDesignatedDecember152020Tranche1Member_727cafad-1a30-4812-87e1-cd7314d208cd" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedDecember152020Tranche2Member_435d9c82-94a3-45ea-9b3d-5ffdf2494abf" xlink:href="iart-20230331.xsd#iart_InterestRateSwapDesignatedDecember152020Tranche2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_8d03f8b4-c119-4681-ba8e-8046f9aa14e6" xlink:to="loc_iart_InterestRateSwapDesignatedDecember152020Tranche2Member_435d9c82-94a3-45ea-9b3d-5ffdf2494abf" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedMarch312023Member_2485f840-7836-4d51-988c-0862bfa126c4" xlink:href="iart-20230331.xsd#iart_InterestRateSwapDesignatedMarch312023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_8d03f8b4-c119-4681-ba8e-8046f9aa14e6" xlink:to="loc_iart_InterestRateSwapDesignatedMarch312023Member_2485f840-7836-4d51-988c-0862bfa126c4" xlink:type="arc" order="9"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails" xlink:type="simple" xlink:href="iart-20230331.xsd#DERIVATIVEINSTRUMENTSNarrativeDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails" xlink:type="extended" id="i463cbdaee2f44ef3a79937159bf44a33_DERIVATIVEINSTRUMENTSNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_87b7452e-3c7a-46b9-bdd7-504bbd0fe8d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DerivativeNotionalAmountTerminated_0ed107d1-0c82-41b5-9dec-65e7766d1233" xlink:href="iart-20230331.xsd#iart_DerivativeNotionalAmountTerminated"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_87b7452e-3c7a-46b9-bdd7-504bbd0fe8d5" xlink:to="loc_iart_DerivativeNotionalAmountTerminated_0ed107d1-0c82-41b5-9dec-65e7766d1233" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_a11815b2-9c2e-4544-b748-3618b52d5a71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_87b7452e-3c7a-46b9-bdd7-504bbd0fe8d5" xlink:to="loc_us-gaap_DerivativeNotionalAmount_a11815b2-9c2e-4544-b748-3618b52d5a71" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_IntercompanyLoanQuarterlyPayment_ebed5491-0cba-4918-9b9b-0c2455020c56" xlink:href="iart-20230331.xsd#iart_IntercompanyLoanQuarterlyPayment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_87b7452e-3c7a-46b9-bdd7-504bbd0fe8d5" xlink:to="loc_iart_IntercompanyLoanQuarterlyPayment_ebed5491-0cba-4918-9b9b-0c2455020c56" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_032fec8b-b8d8-469c-a76a-31426cbe83d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnDerivativeInstrumentsNetPretax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_87b7452e-3c7a-46b9-bdd7-504bbd0fe8d5" xlink:to="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_032fec8b-b8d8-469c-a76a-31426cbe83d0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_9932d67b-715d-425c-afb3-10659eaaabd5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_87b7452e-3c7a-46b9-bdd7-504bbd0fe8d5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_9932d67b-715d-425c-afb3-10659eaaabd5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_ecadda0b-9bf4-4e45-8878-d53d204fa978" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_87b7452e-3c7a-46b9-bdd7-504bbd0fe8d5" xlink:to="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_ecadda0b-9bf4-4e45-8878-d53d204fa978" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_c3ecc249-89cb-418f-821f-06abf1de428b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_87b7452e-3c7a-46b9-bdd7-504bbd0fe8d5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_c3ecc249-89cb-418f-821f-06abf1de428b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_fcc8eb20-06d5-444e-8134-8c998b0bf58f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_87b7452e-3c7a-46b9-bdd7-504bbd0fe8d5" xlink:to="loc_us-gaap_DerivativeTable_fcc8eb20-06d5-444e-8134-8c998b0bf58f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_163e3e79-4e0f-418e-bcf8-5a9ae06da6bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_fcc8eb20-06d5-444e-8134-8c998b0bf58f" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_163e3e79-4e0f-418e-bcf8-5a9ae06da6bd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_163e3e79-4e0f-418e-bcf8-5a9ae06da6bd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_163e3e79-4e0f-418e-bcf8-5a9ae06da6bd" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_163e3e79-4e0f-418e-bcf8-5a9ae06da6bd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_e46976dd-ffdb-483f-9c47-f3ab27758e11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_163e3e79-4e0f-418e-bcf8-5a9ae06da6bd" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_e46976dd-ffdb-483f-9c47-f3ab27758e11" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_03f2b9d3-3a8d-45c1-9ef8-32cff5565433" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_e46976dd-ffdb-483f-9c47-f3ab27758e11" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_03f2b9d3-3a8d-45c1-9ef8-32cff5565433" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_331a1539-8c5d-4de2-9696-e0a1690ba37b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrencySwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_e46976dd-ffdb-483f-9c47-f3ab27758e11" xlink:to="loc_us-gaap_CurrencySwapMember_331a1539-8c5d-4de2-9696-e0a1690ba37b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_9a7ca1dd-ffca-4f81-8740-3ca8f4b1f656" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_e46976dd-ffdb-483f-9c47-f3ab27758e11" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_9a7ca1dd-ffca-4f81-8740-3ca8f4b1f656" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionAxis_505f3737-48bb-4194-b804-22d39385f153" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PositionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_fcc8eb20-06d5-444e-8134-8c998b0bf58f" xlink:to="loc_us-gaap_PositionAxis_505f3737-48bb-4194-b804-22d39385f153" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionDomain_505f3737-48bb-4194-b804-22d39385f153_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PositionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PositionAxis_505f3737-48bb-4194-b804-22d39385f153" xlink:to="loc_us-gaap_PositionDomain_505f3737-48bb-4194-b804-22d39385f153_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionDomain_3b887f9d-7aff-495d-a42a-340c420153d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PositionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PositionAxis_505f3737-48bb-4194-b804-22d39385f153" xlink:to="loc_us-gaap_PositionDomain_3b887f9d-7aff-495d-a42a-340c420153d2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortMember_f65f234e-9009-4d7e-9d67-368c3a6cb2a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PositionDomain_3b887f9d-7aff-495d-a42a-340c420153d2" xlink:to="loc_us-gaap_ShortMember_f65f234e-9009-4d7e-9d67-368c3a6cb2a8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongMember_e4cd2c7e-b5d1-443c-a70e-b57081bd1b85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PositionDomain_3b887f9d-7aff-495d-a42a-340c420153d2" xlink:to="loc_us-gaap_LongMember_e4cd2c7e-b5d1-443c-a70e-b57081bd1b85" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_14a16e90-554d-48a9-82ce-c8661bf6d1cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_fcc8eb20-06d5-444e-8134-8c998b0bf58f" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_14a16e90-554d-48a9-82ce-c8661bf6d1cc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_14a16e90-554d-48a9-82ce-c8661bf6d1cc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_14a16e90-554d-48a9-82ce-c8661bf6d1cc" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_14a16e90-554d-48a9-82ce-c8661bf6d1cc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_75d5aaa4-0eab-40dc-9031-84394d07abeb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_14a16e90-554d-48a9-82ce-c8661bf6d1cc" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_75d5aaa4-0eab-40dc-9031-84394d07abeb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CodmanMember_f4d7cdfe-4426-41af-9dcd-7c1668271549" xlink:href="iart-20230331.xsd#iart_CodmanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_75d5aaa4-0eab-40dc-9031-84394d07abeb" xlink:to="loc_iart_CodmanMember_f4d7cdfe-4426-41af-9dcd-7c1668271549" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_b76e4283-084f-4f66-845f-c07c00ce5880" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_fcc8eb20-06d5-444e-8134-8c998b0bf58f" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_b76e4283-084f-4f66-845f-c07c00ce5880" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_b76e4283-084f-4f66-845f-c07c00ce5880_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_b76e4283-084f-4f66-845f-c07c00ce5880" xlink:to="loc_us-gaap_HedgingRelationshipDomain_b76e4283-084f-4f66-845f-c07c00ce5880_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_bcdb3ef8-5861-4daa-bfc6-4bfcced810b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_b76e4283-084f-4f66-845f-c07c00ce5880" xlink:to="loc_us-gaap_HedgingRelationshipDomain_bcdb3ef8-5861-4daa-bfc6-4bfcced810b8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_a7598b4f-5d73-455f-9c51-34d892b4e9e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_bcdb3ef8-5861-4daa-bfc6-4bfcced810b8" xlink:to="loc_us-gaap_CashFlowHedgingMember_a7598b4f-5d73-455f-9c51-34d892b4e9e6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_e353089f-5e3b-432d-9e6e-3c9b9f85ac51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_bcdb3ef8-5861-4daa-bfc6-4bfcced810b8" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_e353089f-5e3b-432d-9e6e-3c9b9f85ac51" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_0b814c87-bf0a-4a2d-8deb-12aea8857b6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_bcdb3ef8-5861-4daa-bfc6-4bfcced810b8" xlink:to="loc_us-gaap_NondesignatedMember_0b814c87-bf0a-4a2d-8deb-12aea8857b6d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_c217176a-fd4c-41e4-9a77-58f2b7f13fd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_fcc8eb20-06d5-444e-8134-8c998b0bf58f" xlink:to="loc_us-gaap_HedgingDesignationAxis_c217176a-fd4c-41e4-9a77-58f2b7f13fd4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_c217176a-fd4c-41e4-9a77-58f2b7f13fd4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_c217176a-fd4c-41e4-9a77-58f2b7f13fd4" xlink:to="loc_us-gaap_HedgingDesignationDomain_c217176a-fd4c-41e4-9a77-58f2b7f13fd4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_fa0f1075-55af-47e9-b79d-4f4e00829d9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_c217176a-fd4c-41e4-9a77-58f2b7f13fd4" xlink:to="loc_us-gaap_HedgingDesignationDomain_fa0f1075-55af-47e9-b79d-4f4e00829d9f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_9619603d-62be-4d7e-a3cf-b2c0c56e9489" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_fa0f1075-55af-47e9-b79d-4f4e00829d9f" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_9619603d-62be-4d7e-a3cf-b2c0c56e9489" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_b437cca5-c762-4c84-90fa-7e6c2ec3121b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_fa0f1075-55af-47e9-b79d-4f4e00829d9f" xlink:to="loc_us-gaap_NondesignatedMember_b437cca5-c762-4c84-90fa-7e6c2ec3121b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_7d0a037b-3fdb-4a63-b4a4-cb36cdbce7d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_fcc8eb20-06d5-444e-8134-8c998b0bf58f" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_7d0a037b-3fdb-4a63-b4a4-cb36cdbce7d9" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_7d0a037b-3fdb-4a63-b4a4-cb36cdbce7d9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_7d0a037b-3fdb-4a63-b4a4-cb36cdbce7d9" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_7d0a037b-3fdb-4a63-b4a4-cb36cdbce7d9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_5a7524fa-3d64-4df6-b05b-dc61a83a121b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_7d0a037b-3fdb-4a63-b4a4-cb36cdbce7d9" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_5a7524fa-3d64-4df6-b05b-dc61a83a121b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_13c3c059-6319-4bd3-b30f-e6cfcc38e919" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_5a7524fa-3d64-4df6-b05b-dc61a83a121b" xlink:to="loc_us-gaap_CostOfSalesMember_13c3c059-6319-4bd3-b30f-e6cfcc38e919" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_655e53e1-2730-49d9-94b0-7dbccac1d312" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_5a7524fa-3d64-4df6-b05b-dc61a83a121b" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_655e53e1-2730-49d9-94b0-7dbccac1d312" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails" xlink:type="simple" xlink:href="iart-20230331.xsd#DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails" xlink:type="extended" id="i9c6d0cd474284f0888f13b73485b239a_DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_207ae1ba-4957-4c92-a8e5-74637872b953" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFixedInterestRate_de8c8144-6ab2-47c5-ad9f-051eac80188a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFixedInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_207ae1ba-4957-4c92-a8e5-74637872b953" xlink:to="loc_us-gaap_DerivativeFixedInterestRate_de8c8144-6ab2-47c5-ad9f-051eac80188a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_f8cafb74-4270-4f32-b21a-d51c3725a6d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_207ae1ba-4957-4c92-a8e5-74637872b953" xlink:to="loc_us-gaap_DerivativeNotionalAmount_f8cafb74-4270-4f32-b21a-d51c3725a6d4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeNet_356cb4cd-01ae-4be3-98a4-1a30854618f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_207ae1ba-4957-4c92-a8e5-74637872b953" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeNet_356cb4cd-01ae-4be3-98a4-1a30854618f1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_4d9ad558-f22e-41d4-963f-0e59a3ddadb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_207ae1ba-4957-4c92-a8e5-74637872b953" xlink:to="loc_us-gaap_DerivativeTable_4d9ad558-f22e-41d4-963f-0e59a3ddadb5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_cf0fef19-31e9-4f93-878c-d1e671888a2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_4d9ad558-f22e-41d4-963f-0e59a3ddadb5" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_cf0fef19-31e9-4f93-878c-d1e671888a2d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_cf0fef19-31e9-4f93-878c-d1e671888a2d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_cf0fef19-31e9-4f93-878c-d1e671888a2d" xlink:to="loc_us-gaap_HedgingRelationshipDomain_cf0fef19-31e9-4f93-878c-d1e671888a2d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_a24da209-5af6-405f-9526-dfda11e0a0ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_cf0fef19-31e9-4f93-878c-d1e671888a2d" xlink:to="loc_us-gaap_HedgingRelationshipDomain_a24da209-5af6-405f-9526-dfda11e0a0ca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_0c3ce622-f54a-45eb-9563-db73ceff6ed6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_a24da209-5af6-405f-9526-dfda11e0a0ca" xlink:to="loc_us-gaap_CashFlowHedgingMember_0c3ce622-f54a-45eb-9563-db73ceff6ed6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_b4f3cebb-f6dd-4ba4-988b-a35a6bc8e891" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_4d9ad558-f22e-41d4-963f-0e59a3ddadb5" xlink:to="loc_us-gaap_HedgingDesignationAxis_b4f3cebb-f6dd-4ba4-988b-a35a6bc8e891" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_b4f3cebb-f6dd-4ba4-988b-a35a6bc8e891_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_b4f3cebb-f6dd-4ba4-988b-a35a6bc8e891" xlink:to="loc_us-gaap_HedgingDesignationDomain_b4f3cebb-f6dd-4ba4-988b-a35a6bc8e891_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_06b8c312-7e51-446a-9c68-6c973b5c63dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_b4f3cebb-f6dd-4ba4-988b-a35a6bc8e891" xlink:to="loc_us-gaap_HedgingDesignationDomain_06b8c312-7e51-446a-9c68-6c973b5c63dc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_d2b6d6d5-f9f9-4d9a-9ea0-260ba4cb099f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_06b8c312-7e51-446a-9c68-6c973b5c63dc" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_d2b6d6d5-f9f9-4d9a-9ea0-260ba4cb099f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_e8347d1e-5e3a-47b6-935d-8b55d15cdc3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_4d9ad558-f22e-41d4-963f-0e59a3ddadb5" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_e8347d1e-5e3a-47b6-935d-8b55d15cdc3c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_e8347d1e-5e3a-47b6-935d-8b55d15cdc3c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_e8347d1e-5e3a-47b6-935d-8b55d15cdc3c" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_e8347d1e-5e3a-47b6-935d-8b55d15cdc3c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_2eabb975-939c-42ad-9126-d36f3483681f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_e8347d1e-5e3a-47b6-935d-8b55d15cdc3c" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_2eabb975-939c-42ad-9126-d36f3483681f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_a5790cd2-6494-4a17-b158-6d10df05a1d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_2eabb975-939c-42ad-9126-d36f3483681f" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_a5790cd2-6494-4a17-b158-6d10df05a1d6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CrossCurrencyInterestRateContractOneMember_da576ecd-dfce-4edf-ae8f-f68366578838" xlink:href="iart-20230331.xsd#iart_CrossCurrencyInterestRateContractOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CrossCurrencyInterestRateContractMember_a5790cd2-6494-4a17-b158-6d10df05a1d6" xlink:to="loc_iart_CrossCurrencyInterestRateContractOneMember_da576ecd-dfce-4edf-ae8f-f68366578838" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CrossCurrencyInterestRateContractTwoMember_f24215c6-5ddc-4f63-ae56-6e13b1b8ea40" xlink:href="iart-20230331.xsd#iart_CrossCurrencyInterestRateContractTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CrossCurrencyInterestRateContractMember_a5790cd2-6494-4a17-b158-6d10df05a1d6" xlink:to="loc_iart_CrossCurrencyInterestRateContractTwoMember_f24215c6-5ddc-4f63-ae56-6e13b1b8ea40" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionAxis_f95bf060-96ae-43c4-bcb2-5d9313753970" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PositionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_4d9ad558-f22e-41d4-963f-0e59a3ddadb5" xlink:to="loc_us-gaap_PositionAxis_f95bf060-96ae-43c4-bcb2-5d9313753970" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionDomain_f95bf060-96ae-43c4-bcb2-5d9313753970_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PositionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PositionAxis_f95bf060-96ae-43c4-bcb2-5d9313753970" xlink:to="loc_us-gaap_PositionDomain_f95bf060-96ae-43c4-bcb2-5d9313753970_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionDomain_c9dbaf21-87a6-407c-a876-77f7734a87ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PositionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PositionAxis_f95bf060-96ae-43c4-bcb2-5d9313753970" xlink:to="loc_us-gaap_PositionDomain_c9dbaf21-87a6-407c-a876-77f7734a87ac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongMember_997135f7-c7b9-420f-bbc9-b2872afd6c4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PositionDomain_c9dbaf21-87a6-407c-a876-77f7734a87ac" xlink:to="loc_us-gaap_LongMember_997135f7-c7b9-420f-bbc9-b2872afd6c4a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortMember_70f12687-829b-43ae-8d0d-697de79cd76e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PositionDomain_c9dbaf21-87a6-407c-a876-77f7734a87ac" xlink:to="loc_us-gaap_ShortMember_70f12687-829b-43ae-8d0d-697de79cd76e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_799a9f62-0071-42a8-97dc-48d705fb69e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_4d9ad558-f22e-41d4-963f-0e59a3ddadb5" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_799a9f62-0071-42a8-97dc-48d705fb69e5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_799a9f62-0071-42a8-97dc-48d705fb69e5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_799a9f62-0071-42a8-97dc-48d705fb69e5" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_799a9f62-0071-42a8-97dc-48d705fb69e5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_eb65da64-4bfd-4eae-b7fb-fe1ec29a8da9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_799a9f62-0071-42a8-97dc-48d705fb69e5" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_eb65da64-4bfd-4eae-b7fb-fe1ec29a8da9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CodmanMember_16154427-8c0a-43c9-9206-d6445715442d" xlink:href="iart-20230331.xsd#iart_CodmanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_eb65da64-4bfd-4eae-b7fb-fe1ec29a8da9" xlink:to="loc_iart_CodmanMember_16154427-8c0a-43c9-9206-d6445715442d" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails" xlink:type="simple" xlink:href="iart-20230331.xsd#DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails" xlink:type="extended" id="i4a58afd76de147949ecdcee892942eb2_DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_480aa277-4772-4451-ae16-befcedfd1810" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFixedInterestRate_0811f521-7b8b-4fda-81a3-5a9917a7827e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFixedInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_480aa277-4772-4451-ae16-befcedfd1810" xlink:to="loc_us-gaap_DerivativeFixedInterestRate_0811f521-7b8b-4fda-81a3-5a9917a7827e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_ab613360-3edd-444b-8eb2-aedccab618a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_480aa277-4772-4451-ae16-befcedfd1810" xlink:to="loc_us-gaap_DerivativeNotionalAmount_ab613360-3edd-444b-8eb2-aedccab618a9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeNet_9872a576-252d-444e-9293-95403d61eca0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_480aa277-4772-4451-ae16-befcedfd1810" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeNet_9872a576-252d-444e-9293-95403d61eca0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_c7dd2b87-688e-4ca3-a82e-069f17794cd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_480aa277-4772-4451-ae16-befcedfd1810" xlink:to="loc_us-gaap_DerivativeTable_c7dd2b87-688e-4ca3-a82e-069f17794cd4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_056a916c-1aca-4d12-b9dd-89919795d9e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_c7dd2b87-688e-4ca3-a82e-069f17794cd4" xlink:to="loc_us-gaap_HedgingDesignationAxis_056a916c-1aca-4d12-b9dd-89919795d9e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_056a916c-1aca-4d12-b9dd-89919795d9e1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_056a916c-1aca-4d12-b9dd-89919795d9e1" xlink:to="loc_us-gaap_HedgingDesignationDomain_056a916c-1aca-4d12-b9dd-89919795d9e1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_733e0ea6-e8d4-4446-aa49-2f22f3c0b2f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_056a916c-1aca-4d12-b9dd-89919795d9e1" xlink:to="loc_us-gaap_HedgingDesignationDomain_733e0ea6-e8d4-4446-aa49-2f22f3c0b2f8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_33b7ca43-d3fa-4173-acc2-222c5eb9da81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_733e0ea6-e8d4-4446-aa49-2f22f3c0b2f8" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_33b7ca43-d3fa-4173-acc2-222c5eb9da81" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_26c3951d-1faf-4cee-b448-bedfa8517228" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_c7dd2b87-688e-4ca3-a82e-069f17794cd4" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_26c3951d-1faf-4cee-b448-bedfa8517228" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_26c3951d-1faf-4cee-b448-bedfa8517228_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_26c3951d-1faf-4cee-b448-bedfa8517228" xlink:to="loc_us-gaap_HedgingRelationshipDomain_26c3951d-1faf-4cee-b448-bedfa8517228_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_7a1b67a8-7129-4b48-ad6a-cf16f02899e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_26c3951d-1faf-4cee-b448-bedfa8517228" xlink:to="loc_us-gaap_HedgingRelationshipDomain_7a1b67a8-7129-4b48-ad6a-cf16f02899e5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_dbcf2bb1-65da-4a92-8aff-439af0cab63a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_7a1b67a8-7129-4b48-ad6a-cf16f02899e5" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_dbcf2bb1-65da-4a92-8aff-439af0cab63a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_917ff3c1-e001-454b-9a6c-28abfa1472c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_c7dd2b87-688e-4ca3-a82e-069f17794cd4" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_917ff3c1-e001-454b-9a6c-28abfa1472c8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_917ff3c1-e001-454b-9a6c-28abfa1472c8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_917ff3c1-e001-454b-9a6c-28abfa1472c8" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_917ff3c1-e001-454b-9a6c-28abfa1472c8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_161781a1-3fa3-4451-bb17-cf046c76c565" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_917ff3c1-e001-454b-9a6c-28abfa1472c8" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_161781a1-3fa3-4451-bb17-cf046c76c565" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_54f5eaa0-1c28-46b5-bfd8-ad39432d263f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_161781a1-3fa3-4451-bb17-cf046c76c565" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_54f5eaa0-1c28-46b5-bfd8-ad39432d263f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CrossCurrencyInterestRateContractOneMember_42983344-64c1-4e1f-9299-7d2be781ecf9" xlink:href="iart-20230331.xsd#iart_CrossCurrencyInterestRateContractOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CrossCurrencyInterestRateContractMember_54f5eaa0-1c28-46b5-bfd8-ad39432d263f" xlink:to="loc_iart_CrossCurrencyInterestRateContractOneMember_42983344-64c1-4e1f-9299-7d2be781ecf9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CrossCurrencyInterestRateContractTwoMember_f7e12b5c-ffb0-4cc6-b12d-a5a41faece07" xlink:href="iart-20230331.xsd#iart_CrossCurrencyInterestRateContractTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CrossCurrencyInterestRateContractMember_54f5eaa0-1c28-46b5-bfd8-ad39432d263f" xlink:to="loc_iart_CrossCurrencyInterestRateContractTwoMember_f7e12b5c-ffb0-4cc6-b12d-a5a41faece07" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CrossCurrencyInterestRateContractThreeMember_1843c08e-cf81-46bd-b024-9edde1070726" xlink:href="iart-20230331.xsd#iart_CrossCurrencyInterestRateContractThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CrossCurrencyInterestRateContractMember_54f5eaa0-1c28-46b5-bfd8-ad39432d263f" xlink:to="loc_iart_CrossCurrencyInterestRateContractThreeMember_1843c08e-cf81-46bd-b024-9edde1070726" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionAxis_bd1f12f7-7269-425e-b04c-b6e2785e49c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PositionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_c7dd2b87-688e-4ca3-a82e-069f17794cd4" xlink:to="loc_us-gaap_PositionAxis_bd1f12f7-7269-425e-b04c-b6e2785e49c6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionDomain_bd1f12f7-7269-425e-b04c-b6e2785e49c6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PositionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PositionAxis_bd1f12f7-7269-425e-b04c-b6e2785e49c6" xlink:to="loc_us-gaap_PositionDomain_bd1f12f7-7269-425e-b04c-b6e2785e49c6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionDomain_c81c74c2-51ee-4e7a-8b56-51e5b8bc2e5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PositionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PositionAxis_bd1f12f7-7269-425e-b04c-b6e2785e49c6" xlink:to="loc_us-gaap_PositionDomain_c81c74c2-51ee-4e7a-8b56-51e5b8bc2e5c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongMember_1f50ffe7-50ba-46a6-916c-9b6ef9c7111a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PositionDomain_c81c74c2-51ee-4e7a-8b56-51e5b8bc2e5c" xlink:to="loc_us-gaap_LongMember_1f50ffe7-50ba-46a6-916c-9b6ef9c7111a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortMember_a6fafca7-c85e-4271-97f4-81f802e5b6b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PositionDomain_c81c74c2-51ee-4e7a-8b56-51e5b8bc2e5c" xlink:to="loc_us-gaap_ShortMember_a6fafca7-c85e-4271-97f4-81f802e5b6b0" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails" xlink:type="simple" xlink:href="iart-20230331.xsd#DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails" xlink:type="extended" id="ie5db910f15e34c3ea1346f905650c9ed_DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_ffa33832-b9bb-480d-88af-ee2409bd6a3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_a6618551-ffca-43c8-8de1-085b5b31181e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_ffa33832-b9bb-480d-88af-ee2409bd6a3c" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_a6618551-ffca-43c8-8de1-085b5b31181e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_0b594cd5-e27f-4e53-a8ac-a44d95776c9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_ffa33832-b9bb-480d-88af-ee2409bd6a3c" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_0b594cd5-e27f-4e53-a8ac-a44d95776c9f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_319dbf5d-f3d3-4851-ae2b-145f17511072" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_ffa33832-b9bb-480d-88af-ee2409bd6a3c" xlink:to="loc_us-gaap_DerivativeNotionalAmount_319dbf5d-f3d3-4851-ae2b-145f17511072" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_a442e6af-ece6-4aa3-9499-0649619dfb57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_ffa33832-b9bb-480d-88af-ee2409bd6a3c" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_a442e6af-ece6-4aa3-9499-0649619dfb57" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_80c82dd6-b502-463b-9757-3e1a85d59bc2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_a442e6af-ece6-4aa3-9499-0649619dfb57" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_80c82dd6-b502-463b-9757-3e1a85d59bc2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_80c82dd6-b502-463b-9757-3e1a85d59bc2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_80c82dd6-b502-463b-9757-3e1a85d59bc2" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_80c82dd6-b502-463b-9757-3e1a85d59bc2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_bf72a0c1-bfb6-41e1-a68e-1ccf25d180f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_80c82dd6-b502-463b-9757-3e1a85d59bc2" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_bf72a0c1-bfb6-41e1-a68e-1ccf25d180f3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_de74de94-4350-41e3-a440-8e070496efca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_bf72a0c1-bfb6-41e1-a68e-1ccf25d180f3" xlink:to="loc_us-gaap_InterestRateSwapMember_de74de94-4350-41e3-a440-8e070496efca" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_ba7746de-69bf-4f2d-b83a-a60a644ab202" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_bf72a0c1-bfb6-41e1-a68e-1ccf25d180f3" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_ba7746de-69bf-4f2d-b83a-a60a644ab202" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_3bbfa77b-b36b-4dcd-be62-16153e64be19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_bf72a0c1-bfb6-41e1-a68e-1ccf25d180f3" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_3bbfa77b-b36b-4dcd-be62-16153e64be19" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_336290d7-0ecb-4a2e-a2fd-bdc1ebf0bc08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_a442e6af-ece6-4aa3-9499-0649619dfb57" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_336290d7-0ecb-4a2e-a2fd-bdc1ebf0bc08" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_336290d7-0ecb-4a2e-a2fd-bdc1ebf0bc08_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_336290d7-0ecb-4a2e-a2fd-bdc1ebf0bc08" xlink:to="loc_us-gaap_HedgingRelationshipDomain_336290d7-0ecb-4a2e-a2fd-bdc1ebf0bc08_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_285087ab-de69-437e-949c-7ce00312a5d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_336290d7-0ecb-4a2e-a2fd-bdc1ebf0bc08" xlink:to="loc_us-gaap_HedgingRelationshipDomain_285087ab-de69-437e-949c-7ce00312a5d9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_581bb12b-64a9-442d-a51f-10d8ebeb57c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_285087ab-de69-437e-949c-7ce00312a5d9" xlink:to="loc_us-gaap_CashFlowHedgingMember_581bb12b-64a9-442d-a51f-10d8ebeb57c1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_1be9b05c-3993-40c7-842a-1995821e0837" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_285087ab-de69-437e-949c-7ce00312a5d9" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_1be9b05c-3993-40c7-842a-1995821e0837" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_130d2b42-7499-4605-88f1-0c69287235d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_a442e6af-ece6-4aa3-9499-0649619dfb57" xlink:to="loc_us-gaap_HedgingDesignationAxis_130d2b42-7499-4605-88f1-0c69287235d1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_130d2b42-7499-4605-88f1-0c69287235d1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_130d2b42-7499-4605-88f1-0c69287235d1" xlink:to="loc_us-gaap_HedgingDesignationDomain_130d2b42-7499-4605-88f1-0c69287235d1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_5a085013-57de-4f25-bfda-36109b4d4c49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_130d2b42-7499-4605-88f1-0c69287235d1" xlink:to="loc_us-gaap_HedgingDesignationDomain_5a085013-57de-4f25-bfda-36109b4d4c49" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_ac34e38c-7b85-4e28-8701-a59b4e1d6e77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_5a085013-57de-4f25-bfda-36109b4d4c49" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_ac34e38c-7b85-4e28-8701-a59b4e1d6e77" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_4a510c74-252d-4db2-9ffd-774969842b59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_a442e6af-ece6-4aa3-9499-0649619dfb57" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_4a510c74-252d-4db2-9ffd-774969842b59" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_4a510c74-252d-4db2-9ffd-774969842b59_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_4a510c74-252d-4db2-9ffd-774969842b59" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_4a510c74-252d-4db2-9ffd-774969842b59_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_c3506635-1dd8-415e-8c3c-fbe05212aa57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_4a510c74-252d-4db2-9ffd-774969842b59" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_c3506635-1dd8-415e-8c3c-fbe05212aa57" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_c6519fc9-1bf1-4746-a7e9-aa5c459b1e02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_c3506635-1dd8-415e-8c3c-fbe05212aa57" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_c6519fc9-1bf1-4746-a7e9-aa5c459b1e02" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember_4b539e92-580d-424d-a0da-b1c4b236fcba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_c3506635-1dd8-415e-8c3c-fbe05212aa57" xlink:to="loc_us-gaap_OtherAssetsMember_4b539e92-580d-424d-a0da-b1c4b236fcba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AccruedExpensesAndOtherCurrentLiabilitiesMember_f086bfd3-9db3-43fb-8900-dcde6b50e833" xlink:href="iart-20230331.xsd#iart_AccruedExpensesAndOtherCurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_c3506635-1dd8-415e-8c3c-fbe05212aa57" xlink:to="loc_iart_AccruedExpensesAndOtherCurrentLiabilitiesMember_f086bfd3-9db3-43fb-8900-dcde6b50e833" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesMember_71463aad-8a22-43b2-994d-3428866049e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_c3506635-1dd8-415e-8c3c-fbe05212aa57" xlink:to="loc_us-gaap_OtherLiabilitiesMember_71463aad-8a22-43b2-994d-3428866049e4" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails" xlink:type="simple" xlink:href="iart-20230331.xsd#DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails" xlink:type="extended" id="ia62e04347fa34511a24cec17fc14587d_DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_309b1d4b-f4cc-4986-8ed3-15660f8ecc3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_cee28157-01fd-4db3-afe3-25ffeaab57f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_309b1d4b-f4cc-4986-8ed3-15660f8ecc3e" xlink:to="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_cee28157-01fd-4db3-afe3-25ffeaab57f1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_82d18d1c-a858-4732-aa90-fa2b28f7937e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_cee28157-01fd-4db3-afe3-25ffeaab57f1" xlink:to="loc_us-gaap_StockholdersEquity_82d18d1c-a858-4732-aa90-fa2b28f7937e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_51e92c74-6951-4d7e-bb78-95e827334fbb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_cee28157-01fd-4db3-afe3-25ffeaab57f1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_51e92c74-6951-4d7e-bb78-95e827334fbb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_742e89ef-8362-48bf-9022-cb1373c5b92d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_cee28157-01fd-4db3-afe3-25ffeaab57f1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_742e89ef-8362-48bf-9022-cb1373c5b92d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_02f084f4-1885-4192-83b0-5cef5528b05b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_7666e8cf-77cd-4ccb-9746-3405872b5785" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_309b1d4b-f4cc-4986-8ed3-15660f8ecc3e" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_7666e8cf-77cd-4ccb-9746-3405872b5785" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_7e3693ce-3da6-4a27-9bdd-d4082a592e31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_7666e8cf-77cd-4ccb-9746-3405872b5785" xlink:to="loc_us-gaap_HedgingDesignationAxis_7e3693ce-3da6-4a27-9bdd-d4082a592e31" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_7e3693ce-3da6-4a27-9bdd-d4082a592e31_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_7e3693ce-3da6-4a27-9bdd-d4082a592e31" xlink:to="loc_us-gaap_HedgingDesignationDomain_7e3693ce-3da6-4a27-9bdd-d4082a592e31_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_ceadc37a-525b-4b21-9130-eccabf6fc720" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_7e3693ce-3da6-4a27-9bdd-d4082a592e31" xlink:to="loc_us-gaap_HedgingDesignationDomain_ceadc37a-525b-4b21-9130-eccabf6fc720" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_74d1b0a0-adf3-411b-ab41-a1412e954c17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_ceadc37a-525b-4b21-9130-eccabf6fc720" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_74d1b0a0-adf3-411b-ab41-a1412e954c17" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_b21c8853-b719-46e3-b8fb-5b9f9ebbfc3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_7666e8cf-77cd-4ccb-9746-3405872b5785" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_b21c8853-b719-46e3-b8fb-5b9f9ebbfc3b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_b21c8853-b719-46e3-b8fb-5b9f9ebbfc3b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_b21c8853-b719-46e3-b8fb-5b9f9ebbfc3b" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_b21c8853-b719-46e3-b8fb-5b9f9ebbfc3b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_3d822a5b-ccc0-4dfa-ac26-4397ddc2fd0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_b21c8853-b719-46e3-b8fb-5b9f9ebbfc3b" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_3d822a5b-ccc0-4dfa-ac26-4397ddc2fd0d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_6c7b1e56-f649-4c07-9c8f-0f054935d079" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_3d822a5b-ccc0-4dfa-ac26-4397ddc2fd0d" xlink:to="loc_us-gaap_InterestRateSwapMember_6c7b1e56-f649-4c07-9c8f-0f054935d079" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_3778a9c7-3f76-4ff4-9dbe-e8d59309f65e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_3d822a5b-ccc0-4dfa-ac26-4397ddc2fd0d" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_3778a9c7-3f76-4ff4-9dbe-e8d59309f65e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_453d72b0-28ee-42be-a552-44b70e1e90c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_3d822a5b-ccc0-4dfa-ac26-4397ddc2fd0d" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_453d72b0-28ee-42be-a552-44b70e1e90c7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_78be6d3f-52f8-454a-84b1-0146e8ceb277" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_7666e8cf-77cd-4ccb-9746-3405872b5785" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_78be6d3f-52f8-454a-84b1-0146e8ceb277" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_78be6d3f-52f8-454a-84b1-0146e8ceb277_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_78be6d3f-52f8-454a-84b1-0146e8ceb277" xlink:to="loc_us-gaap_HedgingRelationshipDomain_78be6d3f-52f8-454a-84b1-0146e8ceb277_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_2a30986d-e368-40a1-b0ae-8f4a928218b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_78be6d3f-52f8-454a-84b1-0146e8ceb277" xlink:to="loc_us-gaap_HedgingRelationshipDomain_2a30986d-e368-40a1-b0ae-8f4a928218b4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_1b098e35-179f-426d-b2fc-24a0357c0709" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_2a30986d-e368-40a1-b0ae-8f4a928218b4" xlink:to="loc_us-gaap_CashFlowHedgingMember_1b098e35-179f-426d-b2fc-24a0357c0709" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_28173563-b51d-4d1b-a9f7-4bd1f0265832" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_2a30986d-e368-40a1-b0ae-8f4a928218b4" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_28173563-b51d-4d1b-a9f7-4bd1f0265832" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_e9360794-c166-4e9c-b9dc-03c5c0c78efd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_7666e8cf-77cd-4ccb-9746-3405872b5785" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_e9360794-c166-4e9c-b9dc-03c5c0c78efd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_e9360794-c166-4e9c-b9dc-03c5c0c78efd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_e9360794-c166-4e9c-b9dc-03c5c0c78efd" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_e9360794-c166-4e9c-b9dc-03c5c0c78efd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_6efef953-6c2c-4a88-a565-7bc3fb3bd252" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_e9360794-c166-4e9c-b9dc-03c5c0c78efd" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_6efef953-6c2c-4a88-a565-7bc3fb3bd252" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_92c57e43-c4f8-4348-bb75-0820d6f4b7e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_6efef953-6c2c-4a88-a565-7bc3fb3bd252" xlink:to="loc_us-gaap_InterestExpenseMember_92c57e43-c4f8-4348-bb75-0820d6f4b7e7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_63a048f3-596b-485f-a27d-bf33254f069e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_6efef953-6c2c-4a88-a565-7bc3fb3bd252" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_63a048f3-596b-485f-a27d-bf33254f069e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_ba1b0dc0-e0a2-4a13-8abe-4bafa8d5ed9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_6efef953-6c2c-4a88-a565-7bc3fb3bd252" xlink:to="loc_us-gaap_CostOfSalesMember_ba1b0dc0-e0a2-4a13-8abe-4bafa8d5ed9c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeMember_3b588392-7dd9-4358-ba22-74bd39353115" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_6efef953-6c2c-4a88-a565-7bc3fb3bd252" xlink:to="loc_us-gaap_InterestIncomeMember_3b588392-7dd9-4358-ba22-74bd39353115" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_d2fa8942-4747-4e2a-87ac-29299e7c6249" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_7666e8cf-77cd-4ccb-9746-3405872b5785" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_d2fa8942-4747-4e2a-87ac-29299e7c6249" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_d2fa8942-4747-4e2a-87ac-29299e7c6249_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_d2fa8942-4747-4e2a-87ac-29299e7c6249" xlink:to="loc_us-gaap_EquityComponentDomain_d2fa8942-4747-4e2a-87ac-29299e7c6249_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_d008d2e2-bf8f-476f-a01b-2484cf57bfa9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_d2fa8942-4747-4e2a-87ac-29299e7c6249" xlink:to="loc_us-gaap_EquityComponentDomain_d008d2e2-bf8f-476f-a01b-2484cf57bfa9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_e58104b2-d4ac-4efa-8943-5d24e9cf2d0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_d008d2e2-bf8f-476f-a01b-2484cf57bfa9" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_e58104b2-d4ac-4efa-8943-5d24e9cf2d0f" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofDerivativesNotDesignatedasHedgingInstrumentsDetails" xlink:type="simple" xlink:href="iart-20230331.xsd#DERIVATIVEINSTRUMENTSScheduleofDerivativesNotDesignatedasHedgingInstrumentsDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofDerivativesNotDesignatedasHedgingInstrumentsDetails" xlink:type="extended" id="ie11b1668457a41dc9d6c19d5c8506bb6_DERIVATIVEINSTRUMENTSScheduleofDerivativesNotDesignatedasHedgingInstrumentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_b0229b32-9885-4858-8cc0-5df4b0b3cee7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_d01a0265-3c39-43fb-9016-ddbae2a90cda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_b0229b32-9885-4858-8cc0-5df4b0b3cee7" xlink:to="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_d01a0265-3c39-43fb-9016-ddbae2a90cda" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_4a8e8d7b-7436-4322-a729-74cd0b23db46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_b0229b32-9885-4858-8cc0-5df4b0b3cee7" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_4a8e8d7b-7436-4322-a729-74cd0b23db46" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_62c59b50-ebb2-4d66-85b0-8e21200d3030" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_4a8e8d7b-7436-4322-a729-74cd0b23db46" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_62c59b50-ebb2-4d66-85b0-8e21200d3030" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_62c59b50-ebb2-4d66-85b0-8e21200d3030_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_62c59b50-ebb2-4d66-85b0-8e21200d3030" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_62c59b50-ebb2-4d66-85b0-8e21200d3030_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_778e4076-37a8-4fa6-8b7b-1da78a0e42ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_62c59b50-ebb2-4d66-85b0-8e21200d3030" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_778e4076-37a8-4fa6-8b7b-1da78a0e42ec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_75c6c6e6-2ccf-4c4d-aafd-d2ba513f87ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_778e4076-37a8-4fa6-8b7b-1da78a0e42ec" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_75c6c6e6-2ccf-4c4d-aafd-d2ba513f87ba" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_1427e29a-6bab-4947-8583-526b1377c95c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrencySwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_778e4076-37a8-4fa6-8b7b-1da78a0e42ec" xlink:to="loc_us-gaap_CurrencySwapMember_1427e29a-6bab-4947-8583-526b1377c95c" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" xlink:type="simple" xlink:href="iart-20230331.xsd#STOCKBASEDCOMPENSATIONNarrativeDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" xlink:type="extended" id="ic64874932cc3480ca58da69fcd5185a2_STOCKBASEDCOMPENSATIONNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_689315f2-9061-44c1-9acc-33bf1fed33d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_da9085ae-d82c-4be0-9cfd-98d39b5bdcfa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_689315f2-9061-44c1-9acc-33bf1fed33d8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_da9085ae-d82c-4be0-9cfd-98d39b5bdcfa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_75f3e05e-4c69-43d3-be4e-ea7f18a34774" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_689315f2-9061-44c1-9acc-33bf1fed33d8" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_75f3e05e-4c69-43d3-be4e-ea7f18a34774" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_9ffad507-865e-4f81-b17d-96414a9c3c47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_689315f2-9061-44c1-9acc-33bf1fed33d8" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_9ffad507-865e-4f81-b17d-96414a9c3c47" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_f4cba230-cdb2-4b20-844d-c17e3493ac34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_689315f2-9061-44c1-9acc-33bf1fed33d8" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_f4cba230-cdb2-4b20-844d-c17e3493ac34" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_0771160d-e8a3-4b12-8015-d9e943149b16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_689315f2-9061-44c1-9acc-33bf1fed33d8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_0771160d-e8a3-4b12-8015-d9e943149b16" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1996972c-3d7d-4bcc-a075-8a29866e6959" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_689315f2-9061-44c1-9acc-33bf1fed33d8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1996972c-3d7d-4bcc-a075-8a29866e6959" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_b2676e95-f05a-446b-bddb-a3dfe98dd6a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_689315f2-9061-44c1-9acc-33bf1fed33d8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_b2676e95-f05a-446b-bddb-a3dfe98dd6a3" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_323455b8-064d-47ae-b79b-73a206a37d50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_689315f2-9061-44c1-9acc-33bf1fed33d8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_323455b8-064d-47ae-b79b-73a206a37d50" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_76d199b5-df63-465c-b7a9-43282a6072cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_689315f2-9061-44c1-9acc-33bf1fed33d8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_76d199b5-df63-465c-b7a9-43282a6072cc" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5e3f532e-f76e-4ecb-859b-0176d8cbeb73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_689315f2-9061-44c1-9acc-33bf1fed33d8" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5e3f532e-f76e-4ecb-859b-0176d8cbeb73" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_b61b5aea-6edc-4530-a0f7-397bf17cabc6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5e3f532e-f76e-4ecb-859b-0176d8cbeb73" xlink:to="loc_srt_RangeAxis_b61b5aea-6edc-4530-a0f7-397bf17cabc6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_b61b5aea-6edc-4530-a0f7-397bf17cabc6_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_b61b5aea-6edc-4530-a0f7-397bf17cabc6" xlink:to="loc_srt_RangeMember_b61b5aea-6edc-4530-a0f7-397bf17cabc6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_5c5b29c0-eb1c-4462-9049-582f9ce1c1b0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_b61b5aea-6edc-4530-a0f7-397bf17cabc6" xlink:to="loc_srt_RangeMember_5c5b29c0-eb1c-4462-9049-582f9ce1c1b0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_f0b9d203-a041-4f9a-bdef-1777d2ce1638" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_5c5b29c0-eb1c-4462-9049-582f9ce1c1b0" xlink:to="loc_srt_MinimumMember_f0b9d203-a041-4f9a-bdef-1777d2ce1638" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_cc264250-b43c-4b31-9d99-813ce3580bac" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_5c5b29c0-eb1c-4462-9049-582f9ce1c1b0" xlink:to="loc_srt_MaximumMember_cc264250-b43c-4b31-9d99-813ce3580bac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_346fb420-d3f8-498b-b58d-fa229d0e72ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5e3f532e-f76e-4ecb-859b-0176d8cbeb73" xlink:to="loc_us-gaap_AwardTypeAxis_346fb420-d3f8-498b-b58d-fa229d0e72ce" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_346fb420-d3f8-498b-b58d-fa229d0e72ce_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_346fb420-d3f8-498b-b58d-fa229d0e72ce" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_346fb420-d3f8-498b-b58d-fa229d0e72ce_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4927ac22-670a-4c85-a4bf-7179ed391d26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_346fb420-d3f8-498b-b58d-fa229d0e72ce" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4927ac22-670a-4c85-a4bf-7179ed391d26" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_7896fede-bd5f-4b82-a5dc-2c8213051283" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4927ac22-670a-4c85-a4bf-7179ed391d26" xlink:to="loc_us-gaap_EmployeeStockOptionMember_7896fede-bd5f-4b82-a5dc-2c8213051283" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_954a5161-d019-4e3b-8a34-d6f88bc86008" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4927ac22-670a-4c85-a4bf-7179ed391d26" xlink:to="loc_us-gaap_RestrictedStockMember_954a5161-d019-4e3b-8a34-d6f88bc86008" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_PerformanceStockAndRestrictedStockAwardsMember_b26edeba-405e-42c2-a9ca-4613f2652b1f" xlink:href="iart-20230331.xsd#iart_PerformanceStockAndRestrictedStockAwardsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4927ac22-670a-4c85-a4bf-7179ed391d26" xlink:to="loc_iart_PerformanceStockAndRestrictedStockAwardsMember_b26edeba-405e-42c2-a9ca-4613f2652b1f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_1b1df0f1-e170-4826-9f15-30c08faed560" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4927ac22-670a-4c85-a4bf-7179ed391d26" xlink:to="loc_us-gaap_PerformanceSharesMember_1b1df0f1-e170-4826-9f15-30c08faed560" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_b104b295-e225-4cec-bf68-426508b98fb8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5e3f532e-f76e-4ecb-859b-0176d8cbeb73" xlink:to="loc_srt_TitleOfIndividualAxis_b104b295-e225-4cec-bf68-426508b98fb8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_b104b295-e225-4cec-bf68-426508b98fb8_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_TitleOfIndividualAxis_b104b295-e225-4cec-bf68-426508b98fb8" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_b104b295-e225-4cec-bf68-426508b98fb8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_59a4f1b7-a587-4b7e-80cf-40ff4b11c16a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_TitleOfIndividualAxis_b104b295-e225-4cec-bf68-426508b98fb8" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_59a4f1b7-a587-4b7e-80cf-40ff4b11c16a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_DirectorMember_3048d61c-098e-48a1-82a8-f2a3432f869a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_DirectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_59a4f1b7-a587-4b7e-80cf-40ff4b11c16a" xlink:to="loc_srt_DirectorMember_3048d61c-098e-48a1-82a8-f2a3432f869a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EmployeeMember_741c9022-069e-45f7-a425-8dfad24f33d7" xlink:href="iart-20230331.xsd#iart_EmployeeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_59a4f1b7-a587-4b7e-80cf-40ff4b11c16a" xlink:to="loc_iart_EmployeeMember_741c9022-069e-45f7-a425-8dfad24f33d7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DirectorsandCertainExecutiveOfficersMember_4d410c37-fa2f-431c-8395-a64df41dcaa6" xlink:href="iart-20230331.xsd#iart_DirectorsandCertainExecutiveOfficersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_59a4f1b7-a587-4b7e-80cf-40ff4b11c16a" xlink:to="loc_iart_DirectorsandCertainExecutiveOfficersMember_4d410c37-fa2f-431c-8395-a64df41dcaa6" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESNarrativeDetails" xlink:type="simple" xlink:href="iart-20230331.xsd#LEASESANDRELATEDPARTYLEASESNarrativeDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESNarrativeDetails" xlink:type="extended" id="i69a23c917b9346a5a7a82971d8e721aa_LEASESANDRELATEDPARTYLEASESNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasedAssetsLineItems_73d174ad-d6e2-4438-9c3d-0e609822386a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasedAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_LesseeOperatingLeaseNumberOfRenewalOptions_20eed078-4caa-4ea9-a478-084780639d88" xlink:href="iart-20230331.xsd#iart_LesseeOperatingLeaseNumberOfRenewalOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_73d174ad-d6e2-4438-9c3d-0e609822386a" xlink:to="loc_iart_LesseeOperatingLeaseNumberOfRenewalOptions_20eed078-4caa-4ea9-a478-084780639d88" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense_8726dd25-71c7-4c6d-ae79-28197cdbfee8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_73d174ad-d6e2-4438-9c3d-0e609822386a" xlink:to="loc_us-gaap_OperatingLeaseExpense_8726dd25-71c7-4c6d-ae79-28197cdbfee8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_PercentOfManufacturingFacilityOwnedByCorporationWhoseShareholdersAreTrustsWhoseBeneficiariesIncludeFamilyMembersOfCompanysFormerDirector_4d228954-2757-4e5d-a1f4-8617e19a37e0" xlink:href="iart-20230331.xsd#iart_PercentOfManufacturingFacilityOwnedByCorporationWhoseShareholdersAreTrustsWhoseBeneficiariesIncludeFamilyMembersOfCompanysFormerDirector"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_73d174ad-d6e2-4438-9c3d-0e609822386a" xlink:to="loc_iart_PercentOfManufacturingFacilityOwnedByCorporationWhoseShareholdersAreTrustsWhoseBeneficiariesIncludeFamilyMembersOfCompanysFormerDirector_4d228954-2757-4e5d-a1f4-8617e19a37e0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AnnualRateOfLeaseAgreement_1770bf7b-419a-4ab6-8388-3d48c05a842b" xlink:href="iart-20230331.xsd#iart_AnnualRateOfLeaseAgreement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_73d174ad-d6e2-4438-9c3d-0e609822386a" xlink:to="loc_iart_AnnualRateOfLeaseAgreement_1770bf7b-419a-4ab6-8388-3d48c05a842b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_1d83dd2f-6f98-48bb-abd1-535d7a27d67a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_73d174ad-d6e2-4438-9c3d-0e609822386a" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_1d83dd2f-6f98-48bb-abd1-535d7a27d67a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseOptionToExtend_f8296400-6f55-4416-9337-ee55420e8d81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseOptionToExtend"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_73d174ad-d6e2-4438-9c3d-0e609822386a" xlink:to="loc_us-gaap_LesseeOperatingLeaseOptionToExtend_f8296400-6f55-4416-9337-ee55420e8d81" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_a8863b76-8b17-474b-9fd1-a7370bdfa6e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfOperatingLeasedAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_73d174ad-d6e2-4438-9c3d-0e609822386a" xlink:to="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_a8863b76-8b17-474b-9fd1-a7370bdfa6e6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_77671bdf-039d-481b-ba5c-bd7e8579bbd1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_a8863b76-8b17-474b-9fd1-a7370bdfa6e6" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_77671bdf-039d-481b-ba5c-bd7e8579bbd1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_77671bdf-039d-481b-ba5c-bd7e8579bbd1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_77671bdf-039d-481b-ba5c-bd7e8579bbd1" xlink:to="loc_us-gaap_RelatedPartyDomain_77671bdf-039d-481b-ba5c-bd7e8579bbd1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_0dedcbb5-0026-4e45-b9ac-8469e50bba2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_77671bdf-039d-481b-ba5c-bd7e8579bbd1" xlink:to="loc_us-gaap_RelatedPartyDomain_0dedcbb5-0026-4e45-b9ac-8469e50bba2f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AffiliatedEntityMember_1081adb0-4f86-4253-8fb8-4ca9c4f19891" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AffiliatedEntityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_0dedcbb5-0026-4e45-b9ac-8469e50bba2f" xlink:to="loc_srt_AffiliatedEntityMember_1081adb0-4f86-4253-8fb8-4ca9c4f19891" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseContractualTermAxis_2a5f8d80-fcdc-46cf-bffb-5a81ec31f1ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseContractualTermAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_a8863b76-8b17-474b-9fd1-a7370bdfa6e6" xlink:to="loc_us-gaap_LeaseContractualTermAxis_2a5f8d80-fcdc-46cf-bffb-5a81ec31f1ab" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseContractualTermDomain_2a5f8d80-fcdc-46cf-bffb-5a81ec31f1ab_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseContractualTermDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LeaseContractualTermAxis_2a5f8d80-fcdc-46cf-bffb-5a81ec31f1ab" xlink:to="loc_us-gaap_LeaseContractualTermDomain_2a5f8d80-fcdc-46cf-bffb-5a81ec31f1ab_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseContractualTermDomain_71568a9a-e07f-4582-907b-953a334c5040" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseContractualTermDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LeaseContractualTermAxis_2a5f8d80-fcdc-46cf-bffb-5a81ec31f1ab" xlink:to="loc_us-gaap_LeaseContractualTermDomain_71568a9a-e07f-4582-907b-953a334c5040" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_FiveYearOptionLeasePeriodOneMember_c37f7a0d-dd15-4dc3-a39e-0d436fed1373" xlink:href="iart-20230331.xsd#iart_FiveYearOptionLeasePeriodOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LeaseContractualTermDomain_71568a9a-e07f-4582-907b-953a334c5040" xlink:to="loc_iart_FiveYearOptionLeasePeriodOneMember_c37f7a0d-dd15-4dc3-a39e-0d436fed1373" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_FiveYearOptionLeasePeriodTwoMember_3bf2c9eb-1582-4a0a-80f4-6d688540b1fe" xlink:href="iart-20230331.xsd#iart_FiveYearOptionLeasePeriodTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LeaseContractualTermDomain_71568a9a-e07f-4582-907b-953a334c5040" xlink:to="loc_iart_FiveYearOptionLeasePeriodTwoMember_3bf2c9eb-1582-4a0a-80f4-6d688540b1fe" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalBalanceSheetInformationDetails" xlink:type="simple" xlink:href="iart-20230331.xsd#LEASESANDRELATEDPARTYLEASESSupplementalBalanceSheetInformationDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalBalanceSheetInformationDetails" xlink:type="extended" id="i15c605cbe270482da6c95e8dba7d4ecf_LEASESANDRELATEDPARTYLEASESSupplementalBalanceSheetInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_c4e8eeca-320f-4ca0-a948-7686d826e183" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_eed9b76e-bb24-4f32-a561-c26d1268c706" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_c4e8eeca-320f-4ca0-a948-7686d826e183" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_eed9b76e-bb24-4f32-a561-c26d1268c706" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_c73a9bdd-7757-40b4-906a-1985f3172b05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_c4e8eeca-320f-4ca0-a948-7686d826e183" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_c73a9bdd-7757-40b4-906a-1985f3172b05" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_b5a95b88-60b3-478d-aa19-0e433cb21631" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_c4e8eeca-320f-4ca0-a948-7686d826e183" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_b5a95b88-60b3-478d-aa19-0e433cb21631" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_0337990f-fb42-482c-83f8-bbd773584d9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_c4e8eeca-320f-4ca0-a948-7686d826e183" xlink:to="loc_us-gaap_OperatingLeaseLiability_0337990f-fb42-482c-83f8-bbd773584d9e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_88e48848-6c10-4d91-ad1f-db692776af7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_c4e8eeca-320f-4ca0-a948-7686d826e183" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_88e48848-6c10-4d91-ad1f-db692776af7b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_3fe196a3-0a94-431e-a172-add88e469441" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_c4e8eeca-320f-4ca0-a948-7686d826e183" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_3fe196a3-0a94-431e-a172-add88e469441" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_4c8bf092-ef98-4179-8ae9-dc0833b0fb66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_c4e8eeca-320f-4ca0-a948-7686d826e183" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_4c8bf092-ef98-4179-8ae9-dc0833b0fb66" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_3d132182-ce87-4b9f-aff5-71f4206d1671" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_4c8bf092-ef98-4179-8ae9-dc0833b0fb66" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_3d132182-ce87-4b9f-aff5-71f4206d1671" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3d132182-ce87-4b9f-aff5-71f4206d1671_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_3d132182-ce87-4b9f-aff5-71f4206d1671" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3d132182-ce87-4b9f-aff5-71f4206d1671_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_583c931e-4bba-4e4c-a385-c4ce77388752" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_3d132182-ce87-4b9f-aff5-71f4206d1671" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_583c931e-4bba-4e4c-a385-c4ce77388752" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember_89dafed7-9108-4b75-84eb-af19e9121689" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_583c931e-4bba-4e4c-a385-c4ce77388752" xlink:to="loc_us-gaap_BuildingMember_89dafed7-9108-4b75-84eb-af19e9121689" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VehiclesMember_94dd827d-592d-4d32-9433-f90e33969344" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VehiclesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_583c931e-4bba-4e4c-a385-c4ce77388752" xlink:to="loc_us-gaap_VehiclesMember_94dd827d-592d-4d32-9433-f90e33969344" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesDetails" xlink:type="simple" xlink:href="iart-20230331.xsd#LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesDetails" xlink:type="extended" id="i38f8668f04a546d897d8475ba5f4780f_LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasedAssetsLineItems_443d71fc-5d0c-4f7f-ad15-83477a759ddf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasedAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_75d7c71c-fe70-4d5c-ac3c-0a983de639a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_443d71fc-5d0c-4f7f-ad15-83477a759ddf" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_75d7c71c-fe70-4d5c-ac3c-0a983de639a2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_f46e0878-2792-4784-aa9d-9b620927f860" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_443d71fc-5d0c-4f7f-ad15-83477a759ddf" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_f46e0878-2792-4784-aa9d-9b620927f860" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_30c72956-0e56-4543-8986-25c1bded0033" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_443d71fc-5d0c-4f7f-ad15-83477a759ddf" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_30c72956-0e56-4543-8986-25c1bded0033" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_42ecb3a1-a771-470f-9c6f-83436a98878f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_443d71fc-5d0c-4f7f-ad15-83477a759ddf" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_42ecb3a1-a771-470f-9c6f-83436a98878f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_43bb64a8-86d6-4920-bc88-60a5ca96d1db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_443d71fc-5d0c-4f7f-ad15-83477a759ddf" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_43bb64a8-86d6-4920-bc88-60a5ca96d1db" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_ffa4f986-c504-4d35-88ac-554ee162202a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_443d71fc-5d0c-4f7f-ad15-83477a759ddf" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_ffa4f986-c504-4d35-88ac-554ee162202a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_b4173dd2-36df-43a2-ad6f-26783f2c9265" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_443d71fc-5d0c-4f7f-ad15-83477a759ddf" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_b4173dd2-36df-43a2-ad6f-26783f2c9265" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_2186847b-81b0-419d-9383-6cc64baf2596" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_443d71fc-5d0c-4f7f-ad15-83477a759ddf" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_2186847b-81b0-419d-9383-6cc64baf2596" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_90c6c904-2f35-433f-a9f3-7f31b8ddd0ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_443d71fc-5d0c-4f7f-ad15-83477a759ddf" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_90c6c904-2f35-433f-a9f3-7f31b8ddd0ad" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_71e675d7-2aed-4341-bb54-1213c919bc57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_443d71fc-5d0c-4f7f-ad15-83477a759ddf" xlink:to="loc_us-gaap_OperatingLeaseLiability_71e675d7-2aed-4341-bb54-1213c919bc57" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_197f19a7-98d4-433b-8d03-749c2f6d5115" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_443d71fc-5d0c-4f7f-ad15-83477a759ddf" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_197f19a7-98d4-433b-8d03-749c2f6d5115" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_d69df2f4-0b57-4a35-a49d-38baaf0f2881" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_443d71fc-5d0c-4f7f-ad15-83477a759ddf" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_d69df2f4-0b57-4a35-a49d-38baaf0f2881" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_88dcc65c-2466-4d33-b8ac-51398b4e5378" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfOperatingLeasedAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_443d71fc-5d0c-4f7f-ad15-83477a759ddf" xlink:to="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_88dcc65c-2466-4d33-b8ac-51398b4e5378" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_ad50750c-8a9f-4fca-a6c5-287ba984ebd3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_88dcc65c-2466-4d33-b8ac-51398b4e5378" xlink:to="loc_srt_CounterpartyNameAxis_ad50750c-8a9f-4fca-a6c5-287ba984ebd3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_ad50750c-8a9f-4fca-a6c5-287ba984ebd3_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_ad50750c-8a9f-4fca-a6c5-287ba984ebd3" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_ad50750c-8a9f-4fca-a6c5-287ba984ebd3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_98f0a81e-74da-4671-b658-4289a5817eaf" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_ad50750c-8a9f-4fca-a6c5-287ba984ebd3" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_98f0a81e-74da-4671-b658-4289a5817eaf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_RelatedPartiesMember_3128576c-fb35-48de-bac0-d7b0723b8f48" xlink:href="iart-20230331.xsd#iart_RelatedPartiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_98f0a81e-74da-4671-b658-4289a5817eaf" xlink:to="loc_iart_RelatedPartiesMember_3128576c-fb35-48de-bac0-d7b0723b8f48" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ThirdPartiesMember_59f2ad12-0a80-4c07-b6fc-a9128b752922" xlink:href="iart-20230331.xsd#iart_ThirdPartiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_98f0a81e-74da-4671-b658-4289a5817eaf" xlink:to="loc_iart_ThirdPartiesMember_59f2ad12-0a80-4c07-b6fc-a9128b752922" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails" xlink:type="simple" xlink:href="iart-20230331.xsd#ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails" xlink:type="extended" id="ie02881b197d1464684437205ece225e7_ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_a8cbe1f5-625e-4cc8-aece-02706d614c4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_a16e1d8b-dd75-4fbc-b1f5-b8e53294a0f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_a8cbe1f5-625e-4cc8-aece-02706d614c4f" xlink:to="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_a16e1d8b-dd75-4fbc-b1f5-b8e53294a0f8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_4714badb-8ec1-4ded-b48f-5c6cb3ec9e08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_a16e1d8b-dd75-4fbc-b1f5-b8e53294a0f8" xlink:to="loc_us-gaap_StockholdersEquity_4714badb-8ec1-4ded-b48f-5c6cb3ec9e08" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_64627042-de45-48fe-81f3-81e8e74ac15d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_a16e1d8b-dd75-4fbc-b1f5-b8e53294a0f8" xlink:to="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_64627042-de45-48fe-81f3-81e8e74ac15d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_e09e4b73-ad6a-4254-89d5-6d9901107a19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_a16e1d8b-dd75-4fbc-b1f5-b8e53294a0f8" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_e09e4b73-ad6a-4254-89d5-6d9901107a19" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_e44ac261-1151-4317-85ff-252eb775b618" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_a16e1d8b-dd75-4fbc-b1f5-b8e53294a0f8" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_e44ac261-1151-4317-85ff-252eb775b618" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_2e908c58-85f3-4f11-8332-5ab8c2f90789" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_36d2a43b-cad6-4682-a02f-9a3375e6e2c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_a8cbe1f5-625e-4cc8-aece-02706d614c4f" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_36d2a43b-cad6-4682-a02f-9a3375e6e2c5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_a46ce5d8-ac7e-4165-a4cc-f03cb89405d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_36d2a43b-cad6-4682-a02f-9a3375e6e2c5" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_a46ce5d8-ac7e-4165-a4cc-f03cb89405d0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_a46ce5d8-ac7e-4165-a4cc-f03cb89405d0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_a46ce5d8-ac7e-4165-a4cc-f03cb89405d0" xlink:to="loc_us-gaap_EquityComponentDomain_a46ce5d8-ac7e-4165-a4cc-f03cb89405d0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_f3a43716-1afc-4b0f-9144-a8d7620b6dfb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_a46ce5d8-ac7e-4165-a4cc-f03cb89405d0" xlink:to="loc_us-gaap_EquityComponentDomain_f3a43716-1afc-4b0f-9144-a8d7620b6dfb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_b7a535b8-3cc8-4a3a-ab2e-18e9b6aa19ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_f3a43716-1afc-4b0f-9144-a8d7620b6dfb" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_b7a535b8-3cc8-4a3a-ab2e-18e9b6aa19ba" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_fb6b5f4d-f175-41dd-ac87-b16e155c11ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_b7a535b8-3cc8-4a3a-ab2e-18e9b6aa19ba" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_fb6b5f4d-f175-41dd-ac87-b16e155c11ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_cca20a77-f49e-4a02-902e-1ed02981e9da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_b7a535b8-3cc8-4a3a-ab2e-18e9b6aa19ba" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_cca20a77-f49e-4a02-902e-1ed02981e9da" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_3a52fbb4-d64d-4bec-9b5b-fe6be053a502" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_b7a535b8-3cc8-4a3a-ab2e-18e9b6aa19ba" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_3a52fbb4-d64d-4bec-9b5b-fe6be053a502" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSNarrativeDetails" xlink:type="simple" xlink:href="iart-20230331.xsd#ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSNarrativeDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSNarrativeDetails" xlink:type="extended" id="i34b329915bd84f25ae7f3bedbe004165_ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_1ae713b5-cd2f-4d72-a622-9316013ec958" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_b2d033f7-6b99-4622-bdf3-9fc4a4d8577f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_1ae713b5-cd2f-4d72-a622-9316013ec958" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_b2d033f7-6b99-4622-bdf3-9fc4a4d8577f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_d8efe9be-a768-454e-9270-02eec204a1a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_1ae713b5-cd2f-4d72-a622-9316013ec958" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_d8efe9be-a768-454e-9270-02eec204a1a0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_32185b51-c546-49a4-a37d-0483104043e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_d8efe9be-a768-454e-9270-02eec204a1a0" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_32185b51-c546-49a4-a37d-0483104043e4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_32185b51-c546-49a4-a37d-0483104043e4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_32185b51-c546-49a4-a37d-0483104043e4" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_32185b51-c546-49a4-a37d-0483104043e4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_97739368-16ef-4d1c-af2e-0611df035a2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_32185b51-c546-49a4-a37d-0483104043e4" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_97739368-16ef-4d1c-af2e-0611df035a2c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherExpenseMember_c1065e43-20ed-4a6f-b4be-cbdd43b8927e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_97739368-16ef-4d1c-af2e-0611df035a2c" xlink:to="loc_us-gaap_OtherExpenseMember_c1065e43-20ed-4a6f-b4be-cbdd43b8927e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeMember_b4390775-d66e-46d4-ba6a-6104c21998b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_97739368-16ef-4d1c-af2e-0611df035a2c" xlink:to="loc_us-gaap_InterestIncomeMember_b4390775-d66e-46d4-ba6a-6104c21998b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_2c93baee-a279-4775-85b7-32d87913b246" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_d8efe9be-a768-454e-9270-02eec204a1a0" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_2c93baee-a279-4775-85b7-32d87913b246" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_2c93baee-a279-4775-85b7-32d87913b246_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_2c93baee-a279-4775-85b7-32d87913b246" xlink:to="loc_us-gaap_EquityComponentDomain_2c93baee-a279-4775-85b7-32d87913b246_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_64c84bac-40d2-4286-b20c-10402069795c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_2c93baee-a279-4775-85b7-32d87913b246" xlink:to="loc_us-gaap_EquityComponentDomain_64c84bac-40d2-4286-b20c-10402069795c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_15034e1f-ef85-4a5f-a6fd-fb57b655dea1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_64c84bac-40d2-4286-b20c-10402069795c" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_15034e1f-ef85-4a5f-a6fd-fb57b655dea1" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNarrativeDetails" xlink:type="simple" xlink:href="iart-20230331.xsd#SEGMENTANDGEOGRAPHICINFORMATIONNarrativeDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNarrativeDetails" xlink:type="extended" id="i3e09c35765ae41178f3ad40704aab76a_SEGMENTANDGEOGRAPHICINFORMATIONNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_1e0aa234-df2e-440d-96f4-a4bb55610791" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_9654f97f-6d55-4405-bcd8-1eb4f0176682" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_1e0aa234-df2e-440d-96f4-a4bb55610791" xlink:to="loc_us-gaap_NumberOfReportableSegments_9654f97f-6d55-4405-bcd8-1eb4f0176682" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SegmentReportingInformationNumberOfProductsOffered_61ac048d-7d13-4252-b39a-68ee4a072114" xlink:href="iart-20230331.xsd#iart_SegmentReportingInformationNumberOfProductsOffered"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_1e0aa234-df2e-440d-96f4-a4bb55610791" xlink:to="loc_iart_SegmentReportingInformationNumberOfProductsOffered_61ac048d-7d13-4252-b39a-68ee4a072114" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_9bb9b11f-cdf5-49b7-a80d-8bf456f6c9d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_1e0aa234-df2e-440d-96f4-a4bb55610791" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_9bb9b11f-cdf5-49b7-a80d-8bf456f6c9d1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_1c780e07-9e8d-4478-bb7c-37aec9f936df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_9bb9b11f-cdf5-49b7-a80d-8bf456f6c9d1" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_1c780e07-9e8d-4478-bb7c-37aec9f936df" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_1c780e07-9e8d-4478-bb7c-37aec9f936df_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_1c780e07-9e8d-4478-bb7c-37aec9f936df" xlink:to="loc_us-gaap_SegmentDomain_1c780e07-9e8d-4478-bb7c-37aec9f936df_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_a5ffca31-1530-4d9e-af35-ef7a679fe87f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_1c780e07-9e8d-4478-bb7c-37aec9f936df" xlink:to="loc_us-gaap_SegmentDomain_a5ffca31-1530-4d9e-af35-ef7a679fe87f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CodmanSpecialtySurgicalMember_04ce38e4-bc48-4bfe-9811-8de2fc63e157" xlink:href="iart-20230331.xsd#iart_CodmanSpecialtySurgicalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_a5ffca31-1530-4d9e-af35-ef7a679fe87f" xlink:to="loc_iart_CodmanSpecialtySurgicalMember_04ce38e4-bc48-4bfe-9811-8de2fc63e157" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails" xlink:type="simple" xlink:href="iart-20230331.xsd#SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails" xlink:type="extended" id="i3ab9a268e59643148e8539d56ef6d544_SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_eafa3353-4757-4e7a-9923-a1b12de09e23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract_6d5ce3c6-5cc6-48c2-a06b-a9444c67b8d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_eafa3353-4757-4e7a-9923-a1b12de09e23" xlink:to="loc_us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract_6d5ce3c6-5cc6-48c2-a06b-a9444c67b8d7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_55c5a003-58cb-42d3-8171-d7d7102653eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract_6d5ce3c6-5cc6-48c2-a06b-a9444c67b8d7" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_55c5a003-58cb-42d3-8171-d7d7102653eb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_22a43220-116d-4350-9b37-de133b4d45d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationProfitLossAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_eafa3353-4757-4e7a-9923-a1b12de09e23" xlink:to="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_22a43220-116d-4350-9b37-de133b4d45d1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_33d8daf3-cd76-4e63-9066-293ad2ac44b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_22a43220-116d-4350-9b37-de133b4d45d1" xlink:to="loc_us-gaap_OperatingIncomeLoss_33d8daf3-cd76-4e63-9066-293ad2ac44b6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_e6e847e5-de5c-4e7d-a06d-71de27a56ace" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_eafa3353-4757-4e7a-9923-a1b12de09e23" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_e6e847e5-de5c-4e7d-a06d-71de27a56ace" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_1cadc11f-b444-4be8-bd29-bb9ab6bd5f4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_eafa3353-4757-4e7a-9923-a1b12de09e23" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_1cadc11f-b444-4be8-bd29-bb9ab6bd5f4f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_51724535-38a0-4b5a-a23c-784137913cff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_1cadc11f-b444-4be8-bd29-bb9ab6bd5f4f" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_51724535-38a0-4b5a-a23c-784137913cff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_51724535-38a0-4b5a-a23c-784137913cff_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_51724535-38a0-4b5a-a23c-784137913cff" xlink:to="loc_us-gaap_SegmentDomain_51724535-38a0-4b5a-a23c-784137913cff_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_53e4767d-286a-4a17-a7ab-d11f22f9e0cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_51724535-38a0-4b5a-a23c-784137913cff" xlink:to="loc_us-gaap_SegmentDomain_53e4767d-286a-4a17-a7ab-d11f22f9e0cb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CodmanSpecialtySurgicalMember_b0e95a47-d7d6-4d71-9907-14b47716e3d0" xlink:href="iart-20230331.xsd#iart_CodmanSpecialtySurgicalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_53e4767d-286a-4a17-a7ab-d11f22f9e0cb" xlink:to="loc_iart_CodmanSpecialtySurgicalMember_b0e95a47-d7d6-4d71-9907-14b47716e3d0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_TissueTechnologiesMember_b9798a7c-9f2a-4055-8112-13682b569636" xlink:href="iart-20230331.xsd#iart_TissueTechnologiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_53e4767d-286a-4a17-a7ab-d11f22f9e0cb" xlink:to="loc_iart_TissueTechnologiesMember_b9798a7c-9f2a-4055-8112-13682b569636" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_82320645-410a-4053-b95f-69af617bee4e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_1cadc11f-b444-4be8-bd29-bb9ab6bd5f4f" xlink:to="loc_srt_ConsolidationItemsAxis_82320645-410a-4053-b95f-69af617bee4e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_82320645-410a-4053-b95f-69af617bee4e_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_82320645-410a-4053-b95f-69af617bee4e" xlink:to="loc_srt_ConsolidationItemsDomain_82320645-410a-4053-b95f-69af617bee4e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_66283b51-cdfc-43f3-b5de-201224b35fe5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_82320645-410a-4053-b95f-69af617bee4e" xlink:to="loc_srt_ConsolidationItemsDomain_66283b51-cdfc-43f3-b5de-201224b35fe5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_2a94cae5-d8ae-4022-a185-16df6acc9288" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_66283b51-cdfc-43f3-b5de-201224b35fe5" xlink:to="loc_us-gaap_OperatingSegmentsMember_2a94cae5-d8ae-4022-a185-16df6acc9288" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_f238ba7c-bb0f-42b7-b297-e374381c3f06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_66283b51-cdfc-43f3-b5de-201224b35fe5" xlink:to="loc_us-gaap_CorporateNonSegmentMember_f238ba7c-bb0f-42b7-b297-e374381c3f06" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTotalRevenuebyMajorGeographicAreaDetails" xlink:type="simple" xlink:href="iart-20230331.xsd#SEGMENTANDGEOGRAPHICINFORMATIONTotalRevenuebyMajorGeographicAreaDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTotalRevenuebyMajorGeographicAreaDetails" xlink:type="extended" id="i7862aae54bfc453a949d7a41c562e6c1_SEGMENTANDGEOGRAPHICINFORMATIONTotalRevenuebyMajorGeographicAreaDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_2c36a649-e920-4010-b1f1-c8273d8fbc0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_5fd89d87-af96-4d3d-b3a6-7e68d9d69aa7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2c36a649-e920-4010-b1f1-c8273d8fbc0e" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_5fd89d87-af96-4d3d-b3a6-7e68d9d69aa7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_cd12f723-a7e8-422e-9f3f-489224774251" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2c36a649-e920-4010-b1f1-c8273d8fbc0e" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_cd12f723-a7e8-422e-9f3f-489224774251" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_f5564a3a-ed33-4f90-9656-69b4a555634c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_cd12f723-a7e8-422e-9f3f-489224774251" xlink:to="loc_srt_StatementGeographicalAxis_f5564a3a-ed33-4f90-9656-69b4a555634c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_f5564a3a-ed33-4f90-9656-69b4a555634c_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_f5564a3a-ed33-4f90-9656-69b4a555634c" xlink:to="loc_srt_SegmentGeographicalDomain_f5564a3a-ed33-4f90-9656-69b4a555634c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_2444aaf0-4f27-4edd-bfac-fdd5586bdd0b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_f5564a3a-ed33-4f90-9656-69b4a555634c" xlink:to="loc_srt_SegmentGeographicalDomain_2444aaf0-4f27-4edd-bfac-fdd5586bdd0b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_f22e0ded-d8ad-4c7a-9518-6c082d36ef63" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_2444aaf0-4f27-4edd-bfac-fdd5586bdd0b" xlink:to="loc_country_US_f22e0ded-d8ad-4c7a-9518-6c082d36ef63" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_09464f55-fb5c-49e5-a3e8-2cf35f97a4ec" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EuropeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_2444aaf0-4f27-4edd-bfac-fdd5586bdd0b" xlink:to="loc_srt_EuropeMember_09464f55-fb5c-49e5-a3e8-2cf35f97a4ec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember_a243b19f-8f9e-4a55-af29-9282dd53cfe2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AsiaPacificMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_2444aaf0-4f27-4edd-bfac-fdd5586bdd0b" xlink:to="loc_srt_AsiaPacificMember_a243b19f-8f9e-4a55-af29-9282dd53cfe2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_RestOfWorldMember_ae8e9df7-e110-4024-a2ff-47cb90b2aba9" xlink:href="iart-20230331.xsd#iart_RestOfWorldMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_2444aaf0-4f27-4edd-bfac-fdd5586bdd0b" xlink:to="loc_iart_RestOfWorldMember_ae8e9df7-e110-4024-a2ff-47cb90b2aba9" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails" xlink:type="simple" xlink:href="iart-20230331.xsd#COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails" xlink:type="extended" id="i35ef6b9d4671412496fd39b606f1a5fc_COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_06652f7d-e586-4a2a-90d3-7a62d09641dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_d49a0b78-ecf2-429c-b4a0-56ab776a3a54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_06652f7d-e586-4a2a-90d3-7a62d09641dd" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_d49a0b78-ecf2-429c-b4a0-56ab776a3a54" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_a55556e3-2f05-4090-ad97-e328c36b6bd8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_d49a0b78-ecf2-429c-b4a0-56ab776a3a54" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_a55556e3-2f05-4090-ad97-e328c36b6bd8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent_455ddfb8-2799-4779-bae8-339e12fba8d5" xlink:href="iart-20230331.xsd#iart_FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_d49a0b78-ecf2-429c-b4a0-56ab776a3a54" xlink:to="loc_iart_FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent_455ddfb8-2799-4779-bae8-339e12fba8d5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_46b71260-6345-474c-b924-10dca2ee848c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_d49a0b78-ecf2-429c-b4a0-56ab776a3a54" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_46b71260-6345-474c-b924-10dca2ee848c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_79b178cb-7375-437d-9c7b-9fdb9c8470c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_7c7cc496-b20a-4e0b-8347-d9eb1cff9770" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_06652f7d-e586-4a2a-90d3-7a62d09641dd" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_7c7cc496-b20a-4e0b-8347-d9eb1cff9770" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_e42d1464-0ab8-459a-81ec-5eb781c33898" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_7c7cc496-b20a-4e0b-8347-d9eb1cff9770" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_e42d1464-0ab8-459a-81ec-5eb781c33898" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e42d1464-0ab8-459a-81ec-5eb781c33898_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_e42d1464-0ab8-459a-81ec-5eb781c33898" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e42d1464-0ab8-459a-81ec-5eb781c33898_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f436086d-ec11-4599-b90a-1959d9d55931" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_e42d1464-0ab8-459a-81ec-5eb781c33898" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f436086d-ec11-4599-b90a-1959d9d55931" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ArkisBioSciencesInc.Member_871db09d-f7e6-4719-8f26-9f479767857e" xlink:href="iart-20230331.xsd#iart_ArkisBioSciencesInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f436086d-ec11-4599-b90a-1959d9d55931" xlink:to="loc_iart_ArkisBioSciencesInc.Member_871db09d-f7e6-4719-8f26-9f479767857e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DermaSciencesMember_4bad9615-de1b-4720-a60a-ff94c30fc774" xlink:href="iart-20230331.xsd#iart_DermaSciencesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f436086d-ec11-4599-b90a-1959d9d55931" xlink:to="loc_iart_DermaSciencesMember_4bad9615-de1b-4720-a60a-ff94c30fc774" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ACellMember_5f180b4c-7e77-4284-b782-3ece6044b9a4" xlink:href="iart-20230331.xsd#iart_ACellMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f436086d-ec11-4599-b90a-1959d9d55931" xlink:to="loc_iart_ACellMember_5f180b4c-7e77-4284-b782-3ece6044b9a4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SurgicalInnovationAssociatesIncMember_8192fdd9-3292-44e8-a3d1-205ad967392a" xlink:href="iart-20230331.xsd#iart_SurgicalInnovationAssociatesIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f436086d-ec11-4599-b90a-1959d9d55931" xlink:to="loc_iart_SurgicalInnovationAssociatesIncMember_8192fdd9-3292-44e8-a3d1-205ad967392a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_1acc41ff-d848-4421-a245-9cb33c6053e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_7c7cc496-b20a-4e0b-8347-d9eb1cff9770" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_1acc41ff-d848-4421-a245-9cb33c6053e4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_1acc41ff-d848-4421-a245-9cb33c6053e4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_1acc41ff-d848-4421-a245-9cb33c6053e4" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_1acc41ff-d848-4421-a245-9cb33c6053e4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_204c0000-6d54-4ea3-af32-ac0f45b4b9c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_1acc41ff-d848-4421-a245-9cb33c6053e4" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_204c0000-6d54-4ea3-af32-ac0f45b4b9c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ContingentConsiderationLiabilityMember_0e1275b3-8694-4325-8354-130c46cc16c5" xlink:href="iart-20230331.xsd#iart_ContingentConsiderationLiabilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_204c0000-6d54-4ea3-af32-ac0f45b4b9c8" xlink:to="loc_iart_ContingentConsiderationLiabilityMember_0e1275b3-8694-4325-8354-130c46cc16c5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_68e44c61-fbaf-4bd3-a770-ceeb16db6a5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_7c7cc496-b20a-4e0b-8347-d9eb1cff9770" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_68e44c61-fbaf-4bd3-a770-ceeb16db6a5d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_68e44c61-fbaf-4bd3-a770-ceeb16db6a5d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_68e44c61-fbaf-4bd3-a770-ceeb16db6a5d" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_68e44c61-fbaf-4bd3-a770-ceeb16db6a5d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e7ab3555-af39-4ad2-b488-ba8e36e9c818" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_68e44c61-fbaf-4bd3-a770-ceeb16db6a5d" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e7ab3555-af39-4ad2-b488-ba8e36e9c818" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_219965f6-8803-4ea4-a618-11a1631dd9e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e7ab3555-af39-4ad2-b488-ba8e36e9c818" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_219965f6-8803-4ea4-a618-11a1631dd9e6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_1aa59038-60bf-41a8-ad7b-5e8eebdc802d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_7c7cc496-b20a-4e0b-8347-d9eb1cff9770" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_1aa59038-60bf-41a8-ad7b-5e8eebdc802d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_1aa59038-60bf-41a8-ad7b-5e8eebdc802d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_1aa59038-60bf-41a8-ad7b-5e8eebdc802d" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_1aa59038-60bf-41a8-ad7b-5e8eebdc802d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_11511bba-6b4e-47b2-ba87-cd37d5d4e885" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_1aa59038-60bf-41a8-ad7b-5e8eebdc802d" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_11511bba-6b4e-47b2-ba87-cd37d5d4e885" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_9e02e140-a745-43f3-90b3-9068fb547bc8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_11511bba-6b4e-47b2-ba87-cd37d5d4e885" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_9e02e140-a745-43f3-90b3-9068fb547bc8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_b1540ca8-c640-4299-97af-8c1fc2d9308f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_11511bba-6b4e-47b2-ba87-cd37d5d4e885" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_b1540ca8-c640-4299-97af-8c1fc2d9308f" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://integralife.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails" xlink:type="simple" xlink:href="iart-20230331.xsd#COMMITMENTSANDCONTINGENCIESNarrativeDetails"/>
  <link:definitionLink xlink:role="http://integralife.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails" xlink:type="extended" id="i77e8c6e300644f3dabeec66b03e43bb6_COMMITMENTSANDCONTINGENCIESNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_c41e6af4-5c9e-4426-8475-36b9071edddb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_6086d866-4cd5-43fd-befa-8da3b0dcfd63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_c41e6af4-5c9e-4426-8475-36b9071edddb" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_6086d866-4cd5-43fd-befa-8da3b0dcfd63" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability_3fb024c1-5820-40cd-8ffb-074989f10f9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_c41e6af4-5c9e-4426-8475-36b9071edddb" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability_3fb024c1-5820-40cd-8ffb-074989f10f9e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_f84c7b09-1265-4967-b0de-7f0786594406" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_c41e6af4-5c9e-4426-8475-36b9071edddb" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_f84c7b09-1265-4967-b0de-7f0786594406" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_774e6957-f5d6-4fde-821f-5b7c0da7ee51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_c41e6af4-5c9e-4426-8475-36b9071edddb" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_774e6957-f5d6-4fde-821f-5b7c0da7ee51" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_BusinessCombinationContingentConsiderationNumberOfLiabilities_2c61e6d7-2b47-4b68-9406-5a07b1969ac3" xlink:href="iart-20230331.xsd#iart_BusinessCombinationContingentConsiderationNumberOfLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_c41e6af4-5c9e-4426-8475-36b9071edddb" xlink:to="loc_iart_BusinessCombinationContingentConsiderationNumberOfLiabilities_2c61e6d7-2b47-4b68-9406-5a07b1969ac3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_dc1d3900-3f8f-49ac-b689-6a9758aee964" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_c41e6af4-5c9e-4426-8475-36b9071edddb" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_dc1d3900-3f8f-49ac-b689-6a9758aee964" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_8d6eb10e-b80d-4f36-8a6d-7065344e744d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_c41e6af4-5c9e-4426-8475-36b9071edddb" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_8d6eb10e-b80d-4f36-8a6d-7065344e744d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_aedc3bf7-4d2d-4de0-be7e-a01b02db3165" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_c41e6af4-5c9e-4426-8475-36b9071edddb" xlink:to="loc_us-gaap_LossContingenciesTable_aedc3bf7-4d2d-4de0-be7e-a01b02db3165" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_7f8c34a8-0aaf-477c-8f12-f651bd6ebc7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_aedc3bf7-4d2d-4de0-be7e-a01b02db3165" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_7f8c34a8-0aaf-477c-8f12-f651bd6ebc7a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7f8c34a8-0aaf-477c-8f12-f651bd6ebc7a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_7f8c34a8-0aaf-477c-8f12-f651bd6ebc7a" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7f8c34a8-0aaf-477c-8f12-f651bd6ebc7a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d64bbf4f-b4fa-4a80-97dc-08f8b8ac84d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_7f8c34a8-0aaf-477c-8f12-f651bd6ebc7a" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d64bbf4f-b4fa-4a80-97dc-08f8b8ac84d7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ArkisBioSciencesInc.Member_734293a0-0e6b-4f11-b1e2-654eb7f1a8e8" xlink:href="iart-20230331.xsd#iart_ArkisBioSciencesInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d64bbf4f-b4fa-4a80-97dc-08f8b8ac84d7" xlink:to="loc_iart_ArkisBioSciencesInc.Member_734293a0-0e6b-4f11-b1e2-654eb7f1a8e8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DermaSciencesMember_ffc311e6-45f5-4b01-b339-a1f72e4848b6" xlink:href="iart-20230331.xsd#iart_DermaSciencesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d64bbf4f-b4fa-4a80-97dc-08f8b8ac84d7" xlink:to="loc_iart_DermaSciencesMember_ffc311e6-45f5-4b01-b339-a1f72e4848b6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ACellIncMember_52d045bb-af33-44b6-9e26-6db1dd382ca5" xlink:href="iart-20230331.xsd#iart_ACellIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d64bbf4f-b4fa-4a80-97dc-08f8b8ac84d7" xlink:to="loc_iart_ACellIncMember_52d045bb-af33-44b6-9e26-6db1dd382ca5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_e2edd7f0-8fc7-4960-afe0-42071c0a0b22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_aedc3bf7-4d2d-4de0-be7e-a01b02db3165" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_e2edd7f0-8fc7-4960-afe0-42071c0a0b22" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_e2edd7f0-8fc7-4960-afe0-42071c0a0b22_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_e2edd7f0-8fc7-4960-afe0-42071c0a0b22" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_e2edd7f0-8fc7-4960-afe0-42071c0a0b22_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_d287589b-b868-4a9b-a06f-d1369a97398b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_e2edd7f0-8fc7-4960-afe0-42071c0a0b22" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_d287589b-b868-4a9b-a06f-d1369a97398b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_MilestonePaymentOneMember_e198b495-9c89-4792-98f7-8172b119d570" xlink:href="iart-20230331.xsd#iart_MilestonePaymentOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_d287589b-b868-4a9b-a06f-d1369a97398b" xlink:to="loc_iart_MilestonePaymentOneMember_e198b495-9c89-4792-98f7-8172b119d570" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_MilestonePaymentTwoMember_820cd705-79a1-44e9-b9a4-b6ed000adea4" xlink:href="iart-20230331.xsd#iart_MilestonePaymentTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_d287589b-b868-4a9b-a06f-d1369a97398b" xlink:to="loc_iart_MilestonePaymentTwoMember_820cd705-79a1-44e9-b9a4-b6ed000adea4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_BioDEarnoutPaymentsandMedihoneyEarnoutPaymentsMember_d25b8246-0fed-4dc2-aea9-791c56fd1404" xlink:href="iart-20230331.xsd#iart_BioDEarnoutPaymentsandMedihoneyEarnoutPaymentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_d287589b-b868-4a9b-a06f-d1369a97398b" xlink:to="loc_iart_BioDEarnoutPaymentsandMedihoneyEarnoutPaymentsMember_d25b8246-0fed-4dc2-aea9-791c56fd1404" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_235ddd36-f54e-476d-9758-6d16683f3046" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_aedc3bf7-4d2d-4de0-be7e-a01b02db3165" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_235ddd36-f54e-476d-9758-6d16683f3046" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_235ddd36-f54e-476d-9758-6d16683f3046_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_235ddd36-f54e-476d-9758-6d16683f3046" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_235ddd36-f54e-476d-9758-6d16683f3046_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_3f359ce9-3053-4a04-b327-bcb052899373" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_235ddd36-f54e-476d-9758-6d16683f3046" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_3f359ce9-3053-4a04-b327-bcb052899373" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_83898d3d-c22d-42e3-87e5-3778b8df6a3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_3f359ce9-3053-4a04-b327-bcb052899373" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_83898d3d-c22d-42e3-87e5-3778b8df6a3a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AccruedExpensesAndOtherCurrentLiabilitiesMember_6fff3cfb-1a1d-44d8-aa3f-b9c7d2cc220a" xlink:href="iart-20230331.xsd#iart_AccruedExpensesAndOtherCurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_3f359ce9-3053-4a04-b327-bcb052899373" xlink:to="loc_iart_AccruedExpensesAndOtherCurrentLiabilitiesMember_6fff3cfb-1a1d-44d8-aa3f-b9c7d2cc220a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_4d7b1929-1f68-43d0-ab66-1ea3d58ffcb8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_aedc3bf7-4d2d-4de0-be7e-a01b02db3165" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_4d7b1929-1f68-43d0-ab66-1ea3d58ffcb8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4d7b1929-1f68-43d0-ab66-1ea3d58ffcb8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_4d7b1929-1f68-43d0-ab66-1ea3d58ffcb8" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4d7b1929-1f68-43d0-ab66-1ea3d58ffcb8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7cc84ee1-ab02-426f-80a1-a49eb2d6915c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_4d7b1929-1f68-43d0-ab66-1ea3d58ffcb8" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7cc84ee1-ab02-426f-80a1-a49eb2d6915c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_135317fe-731c-483b-9e5b-e6a2aafbfbd6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7cc84ee1-ab02-426f-80a1-a49eb2d6915c" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_135317fe-731c-483b-9e5b-e6a2aafbfbd6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_b9f9a5c3-7253-4aad-aa7b-7fd0627f8f11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_aedc3bf7-4d2d-4de0-be7e-a01b02db3165" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_b9f9a5c3-7253-4aad-aa7b-7fd0627f8f11" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_b9f9a5c3-7253-4aad-aa7b-7fd0627f8f11_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_b9f9a5c3-7253-4aad-aa7b-7fd0627f8f11" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_b9f9a5c3-7253-4aad-aa7b-7fd0627f8f11_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_c4203494-edcf-4ab6-83ce-5980b5a04d37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_b9f9a5c3-7253-4aad-aa7b-7fd0627f8f11" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_c4203494-edcf-4ab6-83ce-5980b5a04d37" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ContingentConsiderationLiabilityMember_1b1abe3f-dfd5-42ae-9dc0-598f288727c6" xlink:href="iart-20230331.xsd#iart_ContingentConsiderationLiabilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_c4203494-edcf-4ab6-83ce-5980b5a04d37" xlink:to="loc_iart_ContingentConsiderationLiabilityMember_1b1abe3f-dfd5-42ae-9dc0-598f288727c6" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>10
<FILENAME>iart-20230331_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:0e3cd8f8-520d-473a-a9d1-16bfb1ec7d66,g:2b3f0039-4147-46cc-8b95-ac89c1bf8f8d-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_c906721b-8619-445e-afa3-a2b69f10d6bb_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_842f8523-9598-4ab8-86ef-180680490de9_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_bd774410-e85c-4f0f-87a0-58c26b970276_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total minimum lease payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_dd172738-2ea4-487f-a4a8-23d4f9a2511a_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Noncurrent Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_8b79a9f4-993b-4f66-a13c-65175a35477d_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets, net</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_fb656f12-1b8a-4d10-ac23-502ef2cb32e4_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_ChangeInContractWithCustomerLiabilityRollForward_190c66e8-6623-4b36-8d59-5b0fbd92d48e_terseLabel_en-US" xlink:label="lab_iart_ChangeInContractWithCustomerLiabilityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract Liability</link:label>
    <link:label id="lab_iart_ChangeInContractWithCustomerLiabilityRollForward_label_en-US" xlink:label="lab_iart_ChangeInContractWithCustomerLiabilityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change In Contract With Customer, Liability [Roll Forward]</link:label>
    <link:label id="lab_iart_ChangeInContractWithCustomerLiabilityRollForward_documentation_en-US" xlink:label="lab_iart_ChangeInContractWithCustomerLiabilityRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change In Contract With Customer, Liability [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ChangeInContractWithCustomerLiabilityRollForward" xlink:href="iart-20230331.xsd#iart_ChangeInContractWithCustomerLiabilityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_ChangeInContractWithCustomerLiabilityRollForward" xlink:to="lab_iart_ChangeInContractWithCustomerLiabilityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_267ea02e-d08e-4160-9daf-7f1344d1e6c9_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, outstanding shares (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_6f4df457-35ac-401b-aa58-b477eade267a_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_AssetsAndLiabilitiesLesseeTableTextBlock_51807a8b-582f-4009-9fbd-5fd7098719aa_terseLabel_en-US" xlink:label="lab_iart_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Balance Sheet Information</link:label>
    <link:label id="lab_iart_AssetsAndLiabilitiesLesseeTableTextBlock_label_en-US" xlink:label="lab_iart_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets And Liabilities, Lessee [Table Text Block]</link:label>
    <link:label id="lab_iart_AssetsAndLiabilitiesLesseeTableTextBlock_documentation_en-US" xlink:label="lab_iart_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets And Liabilities, Lessee [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:href="iart-20230331.xsd#iart_AssetsAndLiabilitiesLesseeTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:to="lab_iart_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_DebtCovenantPeriodAxis_86f0bc95-727b-41bf-ba83-0f7dc8b2fe64_terseLabel_en-US" xlink:label="lab_iart_DebtCovenantPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Covenant Period [Axis]</link:label>
    <link:label id="lab_iart_DebtCovenantPeriodAxis_label_en-US" xlink:label="lab_iart_DebtCovenantPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Covenant Period [Axis]</link:label>
    <link:label id="lab_iart_DebtCovenantPeriodAxis_documentation_en-US" xlink:label="lab_iart_DebtCovenantPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Covenant Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtCovenantPeriodAxis" xlink:href="iart-20230331.xsd#iart_DebtCovenantPeriodAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_DebtCovenantPeriodAxis" xlink:to="lab_iart_DebtCovenantPeriodAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_2dcacf7d-ba01-4867-97f3-f2294a681b8a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_f8cefe13-b2ed-4b1b-b605-8a57c1bfd83d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_LesseeOperatingLeaseNumberOfRenewalOptions_efd7c6a6-8bc8-450a-8c69-5adf0502e349_terseLabel_en-US" xlink:label="lab_iart_LesseeOperatingLeaseNumberOfRenewalOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of renewal options (or more)</link:label>
    <link:label id="lab_iart_LesseeOperatingLeaseNumberOfRenewalOptions_label_en-US" xlink:label="lab_iart_LesseeOperatingLeaseNumberOfRenewalOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Number Of Renewal Options</link:label>
    <link:label id="lab_iart_LesseeOperatingLeaseNumberOfRenewalOptions_documentation_en-US" xlink:label="lab_iart_LesseeOperatingLeaseNumberOfRenewalOptions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Number Of Renewal Options</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_LesseeOperatingLeaseNumberOfRenewalOptions" xlink:href="iart-20230331.xsd#iart_LesseeOperatingLeaseNumberOfRenewalOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_LesseeOperatingLeaseNumberOfRenewalOptions" xlink:to="lab_iart_LesseeOperatingLeaseNumberOfRenewalOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_0007ad28-bdd8-4453-9a18-c357f150949c_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum borrowing capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_FDAApprovalOfPremarketApprovalMember_239819e2-2217-4982-b36e-4cbf1e6c3879_terseLabel_en-US" xlink:label="lab_iart_FDAApprovalOfPremarketApprovalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FDA Approval Of Premarket Approval</link:label>
    <link:label id="lab_iart_FDAApprovalOfPremarketApprovalMember_label_en-US" xlink:label="lab_iart_FDAApprovalOfPremarketApprovalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FDA Approval Of Premarket Approval [Member]</link:label>
    <link:label id="lab_iart_FDAApprovalOfPremarketApprovalMember_documentation_en-US" xlink:label="lab_iart_FDAApprovalOfPremarketApprovalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FDA Approval Of Premarket Approval</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_FDAApprovalOfPremarketApprovalMember" xlink:href="iart-20230331.xsd#iart_FDAApprovalOfPremarketApprovalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_FDAApprovalOfPremarketApprovalMember" xlink:to="lab_iart_FDAApprovalOfPremarketApprovalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_3fcb4e38-5a3b-4edd-8e00-f2dea0ed2a54_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_d20956b7-b006-4e09-9ac6-0dee3f3951dc_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFairValue" xlink:to="lab_us-gaap_DebtInstrumentFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_95d0c4d9-d829-48a1-b2e3-38f981bc28e6_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCompensationPlanAssets_d5527ea8-3f16-4169-9175-6faf3451461d_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCompensationPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred compensation plan, fair value of assets</link:label>
    <link:label id="lab_us-gaap_DeferredCompensationPlanAssets_label_en-US" xlink:label="lab_us-gaap_DeferredCompensationPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCompensationPlanAssets" xlink:to="lab_us-gaap_DeferredCompensationPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment_ecd2eb38-ec28-4114-b155-d129c1a80631_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired in-process research and development milestone</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire in Process Research and Development</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment" xlink:to="lab_us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherDepreciationAndAmortization_1fb3ea23-f7f9-4a80-a845-f1fe8b8e59a5_terseLabel_en-US" xlink:label="lab_us-gaap_OtherDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_OtherDepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_OtherDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Depreciation and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherDepreciationAndAmortization" xlink:to="lab_us-gaap_OtherDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_d086ba8b-ec0b-4046-83c6-5884ac795ca8_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rates available</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_d46b9d6c-3d8d-41d6-866a-ed1a17d0077e_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_413b042a-c198-4e25-8c60-b2060e4c38fe_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_TissueTechnologiesMember_70fd246a-14a0-4be8-b561-c3c5e9da083f_terseLabel_en-US" xlink:label="lab_iart_TissueTechnologiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tissue Technologies</link:label>
    <link:label id="lab_iart_TissueTechnologiesMember_label_en-US" xlink:label="lab_iart_TissueTechnologiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tissue Technologies [Member]</link:label>
    <link:label id="lab_iart_TissueTechnologiesMember_documentation_en-US" xlink:label="lab_iart_TissueTechnologiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Orthopedics and Tissue Technologies [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_TissueTechnologiesMember" xlink:href="iart-20230331.xsd#iart_TissueTechnologiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_TissueTechnologiesMember" xlink:to="lab_iart_TissueTechnologiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_e720d6ac-dff0-4540-8523-273f93e53880_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average discount rate</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_45110867-5457-4f4e-b630-76f4de1457a5_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible notes, interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_cdf30605-0967-4623-8b8d-6dd05d4d305d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Derivative Instruments Designated as Cash Flow Hedges on Statements of Operations</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6b0ff238-228b-4ba9-9505-7a6677c5ff5c_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_cb632028-f161-48e5-aafe-4ff9b276023b_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseOptionToExtend_65ae648c-d4ef-41d1-86bd-7972ff8af9f3_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseOptionToExtend" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period for extended lease</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseOptionToExtend_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseOptionToExtend" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Option to Extend</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseOptionToExtend" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseOptionToExtend"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseOptionToExtend" xlink:to="lab_us-gaap_LesseeOperatingLeaseOptionToExtend" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OptionIndexedToIssuersEquityEquityAxis_eccd5bf4-20e8-4e9d-b659-f00da975df8d_terseLabel_en-US" xlink:label="lab_us-gaap_OptionIndexedToIssuersEquityEquityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option Indexed to Issuer's Equity [Axis]</link:label>
    <link:label id="lab_us-gaap_OptionIndexedToIssuersEquityEquityAxis_label_en-US" xlink:label="lab_us-gaap_OptionIndexedToIssuersEquityEquityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option Indexed to Issuer's Equity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityEquityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OptionIndexedToIssuersEquityEquityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OptionIndexedToIssuersEquityEquityAxis" xlink:to="lab_us-gaap_OptionIndexedToIssuersEquityEquityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_78afa386-d74e-4abf-a9a0-edd81b1d2c83_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net periodic benefit costs</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:to="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent_f906e816-bf79-414a-b0d4-51222a8bfd88_terseLabel_en-US" xlink:label="lab_iart_FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfers</link:label>
    <link:label id="lab_iart_FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent_label_en-US" xlink:label="lab_iart_FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers From Long-Term to Current</link:label>
    <link:label id="lab_iart_FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent_documentation_en-US" xlink:label="lab_iart_FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers From Long-Term to Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent" xlink:href="iart-20230331.xsd#iart_FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent" xlink:to="lab_iart_FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_EmployeeMember_5de52bbd-d63c-4727-8577-bd26d6c2527d_terseLabel_en-US" xlink:label="lab_iart_EmployeeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employees</link:label>
    <link:label id="lab_iart_EmployeeMember_label_en-US" xlink:label="lab_iart_EmployeeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee [Member]</link:label>
    <link:label id="lab_iart_EmployeeMember_documentation_en-US" xlink:label="lab_iart_EmployeeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EmployeeMember" xlink:href="iart-20230331.xsd#iart_EmployeeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_EmployeeMember" xlink:to="lab_iart_EmployeeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetReclassifiedToReceivable_3f5ef634-ee92-46d1-b11c-a9ea3cbbce47_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetReclassifiedToReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transferred to trade receivable from contract asset included in beginning of the year contract asset</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetReclassifiedToReceivable_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetReclassifiedToReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, Reclassified to Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetReclassifiedToReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetReclassifiedToReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetReclassifiedToReceivable" xlink:to="lab_us-gaap_ContractWithCustomerAssetReclassifiedToReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_0af05153-4c06-49a1-b119-4998057de3fe_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_056be547-983b-493a-91a8-d2610662a178_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_c71c64f9-eb2f-47af-9196-774ea73959c8_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_5655137d-0154-4568-9c82-211caaedbf08_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_4f7dac8a-31b4-411e-8d04-6ba0b29ca6ce_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:to="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_TransferorsInterestsInTransferredFinancialAssetsMaximumInvestmentLimit_dd654b20-1e59-4a77-914a-722ad50ed3f8_terseLabel_en-US" xlink:label="lab_iart_TransferorsInterestsInTransferredFinancialAssetsMaximumInvestmentLimit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Securitization program outstanding borrowings, maximum limit</link:label>
    <link:label id="lab_iart_TransferorsInterestsInTransferredFinancialAssetsMaximumInvestmentLimit_label_en-US" xlink:label="lab_iart_TransferorsInterestsInTransferredFinancialAssetsMaximumInvestmentLimit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transferor's Interests In Transferred Financial Assets, Maximum Investment Limit</link:label>
    <link:label id="lab_iart_TransferorsInterestsInTransferredFinancialAssetsMaximumInvestmentLimit_documentation_en-US" xlink:label="lab_iart_TransferorsInterestsInTransferredFinancialAssetsMaximumInvestmentLimit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transferor's Interests In Transferred Financial Assets, Maximum Investment Limit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_TransferorsInterestsInTransferredFinancialAssetsMaximumInvestmentLimit" xlink:href="iart-20230331.xsd#iart_TransferorsInterestsInTransferredFinancialAssetsMaximumInvestmentLimit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_TransferorsInterestsInTransferredFinancialAssetsMaximumInvestmentLimit" xlink:to="lab_iart_TransferorsInterestsInTransferredFinancialAssetsMaximumInvestmentLimit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationProfitLossAbstract_d26d26a7-84aa-48ca-bf42-250f5b501dc8_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationProfitLossAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Profit</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationProfitLossAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationProfitLossAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information, Profit (Loss) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationProfitLossAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationProfitLossAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract" xlink:to="lab_us-gaap_SegmentReportingInformationProfitLossAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_b397aedb-8442-4b31-abf3-0aee33b1c04c_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares excluded from computation as their effect would be antidilutive (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContingentConsiderationByTypeAxis_d37f2f51-41a9-43d1-a4ba-a2090f4d37ab_terseLabel_en-US" xlink:label="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration by Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ContingentConsiderationByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration by Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis" xlink:to="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_7cd1a743-647f-4de8-a1ce-dc97a1dc7bf0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Contractual Repayments of Long-Term Debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Maturities of Long-Term Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FederalFundsEffectiveSwapRateMember_5cd10de2-a7a2-44cc-b23a-309e0df40117_terseLabel_en-US" xlink:label="lab_us-gaap_FederalFundsEffectiveSwapRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Overnight Federal Funds</link:label>
    <link:label id="lab_us-gaap_FederalFundsEffectiveSwapRateMember_label_en-US" xlink:label="lab_us-gaap_FederalFundsEffectiveSwapRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fed Funds Effective Rate Overnight Index Swap Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalFundsEffectiveSwapRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FederalFundsEffectiveSwapRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FederalFundsEffectiveSwapRateMember" xlink:to="lab_us-gaap_FederalFundsEffectiveSwapRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_fe8619ee-50a8-4829-a223-371c13c28074_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_dd743067-1077-4b35-be4a-921095edb0c9_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseMember_cbadaa03-d2dd-42a6-b3d0-fc795b8fe80c_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpenseMember_label_en-US" xlink:label="lab_us-gaap_InterestExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseMember" xlink:to="lab_us-gaap_InterestExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuredDebtMember_620f1631-3bc3-4a95-9c94-e8c89deebf59_terseLabel_en-US" xlink:label="lab_us-gaap_SecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Debt</link:label>
    <link:label id="lab_us-gaap_SecuredDebtMember_label_en-US" xlink:label="lab_us-gaap_SecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuredDebtMember" xlink:to="lab_us-gaap_SecuredDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPricePercentage_88b48561-37b6-4ad3-9caa-dbe642ef2525_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redemption price, percentage</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPricePercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption Price, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_da4a59d4-ed30-4480-9126-6dc030d8967f_terseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_69af9fc3-6d85-48f8-9670-2b48ecb94dfc_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LEASES AND RELATED PARTY LEASES</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonValue_2ec7fa79-c718-4010-8f23-230b44fa84fd_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Common, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonValue" xlink:to="lab_us-gaap_TreasuryStockCommonValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_09bf08e5-469c-48d6-b3c7-8efad5a290af_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyDomain_34f551c4-a3b8-4f70-9618-190a7f0e6e1d_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyDomain" xlink:to="lab_us-gaap_RelatedPartyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_InstrumentsMember_ef6a2081-3b9a-4d8b-9755-2f9e32995fd0_terseLabel_en-US" xlink:label="lab_iart_InstrumentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Instruments</link:label>
    <link:label id="lab_iart_InstrumentsMember_label_en-US" xlink:label="lab_iart_InstrumentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Instruments [Member]</link:label>
    <link:label id="lab_iart_InstrumentsMember_documentation_en-US" xlink:label="lab_iart_InstrumentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Instruments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InstrumentsMember" xlink:href="iart-20230331.xsd#iart_InstrumentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_InstrumentsMember" xlink:to="lab_iart_InstrumentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNet_1f26d70c-d8e5-4b24-a5d3-a1c24a4834a0_periodStartLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNet" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract asset, Beginning of period</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNet_9c74cd04-2019-4d0b-8a7e-eea022623a53_periodEndLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNet" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract asset, End of Period</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNet_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, after Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetNet" xlink:to="lab_us-gaap_ContractWithCustomerAssetNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DilutiveSecuritiesAbstract_e1be9806-513c-4c95-b7ed-3bea76ef9100_terseLabel_en-US" xlink:label="lab_us-gaap_DilutiveSecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of dilutive securities:</link:label>
    <link:label id="lab_us-gaap_DilutiveSecuritiesAbstract_label_en-US" xlink:label="lab_us-gaap_DilutiveSecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive Securities, Effect on Basic Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DilutiveSecuritiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DilutiveSecuritiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DilutiveSecuritiesAbstract" xlink:to="lab_us-gaap_DilutiveSecuritiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StandbyLettersOfCreditMember_94fc533d-7266-40ea-9a49-4f610fe84225_terseLabel_en-US" xlink:label="lab_us-gaap_StandbyLettersOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standby Letters of Credit</link:label>
    <link:label id="lab_us-gaap_StandbyLettersOfCreditMember_label_en-US" xlink:label="lab_us-gaap_StandbyLettersOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standby Letters of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandbyLettersOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StandbyLettersOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StandbyLettersOfCreditMember" xlink:to="lab_us-gaap_StandbyLettersOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_e7fc0226-b534-4043-8f55-042faa44a22a_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationDomain" xlink:to="lab_us-gaap_HedgingDesignationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_2127af65-55f9-4ee6-a76d-bf204b8ad1e4_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated fair value of plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_RestOfWorldMember_3a3dc890-e1fa-4765-af34-97d9352137a6_terseLabel_en-US" xlink:label="lab_iart_RestOfWorldMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rest of World</link:label>
    <link:label id="lab_iart_RestOfWorldMember_label_en-US" xlink:label="lab_iart_RestOfWorldMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rest Of World [Member]</link:label>
    <link:label id="lab_iart_RestOfWorldMember_documentation_en-US" xlink:label="lab_iart_RestOfWorldMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues from rest of the world.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_RestOfWorldMember" xlink:href="iart-20230331.xsd#iart_RestOfWorldMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_RestOfWorldMember" xlink:to="lab_iart_RestOfWorldMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_c4826d9a-7dab-412e-8666-55be64b0af55_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_1b22cb33-e884-44ba-a389-70fb542f92d0_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, by Nature [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseContractualTermDomain_4ca6a777-87ee-4cf2-b032-3d790f4107cd_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseContractualTermDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Contractual Term [Domain]</link:label>
    <link:label id="lab_us-gaap_LeaseContractualTermDomain_label_en-US" xlink:label="lab_us-gaap_LeaseContractualTermDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Contractual Term [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseContractualTermDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseContractualTermDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseContractualTermDomain" xlink:to="lab_us-gaap_LeaseContractualTermDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_24e042ff-58b4-4d4f-8644-76c0ea29a04a_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remainder of 2023</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillLineItems_488a7da5-a9d3-47ab-9943-c02e9f69c284_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:label id="lab_us-gaap_GoodwillLineItems_label_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillLineItems" xlink:to="lab_us-gaap_GoodwillLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_d6d14cfd-9c86-4f88-9bc1-0c5e49fd38e6_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCredit_2d4294ec-5567-4709-adde-851adc7068ca_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of credit facility outstanding</link:label>
    <link:label id="lab_us-gaap_LineOfCredit_label_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Line of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCredit" xlink:to="lab_us-gaap_LineOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_5fc9e2ef-433e-45c8-8f7d-5c6cbfa18b90_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity State</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_InterestPaymentsYearOne_2658f744-772c-4796-83c5-f537d46d06fc_terseLabel_en-US" xlink:label="lab_iart_InterestPaymentsYearOne" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest payments, year one</link:label>
    <link:label id="lab_iart_InterestPaymentsYearOne_label_en-US" xlink:label="lab_iart_InterestPaymentsYearOne" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Payments, Year One</link:label>
    <link:label id="lab_iart_InterestPaymentsYearOne_documentation_en-US" xlink:label="lab_iart_InterestPaymentsYearOne" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Payments, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestPaymentsYearOne" xlink:href="iart-20230331.xsd#iart_InterestPaymentsYearOne"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_InterestPaymentsYearOne" xlink:to="lab_iart_InterestPaymentsYearOne" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_bb158f7b-82c7-40c3-8dac-fb31b25ec735_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContingentConsiderationTypeDomain_2130ef0d-c8ff-4f1d-892e-8a25e960dee2_terseLabel_en-US" xlink:label="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ContingentConsiderationTypeDomain_label_en-US" xlink:label="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain" xlink:to="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_a6fe6956-b54a-4143-9545-40cbe90d43c8_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_da7a8e9d-fcdd-4c62-8846-fbb77b0bb4a5_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of lease liability - operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_723ea644-666b-49d3-888c-46630c6ae800_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_af010fdb-dbfd-4454-94f0-e325f12c8ce9_netLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Current lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_2d06a1ec-53ea-45e5-81f3-0d95093702f0_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of business</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Divestiture of Businesses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:to="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpensesAbstract_176a81d1-af0c-4d84-b955-086650e6c42e_terseLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and expenses:</link:label>
    <link:label id="lab_us-gaap_CostsAndExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_CostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpensesAbstract" xlink:to="lab_us-gaap_CostsAndExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_4ec90799-de39-415b-a801-04c76cdcf4c2_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain expected to be reclassified to earnings in the next twelve months</link:label>
    <link:label id="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_label_en-US" xlink:label="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:to="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_DerivativeNotionalAmountTerminated_2daa3c33-6cb7-4bfd-b51d-1719c0a75a17_terseLabel_en-US" xlink:label="lab_iart_DerivativeNotionalAmountTerminated" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Terminated notional amount</link:label>
    <link:label id="lab_iart_DerivativeNotionalAmountTerminated_label_en-US" xlink:label="lab_iart_DerivativeNotionalAmountTerminated" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount, Terminated</link:label>
    <link:label id="lab_iart_DerivativeNotionalAmountTerminated_documentation_en-US" xlink:label="lab_iart_DerivativeNotionalAmountTerminated" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount, Terminated</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DerivativeNotionalAmountTerminated" xlink:href="iart-20230331.xsd#iart_DerivativeNotionalAmountTerminated"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_DerivativeNotionalAmountTerminated" xlink:to="lab_iart_DerivativeNotionalAmountTerminated" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_8db743e1-9f86-4f2a-8ab2-ad81499ac987_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_b7790f8d-7dfc-445f-bc23-888f619faecb_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis" xlink:to="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_CrossCurrencyInterestRateContractTwoMember_d219b7cf-e857-4b3a-b5c5-5ec8d628ca70_terseLabel_en-US" xlink:label="lab_iart_CrossCurrencyInterestRateContractTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross Currency Interest Rate Swap Two</link:label>
    <link:label id="lab_iart_CrossCurrencyInterestRateContractTwoMember_label_en-US" xlink:label="lab_iart_CrossCurrencyInterestRateContractTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross Currency Interest Rate Contract Two [Member]</link:label>
    <link:label id="lab_iart_CrossCurrencyInterestRateContractTwoMember_documentation_en-US" xlink:label="lab_iart_CrossCurrencyInterestRateContractTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross Currency Interest Rate Contract Two [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CrossCurrencyInterestRateContractTwoMember" xlink:href="iart-20230331.xsd#iart_CrossCurrencyInterestRateContractTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_CrossCurrencyInterestRateContractTwoMember" xlink:to="lab_iart_CrossCurrencyInterestRateContractTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_InterestRateSwapDesignatedOctober102018Tranche2Member_b39cac9b-f146-405f-a5cb-a9649a0e61e6_terseLabel_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedOctober102018Tranche2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated October 10, 2018 Tranche 2</link:label>
    <link:label id="lab_iart_InterestRateSwapDesignatedOctober102018Tranche2Member_label_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedOctober102018Tranche2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated October 10, 2018 Tranche 2 [Member]</link:label>
    <link:label id="lab_iart_InterestRateSwapDesignatedOctober102018Tranche2Member_documentation_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedOctober102018Tranche2Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated October 10, 2018 Tranche 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedOctober102018Tranche2Member" xlink:href="iart-20230331.xsd#iart_InterestRateSwapDesignatedOctober102018Tranche2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_InterestRateSwapDesignatedOctober102018Tranche2Member" xlink:to="lab_iart_InterestRateSwapDesignatedOctober102018Tranche2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_33cca65c-501f-4954-9127-b674daebec12_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_ThirdPartiesMember_aa46a4e8-eda1-476b-bf55-a0c5e8faae42_verboseLabel_en-US" xlink:label="lab_iart_ThirdPartiesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Third Parties</link:label>
    <link:label id="lab_iart_ThirdPartiesMember_label_en-US" xlink:label="lab_iart_ThirdPartiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Third Parties [Member]</link:label>
    <link:label id="lab_iart_ThirdPartiesMember_documentation_en-US" xlink:label="lab_iart_ThirdPartiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Third Parties [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ThirdPartiesMember" xlink:href="iart-20230331.xsd#iart_ThirdPartiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_ThirdPartiesMember" xlink:to="lab_iart_ThirdPartiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_59e60dce-4fcb-47bc-9e21-2efb816674cf_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining lease term (in years)</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_ec4d1f7b-d478-4ba5-865b-1339af8be145_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c98c170f-ab26-4538-8621-90eb85c7eef8_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_ArkisBioSciencesInc.Member_83ed2dd9-a988-4323-b65c-1d6eb6828585_terseLabel_en-US" xlink:label="lab_iart_ArkisBioSciencesInc.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Arkis</link:label>
    <link:label id="lab_iart_ArkisBioSciencesInc.Member_label_en-US" xlink:label="lab_iart_ArkisBioSciencesInc.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Arkis BioSciences Inc. [Member]</link:label>
    <link:label id="lab_iart_ArkisBioSciencesInc.Member_documentation_en-US" xlink:label="lab_iart_ArkisBioSciencesInc.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Arkis BioSciences Inc. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ArkisBioSciencesInc.Member" xlink:href="iart-20230331.xsd#iart_ArkisBioSciencesInc.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_ArkisBioSciencesInc.Member" xlink:to="lab_iart_ArkisBioSciencesInc.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillPurchaseAccountingAdjustments_dcd4f0e5-e0c4-48b2-be01-585a7c9007f0_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SIA Acquisition Working Capital Adjustment</link:label>
    <link:label id="lab_us-gaap_GoodwillPurchaseAccountingAdjustments_label_en-US" xlink:label="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Purchase Accounting Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:to="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_dae043e9-c975-40f7-b365-d2f773dfcf70_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INVESTING ACTIVITIES:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PositionAxis_0b2fa171-b5c5-49bf-8d05-97940d0b0932_terseLabel_en-US" xlink:label="lab_us-gaap_PositionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Position [Axis]</link:label>
    <link:label id="lab_us-gaap_PositionAxis_label_en-US" xlink:label="lab_us-gaap_PositionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Position [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PositionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PositionAxis" xlink:to="lab_us-gaap_PositionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_f663899f-6967-4156-82b0-965de4617a48_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_DermaSciencesMember_a658610d-9679-4278-8b50-ae5b8aa9dcdb_terseLabel_en-US" xlink:label="lab_iart_DermaSciencesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derma Sciences</link:label>
    <link:label id="lab_iart_DermaSciencesMember_label_en-US" xlink:label="lab_iart_DermaSciencesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derma Sciences [Member]</link:label>
    <link:label id="lab_iart_DermaSciencesMember_documentation_en-US" xlink:label="lab_iart_DermaSciencesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derma Sciences [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DermaSciencesMember" xlink:href="iart-20230331.xsd#iart_DermaSciencesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_DermaSciencesMember" xlink:to="lab_iart_DermaSciencesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasedAssetsLineItems_ea0beb5a-0211-454c-8043-5d263b902713_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasedAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leased Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_OperatingLeasedAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_OperatingLeasedAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leased Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasedAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasedAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems" xlink:to="lab_us-gaap_OperatingLeasedAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_ee9f7c30-07f6-40a0-b883-e1289a7c7738_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding (in shares)</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7ccecb85-41f2-475b-a93a-0e321d2cbd55_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_8c46673e-f24e-47c8-bb35-45f1297fe61c_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_e29b0a3a-c1ed-4c53-a2ef-6df9187eb7a5_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Accounting Policies on Revenue Recognition and Shipping and Handling Fees</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_d5bfe6c9-0b49-4bac-a073-017d3a6ed903_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_3e2da2a6-00a8-4d81-9913-dda92d6e984e_terseLabel_en-US" xlink:label="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate</link:label>
    <link:label id="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_label_en-US" xlink:label="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:to="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_RevenueBasedPerformanceMilestonesMember_5eb5c7e7-6ed6-4799-bb7d-0ae9e09b5fd5_terseLabel_en-US" xlink:label="lab_iart_RevenueBasedPerformanceMilestonesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Based Performance Milestones</link:label>
    <link:label id="lab_iart_RevenueBasedPerformanceMilestonesMember_label_en-US" xlink:label="lab_iart_RevenueBasedPerformanceMilestonesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Based Performance Milestones [Member]</link:label>
    <link:label id="lab_iart_RevenueBasedPerformanceMilestonesMember_documentation_en-US" xlink:label="lab_iart_RevenueBasedPerformanceMilestonesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Based Performance Milestones</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_RevenueBasedPerformanceMilestonesMember" xlink:href="iart-20230331.xsd#iart_RevenueBasedPerformanceMilestonesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_RevenueBasedPerformanceMilestonesMember" xlink:to="lab_iart_RevenueBasedPerformanceMilestonesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_InterestPaymentsYearTwo_c6b9a7ad-78c7-44ec-b6f2-34cc841a5372_terseLabel_en-US" xlink:label="lab_iart_InterestPaymentsYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest payments, year two</link:label>
    <link:label id="lab_iart_InterestPaymentsYearTwo_label_en-US" xlink:label="lab_iart_InterestPaymentsYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Payments, Year Two</link:label>
    <link:label id="lab_iart_InterestPaymentsYearTwo_documentation_en-US" xlink:label="lab_iart_InterestPaymentsYearTwo" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Payments, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestPaymentsYearTwo" xlink:href="iart-20230331.xsd#iart_InterestPaymentsYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_InterestPaymentsYearTwo" xlink:to="lab_iart_InterestPaymentsYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_fba9737d-6d81-4002-9ec3-0c5d175d8351_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_fadf92c7-a77f-4176-8f38-3ce664fec0a9_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_2f8913cf-b8bb-4608-9a94-da8ed20393fa_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_36a8f16a-8d1e-42e9-bea6-305e0463c034_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DEBT</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashDivestedFromDeconsolidation_7ac801c1-68eb-4c9c-973c-5b1152be74a1_terseLabel_en-US" xlink:label="lab_us-gaap_CashDivestedFromDeconsolidation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash divested from deconsolidation</link:label>
    <link:label id="lab_us-gaap_CashDivestedFromDeconsolidation_label_en-US" xlink:label="lab_us-gaap_CashDivestedFromDeconsolidation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Divested from Deconsolidation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashDivestedFromDeconsolidation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashDivestedFromDeconsolidation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashDivestedFromDeconsolidation" xlink:to="lab_us-gaap_CashDivestedFromDeconsolidation" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_41a6b095-bc2b-4e1b-931d-365a1406daa8_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_44e34a91-ab69-468f-8483-b28282f38c2a_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_4bf61c93-e78a-4476-831d-8ab3fe346337_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income tax provision</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_70d43fda-1dc2-458b-894a-0c6ed47238ad_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_4ae37e4a-57aa-48e9-912f-58a0803da276_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) recorded in AOCL, change in fair value</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_d79086f1-4672-4d9a-83cc-5e5d5b54d965_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount&#160;of Gain (Loss) Recognized&#160;in AOCL</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_49952915-6bc6-4a8a-86e4-06841f3f4925_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VehiclesMember_8f80ab1e-4dd6-4edc-bd0b-23c684bd0b43_terseLabel_en-US" xlink:label="lab_us-gaap_VehiclesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leased vehicles</link:label>
    <link:label id="lab_us-gaap_VehiclesMember_label_en-US" xlink:label="lab_us-gaap_VehiclesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vehicles [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VehiclesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VehiclesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VehiclesMember" xlink:to="lab_us-gaap_VehiclesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_AffiliatedEntityMember_23ca868b-3d01-432b-b509-f178afa16595_terseLabel_en-US" xlink:label="lab_srt_AffiliatedEntityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Affiliated Entity</link:label>
    <link:label id="lab_srt_AffiliatedEntityMember_label_en-US" xlink:label="lab_srt_AffiliatedEntityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Affiliated Entity [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AffiliatedEntityMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AffiliatedEntityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_AffiliatedEntityMember" xlink:to="lab_srt_AffiliatedEntityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_InterestRateSwapDesignatedDecember132017Tranche3Member_bc9a33ee-cce5-4d34-92d2-562c906c3dd9_terseLabel_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedDecember132017Tranche3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated December 13, 2017 Tranche 3</link:label>
    <link:label id="lab_iart_InterestRateSwapDesignatedDecember132017Tranche3Member_label_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedDecember132017Tranche3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated December 13, 2017 Tranche 3 [Member]</link:label>
    <link:label id="lab_iart_InterestRateSwapDesignatedDecember132017Tranche3Member_documentation_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedDecember132017Tranche3Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated December 13, 2017 Tranche 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedDecember132017Tranche3Member" xlink:href="iart-20230331.xsd#iart_InterestRateSwapDesignatedDecember132017Tranche3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_InterestRateSwapDesignatedDecember132017Tranche3Member" xlink:to="lab_iart_InterestRateSwapDesignatedDecember132017Tranche3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_9a2621c2-bd94-47bd-a300-a3305bfb6ee8_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Activities [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OptionIndexedToIssuersEquityTypeDomain_0beb9c17-68c8-4b44-b3a6-0352aaf37fef_terseLabel_en-US" xlink:label="lab_us-gaap_OptionIndexedToIssuersEquityTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option Indexed to Issuer's Equity, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_OptionIndexedToIssuersEquityTypeDomain_label_en-US" xlink:label="lab_us-gaap_OptionIndexedToIssuersEquityTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option Indexed to Issuer's Equity, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OptionIndexedToIssuersEquityTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain" xlink:to="lab_us-gaap_OptionIndexedToIssuersEquityTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_8b46a466-267b-4a4c-bb2e-577438c22e58_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Changes in Contract Assets and Contract Liabilities</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:to="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_f320a5c6-bec4-46d0-b97b-de0d9ae06c3b_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuredDebtCurrent_9e4da77e-6090-4082-b743-7b534d6ebb79_terseLabel_en-US" xlink:label="lab_us-gaap_SecuredDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of borrowings under senior credit facility</link:label>
    <link:label id="lab_us-gaap_SecuredDebtCurrent_1567cf6a-1f60-4087-8d4b-5915acd84f65_verboseLabel_en-US" xlink:label="lab_us-gaap_SecuredDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term loan component of senior credit facility</link:label>
    <link:label id="lab_us-gaap_SecuredDebtCurrent_label_en-US" xlink:label="lab_us-gaap_SecuredDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Debt, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuredDebtCurrent" xlink:to="lab_us-gaap_SecuredDebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_311c595f-bfb8-4861-9981-4ed186803c2c_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) by Hedging Relationship, by Income Statement Location, by Derivative Instrument Risk [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_4af1a881-880e-48cd-9c44-439cbec7c45b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Changes in Accumulated Other Comprehensive Loss by Component</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_4b41ab7e-42ff-4980-93fb-a04b8749a92a_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OptionIndexedToIssuersEquityStrikePrice1_5483673e-328f-4e81-9fc9-dc645ad664f2_terseLabel_en-US" xlink:label="lab_us-gaap_OptionIndexedToIssuersEquityStrikePrice1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial strike price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_OptionIndexedToIssuersEquityStrikePrice1_label_en-US" xlink:label="lab_us-gaap_OptionIndexedToIssuersEquityStrikePrice1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option Indexed to Issuer's Equity, Strike Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityStrikePrice1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OptionIndexedToIssuersEquityStrikePrice1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OptionIndexedToIssuersEquityStrikePrice1" xlink:to="lab_us-gaap_OptionIndexedToIssuersEquityStrikePrice1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_814e0976-1fd5-41d0-b74c-7685526237cc_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_7b982bbe-89bf-4a60-a1d4-6dd45aa1821b_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income per share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_a049046d-1f74-4510-ac46-3425c601d6d6_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_ad2ec8f9-3f89-42bb-a503-483156ffcaa7_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PerformanceSharesMember_fa6c4649-0608-4189-b1d8-84b6da269f2b_terseLabel_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Stock</link:label>
    <link:label id="lab_us-gaap_PerformanceSharesMember_label_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Shares [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PerformanceSharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PerformanceSharesMember" xlink:to="lab_us-gaap_PerformanceSharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateSwapMember_346d8550-32ee-4b4e-9f74-43f5f3dd8b52_verboseLabel_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate swap</link:label>
    <link:label id="lab_us-gaap_InterestRateSwapMember_label_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateSwapMember" xlink:to="lab_us-gaap_InterestRateSwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesIssued_770973ca-8740-4891-9127-f849fcef56b5_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Beginning of Period, Shares (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesIssued_6083a8de-e9a4-4050-b170-9f8d20689d4c_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance End of Period, Shares (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesIssued_label_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesIssued" xlink:to="lab_us-gaap_SharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_2864f80c-40c2-4fb6-8048-648b892c5c0c_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses and other current liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_SecuredLongTermDebtSecuritizationProgram_79187f82-946b-41bc-826a-ebfca2ad7185_terseLabel_en-US" xlink:label="lab_iart_SecuredLongTermDebtSecuritizationProgram" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured long-term debt, securitization program</link:label>
    <link:label id="lab_iart_SecuredLongTermDebtSecuritizationProgram_label_en-US" xlink:label="lab_iart_SecuredLongTermDebtSecuritizationProgram" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Long-Term Debt, Securitization Program</link:label>
    <link:label id="lab_iart_SecuredLongTermDebtSecuritizationProgram_documentation_en-US" xlink:label="lab_iart_SecuredLongTermDebtSecuritizationProgram" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Long-Term Debt, Securitization Program</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SecuredLongTermDebtSecuritizationProgram" xlink:href="iart-20230331.xsd#iart_SecuredLongTermDebtSecuritizationProgram"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_SecuredLongTermDebtSecuritizationProgram" xlink:to="lab_iart_SecuredLongTermDebtSecuritizationProgram" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_d182c035-c8aa-4656-8cdf-77361b0975d8_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2028</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_b4db7496-2998-4599-9a97-ba46069c192c_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_782b9175-ccbd-44fb-95e3-53a5c735d11c_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Amounts reclassified from accumulated other comprehensive income, net</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_73219d4c-4ee2-4f98-a543-5294da6b1650_verboseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) reclassified from AOCI</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from AOCI, Current Period, Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:to="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ExtendedProductWarrantyPolicy_d8e0c0b3-d367-4c7e-be3f-b950e4290ade_terseLabel_en-US" xlink:label="lab_us-gaap_ExtendedProductWarrantyPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Warranties</link:label>
    <link:label id="lab_us-gaap_ExtendedProductWarrantyPolicy_label_en-US" xlink:label="lab_us-gaap_ExtendedProductWarrantyPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extended Product Warranty, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtendedProductWarrantyPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtendedProductWarrantyPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ExtendedProductWarrantyPolicy" xlink:to="lab_us-gaap_ExtendedProductWarrantyPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_6c91fa1b-e0a6-4e30-a72d-3276aaca898e_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued compensation</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfBusiness_85196783-2238-419a-b4da-b81d7fb86caf_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain from sale of businesses</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfBusiness_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfBusiness" xlink:to="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_b0b5227b-c75d-4e9b-883d-ee362070ef0a_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders&#8217; equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_7ed5e2e2-cb72-403f-a766-68690ebc9932_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2cd95213-c52a-4846-9c63-970a77e9d2f9_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_a3dfaf44-d25a-4d23-b408-66e334b3b962_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_302428ac-ae05-427b-9fba-7cf92c431631_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_DebtInstrumentBasisSpreadAdjustmentOnVariableRate_71e7be5f-5cff-4529-a630-029dd0f36e71_terseLabel_en-US" xlink:label="lab_iart_DebtInstrumentBasisSpreadAdjustmentOnVariableRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate adjustment</link:label>
    <link:label id="lab_iart_DebtInstrumentBasisSpreadAdjustmentOnVariableRate_label_en-US" xlink:label="lab_iart_DebtInstrumentBasisSpreadAdjustmentOnVariableRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread Adjustment On Variable Rate</link:label>
    <link:label id="lab_iart_DebtInstrumentBasisSpreadAdjustmentOnVariableRate_documentation_en-US" xlink:label="lab_iart_DebtInstrumentBasisSpreadAdjustmentOnVariableRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread Adjustment On Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtInstrumentBasisSpreadAdjustmentOnVariableRate" xlink:href="iart-20230331.xsd#iart_DebtInstrumentBasisSpreadAdjustmentOnVariableRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_DebtInstrumentBasisSpreadAdjustmentOnVariableRate" xlink:to="lab_iart_DebtInstrumentBasisSpreadAdjustmentOnVariableRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_428f8ff4-8926-4a89-a845-3f15d2590165_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NET INCOME PER SHARE</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_RevenueProductWarrantyPeriod_8315d89c-1449-4b77-b9b5-f2ba87337f98_terseLabel_en-US" xlink:label="lab_iart_RevenueProductWarrantyPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product warranty period (up to)</link:label>
    <link:label id="lab_iart_RevenueProductWarrantyPeriod_label_en-US" xlink:label="lab_iart_RevenueProductWarrantyPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Product Warranty Period</link:label>
    <link:label id="lab_iart_RevenueProductWarrantyPeriod_documentation_en-US" xlink:label="lab_iart_RevenueProductWarrantyPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Product Warranty Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_RevenueProductWarrantyPeriod" xlink:href="iart-20230331.xsd#iart_RevenueProductWarrantyPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_RevenueProductWarrantyPeriod" xlink:to="lab_iart_RevenueProductWarrantyPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_4f04f164-7385-4351-8394-e76b8177ea0a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Long-term Liabilities</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:to="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_InterestRateSwapDesignatedMarch312023Member_65a44a6d-1fc1-43e5-af58-a3ae6fd42135_terseLabel_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedMarch312023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated March 31, 2023</link:label>
    <link:label id="lab_iart_InterestRateSwapDesignatedMarch312023Member_label_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedMarch312023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated March 31, 2023 [Member]</link:label>
    <link:label id="lab_iart_InterestRateSwapDesignatedMarch312023Member_documentation_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedMarch312023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated March 31, 2023</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedMarch312023Member" xlink:href="iart-20230331.xsd#iart_InterestRateSwapDesignatedMarch312023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_InterestRateSwapDesignatedMarch312023Member" xlink:to="lab_iart_InterestRateSwapDesignatedMarch312023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_db5fd2c6-aa1a-4518-bfb0-05b22d8d5755_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Disposed of by Sale, Not Discontinued Operations</link:label>
    <link:label id="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_label_en-US" xlink:label="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:to="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_DirectorsandCertainExecutiveOfficersMember_db6c7891-9f65-4df3-ba0f-936c5dff25b9_terseLabel_en-US" xlink:label="lab_iart_DirectorsandCertainExecutiveOfficersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Directors and Certain Executive Officers</link:label>
    <link:label id="lab_iart_DirectorsandCertainExecutiveOfficersMember_label_en-US" xlink:label="lab_iart_DirectorsandCertainExecutiveOfficersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Directors and Certain Executive Officers [Member]</link:label>
    <link:label id="lab_iart_DirectorsandCertainExecutiveOfficersMember_documentation_en-US" xlink:label="lab_iart_DirectorsandCertainExecutiveOfficersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Directors and Certain Executive Officers [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DirectorsandCertainExecutiveOfficersMember" xlink:href="iart-20230331.xsd#iart_DirectorsandCertainExecutiveOfficersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_DirectorsandCertainExecutiveOfficersMember" xlink:to="lab_iart_DirectorsandCertainExecutiveOfficersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_96e03d26-aaa5-4a6d-80db-0924cdaf5fe6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) recorded, net investment hedge, change in fair value</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_63261d49-c2b2-4c9e-b1a1-24cf8ea5dacf_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value and Presentation of Derivatives</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7866ae2c-2ef1-4a92-80e5-e85f16b251b2_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_d7725dc7-405b-4f2b-bb42-0bc38a551cd5_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average period for cost recognition</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_302f35db-acdb-4725-b0a0-fd1bc2bfb937_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_3057fce4-08e6-41ea-bbbe-f5c68455ff0d_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to acquire businesses, gross</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_b12fdb59-5479-44dc-a731-ee1594d54e0c_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_812dee5d-ea37-48cc-b496-8538853f165c_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetInvestmentHedgingMember_897feae5-7c87-40d1-96ad-3fa5721247d5_terseLabel_en-US" xlink:label="lab_us-gaap_NetInvestmentHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Hedges</link:label>
    <link:label id="lab_us-gaap_NetInvestmentHedgingMember_label_en-US" xlink:label="lab_us-gaap_NetInvestmentHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetInvestmentHedgingMember" xlink:to="lab_us-gaap_NetInvestmentHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_1ac0449b-0a73-4efe-8fb3-5c03b5f2a5da_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_9af4e9d0-be33-47cb-9798-fdd8e61349b2_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories, net</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_0e816fd5-4109-432a-9d0a-58350bbcc194_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation</link:label>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:to="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_2b20bee6-8633-414f-92d2-ed1b502cbd5c_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Items</link:label>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_85e0fd70-bc1d-417e-ba6e-f9588fa02f42_verboseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember" xlink:to="lab_us-gaap_CustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_d57442fc-78f7-47d9-9b67-a650f8d7804a_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity City</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_57793c22-7e50-43dd-a187-2e4cda6de7ad_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RETIREMENT PLANS</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:to="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_0f4bde24-15d1-433c-8e51-893b8ed78888_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gains and Losses on Derivatives</link:label>
    <link:label id="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:to="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_f358fc96-c7bf-409b-878a-52e68937276b_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_ReturnPolicyIssueOfCreditNumberOfDaysFromShipment_566334d1-1a52-4aa1-bb90-e6c37fa9ce47_terseLabel_en-US" xlink:label="lab_iart_ReturnPolicyIssueOfCreditNumberOfDaysFromShipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of days from shipment to issue a credit</link:label>
    <link:label id="lab_iart_ReturnPolicyIssueOfCreditNumberOfDaysFromShipment_label_en-US" xlink:label="lab_iart_ReturnPolicyIssueOfCreditNumberOfDaysFromShipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Return Policy, Issue Of Credit, Number Of Days From Shipment</link:label>
    <link:label id="lab_iart_ReturnPolicyIssueOfCreditNumberOfDaysFromShipment_documentation_en-US" xlink:label="lab_iart_ReturnPolicyIssueOfCreditNumberOfDaysFromShipment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Return Policy, Issue of Credit, Number of Days from Shipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ReturnPolicyIssueOfCreditNumberOfDaysFromShipment" xlink:href="iart-20230331.xsd#iart_ReturnPolicyIssueOfCreditNumberOfDaysFromShipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_ReturnPolicyIssueOfCreditNumberOfDaysFromShipment" xlink:to="lab_iart_ReturnPolicyIssueOfCreditNumberOfDaysFromShipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockTextBlock_686a2384-b322-4b15-86f1-c40f1595d599_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TREASURY STOCK</link:label>
    <link:label id="lab_us-gaap_TreasuryStockTextBlock_label_en-US" xlink:label="lab_us-gaap_TreasuryStockTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockTextBlock" xlink:to="lab_us-gaap_TreasuryStockTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_efe1c5d5-829c-4aae-abed-e8df526aec95_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1_2387608f-82e2-49aa-9858-686533593fc0_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial conversion rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Conversion Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:to="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_DiscontinuedOperationContinuingInvolvementPrepaidAssetsCurrent_d32cdd9a-beba-4adb-880b-6b1299d1915b_terseLabel_en-US" xlink:label="lab_iart_DiscontinuedOperationContinuingInvolvementPrepaidAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory purchase, prepaid expenses and other current assets</link:label>
    <link:label id="lab_iart_DiscontinuedOperationContinuingInvolvementPrepaidAssetsCurrent_label_en-US" xlink:label="lab_iart_DiscontinuedOperationContinuingInvolvementPrepaidAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operation, Continuing Involvement, Prepaid Assets , Current</link:label>
    <link:label id="lab_iart_DiscontinuedOperationContinuingInvolvementPrepaidAssetsCurrent_documentation_en-US" xlink:label="lab_iart_DiscontinuedOperationContinuingInvolvementPrepaidAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operation, Continuing Involvement, Prepaid Expenses, Current Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DiscontinuedOperationContinuingInvolvementPrepaidAssetsCurrent" xlink:href="iart-20230331.xsd#iart_DiscontinuedOperationContinuingInvolvementPrepaidAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_DiscontinuedOperationContinuingInvolvementPrepaidAssetsCurrent" xlink:to="lab_iart_DiscontinuedOperationContinuingInvolvementPrepaidAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_6456da5f-32be-43f5-a4b5-a5fe638356cd_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_4000bb25-2abc-4e2e-8ca9-97eab27521f8_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_be076f4f-b944-4a2c-851c-4831d8fe2240_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSecuredDebt_ec44a991-4eda-4f22-9069-15004e212935_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSecuredDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from borrowings of long-term indebtedness</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSecuredDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSecuredDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Secured Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSecuredDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSecuredDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSecuredDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfSecuredDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNet_121fd5b7-d377-4784-abb7-86b20658c964_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt issuance costs capitalized</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNet_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsNet" xlink:to="lab_us-gaap_DeferredFinanceCostsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_a11d1b5b-1de3-4f72-ae97-08c0a5318c30_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f22cf09a-f9a1-4422-a240-12ad46b62ce2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_1914ee39-7126-4140-9408-5fea302dc1d9_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_9ce24219-c16c-4763-8202-c4e85515990d_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesMember_4086218e-820d-4e57-a1b5-9430012ef6c0_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesMember" xlink:to="lab_us-gaap_OtherLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_e41469ee-76e7-4285-b415-8a31a5c48d5d_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, average cost per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_label_en-US" xlink:label="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock Acquired, Average Cost Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:to="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_99ee4b2e-8242-40db-ab91-b6773b653c16_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Common, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonShares" xlink:to="lab_us-gaap_TreasuryStockCommonShares" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_MilestonePaymentOneMember_4dff29e4-a771-4f3c-b528-5f2d41031339_terseLabel_en-US" xlink:label="lab_iart_MilestonePaymentOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Development Milestones</link:label>
    <link:label id="lab_iart_MilestonePaymentOneMember_label_en-US" xlink:label="lab_iart_MilestonePaymentOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone Payment One [Member]</link:label>
    <link:label id="lab_iart_MilestonePaymentOneMember_documentation_en-US" xlink:label="lab_iart_MilestonePaymentOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone Payment One [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_MilestonePaymentOneMember" xlink:href="iart-20230331.xsd#iart_MilestonePaymentOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_MilestonePaymentOneMember" xlink:to="lab_iart_MilestonePaymentOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableTradeCurrent_a998f3f0-2268-4420-9f68-8aa2502b5371_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableTradeCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable, trade</link:label>
    <link:label id="lab_us-gaap_AccountsPayableTradeCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableTradeCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Trade, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableTradeCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableTradeCurrent" xlink:to="lab_us-gaap_AccountsPayableTradeCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_b8efb534-e47e-4bae-82f3-abd1322cfbb3_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_64a4f55d-e5c1-4a57-8b6c-c24ce65d173f_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected annual amortization expense, in 2026</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent_98c8aab3-9596-46db-b839-c6d70147b331_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term portion of contract liability</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_BusinessCombinationContingentConsiderationNumberOfLiabilities_916bed1c-b342-4214-b8a0-732796949ac4_terseLabel_en-US" xlink:label="lab_iart_BusinessCombinationContingentConsiderationNumberOfLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of contingent liabilities remaining</link:label>
    <link:label id="lab_iart_BusinessCombinationContingentConsiderationNumberOfLiabilities_label_en-US" xlink:label="lab_iart_BusinessCombinationContingentConsiderationNumberOfLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Number Of Liabilities</link:label>
    <link:label id="lab_iart_BusinessCombinationContingentConsiderationNumberOfLiabilities_documentation_en-US" xlink:label="lab_iart_BusinessCombinationContingentConsiderationNumberOfLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Number Of Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_BusinessCombinationContingentConsiderationNumberOfLiabilities" xlink:href="iart-20230331.xsd#iart_BusinessCombinationContingentConsiderationNumberOfLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_BusinessCombinationContingentConsiderationNumberOfLiabilities" xlink:to="lab_iart_BusinessCombinationContingentConsiderationNumberOfLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_5d9dcff4-85c8-45b9-8df7-b1d4f7d6eab9_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value by Liability Class [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value by Liability Class [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_a1ba405c-5d4f-4c23-a51f-3f1ab29f08c2_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis" xlink:to="lab_us-gaap_DisposalGroupClassificationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_SecuredLongTermDebtSecuritizationProgramNoncurrent_c5801af0-db1d-44af-a796-4926e4d7200d_terseLabel_en-US" xlink:label="lab_iart_SecuredLongTermDebtSecuritizationProgramNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term borrowings under securitization facility</link:label>
    <link:label id="lab_iart_SecuredLongTermDebtSecuritizationProgramNoncurrent_label_en-US" xlink:label="lab_iart_SecuredLongTermDebtSecuritizationProgramNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Long-Term Debt, Securitization Program, Noncurrent</link:label>
    <link:label id="lab_iart_SecuredLongTermDebtSecuritizationProgramNoncurrent_documentation_en-US" xlink:label="lab_iart_SecuredLongTermDebtSecuritizationProgramNoncurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Long-Term Debt, Securitization Program, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SecuredLongTermDebtSecuritizationProgramNoncurrent" xlink:href="iart-20230331.xsd#iart_SecuredLongTermDebtSecuritizationProgramNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_SecuredLongTermDebtSecuritizationProgramNoncurrent" xlink:to="lab_iart_SecuredLongTermDebtSecuritizationProgramNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualAxis_bde01fb3-8a05-42dc-a946-89b6a4519b1e_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:label id="lab_srt_TitleOfIndividualAxis_label_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualAxis" xlink:to="lab_srt_TitleOfIndividualAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_d807bf1c-379d-45e1-9b95-c0080dd54f64_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards granted during the period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_fffa4145-6419-4e98-9673-eea2d4faeab5_verboseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reported tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_09826958-d4b9-4579-a99c-d07b36c4e489_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective income tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_c8395ec3-4c85-46b9-ab60-b1b78a7687a4_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities assumed</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_a1d87c22-95ca-44e8-a9cf-26b0bb143703_periodStartLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, Beginning of Period</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_eb11ae55-a30c-4dd8-b1e9-a58fa4582e0c_periodEndLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, End of Period</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_d6bdcf38-77bf-4769-8508-8c079f9b1e0b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_1560e803-bf8f-4f8d-872a-32036ddd23b0_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable, accrued expenses and other current liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_2509555e-5da0-4452-91a8-c213c821770c_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INCOME TAXES</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtWeightedAverageInterestRate_a81f431d-b693-490f-86e6-f60a9abd12c5_terseLabel_en-US" xlink:label="lab_us-gaap_DebtWeightedAverageInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average interest rate on debt</link:label>
    <link:label id="lab_us-gaap_DebtWeightedAverageInterestRate_label_en-US" xlink:label="lab_us-gaap_DebtWeightedAverageInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Weighted Average Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtWeightedAverageInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtWeightedAverageInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtWeightedAverageInterestRate" xlink:to="lab_us-gaap_DebtWeightedAverageInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuredLongTermDebt_527493f7-6e8b-4d7f-87f6-817fcc8d89f0_terseLabel_en-US" xlink:label="lab_us-gaap_SecuredLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term borrowings under senior credit facility</link:label>
    <link:label id="lab_us-gaap_SecuredLongTermDebt_label_en-US" xlink:label="lab_us-gaap_SecuredLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Long-Term Debt, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuredLongTermDebt" xlink:to="lab_us-gaap_SecuredLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_312164af-b91e-4a1b-ba08-d4ea7f16b4e3_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finished goods</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:to="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_fbd0a8db-c920-4001-a39e-a1328c55bf6a_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_46005b00-2ced-4976-9482-bfc7ef973a1b_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible asset amortization</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_0a4ea00c-9871-426d-9722-a9fda20305de_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_3cc37af6-b7e7-41e7-a3a2-0f5827448848_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrant strike price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right, Exercise Price of Warrants or Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_InterestPaymentsYearThree_6520d2be-ed28-4d3c-a722-8327ecc55b4f_terseLabel_en-US" xlink:label="lab_iart_InterestPaymentsYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest payments, year three</link:label>
    <link:label id="lab_iart_InterestPaymentsYearThree_label_en-US" xlink:label="lab_iart_InterestPaymentsYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Payments, Year Three</link:label>
    <link:label id="lab_iart_InterestPaymentsYearThree_documentation_en-US" xlink:label="lab_iart_InterestPaymentsYearThree" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Payments, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestPaymentsYearThree" xlink:href="iart-20230331.xsd#iart_InterestPaymentsYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_InterestPaymentsYearThree" xlink:to="lab_iart_InterestPaymentsYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_c741bea0-c6dd-4599-9ee0-833dcfa5ba77_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Changes in Carrying Amount of Goodwill</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage_be8bcca4-9628-4018-b8d3-f716ce28717d_terseLabel_en-US" xlink:label="lab_iart_DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defer payment and taxation, base salary, percentage (up to)</link:label>
    <link:label id="lab_iart_DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage_label_en-US" xlink:label="lab_iart_DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Defer Payment And Taxation, Base Salary, Percentage</link:label>
    <link:label id="lab_iart_DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage_documentation_en-US" xlink:label="lab_iart_DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Defer Payment And Taxation, Base Salary, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage" xlink:href="iart-20230331.xsd#iart_DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage" xlink:to="lab_iart_DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_a1cefc4c-f82c-4068-a073-af3646aa9cd3_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_2b1dd4cd-517e-46ef-968a-6bb27fd6fa25_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic net income per common share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_NeurosurgeryMember_717a62c9-bf85-4164-84cd-902735d6530e_terseLabel_en-US" xlink:label="lab_iart_NeurosurgeryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Neurosurgery</link:label>
    <link:label id="lab_iart_NeurosurgeryMember_label_en-US" xlink:label="lab_iart_NeurosurgeryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Neurosurgery [Member]</link:label>
    <link:label id="lab_iart_NeurosurgeryMember_documentation_en-US" xlink:label="lab_iart_NeurosurgeryMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Neurosurgery [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_NeurosurgeryMember" xlink:href="iart-20230331.xsd#iart_NeurosurgeryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_NeurosurgeryMember" xlink:to="lab_iart_NeurosurgeryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_d04d9700-401d-40d2-a9ed-d9611086e07b_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_2f29657e-dd83-43d2-b748-d338a3419405_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requisite service periods of awards</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Requisite Service Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsMember_628fa1cb-83e0-4b78-ad1e-6fd2c307f151_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsMember" xlink:to="lab_us-gaap_OtherAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_071d5aba-45d8-4460-8cbd-b4cd61fddca0_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate and other</link:label>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_label_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate, Non-Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateNonSegmentMember" xlink:to="lab_us-gaap_CorporateNonSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_6906fc8d-3058-4d5b-b53c-4ac2091a4134_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Pension Items</link:label>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_32f26efe-425a-4b01-91f1-9d777b679fb0_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and accrued expenses</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_c7806262-2de5-4484-ac42-ab0b333b71b4_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockMember_25d1e15c-2626-4f19-8e3e-a61b8b9b6887_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockMember" xlink:to="lab_us-gaap_TreasuryStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_dbf01e1c-5638-458d-9765-014cdc1a92fd_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_62ac8e06-e15a-44b7-a911-30d5408e7e68_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_8d8576b9-e1e2-4860-8bd7-c1c5ce30a1d1_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, beginning of period</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_ffd39e35-70dd-4887-a916-7d8c8e80ae36_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, end of period</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_848f49b0-6465-41ee-80dd-88e08955f322_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DERIVATIVE INSTRUMENTS</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_DirectorMember_af4752fc-fec9-466c-b3e6-688abc8c2fca_terseLabel_en-US" xlink:label="lab_srt_DirectorMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Directors</link:label>
    <link:label id="lab_srt_DirectorMember_label_en-US" xlink:label="lab_srt_DirectorMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Director [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_DirectorMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_DirectorMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_DirectorMember" xlink:to="lab_srt_DirectorMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseContractualTermAxis_22797cf1-c68b-46e0-b345-5dff25cd8f77_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseContractualTermAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Contractual Term [Axis]</link:label>
    <link:label id="lab_us-gaap_LeaseContractualTermAxis_label_en-US" xlink:label="lab_us-gaap_LeaseContractualTermAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Contractual Term [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseContractualTermAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseContractualTermAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseContractualTermAxis" xlink:to="lab_us-gaap_LeaseContractualTermAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_AcceleratedShareRepurchasesAdditionalSharesReceived_e61e2a6c-405b-448d-be17-3c1d69281d31_terseLabel_en-US" xlink:label="lab_iart_AcceleratedShareRepurchasesAdditionalSharesReceived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated share repurchases, additional shares received</link:label>
    <link:label id="lab_iart_AcceleratedShareRepurchasesAdditionalSharesReceived_label_en-US" xlink:label="lab_iart_AcceleratedShareRepurchasesAdditionalSharesReceived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases, Additional Shares Received</link:label>
    <link:label id="lab_iart_AcceleratedShareRepurchasesAdditionalSharesReceived_documentation_en-US" xlink:label="lab_iart_AcceleratedShareRepurchasesAdditionalSharesReceived" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases, Additional Shares Received</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AcceleratedShareRepurchasesAdditionalSharesReceived" xlink:href="iart-20230331.xsd#iart_AcceleratedShareRepurchasesAdditionalSharesReceived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_AcceleratedShareRepurchasesAdditionalSharesReceived" xlink:to="lab_iart_AcceleratedShareRepurchasesAdditionalSharesReceived" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract_9d597f2c-85b7-4a03-8714-f7a0a2c3d9eb_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_1394b083-3b63-4aaf-a2e2-c583992ae4c8_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_b20edfd6-dccc-4379-8395-a3bbee5b1c78_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_SupplierRelationShipsMember_71924ec6-ca7a-440c-8d0e-6521bffffc6d_terseLabel_en-US" xlink:label="lab_iart_SupplierRelationShipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplier relationships</link:label>
    <link:label id="lab_iart_SupplierRelationShipsMember_label_en-US" xlink:label="lab_iart_SupplierRelationShipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplier Relation Ships [Member]</link:label>
    <link:label id="lab_iart_SupplierRelationShipsMember_documentation_en-US" xlink:label="lab_iart_SupplierRelationShipsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplier Relation Ships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SupplierRelationShipsMember" xlink:href="iart-20230331.xsd#iart_SupplierRelationShipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_SupplierRelationShipsMember" xlink:to="lab_iart_SupplierRelationShipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_d8fb5ff1-7ac8-4e9f-901c-661cf7bf63de_negatedLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_3c658378-f1e8-4d1d-91ef-aa09ece23e79_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expenses and Other Current Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:to="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_bfcced09-9805-483d-8fb2-869fd41f7612_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected annual amortization expense, in 2025</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_0a239d32-aacf-4c16-9d9c-a08f79a1b678_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Contingent Consideration</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_95c57f5f-93fb-466a-a89d-f2d3fd810872_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_a1340a14-661f-46cc-b290-363221453e3a_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_6173ade0-b0c1-484a-85dc-9229e302d994_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_8140ab8a-6424-4210-9262-f7f029babe76_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_6db0171c-b748-4397-9eec-810bcca9331f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss), net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_f28c9702-4047-48a9-8116-dceab390d4db_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net current-period other comprehensive gain (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_502cfe3d-11a8-445f-862e-ea3c1b516fff_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock for vesting of share based awards, net of shares withheld for taxes</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_32313d76-2960-4e60-982c-583f23de70fc_terseLabel_en-US" xlink:label="lab_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive gain (loss)</link:label>
    <link:label id="lab_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, before Reclassifications, Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent" xlink:to="lab_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_d16156bf-2311-4d27-9317-a96c0cce8f91_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reportable segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_DiscontinuedOperationContinuingInvolvementPrepaidAsset_f03aef5b-6624-496f-a36d-f94ecf34c0d9_terseLabel_en-US" xlink:label="lab_iart_DiscontinuedOperationContinuingInvolvementPrepaidAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued operation, continuing involvement, prepaid asset</link:label>
    <link:label id="lab_iart_DiscontinuedOperationContinuingInvolvementPrepaidAsset_label_en-US" xlink:label="lab_iart_DiscontinuedOperationContinuingInvolvementPrepaidAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operation, Continuing Involvement, Prepaid Asset</link:label>
    <link:label id="lab_iart_DiscontinuedOperationContinuingInvolvementPrepaidAsset_documentation_en-US" xlink:label="lab_iart_DiscontinuedOperationContinuingInvolvementPrepaidAsset" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operation, Continuing Involvement, Prepaid Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DiscontinuedOperationContinuingInvolvementPrepaidAsset" xlink:href="iart-20230331.xsd#iart_DiscontinuedOperationContinuingInvolvementPrepaidAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_DiscontinuedOperationContinuingInvolvementPrepaidAsset" xlink:to="lab_iart_DiscontinuedOperationContinuingInvolvementPrepaidAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_620dae4d-2926-45ba-87d2-f3e1746b9e2b_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of treasury stock</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_86349747-05fa-496a-a5da-1d1a0b457755_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration, estimated fair value</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_RegenerativeSkinAndWoundMember_21962ffb-e02e-4001-a6a3-0ee424c2bdc5_terseLabel_en-US" xlink:label="lab_iart_RegenerativeSkinAndWoundMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Wound Reconstruction and Care</link:label>
    <link:label id="lab_iart_RegenerativeSkinAndWoundMember_label_en-US" xlink:label="lab_iart_RegenerativeSkinAndWoundMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Regenerative Skin And Wound [Member]</link:label>
    <link:label id="lab_iart_RegenerativeSkinAndWoundMember_documentation_en-US" xlink:label="lab_iart_RegenerativeSkinAndWoundMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Regenerative Skin And Wound [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_RegenerativeSkinAndWoundMember" xlink:href="iart-20230331.xsd#iart_RegenerativeSkinAndWoundMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_RegenerativeSkinAndWoundMember" xlink:to="lab_iart_RegenerativeSkinAndWoundMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_4c473a81-289e-4031-9316-a0f8ef5bf4aa_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_e8776b83-ce67-4cca-ad91-8d9bd6d95e3c_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option to extend lease, years</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Renewal Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:to="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_b355779e-b8b4-440c-a7f1-c4c179dd8a0d_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_3f525402-5db7-4c23-af99-3bae98aa1254_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnDerivativeInstrumentsNetPretax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) reclassified into other income</link:label>
    <link:label id="lab_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_label_en-US" xlink:label="lab_us-gaap_GainLossOnDerivativeInstrumentsNetPretax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Derivative Instruments, Net, Pretax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnDerivativeInstrumentsNetPretax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax" xlink:to="lab_us-gaap_GainLossOnDerivativeInstrumentsNetPretax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract_b864aaa3-ce03-4c13-ae70-09ddf1c2c8dc_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_a14e17a6-a032-4bd1-8646-58119c021c04_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_9dd46a1f-ffc0-45d8-a56e-9bf4df25ece3_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease liability - operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_36179b97-96ec-4a97-afc6-09d6777ce1f3_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_0d9ee31c-ae1c-4c2c-9086-9f1f21b50468_netLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_9ec13c78-1e84-49bd-bf00-499455497c40_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension liability adjustment, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt_c8099ab1-815e-43e0-bf35-d6dadfb978e3_terseLabel_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated share repurchase program, receipt (payment)</link:label>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt_label_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases, Settlement (Payment) or Receipt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt" xlink:to="lab_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_CrossCurrencyInterestRateContractOneMember_4a88566e-a294-48d9-bbd0-06c33ef029e1_terseLabel_en-US" xlink:label="lab_iart_CrossCurrencyInterestRateContractOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross Currency Interest Rate Swap One</link:label>
    <link:label id="lab_iart_CrossCurrencyInterestRateContractOneMember_label_en-US" xlink:label="lab_iart_CrossCurrencyInterestRateContractOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross Currency Interest Rate Contract One [Member]</link:label>
    <link:label id="lab_iart_CrossCurrencyInterestRateContractOneMember_documentation_en-US" xlink:label="lab_iart_CrossCurrencyInterestRateContractOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross Currency Interest Rate Contract One [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CrossCurrencyInterestRateContractOneMember" xlink:href="iart-20230331.xsd#iart_CrossCurrencyInterestRateContractOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_CrossCurrencyInterestRateContractOneMember" xlink:to="lab_iart_CrossCurrencyInterestRateContractOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_08bca847-7743-4453-a48a-1a6c170f6d62_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_1d0a4208-fc85-4cf2-ad9c-d30c102cabc9_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for contingent consideration</link:label>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for Contingent Consideration Liability, Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:to="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_d6ac11b5-4ebc-48ad-ab97-c391a54774bb_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cb1e0603-c5ac-4ca1-bcce-b963f141525c_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_37fb8fff-a987-496e-825d-a50da0dbb404_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade accounts receivable, net of allowances of $3,544 and $4,304</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_f5ca1914-671a-47ca-9c28-5ead227d7afc_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_RelatedPartiesMember_23312df7-862c-40af-a6c1-fa26a7aefc38_terseLabel_en-US" xlink:label="lab_iart_RelatedPartiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Parties</link:label>
    <link:label id="lab_iart_RelatedPartiesMember_label_en-US" xlink:label="lab_iart_RelatedPartiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Parties [Member]</link:label>
    <link:label id="lab_iart_RelatedPartiesMember_documentation_en-US" xlink:label="lab_iart_RelatedPartiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Parties [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_RelatedPartiesMember" xlink:href="iart-20230331.xsd#iart_RelatedPartiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_RelatedPartiesMember" xlink:to="lab_iart_RelatedPartiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_46c14735-f326-4fc6-966b-f5a972388119_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_22d77943-2f28-44ed-9145-c3542705cbde_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OPERATING ACTIVITIES:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_ca0fc586-4978-47f8-b15c-b938dfb805d2_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_785e7d01-c8d0-4ab1-9632-e99f9306a471_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of business, disposition price</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Consideration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_InterestPaymentsAfterYearThree_db7cfdb1-038b-482f-bc71-dbb5af794625_terseLabel_en-US" xlink:label="lab_iart_InterestPaymentsAfterYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest payments, after year three</link:label>
    <link:label id="lab_iart_InterestPaymentsAfterYearThree_label_en-US" xlink:label="lab_iart_InterestPaymentsAfterYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Payments, After Year Three</link:label>
    <link:label id="lab_iart_InterestPaymentsAfterYearThree_documentation_en-US" xlink:label="lab_iart_InterestPaymentsAfterYearThree" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Payments, After Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestPaymentsAfterYearThree" xlink:href="iart-20230331.xsd#iart_InterestPaymentsAfterYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_InterestPaymentsAfterYearThree" xlink:to="lab_iart_InterestPaymentsAfterYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_0245890d-4618-415f-a125-92a9dba7b795_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration, current</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_d1c92f22-ab34-4306-a232-d0b3a9d52a11_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_683064b8-c9d5-4858-afe1-fb75beda4ecb_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_48db4e1c-f325-4cc7-bbe3-1399f9fc66a9_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_739a7b32-563f-4b93-9f6d-7878d467bda4_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesTable_2d38099f-a700-405a-a44d-4f0027d26322_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable" xlink:to="lab_us-gaap_LossContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_68400759-cd49-4931-9910-1b69e47f21b2_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in fair value of contingent consideration and others</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_ChangeInContractWithCustomerAssetRollForward_730d0de9-b603-44c2-810d-f840aada1f27_terseLabel_en-US" xlink:label="lab_iart_ChangeInContractWithCustomerAssetRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract Asset</link:label>
    <link:label id="lab_iart_ChangeInContractWithCustomerAssetRollForward_label_en-US" xlink:label="lab_iart_ChangeInContractWithCustomerAssetRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change In Contract With Customer, Asset [Roll Forward]</link:label>
    <link:label id="lab_iart_ChangeInContractWithCustomerAssetRollForward_documentation_en-US" xlink:label="lab_iart_ChangeInContractWithCustomerAssetRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change In Contract With Customer, Asset [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ChangeInContractWithCustomerAssetRollForward" xlink:href="iart-20230331.xsd#iart_ChangeInContractWithCustomerAssetRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_ChangeInContractWithCustomerAssetRollForward" xlink:to="lab_iart_ChangeInContractWithCustomerAssetRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_09788a07-800f-41a0-be8d-058f46e3239e_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right of use asset - operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_f924d6f8-3861-44b1-9753-a97dbd06c4c2_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ROU assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_fafd8fa2-b8d9-4711-8a44-73cd0cf53815_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated shares repurchased</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodValue" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_cf376f2f-326a-4216-af08-31dcd68a5432_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_3ba15d55-74e9-437f-a803-8c1778ae9d0d_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_067a148d-fea8-4b6d-bc49-be192f76b2eb_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss) Note [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_ExciseTaxPayableOnShareRepurchases_780b0398-8b4f-4b0f-98c9-539f1928e269_terseLabel_en-US" xlink:label="lab_iart_ExciseTaxPayableOnShareRepurchases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share repurchases, accrued excise tax</link:label>
    <link:label id="lab_iart_ExciseTaxPayableOnShareRepurchases_label_en-US" xlink:label="lab_iart_ExciseTaxPayableOnShareRepurchases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Excise Tax Payable On Share Repurchases</link:label>
    <link:label id="lab_iart_ExciseTaxPayableOnShareRepurchases_documentation_en-US" xlink:label="lab_iart_ExciseTaxPayableOnShareRepurchases" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Excise Tax Payable On Share Repurchases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ExciseTaxPayableOnShareRepurchases" xlink:href="iart-20230331.xsd#iart_ExciseTaxPayableOnShareRepurchases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_ExciseTaxPayableOnShareRepurchases" xlink:to="lab_iart_ExciseTaxPayableOnShareRepurchases" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseExpense_d6fa62b0-0ff2-4c13-81c6-0b7b3b43b39d_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease expense</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseExpense_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseExpense" xlink:to="lab_us-gaap_OperatingLeaseExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_MilestonePaymentTwoMember_03dc5223-6f9b-46fe-98c7-8d935048b5ea_terseLabel_en-US" xlink:label="lab_iart_MilestonePaymentTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Sales Milestones</link:label>
    <link:label id="lab_iart_MilestonePaymentTwoMember_label_en-US" xlink:label="lab_iart_MilestonePaymentTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone Payment Two [Member]</link:label>
    <link:label id="lab_iart_MilestonePaymentTwoMember_documentation_en-US" xlink:label="lab_iart_MilestonePaymentTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone Payment Two [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_MilestonePaymentTwoMember" xlink:href="iart-20230331.xsd#iart_MilestonePaymentTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_MilestonePaymentTwoMember" xlink:to="lab_iart_MilestonePaymentTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_ecb390f6-e7ae-4bcf-8d3e-d64eb97cdaae_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_e01b5bf6-dd62-4497-93a0-9c71c9edba41_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_c6eb8dba-8c2c-4cc5-b190-244f24db10bc_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_f3608c55-2aa8-41da-baf8-6113227d5aa9_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_121a9998-b7c6-4960-a1d0-42c79eef6874_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_ContractWithCustomerAssetNetOfReclassifiedToReceivable_be5961fc-2929-4c42-b422-4796328c3fec_terseLabel_en-US" xlink:label="lab_iart_ContractWithCustomerAssetNetOfReclassifiedToReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract asset, net of transferred to trade receivables on contracts during the period</link:label>
    <link:label id="lab_iart_ContractWithCustomerAssetNetOfReclassifiedToReceivable_label_en-US" xlink:label="lab_iart_ContractWithCustomerAssetNetOfReclassifiedToReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Asset, Net Of Reclassified To Receivable</link:label>
    <link:label id="lab_iart_ContractWithCustomerAssetNetOfReclassifiedToReceivable_documentation_en-US" xlink:label="lab_iart_ContractWithCustomerAssetNetOfReclassifiedToReceivable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Asset, Net Of Reclassified To Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ContractWithCustomerAssetNetOfReclassifiedToReceivable" xlink:href="iart-20230331.xsd#iart_ContractWithCustomerAssetNetOfReclassifiedToReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_ContractWithCustomerAssetNetOfReclassifiedToReceivable" xlink:to="lab_iart_ContractWithCustomerAssetNetOfReclassifiedToReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeNet_8fa5f8b7-ac30-423f-aa16-1e8e5828d6bd_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Fair Value</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeNet_299552c6-8978-44db-83f5-1ab913faf03f_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Asset (Liability)</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeNet_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Fair Value, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeNet" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_75a4bead-f65a-47a0-ab01-59f111be4b84_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recent Accounting Pronouncements</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_cf6e4ab0-49af-479a-9895-2037c8fce949_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PositionDomain_0f37efbf-a094-4081-8ef1-e16a5ca98f62_terseLabel_en-US" xlink:label="lab_us-gaap_PositionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Position [Domain]</link:label>
    <link:label id="lab_us-gaap_PositionDomain_label_en-US" xlink:label="lab_us-gaap_PositionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Position [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PositionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PositionDomain" xlink:to="lab_us-gaap_PositionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_AnnualRateOfLeaseAgreement_33b84664-ff54-4559-bf76-20f7fcb6f9db_terseLabel_en-US" xlink:label="lab_iart_AnnualRateOfLeaseAgreement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annual rate of lease agreement</link:label>
    <link:label id="lab_iart_AnnualRateOfLeaseAgreement_label_en-US" xlink:label="lab_iart_AnnualRateOfLeaseAgreement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annual Rate Of Lease Agreement</link:label>
    <link:label id="lab_iart_AnnualRateOfLeaseAgreement_documentation_en-US" xlink:label="lab_iart_AnnualRateOfLeaseAgreement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annual rate of lease agreement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AnnualRateOfLeaseAgreement" xlink:href="iart-20230331.xsd#iart_AnnualRateOfLeaseAgreement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_AnnualRateOfLeaseAgreement" xlink:to="lab_iart_AnnualRateOfLeaseAgreement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_2421028d-72fa-4496-a5f3-a86f1afcd95f_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_d2a09712-511d-419a-bf7c-5e5ae5f76cd8_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning of Period</link:label>
    <link:label id="lab_us-gaap_Goodwill_95828e76-7114-4376-a678-fcdb424b343f_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">End of Period</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesMember_a816dac1-a440-4d8b-9a55-e201452a4f7b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities</link:label>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCurrentLiabilitiesMember" xlink:to="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockShares_e22c7690-a019-4de0-bcc8-cd4330a5811b_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, shares (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_3f625c04-8dd7-4b74-a514-7816a19bc8d5_negatedPeriodStartLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, beginning of period, treasury stock, shares (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_fa785517-5549-401e-8cbd-e277c4040b43_negatedPeriodEndLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, end of period, treasury stock, shares (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockShares" xlink:to="lab_us-gaap_TreasuryStockShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_d8dfeaaa-df43-4a57-a42d-a8231ff20301_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_6b869caf-0d66-431f-83fa-cc260da84a1c_negatedLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated shares repurchased (shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_4ba9aba4-5ef1-47de-9ca7-fb5e76c3d338_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2ff1a1ff-0157-494d-bc62-369405dc37ca_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net income to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_c3933797-b06b-4cfd-8467-3d07a9a62c4b_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GOODWILL AND OTHER INTANGIBLE ASSETS</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_4dec4132-f3eb-4303-918f-c56fe9dbc3ea_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_dc40430c-6bbb-460a-bc1f-b78931a019e7_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_0edd2689-200b-4b6e-b43a-7c5defca9395_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_cc316d3f-6360-42a0-b8d9-0bd31f660b3a_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0909dfd9-1e7c-430c-8558-106132a33ed5_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_51639b18-1c42-4cb7-8529-041a9d615ee1_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_2703c31a-68d1-40d5-b6e0-1f7dd8ea3d5f_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_6a57b5de-2770-4f6f-b91a-8237da4e306f_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-In Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_23dc8eea-61a6-4588-81de-8b902db9e314_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_0f0f92c7-5e24-44b4-8234-3fa71df8fc5b_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_ab2b83a5-2d29-492d-9149-41453b0916cc_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic net income per share:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_554a0ae9-5f05-409a-88ec-0c04dea4d36b_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of goods sold</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLineItems_1c86eecf-10d3-46e3-b2d4-68fd52e322ee_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLineItems" xlink:to="lab_us-gaap_DerivativeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_20752734-e8b6-43bb-b6ff-b8022e10fcaf_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_ce5e1f90-db34-4545-88fa-db6b470ad771_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average common shares for diluted earnings per share (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_7217c3ac-ff68-4dee-8232-aab40c9f7309_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventories, Net</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_cbfc17db-7ef0-45c5-a7ef-86ea6b0802f9_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total derivatives designated as hedges &#8212; Liabilities</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Subject to Master Netting Arrangement, before Offset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_ef2a99bc-dd8c-4a8c-972b-6ed36ed12af6_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems" xlink:to="lab_us-gaap_LossContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebtNoncurrent_3704ddad-9c72-4d6f-b28b-fa2bdfbb503b_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term convertible securities</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtNoncurrent" xlink:to="lab_us-gaap_ConvertibleDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsGross_26f03230-6ced-4db9-9957-278bef21dd0a_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental financing costs capitalized</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsGross_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsGross" xlink:to="lab_us-gaap_DeferredFinanceCostsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_fc06f256-44b6-4034-9024-3b89bde33680_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock; $0.01 par value; 240,000 authorized shares; 90,813 and 90,477 issued at March&#160;31, 2023 and December&#160;31, 2022, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_7c0a8d0e-6f45-4130-8250-758b0694dfd3_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_43c4a33b-70f9-4aea-94f7-30bdd7443a4c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_1ec60bc5-5734-47bb-b207-1d893d98a423_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_InterestRateSwapDesignatedDecember132017Tranche2Member_9fb2f445-b1db-4e82-aa17-4d819bce73c1_terseLabel_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedDecember132017Tranche2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated December 13, 2017 Tranche 2</link:label>
    <link:label id="lab_iart_InterestRateSwapDesignatedDecember132017Tranche2Member_label_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedDecember132017Tranche2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated December 13, 2017 Tranche 2 [Member]</link:label>
    <link:label id="lab_iart_InterestRateSwapDesignatedDecember132017Tranche2Member_documentation_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedDecember132017Tranche2Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated December 13, 2017 Tranche 2</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedDecember132017Tranche2Member" xlink:href="iart-20230331.xsd#iart_InterestRateSwapDesignatedDecember132017Tranche2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_InterestRateSwapDesignatedDecember132017Tranche2Member" xlink:to="lab_iart_InterestRateSwapDesignatedDecember132017Tranche2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_SwinglineLoanMember_091094b6-1718-447e-8e33-3773a95f4307_terseLabel_en-US" xlink:label="lab_iart_SwinglineLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Swingline Loans</link:label>
    <link:label id="lab_iart_SwinglineLoanMember_label_en-US" xlink:label="lab_iart_SwinglineLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Swingline Loan [Member]</link:label>
    <link:label id="lab_iart_SwinglineLoanMember_documentation_en-US" xlink:label="lab_iart_SwinglineLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Swingline Loan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SwinglineLoanMember" xlink:href="iart-20230331.xsd#iart_SwinglineLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_SwinglineLoanMember" xlink:to="lab_iart_SwinglineLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_bc884241-5de0-4906-af30-91a39e02da3c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other than options, weighted average grant date fair value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_AsiaPacificMember_163f5239-3e9c-4dac-95be-e50b1ca58e98_terseLabel_en-US" xlink:label="lab_srt_AsiaPacificMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asia Pacific</link:label>
    <link:label id="lab_srt_AsiaPacificMember_label_en-US" xlink:label="lab_srt_AsiaPacificMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asia Pacific [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AsiaPacificMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_AsiaPacificMember" xlink:to="lab_srt_AsiaPacificMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1_990361ad-9774-4b2f-b1d9-70cb3ff31b95_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial conversion price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Conversion Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:to="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_9c537b7b-18d7-4ef5-a7cd-c24d29c05451_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments</link:label>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_label_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingSegmentsMember" xlink:to="lab_us-gaap_OperatingSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebtMember_06dffec8-c9fc-4ce0-876b-8d2915623f92_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtMember_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtMember" xlink:to="lab_us-gaap_ConvertibleDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_65016227-87d2-4432-ab0f-a4660091bab9_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_3dc67016-61c5-47d9-9cc7-415e6012d960_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, authorized shares (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_TwoThousandTwentyFiveSeniorConvertibleNotesMember_c0c479a7-8884-4b9f-8cf5-07ef35f0e507_terseLabel_en-US" xlink:label="lab_iart_TwoThousandTwentyFiveSeniorConvertibleNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025 Notes</link:label>
    <link:label id="lab_iart_TwoThousandTwentyFiveSeniorConvertibleNotesMember_label_en-US" xlink:label="lab_iart_TwoThousandTwentyFiveSeniorConvertibleNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand Twenty Five Senior Convertible Notes [Member]</link:label>
    <link:label id="lab_iart_TwoThousandTwentyFiveSeniorConvertibleNotesMember_documentation_en-US" xlink:label="lab_iart_TwoThousandTwentyFiveSeniorConvertibleNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand Twenty Five Senior Convertible Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_TwoThousandTwentyFiveSeniorConvertibleNotesMember" xlink:href="iart-20230331.xsd#iart_TwoThousandTwentyFiveSeniorConvertibleNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_TwoThousandTwentyFiveSeniorConvertibleNotesMember" xlink:to="lab_iart_TwoThousandTwentyFiveSeniorConvertibleNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5854af5e-72cb-4765-8f22-18d91de64b76_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents at beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_9960f96a-1c1a-4de7-ad61-6dcc1910a921_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents at end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_CrossCurrencyInterestRateContractThreeMember_f2333b8c-2126-4a5c-ba13-3bfa891463df_terseLabel_en-US" xlink:label="lab_iart_CrossCurrencyInterestRateContractThreeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross Currency Interest Rate Swap Three</link:label>
    <link:label id="lab_iart_CrossCurrencyInterestRateContractThreeMember_label_en-US" xlink:label="lab_iart_CrossCurrencyInterestRateContractThreeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross Currency Interest Rate Contract Three [Member]</link:label>
    <link:label id="lab_iart_CrossCurrencyInterestRateContractThreeMember_documentation_en-US" xlink:label="lab_iart_CrossCurrencyInterestRateContractThreeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross Currency Interest Rate Contract Three [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CrossCurrencyInterestRateContractThreeMember" xlink:href="iart-20230331.xsd#iart_CrossCurrencyInterestRateContractThreeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_CrossCurrencyInterestRateContractThreeMember" xlink:to="lab_iart_CrossCurrencyInterestRateContractThreeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_76916704-81d4-445f-8e5c-b3e0515697a9_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COMMITMENTS AND CONTINGENCIES</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_9a5e9ad8-497f-40d2-8b1c-bd30bc6a2e3e_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeForwardMember_e1ad23b9-000e-46a5-b22d-3d70cd66f34f_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeForwardMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency forward contracts</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeForwardMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeForwardMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Forward [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeForwardMember" xlink:to="lab_us-gaap_ForeignExchangeForwardMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_395a7d60-cec3-4502-8ce7-214e9aafd06f_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_90f302db-2975-4f5b-9dfe-4363b0daab9e_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from exercised stock options</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_db2ae70c-ef08-4466-8369-a45307c8cdd8_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, issued shares (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_AcceleratedShareRepurchasesSharesReceivedAtInception_7f184b82-1ee0-4939-ab11-a880cb30d0a5_terseLabel_en-US" xlink:label="lab_iart_AcceleratedShareRepurchasesSharesReceivedAtInception" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated share repurchases, shares received at inception</link:label>
    <link:label id="lab_iart_AcceleratedShareRepurchasesSharesReceivedAtInception_label_en-US" xlink:label="lab_iart_AcceleratedShareRepurchasesSharesReceivedAtInception" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases, Shares Received at Inception</link:label>
    <link:label id="lab_iart_AcceleratedShareRepurchasesSharesReceivedAtInception_documentation_en-US" xlink:label="lab_iart_AcceleratedShareRepurchasesSharesReceivedAtInception" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases, Shares Received at Inception</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AcceleratedShareRepurchasesSharesReceivedAtInception" xlink:href="iart-20230331.xsd#iart_AcceleratedShareRepurchasesSharesReceivedAtInception"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_AcceleratedShareRepurchasesSharesReceivedAtInception" xlink:to="lab_iart_AcceleratedShareRepurchasesSharesReceivedAtInception" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_InterestRateSwapDesignatedOctober102018Tranche1Member_5d646241-3550-46d6-8dad-0620fc398ad8_terseLabel_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedOctober102018Tranche1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated October 10, 2018 Tranche 1</link:label>
    <link:label id="lab_iart_InterestRateSwapDesignatedOctober102018Tranche1Member_label_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedOctober102018Tranche1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated October 10, 2018 Tranche 1 [Member]</link:label>
    <link:label id="lab_iart_InterestRateSwapDesignatedOctober102018Tranche1Member_documentation_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedOctober102018Tranche1Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated October 10, 2018 Tranche 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedOctober102018Tranche1Member" xlink:href="iart-20230331.xsd#iart_InterestRateSwapDesignatedOctober102018Tranche1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_InterestRateSwapDesignatedOctober102018Tranche1Member" xlink:to="lab_iart_InterestRateSwapDesignatedOctober102018Tranche1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_1a7a9f3c-7c09-4372-b548-b855512f7bcf_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract liabilities</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_e8165445-cf5a-4926-b7e9-920b9dd190bb_verboseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term portion of contract liability</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_fa4f8ac5-66ea-4e35-a0c4-00494415a0ae_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_67804e82-cda1-46bd-8b91-29dd4413046c_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedges</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgingMember" xlink:to="lab_us-gaap_CashFlowHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_a65d43c9-c952-45e6-9ea7-e61f64fda90f_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_TermLoanFacilityMember_b7460d80-a2ec-47ad-88e5-5208c0cd4d3f_terseLabel_en-US" xlink:label="lab_iart_TermLoanFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Facility</link:label>
    <link:label id="lab_iart_TermLoanFacilityMember_label_en-US" xlink:label="lab_iart_TermLoanFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Facility [Member]</link:label>
    <link:label id="lab_iart_TermLoanFacilityMember_documentation_en-US" xlink:label="lab_iart_TermLoanFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_TermLoanFacilityMember" xlink:href="iart-20230331.xsd#iart_TermLoanFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_TermLoanFacilityMember" xlink:to="lab_iart_TermLoanFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_3b00ac58-c281-479a-afc0-16d67b9b61a3_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Life</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_a54672f3-2426-45d5-b495-1377b1c83c78_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_ec29da4f-b243-4998-a2ca-3e71f3c51e7c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible notes, maximum borrowing capacity</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_38531f7e-f901-496a-910d-ea32e0a2a692_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock through employee stock purchase plan</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Employee Stock Purchase Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_54f62d36-7cc5-44d7-ac20-76560b485085_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income (See Note 14)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_952da324-3279-4f17-9e19-62141a8fccd6_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income, net</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_0927c7a3-b9e6-41fc-ac63-9357663a4694_terseLabel_en-US" xlink:label="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ACQUISITIONS AND DIVESTITURES</link:label>
    <link:label id="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mergers, Acquisitions and Dispositions Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:to="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_77abdf21-1deb-4c19-bbb5-7b57e166056a_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities assumed</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_b0b3b7ce-a2ff-45b9-a8b8-3c972765711e_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Net Sales and Profit by Segments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_b6df5feb-9b8a-471f-a8bd-7c24cc57109b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Geographic Revenue by Area</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_e1a68923-22de-4bd2-a603-c13c80f36d86_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_5ce5396a-093b-4952-b3cd-89cf0faaa157_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_2c11a5a9-4fc8-47c7-bf87-9864c23be935_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liability</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_a4efc250-3815-4dcd-a44e-aac442e2be77_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_ContractWithCustomerLiabilityNetOfRevenueRecognized_520b0cdd-ac07-4e80-bcb3-da4611f15170_terseLabel_en-US" xlink:label="lab_iart_ContractWithCustomerLiabilityNetOfRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recognition of revenue included in beginning of year contract liability</link:label>
    <link:label id="lab_iart_ContractWithCustomerLiabilityNetOfRevenueRecognized_label_en-US" xlink:label="lab_iart_ContractWithCustomerLiabilityNetOfRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Liability, Net Of Revenue Recognized</link:label>
    <link:label id="lab_iart_ContractWithCustomerLiabilityNetOfRevenueRecognized_documentation_en-US" xlink:label="lab_iart_ContractWithCustomerLiabilityNetOfRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Liability, Net Of Revenue Recognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ContractWithCustomerLiabilityNetOfRevenueRecognized" xlink:href="iart-20230331.xsd#iart_ContractWithCustomerLiabilityNetOfRevenueRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_ContractWithCustomerLiabilityNetOfRevenueRecognized" xlink:to="lab_iart_ContractWithCustomerLiabilityNetOfRevenueRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CrossCurrencyInterestRateContractMember_90736132-2acb-4177-84be-d43e10350c0f_terseLabel_en-US" xlink:label="lab_us-gaap_CrossCurrencyInterestRateContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross-currency swap</link:label>
    <link:label id="lab_us-gaap_CrossCurrencyInterestRateContractMember_label_en-US" xlink:label="lab_us-gaap_CrossCurrencyInterestRateContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross Currency Interest Rate Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CrossCurrencyInterestRateContractMember" xlink:to="lab_us-gaap_CrossCurrencyInterestRateContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_78f7599e-f7ab-4784-abb9-35a089f841da_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_PerformanceStockAndRestrictedStockAwardsMember_64f63c1b-0509-446f-adcd-c5c0df16752c_terseLabel_en-US" xlink:label="lab_iart_PerformanceStockAndRestrictedStockAwardsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Stock and Restricted Stock Awards</link:label>
    <link:label id="lab_iart_PerformanceStockAndRestrictedStockAwardsMember_label_en-US" xlink:label="lab_iart_PerformanceStockAndRestrictedStockAwardsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Stock And Restricted Stock Awards [Member]</link:label>
    <link:label id="lab_iart_PerformanceStockAndRestrictedStockAwardsMember_documentation_en-US" xlink:label="lab_iart_PerformanceStockAndRestrictedStockAwardsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Stock And Restricted Stock Awards [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_PerformanceStockAndRestrictedStockAwardsMember" xlink:href="iart-20230331.xsd#iart_PerformanceStockAndRestrictedStockAwardsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_PerformanceStockAndRestrictedStockAwardsMember" xlink:to="lab_iart_PerformanceStockAndRestrictedStockAwardsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_3a333146-2e83-4898-8115-0a8ad5abf123_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected annual amortization expense, thereafter</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_23fcc3a6-9b9e-4feb-bcb6-09d24a0414cb_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock through employee stock purchase plan (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Employee Stock Purchase Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CounterpartyNameAxis_b84a0d90-c8b8-4849-88fa-3c6c30a6c591_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:label id="lab_srt_CounterpartyNameAxis_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis" xlink:to="lab_srt_CounterpartyNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_fae92e39-7550-4d92-90e9-60a2e4ddcb98_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Assets Acquired and Liabilities Assumed</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeTable_0b74020a-88be-4972-a200-3d4969b47255_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeTable_label_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeTable" xlink:to="lab_us-gaap_DerivativeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_fb61e1f7-9418-4ad8-a5e7-823fe283b907_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_CodmanSpecialtySurgicalMember_df67b233-a29c-42d0-a210-970172b2f97e_terseLabel_en-US" xlink:label="lab_iart_CodmanSpecialtySurgicalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Codman Specialty Surgical</link:label>
    <link:label id="lab_iart_CodmanSpecialtySurgicalMember_afb35d19-ed45-4ff0-9f17-762b8b5fda43_verboseLabel_en-US" xlink:label="lab_iart_CodmanSpecialtySurgicalMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Codman Specialty Surgical</link:label>
    <link:label id="lab_iart_CodmanSpecialtySurgicalMember_label_en-US" xlink:label="lab_iart_CodmanSpecialtySurgicalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Codman Specialty Surgical [Member]</link:label>
    <link:label id="lab_iart_CodmanSpecialtySurgicalMember_documentation_en-US" xlink:label="lab_iart_CodmanSpecialtySurgicalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Codman Specialty Surgical [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CodmanSpecialtySurgicalMember" xlink:href="iart-20230331.xsd#iart_CodmanSpecialtySurgicalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_CodmanSpecialtySurgicalMember" xlink:to="lab_iart_CodmanSpecialtySurgicalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_befad261-48ad-4493-9987-16d4a8d74c8b_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_97f4535e-284a-49dc-982d-6688c6a4c6ec_totalLabel_en-US" xlink:label="lab_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets acquired</link:label>
    <link:label id="lab_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_label_en-US" xlink:label="lab_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Acquired Including Goodwill</link:label>
    <link:label id="lab_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_documentation_en-US" xlink:label="lab_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Acquired Including Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill" xlink:href="iart-20230331.xsd#iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill" xlink:to="lab_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_330588bf-dfe0-4676-b75e-716b34d88fd7_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_NoncashLeaseExpense_ccb69345-bd8e-4add-b381-7083a5e63fb4_terseLabel_en-US" xlink:label="lab_iart_NoncashLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash lease expense</link:label>
    <link:label id="lab_iart_NoncashLeaseExpense_label_en-US" xlink:label="lab_iart_NoncashLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash Lease Expense</link:label>
    <link:label id="lab_iart_NoncashLeaseExpense_documentation_en-US" xlink:label="lab_iart_NoncashLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash Lease Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_NoncashLeaseExpense" xlink:href="iart-20230331.xsd#iart_NoncashLeaseExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_NoncashLeaseExpense" xlink:to="lab_iart_NoncashLeaseExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill_be3b6995-7302-4217-8a1d-09fec7e36120_terseLabel_en-US" xlink:label="lab_iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost</link:label>
    <link:label id="lab_iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill_label_en-US" xlink:label="lab_iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost Of Definite And Indefinite Lived Intangible Assets Gross Excluding Goodwill</link:label>
    <link:label id="lab_iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill_documentation_en-US" xlink:label="lab_iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost Of Definite And Indefinite Lived Intangible Assets Gross Excluding Goodwill.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill" xlink:href="iart-20230331.xsd#iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill" xlink:to="lab_iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability_5f5ee7f4-81df-4b22-bcbb-408829a2ac5b_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Contingent Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_aa6239b5-e0b8-4724-a817-61db5cb38339_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis Of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_17dc50da-686b-4b9f-b4dd-55eada53daf4_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of exchange rate changes on cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_e5895406-476f-4074-9d30-b0054783e491_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_817cfd89-a14c-4dd4-bc55-f60a60e52f1f_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating cash flows from operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract_b22c3511-f688-440d-a4ce-dbd152fc0ef5_terseLabel_en-US" xlink:label="lab_iart_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ROU assets obtained in exchange for lease liabilities:</link:label>
    <link:label id="lab_iart_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract_label_en-US" xlink:label="lab_iart_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right Of Use Asset Obtained In Exchange For Lease Liability [Abstract]</link:label>
    <link:label id="lab_iart_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract_documentation_en-US" xlink:label="lab_iart_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right Of Use Asset Obtained In Exchange For Lease Liability [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract" xlink:href="iart-20230331.xsd#iart_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract" xlink:to="lab_iart_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_5e8fe419-56db-47f0-b8d1-bc6cef1da754_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in fair value of contingent consideration liabilities</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_114292fb-998b-4e3f-ab88-cdaf53db6c44_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValue_8d5e91bd-3448-44dd-977e-dab8bc0f4ac9_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, at cost; 8,918 shares and 6,823 shares at March&#160;31, 2023 and December&#160;31, 2022, respectively</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue" xlink:to="lab_us-gaap_TreasuryStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_1df45b3a-3adc-4234-9994-fe267aa95748_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Domain]</link:label>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_label_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_029e98ba-8837-4817-9745-09d8e5efbee7_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration, maximum undiscounted payment amount</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_AcceleratedShareRepurchasesPercentageOfExpectedTotalRepurchased_43874874-8de2-41ef-86e4-c7a0dc30dc6c_terseLabel_en-US" xlink:label="lab_iart_AcceleratedShareRepurchasesPercentageOfExpectedTotalRepurchased" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated share repurchases, percentage of expected total repurchased</link:label>
    <link:label id="lab_iart_AcceleratedShareRepurchasesPercentageOfExpectedTotalRepurchased_label_en-US" xlink:label="lab_iart_AcceleratedShareRepurchasesPercentageOfExpectedTotalRepurchased" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases, Percentage Of Expected Total Repurchased</link:label>
    <link:label id="lab_iart_AcceleratedShareRepurchasesPercentageOfExpectedTotalRepurchased_documentation_en-US" xlink:label="lab_iart_AcceleratedShareRepurchasesPercentageOfExpectedTotalRepurchased" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases, Percentage Of Expected Total Repurchased</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AcceleratedShareRepurchasesPercentageOfExpectedTotalRepurchased" xlink:href="iart-20230331.xsd#iart_AcceleratedShareRepurchasesPercentageOfExpectedTotalRepurchased"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_AcceleratedShareRepurchasesPercentageOfExpectedTotalRepurchased" xlink:to="lab_iart_AcceleratedShareRepurchasesPercentageOfExpectedTotalRepurchased" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_8ea0717c-8350-49fe-8c23-51c0a827a4d2_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade accounts receivable, allowance</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_b0d5dcfa-f711-475c-940b-a870ac13da85_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal Repayment</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_3bc79721-22e9-4dc4-8faf-6e9bc089de48_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_FiveYearOptionLeasePeriodTwoMember_d978c023-56e2-453b-810e-6dd50a03560a_terseLabel_en-US" xlink:label="lab_iart_FiveYearOptionLeasePeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Five Year Option Lease From November 1, 2034 Through October 31, 2039</link:label>
    <link:label id="lab_iart_FiveYearOptionLeasePeriodTwoMember_label_en-US" xlink:label="lab_iart_FiveYearOptionLeasePeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Five Year Option Lease Period Two [Member]</link:label>
    <link:label id="lab_iart_FiveYearOptionLeasePeriodTwoMember_documentation_en-US" xlink:label="lab_iart_FiveYearOptionLeasePeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Five-Year Option Lease Period Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_FiveYearOptionLeasePeriodTwoMember" xlink:href="iart-20230331.xsd#iart_FiveYearOptionLeasePeriodTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_FiveYearOptionLeasePeriodTwoMember" xlink:to="lab_iart_FiveYearOptionLeasePeriodTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_ec68066d-0758-4fea-9e0e-a54c4c457d69_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_37dbcf7f-f4b1-4aa1-9e4d-055696754cb7_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration, noncurrent</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_02bdd7f9-9c2f-4a25-86be-5f1b3a30509b_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, authorized shares (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_DebtWeightedAverageInterestRateFromSecuritization_fc732722-306b-4eae-a23d-b0edc8b4217e_terseLabel_en-US" xlink:label="lab_iart_DebtWeightedAverageInterestRateFromSecuritization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average interest rate, accounts receivable securitization revolving loan facility</link:label>
    <link:label id="lab_iart_DebtWeightedAverageInterestRateFromSecuritization_label_en-US" xlink:label="lab_iart_DebtWeightedAverageInterestRateFromSecuritization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Weighted Average Interest Rate, From Securitization</link:label>
    <link:label id="lab_iart_DebtWeightedAverageInterestRateFromSecuritization_documentation_en-US" xlink:label="lab_iart_DebtWeightedAverageInterestRateFromSecuritization" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Weighted Average Interest Rate, From Securitization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtWeightedAverageInterestRateFromSecuritization" xlink:href="iart-20230331.xsd#iart_DebtWeightedAverageInterestRateFromSecuritization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_DebtWeightedAverageInterestRateFromSecuritization" xlink:to="lab_iart_DebtWeightedAverageInterestRateFromSecuritization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_b0149095-be71-4b36-a0a4-cdc57dafa98b_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative instruments not designated as hedging instruments, gain (loss), net</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:to="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_eb386557-801d-4e06-9425-c6c86d21efca_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_d7e0f47e-a785-4412-bb9c-339c8d4e8e73_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_e9c6aa3c-1925-4f16-b043-e08a9b62c271_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of credit facility, fair value of amount outstanding</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Fair Value of Amount Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding" xlink:to="lab_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortMember_2ce84739-e00f-444a-a0e8-d2a2e7c0f248_terseLabel_en-US" xlink:label="lab_us-gaap_ShortMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short</link:label>
    <link:label id="lab_us-gaap_ShortMember_label_en-US" xlink:label="lab_us-gaap_ShortMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortMember" xlink:to="lab_us-gaap_ShortMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_DebtInstrumentCombinationSettlementForDebtConversionMinimumSettledInCashPerPrincipalAmount_febf16c7-8796-4448-8dc3-40d781f9db83_terseLabel_en-US" xlink:label="lab_iart_DebtInstrumentCombinationSettlementForDebtConversionMinimumSettledInCashPerPrincipalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum settled in cash per principal amount</link:label>
    <link:label id="lab_iart_DebtInstrumentCombinationSettlementForDebtConversionMinimumSettledInCashPerPrincipalAmount_label_en-US" xlink:label="lab_iart_DebtInstrumentCombinationSettlementForDebtConversionMinimumSettledInCashPerPrincipalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Combination Settlement For Debt Conversion, Minimum Settled In Cash Per Principal Amount</link:label>
    <link:label id="lab_iart_DebtInstrumentCombinationSettlementForDebtConversionMinimumSettledInCashPerPrincipalAmount_documentation_en-US" xlink:label="lab_iart_DebtInstrumentCombinationSettlementForDebtConversionMinimumSettledInCashPerPrincipalAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Combination Settlement For Debt Conversion, Minimum Settled In Cash Per Principal Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtInstrumentCombinationSettlementForDebtConversionMinimumSettledInCashPerPrincipalAmount" xlink:href="iart-20230331.xsd#iart_DebtInstrumentCombinationSettlementForDebtConversionMinimumSettledInCashPerPrincipalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_DebtInstrumentCombinationSettlementForDebtConversionMinimumSettledInCashPerPrincipalAmount" xlink:to="lab_iart_DebtInstrumentCombinationSettlementForDebtConversionMinimumSettledInCashPerPrincipalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_73f4b1d8-6548-4c4d-8772-c1654de71ddf_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_afd46818-2990-47c6-bf89-c0a9d63c6a3b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives Not Designated as Hedging Instruments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives Not Designated as Hedging Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_c2253d29-3175-49f0-8e5e-7001508a40fa_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_e6c26761-a954-4fd9-84e2-776bb564a905_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_b65300ae-7d01-4087-824d-27e323d6efd9_terseLabel_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument</link:label>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_label_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:to="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_a62ac640-dba2-4883-a610-62e2f946dcf0_negatedLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract liability, net of revenue recognized on contracts during the period</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Revenue Recognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_fee6809a-45f8-405d-9991-118a095683b6_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_4510dd8d-9694-47d2-a6d2-5244e7058048_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Smaller Reporting Company</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_SegmentReportingInformationNumberOfProductsOffered_ca453f44-b45e-433f-a721-714e36d1d941_terseLabel_en-US" xlink:label="lab_iart_SegmentReportingInformationNumberOfProductsOffered" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of products offered (more than)</link:label>
    <link:label id="lab_iart_SegmentReportingInformationNumberOfProductsOffered_label_en-US" xlink:label="lab_iart_SegmentReportingInformationNumberOfProductsOffered" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information, Number Of Products Offered</link:label>
    <link:label id="lab_iart_SegmentReportingInformationNumberOfProductsOffered_documentation_en-US" xlink:label="lab_iart_SegmentReportingInformationNumberOfProductsOffered" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of products sold by a segment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SegmentReportingInformationNumberOfProductsOffered" xlink:href="iart-20230331.xsd#iart_SegmentReportingInformationNumberOfProductsOffered"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_SegmentReportingInformationNumberOfProductsOffered" xlink:to="lab_iart_SegmentReportingInformationNumberOfProductsOffered" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent_ae2d711f-a9b2-4927-99ea-02b6c903c192_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in unrealized loss/(gain) on derivatives, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax, Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_ACellMember_a6bfa8ab-c590-4fad-af5a-1982f58a2fd4_terseLabel_en-US" xlink:label="lab_iart_ACellMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ACell</link:label>
    <link:label id="lab_iart_ACellMember_label_en-US" xlink:label="lab_iart_ACellMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ACell [Member]</link:label>
    <link:label id="lab_iart_ACellMember_documentation_en-US" xlink:label="lab_iart_ACellMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ACell</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ACellMember" xlink:href="iart-20230331.xsd#iart_ACellMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_ACellMember" xlink:to="lab_iart_ACellMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage_f222e88c-c3bb-4e66-9897-a1fc7939cc5b_terseLabel_en-US" xlink:label="lab_iart_DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defer payment and taxation, bonus and other eligible cash compensation, percentage (up to)</link:label>
    <link:label id="lab_iart_DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage_label_en-US" xlink:label="lab_iart_DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Defer Payment And Taxation, Bonus And Other Compensation, Percentage</link:label>
    <link:label id="lab_iart_DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage_documentation_en-US" xlink:label="lab_iart_DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Defer Payment And Taxation, Bonus And Other Compensation, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage" xlink:href="iart-20230331.xsd#iart_DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage" xlink:to="lab_iart_DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsideration_ef05ae50-93bd-49e1-9732-e54e2b27c19e_terseLabel_en-US" xlink:label="lab_iart_DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of business, contingent consideration</link:label>
    <link:label id="lab_iart_DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsideration_label_en-US" xlink:label="lab_iart_DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Consideration, Contingent Consideration</link:label>
    <link:label id="lab_iart_DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsideration_documentation_en-US" xlink:label="lab_iart_DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Consideration, Contingent Consideration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsideration" xlink:href="iart-20230331.xsd#iart_DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsideration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsideration" xlink:to="lab_iart_DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsideration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_0da91607-22a2-4864-bfb2-8e58db2415f8_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance obligations expected to be satisfied, expected timing</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_494b2013-e6cc-4769-972c-348809a9190b_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total unrecognized compensation costs</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestIncomeMember_e048057c-a205-46b8-9abe-ee87df206fe5_terseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InterestIncomeMember_ed9cad2c-9835-4ce9-b5dc-8cc64765d042_verboseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InterestIncomeMember_label_en-US" xlink:label="lab_us-gaap_InterestIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeMember" xlink:to="lab_us-gaap_InterestIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_5510ad9e-76c5-4c94-b55b-32c40e31bcf1_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongMember_bf7f5f4c-75ae-4ba2-bfc1-90714fae12c5_terseLabel_en-US" xlink:label="lab_us-gaap_LongMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long</link:label>
    <link:label id="lab_us-gaap_LongMember_label_en-US" xlink:label="lab_us-gaap_LongMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongMember" xlink:to="lab_us-gaap_LongMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_DebtInstrumentMaximumAverageConversionValueOfNotes_afab012a-f409-40bb-907c-2888bfbe55b0_terseLabel_en-US" xlink:label="lab_iart_DebtInstrumentMaximumAverageConversionValueOfNotes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum average conversion value of notes</link:label>
    <link:label id="lab_iart_DebtInstrumentMaximumAverageConversionValueOfNotes_label_en-US" xlink:label="lab_iart_DebtInstrumentMaximumAverageConversionValueOfNotes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Maximum Average Conversion Value Of Notes</link:label>
    <link:label id="lab_iart_DebtInstrumentMaximumAverageConversionValueOfNotes_documentation_en-US" xlink:label="lab_iart_DebtInstrumentMaximumAverageConversionValueOfNotes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Maximum Average Conversion Value Of Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtInstrumentMaximumAverageConversionValueOfNotes" xlink:href="iart-20230331.xsd#iart_DebtInstrumentMaximumAverageConversionValueOfNotes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_DebtInstrumentMaximumAverageConversionValueOfNotes" xlink:to="lab_iart_DebtInstrumentMaximumAverageConversionValueOfNotes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_e9762ed4-4b3b-4272-86b5-93fa21b211d2_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_b513b6fe-f668-4500-8d2f-ff33fdbd1931_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_c0f86c58-8a68-422a-afae-421c226d8853_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BASIS OF PRESENTATION</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_TrademarksBrandNamesMember_f720f1ef-df54-4988-ac45-8f72adbfc7e4_terseLabel_en-US" xlink:label="lab_iart_TrademarksBrandNamesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks/brand names</link:label>
    <link:label id="lab_iart_TrademarksBrandNamesMember_label_en-US" xlink:label="lab_iart_TrademarksBrandNamesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks Brand Names [Member]</link:label>
    <link:label id="lab_iart_TrademarksBrandNamesMember_documentation_en-US" xlink:label="lab_iart_TrademarksBrandNamesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks Brand Names.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_TrademarksBrandNamesMember" xlink:href="iart-20230331.xsd#iart_TrademarksBrandNamesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_TrademarksBrandNamesMember" xlink:to="lab_iart_TrademarksBrandNamesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpenses_06669593-5607-4e90-bc8a-68da7a3eb09b_totalLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total costs and expenses</link:label>
    <link:label id="lab_us-gaap_CostsAndExpenses_label_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpenses" xlink:to="lab_us-gaap_CostsAndExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_d6fa1f9d-480c-4fc5-a618-28801fc74cc5_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grants in period, net of forfeitures (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_CompletedTechnologyMember_684be502-ece0-44a2-9c67-fca784b88bb0_terseLabel_en-US" xlink:label="lab_iart_CompletedTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Completed technology</link:label>
    <link:label id="lab_iart_CompletedTechnologyMember_label_en-US" xlink:label="lab_iart_CompletedTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Completed Technology [Member]</link:label>
    <link:label id="lab_iart_CompletedTechnologyMember_documentation_en-US" xlink:label="lab_iart_CompletedTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Completed technology.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CompletedTechnologyMember" xlink:href="iart-20230331.xsd#iart_CompletedTechnologyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_CompletedTechnologyMember" xlink:to="lab_iart_CompletedTechnologyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_4e6e87a8-4654-4592-acf1-59e8032f7d51_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:to="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_BioDEarnoutPaymentsandMedihoneyEarnoutPaymentsMember_45839097-f53e-4028-91eb-edaec6f6531b_terseLabel_en-US" xlink:label="lab_iart_BioDEarnoutPaymentsandMedihoneyEarnoutPaymentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BioD Earnout Payments and Medihoney Earnout Payments</link:label>
    <link:label id="lab_iart_BioDEarnoutPaymentsandMedihoneyEarnoutPaymentsMember_label_en-US" xlink:label="lab_iart_BioDEarnoutPaymentsandMedihoneyEarnoutPaymentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BioD Earnout Payments and Medihoney Earnout Payments [Member]</link:label>
    <link:label id="lab_iart_BioDEarnoutPaymentsandMedihoneyEarnoutPaymentsMember_documentation_en-US" xlink:label="lab_iart_BioDEarnoutPaymentsandMedihoneyEarnoutPaymentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BioD Earnout Payments and Medihoney Earnout Payments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_BioDEarnoutPaymentsandMedihoneyEarnoutPaymentsMember" xlink:href="iart-20230331.xsd#iart_BioDEarnoutPaymentsandMedihoneyEarnoutPaymentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_BioDEarnoutPaymentsandMedihoneyEarnoutPaymentsMember" xlink:to="lab_iart_BioDEarnoutPaymentsandMedihoneyEarnoutPaymentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_f59e310b-8231-4f84-bf79-dc3532559676_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_b8dfd8e7-1fa2-4349-9263-1d4abe9c035e_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock for vesting of share based awards, net of shares withheld for taxes (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_2556026a-9c7b-4a54-b5ee-f7daf621f7e6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of debt issuance costs</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:to="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_d731463a-a7df-47b7-8957-6f879308f525_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_f4693b8d-9807-4369-95b2-c52c45cca230_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_7809e93a-33ae-40ad-8850-6eb2da38bf12_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEGMENT AND GEOGRAPHIC INFORMATION</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_843fba82-56fe-49e1-b772-2cd73aca0add_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected annual amortization expense, in 2024</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_d2817abf-03bf-43f1-9167-6f2aea16fa35_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_415d5ec1-d7ec-41f2-8d09-9ce23809bd56_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustment</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_92a6b9f0-9170-4da5-b895-be5dbfef2e9f_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remainder of 2023</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_4718b462-7ed3-4f75-a2bc-788d85c14714_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average common shares outstanding (See Note 13):</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnDispositionOfAssets_05e5da3d-efaf-4f9c-b643-09438de55493_negatedLabel_en-US" xlink:label="lab_us-gaap_GainLossOnDispositionOfAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss (gain) on disposal of property and equipment</link:label>
    <link:label id="lab_us-gaap_GainLossOnDispositionOfAssets_label_en-US" xlink:label="lab_us-gaap_GainLossOnDispositionOfAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnDispositionOfAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnDispositionOfAssets" xlink:to="lab_us-gaap_GainLossOnDispositionOfAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherExpenseMember_485de931-1f2c-4065-8d40-c8cb18501906_terseLabel_en-US" xlink:label="lab_us-gaap_OtherExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expense)</link:label>
    <link:label id="lab_us-gaap_OtherExpenseMember_label_en-US" xlink:label="lab_us-gaap_OtherExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherExpenseMember" xlink:to="lab_us-gaap_OtherExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_cf5c6c73-2c90-4cec-8e6f-0e5d96f1638b_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories, net</link:label>
    <link:label id="lab_us-gaap_InventoryNet_cc8ab718-bd54-4934-95e7-8f68a20d6405_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories, net</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_CodmanMember_c0557745-988f-4851-a7bd-4df2973100fa_terseLabel_en-US" xlink:label="lab_iart_CodmanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Codman</link:label>
    <link:label id="lab_iart_CodmanMember_label_en-US" xlink:label="lab_iart_CodmanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Codman [Member]</link:label>
    <link:label id="lab_iart_CodmanMember_documentation_en-US" xlink:label="lab_iart_CodmanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Codman [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CodmanMember" xlink:href="iart-20230331.xsd#iart_CodmanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_CodmanMember" xlink:to="lab_iart_CodmanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_ACellIncMember_fed3e7d2-d599-4599-b831-a3fcd71974ef_terseLabel_en-US" xlink:label="lab_iart_ACellIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ACell, Inc.</link:label>
    <link:label id="lab_iart_ACellIncMember_label_en-US" xlink:label="lab_iart_ACellIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ACell, Inc. [Member]</link:label>
    <link:label id="lab_iart_ACellIncMember_documentation_en-US" xlink:label="lab_iart_ACellIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ACell, Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ACellIncMember" xlink:href="iart-20230331.xsd#iart_ACellIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_ACellIncMember" xlink:to="lab_iart_ACellIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_InterestPaymentsReminderOfFiscalYear_5aa8b020-1e20-4fe2-8f3d-357565999cf6_terseLabel_en-US" xlink:label="lab_iart_InterestPaymentsReminderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest payments, remainder of fiscal year</link:label>
    <link:label id="lab_iart_InterestPaymentsReminderOfFiscalYear_label_en-US" xlink:label="lab_iart_InterestPaymentsReminderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Payments, Reminder Of Fiscal Year</link:label>
    <link:label id="lab_iart_InterestPaymentsReminderOfFiscalYear_documentation_en-US" xlink:label="lab_iart_InterestPaymentsReminderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Payments, Reminder Of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestPaymentsReminderOfFiscalYear" xlink:href="iart-20230331.xsd#iart_InterestPaymentsReminderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_InterestPaymentsReminderOfFiscalYear" xlink:to="lab_iart_InterestPaymentsReminderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_3099713a-0396-4e27-89c2-52895f467350_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_25d9ded3-a0a9-4889-a669-a1aaea61c3b1_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_label_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingRelationshipDomain" xlink:to="lab_us-gaap_HedgingRelationshipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_6364c0fe-c5a4-4b43-baa3-5215b0b8da97_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationAxis" xlink:to="lab_us-gaap_HedgingDesignationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WriteOffOfDeferredDebtIssuanceCost_4766d964-5d37-41f2-89bf-3c14d3b3ca2c_terseLabel_en-US" xlink:label="lab_us-gaap_WriteOffOfDeferredDebtIssuanceCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Write off of debt issuance costs</link:label>
    <link:label id="lab_us-gaap_WriteOffOfDeferredDebtIssuanceCost_label_en-US" xlink:label="lab_us-gaap_WriteOffOfDeferredDebtIssuanceCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Write off of Deferred Debt Issuance Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WriteOffOfDeferredDebtIssuanceCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost" xlink:to="lab_us-gaap_WriteOffOfDeferredDebtIssuanceCost" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_e5df9c47-9547-4402-83db-bcdf7cb99f6d_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_890f2d52-0ad6-4251-8e7a-635fb8635e1a_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_a4b8ce3e-2be1-4d58-be3a-20b7963a789a_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average common shares outstanding - Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_ad10d25b-80b7-4d2d-94c3-6faef50beec5_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_257ebfee-8a08-4a65-9d11-4ab07c28872d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_InterestRateSwapDesignatedOctober102018Tranche3Member_69abe914-f35d-4fe2-a5a8-62f7a4ecf02f_terseLabel_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedOctober102018Tranche3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated October 10, 2018 Tranche 3</link:label>
    <link:label id="lab_iart_InterestRateSwapDesignatedOctober102018Tranche3Member_label_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedOctober102018Tranche3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated October 10, 2018 Tranche 3 [Member]</link:label>
    <link:label id="lab_iart_InterestRateSwapDesignatedOctober102018Tranche3Member_documentation_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedOctober102018Tranche3Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated October 10, 2018 Tranche 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedOctober102018Tranche3Member" xlink:href="iart-20230331.xsd#iart_InterestRateSwapDesignatedOctober102018Tranche3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_InterestRateSwapDesignatedOctober102018Tranche3Member" xlink:to="lab_iart_InterestRateSwapDesignatedOctober102018Tranche3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_1c433c12-6f28-451e-819f-8376f9122c97_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_PaymentsForOptionIndexToIssuersEquity_bf5b3d34-7611-4c85-a001-c78fc47a4cb6_terseLabel_en-US" xlink:label="lab_iart_PaymentsForOptionIndexToIssuersEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of call transactions</link:label>
    <link:label id="lab_iart_PaymentsForOptionIndexToIssuersEquity_label_en-US" xlink:label="lab_iart_PaymentsForOptionIndexToIssuersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments For Option Index To Issuers Equity</link:label>
    <link:label id="lab_iart_PaymentsForOptionIndexToIssuersEquity_documentation_en-US" xlink:label="lab_iart_PaymentsForOptionIndexToIssuersEquity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments For Options Indexed to Issuer's Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_PaymentsForOptionIndexToIssuersEquity" xlink:href="iart-20230331.xsd#iart_PaymentsForOptionIndexToIssuersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_PaymentsForOptionIndexToIssuersEquity" xlink:to="lab_iart_PaymentsForOptionIndexToIssuersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_2d57cc32-25fa-46a2-b2b0-fd039a871a15_terseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average life</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_label_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_b116b1c3-5009-4593-b77f-fb72a2550eb6_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notional Amount</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_3f953507-ad93-4a95-8128-90da8614109c_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current notional amount</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_d7309cdb-fcad-4598-bed8-2863fe4db896_netLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Notional Amount</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNotionalAmount" xlink:to="lab_us-gaap_DerivativeNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_4d33146c-a755-4712-b9ce-7d3e00112bba_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock; no par value; 15,000 authorized shares; none outstanding</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_7bcbeadf-cd2f-43a0-b157-0b0d2c10374c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount&#160;of&#160;Gain (Loss) Reclassified from AOCL into Earnings</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_PercentOfManufacturingFacilityOwnedByCorporationWhoseShareholdersAreTrustsWhoseBeneficiariesIncludeFamilyMembersOfCompanysFormerDirector_bec48acc-96e5-49cc-9c00-0a5dac6a41b9_terseLabel_en-US" xlink:label="lab_iart_PercentOfManufacturingFacilityOwnedByCorporationWhoseShareholdersAreTrustsWhoseBeneficiariesIncludeFamilyMembersOfCompanysFormerDirector" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent of manufacturing facility owned by corporation whose shareholders are trusts whose beneficiaries include family members of company's former director</link:label>
    <link:label id="lab_iart_PercentOfManufacturingFacilityOwnedByCorporationWhoseShareholdersAreTrustsWhoseBeneficiariesIncludeFamilyMembersOfCompanysFormerDirector_label_en-US" xlink:label="lab_iart_PercentOfManufacturingFacilityOwnedByCorporationWhoseShareholdersAreTrustsWhoseBeneficiariesIncludeFamilyMembersOfCompanysFormerDirector" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent Of Manufacturing Facility Owned By Corporation Whose Shareholders Are Trusts, Whose Beneficiaries Include Family Members Of Company's Former Director</link:label>
    <link:label id="lab_iart_PercentOfManufacturingFacilityOwnedByCorporationWhoseShareholdersAreTrustsWhoseBeneficiariesIncludeFamilyMembersOfCompanysFormerDirector_documentation_en-US" xlink:label="lab_iart_PercentOfManufacturingFacilityOwnedByCorporationWhoseShareholdersAreTrustsWhoseBeneficiariesIncludeFamilyMembersOfCompanysFormerDirector" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent Of Manufacturing Facility Owned By Corporation Whose Shareholders Are Trusts, Whose Beneficiaries Include Family Members Of Company's Former Director</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_PercentOfManufacturingFacilityOwnedByCorporationWhoseShareholdersAreTrustsWhoseBeneficiariesIncludeFamilyMembersOfCompanysFormerDirector" xlink:href="iart-20230331.xsd#iart_PercentOfManufacturingFacilityOwnedByCorporationWhoseShareholdersAreTrustsWhoseBeneficiariesIncludeFamilyMembersOfCompanysFormerDirector"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_PercentOfManufacturingFacilityOwnedByCorporationWhoseShareholdersAreTrustsWhoseBeneficiariesIncludeFamilyMembersOfCompanysFormerDirector" xlink:to="lab_iart_PercentOfManufacturingFacilityOwnedByCorporationWhoseShareholdersAreTrustsWhoseBeneficiariesIncludeFamilyMembersOfCompanysFormerDirector" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_dffccdbd-d76a-40e2-b845-38913106891c_terseLabel_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of credit outstanding</link:label>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_label_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of Credit Outstanding, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:to="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockMember_76af83dd-67bc-40b4-a81f-f34117efc1be_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock</link:label>
    <link:label id="lab_us-gaap_RestrictedStockMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockMember" xlink:to="lab_us-gaap_RestrictedStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_882fe9cf-03ed-49ef-a10a-dad33b7f483c_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenue, net</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_56230972-7b66-4af7-b474-79757f82faa2_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOperatingLeasedAssetsTable_9344b799-1f6a-4bd5-a0c7-155509e0beac_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Operating Leased Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOperatingLeasedAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Operating Leased Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfOperatingLeasedAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:to="lab_us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_CashFlowLesseeTableTextBlock_7d613a7c-6aad-4c71-86f4-0d79523d5718_terseLabel_en-US" xlink:label="lab_iart_CashFlowLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information</link:label>
    <link:label id="lab_iart_CashFlowLesseeTableTextBlock_label_en-US" xlink:label="lab_iart_CashFlowLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow, Lessee [Table Text Block]</link:label>
    <link:label id="lab_iart_CashFlowLesseeTableTextBlock_documentation_en-US" xlink:label="lab_iart_CashFlowLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow, Lessee [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CashFlowLesseeTableTextBlock" xlink:href="iart-20230331.xsd#iart_CashFlowLesseeTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_CashFlowLesseeTableTextBlock" xlink:to="lab_iart_CashFlowLesseeTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_d7a4c9d2-d136-4a20-83d2-214430e433a7_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service cost component</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Service Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanServiceCost" xlink:to="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_SecuritizationFacilityFairValueOfAmountOutstanding_7b812a8e-5dc6-47e9-a1ac-59a1108a1e2f_terseLabel_en-US" xlink:label="lab_iart_SecuritizationFacilityFairValueOfAmountOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Securitization facility, outstanding borrowings, fair value</link:label>
    <link:label id="lab_iart_SecuritizationFacilityFairValueOfAmountOutstanding_label_en-US" xlink:label="lab_iart_SecuritizationFacilityFairValueOfAmountOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Securitization Facility, Fair Value Of Amount Outstanding</link:label>
    <link:label id="lab_iart_SecuritizationFacilityFairValueOfAmountOutstanding_documentation_en-US" xlink:label="lab_iart_SecuritizationFacilityFairValueOfAmountOutstanding" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Securitization Facility, Fair Value Of Amount Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SecuritizationFacilityFairValueOfAmountOutstanding" xlink:href="iart-20230331.xsd#iart_SecuritizationFacilityFairValueOfAmountOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_SecuritizationFacilityFairValueOfAmountOutstanding" xlink:to="lab_iart_SecuritizationFacilityFairValueOfAmountOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_BusinessAcquisitionNumberOfContingentLiabilities_0c5112c6-0634-4060-92fd-1b81e88195dc_terseLabel_en-US" xlink:label="lab_iart_BusinessAcquisitionNumberOfContingentLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of contingent liabilities</link:label>
    <link:label id="lab_iart_BusinessAcquisitionNumberOfContingentLiabilities_label_en-US" xlink:label="lab_iart_BusinessAcquisitionNumberOfContingentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Number Of Contingent Liabilities</link:label>
    <link:label id="lab_iart_BusinessAcquisitionNumberOfContingentLiabilities_documentation_en-US" xlink:label="lab_iart_BusinessAcquisitionNumberOfContingentLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Number Of Contingent Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_BusinessAcquisitionNumberOfContingentLiabilities" xlink:href="iart-20230331.xsd#iart_BusinessAcquisitionNumberOfContingentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_BusinessAcquisitionNumberOfContingentLiabilities" xlink:to="lab_iart_BusinessAcquisitionNumberOfContingentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_99500898-02b7-4f6b-8443-2b9a7aad414c_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_e02cb42f-4ac0-4480-91a3-cbd325f6808b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_65bae8b8-7213-4ac5-bb7d-fdcf0fba416c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_7d896c75-336e-47e7-b802-618224c513ad_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">STOCK-BASED COMPENSATION</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_57a4af53-9ce4-46ce-9f88-4d734bac6981_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_34e65593-bc3d-492d-a06b-0bb39f8388a8_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Work in process</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:to="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_9f1187a5-e433-4c72-8254-92d07fa1621b_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">REVENUES FROM CONTRACTS WITH CUSTOMERS</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_9e808bd3-8523-4db8-b6ef-e375b454f87d_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CallOptionMember_e3362ea4-7cc1-4629-ba9b-710b8ac5a2ea_terseLabel_en-US" xlink:label="lab_us-gaap_CallOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Call Option</link:label>
    <link:label id="lab_us-gaap_CallOptionMember_label_en-US" xlink:label="lab_us-gaap_CallOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Call Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CallOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CallOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CallOptionMember" xlink:to="lab_us-gaap_CallOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_4b200ace-5699-430c-b7fb-1c9879b597fd_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash taxes paid in net equity settlement</link:label>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment, Tax Withholding, Share-Based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_f039ae07-c7aa-4708-8324-39052e4f993a_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_LongTermDebtMaturityAfterYearThree_31c058a4-d1c9-4b8f-8d15-7872178ba0e7_terseLabel_en-US" xlink:label="lab_iart_LongTermDebtMaturityAfterYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_iart_LongTermDebtMaturityAfterYearThree_label_en-US" xlink:label="lab_iart_LongTermDebtMaturityAfterYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, after Year Three</link:label>
    <link:label id="lab_iart_LongTermDebtMaturityAfterYearThree_documentation_en-US" xlink:label="lab_iart_LongTermDebtMaturityAfterYearThree" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, after Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_LongTermDebtMaturityAfterYearThree" xlink:href="iart-20230331.xsd#iart_LongTermDebtMaturityAfterYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_LongTermDebtMaturityAfterYearThree" xlink:to="lab_iart_LongTermDebtMaturityAfterYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_6187a964-f599-4419-892f-b1d34f35b8f8_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_d54283c1-6e13-4254-93f2-37494a86374a_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_a74440c7-aea2-4ae4-815e-ef682ed86a71_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_TraditionalWoundCareMember_bedee0c3-7b13-495f-a021-662a4fb1f304_terseLabel_en-US" xlink:label="lab_iart_TraditionalWoundCareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Traditional Wound Care</link:label>
    <link:label id="lab_iart_TraditionalWoundCareMember_label_en-US" xlink:label="lab_iart_TraditionalWoundCareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Traditional Wound Care [Member]</link:label>
    <link:label id="lab_iart_TraditionalWoundCareMember_documentation_en-US" xlink:label="lab_iart_TraditionalWoundCareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Traditional Wound Care</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_TraditionalWoundCareMember" xlink:href="iart-20230331.xsd#iart_TraditionalWoundCareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_TraditionalWoundCareMember" xlink:to="lab_iart_TraditionalWoundCareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_b63810cd-9c2e-47a5-9264-533d3f4aa26a_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options and restricted stock (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedAbstract_321d8d45-31a3-42e4-98f0-61ec1b1241d8_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted net income per share:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract" xlink:to="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_97564756-71bf-4dba-ba8b-165f66844518_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NondesignatedMember_5c4e29c3-b743-454f-b1f7-39127f139481_terseLabel_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Designated as Hedging Instrument</link:label>
    <link:label id="lab_us-gaap_NondesignatedMember_label_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NondesignatedMember" xlink:to="lab_us-gaap_NondesignatedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_5035605b-2773-483a-a2ea-da2d86fbc84e_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_6b040733-0054-45a2-92f5-22a26a8bc169_terseLabel_en-US" xlink:label="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_19254b33-1add-4a54-b791-cb1735a0d981_verboseLabel_en-US" xlink:label="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_label_en-US" xlink:label="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent, Net of Tax [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:to="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_23ec81a4-b94e-488a-b1d1-c21cc4a8002e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_4e8d388c-128c-4f0f-a6e7-e7384408c4dd_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_5c1aba17-cc29-45ee-907c-c753b3ae7189_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Imputed interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_88100912-facb-430e-931d-fbfd89777c63_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_97eb4c96-5ac1-42e3-bad1-6e1afd2131ec_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_0b385121-cac0-4f33-9690-05419802b602_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted net income per common share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_ContingentConsiderationLiabilityMember_6612694c-6bc8-44b2-aee6-e905c38eb90a_terseLabel_en-US" xlink:label="lab_iart_ContingentConsiderationLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Liability</link:label>
    <link:label id="lab_iart_ContingentConsiderationLiabilityMember_label_en-US" xlink:label="lab_iart_ContingentConsiderationLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Liability [Member]</link:label>
    <link:label id="lab_iart_ContingentConsiderationLiabilityMember_documentation_en-US" xlink:label="lab_iart_ContingentConsiderationLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Liability [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ContingentConsiderationLiabilityMember" xlink:href="iart-20230331.xsd#iart_ContingentConsiderationLiabilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_ContingentConsiderationLiabilityMember" xlink:to="lab_iart_ContingentConsiderationLiabilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_1eabb72a-a163-436c-87b7-b9522ba53ae7_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options exercisable, vesting period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_40afbc31-06e2-4d0a-a817-868da246be4b_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_6a7427c7-4037-4770-b041-597665d14387_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_ContractWithCustomerLiabilityIncreaseDecreaseFromForeignCurrencyTranslation_a60f7e8c-ac06-4875-aaf7-de71b53e4d31_terseLabel_en-US" xlink:label="lab_iart_ContractWithCustomerLiabilityIncreaseDecreaseFromForeignCurrencyTranslation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation</link:label>
    <link:label id="lab_iart_ContractWithCustomerLiabilityIncreaseDecreaseFromForeignCurrencyTranslation_label_en-US" xlink:label="lab_iart_ContractWithCustomerLiabilityIncreaseDecreaseFromForeignCurrencyTranslation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Liability, Increase (Decrease) From Foreign Currency Translation</link:label>
    <link:label id="lab_iart_ContractWithCustomerLiabilityIncreaseDecreaseFromForeignCurrencyTranslation_documentation_en-US" xlink:label="lab_iart_ContractWithCustomerLiabilityIncreaseDecreaseFromForeignCurrencyTranslation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Liability, Increase (Decrease) From Foreign Currency Translation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ContractWithCustomerLiabilityIncreaseDecreaseFromForeignCurrencyTranslation" xlink:href="iart-20230331.xsd#iart_ContractWithCustomerLiabilityIncreaseDecreaseFromForeignCurrencyTranslation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_ContractWithCustomerLiabilityIncreaseDecreaseFromForeignCurrencyTranslation" xlink:to="lab_iart_ContractWithCustomerLiabilityIncreaseDecreaseFromForeignCurrencyTranslation" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsiderationPeriod_703c8ee6-d822-4761-9007-6275d89eedba_terseLabel_en-US" xlink:label="lab_iart_DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsiderationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period for revenue based performance milestone</link:label>
    <link:label id="lab_iart_DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsiderationPeriod_label_en-US" xlink:label="lab_iart_DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsiderationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Consideration, Contingent Consideration, Period</link:label>
    <link:label id="lab_iart_DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsiderationPeriod_documentation_en-US" xlink:label="lab_iart_DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsiderationPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Consideration, Contingent Consideration, Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsiderationPeriod" xlink:href="iart-20230331.xsd#iart_DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsiderationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsiderationPeriod" xlink:to="lab_iart_DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsiderationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill_b4ba97fc-f7ad-4ff0-a243-c6d697c6058f_totalLabel_en-US" xlink:label="lab_iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net</link:label>
    <link:label id="lab_iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Definite And Indefinite Lived Intangible Assets Net Excluding Goodwill</link:label>
    <link:label id="lab_iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill_documentation_en-US" xlink:label="lab_iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Definite And Indefinite Lived Intangible Assets Net Excluding Goodwill.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill" xlink:href="iart-20230331.xsd#iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill" xlink:to="lab_iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_49bc0c55-86e4-4eab-b8c2-2ca621f85f89_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_DebtInstrumentCovenantMaximumLeverageRatio_8110ac76-02c3-4556-9848-9e0c34bdafb6_terseLabel_en-US" xlink:label="lab_iart_DebtInstrumentCovenantMaximumLeverageRatio" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Consolidated Total Leverage Ratio</link:label>
    <link:label id="lab_iart_DebtInstrumentCovenantMaximumLeverageRatio_label_en-US" xlink:label="lab_iart_DebtInstrumentCovenantMaximumLeverageRatio" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Maximum Leverage Ratio</link:label>
    <link:label id="lab_iart_DebtInstrumentCovenantMaximumLeverageRatio_documentation_en-US" xlink:label="lab_iart_DebtInstrumentCovenantMaximumLeverageRatio" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Maximum Leverage Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtInstrumentCovenantMaximumLeverageRatio" xlink:href="iart-20230331.xsd#iart_DebtInstrumentCovenantMaximumLeverageRatio"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_DebtInstrumentCovenantMaximumLeverageRatio" xlink:to="lab_iart_DebtInstrumentCovenantMaximumLeverageRatio" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_DebtCovenantPeriodDomain_d23a115a-cfd0-4687-a73b-6b1b9d9f6bf3_terseLabel_en-US" xlink:label="lab_iart_DebtCovenantPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Covenant Period [Domain]</link:label>
    <link:label id="lab_iart_DebtCovenantPeriodDomain_label_en-US" xlink:label="lab_iart_DebtCovenantPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Covenant Period [Domain]</link:label>
    <link:label id="lab_iart_DebtCovenantPeriodDomain_documentation_en-US" xlink:label="lab_iart_DebtCovenantPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Domain] for Debt Covenant Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtCovenantPeriodDomain" xlink:href="iart-20230331.xsd#iart_DebtCovenantPeriodDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_DebtCovenantPeriodDomain" xlink:to="lab_iart_DebtCovenantPeriodDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_41ce5ba3-bc7c-4567-b9a1-41d1a33c02a5_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_DebtInstrumentMaximumSellingPriceOfCommonStockOfTheConversionPriceDuringPeriod_81d1e84e-ef4f-449d-8182-9b880d2f3f28_terseLabel_en-US" xlink:label="lab_iart_DebtInstrumentMaximumSellingPriceOfCommonStockOfTheConversionPriceDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum selling price of the company's common stock of the conversion price</link:label>
    <link:label id="lab_iart_DebtInstrumentMaximumSellingPriceOfCommonStockOfTheConversionPriceDuringPeriod_label_en-US" xlink:label="lab_iart_DebtInstrumentMaximumSellingPriceOfCommonStockOfTheConversionPriceDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Maximum Selling Price Of Common Stock Of The Conversion Price During Period</link:label>
    <link:label id="lab_iart_DebtInstrumentMaximumSellingPriceOfCommonStockOfTheConversionPriceDuringPeriod_documentation_en-US" xlink:label="lab_iart_DebtInstrumentMaximumSellingPriceOfCommonStockOfTheConversionPriceDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Maximum Selling Price Of Common Stock Of The Conversion Price During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtInstrumentMaximumSellingPriceOfCommonStockOfTheConversionPriceDuringPeriod" xlink:href="iart-20230331.xsd#iart_DebtInstrumentMaximumSellingPriceOfCommonStockOfTheConversionPriceDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_DebtInstrumentMaximumSellingPriceOfCommonStockOfTheConversionPriceDuringPeriod" xlink:to="lab_iart_DebtInstrumentMaximumSellingPriceOfCommonStockOfTheConversionPriceDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueTransactionPriceMeasurementTaxExclusionPolicyTextBlock_835b9ac4-c554-4129-86b5-c43ac5e197b5_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueTransactionPriceMeasurementTaxExclusionPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes Collected from Customers</link:label>
    <link:label id="lab_us-gaap_RevenueTransactionPriceMeasurementTaxExclusionPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueTransactionPriceMeasurementTaxExclusionPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Transaction Price Measurement, Tax Exclusion [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueTransactionPriceMeasurementTaxExclusionPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueTransactionPriceMeasurementTaxExclusionPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueTransactionPriceMeasurementTaxExclusionPolicyTextBlock" xlink:to="lab_us-gaap_RevenueTransactionPriceMeasurementTaxExclusionPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_6deaa0c7-c74c-463a-94e1-330b93140003_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expiration period</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_9d6693ee-6b0f-47fd-a6b7-6477b9039899_terseLabel_en-US" xlink:label="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]</link:label>
    <link:label id="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_label_en-US" xlink:label="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:to="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_e491bcbb-7524-4c55-89a1-2992306a1567_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of credit, commitment fee percentage</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Commitment Fee Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:to="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_e4a50614-0e8a-4f84-b19d-be394db32770_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeInstrumentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_IntercompanyLoanQuarterlyPayment_8c794fa5-67d0-4c0e-be7a-5db639f9738a_terseLabel_en-US" xlink:label="lab_iart_IntercompanyLoanQuarterlyPayment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intercompany loan quarterly payments</link:label>
    <link:label id="lab_iart_IntercompanyLoanQuarterlyPayment_label_en-US" xlink:label="lab_iart_IntercompanyLoanQuarterlyPayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intercompany Loan, Quarterly Payment</link:label>
    <link:label id="lab_iart_IntercompanyLoanQuarterlyPayment_documentation_en-US" xlink:label="lab_iart_IntercompanyLoanQuarterlyPayment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intercompany Loan, Quarterly Payment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_IntercompanyLoanQuarterlyPayment" xlink:href="iart-20230331.xsd#iart_IntercompanyLoanQuarterlyPayment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_IntercompanyLoanQuarterlyPayment" xlink:to="lab_iart_IntercompanyLoanQuarterlyPayment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_3fcd6391-09dd-4efb-9ceb-7b30020aad8e_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total derivatives designated as hedges &#8212; Assets</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Subject to Master Netting Arrangement, before Offset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_f96d5609-7fe3-4c6d-860d-c1fe59bb1b53_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Operating Lease Maturities</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_ca90820c-930a-4309-a7cc-fa24b15dd6c7_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_82c2fa2a-2d27-4d7b-9f7a-75d110250d59_periodStartLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract liability, Beginning of Period</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_62403f08-f663-41a7-b6b0-5e2a6f3bed94_periodEndLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract liability, End of Period</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiability" xlink:to="lab_us-gaap_ContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_3ae5e107-c049-4594-9472-adadbfc9a3fc_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EuropeMember_ee502b58-fa02-4a93-9514-e29454db6f7e_terseLabel_en-US" xlink:label="lab_srt_EuropeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe</link:label>
    <link:label id="lab_srt_EuropeMember_label_en-US" xlink:label="lab_srt_EuropeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EuropeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EuropeMember" xlink:to="lab_srt_EuropeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_DebtCovenantPeriod1Member_3051e5b6-0458-45b6-bcd3-86aaa1ff6967_terseLabel_en-US" xlink:label="lab_iart_DebtCovenantPeriod1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 31, 2023 through December 31, 2024</link:label>
    <link:label id="lab_iart_DebtCovenantPeriod1Member_label_en-US" xlink:label="lab_iart_DebtCovenantPeriod1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Covenant Period 1 [Member]</link:label>
    <link:label id="lab_iart_DebtCovenantPeriod1Member_documentation_en-US" xlink:label="lab_iart_DebtCovenantPeriod1Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Covenant Period 1</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtCovenantPeriod1Member" xlink:href="iart-20230331.xsd#iart_DebtCovenantPeriod1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_DebtCovenantPeriod1Member" xlink:to="lab_iart_DebtCovenantPeriod1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_3ef5abb9-4a00-4741-89d5-5a3d25a4f64b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_974a27e6-743f-4b48-9d6e-a6e5d6866265_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradeNamesMember_a4312a07-1fd5-445a-aa2a-175ec0cf97e3_terseLabel_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Codman tradename</link:label>
    <link:label id="lab_us-gaap_TradeNamesMember_label_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade Names [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradeNamesMember" xlink:to="lab_us-gaap_TradeNamesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_f37a69c5-97a0-4686-961f-33df80eb6c59_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable_479cdb14-4e73-4981-9085-157c6a12d3f8_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal group, payable recognized</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_FiveYearOptionLeasePeriodOneMember_38059aee-2dc8-4081-bf4c-d11ca28e1709_terseLabel_en-US" xlink:label="lab_iart_FiveYearOptionLeasePeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Five Year Option Lease From November 1, 2029 Through October 31, 2034</link:label>
    <link:label id="lab_iart_FiveYearOptionLeasePeriodOneMember_label_en-US" xlink:label="lab_iart_FiveYearOptionLeasePeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Five Year Option Lease Period One [Member]</link:label>
    <link:label id="lab_iart_FiveYearOptionLeasePeriodOneMember_documentation_en-US" xlink:label="lab_iart_FiveYearOptionLeasePeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Five-Year Option Lease Period One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_FiveYearOptionLeasePeriodOneMember" xlink:href="iart-20230331.xsd#iart_FiveYearOptionLeasePeriodOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_FiveYearOptionLeasePeriodOneMember" xlink:to="lab_iart_FiveYearOptionLeasePeriodOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_ca38c4d2-47e1-492a-8958-3b5a4be894b3_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INVENTORIES</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureTextBlock" xlink:to="lab_us-gaap_InventoryDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_ec63bfd1-653b-4297-8f4a-13cd3551ee8c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Maximum Leverage Ratios</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_942b1523-042d-4844-a134-e0a99528c45a_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingMember_1a695f7d-c52e-4619-a9ee-866c413e9108_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leased facilities</link:label>
    <link:label id="lab_us-gaap_BuildingMember_label_en-US" xlink:label="lab_us-gaap_BuildingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingMember" xlink:to="lab_us-gaap_BuildingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfWarrants_7c6213a9-9540-48d3-b958-1a9fe6e01df0_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfWarrants" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from warrant transactions</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfWarrants_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfWarrants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfWarrants" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfWarrants" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureAbstract" xlink:to="lab_us-gaap_InventoryDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_InterestRateSwapDesignatedDecember152020Tranche2Member_9f5aed46-1fa6-42fc-8cb4-18a22e484672_terseLabel_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedDecember152020Tranche2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated December 15, 2020 Tranche 2</link:label>
    <link:label id="lab_iart_InterestRateSwapDesignatedDecember152020Tranche2Member_label_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedDecember152020Tranche2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated December 15, 2020 Tranche 2 [Member]</link:label>
    <link:label id="lab_iart_InterestRateSwapDesignatedDecember152020Tranche2Member_documentation_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedDecember152020Tranche2Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated December 15, 2020 Tranche 2</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedDecember152020Tranche2Member" xlink:href="iart-20230331.xsd#iart_InterestRateSwapDesignatedDecember152020Tranche2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_InterestRateSwapDesignatedDecember152020Tranche2Member" xlink:to="lab_iart_InterestRateSwapDesignatedDecember152020Tranche2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_20040c0e-6be4-48d0-9dfd-dc3b381a7099_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesFairValueLineItems_2ce97208-7e33-493b-864d-659e6b634419_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesFairValueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Fair Value [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativesFairValueLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativesFairValueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Fair Value [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesFairValueLineItems" xlink:to="lab_us-gaap_DerivativesFairValueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_MergersAcquisitionsAndDispositionsAbstract_label_en-US" xlink:label="lab_iart_MergersAcquisitionsAndDispositionsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mergers, Acquisitions and Dispositions [Abstract]</link:label>
    <link:label id="lab_iart_MergersAcquisitionsAndDispositionsAbstract_documentation_en-US" xlink:label="lab_iart_MergersAcquisitionsAndDispositionsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mergers, Acquisitions and Dispositions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_MergersAcquisitionsAndDispositionsAbstract" xlink:href="iart-20230331.xsd#iart_MergersAcquisitionsAndDispositionsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_MergersAcquisitionsAndDispositionsAbstract" xlink:to="lab_iart_MergersAcquisitionsAndDispositionsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFixedInterestRate_94aa8668-769a-4048-a085-1e90f3ffe08f_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFixedInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed Interest Rate</link:label>
    <link:label id="lab_us-gaap_DerivativeFixedInterestRate_7a526eba-701c-4e72-9764-fd69d84b9ba5_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFixedInterestRate" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed Rate</link:label>
    <link:label id="lab_us-gaap_DerivativeFixedInterestRate_label_en-US" xlink:label="lab_us-gaap_DerivativeFixedInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Fixed Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFixedInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFixedInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFixedInterestRate" xlink:to="lab_us-gaap_DerivativeFixedInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_SurgicalInnovationAssociatesIncMember_e1bb1720-4766-4fbb-b716-3570647fe7e6_terseLabel_en-US" xlink:label="lab_iart_SurgicalInnovationAssociatesIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Surgical Innovation Associates Inc</link:label>
    <link:label id="lab_iart_SurgicalInnovationAssociatesIncMember_label_en-US" xlink:label="lab_iart_SurgicalInnovationAssociatesIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Surgical Innovation Associates Inc [Member]</link:label>
    <link:label id="lab_iart_SurgicalInnovationAssociatesIncMember_documentation_en-US" xlink:label="lab_iart_SurgicalInnovationAssociatesIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Surgical Innovation Associates Inc</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SurgicalInnovationAssociatesIncMember" xlink:href="iart-20230331.xsd#iart_SurgicalInnovationAssociatesIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_SurgicalInnovationAssociatesIncMember" xlink:to="lab_iart_SurgicalInnovationAssociatesIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_69fcc6f5-6db0-48de-a937-9a85c998e60d_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Disaggregation of Revenue</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_f9489361-45dc-4523-8bd7-95746a0abdc0_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_076dcee5-eb7a-4b04-9fd1-dff2230a49bd_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected annual amortization expense, remainder of 2022</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_InterestRateSwapDesignatedDecember182018Tranche1Member_933f4c90-24e8-487d-b700-044c6896be37_terseLabel_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedDecember182018Tranche1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated December 18, 2018 Tranche 1</link:label>
    <link:label id="lab_iart_InterestRateSwapDesignatedDecember182018Tranche1Member_label_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedDecember182018Tranche1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated December 18, 2018 Tranche 1 [Member]</link:label>
    <link:label id="lab_iart_InterestRateSwapDesignatedDecember182018Tranche1Member_documentation_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedDecember182018Tranche1Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated December 18, 2018 Tranche 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedDecember182018Tranche1Member" xlink:href="iart-20230331.xsd#iart_InterestRateSwapDesignatedDecember182018Tranche1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_InterestRateSwapDesignatedDecember182018Tranche1Member" xlink:to="lab_iart_InterestRateSwapDesignatedDecember182018Tranche1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_fc02772e-54de-4c19-a2a9-756fc651a491_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense (Excluding Acquired in Process Cost)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract_f80e6548-9adc-4dde-b91b-6cabc674ed56_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Net Sales</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information, Operating Income (Loss) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract" xlink:to="lab_us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_19dfa0f6-ce0e-42e2-9346-e43097f8a83c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrencySwapMember_361ffdaa-0246-4757-8260-f540ffdfa5b5_terseLabel_en-US" xlink:label="lab_us-gaap_CurrencySwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency swaps</link:label>
    <link:label id="lab_us-gaap_CurrencySwapMember_label_en-US" xlink:label="lab_us-gaap_CurrencySwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrencySwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrencySwapMember" xlink:to="lab_us-gaap_CurrencySwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_ee2698d2-8a53-423d-a056-a5633582b7b3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_DebtCovenantPeriod3Member_c52f08b8-6f8d-41ec-bf78-5fabe563a8ca_terseLabel_en-US" xlink:label="lab_iart_DebtCovenantPeriod3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">September 30, 2026 and the last day of each fiscal quarter thereafter</link:label>
    <link:label id="lab_iart_DebtCovenantPeriod3Member_label_en-US" xlink:label="lab_iart_DebtCovenantPeriod3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Covenant Period 3 [Member]</link:label>
    <link:label id="lab_iart_DebtCovenantPeriod3Member_documentation_en-US" xlink:label="lab_iart_DebtCovenantPeriod3Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Covenant Period 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtCovenantPeriod3Member" xlink:href="iart-20230331.xsd#iart_DebtCovenantPeriod3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_DebtCovenantPeriod3Member" xlink:to="lab_iart_DebtCovenantPeriod3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1e6670e2-3417-43b4-b1bf-d92d5f342ad0_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net decrease in cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_PrivateLabelMember_2249a192-cc99-4435-89d9-02ed157526db_terseLabel_en-US" xlink:label="lab_iart_PrivateLabelMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Private Label</link:label>
    <link:label id="lab_iart_PrivateLabelMember_label_en-US" xlink:label="lab_iart_PrivateLabelMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Private Label [Member]</link:label>
    <link:label id="lab_iart_PrivateLabelMember_documentation_en-US" xlink:label="lab_iart_PrivateLabelMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Private Label [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_PrivateLabelMember" xlink:href="iart-20230331.xsd#iart_PrivateLabelMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_PrivateLabelMember" xlink:to="lab_iart_PrivateLabelMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_AllOtherMember_f1f5d381-a445-490a-a450-c8db9b8a5a20_terseLabel_en-US" xlink:label="lab_iart_AllOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All other</link:label>
    <link:label id="lab_iart_AllOtherMember_label_en-US" xlink:label="lab_iart_AllOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Other [Member]</link:label>
    <link:label id="lab_iart_AllOtherMember_documentation_en-US" xlink:label="lab_iart_AllOtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AllOtherMember" xlink:href="iart-20230331.xsd#iart_AllOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_AllOtherMember" xlink:to="lab_iart_AllOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_AccruedExpensesAndOtherCurrentLiabilitiesMember_85f8deb0-de4c-4a7e-9ca7-06e05958709f_terseLabel_en-US" xlink:label="lab_iart_AccruedExpensesAndOtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses and other current liabilities</link:label>
    <link:label id="lab_iart_AccruedExpensesAndOtherCurrentLiabilitiesMember_label_en-US" xlink:label="lab_iart_AccruedExpensesAndOtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Expenses And Other Current Liabilities [Member]</link:label>
    <link:label id="lab_iart_AccruedExpensesAndOtherCurrentLiabilitiesMember_documentation_en-US" xlink:label="lab_iart_AccruedExpensesAndOtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses and other current liabilities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AccruedExpensesAndOtherCurrentLiabilitiesMember" xlink:href="iart-20230331.xsd#iart_AccruedExpensesAndOtherCurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_AccruedExpensesAndOtherCurrentLiabilitiesMember" xlink:to="lab_iart_AccruedExpensesAndOtherCurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_915a563f-1243-4009-b265-d1495384de1f_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected annual amortization expense, in 2027</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_f450bc4c-0e8d-4b30-9970-799b12735c72_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfSecuredDebt_5f9d05ec-c507-47a9-bf1c-e54e48d07014_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfSecuredDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments on debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfSecuredDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfSecuredDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Secured Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSecuredDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfSecuredDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfSecuredDebt" xlink:to="lab_us-gaap_RepaymentsOfSecuredDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_b78f37ed-ef57-400e-8019-fb4fad98ec4a_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeInterest" xlink:to="lab_us-gaap_InvestmentIncomeInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_BusinessCombinationIntangibleAssetAcquiredDiscountRate_91fc59ac-7293-4785-9e41-876c5aad28e1_terseLabel_en-US" xlink:label="lab_iart_BusinessCombinationIntangibleAssetAcquiredDiscountRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible asset acquired, discount rate (percent)</link:label>
    <link:label id="lab_iart_BusinessCombinationIntangibleAssetAcquiredDiscountRate_label_en-US" xlink:label="lab_iart_BusinessCombinationIntangibleAssetAcquiredDiscountRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Intangible Asset Acquired, Discount Rate</link:label>
    <link:label id="lab_iart_BusinessCombinationIntangibleAssetAcquiredDiscountRate_documentation_en-US" xlink:label="lab_iart_BusinessCombinationIntangibleAssetAcquiredDiscountRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Intangible Asset Acquired, Discount Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_BusinessCombinationIntangibleAssetAcquiredDiscountRate" xlink:href="iart-20230331.xsd#iart_BusinessCombinationIntangibleAssetAcquiredDiscountRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_BusinessCombinationIntangibleAssetAcquiredDiscountRate" xlink:to="lab_iart_BusinessCombinationIntangibleAssetAcquiredDiscountRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_817618f1-6fa2-449f-ad61-c148ea88b402_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d17efa7a-ded9-4bda-b6b2-9dcc684bdb4e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterialsAndPurchasedPartsNetOfReserves_5b16dc9e-8d78-4d1b-9f30-0e0ea7fc56b8_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsAndPurchasedPartsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raw materials</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterialsAndPurchasedPartsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsAndPurchasedPartsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials and Purchased Parts, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsAndPurchasedPartsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterialsAndPurchasedPartsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterialsAndPurchasedPartsNetOfReserves" xlink:to="lab_us-gaap_InventoryRawMaterialsAndPurchasedPartsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock_383abefb-3e3b-420e-99ac-3226066bbd15_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_InterestRateSwapDesignatedDecember152020Tranche1Member_57530515-28db-47c7-8df0-27f5b9372706_terseLabel_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedDecember152020Tranche1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated December 15, 2020 Tranche 1</link:label>
    <link:label id="lab_iart_InterestRateSwapDesignatedDecember152020Tranche1Member_label_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedDecember152020Tranche1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated December 15, 2020 Tranche 1 [Member]</link:label>
    <link:label id="lab_iart_InterestRateSwapDesignatedDecember152020Tranche1Member_documentation_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedDecember152020Tranche1Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated December 15, 2020 Tranche 1</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedDecember152020Tranche1Member" xlink:href="iart-20230331.xsd#iart_InterestRateSwapDesignatedDecember152020Tranche1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_InterestRateSwapDesignatedDecember152020Tranche1Member" xlink:to="lab_iart_InterestRateSwapDesignatedDecember152020Tranche1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_InterestRateSwapDesignatedDecember182018Tranche2Member_7761c456-b4e6-4a6a-b243-3f9db3ca9e5b_terseLabel_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedDecember182018Tranche2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated December 18, 2018 Tranche 2</link:label>
    <link:label id="lab_iart_InterestRateSwapDesignatedDecember182018Tranche2Member_label_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedDecember182018Tranche2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated December 18, 2018 Tranche 2 [Member]</link:label>
    <link:label id="lab_iart_InterestRateSwapDesignatedDecember182018Tranche2Member_documentation_en-US" xlink:label="lab_iart_InterestRateSwapDesignatedDecember182018Tranche2Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Designated December 18, 2018 Tranche 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedDecember182018Tranche2Member" xlink:href="iart-20230331.xsd#iart_InterestRateSwapDesignatedDecember182018Tranche2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_InterestRateSwapDesignatedDecember182018Tranche2Member" xlink:to="lab_iart_InterestRateSwapDesignatedDecember182018Tranche2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_18bf27e2-2cd6-476b-864b-2b8c74087284_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_3d017330-4f03-40a3-8000-4b83f8c2821e_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_2f5d3b80-2906-465a-84fa-44ab1295c571_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_8d3148cd-864f-4f9c-80d2-b74bd7630d9a_terseLabel_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_106e1d79-4bdf-4a3a-ada6-ca004452c3cb_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationPercentage_a9447ed2-c271-4efb-bea3-9df233d4ff00_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected performance obligation through 2021, percentage</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationPercentage_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_02abfbb2-9570-46ec-a5f3-beb4c91806a0_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FINANCING ACTIVITIES:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_88d279fa-3603-4d49-beb8-f4db9b687238_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_ff8d0946-88ea-4c47-b1e3-4fdc1b453b31_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_cbf21a51-3c36-4ae6-abda-86eebc307bb1_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options, weighted average grant date fair value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_2b69a3ba-c027-4eec-be4d-a49da33845de_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_fbd4b61a-3a27-4db6-8967-219319df0438_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_DebtCovenantPeriod2Member_2c50e97c-0544-4808-9ddc-183a741505c7_terseLabel_en-US" xlink:label="lab_iart_DebtCovenantPeriod2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 31, 2025 through June 30, 2026</link:label>
    <link:label id="lab_iart_DebtCovenantPeriod2Member_label_en-US" xlink:label="lab_iart_DebtCovenantPeriod2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Covenant Period 2 [Member]</link:label>
    <link:label id="lab_iart_DebtCovenantPeriod2Member_documentation_en-US" xlink:label="lab_iart_DebtCovenantPeriod2Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Covenant Period 2</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtCovenantPeriod2Member" xlink:href="iart-20230331.xsd#iart_DebtCovenantPeriod2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_DebtCovenantPeriod2Member" xlink:to="lab_iart_DebtCovenantPeriod2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_CashFlowLesseeAbstract_a2ab8485-d6f5-49e5-bd92-9edc40570395_terseLabel_en-US" xlink:label="lab_iart_CashFlowLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for amounts included in the measurement of lease liabilities:</link:label>
    <link:label id="lab_iart_CashFlowLesseeAbstract_label_en-US" xlink:label="lab_iart_CashFlowLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow, Lessee [Abstract]</link:label>
    <link:label id="lab_iart_CashFlowLesseeAbstract_documentation_en-US" xlink:label="lab_iart_CashFlowLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow, Lessee [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CashFlowLesseeAbstract" xlink:href="iart-20230331.xsd#iart_CashFlowLesseeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_CashFlowLesseeAbstract" xlink:to="lab_iart_CashFlowLesseeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_b1c0f091-cf2a-4d8e-85b0-8fe89bcc224e_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain" xlink:to="lab_us-gaap_DisposalGroupClassificationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_ChangesInAssetsAndLiabilitiesAbstract_934d47c5-b1fb-4295-935c-5cff958c2d9f_terseLabel_en-US" xlink:label="lab_iart_ChangesInAssetsAndLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in assets and liabilities:</link:label>
    <link:label id="lab_iart_ChangesInAssetsAndLiabilitiesAbstract_label_en-US" xlink:label="lab_iart_ChangesInAssetsAndLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes In Assets And Liabilities [Abstract]</link:label>
    <link:label id="lab_iart_ChangesInAssetsAndLiabilitiesAbstract_documentation_en-US" xlink:label="lab_iart_ChangesInAssetsAndLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes In Assets And Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ChangesInAssetsAndLiabilitiesAbstract" xlink:href="iart-20230331.xsd#iart_ChangesInAssetsAndLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_ChangesInAssetsAndLiabilitiesAbstract" xlink:to="lab_iart_ChangesInAssetsAndLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_c9fd6b60-cf44-4785-aeb3-70352a93a16a_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_04bbc28e-998e-4d38-b15a-31650bc188a6_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_7e16b155-9674-4c38-bac6-4a68b4bf4f8f_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected annual amortization expense, in 2023</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_24f7e686-00c6-4040-a49c-4c2cd2aa3dc7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic and Diluted Net Income (Loss) Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_30eabb10-e8f9-44d1-aa02-15118ae89ff0_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating leases</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesMember_033b701f-7f0a-4235-8637-4d9e1d73debd_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_label_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesMember" xlink:to="lab_us-gaap_CostOfSalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees_3e770bcc-9174-4470-bad5-2a1aa17baed0_terseLabel_en-US" xlink:label="lab_iart_AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of debt issuance costs and expenses associated with debt refinancing</link:label>
    <link:label id="lab_iart_AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees_label_en-US" xlink:label="lab_iart_AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization Of Debt Issuance Costs And Debt Refinanced Fees</link:label>
    <link:label id="lab_iart_AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees_documentation_en-US" xlink:label="lab_iart_AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization Of Debt Issuance Costs And Debt Refinanced Fees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees" xlink:href="iart-20230331.xsd#iart_AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees" xlink:to="lab_iart_AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees" xlink:type="arc" order="1"/>
    <link:label id="lab_iart_SeniorCreditFacilityMember_dd18d2d3-efa3-499f-979e-4f61a9a204fd_terseLabel_en-US" xlink:label="lab_iart_SeniorCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Credit Facility</link:label>
    <link:label id="lab_iart_SeniorCreditFacilityMember_label_en-US" xlink:label="lab_iart_SeniorCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Credit Facility [Member]</link:label>
    <link:label id="lab_iart_SeniorCreditFacilityMember_documentation_en-US" xlink:label="lab_iart_SeniorCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Credit Facility.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SeniorCreditFacilityMember" xlink:href="iart-20230331.xsd#iart_SeniorCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iart_SeniorCreditFacilityMember" xlink:to="lab_iart_SeniorCreditFacilityMember" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>11
<FILENAME>iart-20230331_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:0e3cd8f8-520d-473a-a9d1-16bfb1ec7d66,g:2b3f0039-4147-46cc-8b95-ac89c1bf8f8d-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://integralife.com/role/Cover" xlink:type="simple" xlink:href="iart-20230331.xsd#Cover"/>
  <link:presentationLink xlink:role="http://integralife.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_5118ff43-0b3e-4168-b2e8-62b2255c4727" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_07253173-84c1-4eaf-b35d-1b7949bf83e6" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5118ff43-0b3e-4168-b2e8-62b2255c4727" xlink:to="loc_dei_DocumentType_07253173-84c1-4eaf-b35d-1b7949bf83e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_1cc25ca1-d02b-4aef-8f37-548cc5ba872c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5118ff43-0b3e-4168-b2e8-62b2255c4727" xlink:to="loc_dei_DocumentQuarterlyReport_1cc25ca1-d02b-4aef-8f37-548cc5ba872c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_c79921c0-f925-43b5-a113-fc8244f1e00d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5118ff43-0b3e-4168-b2e8-62b2255c4727" xlink:to="loc_dei_DocumentPeriodEndDate_c79921c0-f925-43b5-a113-fc8244f1e00d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_6a4d6111-0eff-4d0c-87d1-ac87117af519" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5118ff43-0b3e-4168-b2e8-62b2255c4727" xlink:to="loc_dei_DocumentTransitionReport_6a4d6111-0eff-4d0c-87d1-ac87117af519" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_a9efaf6c-7dba-4a1a-8abb-bbf6cee89bda" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5118ff43-0b3e-4168-b2e8-62b2255c4727" xlink:to="loc_dei_EntityFileNumber_a9efaf6c-7dba-4a1a-8abb-bbf6cee89bda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_f2cdf24a-11f1-4aeb-915a-f85f0e48d8e9" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5118ff43-0b3e-4168-b2e8-62b2255c4727" xlink:to="loc_dei_EntityRegistrantName_f2cdf24a-11f1-4aeb-915a-f85f0e48d8e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_cf856542-ce62-4068-8286-73e005af2d7e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5118ff43-0b3e-4168-b2e8-62b2255c4727" xlink:to="loc_dei_EntityIncorporationStateCountryCode_cf856542-ce62-4068-8286-73e005af2d7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_41d111ca-22e9-4587-96ba-da48113197e9" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5118ff43-0b3e-4168-b2e8-62b2255c4727" xlink:to="loc_dei_EntityTaxIdentificationNumber_41d111ca-22e9-4587-96ba-da48113197e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_bb326e21-89ea-4080-9a05-40c63036c4cd" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5118ff43-0b3e-4168-b2e8-62b2255c4727" xlink:to="loc_dei_EntityAddressAddressLine1_bb326e21-89ea-4080-9a05-40c63036c4cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_eb92b222-8fdd-4512-9d32-f4a2451164cc" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5118ff43-0b3e-4168-b2e8-62b2255c4727" xlink:to="loc_dei_EntityAddressCityOrTown_eb92b222-8fdd-4512-9d32-f4a2451164cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_b3c1548e-54c2-4b7b-8d47-72e529ace464" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5118ff43-0b3e-4168-b2e8-62b2255c4727" xlink:to="loc_dei_EntityAddressStateOrProvince_b3c1548e-54c2-4b7b-8d47-72e529ace464" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_91344a5b-b00d-4d7b-8629-6c58e1f091fe" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5118ff43-0b3e-4168-b2e8-62b2255c4727" xlink:to="loc_dei_EntityAddressPostalZipCode_91344a5b-b00d-4d7b-8629-6c58e1f091fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_0c4f56d6-0cac-4179-b6b0-9114c28397ff" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5118ff43-0b3e-4168-b2e8-62b2255c4727" xlink:to="loc_dei_CityAreaCode_0c4f56d6-0cac-4179-b6b0-9114c28397ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_80518ddc-dc80-4b78-a769-a6011c88761e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5118ff43-0b3e-4168-b2e8-62b2255c4727" xlink:to="loc_dei_LocalPhoneNumber_80518ddc-dc80-4b78-a769-a6011c88761e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_2b1d3243-afb1-4232-8687-6936937ce7a1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5118ff43-0b3e-4168-b2e8-62b2255c4727" xlink:to="loc_dei_Security12bTitle_2b1d3243-afb1-4232-8687-6936937ce7a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_23a93328-9239-4b40-87d7-9324b9774db3" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5118ff43-0b3e-4168-b2e8-62b2255c4727" xlink:to="loc_dei_TradingSymbol_23a93328-9239-4b40-87d7-9324b9774db3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_0f7349cd-3f20-4ea6-a734-93aaa42f338f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5118ff43-0b3e-4168-b2e8-62b2255c4727" xlink:to="loc_dei_SecurityExchangeName_0f7349cd-3f20-4ea6-a734-93aaa42f338f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_0caf64bb-bf6a-445b-b6d4-6ae3dcaed31f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5118ff43-0b3e-4168-b2e8-62b2255c4727" xlink:to="loc_dei_EntityCurrentReportingStatus_0caf64bb-bf6a-445b-b6d4-6ae3dcaed31f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_dedda3d8-d47a-43a4-a99a-9dd977342574" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5118ff43-0b3e-4168-b2e8-62b2255c4727" xlink:to="loc_dei_EntityInteractiveDataCurrent_dedda3d8-d47a-43a4-a99a-9dd977342574" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_b74bffe2-860b-4f42-a36d-ebf1751ebfd0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5118ff43-0b3e-4168-b2e8-62b2255c4727" xlink:to="loc_dei_EntityFilerCategory_b74bffe2-860b-4f42-a36d-ebf1751ebfd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_e28e92f7-8cff-4c48-8ccc-a7ce9c4076ff" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5118ff43-0b3e-4168-b2e8-62b2255c4727" xlink:to="loc_dei_EntitySmallBusiness_e28e92f7-8cff-4c48-8ccc-a7ce9c4076ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_d6985fc8-38a5-41b8-a968-bb69036030bd" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5118ff43-0b3e-4168-b2e8-62b2255c4727" xlink:to="loc_dei_EntityEmergingGrowthCompany_d6985fc8-38a5-41b8-a968-bb69036030bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_78a39b05-dcfe-4ec9-894b-abc829c08ee8" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5118ff43-0b3e-4168-b2e8-62b2255c4727" xlink:to="loc_dei_EntityShellCompany_78a39b05-dcfe-4ec9-894b-abc829c08ee8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_7f697112-f5e4-45c8-b750-75b8dbe90a3a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5118ff43-0b3e-4168-b2e8-62b2255c4727" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_7f697112-f5e4-45c8-b750-75b8dbe90a3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_1e167e27-cfe8-429a-816d-596d47a7336e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5118ff43-0b3e-4168-b2e8-62b2255c4727" xlink:to="loc_dei_AmendmentFlag_1e167e27-cfe8-429a-816d-596d47a7336e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_43c53222-3d2f-419c-a3b8-f1acabe8e04d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5118ff43-0b3e-4168-b2e8-62b2255c4727" xlink:to="loc_dei_DocumentFiscalYearFocus_43c53222-3d2f-419c-a3b8-f1acabe8e04d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_31364689-f5e9-4a17-82c9-444839ea85ad" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5118ff43-0b3e-4168-b2e8-62b2255c4727" xlink:to="loc_dei_DocumentFiscalPeriodFocus_31364689-f5e9-4a17-82c9-444839ea85ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_150cfcfd-b594-4a0b-a0cf-9039c52f3928" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5118ff43-0b3e-4168-b2e8-62b2255c4727" xlink:to="loc_dei_EntityCentralIndexKey_150cfcfd-b594-4a0b-a0cf-9039c52f3928" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_7963f643-986d-4b31-a9bb-1d455af81231" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5118ff43-0b3e-4168-b2e8-62b2255c4727" xlink:to="loc_dei_CurrentFiscalYearEndDate_7963f643-986d-4b31-a9bb-1d455af81231" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED" xlink:type="simple" xlink:href="iart-20230331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED"/>
  <link:presentationLink xlink:role="http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_30ce5635-a732-4085-a471-af106c639509" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_96d768c0-cdee-484a-a310-532a4ed73834" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_30ce5635-a732-4085-a471-af106c639509" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_96d768c0-cdee-484a-a310-532a4ed73834" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpensesAbstract_d8bc70b0-c92a-4192-bc25-8768c7d59fa1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_30ce5635-a732-4085-a471-af106c639509" xlink:to="loc_us-gaap_CostsAndExpensesAbstract_d8bc70b0-c92a-4192-bc25-8768c7d59fa1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_12f5e15e-681b-48df-a148-27a6ee5609cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_d8bc70b0-c92a-4192-bc25-8768c7d59fa1" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_12f5e15e-681b-48df-a148-27a6ee5609cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_72a79c65-ad55-4d95-9992-d2544cd173ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_d8bc70b0-c92a-4192-bc25-8768c7d59fa1" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_72a79c65-ad55-4d95-9992-d2544cd173ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_17bd9945-61da-44f8-a408-e1a1113bc264" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_d8bc70b0-c92a-4192-bc25-8768c7d59fa1" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_17bd9945-61da-44f8-a408-e1a1113bc264" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_a5afadf7-a14c-45e7-a30b-7fbd4ad79035" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_d8bc70b0-c92a-4192-bc25-8768c7d59fa1" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_a5afadf7-a14c-45e7-a30b-7fbd4ad79035" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_bddd8676-f17c-489c-9db4-ca65884e89d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_d8bc70b0-c92a-4192-bc25-8768c7d59fa1" xlink:to="loc_us-gaap_CostsAndExpenses_bddd8676-f17c-489c-9db4-ca65884e89d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_5c95a2fd-fa91-4cb1-8a6f-05c1dd8d2f0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_30ce5635-a732-4085-a471-af106c639509" xlink:to="loc_us-gaap_OperatingIncomeLoss_5c95a2fd-fa91-4cb1-8a6f-05c1dd8d2f0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_8e8e5116-11cc-4fb2-8da1-d2e4516951c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_30ce5635-a732-4085-a471-af106c639509" xlink:to="loc_us-gaap_InvestmentIncomeInterest_8e8e5116-11cc-4fb2-8da1-d2e4516951c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_2662ac6e-6829-4dc3-b611-1f97cf5e546d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_30ce5635-a732-4085-a471-af106c639509" xlink:to="loc_us-gaap_InterestExpense_2662ac6e-6829-4dc3-b611-1f97cf5e546d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_8c306270-ec75-4cd6-abeb-ae95e44b1066" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_30ce5635-a732-4085-a471-af106c639509" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_8c306270-ec75-4cd6-abeb-ae95e44b1066" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_ee62156b-ba0e-4210-9419-99fbd2c945e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_30ce5635-a732-4085-a471-af106c639509" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_ee62156b-ba0e-4210-9419-99fbd2c945e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_eeb079b6-182a-4986-976f-896278246e1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_30ce5635-a732-4085-a471-af106c639509" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_eeb079b6-182a-4986-976f-896278246e1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_c3eb953b-0de5-4e16-ae5f-0808e23b48e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_30ce5635-a732-4085-a471-af106c639509" xlink:to="loc_us-gaap_NetIncomeLoss_c3eb953b-0de5-4e16-ae5f-0808e23b48e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_cc1e31cc-e7fd-43e5-9622-b343089839b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_30ce5635-a732-4085-a471-af106c639509" xlink:to="loc_us-gaap_EarningsPerShareAbstract_cc1e31cc-e7fd-43e5-9622-b343089839b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_65078c1f-d493-4ea8-868c-826a21b2f5ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_cc1e31cc-e7fd-43e5-9622-b343089839b8" xlink:to="loc_us-gaap_EarningsPerShareBasic_65078c1f-d493-4ea8-868c-826a21b2f5ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_7dd59433-4163-448b-a721-ed917d6c630d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_cc1e31cc-e7fd-43e5-9622-b343089839b8" xlink:to="loc_us-gaap_EarningsPerShareDiluted_7dd59433-4163-448b-a721-ed917d6c630d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_0c93aeac-0d7d-4851-b52d-a2042f7ed1e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_30ce5635-a732-4085-a471-af106c639509" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_0c93aeac-0d7d-4851-b52d-a2042f7ed1e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_6111b7f3-a23e-435d-b995-8b7e379861cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_0c93aeac-0d7d-4851-b52d-a2042f7ed1e6" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_6111b7f3-a23e-435d-b995-8b7e379861cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_114d0895-0beb-4368-a9c6-d432803f8c06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_0c93aeac-0d7d-4851-b52d-a2042f7ed1e6" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_114d0895-0beb-4368-a9c6-d432803f8c06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_853e19f5-6dca-4893-89b6-0c7de7d1184d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_30ce5635-a732-4085-a471-af106c639509" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_853e19f5-6dca-4893-89b6-0c7de7d1184d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" xlink:type="simple" xlink:href="iart-20230331.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"/>
  <link:presentationLink xlink:role="http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_980e4f88-808a-4e02-b081-4fa41f868e1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_b972b8ab-abd5-457d-8e1a-b8f9fc8f275b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_980e4f88-808a-4e02-b081-4fa41f868e1c" xlink:to="loc_us-gaap_AssetsAbstract_b972b8ab-abd5-457d-8e1a-b8f9fc8f275b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_f7d6f378-d6d4-4a68-a6d2-83ffc798715c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_b972b8ab-abd5-457d-8e1a-b8f9fc8f275b" xlink:to="loc_us-gaap_AssetsCurrentAbstract_f7d6f378-d6d4-4a68-a6d2-83ffc798715c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_99318024-d39f-4553-975e-32f95ad8659e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f7d6f378-d6d4-4a68-a6d2-83ffc798715c" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_99318024-d39f-4553-975e-32f95ad8659e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_9b8fb139-0e64-4066-bca7-55a9f9a71248" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f7d6f378-d6d4-4a68-a6d2-83ffc798715c" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_9b8fb139-0e64-4066-bca7-55a9f9a71248" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_9d3500af-5c7f-4216-b869-1fc7a91b51fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f7d6f378-d6d4-4a68-a6d2-83ffc798715c" xlink:to="loc_us-gaap_InventoryNet_9d3500af-5c7f-4216-b869-1fc7a91b51fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_05f64cba-2a94-470b-ac84-dfa32170cf29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f7d6f378-d6d4-4a68-a6d2-83ffc798715c" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_05f64cba-2a94-470b-ac84-dfa32170cf29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_4d7bc588-43cb-4a71-a8aa-c955373ddf3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f7d6f378-d6d4-4a68-a6d2-83ffc798715c" xlink:to="loc_us-gaap_AssetsCurrent_4d7bc588-43cb-4a71-a8aa-c955373ddf3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_d749e904-8be1-4992-8caa-a36cbb7a59e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_b972b8ab-abd5-457d-8e1a-b8f9fc8f275b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_d749e904-8be1-4992-8caa-a36cbb7a59e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_969b05f5-d77e-474f-871a-2322a84a1857" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_b972b8ab-abd5-457d-8e1a-b8f9fc8f275b" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_969b05f5-d77e-474f-871a-2322a84a1857" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_af62fbc3-8fa6-49d9-91eb-8fa9ae637afe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_b972b8ab-abd5-457d-8e1a-b8f9fc8f275b" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_af62fbc3-8fa6-49d9-91eb-8fa9ae637afe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_3c6bb6ce-ba79-40fb-960b-72d21737474a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_b972b8ab-abd5-457d-8e1a-b8f9fc8f275b" xlink:to="loc_us-gaap_Goodwill_3c6bb6ce-ba79-40fb-960b-72d21737474a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_cb99d215-461e-427e-ba2a-42a49030c1b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_b972b8ab-abd5-457d-8e1a-b8f9fc8f275b" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_cb99d215-461e-427e-ba2a-42a49030c1b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_7bbb6d2b-4447-4cc2-a5eb-86e3989cae72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_b972b8ab-abd5-457d-8e1a-b8f9fc8f275b" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_7bbb6d2b-4447-4cc2-a5eb-86e3989cae72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_652373b7-a413-4533-8bc4-598450262b5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_b972b8ab-abd5-457d-8e1a-b8f9fc8f275b" xlink:to="loc_us-gaap_Assets_652373b7-a413-4533-8bc4-598450262b5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_fe8e0f18-ada2-4a78-88cf-987810576cb8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_980e4f88-808a-4e02-b081-4fa41f868e1c" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_fe8e0f18-ada2-4a78-88cf-987810576cb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_f101cbbe-65b6-4b61-a269-c6bab45d6424" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_fe8e0f18-ada2-4a78-88cf-987810576cb8" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_f101cbbe-65b6-4b61-a269-c6bab45d6424" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtCurrent_26813b82-6273-4f39-b251-b6f6be580811" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebtCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_f101cbbe-65b6-4b61-a269-c6bab45d6424" xlink:to="loc_us-gaap_SecuredDebtCurrent_26813b82-6273-4f39-b251-b6f6be580811" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_75211b03-7925-40b2-8d37-9e0b3753f8fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_f101cbbe-65b6-4b61-a269-c6bab45d6424" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_75211b03-7925-40b2-8d37-9e0b3753f8fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableTradeCurrent_477980e0-d0d3-4735-8971-6ac1efea19e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_f101cbbe-65b6-4b61-a269-c6bab45d6424" xlink:to="loc_us-gaap_AccountsPayableTradeCurrent_477980e0-d0d3-4735-8971-6ac1efea19e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_be73100b-a233-41f4-ae7e-f8665084ba69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_f101cbbe-65b6-4b61-a269-c6bab45d6424" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_be73100b-a233-41f4-ae7e-f8665084ba69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_1050a03c-03c4-4561-bad8-db279b4a7ac5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_f101cbbe-65b6-4b61-a269-c6bab45d6424" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_1050a03c-03c4-4561-bad8-db279b4a7ac5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_55e8c210-f5dd-4ee6-ba4c-dbdf07499761" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_f101cbbe-65b6-4b61-a269-c6bab45d6424" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_55e8c210-f5dd-4ee6-ba4c-dbdf07499761" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_1e61a588-3cea-4529-bd2e-75233268784a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_f101cbbe-65b6-4b61-a269-c6bab45d6424" xlink:to="loc_us-gaap_LiabilitiesCurrent_1e61a588-3cea-4529-bd2e-75233268784a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredLongTermDebt_86a05642-310a-497c-9c39-9d9b3bff848d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredLongTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_fe8e0f18-ada2-4a78-88cf-987810576cb8" xlink:to="loc_us-gaap_SecuredLongTermDebt_86a05642-310a-497c-9c39-9d9b3bff848d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SecuredLongTermDebtSecuritizationProgramNoncurrent_2445f262-ee80-4c37-9c3d-6a556197703f" xlink:href="iart-20230331.xsd#iart_SecuredLongTermDebtSecuritizationProgramNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_fe8e0f18-ada2-4a78-88cf-987810576cb8" xlink:to="loc_iart_SecuredLongTermDebtSecuritizationProgramNoncurrent_2445f262-ee80-4c37-9c3d-6a556197703f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtNoncurrent_65203787-18f0-41cf-8ea0-8b3a2d7d6195" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_fe8e0f18-ada2-4a78-88cf-987810576cb8" xlink:to="loc_us-gaap_ConvertibleDebtNoncurrent_65203787-18f0-41cf-8ea0-8b3a2d7d6195" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_448173d8-5546-47c3-b30f-8c3dbca3022f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_fe8e0f18-ada2-4a78-88cf-987810576cb8" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_448173d8-5546-47c3-b30f-8c3dbca3022f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_2857f405-2213-4368-9107-0a28ffc4704f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_fe8e0f18-ada2-4a78-88cf-987810576cb8" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_2857f405-2213-4368-9107-0a28ffc4704f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_77143853-201b-4dbb-adb1-381d9829af74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_fe8e0f18-ada2-4a78-88cf-987810576cb8" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_77143853-201b-4dbb-adb1-381d9829af74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_9a03a1fb-57d8-49b5-ac76-9e9e16bc45b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_fe8e0f18-ada2-4a78-88cf-987810576cb8" xlink:to="loc_us-gaap_Liabilities_9a03a1fb-57d8-49b5-ac76-9e9e16bc45b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_573d6f73-fd5b-4420-8dd3-fa21b4ee3e66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_fe8e0f18-ada2-4a78-88cf-987810576cb8" xlink:to="loc_us-gaap_StockholdersEquityAbstract_573d6f73-fd5b-4420-8dd3-fa21b4ee3e66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_cd86a743-b6ef-4ae4-b33b-85e7611ad1d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_573d6f73-fd5b-4420-8dd3-fa21b4ee3e66" xlink:to="loc_us-gaap_PreferredStockValue_cd86a743-b6ef-4ae4-b33b-85e7611ad1d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_3acfe718-dc2c-4dfa-9294-f20bea1b88f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_573d6f73-fd5b-4420-8dd3-fa21b4ee3e66" xlink:to="loc_us-gaap_CommonStockValue_3acfe718-dc2c-4dfa-9294-f20bea1b88f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_72257784-6ae6-4593-8b08-516c07ed59c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_573d6f73-fd5b-4420-8dd3-fa21b4ee3e66" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_72257784-6ae6-4593-8b08-516c07ed59c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_053188c4-de1c-4166-a214-eaf448442e4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_573d6f73-fd5b-4420-8dd3-fa21b4ee3e66" xlink:to="loc_us-gaap_TreasuryStockValue_053188c4-de1c-4166-a214-eaf448442e4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_86a706f3-bc86-4ad9-ad37-d63d2223bdc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_573d6f73-fd5b-4420-8dd3-fa21b4ee3e66" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_86a706f3-bc86-4ad9-ad37-d63d2223bdc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_e02c1144-a1ca-4e8d-a1d7-5d7c179eb0ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_573d6f73-fd5b-4420-8dd3-fa21b4ee3e66" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_e02c1144-a1ca-4e8d-a1d7-5d7c179eb0ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_b678d70f-4b3a-4c9d-a83f-ed67c345acb1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_573d6f73-fd5b-4420-8dd3-fa21b4ee3e66" xlink:to="loc_us-gaap_StockholdersEquity_b678d70f-4b3a-4c9d-a83f-ed67c345acb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_8da16ac5-6c7d-4327-a18f-e4660961715f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_fe8e0f18-ada2-4a78-88cf-987810576cb8" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_8da16ac5-6c7d-4327-a18f-e4660961715f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITEDParenthetical" xlink:type="simple" xlink:href="iart-20230331.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITEDParenthetical"/>
  <link:presentationLink xlink:role="http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITEDParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_cdd7570a-eca0-4cec-b670-e899d40b5929" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_a8dc1132-a6a4-4eec-8fe3-cd07fe2434de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_cdd7570a-eca0-4cec-b670-e899d40b5929" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_a8dc1132-a6a4-4eec-8fe3-cd07fe2434de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_5b1ea0b6-3d7b-45e1-a023-2941f676fb47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_cdd7570a-eca0-4cec-b670-e899d40b5929" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_5b1ea0b6-3d7b-45e1-a023-2941f676fb47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_e9138554-f580-4e74-847c-541c06282cd8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_cdd7570a-eca0-4cec-b670-e899d40b5929" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_e9138554-f580-4e74-847c-541c06282cd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_d9370d0b-9d78-47bd-99c0-28c0bf6f4f3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_cdd7570a-eca0-4cec-b670-e899d40b5929" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_d9370d0b-9d78-47bd-99c0-28c0bf6f4f3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_b450aefe-c59b-4d50-97ff-82469fbb41cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_cdd7570a-eca0-4cec-b670-e899d40b5929" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_b450aefe-c59b-4d50-97ff-82469fbb41cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_a4fc2d56-d558-4f4a-a498-64b3e88ca700" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_cdd7570a-eca0-4cec-b670-e899d40b5929" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_a4fc2d56-d558-4f4a-a498-64b3e88ca700" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_c84056a3-123e-45a0-ba99-bb23a0832d50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_cdd7570a-eca0-4cec-b670-e899d40b5929" xlink:to="loc_us-gaap_CommonStockSharesIssued_c84056a3-123e-45a0-ba99-bb23a0832d50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_853ac214-483b-4ba4-ac11-ccec9f029566" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_cdd7570a-eca0-4cec-b670-e899d40b5929" xlink:to="loc_us-gaap_TreasuryStockShares_853ac214-483b-4ba4-ac11-ccec9f029566" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" xlink:type="simple" xlink:href="iart-20230331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"/>
  <link:presentationLink xlink:role="http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_e2e0eed8-f585-46c8-ad9a-0a6d9ff59e67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_81359b79-ec2a-4773-a6b2-24ff5e680523" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_e2e0eed8-f585-46c8-ad9a-0a6d9ff59e67" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_81359b79-ec2a-4773-a6b2-24ff5e680523" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_4054fc88-103d-4143-b0b1-d30219d1590d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_81359b79-ec2a-4773-a6b2-24ff5e680523" xlink:to="loc_us-gaap_NetIncomeLoss_4054fc88-103d-4143-b0b1-d30219d1590d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_51024011-e1f0-4ab2-bc13-0349bf09f92b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_81359b79-ec2a-4773-a6b2-24ff5e680523" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_51024011-e1f0-4ab2-bc13-0349bf09f92b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDepreciationAndAmortization_1b431e8e-7633-4a65-b354-ca7a080c1ec4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherDepreciationAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_51024011-e1f0-4ab2-bc13-0349bf09f92b" xlink:to="loc_us-gaap_OtherDepreciationAndAmortization_1b431e8e-7633-4a65-b354-ca7a080c1ec4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_896862aa-cb0a-45e8-a95e-fb61f22a9829" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_51024011-e1f0-4ab2-bc13-0349bf09f92b" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_896862aa-cb0a-45e8-a95e-fb61f22a9829" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_1ae9cc57-a95a-46dd-a6ee-15259a524e80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_51024011-e1f0-4ab2-bc13-0349bf09f92b" xlink:to="loc_us-gaap_ShareBasedCompensation_1ae9cc57-a95a-46dd-a6ee-15259a524e80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees_10d86692-0311-4975-a95b-8eac2b704690" xlink:href="iart-20230331.xsd#iart_AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_51024011-e1f0-4ab2-bc13-0349bf09f92b" xlink:to="loc_iart_AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees_10d86692-0311-4975-a95b-8eac2b704690" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_NoncashLeaseExpense_fb648659-e71e-4556-91ab-284100d7f7cb" xlink:href="iart-20230331.xsd#iart_NoncashLeaseExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_51024011-e1f0-4ab2-bc13-0349bf09f92b" xlink:to="loc_iart_NoncashLeaseExpense_fb648659-e71e-4556-91ab-284100d7f7cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets_d3f37fb2-d2a1-4e8d-8ff3-c6b1db9a7ff1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnDispositionOfAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_51024011-e1f0-4ab2-bc13-0349bf09f92b" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets_d3f37fb2-d2a1-4e8d-8ff3-c6b1db9a7ff1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_084e520d-2fcb-4099-9361-ad1001f4145c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_51024011-e1f0-4ab2-bc13-0349bf09f92b" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_084e520d-2fcb-4099-9361-ad1001f4145c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ChangesInAssetsAndLiabilitiesAbstract_7a74ef68-70f4-4b17-b843-4d89477937ba" xlink:href="iart-20230331.xsd#iart_ChangesInAssetsAndLiabilitiesAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_51024011-e1f0-4ab2-bc13-0349bf09f92b" xlink:to="loc_iart_ChangesInAssetsAndLiabilitiesAbstract_7a74ef68-70f4-4b17-b843-4d89477937ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_fa41ec32-2125-4fd0-97b3-efa451c92271" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_ChangesInAssetsAndLiabilitiesAbstract_7a74ef68-70f4-4b17-b843-4d89477937ba" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_fa41ec32-2125-4fd0-97b3-efa451c92271" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_b0c5f831-30c1-4826-900b-3221e4cab4d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_ChangesInAssetsAndLiabilitiesAbstract_7a74ef68-70f4-4b17-b843-4d89477937ba" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_b0c5f831-30c1-4826-900b-3221e4cab4d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_a0e545dd-2972-47ec-a588-7eef5dfe52fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_ChangesInAssetsAndLiabilitiesAbstract_7a74ef68-70f4-4b17-b843-4d89477937ba" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_a0e545dd-2972-47ec-a588-7eef5dfe52fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_e140a798-9f0e-4308-903a-3073d1806a58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_ChangesInAssetsAndLiabilitiesAbstract_7a74ef68-70f4-4b17-b843-4d89477937ba" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_e140a798-9f0e-4308-903a-3073d1806a58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_6de2d618-af47-4c20-8f65-a672367786f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_ChangesInAssetsAndLiabilitiesAbstract_7a74ef68-70f4-4b17-b843-4d89477937ba" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_6de2d618-af47-4c20-8f65-a672367786f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_9997b09c-4d6f-4b63-a47e-edcd33564d41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_ChangesInAssetsAndLiabilitiesAbstract_7a74ef68-70f4-4b17-b843-4d89477937ba" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_9997b09c-4d6f-4b63-a47e-edcd33564d41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3153f003-788e-4cc8-9e99-a278e10f0ffc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_51024011-e1f0-4ab2-bc13-0349bf09f92b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3153f003-788e-4cc8-9e99-a278e10f0ffc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b16c6599-99e1-40ed-84ed-8365a3e2d8d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_e2e0eed8-f585-46c8-ad9a-0a6d9ff59e67" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b16c6599-99e1-40ed-84ed-8365a3e2d8d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_7896b2e0-59be-45d6-9ff3-73b101ac6c73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b16c6599-99e1-40ed-84ed-8365a3e2d8d1" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_7896b2e0-59be-45d6-9ff3-73b101ac6c73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment_8e4185de-41e6-461d-a624-bfb136d9978e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b16c6599-99e1-40ed-84ed-8365a3e2d8d1" xlink:to="loc_us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment_8e4185de-41e6-461d-a624-bfb136d9978e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_b9b844a5-ecfd-4818-b839-ff7f86226b0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b16c6599-99e1-40ed-84ed-8365a3e2d8d1" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_b9b844a5-ecfd-4818-b839-ff7f86226b0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_e62f0302-336e-4204-9b39-1e1ac79456c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_e2e0eed8-f585-46c8-ad9a-0a6d9ff59e67" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_e62f0302-336e-4204-9b39-1e1ac79456c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSecuredDebt_bf4b0f21-a8e0-4ea9-bcbb-2afcc0887eea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSecuredDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_e62f0302-336e-4204-9b39-1e1ac79456c0" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSecuredDebt_bf4b0f21-a8e0-4ea9-bcbb-2afcc0887eea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSecuredDebt_950213da-d517-4e2c-8d41-2cf2ffab9615" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfSecuredDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_e62f0302-336e-4204-9b39-1e1ac79456c0" xlink:to="loc_us-gaap_RepaymentsOfSecuredDebt_950213da-d517-4e2c-8d41-2cf2ffab9615" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_2fa173cd-fbca-4a69-a701-96a8f1a38aa9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_e62f0302-336e-4204-9b39-1e1ac79456c0" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_2fa173cd-fbca-4a69-a701-96a8f1a38aa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_40db914c-ba99-4371-bb78-1f9dd087a189" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_e62f0302-336e-4204-9b39-1e1ac79456c0" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_40db914c-ba99-4371-bb78-1f9dd087a189" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_cc807b7f-b0ae-4381-a866-1c2fe498e486" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_e62f0302-336e-4204-9b39-1e1ac79456c0" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_cc807b7f-b0ae-4381-a866-1c2fe498e486" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_1520688f-3018-4cb8-89a7-5f5063f8c2d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_e62f0302-336e-4204-9b39-1e1ac79456c0" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_1520688f-3018-4cb8-89a7-5f5063f8c2d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_6d978d18-2039-4925-b426-bf18d3d79cbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_e62f0302-336e-4204-9b39-1e1ac79456c0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_6d978d18-2039-4925-b426-bf18d3d79cbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1974927e-ccf8-4434-893f-5bd7561f0628" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_e2e0eed8-f585-46c8-ad9a-0a6d9ff59e67" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1974927e-ccf8-4434-893f-5bd7561f0628" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_f5b27e1c-1ac6-4966-9b97-48d6f286c0f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_e2e0eed8-f585-46c8-ad9a-0a6d9ff59e67" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_f5b27e1c-1ac6-4966-9b97-48d6f286c0f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_9916b217-bc91-4461-9b8e-badefb88a434" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_e2e0eed8-f585-46c8-ad9a-0a6d9ff59e67" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_9916b217-bc91-4461-9b8e-badefb88a434" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c9809be7-1a2e-469b-bbc3-f5fcbf7f26ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_e2e0eed8-f585-46c8-ad9a-0a6d9ff59e67" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c9809be7-1a2e-469b-bbc3-f5fcbf7f26ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUNAUDITED" xlink:type="simple" xlink:href="iart-20230331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUNAUDITED"/>
  <link:presentationLink xlink:role="http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUNAUDITED" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_3cad2c1f-a426-40a6-9971-5cc1838b07b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_ef97a230-a586-41bf-92fb-aa05afb9321b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_3cad2c1f-a426-40a6-9971-5cc1838b07b2" xlink:to="loc_us-gaap_StatementTable_ef97a230-a586-41bf-92fb-aa05afb9321b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_35cba81b-6606-475d-875a-223d5e248ef2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_ef97a230-a586-41bf-92fb-aa05afb9321b" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_35cba81b-6606-475d-875a-223d5e248ef2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_a046491c-3532-4af1-89d4-14294a458803" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_35cba81b-6606-475d-875a-223d5e248ef2" xlink:to="loc_us-gaap_EquityComponentDomain_a046491c-3532-4af1-89d4-14294a458803" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_b0829400-d678-4781-a8e0-63431e80bffc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_a046491c-3532-4af1-89d4-14294a458803" xlink:to="loc_us-gaap_CommonStockMember_b0829400-d678-4781-a8e0-63431e80bffc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_8733ef3a-c31e-40fb-af85-d497e5fd2595" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_a046491c-3532-4af1-89d4-14294a458803" xlink:to="loc_us-gaap_TreasuryStockMember_8733ef3a-c31e-40fb-af85-d497e5fd2595" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_095dd3c5-8435-4841-9df3-00db061ccb61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_a046491c-3532-4af1-89d4-14294a458803" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_095dd3c5-8435-4841-9df3-00db061ccb61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_c9c6cddf-c959-4f22-8f22-5a4cf529f857" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_a046491c-3532-4af1-89d4-14294a458803" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_c9c6cddf-c959-4f22-8f22-5a4cf529f857" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_57dd2bb8-6da0-4c6b-b2fe-eec44354b41b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_a046491c-3532-4af1-89d4-14294a458803" xlink:to="loc_us-gaap_RetainedEarningsMember_57dd2bb8-6da0-4c6b-b2fe-eec44354b41b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_ea89147b-d050-4400-9cd2-bbe332551498" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_ef97a230-a586-41bf-92fb-aa05afb9321b" xlink:to="loc_us-gaap_StatementLineItems_ea89147b-d050-4400-9cd2-bbe332551498" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_84444d4a-08bc-41cc-8fc5-8478f10075e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ea89147b-d050-4400-9cd2-bbe332551498" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_84444d4a-08bc-41cc-8fc5-8478f10075e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_aa8a8ca8-c862-4f5d-916d-809218d78496" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_84444d4a-08bc-41cc-8fc5-8478f10075e9" xlink:to="loc_us-gaap_SharesIssued_aa8a8ca8-c862-4f5d-916d-809218d78496" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_bdd0578f-cf0d-402e-b35b-68dab7391d29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_84444d4a-08bc-41cc-8fc5-8478f10075e9" xlink:to="loc_us-gaap_StockholdersEquity_bdd0578f-cf0d-402e-b35b-68dab7391d29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_4a25069c-be6e-4691-9576-4f9ad48e9313" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_84444d4a-08bc-41cc-8fc5-8478f10075e9" xlink:to="loc_us-gaap_TreasuryStockShares_4a25069c-be6e-4691-9576-4f9ad48e9313" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_551bd3de-ffab-4415-bb8d-a225f59bffbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_84444d4a-08bc-41cc-8fc5-8478f10075e9" xlink:to="loc_us-gaap_NetIncomeLoss_551bd3de-ffab-4415-bb8d-a225f59bffbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_9c01a171-ff58-4220-a194-8c9b77133025" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_84444d4a-08bc-41cc-8fc5-8478f10075e9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_9c01a171-ff58-4220-a194-8c9b77133025" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_b3269622-8c75-4ec7-93b8-a4266b9d3466" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_84444d4a-08bc-41cc-8fc5-8478f10075e9" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_b3269622-8c75-4ec7-93b8-a4266b9d3466" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_a6237c5f-2163-4f47-ac23-3257e51ba00f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_84444d4a-08bc-41cc-8fc5-8478f10075e9" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_a6237c5f-2163-4f47-ac23-3257e51ba00f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_2f21c9de-d624-4a2d-a4e8-16b7acec57c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_84444d4a-08bc-41cc-8fc5-8478f10075e9" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_2f21c9de-d624-4a2d-a4e8-16b7acec57c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_09939b38-a818-42bc-8e96-5a04688eab66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_84444d4a-08bc-41cc-8fc5-8478f10075e9" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_09939b38-a818-42bc-8e96-5a04688eab66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_b628c90e-a581-45d0-ac68-bdd1eccf37dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_84444d4a-08bc-41cc-8fc5-8478f10075e9" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_b628c90e-a581-45d0-ac68-bdd1eccf37dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_18663ec6-47f5-4ff5-935a-ce529e0ea99f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_84444d4a-08bc-41cc-8fc5-8478f10075e9" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_18663ec6-47f5-4ff5-935a-ce529e0ea99f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_ef92b9a8-f8c0-4cf2-90d2-5efd8bcd62a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_84444d4a-08bc-41cc-8fc5-8478f10075e9" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_ef92b9a8-f8c0-4cf2-90d2-5efd8bcd62a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_e059c8b6-b45e-4b89-a8ff-2aef3544f7cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssued"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_84444d4a-08bc-41cc-8fc5-8478f10075e9" xlink:to="loc_us-gaap_SharesIssued_e059c8b6-b45e-4b89-a8ff-2aef3544f7cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_f07b5163-dd19-49a3-8f0b-121643c74e7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_84444d4a-08bc-41cc-8fc5-8478f10075e9" xlink:to="loc_us-gaap_StockholdersEquity_f07b5163-dd19-49a3-8f0b-121643c74e7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_ee2c8f69-7374-4fb0-b963-f66a1ffec991" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_84444d4a-08bc-41cc-8fc5-8478f10075e9" xlink:to="loc_us-gaap_TreasuryStockShares_ee2c8f69-7374-4fb0-b963-f66a1ffec991" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/BASISOFPRESENTATION" xlink:type="simple" xlink:href="iart-20230331.xsd#BASISOFPRESENTATION"/>
  <link:presentationLink xlink:role="http://integralife.com/role/BASISOFPRESENTATION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0da7d365-0506-4bd4-96d5-0eb825b6248f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_85336fc5-7945-41ab-9a8d-53f5ed503a18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0da7d365-0506-4bd4-96d5-0eb825b6248f" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_85336fc5-7945-41ab-9a8d-53f5ed503a18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/ACQUISITIONSANDDIVESTITURES" xlink:type="simple" xlink:href="iart-20230331.xsd#ACQUISITIONSANDDIVESTITURES"/>
  <link:presentationLink xlink:role="http://integralife.com/role/ACQUISITIONSANDDIVESTITURES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_iart_MergersAcquisitionsAndDispositionsAbstract_edbe6518-4bd2-4eaa-ab2e-5301a06d3d4b" xlink:href="iart-20230331.xsd#iart_MergersAcquisitionsAndDispositionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_f1a4cb95-3086-4957-8c26-4048af32bf9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_MergersAcquisitionsAndDispositionsAbstract_edbe6518-4bd2-4eaa-ab2e-5301a06d3d4b" xlink:to="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_f1a4cb95-3086-4957-8c26-4048af32bf9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERS" xlink:type="simple" xlink:href="iart-20230331.xsd#REVENUESFROMCONTRACTSWITHCUSTOMERS"/>
  <link:presentationLink xlink:role="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_2947bbcf-7c65-4e97-9bd3-82c9c70de1ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_8905f5b8-53f7-4623-b197-af2a534bdd9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_2947bbcf-7c65-4e97-9bd3-82c9c70de1ff" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_8905f5b8-53f7-4623-b197-af2a534bdd9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/INVENTORIES" xlink:type="simple" xlink:href="iart-20230331.xsd#INVENTORIES"/>
  <link:presentationLink xlink:role="http://integralife.com/role/INVENTORIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_e86bde19-3abb-4740-a5f3-45cd3c11c4ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock_66e6209f-5e2d-4c86-9916-f29f434d0b59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_e86bde19-3abb-4740-a5f3-45cd3c11c4ad" xlink:to="loc_us-gaap_InventoryDisclosureTextBlock_66e6209f-5e2d-4c86-9916-f29f434d0b59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETS" xlink:type="simple" xlink:href="iart-20230331.xsd#GOODWILLANDOTHERINTANGIBLEASSETS"/>
  <link:presentationLink xlink:role="http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_df402f35-c09a-4c44-8e71-2f170823983c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_dbf7cf24-7765-49b4-a4c4-59b29f5c9c57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_df402f35-c09a-4c44-8e71-2f170823983c" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_dbf7cf24-7765-49b4-a4c4-59b29f5c9c57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/DEBT" xlink:type="simple" xlink:href="iart-20230331.xsd#DEBT"/>
  <link:presentationLink xlink:role="http://integralife.com/role/DEBT" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_bf4c4a4c-60ef-4443-b829-c95620db5c47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_22040255-88fc-4dbc-84ea-f9e012045845" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_bf4c4a4c-60ef-4443-b829-c95620db5c47" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_22040255-88fc-4dbc-84ea-f9e012045845" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/DERIVATIVEINSTRUMENTS" xlink:type="simple" xlink:href="iart-20230331.xsd#DERIVATIVEINSTRUMENTS"/>
  <link:presentationLink xlink:role="http://integralife.com/role/DERIVATIVEINSTRUMENTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_df442499-84f6-4a6c-991f-85db2fae20a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_37c66f01-51ae-4dfa-a968-e08c6e489a02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_df442499-84f6-4a6c-991f-85db2fae20a0" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_37c66f01-51ae-4dfa-a968-e08c6e489a02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/STOCKBASEDCOMPENSATION" xlink:type="simple" xlink:href="iart-20230331.xsd#STOCKBASEDCOMPENSATION"/>
  <link:presentationLink xlink:role="http://integralife.com/role/STOCKBASEDCOMPENSATION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f1f488d1-ffa6-479c-bad1-033a5409ce0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_57f9ff89-2051-43b8-bb00-c6c07262d91b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f1f488d1-ffa6-479c-bad1-033a5409ce0c" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_57f9ff89-2051-43b8-bb00-c6c07262d91b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/RETIREMENTPLANS" xlink:type="simple" xlink:href="iart-20230331.xsd#RETIREMENTPLANS"/>
  <link:presentationLink xlink:role="http://integralife.com/role/RETIREMENTPLANS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_f9e60ff5-8699-4c66-a05c-4ee42a3023cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_209c95c2-7b92-472c-b8d5-87be5e307320" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_f9e60ff5-8699-4c66-a05c-4ee42a3023cf" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_209c95c2-7b92-472c-b8d5-87be5e307320" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/LEASESANDRELATEDPARTYLEASES" xlink:type="simple" xlink:href="iart-20230331.xsd#LEASESANDRELATEDPARTYLEASES"/>
  <link:presentationLink xlink:role="http://integralife.com/role/LEASESANDRELATEDPARTYLEASES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_9bbdc722-a4b9-40a0-aa76-0ee1085aeb0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_7441aea6-cbe4-456e-a865-4504236aa110" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_9bbdc722-a4b9-40a0-aa76-0ee1085aeb0f" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_7441aea6-cbe4-456e-a865-4504236aa110" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/TREASURYSTOCK" xlink:type="simple" xlink:href="iart-20230331.xsd#TREASURYSTOCK"/>
  <link:presentationLink xlink:role="http://integralife.com/role/TREASURYSTOCK" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_19b6fbf9-d3c0-4fb0-a9d7-a129213d81ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockTextBlock_74cd5b7b-7c46-4164-b135-9e707ed695f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_19b6fbf9-d3c0-4fb0-a9d7-a129213d81ba" xlink:to="loc_us-gaap_TreasuryStockTextBlock_74cd5b7b-7c46-4164-b135-9e707ed695f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/INCOMETAXES" xlink:type="simple" xlink:href="iart-20230331.xsd#INCOMETAXES"/>
  <link:presentationLink xlink:role="http://integralife.com/role/INCOMETAXES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_58c447b0-96b9-42a2-b445-f968eceb26f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_afecf27b-be64-4666-9b0d-3d18956bb1f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_58c447b0-96b9-42a2-b445-f968eceb26f2" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_afecf27b-be64-4666-9b0d-3d18956bb1f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/NETINCOMEPERSHARE" xlink:type="simple" xlink:href="iart-20230331.xsd#NETINCOMEPERSHARE"/>
  <link:presentationLink xlink:role="http://integralife.com/role/NETINCOMEPERSHARE" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_23eb68ef-2212-4db9-845c-f18d2cf133a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_9a9107aa-bb6d-47a2-88c4-df2b6d63ac81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_23eb68ef-2212-4db9-845c-f18d2cf133a7" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_9a9107aa-bb6d-47a2-88c4-df2b6d63ac81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSS" xlink:type="simple" xlink:href="iart-20230331.xsd#ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSS"/>
  <link:presentationLink xlink:role="http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_0956921e-0042-4b91-bf1f-a415e4c3b53e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_a06a418c-a607-427b-bfae-6fd9c60b662c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_0956921e-0042-4b91-bf1f-a415e4c3b53e" xlink:to="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_a06a418c-a607-427b-bfae-6fd9c60b662c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATION" xlink:type="simple" xlink:href="iart-20230331.xsd#SEGMENTANDGEOGRAPHICINFORMATION"/>
  <link:presentationLink xlink:role="http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_4c814ec1-635e-42ad-ba92-d72a08a3b856" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_60b9ffac-b29c-4177-95c6-8e3f1da01195" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_4c814ec1-635e-42ad-ba92-d72a08a3b856" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_60b9ffac-b29c-4177-95c6-8e3f1da01195" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/COMMITMENTSANDCONTINGENCIES" xlink:type="simple" xlink:href="iart-20230331.xsd#COMMITMENTSANDCONTINGENCIES"/>
  <link:presentationLink xlink:role="http://integralife.com/role/COMMITMENTSANDCONTINGENCIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_346ce730-0f66-412f-be31-da3e972aeb6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_7c4896f3-56d1-4306-a94b-6bd7e49cc7f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_346ce730-0f66-412f-be31-da3e972aeb6b" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_7c4896f3-56d1-4306-a94b-6bd7e49cc7f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/BASISOFPRESENTATIONPolicies" xlink:type="simple" xlink:href="iart-20230331.xsd#BASISOFPRESENTATIONPolicies"/>
  <link:presentationLink xlink:role="http://integralife.com/role/BASISOFPRESENTATIONPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_9622eded-c60a-4db0-a389-6ffed9e1c03f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_9559b74e-6c74-42d6-843f-fdcc9623bb93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_9622eded-c60a-4db0-a389-6ffed9e1c03f" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_9559b74e-6c74-42d6-843f-fdcc9623bb93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_a9ee1682-f13c-4ee8-8d12-72be69c8feb6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_9622eded-c60a-4db0-a389-6ffed9e1c03f" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_a9ee1682-f13c-4ee8-8d12-72be69c8feb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_5329e59e-759e-4761-afba-016b57238bf8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_9622eded-c60a-4db0-a389-6ffed9e1c03f" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_5329e59e-759e-4761-afba-016b57238bf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtendedProductWarrantyPolicy_efd8f65d-72ec-4208-9b00-9189264ee6ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtendedProductWarrantyPolicy"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_9622eded-c60a-4db0-a389-6ffed9e1c03f" xlink:to="loc_us-gaap_ExtendedProductWarrantyPolicy_efd8f65d-72ec-4208-9b00-9189264ee6ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueTransactionPriceMeasurementTaxExclusionPolicyTextBlock_9271e75e-f3f1-4d11-b264-685a83d03cda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueTransactionPriceMeasurementTaxExclusionPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_9622eded-c60a-4db0-a389-6ffed9e1c03f" xlink:to="loc_us-gaap_RevenueTransactionPriceMeasurementTaxExclusionPolicyTextBlock_9271e75e-f3f1-4d11-b264-685a83d03cda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/ACQUISITIONSANDDIVESTITURESTables" xlink:type="simple" xlink:href="iart-20230331.xsd#ACQUISITIONSANDDIVESTITURESTables"/>
  <link:presentationLink xlink:role="http://integralife.com/role/ACQUISITIONSANDDIVESTITURESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_iart_MergersAcquisitionsAndDispositionsAbstract_b66171a8-70e2-4004-93e1-d6296cd93fd1" xlink:href="iart-20230331.xsd#iart_MergersAcquisitionsAndDispositionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_c29a812b-06e1-4a75-a41e-84eabc5ff06c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_MergersAcquisitionsAndDispositionsAbstract_b66171a8-70e2-4004-93e1-d6296cd93fd1" xlink:to="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_c29a812b-06e1-4a75-a41e-84eabc5ff06c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSTables" xlink:type="simple" xlink:href="iart-20230331.xsd#REVENUESFROMCONTRACTSWITHCUSTOMERSTables"/>
  <link:presentationLink xlink:role="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_a90128fd-f3bd-446a-8c0d-b5584b0371a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_c4b48055-688a-47f3-8ba1-a42d2ebe0592" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_a90128fd-f3bd-446a-8c0d-b5584b0371a7" xlink:to="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_c4b48055-688a-47f3-8ba1-a42d2ebe0592" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_6ee3fc57-ab53-42cd-8ec4-bf8a970a8485" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_a90128fd-f3bd-446a-8c0d-b5584b0371a7" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_6ee3fc57-ab53-42cd-8ec4-bf8a970a8485" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/INVENTORIESTables" xlink:type="simple" xlink:href="iart-20230331.xsd#INVENTORIESTables"/>
  <link:presentationLink xlink:role="http://integralife.com/role/INVENTORIESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_4cf0a6f2-d519-42a7-a457-7057c5c69d07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_92080055-2257-4fba-b6bc-df0ccb3640ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_4cf0a6f2-d519-42a7-a457-7057c5c69d07" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_92080055-2257-4fba-b6bc-df0ccb3640ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables" xlink:type="simple" xlink:href="iart-20230331.xsd#GOODWILLANDOTHERINTANGIBLEASSETSTables"/>
  <link:presentationLink xlink:role="http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_1477f9e2-c6a8-4b83-9668-4b34476c996e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_7de492bd-717c-45f5-8ab0-1a7f9b799611" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_1477f9e2-c6a8-4b83-9668-4b34476c996e" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_7de492bd-717c-45f5-8ab0-1a7f9b799611" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_cd07815c-6076-4cb4-a2aa-4aa198b3b06e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_1477f9e2-c6a8-4b83-9668-4b34476c996e" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_cd07815c-6076-4cb4-a2aa-4aa198b3b06e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_871797e3-e6fe-4b86-becc-c9a636dcbe88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_1477f9e2-c6a8-4b83-9668-4b34476c996e" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_871797e3-e6fe-4b86-becc-c9a636dcbe88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/DEBTTables" xlink:type="simple" xlink:href="iart-20230331.xsd#DEBTTables"/>
  <link:presentationLink xlink:role="http://integralife.com/role/DEBTTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_8327aec2-1ae6-4b86-9f9f-11d1cfc69cef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_2abb00e0-2939-46f5-8047-3ab1d7b17fcc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_8327aec2-1ae6-4b86-9f9f-11d1cfc69cef" xlink:to="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_2abb00e0-2939-46f5-8047-3ab1d7b17fcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_f3577fac-94a1-43b7-88ea-e97ae7fef3d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_8327aec2-1ae6-4b86-9f9f-11d1cfc69cef" xlink:to="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_f3577fac-94a1-43b7-88ea-e97ae7fef3d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/DERIVATIVEINSTRUMENTSTables" xlink:type="simple" xlink:href="iart-20230331.xsd#DERIVATIVEINSTRUMENTSTables"/>
  <link:presentationLink xlink:role="http://integralife.com/role/DERIVATIVEINSTRUMENTSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_5b382fc7-0947-4082-8e0c-04c8f824a3d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_bcadf668-ff38-46e5-ba00-51b5c534501a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeInstrumentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_5b382fc7-0947-4082-8e0c-04c8f824a3d7" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_bcadf668-ff38-46e5-ba00-51b5c534501a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_7a438f6e-8c56-4fec-b40c-cae1422803f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_5b382fc7-0947-4082-8e0c-04c8f824a3d7" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_7a438f6e-8c56-4fec-b40c-cae1422803f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_34b6c7e0-5364-4ae9-877b-33f16d0f595f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_5b382fc7-0947-4082-8e0c-04c8f824a3d7" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_34b6c7e0-5364-4ae9-877b-33f16d0f595f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_afa54b49-f8a3-4a9b-8b47-808f4c88bac4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_5b382fc7-0947-4082-8e0c-04c8f824a3d7" xlink:to="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_afa54b49-f8a3-4a9b-8b47-808f4c88bac4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESTables" xlink:type="simple" xlink:href="iart-20230331.xsd#LEASESANDRELATEDPARTYLEASESTables"/>
  <link:presentationLink xlink:role="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_24710c8f-c471-4f4a-a5af-42b86be4c8a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AssetsAndLiabilitiesLesseeTableTextBlock_dc64ff9d-6736-40d1-9ae8-c956a97400c8" xlink:href="iart-20230331.xsd#iart_AssetsAndLiabilitiesLesseeTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_24710c8f-c471-4f4a-a5af-42b86be4c8a3" xlink:to="loc_iart_AssetsAndLiabilitiesLesseeTableTextBlock_dc64ff9d-6736-40d1-9ae8-c956a97400c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CashFlowLesseeTableTextBlock_a3237cc8-50d7-4b33-b883-1d462d1c6847" xlink:href="iart-20230331.xsd#iart_CashFlowLesseeTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_24710c8f-c471-4f4a-a5af-42b86be4c8a3" xlink:to="loc_iart_CashFlowLesseeTableTextBlock_a3237cc8-50d7-4b33-b883-1d462d1c6847" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_4c8e0b41-6fd1-4c34-a501-355ab45bea97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_24710c8f-c471-4f4a-a5af-42b86be4c8a3" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_4c8e0b41-6fd1-4c34-a501-355ab45bea97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/INCOMETAXESTables" xlink:type="simple" xlink:href="iart-20230331.xsd#INCOMETAXESTables"/>
  <link:presentationLink xlink:role="http://integralife.com/role/INCOMETAXESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_f1edc466-817b-471f-a44f-7417c7c868ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_0b374367-0157-4bf4-ac0e-2103c5e52843" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f1edc466-817b-471f-a44f-7417c7c868ce" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_0b374367-0157-4bf4-ac0e-2103c5e52843" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/NETINCOMEPERSHARETables" xlink:type="simple" xlink:href="iart-20230331.xsd#NETINCOMEPERSHARETables"/>
  <link:presentationLink xlink:role="http://integralife.com/role/NETINCOMEPERSHARETables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_6601dd5f-dccd-4056-b256-123a177a9c6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_8170329d-ab31-44a5-afb6-c1a20b52ec23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_6601dd5f-dccd-4056-b256-123a177a9c6a" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_8170329d-ab31-44a5-afb6-c1a20b52ec23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSTables" xlink:type="simple" xlink:href="iart-20230331.xsd#ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSTables"/>
  <link:presentationLink xlink:role="http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_5804070c-848c-4b97-a42a-611e8668c761" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock_5ab2c88d-ca36-406d-9cf8-40382d6e1f5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_5804070c-848c-4b97-a42a-611e8668c761" xlink:to="loc_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock_5ab2c88d-ca36-406d-9cf8-40382d6e1f5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_207fcde4-8a81-47c4-82c3-15d18d552ffd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_5804070c-848c-4b97-a42a-611e8668c761" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_207fcde4-8a81-47c4-82c3-15d18d552ffd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTables" xlink:type="simple" xlink:href="iart-20230331.xsd#SEGMENTANDGEOGRAPHICINFORMATIONTables"/>
  <link:presentationLink xlink:role="http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_164319d0-3156-4657-bd49-e296fa330fc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_6f713f05-dda6-478e-8671-811f76807ecb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_164319d0-3156-4657-bd49-e296fa330fc4" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_6f713f05-dda6-478e-8671-811f76807ecb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_5bcb0990-63b3-4044-b6c1-e85ab248d97c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_164319d0-3156-4657-bd49-e296fa330fc4" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_5bcb0990-63b3-4044-b6c1-e85ab248d97c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/COMMITMENTSANDCONTINGENCIESTables" xlink:type="simple" xlink:href="iart-20230331.xsd#COMMITMENTSANDCONTINGENCIESTables"/>
  <link:presentationLink xlink:role="http://integralife.com/role/COMMITMENTSANDCONTINGENCIESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_42266b71-ecb6-41e9-aae5-2c96ac45ab51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_ce8f4039-6248-4c6c-a9b5-3947297179f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_42266b71-ecb6-41e9-aae5-2c96ac45ab51" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_ce8f4039-6248-4c6c-a9b5-3947297179f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationNarrativeDetails" xlink:type="simple" xlink:href="iart-20230331.xsd#ACQUISITIONSANDDIVESTITURESBusinessCombinationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_iart_MergersAcquisitionsAndDispositionsAbstract_bce0f93c-c818-4f27-b576-68de2f8111ea" xlink:href="iart-20230331.xsd#iart_MergersAcquisitionsAndDispositionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_caf8a69d-b700-4267-b3d2-27919c840f50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_MergersAcquisitionsAndDispositionsAbstract_bce0f93c-c818-4f27-b576-68de2f8111ea" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_caf8a69d-b700-4267-b3d2-27919c840f50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_356e3d5b-13f6-4c0d-80e1-bc4c646c73c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_caf8a69d-b700-4267-b3d2-27919c840f50" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_356e3d5b-13f6-4c0d-80e1-bc4c646c73c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9442030e-f7df-4582-9ab4-e34b18b98225" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_356e3d5b-13f6-4c0d-80e1-bc4c646c73c9" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9442030e-f7df-4582-9ab4-e34b18b98225" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SurgicalInnovationAssociatesIncMember_4d4b967c-ba06-48b6-abd2-7658dfdf81bc" xlink:href="iart-20230331.xsd#iart_SurgicalInnovationAssociatesIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9442030e-f7df-4582-9ab4-e34b18b98225" xlink:to="loc_iart_SurgicalInnovationAssociatesIncMember_4d4b967c-ba06-48b6-abd2-7658dfdf81bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_206def7f-6d62-4def-866f-c7269fa672a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_caf8a69d-b700-4267-b3d2-27919c840f50" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_206def7f-6d62-4def-866f-c7269fa672a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_226dcaa9-9490-487f-9b11-ef6e93235bda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_206def7f-6d62-4def-866f-c7269fa672a5" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_226dcaa9-9490-487f-9b11-ef6e93235bda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_RevenueBasedPerformanceMilestonesMember_fab407a8-b675-45b4-8ca2-50a3411d1e56" xlink:href="iart-20230331.xsd#iart_RevenueBasedPerformanceMilestonesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_226dcaa9-9490-487f-9b11-ef6e93235bda" xlink:to="loc_iart_RevenueBasedPerformanceMilestonesMember_fab407a8-b675-45b4-8ca2-50a3411d1e56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_FDAApprovalOfPremarketApprovalMember_a48fc723-88b1-46e8-93c4-42295957a86e" xlink:href="iart-20230331.xsd#iart_FDAApprovalOfPremarketApprovalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_226dcaa9-9490-487f-9b11-ef6e93235bda" xlink:to="loc_iart_FDAApprovalOfPremarketApprovalMember_a48fc723-88b1-46e8-93c4-42295957a86e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_e550aa6e-a1fb-4c18-9fce-d507f125b030" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_caf8a69d-b700-4267-b3d2-27919c840f50" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_e550aa6e-a1fb-4c18-9fce-d507f125b030" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_0804ae04-a64b-4533-980f-60a9c2825503" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e550aa6e-a1fb-4c18-9fce-d507f125b030" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_0804ae04-a64b-4533-980f-60a9c2825503" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_BusinessAcquisitionNumberOfContingentLiabilities_82536f50-8992-4bc6-be4c-141a0cfd2370" xlink:href="iart-20230331.xsd#iart_BusinessAcquisitionNumberOfContingentLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e550aa6e-a1fb-4c18-9fce-d507f125b030" xlink:to="loc_iart_BusinessAcquisitionNumberOfContingentLiabilities_82536f50-8992-4bc6-be4c-141a0cfd2370" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_7f89a141-24d6-46ab-8a04-77a4c45e2685" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e550aa6e-a1fb-4c18-9fce-d507f125b030" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_7f89a141-24d6-46ab-8a04-77a4c45e2685" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_BusinessCombinationIntangibleAssetAcquiredDiscountRate_b4b29c64-575f-4d8d-b18d-49ff7b84d03f" xlink:href="iart-20230331.xsd#iart_BusinessCombinationIntangibleAssetAcquiredDiscountRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e550aa6e-a1fb-4c18-9fce-d507f125b030" xlink:to="loc_iart_BusinessCombinationIntangibleAssetAcquiredDiscountRate_b4b29c64-575f-4d8d-b18d-49ff7b84d03f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_b78ab744-c01e-4edb-9551-94178537fac8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e550aa6e-a1fb-4c18-9fce-d507f125b030" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_b78ab744-c01e-4edb-9551-94178537fac8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_8fdd789c-0a35-4b66-8dfa-f7b5b28b5756" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e550aa6e-a1fb-4c18-9fce-d507f125b030" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_8fdd789c-0a35-4b66-8dfa-f7b5b28b5756" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_b1ed6389-719e-4eda-a091-34e6a51f42bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e550aa6e-a1fb-4c18-9fce-d507f125b030" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_b1ed6389-719e-4eda-a091-34e6a51f42bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails" xlink:type="simple" xlink:href="iart-20230331.xsd#ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_iart_MergersAcquisitionsAndDispositionsAbstract_007e4328-dba3-4294-9c16-deb58e495017" xlink:href="iart-20230331.xsd#iart_MergersAcquisitionsAndDispositionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_932b19f2-d841-4895-b22c-4a52d101fe2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_MergersAcquisitionsAndDispositionsAbstract_007e4328-dba3-4294-9c16-deb58e495017" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_932b19f2-d841-4895-b22c-4a52d101fe2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_5da3a72d-de8d-42ce-b95c-ce488a3cd1e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_932b19f2-d841-4895-b22c-4a52d101fe2c" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_5da3a72d-de8d-42ce-b95c-ce488a3cd1e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1ae69d75-587c-4621-b48e-85603390f8e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_5da3a72d-de8d-42ce-b95c-ce488a3cd1e6" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1ae69d75-587c-4621-b48e-85603390f8e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SurgicalInnovationAssociatesIncMember_a0a7e938-6b4f-4f36-9d4c-15b9fa59a7b4" xlink:href="iart-20230331.xsd#iart_SurgicalInnovationAssociatesIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1ae69d75-587c-4621-b48e-85603390f8e0" xlink:to="loc_iart_SurgicalInnovationAssociatesIncMember_a0a7e938-6b4f-4f36-9d4c-15b9fa59a7b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_a5c8c27e-a3f4-4d78-9b25-54f8be4f98e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_932b19f2-d841-4895-b22c-4a52d101fe2c" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_a5c8c27e-a3f4-4d78-9b25-54f8be4f98e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract_e7642665-6c04-4d1b-b43b-1b6c5ca44684" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a5c8c27e-a3f4-4d78-9b25-54f8be4f98e0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract_e7642665-6c04-4d1b-b43b-1b6c5ca44684" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_30095b7d-b15f-4848-9d10-fada50371c34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract_e7642665-6c04-4d1b-b43b-1b6c5ca44684" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_30095b7d-b15f-4848-9d10-fada50371c34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_57d75cf3-4873-4d25-ba02-d971abed8782" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract_e7642665-6c04-4d1b-b43b-1b6c5ca44684" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_57d75cf3-4873-4d25-ba02-d971abed8782" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_9714310a-0856-4a1e-9bca-e1a28f7ca517" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract_e7642665-6c04-4d1b-b43b-1b6c5ca44684" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_9714310a-0856-4a1e-9bca-e1a28f7ca517" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_bed41a78-085f-4cf4-a92b-939f96b0bb4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract_e7642665-6c04-4d1b-b43b-1b6c5ca44684" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_bed41a78-085f-4cf4-a92b-939f96b0bb4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_e3edbec1-355b-46ad-b9e3-5261acdf4832" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract_e7642665-6c04-4d1b-b43b-1b6c5ca44684" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_e3edbec1-355b-46ad-b9e3-5261acdf4832" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_91cd697e-7a57-4481-9281-4f25d098fe98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a5c8c27e-a3f4-4d78-9b25-54f8be4f98e0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_91cd697e-7a57-4481-9281-4f25d098fe98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_9144a366-51e3-4de8-a88f-4c2abd7ab5e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a5c8c27e-a3f4-4d78-9b25-54f8be4f98e0" xlink:to="loc_us-gaap_Goodwill_9144a366-51e3-4de8-a88f-4c2abd7ab5e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_26b8fec2-7737-4c27-be23-d277c4cb393f" xlink:href="iart-20230331.xsd#iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a5c8c27e-a3f4-4d78-9b25-54f8be4f98e0" xlink:to="loc_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_26b8fec2-7737-4c27-be23-d277c4cb393f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract_c475b5b5-bdc9-4282-a20d-b998d773227f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a5c8c27e-a3f4-4d78-9b25-54f8be4f98e0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract_c475b5b5-bdc9-4282-a20d-b998d773227f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_c6529aa8-1e1b-42b3-9efc-49924128db71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract_c475b5b5-bdc9-4282-a20d-b998d773227f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_c6529aa8-1e1b-42b3-9efc-49924128db71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_d4869ecd-caea-440a-ac08-0c659f14b7c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract_c475b5b5-bdc9-4282-a20d-b998d773227f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_d4869ecd-caea-440a-ac08-0c659f14b7c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_de53b5bc-bd7e-4fb6-9b37-1ae1c26b672c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a5c8c27e-a3f4-4d78-9b25-54f8be4f98e0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_de53b5bc-bd7e-4fb6-9b37-1ae1c26b672c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability_0b957452-9a64-4f6c-905c-18f69ada6c57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a5c8c27e-a3f4-4d78-9b25-54f8be4f98e0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability_0b957452-9a64-4f6c-905c-18f69ada6c57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_7879cbd6-fb5d-41d2-bd4b-18c1c86aa51a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a5c8c27e-a3f4-4d78-9b25-54f8be4f98e0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_7879cbd6-fb5d-41d2-bd4b-18c1c86aa51a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_ffd3ed21-a903-4d27-95f2-b0acfbf81cfa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a5c8c27e-a3f4-4d78-9b25-54f8be4f98e0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_ffd3ed21-a903-4d27-95f2-b0acfbf81cfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_2df815c4-401f-4b09-8be4-bff12f883956" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a5c8c27e-a3f4-4d78-9b25-54f8be4f98e0" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_2df815c4-401f-4b09-8be4-bff12f883956" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/ACQUISITIONSANDDIVESTITURESDivestituresNarrativeDetails" xlink:type="simple" xlink:href="iart-20230331.xsd#ACQUISITIONSANDDIVESTITURESDivestituresNarrativeDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/ACQUISITIONSANDDIVESTITURESDivestituresNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_iart_MergersAcquisitionsAndDispositionsAbstract_7a258fff-773a-4a18-9508-d09a9a4fb5bf" xlink:href="iart-20230331.xsd#iart_MergersAcquisitionsAndDispositionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_d724d567-8f58-45f8-9ed3-f4a252af0239" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_MergersAcquisitionsAndDispositionsAbstract_7a258fff-773a-4a18-9508-d09a9a4fb5bf" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_d724d567-8f58-45f8-9ed3-f4a252af0239" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_7b35d0e3-f769-4b02-bf87-36f587942da8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_d724d567-8f58-45f8-9ed3-f4a252af0239" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_7b35d0e3-f769-4b02-bf87-36f587942da8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_8fef1017-0368-4f50-8df4-e8bcdaad7ef5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_7b35d0e3-f769-4b02-bf87-36f587942da8" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_8fef1017-0368-4f50-8df4-e8bcdaad7ef5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_c7ae5181-103e-42a8-8d14-2d2d2f3bf1f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_8fef1017-0368-4f50-8df4-e8bcdaad7ef5" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_c7ae5181-103e-42a8-8d14-2d2d2f3bf1f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_22434595-2c3e-4af9-9e3c-64e3aa4462c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_d724d567-8f58-45f8-9ed3-f4a252af0239" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_22434595-2c3e-4af9-9e3c-64e3aa4462c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_5b90646e-f75e-4605-a862-7b82939a5a23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_22434595-2c3e-4af9-9e3c-64e3aa4462c8" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_5b90646e-f75e-4605-a862-7b82939a5a23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_TraditionalWoundCareMember_01976f8c-80d1-4dc8-97d4-790179441315" xlink:href="iart-20230331.xsd#iart_TraditionalWoundCareMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_5b90646e-f75e-4605-a862-7b82939a5a23" xlink:to="loc_iart_TraditionalWoundCareMember_01976f8c-80d1-4dc8-97d4-790179441315" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7b71ed3e-3f64-4f7b-9ff5-2858b47f21fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_d724d567-8f58-45f8-9ed3-f4a252af0239" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7b71ed3e-3f64-4f7b-9ff5-2858b47f21fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_bda4a3fe-3b76-4a60-9cd2-7eedda485ed8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7b71ed3e-3f64-4f7b-9ff5-2858b47f21fc" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_bda4a3fe-3b76-4a60-9cd2-7eedda485ed8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_3cf11cdf-2b76-4ee3-ae8a-db0a7f3b52a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7b71ed3e-3f64-4f7b-9ff5-2858b47f21fc" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_3cf11cdf-2b76-4ee3-ae8a-db0a7f3b52a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsideration_38f94f40-fbf0-4ee9-99c8-f26d2584656e" xlink:href="iart-20230331.xsd#iart_DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsideration"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7b71ed3e-3f64-4f7b-9ff5-2858b47f21fc" xlink:to="loc_iart_DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsideration_38f94f40-fbf0-4ee9-99c8-f26d2584656e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsiderationPeriod_74ee45d1-a9cf-45b3-9518-5474d3463e7f" xlink:href="iart-20230331.xsd#iart_DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsiderationPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7b71ed3e-3f64-4f7b-9ff5-2858b47f21fc" xlink:to="loc_iart_DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsiderationPeriod_74ee45d1-a9cf-45b3-9518-5474d3463e7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashDivestedFromDeconsolidation_813b7324-dc08-4c97-a2ea-b5c59de8ab56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashDivestedFromDeconsolidation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7b71ed3e-3f64-4f7b-9ff5-2858b47f21fc" xlink:to="loc_us-gaap_CashDivestedFromDeconsolidation_813b7324-dc08-4c97-a2ea-b5c59de8ab56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_362881b0-509e-4166-9148-603d70af206e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7b71ed3e-3f64-4f7b-9ff5-2858b47f21fc" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_362881b0-509e-4166-9148-603d70af206e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DiscontinuedOperationContinuingInvolvementPrepaidAsset_f2288ee4-1a9e-4514-a6c7-bc5e884b8c27" xlink:href="iart-20230331.xsd#iart_DiscontinuedOperationContinuingInvolvementPrepaidAsset"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7b71ed3e-3f64-4f7b-9ff5-2858b47f21fc" xlink:to="loc_iart_DiscontinuedOperationContinuingInvolvementPrepaidAsset_f2288ee4-1a9e-4514-a6c7-bc5e884b8c27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DiscontinuedOperationContinuingInvolvementPrepaidAssetsCurrent_c723d8a9-80d2-4b1c-b239-60fe9ace261a" xlink:href="iart-20230331.xsd#iart_DiscontinuedOperationContinuingInvolvementPrepaidAssetsCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7b71ed3e-3f64-4f7b-9ff5-2858b47f21fc" xlink:to="loc_iart_DiscontinuedOperationContinuingInvolvementPrepaidAssetsCurrent_c723d8a9-80d2-4b1c-b239-60fe9ace261a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable_8f381c50-526c-40e9-932d-6353ed9c94b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7b71ed3e-3f64-4f7b-9ff5-2858b47f21fc" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable_8f381c50-526c-40e9-932d-6353ed9c94b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeDetails" xlink:type="simple" xlink:href="iart-20230331.xsd#REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_c8c7842e-df38-4830-bfb1-b149d358955c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ReturnPolicyIssueOfCreditNumberOfDaysFromShipment_b39ef730-8f03-4b36-8a8b-08f74610dd8a" xlink:href="iart-20230331.xsd#iart_ReturnPolicyIssueOfCreditNumberOfDaysFromShipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_c8c7842e-df38-4830-bfb1-b149d358955c" xlink:to="loc_iart_ReturnPolicyIssueOfCreditNumberOfDaysFromShipment_b39ef730-8f03-4b36-8a8b-08f74610dd8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_c41a5d90-6c28-4e9e-bc77-c1aeeb6d7467" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_c8c7842e-df38-4830-bfb1-b149d358955c" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_c41a5d90-6c28-4e9e-bc77-c1aeeb6d7467" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_c0bf5e71-9298-4319-bc5a-6c53aa9fe267" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_c8c7842e-df38-4830-bfb1-b149d358955c" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_c0bf5e71-9298-4319-bc5a-6c53aa9fe267" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_RevenueProductWarrantyPeriod_cfcb7848-3628-4385-b31f-4a2592291157" xlink:href="iart-20230331.xsd#iart_RevenueProductWarrantyPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_c8c7842e-df38-4830-bfb1-b149d358955c" xlink:to="loc_iart_RevenueProductWarrantyPeriod_cfcb7848-3628-4385-b31f-4a2592291157" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeRevenueRemainingPerformanceObligationDetails" xlink:type="simple" xlink:href="iart-20230331.xsd#REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeRevenueRemainingPerformanceObligationDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeRevenueRemainingPerformanceObligationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_56ba3432-4e09-48ca-a378-a0bcdd3b0ff3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_b89f3dc2-6c70-4e07-aa3e-8a12592dc32f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_56ba3432-4e09-48ca-a378-a0bcdd3b0ff3" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_b89f3dc2-6c70-4e07-aa3e-8a12592dc32f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_23f649ac-406a-4b43-8b57-21f3676b1c05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_b89f3dc2-6c70-4e07-aa3e-8a12592dc32f" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_23f649ac-406a-4b43-8b57-21f3676b1c05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_4c26d446-c6b2-4372-aa35-b8992a17d2ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_b89f3dc2-6c70-4e07-aa3e-8a12592dc32f" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_4c26d446-c6b2-4372-aa35-b8992a17d2ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_47f152d3-f36f-4783-9c61-0347c77933ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_4c26d446-c6b2-4372-aa35-b8992a17d2ad" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_47f152d3-f36f-4783-9c61-0347c77933ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_d8a3f3c8-afe6-46ac-bc24-7bae5f2916ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_4c26d446-c6b2-4372-aa35-b8992a17d2ad" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_d8a3f3c8-afe6-46ac-bc24-7bae5f2916ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeRevenueRemainingPerformanceObligationDetails_1" xlink:type="simple" xlink:href="iart-20230331.xsd#REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeRevenueRemainingPerformanceObligationDetails_1"/>
  <link:presentationLink xlink:role="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeRevenueRemainingPerformanceObligationDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofChangesinContractAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="iart-20230331.xsd#REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofChangesinContractAssetsandLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofChangesinContractAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_5420d0fc-4d5d-447b-ab4f-7a4ca822598a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ChangeInContractWithCustomerAssetRollForward_a6f80782-39d1-4d3c-92ab-f3ee20226fd6" xlink:href="iart-20230331.xsd#iart_ChangeInContractWithCustomerAssetRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_5420d0fc-4d5d-447b-ab4f-7a4ca822598a" xlink:to="loc_iart_ChangeInContractWithCustomerAssetRollForward_a6f80782-39d1-4d3c-92ab-f3ee20226fd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet_67632f87-039d-4503-9580-9e5ca010e723" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_ChangeInContractWithCustomerAssetRollForward_a6f80782-39d1-4d3c-92ab-f3ee20226fd6" xlink:to="loc_us-gaap_ContractWithCustomerAssetNet_67632f87-039d-4503-9580-9e5ca010e723" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetReclassifiedToReceivable_1fb0c9c7-f01f-4fc6-a66d-65a5fffb7265" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetReclassifiedToReceivable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_ChangeInContractWithCustomerAssetRollForward_a6f80782-39d1-4d3c-92ab-f3ee20226fd6" xlink:to="loc_us-gaap_ContractWithCustomerAssetReclassifiedToReceivable_1fb0c9c7-f01f-4fc6-a66d-65a5fffb7265" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ContractWithCustomerAssetNetOfReclassifiedToReceivable_bc77d2ca-03e2-415c-8033-a7d7ad824d02" xlink:href="iart-20230331.xsd#iart_ContractWithCustomerAssetNetOfReclassifiedToReceivable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_ChangeInContractWithCustomerAssetRollForward_a6f80782-39d1-4d3c-92ab-f3ee20226fd6" xlink:to="loc_iart_ContractWithCustomerAssetNetOfReclassifiedToReceivable_bc77d2ca-03e2-415c-8033-a7d7ad824d02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet_5c42ddc5-0eef-47ab-a532-cc6ee541f1c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_ChangeInContractWithCustomerAssetRollForward_a6f80782-39d1-4d3c-92ab-f3ee20226fd6" xlink:to="loc_us-gaap_ContractWithCustomerAssetNet_5c42ddc5-0eef-47ab-a532-cc6ee541f1c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ChangeInContractWithCustomerLiabilityRollForward_9e0ad2b8-8ab5-4f98-a604-05977cbfa3a7" xlink:href="iart-20230331.xsd#iart_ChangeInContractWithCustomerLiabilityRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_5420d0fc-4d5d-447b-ab4f-7a4ca822598a" xlink:to="loc_iart_ChangeInContractWithCustomerLiabilityRollForward_9e0ad2b8-8ab5-4f98-a604-05977cbfa3a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_143524d2-3e0d-4149-9e40-34b6bfb2081e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_ChangeInContractWithCustomerLiabilityRollForward_9e0ad2b8-8ab5-4f98-a604-05977cbfa3a7" xlink:to="loc_us-gaap_ContractWithCustomerLiability_143524d2-3e0d-4149-9e40-34b6bfb2081e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ContractWithCustomerLiabilityNetOfRevenueRecognized_5d743561-c4a6-4487-8046-9f419c17e61a" xlink:href="iart-20230331.xsd#iart_ContractWithCustomerLiabilityNetOfRevenueRecognized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_ChangeInContractWithCustomerLiabilityRollForward_9e0ad2b8-8ab5-4f98-a604-05977cbfa3a7" xlink:to="loc_iart_ContractWithCustomerLiabilityNetOfRevenueRecognized_5d743561-c4a6-4487-8046-9f419c17e61a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_2f697df5-c581-4b15-96a5-fa6d9b1f5c52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_ChangeInContractWithCustomerLiabilityRollForward_9e0ad2b8-8ab5-4f98-a604-05977cbfa3a7" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_2f697df5-c581-4b15-96a5-fa6d9b1f5c52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ContractWithCustomerLiabilityIncreaseDecreaseFromForeignCurrencyTranslation_9b6bf4b8-8d6f-4a4f-b500-ef9a854bd923" xlink:href="iart-20230331.xsd#iart_ContractWithCustomerLiabilityIncreaseDecreaseFromForeignCurrencyTranslation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_ChangeInContractWithCustomerLiabilityRollForward_9e0ad2b8-8ab5-4f98-a604-05977cbfa3a7" xlink:to="loc_iart_ContractWithCustomerLiabilityIncreaseDecreaseFromForeignCurrencyTranslation_9b6bf4b8-8d6f-4a4f-b500-ef9a854bd923" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_dd70f8ce-3693-4dba-8cea-3fb6726b74ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_ChangeInContractWithCustomerLiabilityRollForward_9e0ad2b8-8ab5-4f98-a604-05977cbfa3a7" xlink:to="loc_us-gaap_ContractWithCustomerLiability_dd70f8ce-3693-4dba-8cea-3fb6726b74ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofRevenuesDisaggregatedbyMajorSourceDetails" xlink:type="simple" xlink:href="iart-20230331.xsd#REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofRevenuesDisaggregatedbyMajorSourceDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofRevenuesDisaggregatedbyMajorSourceDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_31857eec-c23f-4267-9adc-4071cafe64ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_e00aabf0-a9d2-4a89-b569-705ecd3473d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_31857eec-c23f-4267-9adc-4071cafe64ee" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_e00aabf0-a9d2-4a89-b569-705ecd3473d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_7129b1a7-9ec6-422b-a374-8836d0b5b83f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_e00aabf0-a9d2-4a89-b569-705ecd3473d7" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_7129b1a7-9ec6-422b-a374-8836d0b5b83f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_6d2e378f-802f-4d56-a3e6-490a1648c3f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_7129b1a7-9ec6-422b-a374-8836d0b5b83f" xlink:to="loc_us-gaap_SegmentDomain_6d2e378f-802f-4d56-a3e6-490a1648c3f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CodmanSpecialtySurgicalMember_8d485526-748a-461a-8b74-1f5852c18f2c" xlink:href="iart-20230331.xsd#iart_CodmanSpecialtySurgicalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_6d2e378f-802f-4d56-a3e6-490a1648c3f1" xlink:to="loc_iart_CodmanSpecialtySurgicalMember_8d485526-748a-461a-8b74-1f5852c18f2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_TissueTechnologiesMember_c1c025a6-9d99-40da-9cd8-49d532dee698" xlink:href="iart-20230331.xsd#iart_TissueTechnologiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_6d2e378f-802f-4d56-a3e6-490a1648c3f1" xlink:to="loc_iart_TissueTechnologiesMember_c1c025a6-9d99-40da-9cd8-49d532dee698" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_765c641b-4246-4d40-a9f9-a0f4bf9c12ef" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_e00aabf0-a9d2-4a89-b569-705ecd3473d7" xlink:to="loc_srt_ProductOrServiceAxis_765c641b-4246-4d40-a9f9-a0f4bf9c12ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_90473350-e4d1-4677-bdfb-2479735b6cec" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_765c641b-4246-4d40-a9f9-a0f4bf9c12ef" xlink:to="loc_srt_ProductsAndServicesDomain_90473350-e4d1-4677-bdfb-2479735b6cec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_NeurosurgeryMember_06b9c620-c694-48fc-8736-4a7b410d9300" xlink:href="iart-20230331.xsd#iart_NeurosurgeryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_90473350-e4d1-4677-bdfb-2479735b6cec" xlink:to="loc_iart_NeurosurgeryMember_06b9c620-c694-48fc-8736-4a7b410d9300" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InstrumentsMember_956468f2-f0e1-4626-aa85-dabd4511a4fe" xlink:href="iart-20230331.xsd#iart_InstrumentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_90473350-e4d1-4677-bdfb-2479735b6cec" xlink:to="loc_iart_InstrumentsMember_956468f2-f0e1-4626-aa85-dabd4511a4fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_RegenerativeSkinAndWoundMember_69e2e633-22a4-4b8e-b62a-062da26dc3e2" xlink:href="iart-20230331.xsd#iart_RegenerativeSkinAndWoundMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_90473350-e4d1-4677-bdfb-2479735b6cec" xlink:to="loc_iart_RegenerativeSkinAndWoundMember_69e2e633-22a4-4b8e-b62a-062da26dc3e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_PrivateLabelMember_c73dde0e-6576-4c6b-9d7e-c7f5d57836ae" xlink:href="iart-20230331.xsd#iart_PrivateLabelMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_90473350-e4d1-4677-bdfb-2479735b6cec" xlink:to="loc_iart_PrivateLabelMember_c73dde0e-6576-4c6b-9d7e-c7f5d57836ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_9d9ffd07-7e51-4d20-958c-c16e0e0dbf18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_e00aabf0-a9d2-4a89-b569-705ecd3473d7" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_9d9ffd07-7e51-4d20-958c-c16e0e0dbf18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_85969e9c-930a-4891-8e1d-1e332bae921a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_9d9ffd07-7e51-4d20-958c-c16e0e0dbf18" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_85969e9c-930a-4891-8e1d-1e332bae921a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/INVENTORIESScheduleofNetInventoriesDetails" xlink:type="simple" xlink:href="iart-20230331.xsd#INVENTORIESScheduleofNetInventoriesDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/INVENTORIESScheduleofNetInventoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_04109409-e6b0-4a23-8ae9-dc4dc97c4b7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_531cb363-eda3-4322-966d-14ecf4c07c1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_04109409-e6b0-4a23-8ae9-dc4dc97c4b7a" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_531cb363-eda3-4322-966d-14ecf4c07c1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_2e6c2d0c-c6e0-41d0-a901-9714c9610589" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_04109409-e6b0-4a23-8ae9-dc4dc97c4b7a" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_2e6c2d0c-c6e0-41d0-a901-9714c9610589" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsAndPurchasedPartsNetOfReserves_9f63d1dc-6e9f-4db9-8802-14922cee0ed9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterialsAndPurchasedPartsNetOfReserves"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_04109409-e6b0-4a23-8ae9-dc4dc97c4b7a" xlink:to="loc_us-gaap_InventoryRawMaterialsAndPurchasedPartsNetOfReserves_9f63d1dc-6e9f-4db9-8802-14922cee0ed9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_fba431ba-bc7f-44b9-9c74-fd390a6f740b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_04109409-e6b0-4a23-8ae9-dc4dc97c4b7a" xlink:to="loc_us-gaap_InventoryNet_fba431ba-bc7f-44b9-9c74-fd390a6f740b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesinCarryingAmountofGoodwillDetails" xlink:type="simple" xlink:href="iart-20230331.xsd#GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesinCarryingAmountofGoodwillDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesinCarryingAmountofGoodwillDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_cf6fc6a5-1ce4-43ea-b6e9-85592802a0f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_84ca9a29-e8f4-4f65-b29f-6b6dcb0cde5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_cf6fc6a5-1ce4-43ea-b6e9-85592802a0f7" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_84ca9a29-e8f4-4f65-b29f-6b6dcb0cde5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_b78c84fb-91ec-4062-b2a5-314110729066" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_84ca9a29-e8f4-4f65-b29f-6b6dcb0cde5b" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_b78c84fb-91ec-4062-b2a5-314110729066" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_c47b3753-c304-446d-8448-7bb88560f732" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_b78c84fb-91ec-4062-b2a5-314110729066" xlink:to="loc_us-gaap_SegmentDomain_c47b3753-c304-446d-8448-7bb88560f732" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CodmanSpecialtySurgicalMember_a12615db-6896-426b-8740-fa3f2871143b" xlink:href="iart-20230331.xsd#iart_CodmanSpecialtySurgicalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_c47b3753-c304-446d-8448-7bb88560f732" xlink:to="loc_iart_CodmanSpecialtySurgicalMember_a12615db-6896-426b-8740-fa3f2871143b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_TissueTechnologiesMember_dda9b2f2-ae58-4c27-8d71-6cec6c2c2854" xlink:href="iart-20230331.xsd#iart_TissueTechnologiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_c47b3753-c304-446d-8448-7bb88560f732" xlink:to="loc_iart_TissueTechnologiesMember_dda9b2f2-ae58-4c27-8d71-6cec6c2c2854" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_899d57a0-9ca3-4e30-8aee-08ee3857bf9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_84ca9a29-e8f4-4f65-b29f-6b6dcb0cde5b" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_899d57a0-9ca3-4e30-8aee-08ee3857bf9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b226b924-66cd-493c-a1ee-89fb55ca05a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_899d57a0-9ca3-4e30-8aee-08ee3857bf9f" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b226b924-66cd-493c-a1ee-89fb55ca05a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SurgicalInnovationAssociatesIncMember_85e9784c-5833-4753-a45c-de05dbe44ecc" xlink:href="iart-20230331.xsd#iart_SurgicalInnovationAssociatesIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b226b924-66cd-493c-a1ee-89fb55ca05a3" xlink:to="loc_iart_SurgicalInnovationAssociatesIncMember_85e9784c-5833-4753-a45c-de05dbe44ecc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_2a1f4198-c20f-4015-a7a7-432faa52ce90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_84ca9a29-e8f4-4f65-b29f-6b6dcb0cde5b" xlink:to="loc_us-gaap_GoodwillLineItems_2a1f4198-c20f-4015-a7a7-432faa52ce90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_93c15dbe-3302-413b-9b12-9dad669d6459" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_2a1f4198-c20f-4015-a7a7-432faa52ce90" xlink:to="loc_us-gaap_GoodwillRollForward_93c15dbe-3302-413b-9b12-9dad669d6459" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_f914df1e-9ad0-49c6-aa99-023ef087de7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_93c15dbe-3302-413b-9b12-9dad669d6459" xlink:to="loc_us-gaap_Goodwill_f914df1e-9ad0-49c6-aa99-023ef087de7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_fcb8e6e8-e120-48a7-af4a-b986b5be4cc1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_93c15dbe-3302-413b-9b12-9dad669d6459" xlink:to="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_fcb8e6e8-e120-48a7-af4a-b986b5be4cc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_a6c1a7d6-1cbd-461b-91ba-780b56deeeb2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_93c15dbe-3302-413b-9b12-9dad669d6459" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_a6c1a7d6-1cbd-461b-91ba-780b56deeeb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_cd92dcd2-6395-4446-bc80-57dadfd0bf3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_93c15dbe-3302-413b-9b12-9dad669d6459" xlink:to="loc_us-gaap_Goodwill_cd92dcd2-6395-4446-bc80-57dadfd0bf3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails" xlink:type="simple" xlink:href="iart-20230331.xsd#GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_12780df3-93cd-44a0-8a12-9461d92bd027" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_e44c9e22-7896-45e7-aa12-f501c4630b6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_12780df3-93cd-44a0-8a12-9461d92bd027" xlink:to="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_e44c9e22-7896-45e7-aa12-f501c4630b6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_fe91f3ad-3a0f-4b3f-8aee-8df29980862d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_e44c9e22-7896-45e7-aa12-f501c4630b6c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_fe91f3ad-3a0f-4b3f-8aee-8df29980862d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_59c2886c-c18f-4186-9c41-3a3f385307f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_fe91f3ad-3a0f-4b3f-8aee-8df29980862d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_59c2886c-c18f-4186-9c41-3a3f385307f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CompletedTechnologyMember_854c4088-ec0e-40cf-8343-0db2f9431770" xlink:href="iart-20230331.xsd#iart_CompletedTechnologyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_59c2886c-c18f-4186-9c41-3a3f385307f9" xlink:to="loc_iart_CompletedTechnologyMember_854c4088-ec0e-40cf-8343-0db2f9431770" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_d032c2b4-00ec-4f03-b44a-0c93e3127357" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_59c2886c-c18f-4186-9c41-3a3f385307f9" xlink:to="loc_us-gaap_CustomerRelationshipsMember_d032c2b4-00ec-4f03-b44a-0c93e3127357" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_TrademarksBrandNamesMember_db984733-69e5-4842-9eb5-d30593909e31" xlink:href="iart-20230331.xsd#iart_TrademarksBrandNamesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_59c2886c-c18f-4186-9c41-3a3f385307f9" xlink:to="loc_iart_TrademarksBrandNamesMember_db984733-69e5-4842-9eb5-d30593909e31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SupplierRelationShipsMember_56d2c71c-a978-48f5-a241-86fb278d44db" xlink:href="iart-20230331.xsd#iart_SupplierRelationShipsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_59c2886c-c18f-4186-9c41-3a3f385307f9" xlink:to="loc_iart_SupplierRelationShipsMember_56d2c71c-a978-48f5-a241-86fb278d44db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AllOtherMember_64d18f05-55f6-45b4-a741-fda5c7e165ed" xlink:href="iart-20230331.xsd#iart_AllOtherMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_59c2886c-c18f-4186-9c41-3a3f385307f9" xlink:to="loc_iart_AllOtherMember_64d18f05-55f6-45b4-a741-fda5c7e165ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_cb53cf1c-e4ee-42fd-9f8c-3b54135fb092" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_e44c9e22-7896-45e7-aa12-f501c4630b6c" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_cb53cf1c-e4ee-42fd-9f8c-3b54135fb092" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_02b824da-d371-4e7e-9d6d-9356e3a7617a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_cb53cf1c-e4ee-42fd-9f8c-3b54135fb092" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_02b824da-d371-4e7e-9d6d-9356e3a7617a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_baad7e57-10cb-4660-a2ea-23fcdd23a8a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_02b824da-d371-4e7e-9d6d-9356e3a7617a" xlink:to="loc_us-gaap_TradeNamesMember_baad7e57-10cb-4660-a2ea-23fcdd23a8a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_50c8654a-f945-49e4-bede-c85229e2bcab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_e44c9e22-7896-45e7-aa12-f501c4630b6c" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_50c8654a-f945-49e4-bede-c85229e2bcab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_c1c31aeb-4f90-4a5f-a52d-ed8cad6a4405" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_50c8654a-f945-49e4-bede-c85229e2bcab" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_c1c31aeb-4f90-4a5f-a52d-ed8cad6a4405" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill_c97a5675-a197-4985-8a90-ffa9a44d16af" xlink:href="iart-20230331.xsd#iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_50c8654a-f945-49e4-bede-c85229e2bcab" xlink:to="loc_iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill_c97a5675-a197-4985-8a90-ffa9a44d16af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_d44b5188-d652-4252-a79b-7d95c1e939de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_50c8654a-f945-49e4-bede-c85229e2bcab" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_d44b5188-d652-4252-a79b-7d95c1e939de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill_11e1dd9c-e2db-43d3-be95-042a36eabfce" xlink:href="iart-20230331.xsd#iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_50c8654a-f945-49e4-bede-c85229e2bcab" xlink:to="loc_iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill_11e1dd9c-e2db-43d3-be95-042a36eabfce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails" xlink:type="simple" xlink:href="iart-20230331.xsd#GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_26f19600-4c25-43c0-bea4-b007aca0ed7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_b16f069c-6078-4d96-88f9-c4556220fccb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_26f19600-4c25-43c0-bea4-b007aca0ed7a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_b16f069c-6078-4d96-88f9-c4556220fccb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_c8b8039d-7060-4c53-b69f-50661269ee2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_26f19600-4c25-43c0-bea4-b007aca0ed7a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_c8b8039d-7060-4c53-b69f-50661269ee2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_dc1f4183-2508-4af2-a489-12e82ce57ca9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_26f19600-4c25-43c0-bea4-b007aca0ed7a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_dc1f4183-2508-4af2-a489-12e82ce57ca9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_8daee3fb-2914-4375-9aea-281176ea58ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_26f19600-4c25-43c0-bea4-b007aca0ed7a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_8daee3fb-2914-4375-9aea-281176ea58ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_71e3a195-ffd1-4579-b610-95ad967d4cac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_26f19600-4c25-43c0-bea4-b007aca0ed7a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_71e3a195-ffd1-4579-b610-95ad967d4cac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_6a81b8ff-ddb0-42c2-80cd-c5eab48d1b9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_26f19600-4c25-43c0-bea4-b007aca0ed7a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_6a81b8ff-ddb0-42c2-80cd-c5eab48d1b9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_a8a9ce0f-9b2f-43cc-91c2-2440ec04fc1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_26f19600-4c25-43c0-bea4-b007aca0ed7a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_a8a9ce0f-9b2f-43cc-91c2-2440ec04fc1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/DEBTNarrativeDetails" xlink:type="simple" xlink:href="iart-20230331.xsd#DEBTNarrativeDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/DEBTNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_b01fe0bb-a2e6-4ddb-99e6-38ebf8abfae2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_b048e5a0-0dd5-4727-87f8-5345d11b0599" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_b01fe0bb-a2e6-4ddb-99e6-38ebf8abfae2" xlink:to="loc_us-gaap_DebtInstrumentTable_b048e5a0-0dd5-4727-87f8-5345d11b0599" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_23ee7a46-6dfd-4c86-beb8-d779ea6c4bdc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_b048e5a0-0dd5-4727-87f8-5345d11b0599" xlink:to="loc_us-gaap_DebtInstrumentAxis_23ee7a46-6dfd-4c86-beb8-d779ea6c4bdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_3e1b2792-f19f-4cc4-889c-76c8b2aebc5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_23ee7a46-6dfd-4c86-beb8-d779ea6c4bdc" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_3e1b2792-f19f-4cc4-889c-76c8b2aebc5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SeniorCreditFacilityMember_67e66495-732f-4db8-8124-f5693c2e6810" xlink:href="iart-20230331.xsd#iart_SeniorCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3e1b2792-f19f-4cc4-889c-76c8b2aebc5d" xlink:to="loc_iart_SeniorCreditFacilityMember_67e66495-732f-4db8-8124-f5693c2e6810" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_TermLoanFacilityMember_6c3e38c9-635b-4893-b680-2526b01eb1d5" xlink:href="iart-20230331.xsd#iart_TermLoanFacilityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3e1b2792-f19f-4cc4-889c-76c8b2aebc5d" xlink:to="loc_iart_TermLoanFacilityMember_6c3e38c9-635b-4893-b680-2526b01eb1d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_TwoThousandTwentyFiveSeniorConvertibleNotesMember_7f571709-8979-4ef6-804c-244f9281672a" xlink:href="iart-20230331.xsd#iart_TwoThousandTwentyFiveSeniorConvertibleNotesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3e1b2792-f19f-4cc4-889c-76c8b2aebc5d" xlink:to="loc_iart_TwoThousandTwentyFiveSeniorConvertibleNotesMember_7f571709-8979-4ef6-804c-244f9281672a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_c3a45898-8f97-4934-bf49-4fa558b9260a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_b048e5a0-0dd5-4727-87f8-5345d11b0599" xlink:to="loc_us-gaap_CreditFacilityAxis_c3a45898-8f97-4934-bf49-4fa558b9260a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_6eb23496-aac1-41e7-81e8-1f5af9177f5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_c3a45898-8f97-4934-bf49-4fa558b9260a" xlink:to="loc_us-gaap_CreditFacilityDomain_6eb23496-aac1-41e7-81e8-1f5af9177f5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_e38d4b41-b7b7-4bf2-a2d4-b9270eb1a129" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_6eb23496-aac1-41e7-81e8-1f5af9177f5b" xlink:to="loc_us-gaap_SecuredDebtMember_e38d4b41-b7b7-4bf2-a2d4-b9270eb1a129" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_7d5261d7-1a06-43f1-a23c-baba2e59d224" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_6eb23496-aac1-41e7-81e8-1f5af9177f5b" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_7d5261d7-1a06-43f1-a23c-baba2e59d224" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandbyLettersOfCreditMember_337ce48d-29df-4549-bfa8-cf7e007606b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StandbyLettersOfCreditMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_6eb23496-aac1-41e7-81e8-1f5af9177f5b" xlink:to="loc_us-gaap_StandbyLettersOfCreditMember_337ce48d-29df-4549-bfa8-cf7e007606b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SwinglineLoanMember_448c6f9f-1ce6-4490-8a1f-30cf60610569" xlink:href="iart-20230331.xsd#iart_SwinglineLoanMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_6eb23496-aac1-41e7-81e8-1f5af9177f5b" xlink:to="loc_iart_SwinglineLoanMember_448c6f9f-1ce6-4490-8a1f-30cf60610569" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_a4a0278a-e472-430c-a512-ccbf262cf146" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_b048e5a0-0dd5-4727-87f8-5345d11b0599" xlink:to="loc_srt_RangeAxis_a4a0278a-e472-430c-a512-ccbf262cf146" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_0152b1e8-6fe9-432b-9399-687367a1aea7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_a4a0278a-e472-430c-a512-ccbf262cf146" xlink:to="loc_srt_RangeMember_0152b1e8-6fe9-432b-9399-687367a1aea7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_bde1040d-24de-4942-b19e-de42cef6b484" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_0152b1e8-6fe9-432b-9399-687367a1aea7" xlink:to="loc_srt_MinimumMember_bde1040d-24de-4942-b19e-de42cef6b484" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_6b5ad471-da3d-405d-8a94-e329ef5d464e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_0152b1e8-6fe9-432b-9399-687367a1aea7" xlink:to="loc_srt_MaximumMember_6b5ad471-da3d-405d-8a94-e329ef5d464e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_cc5e43a0-4360-41d6-ad92-7c80aa32b609" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_b048e5a0-0dd5-4727-87f8-5345d11b0599" xlink:to="loc_us-gaap_VariableRateAxis_cc5e43a0-4360-41d6-ad92-7c80aa32b609" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_da0bcba1-8546-4e10-b8fe-a346c07a66a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_cc5e43a0-4360-41d6-ad92-7c80aa32b609" xlink:to="loc_us-gaap_VariableRateDomain_da0bcba1-8546-4e10-b8fe-a346c07a66a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalFundsEffectiveSwapRateMember_0dc01a5b-fcb1-4809-bf43-4cb8d36667c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FederalFundsEffectiveSwapRateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_da0bcba1-8546-4e10-b8fe-a346c07a66a7" xlink:to="loc_us-gaap_FederalFundsEffectiveSwapRateMember_0dc01a5b-fcb1-4809-bf43-4cb8d36667c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_bec59897-f2be-4f26-80c8-90b69aad0a6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_da0bcba1-8546-4e10-b8fe-a346c07a66a7" xlink:to="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_bec59897-f2be-4f26-80c8-90b69aad0a6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_fcfadb19-db45-464f-87eb-8ee1f00fa497" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_b048e5a0-0dd5-4727-87f8-5345d11b0599" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_fcfadb19-db45-464f-87eb-8ee1f00fa497" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_da33ebec-b956-4f20-b21b-1344e127f157" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_fcfadb19-db45-464f-87eb-8ee1f00fa497" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_da33ebec-b956-4f20-b21b-1344e127f157" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_69314569-30eb-453d-a195-2b93a9394974" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_da33ebec-b956-4f20-b21b-1344e127f157" xlink:to="loc_us-gaap_ConvertibleDebtMember_69314569-30eb-453d-a195-2b93a9394974" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityEquityAxis_ad084951-bdc4-41c4-a516-801b36bdd685" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OptionIndexedToIssuersEquityEquityAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_b048e5a0-0dd5-4727-87f8-5345d11b0599" xlink:to="loc_us-gaap_OptionIndexedToIssuersEquityEquityAxis_ad084951-bdc4-41c4-a516-801b36bdd685" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_3f2a7d58-302c-42d4-a956-1ed5bc578436" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OptionIndexedToIssuersEquityTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OptionIndexedToIssuersEquityEquityAxis_ad084951-bdc4-41c4-a516-801b36bdd685" xlink:to="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_3f2a7d58-302c-42d4-a956-1ed5bc578436" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CallOptionMember_027de236-77e0-4ef5-bbcc-c1dcb62f02f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CallOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_3f2a7d58-302c-42d4-a956-1ed5bc578436" xlink:to="loc_us-gaap_CallOptionMember_027de236-77e0-4ef5-bbcc-c1dcb62f02f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_2e9a4710-3212-4ae8-992e-62daba7182c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_b048e5a0-0dd5-4727-87f8-5345d11b0599" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_2e9a4710-3212-4ae8-992e-62daba7182c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_bc8888d6-7916-4de3-a284-7016cff7bfc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_2e9a4710-3212-4ae8-992e-62daba7182c4" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_bc8888d6-7916-4de3-a284-7016cff7bfc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_c9d23430-b8f4-4f71-b8f3-3f2ae23a3d7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_bc8888d6-7916-4de3-a284-7016cff7bfc0" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_c9d23430-b8f4-4f71-b8f3-3f2ae23a3d7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_89acf97d-962c-44f3-981e-6b2dd514710b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_b048e5a0-0dd5-4727-87f8-5345d11b0599" xlink:to="loc_us-gaap_DebtInstrumentLineItems_89acf97d-962c-44f3-981e-6b2dd514710b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_03775543-4e69-4a65-8126-c8cf538da08a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_89acf97d-962c-44f3-981e-6b2dd514710b" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_03775543-4e69-4a65-8126-c8cf538da08a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtInstrumentBasisSpreadAdjustmentOnVariableRate_2fa9a697-2925-45c2-a19f-6d2b565f0db6" xlink:href="iart-20230331.xsd#iart_DebtInstrumentBasisSpreadAdjustmentOnVariableRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_89acf97d-962c-44f3-981e-6b2dd514710b" xlink:to="loc_iart_DebtInstrumentBasisSpreadAdjustmentOnVariableRate_2fa9a697-2925-45c2-a19f-6d2b565f0db6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_906df256-f952-4beb-92bb-8dd0b98f2842" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_89acf97d-962c-44f3-981e-6b2dd514710b" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_906df256-f952-4beb-92bb-8dd0b98f2842" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_790061cb-191e-4c4f-8fad-d975caa84517" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_89acf97d-962c-44f3-981e-6b2dd514710b" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_790061cb-191e-4c4f-8fad-d975caa84517" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_e6db4e60-8a00-457d-a35e-cefc9138be2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_89acf97d-962c-44f3-981e-6b2dd514710b" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_e6db4e60-8a00-457d-a35e-cefc9138be2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost_e1f94f54-c640-492d-82b4-d676cc9de622" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WriteOffOfDeferredDebtIssuanceCost"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_89acf97d-962c-44f3-981e-6b2dd514710b" xlink:to="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost_e1f94f54-c640-492d-82b4-d676cc9de622" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_51f88868-2d1c-4b69-8390-705aea30af24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCredit"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_89acf97d-962c-44f3-981e-6b2dd514710b" xlink:to="loc_us-gaap_LineOfCredit_51f88868-2d1c-4b69-8390-705aea30af24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtWeightedAverageInterestRate_22ea94b6-a636-41e9-8228-df730ade3d08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtWeightedAverageInterestRate"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_89acf97d-962c-44f3-981e-6b2dd514710b" xlink:to="loc_us-gaap_DebtWeightedAverageInterestRate_22ea94b6-a636-41e9-8228-df730ade3d08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtCurrent_fe3dffbb-ac11-42f3-aad6-5e52f515855a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebtCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_89acf97d-962c-44f3-981e-6b2dd514710b" xlink:to="loc_us-gaap_SecuredDebtCurrent_fe3dffbb-ac11-42f3-aad6-5e52f515855a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_ca861275-74d6-4520-8565-86c131d77519" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_89acf97d-962c-44f3-981e-6b2dd514710b" xlink:to="loc_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_ca861275-74d6-4520-8565-86c131d77519" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_6de6d491-c46d-4007-b4d4-287fb5a5999e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_89acf97d-962c-44f3-981e-6b2dd514710b" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_6de6d491-c46d-4007-b4d4-287fb5a5999e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestPaymentsReminderOfFiscalYear_e70affb5-75d0-4ffe-93ae-f3a435167432" xlink:href="iart-20230331.xsd#iart_InterestPaymentsReminderOfFiscalYear"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_89acf97d-962c-44f3-981e-6b2dd514710b" xlink:to="loc_iart_InterestPaymentsReminderOfFiscalYear_e70affb5-75d0-4ffe-93ae-f3a435167432" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestPaymentsYearOne_82f9fc87-5d1f-4108-8d62-157e43aaef00" xlink:href="iart-20230331.xsd#iart_InterestPaymentsYearOne"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_89acf97d-962c-44f3-981e-6b2dd514710b" xlink:to="loc_iart_InterestPaymentsYearOne_82f9fc87-5d1f-4108-8d62-157e43aaef00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestPaymentsYearTwo_ee0bf564-bfb4-4a39-a769-7ae9a469a486" xlink:href="iart-20230331.xsd#iart_InterestPaymentsYearTwo"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_89acf97d-962c-44f3-981e-6b2dd514710b" xlink:to="loc_iart_InterestPaymentsYearTwo_ee0bf564-bfb4-4a39-a769-7ae9a469a486" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestPaymentsYearThree_196ca44d-1c57-4bd2-bbdb-e55c6e38accc" xlink:href="iart-20230331.xsd#iart_InterestPaymentsYearThree"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_89acf97d-962c-44f3-981e-6b2dd514710b" xlink:to="loc_iart_InterestPaymentsYearThree_196ca44d-1c57-4bd2-bbdb-e55c6e38accc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestPaymentsAfterYearThree_fb142a74-14a6-46bc-8488-3ca9916fc567" xlink:href="iart-20230331.xsd#iart_InterestPaymentsAfterYearThree"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_89acf97d-962c-44f3-981e-6b2dd514710b" xlink:to="loc_iart_InterestPaymentsAfterYearThree_fb142a74-14a6-46bc-8488-3ca9916fc567" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_f2d23b92-ab2e-4df9-8f18-cd1f18fff597" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_89acf97d-962c-44f3-981e-6b2dd514710b" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_f2d23b92-ab2e-4df9-8f18-cd1f18fff597" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_b9465f2e-1582-4c7c-8acc-983abd159c43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_89acf97d-962c-44f3-981e-6b2dd514710b" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_b9465f2e-1582-4c7c-8acc-983abd159c43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross_5023aa9a-5bcb-47cc-8978-e6c82883fb2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_89acf97d-962c-44f3-981e-6b2dd514710b" xlink:to="loc_us-gaap_DeferredFinanceCostsGross_5023aa9a-5bcb-47cc-8978-e6c82883fb2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_3bc70e56-530c-4364-ac06-97129c6c280c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_89acf97d-962c-44f3-981e-6b2dd514710b" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_3bc70e56-530c-4364-ac06-97129c6c280c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_246849f4-45f2-42a7-915b-c2580716cafb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_89acf97d-962c-44f3-981e-6b2dd514710b" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_246849f4-45f2-42a7-915b-c2580716cafb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtInstrumentMaximumSellingPriceOfCommonStockOfTheConversionPriceDuringPeriod_b6886e61-6b95-4551-8cb8-d3990718e132" xlink:href="iart-20230331.xsd#iart_DebtInstrumentMaximumSellingPriceOfCommonStockOfTheConversionPriceDuringPeriod"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_89acf97d-962c-44f3-981e-6b2dd514710b" xlink:to="loc_iart_DebtInstrumentMaximumSellingPriceOfCommonStockOfTheConversionPriceDuringPeriod_b6886e61-6b95-4551-8cb8-d3990718e132" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtInstrumentMaximumAverageConversionValueOfNotes_d77b2f47-558a-416b-b933-370390b2b26e" xlink:href="iart-20230331.xsd#iart_DebtInstrumentMaximumAverageConversionValueOfNotes"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_89acf97d-962c-44f3-981e-6b2dd514710b" xlink:to="loc_iart_DebtInstrumentMaximumAverageConversionValueOfNotes_d77b2f47-558a-416b-b933-370390b2b26e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtInstrumentCombinationSettlementForDebtConversionMinimumSettledInCashPerPrincipalAmount_0e988cad-2201-4745-85bd-e8c009fc8b31" xlink:href="iart-20230331.xsd#iart_DebtInstrumentCombinationSettlementForDebtConversionMinimumSettledInCashPerPrincipalAmount"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_89acf97d-962c-44f3-981e-6b2dd514710b" xlink:to="loc_iart_DebtInstrumentCombinationSettlementForDebtConversionMinimumSettledInCashPerPrincipalAmount_0e988cad-2201-4745-85bd-e8c009fc8b31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_b68f2d30-fc23-4cb6-800f-76961453076d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_89acf97d-962c-44f3-981e-6b2dd514710b" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_b68f2d30-fc23-4cb6-800f-76961453076d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_PaymentsForOptionIndexToIssuersEquity_edad462c-c3da-459a-a881-6a7c05341c96" xlink:href="iart-20230331.xsd#iart_PaymentsForOptionIndexToIssuersEquity"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_89acf97d-962c-44f3-981e-6b2dd514710b" xlink:to="loc_iart_PaymentsForOptionIndexToIssuersEquity_edad462c-c3da-459a-a881-6a7c05341c96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfWarrants_becb5d37-3d66-4bd7-8205-ec286f8c5256" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_89acf97d-962c-44f3-981e-6b2dd514710b" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfWarrants_becb5d37-3d66-4bd7-8205-ec286f8c5256" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityStrikePrice1_5a3bd9e6-a0a9-42e2-835d-843f9c99be82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OptionIndexedToIssuersEquityStrikePrice1"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_89acf97d-962c-44f3-981e-6b2dd514710b" xlink:to="loc_us-gaap_OptionIndexedToIssuersEquityStrikePrice1_5a3bd9e6-a0a9-42e2-835d-843f9c99be82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_51ce8bc1-1a9d-450b-afe4-d9bda0cf564e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_89acf97d-962c-44f3-981e-6b2dd514710b" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_51ce8bc1-1a9d-450b-afe4-d9bda0cf564e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_bfb0f70a-175a-4b4f-b249-d8e9b9a3d488" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_89acf97d-962c-44f3-981e-6b2dd514710b" xlink:to="loc_us-gaap_DebtInstrumentFairValue_bfb0f70a-175a-4b4f-b249-d8e9b9a3d488" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_TransferorsInterestsInTransferredFinancialAssetsMaximumInvestmentLimit_ab41d701-1b9e-424e-8352-dfdf28559f8b" xlink:href="iart-20230331.xsd#iart_TransferorsInterestsInTransferredFinancialAssetsMaximumInvestmentLimit"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_89acf97d-962c-44f3-981e-6b2dd514710b" xlink:to="loc_iart_TransferorsInterestsInTransferredFinancialAssetsMaximumInvestmentLimit_ab41d701-1b9e-424e-8352-dfdf28559f8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SecuredLongTermDebtSecuritizationProgram_0cc32fc1-9db7-426f-8136-3a19a1482dfa" xlink:href="iart-20230331.xsd#iart_SecuredLongTermDebtSecuritizationProgram"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_89acf97d-962c-44f3-981e-6b2dd514710b" xlink:to="loc_iart_SecuredLongTermDebtSecuritizationProgram_0cc32fc1-9db7-426f-8136-3a19a1482dfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtWeightedAverageInterestRateFromSecuritization_264cd339-b89f-467a-b2f4-cd66a623d71c" xlink:href="iart-20230331.xsd#iart_DebtWeightedAverageInterestRateFromSecuritization"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_89acf97d-962c-44f3-981e-6b2dd514710b" xlink:to="loc_iart_DebtWeightedAverageInterestRateFromSecuritization_264cd339-b89f-467a-b2f4-cd66a623d71c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SecuritizationFacilityFairValueOfAmountOutstanding_a76c1e17-2c81-4ed8-b5fa-ab74e11ca53b" xlink:href="iart-20230331.xsd#iart_SecuritizationFacilityFairValueOfAmountOutstanding"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_89acf97d-962c-44f3-981e-6b2dd514710b" xlink:to="loc_iart_SecuritizationFacilityFairValueOfAmountOutstanding_a76c1e17-2c81-4ed8-b5fa-ab74e11ca53b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/DEBTMaximumTotalLeverageRatioTableDetails" xlink:type="simple" xlink:href="iart-20230331.xsd#DEBTMaximumTotalLeverageRatioTableDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/DEBTMaximumTotalLeverageRatioTableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_e0ee93b3-4a28-4c2d-995f-d6c96b7f1f92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_658506b5-d289-4118-9dec-3331752ce36d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_e0ee93b3-4a28-4c2d-995f-d6c96b7f1f92" xlink:to="loc_us-gaap_DebtInstrumentTable_658506b5-d289-4118-9dec-3331752ce36d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtCovenantPeriodAxis_050c46b2-cdbf-4c96-aa80-4112a647eed8" xlink:href="iart-20230331.xsd#iart_DebtCovenantPeriodAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_658506b5-d289-4118-9dec-3331752ce36d" xlink:to="loc_iart_DebtCovenantPeriodAxis_050c46b2-cdbf-4c96-aa80-4112a647eed8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtCovenantPeriodDomain_1263928b-dddc-4a94-b4d7-c6a1a74e5d88" xlink:href="iart-20230331.xsd#iart_DebtCovenantPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_DebtCovenantPeriodAxis_050c46b2-cdbf-4c96-aa80-4112a647eed8" xlink:to="loc_iart_DebtCovenantPeriodDomain_1263928b-dddc-4a94-b4d7-c6a1a74e5d88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtCovenantPeriod1Member_415eeb2d-6422-4fbe-bda0-c9d820838350" xlink:href="iart-20230331.xsd#iart_DebtCovenantPeriod1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_DebtCovenantPeriodDomain_1263928b-dddc-4a94-b4d7-c6a1a74e5d88" xlink:to="loc_iart_DebtCovenantPeriod1Member_415eeb2d-6422-4fbe-bda0-c9d820838350" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtCovenantPeriod2Member_32b1f9fa-ef02-4a30-b77f-692a54a505de" xlink:href="iart-20230331.xsd#iart_DebtCovenantPeriod2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_DebtCovenantPeriodDomain_1263928b-dddc-4a94-b4d7-c6a1a74e5d88" xlink:to="loc_iart_DebtCovenantPeriod2Member_32b1f9fa-ef02-4a30-b77f-692a54a505de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtCovenantPeriod3Member_0ff2162e-09ea-459b-a264-7cf80c6afcaf" xlink:href="iart-20230331.xsd#iart_DebtCovenantPeriod3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_DebtCovenantPeriodDomain_1263928b-dddc-4a94-b4d7-c6a1a74e5d88" xlink:to="loc_iart_DebtCovenantPeriod3Member_0ff2162e-09ea-459b-a264-7cf80c6afcaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_14f6379c-0d1c-4226-b2a4-13e126a6e5e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_658506b5-d289-4118-9dec-3331752ce36d" xlink:to="loc_us-gaap_DebtInstrumentAxis_14f6379c-0d1c-4226-b2a4-13e126a6e5e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_8c108e8d-0c52-4da7-af63-655019508c5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_14f6379c-0d1c-4226-b2a4-13e126a6e5e7" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_8c108e8d-0c52-4da7-af63-655019508c5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SeniorCreditFacilityMember_3f8f7c3e-2fc2-4f93-8e1e-cf7fb7426872" xlink:href="iart-20230331.xsd#iart_SeniorCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8c108e8d-0c52-4da7-af63-655019508c5e" xlink:to="loc_iart_SeniorCreditFacilityMember_3f8f7c3e-2fc2-4f93-8e1e-cf7fb7426872" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_3b1e9af6-77fd-4b57-87ab-6f6eb123db79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_658506b5-d289-4118-9dec-3331752ce36d" xlink:to="loc_us-gaap_DebtInstrumentLineItems_3b1e9af6-77fd-4b57-87ab-6f6eb123db79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DebtInstrumentCovenantMaximumLeverageRatio_60f6f440-2cbe-4432-a42d-949999a7d9a7" xlink:href="iart-20230331.xsd#iart_DebtInstrumentCovenantMaximumLeverageRatio"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3b1e9af6-77fd-4b57-87ab-6f6eb123db79" xlink:to="loc_iart_DebtInstrumentCovenantMaximumLeverageRatio_60f6f440-2cbe-4432-a42d-949999a7d9a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/DEBTContractualMaturityTableDetails" xlink:type="simple" xlink:href="iart-20230331.xsd#DEBTContractualMaturityTableDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/DEBTContractualMaturityTableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_e6ca4f48-4a82-47b4-a15a-cffb3055b07e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_d25f85c8-09a8-4206-a7f8-3f8dbfc323ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_e6ca4f48-4a82-47b4-a15a-cffb3055b07e" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_d25f85c8-09a8-4206-a7f8-3f8dbfc323ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_c869af11-2712-4992-bb31-487aa2128a6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_e6ca4f48-4a82-47b4-a15a-cffb3055b07e" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_c869af11-2712-4992-bb31-487aa2128a6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_907439c6-1441-4e2a-84aa-47592edb5fd1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_e6ca4f48-4a82-47b4-a15a-cffb3055b07e" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_907439c6-1441-4e2a-84aa-47592edb5fd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_9091b8a6-0cbf-443a-b133-68ac78f8cc8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_e6ca4f48-4a82-47b4-a15a-cffb3055b07e" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_9091b8a6-0cbf-443a-b133-68ac78f8cc8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_LongTermDebtMaturityAfterYearThree_e081946e-0ca7-43e1-8043-a4d2d1249fd6" xlink:href="iart-20230331.xsd#iart_LongTermDebtMaturityAfterYearThree"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_e6ca4f48-4a82-47b4-a15a-cffb3055b07e" xlink:to="loc_iart_LongTermDebtMaturityAfterYearThree_e081946e-0ca7-43e1-8043-a4d2d1249fd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_65c8df09-54e8-48d2-9d57-78f1d072db10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_e6ca4f48-4a82-47b4-a15a-cffb3055b07e" xlink:to="loc_us-gaap_LongTermDebt_65c8df09-54e8-48d2-9d57-78f1d072db10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofDerivativeInstrumentsDetails" xlink:type="simple" xlink:href="iart-20230331.xsd#DERIVATIVEINSTRUMENTSScheduleofDerivativeInstrumentsDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofDerivativeInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_dbfd24a7-3811-48c5-a1d3-1d0343454334" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_5ee183e1-2582-49ff-99b9-dbaa92ab2d30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_dbfd24a7-3811-48c5-a1d3-1d0343454334" xlink:to="loc_us-gaap_DerivativeTable_5ee183e1-2582-49ff-99b9-dbaa92ab2d30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_2e007487-290b-43ab-aec4-45787949abfd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_5ee183e1-2582-49ff-99b9-dbaa92ab2d30" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_2e007487-290b-43ab-aec4-45787949abfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_5fe1dda6-0275-4594-96ac-f4aa9d0c3080" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_2e007487-290b-43ab-aec4-45787949abfd" xlink:to="loc_us-gaap_HedgingRelationshipDomain_5fe1dda6-0275-4594-96ac-f4aa9d0c3080" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_2a89b3df-56bb-4def-adcb-7751993664f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_5fe1dda6-0275-4594-96ac-f4aa9d0c3080" xlink:to="loc_us-gaap_CashFlowHedgingMember_2a89b3df-56bb-4def-adcb-7751993664f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_2dce7095-309d-4ebd-9817-6dda55020a92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_5ee183e1-2582-49ff-99b9-dbaa92ab2d30" xlink:to="loc_us-gaap_HedgingDesignationAxis_2dce7095-309d-4ebd-9817-6dda55020a92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_8a213e35-53dc-4af4-89a7-429022bf579a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_2dce7095-309d-4ebd-9817-6dda55020a92" xlink:to="loc_us-gaap_HedgingDesignationDomain_8a213e35-53dc-4af4-89a7-429022bf579a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_7bd609dc-3f38-4413-a5b1-1a8054cec3ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_8a213e35-53dc-4af4-89a7-429022bf579a" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_7bd609dc-3f38-4413-a5b1-1a8054cec3ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_fad2fbaf-6dc0-4d78-bab0-f78a1fdffb5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_5ee183e1-2582-49ff-99b9-dbaa92ab2d30" xlink:to="loc_us-gaap_VariableRateAxis_fad2fbaf-6dc0-4d78-bab0-f78a1fdffb5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_015fa07b-7783-46e5-ba07-8a7c97383584" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_fad2fbaf-6dc0-4d78-bab0-f78a1fdffb5d" xlink:to="loc_us-gaap_VariableRateDomain_015fa07b-7783-46e5-ba07-8a7c97383584" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_e0cddb89-fff5-4206-86c9-c79dd17bdded" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_015fa07b-7783-46e5-ba07-8a7c97383584" xlink:to="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_e0cddb89-fff5-4206-86c9-c79dd17bdded" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_74333183-ec67-4a25-9373-98cc3b0b9326" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_5ee183e1-2582-49ff-99b9-dbaa92ab2d30" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_74333183-ec67-4a25-9373-98cc3b0b9326" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_8d03f8b4-c119-4681-ba8e-8046f9aa14e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_74333183-ec67-4a25-9373-98cc3b0b9326" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_8d03f8b4-c119-4681-ba8e-8046f9aa14e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedDecember132017Tranche2Member_f21973c4-5594-404a-ae36-dca16fc63422" xlink:href="iart-20230331.xsd#iart_InterestRateSwapDesignatedDecember132017Tranche2Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_8d03f8b4-c119-4681-ba8e-8046f9aa14e6" xlink:to="loc_iart_InterestRateSwapDesignatedDecember132017Tranche2Member_f21973c4-5594-404a-ae36-dca16fc63422" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedDecember132017Tranche3Member_ab3e0c22-5a82-4460-8090-0421926fa7ce" xlink:href="iart-20230331.xsd#iart_InterestRateSwapDesignatedDecember132017Tranche3Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_8d03f8b4-c119-4681-ba8e-8046f9aa14e6" xlink:to="loc_iart_InterestRateSwapDesignatedDecember132017Tranche3Member_ab3e0c22-5a82-4460-8090-0421926fa7ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedOctober102018Tranche1Member_85e4057e-d4a7-4ba3-89d0-3e02ac1862d7" xlink:href="iart-20230331.xsd#iart_InterestRateSwapDesignatedOctober102018Tranche1Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_8d03f8b4-c119-4681-ba8e-8046f9aa14e6" xlink:to="loc_iart_InterestRateSwapDesignatedOctober102018Tranche1Member_85e4057e-d4a7-4ba3-89d0-3e02ac1862d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedOctober102018Tranche2Member_11bb151f-71a8-4f1e-9f80-2c664e0c56b0" xlink:href="iart-20230331.xsd#iart_InterestRateSwapDesignatedOctober102018Tranche2Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_8d03f8b4-c119-4681-ba8e-8046f9aa14e6" xlink:to="loc_iart_InterestRateSwapDesignatedOctober102018Tranche2Member_11bb151f-71a8-4f1e-9f80-2c664e0c56b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedOctober102018Tranche3Member_46162cf2-68a2-436f-944f-22c773762e0c" xlink:href="iart-20230331.xsd#iart_InterestRateSwapDesignatedOctober102018Tranche3Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_8d03f8b4-c119-4681-ba8e-8046f9aa14e6" xlink:to="loc_iart_InterestRateSwapDesignatedOctober102018Tranche3Member_46162cf2-68a2-436f-944f-22c773762e0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedDecember182018Tranche1Member_5ba67a47-d162-4bb5-87fc-260e0992d72e" xlink:href="iart-20230331.xsd#iart_InterestRateSwapDesignatedDecember182018Tranche1Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_8d03f8b4-c119-4681-ba8e-8046f9aa14e6" xlink:to="loc_iart_InterestRateSwapDesignatedDecember182018Tranche1Member_5ba67a47-d162-4bb5-87fc-260e0992d72e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedDecember182018Tranche2Member_fa9eff82-5e67-4774-b3d7-9ebab1cc56ec" xlink:href="iart-20230331.xsd#iart_InterestRateSwapDesignatedDecember182018Tranche2Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_8d03f8b4-c119-4681-ba8e-8046f9aa14e6" xlink:to="loc_iart_InterestRateSwapDesignatedDecember182018Tranche2Member_fa9eff82-5e67-4774-b3d7-9ebab1cc56ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedDecember152020Tranche1Member_727cafad-1a30-4812-87e1-cd7314d208cd" xlink:href="iart-20230331.xsd#iart_InterestRateSwapDesignatedDecember152020Tranche1Member"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_8d03f8b4-c119-4681-ba8e-8046f9aa14e6" xlink:to="loc_iart_InterestRateSwapDesignatedDecember152020Tranche1Member_727cafad-1a30-4812-87e1-cd7314d208cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedDecember152020Tranche2Member_435d9c82-94a3-45ea-9b3d-5ffdf2494abf" xlink:href="iart-20230331.xsd#iart_InterestRateSwapDesignatedDecember152020Tranche2Member"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_8d03f8b4-c119-4681-ba8e-8046f9aa14e6" xlink:to="loc_iart_InterestRateSwapDesignatedDecember152020Tranche2Member_435d9c82-94a3-45ea-9b3d-5ffdf2494abf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_InterestRateSwapDesignatedMarch312023Member_2485f840-7836-4d51-988c-0862bfa126c4" xlink:href="iart-20230331.xsd#iart_InterestRateSwapDesignatedMarch312023Member"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_8d03f8b4-c119-4681-ba8e-8046f9aa14e6" xlink:to="loc_iart_InterestRateSwapDesignatedMarch312023Member_2485f840-7836-4d51-988c-0862bfa126c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_c96ca175-5a43-41b0-94bb-83f60f95ba4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_5ee183e1-2582-49ff-99b9-dbaa92ab2d30" xlink:to="loc_us-gaap_DerivativeLineItems_c96ca175-5a43-41b0-94bb-83f60f95ba4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_e844bea0-31c6-4be3-b76a-c14aab89b68b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_c96ca175-5a43-41b0-94bb-83f60f95ba4a" xlink:to="loc_us-gaap_DerivativeNotionalAmount_e844bea0-31c6-4be3-b76a-c14aab89b68b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFixedInterestRate_b230e8db-3a65-4af7-b7f4-41b71a650554" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFixedInterestRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_c96ca175-5a43-41b0-94bb-83f60f95ba4a" xlink:to="loc_us-gaap_DerivativeFixedInterestRate_b230e8db-3a65-4af7-b7f4-41b71a650554" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeNet_d480cf2b-6eed-4721-b301-0cd24aa4d77c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_c96ca175-5a43-41b0-94bb-83f60f95ba4a" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeNet_d480cf2b-6eed-4721-b301-0cd24aa4d77c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails" xlink:type="simple" xlink:href="iart-20230331.xsd#DERIVATIVEINSTRUMENTSNarrativeDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_2c1d6c31-b47c-48e4-8551-86182f1249ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_fcc8eb20-06d5-444e-8134-8c998b0bf58f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_2c1d6c31-b47c-48e4-8551-86182f1249ac" xlink:to="loc_us-gaap_DerivativeTable_fcc8eb20-06d5-444e-8134-8c998b0bf58f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_163e3e79-4e0f-418e-bcf8-5a9ae06da6bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_fcc8eb20-06d5-444e-8134-8c998b0bf58f" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_163e3e79-4e0f-418e-bcf8-5a9ae06da6bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_e46976dd-ffdb-483f-9c47-f3ab27758e11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_163e3e79-4e0f-418e-bcf8-5a9ae06da6bd" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_e46976dd-ffdb-483f-9c47-f3ab27758e11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_03f2b9d3-3a8d-45c1-9ef8-32cff5565433" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_e46976dd-ffdb-483f-9c47-f3ab27758e11" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_03f2b9d3-3a8d-45c1-9ef8-32cff5565433" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_331a1539-8c5d-4de2-9696-e0a1690ba37b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrencySwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_e46976dd-ffdb-483f-9c47-f3ab27758e11" xlink:to="loc_us-gaap_CurrencySwapMember_331a1539-8c5d-4de2-9696-e0a1690ba37b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_9a7ca1dd-ffca-4f81-8740-3ca8f4b1f656" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_e46976dd-ffdb-483f-9c47-f3ab27758e11" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_9a7ca1dd-ffca-4f81-8740-3ca8f4b1f656" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionAxis_505f3737-48bb-4194-b804-22d39385f153" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PositionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_fcc8eb20-06d5-444e-8134-8c998b0bf58f" xlink:to="loc_us-gaap_PositionAxis_505f3737-48bb-4194-b804-22d39385f153" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionDomain_3b887f9d-7aff-495d-a42a-340c420153d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PositionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PositionAxis_505f3737-48bb-4194-b804-22d39385f153" xlink:to="loc_us-gaap_PositionDomain_3b887f9d-7aff-495d-a42a-340c420153d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortMember_f65f234e-9009-4d7e-9d67-368c3a6cb2a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PositionDomain_3b887f9d-7aff-495d-a42a-340c420153d2" xlink:to="loc_us-gaap_ShortMember_f65f234e-9009-4d7e-9d67-368c3a6cb2a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongMember_e4cd2c7e-b5d1-443c-a70e-b57081bd1b85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PositionDomain_3b887f9d-7aff-495d-a42a-340c420153d2" xlink:to="loc_us-gaap_LongMember_e4cd2c7e-b5d1-443c-a70e-b57081bd1b85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_14a16e90-554d-48a9-82ce-c8661bf6d1cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_fcc8eb20-06d5-444e-8134-8c998b0bf58f" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_14a16e90-554d-48a9-82ce-c8661bf6d1cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_75d5aaa4-0eab-40dc-9031-84394d07abeb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_14a16e90-554d-48a9-82ce-c8661bf6d1cc" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_75d5aaa4-0eab-40dc-9031-84394d07abeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CodmanMember_f4d7cdfe-4426-41af-9dcd-7c1668271549" xlink:href="iart-20230331.xsd#iart_CodmanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_75d5aaa4-0eab-40dc-9031-84394d07abeb" xlink:to="loc_iart_CodmanMember_f4d7cdfe-4426-41af-9dcd-7c1668271549" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_b76e4283-084f-4f66-845f-c07c00ce5880" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_fcc8eb20-06d5-444e-8134-8c998b0bf58f" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_b76e4283-084f-4f66-845f-c07c00ce5880" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_bcdb3ef8-5861-4daa-bfc6-4bfcced810b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_b76e4283-084f-4f66-845f-c07c00ce5880" xlink:to="loc_us-gaap_HedgingRelationshipDomain_bcdb3ef8-5861-4daa-bfc6-4bfcced810b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_a7598b4f-5d73-455f-9c51-34d892b4e9e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_bcdb3ef8-5861-4daa-bfc6-4bfcced810b8" xlink:to="loc_us-gaap_CashFlowHedgingMember_a7598b4f-5d73-455f-9c51-34d892b4e9e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_e353089f-5e3b-432d-9e6e-3c9b9f85ac51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_bcdb3ef8-5861-4daa-bfc6-4bfcced810b8" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_e353089f-5e3b-432d-9e6e-3c9b9f85ac51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_0b814c87-bf0a-4a2d-8deb-12aea8857b6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_bcdb3ef8-5861-4daa-bfc6-4bfcced810b8" xlink:to="loc_us-gaap_NondesignatedMember_0b814c87-bf0a-4a2d-8deb-12aea8857b6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_c217176a-fd4c-41e4-9a77-58f2b7f13fd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_fcc8eb20-06d5-444e-8134-8c998b0bf58f" xlink:to="loc_us-gaap_HedgingDesignationAxis_c217176a-fd4c-41e4-9a77-58f2b7f13fd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_fa0f1075-55af-47e9-b79d-4f4e00829d9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_c217176a-fd4c-41e4-9a77-58f2b7f13fd4" xlink:to="loc_us-gaap_HedgingDesignationDomain_fa0f1075-55af-47e9-b79d-4f4e00829d9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_9619603d-62be-4d7e-a3cf-b2c0c56e9489" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_fa0f1075-55af-47e9-b79d-4f4e00829d9f" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_9619603d-62be-4d7e-a3cf-b2c0c56e9489" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_b437cca5-c762-4c84-90fa-7e6c2ec3121b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_fa0f1075-55af-47e9-b79d-4f4e00829d9f" xlink:to="loc_us-gaap_NondesignatedMember_b437cca5-c762-4c84-90fa-7e6c2ec3121b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_7d0a037b-3fdb-4a63-b4a4-cb36cdbce7d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_fcc8eb20-06d5-444e-8134-8c998b0bf58f" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_7d0a037b-3fdb-4a63-b4a4-cb36cdbce7d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_5a7524fa-3d64-4df6-b05b-dc61a83a121b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_7d0a037b-3fdb-4a63-b4a4-cb36cdbce7d9" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_5a7524fa-3d64-4df6-b05b-dc61a83a121b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_13c3c059-6319-4bd3-b30f-e6cfcc38e919" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_5a7524fa-3d64-4df6-b05b-dc61a83a121b" xlink:to="loc_us-gaap_CostOfSalesMember_13c3c059-6319-4bd3-b30f-e6cfcc38e919" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_655e53e1-2730-49d9-94b0-7dbccac1d312" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_5a7524fa-3d64-4df6-b05b-dc61a83a121b" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_655e53e1-2730-49d9-94b0-7dbccac1d312" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_87b7452e-3c7a-46b9-bdd7-504bbd0fe8d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_fcc8eb20-06d5-444e-8134-8c998b0bf58f" xlink:to="loc_us-gaap_DerivativeLineItems_87b7452e-3c7a-46b9-bdd7-504bbd0fe8d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DerivativeNotionalAmountTerminated_0ed107d1-0c82-41b5-9dec-65e7766d1233" xlink:href="iart-20230331.xsd#iart_DerivativeNotionalAmountTerminated"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_87b7452e-3c7a-46b9-bdd7-504bbd0fe8d5" xlink:to="loc_iart_DerivativeNotionalAmountTerminated_0ed107d1-0c82-41b5-9dec-65e7766d1233" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_a11815b2-9c2e-4544-b748-3618b52d5a71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_87b7452e-3c7a-46b9-bdd7-504bbd0fe8d5" xlink:to="loc_us-gaap_DerivativeNotionalAmount_a11815b2-9c2e-4544-b748-3618b52d5a71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_IntercompanyLoanQuarterlyPayment_ebed5491-0cba-4918-9b9b-0c2455020c56" xlink:href="iart-20230331.xsd#iart_IntercompanyLoanQuarterlyPayment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_87b7452e-3c7a-46b9-bdd7-504bbd0fe8d5" xlink:to="loc_iart_IntercompanyLoanQuarterlyPayment_ebed5491-0cba-4918-9b9b-0c2455020c56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_032fec8b-b8d8-469c-a76a-31426cbe83d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnDerivativeInstrumentsNetPretax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_87b7452e-3c7a-46b9-bdd7-504bbd0fe8d5" xlink:to="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_032fec8b-b8d8-469c-a76a-31426cbe83d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_9932d67b-715d-425c-afb3-10659eaaabd5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_87b7452e-3c7a-46b9-bdd7-504bbd0fe8d5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_9932d67b-715d-425c-afb3-10659eaaabd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_ecadda0b-9bf4-4e45-8878-d53d204fa978" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_87b7452e-3c7a-46b9-bdd7-504bbd0fe8d5" xlink:to="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_ecadda0b-9bf4-4e45-8878-d53d204fa978" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_c3ecc249-89cb-418f-821f-06abf1de428b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_87b7452e-3c7a-46b9-bdd7-504bbd0fe8d5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_c3ecc249-89cb-418f-821f-06abf1de428b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails" xlink:type="simple" xlink:href="iart-20230331.xsd#DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_1ceea4d3-c8bb-4f1c-855f-d8b7124e6d62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_4d9ad558-f22e-41d4-963f-0e59a3ddadb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_1ceea4d3-c8bb-4f1c-855f-d8b7124e6d62" xlink:to="loc_us-gaap_DerivativeTable_4d9ad558-f22e-41d4-963f-0e59a3ddadb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_cf0fef19-31e9-4f93-878c-d1e671888a2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_4d9ad558-f22e-41d4-963f-0e59a3ddadb5" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_cf0fef19-31e9-4f93-878c-d1e671888a2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_a24da209-5af6-405f-9526-dfda11e0a0ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_cf0fef19-31e9-4f93-878c-d1e671888a2d" xlink:to="loc_us-gaap_HedgingRelationshipDomain_a24da209-5af6-405f-9526-dfda11e0a0ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_0c3ce622-f54a-45eb-9563-db73ceff6ed6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_a24da209-5af6-405f-9526-dfda11e0a0ca" xlink:to="loc_us-gaap_CashFlowHedgingMember_0c3ce622-f54a-45eb-9563-db73ceff6ed6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_b4f3cebb-f6dd-4ba4-988b-a35a6bc8e891" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_4d9ad558-f22e-41d4-963f-0e59a3ddadb5" xlink:to="loc_us-gaap_HedgingDesignationAxis_b4f3cebb-f6dd-4ba4-988b-a35a6bc8e891" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_06b8c312-7e51-446a-9c68-6c973b5c63dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_b4f3cebb-f6dd-4ba4-988b-a35a6bc8e891" xlink:to="loc_us-gaap_HedgingDesignationDomain_06b8c312-7e51-446a-9c68-6c973b5c63dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_d2b6d6d5-f9f9-4d9a-9ea0-260ba4cb099f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_06b8c312-7e51-446a-9c68-6c973b5c63dc" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_d2b6d6d5-f9f9-4d9a-9ea0-260ba4cb099f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_e8347d1e-5e3a-47b6-935d-8b55d15cdc3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_4d9ad558-f22e-41d4-963f-0e59a3ddadb5" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_e8347d1e-5e3a-47b6-935d-8b55d15cdc3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_2eabb975-939c-42ad-9126-d36f3483681f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_e8347d1e-5e3a-47b6-935d-8b55d15cdc3c" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_2eabb975-939c-42ad-9126-d36f3483681f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_a5790cd2-6494-4a17-b158-6d10df05a1d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_2eabb975-939c-42ad-9126-d36f3483681f" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_a5790cd2-6494-4a17-b158-6d10df05a1d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CrossCurrencyInterestRateContractOneMember_da576ecd-dfce-4edf-ae8f-f68366578838" xlink:href="iart-20230331.xsd#iart_CrossCurrencyInterestRateContractOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CrossCurrencyInterestRateContractMember_a5790cd2-6494-4a17-b158-6d10df05a1d6" xlink:to="loc_iart_CrossCurrencyInterestRateContractOneMember_da576ecd-dfce-4edf-ae8f-f68366578838" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CrossCurrencyInterestRateContractTwoMember_f24215c6-5ddc-4f63-ae56-6e13b1b8ea40" xlink:href="iart-20230331.xsd#iart_CrossCurrencyInterestRateContractTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CrossCurrencyInterestRateContractMember_a5790cd2-6494-4a17-b158-6d10df05a1d6" xlink:to="loc_iart_CrossCurrencyInterestRateContractTwoMember_f24215c6-5ddc-4f63-ae56-6e13b1b8ea40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionAxis_f95bf060-96ae-43c4-bcb2-5d9313753970" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PositionAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_4d9ad558-f22e-41d4-963f-0e59a3ddadb5" xlink:to="loc_us-gaap_PositionAxis_f95bf060-96ae-43c4-bcb2-5d9313753970" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionDomain_c9dbaf21-87a6-407c-a876-77f7734a87ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PositionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PositionAxis_f95bf060-96ae-43c4-bcb2-5d9313753970" xlink:to="loc_us-gaap_PositionDomain_c9dbaf21-87a6-407c-a876-77f7734a87ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongMember_997135f7-c7b9-420f-bbc9-b2872afd6c4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PositionDomain_c9dbaf21-87a6-407c-a876-77f7734a87ac" xlink:to="loc_us-gaap_LongMember_997135f7-c7b9-420f-bbc9-b2872afd6c4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortMember_70f12687-829b-43ae-8d0d-697de79cd76e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PositionDomain_c9dbaf21-87a6-407c-a876-77f7734a87ac" xlink:to="loc_us-gaap_ShortMember_70f12687-829b-43ae-8d0d-697de79cd76e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_799a9f62-0071-42a8-97dc-48d705fb69e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_4d9ad558-f22e-41d4-963f-0e59a3ddadb5" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_799a9f62-0071-42a8-97dc-48d705fb69e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_eb65da64-4bfd-4eae-b7fb-fe1ec29a8da9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_799a9f62-0071-42a8-97dc-48d705fb69e5" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_eb65da64-4bfd-4eae-b7fb-fe1ec29a8da9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CodmanMember_16154427-8c0a-43c9-9206-d6445715442d" xlink:href="iart-20230331.xsd#iart_CodmanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_eb65da64-4bfd-4eae-b7fb-fe1ec29a8da9" xlink:to="loc_iart_CodmanMember_16154427-8c0a-43c9-9206-d6445715442d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_207ae1ba-4957-4c92-a8e5-74637872b953" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_4d9ad558-f22e-41d4-963f-0e59a3ddadb5" xlink:to="loc_us-gaap_DerivativeLineItems_207ae1ba-4957-4c92-a8e5-74637872b953" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFixedInterestRate_de8c8144-6ab2-47c5-ad9f-051eac80188a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFixedInterestRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_207ae1ba-4957-4c92-a8e5-74637872b953" xlink:to="loc_us-gaap_DerivativeFixedInterestRate_de8c8144-6ab2-47c5-ad9f-051eac80188a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_f8cafb74-4270-4f32-b21a-d51c3725a6d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_207ae1ba-4957-4c92-a8e5-74637872b953" xlink:to="loc_us-gaap_DerivativeNotionalAmount_f8cafb74-4270-4f32-b21a-d51c3725a6d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeNet_356cb4cd-01ae-4be3-98a4-1a30854618f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_207ae1ba-4957-4c92-a8e5-74637872b953" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeNet_356cb4cd-01ae-4be3-98a4-1a30854618f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails" xlink:type="simple" xlink:href="iart-20230331.xsd#DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_7c7a36dd-22a8-415a-9c29-e9b7f8b5588d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_c7dd2b87-688e-4ca3-a82e-069f17794cd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_7c7a36dd-22a8-415a-9c29-e9b7f8b5588d" xlink:to="loc_us-gaap_DerivativeTable_c7dd2b87-688e-4ca3-a82e-069f17794cd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_056a916c-1aca-4d12-b9dd-89919795d9e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_c7dd2b87-688e-4ca3-a82e-069f17794cd4" xlink:to="loc_us-gaap_HedgingDesignationAxis_056a916c-1aca-4d12-b9dd-89919795d9e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_733e0ea6-e8d4-4446-aa49-2f22f3c0b2f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_056a916c-1aca-4d12-b9dd-89919795d9e1" xlink:to="loc_us-gaap_HedgingDesignationDomain_733e0ea6-e8d4-4446-aa49-2f22f3c0b2f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_33b7ca43-d3fa-4173-acc2-222c5eb9da81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_733e0ea6-e8d4-4446-aa49-2f22f3c0b2f8" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_33b7ca43-d3fa-4173-acc2-222c5eb9da81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_26c3951d-1faf-4cee-b448-bedfa8517228" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_c7dd2b87-688e-4ca3-a82e-069f17794cd4" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_26c3951d-1faf-4cee-b448-bedfa8517228" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_7a1b67a8-7129-4b48-ad6a-cf16f02899e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_26c3951d-1faf-4cee-b448-bedfa8517228" xlink:to="loc_us-gaap_HedgingRelationshipDomain_7a1b67a8-7129-4b48-ad6a-cf16f02899e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_dbcf2bb1-65da-4a92-8aff-439af0cab63a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_7a1b67a8-7129-4b48-ad6a-cf16f02899e5" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_dbcf2bb1-65da-4a92-8aff-439af0cab63a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_917ff3c1-e001-454b-9a6c-28abfa1472c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_c7dd2b87-688e-4ca3-a82e-069f17794cd4" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_917ff3c1-e001-454b-9a6c-28abfa1472c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_161781a1-3fa3-4451-bb17-cf046c76c565" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_917ff3c1-e001-454b-9a6c-28abfa1472c8" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_161781a1-3fa3-4451-bb17-cf046c76c565" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_54f5eaa0-1c28-46b5-bfd8-ad39432d263f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_161781a1-3fa3-4451-bb17-cf046c76c565" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_54f5eaa0-1c28-46b5-bfd8-ad39432d263f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CrossCurrencyInterestRateContractOneMember_42983344-64c1-4e1f-9299-7d2be781ecf9" xlink:href="iart-20230331.xsd#iart_CrossCurrencyInterestRateContractOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CrossCurrencyInterestRateContractMember_54f5eaa0-1c28-46b5-bfd8-ad39432d263f" xlink:to="loc_iart_CrossCurrencyInterestRateContractOneMember_42983344-64c1-4e1f-9299-7d2be781ecf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CrossCurrencyInterestRateContractTwoMember_f7e12b5c-ffb0-4cc6-b12d-a5a41faece07" xlink:href="iart-20230331.xsd#iart_CrossCurrencyInterestRateContractTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CrossCurrencyInterestRateContractMember_54f5eaa0-1c28-46b5-bfd8-ad39432d263f" xlink:to="loc_iart_CrossCurrencyInterestRateContractTwoMember_f7e12b5c-ffb0-4cc6-b12d-a5a41faece07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CrossCurrencyInterestRateContractThreeMember_1843c08e-cf81-46bd-b024-9edde1070726" xlink:href="iart-20230331.xsd#iart_CrossCurrencyInterestRateContractThreeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CrossCurrencyInterestRateContractMember_54f5eaa0-1c28-46b5-bfd8-ad39432d263f" xlink:to="loc_iart_CrossCurrencyInterestRateContractThreeMember_1843c08e-cf81-46bd-b024-9edde1070726" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionAxis_bd1f12f7-7269-425e-b04c-b6e2785e49c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PositionAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_c7dd2b87-688e-4ca3-a82e-069f17794cd4" xlink:to="loc_us-gaap_PositionAxis_bd1f12f7-7269-425e-b04c-b6e2785e49c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionDomain_c81c74c2-51ee-4e7a-8b56-51e5b8bc2e5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PositionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PositionAxis_bd1f12f7-7269-425e-b04c-b6e2785e49c6" xlink:to="loc_us-gaap_PositionDomain_c81c74c2-51ee-4e7a-8b56-51e5b8bc2e5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongMember_1f50ffe7-50ba-46a6-916c-9b6ef9c7111a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PositionDomain_c81c74c2-51ee-4e7a-8b56-51e5b8bc2e5c" xlink:to="loc_us-gaap_LongMember_1f50ffe7-50ba-46a6-916c-9b6ef9c7111a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortMember_a6fafca7-c85e-4271-97f4-81f802e5b6b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PositionDomain_c81c74c2-51ee-4e7a-8b56-51e5b8bc2e5c" xlink:to="loc_us-gaap_ShortMember_a6fafca7-c85e-4271-97f4-81f802e5b6b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_480aa277-4772-4451-ae16-befcedfd1810" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_c7dd2b87-688e-4ca3-a82e-069f17794cd4" xlink:to="loc_us-gaap_DerivativeLineItems_480aa277-4772-4451-ae16-befcedfd1810" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFixedInterestRate_0811f521-7b8b-4fda-81a3-5a9917a7827e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFixedInterestRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_480aa277-4772-4451-ae16-befcedfd1810" xlink:to="loc_us-gaap_DerivativeFixedInterestRate_0811f521-7b8b-4fda-81a3-5a9917a7827e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_ab613360-3edd-444b-8eb2-aedccab618a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_480aa277-4772-4451-ae16-befcedfd1810" xlink:to="loc_us-gaap_DerivativeNotionalAmount_ab613360-3edd-444b-8eb2-aedccab618a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeNet_9872a576-252d-444e-9293-95403d61eca0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_480aa277-4772-4451-ae16-befcedfd1810" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeNet_9872a576-252d-444e-9293-95403d61eca0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails" xlink:type="simple" xlink:href="iart-20230331.xsd#DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_c157a506-dd83-4e76-a761-82aea57ff2bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_a442e6af-ece6-4aa3-9499-0649619dfb57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_c157a506-dd83-4e76-a761-82aea57ff2bd" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_a442e6af-ece6-4aa3-9499-0649619dfb57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_80c82dd6-b502-463b-9757-3e1a85d59bc2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_a442e6af-ece6-4aa3-9499-0649619dfb57" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_80c82dd6-b502-463b-9757-3e1a85d59bc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_bf72a0c1-bfb6-41e1-a68e-1ccf25d180f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_80c82dd6-b502-463b-9757-3e1a85d59bc2" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_bf72a0c1-bfb6-41e1-a68e-1ccf25d180f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_de74de94-4350-41e3-a440-8e070496efca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_bf72a0c1-bfb6-41e1-a68e-1ccf25d180f3" xlink:to="loc_us-gaap_InterestRateSwapMember_de74de94-4350-41e3-a440-8e070496efca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_ba7746de-69bf-4f2d-b83a-a60a644ab202" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_bf72a0c1-bfb6-41e1-a68e-1ccf25d180f3" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_ba7746de-69bf-4f2d-b83a-a60a644ab202" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_3bbfa77b-b36b-4dcd-be62-16153e64be19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_bf72a0c1-bfb6-41e1-a68e-1ccf25d180f3" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_3bbfa77b-b36b-4dcd-be62-16153e64be19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_336290d7-0ecb-4a2e-a2fd-bdc1ebf0bc08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_a442e6af-ece6-4aa3-9499-0649619dfb57" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_336290d7-0ecb-4a2e-a2fd-bdc1ebf0bc08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_285087ab-de69-437e-949c-7ce00312a5d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_336290d7-0ecb-4a2e-a2fd-bdc1ebf0bc08" xlink:to="loc_us-gaap_HedgingRelationshipDomain_285087ab-de69-437e-949c-7ce00312a5d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_581bb12b-64a9-442d-a51f-10d8ebeb57c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_285087ab-de69-437e-949c-7ce00312a5d9" xlink:to="loc_us-gaap_CashFlowHedgingMember_581bb12b-64a9-442d-a51f-10d8ebeb57c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_1be9b05c-3993-40c7-842a-1995821e0837" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_285087ab-de69-437e-949c-7ce00312a5d9" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_1be9b05c-3993-40c7-842a-1995821e0837" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_130d2b42-7499-4605-88f1-0c69287235d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_a442e6af-ece6-4aa3-9499-0649619dfb57" xlink:to="loc_us-gaap_HedgingDesignationAxis_130d2b42-7499-4605-88f1-0c69287235d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_5a085013-57de-4f25-bfda-36109b4d4c49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_130d2b42-7499-4605-88f1-0c69287235d1" xlink:to="loc_us-gaap_HedgingDesignationDomain_5a085013-57de-4f25-bfda-36109b4d4c49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_ac34e38c-7b85-4e28-8701-a59b4e1d6e77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_5a085013-57de-4f25-bfda-36109b4d4c49" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_ac34e38c-7b85-4e28-8701-a59b4e1d6e77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_4a510c74-252d-4db2-9ffd-774969842b59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_a442e6af-ece6-4aa3-9499-0649619dfb57" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_4a510c74-252d-4db2-9ffd-774969842b59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_c3506635-1dd8-415e-8c3c-fbe05212aa57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_4a510c74-252d-4db2-9ffd-774969842b59" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_c3506635-1dd8-415e-8c3c-fbe05212aa57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_c6519fc9-1bf1-4746-a7e9-aa5c459b1e02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_c3506635-1dd8-415e-8c3c-fbe05212aa57" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_c6519fc9-1bf1-4746-a7e9-aa5c459b1e02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember_4b539e92-580d-424d-a0da-b1c4b236fcba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_c3506635-1dd8-415e-8c3c-fbe05212aa57" xlink:to="loc_us-gaap_OtherAssetsMember_4b539e92-580d-424d-a0da-b1c4b236fcba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AccruedExpensesAndOtherCurrentLiabilitiesMember_f086bfd3-9db3-43fb-8900-dcde6b50e833" xlink:href="iart-20230331.xsd#iart_AccruedExpensesAndOtherCurrentLiabilitiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_c3506635-1dd8-415e-8c3c-fbe05212aa57" xlink:to="loc_iart_AccruedExpensesAndOtherCurrentLiabilitiesMember_f086bfd3-9db3-43fb-8900-dcde6b50e833" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesMember_71463aad-8a22-43b2-994d-3428866049e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_c3506635-1dd8-415e-8c3c-fbe05212aa57" xlink:to="loc_us-gaap_OtherLiabilitiesMember_71463aad-8a22-43b2-994d-3428866049e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_ffa33832-b9bb-480d-88af-ee2409bd6a3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_a442e6af-ece6-4aa3-9499-0649619dfb57" xlink:to="loc_us-gaap_DerivativesFairValueLineItems_ffa33832-b9bb-480d-88af-ee2409bd6a3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_a6618551-ffca-43c8-8de1-085b5b31181e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_ffa33832-b9bb-480d-88af-ee2409bd6a3c" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_a6618551-ffca-43c8-8de1-085b5b31181e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_0b594cd5-e27f-4e53-a8ac-a44d95776c9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_ffa33832-b9bb-480d-88af-ee2409bd6a3c" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_0b594cd5-e27f-4e53-a8ac-a44d95776c9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_319dbf5d-f3d3-4851-ae2b-145f17511072" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_ffa33832-b9bb-480d-88af-ee2409bd6a3c" xlink:to="loc_us-gaap_DerivativeNotionalAmount_319dbf5d-f3d3-4851-ae2b-145f17511072" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails" xlink:type="simple" xlink:href="iart-20230331.xsd#DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_61936fae-1fa9-46cf-abae-528d995bf0cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_7666e8cf-77cd-4ccb-9746-3405872b5785" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_61936fae-1fa9-46cf-abae-528d995bf0cf" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_7666e8cf-77cd-4ccb-9746-3405872b5785" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_7e3693ce-3da6-4a27-9bdd-d4082a592e31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_7666e8cf-77cd-4ccb-9746-3405872b5785" xlink:to="loc_us-gaap_HedgingDesignationAxis_7e3693ce-3da6-4a27-9bdd-d4082a592e31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_ceadc37a-525b-4b21-9130-eccabf6fc720" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_7e3693ce-3da6-4a27-9bdd-d4082a592e31" xlink:to="loc_us-gaap_HedgingDesignationDomain_ceadc37a-525b-4b21-9130-eccabf6fc720" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_74d1b0a0-adf3-411b-ab41-a1412e954c17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_ceadc37a-525b-4b21-9130-eccabf6fc720" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_74d1b0a0-adf3-411b-ab41-a1412e954c17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_b21c8853-b719-46e3-b8fb-5b9f9ebbfc3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_7666e8cf-77cd-4ccb-9746-3405872b5785" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_b21c8853-b719-46e3-b8fb-5b9f9ebbfc3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_3d822a5b-ccc0-4dfa-ac26-4397ddc2fd0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_b21c8853-b719-46e3-b8fb-5b9f9ebbfc3b" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_3d822a5b-ccc0-4dfa-ac26-4397ddc2fd0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_6c7b1e56-f649-4c07-9c8f-0f054935d079" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_3d822a5b-ccc0-4dfa-ac26-4397ddc2fd0d" xlink:to="loc_us-gaap_InterestRateSwapMember_6c7b1e56-f649-4c07-9c8f-0f054935d079" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_3778a9c7-3f76-4ff4-9dbe-e8d59309f65e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_3d822a5b-ccc0-4dfa-ac26-4397ddc2fd0d" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_3778a9c7-3f76-4ff4-9dbe-e8d59309f65e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_453d72b0-28ee-42be-a552-44b70e1e90c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_3d822a5b-ccc0-4dfa-ac26-4397ddc2fd0d" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_453d72b0-28ee-42be-a552-44b70e1e90c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_78be6d3f-52f8-454a-84b1-0146e8ceb277" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_7666e8cf-77cd-4ccb-9746-3405872b5785" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_78be6d3f-52f8-454a-84b1-0146e8ceb277" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_2a30986d-e368-40a1-b0ae-8f4a928218b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_78be6d3f-52f8-454a-84b1-0146e8ceb277" xlink:to="loc_us-gaap_HedgingRelationshipDomain_2a30986d-e368-40a1-b0ae-8f4a928218b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_1b098e35-179f-426d-b2fc-24a0357c0709" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_2a30986d-e368-40a1-b0ae-8f4a928218b4" xlink:to="loc_us-gaap_CashFlowHedgingMember_1b098e35-179f-426d-b2fc-24a0357c0709" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_28173563-b51d-4d1b-a9f7-4bd1f0265832" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_2a30986d-e368-40a1-b0ae-8f4a928218b4" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_28173563-b51d-4d1b-a9f7-4bd1f0265832" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_e9360794-c166-4e9c-b9dc-03c5c0c78efd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_7666e8cf-77cd-4ccb-9746-3405872b5785" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_e9360794-c166-4e9c-b9dc-03c5c0c78efd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_6efef953-6c2c-4a88-a565-7bc3fb3bd252" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_e9360794-c166-4e9c-b9dc-03c5c0c78efd" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_6efef953-6c2c-4a88-a565-7bc3fb3bd252" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_92c57e43-c4f8-4348-bb75-0820d6f4b7e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_6efef953-6c2c-4a88-a565-7bc3fb3bd252" xlink:to="loc_us-gaap_InterestExpenseMember_92c57e43-c4f8-4348-bb75-0820d6f4b7e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_63a048f3-596b-485f-a27d-bf33254f069e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_6efef953-6c2c-4a88-a565-7bc3fb3bd252" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_63a048f3-596b-485f-a27d-bf33254f069e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_ba1b0dc0-e0a2-4a13-8abe-4bafa8d5ed9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_6efef953-6c2c-4a88-a565-7bc3fb3bd252" xlink:to="loc_us-gaap_CostOfSalesMember_ba1b0dc0-e0a2-4a13-8abe-4bafa8d5ed9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeMember_3b588392-7dd9-4358-ba22-74bd39353115" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_6efef953-6c2c-4a88-a565-7bc3fb3bd252" xlink:to="loc_us-gaap_InterestIncomeMember_3b588392-7dd9-4358-ba22-74bd39353115" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_d2fa8942-4747-4e2a-87ac-29299e7c6249" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_7666e8cf-77cd-4ccb-9746-3405872b5785" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_d2fa8942-4747-4e2a-87ac-29299e7c6249" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_d008d2e2-bf8f-476f-a01b-2484cf57bfa9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_d2fa8942-4747-4e2a-87ac-29299e7c6249" xlink:to="loc_us-gaap_EquityComponentDomain_d008d2e2-bf8f-476f-a01b-2484cf57bfa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_e58104b2-d4ac-4efa-8943-5d24e9cf2d0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_d008d2e2-bf8f-476f-a01b-2484cf57bfa9" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_e58104b2-d4ac-4efa-8943-5d24e9cf2d0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_309b1d4b-f4cc-4986-8ed3-15660f8ecc3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_7666e8cf-77cd-4ccb-9746-3405872b5785" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_309b1d4b-f4cc-4986-8ed3-15660f8ecc3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_cee28157-01fd-4db3-afe3-25ffeaab57f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_309b1d4b-f4cc-4986-8ed3-15660f8ecc3e" xlink:to="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_cee28157-01fd-4db3-afe3-25ffeaab57f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_82d18d1c-a858-4732-aa90-fa2b28f7937e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_cee28157-01fd-4db3-afe3-25ffeaab57f1" xlink:to="loc_us-gaap_StockholdersEquity_82d18d1c-a858-4732-aa90-fa2b28f7937e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_51e92c74-6951-4d7e-bb78-95e827334fbb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_cee28157-01fd-4db3-afe3-25ffeaab57f1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_51e92c74-6951-4d7e-bb78-95e827334fbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_742e89ef-8362-48bf-9022-cb1373c5b92d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_cee28157-01fd-4db3-afe3-25ffeaab57f1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_742e89ef-8362-48bf-9022-cb1373c5b92d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_02f084f4-1885-4192-83b0-5cef5528b05b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_cee28157-01fd-4db3-afe3-25ffeaab57f1" xlink:to="loc_us-gaap_StockholdersEquity_02f084f4-1885-4192-83b0-5cef5528b05b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofDerivativesNotDesignatedasHedgingInstrumentsDetails" xlink:type="simple" xlink:href="iart-20230331.xsd#DERIVATIVEINSTRUMENTSScheduleofDerivativesNotDesignatedasHedgingInstrumentsDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofDerivativesNotDesignatedasHedgingInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_bcb9e7c1-a6b3-4e8c-be2b-f6befa32c814" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_4a8e8d7b-7436-4322-a729-74cd0b23db46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_bcb9e7c1-a6b3-4e8c-be2b-f6befa32c814" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_4a8e8d7b-7436-4322-a729-74cd0b23db46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_62c59b50-ebb2-4d66-85b0-8e21200d3030" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_4a8e8d7b-7436-4322-a729-74cd0b23db46" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_62c59b50-ebb2-4d66-85b0-8e21200d3030" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_778e4076-37a8-4fa6-8b7b-1da78a0e42ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_62c59b50-ebb2-4d66-85b0-8e21200d3030" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_778e4076-37a8-4fa6-8b7b-1da78a0e42ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_75c6c6e6-2ccf-4c4d-aafd-d2ba513f87ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_778e4076-37a8-4fa6-8b7b-1da78a0e42ec" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_75c6c6e6-2ccf-4c4d-aafd-d2ba513f87ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_1427e29a-6bab-4947-8583-526b1377c95c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrencySwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_778e4076-37a8-4fa6-8b7b-1da78a0e42ec" xlink:to="loc_us-gaap_CurrencySwapMember_1427e29a-6bab-4947-8583-526b1377c95c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_b0229b32-9885-4858-8cc0-5df4b0b3cee7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_4a8e8d7b-7436-4322-a729-74cd0b23db46" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_b0229b32-9885-4858-8cc0-5df4b0b3cee7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_d01a0265-3c39-43fb-9016-ddbae2a90cda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_b0229b32-9885-4858-8cc0-5df4b0b3cee7" xlink:to="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_d01a0265-3c39-43fb-9016-ddbae2a90cda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" xlink:type="simple" xlink:href="iart-20230331.xsd#STOCKBASEDCOMPENSATIONNarrativeDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_9b91791e-00a9-4e92-8c14-60fa7d37fb8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5e3f532e-f76e-4ecb-859b-0176d8cbeb73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_9b91791e-00a9-4e92-8c14-60fa7d37fb8a" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5e3f532e-f76e-4ecb-859b-0176d8cbeb73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_b61b5aea-6edc-4530-a0f7-397bf17cabc6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5e3f532e-f76e-4ecb-859b-0176d8cbeb73" xlink:to="loc_srt_RangeAxis_b61b5aea-6edc-4530-a0f7-397bf17cabc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_5c5b29c0-eb1c-4462-9049-582f9ce1c1b0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_b61b5aea-6edc-4530-a0f7-397bf17cabc6" xlink:to="loc_srt_RangeMember_5c5b29c0-eb1c-4462-9049-582f9ce1c1b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_f0b9d203-a041-4f9a-bdef-1777d2ce1638" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_5c5b29c0-eb1c-4462-9049-582f9ce1c1b0" xlink:to="loc_srt_MinimumMember_f0b9d203-a041-4f9a-bdef-1777d2ce1638" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_cc264250-b43c-4b31-9d99-813ce3580bac" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_5c5b29c0-eb1c-4462-9049-582f9ce1c1b0" xlink:to="loc_srt_MaximumMember_cc264250-b43c-4b31-9d99-813ce3580bac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_346fb420-d3f8-498b-b58d-fa229d0e72ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5e3f532e-f76e-4ecb-859b-0176d8cbeb73" xlink:to="loc_us-gaap_AwardTypeAxis_346fb420-d3f8-498b-b58d-fa229d0e72ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4927ac22-670a-4c85-a4bf-7179ed391d26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_346fb420-d3f8-498b-b58d-fa229d0e72ce" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4927ac22-670a-4c85-a4bf-7179ed391d26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_7896fede-bd5f-4b82-a5dc-2c8213051283" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4927ac22-670a-4c85-a4bf-7179ed391d26" xlink:to="loc_us-gaap_EmployeeStockOptionMember_7896fede-bd5f-4b82-a5dc-2c8213051283" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_954a5161-d019-4e3b-8a34-d6f88bc86008" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4927ac22-670a-4c85-a4bf-7179ed391d26" xlink:to="loc_us-gaap_RestrictedStockMember_954a5161-d019-4e3b-8a34-d6f88bc86008" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_PerformanceStockAndRestrictedStockAwardsMember_b26edeba-405e-42c2-a9ca-4613f2652b1f" xlink:href="iart-20230331.xsd#iart_PerformanceStockAndRestrictedStockAwardsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4927ac22-670a-4c85-a4bf-7179ed391d26" xlink:to="loc_iart_PerformanceStockAndRestrictedStockAwardsMember_b26edeba-405e-42c2-a9ca-4613f2652b1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_1b1df0f1-e170-4826-9f15-30c08faed560" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4927ac22-670a-4c85-a4bf-7179ed391d26" xlink:to="loc_us-gaap_PerformanceSharesMember_1b1df0f1-e170-4826-9f15-30c08faed560" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_b104b295-e225-4cec-bf68-426508b98fb8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5e3f532e-f76e-4ecb-859b-0176d8cbeb73" xlink:to="loc_srt_TitleOfIndividualAxis_b104b295-e225-4cec-bf68-426508b98fb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_59a4f1b7-a587-4b7e-80cf-40ff4b11c16a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualAxis_b104b295-e225-4cec-bf68-426508b98fb8" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_59a4f1b7-a587-4b7e-80cf-40ff4b11c16a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_DirectorMember_3048d61c-098e-48a1-82a8-f2a3432f869a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_DirectorMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_59a4f1b7-a587-4b7e-80cf-40ff4b11c16a" xlink:to="loc_srt_DirectorMember_3048d61c-098e-48a1-82a8-f2a3432f869a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_EmployeeMember_741c9022-069e-45f7-a425-8dfad24f33d7" xlink:href="iart-20230331.xsd#iart_EmployeeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_59a4f1b7-a587-4b7e-80cf-40ff4b11c16a" xlink:to="loc_iart_EmployeeMember_741c9022-069e-45f7-a425-8dfad24f33d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DirectorsandCertainExecutiveOfficersMember_4d410c37-fa2f-431c-8395-a64df41dcaa6" xlink:href="iart-20230331.xsd#iart_DirectorsandCertainExecutiveOfficersMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_59a4f1b7-a587-4b7e-80cf-40ff4b11c16a" xlink:to="loc_iart_DirectorsandCertainExecutiveOfficersMember_4d410c37-fa2f-431c-8395-a64df41dcaa6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_689315f2-9061-44c1-9acc-33bf1fed33d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5e3f532e-f76e-4ecb-859b-0176d8cbeb73" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_689315f2-9061-44c1-9acc-33bf1fed33d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_da9085ae-d82c-4be0-9cfd-98d39b5bdcfa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_689315f2-9061-44c1-9acc-33bf1fed33d8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_da9085ae-d82c-4be0-9cfd-98d39b5bdcfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_75f3e05e-4c69-43d3-be4e-ea7f18a34774" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_689315f2-9061-44c1-9acc-33bf1fed33d8" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_75f3e05e-4c69-43d3-be4e-ea7f18a34774" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_9ffad507-865e-4f81-b17d-96414a9c3c47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_689315f2-9061-44c1-9acc-33bf1fed33d8" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_9ffad507-865e-4f81-b17d-96414a9c3c47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_f4cba230-cdb2-4b20-844d-c17e3493ac34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_689315f2-9061-44c1-9acc-33bf1fed33d8" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_f4cba230-cdb2-4b20-844d-c17e3493ac34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_0771160d-e8a3-4b12-8015-d9e943149b16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_689315f2-9061-44c1-9acc-33bf1fed33d8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_0771160d-e8a3-4b12-8015-d9e943149b16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1996972c-3d7d-4bcc-a075-8a29866e6959" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_689315f2-9061-44c1-9acc-33bf1fed33d8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1996972c-3d7d-4bcc-a075-8a29866e6959" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_b2676e95-f05a-446b-bddb-a3dfe98dd6a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_689315f2-9061-44c1-9acc-33bf1fed33d8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_b2676e95-f05a-446b-bddb-a3dfe98dd6a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_323455b8-064d-47ae-b79b-73a206a37d50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_689315f2-9061-44c1-9acc-33bf1fed33d8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_323455b8-064d-47ae-b79b-73a206a37d50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_76d199b5-df63-465c-b7a9-43282a6072cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_689315f2-9061-44c1-9acc-33bf1fed33d8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_76d199b5-df63-465c-b7a9-43282a6072cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/RETIREMENTPLANSNarrativeDetails" xlink:type="simple" xlink:href="iart-20230331.xsd#RETIREMENTPLANSNarrativeDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/RETIREMENTPLANSNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_b8368207-ca39-4f47-9974-f1f9bb2aaf8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_52e052e8-d2d2-42dd-9553-55540a34cb07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_b8368207-ca39-4f47-9974-f1f9bb2aaf8c" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_52e052e8-d2d2-42dd-9553-55540a34cb07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_01102089-5bc4-4980-b244-8fafb8f34073" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_b8368207-ca39-4f47-9974-f1f9bb2aaf8c" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_01102089-5bc4-4980-b244-8fafb8f34073" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_5ecbd152-f6f9-4add-b9a2-e89078035548" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_b8368207-ca39-4f47-9974-f1f9bb2aaf8c" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_5ecbd152-f6f9-4add-b9a2-e89078035548" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage_ed8300f1-e66d-477c-ac8b-696cfd373945" xlink:href="iart-20230331.xsd#iart_DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_b8368207-ca39-4f47-9974-f1f9bb2aaf8c" xlink:to="loc_iart_DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage_ed8300f1-e66d-477c-ac8b-696cfd373945" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage_69c27e7d-bbea-4a05-9726-39173a62fd55" xlink:href="iart-20230331.xsd#iart_DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_b8368207-ca39-4f47-9974-f1f9bb2aaf8c" xlink:to="loc_iart_DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage_69c27e7d-bbea-4a05-9726-39173a62fd55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationPlanAssets_05645a98-891a-4f7c-913f-99203f98dd20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationPlanAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_b8368207-ca39-4f47-9974-f1f9bb2aaf8c" xlink:to="loc_us-gaap_DeferredCompensationPlanAssets_05645a98-891a-4f7c-913f-99203f98dd20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESNarrativeDetails" xlink:type="simple" xlink:href="iart-20230331.xsd#LEASESANDRELATEDPARTYLEASESNarrativeDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_73f291ae-bd99-4b9a-9196-b94a70ede7ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_a8863b76-8b17-474b-9fd1-a7370bdfa6e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfOperatingLeasedAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_73f291ae-bd99-4b9a-9196-b94a70ede7ac" xlink:to="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_a8863b76-8b17-474b-9fd1-a7370bdfa6e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_77671bdf-039d-481b-ba5c-bd7e8579bbd1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_a8863b76-8b17-474b-9fd1-a7370bdfa6e6" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_77671bdf-039d-481b-ba5c-bd7e8579bbd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_0dedcbb5-0026-4e45-b9ac-8469e50bba2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_77671bdf-039d-481b-ba5c-bd7e8579bbd1" xlink:to="loc_us-gaap_RelatedPartyDomain_0dedcbb5-0026-4e45-b9ac-8469e50bba2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AffiliatedEntityMember_1081adb0-4f86-4253-8fb8-4ca9c4f19891" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AffiliatedEntityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_0dedcbb5-0026-4e45-b9ac-8469e50bba2f" xlink:to="loc_srt_AffiliatedEntityMember_1081adb0-4f86-4253-8fb8-4ca9c4f19891" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseContractualTermAxis_2a5f8d80-fcdc-46cf-bffb-5a81ec31f1ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseContractualTermAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_a8863b76-8b17-474b-9fd1-a7370bdfa6e6" xlink:to="loc_us-gaap_LeaseContractualTermAxis_2a5f8d80-fcdc-46cf-bffb-5a81ec31f1ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseContractualTermDomain_71568a9a-e07f-4582-907b-953a334c5040" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseContractualTermDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseContractualTermAxis_2a5f8d80-fcdc-46cf-bffb-5a81ec31f1ab" xlink:to="loc_us-gaap_LeaseContractualTermDomain_71568a9a-e07f-4582-907b-953a334c5040" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_FiveYearOptionLeasePeriodOneMember_c37f7a0d-dd15-4dc3-a39e-0d436fed1373" xlink:href="iart-20230331.xsd#iart_FiveYearOptionLeasePeriodOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseContractualTermDomain_71568a9a-e07f-4582-907b-953a334c5040" xlink:to="loc_iart_FiveYearOptionLeasePeriodOneMember_c37f7a0d-dd15-4dc3-a39e-0d436fed1373" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_FiveYearOptionLeasePeriodTwoMember_3bf2c9eb-1582-4a0a-80f4-6d688540b1fe" xlink:href="iart-20230331.xsd#iart_FiveYearOptionLeasePeriodTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseContractualTermDomain_71568a9a-e07f-4582-907b-953a334c5040" xlink:to="loc_iart_FiveYearOptionLeasePeriodTwoMember_3bf2c9eb-1582-4a0a-80f4-6d688540b1fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasedAssetsLineItems_73d174ad-d6e2-4438-9c3d-0e609822386a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasedAssetsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_a8863b76-8b17-474b-9fd1-a7370bdfa6e6" xlink:to="loc_us-gaap_OperatingLeasedAssetsLineItems_73d174ad-d6e2-4438-9c3d-0e609822386a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_LesseeOperatingLeaseNumberOfRenewalOptions_20eed078-4caa-4ea9-a478-084780639d88" xlink:href="iart-20230331.xsd#iart_LesseeOperatingLeaseNumberOfRenewalOptions"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_73d174ad-d6e2-4438-9c3d-0e609822386a" xlink:to="loc_iart_LesseeOperatingLeaseNumberOfRenewalOptions_20eed078-4caa-4ea9-a478-084780639d88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense_8726dd25-71c7-4c6d-ae79-28197cdbfee8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_73d174ad-d6e2-4438-9c3d-0e609822386a" xlink:to="loc_us-gaap_OperatingLeaseExpense_8726dd25-71c7-4c6d-ae79-28197cdbfee8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_PercentOfManufacturingFacilityOwnedByCorporationWhoseShareholdersAreTrustsWhoseBeneficiariesIncludeFamilyMembersOfCompanysFormerDirector_4d228954-2757-4e5d-a1f4-8617e19a37e0" xlink:href="iart-20230331.xsd#iart_PercentOfManufacturingFacilityOwnedByCorporationWhoseShareholdersAreTrustsWhoseBeneficiariesIncludeFamilyMembersOfCompanysFormerDirector"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_73d174ad-d6e2-4438-9c3d-0e609822386a" xlink:to="loc_iart_PercentOfManufacturingFacilityOwnedByCorporationWhoseShareholdersAreTrustsWhoseBeneficiariesIncludeFamilyMembersOfCompanysFormerDirector_4d228954-2757-4e5d-a1f4-8617e19a37e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AnnualRateOfLeaseAgreement_1770bf7b-419a-4ab6-8388-3d48c05a842b" xlink:href="iart-20230331.xsd#iart_AnnualRateOfLeaseAgreement"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_73d174ad-d6e2-4438-9c3d-0e609822386a" xlink:to="loc_iart_AnnualRateOfLeaseAgreement_1770bf7b-419a-4ab6-8388-3d48c05a842b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_1d83dd2f-6f98-48bb-abd1-535d7a27d67a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_73d174ad-d6e2-4438-9c3d-0e609822386a" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_1d83dd2f-6f98-48bb-abd1-535d7a27d67a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseOptionToExtend_f8296400-6f55-4416-9337-ee55420e8d81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseOptionToExtend"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_73d174ad-d6e2-4438-9c3d-0e609822386a" xlink:to="loc_us-gaap_LesseeOperatingLeaseOptionToExtend_f8296400-6f55-4416-9337-ee55420e8d81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalBalanceSheetInformationDetails" xlink:type="simple" xlink:href="iart-20230331.xsd#LEASESANDRELATEDPARTYLEASESSupplementalBalanceSheetInformationDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalBalanceSheetInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_d22d991d-2f91-4532-9807-dd4244cfc829" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_4c8bf092-ef98-4179-8ae9-dc0833b0fb66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_d22d991d-2f91-4532-9807-dd4244cfc829" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_4c8bf092-ef98-4179-8ae9-dc0833b0fb66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_3d132182-ce87-4b9f-aff5-71f4206d1671" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_4c8bf092-ef98-4179-8ae9-dc0833b0fb66" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_3d132182-ce87-4b9f-aff5-71f4206d1671" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_583c931e-4bba-4e4c-a385-c4ce77388752" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_3d132182-ce87-4b9f-aff5-71f4206d1671" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_583c931e-4bba-4e4c-a385-c4ce77388752" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember_89dafed7-9108-4b75-84eb-af19e9121689" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_583c931e-4bba-4e4c-a385-c4ce77388752" xlink:to="loc_us-gaap_BuildingMember_89dafed7-9108-4b75-84eb-af19e9121689" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VehiclesMember_94dd827d-592d-4d32-9433-f90e33969344" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VehiclesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_583c931e-4bba-4e4c-a385-c4ce77388752" xlink:to="loc_us-gaap_VehiclesMember_94dd827d-592d-4d32-9433-f90e33969344" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_c4e8eeca-320f-4ca0-a948-7686d826e183" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_4c8bf092-ef98-4179-8ae9-dc0833b0fb66" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_c4e8eeca-320f-4ca0-a948-7686d826e183" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_eed9b76e-bb24-4f32-a561-c26d1268c706" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_c4e8eeca-320f-4ca0-a948-7686d826e183" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_eed9b76e-bb24-4f32-a561-c26d1268c706" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_c73a9bdd-7757-40b4-906a-1985f3172b05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_c4e8eeca-320f-4ca0-a948-7686d826e183" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_c73a9bdd-7757-40b4-906a-1985f3172b05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_b5a95b88-60b3-478d-aa19-0e433cb21631" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_c4e8eeca-320f-4ca0-a948-7686d826e183" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_b5a95b88-60b3-478d-aa19-0e433cb21631" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_0337990f-fb42-482c-83f8-bbd773584d9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_c4e8eeca-320f-4ca0-a948-7686d826e183" xlink:to="loc_us-gaap_OperatingLeaseLiability_0337990f-fb42-482c-83f8-bbd773584d9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_88e48848-6c10-4d91-ad1f-db692776af7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_c4e8eeca-320f-4ca0-a948-7686d826e183" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_88e48848-6c10-4d91-ad1f-db692776af7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_3fe196a3-0a94-431e-a172-add88e469441" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_c4e8eeca-320f-4ca0-a948-7686d826e183" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_3fe196a3-0a94-431e-a172-add88e469441" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalCashFlowInformationDetails" xlink:type="simple" xlink:href="iart-20230331.xsd#LEASESANDRELATEDPARTYLEASESSupplementalCashFlowInformationDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalCashFlowInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_d7b328df-4c7e-4f46-ae83-bc215eea0882" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CashFlowLesseeAbstract_85160561-0c12-4773-a0ef-2c433230c8b2" xlink:href="iart-20230331.xsd#iart_CashFlowLesseeAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_d7b328df-4c7e-4f46-ae83-bc215eea0882" xlink:to="loc_iart_CashFlowLesseeAbstract_85160561-0c12-4773-a0ef-2c433230c8b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_517efeb3-cee8-4b3d-bac6-de3cf5877c3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_CashFlowLesseeAbstract_85160561-0c12-4773-a0ef-2c433230c8b2" xlink:to="loc_us-gaap_OperatingLeasePayments_517efeb3-cee8-4b3d-bac6-de3cf5877c3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract_0e8b71b0-12ce-4225-a6db-c0c4aceaea68" xlink:href="iart-20230331.xsd#iart_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_d7b328df-4c7e-4f46-ae83-bc215eea0882" xlink:to="loc_iart_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract_0e8b71b0-12ce-4225-a6db-c0c4aceaea68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_2cc050c9-a626-4692-894e-6d40a2ab12fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iart_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract_0e8b71b0-12ce-4225-a6db-c0c4aceaea68" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_2cc050c9-a626-4692-894e-6d40a2ab12fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesDetails" xlink:type="simple" xlink:href="iart-20230331.xsd#LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_391a2b6d-292a-4dab-b923-6de2fb03c10e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_88dcc65c-2466-4d33-b8ac-51398b4e5378" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfOperatingLeasedAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_391a2b6d-292a-4dab-b923-6de2fb03c10e" xlink:to="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_88dcc65c-2466-4d33-b8ac-51398b4e5378" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_ad50750c-8a9f-4fca-a6c5-287ba984ebd3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_88dcc65c-2466-4d33-b8ac-51398b4e5378" xlink:to="loc_srt_CounterpartyNameAxis_ad50750c-8a9f-4fca-a6c5-287ba984ebd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_98f0a81e-74da-4671-b658-4289a5817eaf" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_ad50750c-8a9f-4fca-a6c5-287ba984ebd3" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_98f0a81e-74da-4671-b658-4289a5817eaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_RelatedPartiesMember_3128576c-fb35-48de-bac0-d7b0723b8f48" xlink:href="iart-20230331.xsd#iart_RelatedPartiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_98f0a81e-74da-4671-b658-4289a5817eaf" xlink:to="loc_iart_RelatedPartiesMember_3128576c-fb35-48de-bac0-d7b0723b8f48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ThirdPartiesMember_59f2ad12-0a80-4c07-b6fc-a9128b752922" xlink:href="iart-20230331.xsd#iart_ThirdPartiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_98f0a81e-74da-4671-b658-4289a5817eaf" xlink:to="loc_iart_ThirdPartiesMember_59f2ad12-0a80-4c07-b6fc-a9128b752922" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasedAssetsLineItems_443d71fc-5d0c-4f7f-ad15-83477a759ddf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasedAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_88dcc65c-2466-4d33-b8ac-51398b4e5378" xlink:to="loc_us-gaap_OperatingLeasedAssetsLineItems_443d71fc-5d0c-4f7f-ad15-83477a759ddf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_75d7c71c-fe70-4d5c-ac3c-0a983de639a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_443d71fc-5d0c-4f7f-ad15-83477a759ddf" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_75d7c71c-fe70-4d5c-ac3c-0a983de639a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_f46e0878-2792-4784-aa9d-9b620927f860" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_443d71fc-5d0c-4f7f-ad15-83477a759ddf" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_f46e0878-2792-4784-aa9d-9b620927f860" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_30c72956-0e56-4543-8986-25c1bded0033" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_443d71fc-5d0c-4f7f-ad15-83477a759ddf" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_30c72956-0e56-4543-8986-25c1bded0033" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_42ecb3a1-a771-470f-9c6f-83436a98878f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_443d71fc-5d0c-4f7f-ad15-83477a759ddf" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_42ecb3a1-a771-470f-9c6f-83436a98878f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_43bb64a8-86d6-4920-bc88-60a5ca96d1db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_443d71fc-5d0c-4f7f-ad15-83477a759ddf" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_43bb64a8-86d6-4920-bc88-60a5ca96d1db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_ffa4f986-c504-4d35-88ac-554ee162202a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_443d71fc-5d0c-4f7f-ad15-83477a759ddf" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_ffa4f986-c504-4d35-88ac-554ee162202a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_b4173dd2-36df-43a2-ad6f-26783f2c9265" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_443d71fc-5d0c-4f7f-ad15-83477a759ddf" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_b4173dd2-36df-43a2-ad6f-26783f2c9265" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_2186847b-81b0-419d-9383-6cc64baf2596" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_443d71fc-5d0c-4f7f-ad15-83477a759ddf" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_2186847b-81b0-419d-9383-6cc64baf2596" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_90c6c904-2f35-433f-a9f3-7f31b8ddd0ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_443d71fc-5d0c-4f7f-ad15-83477a759ddf" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_90c6c904-2f35-433f-a9f3-7f31b8ddd0ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_71e675d7-2aed-4341-bb54-1213c919bc57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_443d71fc-5d0c-4f7f-ad15-83477a759ddf" xlink:to="loc_us-gaap_OperatingLeaseLiability_71e675d7-2aed-4341-bb54-1213c919bc57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_197f19a7-98d4-433b-8d03-749c2f6d5115" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_443d71fc-5d0c-4f7f-ad15-83477a759ddf" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_197f19a7-98d4-433b-8d03-749c2f6d5115" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_d69df2f4-0b57-4a35-a49d-38baaf0f2881" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_443d71fc-5d0c-4f7f-ad15-83477a759ddf" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_d69df2f4-0b57-4a35-a49d-38baaf0f2881" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesDetails_1" xlink:type="simple" xlink:href="iart-20230331.xsd#LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesDetails_1"/>
  <link:presentationLink xlink:role="http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://integralife.com/role/TREASURYSTOCKNarrativeDetails" xlink:type="simple" xlink:href="iart-20230331.xsd#TREASURYSTOCKNarrativeDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/TREASURYSTOCKNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_ac3efa5d-3dfa-4f93-8c1e-e0955482567a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_0b920c57-2e92-4e71-ae7d-7e4bcd47e9b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_ac3efa5d-3dfa-4f93-8c1e-e0955482567a" xlink:to="loc_us-gaap_TreasuryStockCommonShares_0b920c57-2e92-4e71-ae7d-7e4bcd47e9b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonValue_ec3ea0ad-5ce3-45ff-a9cf-7300c4d3216b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_ac3efa5d-3dfa-4f93-8c1e-e0955482567a" xlink:to="loc_us-gaap_TreasuryStockCommonValue_ec3ea0ad-5ce3-45ff-a9cf-7300c4d3216b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_96bc7c9b-fe01-4c04-811a-f4119bedf847" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_ac3efa5d-3dfa-4f93-8c1e-e0955482567a" xlink:to="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_96bc7c9b-fe01-4c04-811a-f4119bedf847" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt_94c23731-579b-4d22-8f6c-7ebcba5f3b8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_ac3efa5d-3dfa-4f93-8c1e-e0955482567a" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt_94c23731-579b-4d22-8f6c-7ebcba5f3b8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AcceleratedShareRepurchasesSharesReceivedAtInception_68b70e35-472a-489d-ba1f-cce57a543e84" xlink:href="iart-20230331.xsd#iart_AcceleratedShareRepurchasesSharesReceivedAtInception"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_ac3efa5d-3dfa-4f93-8c1e-e0955482567a" xlink:to="loc_iart_AcceleratedShareRepurchasesSharesReceivedAtInception_68b70e35-472a-489d-ba1f-cce57a543e84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AcceleratedShareRepurchasesPercentageOfExpectedTotalRepurchased_7b37959f-0b18-4653-8275-edfbad4b8838" xlink:href="iart-20230331.xsd#iart_AcceleratedShareRepurchasesPercentageOfExpectedTotalRepurchased"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_ac3efa5d-3dfa-4f93-8c1e-e0955482567a" xlink:to="loc_iart_AcceleratedShareRepurchasesPercentageOfExpectedTotalRepurchased_7b37959f-0b18-4653-8275-edfbad4b8838" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ExciseTaxPayableOnShareRepurchases_80d21913-5581-4108-bbce-6ab34fd4daf0" xlink:href="iart-20230331.xsd#iart_ExciseTaxPayableOnShareRepurchases"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_ac3efa5d-3dfa-4f93-8c1e-e0955482567a" xlink:to="loc_iart_ExciseTaxPayableOnShareRepurchases_80d21913-5581-4108-bbce-6ab34fd4daf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AcceleratedShareRepurchasesAdditionalSharesReceived_18f90778-0bb9-423f-9841-0187c51f86bd" xlink:href="iart-20230331.xsd#iart_AcceleratedShareRepurchasesAdditionalSharesReceived"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_ac3efa5d-3dfa-4f93-8c1e-e0955482567a" xlink:to="loc_iart_AcceleratedShareRepurchasesAdditionalSharesReceived_18f90778-0bb9-423f-9841-0187c51f86bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/INCOMETAXESSummaryofEffectiveTaxRateDetails" xlink:type="simple" xlink:href="iart-20230331.xsd#INCOMETAXESSummaryofEffectiveTaxRateDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/INCOMETAXESSummaryofEffectiveTaxRateDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_cc8038df-8765-47cb-9ba3-c129a79f33c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_d431323f-a0d1-4af3-a561-962cfe61f496" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_cc8038df-8765-47cb-9ba3-c129a79f33c7" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_d431323f-a0d1-4af3-a561-962cfe61f496" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/INCOMETAXESNarrativeDetails" xlink:type="simple" xlink:href="iart-20230331.xsd#INCOMETAXESNarrativeDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/INCOMETAXESNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_947b7ae1-2cf8-41a7-8b00-7bcf5c8516ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_58d3eb89-1994-4fde-8f65-d5158e97213e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_947b7ae1-2cf8-41a7-8b00-7bcf5c8516ac" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_58d3eb89-1994-4fde-8f65-d5158e97213e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/NETINCOMEPERSHAREBasicandDilutedNetIncomePerShareDetails" xlink:type="simple" xlink:href="iart-20230331.xsd#NETINCOMEPERSHAREBasicandDilutedNetIncomePerShareDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/NETINCOMEPERSHAREBasicandDilutedNetIncomePerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_c25633b3-d574-4437-a401-72acc1e06276" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract_39e6a6dc-6815-4d49-85a8-3bc3230fedb8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_c25633b3-d574-4437-a401-72acc1e06276" xlink:to="loc_us-gaap_EarningsPerShareBasicAbstract_39e6a6dc-6815-4d49-85a8-3bc3230fedb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_bd6bcfd5-b0d8-46c9-b3a1-6e05024b98cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_39e6a6dc-6815-4d49-85a8-3bc3230fedb8" xlink:to="loc_us-gaap_NetIncomeLoss_bd6bcfd5-b0d8-46c9-b3a1-6e05024b98cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_6e15f0b0-eacf-4348-8e2b-4231117b0daa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_39e6a6dc-6815-4d49-85a8-3bc3230fedb8" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_6e15f0b0-eacf-4348-8e2b-4231117b0daa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_026aeed9-f111-4be4-8e2e-4509f5741c49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_39e6a6dc-6815-4d49-85a8-3bc3230fedb8" xlink:to="loc_us-gaap_EarningsPerShareBasic_026aeed9-f111-4be4-8e2e-4509f5741c49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract_1f288549-71e7-43b6-9639-be12bfd9ae6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_c25633b3-d574-4437-a401-72acc1e06276" xlink:to="loc_us-gaap_EarningsPerShareDilutedAbstract_1f288549-71e7-43b6-9639-be12bfd9ae6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_e7e2ecc2-a0ae-462b-b177-c48bff8f3b99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_1f288549-71e7-43b6-9639-be12bfd9ae6c" xlink:to="loc_us-gaap_NetIncomeLoss_e7e2ecc2-a0ae-462b-b177-c48bff8f3b99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_6186ddf0-2ac3-48d9-ba6b-4b616dc31e28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_1f288549-71e7-43b6-9639-be12bfd9ae6c" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_6186ddf0-2ac3-48d9-ba6b-4b616dc31e28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DilutiveSecuritiesAbstract_e28c641e-dc8e-4027-8442-ec330d0a422a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DilutiveSecuritiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_1f288549-71e7-43b6-9639-be12bfd9ae6c" xlink:to="loc_us-gaap_DilutiveSecuritiesAbstract_e28c641e-dc8e-4027-8442-ec330d0a422a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_c99b018e-dc02-4725-b6ec-0e95a268bdb0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DilutiveSecuritiesAbstract_e28c641e-dc8e-4027-8442-ec330d0a422a" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_c99b018e-dc02-4725-b6ec-0e95a268bdb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_fa7a4cdf-33b3-4d6d-b476-eaca6f5c2d29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DilutiveSecuritiesAbstract_e28c641e-dc8e-4027-8442-ec330d0a422a" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_fa7a4cdf-33b3-4d6d-b476-eaca6f5c2d29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_3f635cf9-51ad-4822-a6f7-464b8d85713c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_1f288549-71e7-43b6-9639-be12bfd9ae6c" xlink:to="loc_us-gaap_EarningsPerShareDiluted_3f635cf9-51ad-4822-a6f7-464b8d85713c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/NETINCOMEPERSHARENarrativeDetails" xlink:type="simple" xlink:href="iart-20230331.xsd#NETINCOMEPERSHARENarrativeDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/NETINCOMEPERSHARENarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_a5af83fc-539b-4f73-8f55-8eef663f07bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_fceac952-f0a9-4cf4-870f-98c708e65fbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_a5af83fc-539b-4f73-8f55-8eef663f07bc" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_fceac952-f0a9-4cf4-870f-98c708e65fbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSScheduleofComprehensiveIncomeDetails" xlink:type="simple" xlink:href="iart-20230331.xsd#ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSScheduleofComprehensiveIncomeDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSScheduleofComprehensiveIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_6ca6c574-7a60-434f-ad90-bf3e7c743b21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_90f51d96-9a01-4cfb-a5ab-3172b0b6d51f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_6ca6c574-7a60-434f-ad90-bf3e7c743b21" xlink:to="loc_us-gaap_NetIncomeLoss_90f51d96-9a01-4cfb-a5ab-3172b0b6d51f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_9f41869e-8244-44e6-b334-4e75b1758367" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_6ca6c574-7a60-434f-ad90-bf3e7c743b21" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_9f41869e-8244-44e6-b334-4e75b1758367" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent_7d830071-5de5-4168-8bec-552202966cf1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_6ca6c574-7a60-434f-ad90-bf3e7c743b21" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent_7d830071-5de5-4168-8bec-552202966cf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_419b4ab8-7f27-4ff4-b4b0-05ed761ab540" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_6ca6c574-7a60-434f-ad90-bf3e7c743b21" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_419b4ab8-7f27-4ff4-b4b0-05ed761ab540" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_76833aca-dd47-4529-8466-755348810864" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_6ca6c574-7a60-434f-ad90-bf3e7c743b21" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_76833aca-dd47-4529-8466-755348810864" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails" xlink:type="simple" xlink:href="iart-20230331.xsd#ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_721f67a4-8480-4be6-b26c-96ebc676218f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_36d2a43b-cad6-4682-a02f-9a3375e6e2c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_721f67a4-8480-4be6-b26c-96ebc676218f" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_36d2a43b-cad6-4682-a02f-9a3375e6e2c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_a46ce5d8-ac7e-4165-a4cc-f03cb89405d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_36d2a43b-cad6-4682-a02f-9a3375e6e2c5" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_a46ce5d8-ac7e-4165-a4cc-f03cb89405d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_f3a43716-1afc-4b0f-9144-a8d7620b6dfb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_a46ce5d8-ac7e-4165-a4cc-f03cb89405d0" xlink:to="loc_us-gaap_EquityComponentDomain_f3a43716-1afc-4b0f-9144-a8d7620b6dfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_b7a535b8-3cc8-4a3a-ab2e-18e9b6aa19ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_f3a43716-1afc-4b0f-9144-a8d7620b6dfb" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_b7a535b8-3cc8-4a3a-ab2e-18e9b6aa19ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_fb6b5f4d-f175-41dd-ac87-b16e155c11ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_b7a535b8-3cc8-4a3a-ab2e-18e9b6aa19ba" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_fb6b5f4d-f175-41dd-ac87-b16e155c11ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_cca20a77-f49e-4a02-902e-1ed02981e9da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_b7a535b8-3cc8-4a3a-ab2e-18e9b6aa19ba" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_cca20a77-f49e-4a02-902e-1ed02981e9da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_3a52fbb4-d64d-4bec-9b5b-fe6be053a502" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_b7a535b8-3cc8-4a3a-ab2e-18e9b6aa19ba" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_3a52fbb4-d64d-4bec-9b5b-fe6be053a502" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_a8cbe1f5-625e-4cc8-aece-02706d614c4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_36d2a43b-cad6-4682-a02f-9a3375e6e2c5" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_a8cbe1f5-625e-4cc8-aece-02706d614c4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_a16e1d8b-dd75-4fbc-b1f5-b8e53294a0f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_a8cbe1f5-625e-4cc8-aece-02706d614c4f" xlink:to="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_a16e1d8b-dd75-4fbc-b1f5-b8e53294a0f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_4714badb-8ec1-4ded-b48f-5c6cb3ec9e08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_a16e1d8b-dd75-4fbc-b1f5-b8e53294a0f8" xlink:to="loc_us-gaap_StockholdersEquity_4714badb-8ec1-4ded-b48f-5c6cb3ec9e08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_64627042-de45-48fe-81f3-81e8e74ac15d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_a16e1d8b-dd75-4fbc-b1f5-b8e53294a0f8" xlink:to="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_64627042-de45-48fe-81f3-81e8e74ac15d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_e09e4b73-ad6a-4254-89d5-6d9901107a19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_a16e1d8b-dd75-4fbc-b1f5-b8e53294a0f8" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_e09e4b73-ad6a-4254-89d5-6d9901107a19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_e44ac261-1151-4317-85ff-252eb775b618" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_a16e1d8b-dd75-4fbc-b1f5-b8e53294a0f8" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_e44ac261-1151-4317-85ff-252eb775b618" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_2e908c58-85f3-4f11-8332-5ab8c2f90789" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_a16e1d8b-dd75-4fbc-b1f5-b8e53294a0f8" xlink:to="loc_us-gaap_StockholdersEquity_2e908c58-85f3-4f11-8332-5ab8c2f90789" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSNarrativeDetails" xlink:type="simple" xlink:href="iart-20230331.xsd#ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSNarrativeDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_543d1a6a-c581-48ff-8edc-4cb9f2caa0f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_d8efe9be-a768-454e-9270-02eec204a1a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_543d1a6a-c581-48ff-8edc-4cb9f2caa0f4" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_d8efe9be-a768-454e-9270-02eec204a1a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_32185b51-c546-49a4-a37d-0483104043e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_d8efe9be-a768-454e-9270-02eec204a1a0" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_32185b51-c546-49a4-a37d-0483104043e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_97739368-16ef-4d1c-af2e-0611df035a2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_32185b51-c546-49a4-a37d-0483104043e4" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_97739368-16ef-4d1c-af2e-0611df035a2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherExpenseMember_c1065e43-20ed-4a6f-b4be-cbdd43b8927e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_97739368-16ef-4d1c-af2e-0611df035a2c" xlink:to="loc_us-gaap_OtherExpenseMember_c1065e43-20ed-4a6f-b4be-cbdd43b8927e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeMember_b4390775-d66e-46d4-ba6a-6104c21998b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_97739368-16ef-4d1c-af2e-0611df035a2c" xlink:to="loc_us-gaap_InterestIncomeMember_b4390775-d66e-46d4-ba6a-6104c21998b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_2c93baee-a279-4775-85b7-32d87913b246" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_d8efe9be-a768-454e-9270-02eec204a1a0" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_2c93baee-a279-4775-85b7-32d87913b246" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_64c84bac-40d2-4286-b20c-10402069795c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_2c93baee-a279-4775-85b7-32d87913b246" xlink:to="loc_us-gaap_EquityComponentDomain_64c84bac-40d2-4286-b20c-10402069795c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_15034e1f-ef85-4a5f-a6fd-fb57b655dea1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_64c84bac-40d2-4286-b20c-10402069795c" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_15034e1f-ef85-4a5f-a6fd-fb57b655dea1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_1ae713b5-cd2f-4d72-a622-9316013ec958" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_d8efe9be-a768-454e-9270-02eec204a1a0" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_1ae713b5-cd2f-4d72-a622-9316013ec958" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_b2d033f7-6b99-4622-bdf3-9fc4a4d8577f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_1ae713b5-cd2f-4d72-a622-9316013ec958" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_b2d033f7-6b99-4622-bdf3-9fc4a4d8577f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNarrativeDetails" xlink:type="simple" xlink:href="iart-20230331.xsd#SEGMENTANDGEOGRAPHICINFORMATIONNarrativeDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_7dacf141-ecc0-4a89-ad9f-f29d5a41c8cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_9bb9b11f-cdf5-49b7-a80d-8bf456f6c9d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_7dacf141-ecc0-4a89-ad9f-f29d5a41c8cc" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_9bb9b11f-cdf5-49b7-a80d-8bf456f6c9d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_1c780e07-9e8d-4478-bb7c-37aec9f936df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_9bb9b11f-cdf5-49b7-a80d-8bf456f6c9d1" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_1c780e07-9e8d-4478-bb7c-37aec9f936df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_a5ffca31-1530-4d9e-af35-ef7a679fe87f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_1c780e07-9e8d-4478-bb7c-37aec9f936df" xlink:to="loc_us-gaap_SegmentDomain_a5ffca31-1530-4d9e-af35-ef7a679fe87f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CodmanSpecialtySurgicalMember_04ce38e4-bc48-4bfe-9811-8de2fc63e157" xlink:href="iart-20230331.xsd#iart_CodmanSpecialtySurgicalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_a5ffca31-1530-4d9e-af35-ef7a679fe87f" xlink:to="loc_iart_CodmanSpecialtySurgicalMember_04ce38e4-bc48-4bfe-9811-8de2fc63e157" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_1e0aa234-df2e-440d-96f4-a4bb55610791" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_9bb9b11f-cdf5-49b7-a80d-8bf456f6c9d1" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_1e0aa234-df2e-440d-96f4-a4bb55610791" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_9654f97f-6d55-4405-bcd8-1eb4f0176682" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_1e0aa234-df2e-440d-96f4-a4bb55610791" xlink:to="loc_us-gaap_NumberOfReportableSegments_9654f97f-6d55-4405-bcd8-1eb4f0176682" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SegmentReportingInformationNumberOfProductsOffered_61ac048d-7d13-4252-b39a-68ee4a072114" xlink:href="iart-20230331.xsd#iart_SegmentReportingInformationNumberOfProductsOffered"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_1e0aa234-df2e-440d-96f4-a4bb55610791" xlink:to="loc_iart_SegmentReportingInformationNumberOfProductsOffered_61ac048d-7d13-4252-b39a-68ee4a072114" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails" xlink:type="simple" xlink:href="iart-20230331.xsd#SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_d85eb5ac-07c3-44af-8d62-87a836fdb61c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_1cadc11f-b444-4be8-bd29-bb9ab6bd5f4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_d85eb5ac-07c3-44af-8d62-87a836fdb61c" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_1cadc11f-b444-4be8-bd29-bb9ab6bd5f4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_51724535-38a0-4b5a-a23c-784137913cff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_1cadc11f-b444-4be8-bd29-bb9ab6bd5f4f" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_51724535-38a0-4b5a-a23c-784137913cff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_53e4767d-286a-4a17-a7ab-d11f22f9e0cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_51724535-38a0-4b5a-a23c-784137913cff" xlink:to="loc_us-gaap_SegmentDomain_53e4767d-286a-4a17-a7ab-d11f22f9e0cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_CodmanSpecialtySurgicalMember_b0e95a47-d7d6-4d71-9907-14b47716e3d0" xlink:href="iart-20230331.xsd#iart_CodmanSpecialtySurgicalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_53e4767d-286a-4a17-a7ab-d11f22f9e0cb" xlink:to="loc_iart_CodmanSpecialtySurgicalMember_b0e95a47-d7d6-4d71-9907-14b47716e3d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_TissueTechnologiesMember_b9798a7c-9f2a-4055-8112-13682b569636" xlink:href="iart-20230331.xsd#iart_TissueTechnologiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_53e4767d-286a-4a17-a7ab-d11f22f9e0cb" xlink:to="loc_iart_TissueTechnologiesMember_b9798a7c-9f2a-4055-8112-13682b569636" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_82320645-410a-4053-b95f-69af617bee4e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_1cadc11f-b444-4be8-bd29-bb9ab6bd5f4f" xlink:to="loc_srt_ConsolidationItemsAxis_82320645-410a-4053-b95f-69af617bee4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_66283b51-cdfc-43f3-b5de-201224b35fe5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_82320645-410a-4053-b95f-69af617bee4e" xlink:to="loc_srt_ConsolidationItemsDomain_66283b51-cdfc-43f3-b5de-201224b35fe5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_2a94cae5-d8ae-4022-a185-16df6acc9288" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_66283b51-cdfc-43f3-b5de-201224b35fe5" xlink:to="loc_us-gaap_OperatingSegmentsMember_2a94cae5-d8ae-4022-a185-16df6acc9288" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_f238ba7c-bb0f-42b7-b297-e374381c3f06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_66283b51-cdfc-43f3-b5de-201224b35fe5" xlink:to="loc_us-gaap_CorporateNonSegmentMember_f238ba7c-bb0f-42b7-b297-e374381c3f06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_eafa3353-4757-4e7a-9923-a1b12de09e23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_1cadc11f-b444-4be8-bd29-bb9ab6bd5f4f" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_eafa3353-4757-4e7a-9923-a1b12de09e23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract_6d5ce3c6-5cc6-48c2-a06b-a9444c67b8d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_eafa3353-4757-4e7a-9923-a1b12de09e23" xlink:to="loc_us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract_6d5ce3c6-5cc6-48c2-a06b-a9444c67b8d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_55c5a003-58cb-42d3-8171-d7d7102653eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract_6d5ce3c6-5cc6-48c2-a06b-a9444c67b8d7" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_55c5a003-58cb-42d3-8171-d7d7102653eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_22a43220-116d-4350-9b37-de133b4d45d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationProfitLossAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_eafa3353-4757-4e7a-9923-a1b12de09e23" xlink:to="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_22a43220-116d-4350-9b37-de133b4d45d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_33d8daf3-cd76-4e63-9066-293ad2ac44b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_22a43220-116d-4350-9b37-de133b4d45d1" xlink:to="loc_us-gaap_OperatingIncomeLoss_33d8daf3-cd76-4e63-9066-293ad2ac44b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_e6e847e5-de5c-4e7d-a06d-71de27a56ace" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_eafa3353-4757-4e7a-9923-a1b12de09e23" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_e6e847e5-de5c-4e7d-a06d-71de27a56ace" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTotalRevenuebyMajorGeographicAreaDetails" xlink:type="simple" xlink:href="iart-20230331.xsd#SEGMENTANDGEOGRAPHICINFORMATIONTotalRevenuebyMajorGeographicAreaDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTotalRevenuebyMajorGeographicAreaDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_3f668e72-ccb7-4c2a-a4ce-adc21676894a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_cd12f723-a7e8-422e-9f3f-489224774251" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_3f668e72-ccb7-4c2a-a4ce-adc21676894a" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_cd12f723-a7e8-422e-9f3f-489224774251" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_f5564a3a-ed33-4f90-9656-69b4a555634c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_cd12f723-a7e8-422e-9f3f-489224774251" xlink:to="loc_srt_StatementGeographicalAxis_f5564a3a-ed33-4f90-9656-69b4a555634c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_2444aaf0-4f27-4edd-bfac-fdd5586bdd0b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_f5564a3a-ed33-4f90-9656-69b4a555634c" xlink:to="loc_srt_SegmentGeographicalDomain_2444aaf0-4f27-4edd-bfac-fdd5586bdd0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_f22e0ded-d8ad-4c7a-9518-6c082d36ef63" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_2444aaf0-4f27-4edd-bfac-fdd5586bdd0b" xlink:to="loc_country_US_f22e0ded-d8ad-4c7a-9518-6c082d36ef63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_09464f55-fb5c-49e5-a3e8-2cf35f97a4ec" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EuropeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_2444aaf0-4f27-4edd-bfac-fdd5586bdd0b" xlink:to="loc_srt_EuropeMember_09464f55-fb5c-49e5-a3e8-2cf35f97a4ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember_a243b19f-8f9e-4a55-af29-9282dd53cfe2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AsiaPacificMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_2444aaf0-4f27-4edd-bfac-fdd5586bdd0b" xlink:to="loc_srt_AsiaPacificMember_a243b19f-8f9e-4a55-af29-9282dd53cfe2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_RestOfWorldMember_ae8e9df7-e110-4024-a2ff-47cb90b2aba9" xlink:href="iart-20230331.xsd#iart_RestOfWorldMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_2444aaf0-4f27-4edd-bfac-fdd5586bdd0b" xlink:to="loc_iart_RestOfWorldMember_ae8e9df7-e110-4024-a2ff-47cb90b2aba9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_2c36a649-e920-4010-b1f1-c8273d8fbc0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_cd12f723-a7e8-422e-9f3f-489224774251" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_2c36a649-e920-4010-b1f1-c8273d8fbc0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_5fd89d87-af96-4d3d-b3a6-7e68d9d69aa7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2c36a649-e920-4010-b1f1-c8273d8fbc0e" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_5fd89d87-af96-4d3d-b3a6-7e68d9d69aa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails" xlink:type="simple" xlink:href="iart-20230331.xsd#COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_4d6c0445-7f61-498b-8378-8425d8cecb42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_7c7cc496-b20a-4e0b-8347-d9eb1cff9770" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_4d6c0445-7f61-498b-8378-8425d8cecb42" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_7c7cc496-b20a-4e0b-8347-d9eb1cff9770" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_e42d1464-0ab8-459a-81ec-5eb781c33898" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_7c7cc496-b20a-4e0b-8347-d9eb1cff9770" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_e42d1464-0ab8-459a-81ec-5eb781c33898" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f436086d-ec11-4599-b90a-1959d9d55931" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_e42d1464-0ab8-459a-81ec-5eb781c33898" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f436086d-ec11-4599-b90a-1959d9d55931" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ArkisBioSciencesInc.Member_871db09d-f7e6-4719-8f26-9f479767857e" xlink:href="iart-20230331.xsd#iart_ArkisBioSciencesInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f436086d-ec11-4599-b90a-1959d9d55931" xlink:to="loc_iart_ArkisBioSciencesInc.Member_871db09d-f7e6-4719-8f26-9f479767857e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DermaSciencesMember_4bad9615-de1b-4720-a60a-ff94c30fc774" xlink:href="iart-20230331.xsd#iart_DermaSciencesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f436086d-ec11-4599-b90a-1959d9d55931" xlink:to="loc_iart_DermaSciencesMember_4bad9615-de1b-4720-a60a-ff94c30fc774" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ACellMember_5f180b4c-7e77-4284-b782-3ece6044b9a4" xlink:href="iart-20230331.xsd#iart_ACellMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f436086d-ec11-4599-b90a-1959d9d55931" xlink:to="loc_iart_ACellMember_5f180b4c-7e77-4284-b782-3ece6044b9a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_SurgicalInnovationAssociatesIncMember_8192fdd9-3292-44e8-a3d1-205ad967392a" xlink:href="iart-20230331.xsd#iart_SurgicalInnovationAssociatesIncMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f436086d-ec11-4599-b90a-1959d9d55931" xlink:to="loc_iart_SurgicalInnovationAssociatesIncMember_8192fdd9-3292-44e8-a3d1-205ad967392a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_1acc41ff-d848-4421-a245-9cb33c6053e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_7c7cc496-b20a-4e0b-8347-d9eb1cff9770" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_1acc41ff-d848-4421-a245-9cb33c6053e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_204c0000-6d54-4ea3-af32-ac0f45b4b9c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_1acc41ff-d848-4421-a245-9cb33c6053e4" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_204c0000-6d54-4ea3-af32-ac0f45b4b9c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ContingentConsiderationLiabilityMember_0e1275b3-8694-4325-8354-130c46cc16c5" xlink:href="iart-20230331.xsd#iart_ContingentConsiderationLiabilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_204c0000-6d54-4ea3-af32-ac0f45b4b9c8" xlink:to="loc_iart_ContingentConsiderationLiabilityMember_0e1275b3-8694-4325-8354-130c46cc16c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_68e44c61-fbaf-4bd3-a770-ceeb16db6a5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_7c7cc496-b20a-4e0b-8347-d9eb1cff9770" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_68e44c61-fbaf-4bd3-a770-ceeb16db6a5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e7ab3555-af39-4ad2-b488-ba8e36e9c818" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_68e44c61-fbaf-4bd3-a770-ceeb16db6a5d" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e7ab3555-af39-4ad2-b488-ba8e36e9c818" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_219965f6-8803-4ea4-a618-11a1631dd9e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e7ab3555-af39-4ad2-b488-ba8e36e9c818" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_219965f6-8803-4ea4-a618-11a1631dd9e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_1aa59038-60bf-41a8-ad7b-5e8eebdc802d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_7c7cc496-b20a-4e0b-8347-d9eb1cff9770" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_1aa59038-60bf-41a8-ad7b-5e8eebdc802d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_11511bba-6b4e-47b2-ba87-cd37d5d4e885" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_1aa59038-60bf-41a8-ad7b-5e8eebdc802d" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_11511bba-6b4e-47b2-ba87-cd37d5d4e885" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_9e02e140-a745-43f3-90b3-9068fb547bc8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_11511bba-6b4e-47b2-ba87-cd37d5d4e885" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_9e02e140-a745-43f3-90b3-9068fb547bc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_b1540ca8-c640-4299-97af-8c1fc2d9308f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_11511bba-6b4e-47b2-ba87-cd37d5d4e885" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_b1540ca8-c640-4299-97af-8c1fc2d9308f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_06652f7d-e586-4a2a-90d3-7a62d09641dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_7c7cc496-b20a-4e0b-8347-d9eb1cff9770" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_06652f7d-e586-4a2a-90d3-7a62d09641dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_d49a0b78-ecf2-429c-b4a0-56ab776a3a54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_06652f7d-e586-4a2a-90d3-7a62d09641dd" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_d49a0b78-ecf2-429c-b4a0-56ab776a3a54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_a55556e3-2f05-4090-ad97-e328c36b6bd8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_d49a0b78-ecf2-429c-b4a0-56ab776a3a54" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_a55556e3-2f05-4090-ad97-e328c36b6bd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent_455ddfb8-2799-4779-bae8-339e12fba8d5" xlink:href="iart-20230331.xsd#iart_FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_d49a0b78-ecf2-429c-b4a0-56ab776a3a54" xlink:to="loc_iart_FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent_455ddfb8-2799-4779-bae8-339e12fba8d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_46b71260-6345-474c-b924-10dca2ee848c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_d49a0b78-ecf2-429c-b4a0-56ab776a3a54" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_46b71260-6345-474c-b924-10dca2ee848c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_79b178cb-7375-437d-9c7b-9fdb9c8470c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_d49a0b78-ecf2-429c-b4a0-56ab776a3a54" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_79b178cb-7375-437d-9c7b-9fdb9c8470c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://integralife.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails" xlink:type="simple" xlink:href="iart-20230331.xsd#COMMITMENTSANDCONTINGENCIESNarrativeDetails"/>
  <link:presentationLink xlink:role="http://integralife.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_eb4d61fb-69a8-4492-bc93-0efd40f58399" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_aedc3bf7-4d2d-4de0-be7e-a01b02db3165" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_eb4d61fb-69a8-4492-bc93-0efd40f58399" xlink:to="loc_us-gaap_LossContingenciesTable_aedc3bf7-4d2d-4de0-be7e-a01b02db3165" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_7f8c34a8-0aaf-477c-8f12-f651bd6ebc7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_aedc3bf7-4d2d-4de0-be7e-a01b02db3165" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_7f8c34a8-0aaf-477c-8f12-f651bd6ebc7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d64bbf4f-b4fa-4a80-97dc-08f8b8ac84d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_7f8c34a8-0aaf-477c-8f12-f651bd6ebc7a" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d64bbf4f-b4fa-4a80-97dc-08f8b8ac84d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ArkisBioSciencesInc.Member_734293a0-0e6b-4f11-b1e2-654eb7f1a8e8" xlink:href="iart-20230331.xsd#iart_ArkisBioSciencesInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d64bbf4f-b4fa-4a80-97dc-08f8b8ac84d7" xlink:to="loc_iart_ArkisBioSciencesInc.Member_734293a0-0e6b-4f11-b1e2-654eb7f1a8e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_DermaSciencesMember_ffc311e6-45f5-4b01-b339-a1f72e4848b6" xlink:href="iart-20230331.xsd#iart_DermaSciencesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d64bbf4f-b4fa-4a80-97dc-08f8b8ac84d7" xlink:to="loc_iart_DermaSciencesMember_ffc311e6-45f5-4b01-b339-a1f72e4848b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ACellIncMember_52d045bb-af33-44b6-9e26-6db1dd382ca5" xlink:href="iart-20230331.xsd#iart_ACellIncMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d64bbf4f-b4fa-4a80-97dc-08f8b8ac84d7" xlink:to="loc_iart_ACellIncMember_52d045bb-af33-44b6-9e26-6db1dd382ca5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_e2edd7f0-8fc7-4960-afe0-42071c0a0b22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_aedc3bf7-4d2d-4de0-be7e-a01b02db3165" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_e2edd7f0-8fc7-4960-afe0-42071c0a0b22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_d287589b-b868-4a9b-a06f-d1369a97398b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_e2edd7f0-8fc7-4960-afe0-42071c0a0b22" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_d287589b-b868-4a9b-a06f-d1369a97398b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_MilestonePaymentOneMember_e198b495-9c89-4792-98f7-8172b119d570" xlink:href="iart-20230331.xsd#iart_MilestonePaymentOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_d287589b-b868-4a9b-a06f-d1369a97398b" xlink:to="loc_iart_MilestonePaymentOneMember_e198b495-9c89-4792-98f7-8172b119d570" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_MilestonePaymentTwoMember_820cd705-79a1-44e9-b9a4-b6ed000adea4" xlink:href="iart-20230331.xsd#iart_MilestonePaymentTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_d287589b-b868-4a9b-a06f-d1369a97398b" xlink:to="loc_iart_MilestonePaymentTwoMember_820cd705-79a1-44e9-b9a4-b6ed000adea4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_BioDEarnoutPaymentsandMedihoneyEarnoutPaymentsMember_d25b8246-0fed-4dc2-aea9-791c56fd1404" xlink:href="iart-20230331.xsd#iart_BioDEarnoutPaymentsandMedihoneyEarnoutPaymentsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_d287589b-b868-4a9b-a06f-d1369a97398b" xlink:to="loc_iart_BioDEarnoutPaymentsandMedihoneyEarnoutPaymentsMember_d25b8246-0fed-4dc2-aea9-791c56fd1404" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_235ddd36-f54e-476d-9758-6d16683f3046" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_aedc3bf7-4d2d-4de0-be7e-a01b02db3165" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_235ddd36-f54e-476d-9758-6d16683f3046" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_3f359ce9-3053-4a04-b327-bcb052899373" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_235ddd36-f54e-476d-9758-6d16683f3046" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_3f359ce9-3053-4a04-b327-bcb052899373" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_83898d3d-c22d-42e3-87e5-3778b8df6a3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_3f359ce9-3053-4a04-b327-bcb052899373" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_83898d3d-c22d-42e3-87e5-3778b8df6a3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_AccruedExpensesAndOtherCurrentLiabilitiesMember_6fff3cfb-1a1d-44d8-aa3f-b9c7d2cc220a" xlink:href="iart-20230331.xsd#iart_AccruedExpensesAndOtherCurrentLiabilitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_3f359ce9-3053-4a04-b327-bcb052899373" xlink:to="loc_iart_AccruedExpensesAndOtherCurrentLiabilitiesMember_6fff3cfb-1a1d-44d8-aa3f-b9c7d2cc220a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_4d7b1929-1f68-43d0-ab66-1ea3d58ffcb8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_aedc3bf7-4d2d-4de0-be7e-a01b02db3165" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_4d7b1929-1f68-43d0-ab66-1ea3d58ffcb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7cc84ee1-ab02-426f-80a1-a49eb2d6915c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_4d7b1929-1f68-43d0-ab66-1ea3d58ffcb8" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7cc84ee1-ab02-426f-80a1-a49eb2d6915c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_135317fe-731c-483b-9e5b-e6a2aafbfbd6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7cc84ee1-ab02-426f-80a1-a49eb2d6915c" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_135317fe-731c-483b-9e5b-e6a2aafbfbd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_b9f9a5c3-7253-4aad-aa7b-7fd0627f8f11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_aedc3bf7-4d2d-4de0-be7e-a01b02db3165" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_b9f9a5c3-7253-4aad-aa7b-7fd0627f8f11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_c4203494-edcf-4ab6-83ce-5980b5a04d37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_b9f9a5c3-7253-4aad-aa7b-7fd0627f8f11" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_c4203494-edcf-4ab6-83ce-5980b5a04d37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_ContingentConsiderationLiabilityMember_1b1abe3f-dfd5-42ae-9dc0-598f288727c6" xlink:href="iart-20230331.xsd#iart_ContingentConsiderationLiabilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_c4203494-edcf-4ab6-83ce-5980b5a04d37" xlink:to="loc_iart_ContingentConsiderationLiabilityMember_1b1abe3f-dfd5-42ae-9dc0-598f288727c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_c41e6af4-5c9e-4426-8475-36b9071edddb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_aedc3bf7-4d2d-4de0-be7e-a01b02db3165" xlink:to="loc_us-gaap_LossContingenciesLineItems_c41e6af4-5c9e-4426-8475-36b9071edddb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_6086d866-4cd5-43fd-befa-8da3b0dcfd63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_c41e6af4-5c9e-4426-8475-36b9071edddb" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_6086d866-4cd5-43fd-befa-8da3b0dcfd63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability_3fb024c1-5820-40cd-8ffb-074989f10f9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_c41e6af4-5c9e-4426-8475-36b9071edddb" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability_3fb024c1-5820-40cd-8ffb-074989f10f9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_f84c7b09-1265-4967-b0de-7f0786594406" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_c41e6af4-5c9e-4426-8475-36b9071edddb" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_f84c7b09-1265-4967-b0de-7f0786594406" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_774e6957-f5d6-4fde-821f-5b7c0da7ee51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_c41e6af4-5c9e-4426-8475-36b9071edddb" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_774e6957-f5d6-4fde-821f-5b7c0da7ee51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iart_BusinessCombinationContingentConsiderationNumberOfLiabilities_2c61e6d7-2b47-4b68-9406-5a07b1969ac3" xlink:href="iart-20230331.xsd#iart_BusinessCombinationContingentConsiderationNumberOfLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_c41e6af4-5c9e-4426-8475-36b9071edddb" xlink:to="loc_iart_BusinessCombinationContingentConsiderationNumberOfLiabilities_2c61e6d7-2b47-4b68-9406-5a07b1969ac3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_dc1d3900-3f8f-49ac-b689-6a9758aee964" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_c41e6af4-5c9e-4426-8475-36b9071edddb" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_dc1d3900-3f8f-49ac-b689-6a9758aee964" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_8d6eb10e-b80d-4f36-8a6d-7065344e744d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_c41e6af4-5c9e-4426-8475-36b9071edddb" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_8d6eb10e-b80d-4f36-8a6d-7065344e744d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140709350553040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Apr. 25, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 31,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">000-26224<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">INTEGRA LIFESCIENCES HOLDINGS CORP<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">51-0317849<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address</a></td>
<td class="text">1100 Campus Road<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity City</a></td>
<td class="text">Princeton<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity State</a></td>
<td class="text">NJ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Postal Zip Code</a></td>
<td class="text">08540<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">609<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">275-0500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, Par Value $.01 Per Share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">IART<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Smaller Reporting Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">81,904,442<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000917520<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140709349358752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (UNAUDITED) - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue, net</a></td>
<td class="nump">$ 380,846<span></span>
</td>
<td class="nump">$ 376,638<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpensesAbstract', window );"><strong>Costs and expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of goods sold</a></td>
<td class="nump">147,975<span></span>
</td>
<td class="nump">142,569<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost', window );">Research and development</a></td>
<td class="nump">26,724<span></span>
</td>
<td class="nump">24,085<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative</a></td>
<td class="nump">166,657<span></span>
</td>
<td class="nump">159,926<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Intangible asset amortization</a></td>
<td class="nump">3,108<span></span>
</td>
<td class="nump">3,894<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total costs and expenses</a></td>
<td class="nump">344,464<span></span>
</td>
<td class="nump">330,474<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="nump">36,382<span></span>
</td>
<td class="nump">46,164<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td>
<td class="nump">4,107<span></span>
</td>
<td class="nump">1,377<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(12,100)<span></span>
</td>
<td class="num">(11,655)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income, net</a></td>
<td class="nump">1,389<span></span>
</td>
<td class="nump">3,429<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before income taxes</a></td>
<td class="nump">29,778<span></span>
</td>
<td class="nump">39,315<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="nump">5,552<span></span>
</td>
<td class="nump">6,414<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 24,226<span></span>
</td>
<td class="nump">$ 32,901<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Net income per share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in dollars per share)</a></td>
<td class="nump">$ 0.30<span></span>
</td>
<td class="nump">$ 0.39<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in dollars per share)</a></td>
<td class="nump">$ 0.29<span></span>
</td>
<td class="nump">$ 0.39<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted average common shares outstanding (See Note 13):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">81,871<span></span>
</td>
<td class="nump">83,632<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">82,323<span></span>
</td>
<td class="nump">84,276<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income (See Note 14)</a></td>
<td class="nump">$ 21,028<span></span>
</td>
<td class="nump">$ 57,031<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The costs incurred in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, excluding in-process research and development acquired in a business combination consummated during the period. Excludes software research and development, which has a separate concept.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140709350285520">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 307,367<span></span>
</td>
<td class="nump">$ 456,661<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Trade accounts receivable, net of allowances of $3,544 and $4,304</a></td>
<td class="nump">253,995<span></span>
</td>
<td class="nump">263,465<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories, net</a></td>
<td class="nump">351,275<span></span>
</td>
<td class="nump">324,583<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">116,845<span></span>
</td>
<td class="nump">116,789<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">1,029,482<span></span>
</td>
<td class="nump">1,161,498<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">315,175<span></span>
</td>
<td class="nump">311,302<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right of use asset - operating leases</a></td>
<td class="nump">146,514<span></span>
</td>
<td class="nump">148,284<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">1,108,759<span></span>
</td>
<td class="nump">1,126,609<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">1,041,606<span></span>
</td>
<td class="nump">1,038,881<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred tax assets, net</a></td>
<td class="nump">44,680<span></span>
</td>
<td class="nump">45,994<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">56,183<span></span>
</td>
<td class="nump">57,190<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">3,742,399<span></span>
</td>
<td class="nump">3,889,758<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecuredDebtCurrent', window );">Current portion of borrowings under senior credit facility</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">38,125<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current portion of lease liability - operating leases</a></td>
<td class="nump">14,792<span></span>
</td>
<td class="nump">14,624<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableTradeCurrent', window );">Accounts payable, trade</a></td>
<td class="nump">112,785<span></span>
</td>
<td class="nump">102,100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Contract liabilities</a></td>
<td class="nump">7,743<span></span>
</td>
<td class="nump">7,253<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued compensation</a></td>
<td class="nump">53,611<span></span>
</td>
<td class="nump">78,771<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses and other current liabilities</a></td>
<td class="nump">93,362<span></span>
</td>
<td class="nump">80,033<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">282,293<span></span>
</td>
<td class="nump">320,906<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecuredLongTermDebt', window );">Long-term borrowings under senior credit facility</a></td>
<td class="nump">769,143<span></span>
</td>
<td class="nump">733,149<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_SecuredLongTermDebtSecuritizationProgramNoncurrent', window );">Long-term borrowings under securitization facility</a></td>
<td class="nump">102,500<span></span>
</td>
<td class="nump">104,700<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebtNoncurrent', window );">Long-term convertible securities</a></td>
<td class="nump">568,069<span></span>
</td>
<td class="nump">567,341<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Lease liability - operating leases</a></td>
<td class="nump">156,910<span></span>
</td>
<td class="nump">157,420<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred tax liabilities</a></td>
<td class="nump">61,693<span></span>
</td>
<td class="nump">63,338<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other liabilities</a></td>
<td class="nump">126,853<span></span>
</td>
<td class="nump">138,501<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">2,067,461<span></span>
</td>
<td class="nump">2,085,355<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock; no par value; 15,000 authorized shares; none outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock; $0.01 par value; 240,000 authorized shares; 90,813 and 90,477 issued at March&#160;31, 2023 and December&#160;31, 2022, respectively</a></td>
<td class="nump">908<span></span>
</td>
<td class="nump">905<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">1,245,297<span></span>
</td>
<td class="nump">1,276,977<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury stock, at cost; 8,918 shares and 6,823 shares at March&#160;31, 2023 and December&#160;31, 2022, respectively</a></td>
<td class="num">(481,678)<span></span>
</td>
<td class="num">(362,862)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="nump">7,067<span></span>
</td>
<td class="nump">10,265<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">903,344<span></span>
</td>
<td class="nump">879,118<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; equity</a></td>
<td class="nump">1,674,938<span></span>
</td>
<td class="nump">1,804,403<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#8217; equity</a></td>
<td class="nump">$ 3,742,399<span></span>
</td>
<td class="nump">$ 3,889,758<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_SecuredLongTermDebtSecuritizationProgramNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Secured Long-Term Debt, Securitization Program, Noncurrent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_SecuredLongTermDebtSecuritizationProgramNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableTradeCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableTradeCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of long-term convertible debt as of the balance sheet date, net of the amount due in the next twelve months or greater than the normal operating cycle, if longer. The debt is convertible into another form of financial instrument, typically the entity's common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecuredDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of the portion of long-term, collateralized debt obligations due within one year or the operating cycle, if longer. Such obligations include mortgage loans, chattel loans, and any other borrowings secured by assets of the borrower.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecuredDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecuredLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of collateralized debt obligations with maturities initially due after one year or beyond the operating cycle, if longer, excluding the current portion. Obligations include, but not limited to, mortgage loans, chattel loans, and other borrowings secured by assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecuredLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140709350453392">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Trade accounts receivable, allowance</a></td>
<td class="nump">$ 3,544<span></span>
</td>
<td class="nump">$ 4,304<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, authorized shares (in shares)</a></td>
<td class="nump">15,000,000<span></span>
</td>
<td class="nump">15,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, outstanding shares (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, authorized shares (in shares)</a></td>
<td class="nump">240,000,000<span></span>
</td>
<td class="nump">240,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, issued shares (in shares)</a></td>
<td class="nump">90,813,000<span></span>
</td>
<td class="nump">90,477,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury stock, shares (in shares)</a></td>
<td class="nump">8,918,000<span></span>
</td>
<td class="nump">6,823,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140709350671744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>OPERATING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 24,226<span></span>
</td>
<td class="nump">$ 32,901<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherDepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">31,143<span></span>
</td>
<td class="nump">29,724<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income tax provision</a></td>
<td class="nump">1,953<span></span>
</td>
<td class="nump">3,544<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">3,620<span></span>
</td>
<td class="nump">6,291<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees', window );">Amortization of debt issuance costs and expenses associated with debt refinancing</a></td>
<td class="nump">1,890<span></span>
</td>
<td class="nump">1,724<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_NoncashLeaseExpense', window );">Non-cash lease expense</a></td>
<td class="nump">1,260<span></span>
</td>
<td class="num">(17)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfAssets', window );">Loss (gain) on disposal of property and equipment</a></td>
<td class="num">(23)<span></span>
</td>
<td class="nump">712<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Change in fair value of contingent consideration and others</a></td>
<td class="nump">4,699<span></span>
</td>
<td class="num">(765)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_ChangesInAssetsAndLiabilitiesAbstract', window );"><strong>Changes in assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="nump">10,041<span></span>
</td>
<td class="num">(3,116)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="num">(25,423)<span></span>
</td>
<td class="num">(11,561)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="num">(2,164)<span></span>
</td>
<td class="num">(5,046)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets', window );">Other non-current assets</a></td>
<td class="num">(6,009)<span></span>
</td>
<td class="nump">2,283<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable, accrued expenses and other current liabilities</a></td>
<td class="num">(4,984)<span></span>
</td>
<td class="num">(9,754)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities', window );">Other non-current liabilities</a></td>
<td class="num">(14,073)<span></span>
</td>
<td class="num">(2,576)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">26,156<span></span>
</td>
<td class="nump">44,344<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>INVESTING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="num">(13,704)<span></span>
</td>
<td class="num">(9,325)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment', window );">Acquired in-process research and development milestone</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(4,742)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(13,704)<span></span>
</td>
<td class="num">(14,067)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>FINANCING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSecuredDebt', window );">Proceeds from borrowings of long-term indebtedness</a></td>
<td class="nump">10,200<span></span>
</td>
<td class="nump">11,250<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfSecuredDebt', window );">Payments on debt</a></td>
<td class="num">(12,400)<span></span>
</td>
<td class="num">(11,750)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtIssuanceCosts', window );">Payment of debt issuance costs</a></td>
<td class="num">(7,578)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Purchases of treasury stock</a></td>
<td class="num">(150,000)<span></span>
</td>
<td class="num">(125,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from exercised stock options</a></td>
<td class="nump">2,326<span></span>
</td>
<td class="nump">1,239<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Cash taxes paid in net equity settlement</a></td>
<td class="num">(5,231)<span></span>
</td>
<td class="num">(9,204)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash used in financing activities</a></td>
<td class="num">(162,683)<span></span>
</td>
<td class="num">(133,465)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of exchange rate changes on cash and cash equivalents</a></td>
<td class="nump">937<span></span>
</td>
<td class="num">(3,168)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net decrease in cash and cash equivalents</a></td>
<td class="num">(149,294)<span></span>
</td>
<td class="num">(106,356)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at beginning of period</a></td>
<td class="nump">456,661<span></span>
</td>
<td class="nump">513,448<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at end of period</a></td>
<td class="nump">$ 307,367<span></span>
</td>
<td class="nump">$ 407,092<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortization Of Debt Issuance Costs And Debt Refinanced Fees</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_ChangesInAssetsAndLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Changes In Assets And Liabilities [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_ChangesInAssetsAndLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_NoncashLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Noncash Lease Expense</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_NoncashLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDispositionOfAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2443-110228<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDispositionOfAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense charged against earnings to allocate the cost of tangible and intangible assets over their remaining economic lives, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflows from the purchase of net carrying value allocated to in-process research and development costs and materials acquired in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSecuredDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from amounts received from issuance of long-term debt that is wholly or partially secured by collateral. Excludes proceeds from tax exempt secured debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSecuredDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfSecuredDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to repay long-term debt that is wholly or partially secured by collateral. Excludes repayments of tax exempt secured debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfSecuredDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140709344453232">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (UNAUDITED) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Treasury Stock</div></th>
<th class="th"><div>Additional Paid-In Capital</div></th>
<th class="th"><div>Accumulated Other Comprehensive Loss</div></th>
<th class="th"><div>Retained Earnings</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance Beginning of Period, Shares (in shares) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">89,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, beginning of period at Dec. 31, 2021</a></td>
<td class="nump">$ 1,684,804<span></span>
</td>
<td class="nump">$ 896<span></span>
</td>
<td class="num">$ (234,448)<span></span>
</td>
<td class="nump">$ 1,264,943<span></span>
</td>
<td class="num">$ (45,155)<span></span>
</td>
<td class="nump">$ 698,568<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Balance, beginning of period, treasury stock, shares (in shares) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,899,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">32,901<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32,901<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="nump">24,130<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,130<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of common stock through employee stock purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of common stock through employee stock purchase plan</a></td>
<td class="nump">1,078<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,078<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of common stock for vesting of share based awards, net of shares withheld for taxes (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">339,000<span></span>
</td>
<td class="nump">14,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of common stock for vesting of share based awards, net of shares withheld for taxes</a></td>
<td class="num">(9,040)<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">$ 714<span></span>
</td>
<td class="num">(9,758)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">6,324<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,324<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Accelerated shares repurchased (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,938,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Accelerated shares repurchased</a></td>
<td class="num">(125,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (129,152)<span></span>
</td>
<td class="nump">4,152<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance End of Period, Shares (in shares) at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">89,956,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, end of period at Mar. 31, 2022</a></td>
<td class="nump">1,615,197<span></span>
</td>
<td class="nump">$ 900<span></span>
</td>
<td class="num">$ (362,886)<span></span>
</td>
<td class="nump">1,266,739<span></span>
</td>
<td class="num">(21,025)<span></span>
</td>
<td class="nump">731,469<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Balance, end of period, treasury stock, shares (in shares) at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,823,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance Beginning of Period, Shares (in shares) at Dec. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90,476,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, beginning of period at Dec. 31, 2022</a></td>
<td class="nump">$ 1,804,403<span></span>
</td>
<td class="nump">$ 905<span></span>
</td>
<td class="num">$ (362,862)<span></span>
</td>
<td class="nump">1,276,977<span></span>
</td>
<td class="nump">10,265<span></span>
</td>
<td class="nump">879,118<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Balance, beginning of period, treasury stock, shares (in shares) at Dec. 31, 2022</a></td>
<td class="num">(6,823,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,823,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 24,226<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,226<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="num">(3,198)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,198)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of common stock through employee stock purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of common stock through employee stock purchase plan</a></td>
<td class="nump">1,107<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,107<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of common stock for vesting of share based awards, net of shares withheld for taxes (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">316,000<span></span>
</td>
<td class="nump">16,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of common stock for vesting of share based awards, net of shares withheld for taxes</a></td>
<td class="num">(4,011)<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 846<span></span>
</td>
<td class="num">(4,858)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">3,611<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,609<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Accelerated shares repurchased (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,111,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Accelerated shares repurchased</a></td>
<td class="num">(151,200)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (119,662)<span></span>
</td>
<td class="num">(31,538)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance End of Period, Shares (in shares) at Mar. 31, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90,813,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, end of period at Mar. 31, 2023</a></td>
<td class="nump">$ 1,674,938<span></span>
</td>
<td class="nump">$ 908<span></span>
</td>
<td class="num">$ (481,678)<span></span>
</td>
<td class="nump">$ 1,245,297<span></span>
</td>
<td class="nump">$ 7,067<span></span>
</td>
<td class="nump">$ 903,344<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Balance, end of period, treasury stock, shares (in shares) at Mar. 31, 2023</a></td>
<td class="num">(8,918,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8,918,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11178-113907<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126961718&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140709353363744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BASIS OF PRESENTATION<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">BASIS OF PRESENTATION</a></td>
<td class="text">BASIS OF PRESENTATION<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">General</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The terms &#8220;we,&#8221; &#8220;our,&#8221; &#8220;us,&#8221; &#8220;Company&#8221; and &#8220;Integra&#8221; refer to Integra LifeSciences Holdings Corporation, a Delaware corporation, and its subsidiaries unless the context suggests otherwise.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the opinion of management, the March&#160;31, 2023 unaudited condensed consolidated financial statements contain all adjustments (consisting only of normal recurring adjustments) necessary for a fair statement of the financial position, statement of changes in shareholders' equity, results of operations and cash flows of the Company. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States ("GAAP") have been condensed or omitted in accordance with the instructions to Form 10-Q and Rule&#160;10-01 of Regulation&#160;S-X. These unaudited condensed consolidated financial statements should be read in conjunction with the Company&#8217;s consolidated financial statements for the year ended December&#160;31, 2022 included in the Company&#8217;s Annual Report on Form 10-K. The December&#160;31, 2022 consolidated balance sheet was derived from audited financial statements, but does not include all disclosures required by GAAP. Operating results for the three-month period ended March&#160;31, 2023 are not necessarily indicative of the results to be expected for the entire year.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements is in conformity with GAAP, which requires management to make estimates and assumptions that affect the reported amount of assets and liabilities, the disclosure of contingent liabilities, and the reported amounts of revenues and expenses. Significant estimates affecting amounts reported or disclosed in the condensed consolidated financial statements include allowances for doubtful accounts receivable and sales returns and allowances, net realizable value of inventories, valuation of intangible assets including amortization periods for acquired intangible assets, discount rates and estimated projected cash flows used to value and test impairments of long-lived assets and goodwill, estimates of projected cash flows and depreciation and amortization periods for long-lived assets, computation of taxes, valuation allowances recorded against deferred tax assets, the valuation of stock-based compensation, valuation of derivative instruments, valuation of contingent liabilities, the fair value of debt instruments and loss contingencies. These estimates are based on historical experience and on various other assumptions that are believed to be reasonable under the current circumstances. Actual results could differ from these estimates. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In March 2020, the FASB issued ASU 2020-04,&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Reference Rate Reform </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(Topic 848), and subsequent amendment to the initial guidance: ASU 2021-01, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Reference Rate Reform</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> (Topic 848): Scope (collectively, &#8220;Topic 848&#8221;). Topic 848 provides optional expedients and exceptions for applying GAAP to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. The amendments apply only to contracts, hedging relationships, and other transactions that reference London Inter-Bank Offered Rate ("LIBOR") or another reference rate expected to be discontinued because of reference rate reform. The guidance generally can be applied through December 31, 2024. The Alternative Reference Rates Committee, a group of private-market participants convened by the U.S. Federal Reserve Board and the New York Federal Reserve, has recommended the use of the Secured Overnight Financing Rate ("SOFR") as a more robust reference rate alternative to LIBOR. The use of SOFR as a substitute for LIBOR is, however, voluntary and may not be suitable for all market participants. There can be no assurance that the replacement rate will be economically equivalent to LIBOR, which could result in higher interest rates for us under our debt facilities. There is no guarantee that a transition from LIBOR to SOFR will not result in financial market disruptions, significant increases in benchmark rates, or our borrowing costs, any of which could have an adverse effect on our business, results of operations and financial condition. On March 24, 2023, the Company entered into the seventh amendment and restatement (the "March 2023 Amendment") of its Senior Credit Facility (the &#8220;Senior Credit Facility&#8221;) with a syndicate of lending banks with Bank of America, N.A., as Administrative Agent. In connection with the March 2023 Amendment the Company replaced all LIBOR-based contracts with SOFR, which is calculated based on overnight transactions under repurchase agreements backed by Treasury securities (See Note 6).  In March 2023, the Company entered into a basis swap where the Company receives Term SOFR and pays LIBOR to convert the portfolio of interest rate swaps from LIBOR to SOFR. Integra has elected to adopt the optional expedient under ASC 848, which will allow the interest rate swap hedging relationship to continue, without de-designation, due to the change in the indexed rate from LIBOR to SOFR. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are no other recently issued accounting pronouncements that are expected to have any significant effect on the Company's financial position, results of operations or cash flows.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI https://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI https://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140709434459440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACQUISITIONS AND DIVESTITURES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_MergersAcquisitionsAndDispositionsAbstract', window );"><strong>Mergers, Acquisitions and Dispositions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock', window );">ACQUISITIONS AND DIVESTITURES</a></td>
<td class="text">ACQUISITIONS AND DIVESTITURES<div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:107%">Surgical Innovation Associates, Inc. Acquisition</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">On December 6, 2022, the Company completed its acquisition of Surgical Innovation Associates, Inc. ("SIA") for an acquisition purchase price of $51.5&#160;million (the "SIA Acquisition"). In addition to the purchase price, the acquisition includes two separate contingent considerations payments, which are dependent on 1) achieving certain revenue-based performance milestones in 2023, 2024, and 2025 (up to $50.0&#160;million in additional payments), as well as 2) the approval by the FDA of the Premarket Approval (&#8220;PMA&#8221;) Application for DuraSorb for certain uses by certain timing targets (up to $40.0&#160;million in additional payments).  SIA's core technology, DuraSorb, is a fully resorbable scaffold of a globally accepted polymer, which is cleared for use in hernia repair, abdominal wall, and other soft tissue reinforcement. DuraSorb sales will be reported within Integra&#8217;s Tissue Technologies ("TT") segment as part of its Wound Reconstruction and Care franchise.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%">Assets Acquired and Liabilities Assumed at Fair Value</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The SIA Acquisition has been accounted for using the acquisition method of accounting. This method requires that assets acquired, and liabilities assumed in a business combination to be recognized at their fair values as of the acquisition date. </span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The following table summarizes the fair values of the assets acquired and liabilities assumed at the acquisition date:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.543%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.028%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.545%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Preliminary Valuation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Life</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,438&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trade accounts receivable, net </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,551&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventories, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,900&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,654&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,543&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14 years</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,854&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total assets acquired</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">127,397</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,044&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,044&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred Tax Liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,799&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">57,607&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total liabilities assumed</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">71,450</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net assets acquired</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">55,947</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%">Developed Technology</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The estimated fair value of the developed technology was determined using the multi-period excess earnings method of the income approach, which estimates value based on the present value of future economic benefits. Some of the more significant assumptions inherent in the development of those asset valuations include the estimated net cash flows for each year for each product including net revenues, cost of sales, R&amp;D costs, selling and marketing costs, working capital, and contributory asset charges, the appropriate discount rate to select in order to measure the risk inherent in each future cash flow stream, the assessment of the asset&#8217;s life cycle, and competitive trends impacting the asset and the cash flow stream.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The Company used a discount rate of 18% to arrive at the present value for the acquired intangible assets to reflect the rate of return a market participant would expect to earn and incremental commercial uncertainty in the cash flow projections. No assurances can be given that the underlying assumptions used to prepare the discounted cash flow analysis will not change. For these and other reasons, actual results may vary significantly from estimated results.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%">Goodwill</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The Company allocated goodwill related to the SIA Acquisition to the TT segment. Goodwill is the excess of the consideration transferred over the net assets recognized and represents the expected revenue and cost synergies of the combined company and assembled workforce. A key factor that contributes to the recognition of goodwill, and a driver for the Company&#8217;s acquisition of SIA, is the attractive growth opportunities presented by the surgical matrix business in the breast reconstruction market. Goodwill recognized as a result of this acquisition is non-deductible for income tax purposes.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%">Contingent Consideration</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The Company determines the acquisition date fair value of contingent consideration obligations based on a probability-weighted income approach derived from revenue estimates and a probability assessment with respect to the likelihood of achieving contingent obligations. The fair value measurement is based on significant inputs not observable in the market and thus represents a Level 3 measurement as defined using the fair value concepts in ASC 820. The resulting most likely payouts are discounted using an appropriate effective annual interest rate. At each reporting date, the contingent consideration obligation will be revalued to estimated fair value and changes in fair value will be reflected as income or expense in the consolidated statement of operations. Changes in the fair value of the contingent considerations may result from changes in discount periods and rates and changes in the timing and amount of revenue estimates. Changes in assumptions utilized in the contingent consideration fair value estimates could result in an increase in the contingent consideration obligation and a corresponding charge to operating results.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">As part of the SIA Acquisition, the Company is required to pay to the shareholder of SIA up to $90.0&#160;million for two separate payments, which are dependent on 1) achieving certain revenue-based performance milestones in 2023, 2024, and 2025 (up to $50.0&#160;million in additional payments), as well as 2) the approval by the FDA of the PMA for DuraSorb for certain uses by certain timing targets (up to $40.0&#160;million in additional payments).  The Company used iterations of the Monte Carlo simulation to calculate the fair value of the contingent consideration for the revenue-based milestone that considered the possible outcomes of scenarios related to each specific milestone for the revenue based performance milestone. The Company used probabilities of achieving the conditions to calculate the fair value of the contingent consideration for the PMA approval milestone.  The Company estimated the fair value of the contingent consideration for the revenue based milestone to be $32.6&#160;million at the acquisition date and $25.0&#160;million for the PMA approval milestone as of December 31, 2022. The company recorded a total of $48.7&#160;million in other liabilities as of March 31, 2023 and $12.5&#160;million in accrued expenses and other current liabilities at March 31, 2023 in the consolidated balance sheet of the company.  </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The change in the fair value of the contingent obligation was primarily as a result of changes in the timing.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%">Deferred Tax Liabilities</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Deferred tax liabilities result from identifiable intangible assets&#8217; fair value adjustments. These adjustments create excess book basis over tax basis which is tax-effected by the statutory tax rates of applicable jurisdictions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:107%">Sale of non-core traditional wound care business</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 31, 2022, the Company completed its sale of its non-core traditional wound care ("TWC") business to Gentell, LLC ("Gentell") for $28.8 million, which consists of $27.8 million in cash plus $1.0 million in contingent consideration which may be received upon achieving certain revenue-based performance milestones two years after the closing date. The proceeds from the sale of the TWC business of $27.8 million is presented in the consolidated statement of cash flows net of cash transferred of $3.5 million and other transaction fees. The transaction included the sale of the Company's TWC products, such as sponges, gauze and conforming bandages, and certain advanced wound care dressings, such as supportive, calcium alginate, hydrogel, and foam dressings.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The divestiture did not represent a strategic shift that had a major effect on the Company's operations and financial statements. Goodwill was allocated to the assets and liabilities divested using the relative fair value method of the TWC business to the Company's TT reportable business segment. In connection with the sale, the Company recognized $0.6 million as a gain from the sale of the business in the condensed consolidated statement of operations for the year ended December&#160;31, 2022. The transaction is subject to final working capital adjustments.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the purchase and sale agreement, the Company also entered into a contract manufacturing agreement with Gentell. Under the terms of the agreement, Gentell received inventory, equipment, and tooling to manufacture certain MediHoney&#174; and TCC-EZ&#174; products on behalf of the Company. On the close date of this transaction, the Company transferred all inventory associated with these products to Gentell and recognized an asset of $11.1 million, as a form of a deposit for the inventory transferred, which based on the expected timing of inventory purchases, was primarily included within prepaid expenses and other current assets in the consolidated balance sheet. This deposit will be utilized by the Company on future orders placed to Gentell for such products. As of March&#160;31, 2023, the Company had a deposit remaining of $7.3 million which is included in prepaid assets and recognized a payable due to Gentell of $0.7 million, which is included in the condensed consolidated balance sheet within accrued expenses and other current liabilities.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_MergersAcquisitionsAndDispositionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Mergers, Acquisitions and Dispositions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_MergersAcquisitionsAndDispositionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for business combinations, including leverage buyout transactions (as applicable), and divestitures. This may include a description of a business combination or divestiture (or series of individually immaterial business combinations or divestitures) completed during the period, including background, timing, and assets and liabilities recognized and reclassified or sold. This element does not include fixed asset sales and plant closings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=2122178<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI https://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140709353216864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUES FROM CONTRACTS WITH CUSTOMERS<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">REVENUES FROM CONTRACTS WITH CUSTOMERS</a></td>
<td class="text">REVENUES FROM CONTRACTS WITH CUSTOMERS <div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Summary of Accounting Policies on Revenue Recognition</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized upon the transfer of control of promised products or services to the customers in an amount that reflects the consideration the Company expects to receive in exchange for those products and services.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Performance Obligations</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's performance obligations consist mainly of transferring control of goods and services identified in the contracts, purchase orders, or invoices. The Company has no significant multi-element contracts with customers.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Significant Estimates</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Usage-based royalties and licenses are estimated based on the provisions of contracts with customers and recognized in the same period that the royalty-based products are sold by the Company's strategic partners. The Company estimates and recognizes royalty revenue based upon communication with licensees, historical information, and expected sales trends. Differences between actual reported licensee sales and those that were estimated are adjusted in the period in which they become known, which is typically the following quarter. Historically, such adjustments have not been significant.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company estimates returns, price concessions, and discount allowances using the expected value method based on historical trends and other known factors. Rebate allowances are estimated using the most likely method based on each customer contract.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's return policy, as set forth in its product catalogs and sales invoices, requires review and authorization in advance prior to the return of product. Upon the authorization, a credit will be issued for the goods returned within a set amount of days from the shipment, which is generally 90 days.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company disregards the effects of a financing component if the Company expects, at contract inception, that the period between the transfer and customer payment for the goods or services will be one year or less. The Company has no significant revenues recognized on payments expected to be received more than one year after the transfer of control of products or services to customers.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contract Asset and Liability</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues recognized from the Company's private label business that are not invoiced to the customers as a result of recognizing revenue over time are recorded as a contract asset included in the prepaid expenses and other current assets account in the consolidated balance sheets.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other operating revenues may include fees received under service agreements. Non-refundable fees received under multiple-period service agreements are recognized as revenue as the Company satisfies the performance obligations to the other party. A portion of the transaction price allocated to the performance obligations to be satisfied in the future periods is recognized as contract liability.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarized the changes in the contract asset and liability balances for the three months ended March 31, 2023:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:79.747%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:18.053%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Contract Asset</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contract asset, January 1, 2023</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,122&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transferred to trade receivable from contract asset included in beginning of the year contract asset</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9,765)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contract asset, net of transferred to trade receivables on contracts during the period</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,713&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contract asset, March&#160;31, 2023</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,070&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Contract Liability</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contract liability, January 1, 2023</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,127&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Recognition of revenue included in beginning of year contract liability</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,492)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contract liability, net of revenue recognized on contracts during the period</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,921&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contract liability, March&#160;31, 2023</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,559&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2023, the short-term portion of the contract liability of $7.7 million and the long-term portion of $8.8 million is included in current liabilities and other liabilities, respectively, in the consolidated balance sheets.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023, the Company is expected to recognize revenue of approximately 47% of unsatisfied (or partially unsatisfied) performance obligations as revenue within 12 months, with the remaining balance to be recognized thereafter.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Shipping and Handling Fees</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company elected to account for shipping and handling activities as a fulfillment cost rather than a separate performance obligation. Amounts billed to customers for shipping and handling are included as part of the transaction price and recognized as revenue when control of underlying products is transferred to the customer. The related shipping and freight charges incurred by the Company are included in the cost of goods sold.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Product Warranties</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of the Company's medical devices, including monitoring systems and neurosurgical systems, are designed to operate over long periods of time. These products are sold with warranties which may extend for up to two years from the date of purchase. The warranties are not considered a separate performance obligation. The Company estimates its product warranties using the expected value method based on historical trends and other known factors. The Company includes them in accrued expenses and other current liabilities in the consolidated balance sheet.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Taxes Collected from Customers</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company elected to exclude from the measurement of the transaction price all taxes assessed by a governmental authority that are both imposed on and concurrent with a specific revenue-producing transaction and collected by the entity from a customer.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Disaggregated Revenue</span></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents revenues disaggregated by the major sources of revenues for the three months ended March&#160;31, 2023 and 2022 (dollar amounts in thousands):</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.028%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.545%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Neurosurgery</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">192,870&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">194,675&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Instruments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55,266&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52,633&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Codman Specialty Surgical</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">248,136&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">247,308&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Wound Reconstruction and Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100,940&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">94,630&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Private Label</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,770&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34,700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Tissue Technologies</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">132,710&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">129,330&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">380,846&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">376,638&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 15, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment and Geographical Information</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for details of revenues based on the location of the customer.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI https://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140709350533360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVENTORIES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">INVENTORIES</a></td>
<td class="text">INVENTORIES<div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories, net consisted of the following:</span></div><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.882%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.545%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finished goods</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">178,626&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">172,088&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">80,532&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70,598&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">92,117&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">81,897&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total inventories, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">351,275&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">324,583&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI https://asc.fasb.org/topic&amp;trid=2126998<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140709353276256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND OTHER INTANGIBLE ASSETS<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">GOODWILL AND OTHER INTANGIBLE ASSETS</a></td>
<td class="text">GOODWILL AND OTHER INTANGIBLE ASSETS<div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the carrying amount of goodwill for the three-month period ended March&#160;31, 2023 were as follows:</span></div><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:55.389%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.911%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.911%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.915%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Codman Specialty <br/>Surgical</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Tissue Technologies</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill at December 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">656,219&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">382,662&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,038,881&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">SIA Acquisition Working Capital Adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,639&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">957&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,596&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill at March&#160;31, 2023</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">657,858&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">383,748&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,041,606&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Intangible Assets</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of the Company&#8217;s identifiable intangible assets were as follows:</span></div><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.367%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.331%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Life</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Completed technology</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,206,748&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(389,297)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">817,451&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">193,297&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(146,098)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47,199&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trademarks/brand names</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">97,554&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(35,665)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">61,889&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Codman tradename</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Indefinite</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">167,529&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">167,529&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Supplier relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,211&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(17,415)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,796&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">All other</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,024&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,129)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,895&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,701,363&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(592,604)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,108,759&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.783%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.331%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Life</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Completed technology</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,204,325&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(370,968)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">833,357&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">193,081&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(144,040)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49,041&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trademarks/brand names</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">97,265&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(34,674)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62,591&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Codman tradename</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Indefinite</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">166,693&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">166,693&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Supplier relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,211&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(17,170)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,041&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">All other</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,957&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,071)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,886&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,697,532&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(570,923)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,126,609&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on quarter-end exchange rates, amortization expense (including amounts reported in cost of goods sold) is expected to be approximately $61.8 million for the remainder of 2023, $81.8 million in 2024, $81.8 million in 2025, $81.6 million in 2026, $79.7 million in 2027, $78.1 million in 2028 and $474.4 million thereafter.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI https://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140709353276256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEBT<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">DEBT</a></td>
<td class="text">DEBT <div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Amendment to the Seventh Amended and Restated Senior Credit Agreement</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 24, 2023, the Company entered into the March 2023 Amendment of the Senior Credit Facility with a syndicate of lending banks with Bank of America, N.A., as Administrative Agent. The March 2023 Amendment extended the maturity date to March&#160;24, 2028, amended the contractual repayments of Term loan A, and amended the interest rate from LIBOR to SOFR-indexed interest. The Company continues to have the aggregate principal amount of up to approximately $2.1 billion available to it through the following facilities: (i) a $775.0 million term loan facility, and (ii) a $1.3 billion revolving credit facility, which includes a $60 million sublimit for the issuance of standby letters of credit and a $60 million sublimit for swingline loans.  </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s maximum consolidated total leverage ratio in the financial covenants (as defined in the Senior Credit Facility) was modified to the following:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:513.00pt"><tr><td style="width:1.0pt"/><td style="width:394.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:111.25pt"/><td style="width:1.0pt"/></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Quarter</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maximum Consolidated Total Leverage Ratio</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 31, 2023 through December 31, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.50 to 1.00</span></div></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 31, 2025 through June 30, 2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.25 to 1.00</span></div></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 30, 2026 and the last day of each fiscal quarter thereafter</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.00 to 1.00</span></div></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Borrowings under the Senior Credit Facility bear interest, at the Company&#8217;s option, at a rate equal to the following:</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.73pt">term SOFR in effect from time to time plus 0.10%  plus the applicable rate (ranging from 1.00% to 1.75%), or </span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ii.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.96pt">the highest of: </span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">the weighted average overnight Federal funds rate, as published by the Federal Reserve Bank of New York, plus 0.50% </span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">the prime lending rate of Bank of America, N.A. or</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">the one-month Term SOFR plus 1.00% </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The applicable rates are based on the Company&#8217;s consolidated total leverage ratio (defined as the ratio of (a)&#160;consolidated funded indebtedness as of such date less cash that is not subject to any restriction on the use or investment thereof to (b) consolidated EBITDA (as defined by the amended Seventh Amended and Restated Credit Agreement (the "Credit Agreement")), for the period of four consecutive fiscal quarters ending on such date).</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company will pay an annual commitment fee (ranging from 0.15% to 0.30%), based on the Company's consolidated total leverage ratio, on the amount available for borrowing under the revolving credit facility.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Senior Credit Facility is collateralized by substantially all of the assets of the Company&#8217;s U.S. subsidiaries, excluding intangible assets. The Senior Credit Facility is subject to various financial and negative covenants and at March&#160;31, 2023, the Company was in compliance with all such covenants. The Company capitalized $7.6&#160;million in deferred financing costs in connection with the modification of the Senior Credit Facility and wrote off $0.2&#160;million of previously capitalized financing costs during the first quarter of 2023.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2023 and December&#160;31, 2022 there wa</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s no balance ou</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">tstanding under the revolving portion of the Senior Credit Facility. At March&#160;31, 2023 and December&#160;31, 2022, there was $775.0 million outstanding under the term loan component of the Senior Credit Facility at a weighted average interest rate of 6.3% and 5.6%, respectively. As of  March&#160;31, 2023 there was no portion of the Term Loan component of the Senior Credit Facility classified as current on the condensed consolidated balance sheet. As of  December&#160;31, 2022, there was $38.1 million of the Term Loan component of the Senior Credit Facility classified as current on the consolidated balance sheets under the prior terms of the agreement.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of outstanding borrowings of the Senior Credit Facility's Term Loan component at March&#160;31, 2023</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> $750.9 million. This fair value was determined by using a discounted cash flow model based on current market interest rates available to the Company. These inputs are corroborated by observable market data for similar liabilities and therefore classified within Level 2 of the fair value hierarchy. Level 2 inputs represent inputs that are observable for the asset or liability, either directly or indirectly, and are other than active market observable i</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nputs that reflect unadjusted quoted prices for identical assets or liabilities.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Letters of credit outstanding as of March&#160;31, 2023 and December&#160;31, 2022 to</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">taled $1.6 million. There were no amounts drawn as of March&#160;31, 2023.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contractual repayments of the Term Loan component of the Senior Credit Facility are due as follows:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.432%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.784%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quarter Ended March&#160;31, 2023</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Principal Repayment</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Remainder of 2023</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,531&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33,906&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">687,813&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">775,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future interest payments on the term loan component of the Senior Credit Facility based on current interest rates are expected to approximate $35.9 million for remainder of 2023, $38.1 million in 2024,  $32.6 million in 2025, $30.0 million in  2026, and $34.5 million thereafter . Interest is calculated on the term loan portion of the Senior Credit Facility based on SOFR plus the certain amounts set forth in the Credit Agreement. As the revolving credit facility and Securitization Facility can be repaid at any time, no interest has been included in the calculation.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any outstanding borrowings on the revolving credit component of the Senior Credit Facility is due on March 24, 2028.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Convertible Senior Notes</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 4, 2020, the Company issued $575.0 million aggregate principal amount of its 0.5% Convertible Senior Notes due 2025 (the "2025 Notes"). The 2025 Notes will mature on August 15, 2025 and bear interest at a rate of 0.5% per annum payable semi-annually in arrears, unless earlier converted, repurchased or redeemed in accordance with the terms of the 2025 Notes. In connection with this offering, the Company capitalized $13.2 million of financing fees.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2025 Notes are senior, unsecured obligations of the Company, and are convertible into cash and shares of its common stock based on initial conversion rate, subject to adjustment of 13.5739 shares per $1,000 principal amounts of the 2025 Notes (which represents an initial conversion price of $73.67 per share). The 2025 Notes convert only in the following circumstances: (1) if the closing price of the Company's common stock has been at least 130% of the conversion price during the period; (2) if the average trading price per $1,000 principal amount of the 2025 Notes is less than or equal to 98% of the average conversion value of the 2025 Notes during a period as defined in the indenture; (3) at any time on or after February 20, 2023; or (4) if specified corporate transactions occur. As of March&#160;31, 2023, none of these conditions existed with respect to the 2025 Notes and as a result the 2025 Notes are classified as long term.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 9, 2020, the Company entered into the First Supplemental Indenture to the original agreement dated as of February 4, 2020 between the Company and Citibank, N.A., as trustee, governing the Company&#8217;s outstanding 2025 Notes. The Company irrevocably elected (1) to eliminate the Company&#8217;s option to choose physical settlement on any conversion of the 2025 Notes that occurs on or after the date of the First Supplemental Indenture and (2) with respect to any Combination Settlement for a conversion of the 2025 Notes, the Specified Dollar Amount that will be settled in cash per $1,000 principal amount of the 2025 Notes shall be no lower than $1,000.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of the Notes will have the right to require the Company to repurchase for cash all or a portion of their Notes at 100% of their principal amount, plus any accrued and unpaid interest, upon the occurrence of a fundamental change (as defined in the indenture relating to the Notes). The Company will also be required to increase the conversion rate for holders who convert their Notes in connection with certain fundamental changes occurring prior to the maturity date or following delivery by the Company of a notice of redemption.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the issuance of the 2025 Notes, the Company entered into call transactions and warrant transactions, primarily with affiliates of the initial purchasers of the 2025 Notes (the &#8220;hedge participants&#8221;). The cost of the call transactions was $104.2 million for the 2025 Notes. The Company received $44.5 million of proceeds from the warrant transactions for the 2025 Notes. The call transactions involved purchasing call options from the hedge participants, and the warrant transactions involved selling call options to the hedge participants with a higher strike price than the purchased call options. The initial strike price of the call transactions was $73.67, subject to anti-dilution adjustments substantially similar to those in the 2025 Notes. The initial strike price of the warrant transactions was $113.34 for the 2025 Notes, subject to customary anti-dilution adjustments.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March&#160;31, 2023</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the carrying amount of the liability w</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">as $575.0 </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">million. The fair value of the 2025 Notes at March&#160;31, 2023 was </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$561.7</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> million. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Factors that the Company considered when estimating the fair value of the 2025 Notes included recent quoted market prices or dealer quote. The level of the 2025 Notes is considered as Level 1.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Securitization Facility</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2018, the Company entered into an accounts receivable securitization facility (the "Securitization Facility") under which accounts receivable of certain domestic subsidiaries are sold on a non-recourse basis to a special purpose entity (&#8220;SPE&#8221;), which is a bankruptcy-remote, consolidated subsidiary of the Company. Accordingly, the assets of the SPE are not available to satisfy the obligations of the Company or any of its subsidiaries. From time to time, the SPE may finance such accounts receivable with a revolving loan facility secured by a pledge of such accounts receivable. The amount of outstanding borrowings on the Securitization Facility at any one time is limited to&#160;$150.0 million. The Securitization Facility Agreement ("Securitization Agreement") governing the Securitization Facility contains certain covenants and termination events. An occurrence of an event of default or a termination event under this Securitization Agreement may give rise to the right of its counterparty to terminate this facility. As of March&#160;31, 2023, the Company was in compliance with the covenants and none of the termination events had occurred.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 28, 2021, the Company entered into an amendment (the "May 2021 Amendment") of the Securitization Facility which extended the maturity date from December 21, 2021 to May 28, 2024. The May 2021 Amendment does not increase the Company&#8217;s total indebtedness.  </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Securitization Facility is currently indexed to LIBOR. At March&#160;31, 2023 and December&#160;31, 2022, the Company had $102.5 million and $104.7 million, respectively, of outstanding borrowings under its Securitization Facility at a weighted average interest rate of&#160;5.8% and 5.0%, respectively. In April 2023, we amended the facility to replace LIBOR with SOFR-indexed interest. The fair value of the outstanding borrowing of the Securitization Facility at&#160;March&#160;31, 2023&#160;was&#160;$102.2 million. These fair values were determined by using a discounted cash flow model based on current market interest rates available to the Company. These inputs are corroborated by observable market data for similar liabilities and therefore classified within Level 2 of the fair value hierarchy. Level 2 inputs represent inputs that are observable for the asset or liability, either directly or indirectly, and are other than active market observable i</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nputs that reflect unadjusted quoted prices for identical assets or liabilities.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI https://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140709353249984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DERIVATIVE INSTRUMENTS<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock', window );">DERIVATIVE INSTRUMENTS</a></td>
<td class="text">DERIVATIVE INSTRUMENTS <div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Hedging</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s interest rate risk relates to U.S. dollar denominated variable interest rate borrowings. The Company uses interest rate swap derivative instruments to manage earnings and cash flow exposure resulting from changes in interest rates. These interest rate swaps apply a fixed interest rate on a portion of the Company's expected SOFR-indexed borrowings. In connection with the March 2023 Amendment to the Senior Credit Facility, the Company amended its interest rate from LIBOR to SOFR-indexed interest. In March 2023, the Company entered into a basis swap where the Company receives Term SOFR and pays LIBOR to convert the portfolio of swaps from LIBOR to SOFR. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company held the following interest rate swaps as of March&#160;31, 2023 and December&#160;31, 2022 (dollar amounts in thousands):</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:center;text-indent:-9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.783%"><tr><td style="width:1.0%"/><td style="width:15.667%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.555%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:10.833%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.404%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:12.646%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.404%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.646%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.404%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.646%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.404%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.625%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.404%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.462%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Hedged Item</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional Amount</span></td><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Designation Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Termination Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fixed Interest Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated Fair Value</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asset (Liability)</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1-month Term SOFR Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">150,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 13, 2017</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">July 1, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">June 30, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.423&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,022&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1-month Term SOFR Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">200,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 13, 2017</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">January 1, 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.313&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,738&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1-month Term SOFR Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">October 10, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">July 1, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">June 30, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.220&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,329&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1-month Term SOFR Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">October 10, 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">July 1, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">June 30, 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.199&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,539&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1-month Term SOFR Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">October 10, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">July 1, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">June 30, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.209&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,441&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1-month Term SOFR Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 18, 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 30, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31, 2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.885&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,770&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1-month Term SOFR Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 18, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31, 2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.867&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,708&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1-month Term SOFR Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">575,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 15, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">July 31, 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31, 2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.415&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19,406&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1-month Term SOFR Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">125,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 15, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">July 1, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31, 2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.404&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,567&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Basis Swap </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">March 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">March 24, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31, 2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,842)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,475,000&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">42,678&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="39" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> The notional of the basis swap amortizes to match the total notional of the interest rate swap portfolio over time</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:center;text-indent:-9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.684%"><tr><td style="width:1.0%"/><td style="width:21.122%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.392%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.392%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.381%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.392%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.381%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.392%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.381%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.392%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.677%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.392%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.573%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Hedged Item</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Designation Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Termination Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fixed Interest Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated Fair Value</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asset (Liability)</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">150,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 13, 2017</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">July 1, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">June 30, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.423&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,012&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">200,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 13, 2017</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">January 1, 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.313&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,380&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">October 10, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">July 1, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">June 30, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.220&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,831&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">October 10, 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">July 1, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">June 30, 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.199&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,905&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">October 10, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">July 1, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">June 30, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.209&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,970&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 18, 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 30, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31, 2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.885&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,252&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 18, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31, 2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.867&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,153&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">575,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 15, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">July 31, 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31, 2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.415&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">23,742&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">125,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 15, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">July 1, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31, 2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.404&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,467&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,475,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">56,712&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has designated these derivative instruments as cash flow hedges. The Company assesses the effectiveness of these derivative instruments and has recorded the changes in the fair value of the derivative instrument designated as a cash flow hedge as unrealized gains or losses in accumulated other comprehensive loss (&#8220;AOCL&#8221;), net of tax, until the hedged item affected earnings, at which point any gain or loss was reclassified to earnings. If the hedged cash flow does not occur, or if it becomes probable that it will not occur, the Company will reclassify the remaining amount of any gain or loss on the related cash flow hedge recorded in AOCL to interest expense at that time.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Hedging</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company enters into foreign currency hedge contracts intended to protect the U.S. dollar value of certain forecasted foreign currency denominated transactions. The Company assesses the effectiveness of the contracts that are designated as hedging instruments. The changes in fair value of foreign currency cash flow hedges are recorded in AOCL, net of tax. Those amounts are subsequently reclassified to earnings from AOCL as impacted by the hedged item when the hedged item affects earnings. If the hedged forecasted transaction does not occur or if it becomes probable that it will not occur, the Company will reclassify the amount of any gain or loss on the related cash flow hedge to earnings at that time. For contracts not designated as hedging instruments, the changes in fair value of the contracts are recognized in other income, net in the consolidated statements of operation, along with the offsetting foreign currency gain or loss on the underlying assets or liabilities.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The success of the Company&#8217;s hedging anticipated currency exchange gains or losses to the extent that there are differences between forecasted and actual activities during periods of currency volatility. In addition, changes in currency exchange rates related to any unhedged transactions may affect earnings and cash flows.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cross-Currency Rate Swaps</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 26, 2022, the Company amended the CHF-denominated intercompany loan to extend the termination date to September 2023 and as a result, the Company early terminated the cross-currency swap designated as cash flow hedge of an intercompany loan with aggregate notional amount of 50.0 million. Simultaneously, the Company entered into a cross-currency swap agreement to convert a notional amount of CHF 48.5 million equivalent to 49.1 million of this amended intercompany loan into U.S. dollars. The loss recorded by the Company upon the settlement of the swap was not material for the period.  </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 21, 2020, the Company entered into cross-currency swap agreements to convert a notional amount of $471.6&#160;million equivalent to 420.1&#160;million of a CHF-denominated intercompany loan into U.S. dollars. The CHF-denominated intercompany loan was the result of an intra-entity transfer of certain intellectual property rights to a subsidiary in Switzerland completed during the fourth quarter of 2020. The intercompany loan requires quarterly payments of CHF 5.8&#160;million plus accrued interest. As a result, the aggregate notional amount of the related cross-currency swaps will decrease by a corresponding amount. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The objective of these cross-currency swaps is to reduce volatility of earnings and cash flows associated with changes in the foreign currency exchange rate. Under the terms of these contracts, which have been designated as cash flow hedges, the Company will make interest payments in Swiss Francs and receive interest in U.S. dollars. Upon the maturity of these contracts, the Company will pay the principal amount of the loans in Swiss Francs and receive U.S. dollars from the counterparties.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company held the following cross-currency rate swaps as of March&#160;31, 2023 and December&#160;31, 2022 (dollar amounts in thousands):</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.747%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.020%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Termination Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fixed Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate Notional Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value<br/>Asset (Liability)</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pay CHF</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">December 21, 2020</span></td><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">December 22, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.00%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CHF</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">373,227&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">397,137&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,033)</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,241)</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Receive U.S.$</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.98%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">418,980&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">445,821&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pay CHF</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 28, 2022</span></td><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 29, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.95%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CHF</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48,533&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48,532&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,011)</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,528)</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Receive U.S.$</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.32%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49,142&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49,142&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,044)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,769)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cross-currency swaps are carried on the consolidated balance sheet at fair value, and changes in the fair values are recorded as unrealized gains or losses in AOCL. For the three months ended March&#160;31, 2023, and 2022, the Company recorded a loss of $4.9 million and a gain $6.5 million, respectively, in other income, net related to change in fair value related to the foreign currency rate translation to offset the losses recognized on the intercompany loans.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March&#160;31, 2023, and 2022, the Company recorded a gain of $7.5 million and $7.9 million in AOCL, respectively, related to change in fair value of the cross-currency swaps.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March&#160;31, 2023, and 2022, the Company recorded a gain of $1.5 million and $1.8 million, respectively, in other income, net included in the consolidated statements of operations related to the interest rate differential of the cross-currency swaps.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated gain that is expected to be reclassified to other income (expense), net from AOCL as of March&#160;31, 2023 within the next twelve months is $0.1 million. As of March&#160;31, 2023, the Company does not expect any gains or losses will be reclassified into earnings as a result of the discontinuance of these cash flow hedges because the original forecasted transaction will not occur.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Investment Hedges</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company manages certain foreign exchange risks through a variety of strategies, including hedging. The Company is exposed to foreign exchange risk from its international operations through foreign currency purchases, net investments in foreign subsidiaries, and foreign currency assets and liabilities created in the normal course of business. On October 1, 2018 and December 16, 2020, the Company entered into cross-currency swap agreements designated as net investment hedges to partially offset the effects of foreign currency on foreign subsidiaries.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company held the following cross-currency rate swaps designated as net investment hedges as of March&#160;31, 2023 and December&#160;31, 2022, respectively (dollar amounts in thousands):</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"><tr><td style="width:1.0%"/><td style="width:14.705%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.390%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.159%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.390%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.390%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.319%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.390%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.660%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.205%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.390%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.614%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.390%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.387%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.390%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.284%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March&#160;31, 2023</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31, 2022</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Termination Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fixed Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate Notional Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value<br/>Asset (Liability)</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pay EUR</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">October 3, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 30, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">EUR</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51,760&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51,760&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,989&#160;</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,713&#160;</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Receive U.S.$</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.57%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pay EUR</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">October 3, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 30, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">EUR</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38,820&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38,820&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,932&#160;</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,307&#160;</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Receive U.S.$</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.19%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pay CHF</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 26, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">December 16, 2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CHF</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">288,210&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">288,210&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14,711)</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14,663)</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Receive U.S.$</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.94%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">300,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">300,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,790)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,643)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cross-currency swaps were carried on the consolidated balance sheet at fair value and changes in the fair values were recorded as unrealized gains or losses in AOCL. For the three months ended March&#160;31, 2023 and 2022, the Company recorded a loss of $1.1 million and a gain $1.3 million, respectively, in AOCL related to the change in fair value of the cross-currency swaps.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March&#160;31, 2023, and 2022, the Company recorded gains of $2.1 million and $1.3 million, respectively, in interest income included in the consolidated statements of operations related to the interest rate differential of the cross-currency swaps.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated gain that is expected to be reclassified to interest income from AOCL as of March&#160;31, 2023 within the next twelve months is $10.9 million.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Forward Contract</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has entered into a hedge for forecasted intercompany purchases denominated in foreign currencies through the use of forward contracts designated as cash flow hedges. To the extent these forward contracts meet hedge accounting criteria, changes in their fair value are not included in accumulated comprehensive loss. These changes in fair value will be recognized into earnings as a component of cost of sales when the forecasted-transaction occurs. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2023 the Company entered into Foreign Currency Forward Contracts with a notional amount of $10.8 million to mitigate the risk of foreign currency on intercompany purchases in CHF.  During the three months ended March&#160;31, 2023 the Company recorded an immaterial  loss in AOCL related to the change in fair value of the Foreign Currency Forward Contracts.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Counterparty Credit Risk</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company manages its concentration of counterparty credit risk on its derivative instruments by limiting acceptable counterparties to a group of major financial institutions with investment grade credit ratings, and by actively monitoring their credit ratings and outstanding positions on an ongoing basis. Therefore, the Company considers the credit risk of the counterparties to be low. Furthermore, none of the Company&#8217;s derivative transactions are subject to collateral or other security arrangements, and none contain provisions that depend upon the Company&#8217;s credit ratings from any credit rating agency.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value of Derivative Instruments</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has classified all of its derivative instruments within Level 2 of the fair value hierarchy because observable inputs are available for substantially the full term of the derivative instruments. The fair values of the interest rate swaps and cross-currency swaps were developed using a market approach based on publicly available market yield curves and the terms of the swap. The Company performs ongoing assessments of counterparty credit risk.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the fair value for derivatives designated as hedging instruments in the condensed consolidated balance sheets as of March&#160;31, 2023 and December&#160;31, 2022:</span></div><div style="margin-bottom:3pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:67.181%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.387%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.024%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.174%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value as of</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location on Balance Sheet </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">:</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivatives designated as hedges &#8212; Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Cash Flow Hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swap</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,659&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,682&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,139&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,497&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Net Investment Hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,942&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,653&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Cash Flow Hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swap</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28,861&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40,030&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Net Investment Hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,940&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,311&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total derivatives designated as hedges &#8212; Assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62,541&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76,173&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivatives designated as hedges &#8212; Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Cash Flow Hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swap</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">762&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,011&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,528&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Net Investment Hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Cash Flow Hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swap</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,080&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,172&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,738&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Net Investment Hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,672&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,608&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total derivatives designated as hedges &#8212; Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33,766&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,874&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:3pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company classifies derivative assets and liabilities as current based on the cash flows expected to be incurred within the following 12&#160;months.</span></div><div style="margin-bottom:12pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> At March&#160;31, 2023 and December&#160;31, 2022, the total notional amounts related to the Company&#8217;s interest rate swaps were both $1.5 billion, respectively.</span></div><div style="margin-bottom:10pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following presents the effect of derivative instruments designated as cash flow hedges and net investment hedges on the accompanying condensed consolidated statement of operations during the three months ended March&#160;31, 2023 and 2022:</span></div><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:30.917%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.911%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.057%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.597%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;in&#160;AOCL<br/>Beginning of<br/>Quarter</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount&#160;of<br/>Gain (Loss)<br/>Recognized&#160;in<br/>AOCL</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount&#160;of&#160;Gain (Loss)<br/>Reclassified from<br/>AOCL into<br/>Earnings</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;in&#160;AOCL<br/>End of Quarter</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location in<br/>Statements&#160;of<br/>Operations</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Cash Flow Hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swap</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">56,712&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10,534)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42,678&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20,271)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,191&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,504)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14,576)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other income, net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign Currency Forward Contract</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(69)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(69)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of Sales</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Net Investment Hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,914)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">950&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,096&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,060)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest income</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,527&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,462)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,092&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,973&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Cash Flow Hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swap</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(43,956)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41,675&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,213)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,932&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9,688)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">316&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,331&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(17,703)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other income, net</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Net Investment Hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,312)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,309&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,320&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,323)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest income</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(55,956)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43,300&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,438&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(17,094)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Derivative Instruments not designated hedges:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the second quarter of 2021, the Company entered into a foreign currency swap, with a notional amount of $7.3 million to mitigate the risk from fluctuations in foreign currency exchange rates associated with an intercompany loan denominated in JPY. In a foreign currency swap transaction, the Company agrees with another party to exchange, at specified intervals, the difference between one currency and another currency at a fixed exchange rate, generally set at inception, calculated by reference to an agreed upon notional amount. The notional amount of each currency is exchanged at the inception and termination of the currency swap by each party. The Company subsequently paid down a portion of this swap, bringing the notional amount down to $6.4 million. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the gains (losses) of derivative instruments not designated as hedges on the condensed consolidated statements of income, which was included in other income:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.736%"><tr><td style="width:1.0%"/><td style="width:64.640%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.417%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:15.412%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.417%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.414%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">360&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">360&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -URI https://asc.fasb.org/topic&amp;trid=2229140<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=d3e90205-114008<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140709353226272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">STOCK-BASED COMPENSATION</a></td>
<td class="text">STOCK-BASED COMPENSATION <div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023, the Company had stock options, restricted stock awards, performance stock awards, contract stock awards and restricted stock unit awards outstanding under the Integra LifeSciences Holdings Corporation Fifth Amended and Restated 2003 Equity Incentive Plan (the &#8220;2003 Plan&#8221;). The 2000 and 2001 Equity Incentive Plans were terminated as of February 19, 2021, and no further awards may be issued under the plans.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock options issued under the 2003 Plan become exercisable over specified periods, generally within four years from the date of grant for officers and employees, within one year from date of grant for directors which generally expire eight years from the grant date for employees, and from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82MS9mcmFnOmVjZjA3OTliODczNTQ2MjFhODNlMzFlYWUxZWEyOTMxL3RleHRyZWdpb246ZWNmMDc5OWI4NzM1NDYyMWE4M2UzMWVhZTFlYTI5MzFfNzIx_2efd93e6-4b81-4ecd-a888-8a73dfd19f51">six</span> to ten years for directors and certain executive officers, except in certain instances that result in accelerated vesting due to death, disability, retirement age or change in-control provisions within their grant agreements. The Company values stock option grants using the binomial distribution model. Restricted stock issued under the Plans vests over specified periods, generally three years after the date of grant. The vesting of performance stock issued under the Plans is subject to service and performance conditions.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Options</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023, there were approximately $5.6 million of total unrecognized compensation costs related to unvested stock options. These costs are expected to be recognized over a weighted-average period of approximately three years. There were 151,293 stock options granted during the three months ended March&#160;31, 2023. For the three months ended March&#160;31, 2023, the weighted average grant date fair value for stock options granted was $21.58 per option.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Awards of Restricted Stock and Performance Stock</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Performance stock and restricted stock awards generally have requisite service periods of three years, except in certain instances that result in accelerated vesting due to death, disability, retirement age provision or change in-control provisions in their grant agreements. Performance stock units are subject to graded vesting conditions based on revenue goals of the Company. The Company expenses the fair value of restricted stock awards on a straight-line basis over the requisite service period. As of March&#160;31, 2023, there was approximately $48.6 million of total unrecognized compensation costs related to these unvested awards. The Company expects to recognize these costs over a weighted-average period of approximately two years. The Company granted 346,745 restricted stock awards and 161,218 performance stock awards during the three months ended March&#160;31, 2023. For the three months ended March&#160;31, 2023, the weighted average grant date fair value for restricted stock awards and performance stock units granted was $53.37 and $52.87 per award, respectively.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also maintains an Employee Stock Purchase Plan (the &#8220;ESPP&#8221;), which provides eligible employees with the opportunity to acquire shares of common stock at periodic intervals by means of accumulated payroll deductions. The ESPP is a non-compensatory plan based on its terms.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI https://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140709353331264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RETIREMENT PLANS<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock', window );">RETIREMENT PLANS</a></td>
<td class="text">RETIREMENT PLANS<div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains defined benefit pension plans that cover certain employees in France, Japan, Germany and Switzerland.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net periodic benefit costs for the Company&#8217;s defined benefit pension plans for the three months ended March 31, 2023 were $0.3 million. The components of the net periodic benefit costs other than the service cost component of $0.5 million for the three months ended March&#160;31, 2023 are included in other income, net in the consolidated statements of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net periodic benefit costs for the Company&#8217;s defined benefit pension plans for the three months ended March 31, 2022 were $0.3 million. The components of the net periodic benefit costs other than the service cost component of $0.7 million for the three months ended March&#160;31, 2022 are included in other income, net in the consolidated statements of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair values of plan assets were $36.4 million and $38.1 million as of March&#160;31, 2023 and December&#160;31, 2022, respectively. The net plan assets of the pension plans are invested in common trusts as of March&#160;31, 2023 and December&#160;31, 2022. Common trusts are classified as Level 2 in the fair value hierarchy. The fair value of common trusts is valued at the net asset value based on the fair values of the underlying investments of the trusts as determined by the sponsor of the trusts. The investment strategy of the Company's defined benefit plans is both to meet the liabilities of the plans as they fall due and to maximize the return on invested assets within an appropriate risk profile.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Deferred Compensation Plan</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains a Deferred Compensation Plan in which certain employees of the Company may defer the payment and taxation of up to 75% of their base salary and up to 100% of bonus amounts and other eligible cash compensation.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This deferred compensation is invested in funds offered under this plan and is valued based on Level 1 measurements in the fair value hierarchy. Assets of the Company's deferred compensation plan are included in other current assets and recorded at fair value based on their quoted market prices. The fair value of these assets were $5.0 million and $4.7 million as of March&#160;31, 2023 and December&#160;31, 2022, respectively. Offsetting liabilities relating to the deferred compensation plan are included in Other liabilities.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for retirement benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section S99<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=21916913&amp;loc=d3e273930-122802<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (o)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (p)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -URI https://asc.fasb.org/topic&amp;trid=2235017<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39689-114964<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (q)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (l)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140709353476368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES AND RELATED PARTY LEASES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">LEASES AND RELATED PARTY LEASES</a></td>
<td class="text">LEASES AND RELATED PARTY LEASESThe Company leases administrative, manufacturing, research and distribution facilities and vehicles through operating lease agreements. The Company has no finance leases as of March&#160;31, 2023. Many of the Company's leases include both lease (e.g., fixed payments including rent) and non-lease components (e.g., common-area or other maintenance costs). For vehicles, the Company has elected the practical expedient to group lease and non-lease components.<div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Most facility leases include one or more options to renew. The exercise of lease renewal options is typically at the Company's sole discretion, therefore, the majority of renewals to extend the lease terms are not included in the Right of Use ("ROU") assets and lease liabilities as they are not reasonably certain of exercise. The Company regularly evaluates renewal options and when they are reasonably certain of exercise, the renewal period is included in the lease term.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As most of the Company's leases do not provide an implicit rate, the Company uses a collateralized incremental borrowing rate based on the information available at the lease commencement date in determining the present value of the lease payments.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total operating lease expense for the three months ended March 31, 2023 and March&#160;31, 2022 was $6.0 million and $4.9 million respectively, which includes $0.1 million, in related party operating lease expense.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental balance sheet information related to operating leases were as follows:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.718%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:18.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.200%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands, except lease term and discount rate</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31, 2022</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ROU assets</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">146,514&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">148,284&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current lease liabilities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,792&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,624&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-current lease liabilities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">156,910&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">157,420&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">171,702&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">172,044&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average remaining lease term (in years):</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Leased facilities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17.1 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.9 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Leased vehicles</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.0 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.0 years</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average discount rate:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Leased facilities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Leased vehicles</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to leases for the three months ended March 31, 2023 and 2022 were as follows:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.075%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.522%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March&#160;31, 2022</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,319&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,696&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ROU assets obtained in exchange for lease liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating leases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,721&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">507&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future minimum lease payments under operating leases at March&#160;31, 2023 were as follows:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:56.940%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.500%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Related Parties</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Third Parties</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Remainder of 2023</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">222&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,870&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,092&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">296&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,086&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,382&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">296&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,753&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,049&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">296&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,148&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,444&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">296&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,205&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,501&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2028</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">296&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,951&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,247&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">246&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">151,206&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">151,452&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total minimum lease payments</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,948&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">255,219&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">257,167&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Imputed interest</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">85,465&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">171,702&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Current lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,792&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">156,910&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no future minimum lease payments under finance leases at March&#160;31, 2023.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Related Party Leases</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company leases its manufacturing facility in Plainsboro, New Jersey, from Plainsboro Associates, a New Jersey general partnership. Ocirne, Inc., a subsidiary of Provco Industries, owns a 50% % interest in Plainsboro Associates. Provco Industries is the corporate general partner of Tru St. Partnership LLP, a principal stockholder of the Company. The term of the current lease agreement is through October&#160;31, 2029 at an annual rate of approximately $0.3 million per year. The current lease agreement also provides (i) a 5-year renewal option for the Company to extend the lease from November 1, 2029 through October 31, 2034 at the fair market rental rate of the premises, and (ii) another 5-year renewal option to extend the lease from November 1, 2034 through October 31, 2039 at the fair market rental rate of the premises.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140709353243824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>TREASURY STOCK<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockTextBlock', window );">TREASURY STOCK</a></td>
<td class="text">TREASURY STOCK<div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023 and December&#160;31, 2022, there were 8.9 million and 6.8 million shares of treasury stock outstanding with a cost of $481.7 million and $362.9 million, at a weighted average cost per share of $54.01 and $53.18, respectively.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On January 26, 2023, the Company entered into a $150 million accelerated share repurchase ("2023 ASR") and received 2.1&#160;million shares of the Company common stock at inception of the 2023 ASR, which represented approximately 80% of the expected total shares under the 2023 ASR.  The remaining repurchase transactions are expected to be completed in the second quarter of 2023.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On August 16, 2022, the Inflation Reduction Act of 2022 (the &#8220;Act&#8221;) was signed into law. The Act implements a new excise tax of 1% on the net share repurchases made by the company effective for share repurchases performed January 1, 2023, or after. The company accrued $1.2 million regarding the excise tax in Q-1 related to the ASR mentioned above.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 12, 2022, the Company entered into a $125&#160;million accelerated share repurchase ("2022 ASR") and received 1.48&#160;million shares of Company common stock at inception of the 2022 ASR, which represented approximately 80% of the expected total shares under the 2022 ASR. On March 24, 2022, the early exercise provision under the 2022 ASR was exercised by 2022 ASR counterparty. Upon settlement on March 24, 2022, the Company received an additional 0.46&#160;million shares determined using the volume-weighted average price of the Company's common stock during the term of the 2022 ASR.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -URI https://asc.fasb.org/subtopic&amp;trid=2208821<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140709353221680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">INCOME TAXES</a></td>
<td class="text">INCOME TAXES<div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a summary of the Company's effective tax rate:</span></div><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.075%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.522%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Reported tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company&#8217;s effective income tax rates for the three months ended March 31, 2023 and 2022 w</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">ere 18.6% and 16.3%, respectively. For the three months ended March 31, 2023, the primary driver of the higher tax rate relates to a reduction of excess tax benefits from stock compensation.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Changes to income tax laws and regulations, in any of the tax jurisdictions in which the Company operates, could impact the effective tax rate. Various governments, both U.S. and non-U.S., are increasingly focused on tax reform and revenue-raising legislation. Further, legislation in foreign jurisdictions may be enacted, in response to the base erosion and profit-sharing project begun by the Organization for Economic Cooperation and Development ("OECD"). The OECD recently finalized major reform of the international tax system with respect to a global minimum tax rate. Such changes in U.S. and non-U.S. jurisdictions could have an adverse effect on the Company&#8217;s effective tax rate.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As of March&#160;31, 2023, the Company has not provided deferred income taxes on unrepatriated earnings from foreign subsidiaries as they are deemed to be indefinitely reinvested unless there is a manner under which to remit the earnings with no material tax cost. Material taxes would primarily be attributable to foreign withholding taxes and local income taxes when such earnings are distributed. The Company will repatriate foreign earnings when there is no need for reinvestment overseas and there is no material cost to bring the earnings back to the United States. Reinvestment considerations would include future acquisitions, transactions, and capital expenditure plans.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI https://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140709353503536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NET INCOME PER SHARE<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">NET INCOME PER SHARE</a></td>
<td class="text">NET INCOME PER SHARE<div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic and diluted net income per share was as follows:</span></div><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.169%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.474%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;Dollars in thousands, except per share amounts</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Basic net income per share:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,226&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,901&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">81,871&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">83,632&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic net income per common share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Diluted net income per share:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,226&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,901&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average common shares outstanding &#8212; Basic</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">81,871&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">83,632&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect of dilutive securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock options and restricted stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">452&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">644&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average common shares for diluted earnings per share</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">82,323&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">84,276&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted net income per common share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Common stock of approximately 0.3 million an</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d 0.2 million shares at March&#160;31, 2023, and 2022, res</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">pectively that are issuable through exercise of dilutive securities were not included in the computation of diluted net income per share because their effect would have been anti-dilutive.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI https://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140709353301584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNoteTextBlock', window );">ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)</a></td>
<td class="text">ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)<div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Comprehensive income for the three months ended March 31, 2023 and 2022 was as follows:</span></div><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.122%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.498%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,226&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,901&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,076&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,683)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in unrealized loss/(gain) on derivatives, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,377)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,822&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pension liability adjustment, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Comprehensive income, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,028&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">57,031&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in accumulated other comprehensive income by component between December&#160;31, 2022 and March&#160;31, 2023 are presented in the table below, net of tax:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.747%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.402%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.287%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains and Losses on Derivatives</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Defined Benefit Pension Items</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Items</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at January 1, 2023</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,817&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,322&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(21,874)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,265&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive gain (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,754)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,076&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,575)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 21.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Amounts reclassified from accumulated other comprehensive income, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,623&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,623&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 21.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net current-period other comprehensive gain (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,377)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,076&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,198)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at March&#160;31, 2023</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,440&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,425&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(17,798)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,067&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March 31, 2023, the Company reclassified a gain of $4.3 million and a loss of $2.7 million from accumulated other comprehensive income to other income, net and interest income, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -URI https://asc.fasb.org/topic&amp;trid=2134417<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140709353433920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT AND GEOGRAPHIC INFORMATION<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">SEGMENT AND GEOGRAPHIC INFORMATION</a></td>
<td class="text">SEGMENT AND GEOGRAPHIC INFORMATION<div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company internally manages&#160;two&#160;global reportable segments and reports the results of its businesses to its chief operating decision maker. The&#160;two&#160;reportable segments and their activities are described below.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Codman Specialty Surgical segment includes (i) the Neurosurgery business, which sells a full line of products for neurosurgery and neuro critical care such as tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment and (ii) the Instruments business, which sells more than 40,000 instrument patterns and surgical and lighting products to hospitals, surgery centers, dental, podiatry, and veterinary offices.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.15pt">The TT segment includes such offerings as skin and wound repair, plastics &amp; surgical reconstruction products, bone grafts, and nerve and tendon repair products.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Corporate and other category includes (i) various executive, finance, human resource, information systems and legal functions, (ii) brand management, and (iii) share-based compensation costs.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The operating results of the various reportable segments as presented are not comparable to one another because (i)&#160;certain operating segments are more dependent than others on corporate functions for unallocated general and administrative and/or operational manufacturing functions, and (ii)&#160;the Company does not allocate certain manufacturing costs and general and administrative costs to the operating segment results. Net sales and profit by each reportable segment for the three months ended March&#160;31, 2023 and 2022 are as follows:</span></div><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.859%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.128%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.129%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Segment Net Sales</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Codman Specialty Surgical</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">248,136&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">247,308&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Tissue Technologies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"> </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">132,710&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">129,330&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">380,846&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">376,638&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Segment Profit </span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Codman Specialty Surgical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">110,933&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">110,160&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Tissue Technologies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"> </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52,281&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53,893&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Segment profit</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">163,214&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">164,053&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,108)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,894)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(123,724)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(113,995)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating income</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36,382&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46,164&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company does not allocate any assets to the reportable segments. No asset information is reported to the chief operating decision maker and disclosed in the financial information for each segment. The Company attributes revenues to geographic areas based on the location of the customer. Total revenue by major geographic area consisted of the following:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.274%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.420%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.422%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">271,002&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">263,351&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41,064&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43,744&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Asia Pacific</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50,473&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47,717&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,307&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,826&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">380,846&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">376,638&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI https://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140709353220096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">COMMITMENTS AND CONTINGENCIES</a></td>
<td class="text">COMMITMENTS AND CONTINGENCIESIn consideration for certain technology, manufacturing, distribution, and selling rights and licenses granted to the Company, the Company has agreed to pay royalties on sales of certain products that it sells. The royalty payments that the Company made under these agreements were not significant for any of the periods presented.<div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to various claims, lawsuits and proceedings in the ordinary course of the Company's business, including claims by current or former employees, distributors and competitors and with respect to its products and product liability claims, lawsuits and proceedings, some of which have been settled by the Company. In the opinion of management, such claims are either adequately covered by insurance or otherwise indemnified, or are not expected, individually or in the aggregate, to result in a material, adverse effect on the Company's financial condition. However, it is possible that the Company's results of operations, financial position and cash flows in a particular period could be materially affected by these contingencies.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accrues for loss contingencies when it is deemed probable that a loss has been incurred and that loss is estimable. The amounts accrued are based on the full amount of the estimated loss before considering insurance proceeds and do not include an estimate for legal fees expected to be incurred in connection with the loss contingency. The Company consistently accrues legal fees expected to be incurred in connection with loss contingencies as those fees are incurred by outside counsel as a period cost.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contingent Consideration</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determined the fair value of contingent consideration during the three month period ended March&#160;31, 2023 and March&#160;31, 2022 to reflect the change in estimate, additions, payments, transfers and the time value of money during the period.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the opening balances to the closing balances of these Level 3 measurements for the three months ended March 31, 2023 and March&#160;31, 2022 is as follows (in thousands):</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"><tr><td style="width:1.0%"/><td style="width:18.988%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.390%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.319%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.390%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.876%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.390%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.535%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.390%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.024%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.390%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:7.319%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.390%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.319%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.390%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.319%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.390%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.681%"/><td style="width:0.1%"/></tr><tr style="height:29pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Contingent Consideration Liability Related to Acquisition of:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:29pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Arkis</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location in Financial Statements</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derma Sciences</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ACell</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Surgical Innovations Associates, Inc. (FN 2)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location in Financial Statements</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Short-term</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Short-term</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of January 1, 2023</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,845&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,050&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">230&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,700&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">57,607&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transfers</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12,500)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in fair value of contingent consideration liabilities </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,543&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,756&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,200)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,600&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of March 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,388&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,806&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">230&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,500&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,500&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48,707&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:28.036%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.831%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.245%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:9.295%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.245%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.684%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.099%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.255%"/><td style="width:0.1%"/></tr><tr style="height:29pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Contingent Consideration Liability Related to Acquisition of:</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:29pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Arkis </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location in Financial Statements</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derma Sciences</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ACell Inc.</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location in Financial Statements</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Short-term</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Short-term</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of January 1, 2022</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,691&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,408&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">230&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,800&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transfers</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(59)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,885&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,885)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in fair value of contingent consideration liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,065)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of March&#160;31, 2022</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,750&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,284&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">230&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,885&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,215&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Arkis BioSciences Inc.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the acquisition of Arkis BioSciences Inc. ("Arkis"), the Company is required to pay the former shareholders of Arkis up to $25.5 million&#160;based on the timing of certain development milestones of $10.0 million and commercial sales milestones of $15.5 million, respectively.&#160;The Company used a probability weighted income approach to calculate the fair value of the contingent consideration that considered the possible outcomes of scenarios related to each specified milestone. The Company estimated the fair value of the contingent consideration to be $13.1 million at the acquisition date. The estimated fair value as of March&#160;31, 2023 and March&#160;31, 2022 was $16.2 million and $14.0 million, respectively. The Company recorded $11.8 million and $10.3 million in other liabilities at March&#160;31, 2023 and March&#160;31, 2022, respectively, and $4.4&#160;million and $3.8&#160;million in accrued expenses and other current liabilities at March&#160;31, 2023 and March&#160;31, 2022, respectively, in the consolidated balance sheet of the Company.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Derma Sciences</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assumed contingent consideration incurred by Derma Sciences, Inc. ("Derma Sciences")&#160;related to its acquisitions of BioD and the intellectual property related to Medihoney products. The Company accounted for the contingent liabilities by recording their fair value on the date of the acquisition based on a probability weighted income approach. The Company has already paid $33.3 million related to the aforementioned contingent liabilities. One contingent milestone remains which relates to net sales of Medihoney&#8482; products exceeding certain amounts defined in the agreement between the Company and Derma Sciences. The potential maximum undiscounted payment amounts to $3.0 million. The estimated fair value as of March&#160;31, 2023 and March&#160;31, 2022 was $0.2 million. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">ACell Inc.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the ACell Acquisition, the Company is required to make payments to the former shareholders of ACell up to $100&#160;million based on the achievement by the Company of certain revenue-based performance milestones in 2023 and 2025. The Company used iterations of the Monte Carlo simulation to calculate the fair value of the contingent consideration that considered the possible outcomes of scenarios related to each specific milestone. The Company estimated the fair value of the contingent consideration to be $23.9&#160;million at the acquisition date. The estimated fair value as of March 31, 2023 was </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$1.5 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company recorded </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$1.5 million </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$17.2 million </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in other liabilities at March 31, 2023 and March 31, 2022, respectively, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and $4.9 million in accrued expenses and other current liabilities at March&#160;31, 2022</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the consolidated balance sheets of the Company. The change in the fair value of the contingent obligation was primarily as a result of changes in the timing and amount of revenue estimates.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI https://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI https://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140709349654336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BASIS OF PRESENTATION (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis Of Presentation</a></td>
<td class="text">BASIS OF PRESENTATION<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">General</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The terms &#8220;we,&#8221; &#8220;our,&#8221; &#8220;us,&#8221; &#8220;Company&#8221; and &#8220;Integra&#8221; refer to Integra LifeSciences Holdings Corporation, a Delaware corporation, and its subsidiaries unless the context suggests otherwise.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the opinion of management, the March&#160;31, 2023 unaudited condensed consolidated financial statements contain all adjustments (consisting only of normal recurring adjustments) necessary for a fair statement of the financial position, statement of changes in shareholders' equity, results of operations and cash flows of the Company. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States ("GAAP") have been condensed or omitted in accordance with the instructions to Form 10-Q and Rule&#160;10-01 of Regulation&#160;S-X. These unaudited condensed consolidated financial statements should be read in conjunction with the Company&#8217;s consolidated financial statements for the year ended December&#160;31, 2022 included in the Company&#8217;s Annual Report on Form 10-K. The December&#160;31, 2022 consolidated balance sheet was derived from audited financial statements, but does not include all disclosures required by GAAP. Operating results for the three-month period ended March&#160;31, 2023 are not necessarily indicative of the results to be expected for the entire year.</span></div>The preparation of consolidated financial statements is in conformity with GAAP, which requires management to make estimates and assumptions that affect the reported amount of assets and liabilities, the disclosure of contingent liabilities, and the reported amounts of revenues and expenses. Significant estimates affecting amounts reported or disclosed in the condensed consolidated financial statements include allowances for doubtful accounts receivable and sales returns and allowances, net realizable value of inventories, valuation of intangible assets including amortization periods for acquired intangible assets, discount rates and estimated projected cash flows used to value and test impairments of long-lived assets and goodwill, estimates of projected cash flows and depreciation and amortization periods for long-lived assets, computation of taxes, valuation allowances recorded against deferred tax assets, the valuation of stock-based compensation, valuation of derivative instruments, valuation of contingent liabilities, the fair value of debt instruments and loss contingencies. These estimates are based on historical experience and on various other assumptions that are believed to be reasonable under the current circumstances. Actual results could differ from these estimates.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Pronouncements</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In March 2020, the FASB issued ASU 2020-04,&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Reference Rate Reform </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(Topic 848), and subsequent amendment to the initial guidance: ASU 2021-01, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Reference Rate Reform</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> (Topic 848): Scope (collectively, &#8220;Topic 848&#8221;). Topic 848 provides optional expedients and exceptions for applying GAAP to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. The amendments apply only to contracts, hedging relationships, and other transactions that reference London Inter-Bank Offered Rate ("LIBOR") or another reference rate expected to be discontinued because of reference rate reform. The guidance generally can be applied through December 31, 2024. The Alternative Reference Rates Committee, a group of private-market participants convened by the U.S. Federal Reserve Board and the New York Federal Reserve, has recommended the use of the Secured Overnight Financing Rate ("SOFR") as a more robust reference rate alternative to LIBOR. The use of SOFR as a substitute for LIBOR is, however, voluntary and may not be suitable for all market participants. There can be no assurance that the replacement rate will be economically equivalent to LIBOR, which could result in higher interest rates for us under our debt facilities. There is no guarantee that a transition from LIBOR to SOFR will not result in financial market disruptions, significant increases in benchmark rates, or our borrowing costs, any of which could have an adverse effect on our business, results of operations and financial condition. On March 24, 2023, the Company entered into the seventh amendment and restatement (the "March 2023 Amendment") of its Senior Credit Facility (the &#8220;Senior Credit Facility&#8221;) with a syndicate of lending banks with Bank of America, N.A., as Administrative Agent. In connection with the March 2023 Amendment the Company replaced all LIBOR-based contracts with SOFR, which is calculated based on overnight transactions under repurchase agreements backed by Treasury securities (See Note 6).  In March 2023, the Company entered into a basis swap where the Company receives Term SOFR and pays LIBOR to convert the portfolio of interest rate swaps from LIBOR to SOFR. Integra has elected to adopt the optional expedient under ASC 848, which will allow the interest rate swap hedging relationship to continue, without de-designation, due to the change in the indexed rate from LIBOR to SOFR. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are no other recently issued accounting pronouncements that are expected to have any significant effect on the Company's financial position, results of operations or cash flows.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Summary of Accounting Policies on Revenue Recognition and Shipping and Handling Fees</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Summary of Accounting Policies on Revenue Recognition</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized upon the transfer of control of promised products or services to the customers in an amount that reflects the consideration the Company expects to receive in exchange for those products and services.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Performance Obligations</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's performance obligations consist mainly of transferring control of goods and services identified in the contracts, purchase orders, or invoices. The Company has no significant multi-element contracts with customers.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Significant Estimates</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Usage-based royalties and licenses are estimated based on the provisions of contracts with customers and recognized in the same period that the royalty-based products are sold by the Company's strategic partners. The Company estimates and recognizes royalty revenue based upon communication with licensees, historical information, and expected sales trends. Differences between actual reported licensee sales and those that were estimated are adjusted in the period in which they become known, which is typically the following quarter. Historically, such adjustments have not been significant.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company estimates returns, price concessions, and discount allowances using the expected value method based on historical trends and other known factors. Rebate allowances are estimated using the most likely method based on each customer contract.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's return policy, as set forth in its product catalogs and sales invoices, requires review and authorization in advance prior to the return of product. Upon the authorization, a credit will be issued for the goods returned within a set amount of days from the shipment, which is generally 90 days.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company disregards the effects of a financing component if the Company expects, at contract inception, that the period between the transfer and customer payment for the goods or services will be one year or less. The Company has no significant revenues recognized on payments expected to be received more than one year after the transfer of control of products or services to customers.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contract Asset and Liability</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues recognized from the Company's private label business that are not invoiced to the customers as a result of recognizing revenue over time are recorded as a contract asset included in the prepaid expenses and other current assets account in the consolidated balance sheets.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other operating revenues may include fees received under service agreements. Non-refundable fees received under multiple-period service agreements are recognized as revenue as the Company satisfies the performance obligations to the other party. A portion of the transaction price allocated to the performance obligations to be satisfied in the future periods is recognized as contract liability.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Shipping and Handling Fees</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company elected to account for shipping and handling activities as a fulfillment cost rather than a separate performance obligation. Amounts billed to customers for shipping and handling are included as part of the transaction price and recognized as revenue when control of underlying products is transferred to the customer. The related shipping and freight charges incurred by the Company are included in the cost of goods sold.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExtendedProductWarrantyPolicy', window );">Product Warranties</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Product Warranties</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of the Company's medical devices, including monitoring systems and neurosurgical systems, are designed to operate over long periods of time. These products are sold with warranties which may extend for up to two years from the date of purchase. The warranties are not considered a separate performance obligation. The Company estimates its product warranties using the expected value method based on historical trends and other known factors. The Company includes them in accrued expenses and other current liabilities in the consolidated balance sheet.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueTransactionPriceMeasurementTaxExclusionPolicyTextBlock', window );">Taxes Collected from Customers</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Taxes Collected from Customers</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company elected to exclude from the measurement of the transaction price all taxes assessed by a governmental authority that are both imposed on and concurrent with a specific revenue-producing transaction and collected by the entity from a customer.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ExtendedProductWarrantyPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for extended product warranties and other guarantee contracts including the methodology for measuring the liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126907703&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ExtendedProductWarrantyPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130561-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130563-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI https://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130563-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130564-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueTransactionPriceMeasurementTaxExclusionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for election to exclude from measurement of transaction price tax assessed by governmental authority that are both imposed on and concurrent with specific revenue-producing transaction, and collected from customer. Includes, but is not limited to, sales, use, value-added and excise tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 32<br> -Paragraph 2A<br> -URI https://asc.fasb.org/extlink&amp;oid=126919569&amp;loc=SL82860478-203043<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueTransactionPriceMeasurementTaxExclusionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140709354897536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACQUISITIONS AND DIVESTITURES (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_MergersAcquisitionsAndDispositionsAbstract', window );"><strong>Mergers, Acquisitions and Dispositions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">Schedule of Assets Acquired and Liabilities Assumed</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The following table summarizes the fair values of the assets acquired and liabilities assumed at the acquisition date:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.543%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.028%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.545%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Preliminary Valuation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Life</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,438&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trade accounts receivable, net </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,551&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventories, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,900&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,654&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,543&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14 years</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,854&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total assets acquired</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">127,397</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,044&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,044&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred Tax Liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,799&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">57,607&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total liabilities assumed</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">71,450</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net assets acquired</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">55,947</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_MergersAcquisitionsAndDispositionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Mergers, Acquisitions and Dispositions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_MergersAcquisitionsAndDispositionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140709353356704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUES FROM CONTRACTS WITH CUSTOMERS (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock', window );">Schedule of Changes in Contract Assets and Contract Liabilities</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarized the changes in the contract asset and liability balances for the three months ended March 31, 2023:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:79.747%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:18.053%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Contract Asset</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contract asset, January 1, 2023</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,122&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transferred to trade receivable from contract asset included in beginning of the year contract asset</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9,765)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contract asset, net of transferred to trade receivables on contracts during the period</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,713&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contract asset, March&#160;31, 2023</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,070&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Contract Liability</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contract liability, January 1, 2023</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,127&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Recognition of revenue included in beginning of year contract liability</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,492)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contract liability, net of revenue recognized on contracts during the period</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,921&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contract liability, March&#160;31, 2023</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,559&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Schedule of Disaggregation of Revenue</a></td>
<td class="text"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents revenues disaggregated by the major sources of revenues for the three months ended March&#160;31, 2023 and 2022 (dollar amounts in thousands):</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.028%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.545%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Neurosurgery</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">192,870&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">194,675&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Instruments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55,266&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52,633&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Codman Specialty Surgical</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">248,136&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">247,308&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Wound Reconstruction and Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100,940&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">94,630&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Private Label</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,770&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34,700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Tissue Technologies</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">132,710&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">129,330&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">380,846&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">376,638&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130551-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140709353476368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVENTORIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of Inventories, Net</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories, net consisted of the following:</span></div><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.882%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.545%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finished goods</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">178,626&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">172,088&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">80,532&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70,598&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">92,117&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">81,897&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total inventories, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">351,275&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">324,583&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140709350639424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Schedule of Changes in Carrying Amount of Goodwill</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the carrying amount of goodwill for the three-month period ended March&#160;31, 2023 were as follows:</span></div><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:55.389%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.911%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.911%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.915%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Codman Specialty <br/>Surgical</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Tissue Technologies</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill at December 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">656,219&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">382,662&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,038,881&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">SIA Acquisition Working Capital Adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,639&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">957&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,596&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill at March&#160;31, 2023</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">657,858&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">383,748&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,041,606&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of Finite-Lived Intangible Assets</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of the Company&#8217;s identifiable intangible assets were as follows:</span></div><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.367%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.331%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Life</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Completed technology</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,206,748&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(389,297)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">817,451&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">193,297&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(146,098)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47,199&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trademarks/brand names</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">97,554&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(35,665)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">61,889&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Codman tradename</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Indefinite</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">167,529&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">167,529&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Supplier relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,211&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(17,415)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,796&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">All other</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,024&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,129)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,895&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,701,363&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(592,604)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,108,759&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.783%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.331%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Life</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Completed technology</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,204,325&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(370,968)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">833,357&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">193,081&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(144,040)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49,041&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trademarks/brand names</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">97,265&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(34,674)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62,591&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Codman tradename</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Indefinite</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">166,693&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">166,693&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Supplier relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,211&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(17,170)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,041&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">All other</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,957&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,071)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,886&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,697,532&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(570,923)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,126,609&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of Indefinite-Lived Intangible Assets</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of the Company&#8217;s identifiable intangible assets were as follows:</span></div><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.367%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.331%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Life</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Completed technology</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,206,748&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(389,297)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">817,451&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">193,297&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(146,098)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47,199&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trademarks/brand names</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">97,554&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(35,665)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">61,889&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Codman tradename</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Indefinite</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">167,529&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">167,529&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Supplier relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,211&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(17,415)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,796&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">All other</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,024&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,129)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,895&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,701,363&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(592,604)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,108,759&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.783%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.331%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Life</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Completed technology</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,204,325&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(370,968)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">833,357&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">193,081&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(144,040)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49,041&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trademarks/brand names</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">97,265&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(34,674)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62,591&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Codman tradename</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Indefinite</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">166,693&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">166,693&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Supplier relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,211&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(17,170)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,041&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">All other</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,957&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,071)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,886&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,697,532&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(570,923)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,126,609&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=SL108378252-109267<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b),(d)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140709350506320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEBT (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock', window );">Schedule of Long-term Debt Maximum Leverage Ratios</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s maximum consolidated total leverage ratio in the financial covenants (as defined in the Senior Credit Facility) was modified to the following:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:513.00pt"><tr><td style="width:1.0pt"/><td style="width:394.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:111.25pt"/><td style="width:1.0pt"/></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Quarter</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maximum Consolidated Total Leverage Ratio</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 31, 2023 through December 31, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.50 to 1.00</span></div></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 31, 2025 through June 30, 2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.25 to 1.00</span></div></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 30, 2026 and the last day of each fiscal quarter thereafter</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.00 to 1.00</span></div></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock', window );">Schedule of Contractual Repayments of Long-Term Debt</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contractual repayments of the Term Loan component of the Senior Credit Facility are due as follows:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.432%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.784%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quarter Ended March&#160;31, 2023</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Principal Repayment</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Remainder of 2023</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,531&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33,906&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">687,813&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">775,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21506-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21521-112644<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21538-112644<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturity and sinking fund requirement for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140709350405904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DERIVATIVE INSTRUMENTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock', window );">Schedule of Derivative Instruments</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company held the following interest rate swaps as of March&#160;31, 2023 and December&#160;31, 2022 (dollar amounts in thousands):</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:center;text-indent:-9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.783%"><tr><td style="width:1.0%"/><td style="width:15.667%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.555%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:10.833%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.404%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:12.646%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.404%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.646%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.404%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.646%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.404%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.625%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.404%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.462%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Hedged Item</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional Amount</span></td><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Designation Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Termination Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fixed Interest Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated Fair Value</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asset (Liability)</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1-month Term SOFR Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">150,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 13, 2017</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">July 1, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">June 30, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.423&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,022&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1-month Term SOFR Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">200,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 13, 2017</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">January 1, 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.313&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,738&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1-month Term SOFR Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">October 10, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">July 1, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">June 30, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.220&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,329&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1-month Term SOFR Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">October 10, 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">July 1, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">June 30, 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.199&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,539&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1-month Term SOFR Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">October 10, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">July 1, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">June 30, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.209&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,441&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1-month Term SOFR Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 18, 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 30, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31, 2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.885&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,770&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1-month Term SOFR Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 18, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31, 2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.867&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,708&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1-month Term SOFR Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">575,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 15, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">July 31, 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31, 2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.415&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19,406&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1-month Term SOFR Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">125,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 15, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">July 1, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31, 2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.404&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,567&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Basis Swap </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">March 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">March 24, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31, 2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,842)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,475,000&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">42,678&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="39" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> The notional of the basis swap amortizes to match the total notional of the interest rate swap portfolio over time</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.684%"><tr><td style="width:1.0%"/><td style="width:21.122%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.392%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.392%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.381%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.392%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.381%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.392%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.381%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.392%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.677%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.392%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.573%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Hedged Item</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Designation Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Termination Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fixed Interest Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated Fair Value</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asset (Liability)</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">150,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 13, 2017</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">July 1, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">June 30, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.423&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,012&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">200,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 13, 2017</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">January 1, 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.313&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,380&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">October 10, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">July 1, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">June 30, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.220&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,831&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">October 10, 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">July 1, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">June 30, 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.199&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,905&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">October 10, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">July 1, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">June 30, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.209&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,970&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 18, 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 30, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31, 2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.885&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,252&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 18, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31, 2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.867&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,153&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">575,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 15, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">July 31, 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31, 2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.415&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">23,742&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1-month USD LIBOR Loan</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">125,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 15, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">July 1, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31, 2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.404&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,467&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,475,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">56,712&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company held the following cross-currency rate swaps as of March&#160;31, 2023 and December&#160;31, 2022 (dollar amounts in thousands):</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.747%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.020%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Termination Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fixed Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate Notional Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value<br/>Asset (Liability)</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pay CHF</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">December 21, 2020</span></td><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">December 22, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.00%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CHF</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">373,227&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">397,137&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,033)</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,241)</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Receive U.S.$</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.98%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">418,980&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">445,821&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pay CHF</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 28, 2022</span></td><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 29, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.95%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CHF</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48,533&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48,532&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,011)</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,528)</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Receive U.S.$</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.32%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49,142&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49,142&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,044)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,769)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company held the following cross-currency rate swaps designated as net investment hedges as of March&#160;31, 2023 and December&#160;31, 2022, respectively (dollar amounts in thousands):</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"><tr><td style="width:1.0%"/><td style="width:14.705%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.390%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.159%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.390%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.390%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.319%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.390%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.660%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.205%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.390%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.614%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.390%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.387%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.390%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.284%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March&#160;31, 2023</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31, 2022</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Termination Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fixed Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate Notional Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value<br/>Asset (Liability)</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pay EUR</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">October 3, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 30, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">EUR</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51,760&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51,760&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,989&#160;</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,713&#160;</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Receive U.S.$</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.57%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pay EUR</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">October 3, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 30, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">EUR</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38,820&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38,820&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,932&#160;</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,307&#160;</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Receive U.S.$</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.19%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pay CHF</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 26, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">December 16, 2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CHF</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">288,210&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">288,210&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14,711)</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14,663)</span></td><td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Receive U.S.$</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.94%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">300,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">300,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,790)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,643)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock', window );">Schedule of Fair Value and Presentation of Derivatives</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the fair value for derivatives designated as hedging instruments in the condensed consolidated balance sheets as of March&#160;31, 2023 and December&#160;31, 2022:</span></div><div style="margin-bottom:3pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:67.181%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.387%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.024%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.174%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value as of</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location on Balance Sheet </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">:</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivatives designated as hedges &#8212; Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Cash Flow Hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swap</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,659&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,682&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,139&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,497&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Net Investment Hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,942&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,653&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Cash Flow Hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swap</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28,861&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40,030&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Net Investment Hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,940&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,311&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total derivatives designated as hedges &#8212; Assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62,541&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76,173&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivatives designated as hedges &#8212; Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Cash Flow Hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swap</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">762&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,011&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,528&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Net Investment Hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Cash Flow Hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swap</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,080&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,172&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,738&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Net Investment Hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,672&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,608&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total derivatives designated as hedges &#8212; Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33,766&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,874&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:3pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company classifies derivative assets and liabilities as current based on the cash flows expected to be incurred within the following 12&#160;months.</span></div><div style="margin-bottom:12pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> At March&#160;31, 2023 and December&#160;31, 2022, the total notional amounts related to the Company&#8217;s interest rate swaps were both $1.5 billion, respectively.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock', window );">Effect of Derivative Instruments Designated as Cash Flow Hedges on Statements of Operations</a></td>
<td class="text"><div style="margin-bottom:10pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following presents the effect of derivative instruments designated as cash flow hedges and net investment hedges on the accompanying condensed consolidated statement of operations during the three months ended March&#160;31, 2023 and 2022:</span></div><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:30.917%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.911%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.057%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.597%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;in&#160;AOCL<br/>Beginning of<br/>Quarter</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount&#160;of<br/>Gain (Loss)<br/>Recognized&#160;in<br/>AOCL</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount&#160;of&#160;Gain (Loss)<br/>Reclassified from<br/>AOCL into<br/>Earnings</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;in&#160;AOCL<br/>End of Quarter</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location in<br/>Statements&#160;of<br/>Operations</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Cash Flow Hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swap</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">56,712&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10,534)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42,678&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20,271)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,191&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,504)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14,576)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other income, net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign Currency Forward Contract</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(69)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(69)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of Sales</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Net Investment Hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,914)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">950&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,096&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,060)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest income</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,527&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,462)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,092&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,973&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Cash Flow Hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swap</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(43,956)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41,675&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,213)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,932&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9,688)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">316&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,331&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(17,703)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other income, net</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Net Investment Hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross-currency swap</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,312)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,309&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,320&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,323)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest income</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(55,956)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43,300&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,438&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(17,094)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock', window );">Derivatives Not Designated as Hedging Instruments</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the gains (losses) of derivative instruments not designated as hedges on the condensed consolidated statements of income, which was included in other income:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.736%"><tr><td style="width:1.0%"/><td style="width:64.640%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.417%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:15.412%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.417%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.414%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">360&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">360&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4E<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624181-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of pertinent information about a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41620-113959<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41638-113959<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41678-113959<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41641-113959<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579240-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of derivative instrument not designated or qualifying as hedging instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CC<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL109998890-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140709353172000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES AND RELATED PARTY LEASES (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_AssetsAndLiabilitiesLesseeTableTextBlock', window );">Supplemental Balance Sheet Information</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental balance sheet information related to operating leases were as follows:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.718%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:18.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.200%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands, except lease term and discount rate</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31, 2022</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ROU assets</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">146,514&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">148,284&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current lease liabilities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,792&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,624&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-current lease liabilities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">156,910&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">157,420&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">171,702&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">172,044&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average remaining lease term (in years):</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Leased facilities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17.1 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.9 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Leased vehicles</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.0 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.0 years</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average discount rate:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Leased facilities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Leased vehicles</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_CashFlowLesseeTableTextBlock', window );">Supplemental Cash Flow Information</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to leases for the three months ended March 31, 2023 and 2022 were as follows:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.075%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.522%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March&#160;31, 2022</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,319&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,696&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ROU assets obtained in exchange for lease liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating leases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,721&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">507&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Schedule of Operating Lease Maturities</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future minimum lease payments under operating leases at March&#160;31, 2023 were as follows:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:56.940%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.500%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Related Parties</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Third Parties</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Remainder of 2023</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">222&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,870&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,092&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">296&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,086&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,382&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">296&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,753&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,049&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">296&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,148&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,444&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">296&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,205&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,501&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2028</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">296&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,951&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,247&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">246&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">151,206&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">151,452&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total minimum lease payments</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,948&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">255,219&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">257,167&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Imputed interest</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">85,465&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">171,702&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Current lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,792&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">156,910&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_AssetsAndLiabilitiesLesseeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Assets And Liabilities, Lessee [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_AssetsAndLiabilitiesLesseeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_CashFlowLesseeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash Flow, Lessee [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_CashFlowLesseeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140709353218096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of Effective Income Tax Rate</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a summary of the Company's effective tax rate:</span></div><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.075%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.522%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Reported tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140709354897536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NET INCOME PER SHARE (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Basic and Diluted Net Income (Loss) Per Share</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic and diluted net income per share was as follows:</span></div><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.169%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.474%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;Dollars in thousands, except per share amounts</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Basic net income per share:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,226&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,901&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">81,871&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">83,632&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic net income per common share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Diluted net income per share:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,226&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,901&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average common shares outstanding &#8212; Basic</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">81,871&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">83,632&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect of dilutive securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock options and restricted stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">452&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">644&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average common shares for diluted earnings per share</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">82,323&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">84,276&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted net income per common share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140709354856720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock', window );">Schedule of Comprehensive Income (Loss)</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Comprehensive income for the three months ended March 31, 2023 and 2022 was as follows:</span></div><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.122%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.498%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,226&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,901&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,076&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,683)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in unrealized loss/(gain) on derivatives, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,377)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,822&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pension liability adjustment, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Comprehensive income, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,028&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">57,031&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Changes in Accumulated Other Comprehensive Loss by Component</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in accumulated other comprehensive income by component between December&#160;31, 2022 and March&#160;31, 2023 are presented in the table below, net of tax:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.747%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.402%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.287%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains and Losses on Derivatives</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Defined Benefit Pension Items</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Items</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at January 1, 2023</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,817&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,322&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(21,874)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,265&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive gain (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,754)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,076&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,575)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 21.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Amounts reclassified from accumulated other comprehensive income, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,623&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,623&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 21.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net current-period other comprehensive gain (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,377)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,076&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,198)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at March&#160;31, 2023</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,440&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,425&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(17,798)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,067&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of components of comprehensive income (loss). Includes, but is not limited to, foreign currency translation adjustments, foreign currency transactions designated as economic hedges of a net investment in foreign entity, gain (loss) and prior service cost (credit) for pension plans and other postretirement benefit plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e526-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140709350093136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT AND GEOGRAPHIC INFORMATION (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Schedule of Net Sales and Profit by Segments</a></td>
<td class="text">Net sales and profit by each reportable segment for the three months ended March&#160;31, 2023 and 2022 are as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.859%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.128%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.129%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Segment Net Sales</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Codman Specialty Surgical</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">248,136&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">247,308&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Tissue Technologies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"> </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">132,710&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">129,330&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">380,846&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">376,638&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Segment Profit </span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Codman Specialty Surgical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">110,933&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">110,160&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Tissue Technologies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"> </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52,281&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53,893&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Segment profit</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">163,214&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">164,053&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,108)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,894)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(123,724)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(113,995)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating income</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36,382&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46,164&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table>Total revenue by major geographic area consisted of the following:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.274%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.420%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.422%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">271,002&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">263,351&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41,064&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43,744&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Asia Pacific</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50,473&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47,717&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,307&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,826&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">380,846&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">376,638&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Schedule of Geographic Revenue by Area</a></td>
<td class="text">Net sales and profit by each reportable segment for the three months ended March&#160;31, 2023 and 2022 are as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.859%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.128%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.129%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Segment Net Sales</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Codman Specialty Surgical</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">248,136&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">247,308&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Tissue Technologies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"> </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">132,710&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">129,330&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">380,846&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">376,638&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Segment Profit </span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Codman Specialty Surgical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">110,933&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">110,160&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Tissue Technologies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"> </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52,281&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53,893&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Segment profit</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">163,214&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">164,053&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,108)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,894)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(123,724)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(113,995)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating income</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36,382&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46,164&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table>Total revenue by major geographic area consisted of the following:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.274%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.420%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.422%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">271,002&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">263,351&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41,064&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43,744&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Asia Pacific</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50,473&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47,717&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,307&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,826&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">380,846&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">376,638&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140709350595760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Schedule of Contingent Consideration</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the opening balances to the closing balances of these Level 3 measurements for the three months ended March 31, 2023 and March&#160;31, 2022 is as follows (in thousands):</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"><tr><td style="width:1.0%"/><td style="width:18.988%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.390%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.319%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.390%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.876%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.390%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.535%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.390%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.024%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.390%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:7.319%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.390%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.319%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.390%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.319%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.390%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.681%"/><td style="width:0.1%"/></tr><tr style="height:29pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Contingent Consideration Liability Related to Acquisition of:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:29pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Arkis</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location in Financial Statements</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derma Sciences</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ACell</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Surgical Innovations Associates, Inc. (FN 2)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location in Financial Statements</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Short-term</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Short-term</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of January 1, 2023</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,845&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,050&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">230&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,700&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">57,607&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transfers</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12,500)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in fair value of contingent consideration liabilities </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,543&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,756&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,200)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,600&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of March 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,388&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,806&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">230&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,500&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,500&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48,707&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:28.036%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.831%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.245%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:9.295%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.245%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.684%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.099%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.255%"/><td style="width:0.1%"/></tr><tr style="height:29pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Contingent Consideration Liability Related to Acquisition of:</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:29pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Arkis </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location in Financial Statements</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derma Sciences</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ACell Inc.</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location in Financial Statements</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Short-term</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Short-term</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of January 1, 2022</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,691&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,408&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">230&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,800&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transfers</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(59)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,885&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,885)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in fair value of contingent consideration liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,065)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of March&#160;31, 2022</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,750&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,284&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">230&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,885&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,215&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19279-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140709350258832">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>ACQUISITIONS AND DIVESTITURES- Business Combination, Narrative (Details) - Surgical Innovation Associates Inc<br> $ in Millions</strong></div></th>
<th class="th">
<div>Dec. 06, 2022 </div>
<div>USD ($) </div>
<div>payment</div>
</th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Payments to acquire businesses, gross</a></td>
<td class="nump">$ 51.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_BusinessAcquisitionNumberOfContingentLiabilities', window );">Number of contingent liabilities | payment</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh', window );">Contingent consideration, maximum undiscounted payment amount</a></td>
<td class="nump">$ 90.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_BusinessCombinationIntangibleAssetAcquiredDiscountRate', window );">Intangible asset acquired, discount rate (percent)</a></td>
<td class="nump">18.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent', window );">Contingent consideration, noncurrent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 48.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent', window );">Contingent consideration, current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iart_SurgicalInnovationAssociatesIncMember', window );">Revenue Based Performance Milestones</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh', window );">Contingent consideration, maximum undiscounted payment amount</a></td>
<td class="nump">$ 50.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration, estimated fair value</a></td>
<td class="nump">32.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iart_SurgicalInnovationAssociatesIncMember', window );">FDA Approval Of Premarket Approval</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh', window );">Contingent consideration, maximum undiscounted payment amount</a></td>
<td class="nump">40.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration, estimated fair value</a></td>
<td class="nump">$ 25.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_BusinessAcquisitionNumberOfContingentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Acquisition, Number Of Contingent Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_BusinessAcquisitionNumberOfContingentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_BusinessCombinationIntangibleAssetAcquiredDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Intangible Asset Acquired, Discount Rate</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_BusinessCombinationIntangibleAssetAcquiredDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126966325&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph b<br> -URI https://asc.fasb.org/extlink&amp;oid=126966325&amp;loc=d3e6819-128478<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled beyond one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph b<br> -URI https://asc.fasb.org/extlink&amp;oid=126966325&amp;loc=d3e6819-128478<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=iart_SurgicalInnovationAssociatesIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=iart_SurgicalInnovationAssociatesIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=iart_RevenueBasedPerformanceMilestonesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=iart_RevenueBasedPerformanceMilestonesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=iart_FDAApprovalOfPremarketApprovalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=iart_FDAApprovalOfPremarketApprovalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140709351287888">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>ACQUISITIONS AND DIVESTITURES - Business Combination, Schedule of Purchase Price Allocation (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 06, 2022</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,041,606<span></span>
</td>
<td class="nump">$ 1,038,881<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iart_SurgicalInnovationAssociatesIncMember', window );">Surgical Innovation Associates Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash</a></td>
<td class="nump">$ 4,438<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Trade accounts receivable, net</a></td>
<td class="nump">1,551<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory', window );">Inventories, net</a></td>
<td class="nump">2,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">1,654<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets', window );">Total current assets</a></td>
<td class="nump">10,543<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets</a></td>
<td class="nump">75,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">41,854<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill', window );">Total assets acquired</a></td>
<td class="nump">127,397<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Accounts payable and accrued expenses</a></td>
<td class="nump">2,044<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities', window );">Total current liabilities</a></td>
<td class="nump">2,044<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Deferred Tax Liability</a></td>
<td class="nump">11,799<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability', window );">Contingent consideration</a></td>
<td class="nump">57,607<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities', window );">Total liabilities assumed</a></td>
<td class="nump">71,450<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Total liabilities assumed</a></td>
<td class="nump">$ 55,947<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted average life</a></td>
<td class="text">14 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Acquired Including Goodwill</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liability arising from an inherited contingency (as defined) which has been recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of inventory recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=iart_SurgicalInnovationAssociatesIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=iart_SurgicalInnovationAssociatesIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140709348555232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACQUISITIONS AND DIVESTITURES - Divestitures, Narrative (Details) - Disposal Group, Disposed of by Sale, Not Discontinued Operations - Traditional Wound Care - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration', window );">Sale of business, disposition price</a></td>
<td class="nump">$ 28.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Proceeds from sale of business</a></td>
<td class="nump">27.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsideration', window );">Sale of business, contingent consideration</a></td>
<td class="nump">$ 1.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsiderationPeriod', window );">Period for revenue based performance milestone</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashDivestedFromDeconsolidation', window );">Cash divested from deconsolidation</a></td>
<td class="nump">$ 3.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">Gain from sale of businesses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_DiscontinuedOperationContinuingInvolvementPrepaidAsset', window );">Discontinued operation, continuing involvement, prepaid asset</a></td>
<td class="nump">$ 11.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_DiscontinuedOperationContinuingInvolvementPrepaidAssetsCurrent', window );">Inventory purchase, prepaid expenses and other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable', window );">Disposal group, payable recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_DiscontinuedOperationContinuingInvolvementPrepaidAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Discontinued Operation, Continuing Involvement, Prepaid Asset</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_DiscontinuedOperationContinuingInvolvementPrepaidAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_DiscontinuedOperationContinuingInvolvementPrepaidAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Discontinued Operation, Continuing Involvement, Prepaid Expenses, Current Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_DiscontinuedOperationContinuingInvolvementPrepaidAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Consideration, Contingent Consideration</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsiderationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Consideration, Contingent Consideration, Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsiderationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashDivestedFromDeconsolidation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reduction in cash due to no longer including the former subsidiary's cash in the consolidated entity's cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashDivestedFromDeconsolidation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as accounts payable attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4582445-111684<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinesses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinesses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=iart_TraditionalWoundCareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=iart_TraditionalWoundCareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140709354748240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUES FROM CONTRACTS WITH CUSTOMERS - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_ReturnPolicyIssueOfCreditNumberOfDaysFromShipment', window );">Number of days from shipment to issue a credit</a></td>
<td class="text">90 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Short-term portion of contract liability</a></td>
<td class="nump">$ 7,743<span></span>
</td>
<td class="nump">$ 7,253<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityNoncurrent', window );">Long-term portion of contract liability</a></td>
<td class="nump">$ 8,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_RevenueProductWarrantyPeriod', window );">Product warranty period (up to)</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_ReturnPolicyIssueOfCreditNumberOfDaysFromShipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Return Policy, Issue of Credit, Number of Days from Shipment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_ReturnPolicyIssueOfCreditNumberOfDaysFromShipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_RevenueProductWarrantyPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revenue, Product Warranty Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_RevenueProductWarrantyPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130532-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140709350638320">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>REVENUES FROM CONTRACTS WITH CUSTOMERS - Narrative, Revenue Remaining Performance Obligation (Details) - Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-04-01<br></strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationPercentage', window );">Expected performance obligation through 2021, percentage</a></td>
<td class="nump">47.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Performance obligations expected to be satisfied, expected timing</a></td>
<td class="text">12 months<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of remaining performance obligation to total remaining performance obligation not recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2023-04-01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2023-04-01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140709350250448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUES FROM CONTRACTS WITH CUSTOMERS - Schedule of Changes in Contract Assets and Liabilities (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_ChangeInContractWithCustomerAssetRollForward', window );"><strong>Contract Asset</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNet', window );">Contract asset, Beginning of period</a></td>
<td class="nump">$ 10,122<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetReclassifiedToReceivable', window );">Transferred to trade receivable from contract asset included in beginning of the year contract asset</a></td>
<td class="num">(9,765)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_ContractWithCustomerAssetNetOfReclassifiedToReceivable', window );">Contract asset, net of transferred to trade receivables on contracts during the period</a></td>
<td class="nump">9,713<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNet', window );">Contract asset, End of Period</a></td>
<td class="nump">10,070<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_ChangeInContractWithCustomerLiabilityRollForward', window );"><strong>Contract Liability</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Contract liability, Beginning of Period</a></td>
<td class="nump">16,127<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_ContractWithCustomerLiabilityNetOfRevenueRecognized', window );">Recognition of revenue included in beginning of year contract liability</a></td>
<td class="num">(2,492)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Contract liability, net of revenue recognized on contracts during the period</a></td>
<td class="nump">2,921<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_ContractWithCustomerLiabilityIncreaseDecreaseFromForeignCurrencyTranslation', window );">Foreign currency translation</a></td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Contract liability, End of Period</a></td>
<td class="nump">$ 16,559<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_ChangeInContractWithCustomerAssetRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change In Contract With Customer, Asset [Roll Forward]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_ChangeInContractWithCustomerAssetRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_ChangeInContractWithCustomerLiabilityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change In Contract With Customer, Liability [Roll Forward]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_ChangeInContractWithCustomerLiabilityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_ContractWithCustomerAssetNetOfReclassifiedToReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contract With Customer, Asset, Net Of Reclassified To Receivable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_ContractWithCustomerAssetNetOfReclassifiedToReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_ContractWithCustomerLiabilityIncreaseDecreaseFromForeignCurrencyTranslation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contract With Customer, Liability, Increase (Decrease) From Foreign Currency Translation</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_ContractWithCustomerLiabilityIncreaseDecreaseFromForeignCurrencyTranslation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_ContractWithCustomerLiabilityNetOfRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contract With Customer, Liability, Net Of Revenue Recognized</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_ContractWithCustomerLiabilityNetOfRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130533-203044<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetReclassifiedToReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time from transfer to receivable due to right to consideration becoming unconditional.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130551-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetReclassifiedToReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130532-203044<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140709347178736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUES FROM CONTRACTS WITH CUSTOMERS - Schedule of Revenues Disaggregated by Major Source (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total Revenues</a></td>
<td class="nump">$ 380,846<span></span>
</td>
<td class="nump">$ 376,638<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=iart_CodmanSpecialtySurgicalMember', window );">Codman Specialty Surgical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total Revenues</a></td>
<td class="nump">248,136<span></span>
</td>
<td class="nump">247,308<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=iart_CodmanSpecialtySurgicalMember', window );">Codman Specialty Surgical | Neurosurgery</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total Revenues</a></td>
<td class="nump">192,870<span></span>
</td>
<td class="nump">194,675<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=iart_CodmanSpecialtySurgicalMember', window );">Codman Specialty Surgical | Instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total Revenues</a></td>
<td class="nump">55,266<span></span>
</td>
<td class="nump">52,633<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=iart_TissueTechnologiesMember', window );">Tissue Technologies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total Revenues</a></td>
<td class="nump">132,710<span></span>
</td>
<td class="nump">129,330<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=iart_TissueTechnologiesMember', window );">Tissue Technologies | Wound Reconstruction and Care</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total Revenues</a></td>
<td class="nump">100,940<span></span>
</td>
<td class="nump">94,630<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=iart_TissueTechnologiesMember', window );">Tissue Technologies | Private Label</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total Revenues</a></td>
<td class="nump">$ 31,770<span></span>
</td>
<td class="nump">$ 34,700<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=iart_CodmanSpecialtySurgicalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=iart_CodmanSpecialtySurgicalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=iart_NeurosurgeryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=iart_NeurosurgeryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=iart_InstrumentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=iart_InstrumentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=iart_TissueTechnologiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=iart_TissueTechnologiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=iart_RegenerativeSkinAndWoundMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=iart_RegenerativeSkinAndWoundMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=iart_PrivateLabelMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=iart_PrivateLabelMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140709347357456">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INVENTORIES - Schedule of Net Inventories (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Finished goods</a></td>
<td class="nump">$ 178,626<span></span>
</td>
<td class="nump">$ 172,088<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcessNetOfReserves', window );">Work in process</a></td>
<td class="nump">80,532<span></span>
</td>
<td class="nump">70,598<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsAndPurchasedPartsNetOfReserves', window );">Raw materials</a></td>
<td class="nump">92,117<span></span>
</td>
<td class="nump">81,897<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories, net</a></td>
<td class="nump">$ 351,275<span></span>
</td>
<td class="nump">$ 324,583<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsAndPurchasedPartsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of items purchased for use as components of a finished product or pieces of machinery and equipment plus any items in their natural and unrefined state. This element may be used when the reporting entity combines raw materials and purchased parts into an aggregate amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsAndPurchasedPartsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcessNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcessNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140709351675040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND OTHER INTANGIBLE ASSETS - Schedule of Changes in Carrying Amount of Goodwill (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning of Period</a></td>
<td class="nump">$ 1,038,881<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency translation</a></td>
<td class="nump">2,596<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">End of Period</a></td>
<td class="nump">1,041,606<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iart_SurgicalInnovationAssociatesIncMember', window );">Surgical Innovation Associates Inc</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">SIA Acquisition Working Capital Adjustment</a></td>
<td class="nump">129<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=iart_CodmanSpecialtySurgicalMember', window );">Codman Specialty Surgical</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning of Period</a></td>
<td class="nump">656,219<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency translation</a></td>
<td class="nump">1,639<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">End of Period</a></td>
<td class="nump">657,858<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=iart_CodmanSpecialtySurgicalMember', window );">Codman Specialty Surgical | Surgical Innovation Associates Inc</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">SIA Acquisition Working Capital Adjustment</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=iart_TissueTechnologiesMember', window );">Tissue Technologies</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning of Period</a></td>
<td class="nump">382,662<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency translation</a></td>
<td class="nump">957<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">End of Period</a></td>
<td class="nump">383,748<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=iart_TissueTechnologiesMember', window );">Tissue Technologies | Surgical Innovation Associates Inc</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">SIA Acquisition Working Capital Adjustment</a></td>
<td class="nump">$ 129<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillForeignCurrencyTranslationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillPurchaseAccountingAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=123586518&amp;loc=d3e961-128460<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillPurchaseAccountingAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=iart_SurgicalInnovationAssociatesIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=iart_SurgicalInnovationAssociatesIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=iart_CodmanSpecialtySurgicalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=iart_CodmanSpecialtySurgicalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=iart_TissueTechnologiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=iart_TissueTechnologiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140709347781136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND OTHER INTANGIBLE ASSETS - Components of Company's Identifiable Intangible Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill', window );">Cost</a></td>
<td class="nump">$ 1,701,363<span></span>
</td>
<td class="nump">$ 1,697,532<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(592,604)<span></span>
</td>
<td class="num">(570,923)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill', window );">Net</a></td>
<td class="nump">1,108,759<span></span>
</td>
<td class="nump">1,126,609<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Codman tradename</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill', window );">Cost</a></td>
<td class="nump">167,529<span></span>
</td>
<td class="nump">166,693<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill', window );">Net</a></td>
<td class="nump">$ 167,529<span></span>
</td>
<td class="nump">$ 166,693<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=iart_CompletedTechnologyMember', window );">Completed technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted Average Life</a></td>
<td class="text">18 years<span></span>
</td>
<td class="text">18 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill', window );">Cost</a></td>
<td class="nump">$ 1,206,748<span></span>
</td>
<td class="nump">$ 1,204,325<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(389,297)<span></span>
</td>
<td class="num">(370,968)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill', window );">Net</a></td>
<td class="nump">$ 817,451<span></span>
</td>
<td class="nump">$ 833,357<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted Average Life</a></td>
<td class="text">12 years<span></span>
</td>
<td class="text">12 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill', window );">Cost</a></td>
<td class="nump">$ 193,297<span></span>
</td>
<td class="nump">$ 193,081<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(146,098)<span></span>
</td>
<td class="num">(144,040)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill', window );">Net</a></td>
<td class="nump">$ 47,199<span></span>
</td>
<td class="nump">$ 49,041<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=iart_TrademarksBrandNamesMember', window );">Trademarks/brand names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted Average Life</a></td>
<td class="text">28 years<span></span>
</td>
<td class="text">28 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill', window );">Cost</a></td>
<td class="nump">$ 97,554<span></span>
</td>
<td class="nump">$ 97,265<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(35,665)<span></span>
</td>
<td class="num">(34,674)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill', window );">Net</a></td>
<td class="nump">$ 61,889<span></span>
</td>
<td class="nump">$ 62,591<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=iart_SupplierRelationShipsMember', window );">Supplier relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted Average Life</a></td>
<td class="text">30 years<span></span>
</td>
<td class="text">30 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill', window );">Cost</a></td>
<td class="nump">$ 30,211<span></span>
</td>
<td class="nump">$ 30,211<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(17,415)<span></span>
</td>
<td class="num">(17,170)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill', window );">Net</a></td>
<td class="nump">$ 12,796<span></span>
</td>
<td class="nump">$ 13,041<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=iart_AllOtherMember', window );">All other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted Average Life</a></td>
<td class="text">11 years<span></span>
</td>
<td class="text">11 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill', window );">Cost</a></td>
<td class="nump">$ 6,024<span></span>
</td>
<td class="nump">$ 5,957<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(4,129)<span></span>
</td>
<td class="num">(4,071)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill', window );">Net</a></td>
<td class="nump">$ 1,895<span></span>
</td>
<td class="nump">$ 1,886<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cost Of Definite And Indefinite Lived Intangible Assets Gross Excluding Goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Definite And Indefinite Lived Intangible Assets Net Excluding Goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=iart_CompletedTechnologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=iart_CompletedTechnologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=iart_TrademarksBrandNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=iart_TrademarksBrandNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=iart_SupplierRelationShipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=iart_SupplierRelationShipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=iart_AllOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=iart_AllOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140709351285440">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>GOODWILL AND OTHER INTANGIBLE ASSETS - Narrative (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear', window );">Expected annual amortization expense, remainder of 2022</a></td>
<td class="nump">$ 61.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">Expected annual amortization expense, in 2023</a></td>
<td class="nump">81.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">Expected annual amortization expense, in 2024</a></td>
<td class="nump">81.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">Expected annual amortization expense, in 2025</a></td>
<td class="nump">81.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">Expected annual amortization expense, in 2026</a></td>
<td class="nump">79.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">Expected annual amortization expense, in 2027</a></td>
<td class="nump">78.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">Expected annual amortization expense, thereafter</a></td>
<td class="nump">$ 474.4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140709343725248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEBT - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Feb. 04, 2020 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 24, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 09, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecuredDebtCurrent', window );">Term loan component of senior credit facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 38,125,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_InterestPaymentsReminderOfFiscalYear', window );">Interest payments, remainder of fiscal year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_InterestPaymentsYearOne', window );">Interest payments, year one</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_InterestPaymentsYearTwo', window );">Interest payments, year two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_InterestPaymentsYearThree', window );">Interest payments, year three</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_InterestPaymentsAfterYearThree', window );">Interest payments, after year three</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_TransferorsInterestsInTransferredFinancialAssetsMaximumInvestmentLimit', window );">Securitization program outstanding borrowings, maximum limit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_SecuredLongTermDebtSecuritizationProgram', window );">Secured long-term debt, securitization program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 102,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 104,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_DebtWeightedAverageInterestRateFromSecuritization', window );">Weighted average interest rate, accounts receivable securitization revolving loan facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Fair Value, Inputs, Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_SecuritizationFacilityFairValueOfAmountOutstanding', window );">Securitization facility, outstanding borrowings, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 102,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,300,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Debt issuance costs capitalized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WriteOffOfDeferredDebtIssuanceCost', window );">Write off of debt issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Line of credit facility outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_StandbyLettersOfCreditMember', window );">Standby Letters of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=iart_SwinglineLoanMember', window );">Swingline Loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iart_SeniorCreditFacilityMember', window );">Senior Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iart_SeniorCreditFacilityMember', window );">Senior Credit Facility | Overnight Federal Funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Interest rates available</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iart_SeniorCreditFacilityMember', window );">Senior Credit Facility | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_DebtInstrumentBasisSpreadAdjustmentOnVariableRate', window );">Interest rate adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Interest rates available</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iart_SeniorCreditFacilityMember', window );">Senior Credit Facility | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Line of credit, commitment fee percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.15%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iart_SeniorCreditFacilityMember', window );">Senior Credit Facility | Minimum | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Interest rates available</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iart_SeniorCreditFacilityMember', window );">Senior Credit Facility | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Line of credit, commitment fee percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iart_SeniorCreditFacilityMember', window );">Senior Credit Facility | Maximum | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Interest rates available</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iart_SeniorCreditFacilityMember', window );">Senior Credit Facility | Standby Letters of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Line of credit facility outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LettersOfCreditOutstandingAmount', window );">Letters of credit outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iart_TermLoanFacilityMember', window );">Term Loan Facility | Secured Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 775,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Line of credit facility outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 775,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 775,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtWeightedAverageInterestRate', window );">Weighted average interest rate on debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecuredDebtCurrent', window );">Term loan component of senior credit facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 38,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iart_TermLoanFacilityMember', window );">Term Loan Facility | Secured Debt | Fair Value, Inputs, Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding', window );">Line of credit facility, fair value of amount outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">750,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iart_TwoThousandTwentyFiveSeniorConvertibleNotesMember', window );">2025 Notes | Convertible Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Convertible notes, maximum borrowing capacity</a></td>
<td class="nump">$ 575,000,000<span></span>
</td>
<td class="nump">575,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Convertible notes, interest rate</a></td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsGross', window );">Incremental financing costs capitalized</a></td>
<td class="nump">$ 13,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionRatio1', window );">Initial conversion rate</a></td>
<td class="nump">0.0135739<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Initial conversion price (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 73.67<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_DebtInstrumentMaximumSellingPriceOfCommonStockOfTheConversionPriceDuringPeriod', window );">Maximum selling price of the company's common stock of the conversion price</a></td>
<td class="nump">130.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_DebtInstrumentMaximumAverageConversionValueOfNotes', window );">Maximum average conversion value of notes</a></td>
<td class="nump">98.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_DebtInstrumentCombinationSettlementForDebtConversionMinimumSettledInCashPerPrincipalAmount', window );">Minimum settled in cash per principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Redemption price, percentage</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant strike price (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 113.34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 561,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iart_TwoThousandTwentyFiveSeniorConvertibleNotesMember', window );">2025 Notes | Convertible Debt | Call Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_PaymentsForOptionIndexToIssuersEquity', window );">Cost of call transactions</a></td>
<td class="nump">$ 104,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Proceeds from warrant transactions</a></td>
<td class="nump">$ 44,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OptionIndexedToIssuersEquityStrikePrice1', window );">Initial strike price (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 73.67<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_DebtInstrumentBasisSpreadAdjustmentOnVariableRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Basis Spread Adjustment On Variable Rate</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_DebtInstrumentBasisSpreadAdjustmentOnVariableRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_DebtInstrumentCombinationSettlementForDebtConversionMinimumSettledInCashPerPrincipalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Combination Settlement For Debt Conversion, Minimum Settled In Cash Per Principal Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_DebtInstrumentCombinationSettlementForDebtConversionMinimumSettledInCashPerPrincipalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_DebtInstrumentMaximumAverageConversionValueOfNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Maximum Average Conversion Value Of Notes</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_DebtInstrumentMaximumAverageConversionValueOfNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_DebtInstrumentMaximumSellingPriceOfCommonStockOfTheConversionPriceDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Maximum Selling Price Of Common Stock Of The Conversion Price During Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_DebtInstrumentMaximumSellingPriceOfCommonStockOfTheConversionPriceDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_DebtWeightedAverageInterestRateFromSecuritization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt, Weighted Average Interest Rate, From Securitization</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_DebtWeightedAverageInterestRateFromSecuritization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_InterestPaymentsAfterYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest Payments, After Year Three</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_InterestPaymentsAfterYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_InterestPaymentsReminderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest Payments, Reminder Of Fiscal Year</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_InterestPaymentsReminderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_InterestPaymentsYearOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest Payments, Year One</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_InterestPaymentsYearOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_InterestPaymentsYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest Payments, Year Three</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_InterestPaymentsYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_InterestPaymentsYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest Payments, Year Two</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_InterestPaymentsYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_PaymentsForOptionIndexToIssuersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments For Options Indexed to Issuer's Equity</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_PaymentsForOptionIndexToIssuersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_SecuredLongTermDebtSecuritizationProgram">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Secured Long-Term Debt, Securitization Program</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_SecuredLongTermDebtSecuritizationProgram</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_SecuritizationFacilityFairValueOfAmountOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securitization Facility, Fair Value Of Amount Outstanding</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_SecuritizationFacilityFairValueOfAmountOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_TransferorsInterestsInTransferredFinancialAssetsMaximumInvestmentLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Transferor's Interests In Transferred Financial Assets, Maximum Investment Limit</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_TransferorsInterestsInTransferredFinancialAssetsMaximumInvestmentLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031898-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionRatio1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Ratio applied to the conversion of debt instrument into equity with equity shares divided by debt principal amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21521-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21506-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionRatio1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPricePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph e<br> -URI https://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPricePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtWeightedAverageInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average interest rate of debt outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtWeightedAverageInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LettersOfCreditOutstandingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LettersOfCreditOutstandingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCommitmentFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of the amount outstanding under the credit facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OptionIndexedToIssuersEquityStrikePrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise or strike price stated in the contract for options indexed to the issuer's equity shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=d3e90205-114008<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109262807&amp;loc=d3e22047-110879<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OptionIndexedToIssuersEquityStrikePrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecuredDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of the portion of long-term, collateralized debt obligations due within one year or the operating cycle, if longer. Such obligations include mortgage loans, chattel loans, and any other borrowings secured by assets of the borrower.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecuredDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WriteOffOfDeferredDebtIssuanceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Write-off of amounts previously capitalized as debt issuance cost in an extinguishment of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WriteOffOfDeferredDebtIssuanceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_StandbyLettersOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_StandbyLettersOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=iart_SwinglineLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=iart_SwinglineLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=iart_SeniorCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=iart_SeniorCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_FederalFundsEffectiveSwapRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_FederalFundsEffectiveSwapRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=iart_TermLoanFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=iart_TermLoanFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_SecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_SecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=iart_TwoThousandTwentyFiveSeniorConvertibleNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=iart_TwoThousandTwentyFiveSeniorConvertibleNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OptionIndexedToIssuersEquityEquityAxis=us-gaap_CallOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OptionIndexedToIssuersEquityEquityAxis=us-gaap_CallOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140709349649520">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>DEBT - Maximum Total Leverage Ratio Table (Details) - Senior Credit Facility<br></strong></div></th>
<th class="th"><div>Mar. 24, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_DebtCovenantPeriodAxis=iart_DebtCovenantPeriod1Member', window );">March 31, 2023 through December 31, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_DebtInstrumentCovenantMaximumLeverageRatio', window );">Maximum Consolidated Total Leverage Ratio</a></td>
<td class="nump">4.50<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_DebtCovenantPeriodAxis=iart_DebtCovenantPeriod2Member', window );">March 31, 2025 through June 30, 2026</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_DebtInstrumentCovenantMaximumLeverageRatio', window );">Maximum Consolidated Total Leverage Ratio</a></td>
<td class="nump">4.25<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_DebtCovenantPeriodAxis=iart_DebtCovenantPeriod3Member', window );">September 30, 2026 and the last day of each fiscal quarter thereafter</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_DebtInstrumentCovenantMaximumLeverageRatio', window );">Maximum Consolidated Total Leverage Ratio</a></td>
<td class="nump">4.00<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_DebtInstrumentCovenantMaximumLeverageRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant, Maximum Leverage Ratio</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_DebtInstrumentCovenantMaximumLeverageRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_DebtCovenantPeriodAxis=iart_DebtCovenantPeriod1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_DebtCovenantPeriodAxis=iart_DebtCovenantPeriod1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=iart_SeniorCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=iart_SeniorCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_DebtCovenantPeriodAxis=iart_DebtCovenantPeriod2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_DebtCovenantPeriodAxis=iart_DebtCovenantPeriod2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_DebtCovenantPeriodAxis=iart_DebtCovenantPeriod3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_DebtCovenantPeriodAxis=iart_DebtCovenantPeriod3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140709347749696">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>DEBT - Contractual Maturity Table (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear', window );">Remainder of 2023</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2024</a></td>
<td class="nump">14,531<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2025</a></td>
<td class="nump">33,906<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2026</a></td>
<td class="nump">38,750<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_LongTermDebtMaturityAfterYearThree', window );">Thereafter</a></td>
<td class="nump">687,813<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Principal Repayment</a></td>
<td class="nump">$ 775,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_LongTermDebtMaturityAfterYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Long-Term Debt, Maturity, after Year Three</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_LongTermDebtMaturityAfterYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140709346974512">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>DERIVATIVE INSTRUMENTS - Schedule of Derivative Instruments (Details) - Cash Flow Hedges - Designated as Hedging Instrument - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Estimated Fair Value</a></td>
<td class="nump">$ 42,678<span></span>
</td>
<td class="nump">$ 56,712<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Interest Rate Swap Designated March 31, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional Amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Estimated Fair Value</a></td>
<td class="num">(1,842)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional Amount</a></td>
<td class="nump">1,475,000<span></span>
</td>
<td class="nump">1,475,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate | Interest Rate Swap Designated December 13, 2017 Tranche 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional Amount</a></td>
<td class="nump">$ 150,000<span></span>
</td>
<td class="nump">$ 150,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Fixed Interest Rate</a></td>
<td class="nump">2.423%<span></span>
</td>
<td class="nump">2.423%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Estimated Fair Value</a></td>
<td class="nump">$ 4,022<span></span>
</td>
<td class="nump">$ 5,012<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate | Interest Rate Swap Designated December 13, 2017 Tranche 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional Amount</a></td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Fixed Interest Rate</a></td>
<td class="nump">2.313%<span></span>
</td>
<td class="nump">2.313%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Estimated Fair Value</a></td>
<td class="nump">$ 6,738<span></span>
</td>
<td class="nump">$ 8,380<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate | Interest Rate Swap Designated October 10, 2018 Tranche 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional Amount</a></td>
<td class="nump">$ 75,000<span></span>
</td>
<td class="nump">$ 75,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Fixed Interest Rate</a></td>
<td class="nump">3.22%<span></span>
</td>
<td class="nump">3.22%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Estimated Fair Value</a></td>
<td class="nump">$ 1,329<span></span>
</td>
<td class="nump">$ 1,831<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate | Interest Rate Swap Designated October 10, 2018 Tranche 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional Amount</a></td>
<td class="nump">$ 75,000<span></span>
</td>
<td class="nump">$ 75,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Fixed Interest Rate</a></td>
<td class="nump">3.199%<span></span>
</td>
<td class="nump">3.199%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Estimated Fair Value</a></td>
<td class="nump">$ 1,539<span></span>
</td>
<td class="nump">$ 1,905<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate | Interest Rate Swap Designated October 10, 2018 Tranche 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional Amount</a></td>
<td class="nump">$ 75,000<span></span>
</td>
<td class="nump">$ 75,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Fixed Interest Rate</a></td>
<td class="nump">3.209%<span></span>
</td>
<td class="nump">3.209%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Estimated Fair Value</a></td>
<td class="nump">$ 1,441<span></span>
</td>
<td class="nump">$ 1,970<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate | Interest Rate Swap Designated December 18, 2018 Tranche 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional Amount</a></td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Fixed Interest Rate</a></td>
<td class="nump">2.885%<span></span>
</td>
<td class="nump">2.885%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Estimated Fair Value</a></td>
<td class="nump">$ 2,770<span></span>
</td>
<td class="nump">$ 4,252<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate | Interest Rate Swap Designated December 18, 2018 Tranche 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional Amount</a></td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Fixed Interest Rate</a></td>
<td class="nump">2.867%<span></span>
</td>
<td class="nump">2.867%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Estimated Fair Value</a></td>
<td class="nump">$ 2,708<span></span>
</td>
<td class="nump">$ 4,153<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate | Interest Rate Swap Designated December 15, 2020 Tranche 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional Amount</a></td>
<td class="nump">$ 575,000<span></span>
</td>
<td class="nump">$ 575,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Fixed Interest Rate</a></td>
<td class="nump">1.415%<span></span>
</td>
<td class="nump">1.415%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Estimated Fair Value</a></td>
<td class="nump">$ 19,406<span></span>
</td>
<td class="nump">$ 23,742<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate | Interest Rate Swap Designated December 15, 2020 Tranche 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional Amount</a></td>
<td class="nump">$ 125,000<span></span>
</td>
<td class="nump">$ 125,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Fixed Interest Rate</a></td>
<td class="nump">1.404%<span></span>
</td>
<td class="nump">1.404%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Estimated Fair Value</a></td>
<td class="nump">$ 4,567<span></span>
</td>
<td class="nump">$ 5,467<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of the assets less the liabilities of a derivative or group of derivatives.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFixedInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fixed interest rate related to the interest rate derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFixedInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=iart_InterestRateSwapDesignatedMarch312023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=iart_InterestRateSwapDesignatedMarch312023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=iart_InterestRateSwapDesignatedDecember132017Tranche2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=iart_InterestRateSwapDesignatedDecember132017Tranche2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=iart_InterestRateSwapDesignatedDecember132017Tranche3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=iart_InterestRateSwapDesignatedDecember132017Tranche3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=iart_InterestRateSwapDesignatedOctober102018Tranche1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=iart_InterestRateSwapDesignatedOctober102018Tranche1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=iart_InterestRateSwapDesignatedOctober102018Tranche2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=iart_InterestRateSwapDesignatedOctober102018Tranche2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=iart_InterestRateSwapDesignatedOctober102018Tranche3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=iart_InterestRateSwapDesignatedOctober102018Tranche3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=iart_InterestRateSwapDesignatedDecember182018Tranche1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=iart_InterestRateSwapDesignatedDecember182018Tranche1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=iart_InterestRateSwapDesignatedDecember182018Tranche2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=iart_InterestRateSwapDesignatedDecember182018Tranche2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=iart_InterestRateSwapDesignatedDecember152020Tranche1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=iart_InterestRateSwapDesignatedDecember152020Tranche1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=iart_InterestRateSwapDesignatedDecember152020Tranche2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=iart_InterestRateSwapDesignatedDecember152020Tranche2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140709348170096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DERIVATIVE INSTRUMENTS - Narrative (Details)<br> SFr in Millions</strong></div></th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>CHF (SFr)</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 26, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 26, 2022 </div>
<div>CHF (SFr)</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 21, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 21, 2020 </div>
<div>CHF (SFr)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet', window );">Gain expected to be reclassified to earnings in the next twelve months</a></td>
<td class="nump">$ 10,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Gain (loss) recorded in AOCL, change in fair value</a></td>
<td class="num">(7,462,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 43,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember', window );">Cross-currency swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Current notional amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 471,600,000<span></span>
</td>
<td class="nump">SFr 420.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_IntercompanyLoanQuarterlyPayment', window );">Intercompany loan quarterly payments | SFr</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 5.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnDerivativeInstrumentsNetPretax', window );">Gain (loss) reclassified into other income</a></td>
<td class="nump">1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Gain (loss) recorded in AOCL, change in fair value</a></td>
<td class="nump">7,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet', window );">Gain expected to be reclassified to earnings in the next twelve months</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember', window );">Cross-currency swap | Cash Flow Hedges | Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnDerivativeInstrumentsNetPretax', window );">Gain (loss) reclassified into other income</a></td>
<td class="num">(4,900,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember', window );">Cross-currency swap | Cash Flow Hedges | Designated as Hedging Instrument | Other income, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Gain (loss) recorded in AOCL, change in fair value</a></td>
<td class="nump">2,191,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">316,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember', window );">Cross-currency swap | Net Investment Hedges | Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnDerivativeInstrumentsNetPretax', window );">Gain (loss) reclassified into other income</a></td>
<td class="nump">2,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax', window );">Gain (loss) recorded, net investment hedge, change in fair value</a></td>
<td class="nump">1,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,300,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember', window );">Cross-currency swap | Short | Codman</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_DerivativeNotionalAmountTerminated', window );">Terminated notional amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Current notional amount</a></td>
<td class="nump">49,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 48.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember', window );">Foreign currency swaps | Not Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Current notional amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,400,000<span></span>
</td>
<td class="nump">$ 7,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Foreign currency forward contracts | Cash Flow Hedges | Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Current notional amount</a></td>
<td class="nump">10,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Gain (loss) recorded in AOCL, change in fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Foreign currency forward contracts | Cash Flow Hedges | Designated as Hedging Instrument | Other income, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Gain (loss) recorded in AOCL, change in fair value</a></td>
<td class="num">$ (69,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_DerivativeNotionalAmountTerminated">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Derivative, Notional Amount, Terminated</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_DerivativeNotionalAmountTerminated</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_IntercompanyLoanQuarterlyPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Intercompany Loan, Quarterly Payment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_IntercompanyLoanQuarterlyPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDerivativeInstrumentsNetPretax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate net gain (loss) on all derivative instruments recognized in earnings during the period, before tax effects.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDerivativeInstrumentsNetPretax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated net amount of unrealized gains or losses on interest rate cash flow hedges as of the balance sheet date expected to be reclassified to earnings within the next twelve months.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121549185&amp;loc=d3e80748-113994<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=121577181&amp;loc=SL110061190-113977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification, of gain (loss) from derivative designated and qualifying as net investment hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CCC<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL109998896-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PositionAxis=us-gaap_ShortMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PositionAxis=us-gaap_ShortMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=iart_CodmanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=iart_CodmanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140709344406976">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>DERIVATIVE INSTRUMENTS - Schedule of Cross Currency Swap Derivatives (Details)<br> SFr in Thousands</strong></div></th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>CHF (SFr)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>CHF (SFr)</div>
</th>
<th class="th">
<div>Sep. 26, 2022 </div>
<div>CHF (SFr)</div>
</th>
<th class="th">
<div>Dec. 21, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 21, 2020 </div>
<div>CHF (SFr)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember', window );">Cross-currency swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Aggregate Notional Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 471,600,000<span></span>
</td>
<td class="nump">SFr 420,100<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember', window );">Cross-currency swap | Short | Codman</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Aggregate Notional Amount</a></td>
<td class="nump">$ 49,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 48,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedges | Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Fair Value Asset (Liability)</a></td>
<td class="nump">42,678,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 56,712,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedges | Designated as Hedging Instrument | Cross-currency swap | Codman</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Fair Value Asset (Liability)</a></td>
<td class="num">(7,044,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7,769,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedges | Designated as Hedging Instrument | Cross Currency Interest Rate Swap One | Codman</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Fair Value Asset (Liability)</a></td>
<td class="num">$ (3,033,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,241,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedges | Designated as Hedging Instrument | Cross Currency Interest Rate Swap One | Long | Codman</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Fixed Rate</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Aggregate Notional Amount | SFr</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 373,227<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 397,137<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedges | Designated as Hedging Instrument | Cross Currency Interest Rate Swap One | Short | Codman</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Fixed Rate</a></td>
<td class="nump">3.98%<span></span>
</td>
<td class="nump">3.98%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Aggregate Notional Amount</a></td>
<td class="nump">$ 418,980,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">445,821,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedges | Designated as Hedging Instrument | Cross Currency Interest Rate Swap Two | Codman</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Fair Value Asset (Liability)</a></td>
<td class="num">$ (4,011,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,528,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedges | Designated as Hedging Instrument | Cross Currency Interest Rate Swap Two | Long | Codman</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Fixed Rate</a></td>
<td class="nump">1.95%<span></span>
</td>
<td class="nump">1.95%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Aggregate Notional Amount | SFr</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 48,533<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 48,532<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedges | Designated as Hedging Instrument | Cross Currency Interest Rate Swap Two | Short | Codman</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Fixed Rate</a></td>
<td class="nump">5.32%<span></span>
</td>
<td class="nump">5.32%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Aggregate Notional Amount</a></td>
<td class="nump">$ 49,142,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 49,142,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of the assets less the liabilities of a derivative or group of derivatives.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFixedInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fixed interest rate related to the interest rate derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFixedInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PositionAxis=us-gaap_ShortMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PositionAxis=us-gaap_ShortMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=iart_CodmanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=iart_CodmanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=iart_CrossCurrencyInterestRateContractOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=iart_CrossCurrencyInterestRateContractOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PositionAxis=us-gaap_LongMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PositionAxis=us-gaap_LongMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=iart_CrossCurrencyInterestRateContractTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=iart_CrossCurrencyInterestRateContractTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140709351450512">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>DERIVATIVE INSTRUMENTS - Schedule of Net Investment Hedges Derivatives (Details)<br> &#8364; in Thousands, SFr in Thousands</strong></div></th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>CHF (SFr)</div>
</th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>CHF (SFr)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 21, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 21, 2020 </div>
<div>CHF (SFr)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember', window );">Cross-currency swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Aggregate Notional Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 471,600,000<span></span>
</td>
<td class="nump">SFr 420,100<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Net Investment Hedges | Cross-currency swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Fair Value Asset (Liability)</a></td>
<td class="num">$ (6,790,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (5,643,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Net Investment Hedges | Cross Currency Interest Rate Swap One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Fair Value Asset (Liability)</a></td>
<td class="nump">$ 3,989,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,713,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Net Investment Hedges | Cross Currency Interest Rate Swap One | Long</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Fixed Rate</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Aggregate Notional Amount | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 51,760<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 51,760<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Net Investment Hedges | Cross Currency Interest Rate Swap One | Short</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Fixed Rate</a></td>
<td class="nump">2.57%<span></span>
</td>
<td class="nump">2.57%<span></span>
</td>
<td class="nump">2.57%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Aggregate Notional Amount</a></td>
<td class="nump">$ 60,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Net Investment Hedges | Cross Currency Interest Rate Swap Two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Fair Value Asset (Liability)</a></td>
<td class="nump">$ 3,932,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,307,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Net Investment Hedges | Cross Currency Interest Rate Swap Two | Long</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Fixed Rate</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Aggregate Notional Amount | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 38,820<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 38,820<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Net Investment Hedges | Cross Currency Interest Rate Swap Two | Short</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Fixed Rate</a></td>
<td class="nump">2.19%<span></span>
</td>
<td class="nump">2.19%<span></span>
</td>
<td class="nump">2.19%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Aggregate Notional Amount</a></td>
<td class="nump">$ 45,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Net Investment Hedges | Cross Currency Interest Rate Swap Three</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Fair Value Asset (Liability)</a></td>
<td class="num">$ (14,711,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14,663,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Net Investment Hedges | Cross Currency Interest Rate Swap Three | Long</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Fixed Rate</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Aggregate Notional Amount | SFr</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 288,210<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 288,210<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Net Investment Hedges | Cross Currency Interest Rate Swap Three | Short</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Fixed Rate</a></td>
<td class="nump">1.94%<span></span>
</td>
<td class="nump">1.94%<span></span>
</td>
<td class="nump">1.94%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Aggregate Notional Amount</a></td>
<td class="nump">$ 300,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of the assets less the liabilities of a derivative or group of derivatives.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFixedInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fixed interest rate related to the interest rate derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFixedInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=iart_CrossCurrencyInterestRateContractOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=iart_CrossCurrencyInterestRateContractOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PositionAxis=us-gaap_LongMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PositionAxis=us-gaap_LongMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PositionAxis=us-gaap_ShortMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PositionAxis=us-gaap_ShortMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=iart_CrossCurrencyInterestRateContractTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=iart_CrossCurrencyInterestRateContractTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=iart_CrossCurrencyInterestRateContractThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=iart_CrossCurrencyInterestRateContractThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140709348116512">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>DERIVATIVE INSTRUMENTS - Fair Value of Derivative Instruments By Balance Sheet Location (Details)<br> SFr in Millions</strong></div></th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 21, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 21, 2020 </div>
<div>CHF (SFr)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Total derivatives designated as hedges &#8212; Assets</a></td>
<td class="nump">$ 62,541,000<span></span>
</td>
<td class="nump">$ 76,173,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Total derivatives designated as hedges &#8212; Liabilities</a></td>
<td class="nump">33,766,000<span></span>
</td>
<td class="nump">32,874,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest rate swap | Cash Flow Hedges | Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Current notional amount</a></td>
<td class="nump">1,500,000,000<span></span>
</td>
<td class="nump">1,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest rate swap | Cash Flow Hedges | Designated as Hedging Instrument | Prepaid expenses and other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Total derivatives designated as hedges &#8212; Assets</a></td>
<td class="nump">15,659,000<span></span>
</td>
<td class="nump">16,682,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest rate swap | Cash Flow Hedges | Designated as Hedging Instrument | Other assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Total derivatives designated as hedges &#8212; Assets</a></td>
<td class="nump">28,861,000<span></span>
</td>
<td class="nump">40,030,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest rate swap | Cash Flow Hedges | Designated as Hedging Instrument | Accrued expenses and other current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Total derivatives designated as hedges &#8212; Liabilities</a></td>
<td class="nump">762,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest rate swap | Cash Flow Hedges | Designated as Hedging Instrument | Other liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Total derivatives designated as hedges &#8212; Liabilities</a></td>
<td class="nump">1,080,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember', window );">Cross-currency swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Current notional amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 471,600,000<span></span>
</td>
<td class="nump">SFr 420.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember', window );">Cross-currency swap | Cash Flow Hedges | Designated as Hedging Instrument | Prepaid expenses and other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Total derivatives designated as hedges &#8212; Assets</a></td>
<td class="nump">4,139,000<span></span>
</td>
<td class="nump">4,497,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember', window );">Cross-currency swap | Cash Flow Hedges | Designated as Hedging Instrument | Other assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Total derivatives designated as hedges &#8212; Assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember', window );">Cross-currency swap | Cash Flow Hedges | Designated as Hedging Instrument | Accrued expenses and other current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Total derivatives designated as hedges &#8212; Liabilities</a></td>
<td class="nump">4,011,000<span></span>
</td>
<td class="nump">3,528,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember', window );">Cross-currency swap | Cash Flow Hedges | Designated as Hedging Instrument | Other liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Total derivatives designated as hedges &#8212; Liabilities</a></td>
<td class="nump">7,172,000<span></span>
</td>
<td class="nump">8,738,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember', window );">Cross-currency swap | Net Investment Hedges | Designated as Hedging Instrument | Prepaid expenses and other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Total derivatives designated as hedges &#8212; Assets</a></td>
<td class="nump">10,942,000<span></span>
</td>
<td class="nump">11,653,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember', window );">Cross-currency swap | Net Investment Hedges | Designated as Hedging Instrument | Other assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Total derivatives designated as hedges &#8212; Assets</a></td>
<td class="nump">2,940,000<span></span>
</td>
<td class="nump">3,311,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember', window );">Cross-currency swap | Net Investment Hedges | Designated as Hedging Instrument | Accrued expenses and other current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Total derivatives designated as hedges &#8212; Liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember', window );">Cross-currency swap | Net Investment Hedges | Designated as Hedging Instrument | Other liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Total derivatives designated as hedges &#8212; Liabilities</a></td>
<td class="nump">20,672,000<span></span>
</td>
<td class="nump">20,608,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Foreign currency forward contracts | Cash Flow Hedges | Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Current notional amount</a></td>
<td class="nump">10,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Foreign currency forward contracts | Cash Flow Hedges | Designated as Hedging Instrument | Accrued expenses and other current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Total derivatives designated as hedges &#8212; Liabilities</a></td>
<td class="nump">$ 69,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesFairValueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesFairValueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=iart_AccruedExpensesAndOtherCurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=iart_AccruedExpensesAndOtherCurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140709346909184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DERIVATIVE INSTRUMENTS - Effect of Derivative Instruments Designated Cash Flow Hedges on Statements of Operations (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Derivative Instruments, Gain (Loss) [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, beginning of period</a></td>
<td class="nump">$ 1,804,403<span></span>
</td>
<td class="nump">$ 1,684,804<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, end of period</a></td>
<td class="nump">1,674,938<span></span>
</td>
<td class="nump">1,615,197<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember', window );">Accumulated Other Comprehensive Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Derivative Instruments, Gain (Loss) [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, beginning of period</a></td>
<td class="nump">10,265<span></span>
</td>
<td class="num">(45,155)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, end of period</a></td>
<td class="nump">7,067<span></span>
</td>
<td class="num">(21,025)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember', window );">Cross-currency swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Derivative Instruments, Gain (Loss) [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Amount&#160;of Gain (Loss) Recognized&#160;in AOCL</a></td>
<td class="nump">7,500<span></span>
</td>
<td class="nump">7,900<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Derivative Instruments, Gain (Loss) [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Amount&#160;of Gain (Loss) Recognized&#160;in AOCL</a></td>
<td class="num">(7,462)<span></span>
</td>
<td class="nump">43,300<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Amount&#160;of&#160;Gain (Loss) Reclassified from AOCL into Earnings</a></td>
<td class="nump">2,092<span></span>
</td>
<td class="nump">4,438<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Accumulated Other Comprehensive Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Derivative Instruments, Gain (Loss) [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, beginning of period</a></td>
<td class="nump">29,527<span></span>
</td>
<td class="num">(55,956)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, end of period</a></td>
<td class="nump">19,973<span></span>
</td>
<td class="num">(17,094)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Interest rate swap | Cash Flow Hedges | Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Derivative Instruments, Gain (Loss) [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, beginning of period</a></td>
<td class="nump">56,712<span></span>
</td>
<td class="num">(43,956)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Amount&#160;of Gain (Loss) Recognized&#160;in AOCL</a></td>
<td class="num">(10,534)<span></span>
</td>
<td class="nump">41,675<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Amount&#160;of&#160;Gain (Loss) Reclassified from AOCL into Earnings</a></td>
<td class="nump">3,500<span></span>
</td>
<td class="num">(5,213)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, end of period</a></td>
<td class="nump">42,678<span></span>
</td>
<td class="nump">2,932<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Cross-currency swap | Cash Flow Hedges | Other income, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Derivative Instruments, Gain (Loss) [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, beginning of period</a></td>
<td class="num">(20,271)<span></span>
</td>
<td class="num">(9,688)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Amount&#160;of Gain (Loss) Recognized&#160;in AOCL</a></td>
<td class="nump">2,191<span></span>
</td>
<td class="nump">316<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Amount&#160;of&#160;Gain (Loss) Reclassified from AOCL into Earnings</a></td>
<td class="num">(3,504)<span></span>
</td>
<td class="nump">8,331<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, end of period</a></td>
<td class="num">(14,576)<span></span>
</td>
<td class="num">(17,703)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Cross-currency swap | Net Investment Hedges | Interest income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Derivative Instruments, Gain (Loss) [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, beginning of period</a></td>
<td class="num">(6,914)<span></span>
</td>
<td class="num">(2,312)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Amount&#160;of Gain (Loss) Recognized&#160;in AOCL</a></td>
<td class="nump">950<span></span>
</td>
<td class="nump">1,309<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Amount&#160;of&#160;Gain (Loss) Reclassified from AOCL into Earnings</a></td>
<td class="nump">2,096<span></span>
</td>
<td class="nump">1,320<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, end of period</a></td>
<td class="num">(8,060)<span></span>
</td>
<td class="num">$ (2,323)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Foreign currency forward contracts | Cash Flow Hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Derivative Instruments, Gain (Loss) [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Amount&#160;of Gain (Loss) Recognized&#160;in AOCL</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Foreign currency forward contracts | Cash Flow Hedges | Other income, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Derivative Instruments, Gain (Loss) [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Amount&#160;of Gain (Loss) Recognized&#160;in AOCL</a></td>
<td class="num">(69)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Foreign currency forward contracts | Cash Flow Hedges | Cost of Sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Derivative Instruments, Gain (Loss) [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, beginning of period</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Amount&#160;of&#160;Gain (Loss) Reclassified from AOCL into Earnings</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, end of period</a></td>
<td class="num">$ (69)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AOCIAttributableToParentNetOfTaxRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=121577181&amp;loc=SL110061190-113977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_InterestIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_InterestIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140709347193632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DERIVATIVE INSTRUMENTS - Schedule of Derivatives Not Designated as Hedging Instruments (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet', window );">Derivative instruments not designated as hedging instruments, gain (loss), net</a></td>
<td class="nump">$ 55<span></span>
</td>
<td class="nump">$ 360<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember', window );">Foreign currency swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet', window );">Derivative instruments not designated as hedging instruments, gain (loss), net</a></td>
<td class="nump">$ 55<span></span>
</td>
<td class="nump">$ 360<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized and unrealized gain (loss) of derivative instruments not designated or qualifying as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CC<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL109998890-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140709346987984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION - Narrative (Details)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Grants in period, net of forfeitures (in shares) | shares</a></td>
<td class="nump">151,293<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Options, weighted average grant date fair value (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 21.58<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Total unrecognized compensation costs | $</a></td>
<td class="nump">$ 5.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted-average period for cost recognition</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options | Directors</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Stock options exercisable, vesting period</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options | Employees</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Expiration period</a></td>
<td class="text">8 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Stock options exercisable, vesting period</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Total unrecognized compensation costs | $</a></td>
<td class="nump">$ 48.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted-average period for cost recognition</a></td>
<td class="text">2 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Awards granted during the period (in shares) | shares</a></td>
<td class="nump">346,745<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Other than options, weighted average grant date fair value (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 53.37<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=iart_PerformanceStockAndRestrictedStockAwardsMember', window );">Performance Stock and Restricted Stock Awards</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1', window );">Requisite service periods of awards</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Stock</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Awards granted during the period (in shares) | shares</a></td>
<td class="nump">161,218<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Other than options, weighted average grant date fair value (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 52.87<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Stock Options | Directors and Certain Executive Officers</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Expiration period</a></td>
<td class="text">6 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Stock options exercisable, vesting period</a></td>
<td class="text">4 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Stock Options | Directors and Certain Executive Officers</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Expiration period</a></td>
<td class="text">10 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Estimated period over which an employee is required to provide service in exchange for the equity-based payment award, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_DirectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_DirectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=iart_EmployeeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=iart_EmployeeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=iart_PerformanceStockAndRestrictedStockAwardsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=iart_PerformanceStockAndRestrictedStockAwardsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=iart_DirectorsandCertainExecutiveOfficersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=iart_DirectorsandCertainExecutiveOfficersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140709348343280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RETIREMENT PLANS - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Net periodic benefit costs</a></td>
<td class="nump">$ 0.3<span></span>
</td>
<td class="nump">$ 0.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost component</a></td>
<td class="nump">0.5<span></span>
</td>
<td class="nump">$ 0.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Estimated fair value of plan assets</a></td>
<td class="nump">$ 36.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 38.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage', window );">Defer payment and taxation, base salary, percentage (up to)</a></td>
<td class="nump">75.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage', window );">Defer payment and taxation, bonus and other eligible cash compensation, percentage (up to)</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCompensationPlanAssets', window );">Deferred compensation plan, fair value of assets</a></td>
<td class="nump">$ 5.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Defer Payment And Taxation, Base Salary, Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Defer Payment And Taxation, Bonus And Other Compensation, Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of assets held under deferred compensation agreements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFairValueOfPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of net periodic benefit cost (credit) for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanServiceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanServiceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140709348056672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES AND RELATED PARTY LEASES - Narrative (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($) </div>
<div>renewal_option</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_LesseeOperatingLeaseNumberOfRenewalOptions', window );">Number of renewal options (or more) | renewal_option</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Operating lease expense</a></td>
<td class="nump">$ 6.0<span></span>
</td>
<td class="nump">$ 4.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember', window );">Affiliated Entity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Operating lease expense</a></td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_PercentOfManufacturingFacilityOwnedByCorporationWhoseShareholdersAreTrustsWhoseBeneficiariesIncludeFamilyMembersOfCompanysFormerDirector', window );">Percent of manufacturing facility owned by corporation whose shareholders are trusts whose beneficiaries include family members of company's former director</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_AnnualRateOfLeaseAgreement', window );">Annual rate of lease agreement</a></td>
<td class="nump">$ 0.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember', window );">Affiliated Entity | Five Year Option Lease From November 1, 2029 Through October 31, 2034</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Option to extend lease, years</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseOptionToExtend', window );">Period for extended lease</a></td>
<td class="text">November 1, 2029 through October 31, 2034<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember', window );">Affiliated Entity | Five Year Option Lease From November 1, 2034 Through October 31, 2039</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Option to extend lease, years</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseOptionToExtend', window );">Period for extended lease</a></td>
<td class="text">November 1, 2034 through October 31, 2039<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_AnnualRateOfLeaseAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Annual rate of lease agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_AnnualRateOfLeaseAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_LesseeOperatingLeaseNumberOfRenewalOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Number Of Renewal Options</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_LesseeOperatingLeaseNumberOfRenewalOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_PercentOfManufacturingFacilityOwnedByCorporationWhoseShareholdersAreTrustsWhoseBeneficiariesIncludeFamilyMembersOfCompanysFormerDirector">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percent Of Manufacturing Facility Owned By Corporation Whose Shareholders Are Trusts, Whose Beneficiaries Include Family Members Of Company's Former Director</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_PercentOfManufacturingFacilityOwnedByCorporationWhoseShareholdersAreTrustsWhoseBeneficiariesIncludeFamilyMembersOfCompanysFormerDirector</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseOptionToExtend">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of terms and conditions of option to extend lessee's operating lease. Includes, but is not limited to, information about option recognized as part of right-of-use asset and lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseOptionToExtend</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRenewalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRenewalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease expense. Excludes sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasedAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasedAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseContractualTermAxis=iart_FiveYearOptionLeasePeriodOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseContractualTermAxis=iart_FiveYearOptionLeasePeriodOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseContractualTermAxis=iart_FiveYearOptionLeasePeriodTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseContractualTermAxis=iart_FiveYearOptionLeasePeriodTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140709445668880">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>LEASES AND RELATED PARTY LEASES - Supplemental Balance Sheet Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">ROU assets</a></td>
<td class="nump">$ 146,514<span></span>
</td>
<td class="nump">$ 148,284<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current lease liabilities</a></td>
<td class="nump">14,792<span></span>
</td>
<td class="nump">14,624<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Non-current lease liabilities</a></td>
<td class="nump">156,910<span></span>
</td>
<td class="nump">157,420<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total lease liabilities</a></td>
<td class="nump">$ 171,702<span></span>
</td>
<td class="nump">$ 172,044<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember', window );">Leased facilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted average remaining lease term (in years)</a></td>
<td class="text">17 years 1 month 6 days<span></span>
</td>
<td class="text">16 years 10 months 24 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted average discount rate</a></td>
<td class="nump">5.40%<span></span>
</td>
<td class="nump">5.40%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember', window );">Leased vehicles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted average remaining lease term (in years)</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">2 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted average discount rate</a></td>
<td class="nump">2.80%<span></span>
</td>
<td class="nump">2.70%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140709353119856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES AND RELATED PARTY LEASES - Supplemental Cash Flow Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_CashFlowLesseeAbstract', window );"><strong>Cash paid for amounts included in the measurement of lease liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating cash flows from operating leases</a></td>
<td class="nump">$ 4,319<span></span>
</td>
<td class="nump">$ 4,696<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract', window );"><strong>ROU assets obtained in exchange for lease liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Operating leases</a></td>
<td class="nump">$ 1,721<span></span>
</td>
<td class="nump">$ 507<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_CashFlowLesseeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash Flow, Lessee [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_CashFlowLesseeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Right Of Use Asset Obtained In Exchange For Lease Liability [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140709347812048">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>LEASES AND RELATED PARTY LEASES - Future Minimum Lease Payment Under Operating Leases (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear', window );">Remainder of 2023</a></td>
<td class="nump">$ 16,092<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2024</a></td>
<td class="nump">21,382<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2025</a></td>
<td class="nump">20,049<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2026</a></td>
<td class="nump">17,444<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2027</a></td>
<td class="nump">16,501<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2028</a></td>
<td class="nump">14,247<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">151,452<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total minimum lease payments</a></td>
<td class="nump">257,167<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: Imputed interest</a></td>
<td class="nump">85,465<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total lease liabilities</a></td>
<td class="nump">171,702<span></span>
</td>
<td class="nump">$ 172,044<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Less: Current lease liabilities</a></td>
<td class="nump">14,792<span></span>
</td>
<td class="nump">14,624<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term lease liabilities</a></td>
<td class="nump">156,910<span></span>
</td>
<td class="nump">$ 157,420<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=iart_RelatedPartiesMember', window );">Related Parties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear', window );">Remainder of 2023</a></td>
<td class="nump">222<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2024</a></td>
<td class="nump">296<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2025</a></td>
<td class="nump">296<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2026</a></td>
<td class="nump">296<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2027</a></td>
<td class="nump">296<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2028</a></td>
<td class="nump">296<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">246<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total minimum lease payments</a></td>
<td class="nump">1,948<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=iart_ThirdPartiesMember', window );">Third Parties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear', window );">Remainder of 2023</a></td>
<td class="nump">15,870<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2024</a></td>
<td class="nump">21,086<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2025</a></td>
<td class="nump">19,753<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2026</a></td>
<td class="nump">17,148<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2027</a></td>
<td class="nump">16,205<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2028</a></td>
<td class="nump">13,951<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">151,206<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total minimum lease payments</a></td>
<td class="nump">$ 255,219<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasedAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasedAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=iart_RelatedPartiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=iart_RelatedPartiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=iart_ThirdPartiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=iart_ThirdPartiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140709349342752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>TREASURY STOCK - Narrative (Details) - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Jan. 26, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Jan. 12, 2022</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 24, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock (in shares)</a></td>
<td class="nump">8,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonValue', window );">Treasury stock</a></td>
<td class="nump">$ 481,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 362,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 481,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare', window );">Treasury stock, average cost per share (in dollars per share)</a></td>
<td class="nump">$ 54.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 53.18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt', window );">Accelerated share repurchase program, receipt (payment)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 125,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_AcceleratedShareRepurchasesSharesReceivedAtInception', window );">Accelerated share repurchases, shares received at inception</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,480<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_AcceleratedShareRepurchasesPercentageOfExpectedTotalRepurchased', window );">Accelerated share repurchases, percentage of expected total repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_ExciseTaxPayableOnShareRepurchases', window );">Share repurchases, accrued excise tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_AcceleratedShareRepurchasesAdditionalSharesReceived', window );">Accelerated share repurchases, additional shares received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">460<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_AcceleratedShareRepurchasesAdditionalSharesReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accelerated Share Repurchases, Additional Shares Received</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_AcceleratedShareRepurchasesAdditionalSharesReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_AcceleratedShareRepurchasesPercentageOfExpectedTotalRepurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accelerated Share Repurchases, Percentage Of Expected Total Repurchased</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_AcceleratedShareRepurchasesPercentageOfExpectedTotalRepurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_AcceleratedShareRepurchasesSharesReceivedAtInception">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accelerated Share Repurchases, Shares Received at Inception</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_AcceleratedShareRepurchasesSharesReceivedAtInception</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_ExciseTaxPayableOnShareRepurchases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Excise Tax Payable On Share Repurchases</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_ExciseTaxPayableOnShareRepurchases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash receipt from (payment to) bank; or stock received from (issuance to) bank in the settlement of the accelerated share repurchase agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 25<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=6405686&amp;loc=d3e22802-112653<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total cost of shares repurchased divided by the total number of shares repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockAcquiredAverageCostPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount allocated to previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.30)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140709353399664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES - Summary of Effective Tax Rate (Details)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Reported tax rate</a></td>
<td class="nump">18.60%<span></span>
</td>
<td class="nump">16.30%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140709355016224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective income tax rate</a></td>
<td class="nump">18.60%<span></span>
</td>
<td class="nump">16.30%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140709347201792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NET INCOME PER SHARE - Basic and Diluted Net Income Per Share (Details) - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAbstract', window );"><strong>Basic net income per share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 24,226<span></span>
</td>
<td class="nump">$ 32,901<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average common shares outstanding - Basic (in shares)</a></td>
<td class="nump">81,871<span></span>
</td>
<td class="nump">83,632<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net income per common share (in dollars per share)</a></td>
<td class="nump">$ 0.30<span></span>
</td>
<td class="nump">$ 0.39<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedAbstract', window );"><strong>Diluted net income per share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 24,226<span></span>
</td>
<td class="nump">$ 32,901<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average common shares outstanding - Basic (in shares)</a></td>
<td class="nump">81,871<span></span>
</td>
<td class="nump">83,632<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DilutiveSecuritiesAbstract', window );"><strong>Effect of dilutive securities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Stock options and restricted stock (in shares)</a></td>
<td class="nump">452<span></span>
</td>
<td class="nump">644<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average common shares for diluted earnings per share (in shares)</a></td>
<td class="nump">82,323<span></span>
</td>
<td class="nump">84,276<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net income per common share (in dollars per share)</a></td>
<td class="nump">$ 0.29<span></span>
</td>
<td class="nump">$ 0.39<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DilutiveSecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DilutiveSecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126962052&amp;loc=d3e4991-113900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1707-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1500-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1757-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140709353216864">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>NET INCOME PER SHARE - Narrative (Details) - shares<br> shares in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Shares excluded from computation as their effect would be antidilutive (in shares)</a></td>
<td class="nump">0.3<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140709350504656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) - Schedule of Comprehensive Income (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 24,226<span></span>
</td>
<td class="nump">$ 32,901<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign currency translation adjustment</a></td>
<td class="nump">4,076<span></span>
</td>
<td class="num">(5,683)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent', window );">Change in unrealized loss/(gain) on derivatives, net of tax</a></td>
<td class="num">(7,377)<span></span>
</td>
<td class="nump">29,822<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent', window );">Pension liability adjustment, net of tax</a></td>
<td class="nump">103<span></span>
</td>
<td class="num">(9)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income, net</a></td>
<td class="nump">$ 21,028<span></span>
</td>
<td class="nump">$ 57,031<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan, attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140709347824976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) - Schedule of Changes in Accumulated Other Comprehensive Income by Component (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, beginning of period</a></td>
<td class="nump">$ 1,804,403<span></span>
</td>
<td class="nump">$ 1,684,804<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent', window );">Other comprehensive gain (loss)</a></td>
<td class="num">(1,575)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent', window );">Less: Amounts reclassified from accumulated other comprehensive income, net</a></td>
<td class="nump">1,623<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Net current-period other comprehensive gain (loss)</a></td>
<td class="num">(3,198)<span></span>
</td>
<td class="nump">24,130<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, end of period</a></td>
<td class="nump">1,674,938<span></span>
</td>
<td class="nump">1,615,197<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, beginning of period</a></td>
<td class="nump">10,265<span></span>
</td>
<td class="num">(45,155)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Net current-period other comprehensive gain (loss)</a></td>
<td class="num">(3,198)<span></span>
</td>
<td class="nump">24,130<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, end of period</a></td>
<td class="nump">7,067<span></span>
</td>
<td class="num">$ (21,025)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember', window );">Gains and Losses on Derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, beginning of period</a></td>
<td class="nump">22,817<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent', window );">Other comprehensive gain (loss)</a></td>
<td class="num">(5,754)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent', window );">Less: Amounts reclassified from accumulated other comprehensive income, net</a></td>
<td class="nump">1,623<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Net current-period other comprehensive gain (loss)</a></td>
<td class="num">(7,377)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, end of period</a></td>
<td class="nump">15,440<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember', window );">Defined Benefit Pension Items</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, beginning of period</a></td>
<td class="nump">9,322<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent', window );">Other comprehensive gain (loss)</a></td>
<td class="nump">103<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent', window );">Less: Amounts reclassified from accumulated other comprehensive income, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Net current-period other comprehensive gain (loss)</a></td>
<td class="nump">103<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, end of period</a></td>
<td class="nump">9,425<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember', window );">Foreign Currency Items</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, beginning of period</a></td>
<td class="num">(21,874)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent', window );">Other comprehensive gain (loss)</a></td>
<td class="nump">4,076<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent', window );">Less: Amounts reclassified from accumulated other comprehensive income, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Net current-period other comprehensive gain (loss)</a></td>
<td class="nump">4,076<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, end of period</a></td>
<td class="num">$ (17,798)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AOCIAttributableToParentNetOfTaxRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments, of other comprehensive income (loss), attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss) attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140709343693504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) - Narrative (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent', window );">Gain (loss) reclassified from AOCI</a></td>
<td class="nump">$ 1,623<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember', window );">Gains and Losses on Derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent', window );">Gain (loss) reclassified from AOCI</a></td>
<td class="nump">1,623<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherExpenseMember', window );">Other income (expense) | Gains and Losses on Derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent', window );">Gain (loss) reclassified from AOCI</a></td>
<td class="nump">4,300<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_InterestIncomeMember', window );">Interest income | Gains and Losses on Derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent', window );">Gain (loss) reclassified from AOCI</a></td>
<td class="num">$ (2,700)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss) attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OtherExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_InterestIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_InterestIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140709350638320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT AND GEOGRAPHIC INFORMATION - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2023 </div>
<div>Segment </div>
<div>product</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | Segment</a></td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=iart_CodmanSpecialtySurgicalMember', window );">Codman Specialty Surgical</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_SegmentReportingInformationNumberOfProductsOffered', window );">Number of products offered (more than) | product</a></td>
<td class="nump">40,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_SegmentReportingInformationNumberOfProductsOffered">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of products sold by a segment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_SegmentReportingInformationNumberOfProductsOffered</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=iart_CodmanSpecialtySurgicalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=iart_CodmanSpecialtySurgicalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140709349367856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT AND GEOGRAPHIC INFORMATION - Net Sales and Profit by Reportable Segment (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract', window );"><strong>Segment Net Sales</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total Revenues</a></td>
<td class="nump">$ 380,846<span></span>
</td>
<td class="nump">$ 376,638<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationProfitLossAbstract', window );"><strong>Segment Profit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="nump">36,382<span></span>
</td>
<td class="nump">46,164<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization</a></td>
<td class="num">(3,108)<span></span>
</td>
<td class="num">(3,894)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationProfitLossAbstract', window );"><strong>Segment Profit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="nump">163,214<span></span>
</td>
<td class="nump">164,053<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationProfitLossAbstract', window );"><strong>Segment Profit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="num">(123,724)<span></span>
</td>
<td class="num">(113,995)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=iart_CodmanSpecialtySurgicalMember', window );">Codman Specialty Surgical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract', window );"><strong>Segment Net Sales</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total Revenues</a></td>
<td class="nump">248,136<span></span>
</td>
<td class="nump">247,308<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=iart_CodmanSpecialtySurgicalMember', window );">Codman Specialty Surgical | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationProfitLossAbstract', window );"><strong>Segment Profit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="nump">110,933<span></span>
</td>
<td class="nump">110,160<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=iart_TissueTechnologiesMember', window );">Tissue Technologies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract', window );"><strong>Segment Net Sales</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total Revenues</a></td>
<td class="nump">132,710<span></span>
</td>
<td class="nump">129,330<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=iart_TissueTechnologiesMember', window );">Tissue Technologies | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationProfitLossAbstract', window );"><strong>Segment Profit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="nump">$ 52,281<span></span>
</td>
<td class="nump">$ 53,893<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationProfitLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationProfitLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=iart_CodmanSpecialtySurgicalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=iart_CodmanSpecialtySurgicalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=iart_TissueTechnologiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=iart_TissueTechnologiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140709346876288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT AND GEOGRAPHIC INFORMATION - Total Revenue by Major Geographic Area (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total Revenues</a></td>
<td class="nump">$ 380,846<span></span>
</td>
<td class="nump">$ 376,638<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total Revenues</a></td>
<td class="nump">271,002<span></span>
</td>
<td class="nump">263,351<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_EuropeMember', window );">Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total Revenues</a></td>
<td class="nump">41,064<span></span>
</td>
<td class="nump">43,744<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_AsiaPacificMember', window );">Asia Pacific</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total Revenues</a></td>
<td class="nump">50,473<span></span>
</td>
<td class="nump">47,717<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=iart_RestOfWorldMember', window );">Rest of World</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total Revenues</a></td>
<td class="nump">$ 18,307<span></span>
</td>
<td class="nump">$ 21,826<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_EuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_EuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_AsiaPacificMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_AsiaPacificMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=iart_RestOfWorldMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=iart_RestOfWorldMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140709347382384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES - Fair Value Contingent Consideration, Balance Information (Details) - Contingent Consideration Liability - Fair Value, Inputs, Level 3 - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iart_ArkisBioSciencesInc.Member', window );">Arkis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance, End of Period</a></td>
<td class="nump">$ 16,200<span></span>
</td>
<td class="nump">$ 14,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iart_ArkisBioSciencesInc.Member', window );">Arkis | Other Current Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance, Beginning of Period</a></td>
<td class="nump">2,845<span></span>
</td>
<td class="nump">3,691<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent', window );">Transfers</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">59<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Change in fair value of contingent consideration liabilities</a></td>
<td class="nump">1,543<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance, End of Period</a></td>
<td class="nump">4,388<span></span>
</td>
<td class="nump">3,750<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iart_ArkisBioSciencesInc.Member', window );">Arkis | Other Long-term Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance, Beginning of Period</a></td>
<td class="nump">10,050<span></span>
</td>
<td class="nump">11,408<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent', window );">Transfers</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(59)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Change in fair value of contingent consideration liabilities</a></td>
<td class="nump">1,756<span></span>
</td>
<td class="num">(1,065)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance, End of Period</a></td>
<td class="nump">11,806<span></span>
</td>
<td class="nump">10,284<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iart_DermaSciencesMember', window );">Derma Sciences | Other Long-term Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance, Beginning of Period</a></td>
<td class="nump">230<span></span>
</td>
<td class="nump">230<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent', window );">Transfers</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Change in fair value of contingent consideration liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance, End of Period</a></td>
<td class="nump">230<span></span>
</td>
<td class="nump">230<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iart_ACellMember', window );">ACell | Other Current Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance, Beginning of Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent', window );">Transfers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,885<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Change in fair value of contingent consideration liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance, End of Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,885<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iart_ACellMember', window );">ACell | Other Long-term Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance, Beginning of Period</a></td>
<td class="nump">3,700<span></span>
</td>
<td class="nump">21,800<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent', window );">Transfers</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(4,885)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Change in fair value of contingent consideration liabilities</a></td>
<td class="num">(2,200)<span></span>
</td>
<td class="nump">300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance, End of Period</a></td>
<td class="nump">1,500<span></span>
</td>
<td class="nump">$ 17,215<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iart_SurgicalInnovationAssociatesIncMember', window );">Surgical Innovation Associates Inc | Other Current Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance, Beginning of Period</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent', window );">Transfers</a></td>
<td class="nump">12,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Change in fair value of contingent consideration liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance, End of Period</a></td>
<td class="nump">12,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iart_SurgicalInnovationAssociatesIncMember', window );">Surgical Innovation Associates Inc | Other Long-term Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance, Beginning of Period</a></td>
<td class="nump">57,607<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent', window );">Transfers</a></td>
<td class="num">(12,500)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Change in fair value of contingent consideration liabilities</a></td>
<td class="nump">3,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance, End of Period</a></td>
<td class="nump">$ 48,707<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers From Long-Term to Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=iart_ArkisBioSciencesInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=iart_ArkisBioSciencesInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=iart_ContingentConsiderationLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=iart_ContingentConsiderationLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=iart_DermaSciencesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=iart_DermaSciencesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=iart_ACellMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=iart_ACellMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=iart_SurgicalInnovationAssociatesIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=iart_SurgicalInnovationAssociatesIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140709348234992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($) </div>
<div>liability</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 20, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 29, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iart_ArkisBioSciencesInc.Member', window );">Arkis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration, estimated fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability', window );">Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,100,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iart_ArkisBioSciencesInc.Member', window );">Arkis | Fair Value, Inputs, Level 3 | Contingent Consideration Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Fair value</a></td>
<td class="nump">$ 16,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iart_ArkisBioSciencesInc.Member', window );">Arkis | Other Long-term Liabilities | Fair Value, Inputs, Level 3 | Contingent Consideration Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Fair value</a></td>
<td class="nump">11,806,000<span></span>
</td>
<td class="nump">$ 10,050,000<span></span>
</td>
<td class="nump">10,284,000<span></span>
</td>
<td class="nump">$ 11,408,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iart_ArkisBioSciencesInc.Member', window );">Arkis | Accrued expenses and other current liabilities | Fair Value, Inputs, Level 3 | Contingent Consideration Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Fair value</a></td>
<td class="nump">$ 4,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iart_ArkisBioSciencesInc.Member', window );">Arkis | Development Milestones</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration, estimated fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000,000.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iart_ArkisBioSciencesInc.Member', window );">Arkis | Commercial Sales Milestones</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration, estimated fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,500,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iart_DermaSciencesMember', window );">Derma Sciences</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iart_BusinessCombinationContingentConsiderationNumberOfLiabilities', window );">Number of contingent liabilities remaining | liability</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh', window );">Contingent consideration, maximum undiscounted payment amount</a></td>
<td class="nump">$ 3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iart_DermaSciencesMember', window );">Derma Sciences | Fair Value, Inputs, Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration, estimated fair value</a></td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iart_DermaSciencesMember', window );">Derma Sciences | Other Long-term Liabilities | Fair Value, Inputs, Level 3 | Contingent Consideration Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Fair value</a></td>
<td class="nump">230,000<span></span>
</td>
<td class="nump">$ 230,000<span></span>
</td>
<td class="nump">230,000<span></span>
</td>
<td class="nump">$ 230,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iart_DermaSciencesMember', window );">Derma Sciences | BioD Earnout Payments and Medihoney Earnout Payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities', window );">Payment for contingent consideration</a></td>
<td class="nump">33,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iart_ACellIncMember', window );">ACell, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration, estimated fair value</a></td>
<td class="nump">$ 1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability', window );">Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 23,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh', window );">Contingent consideration, maximum undiscounted payment amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent', window );">Contingent consideration, current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iart_BusinessCombinationContingentConsiderationNumberOfLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Contingent Consideration, Number Of Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iart_BusinessCombinationContingentConsiderationNumberOfLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iart_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126966325&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph b<br> -URI https://asc.fasb.org/extlink&amp;oid=126966325&amp;loc=d3e6819-128478<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liability arising from an inherited contingency (as defined) which has been recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability up to amount recognized at acquisition date, including, but not limited to, measurement period adjustment and less amount paid soon after acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=iart_ArkisBioSciencesInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=iart_ArkisBioSciencesInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=iart_ContingentConsiderationLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=iart_ContingentConsiderationLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=iart_AccruedExpensesAndOtherCurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=iart_AccruedExpensesAndOtherCurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=iart_MilestonePaymentOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=iart_MilestonePaymentOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=iart_MilestonePaymentTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=iart_MilestonePaymentTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=iart_DermaSciencesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=iart_DermaSciencesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=iart_BioDEarnoutPaymentsandMedihoneyEarnoutPaymentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=iart_BioDEarnoutPaymentsandMedihoneyEarnoutPaymentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=iart_ACellIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=iart_ACellIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>iart-20230331_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2022"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:iart="http://integralife.com/20230331"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2022"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="iart-20230331.xsd" xlink:type="simple"/>
    <context id="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i9d6e2966991d4fe6b8a46d9c30f8b61d_I20230425">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
        </entity>
        <period>
            <instant>2023-04-25</instant>
        </period>
    </context>
    <context id="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ica4b4c17b7db4efd96016f438f3fc36e_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i50dcc39eee364391aeb0073e75dcfb4f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i635d765ec67b4491a13addb3d7bc40cd_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i8b664c70cda046d684b591844ea4bde4_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i18a51afa82d740fbbdf6665bed1d8a09_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia60ef6361a9e4be48bde714624b18a33_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia54b6095ce1949b680fbf6e3777f0cd1_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie9da7c98e7334b2b98f63a2448e31bd5_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i5a86b99b663a4de7bdb689dab96e1f70_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i4b3ce7fe6f5d47549cce8165b587a1d0_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ia95f80b5f4b8491b8974cc31b9e4bcd7_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i0fb8907de52a4781af049b3a4064bcdf_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i8a149e1d463f4cca8d2969ce8c1e4a84_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="iaf1259e8da8a41d8874851f04fa9e5d6_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i3e47e80bbb2040c7a084e52b255b0d28_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ifd938a82772142df82f2a578295bcd9a_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ied07d9963f9d439fb1ad815102c390d4_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ia9645160354f47929ed32876cc704c86_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i5173bceb1ba843f5b9ba6fac4ca9b4ca_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i366dba347b9f46848ca7d06dec81acb5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6e56583327fe4abe82cb79ace79055aa_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia84198cc189e4e0f8778dab882b9d737_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5712711f454141d18540576f0d8ead64_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6cfa05b583da44ddab7edd770f9bd953_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ia48c06fa8e984f2682cf6945ce8d6a84_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i7887839e434d4a3eaa3b791ba3071cd7_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i12b2bd10a7124b6b8b76ec49059b3fda_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="iec34d4ae56714939a2ae0fcab654c01c_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i1be1849f53b94167a15b3f9045e8f051_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i73947427cc2b499ab016969c72081ee0_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="idb0fcc9c413d41d28bf9655bcf94a392_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i2313f3e834a34925a9399b4f10d82fd7_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i3e56c025683743ddb68924e934a1c045_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i2aee20b22d6c4af1adc9943efb3a200b_D20221206-20221206">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:SurgicalInnovationAssociatesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-06</startDate>
            <endDate>2022-12-06</endDate>
        </period>
    </context>
    <context id="ic77f745d6f9e48afadfcda799fcc3235_I20221206">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:SurgicalInnovationAssociatesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">iart:RevenueBasedPerformanceMilestonesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-06</instant>
        </period>
    </context>
    <context id="i4a4cd86df7eb418cb65f718c0f4e4dbd_I20221206">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:SurgicalInnovationAssociatesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">iart:FDAApprovalOfPremarketApprovalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-06</instant>
        </period>
    </context>
    <context id="i9562f5f76a11487db81f0d5c50e212ba_I20221206">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:SurgicalInnovationAssociatesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-06</instant>
        </period>
    </context>
    <context id="i5b74908fc42a482b9a714af70be67c23_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:SurgicalInnovationAssociatesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i945ecb5f56064998992427ac8c2997e7_I20220831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">iart:TraditionalWoundCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-08-31</instant>
        </period>
    </context>
    <context id="i04a8a39a1e704ddfa67a4702f8617631_D20220831-20220831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">iart:TraditionalWoundCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-08-31</startDate>
            <endDate>2022-08-31</endDate>
        </period>
    </context>
    <context id="i36c1f405b82c4668bb563f8b0467fa90_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">iart:TraditionalWoundCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i07f57ce44af74eeb8d954e3a7fb7f1bc_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">iart:TraditionalWoundCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i770b51dde44c4f0f852868d1b571cf9e_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2023-04-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i41cd523bdedf46cc95670faedd457b46_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">iart:NeurosurgeryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:CodmanSpecialtySurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ieb2f835f7aba47f8b013ef0af01dc9fa_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">iart:NeurosurgeryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:CodmanSpecialtySurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i1f536ce18eba4aa1b760c5c3107d3a2a_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">iart:InstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:CodmanSpecialtySurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ia5280886888b459382b2676a7723925f_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">iart:InstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:CodmanSpecialtySurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ifd59456ea9aa4f04b19628e881f264f6_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:CodmanSpecialtySurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i6524a64fd30c42eca0a31257f157eeec_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:CodmanSpecialtySurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i5b9610cb297e4cb9a4dacf782076fbbb_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">iart:RegenerativeSkinAndWoundMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:TissueTechnologiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="iac40b4f9e2254c7da7351d7d272012dd_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">iart:RegenerativeSkinAndWoundMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:TissueTechnologiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i90fa502ea15741368ebd39ece562c20f_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">iart:PrivateLabelMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:TissueTechnologiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i0fd180115b9642178d42038efe2b2776_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">iart:PrivateLabelMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:TissueTechnologiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ibcfddd0c2c684ea4acbf2b9ae4cd8527_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:TissueTechnologiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i842208849e5d47b588209f3a26f3a724_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:TissueTechnologiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ib712dcb2854f46f28657fb649d2220db_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:CodmanSpecialtySurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i542245b54ecf4d72b1024950a433c9af_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:TissueTechnologiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1841156103084935b575ef1c38b8e26c_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:SurgicalInnovationAssociatesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:CodmanSpecialtySurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ib0ddadf2f33d42e18b362897b2b47f30_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:SurgicalInnovationAssociatesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:TissueTechnologiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i9796a6882ba147419345a7d80b8e97d0_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:SurgicalInnovationAssociatesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="id96439be0e9c43bc9bdb59971d641299_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:CodmanSpecialtySurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ida3b360960f84ba791b9beca0ffbeacd_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:TissueTechnologiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i97cf8c18c01245a3b5878b1a70debb09_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:CompletedTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="id52aed2cbf2644509a8d761ee366e14e_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:CompletedTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i0c74c93593f04e0a8c727b1e6224e815_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i5dc82ac4ce464f4da5b9c83153642d32_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i42d7a82bf02941cfa73330ae1871acf1_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:TrademarksBrandNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i0660f35837f94b01a3733519c74443b0_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:TrademarksBrandNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ib6126f6a52e94c36bb96da081cbfd6a2_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i6b0ff551735c45b7bfe3c18fdbb4e9b2_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:SupplierRelationShipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i8efb348618694eb0b761b917a80af933_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:SupplierRelationShipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i15371427605f42a2a6b646f1911d4b0f_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:AllOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i300eb0465a16418db26404ea8b152196_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:AllOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ib10821a2be0a4a9cb44ee7405d2e3b3b_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:CompletedTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i5161e2ebe90148f3a9f6b6b4d290dbe4_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:CompletedTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9ec130bce102400abaa3a20544f9f36f_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="iaf15e0a25a2341c0b2b8d2b4ee0f2751_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i64d8a19482454a3586c748993f1474c6_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:TrademarksBrandNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i4d1a3397e8cd4decab44bcff39bb8345_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:TrademarksBrandNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i45871e5e03c54676a898558774ed322e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i79d3d15982c14927ab9ed833406b2dc2_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:SupplierRelationShipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i5182401e0e9b451db9f13c85d749b4b1_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:SupplierRelationShipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4bd0685df71b4334baf2049236ad65c1_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:AllOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i111c837e553e4c579da41292d97ec939_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">iart:AllOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i5f1abf32d8ec43f3a621a5448c21a7a1_I20230324">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:SeniorCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-24</instant>
        </period>
    </context>
    <context id="icd0dbd7f9cc3475488e71805c8369830_I20230324">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:TermLoanFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-24</instant>
        </period>
    </context>
    <context id="i0d1f785d88d94ee08e66c1b385dc0f1d_I20230324">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-24</instant>
        </period>
    </context>
    <context id="i2925166e860d464e857eec9b85318b66_I20230324">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:StandbyLettersOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-24</instant>
        </period>
    </context>
    <context id="i3a69c660cc994e3e89f928d370becf48_I20230324">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">iart:SwinglineLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-24</instant>
        </period>
    </context>
    <context id="i29c495bb726f416f92c438401600a765_I20230324">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:SeniorCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="iart:DebtCovenantPeriodAxis">iart:DebtCovenantPeriod1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-24</instant>
        </period>
    </context>
    <context id="i0a99dd10d5ee423cb63f788fb7285962_I20230324">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:SeniorCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="iart:DebtCovenantPeriodAxis">iart:DebtCovenantPeriod2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-24</instant>
        </period>
    </context>
    <context id="i7f83b1b30bad4b0abf661670d1135229_I20230324">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:SeniorCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="iart:DebtCovenantPeriodAxis">iart:DebtCovenantPeriod3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-24</instant>
        </period>
    </context>
    <context id="i14a19f77eafb4116aa1875402c21a6ac_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:SeniorCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i96878a4e0354445fa679e461e52e913e_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:SeniorCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i7d6d16e6e0d9418c82c2bdc6fe950a0b_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:SeniorCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i82965aae546f4e83a526730570a1e256_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:SeniorCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:FederalFundsEffectiveSwapRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i3f2fb631c5ee4c2fa49138cf5e6235e8_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:SeniorCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i75b239dc572a41de8d6401d6434fe2fa_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:SeniorCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i99b8d45450b94b73be890ff82ddfc718_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i3cf8dd5a6f664b3d8b55fc2f763a1d0e_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i0fc6705bbac14c0a8a85244af899d39c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3b6f2ca5a0ff4bcf9931d0f74490b27a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:TermLoanFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6ace526dcf2e4bd7b1d416abfd600915_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:TermLoanFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i113a67b9524a40fdb5f84333cb215b19_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:TermLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i33d9a2beed6845289ab811beceaf918e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:StandbyLettersOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:SeniorCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2fcddd5311424f18bf9d0ea34cf199ce_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:StandbyLettersOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:SeniorCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i4d85c23c3dd4486a8c0cad316eeb498d_I20200204">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:TwoThousandTwentyFiveSeniorConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-02-04</instant>
        </period>
    </context>
    <context id="i3027f2cbc7194fc49391e18cf6122617_D20200204-20200204">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:TwoThousandTwentyFiveSeniorConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-04</startDate>
            <endDate>2020-02-04</endDate>
        </period>
    </context>
    <context id="i296f2de4222e4edd96bf4c0e1aa8b562_I20201209">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:TwoThousandTwentyFiveSeniorConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-09</instant>
        </period>
    </context>
    <context id="i2a88a3ee579649698c7a806c20baf329_D20200204-20200204">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:TwoThousandTwentyFiveSeniorConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityEquityAxis">us-gaap:CallOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-04</startDate>
            <endDate>2020-02-04</endDate>
        </period>
    </context>
    <context id="i0028dc2843f2423f8f300edeb35aa725_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iart:TwoThousandTwentyFiveSeniorConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="if38b10df1e9e4c7bbece89c49285e3f3_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i660d9b3823f743b9bb93a4c91c601967_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember132017Tranche2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="if90a05dc42874d4c91a7b0d2cd282433_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember132017Tranche3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ic80e820d18594abbb087fa7ea6c97b34_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedOctober102018Tranche1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i242cbbb364f64c76abce2babdef87734_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedOctober102018Tranche2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i1df01832fdb04d5687ddfbc85bd04c29_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedOctober102018Tranche3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="id7f35814aec144359ed4a1f6aca5ff44_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember182018Tranche1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="if455fa2d39f24cf59e0ca350ce4174ae_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember182018Tranche2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i68d02b4ce6b442a39ee633b1a9c0c689_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember152020Tranche1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i4611de47ca424f2880fb6c66abf4c864_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember152020Tranche2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="id3e91944e1f34523a944e5c31a1dcfb8_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedMarch312023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i1b244a95ae9e496fa6a76dbb19e5a1ff_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ibaa12b7418534a0f9c95d84d9ad6b1bb_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i9f5aaca61a204337a8cdf280d2e2d8d1_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember132017Tranche2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i110563708a344d13b6ba6837a8ffdaff_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember132017Tranche3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib8d564f8afa4405eac0fdd8215345e13_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedOctober102018Tranche1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i453cd89c33ef48c7bdfc3ff3788502d2_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedOctober102018Tranche2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iefae8c9c545043389530b336eede02b7_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedOctober102018Tranche3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="idb9a8e940c7a42eb987c4c32a8bdb139_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember182018Tranche1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i107d35b94cbf4cafb70558b912de87a9_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember182018Tranche2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1063bf6f331744358ce9892d6b046199_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember152020Tranche1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i69349b63e94749f680a73aa85071a4f3_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:InterestRateSwapDesignatedDecember152020Tranche2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic0e31fe1684f414cbac936fef047cdc0_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8f1a2f6132444776b0b916c3ec4d150a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id6f12805ce8f48c2a0fbeec9e8c8a8dc_I20220926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:CodmanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-26</instant>
        </period>
    </context>
    <context id="if875fdad2a23408d9d0ed3e81db4e7ee_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:CodmanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i0d2cb496f6d34578a914d07e7359d877_I20201221">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-21</instant>
        </period>
    </context>
    <context id="i7e2dbfd7e64c4a058f61e6ddbb174ba2_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i64420e77a1cf469498e2ca2af1883f9f_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:CodmanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ia25949993bc54e31b057302d171fccae_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:CodmanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6e76d40129eb4fceb7e3cbae9e1a5025_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:CodmanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i12840888426f47f0bfab4c48ba3fa8c5_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:CodmanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4c73f19cfa39458dbce322781befa454_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:CodmanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="icfc6c257ec264f86b565dfd0902ba5f6_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:CodmanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3703f1657e1c4322924cfd69bfd51ed2_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:CodmanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="id9839714200e436fb715c8e97dc0b9e1_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:CodmanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4facc35f040e40778807e0ec5945fd96_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:CodmanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ia9d15227403d47bda86034e4464a9675_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:CodmanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia4d70da53f2e443b81f302d5bc88197c_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:CodmanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i69b25e2065b74ec9b2d6fc10d48a3919_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:CodmanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if68feb9648554b258a953ab0b3cf1b44_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:CodmanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i7aa8838f170544bca9b1f95ebe3e1329_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:CodmanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9d0c5e4a255d4bed9a9758f0390707d2_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i6cc6a5aaf59940698e0bc2bd4666b5dc_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="iebf426920d4e4859b85ce6e6e41cd500_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i17088e89ea1f43888ce939b60c045452_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="if1daaefdc2464e3cb18c32c6114de13b_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i8e00ac098d0d4a64b488a0c17ae543cc_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i71266e4583bc437f92273bca0ecbadeb_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="idd51fbcf77834a9e9093fdb6e8cc4af5_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i84d05810f465447c8eee056a6ea0a040_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i9044d98efacd431b815b8b6162aa3841_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id8fc9bc6fbc8473e98a29ae421b261cb_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i67cb9870e2ce452f89c2a1478634a794_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if26ad90eefe4415185190203179a9d0a_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i9ea815ac7be1481cbb1e19dc878ef6a2_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i91ef1532274e495ca14298a177ea1acc_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i36f4034c904b4615a9bc452fe0768b20_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i29d096aee8e64b748938c9c63aacf5f5_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i9118200971f14bd8b119346ba9f7bff3_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic7c538eff08b4fd6b79f7f5500bdfbfd_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i10a6a1852b544a5986e489c72e4c44c8_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i681f0e0ed1b448caa21fee3e2b8496bd_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i24c7d1057dba44f88ef1cbe078d56c52_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iart:CrossCurrencyInterestRateContractThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i58f139fbd41647c48c9057f1580cdac4_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i09796f9df77e48bca077728e4c8ae491_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0fed5dd652c740a78c23127d0779d0ba_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i5eff930bd16f443f9ec4ab5edde345f2_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i3e5ef68fc663402486e8a4e07e50b256_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i05dafd738acc468dba86e7bafd1510f0_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i57a5868b001f4d67935cf17c02a3c1ef_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i9a4696f581d04cb586ec819e32f565b4_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="icf74fb8aa39848049e1301eb02d39d82_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i99aa6d57dd04424181e96f7c91cc61ec_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9f5e216cf841484db3c4b4c6a4d7360a_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ida7dd09e252d4494a378fddc92937759_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i7f8fb64f3560438aa95a28deccc11b4c_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i5470f9ecb06a401e92323ccc20c80c85_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2be277f4f7ed4c18b787daf8a062f6c9_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ib322bd99c183409fae8ee9d54c859608_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i74d46a8f5e78435b89e68529ae10f606_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i9c9770e2724246d49b05399c4fbab21b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i5fcf3db2e33e4516bb7de79733b0c0d0_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ia1b37fecaa804375ad71d7e5bcdde933_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i71915794f65d4c91bc088e849a5fc799_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">iart:AccruedExpensesAndOtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i7620e47d0bf84bce859b3bad2a16f684_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">iart:AccruedExpensesAndOtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iaec22d28ecc94c71b2b12a038b76b4e4_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">iart:AccruedExpensesAndOtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i996b0ea6443441c4aaaf1bd24cc0bee4_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">iart:AccruedExpensesAndOtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic6da3ccfb9a34aabbeeb47220c6e49ff_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">iart:AccruedExpensesAndOtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ieeb15fbf63ab4f469961445718c86de4_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">iart:AccruedExpensesAndOtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0072310af3d241efafdaf988459146fa_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">iart:AccruedExpensesAndOtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i5aae5383e5894e1282dce76c96936d34_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">iart:AccruedExpensesAndOtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id498dc6dfe534a538bd4b76e7d332cb4_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i69e2392f36f44936a75ae231876a5027_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1b2593474fd840ba8291d49024330993_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i2c7c8157157e4ecd949d6ac6cb41b21c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2f574ae0feba45f79e1abe5b7ec3d086_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="icddae4bb16a64dea817870f7632c24e2_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i56846d631dbe49b18b07a654b7e1ce4d_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i2492f43b74614fcab458b7ed60d99fc2_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8ee9771bb95e427193ef400f91e7f20e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3e6c0e609ad149bdbbfc158b0e5fd68a_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ic4eb84f89dad4116bceeb45741f9a641_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ib3fe4a582ccd4061a97fd0b9da7c7f0d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i178b4152981345408498c8dfbee4cbc7_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i9d6a89764db9416587bce17f35871a44_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="if6fb80266a304dc5be9547704ed56286_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i92388a95dedc4a34a9f55ffd26aca363_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i810224786fad497790a97ede68b59f5f_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i2b3f564951d04d5e92ce288f73dcb9b4_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i560720c3abc24f638935549d00ddf679_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iaf1bbb7d552b43bc97be79bd949d01ce_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i545e60a320824ebca08bfa1384c3f0f0_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i3c8bc030a0e84d8884ff38380b57a524_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie8763013b51645d9b4f267faa1bc585c_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i6f53e0e076bd414e80ef7c0bf8a3584f_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="id2ee30afd022428e9770584749497e62_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id8ccc5370489410a8499e0a9e3753b87_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i2b2554dad56a4166a558274eed8d4fbb_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i579d645e131641bfa09602eb64db21f3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i63c6bd493f22494e9df49e5e6f48e027_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i4b8fe8c3c3e2433a8f7cd9487fff6fef_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="iae8885f4db32466ab5102315e110644a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i837380b9b55a43d9a21479305539ed99_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="iac14ca05a7c84129889affd66eddd064_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ib5284fa32e194b4887c09b3bd11c5196_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2c763dd699df40f7994d4bd081a81d5b_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i2ee28a1877fb49278defab1977e4dfed_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i64221cccd9784e23b84697c3a6cae83e_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i6b9673d1d44547fabe1719aef8ec54e2_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i7cae2dbfb6a5475491033e353f69120b_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i60372d5d4c714e66a7f44c71f2d47770_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="id118186cdcc643509f813c46ce8000ba_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="if7a8dd366e654da081146a5b25db1c1b_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i399d8f6d881640bb810eee6e1458f2ba_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">iart:EmployeeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ia54d728bf30d440cab41cf9be0182655_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">iart:DirectorsandCertainExecutiveOfficersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="if710322947774a689663db2f525eeb6b_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">iart:DirectorsandCertainExecutiveOfficersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i3bc994fc34b64d4cb7c684fd6244bac3_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i6c69b026d57d423eb79ebbdfa493c6b3_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ib4f03ffd86fa4e22af66c496e06ac9ec_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i4989d4c8ef004834bf2980d2722cccaf_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iart:PerformanceStockAndRestrictedStockAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i3046bc1317c642afb36b924feec16501_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i663c47912e30448682d1e675fc6bf6fd_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i0312bf3fc4c644b5a90beedc5b117be5_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ibb2818c35582446bb26bb336b6909032_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ief22d29946704881b53879628a3b3a03_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i77b6f580f27a43fa87d99324c7d3333c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i858dd34246b34029ba59dcfd73afff17_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="iac36470e6fcb4453b97db73bbce55586_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i81703db4530142f4a19d6c5342dd660a_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">iart:RelatedPartiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i96ad5df3ea584444876af27fc107fa44_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">iart:ThirdPartiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i01e32628066d40fc8d8037b63a6a88b0_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">iart:FiveYearOptionLeasePeriodOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="iccf8172c44f8418299899a406aff6ff5_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">iart:FiveYearOptionLeasePeriodOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="idb728fa94349423cada113737d6ec277_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">iart:FiveYearOptionLeasePeriodTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i6657623349984d07affcf737d966245b_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">iart:FiveYearOptionLeasePeriodTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i142beeb645c448e9b1d164dc7254fd2f_D20230331-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
        </entity>
        <period>
            <startDate>2023-03-31</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ia47e8fa146ee495e917d3a8854512649_D20221231-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
        </entity>
        <period>
            <startDate>2022-12-31</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i05fc75ff93f849f6b97ee88d5015c23a_I20230126">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
        </entity>
        <period>
            <instant>2023-01-26</instant>
        </period>
    </context>
    <context id="i6eb2c396ee604c4493e35d50b9e4ab46_D20230126-20230126">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
        </entity>
        <period>
            <startDate>2023-01-26</startDate>
            <endDate>2023-01-26</endDate>
        </period>
    </context>
    <context id="i4a535ba6db064ba5a22bf28443b5a825_I20220112">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
        </entity>
        <period>
            <instant>2022-01-12</instant>
        </period>
    </context>
    <context id="ic6638393ed5a47c19e1abcc6dca5d5d6_D20220112-20220112">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
        </entity>
        <period>
            <startDate>2022-01-12</startDate>
            <endDate>2022-01-12</endDate>
        </period>
    </context>
    <context id="i1e7a618c6acb4e27a31c0800c72f5336_I20220324">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
        </entity>
        <period>
            <instant>2022-03-24</instant>
        </period>
    </context>
    <context id="i646bea5fed00426299f8098e7755c18a_D20220331-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
        </entity>
        <period>
            <startDate>2022-03-31</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="id48bc317ce8e43efa6fa6cdb7b8520e9_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i290c54e5ab7c451886f952e89f0d495a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iec175f17c95341d18708296b15afd58d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if10648f7e149447883c792b44180c76c_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i24ac1f0514474ac28f44980dc2f162ce_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i9130414215c54f04be9fcc0ddd7ed89c_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i13b04fba956e41bc8127fdc101213375_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i805ec6ae450148b0aa6ec4a436b8b09e_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i6afed391e44e4f1f965479a68ca6dcb5_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="icf3a5e50a53a4b55a3ef05b821846b94_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="if45e5d60245d47f7835ea2adf65836fa_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i9189a78d31fb4c448c4078f016f511fb_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:CodmanSpecialtySurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i21203583e6274aefacecda4e30af7977_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:CodmanSpecialtySurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ibb29c4fb3257468aba668e88d86534f1_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:TissueTechnologiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i66b66534a77f456aaf743a7fb2ed1e05_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">iart:TissueTechnologiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ia720faaba52b43d2be21584d13ecec2a_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ib1c1895e254b42068cd689b2d2e0cb17_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="iecf751356922485386ff472a954f4b37_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="if9b97ade31164041b7058022a9eb48a9_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i8ec4e98c494d4152959a7ad4e62f2cdc_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i5c11bb731e264ce287a9ba4be5cf11c6_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i07f997c575a845b49f6c85d88adbf303_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ic7f5c4fd7cee463ca7ad0e86dbcbc6b6_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="id8b5c9cc0fb140aaa998a0d5849918a1_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i5f5d773def504f108c920a0391f44968_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="idceeee4c12c44c50b93f23c34fdf4267_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iart:RestOfWorldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="iaa37c54d794549a99aea38389a6d9606_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iart:RestOfWorldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ifcaf924eb8b044b5959cc99978a303a7_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8389bf8a7d824c2980154809fed6d74d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i87b4b1d7730e401b9ab2ced0eb01926f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:DermaSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib2ebabea23ce4ed1b68823b3506d6cee_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ACellMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i35632a429f994b4c93a6bf032cf1dab3_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:SurgicalInnovationAssociatesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i28c09119df4d46479f028692c5abc6c9_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:SurgicalInnovationAssociatesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iebe056bf287c49189659a150fa4bb005_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ie94f070e4ad14a71bbd6d5a287488485_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ic5212f8a1bee4dc6ba5f12945bceefac_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:DermaSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i5b996d3591a14f7b8ad05792e133d08b_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ACellMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i76cdb8918dd040ca80187c0cd9780d22_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:SurgicalInnovationAssociatesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i4a2f319447e54f4da01d7985e4319c02_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:SurgicalInnovationAssociatesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ibc5039e063bb4575a7f706baf7647a99_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i3a5ab664d800458296dd51aa0092a73a_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ifbf2b5d3f97042bdbb5011c85b4e62ff_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:DermaSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ifda9aebeb4fc4e828e24ac81907aa5d7_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ACellMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ic6f8fb897f9041c8ba230423d37c9561_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:SurgicalInnovationAssociatesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i04a72655453e4dc799f5272ab6e4c43f_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:SurgicalInnovationAssociatesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i03382ae93c3949428c4641c300c15cf5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i63bd28aa464048d382efdc354e8d30ef_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if1f1f28f2ace4bbebc59d26841e82a9c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:DermaSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id31fe52cb24f4c5d8a546c61e9306f16_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ACellMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ida5433fc38b34f3d80d99d0b3ae06943_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ACellMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7ad7e73cd2384933bcc0486859965b91_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i8d4ac64501714cd8b27e0d99a3bc50f1_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i744d6e80b2d2438caf54348f35691d3c_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:DermaSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i2dff9a5632b143f6bcc0a2d0430fc736_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ACellMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i57a65d2fe6b445379851b358047cd045_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ACellMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i57d1bb45844549318bf527ab1d455e38_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i26ba6bc78b3a4d95b2893e8f8c7ad8a8_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i843804a3b389484b948c99a44059b0c4_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:DermaSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="if2bb2185bf654d9fa8253aa6e70cdc7a_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ACellMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i4ac142c72a864f468e0436fe327c0980_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ACellMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i5d9c6f2f864e40aea1985e58d5f1a41e_I20190729">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-07-29</instant>
        </period>
    </context>
    <context id="ifbe9986f6bcd4de881c523419a2fb725_I20190729">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">iart:MilestonePaymentOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-07-29</instant>
        </period>
    </context>
    <context id="id780b85560324a2b8af98ff6056e8d1f_I20190729">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">iart:MilestonePaymentTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-07-29</instant>
        </period>
    </context>
    <context id="iaba62da9aab3440ab34c023a05b0b605_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i28c3ebc588a3437abfe6a86e8e38ae70_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ia93dbf54c16a4910aa3b24636e104e30_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">iart:AccruedExpensesAndOtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i03c41c6e3db74ceab9f18b88621af236_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">iart:AccruedExpensesAndOtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ArkisBioSciencesInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">iart:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i5b8b02acfe4a4006ba624b2aa4272aa9_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:DermaSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">iart:BioDEarnoutPaymentsandMedihoneyEarnoutPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i86b0bf361fcc48fcb96359b69ccfd113_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:DermaSciencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i1a0930d1120745c0909b0d6a10d930ff_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:DermaSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i51cb03d8a5ea47b9bf04b0cbd6cd4e2e_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:DermaSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="id9e1f135607c446e87244607e8e7fb74_I20210120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ACellIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-20</instant>
        </period>
    </context>
    <context id="i52c4ec9dcdbe44349b2eb5a85c04baae_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ACellIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ic09564d0848d46c79b0dbcb1d9f96df9_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iart:ACellIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="payment">
        <measure>iart:payment</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="chf">
        <measure>iso4217:CHF</measure>
    </unit>
    <unit id="eur">
        <measure>iso4217:EUR</measure>
    </unit>
    <unit id="renewal_option">
        <measure>iart:renewal_option</measure>
    </unit>
    <unit id="segment">
        <measure>iart:Segment</measure>
    </unit>
    <unit id="product">
        <measure>iart:product</measure>
    </unit>
    <unit id="liability">
        <measure>iart:liability</measure>
    </unit>
    <dei:AmendmentFlag
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80L2ZyYWc6YTBmMjczMWU4MzRhNGY0ODhiZmZhZDkzZmMxMmNiZTMvdGFibGU6MTUyODM2MmRjY2QyNDBkZGFkMjcxZTVhYWVjMTg4NmIvdGFibGVyYW5nZToxNTI4MzYyZGNjZDI0MGRkYWQyNzFlNWFhZWMxODg2Yl80LTEtMS0xLTE4NjgyMQ_1a7e1092-9252-4431-acb6-68b517c82d6c">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80L2ZyYWc6YTBmMjczMWU4MzRhNGY0ODhiZmZhZDkzZmMxMmNiZTMvdGFibGU6MTUyODM2MmRjY2QyNDBkZGFkMjcxZTVhYWVjMTg4NmIvdGFibGVyYW5nZToxNTI4MzYyZGNjZDI0MGRkYWQyNzFlNWFhZWMxODg2Yl82LTEtMS0xLTE4NjgyMQ_53f46d55-ff36-4b2a-8c4a-ed7414c27776">2023</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80L2ZyYWc6YTBmMjczMWU4MzRhNGY0ODhiZmZhZDkzZmMxMmNiZTMvdGFibGU6MTUyODM2MmRjY2QyNDBkZGFkMjcxZTVhYWVjMTg4NmIvdGFibGVyYW5nZToxNTI4MzYyZGNjZDI0MGRkYWQyNzFlNWFhZWMxODg2Yl83LTEtMS0xLTE4NjgyMQ_96a1325e-61fa-424b-9931-ac3267752316">Q1</dei:DocumentFiscalPeriodFocus>
    <dei:DocumentPeriodEndDate
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80L2ZyYWc6YTBmMjczMWU4MzRhNGY0ODhiZmZhZDkzZmMxMmNiZTMvdGFibGU6MTUyODM2MmRjY2QyNDBkZGFkMjcxZTVhYWVjMTg4NmIvdGFibGVyYW5nZToxNTI4MzYyZGNjZDI0MGRkYWQyNzFlNWFhZWMxODg2Yl8xMC0xLTEtMS0xOTU4Mjg_e0b7504c-1e2c-4902-bebc-ecfcde588b0e">2023-03-31</dei:DocumentPeriodEndDate>
    <dei:EntityCentralIndexKey
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80L2ZyYWc6YTBmMjczMWU4MzRhNGY0ODhiZmZhZDkzZmMxMmNiZTMvdGFibGU6MTUyODM2MmRjY2QyNDBkZGFkMjcxZTVhYWVjMTg4NmIvdGFibGVyYW5nZToxNTI4MzYyZGNjZDI0MGRkYWQyNzFlNWFhZWMxODg2Yl8xMC0xLTEtMS0xODY4MjE_438c6881-7b6f-47fb-bbfb-5d7d584ab757">0000917520</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80L2ZyYWc6YTBmMjczMWU4MzRhNGY0ODhiZmZhZDkzZmMxMmNiZTMvdGFibGU6MTUyODM2MmRjY2QyNDBkZGFkMjcxZTVhYWVjMTg4NmIvdGFibGVyYW5nZToxNTI4MzYyZGNjZDI0MGRkYWQyNzFlNWFhZWMxODg2Yl8xMS0xLTEtMS0xODY4MjE_53c81632-6145-471d-bfec-d0f2bac75980">--12-31</dei:CurrentFiscalYearEndDate>
    <us-gaap:DebtInstrumentConvertibleConversionRatio1
      contextRef="i3027f2cbc7194fc49391e18cf6122617_D20200204-20200204"
      decimals="7"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81NS9mcmFnOjk1N2M0MWY1YjhjMDRlZTc4NzNlOThlMWY2M2YzMDE1L3RleHRyZWdpb246OTU3YzQxZjViOGMwNGVlNzg3M2U5OGUxZjYzZjMwMTVfNA_f11d9e7d-0a4f-414b-a0fa-b0f65a60efd6"
      unitRef="number">0.0135739</us-gaap:DebtInstrumentConvertibleConversionRatio1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="ia54d728bf30d440cab41cf9be0182655_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82MS9mcmFnOmVjZjA3OTliODczNTQ2MjFhODNlMzFlYWUxZWEyOTMxL3RleHRyZWdpb246ZWNmMDc5OWI4NzM1NDYyMWE4M2UzMWVhZTFlYTI5MzFfNzIx_2efd93e6-4b81-4ecd-a888-8a73dfd19f51">P6Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <dei:DocumentType
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xL2ZyYWc6ZGUzM2JhODhmNTZjNGIxZDhjNzMzZTQyYWE2N2ZhZmEvdGV4dHJlZ2lvbjpkZTMzYmE4OGY1NmM0YjFkOGM3MzNlNDJhYTY3ZmFmYV8yMDc2_807614df-8d77-46c7-9824-cfa665276cc6">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xL2ZyYWc6ZGUzM2JhODhmNTZjNGIxZDhjNzMzZTQyYWE2N2ZhZmEvdGFibGU6NTEwZjUzMDUzN2U3NDdhYjkyNmIzMzdhZDAxOTUzODgvdGFibGVyYW5nZTo1MTBmNTMwNTM3ZTc0N2FiOTI2YjMzN2FkMDE5NTM4OF8wLTAtMS0xLTE4NjgyMQ_cb97ad3e-60b8-47a2-82d5-036f93835091">true</dei:DocumentQuarterlyReport>
    <dei:DocumentTransitionReport
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xL2ZyYWc6ZGUzM2JhODhmNTZjNGIxZDhjNzMzZTQyYWE2N2ZhZmEvdGFibGU6MGU5OWYzMTQ5MzAxNDMzZmI3NGQ0MWFkMGJhZDM2MzYvdGFibGVyYW5nZTowZTk5ZjMxNDkzMDE0MzNmYjc0ZDQxYWQwYmFkMzYzNl8wLTAtMS0xLTE4NjgyMQ_91f7c819-40b6-4112-953d-b2d26e359af0">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xL2ZyYWc6ZGUzM2JhODhmNTZjNGIxZDhjNzMzZTQyYWE2N2ZhZmEvdGV4dHJlZ2lvbjpkZTMzYmE4OGY1NmM0YjFkOGM3MzNlNDJhYTY3ZmFmYV8yMDcy_832d0ac9-471a-4972-9876-bca450966a68">000-26224</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xL2ZyYWc6ZGUzM2JhODhmNTZjNGIxZDhjNzMzZTQyYWE2N2ZhZmEvdGV4dHJlZ2lvbjpkZTMzYmE4OGY1NmM0YjFkOGM3MzNlNDJhYTY3ZmFmYV8yMDc3_0bdd231a-5f5e-4656-a16e-b3199a27009c">INTEGRA LIFESCIENCES HOLDINGS CORP</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xL2ZyYWc6ZGUzM2JhODhmNTZjNGIxZDhjNzMzZTQyYWE2N2ZhZmEvdGFibGU6ZGJkY2NkODliMDJjNGE4NmIyNjRmZTY1ZGQxODlmZjEvdGFibGVyYW5nZTpkYmRjY2Q4OWIwMmM0YTg2YjI2NGZlNjVkZDE4OWZmMV8wLTAtMS0xLTE4NjgyMQ_11c06cea-3647-460d-b18f-56fba00f0612">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xL2ZyYWc6ZGUzM2JhODhmNTZjNGIxZDhjNzMzZTQyYWE2N2ZhZmEvdGFibGU6ZGJkY2NkODliMDJjNGE4NmIyNjRmZTY1ZGQxODlmZjEvdGFibGVyYW5nZTpkYmRjY2Q4OWIwMmM0YTg2YjI2NGZlNjVkZDE4OWZmMV8wLTQtMS0xLTE4NjgyMQ_f1d0adeb-dd2a-4624-b8ec-c4af808aabda">51-0317849</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xL2ZyYWc6ZGUzM2JhODhmNTZjNGIxZDhjNzMzZTQyYWE2N2ZhZmEvdGFibGU6ZGJkY2NkODliMDJjNGE4NmIyNjRmZTY1ZGQxODlmZjEvdGFibGVyYW5nZTpkYmRjY2Q4OWIwMmM0YTg2YjI2NGZlNjVkZDE4OWZmMV8zLTAtMS0xLTE4NjgyMQ_dddb6037-fec3-40cb-a85a-9cb75b7f3f26">1100 Campus Road</dei:EntityAddressAddressLine1>
    <dei:EntityAddressPostalZipCode
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xL2ZyYWc6ZGUzM2JhODhmNTZjNGIxZDhjNzMzZTQyYWE2N2ZhZmEvdGFibGU6ZGJkY2NkODliMDJjNGE4NmIyNjRmZTY1ZGQxODlmZjEvdGFibGVyYW5nZTpkYmRjY2Q4OWIwMmM0YTg2YjI2NGZlNjVkZDE4OWZmMV8zLTQtMS0xLTE4NjgyMQ_876dde7a-b5ce-4fc0-9ee4-1f6d2ff95c71">08540</dei:EntityAddressPostalZipCode>
    <dei:EntityAddressCityOrTown
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xL2ZyYWc6ZGUzM2JhODhmNTZjNGIxZDhjNzMzZTQyYWE2N2ZhZmEvdGFibGU6ZGJkY2NkODliMDJjNGE4NmIyNjRmZTY1ZGQxODlmZjEvdGFibGVyYW5nZTpkYmRjY2Q4OWIwMmM0YTg2YjI2NGZlNjVkZDE4OWZmMV80LTAtMS0xLTE4NjgyMQ_980c49df-4fe4-448f-b63a-cd09c3803182">Princeton</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xL2ZyYWc6ZGUzM2JhODhmNTZjNGIxZDhjNzMzZTQyYWE2N2ZhZmEvdGFibGU6ZGJkY2NkODliMDJjNGE4NmIyNjRmZTY1ZGQxODlmZjEvdGFibGVyYW5nZTpkYmRjY2Q4OWIwMmM0YTg2YjI2NGZlNjVkZDE4OWZmMV80LTItMS0xLTE4NjgyMQ_a7707718-5960-4b97-9fe4-b86bf9f83885">NJ</dei:EntityAddressStateOrProvince>
    <dei:CityAreaCode
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xL2ZyYWc6ZGUzM2JhODhmNTZjNGIxZDhjNzMzZTQyYWE2N2ZhZmEvdGV4dHJlZ2lvbjpkZTMzYmE4OGY1NmM0YjFkOGM3MzNlNDJhYTY3ZmFmYV8yMDcz_092a637d-395b-488a-ad73-6c40216701ac">609</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xL2ZyYWc6ZGUzM2JhODhmNTZjNGIxZDhjNzMzZTQyYWE2N2ZhZmEvdGV4dHJlZ2lvbjpkZTMzYmE4OGY1NmM0YjFkOGM3MzNlNDJhYTY3ZmFmYV8yMDc0_200d59eb-4dac-4ac8-b54b-46b5112d6f9e">275-0500</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xL2ZyYWc6ZGUzM2JhODhmNTZjNGIxZDhjNzMzZTQyYWE2N2ZhZmEvdGFibGU6MGFlNTdhZWFmZGI3NDhkNmI0NGNmM2RjNDk4MjU0NmIvdGFibGVyYW5nZTowYWU1N2FlYWZkYjc0OGQ2YjQ0Y2YzZGM0OTgyNTQ2Yl8xLTAtMS0xLTE4NjgyMQ_4fbab122-b29c-4791-ab69-efa7634d627c">Common Stock, Par Value $.01 Per Share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xL2ZyYWc6ZGUzM2JhODhmNTZjNGIxZDhjNzMzZTQyYWE2N2ZhZmEvdGFibGU6MGFlNTdhZWFmZGI3NDhkNmI0NGNmM2RjNDk4MjU0NmIvdGFibGVyYW5nZTowYWU1N2FlYWZkYjc0OGQ2YjQ0Y2YzZGM0OTgyNTQ2Yl8xLTEtMS0xLTE4NjgyMQ_a7648b75-857c-4fc7-92ba-1e3c09226fee">IART</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xL2ZyYWc6ZGUzM2JhODhmNTZjNGIxZDhjNzMzZTQyYWE2N2ZhZmEvdGFibGU6MGFlNTdhZWFmZGI3NDhkNmI0NGNmM2RjNDk4MjU0NmIvdGFibGVyYW5nZTowYWU1N2FlYWZkYjc0OGQ2YjQ0Y2YzZGM0OTgyNTQ2Yl8xLTItMS0xLTE4NjgyMQ_62af41d0-3d35-4b1c-934f-47ac5e0822ad">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xL2ZyYWc6ZGUzM2JhODhmNTZjNGIxZDhjNzMzZTQyYWE2N2ZhZmEvdGV4dHJlZ2lvbjpkZTMzYmE4OGY1NmM0YjFkOGM3MzNlNDJhYTY3ZmFmYV8yMDc4_2eb50966-8d7c-4b70-8fea-b23b06ad5f04">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xL2ZyYWc6ZGUzM2JhODhmNTZjNGIxZDhjNzMzZTQyYWE2N2ZhZmEvdGV4dHJlZ2lvbjpkZTMzYmE4OGY1NmM0YjFkOGM3MzNlNDJhYTY3ZmFmYV8yMDcx_152e2554-6e8d-40d7-94d3-9a51551143ad">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xL2ZyYWc6ZGUzM2JhODhmNTZjNGIxZDhjNzMzZTQyYWE2N2ZhZmEvdGFibGU6ZWRjOWYwOWZjYWMzNGI5ZmI3ZjY3MjQxOTg5Mzk1NTEvdGFibGVyYW5nZTplZGM5ZjA5ZmNhYzM0YjlmYjdmNjcyNDE5ODkzOTU1MV8wLTAtMS0xLTE4NjgyMQ_0aeaa668-a549-40ff-bf6f-b7009f7622e3">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xL2ZyYWc6ZGUzM2JhODhmNTZjNGIxZDhjNzMzZTQyYWE2N2ZhZmEvdGFibGU6ZWRjOWYwOWZjYWMzNGI5ZmI3ZjY3MjQxOTg5Mzk1NTEvdGFibGVyYW5nZTplZGM5ZjA5ZmNhYzM0YjlmYjdmNjcyNDE5ODkzOTU1MV8yLTMtMS0xLTE4NjgyMQ_063c1788-d0ad-41a9-bfea-442ccf8ff0bd">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xL2ZyYWc6ZGUzM2JhODhmNTZjNGIxZDhjNzMzZTQyYWE2N2ZhZmEvdGFibGU6ZWRjOWYwOWZjYWMzNGI5ZmI3ZjY3MjQxOTg5Mzk1NTEvdGFibGVyYW5nZTplZGM5ZjA5ZmNhYzM0YjlmYjdmNjcyNDE5ODkzOTU1MV80LTEtMS0xLTE4NjgyMQ_117e69cc-d9fc-450f-ab1f-93115ba7f9a2">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xL2ZyYWc6ZGUzM2JhODhmNTZjNGIxZDhjNzMzZTQyYWE2N2ZhZmEvdGV4dHJlZ2lvbjpkZTMzYmE4OGY1NmM0YjFkOGM3MzNlNDJhYTY3ZmFmYV8yMDc1_478ce679-31a2-4a49-96de-02914d69b393">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i9d6e2966991d4fe6b8a46d9c30f8b61d_I20230425"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xL2ZyYWc6ZGUzM2JhODhmNTZjNGIxZDhjNzMzZTQyYWE2N2ZhZmEvdGV4dHJlZ2lvbjpkZTMzYmE4OGY1NmM0YjFkOGM3MzNlNDJhYTY3ZmFmYV8yMDY5_1c7445a5-9ff0-4f45-821a-c3a744efb9f8"
      unitRef="shares">81904442</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xNi9mcmFnOjc1OTNhNzRmMzFkMDQ5YjliNDY0ZTMyMTQwMDI5MzAyL3RhYmxlOjlmM2VjZTc1N2VlYTRmMzNiYTk0Nzc4NDllYjNmZWM0L3RhYmxlcmFuZ2U6OWYzZWNlNzU3ZWVhNGYzM2JhOTQ3Nzg0OWViM2ZlYzRfMi0xLTEtMS0xODY4MjE_fcd18600-9b20-4604-abff-7e3da8ada507"
      unitRef="usd">380846000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xNi9mcmFnOjc1OTNhNzRmMzFkMDQ5YjliNDY0ZTMyMTQwMDI5MzAyL3RhYmxlOjlmM2VjZTc1N2VlYTRmMzNiYTk0Nzc4NDllYjNmZWM0L3RhYmxlcmFuZ2U6OWYzZWNlNzU3ZWVhNGYzM2JhOTQ3Nzg0OWViM2ZlYzRfMi0zLTEtMS0xODY4MjE_ba1b1aab-8757-475d-b9ea-23e7e83a0a10"
      unitRef="usd">376638000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xNi9mcmFnOjc1OTNhNzRmMzFkMDQ5YjliNDY0ZTMyMTQwMDI5MzAyL3RhYmxlOjlmM2VjZTc1N2VlYTRmMzNiYTk0Nzc4NDllYjNmZWM0L3RhYmxlcmFuZ2U6OWYzZWNlNzU3ZWVhNGYzM2JhOTQ3Nzg0OWViM2ZlYzRfNS0xLTEtMS0xODY4MjE_9d3832ab-0dd8-4527-9869-358fc9cd21b3"
      unitRef="usd">147975000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xNi9mcmFnOjc1OTNhNzRmMzFkMDQ5YjliNDY0ZTMyMTQwMDI5MzAyL3RhYmxlOjlmM2VjZTc1N2VlYTRmMzNiYTk0Nzc4NDllYjNmZWM0L3RhYmxlcmFuZ2U6OWYzZWNlNzU3ZWVhNGYzM2JhOTQ3Nzg0OWViM2ZlYzRfNS0zLTEtMS0xODY4MjE_71f0a599-700e-4a03-b472-6d59b3fbd70f"
      unitRef="usd">142569000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xNi9mcmFnOjc1OTNhNzRmMzFkMDQ5YjliNDY0ZTMyMTQwMDI5MzAyL3RhYmxlOjlmM2VjZTc1N2VlYTRmMzNiYTk0Nzc4NDllYjNmZWM0L3RhYmxlcmFuZ2U6OWYzZWNlNzU3ZWVhNGYzM2JhOTQ3Nzg0OWViM2ZlYzRfNi0xLTEtMS0xODY4MjE_fd677d7d-4169-480d-a43e-83361dd72141"
      unitRef="usd">26724000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
    <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
      contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xNi9mcmFnOjc1OTNhNzRmMzFkMDQ5YjliNDY0ZTMyMTQwMDI5MzAyL3RhYmxlOjlmM2VjZTc1N2VlYTRmMzNiYTk0Nzc4NDllYjNmZWM0L3RhYmxlcmFuZ2U6OWYzZWNlNzU3ZWVhNGYzM2JhOTQ3Nzg0OWViM2ZlYzRfNi0zLTEtMS0xODY4MjE_5e06bee5-cfbd-4640-b6ff-0170135b7ff5"
      unitRef="usd">24085000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xNi9mcmFnOjc1OTNhNzRmMzFkMDQ5YjliNDY0ZTMyMTQwMDI5MzAyL3RhYmxlOjlmM2VjZTc1N2VlYTRmMzNiYTk0Nzc4NDllYjNmZWM0L3RhYmxlcmFuZ2U6OWYzZWNlNzU3ZWVhNGYzM2JhOTQ3Nzg0OWViM2ZlYzRfNy0xLTEtMS0xODY4MjE_6985d2bb-a23b-450f-8c3a-38b423048306"
      unitRef="usd">166657000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xNi9mcmFnOjc1OTNhNzRmMzFkMDQ5YjliNDY0ZTMyMTQwMDI5MzAyL3RhYmxlOjlmM2VjZTc1N2VlYTRmMzNiYTk0Nzc4NDllYjNmZWM0L3RhYmxlcmFuZ2U6OWYzZWNlNzU3ZWVhNGYzM2JhOTQ3Nzg0OWViM2ZlYzRfNy0zLTEtMS0xODY4MjE_0f52e3cd-4fec-498d-8c41-b4f0d00686ec"
      unitRef="usd">159926000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xNi9mcmFnOjc1OTNhNzRmMzFkMDQ5YjliNDY0ZTMyMTQwMDI5MzAyL3RhYmxlOjlmM2VjZTc1N2VlYTRmMzNiYTk0Nzc4NDllYjNmZWM0L3RhYmxlcmFuZ2U6OWYzZWNlNzU3ZWVhNGYzM2JhOTQ3Nzg0OWViM2ZlYzRfOC0xLTEtMS0xODY4MjE_eec168f4-d4b2-4d6f-96b4-06eebe7085fd"
      unitRef="usd">3108000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xNi9mcmFnOjc1OTNhNzRmMzFkMDQ5YjliNDY0ZTMyMTQwMDI5MzAyL3RhYmxlOjlmM2VjZTc1N2VlYTRmMzNiYTk0Nzc4NDllYjNmZWM0L3RhYmxlcmFuZ2U6OWYzZWNlNzU3ZWVhNGYzM2JhOTQ3Nzg0OWViM2ZlYzRfOC0zLTEtMS0xODY4MjE_20d732a3-f760-4668-a24c-da8668ed9833"
      unitRef="usd">3894000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:CostsAndExpenses
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xNi9mcmFnOjc1OTNhNzRmMzFkMDQ5YjliNDY0ZTMyMTQwMDI5MzAyL3RhYmxlOjlmM2VjZTc1N2VlYTRmMzNiYTk0Nzc4NDllYjNmZWM0L3RhYmxlcmFuZ2U6OWYzZWNlNzU3ZWVhNGYzM2JhOTQ3Nzg0OWViM2ZlYzRfOS0xLTEtMS0xODY4MjE_565c249c-c210-44b7-a3b4-ab7de11292af"
      unitRef="usd">344464000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xNi9mcmFnOjc1OTNhNzRmMzFkMDQ5YjliNDY0ZTMyMTQwMDI5MzAyL3RhYmxlOjlmM2VjZTc1N2VlYTRmMzNiYTk0Nzc4NDllYjNmZWM0L3RhYmxlcmFuZ2U6OWYzZWNlNzU3ZWVhNGYzM2JhOTQ3Nzg0OWViM2ZlYzRfOS0zLTEtMS0xODY4MjE_a189b0d0-0314-4176-9640-91dbac02f9f9"
      unitRef="usd">330474000</us-gaap:CostsAndExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xNi9mcmFnOjc1OTNhNzRmMzFkMDQ5YjliNDY0ZTMyMTQwMDI5MzAyL3RhYmxlOjlmM2VjZTc1N2VlYTRmMzNiYTk0Nzc4NDllYjNmZWM0L3RhYmxlcmFuZ2U6OWYzZWNlNzU3ZWVhNGYzM2JhOTQ3Nzg0OWViM2ZlYzRfMTAtMS0xLTEtMTg2ODIx_7c9920f5-663a-461d-9f63-0735ec83da4f"
      unitRef="usd">36382000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xNi9mcmFnOjc1OTNhNzRmMzFkMDQ5YjliNDY0ZTMyMTQwMDI5MzAyL3RhYmxlOjlmM2VjZTc1N2VlYTRmMzNiYTk0Nzc4NDllYjNmZWM0L3RhYmxlcmFuZ2U6OWYzZWNlNzU3ZWVhNGYzM2JhOTQ3Nzg0OWViM2ZlYzRfMTAtMy0xLTEtMTg2ODIx_4a6e2da6-3334-4e19-a833-5ca3e726b65e"
      unitRef="usd">46164000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InvestmentIncomeInterest
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xNi9mcmFnOjc1OTNhNzRmMzFkMDQ5YjliNDY0ZTMyMTQwMDI5MzAyL3RhYmxlOjlmM2VjZTc1N2VlYTRmMzNiYTk0Nzc4NDllYjNmZWM0L3RhYmxlcmFuZ2U6OWYzZWNlNzU3ZWVhNGYzM2JhOTQ3Nzg0OWViM2ZlYzRfMTEtMS0xLTEtMTg2ODIx_8ae08901-6ecf-453d-abd6-99713f4a6742"
      unitRef="usd">4107000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xNi9mcmFnOjc1OTNhNzRmMzFkMDQ5YjliNDY0ZTMyMTQwMDI5MzAyL3RhYmxlOjlmM2VjZTc1N2VlYTRmMzNiYTk0Nzc4NDllYjNmZWM0L3RhYmxlcmFuZ2U6OWYzZWNlNzU3ZWVhNGYzM2JhOTQ3Nzg0OWViM2ZlYzRfMTEtMy0xLTEtMTg2ODIx_d5ff4f1a-3070-4ac5-b6ff-a3e65a57add2"
      unitRef="usd">1377000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InterestExpense
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xNi9mcmFnOjc1OTNhNzRmMzFkMDQ5YjliNDY0ZTMyMTQwMDI5MzAyL3RhYmxlOjlmM2VjZTc1N2VlYTRmMzNiYTk0Nzc4NDllYjNmZWM0L3RhYmxlcmFuZ2U6OWYzZWNlNzU3ZWVhNGYzM2JhOTQ3Nzg0OWViM2ZlYzRfMTItMS0xLTEtMTg2ODIx_53ac4565-c128-42da-a453-bcc343701269"
      unitRef="usd">12100000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xNi9mcmFnOjc1OTNhNzRmMzFkMDQ5YjliNDY0ZTMyMTQwMDI5MzAyL3RhYmxlOjlmM2VjZTc1N2VlYTRmMzNiYTk0Nzc4NDllYjNmZWM0L3RhYmxlcmFuZ2U6OWYzZWNlNzU3ZWVhNGYzM2JhOTQ3Nzg0OWViM2ZlYzRfMTItMy0xLTEtMTg2ODIx_986ed14c-a525-4850-87fc-88b201d6e77a"
      unitRef="usd">11655000</us-gaap:InterestExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xNi9mcmFnOjc1OTNhNzRmMzFkMDQ5YjliNDY0ZTMyMTQwMDI5MzAyL3RhYmxlOjlmM2VjZTc1N2VlYTRmMzNiYTk0Nzc4NDllYjNmZWM0L3RhYmxlcmFuZ2U6OWYzZWNlNzU3ZWVhNGYzM2JhOTQ3Nzg0OWViM2ZlYzRfMTQtMS0xLTEtMTg2ODIx_ceebe536-9f41-4631-ad9f-459a0f7a25f6"
      unitRef="usd">1389000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xNi9mcmFnOjc1OTNhNzRmMzFkMDQ5YjliNDY0ZTMyMTQwMDI5MzAyL3RhYmxlOjlmM2VjZTc1N2VlYTRmMzNiYTk0Nzc4NDllYjNmZWM0L3RhYmxlcmFuZ2U6OWYzZWNlNzU3ZWVhNGYzM2JhOTQ3Nzg0OWViM2ZlYzRfMTQtMy0xLTEtMTg2ODIx_7992e67f-fad3-4696-98d7-f4e3efcdb3c0"
      unitRef="usd">3429000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xNi9mcmFnOjc1OTNhNzRmMzFkMDQ5YjliNDY0ZTMyMTQwMDI5MzAyL3RhYmxlOjlmM2VjZTc1N2VlYTRmMzNiYTk0Nzc4NDllYjNmZWM0L3RhYmxlcmFuZ2U6OWYzZWNlNzU3ZWVhNGYzM2JhOTQ3Nzg0OWViM2ZlYzRfMTUtMS0xLTEtMTg2ODIx_6d4a4d8b-9c2c-4193-8cf2-20c660e835c3"
      unitRef="usd">29778000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xNi9mcmFnOjc1OTNhNzRmMzFkMDQ5YjliNDY0ZTMyMTQwMDI5MzAyL3RhYmxlOjlmM2VjZTc1N2VlYTRmMzNiYTk0Nzc4NDllYjNmZWM0L3RhYmxlcmFuZ2U6OWYzZWNlNzU3ZWVhNGYzM2JhOTQ3Nzg0OWViM2ZlYzRfMTUtMy0xLTEtMTg2ODIx_3c47b850-7871-40e5-96b7-2c747713284f"
      unitRef="usd">39315000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xNi9mcmFnOjc1OTNhNzRmMzFkMDQ5YjliNDY0ZTMyMTQwMDI5MzAyL3RhYmxlOjlmM2VjZTc1N2VlYTRmMzNiYTk0Nzc4NDllYjNmZWM0L3RhYmxlcmFuZ2U6OWYzZWNlNzU3ZWVhNGYzM2JhOTQ3Nzg0OWViM2ZlYzRfMTYtMS0xLTEtMTg2ODIx_270cf846-94f1-4e4a-a36b-3bbf901924a0"
      unitRef="usd">5552000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xNi9mcmFnOjc1OTNhNzRmMzFkMDQ5YjliNDY0ZTMyMTQwMDI5MzAyL3RhYmxlOjlmM2VjZTc1N2VlYTRmMzNiYTk0Nzc4NDllYjNmZWM0L3RhYmxlcmFuZ2U6OWYzZWNlNzU3ZWVhNGYzM2JhOTQ3Nzg0OWViM2ZlYzRfMTYtMy0xLTEtMTg2ODIx_3d22cd58-8194-48d1-a7e6-da592f0b4e13"
      unitRef="usd">6414000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xNi9mcmFnOjc1OTNhNzRmMzFkMDQ5YjliNDY0ZTMyMTQwMDI5MzAyL3RhYmxlOjlmM2VjZTc1N2VlYTRmMzNiYTk0Nzc4NDllYjNmZWM0L3RhYmxlcmFuZ2U6OWYzZWNlNzU3ZWVhNGYzM2JhOTQ3Nzg0OWViM2ZlYzRfMTctMS0xLTEtMTg2ODIx_6cc18cff-506d-4fac-9073-8525c9af8405"
      unitRef="usd">24226000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xNi9mcmFnOjc1OTNhNzRmMzFkMDQ5YjliNDY0ZTMyMTQwMDI5MzAyL3RhYmxlOjlmM2VjZTc1N2VlYTRmMzNiYTk0Nzc4NDllYjNmZWM0L3RhYmxlcmFuZ2U6OWYzZWNlNzU3ZWVhNGYzM2JhOTQ3Nzg0OWViM2ZlYzRfMTctMy0xLTEtMTg2ODIx_be9f118e-5b06-417f-a7c2-4a1d3e4ded5a"
      unitRef="usd">32901000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xNi9mcmFnOjc1OTNhNzRmMzFkMDQ5YjliNDY0ZTMyMTQwMDI5MzAyL3RhYmxlOjlmM2VjZTc1N2VlYTRmMzNiYTk0Nzc4NDllYjNmZWM0L3RhYmxlcmFuZ2U6OWYzZWNlNzU3ZWVhNGYzM2JhOTQ3Nzg0OWViM2ZlYzRfMjAtMS0xLTEtMTg2ODIx_68b5aff7-a358-4d98-9bce-68dce14f75b2"
      unitRef="usdPerShare">0.30</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xNi9mcmFnOjc1OTNhNzRmMzFkMDQ5YjliNDY0ZTMyMTQwMDI5MzAyL3RhYmxlOjlmM2VjZTc1N2VlYTRmMzNiYTk0Nzc4NDllYjNmZWM0L3RhYmxlcmFuZ2U6OWYzZWNlNzU3ZWVhNGYzM2JhOTQ3Nzg0OWViM2ZlYzRfMjAtMy0xLTEtMTg2ODIx_fc2a538e-0314-47ba-9ca5-7eabf9e688f4"
      unitRef="usdPerShare">0.39</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xNi9mcmFnOjc1OTNhNzRmMzFkMDQ5YjliNDY0ZTMyMTQwMDI5MzAyL3RhYmxlOjlmM2VjZTc1N2VlYTRmMzNiYTk0Nzc4NDllYjNmZWM0L3RhYmxlcmFuZ2U6OWYzZWNlNzU3ZWVhNGYzM2JhOTQ3Nzg0OWViM2ZlYzRfMjEtMS0xLTEtMTg2ODIx_bbcd90d0-d9cc-4edb-b716-aab81394db9a"
      unitRef="usdPerShare">0.29</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xNi9mcmFnOjc1OTNhNzRmMzFkMDQ5YjliNDY0ZTMyMTQwMDI5MzAyL3RhYmxlOjlmM2VjZTc1N2VlYTRmMzNiYTk0Nzc4NDllYjNmZWM0L3RhYmxlcmFuZ2U6OWYzZWNlNzU3ZWVhNGYzM2JhOTQ3Nzg0OWViM2ZlYzRfMjEtMy0xLTEtMTg2ODIx_7f74969a-e23c-4971-b0c8-84ce3b4e2ecd"
      unitRef="usdPerShare">0.39</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xNi9mcmFnOjc1OTNhNzRmMzFkMDQ5YjliNDY0ZTMyMTQwMDI5MzAyL3RhYmxlOjlmM2VjZTc1N2VlYTRmMzNiYTk0Nzc4NDllYjNmZWM0L3RhYmxlcmFuZ2U6OWYzZWNlNzU3ZWVhNGYzM2JhOTQ3Nzg0OWViM2ZlYzRfMjQtMS0xLTEtMTg2ODIx_7cd35af2-d74f-421a-b9b9-aac858d1d0bf"
      unitRef="shares">81871000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xNi9mcmFnOjc1OTNhNzRmMzFkMDQ5YjliNDY0ZTMyMTQwMDI5MzAyL3RhYmxlOjlmM2VjZTc1N2VlYTRmMzNiYTk0Nzc4NDllYjNmZWM0L3RhYmxlcmFuZ2U6OWYzZWNlNzU3ZWVhNGYzM2JhOTQ3Nzg0OWViM2ZlYzRfMjQtMy0xLTEtMTg2ODIx_52493370-e153-47f7-9c82-4fc488e1db36"
      unitRef="shares">83632000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xNi9mcmFnOjc1OTNhNzRmMzFkMDQ5YjliNDY0ZTMyMTQwMDI5MzAyL3RhYmxlOjlmM2VjZTc1N2VlYTRmMzNiYTk0Nzc4NDllYjNmZWM0L3RhYmxlcmFuZ2U6OWYzZWNlNzU3ZWVhNGYzM2JhOTQ3Nzg0OWViM2ZlYzRfMjUtMS0xLTEtMTg2ODIx_7f168f21-956f-4052-b61b-df9c6bc74ce8"
      unitRef="shares">82323000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xNi9mcmFnOjc1OTNhNzRmMzFkMDQ5YjliNDY0ZTMyMTQwMDI5MzAyL3RhYmxlOjlmM2VjZTc1N2VlYTRmMzNiYTk0Nzc4NDllYjNmZWM0L3RhYmxlcmFuZ2U6OWYzZWNlNzU3ZWVhNGYzM2JhOTQ3Nzg0OWViM2ZlYzRfMjUtMy0xLTEtMTg2ODIx_2d915101-d088-4c26-b975-9354d30aa7a9"
      unitRef="shares">84276000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xNi9mcmFnOjc1OTNhNzRmMzFkMDQ5YjliNDY0ZTMyMTQwMDI5MzAyL3RhYmxlOjlmM2VjZTc1N2VlYTRmMzNiYTk0Nzc4NDllYjNmZWM0L3RhYmxlcmFuZ2U6OWYzZWNlNzU3ZWVhNGYzM2JhOTQ3Nzg0OWViM2ZlYzRfMjYtMS0xLTEtMTg2ODIx_4c8e3f33-8757-40a6-9e22-fcd38601b618"
      unitRef="usd">21028000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xNi9mcmFnOjc1OTNhNzRmMzFkMDQ5YjliNDY0ZTMyMTQwMDI5MzAyL3RhYmxlOjlmM2VjZTc1N2VlYTRmMzNiYTk0Nzc4NDllYjNmZWM0L3RhYmxlcmFuZ2U6OWYzZWNlNzU3ZWVhNGYzM2JhOTQ3Nzg0OWViM2ZlYzRfMjYtMy0xLTEtMTg2ODIx_bcf54f0b-51c0-4f29-a1bd-360adf42b686"
      unitRef="usd">57031000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMy0xLTEtMS0xODY4MjE_8776edeb-dba4-4998-b20b-bee49f30faef"
      unitRef="usd">307367000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMy0zLTEtMS0xODY4MjE_5152eecd-53ca-4b0e-8057-f57c15f04ef8"
      unitRef="usd">456661000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfNC0wLTEtMS0xODY4MjEvdGV4dHJlZ2lvbjo3YWRkY2JiZWVjY2E0YmFjOGMzY2VhNWQ4MTA2MDIzZF81Mg_be7b55cc-cfea-4fc8-8d69-677cac5ba9c4"
      unitRef="usd">3544000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfNC0wLTEtMS0xODY4MjEvdGV4dHJlZ2lvbjo3YWRkY2JiZWVjY2E0YmFjOGMzY2VhNWQ4MTA2MDIzZF81OQ_0c62f383-bc94-4b23-a463-e26b29d157a1"
      unitRef="usd">4304000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfNC0xLTEtMS0xODY4MjE_deecbf8e-35cf-4479-a187-8c7a1e397188"
      unitRef="usd">253995000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfNC0zLTEtMS0xODY4MjE_472279aa-79e6-40a0-95c5-c1e3a8c97577"
      unitRef="usd">263465000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfNS0xLTEtMS0xODY4MjE_e2805340-46b7-4ffe-a349-820d073a8e8b"
      unitRef="usd">351275000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfNS0zLTEtMS0xODY4MjE_2e51d810-cade-4234-8d39-8b072772dbbf"
      unitRef="usd">324583000</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfNi0xLTEtMS0xODY4MjE_9d024351-9b30-4cff-a7bd-30af9de8bcad"
      unitRef="usd">116845000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfNi0zLTEtMS0xODY4MjE_4bd5b912-538f-4724-85f7-1b22bc854a0b"
      unitRef="usd">116789000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfNy0xLTEtMS0xODY4MjE_f5c5ad2c-88f6-4f80-9e44-ea3411d447c6"
      unitRef="usd">1029482000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfNy0zLTEtMS0xODY4MjE_4fca8052-02f0-4ad8-962c-66624a137f21"
      unitRef="usd">1161498000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfOC0xLTEtMS0xODY4MjE_df79f148-3d1f-4fcd-919b-bdfc127872b9"
      unitRef="usd">315175000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfOC0zLTEtMS0xODY4MjE_91835406-9997-41e1-ab68-2f3661a75cad"
      unitRef="usd">311302000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfOS0xLTEtMS0xODY4MjE_671bcbaa-bef4-4e2c-9c75-1f8c3c6d1b60"
      unitRef="usd">146514000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfOS0zLTEtMS0xODY4MjE_02aaf061-585c-493d-a83b-af69af2af208"
      unitRef="usd">148284000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMTAtMS0xLTEtMTg2ODIx_f20a0203-015a-4f9e-9f4e-69345f1a5a6b"
      unitRef="usd">1108759000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMTAtMy0xLTEtMTg2ODIx_72ebef04-0ee8-4c6b-8585-8cf9a56fb1af"
      unitRef="usd">1126609000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:Goodwill
      contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMTEtMS0xLTEtMTg2ODIx_22ee83bb-abd1-4409-a68c-f4a8113f0c5d"
      unitRef="usd">1041606000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMTEtMy0xLTEtMTg2ODIx_19a25be0-5432-4184-b66e-1708fb8f1d0e"
      unitRef="usd">1038881000</us-gaap:Goodwill>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMTItMS0xLTEtMTg2ODIx_e66ce578-7984-4dad-a2ee-a173de963a38"
      unitRef="usd">44680000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMTItMy0xLTEtMTg2ODIx_b9a8740e-5819-40ca-b597-e1648890695f"
      unitRef="usd">45994000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMTMtMS0xLTEtMTg2ODIx_f58bfd47-53f8-487a-a29b-5fe33e45c08f"
      unitRef="usd">56183000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMTMtMy0xLTEtMTg2ODIx_66e9fceb-2c4a-4d29-8175-bb2467e21842"
      unitRef="usd">57190000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMTQtMS0xLTEtMTg2ODIx_39380f6e-7ea1-496e-8be7-42452e689ef6"
      unitRef="usd">3742399000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMTQtMy0xLTEtMTg2ODIx_e07730fe-d76c-4bd1-9610-5441da21c1e7"
      unitRef="usd">3889758000</us-gaap:Assets>
    <us-gaap:SecuredDebtCurrent
      contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMTctMS0xLTEtMTg2ODIx_e4b36da7-ba4c-49bd-83d9-ba82a8586d0c"
      unitRef="usd">0</us-gaap:SecuredDebtCurrent>
    <us-gaap:SecuredDebtCurrent
      contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMTctMy0xLTEtMTg2ODIx_b8461577-9a69-4166-8d5a-c2ee39c7441a"
      unitRef="usd">38125000</us-gaap:SecuredDebtCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMTgtMS0xLTEtMTg2ODIx_ef5cb82b-805d-4bb7-bb32-3ebb2aece2d3"
      unitRef="usd">14792000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMTgtMy0xLTEtMTg2ODIx_5c0001ef-bce6-487d-8a92-927eafb0cd1c"
      unitRef="usd">14624000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:AccountsPayableTradeCurrent
      contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMTktMS0xLTEtMTg2ODIx_65b048e0-2d3f-4d50-bd92-e6b24b63f49d"
      unitRef="usd">112785000</us-gaap:AccountsPayableTradeCurrent>
    <us-gaap:AccountsPayableTradeCurrent
      contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMTktMy0xLTEtMTg2ODIx_e1cbc470-2f14-4431-b627-d02d3e37e7ed"
      unitRef="usd">102100000</us-gaap:AccountsPayableTradeCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMjAtMS0xLTEtMTg2ODIx_65ce2192-872d-43c6-8cde-0dbafa2f7711"
      unitRef="usd">7743000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMjAtMy0xLTEtMTg2ODIx_f6060f6f-9fba-477a-bd6b-cb690f5e1d39"
      unitRef="usd">7253000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMjEtMS0xLTEtMTg2ODIx_f555536f-6977-4b9e-af8d-d2fd30a77db0"
      unitRef="usd">53611000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMjEtMy0xLTEtMTg2ODIx_afdc402c-3312-48c7-bcf7-4af9e4b1112f"
      unitRef="usd">78771000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMjItMS0xLTEtMTg2ODIx_da7dafd7-d836-4410-a73e-e7897b03ae68"
      unitRef="usd">93362000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMjItMy0xLTEtMTg2ODIx_45ec3811-d0ed-4dac-a55b-8a044ad140e5"
      unitRef="usd">80033000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMjMtMS0xLTEtMTg2ODIx_c4945710-1c4e-436e-ac96-887d891c2a4c"
      unitRef="usd">282293000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMjMtMy0xLTEtMTg2ODIx_a580cf97-5fe0-4f8e-9994-2bed31362d5d"
      unitRef="usd">320906000</us-gaap:LiabilitiesCurrent>
    <us-gaap:SecuredLongTermDebt
      contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMjQtMS0xLTEtMTg2ODIx_3748f0d6-143c-4912-8efc-29dd379feb9d"
      unitRef="usd">769143000</us-gaap:SecuredLongTermDebt>
    <us-gaap:SecuredLongTermDebt
      contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMjQtMy0xLTEtMTg2ODIx_41933348-43ac-4bd3-b753-297368d28efb"
      unitRef="usd">733149000</us-gaap:SecuredLongTermDebt>
    <iart:SecuredLongTermDebtSecuritizationProgramNoncurrent
      contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMjUtMS0xLTEtMTg2ODIx_fd9bdf9f-4f7e-457a-8d16-c314d1a6a819"
      unitRef="usd">102500000</iart:SecuredLongTermDebtSecuritizationProgramNoncurrent>
    <iart:SecuredLongTermDebtSecuritizationProgramNoncurrent
      contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMjUtMy0xLTEtMTg2ODIx_e5d41deb-5a9b-4053-b198-eb3359ecf045"
      unitRef="usd">104700000</iart:SecuredLongTermDebtSecuritizationProgramNoncurrent>
    <us-gaap:ConvertibleDebtNoncurrent
      contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMjYtMS0xLTEtMTg2ODIx_7c1ec781-ffdd-48fd-928b-7ff9b7782c2b"
      unitRef="usd">568069000</us-gaap:ConvertibleDebtNoncurrent>
    <us-gaap:ConvertibleDebtNoncurrent
      contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMjYtMy0xLTEtMTg2ODIx_b720e0c1-47f5-4d3f-b036-768e60753f45"
      unitRef="usd">567341000</us-gaap:ConvertibleDebtNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMjctMS0xLTEtMTg2ODIx_f61678ae-d4ba-42c8-a078-8336f0160378"
      unitRef="usd">156910000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMjctMy0xLTEtMTg2ODIx_029e0d0f-58f5-4154-aa25-f939e19dba21"
      unitRef="usd">157420000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMjgtMS0xLTEtMTg2ODIx_fecf4281-6b50-4c00-936b-bbd7fc2a91e7"
      unitRef="usd">61693000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMjgtMy0xLTEtMTg2ODIx_cbf35baa-fce8-4008-bacb-174658f560be"
      unitRef="usd">63338000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMjktMS0xLTEtMTg2ODIx_302d1a46-d180-4b9b-b5ba-f51a457746b4"
      unitRef="usd">126853000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMjktMy0xLTEtMTg2ODIx_152856d7-ae80-4d67-8f40-b30601b71d5f"
      unitRef="usd">138501000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMzAtMS0xLTEtMTg2ODIx_f719cca5-cf3a-425f-a16d-3b17705ca64a"
      unitRef="usd">2067461000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMzAtMy0xLTEtMTg2ODIx_dd8637ff-0231-4d45-8e10-90df1ad737b0"
      unitRef="usd">2085355000</us-gaap:Liabilities>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMzItMC0xLTEtMTg2ODIxL3RleHRyZWdpb246ODU4ZTU2ZDY1MGJmNDc2YmJiODM2M2VlMjc0MTlmMjJfMjE_0a09cb4c-e3b0-430c-a009-844940411f96"
      unitRef="usdPerShare">0</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMzItMC0xLTEtMTg2ODIxL3RleHRyZWdpb246ODU4ZTU2ZDY1MGJmNDc2YmJiODM2M2VlMjc0MTlmMjJfMjE_c5320404-beb0-4a1a-af13-130ecb310379"
      unitRef="usdPerShare">0</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMzItMC0xLTEtMTg2ODIxL3RleHRyZWdpb246ODU4ZTU2ZDY1MGJmNDc2YmJiODM2M2VlMjc0MTlmMjJfMzU_8455fcac-2f4f-4949-9e49-90ed08dbf791"
      unitRef="shares">15000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMzItMC0xLTEtMTg2ODIxL3RleHRyZWdpb246ODU4ZTU2ZDY1MGJmNDc2YmJiODM2M2VlMjc0MTlmMjJfMzU_e8f2e9ab-9e39-49b4-8a49-f32d8cd1dbc9"
      unitRef="shares">15000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMzItMC0xLTEtMTg2ODIxL3RleHRyZWdpb246ODU4ZTU2ZDY1MGJmNDc2YmJiODM2M2VlMjc0MTlmMjJfNTc_712022d9-4ea0-4621-a7c1-5a93f089001d"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMzItMC0xLTEtMTg2ODIxL3RleHRyZWdpb246ODU4ZTU2ZDY1MGJmNDc2YmJiODM2M2VlMjc0MTlmMjJfNTc_ced7ab21-4fc0-4fcd-9fad-6fbd03615d83"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValue
      contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMzItMS0xLTEtMTg2ODIx_7cfedd20-c8c8-40f8-8d43-52ceec611f75"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMzItMy0xLTEtMTg2ODIx_d6faa034-c695-4de7-9244-d69bce9da387"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMzMtMC0xLTEtMTg2ODIxL3RleHRyZWdpb246MDI0MzJmYmY1ZDExNGM4OWEwNGVkNmZlNWM3NzA3NGJfMTg_040d8ceb-3fc1-4535-b265-3d4a7f226c36"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMzMtMC0xLTEtMTg2ODIxL3RleHRyZWdpb246MDI0MzJmYmY1ZDExNGM4OWEwNGVkNmZlNWM3NzA3NGJfMTg_20b0c789-ab6a-4f7b-99b5-578188aed9e7"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMzMtMC0xLTEtMTg2ODIxL3RleHRyZWdpb246MDI0MzJmYmY1ZDExNGM4OWEwNGVkNmZlNWM3NzA3NGJfMzI_7acd5135-f00c-4953-9939-52c7914b8268"
      unitRef="shares">240000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMzMtMC0xLTEtMTg2ODIxL3RleHRyZWdpb246MDI0MzJmYmY1ZDExNGM4OWEwNGVkNmZlNWM3NzA3NGJfMzI_857cae0c-910d-4cf0-a11d-88992c3f6032"
      unitRef="shares">240000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMzMtMC0xLTEtMTg2ODIxL3RleHRyZWdpb246MDI0MzJmYmY1ZDExNGM4OWEwNGVkNmZlNWM3NzA3NGJfNTQ_2099c5b2-d499-4921-85a7-70de5edae001"
      unitRef="shares">90813000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMzMtMC0xLTEtMTg2ODIxL3RleHRyZWdpb246MDI0MzJmYmY1ZDExNGM4OWEwNGVkNmZlNWM3NzA3NGJfNjE_1a5c72ea-dcb0-4a2e-9cb3-0e26f86aa71b"
      unitRef="shares">90477000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMzMtMS0xLTEtMTg2ODIx_b3063621-baf7-4f59-bd40-292d5ea2c0e6"
      unitRef="usd">908000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMzMtMy0xLTEtMTg2ODIx_2e8e03b7-67d3-4ac5-887b-fe9fd45b4a3d"
      unitRef="usd">905000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMzQtMS0xLTEtMTg2ODIx_c092c433-5243-4aa7-b73d-2b787dde7e19"
      unitRef="usd">1245297000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMzQtMy0xLTEtMTg2ODIx_e9b4da75-c197-49e5-b89b-ee7a2af76175"
      unitRef="usd">1276977000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:TreasuryStockShares
      contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMzUtMC0xLTEtMTg2ODIxL3RleHRyZWdpb246YzgzY2I0MDM0MDc2NGY3YmE1Y2ViZjljMWJmYzdmOWJfMjk_242c3766-283b-4ba1-b281-a4223d88be4c"
      unitRef="shares">8918000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockShares
      contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMzUtMC0xLTEtMTg2ODIxL3RleHRyZWdpb246YzgzY2I0MDM0MDc2NGY3YmE1Y2ViZjljMWJmYzdmOWJfNDM_f96fd7b5-4a13-4cb9-a332-d3a5f878278d"
      unitRef="shares">6823000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockValue
      contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMzUtMS0xLTEtMTg2ODIx_feaded01-777e-49f9-8350-52ed1d85850f"
      unitRef="usd">481678000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue
      contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMzUtMy0xLTEtMTg2ODIx_445c1f05-5cc9-43ac-bbaf-5345020d20c7"
      unitRef="usd">362862000</us-gaap:TreasuryStockValue>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMzYtMS0xLTEtMTg2ODIx_a5419d63-a5f5-4e68-8070-e722f1cdf444"
      unitRef="usd">7067000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMzYtMy0xLTEtMTg2ODIx_39552300-8332-45e3-beac-b49ec6026318"
      unitRef="usd">10265000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMzctMS0xLTEtMTg2ODIx_373e6c7b-c78e-4f76-9023-e2f52af45b73"
      unitRef="usd">903344000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMzctMy0xLTEtMTg2ODIx_fac272f2-e50f-45cd-b20e-c6befc52a5e6"
      unitRef="usd">879118000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMzgtMS0xLTEtMTg2ODIx_86027962-eace-4f8d-8e5d-e614f4ca1626"
      unitRef="usd">1674938000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMzgtMy0xLTEtMTg2ODIx_3f35cd80-6a3d-4d0b-9213-08586b47995e"
      unitRef="usd">1804403000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMzktMS0xLTEtMTg2ODIx_31008bd4-cd0c-4bfa-b8b8-e20c51e42266"
      unitRef="usd">3742399000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8xOS9mcmFnOjQyNjFkMGEwZGZmNTRhMzI5ZDY2ZDQxYTU5MzM1MDZjL3RhYmxlOmE0NmUxYzU5YTVlYzQ0NGQ4Njg3MTI4ODg0Njg2NjgxL3RhYmxlcmFuZ2U6YTQ2ZTFjNTlhNWVjNDQ0ZDg2ODcxMjg4ODQ2ODY2ODFfMzktMy0xLTEtMTg2ODIx_f0dc237b-52cb-452a-90d7-250645d8598e"
      unitRef="usd">3889758000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yNS9mcmFnOjRmMjUxYWRiMWQxZjQ2ZDBiMzRhODQ0ZjY2ZjEwYjRiL3RhYmxlOjU2NzNlN2QxMWIzZjRiMzhiNTYyMDgwNjAwNGJlOWEyL3RhYmxlcmFuZ2U6NTY3M2U3ZDExYjNmNGIzOGI1NjIwODA2MDA0YmU5YTJfMy0xLTEtMS0xODY4MjE_09514bda-0062-45f8-97dd-35bb51e1257d"
      unitRef="usd">24226000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yNS9mcmFnOjRmMjUxYWRiMWQxZjQ2ZDBiMzRhODQ0ZjY2ZjEwYjRiL3RhYmxlOjU2NzNlN2QxMWIzZjRiMzhiNTYyMDgwNjAwNGJlOWEyL3RhYmxlcmFuZ2U6NTY3M2U3ZDExYjNmNGIzOGI1NjIwODA2MDA0YmU5YTJfMy0zLTEtMS0xODY4MjE_3f2475ad-1526-4af8-8807-c88363ca8fdb"
      unitRef="usd">32901000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherDepreciationAndAmortization
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yNS9mcmFnOjRmMjUxYWRiMWQxZjQ2ZDBiMzRhODQ0ZjY2ZjEwYjRiL3RhYmxlOjU2NzNlN2QxMWIzZjRiMzhiNTYyMDgwNjAwNGJlOWEyL3RhYmxlcmFuZ2U6NTY3M2U3ZDExYjNmNGIzOGI1NjIwODA2MDA0YmU5YTJfNS0xLTEtMS0xODY4MjE_db084cc2-36d2-454a-8f02-ea52f10082a3"
      unitRef="usd">31143000</us-gaap:OtherDepreciationAndAmortization>
    <us-gaap:OtherDepreciationAndAmortization
      contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yNS9mcmFnOjRmMjUxYWRiMWQxZjQ2ZDBiMzRhODQ0ZjY2ZjEwYjRiL3RhYmxlOjU2NzNlN2QxMWIzZjRiMzhiNTYyMDgwNjAwNGJlOWEyL3RhYmxlcmFuZ2U6NTY3M2U3ZDExYjNmNGIzOGI1NjIwODA2MDA0YmU5YTJfNS0zLTEtMS0xODY4MjE_497cc367-9fb8-42bb-9d25-f017313cc7a2"
      unitRef="usd">29724000</us-gaap:OtherDepreciationAndAmortization>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yNS9mcmFnOjRmMjUxYWRiMWQxZjQ2ZDBiMzRhODQ0ZjY2ZjEwYjRiL3RhYmxlOjU2NzNlN2QxMWIzZjRiMzhiNTYyMDgwNjAwNGJlOWEyL3RhYmxlcmFuZ2U6NTY3M2U3ZDExYjNmNGIzOGI1NjIwODA2MDA0YmU5YTJfNy0xLTEtMS0xODY4MjE_1574eaa2-d203-4fc1-9aba-40ec5ddfb983"
      unitRef="usd">1953000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yNS9mcmFnOjRmMjUxYWRiMWQxZjQ2ZDBiMzRhODQ0ZjY2ZjEwYjRiL3RhYmxlOjU2NzNlN2QxMWIzZjRiMzhiNTYyMDgwNjAwNGJlOWEyL3RhYmxlcmFuZ2U6NTY3M2U3ZDExYjNmNGIzOGI1NjIwODA2MDA0YmU5YTJfNy0zLTEtMS0xODY4MjE_4439965a-f5ab-43a1-9a8e-ba8c5459ec68"
      unitRef="usd">3544000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:ShareBasedCompensation
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yNS9mcmFnOjRmMjUxYWRiMWQxZjQ2ZDBiMzRhODQ0ZjY2ZjEwYjRiL3RhYmxlOjU2NzNlN2QxMWIzZjRiMzhiNTYyMDgwNjAwNGJlOWEyL3RhYmxlcmFuZ2U6NTY3M2U3ZDExYjNmNGIzOGI1NjIwODA2MDA0YmU5YTJfOC0xLTEtMS0xODY4MjE_03f00572-c754-4ae5-958d-4cca2eed2aae"
      unitRef="usd">3620000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yNS9mcmFnOjRmMjUxYWRiMWQxZjQ2ZDBiMzRhODQ0ZjY2ZjEwYjRiL3RhYmxlOjU2NzNlN2QxMWIzZjRiMzhiNTYyMDgwNjAwNGJlOWEyL3RhYmxlcmFuZ2U6NTY3M2U3ZDExYjNmNGIzOGI1NjIwODA2MDA0YmU5YTJfOC0zLTEtMS0xODY4MjE_20b01be8-3bf4-4bb3-90a7-5f624b923d55"
      unitRef="usd">6291000</us-gaap:ShareBasedCompensation>
    <iart:AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yNS9mcmFnOjRmMjUxYWRiMWQxZjQ2ZDBiMzRhODQ0ZjY2ZjEwYjRiL3RhYmxlOjU2NzNlN2QxMWIzZjRiMzhiNTYyMDgwNjAwNGJlOWEyL3RhYmxlcmFuZ2U6NTY3M2U3ZDExYjNmNGIzOGI1NjIwODA2MDA0YmU5YTJfOS0xLTEtMS0xODY4MjE_eafa5f64-df9c-428c-9720-800112d96aed"
      unitRef="usd">1890000</iart:AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees>
    <iart:AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees
      contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yNS9mcmFnOjRmMjUxYWRiMWQxZjQ2ZDBiMzRhODQ0ZjY2ZjEwYjRiL3RhYmxlOjU2NzNlN2QxMWIzZjRiMzhiNTYyMDgwNjAwNGJlOWEyL3RhYmxlcmFuZ2U6NTY3M2U3ZDExYjNmNGIzOGI1NjIwODA2MDA0YmU5YTJfOS0zLTEtMS0xODY4MjE_abc24b7e-bda4-4e62-9ef0-b0ffeec74fab"
      unitRef="usd">1724000</iart:AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees>
    <iart:NoncashLeaseExpense
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yNS9mcmFnOjRmMjUxYWRiMWQxZjQ2ZDBiMzRhODQ0ZjY2ZjEwYjRiL3RhYmxlOjU2NzNlN2QxMWIzZjRiMzhiNTYyMDgwNjAwNGJlOWEyL3RhYmxlcmFuZ2U6NTY3M2U3ZDExYjNmNGIzOGI1NjIwODA2MDA0YmU5YTJfMTAtMS0xLTEtMTg2ODIx_2d9567a9-6e2f-4876-a65e-a50f4155ee66"
      unitRef="usd">1260000</iart:NoncashLeaseExpense>
    <iart:NoncashLeaseExpense
      contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yNS9mcmFnOjRmMjUxYWRiMWQxZjQ2ZDBiMzRhODQ0ZjY2ZjEwYjRiL3RhYmxlOjU2NzNlN2QxMWIzZjRiMzhiNTYyMDgwNjAwNGJlOWEyL3RhYmxlcmFuZ2U6NTY3M2U3ZDExYjNmNGIzOGI1NjIwODA2MDA0YmU5YTJfMTAtMy0xLTEtMTg2ODIx_a8478968-bf94-40d4-8f59-5baa4af4e454"
      unitRef="usd">-17000</iart:NoncashLeaseExpense>
    <us-gaap:GainLossOnDispositionOfAssets
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yNS9mcmFnOjRmMjUxYWRiMWQxZjQ2ZDBiMzRhODQ0ZjY2ZjEwYjRiL3RhYmxlOjU2NzNlN2QxMWIzZjRiMzhiNTYyMDgwNjAwNGJlOWEyL3RhYmxlcmFuZ2U6NTY3M2U3ZDExYjNmNGIzOGI1NjIwODA2MDA0YmU5YTJfMTEtMS0xLTEtMTg2ODIx_e6f96db8-1f57-4af4-9039-2f2501a8ce42"
      unitRef="usd">23000</us-gaap:GainLossOnDispositionOfAssets>
    <us-gaap:GainLossOnDispositionOfAssets
      contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yNS9mcmFnOjRmMjUxYWRiMWQxZjQ2ZDBiMzRhODQ0ZjY2ZjEwYjRiL3RhYmxlOjU2NzNlN2QxMWIzZjRiMzhiNTYyMDgwNjAwNGJlOWEyL3RhYmxlcmFuZ2U6NTY3M2U3ZDExYjNmNGIzOGI1NjIwODA2MDA0YmU5YTJfMTEtMy0xLTEtMTg2ODIx_c54b9873-7deb-4bf5-93cc-9b2bb9ae69db"
      unitRef="usd">-712000</us-gaap:GainLossOnDispositionOfAssets>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yNS9mcmFnOjRmMjUxYWRiMWQxZjQ2ZDBiMzRhODQ0ZjY2ZjEwYjRiL3RhYmxlOjU2NzNlN2QxMWIzZjRiMzhiNTYyMDgwNjAwNGJlOWEyL3RhYmxlcmFuZ2U6NTY3M2U3ZDExYjNmNGIzOGI1NjIwODA2MDA0YmU5YTJfMTMtMS0xLTEtMTg2ODIx_8e687750-fb45-4d68-81c7-6672f101f56c"
      unitRef="usd">4699000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yNS9mcmFnOjRmMjUxYWRiMWQxZjQ2ZDBiMzRhODQ0ZjY2ZjEwYjRiL3RhYmxlOjU2NzNlN2QxMWIzZjRiMzhiNTYyMDgwNjAwNGJlOWEyL3RhYmxlcmFuZ2U6NTY3M2U3ZDExYjNmNGIzOGI1NjIwODA2MDA0YmU5YTJfMTMtMy0xLTEtMTg2ODIx_d0eaa635-57c6-49ce-8516-ee96328b2206"
      unitRef="usd">-765000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yNS9mcmFnOjRmMjUxYWRiMWQxZjQ2ZDBiMzRhODQ0ZjY2ZjEwYjRiL3RhYmxlOjU2NzNlN2QxMWIzZjRiMzhiNTYyMDgwNjAwNGJlOWEyL3RhYmxlcmFuZ2U6NTY3M2U3ZDExYjNmNGIzOGI1NjIwODA2MDA0YmU5YTJfMTUtMS0xLTEtMTg2ODIx_1320928a-5563-4cb8-9bca-9c4e0bec0f41"
      unitRef="usd">-10041000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yNS9mcmFnOjRmMjUxYWRiMWQxZjQ2ZDBiMzRhODQ0ZjY2ZjEwYjRiL3RhYmxlOjU2NzNlN2QxMWIzZjRiMzhiNTYyMDgwNjAwNGJlOWEyL3RhYmxlcmFuZ2U6NTY3M2U3ZDExYjNmNGIzOGI1NjIwODA2MDA0YmU5YTJfMTUtMy0xLTEtMTg2ODIx_d7643f92-34f3-481b-8146-fab2a91d8cdf"
      unitRef="usd">3116000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yNS9mcmFnOjRmMjUxYWRiMWQxZjQ2ZDBiMzRhODQ0ZjY2ZjEwYjRiL3RhYmxlOjU2NzNlN2QxMWIzZjRiMzhiNTYyMDgwNjAwNGJlOWEyL3RhYmxlcmFuZ2U6NTY3M2U3ZDExYjNmNGIzOGI1NjIwODA2MDA0YmU5YTJfMTYtMS0xLTEtMTg2ODIx_44d3cf68-a7e2-4a58-8d98-539230bace5d"
      unitRef="usd">25423000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yNS9mcmFnOjRmMjUxYWRiMWQxZjQ2ZDBiMzRhODQ0ZjY2ZjEwYjRiL3RhYmxlOjU2NzNlN2QxMWIzZjRiMzhiNTYyMDgwNjAwNGJlOWEyL3RhYmxlcmFuZ2U6NTY3M2U3ZDExYjNmNGIzOGI1NjIwODA2MDA0YmU5YTJfMTYtMy0xLTEtMTg2ODIx_378ebb42-ba78-43b0-8fc9-bd51059cf6f0"
      unitRef="usd">11561000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yNS9mcmFnOjRmMjUxYWRiMWQxZjQ2ZDBiMzRhODQ0ZjY2ZjEwYjRiL3RhYmxlOjU2NzNlN2QxMWIzZjRiMzhiNTYyMDgwNjAwNGJlOWEyL3RhYmxlcmFuZ2U6NTY3M2U3ZDExYjNmNGIzOGI1NjIwODA2MDA0YmU5YTJfMTctMS0xLTEtMTg2ODIx_b243ca78-c108-45e0-af01-7f3843a473d6"
      unitRef="usd">2164000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yNS9mcmFnOjRmMjUxYWRiMWQxZjQ2ZDBiMzRhODQ0ZjY2ZjEwYjRiL3RhYmxlOjU2NzNlN2QxMWIzZjRiMzhiNTYyMDgwNjAwNGJlOWEyL3RhYmxlcmFuZ2U6NTY3M2U3ZDExYjNmNGIzOGI1NjIwODA2MDA0YmU5YTJfMTctMy0xLTEtMTg2ODIx_4ed59d6b-93d2-43c5-a577-c8987161fc0c"
      unitRef="usd">5046000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yNS9mcmFnOjRmMjUxYWRiMWQxZjQ2ZDBiMzRhODQ0ZjY2ZjEwYjRiL3RhYmxlOjU2NzNlN2QxMWIzZjRiMzhiNTYyMDgwNjAwNGJlOWEyL3RhYmxlcmFuZ2U6NTY3M2U3ZDExYjNmNGIzOGI1NjIwODA2MDA0YmU5YTJfMTgtMS0xLTEtMTg2ODIx_833d900e-9cc0-44fb-9c74-3b90979c0646"
      unitRef="usd">6009000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yNS9mcmFnOjRmMjUxYWRiMWQxZjQ2ZDBiMzRhODQ0ZjY2ZjEwYjRiL3RhYmxlOjU2NzNlN2QxMWIzZjRiMzhiNTYyMDgwNjAwNGJlOWEyL3RhYmxlcmFuZ2U6NTY3M2U3ZDExYjNmNGIzOGI1NjIwODA2MDA0YmU5YTJfMTgtMy0xLTEtMTg2ODIx_c689ea77-f8d7-4809-88a7-c6371d958c8f"
      unitRef="usd">-2283000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yNS9mcmFnOjRmMjUxYWRiMWQxZjQ2ZDBiMzRhODQ0ZjY2ZjEwYjRiL3RhYmxlOjU2NzNlN2QxMWIzZjRiMzhiNTYyMDgwNjAwNGJlOWEyL3RhYmxlcmFuZ2U6NTY3M2U3ZDExYjNmNGIzOGI1NjIwODA2MDA0YmU5YTJfMTktMS0xLTEtMTg2ODIx_831b83a9-4e2d-4283-9adc-cca9818890dd"
      unitRef="usd">-4984000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yNS9mcmFnOjRmMjUxYWRiMWQxZjQ2ZDBiMzRhODQ0ZjY2ZjEwYjRiL3RhYmxlOjU2NzNlN2QxMWIzZjRiMzhiNTYyMDgwNjAwNGJlOWEyL3RhYmxlcmFuZ2U6NTY3M2U3ZDExYjNmNGIzOGI1NjIwODA2MDA0YmU5YTJfMTktMy0xLTEtMTg2ODIx_fce5efba-09bc-41d4-b3c3-c92edbd00fb3"
      unitRef="usd">-9754000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yNS9mcmFnOjRmMjUxYWRiMWQxZjQ2ZDBiMzRhODQ0ZjY2ZjEwYjRiL3RhYmxlOjU2NzNlN2QxMWIzZjRiMzhiNTYyMDgwNjAwNGJlOWEyL3RhYmxlcmFuZ2U6NTY3M2U3ZDExYjNmNGIzOGI1NjIwODA2MDA0YmU5YTJfMjEtMS0xLTEtMTg2ODIx_ca776998-bfd7-4683-8fd5-88c2b1592e3f"
      unitRef="usd">-14073000</us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities
      contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yNS9mcmFnOjRmMjUxYWRiMWQxZjQ2ZDBiMzRhODQ0ZjY2ZjEwYjRiL3RhYmxlOjU2NzNlN2QxMWIzZjRiMzhiNTYyMDgwNjAwNGJlOWEyL3RhYmxlcmFuZ2U6NTY3M2U3ZDExYjNmNGIzOGI1NjIwODA2MDA0YmU5YTJfMjEtMy0xLTEtMTg2ODIx_189aad3c-46b6-428c-9877-b472d743ecd4"
      unitRef="usd">-2576000</us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yNS9mcmFnOjRmMjUxYWRiMWQxZjQ2ZDBiMzRhODQ0ZjY2ZjEwYjRiL3RhYmxlOjU2NzNlN2QxMWIzZjRiMzhiNTYyMDgwNjAwNGJlOWEyL3RhYmxlcmFuZ2U6NTY3M2U3ZDExYjNmNGIzOGI1NjIwODA2MDA0YmU5YTJfMjItMS0xLTEtMTg2ODIx_ae1dec02-7766-4e3a-a581-8b0d01f7d264"
      unitRef="usd">26156000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yNS9mcmFnOjRmMjUxYWRiMWQxZjQ2ZDBiMzRhODQ0ZjY2ZjEwYjRiL3RhYmxlOjU2NzNlN2QxMWIzZjRiMzhiNTYyMDgwNjAwNGJlOWEyL3RhYmxlcmFuZ2U6NTY3M2U3ZDExYjNmNGIzOGI1NjIwODA2MDA0YmU5YTJfMjItMy0xLTEtMTg2ODIx_bffbbda1-9b43-44bf-9212-dfcb19876d1d"
      unitRef="usd">44344000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yNS9mcmFnOjRmMjUxYWRiMWQxZjQ2ZDBiMzRhODQ0ZjY2ZjEwYjRiL3RhYmxlOjU2NzNlN2QxMWIzZjRiMzhiNTYyMDgwNjAwNGJlOWEyL3RhYmxlcmFuZ2U6NTY3M2U3ZDExYjNmNGIzOGI1NjIwODA2MDA0YmU5YTJfMjQtMS0xLTEtMTg2ODIx_85449f30-0603-4e43-909a-eafbbf8926bc"
      unitRef="usd">13704000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yNS9mcmFnOjRmMjUxYWRiMWQxZjQ2ZDBiMzRhODQ0ZjY2ZjEwYjRiL3RhYmxlOjU2NzNlN2QxMWIzZjRiMzhiNTYyMDgwNjAwNGJlOWEyL3RhYmxlcmFuZ2U6NTY3M2U3ZDExYjNmNGIzOGI1NjIwODA2MDA0YmU5YTJfMjQtMy0xLTEtMTg2ODIx_81dd8832-cd98-46b2-9e85-ba3ba37459da"
      unitRef="usd">9325000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireInProcessResearchAndDevelopment
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yNS9mcmFnOjRmMjUxYWRiMWQxZjQ2ZDBiMzRhODQ0ZjY2ZjEwYjRiL3RhYmxlOjU2NzNlN2QxMWIzZjRiMzhiNTYyMDgwNjAwNGJlOWEyL3RhYmxlcmFuZ2U6NTY3M2U3ZDExYjNmNGIzOGI1NjIwODA2MDA0YmU5YTJfMjYtMS0xLTEtMTg2ODIx_dcabd490-9509-46c0-93fb-d6135b0e693b"
      unitRef="usd">0</us-gaap:PaymentsToAcquireInProcessResearchAndDevelopment>
    <us-gaap:PaymentsToAcquireInProcessResearchAndDevelopment
      contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yNS9mcmFnOjRmMjUxYWRiMWQxZjQ2ZDBiMzRhODQ0ZjY2ZjEwYjRiL3RhYmxlOjU2NzNlN2QxMWIzZjRiMzhiNTYyMDgwNjAwNGJlOWEyL3RhYmxlcmFuZ2U6NTY3M2U3ZDExYjNmNGIzOGI1NjIwODA2MDA0YmU5YTJfMjYtMy0xLTEtMTg2ODIx_14308c01-a4fc-48d8-bd9d-b12415177d35"
      unitRef="usd">4742000</us-gaap:PaymentsToAcquireInProcessResearchAndDevelopment>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yNS9mcmFnOjRmMjUxYWRiMWQxZjQ2ZDBiMzRhODQ0ZjY2ZjEwYjRiL3RhYmxlOjU2NzNlN2QxMWIzZjRiMzhiNTYyMDgwNjAwNGJlOWEyL3RhYmxlcmFuZ2U6NTY3M2U3ZDExYjNmNGIzOGI1NjIwODA2MDA0YmU5YTJfMjgtMS0xLTEtMTg2ODIx_a3c45aba-6420-4f53-8e90-4b6e618b2f47"
      unitRef="usd">-13704000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yNS9mcmFnOjRmMjUxYWRiMWQxZjQ2ZDBiMzRhODQ0ZjY2ZjEwYjRiL3RhYmxlOjU2NzNlN2QxMWIzZjRiMzhiNTYyMDgwNjAwNGJlOWEyL3RhYmxlcmFuZ2U6NTY3M2U3ZDExYjNmNGIzOGI1NjIwODA2MDA0YmU5YTJfMjgtMy0xLTEtMTg2ODIx_d2e73e65-f8e9-4a4c-a30b-353c48202668"
      unitRef="usd">-14067000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfSecuredDebt
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yNS9mcmFnOjRmMjUxYWRiMWQxZjQ2ZDBiMzRhODQ0ZjY2ZjEwYjRiL3RhYmxlOjU2NzNlN2QxMWIzZjRiMzhiNTYyMDgwNjAwNGJlOWEyL3RhYmxlcmFuZ2U6NTY3M2U3ZDExYjNmNGIzOGI1NjIwODA2MDA0YmU5YTJfMzAtMS0xLTEtMTg2ODIx_0b126cd8-cfdc-4a88-9e59-878ecb0a343e"
      unitRef="usd">10200000</us-gaap:ProceedsFromIssuanceOfSecuredDebt>
    <us-gaap:ProceedsFromIssuanceOfSecuredDebt
      contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yNS9mcmFnOjRmMjUxYWRiMWQxZjQ2ZDBiMzRhODQ0ZjY2ZjEwYjRiL3RhYmxlOjU2NzNlN2QxMWIzZjRiMzhiNTYyMDgwNjAwNGJlOWEyL3RhYmxlcmFuZ2U6NTY3M2U3ZDExYjNmNGIzOGI1NjIwODA2MDA0YmU5YTJfMzAtMy0xLTEtMTg2ODIx_55340ee9-0885-43a0-878d-2405799f48ee"
      unitRef="usd">11250000</us-gaap:ProceedsFromIssuanceOfSecuredDebt>
    <us-gaap:RepaymentsOfSecuredDebt
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yNS9mcmFnOjRmMjUxYWRiMWQxZjQ2ZDBiMzRhODQ0ZjY2ZjEwYjRiL3RhYmxlOjU2NzNlN2QxMWIzZjRiMzhiNTYyMDgwNjAwNGJlOWEyL3RhYmxlcmFuZ2U6NTY3M2U3ZDExYjNmNGIzOGI1NjIwODA2MDA0YmU5YTJfMzEtMS0xLTEtMTg2ODIx_448767de-6a2e-4bd2-be2c-034e6addd1c7"
      unitRef="usd">12400000</us-gaap:RepaymentsOfSecuredDebt>
    <us-gaap:RepaymentsOfSecuredDebt
      contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yNS9mcmFnOjRmMjUxYWRiMWQxZjQ2ZDBiMzRhODQ0ZjY2ZjEwYjRiL3RhYmxlOjU2NzNlN2QxMWIzZjRiMzhiNTYyMDgwNjAwNGJlOWEyL3RhYmxlcmFuZ2U6NTY3M2U3ZDExYjNmNGIzOGI1NjIwODA2MDA0YmU5YTJfMzEtMy0xLTEtMTg2ODIx_688e4c63-ca67-4a4c-a7c9-76f0dfbca909"
      unitRef="usd">11750000</us-gaap:RepaymentsOfSecuredDebt>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yNS9mcmFnOjRmMjUxYWRiMWQxZjQ2ZDBiMzRhODQ0ZjY2ZjEwYjRiL3RhYmxlOjU2NzNlN2QxMWIzZjRiMzhiNTYyMDgwNjAwNGJlOWEyL3RhYmxlcmFuZ2U6NTY3M2U3ZDExYjNmNGIzOGI1NjIwODA2MDA0YmU5YTJfMjktMS0xLTEtMTk5MDky_78004c4f-cdad-4869-aa6e-10e540aed6bf"
      unitRef="usd">7578000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yNS9mcmFnOjRmMjUxYWRiMWQxZjQ2ZDBiMzRhODQ0ZjY2ZjEwYjRiL3RhYmxlOjU2NzNlN2QxMWIzZjRiMzhiNTYyMDgwNjAwNGJlOWEyL3RhYmxlcmFuZ2U6NTY3M2U3ZDExYjNmNGIzOGI1NjIwODA2MDA0YmU5YTJfMjktMy0xLTEtMTk5MTAx_bde35bac-a6b0-4fcd-87cd-85148b1eee39"
      unitRef="usd">0</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yNS9mcmFnOjRmMjUxYWRiMWQxZjQ2ZDBiMzRhODQ0ZjY2ZjEwYjRiL3RhYmxlOjU2NzNlN2QxMWIzZjRiMzhiNTYyMDgwNjAwNGJlOWEyL3RhYmxlcmFuZ2U6NTY3M2U3ZDExYjNmNGIzOGI1NjIwODA2MDA0YmU5YTJfMzItMS0xLTEtMTg2ODIx_a9285c85-32bd-415f-a5c9-e5dafe46fefa"
      unitRef="usd">150000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yNS9mcmFnOjRmMjUxYWRiMWQxZjQ2ZDBiMzRhODQ0ZjY2ZjEwYjRiL3RhYmxlOjU2NzNlN2QxMWIzZjRiMzhiNTYyMDgwNjAwNGJlOWEyL3RhYmxlcmFuZ2U6NTY3M2U3ZDExYjNmNGIzOGI1NjIwODA2MDA0YmU5YTJfMzItMy0xLTEtMTg2ODIx_68009483-9101-4dd0-ac76-dc6968414b84"
      unitRef="usd">125000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yNS9mcmFnOjRmMjUxYWRiMWQxZjQ2ZDBiMzRhODQ0ZjY2ZjEwYjRiL3RhYmxlOjU2NzNlN2QxMWIzZjRiMzhiNTYyMDgwNjAwNGJlOWEyL3RhYmxlcmFuZ2U6NTY3M2U3ZDExYjNmNGIzOGI1NjIwODA2MDA0YmU5YTJfMzMtMS0xLTEtMTg2ODIx_58c6d868-8ffc-4233-a12b-8de86dbd145b"
      unitRef="usd">2326000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yNS9mcmFnOjRmMjUxYWRiMWQxZjQ2ZDBiMzRhODQ0ZjY2ZjEwYjRiL3RhYmxlOjU2NzNlN2QxMWIzZjRiMzhiNTYyMDgwNjAwNGJlOWEyL3RhYmxlcmFuZ2U6NTY3M2U3ZDExYjNmNGIzOGI1NjIwODA2MDA0YmU5YTJfMzMtMy0xLTEtMTg2ODIx_76628ca5-9544-4868-a5ec-d7e55eb4404c"
      unitRef="usd">1239000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yNS9mcmFnOjRmMjUxYWRiMWQxZjQ2ZDBiMzRhODQ0ZjY2ZjEwYjRiL3RhYmxlOjU2NzNlN2QxMWIzZjRiMzhiNTYyMDgwNjAwNGJlOWEyL3RhYmxlcmFuZ2U6NTY3M2U3ZDExYjNmNGIzOGI1NjIwODA2MDA0YmU5YTJfMzQtMS0xLTEtMTg2ODIx_2fdd6d8a-a18d-4f83-ac92-6e58e19ccae4"
      unitRef="usd">5231000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yNS9mcmFnOjRmMjUxYWRiMWQxZjQ2ZDBiMzRhODQ0ZjY2ZjEwYjRiL3RhYmxlOjU2NzNlN2QxMWIzZjRiMzhiNTYyMDgwNjAwNGJlOWEyL3RhYmxlcmFuZ2U6NTY3M2U3ZDExYjNmNGIzOGI1NjIwODA2MDA0YmU5YTJfMzQtMy0xLTEtMTg2ODIx_67bcf198-0c51-4192-b6dc-9c3d16d4e0a4"
      unitRef="usd">9204000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yNS9mcmFnOjRmMjUxYWRiMWQxZjQ2ZDBiMzRhODQ0ZjY2ZjEwYjRiL3RhYmxlOjU2NzNlN2QxMWIzZjRiMzhiNTYyMDgwNjAwNGJlOWEyL3RhYmxlcmFuZ2U6NTY3M2U3ZDExYjNmNGIzOGI1NjIwODA2MDA0YmU5YTJfMzUtMS0xLTEtMTg2ODIx_d9339c05-809d-457a-b0c9-bae7b57e36ba"
      unitRef="usd">-162683000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yNS9mcmFnOjRmMjUxYWRiMWQxZjQ2ZDBiMzRhODQ0ZjY2ZjEwYjRiL3RhYmxlOjU2NzNlN2QxMWIzZjRiMzhiNTYyMDgwNjAwNGJlOWEyL3RhYmxlcmFuZ2U6NTY3M2U3ZDExYjNmNGIzOGI1NjIwODA2MDA0YmU5YTJfMzUtMy0xLTEtMTg2ODIx_a9a742d4-38fe-40b9-8f17-0e15e2e6e542"
      unitRef="usd">-133465000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yNS9mcmFnOjRmMjUxYWRiMWQxZjQ2ZDBiMzRhODQ0ZjY2ZjEwYjRiL3RhYmxlOjU2NzNlN2QxMWIzZjRiMzhiNTYyMDgwNjAwNGJlOWEyL3RhYmxlcmFuZ2U6NTY3M2U3ZDExYjNmNGIzOGI1NjIwODA2MDA0YmU5YTJfMzYtMS0xLTEtMTg2ODIx_70452226-c426-48b3-8b53-be2ce5e3eb4d"
      unitRef="usd">937000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yNS9mcmFnOjRmMjUxYWRiMWQxZjQ2ZDBiMzRhODQ0ZjY2ZjEwYjRiL3RhYmxlOjU2NzNlN2QxMWIzZjRiMzhiNTYyMDgwNjAwNGJlOWEyL3RhYmxlcmFuZ2U6NTY3M2U3ZDExYjNmNGIzOGI1NjIwODA2MDA0YmU5YTJfMzYtMy0xLTEtMTg2ODIx_f2641063-57a0-4f92-9e3d-6a7b2784d7e5"
      unitRef="usd">-3168000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yNS9mcmFnOjRmMjUxYWRiMWQxZjQ2ZDBiMzRhODQ0ZjY2ZjEwYjRiL3RhYmxlOjU2NzNlN2QxMWIzZjRiMzhiNTYyMDgwNjAwNGJlOWEyL3RhYmxlcmFuZ2U6NTY3M2U3ZDExYjNmNGIzOGI1NjIwODA2MDA0YmU5YTJfMzctMS0xLTEtMTg2ODIx_bed609ca-ff3a-4c8b-bb35-216fc45bd01c"
      unitRef="usd">-149294000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yNS9mcmFnOjRmMjUxYWRiMWQxZjQ2ZDBiMzRhODQ0ZjY2ZjEwYjRiL3RhYmxlOjU2NzNlN2QxMWIzZjRiMzhiNTYyMDgwNjAwNGJlOWEyL3RhYmxlcmFuZ2U6NTY3M2U3ZDExYjNmNGIzOGI1NjIwODA2MDA0YmU5YTJfMzctMy0xLTEtMTg2ODIx_f9c3b8c0-4339-464e-9926-604f9a1c7949"
      unitRef="usd">-106356000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yNS9mcmFnOjRmMjUxYWRiMWQxZjQ2ZDBiMzRhODQ0ZjY2ZjEwYjRiL3RhYmxlOjU2NzNlN2QxMWIzZjRiMzhiNTYyMDgwNjAwNGJlOWEyL3RhYmxlcmFuZ2U6NTY3M2U3ZDExYjNmNGIzOGI1NjIwODA2MDA0YmU5YTJfMzgtMS0xLTEtMTg2ODIx_27091781-aef0-4f50-8faf-808785e49636"
      unitRef="usd">456661000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i50dcc39eee364391aeb0073e75dcfb4f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yNS9mcmFnOjRmMjUxYWRiMWQxZjQ2ZDBiMzRhODQ0ZjY2ZjEwYjRiL3RhYmxlOjU2NzNlN2QxMWIzZjRiMzhiNTYyMDgwNjAwNGJlOWEyL3RhYmxlcmFuZ2U6NTY3M2U3ZDExYjNmNGIzOGI1NjIwODA2MDA0YmU5YTJfMzgtMy0xLTEtMTg2ODIx_eb647b82-ed68-4669-9559-82ba7cbc998e"
      unitRef="usd">513448000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yNS9mcmFnOjRmMjUxYWRiMWQxZjQ2ZDBiMzRhODQ0ZjY2ZjEwYjRiL3RhYmxlOjU2NzNlN2QxMWIzZjRiMzhiNTYyMDgwNjAwNGJlOWEyL3RhYmxlcmFuZ2U6NTY3M2U3ZDExYjNmNGIzOGI1NjIwODA2MDA0YmU5YTJfMzktMS0xLTEtMTg2ODIx_20fdec2a-71bd-4866-83ad-365eba309e98"
      unitRef="usd">307367000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i635d765ec67b4491a13addb3d7bc40cd_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yNS9mcmFnOjRmMjUxYWRiMWQxZjQ2ZDBiMzRhODQ0ZjY2ZjEwYjRiL3RhYmxlOjU2NzNlN2QxMWIzZjRiMzhiNTYyMDgwNjAwNGJlOWEyL3RhYmxlcmFuZ2U6NTY3M2U3ZDExYjNmNGIzOGI1NjIwODA2MDA0YmU5YTJfMzktMy0xLTEtMTg2ODIx_b5a48213-a948-4164-b571-1c15f8d491b7"
      unitRef="usd">407092000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:SharesIssued
      contextRef="i8b664c70cda046d684b591844ea4bde4_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjk0ZDEyNDBkN2YwMzQ0NTdiOGI0YmJhNDM1ZGQzMGMyL3RhYmxlcmFuZ2U6OTRkMTI0MGQ3ZjAzNDQ1N2I4YjRiYmE0MzVkZDMwYzJfMy0xLTEtMS0xODY4MjE_777cede6-ff9b-4612-bcea-087221a804f0"
      unitRef="shares">90476000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i8b664c70cda046d684b591844ea4bde4_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjk0ZDEyNDBkN2YwMzQ0NTdiOGI0YmJhNDM1ZGQzMGMyL3RhYmxlcmFuZ2U6OTRkMTI0MGQ3ZjAzNDQ1N2I4YjRiYmE0MzVkZDMwYzJfMy0zLTEtMS0xODY4MjE_71529c0d-78e3-4402-b3d5-325d00136b98"
      unitRef="usd">905000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockShares
      contextRef="i18a51afa82d740fbbdf6665bed1d8a09_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjk0ZDEyNDBkN2YwMzQ0NTdiOGI0YmJhNDM1ZGQzMGMyL3RhYmxlcmFuZ2U6OTRkMTI0MGQ3ZjAzNDQ1N2I4YjRiYmE0MzVkZDMwYzJfMy01LTEtMS0xODY4MjE_10eca361-9dab-4099-a06f-64f959aaadde"
      unitRef="shares">6823000</us-gaap:TreasuryStockShares>
    <us-gaap:StockholdersEquity
      contextRef="i18a51afa82d740fbbdf6665bed1d8a09_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjk0ZDEyNDBkN2YwMzQ0NTdiOGI0YmJhNDM1ZGQzMGMyL3RhYmxlcmFuZ2U6OTRkMTI0MGQ3ZjAzNDQ1N2I4YjRiYmE0MzVkZDMwYzJfMy03LTEtMS0xODY4MjE_8157e100-b332-4bbd-adf1-abd0435ed211"
      unitRef="usd">-362862000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia60ef6361a9e4be48bde714624b18a33_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjk0ZDEyNDBkN2YwMzQ0NTdiOGI0YmJhNDM1ZGQzMGMyL3RhYmxlcmFuZ2U6OTRkMTI0MGQ3ZjAzNDQ1N2I4YjRiYmE0MzVkZDMwYzJfMy05LTEtMS0xODY4MjE_8d2a96de-d692-4a71-9b10-f16a4a184fd7"
      unitRef="usd">1276977000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia54b6095ce1949b680fbf6e3777f0cd1_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjk0ZDEyNDBkN2YwMzQ0NTdiOGI0YmJhNDM1ZGQzMGMyL3RhYmxlcmFuZ2U6OTRkMTI0MGQ3ZjAzNDQ1N2I4YjRiYmE0MzVkZDMwYzJfMy0xMS0xLTEtMTg2ODIx_b605a912-1188-458c-81c6-4a26766e0f70"
      unitRef="usd">10265000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie9da7c98e7334b2b98f63a2448e31bd5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjk0ZDEyNDBkN2YwMzQ0NTdiOGI0YmJhNDM1ZGQzMGMyL3RhYmxlcmFuZ2U6OTRkMTI0MGQ3ZjAzNDQ1N2I4YjRiYmE0MzVkZDMwYzJfMy0xMy0xLTEtMTg2ODIx_160fb882-38cf-4e08-9982-d7c7cfe90bbe"
      unitRef="usd">879118000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjk0ZDEyNDBkN2YwMzQ0NTdiOGI0YmJhNDM1ZGQzMGMyL3RhYmxlcmFuZ2U6OTRkMTI0MGQ3ZjAzNDQ1N2I4YjRiYmE0MzVkZDMwYzJfMy0xNS0xLTEtMTg2ODIx_8d65af6e-dd02-451e-99fd-acb306078553"
      unitRef="usd">1804403000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i5a86b99b663a4de7bdb689dab96e1f70_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjk0ZDEyNDBkN2YwMzQ0NTdiOGI0YmJhNDM1ZGQzMGMyL3RhYmxlcmFuZ2U6OTRkMTI0MGQ3ZjAzNDQ1N2I4YjRiYmE0MzVkZDMwYzJfNC0xMy0xLTEtMTg2ODIx_fc8bedcc-37bc-456e-ad98-34c5d332708d"
      unitRef="usd">24226000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjk0ZDEyNDBkN2YwMzQ0NTdiOGI0YmJhNDM1ZGQzMGMyL3RhYmxlcmFuZ2U6OTRkMTI0MGQ3ZjAzNDQ1N2I4YjRiYmE0MzVkZDMwYzJfNC0xNS0xLTEtMTg2ODIx_c23ed918-699f-4aa0-bee1-a0ccfd292adc"
      unitRef="usd">24226000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i4b3ce7fe6f5d47549cce8165b587a1d0_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjk0ZDEyNDBkN2YwMzQ0NTdiOGI0YmJhNDM1ZGQzMGMyL3RhYmxlcmFuZ2U6OTRkMTI0MGQ3ZjAzNDQ1N2I4YjRiYmE0MzVkZDMwYzJfNS0xMS0xLTEtMTg2ODIx_ab79abf8-f21a-4824-90ff-f440fbc96bb4"
      unitRef="usd">-3198000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjk0ZDEyNDBkN2YwMzQ0NTdiOGI0YmJhNDM1ZGQzMGMyL3RhYmxlcmFuZ2U6OTRkMTI0MGQ3ZjAzNDQ1N2I4YjRiYmE0MzVkZDMwYzJfNS0xNS0xLTEtMTg2ODIx_2b0a0e70-f103-4108-b588-d4c95bd6324a"
      unitRef="usd">-3198000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="ia95f80b5f4b8491b8974cc31b9e4bcd7_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjk0ZDEyNDBkN2YwMzQ0NTdiOGI0YmJhNDM1ZGQzMGMyL3RhYmxlcmFuZ2U6OTRkMTI0MGQ3ZjAzNDQ1N2I4YjRiYmE0MzVkZDMwYzJfNi0xLTEtMS0xODY4MjE_c25fb0cf-ca5d-42db-aa38-1c7292260ddd"
      unitRef="shares">21000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i0fb8907de52a4781af049b3a4064bcdf_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjk0ZDEyNDBkN2YwMzQ0NTdiOGI0YmJhNDM1ZGQzMGMyL3RhYmxlcmFuZ2U6OTRkMTI0MGQ3ZjAzNDQ1N2I4YjRiYmE0MzVkZDMwYzJfNi05LTEtMS0xODY4MjE_57905c3e-8fba-41b1-92f4-e331d256bcc7"
      unitRef="usd">1107000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjk0ZDEyNDBkN2YwMzQ0NTdiOGI0YmJhNDM1ZGQzMGMyL3RhYmxlcmFuZ2U6OTRkMTI0MGQ3ZjAzNDQ1N2I4YjRiYmE0MzVkZDMwYzJfNi0xNS0xLTEtMTg2ODIx_560c7080-13f4-4819-94d2-6300288ffa4b"
      unitRef="usd">1107000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="ia95f80b5f4b8491b8974cc31b9e4bcd7_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjk0ZDEyNDBkN2YwMzQ0NTdiOGI0YmJhNDM1ZGQzMGMyL3RhYmxlcmFuZ2U6OTRkMTI0MGQ3ZjAzNDQ1N2I4YjRiYmE0MzVkZDMwYzJfNy0xLTEtMS0xODY4MjE_a9b06a9d-255d-4ce2-86ba-c05153297bdb"
      unitRef="shares">316000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ia95f80b5f4b8491b8974cc31b9e4bcd7_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjk0ZDEyNDBkN2YwMzQ0NTdiOGI0YmJhNDM1ZGQzMGMyL3RhYmxlcmFuZ2U6OTRkMTI0MGQ3ZjAzNDQ1N2I4YjRiYmE0MzVkZDMwYzJfNy0zLTEtMS0xODY4MjE_94d87afc-d1b5-428b-a7e4-7bfc1b4d41f7"
      unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i8a149e1d463f4cca8d2969ce8c1e4a84_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjk0ZDEyNDBkN2YwMzQ0NTdiOGI0YmJhNDM1ZGQzMGMyL3RhYmxlcmFuZ2U6OTRkMTI0MGQ3ZjAzNDQ1N2I4YjRiYmE0MzVkZDMwYzJfNy01LTEtMS0xODY4MjE_5bc88d71-bba0-46d6-891f-98e89e046ed3"
      unitRef="shares">16000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i8a149e1d463f4cca8d2969ce8c1e4a84_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjk0ZDEyNDBkN2YwMzQ0NTdiOGI0YmJhNDM1ZGQzMGMyL3RhYmxlcmFuZ2U6OTRkMTI0MGQ3ZjAzNDQ1N2I4YjRiYmE0MzVkZDMwYzJfNy03LTEtMS0xODY4MjE_76614765-c1e9-4069-a8f4-8d7cb7a8712c"
      unitRef="usd">846000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i0fb8907de52a4781af049b3a4064bcdf_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjk0ZDEyNDBkN2YwMzQ0NTdiOGI0YmJhNDM1ZGQzMGMyL3RhYmxlcmFuZ2U6OTRkMTI0MGQ3ZjAzNDQ1N2I4YjRiYmE0MzVkZDMwYzJfNy05LTEtMS0xODY4MjE_247b1cc5-7077-4a1e-bbf6-52292d8bf84d"
      unitRef="usd">-4858000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjk0ZDEyNDBkN2YwMzQ0NTdiOGI0YmJhNDM1ZGQzMGMyL3RhYmxlcmFuZ2U6OTRkMTI0MGQ3ZjAzNDQ1N2I4YjRiYmE0MzVkZDMwYzJfNy0xNS0xLTEtMTg2ODIx_32f90f5a-ce7d-4956-b251-623e015a6188"
      unitRef="usd">-4011000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ia95f80b5f4b8491b8974cc31b9e4bcd7_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjk0ZDEyNDBkN2YwMzQ0NTdiOGI0YmJhNDM1ZGQzMGMyL3RhYmxlcmFuZ2U6OTRkMTI0MGQ3ZjAzNDQ1N2I4YjRiYmE0MzVkZDMwYzJfOC0zLTEtMS0xODY4MjE_f93444d9-883a-4614-a9a3-84e7c434489a"
      unitRef="usd">2000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i0fb8907de52a4781af049b3a4064bcdf_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjk0ZDEyNDBkN2YwMzQ0NTdiOGI0YmJhNDM1ZGQzMGMyL3RhYmxlcmFuZ2U6OTRkMTI0MGQ3ZjAzNDQ1N2I4YjRiYmE0MzVkZDMwYzJfOC05LTEtMS0xODY4MjE_90073cfd-2e3e-4b0d-aa15-524b795f5549"
      unitRef="usd">3609000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjk0ZDEyNDBkN2YwMzQ0NTdiOGI0YmJhNDM1ZGQzMGMyL3RhYmxlcmFuZ2U6OTRkMTI0MGQ3ZjAzNDQ1N2I4YjRiYmE0MzVkZDMwYzJfOC0xNS0xLTEtMTg2ODIx_53c9d6aa-1641-4cd4-b07f-19cee013d635"
      unitRef="usd">3611000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i8a149e1d463f4cca8d2969ce8c1e4a84_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjk0ZDEyNDBkN2YwMzQ0NTdiOGI0YmJhNDM1ZGQzMGMyL3RhYmxlcmFuZ2U6OTRkMTI0MGQ3ZjAzNDQ1N2I4YjRiYmE0MzVkZDMwYzJfOS01LTEtMS0xODY4MjE_26ebae56-9d9e-4897-985a-254b7ee54f4d"
      unitRef="shares">2111000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i8a149e1d463f4cca8d2969ce8c1e4a84_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjk0ZDEyNDBkN2YwMzQ0NTdiOGI0YmJhNDM1ZGQzMGMyL3RhYmxlcmFuZ2U6OTRkMTI0MGQ3ZjAzNDQ1N2I4YjRiYmE0MzVkZDMwYzJfOS03LTEtMS0xODY4MjE_6073cefe-19bf-48c4-a943-ff6cf6dc633b"
      unitRef="usd">119662000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i0fb8907de52a4781af049b3a4064bcdf_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjk0ZDEyNDBkN2YwMzQ0NTdiOGI0YmJhNDM1ZGQzMGMyL3RhYmxlcmFuZ2U6OTRkMTI0MGQ3ZjAzNDQ1N2I4YjRiYmE0MzVkZDMwYzJfOS05LTEtMS0xODY4MjE_53fd621a-67a0-41f7-8db1-ee1dd653ca2e"
      unitRef="usd">31538000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjk0ZDEyNDBkN2YwMzQ0NTdiOGI0YmJhNDM1ZGQzMGMyL3RhYmxlcmFuZ2U6OTRkMTI0MGQ3ZjAzNDQ1N2I4YjRiYmE0MzVkZDMwYzJfOS0xNS0xLTEtMTg2ODIx_f6522247-f6fa-47c9-88f6-9740be55698c"
      unitRef="usd">151200000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:SharesIssued
      contextRef="iaf1259e8da8a41d8874851f04fa9e5d6_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjk0ZDEyNDBkN2YwMzQ0NTdiOGI0YmJhNDM1ZGQzMGMyL3RhYmxlcmFuZ2U6OTRkMTI0MGQ3ZjAzNDQ1N2I4YjRiYmE0MzVkZDMwYzJfMTAtMS0xLTEtMTg2ODIx_97f4d778-6963-4fd9-9462-3235988e8f43"
      unitRef="shares">90813000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="iaf1259e8da8a41d8874851f04fa9e5d6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjk0ZDEyNDBkN2YwMzQ0NTdiOGI0YmJhNDM1ZGQzMGMyL3RhYmxlcmFuZ2U6OTRkMTI0MGQ3ZjAzNDQ1N2I4YjRiYmE0MzVkZDMwYzJfMTAtMy0xLTEtMTg2ODIx_e6d1d5d2-307b-4170-bd3f-b2fc2874cbe7"
      unitRef="usd">908000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockShares
      contextRef="i3e47e80bbb2040c7a084e52b255b0d28_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjk0ZDEyNDBkN2YwMzQ0NTdiOGI0YmJhNDM1ZGQzMGMyL3RhYmxlcmFuZ2U6OTRkMTI0MGQ3ZjAzNDQ1N2I4YjRiYmE0MzVkZDMwYzJfMTAtNS0xLTEtMTg2ODIx_35712a77-825e-417c-b5d4-f5f82b685ab7"
      unitRef="shares">8918000</us-gaap:TreasuryStockShares>
    <us-gaap:StockholdersEquity
      contextRef="i3e47e80bbb2040c7a084e52b255b0d28_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjk0ZDEyNDBkN2YwMzQ0NTdiOGI0YmJhNDM1ZGQzMGMyL3RhYmxlcmFuZ2U6OTRkMTI0MGQ3ZjAzNDQ1N2I4YjRiYmE0MzVkZDMwYzJfMTAtNy0xLTEtMTg2ODIx_d27ad072-50af-496c-91a7-8924eed370e8"
      unitRef="usd">-481678000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ifd938a82772142df82f2a578295bcd9a_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjk0ZDEyNDBkN2YwMzQ0NTdiOGI0YmJhNDM1ZGQzMGMyL3RhYmxlcmFuZ2U6OTRkMTI0MGQ3ZjAzNDQ1N2I4YjRiYmE0MzVkZDMwYzJfMTAtOS0xLTEtMTg2ODIx_2e4b66e0-e338-4047-8a34-915c3581516e"
      unitRef="usd">1245297000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ied07d9963f9d439fb1ad815102c390d4_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjk0ZDEyNDBkN2YwMzQ0NTdiOGI0YmJhNDM1ZGQzMGMyL3RhYmxlcmFuZ2U6OTRkMTI0MGQ3ZjAzNDQ1N2I4YjRiYmE0MzVkZDMwYzJfMTAtMTEtMS0xLTE4NjgyMQ_bc8d5165-0d1c-4072-8a25-0380f53805a1"
      unitRef="usd">7067000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia9645160354f47929ed32876cc704c86_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjk0ZDEyNDBkN2YwMzQ0NTdiOGI0YmJhNDM1ZGQzMGMyL3RhYmxlcmFuZ2U6OTRkMTI0MGQ3ZjAzNDQ1N2I4YjRiYmE0MzVkZDMwYzJfMTAtMTMtMS0xLTE4NjgyMQ_5a8105e9-99a2-4466-9378-c73475e3d6c7"
      unitRef="usd">903344000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjk0ZDEyNDBkN2YwMzQ0NTdiOGI0YmJhNDM1ZGQzMGMyL3RhYmxlcmFuZ2U6OTRkMTI0MGQ3ZjAzNDQ1N2I4YjRiYmE0MzVkZDMwYzJfMTAtMTUtMS0xLTE4NjgyMQ_d9b06a86-e7a7-4415-86c7-4b3a99968c6d"
      unitRef="usd">1674938000</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="i5173bceb1ba843f5b9ba6fac4ca9b4ca_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjQ5MWRkZTMzMGVlYjQwNzQ5MGNiOWY0ZDA4NmMyMjJlL3RhYmxlcmFuZ2U6NDkxZGRlMzMwZWViNDA3NDkwY2I5ZjRkMDg2YzIyMmVfMy0xLTEtMS0xODY4MjE_9eff08f4-ded6-4a1e-9f61-f2e5537c6c15"
      unitRef="shares">89600000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i5173bceb1ba843f5b9ba6fac4ca9b4ca_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjQ5MWRkZTMzMGVlYjQwNzQ5MGNiOWY0ZDA4NmMyMjJlL3RhYmxlcmFuZ2U6NDkxZGRlMzMwZWViNDA3NDkwY2I5ZjRkMDg2YzIyMmVfMy0zLTEtMS0xODY4MjE_bc4eec02-9e4e-4514-8d6f-381158d65650"
      unitRef="usd">896000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockShares
      contextRef="i366dba347b9f46848ca7d06dec81acb5_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjQ5MWRkZTMzMGVlYjQwNzQ5MGNiOWY0ZDA4NmMyMjJlL3RhYmxlcmFuZ2U6NDkxZGRlMzMwZWViNDA3NDkwY2I5ZjRkMDg2YzIyMmVfMy01LTEtMS0xODY4MjE_1ff6c900-d517-4033-9a5f-47d839e2c7ec"
      unitRef="shares">4899000</us-gaap:TreasuryStockShares>
    <us-gaap:StockholdersEquity
      contextRef="i366dba347b9f46848ca7d06dec81acb5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjQ5MWRkZTMzMGVlYjQwNzQ5MGNiOWY0ZDA4NmMyMjJlL3RhYmxlcmFuZ2U6NDkxZGRlMzMwZWViNDA3NDkwY2I5ZjRkMDg2YzIyMmVfMy03LTEtMS0xODY4MjE_1b657607-d874-4462-90fa-843f6a8b6c43"
      unitRef="usd">-234448000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i6e56583327fe4abe82cb79ace79055aa_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjQ5MWRkZTMzMGVlYjQwNzQ5MGNiOWY0ZDA4NmMyMjJlL3RhYmxlcmFuZ2U6NDkxZGRlMzMwZWViNDA3NDkwY2I5ZjRkMDg2YzIyMmVfMy05LTEtMS0xODY4MjE_2b5fe720-b3b0-4efb-9fd1-139f0bd3dcfb"
      unitRef="usd">1264943000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia84198cc189e4e0f8778dab882b9d737_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjQ5MWRkZTMzMGVlYjQwNzQ5MGNiOWY0ZDA4NmMyMjJlL3RhYmxlcmFuZ2U6NDkxZGRlMzMwZWViNDA3NDkwY2I5ZjRkMDg2YzIyMmVfMy0xMS0xLTEtMTg2ODIx_94ac12a6-d267-49b9-942d-db1eccbc28c8"
      unitRef="usd">-45155000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5712711f454141d18540576f0d8ead64_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjQ5MWRkZTMzMGVlYjQwNzQ5MGNiOWY0ZDA4NmMyMjJlL3RhYmxlcmFuZ2U6NDkxZGRlMzMwZWViNDA3NDkwY2I5ZjRkMDg2YzIyMmVfMy0xMy0xLTEtMTg2ODIx_6232f838-8a80-468d-88bf-1937b6f32751"
      unitRef="usd">698568000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i50dcc39eee364391aeb0073e75dcfb4f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjQ5MWRkZTMzMGVlYjQwNzQ5MGNiOWY0ZDA4NmMyMjJlL3RhYmxlcmFuZ2U6NDkxZGRlMzMwZWViNDA3NDkwY2I5ZjRkMDg2YzIyMmVfMy0xNS0xLTEtMTg2ODIx_c08c1772-7b86-4d10-8452-3de4ec4007a3"
      unitRef="usd">1684804000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i6cfa05b583da44ddab7edd770f9bd953_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjQ5MWRkZTMzMGVlYjQwNzQ5MGNiOWY0ZDA4NmMyMjJlL3RhYmxlcmFuZ2U6NDkxZGRlMzMwZWViNDA3NDkwY2I5ZjRkMDg2YzIyMmVfNC0xMy0xLTEtMTg2ODIx_98dd766e-e475-45b1-8595-2cda07c87bac"
      unitRef="usd">32901000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjQ5MWRkZTMzMGVlYjQwNzQ5MGNiOWY0ZDA4NmMyMjJlL3RhYmxlcmFuZ2U6NDkxZGRlMzMwZWViNDA3NDkwY2I5ZjRkMDg2YzIyMmVfNC0xNS0xLTEtMTg2ODIx_4c37efca-2f0a-49dd-966a-9ad354e8077f"
      unitRef="usd">32901000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ia48c06fa8e984f2682cf6945ce8d6a84_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjQ5MWRkZTMzMGVlYjQwNzQ5MGNiOWY0ZDA4NmMyMjJlL3RhYmxlcmFuZ2U6NDkxZGRlMzMwZWViNDA3NDkwY2I5ZjRkMDg2YzIyMmVfNS0xMS0xLTEtMTg2ODIx_cfe0e45d-8b71-4c76-bd02-38a37819d88d"
      unitRef="usd">24130000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjQ5MWRkZTMzMGVlYjQwNzQ5MGNiOWY0ZDA4NmMyMjJlL3RhYmxlcmFuZ2U6NDkxZGRlMzMwZWViNDA3NDkwY2I5ZjRkMDg2YzIyMmVfNS0xNS0xLTEtMTg2ODIx_529a1461-6d17-4dd5-bd2c-70f28145d15e"
      unitRef="usd">24130000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i7887839e434d4a3eaa3b791ba3071cd7_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjQ5MWRkZTMzMGVlYjQwNzQ5MGNiOWY0ZDA4NmMyMjJlL3RhYmxlcmFuZ2U6NDkxZGRlMzMwZWViNDA3NDkwY2I5ZjRkMDg2YzIyMmVfNi0xLTEtMS0xODY4MjE_1bdd0ebf-db5d-4ac3-a883-e553ac5c9032"
      unitRef="shares">17000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i12b2bd10a7124b6b8b76ec49059b3fda_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjQ5MWRkZTMzMGVlYjQwNzQ5MGNiOWY0ZDA4NmMyMjJlL3RhYmxlcmFuZ2U6NDkxZGRlMzMwZWViNDA3NDkwY2I5ZjRkMDg2YzIyMmVfNi05LTEtMS0xODY4MjE_1067cf0b-2103-40d2-b848-e22ab3515c1b"
      unitRef="usd">1078000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjQ5MWRkZTMzMGVlYjQwNzQ5MGNiOWY0ZDA4NmMyMjJlL3RhYmxlcmFuZ2U6NDkxZGRlMzMwZWViNDA3NDkwY2I5ZjRkMDg2YzIyMmVfNi0xNS0xLTEtMTg2ODIx_62593402-92f1-4377-b846-f3bce9e02b51"
      unitRef="usd">1078000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i7887839e434d4a3eaa3b791ba3071cd7_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjQ5MWRkZTMzMGVlYjQwNzQ5MGNiOWY0ZDA4NmMyMjJlL3RhYmxlcmFuZ2U6NDkxZGRlMzMwZWViNDA3NDkwY2I5ZjRkMDg2YzIyMmVfNy0xLTEtMS0xODY4MjE_633c65d1-bc73-4b4a-ab32-9d55caa0734b"
      unitRef="shares">339000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i7887839e434d4a3eaa3b791ba3071cd7_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjQ5MWRkZTMzMGVlYjQwNzQ5MGNiOWY0ZDA4NmMyMjJlL3RhYmxlcmFuZ2U6NDkxZGRlMzMwZWViNDA3NDkwY2I5ZjRkMDg2YzIyMmVfNy0zLTEtMS0xODY4MjE_f6c77850-0d7d-4c10-9c63-3a6d51a50e33"
      unitRef="usd">4000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="iec34d4ae56714939a2ae0fcab654c01c_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjQ5MWRkZTMzMGVlYjQwNzQ5MGNiOWY0ZDA4NmMyMjJlL3RhYmxlcmFuZ2U6NDkxZGRlMzMwZWViNDA3NDkwY2I5ZjRkMDg2YzIyMmVfNy01LTEtMS0xODY4MjE_c074b4d6-ac9f-47c0-b4fe-af49b7640fe3"
      unitRef="shares">14000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="iec34d4ae56714939a2ae0fcab654c01c_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjQ5MWRkZTMzMGVlYjQwNzQ5MGNiOWY0ZDA4NmMyMjJlL3RhYmxlcmFuZ2U6NDkxZGRlMzMwZWViNDA3NDkwY2I5ZjRkMDg2YzIyMmVfNy03LTEtMS0xODY4MjE_db0a42eb-179c-4a2b-a326-727572388e63"
      unitRef="usd">714000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i12b2bd10a7124b6b8b76ec49059b3fda_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjQ5MWRkZTMzMGVlYjQwNzQ5MGNiOWY0ZDA4NmMyMjJlL3RhYmxlcmFuZ2U6NDkxZGRlMzMwZWViNDA3NDkwY2I5ZjRkMDg2YzIyMmVfNy05LTEtMS0xODY4MjE_35bb658a-2a90-4a6d-9eaa-376f4d05ef05"
      unitRef="usd">-9758000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjQ5MWRkZTMzMGVlYjQwNzQ5MGNiOWY0ZDA4NmMyMjJlL3RhYmxlcmFuZ2U6NDkxZGRlMzMwZWViNDA3NDkwY2I5ZjRkMDg2YzIyMmVfNy0xNS0xLTEtMTg2ODIx_3fd8bff4-ce5a-4927-aa07-f6ee676ac6c3"
      unitRef="usd">-9040000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i12b2bd10a7124b6b8b76ec49059b3fda_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjQ5MWRkZTMzMGVlYjQwNzQ5MGNiOWY0ZDA4NmMyMjJlL3RhYmxlcmFuZ2U6NDkxZGRlMzMwZWViNDA3NDkwY2I5ZjRkMDg2YzIyMmVfOC05LTEtMS0xODY4MjE_e4fb9f1c-a024-4d36-858a-e81a80b2ec7a"
      unitRef="usd">6324000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjQ5MWRkZTMzMGVlYjQwNzQ5MGNiOWY0ZDA4NmMyMjJlL3RhYmxlcmFuZ2U6NDkxZGRlMzMwZWViNDA3NDkwY2I5ZjRkMDg2YzIyMmVfOC0xNS0xLTEtMTg2ODIx_360a9180-b4b3-42a1-9724-d8728a89aae5"
      unitRef="usd">6324000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="iec34d4ae56714939a2ae0fcab654c01c_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjQ5MWRkZTMzMGVlYjQwNzQ5MGNiOWY0ZDA4NmMyMjJlL3RhYmxlcmFuZ2U6NDkxZGRlMzMwZWViNDA3NDkwY2I5ZjRkMDg2YzIyMmVfOS01LTEtMS0xODY4MjE_936dede5-890d-433d-8282-509adb084e65"
      unitRef="shares">1938000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="iec34d4ae56714939a2ae0fcab654c01c_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjQ5MWRkZTMzMGVlYjQwNzQ5MGNiOWY0ZDA4NmMyMjJlL3RhYmxlcmFuZ2U6NDkxZGRlMzMwZWViNDA3NDkwY2I5ZjRkMDg2YzIyMmVfOS03LTEtMS0xODY4MjE_f9672cb7-9e6f-40e8-ac10-545669512eb7"
      unitRef="usd">129152000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i12b2bd10a7124b6b8b76ec49059b3fda_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjQ5MWRkZTMzMGVlYjQwNzQ5MGNiOWY0ZDA4NmMyMjJlL3RhYmxlcmFuZ2U6NDkxZGRlMzMwZWViNDA3NDkwY2I5ZjRkMDg2YzIyMmVfOS05LTEtMS0xODY4MjE_1cffe2f9-88c1-4c83-91cb-6fb876a2fa50"
      unitRef="usd">-4152000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjQ5MWRkZTMzMGVlYjQwNzQ5MGNiOWY0ZDA4NmMyMjJlL3RhYmxlcmFuZ2U6NDkxZGRlMzMwZWViNDA3NDkwY2I5ZjRkMDg2YzIyMmVfOS0xNS0xLTEtMTg2ODIx_0106cb77-cd25-4c28-82f0-7a5f7c526a22"
      unitRef="usd">125000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:SharesIssued
      contextRef="i1be1849f53b94167a15b3f9045e8f051_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjQ5MWRkZTMzMGVlYjQwNzQ5MGNiOWY0ZDA4NmMyMjJlL3RhYmxlcmFuZ2U6NDkxZGRlMzMwZWViNDA3NDkwY2I5ZjRkMDg2YzIyMmVfMTAtMS0xLTEtMTg2ODIx_b8b96325-02b0-4567-ab97-0513167070c7"
      unitRef="shares">89956000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i1be1849f53b94167a15b3f9045e8f051_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjQ5MWRkZTMzMGVlYjQwNzQ5MGNiOWY0ZDA4NmMyMjJlL3RhYmxlcmFuZ2U6NDkxZGRlMzMwZWViNDA3NDkwY2I5ZjRkMDg2YzIyMmVfMTAtMy0xLTEtMTg2ODIx_dcf249fc-1d47-4919-aab3-6b419a349a9b"
      unitRef="usd">900000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockShares
      contextRef="i73947427cc2b499ab016969c72081ee0_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjQ5MWRkZTMzMGVlYjQwNzQ5MGNiOWY0ZDA4NmMyMjJlL3RhYmxlcmFuZ2U6NDkxZGRlMzMwZWViNDA3NDkwY2I5ZjRkMDg2YzIyMmVfMTAtNS0xLTEtMTg2ODIx_f2457eb6-26a1-4968-b328-74f80454ad27"
      unitRef="shares">6823000</us-gaap:TreasuryStockShares>
    <us-gaap:StockholdersEquity
      contextRef="i73947427cc2b499ab016969c72081ee0_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjQ5MWRkZTMzMGVlYjQwNzQ5MGNiOWY0ZDA4NmMyMjJlL3RhYmxlcmFuZ2U6NDkxZGRlMzMwZWViNDA3NDkwY2I5ZjRkMDg2YzIyMmVfMTAtNy0xLTEtMTg2ODIx_4da11726-1feb-4656-a855-b78802dc1d68"
      unitRef="usd">-362886000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="idb0fcc9c413d41d28bf9655bcf94a392_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjQ5MWRkZTMzMGVlYjQwNzQ5MGNiOWY0ZDA4NmMyMjJlL3RhYmxlcmFuZ2U6NDkxZGRlMzMwZWViNDA3NDkwY2I5ZjRkMDg2YzIyMmVfMTAtOS0xLTEtMTg2ODIx_eab402c3-57ed-4cd1-b52b-8656e9cde288"
      unitRef="usd">1266739000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i2313f3e834a34925a9399b4f10d82fd7_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjQ5MWRkZTMzMGVlYjQwNzQ5MGNiOWY0ZDA4NmMyMjJlL3RhYmxlcmFuZ2U6NDkxZGRlMzMwZWViNDA3NDkwY2I5ZjRkMDg2YzIyMmVfMTAtMTEtMS0xLTE4NjgyMQ_6bdd3a09-00ca-4413-8fb7-954bc5b68890"
      unitRef="usd">-21025000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i3e56c025683743ddb68924e934a1c045_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjQ5MWRkZTMzMGVlYjQwNzQ5MGNiOWY0ZDA4NmMyMjJlL3RhYmxlcmFuZ2U6NDkxZGRlMzMwZWViNDA3NDkwY2I5ZjRkMDg2YzIyMmVfMTAtMTMtMS0xLTE4NjgyMQ_a55a3bbe-2560-414c-93f2-2d92c68c2b52"
      unitRef="usd">731469000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i635d765ec67b4491a13addb3d7bc40cd_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8yOC9mcmFnOmEyNzJkNzQzYWJiYTRhMjg5OWQxN2FhYzgzNjM0Zjk0L3RhYmxlOjQ5MWRkZTMzMGVlYjQwNzQ5MGNiOWY0ZDA4NmMyMjJlL3RhYmxlcmFuZ2U6NDkxZGRlMzMwZWViNDA3NDkwY2I5ZjRkMDg2YzIyMmVfMTAtMTUtMS0xLTE4NjgyMQ_9b0eaa28-101a-494c-bdeb-30ef50dbb224"
      unitRef="usd">1615197000</us-gaap:StockholdersEquity>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8zNC9mcmFnOjlhMDA5ODY5OGJiZDRlZDdiNGIwNjBiOTRhYzdiNDJiL3RleHRyZWdpb246OWEwMDk4Njk4YmJkNGVkN2I0YjA2MGI5NGFjN2I0MmJfMTE1MzU_9a271c17-48d3-433c-a001-3e0abf5f1725">BASIS OF PRESENTATION&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;General&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The terms &#x201c;we,&#x201d; &#x201c;our,&#x201d; &#x201c;us,&#x201d; &#x201c;Company&#x201d; and &#x201c;Integra&#x201d; refer to Integra LifeSciences Holdings Corporation, a Delaware corporation, and its subsidiaries unless the context suggests otherwise.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the opinion of management, the March&#160;31, 2023 unaudited condensed consolidated financial statements contain all adjustments (consisting only of normal recurring adjustments) necessary for a fair statement of the financial position, statement of changes in shareholders' equity, results of operations and cash flows of the Company. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States ("GAAP") have been condensed or omitted in accordance with the instructions to Form 10-Q and Rule&#160;10-01 of Regulation&#160;S-X. These unaudited condensed consolidated financial statements should be read in conjunction with the Company&#x2019;s consolidated financial statements for the year ended December&#160;31, 2022 included in the Company&#x2019;s Annual Report on Form 10-K. The December&#160;31, 2022 consolidated balance sheet was derived from audited financial statements, but does not include all disclosures required by GAAP. Operating results for the three-month period ended March&#160;31, 2023 are not necessarily indicative of the results to be expected for the entire year.&lt;/span&gt;&lt;/div&gt;The preparation of consolidated financial statements is in conformity with GAAP, which requires management to make estimates and assumptions that affect the reported amount of assets and liabilities, the disclosure of contingent liabilities, and the reported amounts of revenues and expenses. Significant estimates affecting amounts reported or disclosed in the condensed consolidated financial statements include allowances for doubtful accounts receivable and sales returns and allowances, net realizable value of inventories, valuation of intangible assets including amortization periods for acquired intangible assets, discount rates and estimated projected cash flows used to value and test impairments of long-lived assets and goodwill, estimates of projected cash flows and depreciation and amortization periods for long-lived assets, computation of taxes, valuation allowances recorded against deferred tax assets, the valuation of stock-based compensation, valuation of derivative instruments, valuation of contingent liabilities, the fair value of debt instruments and loss contingencies. These estimates are based on historical experience and on various other assumptions that are believed to be reasonable under the current circumstances. Actual results could differ from these estimates.</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8zNC9mcmFnOjlhMDA5ODY5OGJiZDRlZDdiNGIwNjBiOTRhYzdiNDJiL3RleHRyZWdpb246OWEwMDk4Njk4YmJkNGVkN2I0YjA2MGI5NGFjN2I0MmJfMTE1NTg_ea1029b2-f949-44ff-b5bf-d9661e8abd29">BASIS OF PRESENTATION&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;General&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The terms &#x201c;we,&#x201d; &#x201c;our,&#x201d; &#x201c;us,&#x201d; &#x201c;Company&#x201d; and &#x201c;Integra&#x201d; refer to Integra LifeSciences Holdings Corporation, a Delaware corporation, and its subsidiaries unless the context suggests otherwise.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the opinion of management, the March&#160;31, 2023 unaudited condensed consolidated financial statements contain all adjustments (consisting only of normal recurring adjustments) necessary for a fair statement of the financial position, statement of changes in shareholders' equity, results of operations and cash flows of the Company. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States ("GAAP") have been condensed or omitted in accordance with the instructions to Form 10-Q and Rule&#160;10-01 of Regulation&#160;S-X. These unaudited condensed consolidated financial statements should be read in conjunction with the Company&#x2019;s consolidated financial statements for the year ended December&#160;31, 2022 included in the Company&#x2019;s Annual Report on Form 10-K. The December&#160;31, 2022 consolidated balance sheet was derived from audited financial statements, but does not include all disclosures required by GAAP. Operating results for the three-month period ended March&#160;31, 2023 are not necessarily indicative of the results to be expected for the entire year.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of consolidated financial statements is in conformity with GAAP, which requires management to make estimates and assumptions that affect the reported amount of assets and liabilities, the disclosure of contingent liabilities, and the reported amounts of revenues and expenses. Significant estimates affecting amounts reported or disclosed in the condensed consolidated financial statements include allowances for doubtful accounts receivable and sales returns and allowances, net realizable value of inventories, valuation of intangible assets including amortization periods for acquired intangible assets, discount rates and estimated projected cash flows used to value and test impairments of long-lived assets and goodwill, estimates of projected cash flows and depreciation and amortization periods for long-lived assets, computation of taxes, valuation allowances recorded against deferred tax assets, the valuation of stock-based compensation, valuation of derivative instruments, valuation of contingent liabilities, the fair value of debt instruments and loss contingencies. These estimates are based on historical experience and on various other assumptions that are believed to be reasonable under the current circumstances. Actual results could differ from these estimates. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recent Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In March 2020, the FASB issued ASU 2020-04,&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Reference Rate Reform &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;(Topic 848), and subsequent amendment to the initial guidance: ASU 2021-01, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Reference Rate Reform&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt; (Topic 848): Scope (collectively, &#x201c;Topic 848&#x201d;). Topic 848 provides optional expedients and exceptions for applying GAAP to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. The amendments apply only to contracts, hedging relationships, and other transactions that reference London Inter-Bank Offered Rate ("LIBOR") or another reference rate expected to be discontinued because of reference rate reform. The guidance generally can be applied through December 31, 2024. The Alternative Reference Rates Committee, a group of private-market participants convened by the U.S. Federal Reserve Board and the New York Federal Reserve, has recommended the use of the Secured Overnight Financing Rate ("SOFR") as a more robust reference rate alternative to LIBOR. The use of SOFR as a substitute for LIBOR is, however, voluntary and may not be suitable for all market participants. There can be no assurance that the replacement rate will be economically equivalent to LIBOR, which could result in higher interest rates for us under our debt facilities. There is no guarantee that a transition from LIBOR to SOFR will not result in financial market disruptions, significant increases in benchmark rates, or our borrowing costs, any of which could have an adverse effect on our business, results of operations and financial condition. On March 24, 2023, the Company entered into the seventh amendment and restatement (the "March 2023 Amendment") of its Senior Credit Facility (the &#x201c;Senior Credit Facility&#x201d;) with a syndicate of lending banks with Bank of America, N.A., as Administrative Agent. In connection with the March 2023 Amendment the Company replaced all LIBOR-based contracts with SOFR, which is calculated based on overnight transactions under repurchase agreements backed by Treasury securities (See Note 6).  In March 2023, the Company entered into a basis swap where the Company receives Term SOFR and pays LIBOR to convert the portfolio of interest rate swaps from LIBOR to SOFR. Integra has elected to adopt the optional expedient under ASC 848, which will allow the interest rate swap hedging relationship to continue, without de-designation, due to the change in the indexed rate from LIBOR to SOFR. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There are no other recently issued accounting pronouncements that are expected to have any significant effect on the Company's financial position, results of operations or cash flows.&lt;/span&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8zNC9mcmFnOjlhMDA5ODY5OGJiZDRlZDdiNGIwNjBiOTRhYzdiNDJiL3RleHRyZWdpb246OWEwMDk4Njk4YmJkNGVkN2I0YjA2MGI5NGFjN2I0MmJfMTE1NTQ_de73ae4c-95ff-4b47-8c3e-c6b91fb57eef">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recent Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In March 2020, the FASB issued ASU 2020-04,&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Reference Rate Reform &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;(Topic 848), and subsequent amendment to the initial guidance: ASU 2021-01, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Reference Rate Reform&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt; (Topic 848): Scope (collectively, &#x201c;Topic 848&#x201d;). Topic 848 provides optional expedients and exceptions for applying GAAP to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. The amendments apply only to contracts, hedging relationships, and other transactions that reference London Inter-Bank Offered Rate ("LIBOR") or another reference rate expected to be discontinued because of reference rate reform. The guidance generally can be applied through December 31, 2024. The Alternative Reference Rates Committee, a group of private-market participants convened by the U.S. Federal Reserve Board and the New York Federal Reserve, has recommended the use of the Secured Overnight Financing Rate ("SOFR") as a more robust reference rate alternative to LIBOR. The use of SOFR as a substitute for LIBOR is, however, voluntary and may not be suitable for all market participants. There can be no assurance that the replacement rate will be economically equivalent to LIBOR, which could result in higher interest rates for us under our debt facilities. There is no guarantee that a transition from LIBOR to SOFR will not result in financial market disruptions, significant increases in benchmark rates, or our borrowing costs, any of which could have an adverse effect on our business, results of operations and financial condition. On March 24, 2023, the Company entered into the seventh amendment and restatement (the "March 2023 Amendment") of its Senior Credit Facility (the &#x201c;Senior Credit Facility&#x201d;) with a syndicate of lending banks with Bank of America, N.A., as Administrative Agent. In connection with the March 2023 Amendment the Company replaced all LIBOR-based contracts with SOFR, which is calculated based on overnight transactions under repurchase agreements backed by Treasury securities (See Note 6).  In March 2023, the Company entered into a basis swap where the Company receives Term SOFR and pays LIBOR to convert the portfolio of interest rate swaps from LIBOR to SOFR. Integra has elected to adopt the optional expedient under ASC 848, which will allow the interest rate swap hedging relationship to continue, without de-designation, due to the change in the indexed rate from LIBOR to SOFR. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There are no other recently issued accounting pronouncements that are expected to have any significant effect on the Company's financial position, results of operations or cash flows.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8zNy9mcmFnOjM1MjU5OWQwYjU5ODQxYmM5ZjY0N2MxNGMzOWRkYjVjL3RleHRyZWdpb246MzUyNTk5ZDBiNTk4NDFiYzlmNjQ3YzE0YzM5ZGRiNWNfNjkwNg_a655664e-e315-4c8c-844e-95dc6243a1d5">ACQUISITIONS AND DIVESTITURES&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:107%"&gt;Surgical Innovation Associates, Inc. Acquisition&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;On December 6, 2022, the Company completed its acquisition of Surgical Innovation Associates, Inc. ("SIA") for an acquisition purchase price of $51.5&#160;million (the "SIA Acquisition"). In addition to the purchase price, the acquisition includes two separate contingent considerations payments, which are dependent on 1) achieving certain revenue-based performance milestones in 2023, 2024, and 2025 (up to $50.0&#160;million in additional payments), as well as 2) the approval by the FDA of the Premarket Approval (&#x201c;PMA&#x201d;) Application for DuraSorb for certain uses by certain timing targets (up to $40.0&#160;million in additional payments).  SIA's core technology, DuraSorb, is a fully resorbable scaffold of a globally accepted polymer, which is cleared for use in hernia repair, abdominal wall, and other soft tissue reinforcement. DuraSorb sales will be reported within Integra&#x2019;s Tissue Technologies ("TT") segment as part of its Wound Reconstruction and Care franchise.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%"&gt;Assets Acquired and Liabilities Assumed at Fair Value&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;The SIA Acquisition has been accounted for using the acquisition method of accounting. This method requires that assets acquired, and liabilities assumed in a business combination to be recognized at their fair values as of the acquisition date. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;The following table summarizes the fair values of the assets acquired and liabilities assumed at the acquisition date:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.028%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.545%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Preliminary Valuation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average Life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,438&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Trade accounts receivable, net &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,551&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Inventories, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,654&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;127,397&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accounts payable and accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,044&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,044&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred Tax Liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,799&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;57,607&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total liabilities assumed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;71,450&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;55,947&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%"&gt;Developed Technology&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;The estimated fair value of the developed technology was determined using the multi-period excess earnings method of the income approach, which estimates value based on the present value of future economic benefits. Some of the more significant assumptions inherent in the development of those asset valuations include the estimated net cash flows for each year for each product including net revenues, cost of sales, R&amp;amp;D costs, selling and marketing costs, working capital, and contributory asset charges, the appropriate discount rate to select in order to measure the risk inherent in each future cash flow stream, the assessment of the asset&#x2019;s life cycle, and competitive trends impacting the asset and the cash flow stream.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;The Company used a discount rate of 18% to arrive at the present value for the acquired intangible assets to reflect the rate of return a market participant would expect to earn and incremental commercial uncertainty in the cash flow projections. No assurances can be given that the underlying assumptions used to prepare the discounted cash flow analysis will not change. For these and other reasons, actual results may vary significantly from estimated results.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;The Company allocated goodwill related to the SIA Acquisition to the TT segment. Goodwill is the excess of the consideration transferred over the net assets recognized and represents the expected revenue and cost synergies of the combined company and assembled workforce. A key factor that contributes to the recognition of goodwill, and a driver for the Company&#x2019;s acquisition of SIA, is the attractive growth opportunities presented by the surgical matrix business in the breast reconstruction market. Goodwill recognized as a result of this acquisition is non-deductible for income tax purposes.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%"&gt;Contingent Consideration&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;The Company determines the acquisition date fair value of contingent consideration obligations based on a probability-weighted income approach derived from revenue estimates and a probability assessment with respect to the likelihood of achieving contingent obligations. The fair value measurement is based on significant inputs not observable in the market and thus represents a Level 3 measurement as defined using the fair value concepts in ASC 820. The resulting most likely payouts are discounted using an appropriate effective annual interest rate. At each reporting date, the contingent consideration obligation will be revalued to estimated fair value and changes in fair value will be reflected as income or expense in the consolidated statement of operations. Changes in the fair value of the contingent considerations may result from changes in discount periods and rates and changes in the timing and amount of revenue estimates. Changes in assumptions utilized in the contingent consideration fair value estimates could result in an increase in the contingent consideration obligation and a corresponding charge to operating results.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;As part of the SIA Acquisition, the Company is required to pay to the shareholder of SIA up to $90.0&#160;million for two separate payments, which are dependent on 1) achieving certain revenue-based performance milestones in 2023, 2024, and 2025 (up to $50.0&#160;million in additional payments), as well as 2) the approval by the FDA of the PMA for DuraSorb for certain uses by certain timing targets (up to $40.0&#160;million in additional payments).  The Company used iterations of the Monte Carlo simulation to calculate the fair value of the contingent consideration for the revenue-based milestone that considered the possible outcomes of scenarios related to each specific milestone for the revenue based performance milestone. The Company used probabilities of achieving the conditions to calculate the fair value of the contingent consideration for the PMA approval milestone.  The Company estimated the fair value of the contingent consideration for the revenue based milestone to be $32.6&#160;million at the acquisition date and $25.0&#160;million for the PMA approval milestone as of December 31, 2022. The company recorded a total of $48.7&#160;million in other liabilities as of March 31, 2023 and $12.5&#160;million in accrued expenses and other current liabilities at March 31, 2023 in the consolidated balance sheet of the company.  &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;The change in the fair value of the contingent obligation was primarily as a result of changes in the timing.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%"&gt;Deferred Tax Liabilities&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;Deferred tax liabilities result from identifiable intangible assets&#x2019; fair value adjustments. These adjustments create excess book basis over tax basis which is tax-effected by the statutory tax rates of applicable jurisdictions.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:107%"&gt;Sale of non-core traditional wound care business&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August 31, 2022, the Company completed its sale of its non-core traditional wound care ("TWC") business to Gentell, LLC ("Gentell") for $28.8 million, which consists of $27.8 million in cash plus $1.0 million in contingent consideration which may be received upon achieving certain revenue-based performance milestones two years after the closing date. The proceeds from the sale of the TWC business of $27.8 million is presented in the consolidated statement of cash flows net of cash transferred of $3.5 million and other transaction fees. The transaction included the sale of the Company's TWC products, such as sponges, gauze and conforming bandages, and certain advanced wound care dressings, such as supportive, calcium alginate, hydrogel, and foam dressings.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The divestiture did not represent a strategic shift that had a major effect on the Company's operations and financial statements. Goodwill was allocated to the assets and liabilities divested using the relative fair value method of the TWC business to the Company's TT reportable business segment. In connection with the sale, the Company recognized $0.6 million as a gain from the sale of the business in the condensed consolidated statement of operations for the year ended December&#160;31, 2022. The transaction is subject to final working capital adjustments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition to the purchase and sale agreement, the Company also entered into a contract manufacturing agreement with Gentell. Under the terms of the agreement, Gentell received inventory, equipment, and tooling to manufacture certain MediHoney&#xae; and TCC-EZ&#xae; products on behalf of the Company. On the close date of this transaction, the Company transferred all inventory associated with these products to Gentell and recognized an asset of $11.1 million, as a form of a deposit for the inventory transferred, which based on the expected timing of inventory purchases, was primarily included within prepaid expenses and other current assets in the consolidated balance sheet. This deposit will be utilized by the Company on future orders placed to Gentell for such products. As of March&#160;31, 2023, the Company had a deposit remaining of $7.3 million which is included in prepaid assets and recognized a payable due to Gentell of $0.7 million, which is included in the condensed consolidated balance sheet within accrued expenses and other current liabilities.&lt;/span&gt;&lt;/div&gt;</us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i2aee20b22d6c4af1adc9943efb3a200b_D20221206-20221206"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8zNy9mcmFnOjM1MjU5OWQwYjU5ODQxYmM5ZjY0N2MxNGMzOWRkYjVjL3RleHRyZWdpb246MzUyNTk5ZDBiNTk4NDFiYzlmNjQ3YzE0YzM5ZGRiNWNfNDM5ODA0NjUyMzcyMw_9c0722b6-5475-421f-b6c0-00a0d97e7d88"
      unitRef="usd">51500000</us-gaap:PaymentsToAcquireBusinessesGross>
    <iart:BusinessAcquisitionNumberOfContingentLiabilities
      contextRef="i2aee20b22d6c4af1adc9943efb3a200b_D20221206-20221206"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8zNy9mcmFnOjM1MjU5OWQwYjU5ODQxYmM5ZjY0N2MxNGMzOWRkYjVjL3RleHRyZWdpb246MzUyNTk5ZDBiNTk4NDFiYzlmNjQ3YzE0YzM5ZGRiNWNfOTg5NTYwNDY4MTgyOA_de5a27c8-8186-4083-a077-e39fa4492032"
      unitRef="payment">2</iart:BusinessAcquisitionNumberOfContingentLiabilities>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
      contextRef="ic77f745d6f9e48afadfcda799fcc3235_I20221206"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8zNy9mcmFnOjM1MjU5OWQwYjU5ODQxYmM5ZjY0N2MxNGMzOWRkYjVjL3RleHRyZWdpb246MzUyNTk5ZDBiNTk4NDFiYzlmNjQ3YzE0YzM5ZGRiNWNfNDM5ODA0NjUyMzczOQ_c525274d-d38f-42ef-8d48-ffe8b9aa7853"
      unitRef="usd">50000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
      contextRef="i4a4cd86df7eb418cb65f718c0f4e4dbd_I20221206"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8zNy9mcmFnOjM1MjU5OWQwYjU5ODQxYmM5ZjY0N2MxNGMzOWRkYjVjL3RleHRyZWdpb246MzUyNTk5ZDBiNTk4NDFiYzlmNjQ3YzE0YzM5ZGRiNWNfNjA0NzMxMzk2NTQxNg_b617409d-b05a-4571-9351-851b8581d758"
      unitRef="usd">40000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh>
    <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8zNy9mcmFnOjM1MjU5OWQwYjU5ODQxYmM5ZjY0N2MxNGMzOWRkYjVjL3RleHRyZWdpb246MzUyNTk5ZDBiNTk4NDFiYzlmNjQ3YzE0YzM5ZGRiNWNfOTg5NTYwNDY4MTgyMQ_d58679db-b9e4-42a3-8c02-0a4b88965711">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;The following table summarizes the fair values of the assets acquired and liabilities assumed at the acquisition date:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.028%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.545%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Preliminary Valuation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average Life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,438&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Trade accounts receivable, net &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,551&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Inventories, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,654&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;127,397&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accounts payable and accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,044&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,044&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred Tax Liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,799&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;57,607&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total liabilities assumed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;71,450&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;55,947&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="i9562f5f76a11487db81f0d5c50e212ba_I20221206"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8zNy9mcmFnOjM1MjU5OWQwYjU5ODQxYmM5ZjY0N2MxNGMzOWRkYjVjL3RhYmxlOjUyN2VlYzkyMzFjYTQyNjY5OTVjN2U2Nzc1MDI2Yzk0L3RhYmxlcmFuZ2U6NTI3ZWVjOTIzMWNhNDI2Njk5NWM3ZTY3NzUwMjZjOTRfMi0xLTEtMS0xOTA0NTI_e1eb70e5-1bde-481a-bd9c-d59110064992"
      unitRef="usd">4438000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="i9562f5f76a11487db81f0d5c50e212ba_I20221206"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8zNy9mcmFnOjM1MjU5OWQwYjU5ODQxYmM5ZjY0N2MxNGMzOWRkYjVjL3RhYmxlOjUyN2VlYzkyMzFjYTQyNjY5OTVjN2U2Nzc1MDI2Yzk0L3RhYmxlcmFuZ2U6NTI3ZWVjOTIzMWNhNDI2Njk5NWM3ZTY3NzUwMjZjOTRfMy0xLTEtMS0xOTA0NTI_c7c5c069-9947-49c5-8833-356918bc9419"
      unitRef="usd">1551000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
      contextRef="i9562f5f76a11487db81f0d5c50e212ba_I20221206"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8zNy9mcmFnOjM1MjU5OWQwYjU5ODQxYmM5ZjY0N2MxNGMzOWRkYjVjL3RhYmxlOjUyN2VlYzkyMzFjYTQyNjY5OTVjN2U2Nzc1MDI2Yzk0L3RhYmxlcmFuZ2U6NTI3ZWVjOTIzMWNhNDI2Njk5NWM3ZTY3NzUwMjZjOTRfNC0xLTEtMS0xOTA0NTI_39ef4e9e-226d-4c1d-87be-92b6f7ca046d"
      unitRef="usd">2900000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets
      contextRef="i9562f5f76a11487db81f0d5c50e212ba_I20221206"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8zNy9mcmFnOjM1MjU5OWQwYjU5ODQxYmM5ZjY0N2MxNGMzOWRkYjVjL3RhYmxlOjUyN2VlYzkyMzFjYTQyNjY5OTVjN2U2Nzc1MDI2Yzk0L3RhYmxlcmFuZ2U6NTI3ZWVjOTIzMWNhNDI2Njk5NWM3ZTY3NzUwMjZjOTRfNS0xLTEtMS0xOTA0NTI_9c29e468-4f2d-4fc1-8a34-a54507ae88f8"
      unitRef="usd">1654000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets
      contextRef="i9562f5f76a11487db81f0d5c50e212ba_I20221206"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8zNy9mcmFnOjM1MjU5OWQwYjU5ODQxYmM5ZjY0N2MxNGMzOWRkYjVjL3RhYmxlOjUyN2VlYzkyMzFjYTQyNjY5OTVjN2U2Nzc1MDI2Yzk0L3RhYmxlcmFuZ2U6NTI3ZWVjOTIzMWNhNDI2Njk5NWM3ZTY3NzUwMjZjOTRfNi0xLTEtMS0yMDMyNjY_e82e506e-4888-4e14-b847-668410f96da8"
      unitRef="usd">10543000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i9562f5f76a11487db81f0d5c50e212ba_I20221206"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8zNy9mcmFnOjM1MjU5OWQwYjU5ODQxYmM5ZjY0N2MxNGMzOWRkYjVjL3RhYmxlOjUyN2VlYzkyMzFjYTQyNjY5OTVjN2U2Nzc1MDI2Yzk0L3RhYmxlcmFuZ2U6NTI3ZWVjOTIzMWNhNDI2Njk5NWM3ZTY3NzUwMjZjOTRfNy0xLTEtMS0xOTA0NTI_637acf7a-ec85-40a4-a671-96743095dbf2"
      unitRef="usd">75000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i2aee20b22d6c4af1adc9943efb3a200b_D20221206-20221206"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8zNy9mcmFnOjM1MjU5OWQwYjU5ODQxYmM5ZjY0N2MxNGMzOWRkYjVjL3RhYmxlOjUyN2VlYzkyMzFjYTQyNjY5OTVjN2U2Nzc1MDI2Yzk0L3RhYmxlcmFuZ2U6NTI3ZWVjOTIzMWNhNDI2Njk5NWM3ZTY3NzUwMjZjOTRfNy0zLTEtMS0xOTA0NTI_1b05cf1f-1723-4094-97ba-795c456c6e49">P14Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:Goodwill
      contextRef="i9562f5f76a11487db81f0d5c50e212ba_I20221206"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8zNy9mcmFnOjM1MjU5OWQwYjU5ODQxYmM5ZjY0N2MxNGMzOWRkYjVjL3RhYmxlOjUyN2VlYzkyMzFjYTQyNjY5OTVjN2U2Nzc1MDI2Yzk0L3RhYmxlcmFuZ2U6NTI3ZWVjOTIzMWNhNDI2Njk5NWM3ZTY3NzUwMjZjOTRfOC0xLTEtMS0xOTA0NTI_9a05d3ba-9e0d-4f5b-9645-e915b6a3aff2"
      unitRef="usd">41854000</us-gaap:Goodwill>
    <iart:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill
      contextRef="i9562f5f76a11487db81f0d5c50e212ba_I20221206"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8zNy9mcmFnOjM1MjU5OWQwYjU5ODQxYmM5ZjY0N2MxNGMzOWRkYjVjL3RhYmxlOjUyN2VlYzkyMzFjYTQyNjY5OTVjN2U2Nzc1MDI2Yzk0L3RhYmxlcmFuZ2U6NTI3ZWVjOTIzMWNhNDI2Njk5NWM3ZTY3NzUwMjZjOTRfOS0xLTEtMS0yMDMyNjY_96e51be7-5023-4097-b343-f019057ffbd6"
      unitRef="usd">127397000</iart:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
      contextRef="i9562f5f76a11487db81f0d5c50e212ba_I20221206"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8zNy9mcmFnOjM1MjU5OWQwYjU5ODQxYmM5ZjY0N2MxNGMzOWRkYjVjL3RhYmxlOjUyN2VlYzkyMzFjYTQyNjY5OTVjN2U2Nzc1MDI2Yzk0L3RhYmxlcmFuZ2U6NTI3ZWVjOTIzMWNhNDI2Njk5NWM3ZTY3NzUwMjZjOTRfMTItMS0xLTEtMTkwNDUy_d522c00a-25c6-42fc-9423-68d697f131db"
      unitRef="usd">2044000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities
      contextRef="i9562f5f76a11487db81f0d5c50e212ba_I20221206"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8zNy9mcmFnOjM1MjU5OWQwYjU5ODQxYmM5ZjY0N2MxNGMzOWRkYjVjL3RhYmxlOjUyN2VlYzkyMzFjYTQyNjY5OTVjN2U2Nzc1MDI2Yzk0L3RhYmxlcmFuZ2U6NTI3ZWVjOTIzMWNhNDI2Njk5NWM3ZTY3NzUwMjZjOTRfMTMtMS0xLTEtMjAzMjY2_57cfc8de-99ce-4dca-8948-3f95ae766511"
      unitRef="usd">2044000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
      contextRef="i9562f5f76a11487db81f0d5c50e212ba_I20221206"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8zNy9mcmFnOjM1MjU5OWQwYjU5ODQxYmM5ZjY0N2MxNGMzOWRkYjVjL3RhYmxlOjUyN2VlYzkyMzFjYTQyNjY5OTVjN2U2Nzc1MDI2Yzk0L3RhYmxlcmFuZ2U6NTI3ZWVjOTIzMWNhNDI2Njk5NWM3ZTY3NzUwMjZjOTRfMTQtMS0xLTEtMTkwNDUy_b28b28f5-e40b-4ea0-9519-e320ebeafbeb"
      unitRef="usd">11799000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability
      contextRef="i9562f5f76a11487db81f0d5c50e212ba_I20221206"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8zNy9mcmFnOjM1MjU5OWQwYjU5ODQxYmM5ZjY0N2MxNGMzOWRkYjVjL3RhYmxlOjUyN2VlYzkyMzFjYTQyNjY5OTVjN2U2Nzc1MDI2Yzk0L3RhYmxlcmFuZ2U6NTI3ZWVjOTIzMWNhNDI2Njk5NWM3ZTY3NzUwMjZjOTRfMTUtMS0xLTEtMTkwNDUy_d1a29d6a-9376-4638-800f-0b08c827efda"
      unitRef="usd">57607000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="i9562f5f76a11487db81f0d5c50e212ba_I20221206"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8zNy9mcmFnOjM1MjU5OWQwYjU5ODQxYmM5ZjY0N2MxNGMzOWRkYjVjL3RhYmxlOjUyN2VlYzkyMzFjYTQyNjY5OTVjN2U2Nzc1MDI2Yzk0L3RhYmxlcmFuZ2U6NTI3ZWVjOTIzMWNhNDI2Njk5NWM3ZTY3NzUwMjZjOTRfMTYtMS0xLTEtMjAzMjY2_54f10150-c76d-440e-b902-398ff21b8d72"
      unitRef="usd">71450000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i9562f5f76a11487db81f0d5c50e212ba_I20221206"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8zNy9mcmFnOjM1MjU5OWQwYjU5ODQxYmM5ZjY0N2MxNGMzOWRkYjVjL3RhYmxlOjUyN2VlYzkyMzFjYTQyNjY5OTVjN2U2Nzc1MDI2Yzk0L3RhYmxlcmFuZ2U6NTI3ZWVjOTIzMWNhNDI2Njk5NWM3ZTY3NzUwMjZjOTRfMTgtMS0xLTEtMjAzMjY2_cef8e103-5a43-433f-8933-277d6d0c667c"
      unitRef="usd">55947000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <iart:BusinessCombinationIntangibleAssetAcquiredDiscountRate
      contextRef="i9562f5f76a11487db81f0d5c50e212ba_I20221206"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8zNy9mcmFnOjM1MjU5OWQwYjU5ODQxYmM5ZjY0N2MxNGMzOWRkYjVjL3RleHRyZWdpb246MzUyNTk5ZDBiNTk4NDFiYzlmNjQ3YzE0YzM5ZGRiNWNfNDM5ODA0NjUyMDIxMQ_febe47d2-bf07-4388-aca2-5ebc4f2996b0"
      unitRef="number">0.18</iart:BusinessCombinationIntangibleAssetAcquiredDiscountRate>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
      contextRef="i9562f5f76a11487db81f0d5c50e212ba_I20221206"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8zNy9mcmFnOjM1MjU5OWQwYjU5ODQxYmM5ZjY0N2MxNGMzOWRkYjVjL3RleHRyZWdpb246MzUyNTk5ZDBiNTk4NDFiYzlmNjQ3YzE0YzM5ZGRiNWNfMTQyOTM2NTExOTE2NTg_8adf2133-e35e-4e11-92ef-21c5c48d648e"
      unitRef="usd">90000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh>
    <iart:BusinessAcquisitionNumberOfContingentLiabilities
      contextRef="i2aee20b22d6c4af1adc9943efb3a200b_D20221206-20221206"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8zNy9mcmFnOjM1MjU5OWQwYjU5ODQxYmM5ZjY0N2MxNGMzOWRkYjVjL3RleHRyZWdpb246MzUyNTk5ZDBiNTk4NDFiYzlmNjQ3YzE0YzM5ZGRiNWNfMTQyOTM2NTExOTE2NjY_de5a27c8-8186-4083-a077-e39fa4492032"
      unitRef="payment">2</iart:BusinessAcquisitionNumberOfContingentLiabilities>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
      contextRef="ic77f745d6f9e48afadfcda799fcc3235_I20221206"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8zNy9mcmFnOjM1MjU5OWQwYjU5ODQxYmM5ZjY0N2MxNGMzOWRkYjVjL3RleHRyZWdpb246MzUyNTk5ZDBiNTk4NDFiYzlmNjQ3YzE0YzM5ZGRiNWNfMTQyOTM2NTExOTE4MDE_c525274d-d38f-42ef-8d48-ffe8b9aa7853"
      unitRef="usd">50000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
      contextRef="i4a4cd86df7eb418cb65f718c0f4e4dbd_I20221206"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8zNy9mcmFnOjM1MjU5OWQwYjU5ODQxYmM5ZjY0N2MxNGMzOWRkYjVjL3RleHRyZWdpb246MzUyNTk5ZDBiNTk4NDFiYzlmNjQ3YzE0YzM5ZGRiNWNfMTQyOTM2NTExOTE5NDI_3dfa4e95-35a6-48c9-bb5a-14d8cf59db11"
      unitRef="usd">40000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ic77f745d6f9e48afadfcda799fcc3235_I20221206"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8zNy9mcmFnOjM1MjU5OWQwYjU5ODQxYmM5ZjY0N2MxNGMzOWRkYjVjL3RleHRyZWdpb246MzUyNTk5ZDBiNTk4NDFiYzlmNjQ3YzE0YzM5ZGRiNWNfMTQyOTM2NTExOTI1MTI_da5ede24-cd13-4b88-809b-5ec5e03823e3"
      unitRef="usd">32600000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i4a4cd86df7eb418cb65f718c0f4e4dbd_I20221206"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8zNy9mcmFnOjM1MjU5OWQwYjU5ODQxYmM5ZjY0N2MxNGMzOWRkYjVjL3RleHRyZWdpb246MzUyNTk5ZDBiNTk4NDFiYzlmNjQ3YzE0YzM5ZGRiNWNfMTQyOTM2NTExOTI1NDQ_f6b3dbf3-463d-4c3c-bc3f-efd7371ae4db"
      unitRef="usd">25000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent
      contextRef="i5b74908fc42a482b9a714af70be67c23_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8zNy9mcmFnOjM1MjU5OWQwYjU5ODQxYmM5ZjY0N2MxNGMzOWRkYjVjL3RleHRyZWdpb246MzUyNTk5ZDBiNTk4NDFiYzlmNjQ3YzE0YzM5ZGRiNWNfNTQ5NzU1ODQ1OTg3_616bf53a-f7da-4049-9d3c-d5c326d48a98"
      unitRef="usd">48700000</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent
      contextRef="i5b74908fc42a482b9a714af70be67c23_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8zNy9mcmFnOjM1MjU5OWQwYjU5ODQxYmM5ZjY0N2MxNGMzOWRkYjVjL3RleHRyZWdpb246MzUyNTk5ZDBiNTk4NDFiYzlmNjQ3YzE0YzM5ZGRiNWNfNTQ5NzU1ODQ2MDA0_b5fd02fa-be57-4736-b220-d243bba0ac64"
      unitRef="usd">12500000</us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration
      contextRef="i945ecb5f56064998992427ac8c2997e7_I20220831"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8zNy9mcmFnOjM1MjU5OWQwYjU5ODQxYmM5ZjY0N2MxNGMzOWRkYjVjL3RleHRyZWdpb246MzUyNTk5ZDBiNTk4NDFiYzlmNjQ3YzE0YzM5ZGRiNWNfNjA0NzMxMzk2Nzc4MA_2b50af60-c258-4636-82f7-aa0798848164"
      unitRef="usd">28800000</us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="i04a8a39a1e704ddfa67a4702f8617631_D20220831-20220831"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8zNy9mcmFnOjM1MjU5OWQwYjU5ODQxYmM5ZjY0N2MxNGMzOWRkYjVjL3RleHRyZWdpb246MzUyNTk5ZDBiNTk4NDFiYzlmNjQ3YzE0YzM5ZGRiNWNfNjA0NzMxMzk2Nzc4NQ_8af016e9-fa26-4926-9ee7-af67aaca5464"
      unitRef="usd">27800000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <iart:DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsideration
      contextRef="i945ecb5f56064998992427ac8c2997e7_I20220831"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8zNy9mcmFnOjM1MjU5OWQwYjU5ODQxYmM5ZjY0N2MxNGMzOWRkYjVjL3RleHRyZWdpb246MzUyNTk5ZDBiNTk4NDFiYzlmNjQ3YzE0YzM5ZGRiNWNfNjA0NzMxMzk2Nzc5Mw_d3a65443-7ff2-4c6a-8d5d-33d5b3ab5792"
      unitRef="usd">1000000</iart:DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsideration>
    <iart:DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsiderationPeriod
      contextRef="i945ecb5f56064998992427ac8c2997e7_I20220831"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8zNy9mcmFnOjM1MjU5OWQwYjU5ODQxYmM5ZjY0N2MxNGMzOWRkYjVjL3RleHRyZWdpb246MzUyNTk5ZDBiNTk4NDFiYzlmNjQ3YzE0YzM5ZGRiNWNfNjA0NzMxMzk2Nzc5OA_2881b6fc-fdcc-4cc6-a7de-31377fbdf01b">P2Y</iart:DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsiderationPeriod>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="i04a8a39a1e704ddfa67a4702f8617631_D20220831-20220831"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8zNy9mcmFnOjM1MjU5OWQwYjU5ODQxYmM5ZjY0N2MxNGMzOWRkYjVjL3RleHRyZWdpb246MzUyNTk5ZDBiNTk4NDFiYzlmNjQ3YzE0YzM5ZGRiNWNfNjA0NzMxMzk2NzgwMw_8af016e9-fa26-4926-9ee7-af67aaca5464"
      unitRef="usd">27800000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:CashDivestedFromDeconsolidation
      contextRef="i04a8a39a1e704ddfa67a4702f8617631_D20220831-20220831"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8zNy9mcmFnOjM1MjU5OWQwYjU5ODQxYmM5ZjY0N2MxNGMzOWRkYjVjL3RleHRyZWdpb246MzUyNTk5ZDBiNTk4NDFiYzlmNjQ3YzE0YzM5ZGRiNWNfNjA0NzMxMzk2NzgwNw_5f778ce6-0816-4b6e-ba3d-3e6cdf7e003c"
      unitRef="usd">3500000</us-gaap:CashDivestedFromDeconsolidation>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="i36c1f405b82c4668bb563f8b0467fa90_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8zNy9mcmFnOjM1MjU5OWQwYjU5ODQxYmM5ZjY0N2MxNGMzOWRkYjVjL3RleHRyZWdpb246MzUyNTk5ZDBiNTk4NDFiYzlmNjQ3YzE0YzM5ZGRiNWNfNDM5ODA0NjUyNjIyMg_22cf0418-7546-4ea5-af45-99503f5ff795"
      unitRef="usd">600000</us-gaap:GainLossOnSaleOfBusiness>
    <iart:DiscontinuedOperationContinuingInvolvementPrepaidAsset
      contextRef="i945ecb5f56064998992427ac8c2997e7_I20220831"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8zNy9mcmFnOjM1MjU5OWQwYjU5ODQxYmM5ZjY0N2MxNGMzOWRkYjVjL3RleHRyZWdpb246MzUyNTk5ZDBiNTk4NDFiYzlmNjQ3YzE0YzM5ZGRiNWNfNDM5ODA0NjUyNjIyNw_2e28ba02-e86d-4102-a8c7-63d84806aa57"
      unitRef="usd">11100000</iart:DiscontinuedOperationContinuingInvolvementPrepaidAsset>
    <iart:DiscontinuedOperationContinuingInvolvementPrepaidAssetsCurrent
      contextRef="i07f57ce44af74eeb8d954e3a7fb7f1bc_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8zNy9mcmFnOjM1MjU5OWQwYjU5ODQxYmM5ZjY0N2MxNGMzOWRkYjVjL3RleHRyZWdpb246MzUyNTk5ZDBiNTk4NDFiYzlmNjQ3YzE0YzM5ZGRiNWNfNDM5ODA0NjUyNjI3Mw_7df05f0e-d4e0-4671-8636-bc0184185035"
      unitRef="usd">7300000</iart:DiscontinuedOperationContinuingInvolvementPrepaidAssetsCurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsPayable
      contextRef="i07f57ce44af74eeb8d954e3a7fb7f1bc_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF8zNy9mcmFnOjM1MjU5OWQwYjU5ODQxYmM5ZjY0N2MxNGMzOWRkYjVjL3RleHRyZWdpb246MzUyNTk5ZDBiNTk4NDFiYzlmNjQ3YzE0YzM5ZGRiNWNfNDM5ODA0NjUyNjI4OA_ebef7be1-ba6d-4d1f-bb61-904a5902887b"
      unitRef="usd">700000</us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsPayable>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80MC9mcmFnOjM5ODIzMTE1ZWIyYTQ0ZTI5NmEwOGZmNTVmZWQ5NjU3L3RleHRyZWdpb246Mzk4MjMxMTVlYjJhNDRlMjk2YTA4ZmY1NWZlZDk2NTdfNDk4Ng_7aa48cc9-816a-465c-8b21-7400a901fd02">REVENUES FROM CONTRACTS WITH CUSTOMERS &lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Summary of Accounting Policies on Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue is recognized upon the transfer of control of promised products or services to the customers in an amount that reflects the consideration the Company expects to receive in exchange for those products and services.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Performance Obligations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's performance obligations consist mainly of transferring control of goods and services identified in the contracts, purchase orders, or invoices. The Company has no significant multi-element contracts with customers.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Significant Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Usage-based royalties and licenses are estimated based on the provisions of contracts with customers and recognized in the same period that the royalty-based products are sold by the Company's strategic partners. The Company estimates and recognizes royalty revenue based upon communication with licensees, historical information, and expected sales trends. Differences between actual reported licensee sales and those that were estimated are adjusted in the period in which they become known, which is typically the following quarter. Historically, such adjustments have not been significant.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company estimates returns, price concessions, and discount allowances using the expected value method based on historical trends and other known factors. Rebate allowances are estimated using the most likely method based on each customer contract.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's return policy, as set forth in its product catalogs and sales invoices, requires review and authorization in advance prior to the return of product. Upon the authorization, a credit will be issued for the goods returned within a set amount of days from the shipment, which is generally 90 days.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company disregards the effects of a financing component if the Company expects, at contract inception, that the period between the transfer and customer payment for the goods or services will be one year or less. The Company has no significant revenues recognized on payments expected to be received more than one year after the transfer of control of products or services to customers.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Contract Asset and Liability&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues recognized from the Company's private label business that are not invoiced to the customers as a result of recognizing revenue over time are recorded as a contract asset included in the prepaid expenses and other current assets account in the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other operating revenues may include fees received under service agreements. Non-refundable fees received under multiple-period service agreements are recognized as revenue as the Company satisfies the performance obligations to the other party. A portion of the transaction price allocated to the performance obligations to be satisfied in the future periods is recognized as contract liability.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarized the changes in the contract asset and liability balances for the three months ended March 31, 2023:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:79.747%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.053%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Contract Asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Contract asset, January 1, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Transferred to trade receivable from contract asset included in beginning of the year contract asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(9,765)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Contract asset, net of transferred to trade receivables on contracts during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Contract asset, March&#160;31, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Contract Liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Contract liability, January 1, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Recognition of revenue included in beginning of year contract liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,492)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Contract liability, net of revenue recognized on contracts during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,921&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Contract liability, March&#160;31, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,559&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At March&#160;31, 2023, the short-term portion of the contract liability of $7.7 million and the long-term portion of $8.8 million is included in current liabilities and other liabilities, respectively, in the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2023, the Company is expected to recognize revenue of approximately 47% of unsatisfied (or partially unsatisfied) performance obligations as revenue within 12 months, with the remaining balance to be recognized thereafter.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Shipping and Handling Fees&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company elected to account for shipping and handling activities as a fulfillment cost rather than a separate performance obligation. Amounts billed to customers for shipping and handling are included as part of the transaction price and recognized as revenue when control of underlying products is transferred to the customer. The related shipping and freight charges incurred by the Company are included in the cost of goods sold.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Product Warranties&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain of the Company's medical devices, including monitoring systems and neurosurgical systems, are designed to operate over long periods of time. These products are sold with warranties which may extend for up to two years from the date of purchase. The warranties are not considered a separate performance obligation. The Company estimates its product warranties using the expected value method based on historical trends and other known factors. The Company includes them in accrued expenses and other current liabilities in the consolidated balance sheet.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Taxes Collected from Customers&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company elected to exclude from the measurement of the transaction price all taxes assessed by a governmental authority that are both imposed on and concurrent with a specific revenue-producing transaction and collected by the entity from a customer.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Disaggregated Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents revenues disaggregated by the major sources of revenues for the three months ended March&#160;31, 2023 and 2022 (dollar amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.028%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.545%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Neurosurgery&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;192,870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;194,675&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55,266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52,633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total Codman Specialty Surgical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;248,136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;247,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Wound Reconstruction and Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;100,940&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;94,630&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Private Label&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31,770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;34,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total Tissue Technologies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;132,710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;129,330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;380,846&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;376,638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;See Note 15, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Segment and Geographical Information&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, for details of revenues based on the location of the customer.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80MC9mcmFnOjM5ODIzMTE1ZWIyYTQ0ZTI5NmEwOGZmNTVmZWQ5NjU3L3RleHRyZWdpb246Mzk4MjMxMTVlYjJhNDRlMjk2YTA4ZmY1NWZlZDk2NTdfNTAwMA_fd2b8488-39de-4aaa-b957-3d30ccb75091">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Summary of Accounting Policies on Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue is recognized upon the transfer of control of promised products or services to the customers in an amount that reflects the consideration the Company expects to receive in exchange for those products and services.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Performance Obligations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's performance obligations consist mainly of transferring control of goods and services identified in the contracts, purchase orders, or invoices. The Company has no significant multi-element contracts with customers.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Significant Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Usage-based royalties and licenses are estimated based on the provisions of contracts with customers and recognized in the same period that the royalty-based products are sold by the Company's strategic partners. The Company estimates and recognizes royalty revenue based upon communication with licensees, historical information, and expected sales trends. Differences between actual reported licensee sales and those that were estimated are adjusted in the period in which they become known, which is typically the following quarter. Historically, such adjustments have not been significant.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company estimates returns, price concessions, and discount allowances using the expected value method based on historical trends and other known factors. Rebate allowances are estimated using the most likely method based on each customer contract.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's return policy, as set forth in its product catalogs and sales invoices, requires review and authorization in advance prior to the return of product. Upon the authorization, a credit will be issued for the goods returned within a set amount of days from the shipment, which is generally 90 days.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company disregards the effects of a financing component if the Company expects, at contract inception, that the period between the transfer and customer payment for the goods or services will be one year or less. The Company has no significant revenues recognized on payments expected to be received more than one year after the transfer of control of products or services to customers.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Contract Asset and Liability&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues recognized from the Company's private label business that are not invoiced to the customers as a result of recognizing revenue over time are recorded as a contract asset included in the prepaid expenses and other current assets account in the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other operating revenues may include fees received under service agreements. Non-refundable fees received under multiple-period service agreements are recognized as revenue as the Company satisfies the performance obligations to the other party. A portion of the transaction price allocated to the performance obligations to be satisfied in the future periods is recognized as contract liability.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Shipping and Handling Fees&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company elected to account for shipping and handling activities as a fulfillment cost rather than a separate performance obligation. Amounts billed to customers for shipping and handling are included as part of the transaction price and recognized as revenue when control of underlying products is transferred to the customer. The related shipping and freight charges incurred by the Company are included in the cost of goods sold.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <iart:ReturnPolicyIssueOfCreditNumberOfDaysFromShipment
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80MC9mcmFnOjM5ODIzMTE1ZWIyYTQ0ZTI5NmEwOGZmNTVmZWQ5NjU3L3RleHRyZWdpb246Mzk4MjMxMTVlYjJhNDRlMjk2YTA4ZmY1NWZlZDk2NTdfMTc0NQ_9c577405-c679-4006-a076-e5db00ae3dea">P90D</iart:ReturnPolicyIssueOfCreditNumberOfDaysFromShipment>
    <us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80MC9mcmFnOjM5ODIzMTE1ZWIyYTQ0ZTI5NmEwOGZmNTVmZWQ5NjU3L3RleHRyZWdpb246Mzk4MjMxMTVlYjJhNDRlMjk2YTA4ZmY1NWZlZDk2NTdfNDk5Mw_9e3755f4-e76a-49b6-8506-558a126e958a">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarized the changes in the contract asset and liability balances for the three months ended March 31, 2023:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:79.747%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.053%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Contract Asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Contract asset, January 1, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Transferred to trade receivable from contract asset included in beginning of the year contract asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(9,765)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Contract asset, net of transferred to trade receivables on contracts during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Contract asset, March&#160;31, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Contract Liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Contract liability, January 1, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Recognition of revenue included in beginning of year contract liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,492)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Contract liability, net of revenue recognized on contracts during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,921&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Contract liability, March&#160;31, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,559&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock>
    <us-gaap:ContractWithCustomerAssetNet
      contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80MC9mcmFnOjM5ODIzMTE1ZWIyYTQ0ZTI5NmEwOGZmNTVmZWQ5NjU3L3RhYmxlOmU3M2M5NjU5MzIxNzRjMTk4MGM1ZWEwM2Y0ZjQ4MjE3L3RhYmxlcmFuZ2U6ZTczYzk2NTkzMjE3NGMxOTgwYzVlYTAzZjRmNDgyMTdfNC01LTEtMS0xODY4MjE_60e4e016-da0d-4ee5-90ff-23942a65b5fa"
      unitRef="usd">10122000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ContractWithCustomerAssetReclassifiedToReceivable
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80MC9mcmFnOjM5ODIzMTE1ZWIyYTQ0ZTI5NmEwOGZmNTVmZWQ5NjU3L3RhYmxlOmU3M2M5NjU5MzIxNzRjMTk4MGM1ZWEwM2Y0ZjQ4MjE3L3RhYmxlcmFuZ2U6ZTczYzk2NTkzMjE3NGMxOTgwYzVlYTAzZjRmNDgyMTdfNS01LTEtMS0xODY4MjE_59d7cee0-3ceb-419d-b6ae-8c7469dc02d3"
      unitRef="usd">9765000</us-gaap:ContractWithCustomerAssetReclassifiedToReceivable>
    <iart:ContractWithCustomerAssetNetOfReclassifiedToReceivable
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80MC9mcmFnOjM5ODIzMTE1ZWIyYTQ0ZTI5NmEwOGZmNTVmZWQ5NjU3L3RhYmxlOmU3M2M5NjU5MzIxNzRjMTk4MGM1ZWEwM2Y0ZjQ4MjE3L3RhYmxlcmFuZ2U6ZTczYzk2NTkzMjE3NGMxOTgwYzVlYTAzZjRmNDgyMTdfNi01LTEtMS0xODY4MjE_1fdb35de-3dd7-4d2b-b592-345bf7de49b3"
      unitRef="usd">9713000</iart:ContractWithCustomerAssetNetOfReclassifiedToReceivable>
    <us-gaap:ContractWithCustomerAssetNet
      contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80MC9mcmFnOjM5ODIzMTE1ZWIyYTQ0ZTI5NmEwOGZmNTVmZWQ5NjU3L3RhYmxlOmU3M2M5NjU5MzIxNzRjMTk4MGM1ZWEwM2Y0ZjQ4MjE3L3RhYmxlcmFuZ2U6ZTczYzk2NTkzMjE3NGMxOTgwYzVlYTAzZjRmNDgyMTdfNy01LTEtMS0xODY4MjE_a2900e7b-c5bd-44a9-8bd7-8a46d4faba44"
      unitRef="usd">10070000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80MC9mcmFnOjM5ODIzMTE1ZWIyYTQ0ZTI5NmEwOGZmNTVmZWQ5NjU3L3RhYmxlOmU3M2M5NjU5MzIxNzRjMTk4MGM1ZWEwM2Y0ZjQ4MjE3L3RhYmxlcmFuZ2U6ZTczYzk2NTkzMjE3NGMxOTgwYzVlYTAzZjRmNDgyMTdfMTAtNS0xLTEtMTg2ODIx_262f0474-d1e2-4cca-a88b-66b827589250"
      unitRef="usd">16127000</us-gaap:ContractWithCustomerLiability>
    <iart:ContractWithCustomerLiabilityNetOfRevenueRecognized
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80MC9mcmFnOjM5ODIzMTE1ZWIyYTQ0ZTI5NmEwOGZmNTVmZWQ5NjU3L3RhYmxlOmU3M2M5NjU5MzIxNzRjMTk4MGM1ZWEwM2Y0ZjQ4MjE3L3RhYmxlcmFuZ2U6ZTczYzk2NTkzMjE3NGMxOTgwYzVlYTAzZjRmNDgyMTdfMTEtNS0xLTEtMTg2ODIx_5e7be706-eeae-4990-b152-926ba14e5063"
      unitRef="usd">-2492000</iart:ContractWithCustomerLiabilityNetOfRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80MC9mcmFnOjM5ODIzMTE1ZWIyYTQ0ZTI5NmEwOGZmNTVmZWQ5NjU3L3RhYmxlOmU3M2M5NjU5MzIxNzRjMTk4MGM1ZWEwM2Y0ZjQ4MjE3L3RhYmxlcmFuZ2U6ZTczYzk2NTkzMjE3NGMxOTgwYzVlYTAzZjRmNDgyMTdfMTItNS0xLTEtMTg2ODIx_22ccca8e-b5e8-4f5d-bf34-03d923fa435c"
      unitRef="usd">-2921000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <iart:ContractWithCustomerLiabilityIncreaseDecreaseFromForeignCurrencyTranslation
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80MC9mcmFnOjM5ODIzMTE1ZWIyYTQ0ZTI5NmEwOGZmNTVmZWQ5NjU3L3RhYmxlOmU3M2M5NjU5MzIxNzRjMTk4MGM1ZWEwM2Y0ZjQ4MjE3L3RhYmxlcmFuZ2U6ZTczYzk2NTkzMjE3NGMxOTgwYzVlYTAzZjRmNDgyMTdfMTMtNS0xLTEtMTg2ODIx_763a5207-af8a-40f5-b836-da9e21012e4e"
      unitRef="usd">3000</iart:ContractWithCustomerLiabilityIncreaseDecreaseFromForeignCurrencyTranslation>
    <us-gaap:ContractWithCustomerLiability
      contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80MC9mcmFnOjM5ODIzMTE1ZWIyYTQ0ZTI5NmEwOGZmNTVmZWQ5NjU3L3RhYmxlOmU3M2M5NjU5MzIxNzRjMTk4MGM1ZWEwM2Y0ZjQ4MjE3L3RhYmxlcmFuZ2U6ZTczYzk2NTkzMjE3NGMxOTgwYzVlYTAzZjRmNDgyMTdfMTQtNS0xLTEtMTg2ODIx_c324b4d5-6efc-4a52-b40e-c8784aa2daa2"
      unitRef="usd">16559000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80MC9mcmFnOjM5ODIzMTE1ZWIyYTQ0ZTI5NmEwOGZmNTVmZWQ5NjU3L3RleHRyZWdpb246Mzk4MjMxMTVlYjJhNDRlMjk2YTA4ZmY1NWZlZDk2NTdfMzAwNw_a26e267e-6bff-4317-b575-4235d996a62a"
      unitRef="usd">7700000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent
      contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80MC9mcmFnOjM5ODIzMTE1ZWIyYTQ0ZTI5NmEwOGZmNTVmZWQ5NjU3L3RleHRyZWdpb246Mzk4MjMxMTVlYjJhNDRlMjk2YTA4ZmY1NWZlZDk2NTdfMzAzOQ_f3721919-fc3c-4a58-b470-ea0fd056685f"
      unitRef="usd">8800000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="i770b51dde44c4f0f852868d1b571cf9e_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80MC9mcmFnOjM5ODIzMTE1ZWIyYTQ0ZTI5NmEwOGZmNTVmZWQ5NjU3L3RleHRyZWdpb246Mzk4MjMxMTVlYjJhNDRlMjk2YTA4ZmY1NWZlZDk2NTdfMzIyMg_faba3370-4033-4831-9e63-5dfe4dd3d6ef"
      unitRef="number">0.47</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="i770b51dde44c4f0f852868d1b571cf9e_I20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80MC9mcmFnOjM5ODIzMTE1ZWIyYTQ0ZTI5NmEwOGZmNTVmZWQ5NjU3L3RleHRyZWdpb246Mzk4MjMxMTVlYjJhNDRlMjk2YTA4ZmY1NWZlZDk2NTdfMzMwOQ_85345b83-ad3e-417b-b173-d8357f1b2324">P12M</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:ExtendedProductWarrantyPolicy
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80MC9mcmFnOjM5ODIzMTE1ZWIyYTQ0ZTI5NmEwOGZmNTVmZWQ5NjU3L3RleHRyZWdpb246Mzk4MjMxMTVlYjJhNDRlMjk2YTA4ZmY1NWZlZDk2NTdfNDk4Mg_daf016d9-8435-4ce1-8aac-e541b1ef1e11">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Product Warranties&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain of the Company's medical devices, including monitoring systems and neurosurgical systems, are designed to operate over long periods of time. These products are sold with warranties which may extend for up to two years from the date of purchase. The warranties are not considered a separate performance obligation. The Company estimates its product warranties using the expected value method based on historical trends and other known factors. The Company includes them in accrued expenses and other current liabilities in the consolidated balance sheet.&lt;/span&gt;&lt;/div&gt;</us-gaap:ExtendedProductWarrantyPolicy>
    <iart:RevenueProductWarrantyPeriod
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80MC9mcmFnOjM5ODIzMTE1ZWIyYTQ0ZTI5NmEwOGZmNTVmZWQ5NjU3L3RleHRyZWdpb246Mzk4MjMxMTVlYjJhNDRlMjk2YTA4ZmY1NWZlZDk2NTdfNDA2Nw_a5b37686-a444-4976-8e7f-d551433c7eba">P2Y</iart:RevenueProductWarrantyPeriod>
    <us-gaap:RevenueTransactionPriceMeasurementTaxExclusionPolicyTextBlock
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80MC9mcmFnOjM5ODIzMTE1ZWIyYTQ0ZTI5NmEwOGZmNTVmZWQ5NjU3L3RleHRyZWdpb246Mzk4MjMxMTVlYjJhNDRlMjk2YTA4ZmY1NWZlZDk2NTdfNTAwMQ_39f5251a-8d05-438a-922a-1fa22f60c242">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Taxes Collected from Customers&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company elected to exclude from the measurement of the transaction price all taxes assessed by a governmental authority that are both imposed on and concurrent with a specific revenue-producing transaction and collected by the entity from a customer.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueTransactionPriceMeasurementTaxExclusionPolicyTextBlock>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80MC9mcmFnOjM5ODIzMTE1ZWIyYTQ0ZTI5NmEwOGZmNTVmZWQ5NjU3L3RleHRyZWdpb246Mzk4MjMxMTVlYjJhNDRlMjk2YTA4ZmY1NWZlZDk2NTdfNTAwNA_4eee4e43-6a12-427c-8e4a-0d214d86c88e">&lt;div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents revenues disaggregated by the major sources of revenues for the three months ended March&#160;31, 2023 and 2022 (dollar amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.028%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.545%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Neurosurgery&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;192,870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;194,675&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55,266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52,633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total Codman Specialty Surgical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;248,136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;247,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Wound Reconstruction and Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;100,940&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;94,630&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Private Label&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31,770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;34,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total Tissue Technologies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;132,710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;129,330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;380,846&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;376,638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i41cd523bdedf46cc95670faedd457b46_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80MC9mcmFnOjM5ODIzMTE1ZWIyYTQ0ZTI5NmEwOGZmNTVmZWQ5NjU3L3RhYmxlOmI2ZTM5OWI4MzFmZjQ4YTNhOWI4YWU4M2FiNDg0MjAxL3RhYmxlcmFuZ2U6YjZlMzk5YjgzMWZmNDhhM2E5YjhhZTgzYWI0ODQyMDFfMS0xLTEtMS0xODY4MjE_902c8a00-bf2a-416e-9577-d57122a7d0f0"
      unitRef="usd">192870000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ieb2f835f7aba47f8b013ef0af01dc9fa_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80MC9mcmFnOjM5ODIzMTE1ZWIyYTQ0ZTI5NmEwOGZmNTVmZWQ5NjU3L3RhYmxlOmI2ZTM5OWI4MzFmZjQ4YTNhOWI4YWU4M2FiNDg0MjAxL3RhYmxlcmFuZ2U6YjZlMzk5YjgzMWZmNDhhM2E5YjhhZTgzYWI0ODQyMDFfMS0zLTEtMS0xODY4MjE_13424041-7c48-42a6-99f8-46b4035acdd4"
      unitRef="usd">194675000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1f536ce18eba4aa1b760c5c3107d3a2a_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80MC9mcmFnOjM5ODIzMTE1ZWIyYTQ0ZTI5NmEwOGZmNTVmZWQ5NjU3L3RhYmxlOmI2ZTM5OWI4MzFmZjQ4YTNhOWI4YWU4M2FiNDg0MjAxL3RhYmxlcmFuZ2U6YjZlMzk5YjgzMWZmNDhhM2E5YjhhZTgzYWI0ODQyMDFfMi0xLTEtMS0xODY4MjE_8185fb7e-dc1c-4c18-90b4-22b131e443da"
      unitRef="usd">55266000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia5280886888b459382b2676a7723925f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80MC9mcmFnOjM5ODIzMTE1ZWIyYTQ0ZTI5NmEwOGZmNTVmZWQ5NjU3L3RhYmxlOmI2ZTM5OWI4MzFmZjQ4YTNhOWI4YWU4M2FiNDg0MjAxL3RhYmxlcmFuZ2U6YjZlMzk5YjgzMWZmNDhhM2E5YjhhZTgzYWI0ODQyMDFfMi0zLTEtMS0xODY4MjE_a243e3a7-0f73-4bb3-b7ea-4ed8544d4bca"
      unitRef="usd">52633000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifd59456ea9aa4f04b19628e881f264f6_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80MC9mcmFnOjM5ODIzMTE1ZWIyYTQ0ZTI5NmEwOGZmNTVmZWQ5NjU3L3RhYmxlOmI2ZTM5OWI4MzFmZjQ4YTNhOWI4YWU4M2FiNDg0MjAxL3RhYmxlcmFuZ2U6YjZlMzk5YjgzMWZmNDhhM2E5YjhhZTgzYWI0ODQyMDFfMy0xLTEtMS0xODY4MjE_799fc8ee-8554-428c-af38-8b8b098274d5"
      unitRef="usd">248136000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6524a64fd30c42eca0a31257f157eeec_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80MC9mcmFnOjM5ODIzMTE1ZWIyYTQ0ZTI5NmEwOGZmNTVmZWQ5NjU3L3RhYmxlOmI2ZTM5OWI4MzFmZjQ4YTNhOWI4YWU4M2FiNDg0MjAxL3RhYmxlcmFuZ2U6YjZlMzk5YjgzMWZmNDhhM2E5YjhhZTgzYWI0ODQyMDFfMy0zLTEtMS0xODY4MjE_6749f577-5d90-4c28-9d6c-5ba77add67ab"
      unitRef="usd">247308000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5b9610cb297e4cb9a4dacf782076fbbb_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80MC9mcmFnOjM5ODIzMTE1ZWIyYTQ0ZTI5NmEwOGZmNTVmZWQ5NjU3L3RhYmxlOmI2ZTM5OWI4MzFmZjQ4YTNhOWI4YWU4M2FiNDg0MjAxL3RhYmxlcmFuZ2U6YjZlMzk5YjgzMWZmNDhhM2E5YjhhZTgzYWI0ODQyMDFfNS0xLTEtMS0xODY4MjE_e0993c47-596f-4a9f-a88a-3579cd73696f"
      unitRef="usd">100940000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iac40b4f9e2254c7da7351d7d272012dd_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80MC9mcmFnOjM5ODIzMTE1ZWIyYTQ0ZTI5NmEwOGZmNTVmZWQ5NjU3L3RhYmxlOmI2ZTM5OWI4MzFmZjQ4YTNhOWI4YWU4M2FiNDg0MjAxL3RhYmxlcmFuZ2U6YjZlMzk5YjgzMWZmNDhhM2E5YjhhZTgzYWI0ODQyMDFfNS0zLTEtMS0xODY4MjE_245b9b67-0d0c-4acf-85da-1ea7e49e03b9"
      unitRef="usd">94630000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i90fa502ea15741368ebd39ece562c20f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80MC9mcmFnOjM5ODIzMTE1ZWIyYTQ0ZTI5NmEwOGZmNTVmZWQ5NjU3L3RhYmxlOmI2ZTM5OWI4MzFmZjQ4YTNhOWI4YWU4M2FiNDg0MjAxL3RhYmxlcmFuZ2U6YjZlMzk5YjgzMWZmNDhhM2E5YjhhZTgzYWI0ODQyMDFfNi0xLTEtMS0xODY4MjE_97f546c3-c3ea-4eaa-a534-9282519afb79"
      unitRef="usd">31770000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0fd180115b9642178d42038efe2b2776_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80MC9mcmFnOjM5ODIzMTE1ZWIyYTQ0ZTI5NmEwOGZmNTVmZWQ5NjU3L3RhYmxlOmI2ZTM5OWI4MzFmZjQ4YTNhOWI4YWU4M2FiNDg0MjAxL3RhYmxlcmFuZ2U6YjZlMzk5YjgzMWZmNDhhM2E5YjhhZTgzYWI0ODQyMDFfNi0zLTEtMS0xODY4MjE_7a549352-6036-4c54-a67f-75c11961ac3b"
      unitRef="usd">34700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibcfddd0c2c684ea4acbf2b9ae4cd8527_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80MC9mcmFnOjM5ODIzMTE1ZWIyYTQ0ZTI5NmEwOGZmNTVmZWQ5NjU3L3RhYmxlOmI2ZTM5OWI4MzFmZjQ4YTNhOWI4YWU4M2FiNDg0MjAxL3RhYmxlcmFuZ2U6YjZlMzk5YjgzMWZmNDhhM2E5YjhhZTgzYWI0ODQyMDFfNy0xLTEtMS0xODY4MjE_a747fd4b-d608-4be5-b7f7-f2ac29317188"
      unitRef="usd">132710000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i842208849e5d47b588209f3a26f3a724_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80MC9mcmFnOjM5ODIzMTE1ZWIyYTQ0ZTI5NmEwOGZmNTVmZWQ5NjU3L3RhYmxlOmI2ZTM5OWI4MzFmZjQ4YTNhOWI4YWU4M2FiNDg0MjAxL3RhYmxlcmFuZ2U6YjZlMzk5YjgzMWZmNDhhM2E5YjhhZTgzYWI0ODQyMDFfNy0zLTEtMS0xODY4MjE_ca0818ee-56c0-4744-8488-b1501934e561"
      unitRef="usd">129330000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80MC9mcmFnOjM5ODIzMTE1ZWIyYTQ0ZTI5NmEwOGZmNTVmZWQ5NjU3L3RhYmxlOmI2ZTM5OWI4MzFmZjQ4YTNhOWI4YWU4M2FiNDg0MjAxL3RhYmxlcmFuZ2U6YjZlMzk5YjgzMWZmNDhhM2E5YjhhZTgzYWI0ODQyMDFfOC0xLTEtMS0xODY4MjE_888fcd10-59ed-4193-9f40-ad60ccd5500a"
      unitRef="usd">380846000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80MC9mcmFnOjM5ODIzMTE1ZWIyYTQ0ZTI5NmEwOGZmNTVmZWQ5NjU3L3RhYmxlOmI2ZTM5OWI4MzFmZjQ4YTNhOWI4YWU4M2FiNDg0MjAxL3RhYmxlcmFuZ2U6YjZlMzk5YjgzMWZmNDhhM2E5YjhhZTgzYWI0ODQyMDFfOC0zLTEtMS0xODY4MjE_77221196-dfb1-4b9e-854c-25aa48f934e8"
      unitRef="usd">376638000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:InventoryDisclosureTextBlock
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80My9mcmFnOmRkMzJhNzA2ZWM5ZTRiMzJhMjc2MDlkYTBhM2QwOTMwL3RleHRyZWdpb246ZGQzMmE3MDZlYzllNGIzMmEyNzYwOWRhMGEzZDA5MzBfODQ_b4f35900-1b6a-4ee9-89a0-f0ad217e127e">INVENTORIES&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories, net consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.882%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.545%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;178,626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;172,088&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Work in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;80,532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;70,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;92,117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;81,897&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total inventories, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;351,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;324,583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80My9mcmFnOmRkMzJhNzA2ZWM5ZTRiMzJhMjc2MDlkYTBhM2QwOTMwL3RleHRyZWdpb246ZGQzMmE3MDZlYzllNGIzMmEyNzYwOWRhMGEzZDA5MzBfNjU_8c9738bb-3da7-41b7-8a50-7416a48e206d">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories, net consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.882%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.545%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;178,626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;172,088&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Work in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;80,532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;70,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;92,117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;81,897&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total inventories, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;351,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;324,583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80My9mcmFnOmRkMzJhNzA2ZWM5ZTRiMzJhMjc2MDlkYTBhM2QwOTMwL3RhYmxlOjlkZWUxNWMwNjFjZjRmOTFhYTFkOWM5ZjgxYWRmMzVhL3RhYmxlcmFuZ2U6OWRlZTE1YzA2MWNmNGY5MWFhMWQ5YzlmODFhZGYzNWFfMS0xLTEtMS0xODY4MjE_ac4a8038-7551-4c58-91b8-3e2b5e61f0f9"
      unitRef="usd">178626000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80My9mcmFnOmRkMzJhNzA2ZWM5ZTRiMzJhMjc2MDlkYTBhM2QwOTMwL3RhYmxlOjlkZWUxNWMwNjFjZjRmOTFhYTFkOWM5ZjgxYWRmMzVhL3RhYmxlcmFuZ2U6OWRlZTE1YzA2MWNmNGY5MWFhMWQ5YzlmODFhZGYzNWFfMS0zLTEtMS0xODY4MjE_94e06ff1-f405-4916-849b-d67141aff7f6"
      unitRef="usd">172088000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80My9mcmFnOmRkMzJhNzA2ZWM5ZTRiMzJhMjc2MDlkYTBhM2QwOTMwL3RhYmxlOjlkZWUxNWMwNjFjZjRmOTFhYTFkOWM5ZjgxYWRmMzVhL3RhYmxlcmFuZ2U6OWRlZTE1YzA2MWNmNGY5MWFhMWQ5YzlmODFhZGYzNWFfMi0xLTEtMS0xODY4MjE_0b3da39b-f3db-4c4b-8b03-5fff44f4f046"
      unitRef="usd">80532000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80My9mcmFnOmRkMzJhNzA2ZWM5ZTRiMzJhMjc2MDlkYTBhM2QwOTMwL3RhYmxlOjlkZWUxNWMwNjFjZjRmOTFhYTFkOWM5ZjgxYWRmMzVhL3RhYmxlcmFuZ2U6OWRlZTE1YzA2MWNmNGY5MWFhMWQ5YzlmODFhZGYzNWFfMi0zLTEtMS0xODY4MjE_2ec2897e-04a6-4bac-96fa-a062eb73e7d1"
      unitRef="usd">70598000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryRawMaterialsAndPurchasedPartsNetOfReserves
      contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80My9mcmFnOmRkMzJhNzA2ZWM5ZTRiMzJhMjc2MDlkYTBhM2QwOTMwL3RhYmxlOjlkZWUxNWMwNjFjZjRmOTFhYTFkOWM5ZjgxYWRmMzVhL3RhYmxlcmFuZ2U6OWRlZTE1YzA2MWNmNGY5MWFhMWQ5YzlmODFhZGYzNWFfMy0xLTEtMS0xODY4MjE_11ab22d2-9756-4e20-b730-2caa0b6e8fd5"
      unitRef="usd">92117000</us-gaap:InventoryRawMaterialsAndPurchasedPartsNetOfReserves>
    <us-gaap:InventoryRawMaterialsAndPurchasedPartsNetOfReserves
      contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80My9mcmFnOmRkMzJhNzA2ZWM5ZTRiMzJhMjc2MDlkYTBhM2QwOTMwL3RhYmxlOjlkZWUxNWMwNjFjZjRmOTFhYTFkOWM5ZjgxYWRmMzVhL3RhYmxlcmFuZ2U6OWRlZTE1YzA2MWNmNGY5MWFhMWQ5YzlmODFhZGYzNWFfMy0zLTEtMS0xODY4MjE_187ddef1-9d38-4ae2-8d7b-e8f3db1d2a45"
      unitRef="usd">81897000</us-gaap:InventoryRawMaterialsAndPurchasedPartsNetOfReserves>
    <us-gaap:InventoryNet
      contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80My9mcmFnOmRkMzJhNzA2ZWM5ZTRiMzJhMjc2MDlkYTBhM2QwOTMwL3RhYmxlOjlkZWUxNWMwNjFjZjRmOTFhYTFkOWM5ZjgxYWRmMzVhL3RhYmxlcmFuZ2U6OWRlZTE1YzA2MWNmNGY5MWFhMWQ5YzlmODFhZGYzNWFfNC0xLTEtMS0xODY4MjE_0561d775-b972-4683-9f41-85f3b88614f6"
      unitRef="usd">351275000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80My9mcmFnOmRkMzJhNzA2ZWM5ZTRiMzJhMjc2MDlkYTBhM2QwOTMwL3RhYmxlOjlkZWUxNWMwNjFjZjRmOTFhYTFkOWM5ZjgxYWRmMzVhL3RhYmxlcmFuZ2U6OWRlZTE1YzA2MWNmNGY5MWFhMWQ5YzlmODFhZGYzNWFfNC0zLTEtMS0xODY4MjE_4dc724ec-4bdf-48bc-8c5a-ab8295e88def"
      unitRef="usd">324583000</us-gaap:InventoryNet>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RleHRyZWdpb246YTI1ZmIwNDQ3ODBlNGQ4NWI5ZTBlMDY5YjFmOGE1NDNfNTA2_36b42a5f-dd34-4085-9127-ca8a87ec13d7">GOODWILL AND OTHER INTANGIBLE ASSETS&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the carrying amount of goodwill for the three-month period ended March&#160;31, 2023 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.389%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.915%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Codman Specialty &lt;br/&gt;Surgical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Tissue Technologies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Goodwill at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;656,219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;382,662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,038,881&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;SIA Acquisition Working Capital Adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,639&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;957&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Goodwill at March&#160;31, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;657,858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;383,748&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,041,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of the Company&#x2019;s identifiable intangible assets were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.331%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Completed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,206,748&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(389,297)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;817,451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;193,297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(146,098)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;47,199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Trademarks/brand names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;97,554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(35,665)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;61,889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Codman tradename&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Indefinite&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;167,529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;167,529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Supplier relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(17,415)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,796&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;All other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,024&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,129)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,895&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,701,363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(592,604)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,108,759&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.783%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.554%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.331%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Completed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,204,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(370,968)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;833,357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;193,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(144,040)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49,041&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Trademarks/brand names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;97,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(34,674)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;62,591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Codman tradename&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Indefinite&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;166,693&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;166,693&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Supplier relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(17,170)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,041&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;All other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,957&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,071)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,697,532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(570,923)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,126,609&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Based on quarter-end exchange rates, amortization expense (including amounts reported in cost of goods sold) is expected to be approximately $61.8 million for the remainder of 2023, $81.8 million in 2024, $81.8 million in 2025, $81.6 million in 2026, $79.7 million in 2027, $78.1 million in 2028 and $474.4 million thereafter.&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RleHRyZWdpb246YTI1ZmIwNDQ3ODBlNGQ4NWI5ZTBlMDY5YjFmOGE1NDNfNTE4_6b0ea34f-d7ad-4a28-8b51-1a607c8de003">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the carrying amount of goodwill for the three-month period ended March&#160;31, 2023 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.389%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.915%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Codman Specialty &lt;br/&gt;Surgical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Tissue Technologies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Goodwill at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;656,219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;382,662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,038,881&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;SIA Acquisition Working Capital Adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,639&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;957&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Goodwill at March&#160;31, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;657,858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;383,748&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,041,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="ib712dcb2854f46f28657fb649d2220db_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjEwZmU1ZmMzZTY3ZjRlNTU4NGFjNmY5OWRjZjMwZWE3L3RhYmxlcmFuZ2U6MTBmZTVmYzNlNjdmNGU1NTg0YWM2Zjk5ZGNmMzBlYTdfMS0xLTEtMS0xODY4MjE_fa771ed0-9865-4940-afc5-e7e1144fdedd"
      unitRef="usd">656219000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i542245b54ecf4d72b1024950a433c9af_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjEwZmU1ZmMzZTY3ZjRlNTU4NGFjNmY5OWRjZjMwZWE3L3RhYmxlcmFuZ2U6MTBmZTVmYzNlNjdmNGU1NTg0YWM2Zjk5ZGNmMzBlYTdfMS0zLTEtMS0xODY4MjE_1271648b-f709-41d4-8f77-b3cbdb7fcc31"
      unitRef="usd">382662000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjEwZmU1ZmMzZTY3ZjRlNTU4NGFjNmY5OWRjZjMwZWE3L3RhYmxlcmFuZ2U6MTBmZTVmYzNlNjdmNGU1NTg0YWM2Zjk5ZGNmMzBlYTdfMS01LTEtMS0xODY4MjE_f25a98a0-bffd-4725-80b1-0d6be2fa27d7"
      unitRef="usd">1038881000</us-gaap:Goodwill>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="i1841156103084935b575ef1c38b8e26c_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjEwZmU1ZmMzZTY3ZjRlNTU4NGFjNmY5OWRjZjMwZWE3L3RhYmxlcmFuZ2U6MTBmZTVmYzNlNjdmNGU1NTg0YWM2Zjk5ZGNmMzBlYTdfMi0xLTEtMS0xOTc2MjU_bc6def11-9d2c-4225-8c34-98d438979380"
      unitRef="usd">0</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="ib0ddadf2f33d42e18b362897b2b47f30_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjEwZmU1ZmMzZTY3ZjRlNTU4NGFjNmY5OWRjZjMwZWE3L3RhYmxlcmFuZ2U6MTBmZTVmYzNlNjdmNGU1NTg0YWM2Zjk5ZGNmMzBlYTdfMi0zLTEtMS0xOTc1Nzg_5102d1c1-4c03-44bb-9130-373ba2f6f736"
      unitRef="usd">129000</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="i9796a6882ba147419345a7d80b8e97d0_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjEwZmU1ZmMzZTY3ZjRlNTU4NGFjNmY5OWRjZjMwZWE3L3RhYmxlcmFuZ2U6MTBmZTVmYzNlNjdmNGU1NTg0YWM2Zjk5ZGNmMzBlYTdfMi01LTEtMS0xOTc2MjU_0e83aec1-9f8e-4e69-a270-91173b856316"
      unitRef="usd">129000</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="ifd59456ea9aa4f04b19628e881f264f6_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjEwZmU1ZmMzZTY3ZjRlNTU4NGFjNmY5OWRjZjMwZWE3L3RhYmxlcmFuZ2U6MTBmZTVmYzNlNjdmNGU1NTg0YWM2Zjk5ZGNmMzBlYTdfMi0xLTEtMS0xODY4MjE_f86ea784-1846-441a-a8ac-4a1bb22f64a6"
      unitRef="usd">1639000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="ibcfddd0c2c684ea4acbf2b9ae4cd8527_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjEwZmU1ZmMzZTY3ZjRlNTU4NGFjNmY5OWRjZjMwZWE3L3RhYmxlcmFuZ2U6MTBmZTVmYzNlNjdmNGU1NTg0YWM2Zjk5ZGNmMzBlYTdfMi0zLTEtMS0xODY4MjE_2468a2ee-3c72-49f7-9537-2dcab61f907c"
      unitRef="usd">957000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjEwZmU1ZmMzZTY3ZjRlNTU4NGFjNmY5OWRjZjMwZWE3L3RhYmxlcmFuZ2U6MTBmZTVmYzNlNjdmNGU1NTg0YWM2Zjk5ZGNmMzBlYTdfMi01LTEtMS0xODY4MjE_c77f2431-c398-4830-bb7b-4d240b29aa74"
      unitRef="usd">2596000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:Goodwill
      contextRef="id96439be0e9c43bc9bdb59971d641299_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjEwZmU1ZmMzZTY3ZjRlNTU4NGFjNmY5OWRjZjMwZWE3L3RhYmxlcmFuZ2U6MTBmZTVmYzNlNjdmNGU1NTg0YWM2Zjk5ZGNmMzBlYTdfMy0xLTEtMS0xODY4MjE_75a40376-8473-4abb-8bfb-4843c1822d24"
      unitRef="usd">657858000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ida3b360960f84ba791b9beca0ffbeacd_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjEwZmU1ZmMzZTY3ZjRlNTU4NGFjNmY5OWRjZjMwZWE3L3RhYmxlcmFuZ2U6MTBmZTVmYzNlNjdmNGU1NTg0YWM2Zjk5ZGNmMzBlYTdfMy0zLTEtMS0xODY4MjE_7f69268c-a0b7-4f21-84e3-fc08bd9e53a5"
      unitRef="usd">383748000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjEwZmU1ZmMzZTY3ZjRlNTU4NGFjNmY5OWRjZjMwZWE3L3RhYmxlcmFuZ2U6MTBmZTVmYzNlNjdmNGU1NTg0YWM2Zjk5ZGNmMzBlYTdfMy01LTEtMS0xODY4MjE_a1d1d12e-9d07-4f7c-a536-29daf5faf790"
      unitRef="usd">1041606000</us-gaap:Goodwill>
    <us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RleHRyZWdpb246YTI1ZmIwNDQ3ODBlNGQ4NWI5ZTBlMDY5YjFmOGE1NDNfNTA5_fc41183d-bb19-4829-a9cb-64e1918e2c3d">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of the Company&#x2019;s identifiable intangible assets were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.331%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Completed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,206,748&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(389,297)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;817,451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;193,297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(146,098)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;47,199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Trademarks/brand names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;97,554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(35,665)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;61,889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Codman tradename&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Indefinite&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;167,529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;167,529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Supplier relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(17,415)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,796&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;All other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,024&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,129)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,895&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,701,363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(592,604)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,108,759&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.783%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.554%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.331%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Completed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,204,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(370,968)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;833,357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;193,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(144,040)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49,041&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Trademarks/brand names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;97,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(34,674)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;62,591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Codman tradename&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Indefinite&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;166,693&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;166,693&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Supplier relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(17,170)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,041&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;All other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,957&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,071)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,697,532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(570,923)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,126,609&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RleHRyZWdpb246YTI1ZmIwNDQ3ODBlNGQ4NWI5ZTBlMDY5YjFmOGE1NDNfNTE3_1e656ca2-b5a1-4e45-8f46-fd849ccc6066">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of the Company&#x2019;s identifiable intangible assets were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.331%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Completed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,206,748&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(389,297)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;817,451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;193,297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(146,098)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;47,199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Trademarks/brand names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;97,554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(35,665)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;61,889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Codman tradename&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Indefinite&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;167,529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;167,529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Supplier relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(17,415)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,796&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;All other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,024&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,129)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,895&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,701,363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(592,604)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,108,759&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.783%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.554%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.331%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Completed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,204,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(370,968)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;833,357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;193,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(144,040)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49,041&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Trademarks/brand names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;97,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(34,674)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;62,591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Codman tradename&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Indefinite&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;166,693&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;166,693&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Supplier relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(17,170)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,041&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;All other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,957&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,071)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,697,532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(570,923)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,126,609&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i97cf8c18c01245a3b5878b1a70debb09_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjdmNTVhNWU3NTQ1MTRmM2U4YzI2OTgxMDA1YzhmYjNkL3RhYmxlcmFuZ2U6N2Y1NWE1ZTc1NDUxNGYzZThjMjY5ODEwMDVjOGZiM2RfMi0xLTEtMS0xODY4MjE_3ae434fc-e126-4ea9-b000-8f287e24b78e">P18Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill
      contextRef="id52aed2cbf2644509a8d761ee366e14e_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjdmNTVhNWU3NTQ1MTRmM2U4YzI2OTgxMDA1YzhmYjNkL3RhYmxlcmFuZ2U6N2Y1NWE1ZTc1NDUxNGYzZThjMjY5ODEwMDVjOGZiM2RfMi0zLTEtMS0xODY4MjE_ab4d13eb-82c6-4103-b5ca-96bc476f0c70"
      unitRef="usd">1206748000</iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="id52aed2cbf2644509a8d761ee366e14e_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjdmNTVhNWU3NTQ1MTRmM2U4YzI2OTgxMDA1YzhmYjNkL3RhYmxlcmFuZ2U6N2Y1NWE1ZTc1NDUxNGYzZThjMjY5ODEwMDVjOGZiM2RfMi01LTEtMS0xODY4MjE_3cddca0a-030c-462f-ac14-55d8905a377c"
      unitRef="usd">389297000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill
      contextRef="id52aed2cbf2644509a8d761ee366e14e_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjdmNTVhNWU3NTQ1MTRmM2U4YzI2OTgxMDA1YzhmYjNkL3RhYmxlcmFuZ2U6N2Y1NWE1ZTc1NDUxNGYzZThjMjY5ODEwMDVjOGZiM2RfMi03LTEtMS0xODY4MjE_d2298a3a-249a-49b4-bf90-70fbbb7d6829"
      unitRef="usd">817451000</iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i0c74c93593f04e0a8c727b1e6224e815_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjdmNTVhNWU3NTQ1MTRmM2U4YzI2OTgxMDA1YzhmYjNkL3RhYmxlcmFuZ2U6N2Y1NWE1ZTc1NDUxNGYzZThjMjY5ODEwMDVjOGZiM2RfMy0xLTEtMS0xODY4MjE_9d12e343-f85e-4f04-8af5-8027a3443607">P12Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill
      contextRef="i5dc82ac4ce464f4da5b9c83153642d32_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjdmNTVhNWU3NTQ1MTRmM2U4YzI2OTgxMDA1YzhmYjNkL3RhYmxlcmFuZ2U6N2Y1NWE1ZTc1NDUxNGYzZThjMjY5ODEwMDVjOGZiM2RfMy0zLTEtMS0xODY4MjE_f26d72f1-93c2-4002-856d-7adf986f0b23"
      unitRef="usd">193297000</iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i5dc82ac4ce464f4da5b9c83153642d32_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjdmNTVhNWU3NTQ1MTRmM2U4YzI2OTgxMDA1YzhmYjNkL3RhYmxlcmFuZ2U6N2Y1NWE1ZTc1NDUxNGYzZThjMjY5ODEwMDVjOGZiM2RfMy01LTEtMS0xODY4MjE_e14b8b53-59dc-4cc0-8731-d5c9c5a3c923"
      unitRef="usd">146098000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill
      contextRef="i5dc82ac4ce464f4da5b9c83153642d32_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjdmNTVhNWU3NTQ1MTRmM2U4YzI2OTgxMDA1YzhmYjNkL3RhYmxlcmFuZ2U6N2Y1NWE1ZTc1NDUxNGYzZThjMjY5ODEwMDVjOGZiM2RfMy03LTEtMS0xODY4MjE_2de6f260-6d76-4418-a902-eb5efd8f9578"
      unitRef="usd">47199000</iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i42d7a82bf02941cfa73330ae1871acf1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjdmNTVhNWU3NTQ1MTRmM2U4YzI2OTgxMDA1YzhmYjNkL3RhYmxlcmFuZ2U6N2Y1NWE1ZTc1NDUxNGYzZThjMjY5ODEwMDVjOGZiM2RfNC0xLTEtMS0xODY4MjE_a83d9b71-70ba-4dae-b17e-d5e5079c7f08">P28Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill
      contextRef="i0660f35837f94b01a3733519c74443b0_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjdmNTVhNWU3NTQ1MTRmM2U4YzI2OTgxMDA1YzhmYjNkL3RhYmxlcmFuZ2U6N2Y1NWE1ZTc1NDUxNGYzZThjMjY5ODEwMDVjOGZiM2RfNC0zLTEtMS0xODY4MjE_e1ec28ad-1594-4a4c-b7f5-5c3f5c734c65"
      unitRef="usd">97554000</iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i0660f35837f94b01a3733519c74443b0_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjdmNTVhNWU3NTQ1MTRmM2U4YzI2OTgxMDA1YzhmYjNkL3RhYmxlcmFuZ2U6N2Y1NWE1ZTc1NDUxNGYzZThjMjY5ODEwMDVjOGZiM2RfNC01LTEtMS0xODY4MjE_cfdeea13-1ce0-4105-9155-a18a62c05cd2"
      unitRef="usd">35665000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill
      contextRef="i0660f35837f94b01a3733519c74443b0_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjdmNTVhNWU3NTQ1MTRmM2U4YzI2OTgxMDA1YzhmYjNkL3RhYmxlcmFuZ2U6N2Y1NWE1ZTc1NDUxNGYzZThjMjY5ODEwMDVjOGZiM2RfNC03LTEtMS0xODY4MjE_c9490e35-2fa2-4532-b662-19d1e962f3b2"
      unitRef="usd">61889000</iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill>
    <iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill
      contextRef="ib6126f6a52e94c36bb96da081cbfd6a2_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjdmNTVhNWU3NTQ1MTRmM2U4YzI2OTgxMDA1YzhmYjNkL3RhYmxlcmFuZ2U6N2Y1NWE1ZTc1NDUxNGYzZThjMjY5ODEwMDVjOGZiM2RfNS0zLTEtMS0xODY4MjE_aa68bd52-93dc-4baa-bf49-8dddfedde7ea"
      unitRef="usd">167529000</iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill>
    <iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill
      contextRef="ib6126f6a52e94c36bb96da081cbfd6a2_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjdmNTVhNWU3NTQ1MTRmM2U4YzI2OTgxMDA1YzhmYjNkL3RhYmxlcmFuZ2U6N2Y1NWE1ZTc1NDUxNGYzZThjMjY5ODEwMDVjOGZiM2RfNS03LTEtMS0xODY4MjE_dd11e368-98a8-40fb-b97c-8fb2d6c7f312"
      unitRef="usd">167529000</iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i6b0ff551735c45b7bfe3c18fdbb4e9b2_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjdmNTVhNWU3NTQ1MTRmM2U4YzI2OTgxMDA1YzhmYjNkL3RhYmxlcmFuZ2U6N2Y1NWE1ZTc1NDUxNGYzZThjMjY5ODEwMDVjOGZiM2RfNi0xLTEtMS0xODY4MjE_c4082953-c47d-48de-90ff-72cf6b036777">P30Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill
      contextRef="i8efb348618694eb0b761b917a80af933_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjdmNTVhNWU3NTQ1MTRmM2U4YzI2OTgxMDA1YzhmYjNkL3RhYmxlcmFuZ2U6N2Y1NWE1ZTc1NDUxNGYzZThjMjY5ODEwMDVjOGZiM2RfNi0zLTEtMS0xODY4MjE_adfe1a5a-b91b-44b4-9407-ef1991d78fe2"
      unitRef="usd">30211000</iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i8efb348618694eb0b761b917a80af933_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjdmNTVhNWU3NTQ1MTRmM2U4YzI2OTgxMDA1YzhmYjNkL3RhYmxlcmFuZ2U6N2Y1NWE1ZTc1NDUxNGYzZThjMjY5ODEwMDVjOGZiM2RfNi01LTEtMS0xODY4MjE_30e47d71-6bd7-46ce-8c12-5dc423833ac4"
      unitRef="usd">17415000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill
      contextRef="i8efb348618694eb0b761b917a80af933_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjdmNTVhNWU3NTQ1MTRmM2U4YzI2OTgxMDA1YzhmYjNkL3RhYmxlcmFuZ2U6N2Y1NWE1ZTc1NDUxNGYzZThjMjY5ODEwMDVjOGZiM2RfNi03LTEtMS0xODY4MjE_3edbc00d-3c05-45ee-8ba8-a2db321b84a4"
      unitRef="usd">12796000</iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i15371427605f42a2a6b646f1911d4b0f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjdmNTVhNWU3NTQ1MTRmM2U4YzI2OTgxMDA1YzhmYjNkL3RhYmxlcmFuZ2U6N2Y1NWE1ZTc1NDUxNGYzZThjMjY5ODEwMDVjOGZiM2RfNy0xLTEtMS0xODY4MjE_60a107ee-f9b0-4be4-8c96-ccda94ccc4e1">P11Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill
      contextRef="i300eb0465a16418db26404ea8b152196_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjdmNTVhNWU3NTQ1MTRmM2U4YzI2OTgxMDA1YzhmYjNkL3RhYmxlcmFuZ2U6N2Y1NWE1ZTc1NDUxNGYzZThjMjY5ODEwMDVjOGZiM2RfNy0zLTEtMS0xODY4MjE_3ab7ab8e-a339-4237-8c49-b5c3d5d73e9e"
      unitRef="usd">6024000</iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i300eb0465a16418db26404ea8b152196_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjdmNTVhNWU3NTQ1MTRmM2U4YzI2OTgxMDA1YzhmYjNkL3RhYmxlcmFuZ2U6N2Y1NWE1ZTc1NDUxNGYzZThjMjY5ODEwMDVjOGZiM2RfNy01LTEtMS0xODY4MjE_d714fef5-ad4b-4ee9-ad80-e73d83a9358f"
      unitRef="usd">4129000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill
      contextRef="i300eb0465a16418db26404ea8b152196_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjdmNTVhNWU3NTQ1MTRmM2U4YzI2OTgxMDA1YzhmYjNkL3RhYmxlcmFuZ2U6N2Y1NWE1ZTc1NDUxNGYzZThjMjY5ODEwMDVjOGZiM2RfNy03LTEtMS0xODY4MjE_bb5c06ec-0be2-4915-b214-6b7f87511cec"
      unitRef="usd">1895000</iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill>
    <iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill
      contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjdmNTVhNWU3NTQ1MTRmM2U4YzI2OTgxMDA1YzhmYjNkL3RhYmxlcmFuZ2U6N2Y1NWE1ZTc1NDUxNGYzZThjMjY5ODEwMDVjOGZiM2RfOC0zLTEtMS0xODY4MjE_afd1d3e1-370c-45d0-88a3-71b4004d0581"
      unitRef="usd">1701363000</iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjdmNTVhNWU3NTQ1MTRmM2U4YzI2OTgxMDA1YzhmYjNkL3RhYmxlcmFuZ2U6N2Y1NWE1ZTc1NDUxNGYzZThjMjY5ODEwMDVjOGZiM2RfOC01LTEtMS0xODY4MjE_81fcc8d2-3972-414a-b1d6-2b6bc18044bd"
      unitRef="usd">592604000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill
      contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjdmNTVhNWU3NTQ1MTRmM2U4YzI2OTgxMDA1YzhmYjNkL3RhYmxlcmFuZ2U6N2Y1NWE1ZTc1NDUxNGYzZThjMjY5ODEwMDVjOGZiM2RfOC03LTEtMS0xODY4MjE_8fe1f3e3-5fd6-41e3-857a-6e56a54d9bde"
      unitRef="usd">1108759000</iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="ib10821a2be0a4a9cb44ee7405d2e3b3b_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjUyODBhMGIwYjc4NzQzNzFiYzI4ZDc0OTJhMTEzNjQxL3RhYmxlcmFuZ2U6NTI4MGEwYjBiNzg3NDM3MWJjMjhkNzQ5MmExMTM2NDFfMi0xLTEtMS0xODY4MjE_54ac8aeb-23f1-4e51-9142-8b226ba4e361">P18Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill
      contextRef="i5161e2ebe90148f3a9f6b6b4d290dbe4_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjUyODBhMGIwYjc4NzQzNzFiYzI4ZDc0OTJhMTEzNjQxL3RhYmxlcmFuZ2U6NTI4MGEwYjBiNzg3NDM3MWJjMjhkNzQ5MmExMTM2NDFfMi0zLTEtMS0xODY4MjE_2324fee8-a3b1-4798-9bde-b7f6cec14982"
      unitRef="usd">1204325000</iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i5161e2ebe90148f3a9f6b6b4d290dbe4_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjUyODBhMGIwYjc4NzQzNzFiYzI4ZDc0OTJhMTEzNjQxL3RhYmxlcmFuZ2U6NTI4MGEwYjBiNzg3NDM3MWJjMjhkNzQ5MmExMTM2NDFfMi01LTEtMS0xODY4MjE_ccce4fc8-9216-4683-b5ce-3c1206571cff"
      unitRef="usd">370968000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill
      contextRef="i5161e2ebe90148f3a9f6b6b4d290dbe4_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjUyODBhMGIwYjc4NzQzNzFiYzI4ZDc0OTJhMTEzNjQxL3RhYmxlcmFuZ2U6NTI4MGEwYjBiNzg3NDM3MWJjMjhkNzQ5MmExMTM2NDFfMi03LTEtMS0xODY4MjE_317da237-8f57-4dc1-aa83-63f3cb2fd079"
      unitRef="usd">833357000</iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i9ec130bce102400abaa3a20544f9f36f_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjUyODBhMGIwYjc4NzQzNzFiYzI4ZDc0OTJhMTEzNjQxL3RhYmxlcmFuZ2U6NTI4MGEwYjBiNzg3NDM3MWJjMjhkNzQ5MmExMTM2NDFfMy0xLTEtMS0xODY4MjE_5f22aa91-c161-4d13-9963-5a72068b69d3">P12Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill
      contextRef="iaf15e0a25a2341c0b2b8d2b4ee0f2751_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjUyODBhMGIwYjc4NzQzNzFiYzI4ZDc0OTJhMTEzNjQxL3RhYmxlcmFuZ2U6NTI4MGEwYjBiNzg3NDM3MWJjMjhkNzQ5MmExMTM2NDFfMy0zLTEtMS0xODY4MjE_0e52c95c-5e9c-419d-b362-37261498c654"
      unitRef="usd">193081000</iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="iaf15e0a25a2341c0b2b8d2b4ee0f2751_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjUyODBhMGIwYjc4NzQzNzFiYzI4ZDc0OTJhMTEzNjQxL3RhYmxlcmFuZ2U6NTI4MGEwYjBiNzg3NDM3MWJjMjhkNzQ5MmExMTM2NDFfMy01LTEtMS0xODY4MjE_c591a22e-33f9-4e02-9884-ab623e8512c9"
      unitRef="usd">144040000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill
      contextRef="iaf15e0a25a2341c0b2b8d2b4ee0f2751_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjUyODBhMGIwYjc4NzQzNzFiYzI4ZDc0OTJhMTEzNjQxL3RhYmxlcmFuZ2U6NTI4MGEwYjBiNzg3NDM3MWJjMjhkNzQ5MmExMTM2NDFfMy03LTEtMS0xODY4MjE_9cb02c91-b0ec-4095-b188-3dc2428da7be"
      unitRef="usd">49041000</iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i64d8a19482454a3586c748993f1474c6_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjUyODBhMGIwYjc4NzQzNzFiYzI4ZDc0OTJhMTEzNjQxL3RhYmxlcmFuZ2U6NTI4MGEwYjBiNzg3NDM3MWJjMjhkNzQ5MmExMTM2NDFfNC0xLTEtMS0xODY4MjE_53bf784e-3127-42bd-90f4-d913127af600">P28Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill
      contextRef="i4d1a3397e8cd4decab44bcff39bb8345_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjUyODBhMGIwYjc4NzQzNzFiYzI4ZDc0OTJhMTEzNjQxL3RhYmxlcmFuZ2U6NTI4MGEwYjBiNzg3NDM3MWJjMjhkNzQ5MmExMTM2NDFfNC0zLTEtMS0xODY4MjE_b8f52789-e716-4574-9d01-a8ac18961a52"
      unitRef="usd">97265000</iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i4d1a3397e8cd4decab44bcff39bb8345_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjUyODBhMGIwYjc4NzQzNzFiYzI4ZDc0OTJhMTEzNjQxL3RhYmxlcmFuZ2U6NTI4MGEwYjBiNzg3NDM3MWJjMjhkNzQ5MmExMTM2NDFfNC01LTEtMS0xODY4MjE_0de04f54-da64-47ca-b151-6875d1532ccf"
      unitRef="usd">34674000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill
      contextRef="i4d1a3397e8cd4decab44bcff39bb8345_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjUyODBhMGIwYjc4NzQzNzFiYzI4ZDc0OTJhMTEzNjQxL3RhYmxlcmFuZ2U6NTI4MGEwYjBiNzg3NDM3MWJjMjhkNzQ5MmExMTM2NDFfNC03LTEtMS0xODY4MjE_cd068fbc-e8db-42a7-bb3c-115772131abe"
      unitRef="usd">62591000</iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill>
    <iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill
      contextRef="i45871e5e03c54676a898558774ed322e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjUyODBhMGIwYjc4NzQzNzFiYzI4ZDc0OTJhMTEzNjQxL3RhYmxlcmFuZ2U6NTI4MGEwYjBiNzg3NDM3MWJjMjhkNzQ5MmExMTM2NDFfNS0zLTEtMS0xODY4MjE_0c8ffc80-b1d1-4525-95aa-f5dfab081d33"
      unitRef="usd">166693000</iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill>
    <iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill
      contextRef="i45871e5e03c54676a898558774ed322e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjUyODBhMGIwYjc4NzQzNzFiYzI4ZDc0OTJhMTEzNjQxL3RhYmxlcmFuZ2U6NTI4MGEwYjBiNzg3NDM3MWJjMjhkNzQ5MmExMTM2NDFfNS03LTEtMS0xODY4MjE_0547249e-a637-402d-a037-4218c6ccaf18"
      unitRef="usd">166693000</iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i79d3d15982c14927ab9ed833406b2dc2_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjUyODBhMGIwYjc4NzQzNzFiYzI4ZDc0OTJhMTEzNjQxL3RhYmxlcmFuZ2U6NTI4MGEwYjBiNzg3NDM3MWJjMjhkNzQ5MmExMTM2NDFfNi0xLTEtMS0xODY4MjE_593e77d4-472b-4951-8d3b-ae0536907bc4">P30Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill
      contextRef="i5182401e0e9b451db9f13c85d749b4b1_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjUyODBhMGIwYjc4NzQzNzFiYzI4ZDc0OTJhMTEzNjQxL3RhYmxlcmFuZ2U6NTI4MGEwYjBiNzg3NDM3MWJjMjhkNzQ5MmExMTM2NDFfNi0zLTEtMS0xODY4MjE_a5caa854-8e8d-4de5-a9ca-8709a1cf8460"
      unitRef="usd">30211000</iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i5182401e0e9b451db9f13c85d749b4b1_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjUyODBhMGIwYjc4NzQzNzFiYzI4ZDc0OTJhMTEzNjQxL3RhYmxlcmFuZ2U6NTI4MGEwYjBiNzg3NDM3MWJjMjhkNzQ5MmExMTM2NDFfNi01LTEtMS0xODY4MjE_d8e1abc2-066a-47ea-b7f7-60e396ca9d66"
      unitRef="usd">17170000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill
      contextRef="i5182401e0e9b451db9f13c85d749b4b1_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjUyODBhMGIwYjc4NzQzNzFiYzI4ZDc0OTJhMTEzNjQxL3RhYmxlcmFuZ2U6NTI4MGEwYjBiNzg3NDM3MWJjMjhkNzQ5MmExMTM2NDFfNi03LTEtMS0xODY4MjE_e1e8f2b1-2856-4a7e-9920-c6aa8f4491b2"
      unitRef="usd">13041000</iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i4bd0685df71b4334baf2049236ad65c1_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjUyODBhMGIwYjc4NzQzNzFiYzI4ZDc0OTJhMTEzNjQxL3RhYmxlcmFuZ2U6NTI4MGEwYjBiNzg3NDM3MWJjMjhkNzQ5MmExMTM2NDFfNy0xLTEtMS0xODY4MjE_b628a7ea-ac00-4d5f-83c8-3295f9cd4cb2">P11Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill
      contextRef="i111c837e553e4c579da41292d97ec939_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjUyODBhMGIwYjc4NzQzNzFiYzI4ZDc0OTJhMTEzNjQxL3RhYmxlcmFuZ2U6NTI4MGEwYjBiNzg3NDM3MWJjMjhkNzQ5MmExMTM2NDFfNy0zLTEtMS0xODY4MjE_49f8276d-ce37-4df7-ac3d-336447986f19"
      unitRef="usd">5957000</iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i111c837e553e4c579da41292d97ec939_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjUyODBhMGIwYjc4NzQzNzFiYzI4ZDc0OTJhMTEzNjQxL3RhYmxlcmFuZ2U6NTI4MGEwYjBiNzg3NDM3MWJjMjhkNzQ5MmExMTM2NDFfNy01LTEtMS0xODY4MjE_c56a8046-b468-43ba-a8fc-8081fc2760a6"
      unitRef="usd">4071000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill
      contextRef="i111c837e553e4c579da41292d97ec939_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjUyODBhMGIwYjc4NzQzNzFiYzI4ZDc0OTJhMTEzNjQxL3RhYmxlcmFuZ2U6NTI4MGEwYjBiNzg3NDM3MWJjMjhkNzQ5MmExMTM2NDFfNy03LTEtMS0xODY4MjE_1c1c6aaa-26d0-42b2-a9e9-0559a28302d4"
      unitRef="usd">1886000</iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill>
    <iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill
      contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjUyODBhMGIwYjc4NzQzNzFiYzI4ZDc0OTJhMTEzNjQxL3RhYmxlcmFuZ2U6NTI4MGEwYjBiNzg3NDM3MWJjMjhkNzQ5MmExMTM2NDFfOC0zLTEtMS0xODY4MjE_ba05b311-38b9-4aea-a768-d6af090dda4c"
      unitRef="usd">1697532000</iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjUyODBhMGIwYjc4NzQzNzFiYzI4ZDc0OTJhMTEzNjQxL3RhYmxlcmFuZ2U6NTI4MGEwYjBiNzg3NDM3MWJjMjhkNzQ5MmExMTM2NDFfOC01LTEtMS0xODY4MjE_a52ff3e4-9929-477c-bdcb-a5f231a4a9d3"
      unitRef="usd">570923000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill
      contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RhYmxlOjUyODBhMGIwYjc4NzQzNzFiYzI4ZDc0OTJhMTEzNjQxL3RhYmxlcmFuZ2U6NTI4MGEwYjBiNzg3NDM3MWJjMjhkNzQ5MmExMTM2NDFfOC03LTEtMS0xODY4MjE_a3973bde-444a-4cfa-8133-a5bda86713aa"
      unitRef="usd">1126609000</iart:DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
      contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RleHRyZWdpb246YTI1ZmIwNDQ3ODBlNGQ4NWI5ZTBlMDY5YjFmOGE1NDNfMzk4_e1c22f8b-cb81-489e-8773-ea5dde2ef79f"
      unitRef="usd">61800000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RleHRyZWdpb246YTI1ZmIwNDQ3ODBlNGQ4NWI5ZTBlMDY5YjFmOGE1NDNfNDI2_7523a6a6-effe-4ab9-80a9-f90560a276ce"
      unitRef="usd">81800000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RleHRyZWdpb246YTI1ZmIwNDQ3ODBlNGQ4NWI5ZTBlMDY5YjFmOGE1NDNfNDM2_eb1a158b-42e9-42bd-8512-b9d96a9bf323"
      unitRef="usd">81800000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RleHRyZWdpb246YTI1ZmIwNDQ3ODBlNGQ4NWI5ZTBlMDY5YjFmOGE1NDNfNDQ2_92726a24-af0f-45ca-baab-03916d79c673"
      unitRef="usd">81600000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RleHRyZWdpb246YTI1ZmIwNDQ3ODBlNGQ4NWI5ZTBlMDY5YjFmOGE1NDNfNDU2_b46230dc-3639-4c7f-a7ff-89781e5ffb6f"
      unitRef="usd">79700000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RleHRyZWdpb246YTI1ZmIwNDQ3ODBlNGQ4NWI5ZTBlMDY5YjFmOGE1NDNfNDY2_b279b1a9-a4ca-46b4-8aa2-143f1fd9db7e"
      unitRef="usd">78100000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
      contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80Ni9mcmFnOmEyNWZiMDQ0NzgwZTRkODViOWUwZTA2OWIxZjhhNTQzL3RleHRyZWdpb246YTI1ZmIwNDQ3ODBlNGQ4NWI5ZTBlMDY5YjFmOGE1NDNfNDg3_e656f731-e04c-4818-929d-a6fbfaaca262"
      unitRef="usd">474400000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RleHRyZWdpb246OGU2Njc2MjUzNThjNDkxODk1YWE2M2E2YmMwOGI2ODBfMTEzODU_780ae0f2-c731-4f56-9dd3-e2b5c9bbc42c">DEBT &lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Amendment to the Seventh Amended and Restated Senior Credit Agreement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 24, 2023, the Company entered into the March 2023 Amendment of the Senior Credit Facility with a syndicate of lending banks with Bank of America, N.A., as Administrative Agent. The March 2023 Amendment extended the maturity date to March&#160;24, 2028, amended the contractual repayments of Term loan A, and amended the interest rate from LIBOR to SOFR-indexed interest. The Company continues to have the aggregate principal amount of up to approximately $2.1 billion available to it through the following facilities: (i) a $775.0 million term loan facility, and (ii) a $1.3 billion revolving credit facility, which includes a $60 million sublimit for the issuance of standby letters of credit and a $60 million sublimit for swingline loans.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s maximum consolidated total leverage ratio in the financial covenants (as defined in the Senior Credit Facility) was modified to the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:513.00pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:394.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:111.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fiscal Quarter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Maximum Consolidated Total Leverage Ratio&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;March 31, 2023 through December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.50 to 1.00&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;March 31, 2025 through June 30, 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.25 to 1.00&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;September 30, 2026 and the last day of each fiscal quarter thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.00 to 1.00&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Borrowings under the Senior Credit Facility bear interest, at the Company&#x2019;s option, at a rate equal to the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;i.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.73pt"&gt;term SOFR in effect from time to time plus 0.10%  plus the applicable rate (ranging from 1.00% to 1.75%), or &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ii.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.96pt"&gt;the highest of: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt"&gt;the weighted average overnight Federal funds rate, as published by the Federal Reserve Bank of New York, plus 0.50% &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt"&gt;the prime lending rate of Bank of America, N.A. or&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt"&gt;the one-month Term SOFR plus 1.00% &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The applicable rates are based on the Company&#x2019;s consolidated total leverage ratio (defined as the ratio of (a)&#160;consolidated funded indebtedness as of such date less cash that is not subject to any restriction on the use or investment thereof to (b) consolidated EBITDA (as defined by the amended Seventh Amended and Restated Credit Agreement (the "Credit Agreement")), for the period of four consecutive fiscal quarters ending on such date).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company will pay an annual commitment fee (ranging from 0.15% to 0.30%), based on the Company's consolidated total leverage ratio, on the amount available for borrowing under the revolving credit facility.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Senior Credit Facility is collateralized by substantially all of the assets of the Company&#x2019;s U.S. subsidiaries, excluding intangible assets. The Senior Credit Facility is subject to various financial and negative covenants and at March&#160;31, 2023, the Company was in compliance with all such covenants. The Company capitalized $7.6&#160;million in deferred financing costs in connection with the modification of the Senior Credit Facility and wrote off $0.2&#160;million of previously capitalized financing costs during the first quarter of 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At March&#160;31, 2023 and December&#160;31, 2022 there wa&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;s no balance ou&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;tstanding under the revolving portion of the Senior Credit Facility. At March&#160;31, 2023 and December&#160;31, 2022, there was $775.0 million outstanding under the term loan component of the Senior Credit Facility at a weighted average interest rate of 6.3% and 5.6%, respectively. As of  March&#160;31, 2023 there was no portion of the Term Loan component of the Senior Credit Facility classified as current on the condensed consolidated balance sheet. As of  December&#160;31, 2022, there was $38.1 million of the Term Loan component of the Senior Credit Facility classified as current on the consolidated balance sheets under the prior terms of the agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of outstanding borrowings of the Senior Credit Facility's Term Loan component at March&#160;31, 2023&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; was&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; $750.9 million. This fair value was determined by using a discounted cash flow model based on current market interest rates available to the Company. These inputs are corroborated by observable market data for similar liabilities and therefore classified within Level 2 of the fair value hierarchy. Level 2 inputs represent inputs that are observable for the asset or liability, either directly or indirectly, and are other than active market observable i&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;nputs that reflect unadjusted quoted prices for identical assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Letters of credit outstanding as of March&#160;31, 2023 and December&#160;31, 2022 to&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;taled $1.6 million. There were no amounts drawn as of March&#160;31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contractual repayments of the Term Loan component of the Senior Credit Facility are due as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.432%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.784%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Quarter Ended March&#160;31, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Principal Repayment&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Remainder of 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,531&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33,906&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;38,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;687,813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;775,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Future interest payments on the term loan component of the Senior Credit Facility based on current interest rates are expected to approximate $35.9 million for remainder of 2023, $38.1 million in 2024,  $32.6 million in 2025, $30.0 million in  2026, and $34.5 million thereafter . Interest is calculated on the term loan portion of the Senior Credit Facility based on SOFR plus the certain amounts set forth in the Credit Agreement. As the revolving credit facility and Securitization Facility can be repaid at any time, no interest has been included in the calculation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Any outstanding borrowings on the revolving credit component of the Senior Credit Facility is due on March 24, 2028.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Convertible Senior Notes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 4, 2020, the Company issued $575.0 million aggregate principal amount of its 0.5% Convertible Senior Notes due 2025 (the "2025 Notes"). The 2025 Notes will mature on August 15, 2025 and bear interest at a rate of 0.5% per annum payable semi-annually in arrears, unless earlier converted, repurchased or redeemed in accordance with the terms of the 2025 Notes. In connection with this offering, the Company capitalized $13.2 million of financing fees.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The 2025 Notes are senior, unsecured obligations of the Company, and are convertible into cash and shares of its common stock based on initial conversion rate, subject to adjustment of 13.5739 shares per $1,000 principal amounts of the 2025 Notes (which represents an initial conversion price of $73.67 per share). The 2025 Notes convert only in the following circumstances: (1) if the closing price of the Company's common stock has been at least 130% of the conversion price during the period; (2) if the average trading price per $1,000 principal amount of the 2025 Notes is less than or equal to 98% of the average conversion value of the 2025 Notes during a period as defined in the indenture; (3) at any time on or after February 20, 2023; or (4) if specified corporate transactions occur. As of March&#160;31, 2023, none of these conditions existed with respect to the 2025 Notes and as a result the 2025 Notes are classified as long term.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 9, 2020, the Company entered into the First Supplemental Indenture to the original agreement dated as of February 4, 2020 between the Company and Citibank, N.A., as trustee, governing the Company&#x2019;s outstanding 2025 Notes. The Company irrevocably elected (1) to eliminate the Company&#x2019;s option to choose physical settlement on any conversion of the 2025 Notes that occurs on or after the date of the First Supplemental Indenture and (2) with respect to any Combination Settlement for a conversion of the 2025 Notes, the Specified Dollar Amount that will be settled in cash per $1,000 principal amount of the 2025 Notes shall be no lower than $1,000.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Holders of the Notes will have the right to require the Company to repurchase for cash all or a portion of their Notes at 100% of their principal amount, plus any accrued and unpaid interest, upon the occurrence of a fundamental change (as defined in the indenture relating to the Notes). The Company will also be required to increase the conversion rate for holders who convert their Notes in connection with certain fundamental changes occurring prior to the maturity date or following delivery by the Company of a notice of redemption.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the issuance of the 2025 Notes, the Company entered into call transactions and warrant transactions, primarily with affiliates of the initial purchasers of the 2025 Notes (the &#x201c;hedge participants&#x201d;). The cost of the call transactions was $104.2 million for the 2025 Notes. The Company received $44.5 million of proceeds from the warrant transactions for the 2025 Notes. The call transactions involved purchasing call options from the hedge participants, and the warrant transactions involved selling call options to the hedge participants with a higher strike price than the purchased call options. The initial strike price of the call transactions was $73.67, subject to anti-dilution adjustments substantially similar to those in the 2025 Notes. The initial strike price of the warrant transactions was $113.34 for the 2025 Notes, subject to customary anti-dilution adjustments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;March&#160;31, 2023&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, the carrying amount of the liability w&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;as $575.0 &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;million. The fair value of the 2025 Notes at March&#160;31, 2023 was &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$561.7&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; million. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Factors that the Company considered when estimating the fair value of the 2025 Notes included recent quoted market prices or dealer quote. The level of the 2025 Notes is considered as Level 1.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Securitization Facility&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2018, the Company entered into an accounts receivable securitization facility (the "Securitization Facility") under which accounts receivable of certain domestic subsidiaries are sold on a non-recourse basis to a special purpose entity (&#x201c;SPE&#x201d;), which is a bankruptcy-remote, consolidated subsidiary of the Company. Accordingly, the assets of the SPE are not available to satisfy the obligations of the Company or any of its subsidiaries. From time to time, the SPE may finance such accounts receivable with a revolving loan facility secured by a pledge of such accounts receivable. The amount of outstanding borrowings on the Securitization Facility at any one time is limited to&#160;$150.0 million. The Securitization Facility Agreement ("Securitization Agreement") governing the Securitization Facility contains certain covenants and termination events. An occurrence of an event of default or a termination event under this Securitization Agreement may give rise to the right of its counterparty to terminate this facility. As of March&#160;31, 2023, the Company was in compliance with the covenants and none of the termination events had occurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May 28, 2021, the Company entered into an amendment (the "May 2021 Amendment") of the Securitization Facility which extended the maturity date from December 21, 2021 to May 28, 2024. The May 2021 Amendment does not increase the Company&#x2019;s total indebtedness.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Securitization Facility is currently indexed to LIBOR. At March&#160;31, 2023 and December&#160;31, 2022, the Company had $102.5 million and $104.7 million, respectively, of outstanding borrowings under its Securitization Facility at a weighted average interest rate of&#160;5.8% and 5.0%, respectively. In April 2023, we amended the facility to replace LIBOR with SOFR-indexed interest. The fair value of the outstanding borrowing of the Securitization Facility at&#160;March&#160;31, 2023&#160;was&#160;$102.2 million. These fair values were determined by using a discounted cash flow model based on current market interest rates available to the Company. These inputs are corroborated by observable market data for similar liabilities and therefore classified within Level 2 of the fair value hierarchy. Level 2 inputs represent inputs that are observable for the asset or liability, either directly or indirectly, and are other than active market observable i&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;nputs that reflect unadjusted quoted prices for identical assets or liabilities.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i5f1abf32d8ec43f3a621a5448c21a7a1_I20230324"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RleHRyZWdpb246OGU2Njc2MjUzNThjNDkxODk1YWE2M2E2YmMwOGI2ODBfNTA0_0ab8bba5-6439-4b86-812e-2c53645c5319"
      unitRef="usd">2100000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="icd0dbd7f9cc3475488e71805c8369830_I20230324"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RleHRyZWdpb246OGU2Njc2MjUzNThjNDkxODk1YWE2M2E2YmMwOGI2ODBfNTYz_13d44367-6c06-43e5-980b-899d11256cca"
      unitRef="usd">775000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i0d1f785d88d94ee08e66c1b385dc0f1d_I20230324"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RleHRyZWdpb246OGU2Njc2MjUzNThjNDkxODk1YWE2M2E2YmMwOGI2ODBfNTk3_8a93ae9e-c409-4866-8d1d-a2fca706a143"
      unitRef="usd">1300000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i2925166e860d464e857eec9b85318b66_I20230324"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RleHRyZWdpb246OGU2Njc2MjUzNThjNDkxODk1YWE2M2E2YmMwOGI2ODBfNjQ0_4bb52d25-2461-419a-b766-d945b817f1cb"
      unitRef="usd">60000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i3a69c660cc994e3e89f928d370becf48_I20230324"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RleHRyZWdpb246OGU2Njc2MjUzNThjNDkxODk1YWE2M2E2YmMwOGI2ODBfNzA4_e81a7911-ed0a-4c1c-8afc-c4b8e2123a6a"
      unitRef="usd">60000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:ScheduleOfDebtInstrumentsTextBlock
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RleHRyZWdpb246OGU2Njc2MjUzNThjNDkxODk1YWE2M2E2YmMwOGI2ODBfMTEzNjk_035270fd-b7f0-4e21-8731-aa612c6c4671">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s maximum consolidated total leverage ratio in the financial covenants (as defined in the Senior Credit Facility) was modified to the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:513.00pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:394.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:111.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fiscal Quarter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Maximum Consolidated Total Leverage Ratio&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;March 31, 2023 through December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.50 to 1.00&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;March 31, 2025 through June 30, 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.25 to 1.00&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;September 30, 2026 and the last day of each fiscal quarter thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.00 to 1.00&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
    <iart:DebtInstrumentCovenantMaximumLeverageRatio
      contextRef="i29c495bb726f416f92c438401600a765_I20230324"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RhYmxlOjgwYzBmMTczZmFlYTRiYWY5YmMyY2MwYmQ2MzNlNjE0L3RhYmxlcmFuZ2U6ODBjMGYxNzNmYWVhNGJhZjliYzJjYzBiZDYzM2U2MTRfMS0yLTEtMS0xODY4MjEvdGV4dHJlZ2lvbjphODhmMzJiZjEwZjg0Yzk5YjhmMGJlMGQ0MzRhYTI0Zl80Mzk4MDQ2NTExMTI0_b39a4d35-9df4-4f62-90c4-8dad7c4d436e"
      unitRef="number">4.50</iart:DebtInstrumentCovenantMaximumLeverageRatio>
    <iart:DebtInstrumentCovenantMaximumLeverageRatio
      contextRef="i0a99dd10d5ee423cb63f788fb7285962_I20230324"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RhYmxlOjgwYzBmMTczZmFlYTRiYWY5YmMyY2MwYmQ2MzNlNjE0L3RhYmxlcmFuZ2U6ODBjMGYxNzNmYWVhNGJhZjliYzJjYzBiZDYzM2U2MTRfMi0yLTEtMS0xODY4MjEvdGV4dHJlZ2lvbjpjYTcwMzQxYzBmNzM0YzlmYjZmNjY1ZTBjNDQ5YTk3Yl80Mzk4MDQ2NTExMTI0_a667cd81-0a25-41e7-8f44-7d93ec0f830c"
      unitRef="number">4.25</iart:DebtInstrumentCovenantMaximumLeverageRatio>
    <iart:DebtInstrumentCovenantMaximumLeverageRatio
      contextRef="i7f83b1b30bad4b0abf661670d1135229_I20230324"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RhYmxlOjgwYzBmMTczZmFlYTRiYWY5YmMyY2MwYmQ2MzNlNjE0L3RhYmxlcmFuZ2U6ODBjMGYxNzNmYWVhNGJhZjliYzJjYzBiZDYzM2U2MTRfMy0yLTEtMS0xODY4MjEvdGV4dHJlZ2lvbjo0M2U3NTJhYmU5OWE0N2JiYTE5YTU5MjhjNWVmOTdhZF80Mzk4MDQ2NTExMTI0_fa2b1833-cf69-4c8f-a8eb-3b485b586fe9"
      unitRef="number">4.00</iart:DebtInstrumentCovenantMaximumLeverageRatio>
    <iart:DebtInstrumentBasisSpreadAdjustmentOnVariableRate
      contextRef="i14a19f77eafb4116aa1875402c21a6ac_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RleHRyZWdpb246OGU2Njc2MjUzNThjNDkxODk1YWE2M2E2YmMwOGI2ODBfNDM5ODA0NjUyMzk3OQ_a64a61b6-500a-45fc-a951-bfd65c90c225"
      unitRef="number">0.0010</iart:DebtInstrumentBasisSpreadAdjustmentOnVariableRate>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i96878a4e0354445fa679e461e52e913e_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RleHRyZWdpb246OGU2Njc2MjUzNThjNDkxODk1YWE2M2E2YmMwOGI2ODBfMTU3NA_f1a068c2-770a-4e50-aff1-c0a264244332"
      unitRef="number">0.0100</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i7d6d16e6e0d9418c82c2bdc6fe950a0b_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RleHRyZWdpb246OGU2Njc2MjUzNThjNDkxODk1YWE2M2E2YmMwOGI2ODBfMTU4MA_cdc72ef8-a68d-4f43-a61e-1740dd011f91"
      unitRef="number">0.0175</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i82965aae546f4e83a526730570a1e256_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RleHRyZWdpb246OGU2Njc2MjUzNThjNDkxODk1YWE2M2E2YmMwOGI2ODBfMTcxNw_991e35fd-a586-43ff-99c0-e8514f774097"
      unitRef="number">0.0050</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i14a19f77eafb4116aa1875402c21a6ac_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RleHRyZWdpb246OGU2Njc2MjUzNThjNDkxODk1YWE2M2E2YmMwOGI2ODBfMTgwNw_7758deea-74e2-47f2-a703-bc4ea0f5fa97"
      unitRef="number">0.0100</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="i3f2fb631c5ee4c2fa49138cf5e6235e8_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RleHRyZWdpb246OGU2Njc2MjUzNThjNDkxODk1YWE2M2E2YmMwOGI2ODBfMjI1NA_79e7288a-1e45-4eb6-9f7d-8bb47abf8163"
      unitRef="number">0.0015</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="i75b239dc572a41de8d6401d6434fe2fa_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RleHRyZWdpb246OGU2Njc2MjUzNThjNDkxODk1YWE2M2E2YmMwOGI2ODBfMjI2MA_7b649b0f-f292-4831-9a62-97c42e25727d"
      unitRef="number">0.0030</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="i99b8d45450b94b73be890ff82ddfc718_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RleHRyZWdpb246OGU2Njc2MjUzNThjNDkxODk1YWE2M2E2YmMwOGI2ODBfNzY5NjU4MTQxMTY3Mw_cd68367a-e869-48ce-8102-48ccee609804"
      unitRef="usd">7600000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:WriteOffOfDeferredDebtIssuanceCost
      contextRef="i3cf8dd5a6f664b3d8b55fc2f763a1d0e_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RleHRyZWdpb246OGU2Njc2MjUzNThjNDkxODk1YWE2M2E2YmMwOGI2ODBfNzY5NjU4MTQxMTY4Nw_7512b54a-e412-41d5-897a-4e69c87c59f3"
      unitRef="usd">200000</us-gaap:WriteOffOfDeferredDebtIssuanceCost>
    <us-gaap:LineOfCredit
      contextRef="i0fc6705bbac14c0a8a85244af899d39c_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RleHRyZWdpb246OGU2Njc2MjUzNThjNDkxODk1YWE2M2E2YmMwOGI2ODBfMjcxNQ_26cd12bf-20a4-496a-835d-5316de350ea0"
      unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit
      contextRef="i99b8d45450b94b73be890ff82ddfc718_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RleHRyZWdpb246OGU2Njc2MjUzNThjNDkxODk1YWE2M2E2YmMwOGI2ODBfMjcxNQ_f66c635f-eb0f-49e4-b04d-864dd0b4ca0b"
      unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit
      contextRef="i3b6f2ca5a0ff4bcf9931d0f74490b27a_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RleHRyZWdpb246OGU2Njc2MjUzNThjNDkxODk1YWE2M2E2YmMwOGI2ODBfMjg5Nw_14fb55c3-892e-474c-b363-d5cc73212194"
      unitRef="usd">775000000</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit
      contextRef="i6ace526dcf2e4bd7b1d416abfd600915_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RleHRyZWdpb246OGU2Njc2MjUzNThjNDkxODk1YWE2M2E2YmMwOGI2ODBfMjg5Nw_a69985e2-7664-47fc-90cd-395fa31d8ba9"
      unitRef="usd">775000000</us-gaap:LineOfCredit>
    <us-gaap:DebtWeightedAverageInterestRate
      contextRef="i6ace526dcf2e4bd7b1d416abfd600915_I20230331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RleHRyZWdpb246OGU2Njc2MjUzNThjNDkxODk1YWE2M2E2YmMwOGI2ODBfMzAzMw_d1281682-3745-43b6-bd47-165d2a0e703c"
      unitRef="number">0.063</us-gaap:DebtWeightedAverageInterestRate>
    <us-gaap:DebtWeightedAverageInterestRate
      contextRef="i3b6f2ca5a0ff4bcf9931d0f74490b27a_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RleHRyZWdpb246OGU2Njc2MjUzNThjNDkxODk1YWE2M2E2YmMwOGI2ODBfNDM5ODA0NjUyODEwNA_09e2c261-6936-49f6-84c7-049887ec2445"
      unitRef="number">0.056</us-gaap:DebtWeightedAverageInterestRate>
    <us-gaap:SecuredDebtCurrent
      contextRef="i6ace526dcf2e4bd7b1d416abfd600915_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RleHRyZWdpb246OGU2Njc2MjUzNThjNDkxODk1YWE2M2E2YmMwOGI2ODBfNDM5ODA0NjUyNDMwOQ_ebadcf01-b894-4a18-94d1-de9c081bc35b"
      unitRef="usd">0</us-gaap:SecuredDebtCurrent>
    <us-gaap:SecuredDebtCurrent
      contextRef="i3b6f2ca5a0ff4bcf9931d0f74490b27a_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RleHRyZWdpb246OGU2Njc2MjUzNThjNDkxODk1YWE2M2E2YmMwOGI2ODBfMzA4Nw_c94839cb-3358-4328-a48a-eec111f3888c"
      unitRef="usd">38100000</us-gaap:SecuredDebtCurrent>
    <us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding
      contextRef="i113a67b9524a40fdb5f84333cb215b19_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RleHRyZWdpb246OGU2Njc2MjUzNThjNDkxODk1YWE2M2E2YmMwOGI2ODBfMzMzOQ_c21e02b9-07c5-45a3-97a2-7b5cced0faac"
      unitRef="usd">750900000</us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding>
    <us-gaap:LettersOfCreditOutstandingAmount
      contextRef="i33d9a2beed6845289ab811beceaf918e_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RleHRyZWdpb246OGU2Njc2MjUzNThjNDkxODk1YWE2M2E2YmMwOGI2ODBfMzkzNA_10c6f890-cc7d-4c0e-a979-1c704ae976f6"
      unitRef="usd">1600000</us-gaap:LettersOfCreditOutstandingAmount>
    <us-gaap:LettersOfCreditOutstandingAmount
      contextRef="i2fcddd5311424f18bf9d0ea34cf199ce_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RleHRyZWdpb246OGU2Njc2MjUzNThjNDkxODk1YWE2M2E2YmMwOGI2ODBfMzkzNA_a2806eed-62c4-43b3-99cd-b41c0bcfe0a9"
      unitRef="usd">1600000</us-gaap:LettersOfCreditOutstandingAmount>
    <us-gaap:LineOfCredit
      contextRef="i2fcddd5311424f18bf9d0ea34cf199ce_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RleHRyZWdpb246OGU2Njc2MjUzNThjNDkxODk1YWE2M2E2YmMwOGI2ODBfMzk0OQ_be04ebcc-e764-4e04-9d34-083595156a1d"
      unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RleHRyZWdpb246OGU2Njc2MjUzNThjNDkxODk1YWE2M2E2YmMwOGI2ODBfMTEzNzY_d0de4ecf-8eb5-4460-91dd-54ecea52675c">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contractual repayments of the Term Loan component of the Senior Credit Facility are due as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.432%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.784%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Quarter Ended March&#160;31, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Principal Repayment&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Remainder of 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,531&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33,906&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;38,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;687,813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;775,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
      contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RhYmxlOjQ3NGI4NDAwOWMyYzQ1OGZiODdmYTU4M2E1NTU1M2U4L3RhYmxlcmFuZ2U6NDc0Yjg0MDA5YzJjNDU4ZmI4N2ZhNTgzYTU1NTUzZThfMi0yLTEtMS0xODY4MjE_a35ea265-4026-4334-8ae5-cedf8ae941ac"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RhYmxlOjQ3NGI4NDAwOWMyYzQ1OGZiODdmYTU4M2E1NTU1M2U4L3RhYmxlcmFuZ2U6NDc0Yjg0MDA5YzJjNDU4ZmI4N2ZhNTgzYTU1NTUzZThfMy0yLTEtMS0xODY4MjE_a01b6ecc-fb5c-4a49-9750-80ff2e8da359"
      unitRef="usd">14531000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RhYmxlOjQ3NGI4NDAwOWMyYzQ1OGZiODdmYTU4M2E1NTU1M2U4L3RhYmxlcmFuZ2U6NDc0Yjg0MDA5YzJjNDU4ZmI4N2ZhNTgzYTU1NTUzZThfNC0yLTEtMS0xODY4MjE_ccb3e29a-b2ab-4182-9ad8-7c81a3726fa6"
      unitRef="usd">33906000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
      contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RhYmxlOjQ3NGI4NDAwOWMyYzQ1OGZiODdmYTU4M2E1NTU1M2U4L3RhYmxlcmFuZ2U6NDc0Yjg0MDA5YzJjNDU4ZmI4N2ZhNTgzYTU1NTUzZThfNS0yLTEtMS0xODY4MjE_6b00777e-8d2c-402f-8169-c5628c85b613"
      unitRef="usd">38750000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <iart:LongTermDebtMaturityAfterYearThree
      contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RhYmxlOjQ3NGI4NDAwOWMyYzQ1OGZiODdmYTU4M2E1NTU1M2U4L3RhYmxlcmFuZ2U6NDc0Yjg0MDA5YzJjNDU4ZmI4N2ZhNTgzYTU1NTUzZThfNi0yLTEtMS0xOTcyOTk_76466298-638e-418e-9935-5bff3897c74f"
      unitRef="usd">687813000</iart:LongTermDebtMaturityAfterYearThree>
    <us-gaap:LongTermDebt
      contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RhYmxlOjQ3NGI4NDAwOWMyYzQ1OGZiODdmYTU4M2E1NTU1M2U4L3RhYmxlcmFuZ2U6NDc0Yjg0MDA5YzJjNDU4ZmI4N2ZhNTgzYTU1NTUzZThfNi0yLTEtMS0xODY4MjE_23de0699-b23e-4a18-bc19-faf015ab4b21"
      unitRef="usd">775000000</us-gaap:LongTermDebt>
    <iart:InterestPaymentsReminderOfFiscalYear
      contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RleHRyZWdpb246OGU2Njc2MjUzNThjNDkxODk1YWE2M2E2YmMwOGI2ODBfNDIyMA_ed13df71-0aba-4cb8-8aa9-3de9d8c6c049"
      unitRef="usd">35900000</iart:InterestPaymentsReminderOfFiscalYear>
    <iart:InterestPaymentsYearOne
      contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RleHRyZWdpb246OGU2Njc2MjUzNThjNDkxODk1YWE2M2E2YmMwOGI2ODBfNDI0Ng_1d8e5ebd-9636-41d3-a67f-d12807b13ee8"
      unitRef="usd">38100000</iart:InterestPaymentsYearOne>
    <iart:InterestPaymentsYearTwo
      contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RleHRyZWdpb246OGU2Njc2MjUzNThjNDkxODk1YWE2M2E2YmMwOGI2ODBfNDI1OA_b342a0c5-a400-4c32-9f53-fcf827c22156"
      unitRef="usd">32600000</iart:InterestPaymentsYearTwo>
    <iart:InterestPaymentsYearThree
      contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RleHRyZWdpb246OGU2Njc2MjUzNThjNDkxODk1YWE2M2E2YmMwOGI2ODBfNjA0NzMxMzk2ODUzNg_c39020b3-f6fd-4364-8f7a-4b25cb53adbc"
      unitRef="usd">30000000</iart:InterestPaymentsYearThree>
    <iart:InterestPaymentsAfterYearThree
      contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RleHRyZWdpb246OGU2Njc2MjUzNThjNDkxODk1YWE2M2E2YmMwOGI2ODBfNjA0NzMxMzk2ODU1Nw_eea8d2a1-9d32-4c3a-b7af-690008f9fb12"
      unitRef="usd">34500000</iart:InterestPaymentsAfterYearThree>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i4d85c23c3dd4486a8c0cad316eeb498d_I20200204"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RleHRyZWdpb246OGU2Njc2MjUzNThjNDkxODk1YWE2M2E2YmMwOGI2ODBfNDc4NQ_c57d14da-2208-47d0-856c-ac620a3b7c88"
      unitRef="usd">575000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i4d85c23c3dd4486a8c0cad316eeb498d_I20200204"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RleHRyZWdpb246OGU2Njc2MjUzNThjNDkxODk1YWE2M2E2YmMwOGI2ODBfNDgyMg_d9644e3a-3b1b-421e-a5cc-7d6179c3d112"
      unitRef="number">0.005</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i4d85c23c3dd4486a8c0cad316eeb498d_I20200204"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RleHRyZWdpb246OGU2Njc2MjUzNThjNDkxODk1YWE2M2E2YmMwOGI2ODBfNDk1Ng_d9644e3a-3b1b-421e-a5cc-7d6179c3d112"
      unitRef="number">0.005</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DeferredFinanceCostsGross
      contextRef="i4d85c23c3dd4486a8c0cad316eeb498d_I20200204"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RleHRyZWdpb246OGU2Njc2MjUzNThjNDkxODk1YWE2M2E2YmMwOGI2ODBfNTMyNg_d7590dce-3a25-4544-99bf-71403914a694"
      unitRef="usd">13200000</us-gaap:DeferredFinanceCostsGross>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="i4d85c23c3dd4486a8c0cad316eeb498d_I20200204"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RleHRyZWdpb246OGU2Njc2MjUzNThjNDkxODk1YWE2M2E2YmMwOGI2ODBfNTYzNQ_d4195120-2ab0-4c6b-a749-a1ee2bd54d84"
      unitRef="usdPerShare">73.67</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <iart:DebtInstrumentMaximumSellingPriceOfCommonStockOfTheConversionPriceDuringPeriod
      contextRef="i3027f2cbc7194fc49391e18cf6122617_D20200204-20200204"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RleHRyZWdpb246OGU2Njc2MjUzNThjNDkxODk1YWE2M2E2YmMwOGI2ODBfNTc4Mw_40e46432-8c4f-4606-ae97-882afaecf5b1"
      unitRef="number">1.30</iart:DebtInstrumentMaximumSellingPriceOfCommonStockOfTheConversionPriceDuringPeriod>
    <iart:DebtInstrumentMaximumAverageConversionValueOfNotes
      contextRef="i3027f2cbc7194fc49391e18cf6122617_D20200204-20200204"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RleHRyZWdpb246OGU2Njc2MjUzNThjNDkxODk1YWE2M2E2YmMwOGI2ODBfNTkzMw_72c24f0a-a239-4b7d-92a4-76f0c7d3f8f0"
      unitRef="number">0.98</iart:DebtInstrumentMaximumAverageConversionValueOfNotes>
    <iart:DebtInstrumentCombinationSettlementForDebtConversionMinimumSettledInCashPerPrincipalAmount
      contextRef="i296f2de4222e4edd96bf4c0e1aa8b562_I20201209"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RleHRyZWdpb246OGU2Njc2MjUzNThjNDkxODk1YWE2M2E2YmMwOGI2ODBfNDk0NzgwMjMzNzk1OQ_da04dec9-d07b-4ffd-8fef-06f662635979"
      unitRef="usd">1000</iart:DebtInstrumentCombinationSettlementForDebtConversionMinimumSettledInCashPerPrincipalAmount>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="i3027f2cbc7194fc49391e18cf6122617_D20200204-20200204"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RleHRyZWdpb246OGU2Njc2MjUzNThjNDkxODk1YWE2M2E2YmMwOGI2ODBfNzA0NA_160452af-7760-4bab-b46b-2869b50a728a"
      unitRef="number">1</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <iart:PaymentsForOptionIndexToIssuersEquity
      contextRef="i2a88a3ee579649698c7a806c20baf329_D20200204-20200204"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RleHRyZWdpb246OGU2Njc2MjUzNThjNDkxODk1YWE2M2E2YmMwOGI2ODBfNzcxNQ_afb637a3-34bb-40df-883b-5d0387a51bbb"
      unitRef="usd">104200000</iart:PaymentsForOptionIndexToIssuersEquity>
    <us-gaap:ProceedsFromIssuanceOfWarrants
      contextRef="i2a88a3ee579649698c7a806c20baf329_D20200204-20200204"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RleHRyZWdpb246OGU2Njc2MjUzNThjNDkxODk1YWE2M2E2YmMwOGI2ODBfNzc1OQ_d23698b3-0a07-4674-af87-cc4ba38ba984"
      unitRef="usd">44500000</us-gaap:ProceedsFromIssuanceOfWarrants>
    <us-gaap:OptionIndexedToIssuersEquityStrikePrice1
      contextRef="i2a88a3ee579649698c7a806c20baf329_D20200204-20200204"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RleHRyZWdpb246OGU2Njc2MjUzNThjNDkxODk1YWE2M2E2YmMwOGI2ODBfODEwNw_3f3fabb1-2ab2-4d0f-82c0-01a7fe0038da"
      unitRef="usdPerShare">73.67</us-gaap:OptionIndexedToIssuersEquityStrikePrice1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="i4d85c23c3dd4486a8c0cad316eeb498d_I20200204"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RleHRyZWdpb246OGU2Njc2MjUzNThjNDkxODk1YWE2M2E2YmMwOGI2ODBfODI1NQ_fd7cd350-bc74-4774-9924-c90af1350f81"
      unitRef="usdPerShare">113.34</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i0028dc2843f2423f8f300edeb35aa725_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RleHRyZWdpb246OGU2Njc2MjUzNThjNDkxODk1YWE2M2E2YmMwOGI2ODBfODY4OA_00e446a7-320f-46fd-94f5-dfe39cf8b17c"
      unitRef="usd">575000000.0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i0028dc2843f2423f8f300edeb35aa725_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RleHRyZWdpb246OGU2Njc2MjUzNThjNDkxODk1YWE2M2E2YmMwOGI2ODBfODc0Mw_1b49b169-25c1-4707-b4dc-58635d403d40"
      unitRef="usd">561700000</us-gaap:DebtInstrumentFairValue>
    <iart:TransferorsInterestsInTransferredFinancialAssetsMaximumInvestmentLimit
      contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RleHRyZWdpb246OGU2Njc2MjUzNThjNDkxODk1YWE2M2E2YmMwOGI2ODBfOTg3Ng_c76e3620-9564-4b24-81be-0a168fd56f40"
      unitRef="usd">150000000</iart:TransferorsInterestsInTransferredFinancialAssetsMaximumInvestmentLimit>
    <iart:SecuredLongTermDebtSecuritizationProgram
      contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RleHRyZWdpb246OGU2Njc2MjUzNThjNDkxODk1YWE2M2E2YmMwOGI2ODBfMTA2MDY_861597f0-2ee1-41f0-b758-ade0f9e3b14e"
      unitRef="usd">102500000</iart:SecuredLongTermDebtSecuritizationProgram>
    <iart:SecuredLongTermDebtSecuritizationProgram
      contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RleHRyZWdpb246OGU2Njc2MjUzNThjNDkxODk1YWE2M2E2YmMwOGI2ODBfMTA2MTM_043b4fea-8c44-4c50-8470-712aeb8aacb2"
      unitRef="usd">104700000</iart:SecuredLongTermDebtSecuritizationProgram>
    <iart:DebtWeightedAverageInterestRateFromSecuritization
      contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RleHRyZWdpb246OGU2Njc2MjUzNThjNDkxODk1YWE2M2E2YmMwOGI2ODBfMTA3MzA_b3dc7dfc-8a68-49dd-9690-be9524ea9295"
      unitRef="number">0.058</iart:DebtWeightedAverageInterestRateFromSecuritization>
    <iart:DebtWeightedAverageInterestRateFromSecuritization
      contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RleHRyZWdpb246OGU2Njc2MjUzNThjNDkxODk1YWE2M2E2YmMwOGI2ODBfMTA3Mzc_f2d807f2-f657-4839-8cdc-8372b2715ca3"
      unitRef="number">0.050</iart:DebtWeightedAverageInterestRateFromSecuritization>
    <iart:SecuritizationFacilityFairValueOfAmountOutstanding
      contextRef="if38b10df1e9e4c7bbece89c49285e3f3_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF80OS9mcmFnOjhlNjY3NjI1MzU4YzQ5MTg5NWFhNjNhNmJjMDhiNjgwL3RleHRyZWdpb246OGU2Njc2MjUzNThjNDkxODk1YWE2M2E2YmMwOGI2ODBfMTA4NDA_fcfee696-566a-4210-9e2d-267e2d875e92"
      unitRef="usd">102200000</iart:SecuritizationFacilityFairValueOfAmountOutstanding>
    <us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RleHRyZWdpb246ODA4MTIyY2E0NzEyNDJhN2I5MzExOGQ4ZTEyNmQ4NjBfMTA4NTM_a9634748-8fb4-4614-a871-fa4dd8e358f9">DERIVATIVE INSTRUMENTS &lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Interest Rate Hedging&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s interest rate risk relates to U.S. dollar denominated variable interest rate borrowings. The Company uses interest rate swap derivative instruments to manage earnings and cash flow exposure resulting from changes in interest rates. These interest rate swaps apply a fixed interest rate on a portion of the Company's expected SOFR-indexed borrowings. In connection with the March 2023 Amendment to the Senior Credit Facility, the Company amended its interest rate from LIBOR to SOFR-indexed interest. In March 2023, the Company entered into a basis swap where the Company receives Term SOFR and pays LIBOR to convert the portfolio of swaps from LIBOR to SOFR. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company held the following interest rate swaps as of March&#160;31, 2023 and December&#160;31, 2022 (dollar amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:center;text-indent:-9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.783%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.667%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.555%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.833%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.404%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.646%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.404%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.646%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.404%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.646%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.404%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.404%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.462%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Hedged Item&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Notional Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Designation Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Effective Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Termination Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fixed Interest Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Asset (Liability)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1-month Term SOFR Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;150,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;December 13, 2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;July 1, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;June 30, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1-month Term SOFR Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;200,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;December 13, 2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;January 1, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,738&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1-month Term SOFR Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;75,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;October 10, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;July 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;June 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1-month Term SOFR Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;75,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;October 10, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;July 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;June 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1-month Term SOFR Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;75,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;October 10, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;July 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;June 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,441&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1-month Term SOFR Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;100,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;December 18, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;December 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;December 31, 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.885&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1-month Term SOFR Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;100,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;December 18, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;December 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;December 31, 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.867&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,708&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1-month Term SOFR Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;575,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;December 15, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;July 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;December 31, 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1.415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;19,406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1-month Term SOFR Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;125,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;December 15, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;July 1, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;December 31, 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1.404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Basis Swap &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;March 24, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;December 31, 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,842)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,475,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;42,678&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="39" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt; The notional of the basis swap amortizes to match the total notional of the interest rate swap portfolio over time&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:center;text-indent:-9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.684%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.122%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.392%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.392%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.381%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.392%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.381%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.392%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.381%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.392%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.392%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.573%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Hedged Item&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Notional Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Designation Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Effective Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Termination Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fixed Interest Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Asset (Liability)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1-month USD LIBOR Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;150,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;December 13, 2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;July 1, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;June 30, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,012&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1-month USD LIBOR Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;200,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;December 13, 2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;January 1, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1-month USD LIBOR Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;75,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;October 10, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;July 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;June 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,831&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1-month USD LIBOR Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;75,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;October 10, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;July 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;June 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,905&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1-month USD LIBOR Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;75,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;October 10, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;July 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;June 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,970&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1-month USD LIBOR Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;100,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;December 18, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;December 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;December 31, 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.885&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1-month USD LIBOR Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;100,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;December 18, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;December 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;December 31, 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.867&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1-month USD LIBOR Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;575,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;December 15, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;July 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;December 31, 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1.415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;23,742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1-month USD LIBOR Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;125,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;December 15, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;July 1, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;December 31, 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1.404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,475,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;56,712&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has designated these derivative instruments as cash flow hedges. The Company assesses the effectiveness of these derivative instruments and has recorded the changes in the fair value of the derivative instrument designated as a cash flow hedge as unrealized gains or losses in accumulated other comprehensive loss (&#x201c;AOCL&#x201d;), net of tax, until the hedged item affected earnings, at which point any gain or loss was reclassified to earnings. If the hedged cash flow does not occur, or if it becomes probable that it will not occur, the Company will reclassify the remaining amount of any gain or loss on the related cash flow hedge recorded in AOCL to interest expense at that time.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Foreign Currency Hedging&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From time to time, the Company enters into foreign currency hedge contracts intended to protect the U.S. dollar value of certain forecasted foreign currency denominated transactions. The Company assesses the effectiveness of the contracts that are designated as hedging instruments. The changes in fair value of foreign currency cash flow hedges are recorded in AOCL, net of tax. Those amounts are subsequently reclassified to earnings from AOCL as impacted by the hedged item when the hedged item affects earnings. If the hedged forecasted transaction does not occur or if it becomes probable that it will not occur, the Company will reclassify the amount of any gain or loss on the related cash flow hedge to earnings at that time. For contracts not designated as hedging instruments, the changes in fair value of the contracts are recognized in other income, net in the consolidated statements of operation, along with the offsetting foreign currency gain or loss on the underlying assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The success of the Company&#x2019;s hedging anticipated currency exchange gains or losses to the extent that there are differences between forecasted and actual activities during periods of currency volatility. In addition, changes in currency exchange rates related to any unhedged transactions may affect earnings and cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cross-Currency Rate Swaps&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September 26, 2022, the Company amended the CHF-denominated intercompany loan to extend the termination date to September 2023 and as a result, the Company early terminated the cross-currency swap designated as cash flow hedge of an intercompany loan with aggregate notional amount of 50.0 million. Simultaneously, the Company entered into a cross-currency swap agreement to convert a notional amount of CHF 48.5 million equivalent to 49.1 million of this amended intercompany loan into U.S. dollars. The loss recorded by the Company upon the settlement of the swap was not material for the period.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 21, 2020, the Company entered into cross-currency swap agreements to convert a notional amount of $471.6&#160;million equivalent to 420.1&#160;million of a CHF-denominated intercompany loan into U.S. dollars. The CHF-denominated intercompany loan was the result of an intra-entity transfer of certain intellectual property rights to a subsidiary in Switzerland completed during the fourth quarter of 2020. The intercompany loan requires quarterly payments of CHF 5.8&#160;million plus accrued interest. As a result, the aggregate notional amount of the related cross-currency swaps will decrease by a corresponding amount. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The objective of these cross-currency swaps is to reduce volatility of earnings and cash flows associated with changes in the foreign currency exchange rate. Under the terms of these contracts, which have been designated as cash flow hedges, the Company will make interest payments in Swiss Francs and receive interest in U.S. dollars. Upon the maturity of these contracts, the Company will pay the principal amount of the loans in Swiss Francs and receive U.S. dollars from the counterparties.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company held the following cross-currency rate swaps as of March&#160;31, 2023 and December&#160;31, 2022 (dollar amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.747%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.020%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Effective Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Termination Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fixed Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Aggregate Notional Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;br/&gt;Asset (Liability)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Pay CHF&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;December 21, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;December 22, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.00%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;CHF&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;373,227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;397,137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,033)&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,241)&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Receive U.S.$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.98%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;418,980&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;445,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Pay CHF&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;September 28, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;September 29, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.95%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;CHF&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;48,533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;48,532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,011)&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,528)&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Receive U.S.$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.32%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49,142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49,142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7,044)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7,769)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The cross-currency swaps are carried on the consolidated balance sheet at fair value, and changes in the fair values are recorded as unrealized gains or losses in AOCL. For the three months ended March&#160;31, 2023, and 2022, the Company recorded a loss of $4.9 million and a gain $6.5 million, respectively, in other income, net related to change in fair value related to the foreign currency rate translation to offset the losses recognized on the intercompany loans.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three months ended March&#160;31, 2023, and 2022, the Company recorded a gain of $7.5 million and $7.9 million in AOCL, respectively, related to change in fair value of the cross-currency swaps.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three months ended March&#160;31, 2023, and 2022, the Company recorded a gain of $1.5 million and $1.8 million, respectively, in other income, net included in the consolidated statements of operations related to the interest rate differential of the cross-currency swaps.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated gain that is expected to be reclassified to other income (expense), net from AOCL as of March&#160;31, 2023 within the next twelve months is $0.1 million. As of March&#160;31, 2023, the Company does not expect any gains or losses will be reclassified into earnings as a result of the discontinuance of these cash flow hedges because the original forecasted transaction will not occur.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Net Investment Hedges&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company manages certain foreign exchange risks through a variety of strategies, including hedging. The Company is exposed to foreign exchange risk from its international operations through foreign currency purchases, net investments in foreign subsidiaries, and foreign currency assets and liabilities created in the normal course of business. On October 1, 2018 and December 16, 2020, the Company entered into cross-currency swap agreements designated as net investment hedges to partially offset the effects of foreign currency on foreign subsidiaries.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company held the following cross-currency rate swaps designated as net investment hedges as of March&#160;31, 2023 and December&#160;31, 2022, respectively (dollar amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.705%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.390%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.159%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.390%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.390%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.319%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.390%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.660%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.205%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.390%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.390%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.387%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.390%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.284%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="margin-top:6pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March&#160;31, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="margin-top:6pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December&#160;31, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Effective Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Termination Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fixed Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="12" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Aggregate Notional Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;br/&gt;Asset (Liability)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Pay EUR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;October 3, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;EUR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;51,760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;51,760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Receive U.S.$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.57%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;60,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;60,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Pay EUR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;October 3, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;September 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;EUR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;38,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;38,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Receive U.S.$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.19%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Pay CHF&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;May 26, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;December 16, 2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;CHF&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;288,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;288,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(14,711)&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(14,663)&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Receive U.S.$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.94%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;300,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;300,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6,790)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,643)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The cross-currency swaps were carried on the consolidated balance sheet at fair value and changes in the fair values were recorded as unrealized gains or losses in AOCL. For the three months ended March&#160;31, 2023 and 2022, the Company recorded a loss of $1.1 million and a gain $1.3 million, respectively, in AOCL related to the change in fair value of the cross-currency swaps.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three months ended March&#160;31, 2023, and 2022, the Company recorded gains of $2.1 million and $1.3 million, respectively, in interest income included in the consolidated statements of operations related to the interest rate differential of the cross-currency swaps.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated gain that is expected to be reclassified to interest income from AOCL as of March&#160;31, 2023 within the next twelve months is $10.9 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Foreign Currency Forward Contract&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has entered into a hedge for forecasted intercompany purchases denominated in foreign currencies through the use of forward contracts designated as cash flow hedges. To the extent these forward contracts meet hedge accounting criteria, changes in their fair value are not included in accumulated comprehensive loss. These changes in fair value will be recognized into earnings as a component of cost of sales when the forecasted-transaction occurs. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the first quarter of 2023 the Company entered into Foreign Currency Forward Contracts with a notional amount of $10.8 million to mitigate the risk of foreign currency on intercompany purchases in CHF.  During the three months ended March&#160;31, 2023 the Company recorded an immaterial  loss in AOCL related to the change in fair value of the Foreign Currency Forward Contracts.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Counterparty Credit Risk&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company manages its concentration of counterparty credit risk on its derivative instruments by limiting acceptable counterparties to a group of major financial institutions with investment grade credit ratings, and by actively monitoring their credit ratings and outstanding positions on an ongoing basis. Therefore, the Company considers the credit risk of the counterparties to be low. Furthermore, none of the Company&#x2019;s derivative transactions are subject to collateral or other security arrangements, and none contain provisions that depend upon the Company&#x2019;s credit ratings from any credit rating agency.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Fair Value of Derivative Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has classified all of its derivative instruments within Level 2 of the fair value hierarchy because observable inputs are available for substantially the full term of the derivative instruments. The fair values of the interest rate swaps and cross-currency swaps were developed using a market approach based on publicly available market yield curves and the terms of the swap. The Company performs ongoing assessments of counterparty credit risk.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the fair value for derivatives designated as hedging instruments in the condensed consolidated balance sheets as of March&#160;31, 2023 and December&#160;31, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.181%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.387%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.024%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.174%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value as of&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location on Balance Sheet &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Derivatives designated as hedges &#x2014; Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Cash Flow Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest rate swap&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,659&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,682&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Net Investment Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,942&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,653&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Cash Flow Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest rate swap&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28,861&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40,030&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Net Investment Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,940&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total derivatives designated as hedges &#x2014; Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;62,541&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;76,173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Derivatives designated as hedges &#x2014; Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Cash Flow Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest rate swap&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;762&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Net Investment Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Cash Flow Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest rate swap&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,080&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,738&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Net Investment Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,672&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,608&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total derivatives designated as hedges &#x2014; Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33,766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32,874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:9pt;text-align:justify;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company classifies derivative assets and liabilities as current based on the cash flows expected to be incurred within the following 12&#160;months.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:9pt;text-align:justify;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; At March&#160;31, 2023 and December&#160;31, 2022, the total notional amounts related to the Company&#x2019;s interest rate swaps were both $1.5 billion, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following presents the effect of derivative instruments designated as cash flow hedges and net investment hedges on the accompanying condensed consolidated statement of operations during the three months ended March&#160;31, 2023 and 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.917%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.057%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.597%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance&#160;in&#160;AOCL&lt;br/&gt;Beginning of&lt;br/&gt;Quarter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&#160;of&lt;br/&gt;Gain (Loss)&lt;br/&gt;Recognized&#160;in&lt;br/&gt;AOCL&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&#160;of&#160;Gain (Loss)&lt;br/&gt;Reclassified from&lt;br/&gt;AOCL into&lt;br/&gt;Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance&#160;in&#160;AOCL&lt;br/&gt;End of Quarter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location in&lt;br/&gt;Statements&#160;of&lt;br/&gt;Operations&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Cash Flow Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest rate swap&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;56,712&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(10,534)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;42,678&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(20,271)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,191&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,504)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(14,576)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other income, net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign Currency Forward Contract&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(69)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(69)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cost of Sales&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Net Investment Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6,914)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,096&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(8,060)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29,527&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7,462)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,092&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,973&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Cash Flow Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest rate swap&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(43,956)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41,675&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,213)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(9,688)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,331&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(17,703)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other income, net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Net Investment Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,312)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,323)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(55,956)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;43,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,438&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(17,094)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Derivative Instruments not designated hedges:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the second quarter of 2021, the Company entered into a foreign currency swap, with a notional amount of $7.3 million to mitigate the risk from fluctuations in foreign currency exchange rates associated with an intercompany loan denominated in JPY. In a foreign currency swap transaction, the Company agrees with another party to exchange, at specified intervals, the difference between one currency and another currency at a fixed exchange rate, generally set at inception, calculated by reference to an agreed upon notional amount. The notional amount of each currency is exchanged at the inception and termination of the currency swap by each party. The Company subsequently paid down a portion of this swap, bringing the notional amount down to $6.4 million. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the gains (losses) of derivative instruments not designated as hedges on the condensed consolidated statements of income, which was included in other income:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.736%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.417%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.412%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.417%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.414%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfDerivativeInstrumentsTextBlock
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RleHRyZWdpb246ODA4MTIyY2E0NzEyNDJhN2I5MzExOGQ4ZTEyNmQ4NjBfMTA4NjU_320c3d40-81d0-420c-af1a-fdc0640c440c">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company held the following interest rate swaps as of March&#160;31, 2023 and December&#160;31, 2022 (dollar amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;padding-left:4.5pt;padding-right:4.5pt;text-align:center;text-indent:-9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.783%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.667%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.555%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.833%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.404%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.646%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.404%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.646%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.404%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.646%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.404%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.404%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.462%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Hedged Item&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Notional Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Designation Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Effective Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Termination Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fixed Interest Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Asset (Liability)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1-month Term SOFR Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;150,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;December 13, 2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;July 1, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;June 30, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1-month Term SOFR Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;200,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;December 13, 2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;January 1, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,738&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1-month Term SOFR Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;75,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;October 10, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;July 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;June 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1-month Term SOFR Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;75,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;October 10, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;July 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;June 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1-month Term SOFR Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;75,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;October 10, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;July 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;June 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,441&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1-month Term SOFR Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;100,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;December 18, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;December 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;December 31, 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.885&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1-month Term SOFR Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;100,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;December 18, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;December 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;December 31, 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.867&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,708&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1-month Term SOFR Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;575,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;December 15, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;July 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;December 31, 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1.415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;19,406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1-month Term SOFR Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;125,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;December 15, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;July 1, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;December 31, 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1.404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Basis Swap &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;March 24, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;December 31, 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,842)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,475,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;42,678&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="39" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt; The notional of the basis swap amortizes to match the total notional of the interest rate swap portfolio over time&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.684%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.122%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.392%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.392%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.381%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.392%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.381%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.392%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.381%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.392%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.392%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.573%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Hedged Item&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Notional Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Designation Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Effective Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Termination Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fixed Interest Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Asset (Liability)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1-month USD LIBOR Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;150,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;December 13, 2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;July 1, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;June 30, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,012&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1-month USD LIBOR Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;200,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;December 13, 2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;January 1, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1-month USD LIBOR Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;75,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;October 10, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;July 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;June 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,831&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1-month USD LIBOR Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;75,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;October 10, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;July 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;June 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,905&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1-month USD LIBOR Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;75,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;October 10, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;July 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;June 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,970&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1-month USD LIBOR Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;100,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;December 18, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;December 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;December 31, 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.885&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1-month USD LIBOR Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;100,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;December 18, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;December 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;December 31, 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.867&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1-month USD LIBOR Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;575,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;December 15, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;July 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;December 31, 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1.415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;23,742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1-month USD LIBOR Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;125,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;December 15, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;July 1, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;December 31, 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1.404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,475,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;56,712&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company held the following cross-currency rate swaps as of March&#160;31, 2023 and December&#160;31, 2022 (dollar amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.747%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.020%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Effective Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Termination Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fixed Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Aggregate Notional Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;br/&gt;Asset (Liability)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Pay CHF&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;December 21, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;December 22, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.00%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;CHF&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;373,227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;397,137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,033)&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,241)&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Receive U.S.$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.98%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;418,980&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;445,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Pay CHF&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;September 28, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;September 29, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.95%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;CHF&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;48,533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;48,532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,011)&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,528)&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Receive U.S.$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.32%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49,142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49,142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7,044)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7,769)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company held the following cross-currency rate swaps designated as net investment hedges as of March&#160;31, 2023 and December&#160;31, 2022, respectively (dollar amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.705%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.390%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.159%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.390%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.390%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.319%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.390%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.660%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.205%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.390%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.390%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.387%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.390%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.284%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="margin-top:6pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March&#160;31, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="margin-top:6pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December&#160;31, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Effective Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Termination Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fixed Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="12" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Aggregate Notional Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;br/&gt;Asset (Liability)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Pay EUR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;October 3, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;EUR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;51,760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;51,760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Receive U.S.$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.57%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;60,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;60,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Pay EUR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;October 3, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;September 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;EUR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;38,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;38,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Receive U.S.$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.19%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Pay CHF&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;May 26, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;December 16, 2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;CHF&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;288,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;288,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(14,711)&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" rowspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(14,663)&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Receive U.S.$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.94%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;300,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;300,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6,790)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,643)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsTextBlock>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i660d9b3823f743b9bb93a4c91c601967_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjQzZjZiNzkxMTY0YjRlMzRiZGQxNzM1OTYxODIwMWM0L3RhYmxlcmFuZ2U6NDNmNmI3OTExNjRiNGUzNGJkZDE3MzU5NjE4MjAxYzRfNC00LTEtMS0xODY4MjE_216a4106-6fa2-4c83-8543-cf1b48546f37"
      unitRef="usd">150000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="i660d9b3823f743b9bb93a4c91c601967_I20230331"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjQzZjZiNzkxMTY0YjRlMzRiZGQxNzM1OTYxODIwMWM0L3RhYmxlcmFuZ2U6NDNmNmI3OTExNjRiNGUzNGJkZDE3MzU5NjE4MjAxYzRfNC0xNC0xLTEtMTg2ODIx_de395d36-c93c-4d41-8a0a-d6e60af2c8ba"
      unitRef="number">0.02423</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i660d9b3823f743b9bb93a4c91c601967_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjQzZjZiNzkxMTY0YjRlMzRiZGQxNzM1OTYxODIwMWM0L3RhYmxlcmFuZ2U6NDNmNmI3OTExNjRiNGUzNGJkZDE3MzU5NjE4MjAxYzRfNC0xNi0xLTEtMTg2ODIx_9b166945-f88b-417a-8e78-93bca18c19a8"
      unitRef="usd">4022000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeNotionalAmount
      contextRef="if90a05dc42874d4c91a7b0d2cd282433_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjQzZjZiNzkxMTY0YjRlMzRiZGQxNzM1OTYxODIwMWM0L3RhYmxlcmFuZ2U6NDNmNmI3OTExNjRiNGUzNGJkZDE3MzU5NjE4MjAxYzRfNS00LTEtMS0xODY4MjE_da12b221-c104-4a1e-af5c-81ee69ad112b"
      unitRef="usd">200000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="if90a05dc42874d4c91a7b0d2cd282433_I20230331"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjQzZjZiNzkxMTY0YjRlMzRiZGQxNzM1OTYxODIwMWM0L3RhYmxlcmFuZ2U6NDNmNmI3OTExNjRiNGUzNGJkZDE3MzU5NjE4MjAxYzRfNS0xNC0xLTEtMTg2ODIx_f52d7b49-a9af-41a7-89a5-8e5d4a2aeee8"
      unitRef="number">0.02313</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="if90a05dc42874d4c91a7b0d2cd282433_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjQzZjZiNzkxMTY0YjRlMzRiZGQxNzM1OTYxODIwMWM0L3RhYmxlcmFuZ2U6NDNmNmI3OTExNjRiNGUzNGJkZDE3MzU5NjE4MjAxYzRfNS0xNi0xLTEtMTg2ODIx_aa7ccc4b-7f91-4d98-bcd5-641203c50405"
      unitRef="usd">6738000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ic80e820d18594abbb087fa7ea6c97b34_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjQzZjZiNzkxMTY0YjRlMzRiZGQxNzM1OTYxODIwMWM0L3RhYmxlcmFuZ2U6NDNmNmI3OTExNjRiNGUzNGJkZDE3MzU5NjE4MjAxYzRfNi00LTEtMS0xODY4MjE_ec58acfa-4019-43b1-8748-125dffd48fcd"
      unitRef="usd">75000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="ic80e820d18594abbb087fa7ea6c97b34_I20230331"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjQzZjZiNzkxMTY0YjRlMzRiZGQxNzM1OTYxODIwMWM0L3RhYmxlcmFuZ2U6NDNmNmI3OTExNjRiNGUzNGJkZDE3MzU5NjE4MjAxYzRfNi0xNC0xLTEtMTg2ODIx_2e1fb448-91c6-4b95-b44f-100b6b21b792"
      unitRef="number">0.03220</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="ic80e820d18594abbb087fa7ea6c97b34_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjQzZjZiNzkxMTY0YjRlMzRiZGQxNzM1OTYxODIwMWM0L3RhYmxlcmFuZ2U6NDNmNmI3OTExNjRiNGUzNGJkZDE3MzU5NjE4MjAxYzRfNi0xNi0xLTEtMTg2ODIx_1e12f50f-9b96-4898-8168-5de71166c659"
      unitRef="usd">1329000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i242cbbb364f64c76abce2babdef87734_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjQzZjZiNzkxMTY0YjRlMzRiZGQxNzM1OTYxODIwMWM0L3RhYmxlcmFuZ2U6NDNmNmI3OTExNjRiNGUzNGJkZDE3MzU5NjE4MjAxYzRfNy00LTEtMS0xODY4MjE_9b984b57-074e-41d5-910c-04a638174f16"
      unitRef="usd">75000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="i242cbbb364f64c76abce2babdef87734_I20230331"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjQzZjZiNzkxMTY0YjRlMzRiZGQxNzM1OTYxODIwMWM0L3RhYmxlcmFuZ2U6NDNmNmI3OTExNjRiNGUzNGJkZDE3MzU5NjE4MjAxYzRfNy0xNC0xLTEtMTg2ODIx_0750fbec-b081-4690-b2c6-90bc211f95f6"
      unitRef="number">0.03199</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i242cbbb364f64c76abce2babdef87734_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjQzZjZiNzkxMTY0YjRlMzRiZGQxNzM1OTYxODIwMWM0L3RhYmxlcmFuZ2U6NDNmNmI3OTExNjRiNGUzNGJkZDE3MzU5NjE4MjAxYzRfNy0xNi0xLTEtMTg2ODIx_8656ddb1-d67b-4abc-90db-dda577dbfa43"
      unitRef="usd">1539000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i1df01832fdb04d5687ddfbc85bd04c29_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjQzZjZiNzkxMTY0YjRlMzRiZGQxNzM1OTYxODIwMWM0L3RhYmxlcmFuZ2U6NDNmNmI3OTExNjRiNGUzNGJkZDE3MzU5NjE4MjAxYzRfOC00LTEtMS0xODY4MjE_374317d6-b6ee-4e8c-81e2-51dbdac7f277"
      unitRef="usd">75000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="i1df01832fdb04d5687ddfbc85bd04c29_I20230331"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjQzZjZiNzkxMTY0YjRlMzRiZGQxNzM1OTYxODIwMWM0L3RhYmxlcmFuZ2U6NDNmNmI3OTExNjRiNGUzNGJkZDE3MzU5NjE4MjAxYzRfOC0xNC0xLTEtMTg2ODIx_22800d73-bafe-4e77-92a9-344a87e91ae5"
      unitRef="number">0.03209</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i1df01832fdb04d5687ddfbc85bd04c29_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjQzZjZiNzkxMTY0YjRlMzRiZGQxNzM1OTYxODIwMWM0L3RhYmxlcmFuZ2U6NDNmNmI3OTExNjRiNGUzNGJkZDE3MzU5NjE4MjAxYzRfOC0xNi0xLTEtMTg2ODIx_4433c76c-18eb-47cf-b711-b41a9b2376c9"
      unitRef="usd">1441000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeNotionalAmount
      contextRef="id7f35814aec144359ed4a1f6aca5ff44_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjQzZjZiNzkxMTY0YjRlMzRiZGQxNzM1OTYxODIwMWM0L3RhYmxlcmFuZ2U6NDNmNmI3OTExNjRiNGUzNGJkZDE3MzU5NjE4MjAxYzRfOS00LTEtMS0xODY4MjE_64b5846a-9a76-41b6-a78c-795b5b739b04"
      unitRef="usd">100000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="id7f35814aec144359ed4a1f6aca5ff44_I20230331"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjQzZjZiNzkxMTY0YjRlMzRiZGQxNzM1OTYxODIwMWM0L3RhYmxlcmFuZ2U6NDNmNmI3OTExNjRiNGUzNGJkZDE3MzU5NjE4MjAxYzRfOS0xNC0xLTEtMTg2ODIx_59edc221-60e4-4ccc-abf9-f8817a58f71e"
      unitRef="number">0.02885</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="id7f35814aec144359ed4a1f6aca5ff44_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjQzZjZiNzkxMTY0YjRlMzRiZGQxNzM1OTYxODIwMWM0L3RhYmxlcmFuZ2U6NDNmNmI3OTExNjRiNGUzNGJkZDE3MzU5NjE4MjAxYzRfOS0xNi0xLTEtMTg2ODIx_05e34df7-1808-4ec3-8123-3504184aeb4a"
      unitRef="usd">2770000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeNotionalAmount
      contextRef="if455fa2d39f24cf59e0ca350ce4174ae_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjQzZjZiNzkxMTY0YjRlMzRiZGQxNzM1OTYxODIwMWM0L3RhYmxlcmFuZ2U6NDNmNmI3OTExNjRiNGUzNGJkZDE3MzU5NjE4MjAxYzRfMTAtNC0xLTEtMTg2ODIx_3f122ec7-9120-4445-a510-bd16fd4818a4"
      unitRef="usd">100000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="if455fa2d39f24cf59e0ca350ce4174ae_I20230331"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjQzZjZiNzkxMTY0YjRlMzRiZGQxNzM1OTYxODIwMWM0L3RhYmxlcmFuZ2U6NDNmNmI3OTExNjRiNGUzNGJkZDE3MzU5NjE4MjAxYzRfMTAtMTQtMS0xLTE4NjgyMQ_77aed230-4c9e-469a-95c8-539fef299250"
      unitRef="number">0.02867</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="if455fa2d39f24cf59e0ca350ce4174ae_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjQzZjZiNzkxMTY0YjRlMzRiZGQxNzM1OTYxODIwMWM0L3RhYmxlcmFuZ2U6NDNmNmI3OTExNjRiNGUzNGJkZDE3MzU5NjE4MjAxYzRfMTAtMTYtMS0xLTE4NjgyMQ_453ddbf2-bbce-4d73-a61a-a226e8c90755"
      unitRef="usd">2708000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i68d02b4ce6b442a39ee633b1a9c0c689_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjQzZjZiNzkxMTY0YjRlMzRiZGQxNzM1OTYxODIwMWM0L3RhYmxlcmFuZ2U6NDNmNmI3OTExNjRiNGUzNGJkZDE3MzU5NjE4MjAxYzRfMTEtNC0xLTEtMTg2ODIx_c320db32-82d5-425d-9199-9f3365f0df81"
      unitRef="usd">575000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="i68d02b4ce6b442a39ee633b1a9c0c689_I20230331"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjQzZjZiNzkxMTY0YjRlMzRiZGQxNzM1OTYxODIwMWM0L3RhYmxlcmFuZ2U6NDNmNmI3OTExNjRiNGUzNGJkZDE3MzU5NjE4MjAxYzRfMTEtMTQtMS0xLTE4NjgyMQ_0d7c8757-0dc1-411a-ae5d-924eec2c4423"
      unitRef="number">0.01415</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i68d02b4ce6b442a39ee633b1a9c0c689_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjQzZjZiNzkxMTY0YjRlMzRiZGQxNzM1OTYxODIwMWM0L3RhYmxlcmFuZ2U6NDNmNmI3OTExNjRiNGUzNGJkZDE3MzU5NjE4MjAxYzRfMTEtMTYtMS0xLTE4NjgyMQ_12b7b1d5-e239-4436-8560-24249f634755"
      unitRef="usd">19406000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i4611de47ca424f2880fb6c66abf4c864_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjQzZjZiNzkxMTY0YjRlMzRiZGQxNzM1OTYxODIwMWM0L3RhYmxlcmFuZ2U6NDNmNmI3OTExNjRiNGUzNGJkZDE3MzU5NjE4MjAxYzRfMTItNC0xLTEtMTg2ODIx_355c0b93-698b-4908-ade8-147cbdf8da84"
      unitRef="usd">125000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="i4611de47ca424f2880fb6c66abf4c864_I20230331"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjQzZjZiNzkxMTY0YjRlMzRiZGQxNzM1OTYxODIwMWM0L3RhYmxlcmFuZ2U6NDNmNmI3OTExNjRiNGUzNGJkZDE3MzU5NjE4MjAxYzRfMTItMTQtMS0xLTE4NjgyMQ_c9b10ed4-5e90-49fc-8cfc-3dc0afbf686e"
      unitRef="number">0.01404</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i4611de47ca424f2880fb6c66abf4c864_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjQzZjZiNzkxMTY0YjRlMzRiZGQxNzM1OTYxODIwMWM0L3RhYmxlcmFuZ2U6NDNmNmI3OTExNjRiNGUzNGJkZDE3MzU5NjE4MjAxYzRfMTItMTYtMS0xLTE4NjgyMQ_0e29ee73-0bf5-4ca7-9e1b-28f52762a973"
      unitRef="usd">4567000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeNotionalAmount
      contextRef="id3e91944e1f34523a944e5c31a1dcfb8_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjQzZjZiNzkxMTY0YjRlMzRiZGQxNzM1OTYxODIwMWM0L3RhYmxlcmFuZ2U6NDNmNmI3OTExNjRiNGUzNGJkZDE3MzU5NjE4MjAxYzRfMTMtNC0xLTEtMjAzMTc3_5d15dc19-721e-4ee0-8a68-86b6d6c927f4"
      unitRef="usd">0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="id3e91944e1f34523a944e5c31a1dcfb8_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjQzZjZiNzkxMTY0YjRlMzRiZGQxNzM1OTYxODIwMWM0L3RhYmxlcmFuZ2U6NDNmNmI3OTExNjRiNGUzNGJkZDE3MzU5NjE4MjAxYzRfMTMtMTYtMS0xLTIwMzE3Nw_c3d56ec9-1898-434c-b7c5-4f24b0712a88"
      unitRef="usd">-1842000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i1b244a95ae9e496fa6a76dbb19e5a1ff_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjQzZjZiNzkxMTY0YjRlMzRiZGQxNzM1OTYxODIwMWM0L3RhYmxlcmFuZ2U6NDNmNmI3OTExNjRiNGUzNGJkZDE3MzU5NjE4MjAxYzRfMTMtNC0xLTEtMTg2ODIx_2dcbb149-c9b6-4c33-bb1a-54dcb3fd1ea0"
      unitRef="usd">1475000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="ibaa12b7418534a0f9c95d84d9ad6b1bb_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjQzZjZiNzkxMTY0YjRlMzRiZGQxNzM1OTYxODIwMWM0L3RhYmxlcmFuZ2U6NDNmNmI3OTExNjRiNGUzNGJkZDE3MzU5NjE4MjAxYzRfMTMtMTYtMS0xLTE4NjgyMQ_19c51b4a-206f-479a-9c49-af0ef9f03f58"
      unitRef="usd">42678000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i9f5aaca61a204337a8cdf280d2e2d8d1_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjFmNjIwMGUxYzIyOTQ0ZjY4YmQ0MGEzYjcyM2Q5ZmYxL3RhYmxlcmFuZ2U6MWY2MjAwZTFjMjI5NDRmNjhiZDQwYTNiNzIzZDlmZjFfNC02LTEtMS0yMDAyODU_f92a6a66-fe56-4977-bcd2-b9f79af96718"
      unitRef="usd">150000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="i9f5aaca61a204337a8cdf280d2e2d8d1_I20221231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjFmNjIwMGUxYzIyOTQ0ZjY4YmQ0MGEzYjcyM2Q5ZmYxL3RhYmxlcmFuZ2U6MWY2MjAwZTFjMjI5NDRmNjhiZDQwYTNiNzIzZDlmZjFfNC0xNC0xLTEtMjAwMjg1_611efb8a-c336-442b-a002-c71d5a1f1ab7"
      unitRef="number">0.02423</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i9f5aaca61a204337a8cdf280d2e2d8d1_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjFmNjIwMGUxYzIyOTQ0ZjY4YmQ0MGEzYjcyM2Q5ZmYxL3RhYmxlcmFuZ2U6MWY2MjAwZTFjMjI5NDRmNjhiZDQwYTNiNzIzZDlmZjFfNC0xOC0xLTEtMjAwMjg1_a91e5aa3-668c-4a38-b3fc-83e39cb65db6"
      unitRef="usd">5012000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i110563708a344d13b6ba6837a8ffdaff_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjFmNjIwMGUxYzIyOTQ0ZjY4YmQ0MGEzYjcyM2Q5ZmYxL3RhYmxlcmFuZ2U6MWY2MjAwZTFjMjI5NDRmNjhiZDQwYTNiNzIzZDlmZjFfNS02LTEtMS0yMDAyODU_1fc0e455-20af-4f24-a7c1-f9997d7e8f0f"
      unitRef="usd">200000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="i110563708a344d13b6ba6837a8ffdaff_I20221231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjFmNjIwMGUxYzIyOTQ0ZjY4YmQ0MGEzYjcyM2Q5ZmYxL3RhYmxlcmFuZ2U6MWY2MjAwZTFjMjI5NDRmNjhiZDQwYTNiNzIzZDlmZjFfNS0xNC0xLTEtMjAwMjg1_a4ac4b06-3190-4c47-ab9a-c3874eb75f46"
      unitRef="number">0.02313</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i110563708a344d13b6ba6837a8ffdaff_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjFmNjIwMGUxYzIyOTQ0ZjY4YmQ0MGEzYjcyM2Q5ZmYxL3RhYmxlcmFuZ2U6MWY2MjAwZTFjMjI5NDRmNjhiZDQwYTNiNzIzZDlmZjFfNS0xOC0xLTEtMjAwMjg1_bb427c29-d062-4598-ad52-8904683adcad"
      unitRef="usd">8380000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ib8d564f8afa4405eac0fdd8215345e13_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjFmNjIwMGUxYzIyOTQ0ZjY4YmQ0MGEzYjcyM2Q5ZmYxL3RhYmxlcmFuZ2U6MWY2MjAwZTFjMjI5NDRmNjhiZDQwYTNiNzIzZDlmZjFfNi02LTEtMS0yMDAyODU_723cf53d-08f4-49ef-82e9-60cb3eaea02c"
      unitRef="usd">75000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="ib8d564f8afa4405eac0fdd8215345e13_I20221231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjFmNjIwMGUxYzIyOTQ0ZjY4YmQ0MGEzYjcyM2Q5ZmYxL3RhYmxlcmFuZ2U6MWY2MjAwZTFjMjI5NDRmNjhiZDQwYTNiNzIzZDlmZjFfNi0xNC0xLTEtMjAwMjg1_66063123-9a56-400b-81e2-a00351509a64"
      unitRef="number">0.03220</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="ib8d564f8afa4405eac0fdd8215345e13_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjFmNjIwMGUxYzIyOTQ0ZjY4YmQ0MGEzYjcyM2Q5ZmYxL3RhYmxlcmFuZ2U6MWY2MjAwZTFjMjI5NDRmNjhiZDQwYTNiNzIzZDlmZjFfNi0xOC0xLTEtMjAwMjg1_1bfa5de9-9b38-4990-ab8c-d14eae587472"
      unitRef="usd">1831000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i453cd89c33ef48c7bdfc3ff3788502d2_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjFmNjIwMGUxYzIyOTQ0ZjY4YmQ0MGEzYjcyM2Q5ZmYxL3RhYmxlcmFuZ2U6MWY2MjAwZTFjMjI5NDRmNjhiZDQwYTNiNzIzZDlmZjFfNy02LTEtMS0yMDAyODU_08eecccd-bdb5-4fcd-ad31-98127b815f12"
      unitRef="usd">75000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="i453cd89c33ef48c7bdfc3ff3788502d2_I20221231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjFmNjIwMGUxYzIyOTQ0ZjY4YmQ0MGEzYjcyM2Q5ZmYxL3RhYmxlcmFuZ2U6MWY2MjAwZTFjMjI5NDRmNjhiZDQwYTNiNzIzZDlmZjFfNy0xNC0xLTEtMjAwMjg1_ad9cb1b7-113a-4e9d-b003-ce8cdde79e5c"
      unitRef="number">0.03199</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i453cd89c33ef48c7bdfc3ff3788502d2_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjFmNjIwMGUxYzIyOTQ0ZjY4YmQ0MGEzYjcyM2Q5ZmYxL3RhYmxlcmFuZ2U6MWY2MjAwZTFjMjI5NDRmNjhiZDQwYTNiNzIzZDlmZjFfNy0xOC0xLTEtMjAwMjg1_285d7a24-b97d-4020-affc-b40cb4bcf2ee"
      unitRef="usd">1905000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeNotionalAmount
      contextRef="iefae8c9c545043389530b336eede02b7_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjFmNjIwMGUxYzIyOTQ0ZjY4YmQ0MGEzYjcyM2Q5ZmYxL3RhYmxlcmFuZ2U6MWY2MjAwZTFjMjI5NDRmNjhiZDQwYTNiNzIzZDlmZjFfOC02LTEtMS0yMDAyODU_2718cb0b-9e85-4a09-9d58-98a58ffe7297"
      unitRef="usd">75000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="iefae8c9c545043389530b336eede02b7_I20221231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjFmNjIwMGUxYzIyOTQ0ZjY4YmQ0MGEzYjcyM2Q5ZmYxL3RhYmxlcmFuZ2U6MWY2MjAwZTFjMjI5NDRmNjhiZDQwYTNiNzIzZDlmZjFfOC0xNC0xLTEtMjAwMjg1_9dbf8381-9e09-4d05-8004-5a333c74461d"
      unitRef="number">0.03209</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="iefae8c9c545043389530b336eede02b7_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjFmNjIwMGUxYzIyOTQ0ZjY4YmQ0MGEzYjcyM2Q5ZmYxL3RhYmxlcmFuZ2U6MWY2MjAwZTFjMjI5NDRmNjhiZDQwYTNiNzIzZDlmZjFfOC0xOC0xLTEtMjAwMjg1_c1c4ffba-0fa3-4ebc-931d-707b046de78a"
      unitRef="usd">1970000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeNotionalAmount
      contextRef="idb9a8e940c7a42eb987c4c32a8bdb139_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjFmNjIwMGUxYzIyOTQ0ZjY4YmQ0MGEzYjcyM2Q5ZmYxL3RhYmxlcmFuZ2U6MWY2MjAwZTFjMjI5NDRmNjhiZDQwYTNiNzIzZDlmZjFfOS02LTEtMS0yMDAyODU_646b4082-dc6d-40d3-97cc-a526d5eca71a"
      unitRef="usd">100000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="idb9a8e940c7a42eb987c4c32a8bdb139_I20221231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjFmNjIwMGUxYzIyOTQ0ZjY4YmQ0MGEzYjcyM2Q5ZmYxL3RhYmxlcmFuZ2U6MWY2MjAwZTFjMjI5NDRmNjhiZDQwYTNiNzIzZDlmZjFfOS0xNC0xLTEtMjAwMjg1_68e7d5b6-dfdd-4aba-8323-283560528f77"
      unitRef="number">0.02885</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="idb9a8e940c7a42eb987c4c32a8bdb139_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjFmNjIwMGUxYzIyOTQ0ZjY4YmQ0MGEzYjcyM2Q5ZmYxL3RhYmxlcmFuZ2U6MWY2MjAwZTFjMjI5NDRmNjhiZDQwYTNiNzIzZDlmZjFfOS0xOC0xLTEtMjAwMjg1_155388d8-966b-45e7-8597-25142fe824b4"
      unitRef="usd">4252000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i107d35b94cbf4cafb70558b912de87a9_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjFmNjIwMGUxYzIyOTQ0ZjY4YmQ0MGEzYjcyM2Q5ZmYxL3RhYmxlcmFuZ2U6MWY2MjAwZTFjMjI5NDRmNjhiZDQwYTNiNzIzZDlmZjFfMTAtNi0xLTEtMjAwMjg1_1b153e82-d222-4f8b-8616-7786b4363f10"
      unitRef="usd">100000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="i107d35b94cbf4cafb70558b912de87a9_I20221231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjFmNjIwMGUxYzIyOTQ0ZjY4YmQ0MGEzYjcyM2Q5ZmYxL3RhYmxlcmFuZ2U6MWY2MjAwZTFjMjI5NDRmNjhiZDQwYTNiNzIzZDlmZjFfMTAtMTQtMS0xLTIwMDI4NQ_54a9a19d-ac6e-4cec-9139-9d4e403096df"
      unitRef="number">0.02867</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i107d35b94cbf4cafb70558b912de87a9_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjFmNjIwMGUxYzIyOTQ0ZjY4YmQ0MGEzYjcyM2Q5ZmYxL3RhYmxlcmFuZ2U6MWY2MjAwZTFjMjI5NDRmNjhiZDQwYTNiNzIzZDlmZjFfMTAtMTgtMS0xLTIwMDI4NQ_11fbcd1b-8547-46bb-90ee-fb4a832dee4c"
      unitRef="usd">4153000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i1063bf6f331744358ce9892d6b046199_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjFmNjIwMGUxYzIyOTQ0ZjY4YmQ0MGEzYjcyM2Q5ZmYxL3RhYmxlcmFuZ2U6MWY2MjAwZTFjMjI5NDRmNjhiZDQwYTNiNzIzZDlmZjFfMTEtNi0xLTEtMjAwMjg1_95ee5dba-6bc8-45f2-a629-336e3f3b17d9"
      unitRef="usd">575000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="i1063bf6f331744358ce9892d6b046199_I20221231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjFmNjIwMGUxYzIyOTQ0ZjY4YmQ0MGEzYjcyM2Q5ZmYxL3RhYmxlcmFuZ2U6MWY2MjAwZTFjMjI5NDRmNjhiZDQwYTNiNzIzZDlmZjFfMTEtMTQtMS0xLTIwMDI4NQ_083c1660-6480-44b2-bd1c-888b885615ab"
      unitRef="number">0.01415</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i1063bf6f331744358ce9892d6b046199_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjFmNjIwMGUxYzIyOTQ0ZjY4YmQ0MGEzYjcyM2Q5ZmYxL3RhYmxlcmFuZ2U6MWY2MjAwZTFjMjI5NDRmNjhiZDQwYTNiNzIzZDlmZjFfMTEtMTgtMS0xLTIwMDI4NQ_10feda83-0c18-4446-9749-000bf5634258"
      unitRef="usd">23742000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i69349b63e94749f680a73aa85071a4f3_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjFmNjIwMGUxYzIyOTQ0ZjY4YmQ0MGEzYjcyM2Q5ZmYxL3RhYmxlcmFuZ2U6MWY2MjAwZTFjMjI5NDRmNjhiZDQwYTNiNzIzZDlmZjFfMTItNi0xLTEtMjAwMjg1_54a42e23-bbcb-4a99-97ac-0e38c2317309"
      unitRef="usd">125000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="i69349b63e94749f680a73aa85071a4f3_I20221231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjFmNjIwMGUxYzIyOTQ0ZjY4YmQ0MGEzYjcyM2Q5ZmYxL3RhYmxlcmFuZ2U6MWY2MjAwZTFjMjI5NDRmNjhiZDQwYTNiNzIzZDlmZjFfMTItMTQtMS0xLTIwMDI4NQ_fe3815cb-c155-44e6-87d1-5673c94988e7"
      unitRef="number">0.01404</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i69349b63e94749f680a73aa85071a4f3_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjFmNjIwMGUxYzIyOTQ0ZjY4YmQ0MGEzYjcyM2Q5ZmYxL3RhYmxlcmFuZ2U6MWY2MjAwZTFjMjI5NDRmNjhiZDQwYTNiNzIzZDlmZjFfMTItMTgtMS0xLTIwMDI4NQ_3e634f9b-bb76-4095-b22f-9cb8fdd5c446"
      unitRef="usd">5467000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ic0e31fe1684f414cbac936fef047cdc0_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjFmNjIwMGUxYzIyOTQ0ZjY4YmQ0MGEzYjcyM2Q5ZmYxL3RhYmxlcmFuZ2U6MWY2MjAwZTFjMjI5NDRmNjhiZDQwYTNiNzIzZDlmZjFfMTQtNi0xLTEtMjAzMTEx_4f34927d-313f-4d7b-b2ee-51ad9dcc572f"
      unitRef="usd">1475000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i8f1a2f6132444776b0b916c3ec4d150a_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjFmNjIwMGUxYzIyOTQ0ZjY4YmQ0MGEzYjcyM2Q5ZmYxL3RhYmxlcmFuZ2U6MWY2MjAwZTFjMjI5NDRmNjhiZDQwYTNiNzIzZDlmZjFfMTQtMTgtMS0xLTIwMzExMQ_fa14686a-d802-45d2-ab20-f1063c6105c1"
      unitRef="usd">56712000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <iart:DerivativeNotionalAmountTerminated
      contextRef="id6f12805ce8f48c2a0fbeec9e8c8a8dc_I20220926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RleHRyZWdpb246ODA4MTIyY2E0NzEyNDJhN2I5MzExOGQ4ZTEyNmQ4NjBfNDM5ODA0NjUyNDQ0Mg_89854c52-957d-400f-847b-389904002e4a"
      unitRef="usd">50000000</iart:DerivativeNotionalAmountTerminated>
    <us-gaap:DerivativeNotionalAmount
      contextRef="id6f12805ce8f48c2a0fbeec9e8c8a8dc_I20220926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RleHRyZWdpb246ODA4MTIyY2E0NzEyNDJhN2I5MzExOGQ4ZTEyNmQ4NjBfNDM5ODA0NjUyNDQ0OA_03b51077-2aba-4faa-8022-cc832265b2ff"
      unitRef="chf">48500000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="if875fdad2a23408d9d0ed3e81db4e7ee_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RleHRyZWdpb246ODA4MTIyY2E0NzEyNDJhN2I5MzExOGQ4ZTEyNmQ4NjBfNDM5ODA0NjUyNDQ1NA_f7b088ae-2b65-4ab6-8535-6188cb8e5eb5"
      unitRef="usd">49100000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i0d2cb496f6d34578a914d07e7359d877_I20201221"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RleHRyZWdpb246ODA4MTIyY2E0NzEyNDJhN2I5MzExOGQ4ZTEyNmQ4NjBfNDc2MA_9c9bd94e-662d-48da-870c-cc5f70e0738e"
      unitRef="usd">471600000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i0d2cb496f6d34578a914d07e7359d877_I20201221"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RleHRyZWdpb246ODA4MTIyY2E0NzEyNDJhN2I5MzExOGQ4ZTEyNmQ4NjBfNDc3Nw_20dee34a-26c0-432c-a96e-c685068ddac7"
      unitRef="chf">420100000</us-gaap:DerivativeNotionalAmount>
    <iart:IntercompanyLoanQuarterlyPayment
      contextRef="i7e2dbfd7e64c4a058f61e6ddbb174ba2_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RleHRyZWdpb246ODA4MTIyY2E0NzEyNDJhN2I5MzExOGQ4ZTEyNmQ4NjBfNTA5Mg_f79da5fe-f894-427d-bd74-ed8b6effb4d5"
      unitRef="chf">5800000</iart:IntercompanyLoanQuarterlyPayment>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="i64420e77a1cf469498e2ca2af1883f9f_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjdkNDBiYTQ5NDY4YTRjMTk4YzQzNjRjY2Y5ZTliNzZjL3RhYmxlcmFuZ2U6N2Q0MGJhNDk0NjhhNGMxOThjNDM2NGNjZjllOWI3NmNfNi02LTEtMS0xODY4MjE_6cefdc0f-99e6-4e4a-a663-fd1c947ef5cd"
      unitRef="number">0.0300</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i64420e77a1cf469498e2ca2af1883f9f_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjdkNDBiYTQ5NDY4YTRjMTk4YzQzNjRjY2Y5ZTliNzZjL3RhYmxlcmFuZ2U6N2Q0MGJhNDk0NjhhNGMxOThjNDM2NGNjZjllOWI3NmNfNi05LTEtMS0xODY4MjE_ac1c2e76-dda9-4806-a206-ef5d564db029"
      unitRef="chf">373227000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ia25949993bc54e31b057302d171fccae_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjdkNDBiYTQ5NDY4YTRjMTk4YzQzNjRjY2Y5ZTliNzZjL3RhYmxlcmFuZ2U6N2Q0MGJhNDk0NjhhNGMxOThjNDM2NGNjZjllOWI3NmNfNi0xMC0xLTEtMTg2ODIx_d3d05a7d-58e2-445e-8455-127226a18213"
      unitRef="chf">397137000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i6e76d40129eb4fceb7e3cbae9e1a5025_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjdkNDBiYTQ5NDY4YTRjMTk4YzQzNjRjY2Y5ZTliNzZjL3RhYmxlcmFuZ2U6N2Q0MGJhNDk0NjhhNGMxOThjNDM2NGNjZjllOWI3NmNfNi0xMi0yLTEtMTg2ODIx_c230272e-1f09-409e-8825-4324d31aa34e"
      unitRef="usd">-3033000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i12840888426f47f0bfab4c48ba3fa8c5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjdkNDBiYTQ5NDY4YTRjMTk4YzQzNjRjY2Y5ZTliNzZjL3RhYmxlcmFuZ2U6N2Q0MGJhNDk0NjhhNGMxOThjNDM2NGNjZjllOWI3NmNfNi0xNC0xLTEtMTg2ODIx_6da3e335-9c29-4589-b1be-964640b1df74"
      unitRef="usd">-4241000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="i4c73f19cfa39458dbce322781befa454_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjdkNDBiYTQ5NDY4YTRjMTk4YzQzNjRjY2Y5ZTliNzZjL3RhYmxlcmFuZ2U6N2Q0MGJhNDk0NjhhNGMxOThjNDM2NGNjZjllOWI3NmNfNy02LTEtMS0xODY4MjE_8519c737-ec9a-4da8-9ac2-9784e2797caa"
      unitRef="number">0.0398</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i4c73f19cfa39458dbce322781befa454_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjdkNDBiYTQ5NDY4YTRjMTk4YzQzNjRjY2Y5ZTliNzZjL3RhYmxlcmFuZ2U6N2Q0MGJhNDk0NjhhNGMxOThjNDM2NGNjZjllOWI3NmNfNy05LTEtMS0xODY4MjE_236c25b3-33bf-4ab2-9a77-239044808de8"
      unitRef="usd">418980000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="icfc6c257ec264f86b565dfd0902ba5f6_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjdkNDBiYTQ5NDY4YTRjMTk4YzQzNjRjY2Y5ZTliNzZjL3RhYmxlcmFuZ2U6N2Q0MGJhNDk0NjhhNGMxOThjNDM2NGNjZjllOWI3NmNfNy0xMC0xLTEtMTg2ODIx_f97f6d67-714e-47bd-9f31-cd5af7528aca"
      unitRef="usd">445821000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="i3703f1657e1c4322924cfd69bfd51ed2_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjdkNDBiYTQ5NDY4YTRjMTk4YzQzNjRjY2Y5ZTliNzZjL3RhYmxlcmFuZ2U6N2Q0MGJhNDk0NjhhNGMxOThjNDM2NGNjZjllOWI3NmNfOS02LTEtMS0xOTE0Nzk_f9e2343c-9d79-4328-9820-dc8ac647109f"
      unitRef="number">0.0195</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i3703f1657e1c4322924cfd69bfd51ed2_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjdkNDBiYTQ5NDY4YTRjMTk4YzQzNjRjY2Y5ZTliNzZjL3RhYmxlcmFuZ2U6N2Q0MGJhNDk0NjhhNGMxOThjNDM2NGNjZjllOWI3NmNfOS05LTEtMS0xOTE0ODY_985cedd8-c90b-4879-bb66-4c9d3ad76c2a"
      unitRef="chf">48533000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="id9839714200e436fb715c8e97dc0b9e1_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjdkNDBiYTQ5NDY4YTRjMTk4YzQzNjRjY2Y5ZTliNzZjL3RhYmxlcmFuZ2U6N2Q0MGJhNDk0NjhhNGMxOThjNDM2NGNjZjllOWI3NmNfOS0xMC0xLTEtMTkxNDkz_58659d5d-f67f-400c-8fb9-1cf292a9566a"
      unitRef="chf">48532000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i4facc35f040e40778807e0ec5945fd96_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjdkNDBiYTQ5NDY4YTRjMTk4YzQzNjRjY2Y5ZTliNzZjL3RhYmxlcmFuZ2U6N2Q0MGJhNDk0NjhhNGMxOThjNDM2NGNjZjllOWI3NmNfNi0xMi0yLTEtMTk1Nzg3_99f547b5-1b61-4b7b-8999-b33a3c06b661"
      unitRef="usd">-4011000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="ia9d15227403d47bda86034e4464a9675_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjdkNDBiYTQ5NDY4YTRjMTk4YzQzNjRjY2Y5ZTliNzZjL3RhYmxlcmFuZ2U6N2Q0MGJhNDk0NjhhNGMxOThjNDM2NGNjZjllOWI3NmNfNi0xNC0yLTEtMTk1Nzg3_f902eb08-981e-4441-ae84-1c2113f4f2ea"
      unitRef="usd">-3528000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="ia4d70da53f2e443b81f302d5bc88197c_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjdkNDBiYTQ5NDY4YTRjMTk4YzQzNjRjY2Y5ZTliNzZjL3RhYmxlcmFuZ2U6N2Q0MGJhNDk0NjhhNGMxOThjNDM2NGNjZjllOWI3NmNfMTAtNi0xLTEtMTkxNDc5_d1c1a7b2-2fd9-414a-b284-a02a0e9e4241"
      unitRef="number">0.0532</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ia4d70da53f2e443b81f302d5bc88197c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjdkNDBiYTQ5NDY4YTRjMTk4YzQzNjRjY2Y5ZTliNzZjL3RhYmxlcmFuZ2U6N2Q0MGJhNDk0NjhhNGMxOThjNDM2NGNjZjllOWI3NmNfMTAtOS0xLTEtMTkxNDg2_ae4cfca2-4577-40d0-8cd5-2ad99ef029fe"
      unitRef="usd">49142000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i69b25e2065b74ec9b2d6fc10d48a3919_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjdkNDBiYTQ5NDY4YTRjMTk4YzQzNjRjY2Y5ZTliNzZjL3RhYmxlcmFuZ2U6N2Q0MGJhNDk0NjhhNGMxOThjNDM2NGNjZjllOWI3NmNfMTAtMTAtMS0xLTE5MTQ5Mw_1c87be97-5c47-4577-8dd8-8ac151d01ec0"
      unitRef="usd">49142000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="if68feb9648554b258a953ab0b3cf1b44_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjdkNDBiYTQ5NDY4YTRjMTk4YzQzNjRjY2Y5ZTliNzZjL3RhYmxlcmFuZ2U6N2Q0MGJhNDk0NjhhNGMxOThjNDM2NGNjZjllOWI3NmNfOS0xMi0xLTEtMTg2ODIx_5b5f51b8-e818-4e7e-9825-f139b5cd005d"
      unitRef="usd">-7044000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i7aa8838f170544bca9b1f95ebe3e1329_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjdkNDBiYTQ5NDY4YTRjMTk4YzQzNjRjY2Y5ZTliNzZjL3RhYmxlcmFuZ2U6N2Q0MGJhNDk0NjhhNGMxOThjNDM2NGNjZjllOWI3NmNfOS0xNC0xLTEtMTg2ODIx_5a853c4f-ad86-4bca-b27d-6fae5079d0bc"
      unitRef="usd">-7769000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax
      contextRef="i9d0c5e4a255d4bed9a9758f0390707d2_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RleHRyZWdpb246ODA4MTIyY2E0NzEyNDJhN2I5MzExOGQ4ZTEyNmQ4NjBfNjM3Mg_43344a63-8153-4076-849b-997b72ea2dd6"
      unitRef="usd">-4900000</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax
      contextRef="i6cc6a5aaf59940698e0bc2bd4666b5dc_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RleHRyZWdpb246ODA4MTIyY2E0NzEyNDJhN2I5MzExOGQ4ZTEyNmQ4NjBfNjM3OQ_4d8c212c-e807-4541-b9fa-97ab6b78836f"
      unitRef="usd">6500000</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i7e2dbfd7e64c4a058f61e6ddbb174ba2_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RleHRyZWdpb246ODA4MTIyY2E0NzEyNDJhN2I5MzExOGQ4ZTEyNmQ4NjBfNjYyNQ_0152b364-3a07-429e-8f8e-a878fd2461a0"
      unitRef="usd">7500000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="iebf426920d4e4859b85ce6e6e41cd500_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RleHRyZWdpb246ODA4MTIyY2E0NzEyNDJhN2I5MzExOGQ4ZTEyNmQ4NjBfNjYzMg_6241d23b-881e-43ad-8a4e-58c0574c3505"
      unitRef="usd">7900000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax
      contextRef="i7e2dbfd7e64c4a058f61e6ddbb174ba2_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RleHRyZWdpb246ODA4MTIyY2E0NzEyNDJhN2I5MzExOGQ4ZTEyNmQ4NjBfNjc4Ng_60ed6968-664a-4ccf-85b9-a4293d0e7edb"
      unitRef="usd">1500000</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax
      contextRef="iebf426920d4e4859b85ce6e6e41cd500_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RleHRyZWdpb246ODA4MTIyY2E0NzEyNDJhN2I5MzExOGQ4ZTEyNmQ4NjBfNjc5Mw_939d7a11-ccd3-4b24-8f16-7b8c743c305e"
      unitRef="usd">1800000</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet
      contextRef="i17088e89ea1f43888ce939b60c045452_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RleHRyZWdpb246ODA4MTIyY2E0NzEyNDJhN2I5MzExOGQ4ZTEyNmQ4NjBfNzA5NQ_cbb9e51a-66d7-4917-9bc7-b2aa62f5287b"
      unitRef="usd">100000</us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="if1daaefdc2464e3cb18c32c6114de13b_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjQzMWQwYzhhMjVmYTQ0OTM5YzU3YTJmNDcxZTE2MGY4L3RhYmxlcmFuZ2U6NDMxZDBjOGEyNWZhNDQ5MzljNTdhMmY0NzFlMTYwZjhfMy02LTEtMS0xODY4MjE_993d117a-7094-4fdb-a2ec-2b0d75f798d4"
      unitRef="number">0</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeNotionalAmount
      contextRef="if1daaefdc2464e3cb18c32c6114de13b_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjQzMWQwYzhhMjVmYTQ0OTM5YzU3YTJmNDcxZTE2MGY4L3RhYmxlcmFuZ2U6NDMxZDBjOGEyNWZhNDQ5MzljNTdhMmY0NzFlMTYwZjhfMy05LTEtMS0xODY4MjE_2cbcbc4c-6e63-4987-9b2d-fed3a232175c"
      unitRef="eur">51760000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i8e00ac098d0d4a64b488a0c17ae543cc_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjQzMWQwYzhhMjVmYTQ0OTM5YzU3YTJmNDcxZTE2MGY4L3RhYmxlcmFuZ2U6NDMxZDBjOGEyNWZhNDQ5MzljNTdhMmY0NzFlMTYwZjhfMy0xMS0xLTEtMTkyOTA3_c2f5ebc7-f5e5-43a7-9497-d3d2912f0ca4"
      unitRef="eur">51760000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i71266e4583bc437f92273bca0ecbadeb_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjQzMWQwYzhhMjVmYTQ0OTM5YzU3YTJmNDcxZTE2MGY4L3RhYmxlcmFuZ2U6NDMxZDBjOGEyNWZhNDQ5MzljNTdhMmY0NzFlMTYwZjhfMy0xMS0xLTEtMTg2ODIx_83c4c056-6dec-423f-9d54-de2129453e86"
      unitRef="usd">3989000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="idd51fbcf77834a9e9093fdb6e8cc4af5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjQzMWQwYzhhMjVmYTQ0OTM5YzU3YTJmNDcxZTE2MGY4L3RhYmxlcmFuZ2U6NDMxZDBjOGEyNWZhNDQ5MzljNTdhMmY0NzFlMTYwZjhfMy0xMy0xLTEtMTg2ODIx_5375880a-784b-4e13-a04f-7b226f853973"
      unitRef="usd">4713000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="i84d05810f465447c8eee056a6ea0a040_I20230331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjQzMWQwYzhhMjVmYTQ0OTM5YzU3YTJmNDcxZTE2MGY4L3RhYmxlcmFuZ2U6NDMxZDBjOGEyNWZhNDQ5MzljNTdhMmY0NzFlMTYwZjhfNC02LTEtMS0xODY4MjE_ae8f157d-24df-4078-ab64-82083c34d2b4"
      unitRef="number">0.0257</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i84d05810f465447c8eee056a6ea0a040_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjQzMWQwYzhhMjVmYTQ0OTM5YzU3YTJmNDcxZTE2MGY4L3RhYmxlcmFuZ2U6NDMxZDBjOGEyNWZhNDQ5MzljNTdhMmY0NzFlMTYwZjhfNC05LTEtMS0xODY4MjE_3a47504f-53bb-4af1-81f2-c3fb9485d456"
      unitRef="usd">60000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i9044d98efacd431b815b8b6162aa3841_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjQzMWQwYzhhMjVmYTQ0OTM5YzU3YTJmNDcxZTE2MGY4L3RhYmxlcmFuZ2U6NDMxZDBjOGEyNWZhNDQ5MzljNTdhMmY0NzFlMTYwZjhfNC0xMS0xLTEtMTkyOTA3_5e96af97-f3a1-480a-9085-abf54e19bff9"
      unitRef="usd">60000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="id8fc9bc6fbc8473e98a29ae421b261cb_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjQzMWQwYzhhMjVmYTQ0OTM5YzU3YTJmNDcxZTE2MGY4L3RhYmxlcmFuZ2U6NDMxZDBjOGEyNWZhNDQ5MzljNTdhMmY0NzFlMTYwZjhfNi02LTEtMS0xODY4MjE_14fb292c-cc1d-46ea-8d9f-03f2b81347f5"
      unitRef="number">0</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeNotionalAmount
      contextRef="id8fc9bc6fbc8473e98a29ae421b261cb_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjQzMWQwYzhhMjVmYTQ0OTM5YzU3YTJmNDcxZTE2MGY4L3RhYmxlcmFuZ2U6NDMxZDBjOGEyNWZhNDQ5MzljNTdhMmY0NzFlMTYwZjhfNi05LTEtMS0xODY4MjE_ce2ea82e-e47a-4e37-8c4f-a5c5d28f6988"
      unitRef="eur">38820000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i67cb9870e2ce452f89c2a1478634a794_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjQzMWQwYzhhMjVmYTQ0OTM5YzU3YTJmNDcxZTE2MGY4L3RhYmxlcmFuZ2U6NDMxZDBjOGEyNWZhNDQ5MzljNTdhMmY0NzFlMTYwZjhfNi0xMS0xLTEtMTkyOTE0_4056a015-3b5f-44b0-9732-0ee514a38801"
      unitRef="eur">38820000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="if26ad90eefe4415185190203179a9d0a_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjQzMWQwYzhhMjVmYTQ0OTM5YzU3YTJmNDcxZTE2MGY4L3RhYmxlcmFuZ2U6NDMxZDBjOGEyNWZhNDQ5MzljNTdhMmY0NzFlMTYwZjhfNi0xMS0xLTEtMTg2ODIx_f9879289-60cb-4d3e-a6f6-92e4a3d1dcf3"
      unitRef="usd">3932000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i9ea815ac7be1481cbb1e19dc878ef6a2_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjQzMWQwYzhhMjVmYTQ0OTM5YzU3YTJmNDcxZTE2MGY4L3RhYmxlcmFuZ2U6NDMxZDBjOGEyNWZhNDQ5MzljNTdhMmY0NzFlMTYwZjhfNi0xMy0xLTEtMTg2ODIx_16dde0ef-61a0-4de3-9a43-22ced663d50f"
      unitRef="usd">4307000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="i91ef1532274e495ca14298a177ea1acc_I20230331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjQzMWQwYzhhMjVmYTQ0OTM5YzU3YTJmNDcxZTE2MGY4L3RhYmxlcmFuZ2U6NDMxZDBjOGEyNWZhNDQ5MzljNTdhMmY0NzFlMTYwZjhfNy02LTEtMS0xODY4MjE_16639c0e-82b2-45c8-903f-2895a87f2ef1"
      unitRef="number">0.0219</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i91ef1532274e495ca14298a177ea1acc_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjQzMWQwYzhhMjVmYTQ0OTM5YzU3YTJmNDcxZTE2MGY4L3RhYmxlcmFuZ2U6NDMxZDBjOGEyNWZhNDQ5MzljNTdhMmY0NzFlMTYwZjhfNy05LTEtMS0xODY4MjE_eb97ac63-459d-4f61-8e96-c26a69c9157b"
      unitRef="usd">45000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i36f4034c904b4615a9bc452fe0768b20_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjQzMWQwYzhhMjVmYTQ0OTM5YzU3YTJmNDcxZTE2MGY4L3RhYmxlcmFuZ2U6NDMxZDBjOGEyNWZhNDQ5MzljNTdhMmY0NzFlMTYwZjhfNy0xMS0xLTEtMTkyOTE0_2450a6d9-1bc5-456f-b78e-bf6144519267"
      unitRef="usd">45000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="i29d096aee8e64b748938c9c63aacf5f5_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjQzMWQwYzhhMjVmYTQ0OTM5YzU3YTJmNDcxZTE2MGY4L3RhYmxlcmFuZ2U6NDMxZDBjOGEyNWZhNDQ5MzljNTdhMmY0NzFlMTYwZjhfOS02LTEtMS0xODY4MjE_bbbfce70-25f5-406b-a34b-6681a7962206"
      unitRef="number">0</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i29d096aee8e64b748938c9c63aacf5f5_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjQzMWQwYzhhMjVmYTQ0OTM5YzU3YTJmNDcxZTE2MGY4L3RhYmxlcmFuZ2U6NDMxZDBjOGEyNWZhNDQ5MzljNTdhMmY0NzFlMTYwZjhfOS05LTEtMS0xODY4MjE_0ca94e58-f645-400f-ac1e-81a17e6b29d7"
      unitRef="chf">288210000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i9118200971f14bd8b119346ba9f7bff3_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjQzMWQwYzhhMjVmYTQ0OTM5YzU3YTJmNDcxZTE2MGY4L3RhYmxlcmFuZ2U6NDMxZDBjOGEyNWZhNDQ5MzljNTdhMmY0NzFlMTYwZjhfOS0xMS0xLTEtMTkyOTIx_86998207-c561-4a53-bbde-12ef02dd96d3"
      unitRef="chf">288210000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="ic7c538eff08b4fd6b79f7f5500bdfbfd_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjQzMWQwYzhhMjVmYTQ0OTM5YzU3YTJmNDcxZTE2MGY4L3RhYmxlcmFuZ2U6NDMxZDBjOGEyNWZhNDQ5MzljNTdhMmY0NzFlMTYwZjhfOS0xMy0yLTEtMTk4NTQ2_fcf35211-d2af-4d34-8dc3-16530421ec83"
      unitRef="usd">-14711000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i10a6a1852b544a5986e489c72e4c44c8_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjQzMWQwYzhhMjVmYTQ0OTM5YzU3YTJmNDcxZTE2MGY4L3RhYmxlcmFuZ2U6NDMxZDBjOGEyNWZhNDQ5MzljNTdhMmY0NzFlMTYwZjhfOS0xMy0xLTEtMTg2ODIx_9ce426c3-f13e-4a5a-8f0c-d64102b3c393"
      unitRef="usd">-14663000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="i681f0e0ed1b448caa21fee3e2b8496bd_I20230331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjQzMWQwYzhhMjVmYTQ0OTM5YzU3YTJmNDcxZTE2MGY4L3RhYmxlcmFuZ2U6NDMxZDBjOGEyNWZhNDQ5MzljNTdhMmY0NzFlMTYwZjhfMTAtNi0xLTEtMTg2ODIx_6e00bb4e-5930-403b-bb41-e33f1522d6da"
      unitRef="number">0.0194</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i681f0e0ed1b448caa21fee3e2b8496bd_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjQzMWQwYzhhMjVmYTQ0OTM5YzU3YTJmNDcxZTE2MGY4L3RhYmxlcmFuZ2U6NDMxZDBjOGEyNWZhNDQ5MzljNTdhMmY0NzFlMTYwZjhfMTAtOS0xLTEtMTg2ODIx_8a9244a5-297f-4013-96c4-8f0583dabe2d"
      unitRef="usd">300000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i24c7d1057dba44f88ef1cbe078d56c52_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjQzMWQwYzhhMjVmYTQ0OTM5YzU3YTJmNDcxZTE2MGY4L3RhYmxlcmFuZ2U6NDMxZDBjOGEyNWZhNDQ5MzljNTdhMmY0NzFlMTYwZjhfMTAtMTEtMS0xLTE5MjkyMQ_87e826b5-d049-449a-ba60-32bb45242362"
      unitRef="usd">300000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i58f139fbd41647c48c9057f1580cdac4_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjQzMWQwYzhhMjVmYTQ0OTM5YzU3YTJmNDcxZTE2MGY4L3RhYmxlcmFuZ2U6NDMxZDBjOGEyNWZhNDQ5MzljNTdhMmY0NzFlMTYwZjhfMTItMTEtMS0xLTE4NjgyMQ_81ad4921-041d-4fa5-a610-f338cfefb0f9"
      unitRef="usd">-6790000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i09796f9df77e48bca077728e4c8ae491_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjQzMWQwYzhhMjVmYTQ0OTM5YzU3YTJmNDcxZTE2MGY4L3RhYmxlcmFuZ2U6NDMxZDBjOGEyNWZhNDQ5MzljNTdhMmY0NzFlMTYwZjhfMTItMTMtMS0xLTE4NjgyMQ_e92904bb-dbfd-4021-878e-ff482fabee5a"
      unitRef="usd">-5643000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i0fed5dd652c740a78c23127d0779d0ba_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RleHRyZWdpb246ODA4MTIyY2E0NzEyNDJhN2I5MzExOGQ4ZTEyNmQ4NjBfNDM5ODA0NjUyNTQyNQ_309187b7-844f-46e1-a21a-bfb2b0eb12a3"
      unitRef="usd">-1100000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i5eff930bd16f443f9ec4ab5edde345f2_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RleHRyZWdpb246ODA4MTIyY2E0NzEyNDJhN2I5MzExOGQ4ZTEyNmQ4NjBfNDM5ODA0NjUyNTQwNw_12bf3d54-fafb-48ca-9010-598d932e0d2a"
      unitRef="usd">1300000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax
      contextRef="i0fed5dd652c740a78c23127d0779d0ba_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RleHRyZWdpb246ODA4MTIyY2E0NzEyNDJhN2I5MzExOGQ4ZTEyNmQ4NjBfNDM5ODA0NjUyNTQzMg_5ea7b9c6-df47-4094-9944-effcaf9ce02b"
      unitRef="usd">2100000</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax
      contextRef="i5eff930bd16f443f9ec4ab5edde345f2_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RleHRyZWdpb246ODA4MTIyY2E0NzEyNDJhN2I5MzExOGQ4ZTEyNmQ4NjBfNDM5ODA0NjUyNTQxMg_8d1ac80c-c237-4ad5-b102-fef63d36d4bf"
      unitRef="usd">1300000</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet
      contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RleHRyZWdpb246ODA4MTIyY2E0NzEyNDJhN2I5MzExOGQ4ZTEyNmQ4NjBfNDM5ODA0NjUyNTQxOA_38fa313a-0509-47be-ab96-e7dd2586fbeb"
      unitRef="usd">10900000</us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i3e5ef68fc663402486e8a4e07e50b256_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RleHRyZWdpb246ODA4MTIyY2E0NzEyNDJhN2I5MzExOGQ4ZTEyNmQ4NjBfNjA0NzMxMzk3MjYyMQ_f60b6b67-4bb5-4a62-98d8-d74ca7a77001"
      unitRef="usd">10800000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i05dafd738acc468dba86e7bafd1510f0_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RleHRyZWdpb246ODA4MTIyY2E0NzEyNDJhN2I5MzExOGQ4ZTEyNmQ4NjBfNTQ5NzU1ODE2MjgwNQ_dd55b6d3-a940-4e25-81ab-02cf8b4ee40b"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RleHRyZWdpb246ODA4MTIyY2E0NzEyNDJhN2I5MzExOGQ4ZTEyNmQ4NjBfMTA4NTU_1e0e4d4c-5d65-491e-8862-811b46e9ffaf">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the fair value for derivatives designated as hedging instruments in the condensed consolidated balance sheets as of March&#160;31, 2023 and December&#160;31, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.181%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.387%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.024%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.174%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value as of&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location on Balance Sheet &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Derivatives designated as hedges &#x2014; Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Cash Flow Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest rate swap&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,659&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,682&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Net Investment Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,942&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,653&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Cash Flow Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest rate swap&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28,861&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40,030&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Net Investment Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,940&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total derivatives designated as hedges &#x2014; Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;62,541&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;76,173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Derivatives designated as hedges &#x2014; Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Cash Flow Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest rate swap&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;762&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Net Investment Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Cash Flow Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest rate swap&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,080&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,738&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Net Investment Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,672&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,608&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total derivatives designated as hedges &#x2014; Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33,766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32,874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:9pt;text-align:justify;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company classifies derivative assets and liabilities as current based on the cash flows expected to be incurred within the following 12&#160;months.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:9pt;text-align:justify;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; At March&#160;31, 2023 and December&#160;31, 2022, the total notional amounts related to the Company&#x2019;s interest rate swaps were both $1.5 billion, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i57a5868b001f4d67935cf17c02a3c1ef_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjFkZGQ3MTgwOWI4NDRhZmM4MDViMzVmNzVhZWMzYzAxL3RhYmxlcmFuZ2U6MWRkZDcxODA5Yjg0NGFmYzgwNWIzNWY3NWFlYzNjMDFfNi0yLTEtMS0xODY4MjE_71a0c049-471e-4835-aa3b-9a2d1bb15e0c"
      unitRef="usd">15659000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i9a4696f581d04cb586ec819e32f565b4_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjFkZGQ3MTgwOWI4NDRhZmM4MDViMzVmNzVhZWMzYzAxL3RhYmxlcmFuZ2U6MWRkZDcxODA5Yjg0NGFmYzgwNWIzNWY3NWFlYzNjMDFfNi00LTEtMS0xODY4MjE_47282269-8de1-4dfa-a1bd-bef43dcf2eef"
      unitRef="usd">16682000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="icf74fb8aa39848049e1301eb02d39d82_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjFkZGQ3MTgwOWI4NDRhZmM4MDViMzVmNzVhZWMzYzAxL3RhYmxlcmFuZ2U6MWRkZDcxODA5Yjg0NGFmYzgwNWIzNWY3NWFlYzNjMDFfNy0yLTEtMS0xOTY5MDQ_d591ba65-8151-498f-afc4-68524f8a2349"
      unitRef="usd">4139000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i99aa6d57dd04424181e96f7c91cc61ec_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjFkZGQ3MTgwOWI4NDRhZmM4MDViMzVmNzVhZWMzYzAxL3RhYmxlcmFuZ2U6MWRkZDcxODA5Yjg0NGFmYzgwNWIzNWY3NWFlYzNjMDFfNy00LTEtMS0xOTY5MDQ_6cb42eda-be59-4934-9264-ca84b4248ae3"
      unitRef="usd">4497000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i9f5e216cf841484db3c4b4c6a4d7360a_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjFkZGQ3MTgwOWI4NDRhZmM4MDViMzVmNzVhZWMzYzAxL3RhYmxlcmFuZ2U6MWRkZDcxODA5Yjg0NGFmYzgwNWIzNWY3NWFlYzNjMDFfOC0yLTEtMS0xODY4MjE_41ed0188-63f9-498e-8d40-1b9fa5c6a399"
      unitRef="usd">10942000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ida7dd09e252d4494a378fddc92937759_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjFkZGQ3MTgwOWI4NDRhZmM4MDViMzVmNzVhZWMzYzAxL3RhYmxlcmFuZ2U6MWRkZDcxODA5Yjg0NGFmYzgwNWIzNWY3NWFlYzNjMDFfOC00LTEtMS0xODY4MjE_4fafcc96-ef31-412f-a080-13384a23ab0f"
      unitRef="usd">11653000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i7f8fb64f3560438aa95a28deccc11b4c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjFkZGQ3MTgwOWI4NDRhZmM4MDViMzVmNzVhZWMzYzAxL3RhYmxlcmFuZ2U6MWRkZDcxODA5Yjg0NGFmYzgwNWIzNWY3NWFlYzNjMDFfMTEtMi0xLTEtMTg2ODIx_438b2587-217c-4dfc-ac04-57c726a1a8c8"
      unitRef="usd">28861000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i5470f9ecb06a401e92323ccc20c80c85_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjFkZGQ3MTgwOWI4NDRhZmM4MDViMzVmNzVhZWMzYzAxL3RhYmxlcmFuZ2U6MWRkZDcxODA5Yjg0NGFmYzgwNWIzNWY3NWFlYzNjMDFfMTEtNC0xLTEtMTg2ODIx_ed83f792-8c34-42e6-8543-48b71e1ac748"
      unitRef="usd">40030000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i2be277f4f7ed4c18b787daf8a062f6c9_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjFkZGQ3MTgwOWI4NDRhZmM4MDViMzVmNzVhZWMzYzAxL3RhYmxlcmFuZ2U6MWRkZDcxODA5Yjg0NGFmYzgwNWIzNWY3NWFlYzNjMDFfMTItMi0xLTEtMTg2ODIx_c1e80ee4-9032-43c6-af8b-f6b9a64f2274"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ib322bd99c183409fae8ee9d54c859608_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjFkZGQ3MTgwOWI4NDRhZmM4MDViMzVmNzVhZWMzYzAxL3RhYmxlcmFuZ2U6MWRkZDcxODA5Yjg0NGFmYzgwNWIzNWY3NWFlYzNjMDFfMTItNC0xLTEtMTg2ODIx_fb99422f-fdcf-4c5d-84e5-e66e5ac4cd9b"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i74d46a8f5e78435b89e68529ae10f606_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjFkZGQ3MTgwOWI4NDRhZmM4MDViMzVmNzVhZWMzYzAxL3RhYmxlcmFuZ2U6MWRkZDcxODA5Yjg0NGFmYzgwNWIzNWY3NWFlYzNjMDFfMTQtMi0xLTEtMTg2ODIx_1febd7f5-6dd9-4d03-8942-f1758486ef3a"
      unitRef="usd">2940000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i9c9770e2724246d49b05399c4fbab21b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjFkZGQ3MTgwOWI4NDRhZmM4MDViMzVmNzVhZWMzYzAxL3RhYmxlcmFuZ2U6MWRkZDcxODA5Yjg0NGFmYzgwNWIzNWY3NWFlYzNjMDFfMTQtNC0xLTEtMTg2ODIx_764fea7c-1845-40b4-bddd-f90011ebced8"
      unitRef="usd">3311000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i5fcf3db2e33e4516bb7de79733b0c0d0_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjFkZGQ3MTgwOWI4NDRhZmM4MDViMzVmNzVhZWMzYzAxL3RhYmxlcmFuZ2U6MWRkZDcxODA5Yjg0NGFmYzgwNWIzNWY3NWFlYzNjMDFfMTUtMi0xLTEtMTg2ODIx_73d7f753-7286-49c7-8ab4-62acba4ae336"
      unitRef="usd">62541000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ia1b37fecaa804375ad71d7e5bcdde933_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjFkZGQ3MTgwOWI4NDRhZmM4MDViMzVmNzVhZWMzYzAxL3RhYmxlcmFuZ2U6MWRkZDcxODA5Yjg0NGFmYzgwNWIzNWY3NWFlYzNjMDFfMTUtNC0xLTEtMTg2ODIx_a7da6f84-f01b-4bbf-b7ef-844096339a50"
      unitRef="usd">76173000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i71915794f65d4c91bc088e849a5fc799_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjFkZGQ3MTgwOWI4NDRhZmM4MDViMzVmNzVhZWMzYzAxL3RhYmxlcmFuZ2U6MWRkZDcxODA5Yjg0NGFmYzgwNWIzNWY3NWFlYzNjMDFfMjAtMi0xLTEtMTg2ODIx_a1c068ac-e4e5-4fe7-8818-2595d0dc5fd5"
      unitRef="usd">762000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i7620e47d0bf84bce859b3bad2a16f684_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjFkZGQ3MTgwOWI4NDRhZmM4MDViMzVmNzVhZWMzYzAxL3RhYmxlcmFuZ2U6MWRkZDcxODA5Yjg0NGFmYzgwNWIzNWY3NWFlYzNjMDFfMjAtNC0xLTEtMTg2ODIx_8dd593b6-deea-4061-b8de-af096faca159"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="iaec22d28ecc94c71b2b12a038b76b4e4_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjFkZGQ3MTgwOWI4NDRhZmM4MDViMzVmNzVhZWMzYzAxL3RhYmxlcmFuZ2U6MWRkZDcxODA5Yjg0NGFmYzgwNWIzNWY3NWFlYzNjMDFfMjEtMi0xLTEtMTg2ODIx_4df64afe-a003-447c-a0ba-f01369435286"
      unitRef="usd">4011000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i996b0ea6443441c4aaaf1bd24cc0bee4_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjFkZGQ3MTgwOWI4NDRhZmM4MDViMzVmNzVhZWMzYzAxL3RhYmxlcmFuZ2U6MWRkZDcxODA5Yjg0NGFmYzgwNWIzNWY3NWFlYzNjMDFfMjEtNC0xLTEtMTg2ODIx_b89660e4-4eb6-4d9d-ba1d-643ff3ec6099"
      unitRef="usd">3528000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="ic6da3ccfb9a34aabbeeb47220c6e49ff_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjFkZGQ3MTgwOWI4NDRhZmM4MDViMzVmNzVhZWMzYzAxL3RhYmxlcmFuZ2U6MWRkZDcxODA5Yjg0NGFmYzgwNWIzNWY3NWFlYzNjMDFfMjMtMi0xLTEtMTk5NzA3_faab8d13-eb5e-44d8-8509-b8523fa2fbb9"
      unitRef="usd">69000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="ieeb15fbf63ab4f469961445718c86de4_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjFkZGQ3MTgwOWI4NDRhZmM4MDViMzVmNzVhZWMzYzAxL3RhYmxlcmFuZ2U6MWRkZDcxODA5Yjg0NGFmYzgwNWIzNWY3NWFlYzNjMDFfMjMtNC0xLTEtMjAzMTYx_695f6299-2d31-485c-aa49-009a392ce3a4"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i0072310af3d241efafdaf988459146fa_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjFkZGQ3MTgwOWI4NDRhZmM4MDViMzVmNzVhZWMzYzAxL3RhYmxlcmFuZ2U6MWRkZDcxODA5Yjg0NGFmYzgwNWIzNWY3NWFlYzNjMDFfMjMtMi0xLTEtMTg2ODIx_de794642-d4de-4a92-96e9-ca265bad95db"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i5aae5383e5894e1282dce76c96936d34_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjFkZGQ3MTgwOWI4NDRhZmM4MDViMzVmNzVhZWMzYzAxL3RhYmxlcmFuZ2U6MWRkZDcxODA5Yjg0NGFmYzgwNWIzNWY3NWFlYzNjMDFfMjMtNC0xLTEtMTg2ODIx_965acdeb-96ca-4873-9967-43ace6f80f64"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="id498dc6dfe534a538bd4b76e7d332cb4_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjFkZGQ3MTgwOWI4NDRhZmM4MDViMzVmNzVhZWMzYzAxL3RhYmxlcmFuZ2U6MWRkZDcxODA5Yjg0NGFmYzgwNWIzNWY3NWFlYzNjMDFfMjYtMi0xLTEtMTg2ODIx_9496145e-ec13-44ae-9f88-2cb0b29e711b"
      unitRef="usd">1080000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i69e2392f36f44936a75ae231876a5027_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjFkZGQ3MTgwOWI4NDRhZmM4MDViMzVmNzVhZWMzYzAxL3RhYmxlcmFuZ2U6MWRkZDcxODA5Yjg0NGFmYzgwNWIzNWY3NWFlYzNjMDFfMjYtNC0xLTEtMTg2ODIx_0dc13483-1c9a-4543-a492-b4e0bc549578"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i1b2593474fd840ba8291d49024330993_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjFkZGQ3MTgwOWI4NDRhZmM4MDViMzVmNzVhZWMzYzAxL3RhYmxlcmFuZ2U6MWRkZDcxODA5Yjg0NGFmYzgwNWIzNWY3NWFlYzNjMDFfMjctMi0xLTEtMTg2ODIx_f2343750-10dc-40b0-b254-105a051d5b6b"
      unitRef="usd">7172000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i2c7c8157157e4ecd949d6ac6cb41b21c_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjFkZGQ3MTgwOWI4NDRhZmM4MDViMzVmNzVhZWMzYzAxL3RhYmxlcmFuZ2U6MWRkZDcxODA5Yjg0NGFmYzgwNWIzNWY3NWFlYzNjMDFfMjctNC0xLTEtMTg2ODIx_47618516-8bf4-4b6a-9c57-de685487dc13"
      unitRef="usd">8738000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i2f574ae0feba45f79e1abe5b7ec3d086_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjFkZGQ3MTgwOWI4NDRhZmM4MDViMzVmNzVhZWMzYzAxL3RhYmxlcmFuZ2U6MWRkZDcxODA5Yjg0NGFmYzgwNWIzNWY3NWFlYzNjMDFfMjktMi0xLTEtMTg2ODIx_49ec171a-35fc-4821-b90e-9fb1e3eea2c8"
      unitRef="usd">20672000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="icddae4bb16a64dea817870f7632c24e2_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjFkZGQ3MTgwOWI4NDRhZmM4MDViMzVmNzVhZWMzYzAxL3RhYmxlcmFuZ2U6MWRkZDcxODA5Yjg0NGFmYzgwNWIzNWY3NWFlYzNjMDFfMjktNC0xLTEtMTg2ODIx_546993fc-0f92-4741-8d54-8c7ffab4b515"
      unitRef="usd">20608000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i5fcf3db2e33e4516bb7de79733b0c0d0_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjFkZGQ3MTgwOWI4NDRhZmM4MDViMzVmNzVhZWMzYzAxL3RhYmxlcmFuZ2U6MWRkZDcxODA5Yjg0NGFmYzgwNWIzNWY3NWFlYzNjMDFfMzAtMi0xLTEtMTg2ODIx_8e6ba630-8e69-43e1-b029-46888b4f8119"
      unitRef="usd">33766000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="ia1b37fecaa804375ad71d7e5bcdde933_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjFkZGQ3MTgwOWI4NDRhZmM4MDViMzVmNzVhZWMzYzAxL3RhYmxlcmFuZ2U6MWRkZDcxODA5Yjg0NGFmYzgwNWIzNWY3NWFlYzNjMDFfMzAtNC0xLTEtMTg2ODIx_19bbbec1-4027-4081-90d2-3fa5c2b0af5c"
      unitRef="usd">32874000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i56846d631dbe49b18b07a654b7e1ce4d_I20230331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RleHRyZWdpb246ODA4MTIyY2E0NzEyNDJhN2I5MzExOGQ4ZTEyNmQ4NjBfMTA2MDY_24f55ab8-0e0c-4551-af6b-215d4ba3227c"
      unitRef="usd">1500000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i2492f43b74614fcab458b7ed60d99fc2_I20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RleHRyZWdpb246ODA4MTIyY2E0NzEyNDJhN2I5MzExOGQ4ZTEyNmQ4NjBfMTA2MDY_e6ed3272-e18f-4554-a963-8705fbe10d08"
      unitRef="usd">1500000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RleHRyZWdpb246ODA4MTIyY2E0NzEyNDJhN2I5MzExOGQ4ZTEyNmQ4NjBfMTA4Njk_e8c8c22e-f7d1-41e0-8933-11f0e967d96a">&lt;div style="margin-bottom:10pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following presents the effect of derivative instruments designated as cash flow hedges and net investment hedges on the accompanying condensed consolidated statement of operations during the three months ended March&#160;31, 2023 and 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.917%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.057%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.597%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance&#160;in&#160;AOCL&lt;br/&gt;Beginning of&lt;br/&gt;Quarter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&#160;of&lt;br/&gt;Gain (Loss)&lt;br/&gt;Recognized&#160;in&lt;br/&gt;AOCL&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&#160;of&#160;Gain (Loss)&lt;br/&gt;Reclassified from&lt;br/&gt;AOCL into&lt;br/&gt;Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance&#160;in&#160;AOCL&lt;br/&gt;End of Quarter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location in&lt;br/&gt;Statements&#160;of&lt;br/&gt;Operations&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Cash Flow Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest rate swap&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;56,712&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(10,534)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;42,678&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(20,271)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,191&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,504)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(14,576)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other income, net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign Currency Forward Contract&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(69)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(69)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cost of Sales&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Net Investment Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6,914)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,096&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(8,060)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29,527&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7,462)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,092&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,973&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Cash Flow Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest rate swap&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(43,956)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41,675&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,213)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(9,688)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,331&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(17,703)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other income, net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Net Investment Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,312)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,323)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(55,956)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;43,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,438&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(17,094)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock>
    <us-gaap:StockholdersEquity
      contextRef="i8ee9771bb95e427193ef400f91e7f20e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOmI0YWRkYWE5NTM0MDQwZmViMzNiOTU1YzE0MjU1ODAyL3RhYmxlcmFuZ2U6YjRhZGRhYTk1MzQwNDBmZWIzM2I5NTVjMTQyNTU4MDJfMy0xLTEtMS0xODY4MjE_e1eb2d69-cba9-4b3f-940b-4518ab6c5558"
      unitRef="usd">56712000</us-gaap:StockholdersEquity>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i3e6c0e609ad149bdbbfc158b0e5fd68a_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOmI0YWRkYWE5NTM0MDQwZmViMzNiOTU1YzE0MjU1ODAyL3RhYmxlcmFuZ2U6YjRhZGRhYTk1MzQwNDBmZWIzM2I5NTVjMTQyNTU4MDJfMy0zLTEtMS0xODY4MjE_019f5e2d-f95c-47d1-ac5b-4ef72786707a"
      unitRef="usd">-10534000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i3e6c0e609ad149bdbbfc158b0e5fd68a_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOmI0YWRkYWE5NTM0MDQwZmViMzNiOTU1YzE0MjU1ODAyL3RhYmxlcmFuZ2U6YjRhZGRhYTk1MzQwNDBmZWIzM2I5NTVjMTQyNTU4MDJfMy01LTEtMS0xODY4MjE_859a42f0-3bc3-4fc5-9eb9-dddceffa9aea"
      unitRef="usd">3500000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:StockholdersEquity
      contextRef="ic4eb84f89dad4116bceeb45741f9a641_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOmI0YWRkYWE5NTM0MDQwZmViMzNiOTU1YzE0MjU1ODAyL3RhYmxlcmFuZ2U6YjRhZGRhYTk1MzQwNDBmZWIzM2I5NTVjMTQyNTU4MDJfMy03LTEtMS0xODY4MjE_4810f200-2eff-4eb0-909f-9fb1b71877ae"
      unitRef="usd">42678000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib3fe4a582ccd4061a97fd0b9da7c7f0d_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOmI0YWRkYWE5NTM0MDQwZmViMzNiOTU1YzE0MjU1ODAyL3RhYmxlcmFuZ2U6YjRhZGRhYTk1MzQwNDBmZWIzM2I5NTVjMTQyNTU4MDJfNC0xLTEtMS0xODY4MjE_f96a994e-60ac-496e-ad45-a6f80360f83f"
      unitRef="usd">-20271000</us-gaap:StockholdersEquity>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i178b4152981345408498c8dfbee4cbc7_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOmI0YWRkYWE5NTM0MDQwZmViMzNiOTU1YzE0MjU1ODAyL3RhYmxlcmFuZ2U6YjRhZGRhYTk1MzQwNDBmZWIzM2I5NTVjMTQyNTU4MDJfNC0zLTEtMS0xODY4MjE_1ffc2929-d5c5-4d7f-9308-b92af245c4a6"
      unitRef="usd">2191000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i178b4152981345408498c8dfbee4cbc7_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOmI0YWRkYWE5NTM0MDQwZmViMzNiOTU1YzE0MjU1ODAyL3RhYmxlcmFuZ2U6YjRhZGRhYTk1MzQwNDBmZWIzM2I5NTVjMTQyNTU4MDJfNC01LTEtMS0xODY4MjE_28fb0c99-513b-4b0f-8bfb-40d7cec131af"
      unitRef="usd">-3504000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:StockholdersEquity
      contextRef="i9d6a89764db9416587bce17f35871a44_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOmI0YWRkYWE5NTM0MDQwZmViMzNiOTU1YzE0MjU1ODAyL3RhYmxlcmFuZ2U6YjRhZGRhYTk1MzQwNDBmZWIzM2I5NTVjMTQyNTU4MDJfNC03LTEtMS0xODY4MjE_60b0687d-30a2-4617-bbba-ee69954d03df"
      unitRef="usd">-14576000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if6fb80266a304dc5be9547704ed56286_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOmI0YWRkYWE5NTM0MDQwZmViMzNiOTU1YzE0MjU1ODAyL3RhYmxlcmFuZ2U6YjRhZGRhYTk1MzQwNDBmZWIzM2I5NTVjMTQyNTU4MDJfNS0xLTEtMS0xOTgxMTU_ba6a9fe4-b8ac-4a91-a4a3-56088c140987"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i92388a95dedc4a34a9f55ffd26aca363_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOmI0YWRkYWE5NTM0MDQwZmViMzNiOTU1YzE0MjU1ODAyL3RhYmxlcmFuZ2U6YjRhZGRhYTk1MzQwNDBmZWIzM2I5NTVjMTQyNTU4MDJfNS0zLTEtMS0xOTgxMjM_e92de1b0-bc26-4824-ad0c-42d87d19ca00"
      unitRef="usd">-69000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i810224786fad497790a97ede68b59f5f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOmI0YWRkYWE5NTM0MDQwZmViMzNiOTU1YzE0MjU1ODAyL3RhYmxlcmFuZ2U6YjRhZGRhYTk1MzQwNDBmZWIzM2I5NTVjMTQyNTU4MDJfNS01LTEtMS0xOTgxMzE_4f119c2d-d28b-4298-a9fd-4175a742a469"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:StockholdersEquity
      contextRef="i2b3f564951d04d5e92ce288f73dcb9b4_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOmI0YWRkYWE5NTM0MDQwZmViMzNiOTU1YzE0MjU1ODAyL3RhYmxlcmFuZ2U6YjRhZGRhYTk1MzQwNDBmZWIzM2I5NTVjMTQyNTU4MDJfNS03LTEtMS0xOTgxMzg_ee294034-c596-4296-9879-2694d3d84e9b"
      unitRef="usd">-69000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i560720c3abc24f638935549d00ddf679_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOmI0YWRkYWE5NTM0MDQwZmViMzNiOTU1YzE0MjU1ODAyL3RhYmxlcmFuZ2U6YjRhZGRhYTk1MzQwNDBmZWIzM2I5NTVjMTQyNTU4MDJfNi0xLTEtMS0xODY4MjE_e84b8a9d-6136-496a-8157-e4e769498c7b"
      unitRef="usd">-6914000</us-gaap:StockholdersEquity>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="iaf1bbb7d552b43bc97be79bd949d01ce_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOmI0YWRkYWE5NTM0MDQwZmViMzNiOTU1YzE0MjU1ODAyL3RhYmxlcmFuZ2U6YjRhZGRhYTk1MzQwNDBmZWIzM2I5NTVjMTQyNTU4MDJfNi0zLTEtMS0xODY4MjE_f984f628-75c8-4829-be2f-fed8ecb4e3ee"
      unitRef="usd">950000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="iaf1bbb7d552b43bc97be79bd949d01ce_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOmI0YWRkYWE5NTM0MDQwZmViMzNiOTU1YzE0MjU1ODAyL3RhYmxlcmFuZ2U6YjRhZGRhYTk1MzQwNDBmZWIzM2I5NTVjMTQyNTU4MDJfNi01LTEtMS0xODY4MjE_fb33fa4f-1665-4846-949d-c3ee5dd0f093"
      unitRef="usd">2096000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:StockholdersEquity
      contextRef="i545e60a320824ebca08bfa1384c3f0f0_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOmI0YWRkYWE5NTM0MDQwZmViMzNiOTU1YzE0MjU1ODAyL3RhYmxlcmFuZ2U6YjRhZGRhYTk1MzQwNDBmZWIzM2I5NTVjMTQyNTU4MDJfNi03LTEtMS0xODY4MjE_cb507e0d-df89-4a14-9dc6-0241abcba3bb"
      unitRef="usd">-8060000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i3c8bc030a0e84d8884ff38380b57a524_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOmI0YWRkYWE5NTM0MDQwZmViMzNiOTU1YzE0MjU1ODAyL3RhYmxlcmFuZ2U6YjRhZGRhYTk1MzQwNDBmZWIzM2I5NTVjMTQyNTU4MDJfNy0xLTEtMS0xODY4MjE_2863b95c-4b6c-42c4-a864-c82dbedc542a"
      unitRef="usd">29527000</us-gaap:StockholdersEquity>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="ie8763013b51645d9b4f267faa1bc585c_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOmI0YWRkYWE5NTM0MDQwZmViMzNiOTU1YzE0MjU1ODAyL3RhYmxlcmFuZ2U6YjRhZGRhYTk1MzQwNDBmZWIzM2I5NTVjMTQyNTU4MDJfNy0zLTEtMS0xODY4MjE_e1a56a08-f3d3-4d87-a51f-7b3e30bdbbd1"
      unitRef="usd">-7462000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="ie8763013b51645d9b4f267faa1bc585c_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOmI0YWRkYWE5NTM0MDQwZmViMzNiOTU1YzE0MjU1ODAyL3RhYmxlcmFuZ2U6YjRhZGRhYTk1MzQwNDBmZWIzM2I5NTVjMTQyNTU4MDJfNy01LTEtMS0xODY4MjE_f9391dc9-533c-45f0-bd3e-89f577980bc0"
      unitRef="usd">2092000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:StockholdersEquity
      contextRef="i6f53e0e076bd414e80ef7c0bf8a3584f_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOmI0YWRkYWE5NTM0MDQwZmViMzNiOTU1YzE0MjU1ODAyL3RhYmxlcmFuZ2U6YjRhZGRhYTk1MzQwNDBmZWIzM2I5NTVjMTQyNTU4MDJfNy03LTEtMS0xODY4MjE_50dc5b3b-7824-4b4b-9653-792c2559451d"
      unitRef="usd">19973000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id2ee30afd022428e9770584749497e62_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOmI0YWRkYWE5NTM0MDQwZmViMzNiOTU1YzE0MjU1ODAyL3RhYmxlcmFuZ2U6YjRhZGRhYTk1MzQwNDBmZWIzM2I5NTVjMTQyNTU4MDJfMTAtMS0xLTEtMTg2ODIx_9ff5c70d-1189-4ca8-abc6-4f9e70d0a830"
      unitRef="usd">-43956000</us-gaap:StockholdersEquity>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="id8ccc5370489410a8499e0a9e3753b87_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOmI0YWRkYWE5NTM0MDQwZmViMzNiOTU1YzE0MjU1ODAyL3RhYmxlcmFuZ2U6YjRhZGRhYTk1MzQwNDBmZWIzM2I5NTVjMTQyNTU4MDJfMTAtMy0xLTEtMTg2ODIx_eaeedd4d-3b97-47ea-a24f-9a45a7814c31"
      unitRef="usd">41675000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="id8ccc5370489410a8499e0a9e3753b87_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOmI0YWRkYWE5NTM0MDQwZmViMzNiOTU1YzE0MjU1ODAyL3RhYmxlcmFuZ2U6YjRhZGRhYTk1MzQwNDBmZWIzM2I5NTVjMTQyNTU4MDJfMTAtNS0xLTEtMTg2ODIx_b92a52d3-1697-4d01-a164-54cfeb848d6e"
      unitRef="usd">-5213000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:StockholdersEquity
      contextRef="i2b2554dad56a4166a558274eed8d4fbb_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOmI0YWRkYWE5NTM0MDQwZmViMzNiOTU1YzE0MjU1ODAyL3RhYmxlcmFuZ2U6YjRhZGRhYTk1MzQwNDBmZWIzM2I5NTVjMTQyNTU4MDJfMTAtNy0xLTEtMTg2ODIx_2c6a9a14-f70b-4ce8-9f06-ac709b033c2d"
      unitRef="usd">2932000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i579d645e131641bfa09602eb64db21f3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOmI0YWRkYWE5NTM0MDQwZmViMzNiOTU1YzE0MjU1ODAyL3RhYmxlcmFuZ2U6YjRhZGRhYTk1MzQwNDBmZWIzM2I5NTVjMTQyNTU4MDJfMTEtMS0xLTEtMTg2ODIx_eb14b20e-2fbb-4c0c-8ddc-8008d1ccdc69"
      unitRef="usd">-9688000</us-gaap:StockholdersEquity>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i63c6bd493f22494e9df49e5e6f48e027_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOmI0YWRkYWE5NTM0MDQwZmViMzNiOTU1YzE0MjU1ODAyL3RhYmxlcmFuZ2U6YjRhZGRhYTk1MzQwNDBmZWIzM2I5NTVjMTQyNTU4MDJfMTEtMy0xLTEtMTg2ODIx_637592fd-6341-4e1e-941c-4716575aa054"
      unitRef="usd">316000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i63c6bd493f22494e9df49e5e6f48e027_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOmI0YWRkYWE5NTM0MDQwZmViMzNiOTU1YzE0MjU1ODAyL3RhYmxlcmFuZ2U6YjRhZGRhYTk1MzQwNDBmZWIzM2I5NTVjMTQyNTU4MDJfMTEtNS0xLTEtMTg2ODIx_680f0334-49c2-45c7-9a88-6a30d32e6952"
      unitRef="usd">8331000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:StockholdersEquity
      contextRef="i4b8fe8c3c3e2433a8f7cd9487fff6fef_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOmI0YWRkYWE5NTM0MDQwZmViMzNiOTU1YzE0MjU1ODAyL3RhYmxlcmFuZ2U6YjRhZGRhYTk1MzQwNDBmZWIzM2I5NTVjMTQyNTU4MDJfMTEtNy0xLTEtMTg2ODIx_5d23b912-aaaf-4f1e-ac33-b6749cdcf214"
      unitRef="usd">-17703000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iae8885f4db32466ab5102315e110644a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOmI0YWRkYWE5NTM0MDQwZmViMzNiOTU1YzE0MjU1ODAyL3RhYmxlcmFuZ2U6YjRhZGRhYTk1MzQwNDBmZWIzM2I5NTVjMTQyNTU4MDJfMTMtMS0xLTEtMTg2ODIx_06120420-9891-4883-918e-7aa5a244e4cb"
      unitRef="usd">-2312000</us-gaap:StockholdersEquity>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i837380b9b55a43d9a21479305539ed99_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOmI0YWRkYWE5NTM0MDQwZmViMzNiOTU1YzE0MjU1ODAyL3RhYmxlcmFuZ2U6YjRhZGRhYTk1MzQwNDBmZWIzM2I5NTVjMTQyNTU4MDJfMTMtMy0xLTEtMTg2ODIx_c5a4b60b-0528-4f95-be9e-2643010839d9"
      unitRef="usd">1309000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i837380b9b55a43d9a21479305539ed99_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOmI0YWRkYWE5NTM0MDQwZmViMzNiOTU1YzE0MjU1ODAyL3RhYmxlcmFuZ2U6YjRhZGRhYTk1MzQwNDBmZWIzM2I5NTVjMTQyNTU4MDJfMTMtNS0xLTEtMTg2ODIx_8df39807-dc8f-477f-9529-2e884d42cfa7"
      unitRef="usd">1320000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:StockholdersEquity
      contextRef="iac14ca05a7c84129889affd66eddd064_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOmI0YWRkYWE5NTM0MDQwZmViMzNiOTU1YzE0MjU1ODAyL3RhYmxlcmFuZ2U6YjRhZGRhYTk1MzQwNDBmZWIzM2I5NTVjMTQyNTU4MDJfMTMtNy0xLTEtMTg2ODIx_9ba3530e-af0e-4acd-bbf4-96bd65e28111"
      unitRef="usd">-2323000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib5284fa32e194b4887c09b3bd11c5196_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOmI0YWRkYWE5NTM0MDQwZmViMzNiOTU1YzE0MjU1ODAyL3RhYmxlcmFuZ2U6YjRhZGRhYTk1MzQwNDBmZWIzM2I5NTVjMTQyNTU4MDJfMTQtMS0xLTEtMTg2ODIx_c7452925-236d-4afb-a0ed-d7ff8ede069d"
      unitRef="usd">-55956000</us-gaap:StockholdersEquity>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i2c763dd699df40f7994d4bd081a81d5b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOmI0YWRkYWE5NTM0MDQwZmViMzNiOTU1YzE0MjU1ODAyL3RhYmxlcmFuZ2U6YjRhZGRhYTk1MzQwNDBmZWIzM2I5NTVjMTQyNTU4MDJfMTQtMy0xLTEtMTg2ODIx_463b43b3-d52e-4bf9-abf9-19b8ba667dc7"
      unitRef="usd">43300000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i2c763dd699df40f7994d4bd081a81d5b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOmI0YWRkYWE5NTM0MDQwZmViMzNiOTU1YzE0MjU1ODAyL3RhYmxlcmFuZ2U6YjRhZGRhYTk1MzQwNDBmZWIzM2I5NTVjMTQyNTU4MDJfMTQtNS0xLTEtMTg2ODIx_57b85ba3-f65f-4633-9ff2-697599b236db"
      unitRef="usd">4438000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:StockholdersEquity
      contextRef="i2ee28a1877fb49278defab1977e4dfed_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOmI0YWRkYWE5NTM0MDQwZmViMzNiOTU1YzE0MjU1ODAyL3RhYmxlcmFuZ2U6YjRhZGRhYTk1MzQwNDBmZWIzM2I5NTVjMTQyNTU4MDJfMTQtNy0xLTEtMTg2ODIx_05e61f26-4511-4c4f-af04-5102b5b7000c"
      unitRef="usd">-17094000</us-gaap:StockholdersEquity>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i64221cccd9784e23b84697c3a6cae83e_I20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RleHRyZWdpb246ODA4MTIyY2E0NzEyNDJhN2I5MzExOGQ4ZTEyNmQ4NjBfNDM5ODA0NjUyNzM3Mw_2ed27060-7ae6-4cbe-ae3e-18ce3a1199e2"
      unitRef="usd">7300000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i6b9673d1d44547fabe1719aef8ec54e2_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RleHRyZWdpb246ODA4MTIyY2E0NzEyNDJhN2I5MzExOGQ4ZTEyNmQ4NjBfNDM5ODA0NjUyODAwOA_5b9cb4fb-3371-4550-9815-95344bf64f7e"
      unitRef="usd">6400000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RleHRyZWdpb246ODA4MTIyY2E0NzEyNDJhN2I5MzExOGQ4ZTEyNmQ4NjBfODI0NjMzNzIyNjc0Ng_f814dd41-728f-48ba-85d4-d767af84381f">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the gains (losses) of derivative instruments not designated as hedges on the condensed consolidated statements of income, which was included in other income:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.736%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.417%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.412%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.417%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.414%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
      contextRef="i7cae2dbfb6a5475491033e353f69120b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjI2M2ZhY2NlNDE5NjRkMDU5MjM1N2RkMjNjOGUzZThkL3RhYmxlcmFuZ2U6MjYzZmFjY2U0MTk2NGQwNTkyMzU3ZGQyM2M4ZTNlOGRfMy02LTEtMS0xOTc5NTI_1dd82e9f-9081-4d35-9210-fb61f2895549"
      unitRef="usd">55000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
      contextRef="i60372d5d4c714e66a7f44c71f2d47770_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjI2M2ZhY2NlNDE5NjRkMDU5MjM1N2RkMjNjOGUzZThkL3RhYmxlcmFuZ2U6MjYzZmFjY2U0MTk2NGQwNTkyMzU3ZGQyM2M4ZTNlOGRfMy04LTEtMS0xOTc5NTI_cdf1a342-63e5-47c5-b176-b767fa3d23e6"
      unitRef="usd">360000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjI2M2ZhY2NlNDE5NjRkMDU5MjM1N2RkMjNjOGUzZThkL3RhYmxlcmFuZ2U6MjYzZmFjY2U0MTk2NGQwNTkyMzU3ZGQyM2M4ZTNlOGRfNC02LTEtMS0xOTg1Mjg_aa551f27-f084-4355-9c7a-bce6ee7d04ee"
      unitRef="usd">55000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
      contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF81OC9mcmFnOjgwODEyMmNhNDcxMjQyYTdiOTMxMThkOGUxMjZkODYwL3RhYmxlOjI2M2ZhY2NlNDE5NjRkMDU5MjM1N2RkMjNjOGUzZThkL3RhYmxlcmFuZ2U6MjYzZmFjY2U0MTk2NGQwNTkyMzU3ZGQyM2M4ZTNlOGRfNC04LTEtMS0xOTg1Mjg_57eae17e-f2ab-43bb-a400-e9d7d1dc9ea5"
      unitRef="usd">360000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82MS9mcmFnOmVjZjA3OTliODczNTQ2MjFhODNlMzFlYWUxZWEyOTMxL3RleHRyZWdpb246ZWNmMDc5OWI4NzM1NDYyMWE4M2UzMWVhZTFlYTI5MzFfMjk0Mw_2e758e20-6217-45a1-b3ef-45cf6bf37acf">STOCK-BASED COMPENSATION &lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2023, the Company had stock options, restricted stock awards, performance stock awards, contract stock awards and restricted stock unit awards outstanding under the Integra LifeSciences Holdings Corporation Fifth Amended and Restated 2003 Equity Incentive Plan (the &#x201c;2003 Plan&#x201d;). The 2000 and 2001 Equity Incentive Plans were terminated as of February 19, 2021, and no further awards may be issued under the plans.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock options issued under the 2003 Plan become exercisable over specified periods, generally within four years from the date of grant for officers and employees, within one year from date of grant for directors which generally expire eight years from the grant date for employees, and from &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82MS9mcmFnOmVjZjA3OTliODczNTQ2MjFhODNlMzFlYWUxZWEyOTMxL3RleHRyZWdpb246ZWNmMDc5OWI4NzM1NDYyMWE4M2UzMWVhZTFlYTI5MzFfNzIx_2efd93e6-4b81-4ecd-a888-8a73dfd19f51"&gt;six&lt;/span&gt; to ten years for directors and certain executive officers, except in certain instances that result in accelerated vesting due to death, disability, retirement age or change in-control provisions within their grant agreements. The Company values stock option grants using the binomial distribution model. Restricted stock issued under the Plans vests over specified periods, generally three years after the date of grant. The vesting of performance stock issued under the Plans is subject to service and performance conditions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock Options&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2023, there were approximately $5.6 million of total unrecognized compensation costs related to unvested stock options. These costs are expected to be recognized over a weighted-average period of approximately three years. There were 151,293 stock options granted during the three months ended March&#160;31, 2023. For the three months ended March&#160;31, 2023, the weighted average grant date fair value for stock options granted was $21.58 per option.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Awards of Restricted Stock and Performance Stock&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Performance stock and restricted stock awards generally have requisite service periods of three years, except in certain instances that result in accelerated vesting due to death, disability, retirement age provision or change in-control provisions in their grant agreements. Performance stock units are subject to graded vesting conditions based on revenue goals of the Company. The Company expenses the fair value of restricted stock awards on a straight-line basis over the requisite service period. As of March&#160;31, 2023, there was approximately $48.6 million of total unrecognized compensation costs related to these unvested awards. The Company expects to recognize these costs over a weighted-average period of approximately two years. The Company granted 346,745 restricted stock awards and 161,218 performance stock awards during the three months ended March&#160;31, 2023. For the three months ended March&#160;31, 2023, the weighted average grant date fair value for restricted stock awards and performance stock units granted was $53.37 and $52.87 per award, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also maintains an Employee Stock Purchase Plan (the &#x201c;ESPP&#x201d;), which provides eligible employees with the opportunity to acquire shares of common stock at periodic intervals by means of accumulated payroll deductions. The ESPP is a non-compensatory plan based on its terms.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="id118186cdcc643509f813c46ce8000ba_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82MS9mcmFnOmVjZjA3OTliODczNTQ2MjFhODNlMzFlYWUxZWEyOTMxL3RleHRyZWdpb246ZWNmMDc5OWI4NzM1NDYyMWE4M2UzMWVhZTFlYTI5MzFfNTU0_7e16f240-86d3-4a9e-a2b8-449f605044aa">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="if7a8dd366e654da081146a5b25db1c1b_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82MS9mcmFnOmVjZjA3OTliODczNTQ2MjFhODNlMzFlYWUxZWEyOTMxL3RleHRyZWdpb246ZWNmMDc5OWI4NzM1NDYyMWE4M2UzMWVhZTFlYTI5MzFfNjE1_d500d141-2e03-46c3-9c09-024486426d6e">P1Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="i399d8f6d881640bb810eee6e1458f2ba_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82MS9mcmFnOmVjZjA3OTliODczNTQ2MjFhODNlMzFlYWUxZWEyOTMxL3RleHRyZWdpb246ZWNmMDc5OWI4NzM1NDYyMWE4M2UzMWVhZTFlYTI5MzFfNjc0_83652e31-2204-4a79-9862-45b18da39041">P8Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="if710322947774a689663db2f525eeb6b_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82MS9mcmFnOmVjZjA3OTliODczNTQ2MjFhODNlMzFlYWUxZWEyOTMxL3RleHRyZWdpb246ZWNmMDc5OWI4NzM1NDYyMWE4M2UzMWVhZTFlYTI5MzFfNzI3_c5a8a229-0471-4cc8-968c-e80978a2e949">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i3bc994fc34b64d4cb7c684fd6244bac3_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82MS9mcmFnOmVjZjA3OTliODczNTQ2MjFhODNlMzFlYWUxZWEyOTMxL3RleHRyZWdpb246ZWNmMDc5OWI4NzM1NDYyMWE4M2UzMWVhZTFlYTI5MzFfMTEwMQ_01a76cc5-267b-46af-bf20-feb3229b32db">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="i6c69b026d57d423eb79ebbdfa493c6b3_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82MS9mcmFnOmVjZjA3OTliODczNTQ2MjFhODNlMzFlYWUxZWEyOTMxL3RleHRyZWdpb246ZWNmMDc5OWI4NzM1NDYyMWE4M2UzMWVhZTFlYTI5MzFfMTI4NA_abdc7088-3c9d-459f-ba74-403adb94d14e"
      unitRef="usd">5600000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="ib4f03ffd86fa4e22af66c496e06ac9ec_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82MS9mcmFnOmVjZjA3OTliODczNTQ2MjFhODNlMzFlYWUxZWEyOTMxL3RleHRyZWdpb246ZWNmMDc5OWI4NzM1NDYyMWE4M2UzMWVhZTFlYTI5MzFfMTQ1Mw_fcf00cb7-f82f-4a30-8e0a-40544fb880ba">P3Y</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82MS9mcmFnOmVjZjA3OTliODczNTQ2MjFhODNlMzFlYWUxZWEyOTMxL3RleHRyZWdpb246ZWNmMDc5OWI4NzM1NDYyMWE4M2UzMWVhZTFlYTI5MzFfMTQ2OA_8869a51f-349f-4d3a-ac6f-4797f5577373"
      unitRef="shares">151293</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82MS9mcmFnOmVjZjA3OTliODczNTQ2MjFhODNlMzFlYWUxZWEyOTMxL3RleHRyZWdpb246ZWNmMDc5OWI4NzM1NDYyMWE4M2UzMWVhZTFlYTI5MzFfMTYxNw_2e4ce816-8628-4428-bd78-405c3705fde0"
      unitRef="usdPerShare">21.58</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1
      contextRef="i4989d4c8ef004834bf2980d2722cccaf_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82MS9mcmFnOmVjZjA3OTliODczNTQ2MjFhODNlMzFlYWUxZWEyOTMxL3RleHRyZWdpb246ZWNmMDc5OWI4NzM1NDYyMWE4M2UzMWVhZTFlYTI5MzFfMTc3MQ_2546bb17-ed9d-4a37-8faf-98a957aabc7c">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="i3046bc1317c642afb36b924feec16501_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82MS9mcmFnOmVjZjA3OTliODczNTQ2MjFhODNlMzFlYWUxZWEyOTMxL3RleHRyZWdpb246ZWNmMDc5OWI4NzM1NDYyMWE4M2UzMWVhZTFlYTI5MzFfMjIwOQ_352d92e4-f0ca-43cf-a481-5222ebc06630"
      unitRef="usd">48600000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i3bc994fc34b64d4cb7c684fd6244bac3_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82MS9mcmFnOmVjZjA3OTliODczNTQ2MjFhODNlMzFlYWUxZWEyOTMxL3RleHRyZWdpb246ZWNmMDc5OWI4NzM1NDYyMWE4M2UzMWVhZTFlYTI5MzFfMjM4MA_51baa7f7-14d2-4ff8-93aa-b4a34ae8bb32">P2Y</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i3bc994fc34b64d4cb7c684fd6244bac3_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82MS9mcmFnOmVjZjA3OTliODczNTQ2MjFhODNlMzFlYWUxZWEyOTMxL3RleHRyZWdpb246ZWNmMDc5OWI4NzM1NDYyMWE4M2UzMWVhZTFlYTI5MzFfMjQwNA_e9eb2397-1af0-49f7-b8ea-6159c052536b"
      unitRef="shares">346745</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i663c47912e30448682d1e675fc6bf6fd_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82MS9mcmFnOmVjZjA3OTliODczNTQ2MjFhODNlMzFlYWUxZWEyOTMxL3RleHRyZWdpb246ZWNmMDc5OWI4NzM1NDYyMWE4M2UzMWVhZTFlYTI5MzFfMjQzNQ_2d7538fc-3dba-4fda-a250-a3236e5bf5d1"
      unitRef="shares">161218</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i3bc994fc34b64d4cb7c684fd6244bac3_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82MS9mcmFnOmVjZjA3OTliODczNTQ2MjFhODNlMzFlYWUxZWEyOTMxL3RleHRyZWdpb246ZWNmMDc5OWI4NzM1NDYyMWE4M2UzMWVhZTFlYTI5MzFfMjYyNQ_39247259-dd71-4cb2-81ac-e16afe5fa33d"
      unitRef="usdPerShare">53.37</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i663c47912e30448682d1e675fc6bf6fd_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82MS9mcmFnOmVjZjA3OTliODczNTQ2MjFhODNlMzFlYWUxZWEyOTMxL3RleHRyZWdpb246ZWNmMDc5OWI4NzM1NDYyMWE4M2UzMWVhZTFlYTI5MzFfMjYzMg_cb327df4-acea-4893-bce3-43b5e0d6e9bb"
      unitRef="usdPerShare">52.87</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82NC9mcmFnOjdhZTU2MzUyMWE3MzQwZmU5MDZjZDEzMDdlZTE5MGE0L3RleHRyZWdpb246N2FlNTYzNTIxYTczNDBmZTkwNmNkMTMwN2VlMTkwYTRfMjIzNA_42c8702e-0214-4aeb-983f-ed749e468adb">RETIREMENT PLANS&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company maintains defined benefit pension plans that cover certain employees in France, Japan, Germany and Switzerland.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net periodic benefit costs for the Company&#x2019;s defined benefit pension plans for the three months ended March 31, 2023 were $0.3 million. The components of the net periodic benefit costs other than the service cost component of $0.5 million for the three months ended March&#160;31, 2023 are included in other income, net in the consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net periodic benefit costs for the Company&#x2019;s defined benefit pension plans for the three months ended March 31, 2022 were $0.3 million. The components of the net periodic benefit costs other than the service cost component of $0.7 million for the three months ended March&#160;31, 2022 are included in other income, net in the consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated fair values of plan assets were $36.4 million and $38.1 million as of March&#160;31, 2023 and December&#160;31, 2022, respectively. The net plan assets of the pension plans are invested in common trusts as of March&#160;31, 2023 and December&#160;31, 2022. Common trusts are classified as Level 2 in the fair value hierarchy. The fair value of common trusts is valued at the net asset value based on the fair values of the underlying investments of the trusts as determined by the sponsor of the trusts. The investment strategy of the Company's defined benefit plans is both to meet the liabilities of the plans as they fall due and to maximize the return on invested assets within an appropriate risk profile.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Deferred Compensation Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company maintains a Deferred Compensation Plan in which certain employees of the Company may defer the payment and taxation of up to 75% of their base salary and up to 100% of bonus amounts and other eligible cash compensation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;This deferred compensation is invested in funds offered under this plan and is valued based on Level 1 measurements in the fair value hierarchy. Assets of the Company's deferred compensation plan are included in other current assets and recorded at fair value based on their quoted market prices. The fair value of these assets were $5.0 million and $4.7 million as of March&#160;31, 2023 and December&#160;31, 2022, respectively. Offsetting liabilities relating to the deferred compensation plan are included in Other liabilities.&lt;/span&gt;&lt;/div&gt;</us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82NC9mcmFnOjdhZTU2MzUyMWE3MzQwZmU5MDZjZDEzMDdlZTE5MGE0L3RleHRyZWdpb246N2FlNTYzNTIxYTczNDBmZTkwNmNkMTMwN2VlMTkwYTRfMjQw_402cfdd2-5711-4ae6-bb6f-36ed3e0f42ba"
      unitRef="usd">300000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82NC9mcmFnOjdhZTU2MzUyMWE3MzQwZmU5MDZjZDEzMDdlZTE5MGE0L3RleHRyZWdpb246N2FlNTYzNTIxYTczNDBmZTkwNmNkMTMwN2VlMTkwYTRfMzM0_7e06dbb9-6a87-4545-8e3f-c6e2f55804ef"
      unitRef="usd">500000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82NC9mcmFnOjdhZTU2MzUyMWE3MzQwZmU5MDZjZDEzMDdlZTE5MGE0L3RleHRyZWdpb246N2FlNTYzNTIxYTczNDBmZTkwNmNkMTMwN2VlMTkwYTRfNTM1_f0729d2f-9b21-46cd-9659-32aeb5a58ab7"
      unitRef="usd">300000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82NC9mcmFnOjdhZTU2MzUyMWE3MzQwZmU5MDZjZDEzMDdlZTE5MGE0L3RleHRyZWdpb246N2FlNTYzNTIxYTczNDBmZTkwNmNkMTMwN2VlMTkwYTRfNjI5_5405a25c-eda1-46ce-ba85-5b4c07175630"
      unitRef="usd">700000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82NC9mcmFnOjdhZTU2MzUyMWE3MzQwZmU5MDZjZDEzMDdlZTE5MGE0L3RleHRyZWdpb246N2FlNTYzNTIxYTczNDBmZTkwNmNkMTMwN2VlMTkwYTRfNzg1_73c78124-4d46-41f5-abc3-1a002c3eb010"
      unitRef="usd">36400000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82NC9mcmFnOjdhZTU2MzUyMWE3MzQwZmU5MDZjZDEzMDdlZTE5MGE0L3RleHRyZWdpb246N2FlNTYzNTIxYTczNDBmZTkwNmNkMTMwN2VlMTkwYTRfNzky_435b4c9a-43ec-4dd5-8a93-7bec96f3c194"
      unitRef="usd">38100000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <iart:DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82NC9mcmFnOjdhZTU2MzUyMWE3MzQwZmU5MDZjZDEzMDdlZTE5MGE0L3RleHRyZWdpb246N2FlNTYzNTIxYTczNDBmZTkwNmNkMTMwN2VlMTkwYTRfMTUzMg_60c662b6-dddb-45c0-a7f1-abac14ac12f0"
      unitRef="number">0.75</iart:DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage>
    <iart:DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82NC9mcmFnOjdhZTU2MzUyMWE3MzQwZmU5MDZjZDEzMDdlZTE5MGE0L3RleHRyZWdpb246N2FlNTYzNTIxYTczNDBmZTkwNmNkMTMwN2VlMTkwYTRfMTU2Ng_72a6b32d-ba62-41c0-bb9d-8fa877a90dc2"
      unitRef="number">1</iart:DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage>
    <us-gaap:DeferredCompensationPlanAssets
      contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82NC9mcmFnOjdhZTU2MzUyMWE3MzQwZmU5MDZjZDEzMDdlZTE5MGE0L3RleHRyZWdpb246N2FlNTYzNTIxYTczNDBmZTkwNmNkMTMwN2VlMTkwYTRfMjEwMA_2a5cd152-e39f-424c-92b6-d93a583dd3cb"
      unitRef="usd">5000000.0</us-gaap:DeferredCompensationPlanAssets>
    <us-gaap:DeferredCompensationPlanAssets
      contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82NC9mcmFnOjdhZTU2MzUyMWE3MzQwZmU5MDZjZDEzMDdlZTE5MGE0L3RleHRyZWdpb246N2FlNTYzNTIxYTczNDBmZTkwNmNkMTMwN2VlMTkwYTRfMjExNQ_0abcc7b0-325e-44b0-8bd2-9f3e48873e37"
      unitRef="usd">4700000</us-gaap:DeferredCompensationPlanAssets>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RleHRyZWdpb246MzQ4MGRhZmY0OTEzNGYxNzhjZDkzNGM2ZTExNWU0NThfMjQzMA_aea4982f-303d-4aac-a701-76af0ed69065">LEASES AND RELATED PARTY LEASESThe Company leases administrative, manufacturing, research and distribution facilities and vehicles through operating lease agreements. The Company has no finance leases as of March&#160;31, 2023. Many of the Company's leases include both lease (e.g., fixed payments including rent) and non-lease components (e.g., common-area or other maintenance costs). For vehicles, the Company has elected the practical expedient to group lease and non-lease components.&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Most facility leases include one or more options to renew. The exercise of lease renewal options is typically at the Company's sole discretion, therefore, the majority of renewals to extend the lease terms are not included in the Right of Use ("ROU") assets and lease liabilities as they are not reasonably certain of exercise. The Company regularly evaluates renewal options and when they are reasonably certain of exercise, the renewal period is included in the lease term.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As most of the Company's leases do not provide an implicit rate, the Company uses a collateralized incremental borrowing rate based on the information available at the lease commencement date in determining the present value of the lease payments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total operating lease expense for the three months ended March 31, 2023 and March&#160;31, 2022 was $6.0 million and $4.9 million respectively, which includes $0.1 million, in related party operating lease expense.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental balance sheet information related to operating leases were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.718%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.200%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in thousands, except lease term and discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:6pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December&#160;31, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;ROU assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;146,514&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;148,284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,792&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-current lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;156,910&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;157,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;171,702&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;172,044&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted average remaining lease term (in years):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Leased facilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17.1 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16.9 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Leased vehicles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.0 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.0 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted average discount rate:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Leased facilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Leased vehicles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental cash flow information related to leases for the three months ended March 31, 2023 and 2022 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.075%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="margin-top:6pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March&#160;31, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating cash flows from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;ROU assets obtained in exchange for lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,721&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Future minimum lease payments under operating leases at March&#160;31, 2023 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Related Parties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Third Parties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Remainder of 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,092&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21,382&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,753&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,049&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,501&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,951&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;151,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;151,452&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;255,219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;257,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less: Imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;85,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;171,702&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less: Current lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,792&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Long-term lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;156,910&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no future minimum lease payments under finance leases at March&#160;31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Related Party Leases&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company leases its manufacturing facility in Plainsboro, New Jersey, from Plainsboro Associates, a New Jersey general partnership. Ocirne, Inc., a subsidiary of Provco Industries, owns a 50% % interest in Plainsboro Associates. Provco Industries is the corporate general partner of Tru St. Partnership LLP, a principal stockholder of the Company. The term of the current lease agreement is through October&#160;31, 2029 at an annual rate of approximately $0.3 million per year. The current lease agreement also provides (i) a 5-year renewal option for the Company to extend the lease from November 1, 2029 through October 31, 2034 at the fair market rental rate of the premises, and (ii) another 5-year renewal option to extend the lease from November 1, 2034 through October 31, 2039 at the fair market rental rate of the premises.&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <iart:LesseeOperatingLeaseNumberOfRenewalOptions
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RleHRyZWdpb246MzQ4MGRhZmY0OTEzNGYxNzhjZDkzNGM2ZTExNWU0NThfNTEy_430c3387-e050-4472-ac16-5d797da9d461"
      unitRef="renewal_option">1</iart:LesseeOperatingLeaseNumberOfRenewalOptions>
    <us-gaap:OperatingLeaseExpense
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RleHRyZWdpb246MzQ4MGRhZmY0OTEzNGYxNzhjZDkzNGM2ZTExNWU0NThfMTI1OA_e8d48e05-028a-4f0d-9a5c-0717b16ead9d"
      unitRef="usd">6000000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RleHRyZWdpb246MzQ4MGRhZmY0OTEzNGYxNzhjZDkzNGM2ZTExNWU0NThfMTI2NQ_fde76868-e1e8-422e-ab19-11b7e728c77c"
      unitRef="usd">4900000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="i0312bf3fc4c644b5a90beedc5b117be5_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RleHRyZWdpb246MzQ4MGRhZmY0OTEzNGYxNzhjZDkzNGM2ZTExNWU0NThfMTI5Nw_2991498d-8bc4-4588-b161-f18ef97bc033"
      unitRef="usd">100000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="ibb2818c35582446bb26bb336b6909032_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RleHRyZWdpb246MzQ4MGRhZmY0OTEzNGYxNzhjZDkzNGM2ZTExNWU0NThfMTI5Nw_5aac7976-d3bb-45bb-aa87-104b8a78fc6a"
      unitRef="usd">100000</us-gaap:OperatingLeaseExpense>
    <iart:AssetsAndLiabilitiesLesseeTableTextBlock
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RleHRyZWdpb246MzQ4MGRhZmY0OTEzNGYxNzhjZDkzNGM2ZTExNWU0NThfMjQ0Mw_c25e3832-81d0-44d0-be49-3c0f007421e5">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental balance sheet information related to operating leases were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.718%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.200%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in thousands, except lease term and discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:6pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December&#160;31, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;ROU assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;146,514&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;148,284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,792&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-current lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;156,910&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;157,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;171,702&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;172,044&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted average remaining lease term (in years):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Leased facilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17.1 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16.9 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Leased vehicles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.0 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.0 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted average discount rate:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Leased facilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Leased vehicles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</iart:AssetsAndLiabilitiesLesseeTableTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RhYmxlOmQwZGI0MTJkNGE2YzQzOWM5ZGU0OTY1YzRmOGQ5YTBmL3RhYmxlcmFuZ2U6ZDBkYjQxMmQ0YTZjNDM5YzlkZTQ5NjVjNGY4ZDlhMGZfMS01LTEtMS0xODY4MjE_2a1298fe-4a12-4db1-899c-90b0b5021da4"
      unitRef="usd">146514000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RhYmxlOmQwZGI0MTJkNGE2YzQzOWM5ZGU0OTY1YzRmOGQ5YTBmL3RhYmxlcmFuZ2U6ZDBkYjQxMmQ0YTZjNDM5YzlkZTQ5NjVjNGY4ZDlhMGZfMS03LTEtMS0xODY4MjE_c46b1c8d-5947-4401-97db-970453a94d31"
      unitRef="usd">148284000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RhYmxlOmQwZGI0MTJkNGE2YzQzOWM5ZGU0OTY1YzRmOGQ5YTBmL3RhYmxlcmFuZ2U6ZDBkYjQxMmQ0YTZjNDM5YzlkZTQ5NjVjNGY4ZDlhMGZfMy01LTEtMS0xODY4MjE_ace5b1df-2094-4330-ac78-6cb66bed9a25"
      unitRef="usd">14792000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RhYmxlOmQwZGI0MTJkNGE2YzQzOWM5ZGU0OTY1YzRmOGQ5YTBmL3RhYmxlcmFuZ2U6ZDBkYjQxMmQ0YTZjNDM5YzlkZTQ5NjVjNGY4ZDlhMGZfMy03LTEtMS0xODY4MjE_5569f44d-a369-4e76-80a5-a925cee32d13"
      unitRef="usd">14624000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RhYmxlOmQwZGI0MTJkNGE2YzQzOWM5ZGU0OTY1YzRmOGQ5YTBmL3RhYmxlcmFuZ2U6ZDBkYjQxMmQ0YTZjNDM5YzlkZTQ5NjVjNGY4ZDlhMGZfNC01LTEtMS0xODY4MjE_4b21e858-3ce1-42cb-833f-366a20e57341"
      unitRef="usd">156910000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RhYmxlOmQwZGI0MTJkNGE2YzQzOWM5ZGU0OTY1YzRmOGQ5YTBmL3RhYmxlcmFuZ2U6ZDBkYjQxMmQ0YTZjNDM5YzlkZTQ5NjVjNGY4ZDlhMGZfNC03LTEtMS0xODY4MjE_368f0c1c-5145-4c1a-af54-4b679b8b13ad"
      unitRef="usd">157420000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiability
      contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RhYmxlOmQwZGI0MTJkNGE2YzQzOWM5ZGU0OTY1YzRmOGQ5YTBmL3RhYmxlcmFuZ2U6ZDBkYjQxMmQ0YTZjNDM5YzlkZTQ5NjVjNGY4ZDlhMGZfNS01LTEtMS0xODY4MjE_2ac58911-8957-41ea-8ceb-071983784936"
      unitRef="usd">171702000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiability
      contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RhYmxlOmQwZGI0MTJkNGE2YzQzOWM5ZGU0OTY1YzRmOGQ5YTBmL3RhYmxlcmFuZ2U6ZDBkYjQxMmQ0YTZjNDM5YzlkZTQ5NjVjNGY4ZDlhMGZfNS03LTEtMS0xODY4MjE_a60d0986-a219-484b-acf1-b1cf100d0e76"
      unitRef="usd">172044000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="ief22d29946704881b53879628a3b3a03_I20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RhYmxlOmQwZGI0MTJkNGE2YzQzOWM5ZGU0OTY1YzRmOGQ5YTBmL3RhYmxlcmFuZ2U6ZDBkYjQxMmQ0YTZjNDM5YzlkZTQ5NjVjNGY4ZDlhMGZfOC01LTEtMS0xODY4MjE_7515fcb3-0220-41c2-9a02-1698999a7cc6">P17Y1M6D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i77b6f580f27a43fa87d99324c7d3333c_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RhYmxlOmQwZGI0MTJkNGE2YzQzOWM5ZGU0OTY1YzRmOGQ5YTBmL3RhYmxlcmFuZ2U6ZDBkYjQxMmQ0YTZjNDM5YzlkZTQ5NjVjNGY4ZDlhMGZfOC03LTEtMS0xODY4MjE_8c7b7046-97df-4d08-ac5b-3a08246c71c3">P16Y10M24D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i858dd34246b34029ba59dcfd73afff17_I20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RhYmxlOmQwZGI0MTJkNGE2YzQzOWM5ZGU0OTY1YzRmOGQ5YTBmL3RhYmxlcmFuZ2U6ZDBkYjQxMmQ0YTZjNDM5YzlkZTQ5NjVjNGY4ZDlhMGZfOS01LTEtMS0xODY4MjE_5bea49fd-8188-4c37-884d-0c32eda8b083">P2Y</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="iac36470e6fcb4453b97db73bbce55586_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RhYmxlOmQwZGI0MTJkNGE2YzQzOWM5ZGU0OTY1YzRmOGQ5YTBmL3RhYmxlcmFuZ2U6ZDBkYjQxMmQ0YTZjNDM5YzlkZTQ5NjVjNGY4ZDlhMGZfOS03LTEtMS0xODY4MjE_bd41025e-fb79-40a5-8239-7e7e3e87a0be">P2Y</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="ief22d29946704881b53879628a3b3a03_I20230331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RhYmxlOmQwZGI0MTJkNGE2YzQzOWM5ZGU0OTY1YzRmOGQ5YTBmL3RhYmxlcmFuZ2U6ZDBkYjQxMmQ0YTZjNDM5YzlkZTQ5NjVjNGY4ZDlhMGZfMTItNS0xLTEtMTg2ODIx_0b2df3e7-accb-4d0a-a87d-1ea4a3418d0e"
      unitRef="number">0.054</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i77b6f580f27a43fa87d99324c7d3333c_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RhYmxlOmQwZGI0MTJkNGE2YzQzOWM5ZGU0OTY1YzRmOGQ5YTBmL3RhYmxlcmFuZ2U6ZDBkYjQxMmQ0YTZjNDM5YzlkZTQ5NjVjNGY4ZDlhMGZfMTItNy0xLTEtMTg2ODIx_73852bef-31cd-4b59-9919-1ebad8b46b37"
      unitRef="number">0.054</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i858dd34246b34029ba59dcfd73afff17_I20230331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RhYmxlOmQwZGI0MTJkNGE2YzQzOWM5ZGU0OTY1YzRmOGQ5YTBmL3RhYmxlcmFuZ2U6ZDBkYjQxMmQ0YTZjNDM5YzlkZTQ5NjVjNGY4ZDlhMGZfMTMtNS0xLTEtMTg2ODIx_64272e17-0f15-4b01-a4eb-66c910125ec8"
      unitRef="number">0.028</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="iac36470e6fcb4453b97db73bbce55586_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RhYmxlOmQwZGI0MTJkNGE2YzQzOWM5ZGU0OTY1YzRmOGQ5YTBmL3RhYmxlcmFuZ2U6ZDBkYjQxMmQ0YTZjNDM5YzlkZTQ5NjVjNGY4ZDlhMGZfMTMtNy0xLTEtMTg2ODIx_0f68f6df-a7fb-40e1-be51-07169cf27c0e"
      unitRef="number">0.027</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <iart:CashFlowLesseeTableTextBlock
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RleHRyZWdpb246MzQ4MGRhZmY0OTEzNGYxNzhjZDkzNGM2ZTExNWU0NThfMjQzMg_0054dfca-75d6-46f1-9dee-2b41f0cb9535">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental cash flow information related to leases for the three months ended March 31, 2023 and 2022 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.075%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="margin-top:6pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March&#160;31, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating cash flows from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;ROU assets obtained in exchange for lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,721&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</iart:CashFlowLesseeTableTextBlock>
    <us-gaap:OperatingLeasePayments
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RhYmxlOjhkN2YyMDY4ZmZlNDRhODM5OGYzMmMzMzU1ZTFlM2ZiL3RhYmxlcmFuZ2U6OGQ3ZjIwNjhmZmU0NGE4Mzk4ZjMyYzMzNTVlMWUzZmJfMi0xLTEtMS0xODY4MjE_d6bbfbce-bf9d-442b-8fda-8f7a71cd4201"
      unitRef="usd">4319000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RhYmxlOjhkN2YyMDY4ZmZlNDRhODM5OGYzMmMzMzU1ZTFlM2ZiL3RhYmxlcmFuZ2U6OGQ3ZjIwNjhmZmU0NGE4Mzk4ZjMyYzMzNTVlMWUzZmJfMi0zLTEtMS0xODY4MjE_ee1798db-9e87-478a-84ae-56da5d02949b"
      unitRef="usd">4696000</us-gaap:OperatingLeasePayments>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RhYmxlOjhkN2YyMDY4ZmZlNDRhODM5OGYzMmMzMzU1ZTFlM2ZiL3RhYmxlcmFuZ2U6OGQ3ZjIwNjhmZmU0NGE4Mzk4ZjMyYzMzNTVlMWUzZmJfNS0xLTEtMS0xODY4MjE_4a33fc87-4dbe-4a85-9bec-25327fd7b1ed"
      unitRef="usd">1721000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RhYmxlOjhkN2YyMDY4ZmZlNDRhODM5OGYzMmMzMzU1ZTFlM2ZiL3RhYmxlcmFuZ2U6OGQ3ZjIwNjhmZmU0NGE4Mzk4ZjMyYzMzNTVlMWUzZmJfNS0zLTEtMS0xODY4MjE_cc83bdd7-6d29-48dd-874c-4cb5f803cd83"
      unitRef="usd">507000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RleHRyZWdpb246MzQ4MGRhZmY0OTEzNGYxNzhjZDkzNGM2ZTExNWU0NThfMjQ0NA_2c8e62b7-595d-476b-b46b-ad7a9626ec38">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Future minimum lease payments under operating leases at March&#160;31, 2023 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Related Parties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Third Parties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Remainder of 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,092&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21,382&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,753&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,049&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,501&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,951&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;151,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;151,452&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;255,219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;257,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less: Imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;85,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;171,702&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less: Current lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,792&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Long-term lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;156,910&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
      contextRef="i81703db4530142f4a19d6c5342dd660a_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RhYmxlOjk4NzgyNjg2MWI4NjQ5N2Y5MDkzMTJlOGRjYmNmMmNlL3RhYmxlcmFuZ2U6OTg3ODI2ODYxYjg2NDk3ZjkwOTMxMmU4ZGNiY2YyY2VfMS0xLTEtMS0xODY4MjE_2f20c0b8-38b1-4284-8f66-c3b43f5ef04b"
      unitRef="usd">222000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
      contextRef="i96ad5df3ea584444876af27fc107fa44_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RhYmxlOjk4NzgyNjg2MWI4NjQ5N2Y5MDkzMTJlOGRjYmNmMmNlL3RhYmxlcmFuZ2U6OTg3ODI2ODYxYjg2NDk3ZjkwOTMxMmU4ZGNiY2YyY2VfMS0zLTEtMS0xODY4MjE_b9aa7f28-bd42-4de8-9d40-e0006237f567"
      unitRef="usd">15870000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
      contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RhYmxlOjk4NzgyNjg2MWI4NjQ5N2Y5MDkzMTJlOGRjYmNmMmNlL3RhYmxlcmFuZ2U6OTg3ODI2ODYxYjg2NDk3ZjkwOTMxMmU4ZGNiY2YyY2VfMS01LTEtMS0xODY4MjE_b76a74c4-71e8-4ab6-bafa-ad4b2a6c9b19"
      unitRef="usd">16092000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="i81703db4530142f4a19d6c5342dd660a_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RhYmxlOjk4NzgyNjg2MWI4NjQ5N2Y5MDkzMTJlOGRjYmNmMmNlL3RhYmxlcmFuZ2U6OTg3ODI2ODYxYjg2NDk3ZjkwOTMxMmU4ZGNiY2YyY2VfMi0xLTEtMS0xODY4MjE_c5e52115-2220-4d93-9cfd-649350cedce5"
      unitRef="usd">296000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="i96ad5df3ea584444876af27fc107fa44_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RhYmxlOjk4NzgyNjg2MWI4NjQ5N2Y5MDkzMTJlOGRjYmNmMmNlL3RhYmxlcmFuZ2U6OTg3ODI2ODYxYjg2NDk3ZjkwOTMxMmU4ZGNiY2YyY2VfMi0zLTEtMS0xODY4MjE_59e0b73c-b056-4ac3-9551-cd6690cc32e8"
      unitRef="usd">21086000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RhYmxlOjk4NzgyNjg2MWI4NjQ5N2Y5MDkzMTJlOGRjYmNmMmNlL3RhYmxlcmFuZ2U6OTg3ODI2ODYxYjg2NDk3ZjkwOTMxMmU4ZGNiY2YyY2VfMi01LTEtMS0xODY4MjE_32a7b28d-0663-4776-b1a5-bfb276e4996c"
      unitRef="usd">21382000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="i81703db4530142f4a19d6c5342dd660a_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RhYmxlOjk4NzgyNjg2MWI4NjQ5N2Y5MDkzMTJlOGRjYmNmMmNlL3RhYmxlcmFuZ2U6OTg3ODI2ODYxYjg2NDk3ZjkwOTMxMmU4ZGNiY2YyY2VfMy0xLTEtMS0xODY4MjE_6285ff71-8e6c-4585-858f-d4020552a1f5"
      unitRef="usd">296000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="i96ad5df3ea584444876af27fc107fa44_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RhYmxlOjk4NzgyNjg2MWI4NjQ5N2Y5MDkzMTJlOGRjYmNmMmNlL3RhYmxlcmFuZ2U6OTg3ODI2ODYxYjg2NDk3ZjkwOTMxMmU4ZGNiY2YyY2VfMy0zLTEtMS0xODY4MjE_bf8c4c24-b140-452a-ada8-a27488fe370c"
      unitRef="usd">19753000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RhYmxlOjk4NzgyNjg2MWI4NjQ5N2Y5MDkzMTJlOGRjYmNmMmNlL3RhYmxlcmFuZ2U6OTg3ODI2ODYxYjg2NDk3ZjkwOTMxMmU4ZGNiY2YyY2VfMy01LTEtMS0xODY4MjE_4dab2bbe-0b83-41c3-a605-335d202fdc82"
      unitRef="usd">20049000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="i81703db4530142f4a19d6c5342dd660a_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RhYmxlOjk4NzgyNjg2MWI4NjQ5N2Y5MDkzMTJlOGRjYmNmMmNlL3RhYmxlcmFuZ2U6OTg3ODI2ODYxYjg2NDk3ZjkwOTMxMmU4ZGNiY2YyY2VfNC0xLTEtMS0xODY4MjE_c6864cce-1c33-48e9-b8b4-e730c3f49872"
      unitRef="usd">296000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="i96ad5df3ea584444876af27fc107fa44_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RhYmxlOjk4NzgyNjg2MWI4NjQ5N2Y5MDkzMTJlOGRjYmNmMmNlL3RhYmxlcmFuZ2U6OTg3ODI2ODYxYjg2NDk3ZjkwOTMxMmU4ZGNiY2YyY2VfNC0zLTEtMS0xODY4MjE_cc0a4ad1-7456-4a6e-8070-5eb65406a45b"
      unitRef="usd">17148000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RhYmxlOjk4NzgyNjg2MWI4NjQ5N2Y5MDkzMTJlOGRjYmNmMmNlL3RhYmxlcmFuZ2U6OTg3ODI2ODYxYjg2NDk3ZjkwOTMxMmU4ZGNiY2YyY2VfNC01LTEtMS0xODY4MjE_3614aff7-ce32-4842-9a66-d7a3435b4f80"
      unitRef="usd">17444000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="i81703db4530142f4a19d6c5342dd660a_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RhYmxlOjk4NzgyNjg2MWI4NjQ5N2Y5MDkzMTJlOGRjYmNmMmNlL3RhYmxlcmFuZ2U6OTg3ODI2ODYxYjg2NDk3ZjkwOTMxMmU4ZGNiY2YyY2VfNS0xLTEtMS0xODY4MjE_6294ef52-b651-4230-b9eb-d7aa5deb4464"
      unitRef="usd">296000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="i96ad5df3ea584444876af27fc107fa44_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RhYmxlOjk4NzgyNjg2MWI4NjQ5N2Y5MDkzMTJlOGRjYmNmMmNlL3RhYmxlcmFuZ2U6OTg3ODI2ODYxYjg2NDk3ZjkwOTMxMmU4ZGNiY2YyY2VfNS0zLTEtMS0xODY4MjE_9a0f1a2b-8c3a-4376-b553-6961b372d82f"
      unitRef="usd">16205000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RhYmxlOjk4NzgyNjg2MWI4NjQ5N2Y5MDkzMTJlOGRjYmNmMmNlL3RhYmxlcmFuZ2U6OTg3ODI2ODYxYjg2NDk3ZjkwOTMxMmU4ZGNiY2YyY2VfNS01LTEtMS0xODY4MjE_239af2c2-13e7-43b1-b5f5-f7811e2130f1"
      unitRef="usd">16501000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive
      contextRef="i81703db4530142f4a19d6c5342dd660a_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RhYmxlOjk4NzgyNjg2MWI4NjQ5N2Y5MDkzMTJlOGRjYmNmMmNlL3RhYmxlcmFuZ2U6OTg3ODI2ODYxYjg2NDk3ZjkwOTMxMmU4ZGNiY2YyY2VfNi0xLTEtMS0xODY4MjE_fbd35104-5a09-4a40-bb87-eec0ae4a6e80"
      unitRef="usd">296000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive
      contextRef="i96ad5df3ea584444876af27fc107fa44_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RhYmxlOjk4NzgyNjg2MWI4NjQ5N2Y5MDkzMTJlOGRjYmNmMmNlL3RhYmxlcmFuZ2U6OTg3ODI2ODYxYjg2NDk3ZjkwOTMxMmU4ZGNiY2YyY2VfNi0zLTEtMS0xODY4MjE_3ee78d2b-621d-43d5-99c4-6763cd3423f4"
      unitRef="usd">13951000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive
      contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RhYmxlOjk4NzgyNjg2MWI4NjQ5N2Y5MDkzMTJlOGRjYmNmMmNlL3RhYmxlcmFuZ2U6OTg3ODI2ODYxYjg2NDk3ZjkwOTMxMmU4ZGNiY2YyY2VfNi01LTEtMS0xODY4MjE_57d4a5a4-8507-4e6d-976d-253719752fba"
      unitRef="usd">14247000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="i81703db4530142f4a19d6c5342dd660a_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RhYmxlOjk4NzgyNjg2MWI4NjQ5N2Y5MDkzMTJlOGRjYmNmMmNlL3RhYmxlcmFuZ2U6OTg3ODI2ODYxYjg2NDk3ZjkwOTMxMmU4ZGNiY2YyY2VfNy0xLTEtMS0xODY4MjE_f3f6f592-0396-4c00-b3fa-89272f8fa69c"
      unitRef="usd">246000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="i96ad5df3ea584444876af27fc107fa44_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RhYmxlOjk4NzgyNjg2MWI4NjQ5N2Y5MDkzMTJlOGRjYmNmMmNlL3RhYmxlcmFuZ2U6OTg3ODI2ODYxYjg2NDk3ZjkwOTMxMmU4ZGNiY2YyY2VfNy0zLTEtMS0xODY4MjE_f750a281-73ef-4fee-9a61-7e14bf1dac04"
      unitRef="usd">151206000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RhYmxlOjk4NzgyNjg2MWI4NjQ5N2Y5MDkzMTJlOGRjYmNmMmNlL3RhYmxlcmFuZ2U6OTg3ODI2ODYxYjg2NDk3ZjkwOTMxMmU4ZGNiY2YyY2VfNy01LTEtMS0xODY4MjE_284a1307-a0f8-45c1-81ea-0db96f948a2c"
      unitRef="usd">151452000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="i81703db4530142f4a19d6c5342dd660a_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RhYmxlOjk4NzgyNjg2MWI4NjQ5N2Y5MDkzMTJlOGRjYmNmMmNlL3RhYmxlcmFuZ2U6OTg3ODI2ODYxYjg2NDk3ZjkwOTMxMmU4ZGNiY2YyY2VfOC0xLTEtMS0xODY4MjE_d045e340-f9e1-42ea-97b8-07e5d4fe6acb"
      unitRef="usd">1948000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="i96ad5df3ea584444876af27fc107fa44_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RhYmxlOjk4NzgyNjg2MWI4NjQ5N2Y5MDkzMTJlOGRjYmNmMmNlL3RhYmxlcmFuZ2U6OTg3ODI2ODYxYjg2NDk3ZjkwOTMxMmU4ZGNiY2YyY2VfOC0zLTEtMS0xODY4MjE_61f6f545-aa37-461e-849f-2d768e38074b"
      unitRef="usd">255219000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RhYmxlOjk4NzgyNjg2MWI4NjQ5N2Y5MDkzMTJlOGRjYmNmMmNlL3RhYmxlcmFuZ2U6OTg3ODI2ODYxYjg2NDk3ZjkwOTMxMmU4ZGNiY2YyY2VfOC01LTEtMS0xODY4MjE_20b815cc-f9a1-4bde-9cfc-58beb9b022d9"
      unitRef="usd">257167000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RhYmxlOjk4NzgyNjg2MWI4NjQ5N2Y5MDkzMTJlOGRjYmNmMmNlL3RhYmxlcmFuZ2U6OTg3ODI2ODYxYjg2NDk3ZjkwOTMxMmU4ZGNiY2YyY2VfOS01LTEtMS0xODY4MjE_a8bc2b77-30be-412f-b052-9d0d8d941d4c"
      unitRef="usd">85465000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RhYmxlOjk4NzgyNjg2MWI4NjQ5N2Y5MDkzMTJlOGRjYmNmMmNlL3RhYmxlcmFuZ2U6OTg3ODI2ODYxYjg2NDk3ZjkwOTMxMmU4ZGNiY2YyY2VfMTAtNS0xLTEtMTg2ODIx_846b2f9e-e2a1-4247-91b1-a650792e9a04"
      unitRef="usd">171702000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RhYmxlOjk4NzgyNjg2MWI4NjQ5N2Y5MDkzMTJlOGRjYmNmMmNlL3RhYmxlcmFuZ2U6OTg3ODI2ODYxYjg2NDk3ZjkwOTMxMmU4ZGNiY2YyY2VfMTEtNS0xLTEtMTg2ODIx_8fcb7ca7-248b-4c8a-a05e-0ad7ffe8d41c"
      unitRef="usd">14792000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RhYmxlOjk4NzgyNjg2MWI4NjQ5N2Y5MDkzMTJlOGRjYmNmMmNlL3RhYmxlcmFuZ2U6OTg3ODI2ODYxYjg2NDk3ZjkwOTMxMmU4ZGNiY2YyY2VfMTItNS0xLTEtMTg2ODIx_a46dcfe2-8f21-4cd7-900f-e7917be86f30"
      unitRef="usd">156910000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <iart:PercentOfManufacturingFacilityOwnedByCorporationWhoseShareholdersAreTrustsWhoseBeneficiariesIncludeFamilyMembersOfCompanysFormerDirector
      contextRef="ibb2818c35582446bb26bb336b6909032_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RleHRyZWdpb246MzQ4MGRhZmY0OTEzNGYxNzhjZDkzNGM2ZTExNWU0NThfMTc5OA_ff0aedaf-5959-4c56-8034-8795f5d4d784"
      unitRef="number">0.50</iart:PercentOfManufacturingFacilityOwnedByCorporationWhoseShareholdersAreTrustsWhoseBeneficiariesIncludeFamilyMembersOfCompanysFormerDirector>
    <iart:AnnualRateOfLeaseAgreement
      contextRef="ibb2818c35582446bb26bb336b6909032_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RleHRyZWdpb246MzQ4MGRhZmY0OTEzNGYxNzhjZDkzNGM2ZTExNWU0NThfMjA2MQ_84849d97-f54b-4d51-87f2-8dc3f67b3707"
      unitRef="usd">300000</iart:AnnualRateOfLeaseAgreement>
    <us-gaap:LesseeOperatingLeaseRenewalTerm
      contextRef="i01e32628066d40fc8d8037b63a6a88b0_I20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RleHRyZWdpb246MzQ4MGRhZmY0OTEzNGYxNzhjZDkzNGM2ZTExNWU0NThfMjEyMg_88ffe392-2971-4372-bd9e-9c75cb607289">P5Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <us-gaap:LesseeOperatingLeaseOptionToExtend
      contextRef="iccf8172c44f8418299899a406aff6ff5_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RleHRyZWdpb246MzQ4MGRhZmY0OTEzNGYxNzhjZDkzNGM2ZTExNWU0NThfMjQzNA_5469ad99-cfcd-47e2-bab0-25f44eac0e9d">November 1, 2029 through October 31, 2034</us-gaap:LesseeOperatingLeaseOptionToExtend>
    <us-gaap:LesseeOperatingLeaseRenewalTerm
      contextRef="idb728fa94349423cada113737d6ec277_I20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RleHRyZWdpb246MzQ4MGRhZmY0OTEzNGYxNzhjZDkzNGM2ZTExNWU0NThfMjI5Mw_6209948c-23f4-4861-b640-2d592f361f94">P5Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <us-gaap:LesseeOperatingLeaseOptionToExtend
      contextRef="i6657623349984d07affcf737d966245b_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF82Ny9mcmFnOjM0ODBkYWZmNDkxMzRmMTc4Y2Q5MzRjNmUxMTVlNDU4L3RleHRyZWdpb246MzQ4MGRhZmY0OTEzNGYxNzhjZDkzNGM2ZTExNWU0NThfMjQ0Ng_720dbea1-c38e-48c9-b555-90b406219d6d">November 1, 2034 through October 31, 2039</us-gaap:LesseeOperatingLeaseOptionToExtend>
    <us-gaap:TreasuryStockTextBlock
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83MC9mcmFnOmY1MDdjODljMGQyMTQzZWZiZGJiODNkN2VlZTlhNmIxL3RleHRyZWdpb246ZjUwN2M4OWMwZDIxNDNlZmJkYmI4M2Q3ZWVlOWE2YjFfMjA1Ng_edc7ec0c-6f4a-490a-9a57-ccac35498e6b">TREASURY STOCK&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2023 and December&#160;31, 2022, there were 8.9 million and 6.8 million shares of treasury stock outstanding with a cost of $481.7 million and $362.9 million, at a weighted average cost per share of $54.01 and $53.18, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;On January 26, 2023, the Company entered into a $150 million accelerated share repurchase ("2023 ASR") and received 2.1&#160;million shares of the Company common stock at inception of the 2023 ASR, which represented approximately 80% of the expected total shares under the 2023 ASR.  The remaining repurchase transactions are expected to be completed in the second quarter of 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;On August 16, 2022, the Inflation Reduction Act of 2022 (the &#x201c;Act&#x201d;) was signed into law. The Act implements a new excise tax of 1% on the net share repurchases made by the company effective for share repurchases performed January 1, 2023, or after. The company accrued $1.2 million regarding the excise tax in Q-1 related to the ASR mentioned above.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 12, 2022, the Company entered into a $125&#160;million accelerated share repurchase ("2022 ASR") and received 1.48&#160;million shares of Company common stock at inception of the 2022 ASR, which represented approximately 80% of the expected total shares under the 2022 ASR. On March 24, 2022, the early exercise provision under the 2022 ASR was exercised by 2022 ASR counterparty. Upon settlement on March 24, 2022, the Company received an additional 0.46&#160;million shares determined using the volume-weighted average price of the Company's common stock during the term of the 2022 ASR.&lt;/span&gt;&lt;/div&gt;</us-gaap:TreasuryStockTextBlock>
    <us-gaap:TreasuryStockCommonShares
      contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83MC9mcmFnOmY1MDdjODljMGQyMTQzZWZiZGJiODNkN2VlZTlhNmIxL3RleHRyZWdpb246ZjUwN2M4OWMwZDIxNDNlZmJkYmI4M2Q3ZWVlOWE2YjFfNTI_7d3aa839-0970-464c-b37f-6f194c62a9b1"
      unitRef="shares">8900000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonShares
      contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83MC9mcmFnOmY1MDdjODljMGQyMTQzZWZiZGJiODNkN2VlZTlhNmIxL3RleHRyZWdpb246ZjUwN2M4OWMwZDIxNDNlZmJkYmI4M2Q3ZWVlOWE2YjFfNTk_4f88eb72-d501-4e59-b98f-fb57bd9d287c"
      unitRef="shares">6800000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonValue
      contextRef="ica4b4c17b7db4efd96016f438f3fc36e_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83MC9mcmFnOmY1MDdjODljMGQyMTQzZWZiZGJiODNkN2VlZTlhNmIxL3RleHRyZWdpb246ZjUwN2M4OWMwZDIxNDNlZmJkYmI4M2Q3ZWVlOWE2YjFfMTE0_cd0d19a6-aebb-49fd-8b35-ce858767dfbd"
      unitRef="usd">481700000</us-gaap:TreasuryStockCommonValue>
    <us-gaap:TreasuryStockCommonValue
      contextRef="i05f0e25f7b574dc197a1e7d75cd2e313_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83MC9mcmFnOmY1MDdjODljMGQyMTQzZWZiZGJiODNkN2VlZTlhNmIxL3RleHRyZWdpb246ZjUwN2M4OWMwZDIxNDNlZmJkYmI4M2Q3ZWVlOWE2YjFfMTIx_01c6de6c-fd62-4aea-958a-cfbfc54e22db"
      unitRef="usd">362900000</us-gaap:TreasuryStockCommonValue>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="i142beeb645c448e9b1d164dc7254fd2f_D20230331-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83MC9mcmFnOmY1MDdjODljMGQyMTQzZWZiZGJiODNkN2VlZTlhNmIxL3RleHRyZWdpb246ZjUwN2M4OWMwZDIxNDNlZmJkYmI4M2Q3ZWVlOWE2YjFfMTY1_e3d46f3d-5038-4f1e-82c5-cdeda9603443"
      unitRef="usdPerShare">54.01</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="ia47e8fa146ee495e917d3a8854512649_D20221231-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83MC9mcmFnOmY1MDdjODljMGQyMTQzZWZiZGJiODNkN2VlZTlhNmIxL3RleHRyZWdpb246ZjUwN2M4OWMwZDIxNDNlZmJkYmI4M2Q3ZWVlOWE2YjFfMTcy_12294275-3dbb-4bd4-bd16-aa14bf917c41"
      unitRef="usdPerShare">53.18</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:AcceleratedShareRepurchasesSettlementPaymentOrReceipt
      contextRef="i05fc75ff93f849f6b97ee88d5015c23a_I20230126"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83MC9mcmFnOmY1MDdjODljMGQyMTQzZWZiZGJiODNkN2VlZTlhNmIxL3RleHRyZWdpb246ZjUwN2M4OWMwZDIxNDNlZmJkYmI4M2Q3ZWVlOWE2YjFfNTQ5NzU1ODE4NTcz_f0fdd222-79b4-4ca0-af12-96be3775c5f9"
      unitRef="usd">150000000</us-gaap:AcceleratedShareRepurchasesSettlementPaymentOrReceipt>
    <iart:AcceleratedShareRepurchasesSharesReceivedAtInception
      contextRef="i05fc75ff93f849f6b97ee88d5015c23a_I20230126"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83MC9mcmFnOmY1MDdjODljMGQyMTQzZWZiZGJiODNkN2VlZTlhNmIxL3RleHRyZWdpb246ZjUwN2M4OWMwZDIxNDNlZmJkYmI4M2Q3ZWVlOWE2YjFfNDk0NzgwMjMzMjMxNQ_84184a26-dcf1-406e-baa7-b3cb49dc2610"
      unitRef="shares">2100000</iart:AcceleratedShareRepurchasesSharesReceivedAtInception>
    <iart:AcceleratedShareRepurchasesPercentageOfExpectedTotalRepurchased
      contextRef="i6eb2c396ee604c4493e35d50b9e4ab46_D20230126-20230126"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83MC9mcmFnOmY1MDdjODljMGQyMTQzZWZiZGJiODNkN2VlZTlhNmIxL3RleHRyZWdpb246ZjUwN2M4OWMwZDIxNDNlZmJkYmI4M2Q3ZWVlOWE2YjFfNTQ5NzU1ODE4NTk0_d1995710-06a9-4538-97c6-bdcd1b64442e"
      unitRef="number">0.80</iart:AcceleratedShareRepurchasesPercentageOfExpectedTotalRepurchased>
    <iart:ExciseTaxPayableOnShareRepurchases
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83MC9mcmFnOmY1MDdjODljMGQyMTQzZWZiZGJiODNkN2VlZTlhNmIxL3RleHRyZWdpb246ZjUwN2M4OWMwZDIxNDNlZmJkYmI4M2Q3ZWVlOWE2YjFfNTQ5NzU1ODIxNTg0_61407b1f-738a-4862-a7ed-77ba1bb17422"
      unitRef="usd">1200000</iart:ExciseTaxPayableOnShareRepurchases>
    <us-gaap:AcceleratedShareRepurchasesSettlementPaymentOrReceipt
      contextRef="i4a535ba6db064ba5a22bf28443b5a825_I20220112"
      decimals="-4"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83MC9mcmFnOmY1MDdjODljMGQyMTQzZWZiZGJiODNkN2VlZTlhNmIxL3RleHRyZWdpb246ZjUwN2M4OWMwZDIxNDNlZmJkYmI4M2Q3ZWVlOWE2YjFfODM2_ed1c3977-cca2-4362-8f6b-1670eb1e4bb2"
      unitRef="usd">125000000</us-gaap:AcceleratedShareRepurchasesSettlementPaymentOrReceipt>
    <iart:AcceleratedShareRepurchasesSharesReceivedAtInception
      contextRef="i4a535ba6db064ba5a22bf28443b5a825_I20220112"
      decimals="-4"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83MC9mcmFnOmY1MDdjODljMGQyMTQzZWZiZGJiODNkN2VlZTlhNmIxL3RleHRyZWdpb246ZjUwN2M4OWMwZDIxNDNlZmJkYmI4M2Q3ZWVlOWE2YjFfODk0_bfec6390-01c3-45d3-8a6f-ee9df75890ab"
      unitRef="shares">1480000</iart:AcceleratedShareRepurchasesSharesReceivedAtInception>
    <iart:AcceleratedShareRepurchasesPercentageOfExpectedTotalRepurchased
      contextRef="ic6638393ed5a47c19e1abcc6dca5d5d6_D20220112-20220112"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83MC9mcmFnOmY1MDdjODljMGQyMTQzZWZiZGJiODNkN2VlZTlhNmIxL3RleHRyZWdpb246ZjUwN2M4OWMwZDIxNDNlZmJkYmI4M2Q3ZWVlOWE2YjFfOTkw_ccd2aeaa-3488-4b6a-9f50-00ab23529856"
      unitRef="number">0.80</iart:AcceleratedShareRepurchasesPercentageOfExpectedTotalRepurchased>
    <iart:AcceleratedShareRepurchasesAdditionalSharesReceived
      contextRef="i1e7a618c6acb4e27a31c0800c72f5336_I20220324"
      decimals="-4"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83MC9mcmFnOmY1MDdjODljMGQyMTQzZWZiZGJiODNkN2VlZTlhNmIxL3RleHRyZWdpb246ZjUwN2M4OWMwZDIxNDNlZmJkYmI4M2Q3ZWVlOWE2YjFfNTQ5NzU1ODIwMDg5_772fa5f2-d6fd-46b2-8b49-6b86fc1c46ca"
      unitRef="shares">460000</iart:AcceleratedShareRepurchasesAdditionalSharesReceived>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83My9mcmFnOmMyOTg4NzRmZTY0MTRjMjdhMDEwNWRhODBiYzRjYmQ3L3RleHRyZWdpb246YzI5ODg3NGZlNjQxNGMyN2EwMTA1ZGE4MGJjNGNiZDdfMjE2OA_42642d3b-5a33-4c9b-9885-ce565157adc4">INCOME TAXES&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides a summary of the Company's effective tax rate:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.075%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Reported tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company&#x2019;s effective income tax rates for the three months ended March 31, 2023 and 2022 w&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;ere 18.6% and 16.3%, respectively. For the three months ended March 31, 2023, the primary driver of the higher tax rate relates to a reduction of excess tax benefits from stock compensation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Changes to income tax laws and regulations, in any of the tax jurisdictions in which the Company operates, could impact the effective tax rate. Various governments, both U.S. and non-U.S., are increasingly focused on tax reform and revenue-raising legislation. Further, legislation in foreign jurisdictions may be enacted, in response to the base erosion and profit-sharing project begun by the Organization for Economic Cooperation and Development ("OECD"). The OECD recently finalized major reform of the international tax system with respect to a global minimum tax rate. Such changes in U.S. and non-U.S. jurisdictions could have an adverse effect on the Company&#x2019;s effective tax rate.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;As of March&#160;31, 2023, the Company has not provided deferred income taxes on unrepatriated earnings from foreign subsidiaries as they are deemed to be indefinitely reinvested unless there is a manner under which to remit the earnings with no material tax cost. Material taxes would primarily be attributable to foreign withholding taxes and local income taxes when such earnings are distributed. The Company will repatriate foreign earnings when there is no need for reinvestment overseas and there is no material cost to bring the earnings back to the United States. Reinvestment considerations would include future acquisitions, transactions, and capital expenditure plans.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83My9mcmFnOmMyOTg4NzRmZTY0MTRjMjdhMDEwNWRhODBiYzRjYmQ3L3RleHRyZWdpb246YzI5ODg3NGZlNjQxNGMyN2EwMTA1ZGE4MGJjNGNiZDdfMjE4Ng_ac1002a4-5cd1-4877-8381-fa1ba8cd515f">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides a summary of the Company's effective tax rate:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.075%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Reported tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83My9mcmFnOmMyOTg4NzRmZTY0MTRjMjdhMDEwNWRhODBiYzRjYmQ3L3RhYmxlOmM2ZmJlZGJmN2ExYTRjZjg5MjJlYzczZTk0Njg0MjAyL3RhYmxlcmFuZ2U6YzZmYmVkYmY3YTFhNGNmODkyMmVjNzNlOTQ2ODQyMDJfMi0xLTEtMS0xODY4MjE_c28aa383-6099-416d-98c6-3c9d51e3c8da"
      unitRef="number">0.186</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83My9mcmFnOmMyOTg4NzRmZTY0MTRjMjdhMDEwNWRhODBiYzRjYmQ3L3RhYmxlOmM2ZmJlZGJmN2ExYTRjZjg5MjJlYzczZTk0Njg0MjAyL3RhYmxlcmFuZ2U6YzZmYmVkYmY3YTFhNGNmODkyMmVjNzNlOTQ2ODQyMDJfMi0zLTEtMS0xODY4MjE_e5bb285f-9612-488c-9629-426a6c35db73"
      unitRef="number">0.163</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83My9mcmFnOmMyOTg4NzRmZTY0MTRjMjdhMDEwNWRhODBiYzRjYmQ3L3RleHRyZWdpb246YzI5ODg3NGZlNjQxNGMyN2EwMTA1ZGE4MGJjNGNiZDdfMTY1_c28aa383-6099-416d-98c6-3c9d51e3c8da"
      unitRef="number">0.186</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83My9mcmFnOmMyOTg4NzRmZTY0MTRjMjdhMDEwNWRhODBiYzRjYmQ3L3RleHRyZWdpb246YzI5ODg3NGZlNjQxNGMyN2EwMTA1ZGE4MGJjNGNiZDdfMTcy_e5bb285f-9612-488c-9629-426a6c35db73"
      unitRef="number">0.163</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83Ni9mcmFnOjg5YzNkMDI5ODdiODQzNTY5MzMwMTdhYzEwNjlhNzkwL3RleHRyZWdpb246ODljM2QwMjk4N2I4NDM1NjkzMzAxN2FjMTA2OWE3OTBfOTYx_5a1918fa-48fc-4a89-81cc-3d4dfb227e8c">NET INCOME PER SHARE&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic and diluted net income per share was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.169%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.474%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;Dollars in thousands, except per share amounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Basic net income per share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32,901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;81,871&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;83,632&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Basic net income per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Diluted net income per share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32,901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted average common shares outstanding &#x2014; Basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;81,871&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;83,632&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Effect of dilutive securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Stock options and restricted stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;452&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;644&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted average common shares for diluted earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;82,323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;84,276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Diluted net income per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Common stock of approximately 0.3 million an&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;d 0.2 million shares at March&#160;31, 2023, and 2022, res&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;pectively that are issuable through exercise of dilutive securities were not included in the computation of diluted net income per share because their effect would have been anti-dilutive.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83Ni9mcmFnOjg5YzNkMDI5ODdiODQzNTY5MzMwMTdhYzEwNjlhNzkwL3RleHRyZWdpb246ODljM2QwMjk4N2I4NDM1NjkzMzAxN2FjMTA2OWE3OTBfOTY2_c42a2ade-7e36-4077-8778-d99ffd90f4c3">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic and diluted net income per share was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.169%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.474%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;Dollars in thousands, except per share amounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Basic net income per share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32,901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;81,871&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;83,632&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Basic net income per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Diluted net income per share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32,901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted average common shares outstanding &#x2014; Basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;81,871&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;83,632&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Effect of dilutive securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Stock options and restricted stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;452&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;644&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted average common shares for diluted earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;82,323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;84,276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Diluted net income per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83Ni9mcmFnOjg5YzNkMDI5ODdiODQzNTY5MzMwMTdhYzEwNjlhNzkwL3RhYmxlOmFiZmFhN2Q3YTg4ZTRhZDliMWFlMThiYjAxZWM2MWFhL3RhYmxlcmFuZ2U6YWJmYWE3ZDdhODhlNGFkOWIxYWUxOGJiMDFlYzYxYWFfMy0xLTEtMS0xODY4MjE_5c065027-8056-4d84-8ced-d6fcc7ba5aa2"
      unitRef="usd">24226000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83Ni9mcmFnOjg5YzNkMDI5ODdiODQzNTY5MzMwMTdhYzEwNjlhNzkwL3RhYmxlOmFiZmFhN2Q3YTg4ZTRhZDliMWFlMThiYjAxZWM2MWFhL3RhYmxlcmFuZ2U6YWJmYWE3ZDdhODhlNGFkOWIxYWUxOGJiMDFlYzYxYWFfMy0zLTEtMS0xODY4MjE_57c5b32d-b333-48e8-b801-93ef93d9dfcd"
      unitRef="usd">32901000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83Ni9mcmFnOjg5YzNkMDI5ODdiODQzNTY5MzMwMTdhYzEwNjlhNzkwL3RhYmxlOmFiZmFhN2Q3YTg4ZTRhZDliMWFlMThiYjAxZWM2MWFhL3RhYmxlcmFuZ2U6YWJmYWE3ZDdhODhlNGFkOWIxYWUxOGJiMDFlYzYxYWFfNC0xLTEtMS0xODY4MjE_e214a68c-96a7-4ffd-9126-cb1e347407cd"
      unitRef="shares">81871000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83Ni9mcmFnOjg5YzNkMDI5ODdiODQzNTY5MzMwMTdhYzEwNjlhNzkwL3RhYmxlOmFiZmFhN2Q3YTg4ZTRhZDliMWFlMThiYjAxZWM2MWFhL3RhYmxlcmFuZ2U6YWJmYWE3ZDdhODhlNGFkOWIxYWUxOGJiMDFlYzYxYWFfNC0zLTEtMS0xODY4MjE_281bd6c5-e2ab-4181-8ef4-0e8767238f84"
      unitRef="shares">83632000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83Ni9mcmFnOjg5YzNkMDI5ODdiODQzNTY5MzMwMTdhYzEwNjlhNzkwL3RhYmxlOmFiZmFhN2Q3YTg4ZTRhZDliMWFlMThiYjAxZWM2MWFhL3RhYmxlcmFuZ2U6YWJmYWE3ZDdhODhlNGFkOWIxYWUxOGJiMDFlYzYxYWFfNi0xLTEtMS0xODY4MjE_974ffd0d-b916-4bbe-b1ff-5f3246780cdc"
      unitRef="usdPerShare">0.30</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83Ni9mcmFnOjg5YzNkMDI5ODdiODQzNTY5MzMwMTdhYzEwNjlhNzkwL3RhYmxlOmFiZmFhN2Q3YTg4ZTRhZDliMWFlMThiYjAxZWM2MWFhL3RhYmxlcmFuZ2U6YWJmYWE3ZDdhODhlNGFkOWIxYWUxOGJiMDFlYzYxYWFfNi0zLTEtMS0xODY4MjE_73e0f3bd-6510-461e-9de9-b53f8664dff3"
      unitRef="usdPerShare">0.39</us-gaap:EarningsPerShareBasic>
    <us-gaap:NetIncomeLoss
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83Ni9mcmFnOjg5YzNkMDI5ODdiODQzNTY5MzMwMTdhYzEwNjlhNzkwL3RhYmxlOmFiZmFhN2Q3YTg4ZTRhZDliMWFlMThiYjAxZWM2MWFhL3RhYmxlcmFuZ2U6YWJmYWE3ZDdhODhlNGFkOWIxYWUxOGJiMDFlYzYxYWFfOS0xLTEtMS0xODY4MjE_e655bcd0-0dc3-4778-9fa1-5cd823fb88a5"
      unitRef="usd">24226000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83Ni9mcmFnOjg5YzNkMDI5ODdiODQzNTY5MzMwMTdhYzEwNjlhNzkwL3RhYmxlOmFiZmFhN2Q3YTg4ZTRhZDliMWFlMThiYjAxZWM2MWFhL3RhYmxlcmFuZ2U6YWJmYWE3ZDdhODhlNGFkOWIxYWUxOGJiMDFlYzYxYWFfOS0zLTEtMS0xODY4MjE_8f9c8009-7179-4e7c-8cd3-cba930a4d6d1"
      unitRef="usd">32901000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83Ni9mcmFnOjg5YzNkMDI5ODdiODQzNTY5MzMwMTdhYzEwNjlhNzkwL3RhYmxlOmFiZmFhN2Q3YTg4ZTRhZDliMWFlMThiYjAxZWM2MWFhL3RhYmxlcmFuZ2U6YWJmYWE3ZDdhODhlNGFkOWIxYWUxOGJiMDFlYzYxYWFfMTEtMS0xLTEtMTg2ODIx_39a2c038-05b8-4dcb-ab50-cc8338210015"
      unitRef="shares">81871000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83Ni9mcmFnOjg5YzNkMDI5ODdiODQzNTY5MzMwMTdhYzEwNjlhNzkwL3RhYmxlOmFiZmFhN2Q3YTg4ZTRhZDliMWFlMThiYjAxZWM2MWFhL3RhYmxlcmFuZ2U6YWJmYWE3ZDdhODhlNGFkOWIxYWUxOGJiMDFlYzYxYWFfMTEtMy0xLTEtMTg2ODIx_5d1de476-9484-4acf-b877-e9ee2802fbdd"
      unitRef="shares">83632000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83Ni9mcmFnOjg5YzNkMDI5ODdiODQzNTY5MzMwMTdhYzEwNjlhNzkwL3RhYmxlOmFiZmFhN2Q3YTg4ZTRhZDliMWFlMThiYjAxZWM2MWFhL3RhYmxlcmFuZ2U6YWJmYWE3ZDdhODhlNGFkOWIxYWUxOGJiMDFlYzYxYWFfMTMtMS0xLTEtMTg2ODIx_868bdff7-a5e4-406b-a838-20ae2e21807e"
      unitRef="shares">452000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83Ni9mcmFnOjg5YzNkMDI5ODdiODQzNTY5MzMwMTdhYzEwNjlhNzkwL3RhYmxlOmFiZmFhN2Q3YTg4ZTRhZDliMWFlMThiYjAxZWM2MWFhL3RhYmxlcmFuZ2U6YWJmYWE3ZDdhODhlNGFkOWIxYWUxOGJiMDFlYzYxYWFfMTMtMy0xLTEtMTg2ODIx_c8284742-b3fd-40d8-90d1-bb7ce4b9f2a5"
      unitRef="shares">644000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83Ni9mcmFnOjg5YzNkMDI5ODdiODQzNTY5MzMwMTdhYzEwNjlhNzkwL3RhYmxlOmFiZmFhN2Q3YTg4ZTRhZDliMWFlMThiYjAxZWM2MWFhL3RhYmxlcmFuZ2U6YWJmYWE3ZDdhODhlNGFkOWIxYWUxOGJiMDFlYzYxYWFfMTQtMS0xLTEtMTg2ODIx_291bed3d-2543-4419-ae27-fa896cf63f3c"
      unitRef="shares">82323000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83Ni9mcmFnOjg5YzNkMDI5ODdiODQzNTY5MzMwMTdhYzEwNjlhNzkwL3RhYmxlOmFiZmFhN2Q3YTg4ZTRhZDliMWFlMThiYjAxZWM2MWFhL3RhYmxlcmFuZ2U6YWJmYWE3ZDdhODhlNGFkOWIxYWUxOGJiMDFlYzYxYWFfMTQtMy0xLTEtMTg2ODIx_9136cde3-2af8-44df-873c-1d3f39e86842"
      unitRef="shares">84276000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83Ni9mcmFnOjg5YzNkMDI5ODdiODQzNTY5MzMwMTdhYzEwNjlhNzkwL3RhYmxlOmFiZmFhN2Q3YTg4ZTRhZDliMWFlMThiYjAxZWM2MWFhL3RhYmxlcmFuZ2U6YWJmYWE3ZDdhODhlNGFkOWIxYWUxOGJiMDFlYzYxYWFfMTYtMS0xLTEtMTg2ODIx_9e60f02f-9478-4395-bf7c-333ca5915460"
      unitRef="usdPerShare">0.29</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83Ni9mcmFnOjg5YzNkMDI5ODdiODQzNTY5MzMwMTdhYzEwNjlhNzkwL3RhYmxlOmFiZmFhN2Q3YTg4ZTRhZDliMWFlMThiYjAxZWM2MWFhL3RhYmxlcmFuZ2U6YWJmYWE3ZDdhODhlNGFkOWIxYWUxOGJiMDFlYzYxYWFfMTYtMy0xLTEtMTg2ODIx_c92e6e64-8a3e-432d-92ef-6bed697e2e43"
      unitRef="usdPerShare">0.39</us-gaap:EarningsPerShareDiluted>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i142beeb645c448e9b1d164dc7254fd2f_D20230331-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83Ni9mcmFnOjg5YzNkMDI5ODdiODQzNTY5MzMwMTdhYzEwNjlhNzkwL3RleHRyZWdpb246ODljM2QwMjk4N2I4NDM1NjkzMzAxN2FjMTA2OWE3OTBfMTE3_4ad27a12-8b15-4103-8482-b388ddc03b03"
      unitRef="shares">300000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i646bea5fed00426299f8098e7755c18a_D20220331-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83Ni9mcmFnOjg5YzNkMDI5ODdiODQzNTY5MzMwMTdhYzEwNjlhNzkwL3RleHRyZWdpb246ODljM2QwMjk4N2I4NDM1NjkzMzAxN2FjMTA2OWE3OTBfMTI0_97e60589-3b23-42f9-9f00-5bdad57db242"
      unitRef="shares">200000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:ComprehensiveIncomeNoteTextBlock
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83OS9mcmFnOmFiMjU2ZTA0OTdmYTRiMjU5MmEwMTE1ZTE1MTY1YzA0L3RleHRyZWdpb246YWIyNTZlMDQ5N2ZhNGIyNTkyYTAxMTVlMTUxNjVjMDRfNDEz_adae3c85-5df9-40a5-86b0-494095d33a02">ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Comprehensive income for the three months ended March 31, 2023 and 2022 was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.122%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32,901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,076&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,683)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Change in unrealized loss/(gain) on derivatives, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7,377)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29,822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Pension liability adjustment, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Comprehensive income, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21,028&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;57,031&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in accumulated other comprehensive income by component between December&#160;31, 2022 and March&#160;31, 2023 are presented in the table below, net of tax:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.747%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.287%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gains and Losses on Derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Defined Benefit Pension Items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign Currency Items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at January 1, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,817&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(21,874)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other comprehensive gain (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,754)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,076&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,575)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 21.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less: Amounts reclassified from accumulated other comprehensive income, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 21.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net current-period other comprehensive gain (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7,377)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,076&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,198)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at March&#160;31, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(17,798)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,067&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three months ended March 31, 2023, the Company reclassified a gain of $4.3 million and a loss of $2.7 million from accumulated other comprehensive income to other income, net and interest income, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:ComprehensiveIncomeNoteTextBlock>
    <us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83OS9mcmFnOmFiMjU2ZTA0OTdmYTRiMjU5MmEwMTE1ZTE1MTY1YzA0L3RleHRyZWdpb246YWIyNTZlMDQ5N2ZhNGIyNTkyYTAxMTVlMTUxNjVjMDRfNDE1_98c28588-c1e8-4973-b65b-7563da2a4de1">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Comprehensive income for the three months ended March 31, 2023 and 2022 was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.122%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32,901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,076&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,683)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Change in unrealized loss/(gain) on derivatives, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7,377)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29,822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Pension liability adjustment, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Comprehensive income, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21,028&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;57,031&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83OS9mcmFnOmFiMjU2ZTA0OTdmYTRiMjU5MmEwMTE1ZTE1MTY1YzA0L3RhYmxlOjMxYWVmZmJkNDIwNDRkMGNiNmE4ODg0MmI1YzNkMDAyL3RhYmxlcmFuZ2U6MzFhZWZmYmQ0MjA0NGQwY2I2YTg4ODQyYjVjM2QwMDJfMi0xLTEtMS0xODY4MjE_bdb73f57-cd2b-48a9-a402-d7f0cba3f18c"
      unitRef="usd">24226000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83OS9mcmFnOmFiMjU2ZTA0OTdmYTRiMjU5MmEwMTE1ZTE1MTY1YzA0L3RhYmxlOjMxYWVmZmJkNDIwNDRkMGNiNmE4ODg0MmI1YzNkMDAyL3RhYmxlcmFuZ2U6MzFhZWZmYmQ0MjA0NGQwY2I2YTg4ODQyYjVjM2QwMDJfMi0zLTEtMS0xODY4MjE_0682ec87-f039-491b-920d-3aba1b1e136b"
      unitRef="usd">32901000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83OS9mcmFnOmFiMjU2ZTA0OTdmYTRiMjU5MmEwMTE1ZTE1MTY1YzA0L3RhYmxlOjMxYWVmZmJkNDIwNDRkMGNiNmE4ODg0MmI1YzNkMDAyL3RhYmxlcmFuZ2U6MzFhZWZmYmQ0MjA0NGQwY2I2YTg4ODQyYjVjM2QwMDJfMy0xLTEtMS0xODY4MjE_c8fee2ed-da4d-4064-acc8-19f397efa9b9"
      unitRef="usd">4076000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83OS9mcmFnOmFiMjU2ZTA0OTdmYTRiMjU5MmEwMTE1ZTE1MTY1YzA0L3RhYmxlOjMxYWVmZmJkNDIwNDRkMGNiNmE4ODg0MmI1YzNkMDAyL3RhYmxlcmFuZ2U6MzFhZWZmYmQ0MjA0NGQwY2I2YTg4ODQyYjVjM2QwMDJfMy0zLTEtMS0xODY4MjE_35050aa3-307a-4f23-908b-3abbabc8fa3f"
      unitRef="usd">-5683000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83OS9mcmFnOmFiMjU2ZTA0OTdmYTRiMjU5MmEwMTE1ZTE1MTY1YzA0L3RhYmxlOjMxYWVmZmJkNDIwNDRkMGNiNmE4ODg0MmI1YzNkMDAyL3RhYmxlcmFuZ2U6MzFhZWZmYmQ0MjA0NGQwY2I2YTg4ODQyYjVjM2QwMDJfNC0xLTEtMS0xODY4MjE_e9dfa56a-d42d-49ee-8227-9cb094602195"
      unitRef="usd">-7377000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
      contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83OS9mcmFnOmFiMjU2ZTA0OTdmYTRiMjU5MmEwMTE1ZTE1MTY1YzA0L3RhYmxlOjMxYWVmZmJkNDIwNDRkMGNiNmE4ODg0MmI1YzNkMDAyL3RhYmxlcmFuZ2U6MzFhZWZmYmQ0MjA0NGQwY2I2YTg4ODQyYjVjM2QwMDJfNC0zLTEtMS0xODY4MjE_43b9d40f-8077-4c64-b1f9-83ca6a380d15"
      unitRef="usd">29822000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83OS9mcmFnOmFiMjU2ZTA0OTdmYTRiMjU5MmEwMTE1ZTE1MTY1YzA0L3RhYmxlOjMxYWVmZmJkNDIwNDRkMGNiNmE4ODg0MmI1YzNkMDAyL3RhYmxlcmFuZ2U6MzFhZWZmYmQ0MjA0NGQwY2I2YTg4ODQyYjVjM2QwMDJfNS0xLTEtMS0xODY4MjE_92b64f0e-36a9-4b79-9dc3-e263eb36a2a7"
      unitRef="usd">-103000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83OS9mcmFnOmFiMjU2ZTA0OTdmYTRiMjU5MmEwMTE1ZTE1MTY1YzA0L3RhYmxlOjMxYWVmZmJkNDIwNDRkMGNiNmE4ODg0MmI1YzNkMDAyL3RhYmxlcmFuZ2U6MzFhZWZmYmQ0MjA0NGQwY2I2YTg4ODQyYjVjM2QwMDJfNS0zLTEtMS0xODY4MjE_feeabd06-32e3-4d1a-9ba3-0602b5523541"
      unitRef="usd">9000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83OS9mcmFnOmFiMjU2ZTA0OTdmYTRiMjU5MmEwMTE1ZTE1MTY1YzA0L3RhYmxlOjMxYWVmZmJkNDIwNDRkMGNiNmE4ODg0MmI1YzNkMDAyL3RhYmxlcmFuZ2U6MzFhZWZmYmQ0MjA0NGQwY2I2YTg4ODQyYjVjM2QwMDJfNi0xLTEtMS0xODY4MjE_dc463c9c-f774-4a20-96f1-ab55f0f14c72"
      unitRef="usd">21028000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83OS9mcmFnOmFiMjU2ZTA0OTdmYTRiMjU5MmEwMTE1ZTE1MTY1YzA0L3RhYmxlOjMxYWVmZmJkNDIwNDRkMGNiNmE4ODg0MmI1YzNkMDAyL3RhYmxlcmFuZ2U6MzFhZWZmYmQ0MjA0NGQwY2I2YTg4ODQyYjVjM2QwMDJfNi0zLTEtMS0xODY4MjE_6fec9c23-2c67-4d80-9e3a-90232a89ded3"
      unitRef="usd">57031000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83OS9mcmFnOmFiMjU2ZTA0OTdmYTRiMjU5MmEwMTE1ZTE1MTY1YzA0L3RleHRyZWdpb246YWIyNTZlMDQ5N2ZhNGIyNTkyYTAxMTVlMTUxNjVjMDRfMzkz_f2f9c52b-6b0e-43a0-b1e3-8681edbaaf5e">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in accumulated other comprehensive income by component between December&#160;31, 2022 and March&#160;31, 2023 are presented in the table below, net of tax:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.747%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.287%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gains and Losses on Derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Defined Benefit Pension Items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign Currency Items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at January 1, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,817&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(21,874)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other comprehensive gain (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,754)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,076&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,575)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 21.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less: Amounts reclassified from accumulated other comprehensive income, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 21.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net current-period other comprehensive gain (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7,377)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,076&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,198)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at March&#160;31, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(17,798)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,067&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:StockholdersEquity
      contextRef="id48bc317ce8e43efa6fa6cdb7b8520e9_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83OS9mcmFnOmFiMjU2ZTA0OTdmYTRiMjU5MmEwMTE1ZTE1MTY1YzA0L3RhYmxlOjJlMWNiM2FiMGVlMjQzMTBhMzJmNzFiMzAyZjM4NzdhL3RhYmxlcmFuZ2U6MmUxY2IzYWIwZWUyNDMxMGEzMmY3MWIzMDJmMzg3N2FfMS0yLTEtMS0xODY4MjE_51106af8-5ad0-4fe9-bc02-b909c926280a"
      unitRef="usd">22817000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i290c54e5ab7c451886f952e89f0d495a_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83OS9mcmFnOmFiMjU2ZTA0OTdmYTRiMjU5MmEwMTE1ZTE1MTY1YzA0L3RhYmxlOjJlMWNiM2FiMGVlMjQzMTBhMzJmNzFiMzAyZjM4NzdhL3RhYmxlcmFuZ2U6MmUxY2IzYWIwZWUyNDMxMGEzMmY3MWIzMDJmMzg3N2FfMS00LTEtMS0xODY4MjE_18c90081-0453-4190-9a33-c06db0437980"
      unitRef="usd">9322000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iec175f17c95341d18708296b15afd58d_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83OS9mcmFnOmFiMjU2ZTA0OTdmYTRiMjU5MmEwMTE1ZTE1MTY1YzA0L3RhYmxlOjJlMWNiM2FiMGVlMjQzMTBhMzJmNzFiMzAyZjM4NzdhL3RhYmxlcmFuZ2U6MmUxY2IzYWIwZWUyNDMxMGEzMmY3MWIzMDJmMzg3N2FfMS02LTEtMS0xODY4MjE_c3989bd2-65e2-4f5c-9bb9-ea596246aa14"
      unitRef="usd">-21874000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia54b6095ce1949b680fbf6e3777f0cd1_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83OS9mcmFnOmFiMjU2ZTA0OTdmYTRiMjU5MmEwMTE1ZTE1MTY1YzA0L3RhYmxlOjJlMWNiM2FiMGVlMjQzMTBhMzJmNzFiMzAyZjM4NzdhL3RhYmxlcmFuZ2U6MmUxY2IzYWIwZWUyNDMxMGEzMmY3MWIzMDJmMzg3N2FfMS04LTEtMS0xODY4MjE_32dfc6b7-dbc0-47ff-b193-6fbbf92f9542"
      unitRef="usd">10265000</us-gaap:StockholdersEquity>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent
      contextRef="if10648f7e149447883c792b44180c76c_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83OS9mcmFnOmFiMjU2ZTA0OTdmYTRiMjU5MmEwMTE1ZTE1MTY1YzA0L3RhYmxlOjJlMWNiM2FiMGVlMjQzMTBhMzJmNzFiMzAyZjM4NzdhL3RhYmxlcmFuZ2U6MmUxY2IzYWIwZWUyNDMxMGEzMmY3MWIzMDJmMzg3N2FfMi0yLTEtMS0xODY4MjE_d1a2b1e3-6d1a-4d68-97d2-123021ef55d8"
      unitRef="usd">-5754000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent
      contextRef="i24ac1f0514474ac28f44980dc2f162ce_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83OS9mcmFnOmFiMjU2ZTA0OTdmYTRiMjU5MmEwMTE1ZTE1MTY1YzA0L3RhYmxlOjJlMWNiM2FiMGVlMjQzMTBhMzJmNzFiMzAyZjM4NzdhL3RhYmxlcmFuZ2U6MmUxY2IzYWIwZWUyNDMxMGEzMmY3MWIzMDJmMzg3N2FfMi00LTEtMS0xODY4MjE_0c3972a2-6f47-4ba1-91bd-cfacf9f451b7"
      unitRef="usd">103000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent
      contextRef="i9130414215c54f04be9fcc0ddd7ed89c_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83OS9mcmFnOmFiMjU2ZTA0OTdmYTRiMjU5MmEwMTE1ZTE1MTY1YzA0L3RhYmxlOjJlMWNiM2FiMGVlMjQzMTBhMzJmNzFiMzAyZjM4NzdhL3RhYmxlcmFuZ2U6MmUxY2IzYWIwZWUyNDMxMGEzMmY3MWIzMDJmMzg3N2FfMi02LTEtMS0xODY4MjE_b40abab9-00b2-43e6-8495-21ce7dbd0621"
      unitRef="usd">4076000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83OS9mcmFnOmFiMjU2ZTA0OTdmYTRiMjU5MmEwMTE1ZTE1MTY1YzA0L3RhYmxlOjJlMWNiM2FiMGVlMjQzMTBhMzJmNzFiMzAyZjM4NzdhL3RhYmxlcmFuZ2U6MmUxY2IzYWIwZWUyNDMxMGEzMmY3MWIzMDJmMzg3N2FfMi04LTEtMS0xODY4MjE_5cc92d2c-c531-4a92-83b6-525ee3ed5ae8"
      unitRef="usd">-1575000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="if10648f7e149447883c792b44180c76c_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83OS9mcmFnOmFiMjU2ZTA0OTdmYTRiMjU5MmEwMTE1ZTE1MTY1YzA0L3RhYmxlOjJlMWNiM2FiMGVlMjQzMTBhMzJmNzFiMzAyZjM4NzdhL3RhYmxlcmFuZ2U6MmUxY2IzYWIwZWUyNDMxMGEzMmY3MWIzMDJmMzg3N2FfMy0yLTEtMS0xODY4MjE_578ce76f-ba17-47b0-91cc-1a946e77c119"
      unitRef="usd">1623000</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="i24ac1f0514474ac28f44980dc2f162ce_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83OS9mcmFnOmFiMjU2ZTA0OTdmYTRiMjU5MmEwMTE1ZTE1MTY1YzA0L3RhYmxlOjJlMWNiM2FiMGVlMjQzMTBhMzJmNzFiMzAyZjM4NzdhL3RhYmxlcmFuZ2U6MmUxY2IzYWIwZWUyNDMxMGEzMmY3MWIzMDJmMzg3N2FfMy00LTEtMS0xODY4MjE_e2f37ba8-f34b-454f-93f7-5e10a767c41c"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="i9130414215c54f04be9fcc0ddd7ed89c_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83OS9mcmFnOmFiMjU2ZTA0OTdmYTRiMjU5MmEwMTE1ZTE1MTY1YzA0L3RhYmxlOjJlMWNiM2FiMGVlMjQzMTBhMzJmNzFiMzAyZjM4NzdhL3RhYmxlcmFuZ2U6MmUxY2IzYWIwZWUyNDMxMGEzMmY3MWIzMDJmMzg3N2FfMy02LTEtMS0xODY4MjE_7adde660-3c28-4454-ac3f-5636681308e8"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83OS9mcmFnOmFiMjU2ZTA0OTdmYTRiMjU5MmEwMTE1ZTE1MTY1YzA0L3RhYmxlOjJlMWNiM2FiMGVlMjQzMTBhMzJmNzFiMzAyZjM4NzdhL3RhYmxlcmFuZ2U6MmUxY2IzYWIwZWUyNDMxMGEzMmY3MWIzMDJmMzg3N2FfMy04LTEtMS0xODY4MjE_9e39eff4-33fd-4749-a3e7-0c1eed440895"
      unitRef="usd">1623000</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="if10648f7e149447883c792b44180c76c_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83OS9mcmFnOmFiMjU2ZTA0OTdmYTRiMjU5MmEwMTE1ZTE1MTY1YzA0L3RhYmxlOjJlMWNiM2FiMGVlMjQzMTBhMzJmNzFiMzAyZjM4NzdhL3RhYmxlcmFuZ2U6MmUxY2IzYWIwZWUyNDMxMGEzMmY3MWIzMDJmMzg3N2FfNC0yLTEtMS0xODY4MjE_152385fe-942c-4826-9000-76f258f3b06f"
      unitRef="usd">-7377000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i24ac1f0514474ac28f44980dc2f162ce_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83OS9mcmFnOmFiMjU2ZTA0OTdmYTRiMjU5MmEwMTE1ZTE1MTY1YzA0L3RhYmxlOjJlMWNiM2FiMGVlMjQzMTBhMzJmNzFiMzAyZjM4NzdhL3RhYmxlcmFuZ2U6MmUxY2IzYWIwZWUyNDMxMGEzMmY3MWIzMDJmMzg3N2FfNC00LTEtMS0xODY4MjE_acff5440-a07c-4d87-b38f-6ab2e1347b50"
      unitRef="usd">103000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i9130414215c54f04be9fcc0ddd7ed89c_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83OS9mcmFnOmFiMjU2ZTA0OTdmYTRiMjU5MmEwMTE1ZTE1MTY1YzA0L3RhYmxlOjJlMWNiM2FiMGVlMjQzMTBhMzJmNzFiMzAyZjM4NzdhL3RhYmxlcmFuZ2U6MmUxY2IzYWIwZWUyNDMxMGEzMmY3MWIzMDJmMzg3N2FfNC02LTEtMS0xODY4MjE_81425d53-0977-417f-83f6-3006aa809b18"
      unitRef="usd">4076000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83OS9mcmFnOmFiMjU2ZTA0OTdmYTRiMjU5MmEwMTE1ZTE1MTY1YzA0L3RhYmxlOjJlMWNiM2FiMGVlMjQzMTBhMzJmNzFiMzAyZjM4NzdhL3RhYmxlcmFuZ2U6MmUxY2IzYWIwZWUyNDMxMGEzMmY3MWIzMDJmMzg3N2FfNC04LTEtMS0xODY4MjE_0d1914df-022e-4452-b713-5fc9663bef37"
      unitRef="usd">-3198000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockholdersEquity
      contextRef="i13b04fba956e41bc8127fdc101213375_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83OS9mcmFnOmFiMjU2ZTA0OTdmYTRiMjU5MmEwMTE1ZTE1MTY1YzA0L3RhYmxlOjJlMWNiM2FiMGVlMjQzMTBhMzJmNzFiMzAyZjM4NzdhL3RhYmxlcmFuZ2U6MmUxY2IzYWIwZWUyNDMxMGEzMmY3MWIzMDJmMzg3N2FfNS0yLTEtMS0xODY4MjE_3a9958b1-ceab-4961-a74c-27edde27f33f"
      unitRef="usd">15440000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i805ec6ae450148b0aa6ec4a436b8b09e_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83OS9mcmFnOmFiMjU2ZTA0OTdmYTRiMjU5MmEwMTE1ZTE1MTY1YzA0L3RhYmxlOjJlMWNiM2FiMGVlMjQzMTBhMzJmNzFiMzAyZjM4NzdhL3RhYmxlcmFuZ2U6MmUxY2IzYWIwZWUyNDMxMGEzMmY3MWIzMDJmMzg3N2FfNS00LTEtMS0xODY4MjE_4dca5ff0-c2bc-401d-ade0-a5e1b393e778"
      unitRef="usd">9425000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i6afed391e44e4f1f965479a68ca6dcb5_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83OS9mcmFnOmFiMjU2ZTA0OTdmYTRiMjU5MmEwMTE1ZTE1MTY1YzA0L3RhYmxlOjJlMWNiM2FiMGVlMjQzMTBhMzJmNzFiMzAyZjM4NzdhL3RhYmxlcmFuZ2U6MmUxY2IzYWIwZWUyNDMxMGEzMmY3MWIzMDJmMzg3N2FfNS02LTEtMS0xODY4MjE_59030dd8-52fb-41eb-811d-f9108937b2ef"
      unitRef="usd">-17798000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ied07d9963f9d439fb1ad815102c390d4_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83OS9mcmFnOmFiMjU2ZTA0OTdmYTRiMjU5MmEwMTE1ZTE1MTY1YzA0L3RhYmxlOjJlMWNiM2FiMGVlMjQzMTBhMzJmNzFiMzAyZjM4NzdhL3RhYmxlcmFuZ2U6MmUxY2IzYWIwZWUyNDMxMGEzMmY3MWIzMDJmMzg3N2FfNS04LTEtMS0xODY4MjE_c4215315-1970-4bc7-8d84-59df88f1c6f1"
      unitRef="usd">7067000</us-gaap:StockholdersEquity>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="icf3a5e50a53a4b55a3ef05b821846b94_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83OS9mcmFnOmFiMjU2ZTA0OTdmYTRiMjU5MmEwMTE1ZTE1MTY1YzA0L3RleHRyZWdpb246YWIyNTZlMDQ5N2ZhNGIyNTkyYTAxMTVlMTUxNjVjMDRfMjc3_03ccb4eb-0ad6-412d-9704-2227554f8af3"
      unitRef="usd">4300000</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="if45e5d60245d47f7835ea2adf65836fa_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF83OS9mcmFnOmFiMjU2ZTA0OTdmYTRiMjU5MmEwMTE1ZTE1MTY1YzA0L3RleHRyZWdpb246YWIyNTZlMDQ5N2ZhNGIyNTkyYTAxMTVlMTUxNjVjMDRfMjk0_db2cf03b-e06c-4f7b-afd5-85d23e4ffcb1"
      unitRef="usd">-2700000</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84Mi9mcmFnOjIwZmFlOTU4ZjI1MTQ4NGRhOWY1YjY1YWM4NDcwM2JkL3RleHRyZWdpb246MjBmYWU5NThmMjUxNDg0ZGE5ZjViNjVhYzg0NzAzYmRfMjQ3Mg_8d118a4f-6fd6-4a42-99a1-1fb654f6c015">SEGMENT AND GEOGRAPHIC INFORMATION&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company internally manages&#160;two&#160;global reportable segments and reports the results of its businesses to its chief operating decision maker. The&#160;two&#160;reportable segments and their activities are described below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;The Codman Specialty Surgical segment includes (i) the Neurosurgery business, which sells a full line of products for neurosurgery and neuro critical care such as tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment and (ii) the Instruments business, which sells more than 40,000 instrument patterns and surgical and lighting products to hospitals, surgery centers, dental, podiatry, and veterinary offices.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.15pt"&gt;The TT segment includes such offerings as skin and wound repair, plastics &amp;amp; surgical reconstruction products, bone grafts, and nerve and tendon repair products.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Corporate and other category includes (i) various executive, finance, human resource, information systems and legal functions, (ii) brand management, and (iii) share-based compensation costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The operating results of the various reportable segments as presented are not comparable to one another because (i)&#160;certain operating segments are more dependent than others on corporate functions for unallocated general and administrative and/or operational manufacturing functions, and (ii)&#160;the Company does not allocate certain manufacturing costs and general and administrative costs to the operating segment results. Net sales and profit by each reportable segment for the three months ended March&#160;31, 2023 and 2022 are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.859%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.128%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.129%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%"&gt;Segment Net Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Codman Specialty Surgical&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;248,136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;247,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Tissue Technologies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;132,710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;129,330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;380,846&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;376,638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%"&gt;Segment Profit &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Codman Specialty Surgical&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;110,933&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;110,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Tissue Technologies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52,281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;53,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Segment profit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;163,214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;164,053&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,108)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,894)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Corporate and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(123,724)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(113,995)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;36,382&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46,164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company does not allocate any assets to the reportable segments. No asset information is reported to the chief operating decision maker and disclosed in the financial information for each segment. The Company attributes revenues to geographic areas based on the location of the customer. Total revenue by major geographic area consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.274%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.422%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;271,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;263,351&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41,064&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;43,744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Asia Pacific&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;50,473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;47,717&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Rest of World&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total Revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;380,846&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;376,638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84Mi9mcmFnOjIwZmFlOTU4ZjI1MTQ4NGRhOWY1YjY1YWM4NDcwM2JkL3RleHRyZWdpb246MjBmYWU5NThmMjUxNDg0ZGE5ZjViNjVhYzg0NzAzYmRfNzU_23e59eac-ac3e-4e4e-853d-93d1860389f5"
      unitRef="segment">2</us-gaap:NumberOfReportableSegments>
    <us-gaap:NumberOfReportableSegments
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84Mi9mcmFnOjIwZmFlOTU4ZjI1MTQ4NGRhOWY1YjY1YWM4NDcwM2JkL3RleHRyZWdpb246MjBmYWU5NThmMjUxNDg0ZGE5ZjViNjVhYzg0NzAzYmRfMTkw_41735c44-41e4-44e5-990c-f37176f5ee1d"
      unitRef="segment">2</us-gaap:NumberOfReportableSegments>
    <iart:SegmentReportingInformationNumberOfProductsOffered
      contextRef="ifd59456ea9aa4f04b19628e881f264f6_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84Mi9mcmFnOjIwZmFlOTU4ZjI1MTQ4NGRhOWY1YjY1YWM4NDcwM2JkL3RleHRyZWdpb246MjBmYWU5NThmMjUxNDg0ZGE5ZjViNjVhYzg0NzAzYmRfNzQ0_3647e991-e7c3-469e-876d-93f2ac84569a"
      unitRef="product">40000</iart:SegmentReportingInformationNumberOfProductsOffered>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84Mi9mcmFnOjIwZmFlOTU4ZjI1MTQ4NGRhOWY1YjY1YWM4NDcwM2JkL3RleHRyZWdpb246MjBmYWU5NThmMjUxNDg0ZGE5ZjViNjVhYzg0NzAzYmRfMjQ2OA_b4e87798-556d-41df-96d6-c4fa11582248">Net sales and profit by each reportable segment for the three months ended March&#160;31, 2023 and 2022 are as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.859%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.128%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.129%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%"&gt;Segment Net Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Codman Specialty Surgical&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;248,136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;247,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Tissue Technologies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;132,710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;129,330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;380,846&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;376,638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%"&gt;Segment Profit &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Codman Specialty Surgical&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;110,933&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;110,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Tissue Technologies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52,281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;53,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Segment profit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;163,214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;164,053&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,108)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,894)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Corporate and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(123,724)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(113,995)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;36,382&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46,164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;Total revenue by major geographic area consisted of the following:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.274%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.422%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;271,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;263,351&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41,064&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;43,744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Asia Pacific&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;50,473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;47,717&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Rest of World&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total Revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;380,846&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;376,638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifd59456ea9aa4f04b19628e881f264f6_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84Mi9mcmFnOjIwZmFlOTU4ZjI1MTQ4NGRhOWY1YjY1YWM4NDcwM2JkL3RhYmxlOmE4NmYxMDZkMmQ2MjQ2Y2Y4MjJiY2M5ZmQ5MzExYTY0L3RhYmxlcmFuZ2U6YTg2ZjEwNmQyZDYyNDZjZjgyMmJjYzlmZDkzMTFhNjRfMy0xLTEtMS0xODY4MjE_d8080fb1-e443-4930-a9c6-c6c718ccde1d"
      unitRef="usd">248136000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6524a64fd30c42eca0a31257f157eeec_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84Mi9mcmFnOjIwZmFlOTU4ZjI1MTQ4NGRhOWY1YjY1YWM4NDcwM2JkL3RhYmxlOmE4NmYxMDZkMmQ2MjQ2Y2Y4MjJiY2M5ZmQ5MzExYTY0L3RhYmxlcmFuZ2U6YTg2ZjEwNmQyZDYyNDZjZjgyMmJjYzlmZDkzMTFhNjRfMy0zLTEtMS0xODY4MjE_070940e3-54e8-4ce1-b221-c6472aeedf4b"
      unitRef="usd">247308000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibcfddd0c2c684ea4acbf2b9ae4cd8527_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84Mi9mcmFnOjIwZmFlOTU4ZjI1MTQ4NGRhOWY1YjY1YWM4NDcwM2JkL3RhYmxlOmE4NmYxMDZkMmQ2MjQ2Y2Y4MjJiY2M5ZmQ5MzExYTY0L3RhYmxlcmFuZ2U6YTg2ZjEwNmQyZDYyNDZjZjgyMmJjYzlmZDkzMTFhNjRfNC0xLTEtMS0xODY4MjE_cbfd9dd7-fa66-4c78-9c0b-a5294628ae9d"
      unitRef="usd">132710000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i842208849e5d47b588209f3a26f3a724_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84Mi9mcmFnOjIwZmFlOTU4ZjI1MTQ4NGRhOWY1YjY1YWM4NDcwM2JkL3RhYmxlOmE4NmYxMDZkMmQ2MjQ2Y2Y4MjJiY2M5ZmQ5MzExYTY0L3RhYmxlcmFuZ2U6YTg2ZjEwNmQyZDYyNDZjZjgyMmJjYzlmZDkzMTFhNjRfNC0zLTEtMS0xODY4MjE_866b5287-e7b4-4967-8133-daf47c78c540"
      unitRef="usd">129330000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84Mi9mcmFnOjIwZmFlOTU4ZjI1MTQ4NGRhOWY1YjY1YWM4NDcwM2JkL3RhYmxlOmE4NmYxMDZkMmQ2MjQ2Y2Y4MjJiY2M5ZmQ5MzExYTY0L3RhYmxlcmFuZ2U6YTg2ZjEwNmQyZDYyNDZjZjgyMmJjYzlmZDkzMTFhNjRfNS0xLTEtMS0xODY4MjE_dc6fe96c-c11e-48be-aace-6231dc9930ba"
      unitRef="usd">380846000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84Mi9mcmFnOjIwZmFlOTU4ZjI1MTQ4NGRhOWY1YjY1YWM4NDcwM2JkL3RhYmxlOmE4NmYxMDZkMmQ2MjQ2Y2Y4MjJiY2M5ZmQ5MzExYTY0L3RhYmxlcmFuZ2U6YTg2ZjEwNmQyZDYyNDZjZjgyMmJjYzlmZDkzMTFhNjRfNS0zLTEtMS0xODY4MjE_dfde4fd0-baee-4968-8216-254defb8602e"
      unitRef="usd">376638000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:OperatingIncomeLoss
      contextRef="i9189a78d31fb4c448c4078f016f511fb_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84Mi9mcmFnOjIwZmFlOTU4ZjI1MTQ4NGRhOWY1YjY1YWM4NDcwM2JkL3RhYmxlOmE4NmYxMDZkMmQ2MjQ2Y2Y4MjJiY2M5ZmQ5MzExYTY0L3RhYmxlcmFuZ2U6YTg2ZjEwNmQyZDYyNDZjZjgyMmJjYzlmZDkzMTFhNjRfNy0xLTEtMS0xODY4MjE_2c1d384c-ba45-4b7b-9782-b2149f9cd8a2"
      unitRef="usd">110933000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i21203583e6274aefacecda4e30af7977_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84Mi9mcmFnOjIwZmFlOTU4ZjI1MTQ4NGRhOWY1YjY1YWM4NDcwM2JkL3RhYmxlOmE4NmYxMDZkMmQ2MjQ2Y2Y4MjJiY2M5ZmQ5MzExYTY0L3RhYmxlcmFuZ2U6YTg2ZjEwNmQyZDYyNDZjZjgyMmJjYzlmZDkzMTFhNjRfNy0zLTEtMS0xODY4MjE_ca5a4c21-0931-4c0a-939f-cfbb60fd846f"
      unitRef="usd">110160000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ibb29c4fb3257468aba668e88d86534f1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84Mi9mcmFnOjIwZmFlOTU4ZjI1MTQ4NGRhOWY1YjY1YWM4NDcwM2JkL3RhYmxlOmE4NmYxMDZkMmQ2MjQ2Y2Y4MjJiY2M5ZmQ5MzExYTY0L3RhYmxlcmFuZ2U6YTg2ZjEwNmQyZDYyNDZjZjgyMmJjYzlmZDkzMTFhNjRfOC0xLTEtMS0xODY4MjE_d72b2895-5edb-4075-981a-f851e1947f39"
      unitRef="usd">52281000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i66b66534a77f456aaf743a7fb2ed1e05_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84Mi9mcmFnOjIwZmFlOTU4ZjI1MTQ4NGRhOWY1YjY1YWM4NDcwM2JkL3RhYmxlOmE4NmYxMDZkMmQ2MjQ2Y2Y4MjJiY2M5ZmQ5MzExYTY0L3RhYmxlcmFuZ2U6YTg2ZjEwNmQyZDYyNDZjZjgyMmJjYzlmZDkzMTFhNjRfOC0zLTEtMS0xODY4MjE_8d621c48-c277-485a-a5de-5d6dbd976138"
      unitRef="usd">53893000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ia720faaba52b43d2be21584d13ecec2a_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84Mi9mcmFnOjIwZmFlOTU4ZjI1MTQ4NGRhOWY1YjY1YWM4NDcwM2JkL3RhYmxlOmE4NmYxMDZkMmQ2MjQ2Y2Y4MjJiY2M5ZmQ5MzExYTY0L3RhYmxlcmFuZ2U6YTg2ZjEwNmQyZDYyNDZjZjgyMmJjYzlmZDkzMTFhNjRfOS0xLTEtMS0xODY4MjE_4a2cbf05-71a2-40b9-be72-35d989fe0efb"
      unitRef="usd">163214000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ib1c1895e254b42068cd689b2d2e0cb17_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84Mi9mcmFnOjIwZmFlOTU4ZjI1MTQ4NGRhOWY1YjY1YWM4NDcwM2JkL3RhYmxlOmE4NmYxMDZkMmQ2MjQ2Y2Y4MjJiY2M5ZmQ5MzExYTY0L3RhYmxlcmFuZ2U6YTg2ZjEwNmQyZDYyNDZjZjgyMmJjYzlmZDkzMTFhNjRfOS0zLTEtMS0xODY4MjE_1f26489c-6860-4dc1-9141-66aaca29ebdc"
      unitRef="usd">164053000</us-gaap:OperatingIncomeLoss>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84Mi9mcmFnOjIwZmFlOTU4ZjI1MTQ4NGRhOWY1YjY1YWM4NDcwM2JkL3RhYmxlOmE4NmYxMDZkMmQ2MjQ2Y2Y4MjJiY2M5ZmQ5MzExYTY0L3RhYmxlcmFuZ2U6YTg2ZjEwNmQyZDYyNDZjZjgyMmJjYzlmZDkzMTFhNjRfMTAtMS0xLTEtMTg2ODIx_f10897a0-5864-4866-abcd-c640e6c5bcb5"
      unitRef="usd">3108000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84Mi9mcmFnOjIwZmFlOTU4ZjI1MTQ4NGRhOWY1YjY1YWM4NDcwM2JkL3RhYmxlOmE4NmYxMDZkMmQ2MjQ2Y2Y4MjJiY2M5ZmQ5MzExYTY0L3RhYmxlcmFuZ2U6YTg2ZjEwNmQyZDYyNDZjZjgyMmJjYzlmZDkzMTFhNjRfMTAtMy0xLTEtMTg2ODIx_a858fe3f-3ab6-466a-b7db-f0928325010a"
      unitRef="usd">3894000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:OperatingIncomeLoss
      contextRef="iecf751356922485386ff472a954f4b37_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84Mi9mcmFnOjIwZmFlOTU4ZjI1MTQ4NGRhOWY1YjY1YWM4NDcwM2JkL3RhYmxlOmE4NmYxMDZkMmQ2MjQ2Y2Y4MjJiY2M5ZmQ5MzExYTY0L3RhYmxlcmFuZ2U6YTg2ZjEwNmQyZDYyNDZjZjgyMmJjYzlmZDkzMTFhNjRfMTEtMS0xLTEtMTg2ODIx_ca8a4b04-e389-4d34-90f5-586a47cba7d9"
      unitRef="usd">-123724000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="if9b97ade31164041b7058022a9eb48a9_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84Mi9mcmFnOjIwZmFlOTU4ZjI1MTQ4NGRhOWY1YjY1YWM4NDcwM2JkL3RhYmxlOmE4NmYxMDZkMmQ2MjQ2Y2Y4MjJiY2M5ZmQ5MzExYTY0L3RhYmxlcmFuZ2U6YTg2ZjEwNmQyZDYyNDZjZjgyMmJjYzlmZDkzMTFhNjRfMTEtMy0xLTEtMTg2ODIx_48281b35-94e6-4ee3-9756-897accacbd80"
      unitRef="usd">-113995000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84Mi9mcmFnOjIwZmFlOTU4ZjI1MTQ4NGRhOWY1YjY1YWM4NDcwM2JkL3RhYmxlOmE4NmYxMDZkMmQ2MjQ2Y2Y4MjJiY2M5ZmQ5MzExYTY0L3RhYmxlcmFuZ2U6YTg2ZjEwNmQyZDYyNDZjZjgyMmJjYzlmZDkzMTFhNjRfMTItMS0xLTEtMTg2ODIx_84dddb45-7303-4a40-847a-c9e5940848db"
      unitRef="usd">36382000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84Mi9mcmFnOjIwZmFlOTU4ZjI1MTQ4NGRhOWY1YjY1YWM4NDcwM2JkL3RhYmxlOmE4NmYxMDZkMmQ2MjQ2Y2Y4MjJiY2M5ZmQ5MzExYTY0L3RhYmxlcmFuZ2U6YTg2ZjEwNmQyZDYyNDZjZjgyMmJjYzlmZDkzMTFhNjRfMTItMy0xLTEtMTg2ODIx_9097b613-aacd-4c25-9b39-cf1606027088"
      unitRef="usd">46164000</us-gaap:OperatingIncomeLoss>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8ec4e98c494d4152959a7ad4e62f2cdc_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84Mi9mcmFnOjIwZmFlOTU4ZjI1MTQ4NGRhOWY1YjY1YWM4NDcwM2JkL3RhYmxlOjA2MjY5MTc2NWU1ODRlNDA4M2M5ZDBjNzY4NDFlMzRjL3RhYmxlcmFuZ2U6MDYyNjkxNzY1ZTU4NGU0MDgzYzlkMGM3Njg0MWUzNGNfMi0xLTEtMS0xODY4MjE_7e0a5c43-e4d1-4439-b6a3-18f77c114b7d"
      unitRef="usd">271002000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5c11bb731e264ce287a9ba4be5cf11c6_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84Mi9mcmFnOjIwZmFlOTU4ZjI1MTQ4NGRhOWY1YjY1YWM4NDcwM2JkL3RhYmxlOjA2MjY5MTc2NWU1ODRlNDA4M2M5ZDBjNzY4NDFlMzRjL3RhYmxlcmFuZ2U6MDYyNjkxNzY1ZTU4NGU0MDgzYzlkMGM3Njg0MWUzNGNfMi0zLTEtMS0xODY4MjE_546a01bb-d423-497d-ae74-114a1b76e77b"
      unitRef="usd">263351000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i07f997c575a845b49f6c85d88adbf303_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84Mi9mcmFnOjIwZmFlOTU4ZjI1MTQ4NGRhOWY1YjY1YWM4NDcwM2JkL3RhYmxlOjA2MjY5MTc2NWU1ODRlNDA4M2M5ZDBjNzY4NDFlMzRjL3RhYmxlcmFuZ2U6MDYyNjkxNzY1ZTU4NGU0MDgzYzlkMGM3Njg0MWUzNGNfMy0xLTEtMS0xODY4MjE_9b1797fd-29b8-42f1-b49d-0ae18b102f20"
      unitRef="usd">41064000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic7f5c4fd7cee463ca7ad0e86dbcbc6b6_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84Mi9mcmFnOjIwZmFlOTU4ZjI1MTQ4NGRhOWY1YjY1YWM4NDcwM2JkL3RhYmxlOjA2MjY5MTc2NWU1ODRlNDA4M2M5ZDBjNzY4NDFlMzRjL3RhYmxlcmFuZ2U6MDYyNjkxNzY1ZTU4NGU0MDgzYzlkMGM3Njg0MWUzNGNfMy0zLTEtMS0xODY4MjE_60337cd7-ca27-4117-93c7-623f5e7c9249"
      unitRef="usd">43744000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id8b5c9cc0fb140aaa998a0d5849918a1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84Mi9mcmFnOjIwZmFlOTU4ZjI1MTQ4NGRhOWY1YjY1YWM4NDcwM2JkL3RhYmxlOjA2MjY5MTc2NWU1ODRlNDA4M2M5ZDBjNzY4NDFlMzRjL3RhYmxlcmFuZ2U6MDYyNjkxNzY1ZTU4NGU0MDgzYzlkMGM3Njg0MWUzNGNfNC0xLTEtMS0xODY4MjE_ee077826-40e4-439c-875c-994925397438"
      unitRef="usd">50473000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5f5d773def504f108c920a0391f44968_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84Mi9mcmFnOjIwZmFlOTU4ZjI1MTQ4NGRhOWY1YjY1YWM4NDcwM2JkL3RhYmxlOjA2MjY5MTc2NWU1ODRlNDA4M2M5ZDBjNzY4NDFlMzRjL3RhYmxlcmFuZ2U6MDYyNjkxNzY1ZTU4NGU0MDgzYzlkMGM3Njg0MWUzNGNfNC0zLTEtMS0xODY4MjE_41a6624c-53d1-461b-9450-56d31b872c38"
      unitRef="usd">47717000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idceeee4c12c44c50b93f23c34fdf4267_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84Mi9mcmFnOjIwZmFlOTU4ZjI1MTQ4NGRhOWY1YjY1YWM4NDcwM2JkL3RhYmxlOjA2MjY5MTc2NWU1ODRlNDA4M2M5ZDBjNzY4NDFlMzRjL3RhYmxlcmFuZ2U6MDYyNjkxNzY1ZTU4NGU0MDgzYzlkMGM3Njg0MWUzNGNfNS0xLTEtMS0xODY4MjE_b3fdd581-e22e-42cb-bf7f-2d8f4edfd5c4"
      unitRef="usd">18307000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iaa37c54d794549a99aea38389a6d9606_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84Mi9mcmFnOjIwZmFlOTU4ZjI1MTQ4NGRhOWY1YjY1YWM4NDcwM2JkL3RhYmxlOjA2MjY5MTc2NWU1ODRlNDA4M2M5ZDBjNzY4NDFlMzRjL3RhYmxlcmFuZ2U6MDYyNjkxNzY1ZTU4NGU0MDgzYzlkMGM3Njg0MWUzNGNfNS0zLTEtMS0xODY4MjE_89ad6541-2d76-4aec-bb0f-ad62d44875eb"
      unitRef="usd">21826000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84Mi9mcmFnOjIwZmFlOTU4ZjI1MTQ4NGRhOWY1YjY1YWM4NDcwM2JkL3RhYmxlOjA2MjY5MTc2NWU1ODRlNDA4M2M5ZDBjNzY4NDFlMzRjL3RhYmxlcmFuZ2U6MDYyNjkxNzY1ZTU4NGU0MDgzYzlkMGM3Njg0MWUzNGNfNi0xLTEtMS0xODY4MjE_4c61499d-099e-4186-b8f4-939b6e2fd413"
      unitRef="usd">380846000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i54fe897b9a3d403f8f0121a6eedff1d4_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84Mi9mcmFnOjIwZmFlOTU4ZjI1MTQ4NGRhOWY1YjY1YWM4NDcwM2JkL3RhYmxlOjA2MjY5MTc2NWU1ODRlNDA4M2M5ZDBjNzY4NDFlMzRjL3RhYmxlcmFuZ2U6MDYyNjkxNzY1ZTU4NGU0MDgzYzlkMGM3Njg0MWUzNGNfNi0zLTEtMS0xODY4MjE_069d9676-8dd5-427a-8c52-8259fba88ffa"
      unitRef="usd">376638000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RleHRyZWdpb246NDU3ZTAzOThiNGM2NDJjZGFhNGU3M2I3N2E2NGEyZjJfNDE2OA_da3fcce8-e1f7-4f36-a081-cc2458a09e75">COMMITMENTS AND CONTINGENCIESIn consideration for certain technology, manufacturing, distribution, and selling rights and licenses granted to the Company, the Company has agreed to pay royalties on sales of certain products that it sells. The royalty payments that the Company made under these agreements were not significant for any of the periods presented.&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is subject to various claims, lawsuits and proceedings in the ordinary course of the Company's business, including claims by current or former employees, distributors and competitors and with respect to its products and product liability claims, lawsuits and proceedings, some of which have been settled by the Company. In the opinion of management, such claims are either adequately covered by insurance or otherwise indemnified, or are not expected, individually or in the aggregate, to result in a material, adverse effect on the Company's financial condition. However, it is possible that the Company's results of operations, financial position and cash flows in a particular period could be materially affected by these contingencies.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accrues for loss contingencies when it is deemed probable that a loss has been incurred and that loss is estimable. The amounts accrued are based on the full amount of the estimated loss before considering insurance proceeds and do not include an estimate for legal fees expected to be incurred in connection with the loss contingency. The Company consistently accrues legal fees expected to be incurred in connection with loss contingencies as those fees are incurred by outside counsel as a period cost.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Contingent Consideration&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determined the fair value of contingent consideration during the three month period ended March&#160;31, 2023 and March&#160;31, 2022 to reflect the change in estimate, additions, payments, transfers and the time value of money during the period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the opening balances to the closing balances of these Level 3 measurements for the three months ended March 31, 2023 and March&#160;31, 2022 is as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.988%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.390%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.319%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.390%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.876%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.390%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.390%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.024%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.390%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.319%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.390%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.319%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.390%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.319%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.390%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.681%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:29pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Contingent Consideration Liability Related to Acquisition of:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:29pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Arkis&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location in Financial Statements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Derma Sciences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;ACell&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Surgical Innovations Associates, Inc. (FN 2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location in Financial Statements&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Short-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Short-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance as of January 1, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;57,607&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Transfers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(12,500)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Change in fair value of contingent consideration liabilities &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,756&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,200)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance as of March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,388&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,806&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;48,707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.036%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.831%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.245%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.295%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.245%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.684%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.099%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.255%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:29pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Contingent Consideration Liability Related to Acquisition of:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:29pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Arkis &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location in Financial Statements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Derma Sciences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;ACell Inc.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location in Financial Statements&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Short-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Short-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance as of January 1, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,691&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Transfers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(59)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,885&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,885)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Change in fair value of contingent consideration liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,065)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance as of March&#160;31, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,885&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Arkis BioSciences Inc.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As part of the acquisition of Arkis BioSciences Inc. ("Arkis"), the Company is required to pay the former shareholders of Arkis up to $25.5 million&#160;based on the timing of certain development milestones of $10.0 million and commercial sales milestones of $15.5 million, respectively.&#160;The Company used a probability weighted income approach to calculate the fair value of the contingent consideration that considered the possible outcomes of scenarios related to each specified milestone. The Company estimated the fair value of the contingent consideration to be $13.1 million at the acquisition date. The estimated fair value as of March&#160;31, 2023 and March&#160;31, 2022 was $16.2 million and $14.0 million, respectively. The Company recorded $11.8 million and $10.3 million in other liabilities at March&#160;31, 2023 and March&#160;31, 2022, respectively, and $4.4&#160;million and $3.8&#160;million in accrued expenses and other current liabilities at March&#160;31, 2023 and March&#160;31, 2022, respectively, in the consolidated balance sheet of the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Derma Sciences&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company assumed contingent consideration incurred by Derma Sciences, Inc. ("Derma Sciences")&#160;related to its acquisitions of BioD and the intellectual property related to Medihoney products. The Company accounted for the contingent liabilities by recording their fair value on the date of the acquisition based on a probability weighted income approach. The Company has already paid $33.3 million related to the aforementioned contingent liabilities. One contingent milestone remains which relates to net sales of Medihoney&#x2122; products exceeding certain amounts defined in the agreement between the Company and Derma Sciences. The potential maximum undiscounted payment amounts to $3.0 million. The estimated fair value as of March&#160;31, 2023 and March&#160;31, 2022 was $0.2 million. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;ACell Inc.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As part of the ACell Acquisition, the Company is required to make payments to the former shareholders of ACell up to $100&#160;million based on the achievement by the Company of certain revenue-based performance milestones in 2023 and 2025. The Company used iterations of the Monte Carlo simulation to calculate the fair value of the contingent consideration that considered the possible outcomes of scenarios related to each specific milestone. The Company estimated the fair value of the contingent consideration to be $23.9&#160;million at the acquisition date. The estimated fair value as of March 31, 2023 was &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$1.5 million&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The Company recorded &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$1.5 million &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$17.2 million &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;in other liabilities at March 31, 2023 and March 31, 2022, respectively, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and $4.9 million in accrued expenses and other current liabilities at March&#160;31, 2022&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in the consolidated balance sheets of the Company. The change in the fair value of the contingent obligation was primarily as a result of changes in the timing and amount of revenue estimates.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock
      contextRef="ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RleHRyZWdpb246NDU3ZTAzOThiNGM2NDJjZGFhNGU3M2I3N2E2NGEyZjJfNDE3OQ_e02cecfe-6caf-4891-b1d2-ee99d66cbf28">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the opening balances to the closing balances of these Level 3 measurements for the three months ended March 31, 2023 and March&#160;31, 2022 is as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.988%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.390%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.319%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.390%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.876%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.390%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.390%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.024%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.390%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.319%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.390%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.319%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.390%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.319%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.390%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.681%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:29pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Contingent Consideration Liability Related to Acquisition of:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:29pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Arkis&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location in Financial Statements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Derma Sciences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;ACell&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Surgical Innovations Associates, Inc. (FN 2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location in Financial Statements&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Short-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Short-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance as of January 1, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;57,607&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Transfers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(12,500)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Change in fair value of contingent consideration liabilities &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,756&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,200)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance as of March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,388&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,806&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;48,707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.036%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.831%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.245%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.295%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.245%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.684%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.099%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.255%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:29pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Contingent Consideration Liability Related to Acquisition of:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:29pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Arkis &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location in Financial Statements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Derma Sciences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;ACell Inc.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location in Financial Statements&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Short-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Short-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance as of January 1, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,691&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Transfers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(59)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,885&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,885)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Change in fair value of contingent consideration liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,065)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance as of March&#160;31, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,885&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="ifcaf924eb8b044b5959cc99978a303a7_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RhYmxlOjcyZmViOGYzOWI0ZjQzMjE4YmJlYWIxNjE3OGJlNTU2L3RhYmxlcmFuZ2U6NzJmZWI4ZjM5YjRmNDMyMThiYmVhYjE2MTc4YmU1NTZfMy0yLTEtMS0xODY4MjE_c620a907-84c6-4a3d-b230-f4efe78f3bd9"
      unitRef="usd">2845000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i8389bf8a7d824c2980154809fed6d74d_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RhYmxlOjcyZmViOGYzOWI0ZjQzMjE4YmJlYWIxNjE3OGJlNTU2L3RhYmxlcmFuZ2U6NzJmZWI4ZjM5YjRmNDMyMThiYmVhYjE2MTc4YmU1NTZfMy00LTEtMS0xODY4MjE_41024449-62a0-413a-9007-a2ec3869a067"
      unitRef="usd">10050000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i87b4b1d7730e401b9ab2ced0eb01926f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RhYmxlOjcyZmViOGYzOWI0ZjQzMjE4YmJlYWIxNjE3OGJlNTU2L3RhYmxlcmFuZ2U6NzJmZWI4ZjM5YjRmNDMyMThiYmVhYjE2MTc4YmU1NTZfMy04LTEtMS0xODY4MjE_7249e3c2-f391-4e33-b01b-820f3fcc9ddf"
      unitRef="usd">230000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="ib2ebabea23ce4ed1b68823b3506d6cee_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RhYmxlOjcyZmViOGYzOWI0ZjQzMjE4YmJlYWIxNjE3OGJlNTU2L3RhYmxlcmFuZ2U6NzJmZWI4ZjM5YjRmNDMyMThiYmVhYjE2MTc4YmU1NTZfMy0xMi0xLTEtMTg2ODIx_63463b9f-5813-48b6-aed3-8cffc19bb5a4"
      unitRef="usd">3700000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i35632a429f994b4c93a6bf032cf1dab3_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RhYmxlOjcyZmViOGYzOWI0ZjQzMjE4YmJlYWIxNjE3OGJlNTU2L3RhYmxlcmFuZ2U6NzJmZWI4ZjM5YjRmNDMyMThiYmVhYjE2MTc4YmU1NTZfMy0xMy0xLTEtMjAzOTIy_572bb328-61d3-4384-80ab-470c870dd1ac"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i28c09119df4d46479f028692c5abc6c9_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RhYmxlOjcyZmViOGYzOWI0ZjQzMjE4YmJlYWIxNjE3OGJlNTU2L3RhYmxlcmFuZ2U6NzJmZWI4ZjM5YjRmNDMyMThiYmVhYjE2MTc4YmU1NTZfMy0xMy0xLTEtMTkyNDc4_d21cd14d-99a1-458a-a603-a4eab8097405"
      unitRef="usd">57607000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <iart:FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent
      contextRef="iebe056bf287c49189659a150fa4bb005_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RhYmxlOjcyZmViOGYzOWI0ZjQzMjE4YmJlYWIxNjE3OGJlNTU2L3RhYmxlcmFuZ2U6NzJmZWI4ZjM5YjRmNDMyMThiYmVhYjE2MTc4YmU1NTZfNC0yLTEtMS0xODY4MjE_6b830650-4227-43d5-b686-37a2d8260e46"
      unitRef="usd">0</iart:FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent>
    <iart:FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent
      contextRef="ie94f070e4ad14a71bbd6d5a287488485_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RhYmxlOjcyZmViOGYzOWI0ZjQzMjE4YmJlYWIxNjE3OGJlNTU2L3RhYmxlcmFuZ2U6NzJmZWI4ZjM5YjRmNDMyMThiYmVhYjE2MTc4YmU1NTZfNC00LTEtMS0xODY4MjE_40cf116d-1c54-48bb-b7cd-1c35465460fb"
      unitRef="usd">0</iart:FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent>
    <iart:FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent
      contextRef="ic5212f8a1bee4dc6ba5f12945bceefac_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RhYmxlOjcyZmViOGYzOWI0ZjQzMjE4YmJlYWIxNjE3OGJlNTU2L3RhYmxlcmFuZ2U6NzJmZWI4ZjM5YjRmNDMyMThiYmVhYjE2MTc4YmU1NTZfNC04LTEtMS0xODY4MjE_36261f63-cd80-4ebb-8770-d3fa58703c0b"
      unitRef="usd">0</iart:FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent>
    <iart:FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent
      contextRef="i5b996d3591a14f7b8ad05792e133d08b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RhYmxlOjcyZmViOGYzOWI0ZjQzMjE4YmJlYWIxNjE3OGJlNTU2L3RhYmxlcmFuZ2U6NzJmZWI4ZjM5YjRmNDMyMThiYmVhYjE2MTc4YmU1NTZfNC0xMi0xLTEtMTg2ODIx_81189c6e-a0de-4eba-a1ba-30eae0e15b94"
      unitRef="usd">0</iart:FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent>
    <iart:FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent
      contextRef="i76cdb8918dd040ca80187c0cd9780d22_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RhYmxlOjcyZmViOGYzOWI0ZjQzMjE4YmJlYWIxNjE3OGJlNTU2L3RhYmxlcmFuZ2U6NzJmZWI4ZjM5YjRmNDMyMThiYmVhYjE2MTc4YmU1NTZfNC0xMy0xLTEtMjAwNzk0_2ee2bd8e-35b0-41a7-ac83-e000c20e5d49"
      unitRef="usd">12500000</iart:FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent>
    <iart:FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent
      contextRef="i4a2f319447e54f4da01d7985e4319c02_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RhYmxlOjcyZmViOGYzOWI0ZjQzMjE4YmJlYWIxNjE3OGJlNTU2L3RhYmxlcmFuZ2U6NzJmZWI4ZjM5YjRmNDMyMThiYmVhYjE2MTc4YmU1NTZfNC0xMy0xLTEtMTkyNDc4_e7785cfe-7ea7-400f-8829-5c3a1d2b6c85"
      unitRef="usd">-12500000</iart:FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="iebe056bf287c49189659a150fa4bb005_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RhYmxlOjcyZmViOGYzOWI0ZjQzMjE4YmJlYWIxNjE3OGJlNTU2L3RhYmxlcmFuZ2U6NzJmZWI4ZjM5YjRmNDMyMThiYmVhYjE2MTc4YmU1NTZfNS0yLTEtMS0xODY4MjE_c1697de3-9d8d-4fef-98d0-35641c0e0695"
      unitRef="usd">1543000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="ie94f070e4ad14a71bbd6d5a287488485_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RhYmxlOjcyZmViOGYzOWI0ZjQzMjE4YmJlYWIxNjE3OGJlNTU2L3RhYmxlcmFuZ2U6NzJmZWI4ZjM5YjRmNDMyMThiYmVhYjE2MTc4YmU1NTZfNS00LTEtMS0xODY4MjE_842a86c0-29b6-4f23-a772-05558df6cdd8"
      unitRef="usd">1756000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="ic5212f8a1bee4dc6ba5f12945bceefac_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RhYmxlOjcyZmViOGYzOWI0ZjQzMjE4YmJlYWIxNjE3OGJlNTU2L3RhYmxlcmFuZ2U6NzJmZWI4ZjM5YjRmNDMyMThiYmVhYjE2MTc4YmU1NTZfNS04LTEtMS0xODY4MjE_a9513def-f681-41b7-89ff-ba661b6aa54f"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="i5b996d3591a14f7b8ad05792e133d08b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RhYmxlOjcyZmViOGYzOWI0ZjQzMjE4YmJlYWIxNjE3OGJlNTU2L3RhYmxlcmFuZ2U6NzJmZWI4ZjM5YjRmNDMyMThiYmVhYjE2MTc4YmU1NTZfNS0xMi0xLTEtMTg2ODIx_5c57779d-c5a4-48f6-b84f-9eb844195e43"
      unitRef="usd">-2200000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="i76cdb8918dd040ca80187c0cd9780d22_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RhYmxlOjcyZmViOGYzOWI0ZjQzMjE4YmJlYWIxNjE3OGJlNTU2L3RhYmxlcmFuZ2U6NzJmZWI4ZjM5YjRmNDMyMThiYmVhYjE2MTc4YmU1NTZfNS0xMy0xLTEtMjAwODA1_0f14cada-df2d-4037-b6f6-0f7520588390"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="i4a2f319447e54f4da01d7985e4319c02_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RhYmxlOjcyZmViOGYzOWI0ZjQzMjE4YmJlYWIxNjE3OGJlNTU2L3RhYmxlcmFuZ2U6NzJmZWI4ZjM5YjRmNDMyMThiYmVhYjE2MTc4YmU1NTZfNi0xMy0xLTEtMTkyNDc4_ec43da9a-4f69-4cf5-b559-a29ba0448487"
      unitRef="usd">3600000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="ibc5039e063bb4575a7f706baf7647a99_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RhYmxlOjcyZmViOGYzOWI0ZjQzMjE4YmJlYWIxNjE3OGJlNTU2L3RhYmxlcmFuZ2U6NzJmZWI4ZjM5YjRmNDMyMThiYmVhYjE2MTc4YmU1NTZfNi0yLTEtMS0xODY4MjE_4cb678b1-5f4c-4724-8089-c2aafbf6d969"
      unitRef="usd">4388000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i3a5ab664d800458296dd51aa0092a73a_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RhYmxlOjcyZmViOGYzOWI0ZjQzMjE4YmJlYWIxNjE3OGJlNTU2L3RhYmxlcmFuZ2U6NzJmZWI4ZjM5YjRmNDMyMThiYmVhYjE2MTc4YmU1NTZfNi00LTEtMS0xODY4MjE_89e8caf1-7a5c-498c-95da-ac86823f4991"
      unitRef="usd">11806000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="ifbf2b5d3f97042bdbb5011c85b4e62ff_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RhYmxlOjcyZmViOGYzOWI0ZjQzMjE4YmJlYWIxNjE3OGJlNTU2L3RhYmxlcmFuZ2U6NzJmZWI4ZjM5YjRmNDMyMThiYmVhYjE2MTc4YmU1NTZfNi04LTEtMS0xODY4MjE_b73692cc-1dd6-4491-8bb1-59903b789f9c"
      unitRef="usd">230000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="ifda9aebeb4fc4e828e24ac81907aa5d7_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RhYmxlOjcyZmViOGYzOWI0ZjQzMjE4YmJlYWIxNjE3OGJlNTU2L3RhYmxlcmFuZ2U6NzJmZWI4ZjM5YjRmNDMyMThiYmVhYjE2MTc4YmU1NTZfNi0xMi0xLTEtMTg2ODIx_a62f0bae-2e93-4e18-9378-7e4b24f61ac0"
      unitRef="usd">1500000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="ic6f8fb897f9041c8ba230423d37c9561_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RhYmxlOjcyZmViOGYzOWI0ZjQzMjE4YmJlYWIxNjE3OGJlNTU2L3RhYmxlcmFuZ2U6NzJmZWI4ZjM5YjRmNDMyMThiYmVhYjE2MTc4YmU1NTZfNi0xMy0xLTEtMjAzOTIy_09c537ea-99f1-4d50-b155-293242aab4f6"
      unitRef="usd">12500000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i04a72655453e4dc799f5272ab6e4c43f_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RhYmxlOjcyZmViOGYzOWI0ZjQzMjE4YmJlYWIxNjE3OGJlNTU2L3RhYmxlcmFuZ2U6NzJmZWI4ZjM5YjRmNDMyMThiYmVhYjE2MTc4YmU1NTZfNy0xMy0xLTEtMTkyNDc4_56bc341d-05cb-4e02-8076-85be6afeddbe"
      unitRef="usd">48707000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i03382ae93c3949428c4641c300c15cf5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RhYmxlOmE0ZmVhZjA0OTQ1ZjQzMmZiYTVhMDZhYzVkOTg3ZWU5L3RhYmxlcmFuZ2U6YTRmZWFmMDQ5NDVmNDMyZmJhNWEwNmFjNWQ5ODdlZTlfMy0yLTEtMS0xODY4MjE_70efa5fc-f7cb-44f2-a5cd-11dfa9a90850"
      unitRef="usd">3691000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i63bd28aa464048d382efdc354e8d30ef_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RhYmxlOmE0ZmVhZjA0OTQ1ZjQzMmZiYTVhMDZhYzVkOTg3ZWU5L3RhYmxlcmFuZ2U6YTRmZWFmMDQ5NDVmNDMyZmJhNWEwNmFjNWQ5ODdlZTlfMy00LTEtMS0xODY4MjE_76031cd0-ded3-476f-a3f7-cdc908f7223e"
      unitRef="usd">11408000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="if1f1f28f2ace4bbebc59d26841e82a9c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RhYmxlOmE0ZmVhZjA0OTQ1ZjQzMmZiYTVhMDZhYzVkOTg3ZWU5L3RhYmxlcmFuZ2U6YTRmZWFmMDQ5NDVmNDMyZmJhNWEwNmFjNWQ5ODdlZTlfMy04LTEtMS0xODY4MjE_e024e8f8-23db-4a1e-a1e7-67bb39cd4626"
      unitRef="usd">230000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="id31fe52cb24f4c5d8a546c61e9306f16_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RhYmxlOmE0ZmVhZjA0OTQ1ZjQzMmZiYTVhMDZhYzVkOTg3ZWU5L3RhYmxlcmFuZ2U6YTRmZWFmMDQ5NDVmNDMyZmJhNWEwNmFjNWQ5ODdlZTlfMy0xMC0xLTEtMTg2ODIx_53c68479-2c8e-4233-9a4e-64af34bc8047"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="ida5433fc38b34f3d80d99d0b3ae06943_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RhYmxlOmE0ZmVhZjA0OTQ1ZjQzMmZiYTVhMDZhYzVkOTg3ZWU5L3RhYmxlcmFuZ2U6YTRmZWFmMDQ5NDVmNDMyZmJhNWEwNmFjNWQ5ODdlZTlfMy0xNC0xLTEtMTkyMTM3_aec373f2-8bdb-4d9c-9a76-0fac42d0d15b"
      unitRef="usd">21800000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <iart:FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent
      contextRef="i7ad7e73cd2384933bcc0486859965b91_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RhYmxlOmE0ZmVhZjA0OTQ1ZjQzMmZiYTVhMDZhYzVkOTg3ZWU5L3RhYmxlcmFuZ2U6YTRmZWFmMDQ5NDVmNDMyZmJhNWEwNmFjNWQ5ODdlZTlfNS0yLTEtMS0xODY4MjE_13d91bd7-df6b-4c80-bc4d-38a81167039f"
      unitRef="usd">59000</iart:FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent>
    <iart:FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent
      contextRef="i8d4ac64501714cd8b27e0d99a3bc50f1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RhYmxlOmE0ZmVhZjA0OTQ1ZjQzMmZiYTVhMDZhYzVkOTg3ZWU5L3RhYmxlcmFuZ2U6YTRmZWFmMDQ5NDVmNDMyZmJhNWEwNmFjNWQ5ODdlZTlfNS00LTEtMS0xODY4MjE_745834df-a658-4ef7-94c1-fe765308d5ca"
      unitRef="usd">-59000</iart:FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent>
    <iart:FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent
      contextRef="i744d6e80b2d2438caf54348f35691d3c_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RhYmxlOmE0ZmVhZjA0OTQ1ZjQzMmZiYTVhMDZhYzVkOTg3ZWU5L3RhYmxlcmFuZ2U6YTRmZWFmMDQ5NDVmNDMyZmJhNWEwNmFjNWQ5ODdlZTlfNS04LTEtMS0xODY4MjE_bcb404a3-3d6b-4f4f-a73b-fe71bdeb9f18"
      unitRef="usd">0</iart:FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent>
    <iart:FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent
      contextRef="i2dff9a5632b143f6bcc0a2d0430fc736_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RhYmxlOmE0ZmVhZjA0OTQ1ZjQzMmZiYTVhMDZhYzVkOTg3ZWU5L3RhYmxlcmFuZ2U6YTRmZWFmMDQ5NDVmNDMyZmJhNWEwNmFjNWQ5ODdlZTlfNS0xMC0xLTEtMTg2ODIx_85971897-c5eb-4a60-b5dd-68f422eba3f2"
      unitRef="usd">4885000</iart:FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent>
    <iart:FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent
      contextRef="i57a65d2fe6b445379851b358047cd045_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RhYmxlOmE0ZmVhZjA0OTQ1ZjQzMmZiYTVhMDZhYzVkOTg3ZWU5L3RhYmxlcmFuZ2U6YTRmZWFmMDQ5NDVmNDMyZmJhNWEwNmFjNWQ5ODdlZTlfNS0xNC0xLTEtMTkyMTM3_1c0fb2a5-c83b-4b2c-ac66-3516c366664c"
      unitRef="usd">-4885000</iart:FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="i7ad7e73cd2384933bcc0486859965b91_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RhYmxlOmE0ZmVhZjA0OTQ1ZjQzMmZiYTVhMDZhYzVkOTg3ZWU5L3RhYmxlcmFuZ2U6YTRmZWFmMDQ5NDVmNDMyZmJhNWEwNmFjNWQ5ODdlZTlfNi0yLTEtMS0xODY4MjE_36451adf-af71-4040-9dfa-2bc9a68ac5c9"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="i8d4ac64501714cd8b27e0d99a3bc50f1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RhYmxlOmE0ZmVhZjA0OTQ1ZjQzMmZiYTVhMDZhYzVkOTg3ZWU5L3RhYmxlcmFuZ2U6YTRmZWFmMDQ5NDVmNDMyZmJhNWEwNmFjNWQ5ODdlZTlfNi00LTEtMS0xODY4MjE_f12988df-aaa0-422c-b2ae-038f8a090dc8"
      unitRef="usd">-1065000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="i744d6e80b2d2438caf54348f35691d3c_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RhYmxlOmE0ZmVhZjA0OTQ1ZjQzMmZiYTVhMDZhYzVkOTg3ZWU5L3RhYmxlcmFuZ2U6YTRmZWFmMDQ5NDVmNDMyZmJhNWEwNmFjNWQ5ODdlZTlfNi04LTEtMS0xODY4MjE_b7571590-d17f-4587-87f4-ae7a84ff5589"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="i2dff9a5632b143f6bcc0a2d0430fc736_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RhYmxlOmE0ZmVhZjA0OTQ1ZjQzMmZiYTVhMDZhYzVkOTg3ZWU5L3RhYmxlcmFuZ2U6YTRmZWFmMDQ5NDVmNDMyZmJhNWEwNmFjNWQ5ODdlZTlfNi0xMC0xLTEtMTg2ODIx_894a9091-89b9-45bb-b903-8c027aa6fcd2"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="i57a65d2fe6b445379851b358047cd045_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RhYmxlOmE0ZmVhZjA0OTQ1ZjQzMmZiYTVhMDZhYzVkOTg3ZWU5L3RhYmxlcmFuZ2U6YTRmZWFmMDQ5NDVmNDMyZmJhNWEwNmFjNWQ5ODdlZTlfNi0xNC0xLTEtMTkyMTM3_2a9dc401-bedd-4a43-b2d5-2bdc1c3a0137"
      unitRef="usd">300000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i57d1bb45844549318bf527ab1d455e38_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RhYmxlOmE0ZmVhZjA0OTQ1ZjQzMmZiYTVhMDZhYzVkOTg3ZWU5L3RhYmxlcmFuZ2U6YTRmZWFmMDQ5NDVmNDMyZmJhNWEwNmFjNWQ5ODdlZTlfNy0yLTEtMS0xODY4MjE_6cf86ee6-813e-4df4-aa4a-2de9b03ce9c9"
      unitRef="usd">3750000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i26ba6bc78b3a4d95b2893e8f8c7ad8a8_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RhYmxlOmE0ZmVhZjA0OTQ1ZjQzMmZiYTVhMDZhYzVkOTg3ZWU5L3RhYmxlcmFuZ2U6YTRmZWFmMDQ5NDVmNDMyZmJhNWEwNmFjNWQ5ODdlZTlfNy00LTEtMS0xODY4MjE_e4cc71b8-2cdf-4fef-bcc0-3382aaf245ec"
      unitRef="usd">10284000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i843804a3b389484b948c99a44059b0c4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RhYmxlOmE0ZmVhZjA0OTQ1ZjQzMmZiYTVhMDZhYzVkOTg3ZWU5L3RhYmxlcmFuZ2U6YTRmZWFmMDQ5NDVmNDMyZmJhNWEwNmFjNWQ5ODdlZTlfNy04LTEtMS0xODY4MjE_f8eb9e14-6937-4ab8-949b-41031fc84618"
      unitRef="usd">230000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="if2bb2185bf654d9fa8253aa6e70cdc7a_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RhYmxlOmE0ZmVhZjA0OTQ1ZjQzMmZiYTVhMDZhYzVkOTg3ZWU5L3RhYmxlcmFuZ2U6YTRmZWFmMDQ5NDVmNDMyZmJhNWEwNmFjNWQ5ODdlZTlfNy0xMC0xLTEtMTg2ODIx_d647f0c8-1a52-48ff-baeb-4bf6f6eda33b"
      unitRef="usd">4885000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i4ac142c72a864f468e0436fe327c0980_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RhYmxlOmE0ZmVhZjA0OTQ1ZjQzMmZiYTVhMDZhYzVkOTg3ZWU5L3RhYmxlcmFuZ2U6YTRmZWFmMDQ5NDVmNDMyZmJhNWEwNmFjNWQ5ODdlZTlfNy0xNC0xLTEtMTkyMTM3_94f03fff-be99-4e35-b4d1-72c459b00c20"
      unitRef="usd">17215000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i5d9c6f2f864e40aea1985e58d5f1a41e_I20190729"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RleHRyZWdpb246NDU3ZTAzOThiNGM2NDJjZGFhNGU3M2I3N2E2NGEyZjJfMjY5Mg_b3de1bd0-f3db-41d2-b07a-92a99b38311e"
      unitRef="usd">25500000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ifbe9986f6bcd4de881c523419a2fb725_I20190729"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RleHRyZWdpb246NDU3ZTAzOThiNGM2NDJjZGFhNGU3M2I3N2E2NGEyZjJfMjc2MA_a3f04fbb-9abe-47ed-acf6-e2c721b3867f"
      unitRef="usd">10000000.0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="id780b85560324a2b8af98ff6056e8d1f_I20190729"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RleHRyZWdpb246NDU3ZTAzOThiNGM2NDJjZGFhNGU3M2I3N2E2NGEyZjJfMjgwNg_19b1fd77-45a5-4f24-abd2-7ccd9d868658"
      unitRef="usd">15500000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability
      contextRef="i5d9c6f2f864e40aea1985e58d5f1a41e_I20190729"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RleHRyZWdpb246NDU3ZTAzOThiNGM2NDJjZGFhNGU3M2I3N2E2NGEyZjJfMzExMQ_31a64e3c-2ca7-4853-a61a-90f86c5f000a"
      unitRef="usd">13100000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="iaba62da9aab3440ab34c023a05b0b605_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RleHRyZWdpb246NDU3ZTAzOThiNGM2NDJjZGFhNGU3M2I3N2E2NGEyZjJfMzE4NA_8df4559b-e80f-48ae-9ee7-25e8a2e79969"
      unitRef="usd">16200000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i28c3ebc588a3437abfe6a86e8e38ae70_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RleHRyZWdpb246NDU3ZTAzOThiNGM2NDJjZGFhNGU3M2I3N2E2NGEyZjJfMzE5MQ_e6a54d69-76cb-44ec-8780-7b154ddcbf9a"
      unitRef="usd">14000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i3a5ab664d800458296dd51aa0092a73a_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RleHRyZWdpb246NDU3ZTAzOThiNGM2NDJjZGFhNGU3M2I3N2E2NGEyZjJfMzIzMA_c6fc052b-4138-4677-b01d-a6eb83cee55b"
      unitRef="usd">11800000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i26ba6bc78b3a4d95b2893e8f8c7ad8a8_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RleHRyZWdpb246NDU3ZTAzOThiNGM2NDJjZGFhNGU3M2I3N2E2NGEyZjJfMzIzNw_0e72dbb0-f607-47ce-a98c-45b53f36ed95"
      unitRef="usd">10300000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="ia93dbf54c16a4910aa3b24636e104e30_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RleHRyZWdpb246NDU3ZTAzOThiNGM2NDJjZGFhNGU3M2I3N2E2NGEyZjJfMzI5Mw_9f96738a-1933-4cea-ae5b-0f233e4dbdd1"
      unitRef="usd">4400000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i03c41c6e3db74ceab9f18b88621af236_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RleHRyZWdpb246NDU3ZTAzOThiNGM2NDJjZGFhNGU3M2I3N2E2NGEyZjJfNDM5ODA0NjUxNTMwNg_7d85f563-5dc2-4e21-a2fc-582c2bcb9971"
      unitRef="usd">3800000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities
      contextRef="i5b8b02acfe4a4006ba624b2aa4272aa9_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RleHRyZWdpb246NDU3ZTAzOThiNGM2NDJjZGFhNGU3M2I3N2E2NGEyZjJfMzgzMg_0b8ffe2e-118d-4239-90ab-987510f864e4"
      unitRef="usd">33300000</us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities>
    <iart:BusinessCombinationContingentConsiderationNumberOfLiabilities
      contextRef="i86b0bf361fcc48fcb96359b69ccfd113_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RleHRyZWdpb246NDU3ZTAzOThiNGM2NDJjZGFhNGU3M2I3N2E2NGEyZjJfMzg4OQ_274971c6-980c-4903-9e6f-9b9ff0a411f5"
      unitRef="liability">1</iart:BusinessCombinationContingentConsiderationNumberOfLiabilities>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
      contextRef="i86b0bf361fcc48fcb96359b69ccfd113_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RleHRyZWdpb246NDU3ZTAzOThiNGM2NDJjZGFhNGU3M2I3N2E2NGEyZjJfNDExNg_5b10d81f-e262-45b1-a606-c8e7aa519fb6"
      unitRef="usd">3000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i1a0930d1120745c0909b0d6a10d930ff_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RleHRyZWdpb246NDU3ZTAzOThiNGM2NDJjZGFhNGU3M2I3N2E2NGEyZjJfNDE2NQ_5a584e3d-26fb-42b3-a788-d799687e84e0"
      unitRef="usd">200000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i51cb03d8a5ea47b9bf04b0cbd6cd4e2e_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RleHRyZWdpb246NDU3ZTAzOThiNGM2NDJjZGFhNGU3M2I3N2E2NGEyZjJfNDE2NQ_7d5561de-6949-4aeb-9dc7-62c73a249bb1"
      unitRef="usd">200000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
      contextRef="id9e1f135607c446e87244607e8e7fb74_I20210120"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RleHRyZWdpb246NDU3ZTAzOThiNGM2NDJjZGFhNGU3M2I3N2E2NGEyZjJfMTA5OTUxMTYyODg3NDQ_2a635a3d-5f0b-4c97-a0a9-297b9c2ee5f6"
      unitRef="usd">100000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability
      contextRef="id9e1f135607c446e87244607e8e7fb74_I20210120"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RleHRyZWdpb246NDU3ZTAzOThiNGM2NDJjZGFhNGU3M2I3N2E2NGEyZjJfMTA5OTUxMTYyODkxNDE_c8e1054d-35bd-46cd-97d6-308ac71bc3ca"
      unitRef="usd">23900000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i52c4ec9dcdbe44349b2eb5a85c04baae_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RleHRyZWdpb246NDU3ZTAzOThiNGM2NDJjZGFhNGU3M2I3N2E2NGEyZjJfNTQ5NzU1ODI1ODc1_9488e0a4-bbf6-4ed2-bd87-ac146b3fd4d9"
      unitRef="usd">1500000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i52c4ec9dcdbe44349b2eb5a85c04baae_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RleHRyZWdpb246NDU3ZTAzOThiNGM2NDJjZGFhNGU3M2I3N2E2NGEyZjJfNTQ5NzU1ODI1ODk1_9488e0a4-bbf6-4ed2-bd87-ac146b3fd4d9"
      unitRef="usd">1500000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ic09564d0848d46c79b0dbcb1d9f96df9_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RleHRyZWdpb246NDU3ZTAzOThiNGM2NDJjZGFhNGU3M2I3N2E2NGEyZjJfNTQ5NzU1ODI1OTEz_3c75e6e2-bea8-45f8-865b-6fcc876a0550"
      unitRef="usd">17200000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent
      contextRef="ic09564d0848d46c79b0dbcb1d9f96df9_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmMWViMWJkMDFkNTQxYzNhYTA3Nzc3MTIwNzdjMDQ4L3NlYzo1ZjFlYjFiZDAxZDU0MWMzYWEwNzc3NzEyMDc3YzA0OF84NS9mcmFnOjQ1N2UwMzk4YjRjNjQyY2RhYTRlNzNiNzdhNjRhMmYyL3RleHRyZWdpb246NDU3ZTAzOThiNGM2NDJjZGFhNGU3M2I3N2E2NGEyZjJfNTQ5NzU1ODI1OTQ0_8b3a8cca-8ab1-4d91-abfc-c3d3639602b1"
      unitRef="usd">4900000</us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>88
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M;(06)Y(G^5[BBDO)H_QPRZC/A+Y!?;_F7.Y/] ^4V]'#_P%02P,$%     @
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M&J-E*:Q0B*]=@TO@HQF<$]P=;!(39T[XS C#U"\YVTG.@I);OMOUM6KD.K
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MN3^JMT/?.[BR,%RO]7;6-S8*IZA64%]I]"#*E3Q%)!YCC)%8F872Q=_6;"%
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M'DK(ZD93=;3(RTO!4FB\8I3-!&^!($T SJ^$T,\=<\]H[I7AOU!+ P04
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M)Q(E5K;-A"R9QT) .BL=H5?IGV&X(?$&?:4;6L X:\$BH%T'JQDKC4G2V(9
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M!Q+ $YF(*.<%MAY,?OIQI(+\T4&^)-_RB_ZY3\DW_+$R&EFG!?B=7K#U7^B
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MO#<E_]PJ"=/2 CQ?&^/;"SJ@^];P];\!4$L#!!0    ( $*#FE;CABD5MPH
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MUQ'0XI&[=R)V#,3F@XF&B20,-4^!,@2D"X 7XN4T.CR=OMIY?("FD3YD\>?
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MM",#-V%)+R8:7T#K2ZW=;N(WZ-[@R6]02P,$%     @ 0H.:5CB8':@T!0
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M)@5\/U?*[AXHP'X]'_X#4$L#!!0    ( $*#FE8VF 6!8Q   #,R   9
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M@F<K2R@Q\$<F,*X,^^1Y:,%X'\9D7 $3Z</J*'8D@;;6<%Y:B=/)>%9OC(4
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M%B&'!,B8)'X+/2I1XZ= /([ HL2M;;1HL0 I:68&KY/I/RM'&ONE,O0'WI=
M&\241F25FK!$K(@=C9&T_7:M[8MR*#4<R+BPK<RHZ$R;HL,FINBD?Y!(/$:
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MX@M$_%*:@G\6L#0E #I_7"N)2*8'<']E(%'X0AO4OQ-Y^V]02P,$%     @
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M<RNC:H)1E9->X%-3S%B,5P"G$PCQ^QQ".4-5(E<-4^Q.*B8%_2;K!)63Z]D
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MQJD[++$2@T:#*0@[40TEU:CK]!Z&81\SN1(V@XJ%0:F7WNH-@:6/#=!(T&9
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MSYR>DJBL :VOI#3MP ;H'J>S?P%02P,$%     @ 0H.:5L3BSV$I!0  H@L
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MM30&W=Q"P?5-8Z%2JZXU^BAB+HR% I*ENCP5UH<<Z.^V$-4F4IN&A]*Q1&4
MJF6;9C'L]VC8:&5UF08U*W/*M"U@[!X[FXH8.Z(; HJ@E4^&J<QWARP,:RWN
MV!P<WL%A@P,/P&4(_*QB;2:Z8E';6!<RQ;4K/M# %$368S_=HVPI,>6Z1OS(
MR2C%5> 1E./"V'&"[D).N[[J^0-\W9:(O U\<\OB:XN!T0U W.$8G$6WXM@*
MV:B <.@6,[544:?1D,H?NIS'.^^FFMPZO@YC4YB0GE##[O  /4GOKCOQ]'I%
MZ:\5HM:T@NHD?_DB$RZ]"-,BV":^PC [\::+GQ4>T>18 .<K:T._8 ?#LWSQ
M'U!+ P04    " !"@YI6HBB6<78#  ! "   &0   'AL+W=O<FMS:&5E=',O
M<VAE970Q.2YX;6RM5MMNVS@0_96!NNB3UY(EQW%<VT"<>-$^)&O$W>W#H@^T
M-+*(4*1*4E'Z]QU2LN)@8V\++!!8O,P<GKEGWBC]: I$"\^ED&81%-96LS T
M:8$E,T-5H:2;7.F26=KJ?6@JC2SS2J4(XRB:A"7C,EC._=E&+^>JMH)+W&@P
M=5DR_7V%0C6+8!0<#A[XOK#N(%S.*[;'+=J_JHVF7=BC9+Q$:;B2H#%?!->C
MV6KLY+W WQP;<[0&9\E.J4>W^90M@L@10H&I=0B,/D]X@T(X(*+QK<,,^B>=
MXO'Z@/Z'MYULV3&#-TI\X9DM%L$T@ QS5@O[H)J/V-ESX?!2)8S_A::53:(
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MW@:,.A@83&O-+4<*S-:J]!%4Y3J<\7$E<*MYZEXV_G)\$<-D//XO0M3?^YS
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M:2;@^$H(O6^8!=JGV^0?4$L#!!0    ( $*#FE:,F<.QE 8  # /   9
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M@.K0\T(F$E_O<"#O2N)/8E@Y[ I"YP@S_(1AUX46-A+[-Q:K$=G"_2CG&<.
M"L"=+B*3L*%CM5E9$%?&I56(FBK<"MX#,"PAV0195#*Z(96)L"A(8]2H>0TQ
MEMD"C&1:6RU5(@!1PTQ@1>S4DCJLRZ2HB:M@"CN332;'=%9TU2XZ!NG@&Z$7
M2#N[K.P"9ZNXZ$$4!%$\<\1Q13/$[#%K&E@[=QZUA,"0N5!S5K/V[+N )1%<
MK7.$#J$V3#M4SWF%)J VA+!/*79&D[CAXZ+4MA7BJ93.<5]$4 DT(O4BQ0<@
MAXIOQ_VT-(4BR=E'-&S4EITG:IJ&$K\LN#>8&>A[K\ZQM$4N2)RV,C6R_>XA
MB?I%50'C6RGJ#'T B/H42);J-L@(YCI\!1L\QHW5I\ET,J;\F.;H]RUUF9Q+
M4Y!2S0T(G%.9!])MUVD&?HHXSSE9&#X'=)N1=PPNBQ&@$K0!1L _(QG*.HM%
M+L+9<L2 T07;V*>!*1BK]!)22(K&7&>W0F0W!+8&"1V(<1C[ZM$,2/]$>O_Y
MX\E $NP+MB:+8&+8Z#4,INP9'C@S\%M0-^A3(^D "&N]#5WZ,,5Z\12ISP54
MI6,,]-.7MP@[,F_2MJ-$KWS5)/5'YZCRL5-\6.VCHZ:S<](%R=><PX@-%)L(
ME8?[[ZROJ013E1MS !T)6G, H8$<CPUOWI@D@*2/2TH<@M/<PV+>9-?QA)1$
MJZI4=4G2D5H5B3;HG@;:3KC+#RMS9(GM@(,ZJNA%\(>PLRW=31](Q*[/W*>%
MG[=:^/E>Y3J36TI.S9YZC?=B9.HU$4U#A3YSR\JVS>L,<5ES'XX/[_%/01\N
MC-FIG_\,*](S*R4?CW^#\YMU]"]G+5VG4%]/V>\*D2(H=Y3B^"-OB!#@5%(/
MEJY8$G[X2A+\SBTN_BO)J%;-40:TERC!YC$^PR1F-/"*,4=I+:A?@:;T-@[\
MT=K!JCX:,E%7QO-M 97QRWEAEQ$"-P/HK'NC7&]4O$!1=&$M]R?)'5[*6^N/
MI7/Y<&^% R$""]OULCW]V_(>VGXXB&NGK>Z<6-VSCLD"^=3/@!*8M@=@$";N
M!YS<.GVB9KTY[R">2E87GX->FLCGWFTAP0@=9#J 0I<$0?(P3NAQ.1,?=29!
MTFCQU;UC&6WA%!T04&=3H]N)*K9A&RWJX@@;T+>W@K:+%E<YLT2K1 *NXJ/V
M/6;:HPZL"&DG/!+(RXX,==*Z3<4-=:J4T1LD;%8 @:.*6_1OG\:Q$XM\%33=
M!-50MSD,^M$NHM)%03/UAFY_X*B&+]^H>IC6WR9.%5U.8&;?;,P@"N0/N:SK
M_!E=B4]2%_!L2^T+8J!N*[>I>L6YWJZC/N4[/$?5@T#\*^0CRL=$O6\/25UJ
M:#"M?YO(7"R"&D?IP?%KSO>F;CP)2+0M&8.?+B]$4])1N><B/N!"IME3I/N6
M<EN1W HEW7!SN7(]*/8B(A[OM8Y\<I++&(%(7)NYM!KM+D-X=WN6D*L(RBW:
M]"\V-#KK\-WB?O* 2.3,*$ ([9:%68"<!F* )[JZY/M&!C@J4*T+MXRDH>46
M40A@G"Z1:,$[>EM%8W0#BWQ\%\&,FM\Q8\&_SB?.C18(1=-&$_4Y<?E@!>HL
M,Y&CJ8N)13I=& FGR8)X3$E!N_*1(I5CFYPT$LL!SG#4,[G>;H'7]<=_.>+1
M0\!0KV&6Z$NE%$AU9W+1J:0SU98X!=&=7>PJ$#A-QX34ILCMR+BCF9@K*1<'
MM8UOGE-L(?J85X=NZ)>WY"\8))>9^))>"'R3N"/Q#"HM8A-W# ]O)6+%RZ6#
MQDFJ;DN]J(W_1H7>69A[]>$\^6L:.*;PPD>KY]*]7.^PM0USKW3*G80J]-P4
M;>/6R3FY*F5<YU_J N[L8R/*URVRE2A7(6EJ(!1R590EC?!T)<$SVX!K/L##
MNV.^VK="T5+76HZ@UQ_<[M'$D'1IKU!_Y<H87KOD!5SO4C<ZBFX<TJWPPHCG
M)'XBXF,4>JW.!(U,=0 IA %R0;%C&E?[=6$.(H*_7*;U3 P3W]Z(]W089$N
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M3NR#\LL6RB_WPO!&W_.K@"*2%T?H/%''+EC_D?6^QI?HM:6B)7R4?"<W^$7
MSEJ@:MZ/*FP(0@D:R4[W@307$8MZM-YV<F'N2"E#Z\7XLC)S58I!NB<%)DA3
M)9([$ @Q9GJFR.1TW$A)U)1C1WG=VW'<KG@=]GXJA3%+_D$8U2'0N?QJJGW:
M_N9L*C^UZH;+#]9^!C]:E+["+##U:/+BV4AY^1&8?*C=FG]X!0? (/YS932R
MBP;@>_J50_I &[2_Q#O]+U!+ P04    " !"@YI6-BP!]7T#  !]!P  &0
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M[NE]1&4-:'\KI3E-;(#NQ9W^!U!+ P04    " !"@YI6MH HQUP$  "1"@
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M#3-Z,Z*R!VA_(:793&R [2MT]!]02P,$%     @ 0H.:5A"53A*C @  G04
M !D   !X;"]W;W)K<VAE971S+W-H965T,C8N>&UL?53+;MLP$/R5A1H4+2!$
M+S\4UQ80YX'FD#2PT^10]$!+:XL(1;HD%2=_WZ5DJT[A^"(NR9WA+*G9\4;I
M9U,B6GBMA#03K[1V/0H"DY=8,7.JUBAI9ZETQ2Q-]2HP:XVL:$"5".(P' 05
MX]++QLW:O<[&JK:"2[S78.JJ8OIMBD)M)E[D[19F?%5:MQ!DXS5;X1SMS_6]
MIEG0L12\0FFXDJ!Q.?'.H]&TY_*;A$>.&[,7@ZMDH=2SF]P4$R]T@E!@;AT#
MH^$%+U (1T0R_FPYO>Y(!]R/=^S73>U4RX(9O%#BB1>VG'BI!P4N62WL3&V^
MX[:>ON/+E3#-%S9M;A)[D-?&JFH+)@45E^W(7K?WL =(PP\ \180-[K;@QJ5
ME\RR;*S5!K3+)C87-*4V:!+'I7N4N=6TRPEGLYN[QZN[AQ^SFZLY?'E@"X'F
MZSBPQ.SV@WS+,FU9X@]8$KA5TI8&KF2!Q7M\0(HZ6?%.UC0^2GC+]"DDD0]Q
M&"='^)*NS*3A2SXJ4[Z@M$J_P24WN5"FU@B_SA?&:OHO?A^JN"7L'29T7AF9
M-<MQXI$9#.H7]++/GZ)!^.V(W%XGMW>,/9N3]XI:(*@E[*1S-#[<H3VD]2C;
M8:WO:"6Y/U?D-&.Q<(?:$F&I!%F6R]4(+BEDV@"7M*-JPV1A@-XH+[M'@DO,
ML5J@WJW$<,TEIS^S@)52E'\"T3#U!_&@B6(_3%-X(LLZUK56.1H#:>CWDQB&
M-)RE,&,;^M<M:LZ$@;/8CZ(AI)&?G@WA05DF"/I?%2>0]",_'O9=%/?\?IK
MH0<)]BQ3H5XUC<'0)=32MN[I5KO><]Y:[E]ZV[CH'E9<&A"X)&AX.NQ[H-MF
MT$ZL6C<&7"A+=F["DOHG:I= ^TNE[&[B#N@Z<O874$L#!!0    ( $*#FE93
M.()OZ@0  'T/   9    >&PO=V]R:W-H965T<R]S:&5E=#(W+GAM;.U736_;
M.!#]*P-W432 6HOZH*0T,> X:1L@38K:NSDL]D!+M,VM)*HD5=?_?H>4+:>M
MXW8/>]H<$I$49^8-WYN1>;:6ZI-><6[@:U76^GRP,J8Y'0YUON(5TZ]DPVM\
MLY"J8@:G:CG4C>*L<$95.0Q\GPXK)NK!Z,RM?5"C,]F:4M3\@P+=5A53FPM>
MRO7Y@ QV"Q_%<F7LPG!TUK EGW+S>_-!X6S8>RE$Q6LM9 V*+\X'8W)Z0>U^
MM^$/P=?ZP1AL)G,I/]G)=7$^\"T@7O+<6 \,'U_XA)>E=80P/F]]#OJ0UO#A
M>.?]C<L=<YDSS2>RO!>%69T/T@$4?,':TGR4ZW=\FT]L_>6RU.X_K+N]<3B
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M5PG^T%'=9:^;&-FX"]9<&F3+#5=X/^;*;L#W"RG-;F(#]#?NT3]02P,$%
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MW>LWDBK?<Z%I,%."!OT)]4O5[TZ],;)T=_U.&GHYW#*CIQJ5=2![*J5I-S9
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MZ4V[-,^2A5V;!/8IB=D-Y&G7HDH#ZAN6Z>Q4@>VEOY>\:>E@MZ'%>2 C20:
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MAB*1F(<WB1IQJ!<]!W&0A."H3G#>LT6/UXRBE]VF86F2!$5U07>@3_94Z7O
M/KW4VWQ]?Z\:MT%;#%8%NRXGY;'RSBR(AD3\F"F%BZ.5%#;(2(%<.1:KJ>0B
MD!-R#<L7!;!<%JW+DKI=E/,(*]M7+X[A>(Q<K .AGHG*@:OM:OEH!J#TS1(
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MT$V 0:\S.._!(.STPP,6=Y7)1M -@WJX:!/S?SF^/QFP'OO8L'O+>):FU.%
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M.MKM<$UW*91F 7U?"J%W+\9!<SL;_0]02P,$%     @ 0H.:5B0(NGS* P
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M!ZII=9J%D6O77BRDP6;%34OL#JFR GB^E-+L%M9 VV^._@502P,$%     @
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M3)46<1&,&<2,Y__D1U&(2D#]5$!0! 0' 4%P(J!>!-0ST#RS#&M$-.EUI-B
M-'>CFCG(:I-%(PWCYC%.M<2K#.-TKS_\ZVD\'3^.O]Y/H7\_@M'XV\?IX_CQ
MZ>'C] ,,4H4!2L%0Q#/&B2G]-=P3*8DI/[P?44U8I*[@ TQ3N60AB6#,N5AG
MMT)?*1$RHJG"UA#> >/PA4417E,=5R. 2<,-BV0'>;+!B61'-*R!U[J&P L"
M>)J.X/V[*TC(3QQ7^HC<T"[WA<@:U/U,KKZ5VY=QL9QE38.RID&F6S^A6Q:M
M'WY/F6)9)?[Y$]M@K&FL_CU&GDLVCDN:R7RG$A+2KH.S55&YID[O]]_\EO?'
M,>X+B>W1UTOZNDV]-\D?AP(M<))B 22%65$1JJYA*84Z^NQSV78F:U:?=:_I
MUYH==UTEL_9])EFC)&M8R>[3>$8EB 6$@FO&EX@)$2,S%N$SQB'^GV4L#G+M
M9@4O.&"S]GXF6[-D:UK9ACLBA%-L3F4QV7&Q87$:0\KG3(4BY9K.MYQ 8M-P
M##?OKE7!O?4.>*T9G<G;*GE;5MXQUX0OV2RB0'!<ZNU0G5_#%A.P KC")52&
MB'IU##+OX[8"Z=7\]@&F-9$S,6]*S)LS'RL7/$RE/#%8K:JO78UN7DSL1KMV
M4U9I#ZQ=@K7/!+-0625?2]5^0>4'E>5JC^JVI+JU4CW0->4IA0$:DSE,J,Q\
M&@^I>6E2- .XB!X#LZJ^%NQ"8GL%\+V='_$N__(L-"]4@$NI[5>@XLC\7[L4
M%_U5U^+FX5ILS^E<YIUC\JV6Q,*,HYZA6T?0!6$2UB1*Z5'(O /S[$K*>E!K
M'7*^A37R=][(MYNC3Z,^])-$HC^.X.L")A)W9?(9WS_;UJ-L%W(]10G>PD/Y
M.Q/E-]Y@@E_(&Q45> NGY>^LEO^+O5;17]5;-EY,\+=P6_[.;OEVOW6!"=YZ
ML8H%A[L#>Q*OA70KVVKS30/WBTO&%41T@?)>[09+*O//!/F)%DFVTYX)C?OV
M['!%":*:&_#Z0@B]/3&;]_)C3>]_4$L#!!0    ( $*#FE8::M=KY00  ,@:
M   9    >&PO=V]R:W-H965T<R]S:&5E=#,W+GAM;+69:Y/:-A2&_XK&S722
MF>W:\H7+%IC9Q6G+3)/2A4T^"UN )K9%)!EV_WWER_J"O0I,E2]@&YU7TH/.
MT0N:G"C[QO<8"_ <1PF?&GLA#G>FR8,]CA&_I0><R$^VE,5(R%NV,_F!813F
M07%DVI8U,&-$$F,VR9\MV6Q"4Q&1!"\9X&D<(_;R@"-ZFAK0>'WP2'9[D3TP
M9Y,#VN$5%D^')9-W9J42DA@GG- $,+R=&O?PSK?S@+S%%X)/O'$-LJEL*/V6
MW2S"J6%E(\(1#D0F@>3;$<]Q%&5*<AS?2U&CZC,+;%Z_JO^13UY.9H,XGM/H
M*PG%?FJ,#!#B+4HC\4A/?^%R0EZF%]"(YZ_@5+:U#!"D7-"X#)8CB$E2O*/G
M$D0C +IO!-AE@'UI@%,&.)<&N&6 FY,III)S\)% LPFC)\"RUE(MN\AAYM%R
M^B3)OO>58/)3(N/$['[^[]-BM5@O_OF\ O>??> OOGQ<K1?KI\>/*_ ;>$BY
MC. <S&F\(0G*OJP;L)+++TPC#.@6+%,6["5YL&0DP. ^BFB0-P/O?2P0B?@'
MJ?.T\L'[=Q_ .T 2L-[3E*,DY!-3R#ED(S&#<KP/Q7CM-\;KX^ 66(,;8%NV
MW1,^5X=_0NP6.# /=WK"_0MZ+\//>C<E^(J^7=&W<SWG#;UYRAA.!$"<8\'O
M^G 4 FZ_0%85[O@!!7AJR+3GF!VQ,?OU%SBP?N^#HU/,UR36 N=4X!R5^NQ/
M2L,3B:(^8LK(:XD58H-<+*NAQQFT7-EX,#&/31A][9S1: 2K=JUYNM4\7>4\
M5RG;D0!%8)$D]%BDU3WG-"!(8"Z?!GT$E)K7$M IYFL2:['T*I;>_TTV3R<X
MG6*^)K$6N$$%;J!<A'/$]WVT!ITU[[K.J)T8<Z7TM10TB;4H#"L*0R6%-4,A
MECXEH&DBN/0\ 29'M(GP#4BPZ.-3Z'G-FN!Y\(R/LM-K^6@2:_$957Q&2CZ+
MY"BSBS*"^9M$1ATB]MBRSH@HN[F6B":Q%I%Q162L)+)D^(!("/"S=.E<EFMI
M>0 5>\RDLVO6HCY4X^[B&7CN&2IE_]>BTB360@6MVH=:ZO2B0FYS/^92RK3
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M&N>7>XQD8<H:R,^WE(K7F^QLHCJ\FOT'4$L#!!0    ( $*#FE;IF_W#< 0
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M BH;0-^74II]QT[0_'U$OP!02P,$%     @ 0H.:5I[RD%*/ @  U04  !D
M  !X;"]W;W)K<VAE971S+W-H965T-# N>&ULK51=;]HP%/TK5YDT;1(E']!V
M8R%22YE::2V(T/:AZH,)%V(UB3/;?.S?[]H)&9-2]K*7Q([O.3[G.+[A3L@W
ME2)JV.=9H89.JG4Y<%V5I)@SU14E%K2R$C)GFJ9R[:I2(EM:4)ZY@>==N#GC
MA1.%]MM41J'8Z(P7.)6@-GG.Y*]KS,1NZ/C.X<.,KU-M/KA16+(UQJ@?RZFD
MF=NP+'F.A>*B (FKH7/E#Z[[IMX6/''<J:,Q&"<+(=[,Y&XY=#PC"#-,M&%@
M]-KB"+/,$)&,GS6GTVQI@,?C _MWZYV\+)C"D<B>^5*G0^>+ TM<L4VF9V)W
MB[6?<\.7B$S9)^SJ6L^!9*.TR&LP*<AY4;W9OL[A".#WWP$$-2"PNJN-K,H;
MIED42K$#::J)S0RL58LF<;PPAQ)K2:N<<#J:C9_&#X_C&+[/)O<PFCS,9U>C
M>0S/=_-;&#W&\\G]>!;#&3PP*9E)L ,SW&*Q07J;4^?%&J8H[?]1) B31<;7
MS$;^Z08UXYGZ3/@:U/DGJ@/C?4EGADN8\]S4B17$M*16+*D*8LVD!O*+\'*U
MY^IU ($7],Z\_IGGAZZF7(P[-ZDSN*XR"-[)X)[)+O3\CB7Y&^Y2G$VF09-I
M8/EZ[V7ZWZS"RP_BACN-N7IM,U8)Z;<+,1=ZH$J6X-"A&ZM0;M&)/G[P+[QO
M)VSV&IN]4^Q1H[T\,B?^G+Y.I=BL4Y,J94M%"1::+GJ;CVJGKW8GTT>VD=?M
M7X;NMD5?O]'7/ZEOVBI+ 1YT:P$+!&7SYKCL'*W8TV@3>GI+/X!<%#I5;?&Z
M1[?4-#SZ[=:<]&2X(C*O>WGN@*R:2#71HK07=R$TM0$[3*GOHC0%M+X20A\F
MIA<TG3SZ#5!+ P04    " !"@YI6?(I93XD#  "R"@  &0   'AL+W=O<FMS
M:&5E=',O<VAE970T,2YX;6RUEF%SVC@0AO^*QNW<M#-M;(L (0?,!$*GG;DT
M&2#M9V$O6%-9HI(,37_]K6QC(+%]S8?[ I:M73WO6J^UP[W2/TP"8,FO5$@S
M\A)KM]>^;Z($4F8NU!8D/EDKG3*+0[WQS58#B_.@5/@T"'I^RKCTQL/\WH,>
M#U5F!9?PH(G)TI3IIPD(M1]YH7>X,>>;Q+H;_GBX91M8@'W</F@<^566F*<@
M#5>2:%B/O)OP>A)V7$ ^XQN'O3FY)D[*2JD?;O E'GF!(P(!D74I&/[M8 I"
MN$S(\;-,ZE5KNL#3ZT/V3[EX%+-B!J9*?.>Q34;>E4=B6+-,V+G:?X924-?E
MBY0P^2_9EW,#CT29L2HM@Y$@Y;+X9[_*0IP$4-H00,L FG,7"^64M\RR\5"K
M/=%N-F9S%[G4/!KAN'1O96$U/N489\?SV;?9U\?9@GR:W]^1Z?W7Y?QFNER0
M[U^6G\GT<;&\OYO-%^0C6>!^B#,!1*W)-&%R X9P2:9*6HVE)3?&@#6$R9C\
MP]F*"VXY3GEW"Y9Q8=Z3MV[Z,E&9P3EFZ%ND=PQ^5))."E+:0-HA=[A68LA,
MQA"?Q_NHNI).#](GM#7A'=,7I!-^(#2@'?*XN"7OWKYOR=NI2MK)\W8:\IZ7
MI$YH$7]9'^]\>&VV+(*1AT8SH'?@C?]Z$_:"OUOH+BNZR[;L1SKFZ#Z0"6RX
ME%QNW(O=@N8JKD,NDO;RI,[INW$8A)0._5T-2[=BZ;:R+#639@U:0TRL(L@5
M UH] KYC*]QJ:ZU2$IT!XR:*1(8;P.VFU2F[38 \ =// NK$%%3=$S$?!_U>
MMUY,KQ+3>U5A)<(ZK':-AN"GZ4!L2)QI)\=I:7X7O1?X@W[8J:?O5_3]5]&C
MR1S]0R-$_P5$& 3]H)[BJJ*X^C/K'#XA3W5+7_T/]AE4A(,_JY,X$#ZS4'/%
M!B\KU@MIO[YB87#\@ >M1'.(U$;R_(S#]37L0&;0[)-SCXBV0I<KGQF%7@X:
M7!^>G#GAJXM8VN6 KPM5OU' ZPU2+G_*30<T;,"F1VS:BHUM ![R2).AFV7T
M5'A;,%?Z6@SZ J/!I>'Q; E;#X?:TOVG5\N<9U_O7K<[> ;CG[01*>A-WBP9
M+'XF;=%15'>KANRF:$..TXMN#L]6W'*&"%AC:'#1QR+HHD$J!E9M\Z9DI2RV
M./EE@DTE:#<!GZ^5LH>!6Z!J4\?_ E!+ P04    " !"@YI6?A4_M5,$  #L
M%0  &0   'AL+W=O<FMS:&5E=',O<VAE970T,BYX;6RU6%UOVD@4_2LC;[5J
MI6ULC\&&+" E#E4CE23"I'E8[<-@7\!;VT-GQM!(^^,[_HB-P3BA-2_@&=][
M?.^9PW \@RUEW_@*0* ?81#QH;(28GVIJMQ=04CX!5U#).\L* N)D$.V5/F:
M ?'2I#!0L::9:DC\2!D-TKD'-AK06 1^! \,\3@,"7N^AH!NAXJNO$Q,_>5*
M)!/J:+ F2W! /*X?F!RI!8KGAQ!QGT:(P6*H7.F7-L9)0AKQU8<MW[E&22MS
M2K\E@UMOJ&A)11" *Q(((K\V8$,0)$BRCN\YJ%(\,TG<O7Y!_Y0V+YN9$PXV
M#9Y\3ZR&2D]!'BQ('(@IW7Z&O*%N@N?2@*>?:)O':@IR8RYHF"?+"D(_RK[)
MCYR(G02)4Y^ \P2\G] YDF#D"4;::%99VM8-$60T8'2+6!(MT9*+E)LT6W;C
M1\DR.H+)N[[,$Z/I^.OX[G'LH$_3^PFR[^]FTRM[YJ"GV]EG9#\ZL_O)>.J@
MC\B1 O+B !!=H"EL((J!HQN?D^62P9((\-#\&4W(?Y0AA\;,!?3^!@3Q _Y!
MIC\Z-^C]NP_H'?(C-%O1F)/(XP-5R!Z22E0WK_<ZJQ<?J== $QJ)%4?CR .O
MFJ_*W@L"\ L!U[@1<$+8!3+TOQ#6L%%3C_WV=-Q0CE&LAY'B&4?P=AA-5%Z2
MC?[Y(D/1K8"0_UO'6X;;J<=-=H-+OB8N#!7Y<^? -J",_OQ#-[6_ZYIN":Q"
M0:>@H-.$/II108)"8W6M9OEFFI_L4YN1T=-Z'7.@;G:;J FS3-/H%6&5\KI%
M>=W&\FSJA21"SAI<GP3B&3DQ6_HN">HJ;80Z=5%: JMT;19=FV?2I=DF!2V!
M52BP"@JLW]1EEM_=$1SN]'1C7Y=U89:A'=%EKRBO]VNZ1/^C.X@9Y7(,[+FN
M\$;D4]>H); *"?V"A/Z99-IODX*6P"H4Z%KYEZ[]IE!S@%T)ZGW<L[0]I=;&
M=4RK6R]5?<=UZ+\LUMN("Q9+JRCJ:V]$/G6EVD*K\H!+'O"9])H#MT5#2VA5
M&DK3HS<:BK<HUCA08K>+S?VMM2X,FX9Q1*^E)=%?\20^YW)19N"N(AK0I7^D
MRD:4DQ>E);1JSZ7/T;OGTF:KMJ<MM"H-I?'1&TW%6[1I'NZ2!K;T@]VT)@[W
M#4,[HL[2F.BO.)-#=<I]](G&D2<+=VFZH>:OS7+*)@QJ^VA\RLG+UA):E9/2
M#>F]<ZFW53?4%EJ5AM(/Z8U>XRWJ[1^J4M/ZG0/U'L9)*W!,O+AT*_@5MU(K
MW@?F;X@ ](7,H?;-JAGUU%5J"ZW*06F'L'XFL>)6W5!;:%4:2C>$&VW&&\2:
M U3>Z77KP+?6A74L;5^KZLZY60CR[2@Y3N3(E1NGR$Z0BMGBR/(J/:C;F[_6
M+^WLX+&$R<Y!)T3ZVHBC !824KNPY.^'94>+V4#0=7HZ-Z="T#"]7 'Q@"4!
M\OZ"4O$R2!Y0'/".?@)02P,$%     @ 0H.:5JZX<6JG @  [P8  !D   !X
M;"]W;W)K<VAE971S+W-H965T-#,N>&ULK55;;]HP&/TK5E9-G=0UB4,N[2!2
M"ZW&P[H*>GF8]F"2#[#JV)EMH/WWLY,THA#0'O:2^/*=\YWCR^?^1L@7M030
MZ+5@7 V<I=;EI>NJ; D%4>>B!&YFYD(61)NN7+BJE$#R"E0P%WM>Y!:$<B?M
M5V/W,NV+E6:4P[U$:E441+Y= Q.;@>,[[P,3NEAJ.^"F_9(L8 KZL;R7IN>V
M+#DM@"LJ.)(P'SA7_N4PLO%5P!.%C=IJ(^MD)L2+[8SS@>-90< @TY:!F-\:
MAL"8)3(R_C2<3IO2 K?;[^RWE7?C9484# 5[IKE>#IS$03G,R8KIB=A\A\9/
M:/DRP53U19LZ-HX=E*V4%D4#-@H*RNL_>6W680O@]PX < / _PH(&D!0&:V5
M5;9&1).T+\4&21MMV&RC6IL*;=Q0;G=QJJ69I0:GT_'=T\W=P\_)^&:*OJ*I
M.23YB@$2<W1GCM"8KX%K(2DH=#H"32A37TS<XW2$3D^^H!-$.7I8BI4B/%=]
M5QM%EM?-FNS7=79\(/L/(L]1X)\A[.&@ SX\#A]!UL+Q1[AKUJ%=#-PN!J[X
M@D.+T=A]0R.J,B;42@+Z=3536IKC]KO+7TW8ZR:T5_!2E22#@6/NF *Y!B?]
M_,F/O&]=;O\3V0?O0>L].,:>WE).S3'*T4*([JVL\5&%M\5AG?IQ$N&H[ZZW
M372%82])VK /\GJMO-Y1><^F&-C#5DJ1@>K45Q.$6XD3+PSPCKS]J-@++PZH
M"UMUX5%U$[(QEU*#I(1U:@OWLEY@WX]WM.U')7YR$7=KBUIMT5%M6W?X#''0
M7?*BO3T+0A_'X8Z^CC#<"Y-@1Z"[58[L4V!N^8)RA1C,#= [CXU#69?7NJ-%
M656HF="FWE7-I7F10-H ,S\70K]W;-%KW[CT+U!+ P04    " !"@YI6(,\:
M32($  ",$0  &0   'AL+W=O<FMS:&5E=',O<VAE970T-"YX;6RU6%%SFS@0
M_BL:KG/3SEP#"!OCG,V,[:2I9](D$[N7AYM[4$ VNH+D2K+=S-R/KP08R 24
MJ^N^V BTWWZK77V+&.T9_R(2C"7XEJ54C*U$RLVY;8LHP1D29VR#J7JR8CQ#
M4@WYVA8;CE&<&V6I#1W'MS-$J!6.\GMW/!RQK4P)Q7<<B&V6(?XTQ2G;CRW7
M.MRX)^M$ZAMV.-J@-5Y@^7ESQ]7(KE!BDF$J"*. X]78FKCG4]C7!OF,OPC>
MB\8UT*$\,O9%#^;QV'(T(YSB2&H(I/YV>(;35",I'E]+4*ORJ0V;UP?T#WGP
M*IA')/",I0\DELG8"BP0XQ7:IO*>[3_B,J"<8,12D?^"?3G7L4"T%9)EI;%B
MD!%:_*-OY4(T#"#L,("E <QY%XYREA=(HG#$V1YP/5NAZ8L\U-Q:D2-49V4A
MN7I*E)T,KVYO+Q[FU]=@<G,!;I<?+^_!_&8YN;F:3Z\OP62QN%PNP'NP4-40
M;U,,V K,$D376 !"P0QQ_D3H&DPRMJ52/[UB+-Z3- 5O+[!$)!7OP!L]=9FP
MK4 T%B-;*M[:NQV5'*<%1]C!T0.?&)6) )<TQO%S>UO%6P4-#T%/H1'P$^)G
MP'/_ -"!'OB\N !OW[PSX'K58GHYKM>UF(?8_[YGZE>5S1[Q^)^VB N@7CN0
MWHKG8H,B/+;47A.8[[ 5_OZ;ZSM_&FCV*IH]$WHXQ6M"J4Z;RM<=YH3%;10+
M$#\'T9M[%[J.%P2!.[)W+=[[E?>^T;M:%;55J"INSC&-GH#DB(H4Z4W:1J-
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M<SU!/5\Q)@\#[:#Z !-^!U!+ P04    " !"@YI6N#1<P_T%   4(@  &0
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M,%YO3&!5=]QZ8F11=;FE--0SJV%*KQ14UH#V$RG-=F(;9_ON"7\!4$L#!!0
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M#;1=6*#M0@-MJ.9#M0"J4:@60C4&U3A4$RA-KXPVT';M@?8GF:_B[:&E(TX
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M<*F"N4J*!OG[=W&</3TI;I:VOX7@^!]02P,$%     @ 0H.:5KG?@1Y5"
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MA*BCX702N?(<5"9 T6QG&YD@\LL$[CSW1BJ=PK3K59O"'DV^\QO;>XQ!UQQ
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M4K+8;"X(#@G7)ZC?9XS)[8Z>H%BU'?X/4$L#!!0    ( $*#FE:0M&X:? ,
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M,K(&%HIA05:IG+'-1Z@3ZFN^B*6B_$6;.M:Q4+02DF4U6"G(:%[]DQ^U$3L
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M_^Z'.5W(/]3R#]W(/YQ4_D^5[>4@U/(/)Y!_T.SVO7[0-*;FKMJ64AL :&<
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MT!,!=!/'D'S<HPCO9HJN?%8\A^N B0IU/DWA&BT1>TV?""^I)8L?QBBA(4X
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MCMHP$/T5*Y6J5FK)C:4K&B(!2]5]8(N6[46J^F"2";'6L5/;(>S?UY>0LBM
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M*ZD;*L0IN(CYBDFA:KP?$2'"6:C6ZBSAL2K99O'RA@"$Z>+] AB530'HUP(
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M0CHGZUB^L.U76@K*"08L%ODGV):QC@6"M9 L*9,5@R1*BV_RLQR(G02%HT]
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M BD@OI\QECX_R %V%YF'_P-02P,$%     @ 0H.:5H,E<[P2"   E%<  !D
M  !X;"]W;W)K<VAE971S+W-H965T-S4N>&ULO9Q?;]LV%,6_"N$-0P>DL23:
M3M(E!A+SSS(D:=&TW<.P!\5F8J&2Z$ERT@+[\)-DQ3)KAK':D_6AL2W=WZ7"
M$U[JB.;Q@\X^YW.E"O(EB=/\I#<OBL6;?C^?SE42YOMZH=+RR*W.DK HWV9W
M_7R1J7!6!R5Q/_"\43\)H[0W/JX_>Y>-C_6RB*-4O<M(ODR2,/MZIF+]<-+S
M>X\?O(_NYD7U07]\O COU+4J/B[>9>6[_IHRBQ*5YI%.2:9N3WJG_ALY\*J
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M4K^<J[!4575">?Q6Z^+Q395@O1'O^#]02P,$%     @ 0H.:5MY,0X6! P
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M :PJI@W;P3@211@"M6BOT3!$LA/"Q[X^V"X)@BBR(X#9%00!AL!NQ!%, 6C
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M(IAYJ=Q(4OFQI*$":0"0QD4@[[R%%_J4*) F &E>$/)O0X&T $CK@LVM0=H
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MY24:N3]C>;:J2?=Q>,G1LKNWE';[//?EOJA<5&Q[_'_!\;\1M_\ 4$L#!!0
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M(E 7B]F/T\8Q:U58[[NVMBFOL\>A>9<R?TXH\\EI3]RU/E[E#07[,&%<^7O
M\[G?CQ1"V]!L8T.ZL7W>Q0X=B^G842S/E_B@1[?=MC4UKG[H\Y$R^D"VB3NB
MU'?EJ>C5^>24;YA.G_SB_*G,N<"\<Q.<CWEB@3X?]S*2\?3<YT(44GO^%5\3
M<^F+WX_&:3?4_&-VOMXG%_;3/"*;'I??\=L9O];_9!\"I \)TH<"Z4.#]&%
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M4')O<',O87!P+GAM;%!+ 0(4 Q0    ( $*#FE:DV5U[[P   "L"   1
M          "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( $*#
MFE:97)PC$ 8  )PG   3              "  <T!  !X;"]T:&5M92]T:&5M
M93$N>&UL4$L! A0#%     @ 0H.:5J-\BW3"!0  FAX  !@
M ("!#@@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( $*#
MFE:A-X"82P4  !P4   8              " @08.  !X;"]W;W)K<VAE971S
M+W-H965T,BYX;6Q02P$"% ,4    " !"@YI6S%^2<'D'  #L'@  &
M        @(&'$P  >&PO=V]R:W-H965T<R]S:&5E=#,N>&UL4$L! A0#%
M  @ 0H.:5DI]G_1/ P  8PH  !@              ("!-AL  'AL+W=O<FMS
M:&5E=',O<VAE970T+GAM;%!+ 0(4 Q0    ( $*#FE;N(.V%4P<   (>   8
M              " @;L>  !X;"]W;W)K<VAE971S+W-H965T-2YX;6Q02P$"
M% ,4    " !"@YI6C+)K&<L(  !G1   &               @(%$)@  >&PO
M=V]R:W-H965T<R]S:&5E=#8N>&UL4$L! A0#%     @ 0H.:5EH5#YJ-"@
M!1H  !@              ("!12\  'AL+W=O<FMS:&5E=',O<VAE970W+GAM
M;%!+ 0(4 Q0    ( $*#FE:AHILEH X  '<H   8              " @0@Z
M  !X;"]W;W)K<VAE971S+W-H965T."YX;6Q02P$"% ,4    " !"@YI6XX8I
M%;<*  !9'   &               @('>2   >&PO=V]R:W-H965T<R]S:&5E
M=#DN>&UL4$L! A0#%     @ 0H.:5L=H%I:1 @  CP4  !D
M ("!RU,  'AL+W=O<FMS:&5E=',O<VAE970Q,"YX;6Q02P$"% ,4    " !"
M@YI6.)@=J#0%  "J"P  &0              @(&35@  >&PO=V]R:W-H965T
M<R]S:&5E=#$Q+GAM;%!+ 0(4 Q0    ( $*#FE8VF 6!8Q   #,R   9
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M970Q-BYX;6Q02P$"% ,4    " !"@YI6S"X+X6\$  "H"@  &0
M    @(&HDP  >&PO=V]R:W-H965T<R]S:&5E=#$W+GAM;%!+ 0(4 Q0    (
M $*#FE;$XL]A*04  *(+   9              " @4Z8  !X;"]W;W)K<VAE
M971S+W-H965T,3@N>&UL4$L! A0#%     @ 0H.:5J(HEG%V P  0 @  !D
M             ("!KIT  'AL+W=O<FMS:&5E=',O<VAE970Q.2YX;6Q02P$"
M% ,4    " !"@YI650;P!$ $  #&"0  &0              @(%;H0  >&PO
M=V]R:W-H965T<R]S:&5E=#(P+GAM;%!+ 0(4 Q0    ( $*#FE:,F<.QE 8
M # /   9              " @=*E  !X;"]W;W)K<VAE971S+W-H965T,C$N
M>&UL4$L! A0#%     @ 0H.:5I4T[6#1"0  "QT  !D              ("!
MG:P  'AL+W=O<FMS:&5E=',O<VAE970R,BYX;6Q02P$"% ,4    " !"@YI6
MEREG.YL.  "5)P  &0              @(&EM@  >&PO=V]R:W-H965T<R]S
M:&5E=#(S+GAM;%!+ 0(4 Q0    ( $*#FE8V+ 'U?0,  'T'   9
M      " @7?%  !X;"]W;W)K<VAE971S+W-H965T,C0N>&UL4$L! A0#%
M  @ 0H.:5K: *,=<!   D0H  !D              ("!*\D  'AL+W=O<FMS
M:&5E=',O<VAE970R-2YX;6Q02P$"% ,4    " !"@YI6$)5.$J,"  "=!0
M&0              @(&^S0  >&PO=V]R:W-H965T<R]S:&5E=#(V+GAM;%!+
M 0(4 Q0    ( $*#FE93.()OZ@0  'T/   9              " @9C0  !X
M;"]W;W)K<VAE971S+W-H965T,C<N>&UL4$L! A0#%     @ 0H.:5@8&&!.&
M P  " @  !D              ("!N=4  'AL+W=O<FMS:&5E=',O<VAE970R
M."YX;6Q02P$"% ,4    " !"@YI6'.Y?]7()  "P(   &0
M@(%VV0  >&PO=V]R:W-H965T<R]S:&5E=#(Y+GAM;%!+ 0(4 Q0    ( $*#
MFE8K[4^TH 0  ,0+   9              " @1_C  !X;"]W;W)K<VAE971S
M+W-H965T,S N>&UL4$L! A0#%     @ 0H.:5CJD=X)G @  .@4  !D
M         ("!]N<  'AL+W=O<FMS:&5E=',O<VAE970S,2YX;6Q02P$"% ,4
M    " !"@YI6 CJI"!0#  !#!P  &0              @(&4Z@  >&PO=V]R
M:W-H965T<R]S:&5E=#,R+GAM;%!+ 0(4 Q0    ( $*#FE::F7?-.P0  *D)
M   9              " @=_M  !X;"]W;W)K<VAE971S+W-H965T,S,N>&UL
M4$L! A0#%     @ 0H.:5B0(NGS* P  6 L  !D              ("!4?(
M 'AL+W=O<FMS:&5E=',O<VAE970S-"YX;6Q02P$"% ,4    " !"@YI6]_)/
M#!<$  !["@  &0              @(%2]@  >&PO=V]R:W-H965T<R]S:&5E
M=#,U+GAM;%!+ 0(4 Q0    ( $*#FE:N:R2<( 0  +@1   9
M  " @:#Z  !X;"]W;W)K<VAE971S+W-H965T,S8N>&UL4$L! A0#%     @
M0H.:5AIJUVOE!   R!H  !D              ("!]_X  'AL+W=O<FMS:&5E
M=',O<VAE970S-RYX;6Q02P$"% ,4    " !"@YI6Z9O]PW $   I$0  &0
M            @($3! $ >&PO=V]R:W-H965T<R]S:&5E=#,X+GAM;%!+ 0(4
M Q0    ( $*#FE:4_(%E! ,  (D(   9              " @;H( 0!X;"]W
M;W)K<VAE971S+W-H965T,SDN>&UL4$L! A0#%     @ 0H.:5I[RD%*/ @
MU04  !D              ("!]0L! 'AL+W=O<FMS:&5E=',O<VAE970T,"YX
M;6Q02P$"% ,4    " !"@YI6?(I93XD#  "R"@  &0              @(&[
M#@$ >&PO=V]R:W-H965T<R]S:&5E=#0Q+GAM;%!+ 0(4 Q0    ( $*#FE9^
M%3^U4P0  .P5   9              " @7L2 0!X;"]W;W)K<VAE971S+W-H
M965T-#(N>&UL4$L! A0#%     @ 0H.:5JZX<6JG @  [P8  !D
M     ("!!1<! 'AL+W=O<FMS:&5E=',O<VAE970T,RYX;6Q02P$"% ,4
M" !"@YI6(,\:32($  ",$0  &0              @('C&0$ >&PO=V]R:W-H
M965T<R]S:&5E=#0T+GAM;%!+ 0(4 Q0    ( $*#FE:X-%S#_04  !0B   9
M              " @3P> 0!X;"]W;W)K<VAE971S+W-H965T-#4N>&UL4$L!
M A0#%     @ 0H.:5O$&=D;% @  $0@  !D              ("!<"0! 'AL
M+W=O<FMS:&5E=',O<VAE970T-BYX;6Q02P$"% ,4    " !"@YI6.CN2J&(-
M  !VE   &0              @(%L)P$ >&PO=V]R:W-H965T<R]S:&5E=#0W
M+GAM;%!+ 0(4 Q0    ( $*#FE9$"J(XP0(   ,)   9              "
M@04U 0!X;"]W;W)K<VAE971S+W-H965T-#@N>&UL4$L! A0#%     @ 0H.:
M5@C!YO5^ @  5P8  !D              ("!_3<! 'AL+W=O<FMS:&5E=',O
M<VAE970T.2YX;6Q02P$"% ,4    " !"@YI6%1S_1*0&   S,@  &0
M        @(&R.@$ >&PO=V]R:W-H965T<R]S:&5E=#4P+GAM;%!+ 0(4 Q0
M   ( $*#FE9SS4AT:PD  .=U   9              " @8U! 0!X;"]W;W)K
M<VAE971S+W-H965T-3$N>&UL4$L! A0#%     @ 0H.:5B88I\6Z!P  L5@
M !D              ("!+TL! 'AL+W=O<FMS:&5E=',O<VAE970U,BYX;6Q0
M2P$"% ,4    " !"@YI6?F0^Y,P(  !.<   &0              @($@4P$
M>&PO=V]R:W-H965T<R]S:&5E=#4S+GAM;%!+ 0(4 Q0    ( $*#FE:YWX$>
M50@  !=9   9              " @2-< 0!X;"]W;W)K<VAE971S+W-H965T
M-30N>&UL4$L! A0#%     @ 0H.:5LI8GMDB!P  >2\  !D
M ("!KV0! 'AL+W=O<FMS:&5E=',O<VAE970U-2YX;6Q02P$"% ,4    " !"
M@YI6@GNI'>8"   '"0  &0              @($(; $ >&PO=V]R:W-H965T
M<R]S:&5E=#4V+GAM;%!+ 0(4 Q0    ( $*#FE9<D$9T9 4  ,$=   9
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M970V,2YX;6Q02P$"% ,4    " !"@YI6<^5E$P\%  "7'0  &0
M    @($CA $ >&PO=V]R:W-H965T<R]S:&5E=#8R+GAM;%!+ 0(4 Q0    (
M $*#FE8AQ?Q*7@0  * 7   9              " @6F) 0!X;"]W;W)K<VAE
M971S+W-H965T-C,N>&UL4$L! A0#%     @ 0H.:5BPGEUA9 @  I@4  !D
M             ("!_HT! 'AL+W=O<FMS:&5E=',O<VAE970V-"YX;6Q02P$"
M% ,4    " !"@YI62OYBI%("  ":!0  &0              @(&.D $ >&PO
M=V]R:W-H965T<R]S:&5E=#8U+GAM;%!+ 0(4 Q0    ( $*#FE;'YZ*QKP,
M $$-   9              " @1>3 0!X;"]W;W)K<VAE971S+W-H965T-C8N
M>&UL4$L! A0#%     @ 0H.:5CF]#,53 @  3 4  !D              ("!
M_98! 'AL+W=O<FMS:&5E=',O<VAE970V-RYX;6Q02P$"% ,4    " !"@YI6
M1-<4%$0#  "D"   &0              @(&'F0$ >&PO=V]R:W-H965T<R]S
M:&5E=#8X+GAM;%!+ 0(4 Q0    ( $*#FE;)M2YRK 4  " A   9
M      " @0*= 0!X;"]W;W)K<VAE971S+W-H965T-CDN>&UL4$L! A0#%
M  @ 0H.:5KI"/NH; P  .0L  !D              ("!Y:(! 'AL+W=O<FMS
M:&5E=',O<VAE970W,"YX;6Q02P$"% ,4    " !"@YI6O/__1*@"  #3!@
M&0              @($WI@$ >&PO=V]R:W-H965T<R]S:&5E=#<Q+GAM;%!+
M 0(4 Q0    ( $*#FE;04?JM?P0  %47   9              " @1:I 0!X
M;"]W;W)K<VAE971S+W-H965T-S(N>&UL4$L! A0#%     @ 0H.:5I?! [.F
M P  -!   !D              ("!S*T! 'AL+W=O<FMS:&5E=',O<VAE970W
M,RYX;6Q02P$"% ,4    " !"@YI6/5-<[88&  #4+   &0
M@(&IL0$ >&PO=V]R:W-H965T<R]S:&5E=#<T+GAM;%!+ 0(4 Q0    ( $*#
MFE:#)7.\$@@  )17   9              " @6:X 0!X;"]W;W)K<VAE971S
M+W-H965T-S4N>&UL4$L! A0#%     @ 0H.:5MY,0X6! P  E1@   T
M         ( !K\ ! 'AL+W-T>6QE<RYX;6Q02P$"% ,4    " !"@YI6EXJ[
M',     3 @  "P              @ %;Q $ 7W)E;',O+G)E;'-02P$"% ,4
M    " !"@YI6U8X.::T%  "?,0  #P              @ %$Q0$ >&PO=V]R
M:V)O;VLN>&UL4$L! A0#%     @ 0H.:5F?\4D), @  :"P  !H
M     ( !'LL! 'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#%
M  @ 0H.:5H:F8T@, @  82L  !,              ( !HLT! %M#;VYT96YT
A7U1Y<&5S72YX;6Q02P4&     %, 4P"\%@  W\\!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>352</ContextCount>
  <ElementCount>337</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>107</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>11</UnitCount>
  <MyReports>
    <Report instance="iart-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="iart-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0000002 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (UNAUDITED)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (UNAUDITED)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="iart-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>0000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="iart-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>0000004 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITEDParenthetical</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="iart-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>0000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="iart-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>0000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (UNAUDITED)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUNAUDITED</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (UNAUDITED)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="iart-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>0000007 - Disclosure - BASIS OF PRESENTATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/BASISOFPRESENTATION</Role>
      <ShortName>BASIS OF PRESENTATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="iart-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>0000008 - Disclosure - ACQUISITIONS AND DIVESTITURES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/ACQUISITIONSANDDIVESTITURES</Role>
      <ShortName>ACQUISITIONS AND DIVESTITURES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="iart-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>0000009 - Disclosure - REVENUES FROM CONTRACTS WITH CUSTOMERS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERS</Role>
      <ShortName>REVENUES FROM CONTRACTS WITH CUSTOMERS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="iart-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>0000010 - Disclosure - INVENTORIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/INVENTORIES</Role>
      <ShortName>INVENTORIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="iart-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>0000011 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETS</Role>
      <ShortName>GOODWILL AND OTHER INTANGIBLE ASSETS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="iart-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>0000012 - Disclosure - DEBT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/DEBT</Role>
      <ShortName>DEBT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="iart-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>0000013 - Disclosure - DERIVATIVE INSTRUMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/DERIVATIVEINSTRUMENTS</Role>
      <ShortName>DERIVATIVE INSTRUMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="iart-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>0000014 - Disclosure - STOCK-BASED COMPENSATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/STOCKBASEDCOMPENSATION</Role>
      <ShortName>STOCK-BASED COMPENSATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="iart-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>0000015 - Disclosure - RETIREMENT PLANS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/RETIREMENTPLANS</Role>
      <ShortName>RETIREMENT PLANS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="iart-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>0000016 - Disclosure - LEASES AND RELATED PARTY LEASES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/LEASESANDRELATEDPARTYLEASES</Role>
      <ShortName>LEASES AND RELATED PARTY LEASES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="iart-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>0000017 - Disclosure - TREASURY STOCK</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/TREASURYSTOCK</Role>
      <ShortName>TREASURY STOCK</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="iart-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>0000018 - Disclosure - INCOME TAXES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/INCOMETAXES</Role>
      <ShortName>INCOME TAXES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="iart-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>0000019 - Disclosure - NET INCOME PER SHARE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/NETINCOMEPERSHARE</Role>
      <ShortName>NET INCOME PER SHARE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="iart-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>0000020 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSS</Role>
      <ShortName>ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="iart-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>0000021 - Disclosure - SEGMENT AND GEOGRAPHIC INFORMATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATION</Role>
      <ShortName>SEGMENT AND GEOGRAPHIC INFORMATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="iart-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>0000022 - Disclosure - COMMITMENTS AND CONTINGENCIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/COMMITMENTSANDCONTINGENCIES</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="iart-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>0000023 - Disclosure - BASIS OF PRESENTATION (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/BASISOFPRESENTATIONPolicies</Role>
      <ShortName>BASIS OF PRESENTATION (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="iart-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>0000024 - Disclosure - ACQUISITIONS AND DIVESTITURES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/ACQUISITIONSANDDIVESTITURESTables</Role>
      <ShortName>ACQUISITIONS AND DIVESTITURES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://integralife.com/role/ACQUISITIONSANDDIVESTITURES</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="iart-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>0000025 - Disclosure - REVENUES FROM CONTRACTS WITH CUSTOMERS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSTables</Role>
      <ShortName>REVENUES FROM CONTRACTS WITH CUSTOMERS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERS</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="iart-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>0000026 - Disclosure - INVENTORIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/INVENTORIESTables</Role>
      <ShortName>INVENTORIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://integralife.com/role/INVENTORIES</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="iart-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>0000027 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables</Role>
      <ShortName>GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETS</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="iart-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>0000028 - Disclosure - DEBT (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/DEBTTables</Role>
      <ShortName>DEBT (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://integralife.com/role/DEBT</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="iart-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>0000029 - Disclosure - DERIVATIVE INSTRUMENTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/DERIVATIVEINSTRUMENTSTables</Role>
      <ShortName>DERIVATIVE INSTRUMENTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://integralife.com/role/DERIVATIVEINSTRUMENTS</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="iart-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>0000030 - Disclosure - LEASES AND RELATED PARTY LEASES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/LEASESANDRELATEDPARTYLEASESTables</Role>
      <ShortName>LEASES AND RELATED PARTY LEASES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://integralife.com/role/LEASESANDRELATEDPARTYLEASES</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="iart-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>0000031 - Disclosure - INCOME TAXES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/INCOMETAXESTables</Role>
      <ShortName>INCOME TAXES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://integralife.com/role/INCOMETAXES</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="iart-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>0000032 - Disclosure - NET INCOME PER SHARE (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/NETINCOMEPERSHARETables</Role>
      <ShortName>NET INCOME PER SHARE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://integralife.com/role/NETINCOMEPERSHARE</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="iart-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>0000033 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSTables</Role>
      <ShortName>ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSS</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="iart-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>0000034 - Disclosure - SEGMENT AND GEOGRAPHIC INFORMATION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTables</Role>
      <ShortName>SEGMENT AND GEOGRAPHIC INFORMATION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATION</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="iart-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>0000035 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/COMMITMENTSANDCONTINGENCIESTables</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://integralife.com/role/COMMITMENTSANDCONTINGENCIES</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="iart-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>0000036 - Disclosure - ACQUISITIONS AND DIVESTITURES- Business Combination, Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationNarrativeDetails</Role>
      <ShortName>ACQUISITIONS AND DIVESTITURES- Business Combination, Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="iart-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>0000037 - Disclosure - ACQUISITIONS AND DIVESTITURES - Business Combination, Schedule of Purchase Price Allocation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails</Role>
      <ShortName>ACQUISITIONS AND DIVESTITURES - Business Combination, Schedule of Purchase Price Allocation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="iart-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>0000038 - Disclosure - ACQUISITIONS AND DIVESTITURES - Divestitures, Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/ACQUISITIONSANDDIVESTITURESDivestituresNarrativeDetails</Role>
      <ShortName>ACQUISITIONS AND DIVESTITURES - Divestitures, Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="iart-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>0000039 - Disclosure - REVENUES FROM CONTRACTS WITH CUSTOMERS - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeDetails</Role>
      <ShortName>REVENUES FROM CONTRACTS WITH CUSTOMERS - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="iart-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>0000040 - Disclosure - REVENUES FROM CONTRACTS WITH CUSTOMERS - Narrative, Revenue Remaining Performance Obligation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeRevenueRemainingPerformanceObligationDetails</Role>
      <ShortName>REVENUES FROM CONTRACTS WITH CUSTOMERS - Narrative, Revenue Remaining Performance Obligation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="iart-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>0000041 - Disclosure - REVENUES FROM CONTRACTS WITH CUSTOMERS - Schedule of Changes in Contract Assets and Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofChangesinContractAssetsandLiabilitiesDetails</Role>
      <ShortName>REVENUES FROM CONTRACTS WITH CUSTOMERS - Schedule of Changes in Contract Assets and Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="iart-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>0000042 - Disclosure - REVENUES FROM CONTRACTS WITH CUSTOMERS - Schedule of Revenues Disaggregated by Major Source (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofRevenuesDisaggregatedbyMajorSourceDetails</Role>
      <ShortName>REVENUES FROM CONTRACTS WITH CUSTOMERS - Schedule of Revenues Disaggregated by Major Source (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="iart-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>0000043 - Disclosure - INVENTORIES - Schedule of Net Inventories (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/INVENTORIESScheduleofNetInventoriesDetails</Role>
      <ShortName>INVENTORIES - Schedule of Net Inventories (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="iart-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>0000044 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Schedule of Changes in Carrying Amount of Goodwill (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesinCarryingAmountofGoodwillDetails</Role>
      <ShortName>GOODWILL AND OTHER INTANGIBLE ASSETS - Schedule of Changes in Carrying Amount of Goodwill (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="iart-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>0000045 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Components of Company's Identifiable Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails</Role>
      <ShortName>GOODWILL AND OTHER INTANGIBLE ASSETS - Components of Company's Identifiable Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="iart-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>0000046 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails</Role>
      <ShortName>GOODWILL AND OTHER INTANGIBLE ASSETS - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="iart-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>0000047 - Disclosure - DEBT - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/DEBTNarrativeDetails</Role>
      <ShortName>DEBT - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="iart-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>0000048 - Disclosure - DEBT - Maximum Total Leverage Ratio Table (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/DEBTMaximumTotalLeverageRatioTableDetails</Role>
      <ShortName>DEBT - Maximum Total Leverage Ratio Table (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="iart-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>0000049 - Disclosure - DEBT - Contractual Maturity Table (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/DEBTContractualMaturityTableDetails</Role>
      <ShortName>DEBT - Contractual Maturity Table (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="iart-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>0000050 - Disclosure - DERIVATIVE INSTRUMENTS - Schedule of Derivative Instruments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofDerivativeInstrumentsDetails</Role>
      <ShortName>DERIVATIVE INSTRUMENTS - Schedule of Derivative Instruments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="iart-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>0000051 - Disclosure - DERIVATIVE INSTRUMENTS - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails</Role>
      <ShortName>DERIVATIVE INSTRUMENTS - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="iart-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>0000052 - Disclosure - DERIVATIVE INSTRUMENTS - Schedule of Cross Currency Swap Derivatives (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails</Role>
      <ShortName>DERIVATIVE INSTRUMENTS - Schedule of Cross Currency Swap Derivatives (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="iart-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>0000053 - Disclosure - DERIVATIVE INSTRUMENTS - Schedule of Net Investment Hedges Derivatives (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails</Role>
      <ShortName>DERIVATIVE INSTRUMENTS - Schedule of Net Investment Hedges Derivatives (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="iart-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>0000054 - Disclosure - DERIVATIVE INSTRUMENTS - Fair Value of Derivative Instruments By Balance Sheet Location (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails</Role>
      <ShortName>DERIVATIVE INSTRUMENTS - Fair Value of Derivative Instruments By Balance Sheet Location (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="iart-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>0000055 - Disclosure - DERIVATIVE INSTRUMENTS - Effect of Derivative Instruments Designated Cash Flow Hedges on Statements of Operations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails</Role>
      <ShortName>DERIVATIVE INSTRUMENTS - Effect of Derivative Instruments Designated Cash Flow Hedges on Statements of Operations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="iart-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>0000056 - Disclosure - DERIVATIVE INSTRUMENTS - Schedule of Derivatives Not Designated as Hedging Instruments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofDerivativesNotDesignatedasHedgingInstrumentsDetails</Role>
      <ShortName>DERIVATIVE INSTRUMENTS - Schedule of Derivatives Not Designated as Hedging Instruments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="iart-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>0000057 - Disclosure - STOCK-BASED COMPENSATION - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails</Role>
      <ShortName>STOCK-BASED COMPENSATION - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="iart-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>0000058 - Disclosure - RETIREMENT PLANS - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/RETIREMENTPLANSNarrativeDetails</Role>
      <ShortName>RETIREMENT PLANS - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="iart-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>0000059 - Disclosure - LEASES AND RELATED PARTY LEASES - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/LEASESANDRELATEDPARTYLEASESNarrativeDetails</Role>
      <ShortName>LEASES AND RELATED PARTY LEASES - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="iart-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>0000060 - Disclosure - LEASES AND RELATED PARTY LEASES - Supplemental Balance Sheet Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalBalanceSheetInformationDetails</Role>
      <ShortName>LEASES AND RELATED PARTY LEASES - Supplemental Balance Sheet Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="iart-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>0000061 - Disclosure - LEASES AND RELATED PARTY LEASES - Supplemental Cash Flow Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalCashFlowInformationDetails</Role>
      <ShortName>LEASES AND RELATED PARTY LEASES - Supplemental Cash Flow Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="iart-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>0000062 - Disclosure - LEASES AND RELATED PARTY LEASES - Future Minimum Lease Payment Under Operating Leases (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesDetails</Role>
      <ShortName>LEASES AND RELATED PARTY LEASES - Future Minimum Lease Payment Under Operating Leases (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="iart-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>0000063 - Disclosure - TREASURY STOCK - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/TREASURYSTOCKNarrativeDetails</Role>
      <ShortName>TREASURY STOCK - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="iart-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>0000064 - Disclosure - INCOME TAXES - Summary of Effective Tax Rate (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/INCOMETAXESSummaryofEffectiveTaxRateDetails</Role>
      <ShortName>INCOME TAXES - Summary of Effective Tax Rate (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="iart-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>0000065 - Disclosure - INCOME TAXES - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/INCOMETAXESNarrativeDetails</Role>
      <ShortName>INCOME TAXES - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="iart-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>0000066 - Disclosure - NET INCOME PER SHARE - Basic and Diluted Net Income Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/NETINCOMEPERSHAREBasicandDilutedNetIncomePerShareDetails</Role>
      <ShortName>NET INCOME PER SHARE - Basic and Diluted Net Income Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="iart-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>0000067 - Disclosure - NET INCOME PER SHARE - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/NETINCOMEPERSHARENarrativeDetails</Role>
      <ShortName>NET INCOME PER SHARE - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="iart-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>0000068 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) - Schedule of Comprehensive Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSScheduleofComprehensiveIncomeDetails</Role>
      <ShortName>ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) - Schedule of Comprehensive Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSTables</ParentRole>
      <Position>68</Position>
    </Report>
    <Report instance="iart-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>0000069 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) - Schedule of Changes in Accumulated Other Comprehensive Income by Component (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails</Role>
      <ShortName>ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) - Schedule of Changes in Accumulated Other Comprehensive Income by Component (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSTables</ParentRole>
      <Position>69</Position>
    </Report>
    <Report instance="iart-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>0000070 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSNarrativeDetails</Role>
      <ShortName>ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSTables</ParentRole>
      <Position>70</Position>
    </Report>
    <Report instance="iart-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>0000071 - Disclosure - SEGMENT AND GEOGRAPHIC INFORMATION - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNarrativeDetails</Role>
      <ShortName>SEGMENT AND GEOGRAPHIC INFORMATION - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="iart-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>0000072 - Disclosure - SEGMENT AND GEOGRAPHIC INFORMATION - Net Sales and Profit by Reportable Segment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails</Role>
      <ShortName>SEGMENT AND GEOGRAPHIC INFORMATION - Net Sales and Profit by Reportable Segment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="iart-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>0000073 - Disclosure - SEGMENT AND GEOGRAPHIC INFORMATION - Total Revenue by Major Geographic Area (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTotalRevenuebyMajorGeographicAreaDetails</Role>
      <ShortName>SEGMENT AND GEOGRAPHIC INFORMATION - Total Revenue by Major Geographic Area (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="iart-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>0000074 - Disclosure - COMMITMENTS AND CONTINGENCIES - Fair Value Contingent Consideration, Balance Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES - Fair Value Contingent Consideration, Balance Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="iart-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>0000075 - Disclosure - COMMITMENTS AND CONTINGENCIES - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[dq-0542-Deprecated-Concept] Concept TreasuryStockShares in us-gaap/2022 used in 6 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. iart-20230331.htm 4</Log>
    <Log type="Warning">[dq-0542-Deprecated-Concept] Concept TreasuryStockMember in us-gaap/2022 used in 16 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. iart-20230331.htm 4</Log>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 3 fact(s) appearing in ix:hidden were eligible for transformation: dei:DocumentPeriodEndDate, us-gaap:DebtInstrumentConvertibleConversionRatio1, us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod -  iart-20230331.htm 4</Log>
  </Logs>
  <InputFiles>
    <File doctype="10-Q" original="iart-20230331.htm">iart-20230331.htm</File>
    <File>iart-20230331.xsd</File>
    <File>iart-20230331_cal.xml</File>
    <File>iart-20230331_def.xml</File>
    <File>iart-20230331_lab.xml</File>
    <File>iart-20230331_pre.xml</File>
    <File>iart-20230331xexx104.htm</File>
    <File>iart-20230331xexx311.htm</File>
    <File>iart-20230331xexx312.htm</File>
    <File>iart-20230331xexx321.htm</File>
    <File>iart-20230331xexx322.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="851">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="29">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>94
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "iart-20230331.htm": {
   "axisCustom": 1,
   "axisStandard": 32,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2022": 851,
    "http://xbrl.sec.gov/dei/2022": 29
   },
   "contextCount": 352,
   "dts": {
    "calculationLink": {
     "local": [
      "iart-20230331_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "iart-20230331_def.xml"
     ]
    },
    "inline": {
     "local": [
      "iart-20230331.htm"
     ]
    },
    "labelLink": {
     "local": [
      "iart-20230331_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "iart-20230331_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "iart-20230331.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 591,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2022": 2,
    "http://xbrl.sec.gov/dei/2022": 6,
    "total": 8
   },
   "keyCustom": 49,
   "keyStandard": 288,
   "memberCustom": 52,
   "memberStandard": 55,
   "nsprefix": "iart",
   "nsuri": "http://integralife.com/20230331",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0000001 - Document - Cover",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://integralife.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000010 - Disclosure - INVENTORIES",
     "menuCat": "Notes",
     "order": "10",
     "role": "http://integralife.com/role/INVENTORIES",
     "shortName": "INVENTORIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000011 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS",
     "menuCat": "Notes",
     "order": "11",
     "role": "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETS",
     "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000012 - Disclosure - DEBT",
     "menuCat": "Notes",
     "order": "12",
     "role": "http://integralife.com/role/DEBT",
     "shortName": "DEBT",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000013 - Disclosure - DERIVATIVE INSTRUMENTS",
     "menuCat": "Notes",
     "order": "13",
     "role": "http://integralife.com/role/DERIVATIVEINSTRUMENTS",
     "shortName": "DERIVATIVE INSTRUMENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000014 - Disclosure - STOCK-BASED COMPENSATION",
     "menuCat": "Notes",
     "order": "14",
     "role": "http://integralife.com/role/STOCKBASEDCOMPENSATION",
     "shortName": "STOCK-BASED COMPENSATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000015 - Disclosure - RETIREMENT PLANS",
     "menuCat": "Notes",
     "order": "15",
     "role": "http://integralife.com/role/RETIREMENTPLANS",
     "shortName": "RETIREMENT PLANS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000016 - Disclosure - LEASES AND RELATED PARTY LEASES",
     "menuCat": "Notes",
     "order": "16",
     "role": "http://integralife.com/role/LEASESANDRELATEDPARTYLEASES",
     "shortName": "LEASES AND RELATED PARTY LEASES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TreasuryStockTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000017 - Disclosure - TREASURY STOCK",
     "menuCat": "Notes",
     "order": "17",
     "role": "http://integralife.com/role/TREASURYSTOCK",
     "shortName": "TREASURY STOCK",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TreasuryStockTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000018 - Disclosure - INCOME TAXES",
     "menuCat": "Notes",
     "order": "18",
     "role": "http://integralife.com/role/INCOMETAXES",
     "shortName": "INCOME TAXES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000019 - Disclosure - NET INCOME PER SHARE",
     "menuCat": "Notes",
     "order": "19",
     "role": "http://integralife.com/role/NETINCOMEPERSHARE",
     "shortName": "NET INCOME PER SHARE",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000002 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (UNAUDITED)",
     "menuCat": "Statements",
     "order": "2",
     "role": "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (UNAUDITED)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:CostOfGoodsAndServicesSold",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000020 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)",
     "menuCat": "Notes",
     "order": "20",
     "role": "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSS",
     "shortName": "ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000021 - Disclosure - SEGMENT AND GEOGRAPHIC INFORMATION",
     "menuCat": "Notes",
     "order": "21",
     "role": "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATION",
     "shortName": "SEGMENT AND GEOGRAPHIC INFORMATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000022 - Disclosure - COMMITMENTS AND CONTINGENCIES",
     "menuCat": "Notes",
     "order": "22",
     "role": "http://integralife.com/role/COMMITMENTSANDCONTINGENCIES",
     "shortName": "COMMITMENTS AND CONTINGENCIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000023 - Disclosure - BASIS OF PRESENTATION (Policies)",
     "menuCat": "Policies",
     "order": "23",
     "role": "http://integralife.com/role/BASISOFPRESENTATIONPolicies",
     "shortName": "BASIS OF PRESENTATION (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000024 - Disclosure - ACQUISITIONS AND DIVESTITURES (Tables)",
     "menuCat": "Tables",
     "order": "24",
     "role": "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESTables",
     "shortName": "ACQUISITIONS AND DIVESTITURES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000025 - Disclosure - REVENUES FROM CONTRACTS WITH CUSTOMERS (Tables)",
     "menuCat": "Tables",
     "order": "25",
     "role": "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSTables",
     "shortName": "REVENUES FROM CONTRACTS WITH CUSTOMERS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000026 - Disclosure - INVENTORIES (Tables)",
     "menuCat": "Tables",
     "order": "26",
     "role": "http://integralife.com/role/INVENTORIESTables",
     "shortName": "INVENTORIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000027 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)",
     "menuCat": "Tables",
     "order": "27",
     "role": "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables",
     "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000028 - Disclosure - DEBT (Tables)",
     "menuCat": "Tables",
     "order": "28",
     "role": "http://integralife.com/role/DEBTTables",
     "shortName": "DEBT (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000029 - Disclosure - DERIVATIVE INSTRUMENTS (Tables)",
     "menuCat": "Tables",
     "order": "29",
     "role": "http://integralife.com/role/DERIVATIVEINSTRUMENTSTables",
     "shortName": "DERIVATIVE INSTRUMENTS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "ica4b4c17b7db4efd96016f438f3fc36e_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)",
     "menuCat": "Statements",
     "order": "3",
     "role": "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "ica4b4c17b7db4efd96016f438f3fc36e_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "iart:AssetsAndLiabilitiesLesseeTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000030 - Disclosure - LEASES AND RELATED PARTY LEASES (Tables)",
     "menuCat": "Tables",
     "order": "30",
     "role": "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESTables",
     "shortName": "LEASES AND RELATED PARTY LEASES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "iart:AssetsAndLiabilitiesLesseeTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000031 - Disclosure - INCOME TAXES (Tables)",
     "menuCat": "Tables",
     "order": "31",
     "role": "http://integralife.com/role/INCOMETAXESTables",
     "shortName": "INCOME TAXES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000032 - Disclosure - NET INCOME PER SHARE (Tables)",
     "menuCat": "Tables",
     "order": "32",
     "role": "http://integralife.com/role/NETINCOMEPERSHARETables",
     "shortName": "NET INCOME PER SHARE (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000033 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) (Tables)",
     "menuCat": "Tables",
     "order": "33",
     "role": "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSTables",
     "shortName": "ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000034 - Disclosure - SEGMENT AND GEOGRAPHIC INFORMATION (Tables)",
     "menuCat": "Tables",
     "order": "34",
     "role": "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTables",
     "shortName": "SEGMENT AND GEOGRAPHIC INFORMATION (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": null
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000035 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables)",
     "menuCat": "Tables",
     "order": "35",
     "role": "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESTables",
     "shortName": "COMMITMENTS AND CONTINGENCIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "i2aee20b22d6c4af1adc9943efb3a200b_D20221206-20221206",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PaymentsToAcquireBusinessesGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000036 - Disclosure - ACQUISITIONS AND DIVESTITURES- Business Combination, Narrative (Details)",
     "menuCat": "Details",
     "order": "36",
     "role": "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationNarrativeDetails",
     "shortName": "ACQUISITIONS AND DIVESTITURES- Business Combination, Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "i2aee20b22d6c4af1adc9943efb3a200b_D20221206-20221206",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PaymentsToAcquireBusinessesGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "ica4b4c17b7db4efd96016f438f3fc36e_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000037 - Disclosure - ACQUISITIONS AND DIVESTITURES - Business Combination, Schedule of Purchase Price Allocation (Details)",
     "menuCat": "Details",
     "order": "37",
     "role": "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails",
     "shortName": "ACQUISITIONS AND DIVESTITURES - Business Combination, Schedule of Purchase Price Allocation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "i9562f5f76a11487db81f0d5c50e212ba_I20221206",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "i945ecb5f56064998992427ac8c2997e7_I20220831",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000038 - Disclosure - ACQUISITIONS AND DIVESTITURES - Divestitures, Narrative (Details)",
     "menuCat": "Details",
     "order": "38",
     "role": "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESDivestituresNarrativeDetails",
     "shortName": "ACQUISITIONS AND DIVESTITURES - Divestitures, Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "i945ecb5f56064998992427ac8c2997e7_I20220831",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:RevenueFromContractWithCustomerPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "iart:ReturnPolicyIssueOfCreditNumberOfDaysFromShipment",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000039 - Disclosure - REVENUES FROM CONTRACTS WITH CUSTOMERS - Narrative (Details)",
     "menuCat": "Details",
     "order": "39",
     "role": "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeDetails",
     "shortName": "REVENUES FROM CONTRACTS WITH CUSTOMERS - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:RevenueFromContractWithCustomerPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "iart:ReturnPolicyIssueOfCreditNumberOfDaysFromShipment",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "ica4b4c17b7db4efd96016f438f3fc36e_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000004 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical)",
     "menuCat": "Statements",
     "order": "4",
     "role": "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITEDParenthetical",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "ica4b4c17b7db4efd96016f438f3fc36e_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "i770b51dde44c4f0f852868d1b571cf9e_I20230331",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueRemainingPerformanceObligationPercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000040 - Disclosure - REVENUES FROM CONTRACTS WITH CUSTOMERS - Narrative, Revenue Remaining Performance Obligation (Details)",
     "menuCat": "Details",
     "order": "40",
     "role": "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeRevenueRemainingPerformanceObligationDetails",
     "shortName": "REVENUES FROM CONTRACTS WITH CUSTOMERS - Narrative, Revenue Remaining Performance Obligation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "i770b51dde44c4f0f852868d1b571cf9e_I20230331",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueRemainingPerformanceObligationPercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "i05f0e25f7b574dc197a1e7d75cd2e313_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerAssetNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000041 - Disclosure - REVENUES FROM CONTRACTS WITH CUSTOMERS - Schedule of Changes in Contract Assets and Liabilities (Details)",
     "menuCat": "Details",
     "order": "41",
     "role": "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofChangesinContractAssetsandLiabilitiesDetails",
     "shortName": "REVENUES FROM CONTRACTS WITH CUSTOMERS - Schedule of Changes in Contract Assets and Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "i05f0e25f7b574dc197a1e7d75cd2e313_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerAssetNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000042 - Disclosure - REVENUES FROM CONTRACTS WITH CUSTOMERS - Schedule of Revenues Disaggregated by Major Source (Details)",
     "menuCat": "Details",
     "order": "42",
     "role": "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofRevenuesDisaggregatedbyMajorSourceDetails",
     "shortName": "REVENUES FROM CONTRACTS WITH CUSTOMERS - Schedule of Revenues Disaggregated by Major Source (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "i41cd523bdedf46cc95670faedd457b46_D20230101-20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "ica4b4c17b7db4efd96016f438f3fc36e_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryFinishedGoodsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000043 - Disclosure - INVENTORIES - Schedule of Net Inventories (Details)",
     "menuCat": "Details",
     "order": "43",
     "role": "http://integralife.com/role/INVENTORIESScheduleofNetInventoriesDetails",
     "shortName": "INVENTORIES - Schedule of Net Inventories (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "ica4b4c17b7db4efd96016f438f3fc36e_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryFinishedGoodsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "i05f0e25f7b574dc197a1e7d75cd2e313_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000044 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Schedule of Changes in Carrying Amount of Goodwill (Details)",
     "menuCat": "Details",
     "order": "44",
     "role": "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesinCarryingAmountofGoodwillDetails",
     "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS - Schedule of Changes in Carrying Amount of Goodwill (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:GoodwillForeignCurrencyTranslationGainLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "ica4b4c17b7db4efd96016f438f3fc36e_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000045 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Components of Company's Identifiable Intangible Assets (Details)",
     "menuCat": "Details",
     "order": "45",
     "role": "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails",
     "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS - Components of Company's Identifiable Intangible Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "ica4b4c17b7db4efd96016f438f3fc36e_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "iart:CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "ica4b4c17b7db4efd96016f438f3fc36e_I20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000046 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Narrative (Details)",
     "menuCat": "Details",
     "order": "46",
     "role": "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails",
     "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "ica4b4c17b7db4efd96016f438f3fc36e_I20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "ica4b4c17b7db4efd96016f438f3fc36e_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SecuredDebtCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000047 - Disclosure - DEBT - Narrative (Details)",
     "menuCat": "Details",
     "order": "47",
     "role": "http://integralife.com/role/DEBTNarrativeDetails",
     "shortName": "DEBT - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "ica4b4c17b7db4efd96016f438f3fc36e_I20230331",
      "decimals": "-5",
      "lang": "en-US",
      "name": "iart:InterestPaymentsReminderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "i29c495bb726f416f92c438401600a765_I20230324",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "iart:DebtInstrumentCovenantMaximumLeverageRatio",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000048 - Disclosure - DEBT - Maximum Total Leverage Ratio Table (Details)",
     "menuCat": "Details",
     "order": "48",
     "role": "http://integralife.com/role/DEBTMaximumTotalLeverageRatioTableDetails",
     "shortName": "DEBT - Maximum Total Leverage Ratio Table (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "i29c495bb726f416f92c438401600a765_I20230324",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "iart:DebtInstrumentCovenantMaximumLeverageRatio",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "ica4b4c17b7db4efd96016f438f3fc36e_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000049 - Disclosure - DEBT - Contractual Maturity Table (Details)",
     "menuCat": "Details",
     "order": "49",
     "role": "http://integralife.com/role/DEBTContractualMaturityTableDetails",
     "shortName": "DEBT - Contractual Maturity Table (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "ica4b4c17b7db4efd96016f438f3fc36e_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)",
     "menuCat": "Statements",
     "order": "5",
     "role": "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OtherDepreciationAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "ibaa12b7418534a0f9c95d84d9ad6b1bb_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeFairValueOfDerivativeNet",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000050 - Disclosure - DERIVATIVE INSTRUMENTS - Schedule of Derivative Instruments (Details)",
     "menuCat": "Details",
     "order": "50",
     "role": "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofDerivativeInstrumentsDetails",
     "shortName": "DERIVATIVE INSTRUMENTS - Schedule of Derivative Instruments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "id3e91944e1f34523a944e5c31a1dcfb8_I20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DerivativeNotionalAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "ica4b4c17b7db4efd96016f438f3fc36e_I20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000051 - Disclosure - DERIVATIVE INSTRUMENTS - Narrative (Details)",
     "menuCat": "Details",
     "order": "51",
     "role": "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails",
     "shortName": "DERIVATIVE INSTRUMENTS - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "ica4b4c17b7db4efd96016f438f3fc36e_I20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "i0d2cb496f6d34578a914d07e7359d877_I20201221",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeNotionalAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000052 - Disclosure - DERIVATIVE INSTRUMENTS - Schedule of Cross Currency Swap Derivatives (Details)",
     "menuCat": "Details",
     "order": "52",
     "role": "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails",
     "shortName": "DERIVATIVE INSTRUMENTS - Schedule of Cross Currency Swap Derivatives (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "if68feb9648554b258a953ab0b3cf1b44_I20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DerivativeFairValueOfDerivativeNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "i0d2cb496f6d34578a914d07e7359d877_I20201221",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeNotionalAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000053 - Disclosure - DERIVATIVE INSTRUMENTS - Schedule of Net Investment Hedges Derivatives (Details)",
     "menuCat": "Details",
     "order": "53",
     "role": "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails",
     "shortName": "DERIVATIVE INSTRUMENTS - Schedule of Net Investment Hedges Derivatives (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "i58f139fbd41647c48c9057f1580cdac4_I20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DerivativeFairValueOfDerivativeNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "i5fcf3db2e33e4516bb7de79733b0c0d0_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeFairValueOfDerivativeAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000054 - Disclosure - DERIVATIVE INSTRUMENTS - Fair Value of Derivative Instruments By Balance Sheet Location (Details)",
     "menuCat": "Details",
     "order": "54",
     "role": "http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails",
     "shortName": "DERIVATIVE INSTRUMENTS - Fair Value of Derivative Instruments By Balance Sheet Location (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "i5fcf3db2e33e4516bb7de79733b0c0d0_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeFairValueOfDerivativeAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "i05f0e25f7b574dc197a1e7d75cd2e313_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000055 - Disclosure - DERIVATIVE INSTRUMENTS - Effect of Derivative Instruments Designated Cash Flow Hedges on Statements of Operations (Details)",
     "menuCat": "Details",
     "order": "55",
     "role": "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails",
     "shortName": "DERIVATIVE INSTRUMENTS - Effect of Derivative Instruments Designated Cash Flow Hedges on Statements of Operations (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "ie8763013b51645d9b4f267faa1bc585c_D20230101-20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000056 - Disclosure - DERIVATIVE INSTRUMENTS - Schedule of Derivatives Not Designated as Hedging Instruments (Details)",
     "menuCat": "Details",
     "order": "56",
     "role": "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofDerivativesNotDesignatedasHedgingInstrumentsDetails",
     "shortName": "DERIVATIVE INSTRUMENTS - Schedule of Derivatives Not Designated as Hedging Instruments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000057 - Disclosure - STOCK-BASED COMPENSATION - Narrative (Details)",
     "menuCat": "Details",
     "order": "57",
     "role": "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails",
     "shortName": "STOCK-BASED COMPENSATION - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000058 - Disclosure - RETIREMENT PLANS - Narrative (Details)",
     "menuCat": "Details",
     "order": "58",
     "role": "http://integralife.com/role/RETIREMENTPLANSNarrativeDetails",
     "shortName": "RETIREMENT PLANS - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "iart:LesseeOperatingLeaseNumberOfRenewalOptions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "renewal_option",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000059 - Disclosure - LEASES AND RELATED PARTY LEASES - Narrative (Details)",
     "menuCat": "Details",
     "order": "59",
     "role": "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESNarrativeDetails",
     "shortName": "LEASES AND RELATED PARTY LEASES - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "iart:LesseeOperatingLeaseNumberOfRenewalOptions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "renewal_option",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "i5173bceb1ba843f5b9ba6fac4ca9b4ca_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (UNAUDITED)",
     "menuCat": "Statements",
     "order": "6",
     "role": "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUNAUDITED",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (UNAUDITED)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "i5173bceb1ba843f5b9ba6fac4ca9b4ca_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "iart:AssetsAndLiabilitiesLesseeTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "ica4b4c17b7db4efd96016f438f3fc36e_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000060 - Disclosure - LEASES AND RELATED PARTY LEASES - Supplemental Balance Sheet Information (Details)",
     "menuCat": "Details",
     "order": "60",
     "role": "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalBalanceSheetInformationDetails",
     "shortName": "LEASES AND RELATED PARTY LEASES - Supplemental Balance Sheet Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "iart:AssetsAndLiabilitiesLesseeTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "ief22d29946704881b53879628a3b3a03_I20230331",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "iart:CashFlowLesseeTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000061 - Disclosure - LEASES AND RELATED PARTY LEASES - Supplemental Cash Flow Information (Details)",
     "menuCat": "Details",
     "order": "61",
     "role": "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalCashFlowInformationDetails",
     "shortName": "LEASES AND RELATED PARTY LEASES - Supplemental Cash Flow Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "iart:CashFlowLesseeTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "ica4b4c17b7db4efd96016f438f3fc36e_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000062 - Disclosure - LEASES AND RELATED PARTY LEASES - Future Minimum Lease Payment Under Operating Leases (Details)",
     "menuCat": "Details",
     "order": "62",
     "role": "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesDetails",
     "shortName": "LEASES AND RELATED PARTY LEASES - Future Minimum Lease Payment Under Operating Leases (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "ica4b4c17b7db4efd96016f438f3fc36e_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "ica4b4c17b7db4efd96016f438f3fc36e_I20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TreasuryStockCommonShares",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000063 - Disclosure - TREASURY STOCK - Narrative (Details)",
     "menuCat": "Details",
     "order": "63",
     "role": "http://integralife.com/role/TREASURYSTOCKNarrativeDetails",
     "shortName": "TREASURY STOCK - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "i05f0e25f7b574dc197a1e7d75cd2e313_I20221231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:TreasuryStockCommonShares",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000064 - Disclosure - INCOME TAXES - Summary of Effective Tax Rate (Details)",
     "menuCat": "Details",
     "order": "64",
     "role": "http://integralife.com/role/INCOMETAXESSummaryofEffectiveTaxRateDetails",
     "shortName": "INCOME TAXES - Summary of Effective Tax Rate (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000065 - Disclosure - INCOME TAXES - Narrative (Details)",
     "menuCat": "Details",
     "order": "65",
     "role": "http://integralife.com/role/INCOMETAXESNarrativeDetails",
     "shortName": "INCOME TAXES - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000066 - Disclosure - NET INCOME PER SHARE - Basic and Diluted Net Income Per Share (Details)",
     "menuCat": "Details",
     "order": "66",
     "role": "http://integralife.com/role/NETINCOMEPERSHAREBasicandDilutedNetIncomePerShareDetails",
     "shortName": "NET INCOME PER SHARE - Basic and Diluted Net Income Per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "i142beeb645c448e9b1d164dc7254fd2f_D20230331-20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000067 - Disclosure - NET INCOME PER SHARE - Narrative (Details)",
     "menuCat": "Details",
     "order": "67",
     "role": "http://integralife.com/role/NETINCOMEPERSHARENarrativeDetails",
     "shortName": "NET INCOME PER SHARE - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "i142beeb645c448e9b1d164dc7254fd2f_D20230331-20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000068 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) - Schedule of Comprehensive Income (Details)",
     "menuCat": "Details",
     "order": "68",
     "role": "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSScheduleofComprehensiveIncomeDetails",
     "shortName": "ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) - Schedule of Comprehensive Income (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "i05f0e25f7b574dc197a1e7d75cd2e313_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000069 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) - Schedule of Changes in Accumulated Other Comprehensive Income by Component (Details)",
     "menuCat": "Details",
     "order": "69",
     "role": "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails",
     "shortName": "ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) - Schedule of Changes in Accumulated Other Comprehensive Income by Component (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000007 - Disclosure - BASIS OF PRESENTATION",
     "menuCat": "Notes",
     "order": "7",
     "role": "http://integralife.com/role/BASISOFPRESENTATION",
     "shortName": "BASIS OF PRESENTATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000070 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) - Narrative (Details)",
     "menuCat": "Details",
     "order": "70",
     "role": "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSNarrativeDetails",
     "shortName": "ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "icf3a5e50a53a4b55a3ef05b821846b94_D20230101-20230331",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000071 - Disclosure - SEGMENT AND GEOGRAPHIC INFORMATION - Narrative (Details)",
     "menuCat": "Details",
     "order": "71",
     "role": "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNarrativeDetails",
     "shortName": "SEGMENT AND GEOGRAPHIC INFORMATION - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000072 - Disclosure - SEGMENT AND GEOGRAPHIC INFORMATION - Net Sales and Profit by Reportable Segment (Details)",
     "menuCat": "Details",
     "order": "72",
     "role": "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails",
     "shortName": "SEGMENT AND GEOGRAPHIC INFORMATION - Net Sales and Profit by Reportable Segment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "ia720faaba52b43d2be21584d13ecec2a_D20230101-20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OperatingIncomeLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000073 - Disclosure - SEGMENT AND GEOGRAPHIC INFORMATION - Total Revenue by Major Geographic Area (Details)",
     "menuCat": "Details",
     "order": "73",
     "role": "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTotalRevenuebyMajorGeographicAreaDetails",
     "shortName": "SEGMENT AND GEOGRAPHIC INFORMATION - Total Revenue by Major Geographic Area (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "i8ec4e98c494d4152959a7ad4e62f2cdc_D20230101-20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "iaba62da9aab3440ab34c023a05b0b605_I20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000074 - Disclosure - COMMITMENTS AND CONTINGENCIES - Fair Value Contingent Consideration, Balance Information (Details)",
     "menuCat": "Details",
     "order": "74",
     "role": "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails",
     "shortName": "COMMITMENTS AND CONTINGENCIES - Fair Value Contingent Consideration, Balance Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "ifcaf924eb8b044b5959cc99978a303a7_I20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "i5d9c6f2f864e40aea1985e58d5f1a41e_I20190729",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationContingentConsiderationLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000075 - Disclosure - COMMITMENTS AND CONTINGENCIES - Narrative (Details)",
     "menuCat": "Details",
     "order": "75",
     "role": "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails",
     "shortName": "COMMITMENTS AND CONTINGENCIES - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "i5d9c6f2f864e40aea1985e58d5f1a41e_I20190729",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationContingentConsiderationLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000008 - Disclosure - ACQUISITIONS AND DIVESTITURES",
     "menuCat": "Notes",
     "order": "8",
     "role": "http://integralife.com/role/ACQUISITIONSANDDIVESTITURES",
     "shortName": "ACQUISITIONS AND DIVESTITURES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000009 - Disclosure - REVENUES FROM CONTRACTS WITH CUSTOMERS",
     "menuCat": "Notes",
     "order": "9",
     "role": "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERS",
     "shortName": "REVENUES FROM CONTRACTS WITH CUSTOMERS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20230331.htm",
      "contextRef": "ic974d2f05c4044e094a372dbba987fa1_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 107,
   "tag": {
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "United States"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTotalRevenuebyMajorGeographicAreaDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://integralife.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://integralife.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://integralife.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://integralife.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://integralife.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://integralife.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r660"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://integralife.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r661"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://integralife.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://integralife.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://integralife.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity City"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://integralife.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://integralife.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity State"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://integralife.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r658"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://integralife.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding (in shares)"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://integralife.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://integralife.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r658"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://integralife.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://integralife.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r658"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://integralife.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://integralife.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r662"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://integralife.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r658"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://integralife.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r658"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://integralife.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r658"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Smaller Reporting Company"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://integralife.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r658"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://integralife.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://integralife.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r657"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://integralife.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r659"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://integralife.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://integralife.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "iart_ACellIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ACell, Inc.",
        "label": "ACell, Inc. [Member]",
        "terseLabel": "ACell, Inc."
       }
      }
     },
     "localname": "ACellIncMember",
     "nsuri": "http://integralife.com/20230331",
     "presentation": [
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_ACellMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ACell",
        "label": "ACell [Member]",
        "terseLabel": "ACell"
       }
      }
     },
     "localname": "ACellMember",
     "nsuri": "http://integralife.com/20230331",
     "presentation": [
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_AcceleratedShareRepurchasesAdditionalSharesReceived": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accelerated Share Repurchases, Additional Shares Received",
        "label": "Accelerated Share Repurchases, Additional Shares Received",
        "terseLabel": "Accelerated share repurchases, additional shares received"
       }
      }
     },
     "localname": "AcceleratedShareRepurchasesAdditionalSharesReceived",
     "nsuri": "http://integralife.com/20230331",
     "presentation": [
      "http://integralife.com/role/TREASURYSTOCKNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "iart_AcceleratedShareRepurchasesPercentageOfExpectedTotalRepurchased": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accelerated Share Repurchases, Percentage Of Expected Total Repurchased",
        "label": "Accelerated Share Repurchases, Percentage Of Expected Total Repurchased",
        "terseLabel": "Accelerated share repurchases, percentage of expected total repurchased"
       }
      }
     },
     "localname": "AcceleratedShareRepurchasesPercentageOfExpectedTotalRepurchased",
     "nsuri": "http://integralife.com/20230331",
     "presentation": [
      "http://integralife.com/role/TREASURYSTOCKNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "iart_AcceleratedShareRepurchasesSharesReceivedAtInception": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accelerated Share Repurchases, Shares Received at Inception",
        "label": "Accelerated Share Repurchases, Shares Received at Inception",
        "terseLabel": "Accelerated share repurchases, shares received at inception"
       }
      }
     },
     "localname": "AcceleratedShareRepurchasesSharesReceivedAtInception",
     "nsuri": "http://integralife.com/20230331",
     "presentation": [
      "http://integralife.com/role/TREASURYSTOCKNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "iart_AccruedExpensesAndOtherCurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued expenses and other current liabilities.",
        "label": "Accrued Expenses And Other Current Liabilities [Member]",
        "terseLabel": "Accrued expenses and other current liabilities"
       }
      }
     },
     "localname": "AccruedExpensesAndOtherCurrentLiabilitiesMember",
     "nsuri": "http://integralife.com/20230331",
     "presentation": [
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_AllOtherMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All Other [Member]",
        "label": "All Other [Member]",
        "terseLabel": "All other"
       }
      }
     },
     "localname": "AllOtherMember",
     "nsuri": "http://integralife.com/20230331",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees": {
     "auth_ref": [],
     "calculation": {
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortization Of Debt Issuance Costs And Debt Refinanced Fees",
        "label": "Amortization Of Debt Issuance Costs And Debt Refinanced Fees",
        "terseLabel": "Amortization of debt issuance costs and expenses associated with debt refinancing"
       }
      }
     },
     "localname": "AmortizationOfDebtIssuanceCostsAndDebtRefinancedFees",
     "nsuri": "http://integralife.com/20230331",
     "presentation": [
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_AnnualRateOfLeaseAgreement": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Annual rate of lease agreement.",
        "label": "Annual Rate Of Lease Agreement",
        "terseLabel": "Annual rate of lease agreement"
       }
      }
     },
     "localname": "AnnualRateOfLeaseAgreement",
     "nsuri": "http://integralife.com/20230331",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_ArkisBioSciencesInc.Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arkis BioSciences Inc. [Member]",
        "label": "Arkis BioSciences Inc. [Member]",
        "terseLabel": "Arkis"
       }
      }
     },
     "localname": "ArkisBioSciencesInc.Member",
     "nsuri": "http://integralife.com/20230331",
     "presentation": [
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails",
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_AssetsAndLiabilitiesLesseeTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assets And Liabilities, Lessee [Table Text Block]",
        "label": "Assets And Liabilities, Lessee [Table Text Block]",
        "terseLabel": "Supplemental Balance Sheet Information"
       }
      }
     },
     "localname": "AssetsAndLiabilitiesLesseeTableTextBlock",
     "nsuri": "http://integralife.com/20230331",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "iart_BioDEarnoutPaymentsandMedihoneyEarnoutPaymentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "BioD Earnout Payments and Medihoney Earnout Payments [Member]",
        "label": "BioD Earnout Payments and Medihoney Earnout Payments [Member]",
        "terseLabel": "BioD Earnout Payments and Medihoney Earnout Payments"
       }
      }
     },
     "localname": "BioDEarnoutPaymentsandMedihoneyEarnoutPaymentsMember",
     "nsuri": "http://integralife.com/20230331",
     "presentation": [
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_BusinessAcquisitionNumberOfContingentLiabilities": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Acquisition, Number Of Contingent Liabilities",
        "label": "Business Acquisition, Number Of Contingent Liabilities",
        "terseLabel": "Number of contingent liabilities"
       }
      }
     },
     "localname": "BusinessAcquisitionNumberOfContingentLiabilities",
     "nsuri": "http://integralife.com/20230331",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "iart_BusinessCombinationContingentConsiderationNumberOfLiabilities": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Contingent Consideration, Number Of Liabilities",
        "label": "Business Combination, Contingent Consideration, Number Of Liabilities",
        "terseLabel": "Number of contingent liabilities remaining"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationNumberOfLiabilities",
     "nsuri": "http://integralife.com/20230331",
     "presentation": [
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "iart_BusinessCombinationIntangibleAssetAcquiredDiscountRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Intangible Asset Acquired, Discount Rate",
        "label": "Business Combination, Intangible Asset Acquired, Discount Rate",
        "terseLabel": "Intangible asset acquired, discount rate (percent)"
       }
      }
     },
     "localname": "BusinessCombinationIntangibleAssetAcquiredDiscountRate",
     "nsuri": "http://integralife.com/20230331",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill": {
     "auth_ref": [],
     "calculation": {
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Acquired Including Goodwill",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Acquired Including Goodwill",
        "totalLabel": "Total assets acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill",
     "nsuri": "http://integralife.com/20230331",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_CashFlowLesseeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash Flow, Lessee [Abstract]",
        "label": "Cash Flow, Lessee [Abstract]",
        "terseLabel": "Cash paid for amounts included in the measurement of lease liabilities:"
       }
      }
     },
     "localname": "CashFlowLesseeAbstract",
     "nsuri": "http://integralife.com/20230331",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "iart_CashFlowLesseeTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash Flow, Lessee [Table Text Block]",
        "label": "Cash Flow, Lessee [Table Text Block]",
        "terseLabel": "Supplemental Cash Flow Information"
       }
      }
     },
     "localname": "CashFlowLesseeTableTextBlock",
     "nsuri": "http://integralife.com/20230331",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "iart_ChangeInContractWithCustomerAssetRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change In Contract With Customer, Asset [Roll Forward]",
        "label": "Change In Contract With Customer, Asset [Roll Forward]",
        "terseLabel": "Contract Asset"
       }
      }
     },
     "localname": "ChangeInContractWithCustomerAssetRollForward",
     "nsuri": "http://integralife.com/20230331",
     "presentation": [
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofChangesinContractAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "iart_ChangeInContractWithCustomerLiabilityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change In Contract With Customer, Liability [Roll Forward]",
        "label": "Change In Contract With Customer, Liability [Roll Forward]",
        "terseLabel": "Contract Liability"
       }
      }
     },
     "localname": "ChangeInContractWithCustomerLiabilityRollForward",
     "nsuri": "http://integralife.com/20230331",
     "presentation": [
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofChangesinContractAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "iart_ChangesInAssetsAndLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Changes In Assets And Liabilities [Abstract]",
        "label": "Changes In Assets And Liabilities [Abstract]",
        "terseLabel": "Changes in assets and liabilities:"
       }
      }
     },
     "localname": "ChangesInAssetsAndLiabilitiesAbstract",
     "nsuri": "http://integralife.com/20230331",
     "presentation": [
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "stringItemType"
    },
    "iart_CodmanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Codman [Member]",
        "label": "Codman [Member]",
        "terseLabel": "Codman"
       }
      }
     },
     "localname": "CodmanMember",
     "nsuri": "http://integralife.com/20230331",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_CodmanSpecialtySurgicalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Codman Specialty Surgical [Member]",
        "label": "Codman Specialty Surgical [Member]",
        "terseLabel": "Codman Specialty Surgical",
        "verboseLabel": "Codman Specialty Surgical"
       }
      }
     },
     "localname": "CodmanSpecialtySurgicalMember",
     "nsuri": "http://integralife.com/20230331",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesinCarryingAmountofGoodwillDetails",
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofRevenuesDisaggregatedbyMajorSourceDetails",
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNarrativeDetails",
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_CompletedTechnologyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Completed technology.",
        "label": "Completed Technology [Member]",
        "terseLabel": "Completed technology"
       }
      }
     },
     "localname": "CompletedTechnologyMember",
     "nsuri": "http://integralife.com/20230331",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_ContingentConsiderationLiabilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contingent Consideration Liability [Member]",
        "label": "Contingent Consideration Liability [Member]",
        "terseLabel": "Contingent Consideration Liability"
       }
      }
     },
     "localname": "ContingentConsiderationLiabilityMember",
     "nsuri": "http://integralife.com/20230331",
     "presentation": [
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails",
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_ContractWithCustomerAssetNetOfReclassifiedToReceivable": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract With Customer, Asset, Net Of Reclassified To Receivable",
        "label": "Contract With Customer, Asset, Net Of Reclassified To Receivable",
        "terseLabel": "Contract asset, net of transferred to trade receivables on contracts during the period"
       }
      }
     },
     "localname": "ContractWithCustomerAssetNetOfReclassifiedToReceivable",
     "nsuri": "http://integralife.com/20230331",
     "presentation": [
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofChangesinContractAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_ContractWithCustomerLiabilityIncreaseDecreaseFromForeignCurrencyTranslation": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract With Customer, Liability, Increase (Decrease) From Foreign Currency Translation",
        "label": "Contract With Customer, Liability, Increase (Decrease) From Foreign Currency Translation",
        "terseLabel": "Foreign currency translation"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityIncreaseDecreaseFromForeignCurrencyTranslation",
     "nsuri": "http://integralife.com/20230331",
     "presentation": [
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofChangesinContractAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_ContractWithCustomerLiabilityNetOfRevenueRecognized": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract With Customer, Liability, Net Of Revenue Recognized",
        "label": "Contract With Customer, Liability, Net Of Revenue Recognized",
        "terseLabel": "Recognition of revenue included in beginning of year contract liability"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityNetOfRevenueRecognized",
     "nsuri": "http://integralife.com/20230331",
     "presentation": [
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofChangesinContractAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill": {
     "auth_ref": [],
     "calculation": {
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails": {
       "order": 1.0,
       "parentTag": "iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cost Of Definite And Indefinite Lived Intangible Assets Gross Excluding Goodwill.",
        "label": "Cost Of Definite And Indefinite Lived Intangible Assets Gross Excluding Goodwill",
        "terseLabel": "Cost"
       }
      }
     },
     "localname": "CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill",
     "nsuri": "http://integralife.com/20230331",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_CrossCurrencyInterestRateContractOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cross Currency Interest Rate Contract One [Member]",
        "label": "Cross Currency Interest Rate Contract One [Member]",
        "terseLabel": "Cross Currency Interest Rate Swap One"
       }
      }
     },
     "localname": "CrossCurrencyInterestRateContractOneMember",
     "nsuri": "http://integralife.com/20230331",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_CrossCurrencyInterestRateContractThreeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cross Currency Interest Rate Contract Three [Member]",
        "label": "Cross Currency Interest Rate Contract Three [Member]",
        "terseLabel": "Cross Currency Interest Rate Swap Three"
       }
      }
     },
     "localname": "CrossCurrencyInterestRateContractThreeMember",
     "nsuri": "http://integralife.com/20230331",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_CrossCurrencyInterestRateContractTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cross Currency Interest Rate Contract Two [Member]",
        "label": "Cross Currency Interest Rate Contract Two [Member]",
        "terseLabel": "Cross Currency Interest Rate Swap Two"
       }
      }
     },
     "localname": "CrossCurrencyInterestRateContractTwoMember",
     "nsuri": "http://integralife.com/20230331",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_DebtCovenantPeriod1Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Covenant Period 1",
        "label": "Debt Covenant Period 1 [Member]",
        "terseLabel": "March 31, 2023 through December 31, 2024"
       }
      }
     },
     "localname": "DebtCovenantPeriod1Member",
     "nsuri": "http://integralife.com/20230331",
     "presentation": [
      "http://integralife.com/role/DEBTMaximumTotalLeverageRatioTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_DebtCovenantPeriod2Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Covenant Period 2",
        "label": "Debt Covenant Period 2 [Member]",
        "terseLabel": "March 31, 2025 through June 30, 2026"
       }
      }
     },
     "localname": "DebtCovenantPeriod2Member",
     "nsuri": "http://integralife.com/20230331",
     "presentation": [
      "http://integralife.com/role/DEBTMaximumTotalLeverageRatioTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_DebtCovenantPeriod3Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Covenant Period 3 [Member]",
        "label": "Debt Covenant Period 3 [Member]",
        "terseLabel": "September 30, 2026 and the last day of each fiscal quarter thereafter"
       }
      }
     },
     "localname": "DebtCovenantPeriod3Member",
     "nsuri": "http://integralife.com/20230331",
     "presentation": [
      "http://integralife.com/role/DEBTMaximumTotalLeverageRatioTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_DebtCovenantPeriodAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Covenant Period [Axis]",
        "label": "Debt Covenant Period [Axis]",
        "terseLabel": "Debt Covenant Period [Axis]"
       }
      }
     },
     "localname": "DebtCovenantPeriodAxis",
     "nsuri": "http://integralife.com/20230331",
     "presentation": [
      "http://integralife.com/role/DEBTMaximumTotalLeverageRatioTableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "iart_DebtCovenantPeriodDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Domain] for Debt Covenant Period [Axis]",
        "label": "Debt Covenant Period [Domain]",
        "terseLabel": "Debt Covenant Period [Domain]"
       }
      }
     },
     "localname": "DebtCovenantPeriodDomain",
     "nsuri": "http://integralife.com/20230331",
     "presentation": [
      "http://integralife.com/role/DEBTMaximumTotalLeverageRatioTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_DebtInstrumentBasisSpreadAdjustmentOnVariableRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Basis Spread Adjustment On Variable Rate",
        "label": "Debt Instrument, Basis Spread Adjustment On Variable Rate",
        "terseLabel": "Interest rate adjustment"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadAdjustmentOnVariableRate",
     "nsuri": "http://integralife.com/20230331",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "iart_DebtInstrumentCombinationSettlementForDebtConversionMinimumSettledInCashPerPrincipalAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Combination Settlement For Debt Conversion, Minimum Settled In Cash Per Principal Amount",
        "label": "Debt Instrument, Combination Settlement For Debt Conversion, Minimum Settled In Cash Per Principal Amount",
        "terseLabel": "Minimum settled in cash per principal amount"
       }
      }
     },
     "localname": "DebtInstrumentCombinationSettlementForDebtConversionMinimumSettledInCashPerPrincipalAmount",
     "nsuri": "http://integralife.com/20230331",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_DebtInstrumentCovenantMaximumLeverageRatio": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Covenant, Maximum Leverage Ratio",
        "label": "Debt Instrument, Covenant, Maximum Leverage Ratio",
        "terseLabel": "Maximum Consolidated Total Leverage Ratio"
       }
      }
     },
     "localname": "DebtInstrumentCovenantMaximumLeverageRatio",
     "nsuri": "http://integralife.com/20230331",
     "presentation": [
      "http://integralife.com/role/DEBTMaximumTotalLeverageRatioTableDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "iart_DebtInstrumentMaximumAverageConversionValueOfNotes": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Maximum Average Conversion Value Of Notes",
        "label": "Debt Instrument, Maximum Average Conversion Value Of Notes",
        "terseLabel": "Maximum average conversion value of notes"
       }
      }
     },
     "localname": "DebtInstrumentMaximumAverageConversionValueOfNotes",
     "nsuri": "http://integralife.com/20230331",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "iart_DebtInstrumentMaximumSellingPriceOfCommonStockOfTheConversionPriceDuringPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Maximum Selling Price Of Common Stock Of The Conversion Price During Period",
        "label": "Debt Instrument, Maximum Selling Price Of Common Stock Of The Conversion Price During Period",
        "terseLabel": "Maximum selling price of the company's common stock of the conversion price"
       }
      }
     },
     "localname": "DebtInstrumentMaximumSellingPriceOfCommonStockOfTheConversionPriceDuringPeriod",
     "nsuri": "http://integralife.com/20230331",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "iart_DebtWeightedAverageInterestRateFromSecuritization": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt, Weighted Average Interest Rate, From Securitization",
        "label": "Debt, Weighted Average Interest Rate, From Securitization",
        "terseLabel": "Weighted average interest rate, accounts receivable securitization revolving loan facility"
       }
      }
     },
     "localname": "DebtWeightedAverageInterestRateFromSecuritization",
     "nsuri": "http://integralife.com/20230331",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "iart_DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Defer Payment And Taxation, Base Salary, Percentage",
        "label": "Defined Benefit Plan, Defer Payment And Taxation, Base Salary, Percentage",
        "terseLabel": "Defer payment and taxation, base salary, percentage (up to)"
       }
      }
     },
     "localname": "DefinedBenefitPlanDeferPaymentAndTaxationBaseSalaryPercentage",
     "nsuri": "http://integralife.com/20230331",
     "presentation": [
      "http://integralife.com/role/RETIREMENTPLANSNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "iart_DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Defer Payment And Taxation, Bonus And Other Compensation, Percentage",
        "label": "Defined Benefit Plan, Defer Payment And Taxation, Bonus And Other Compensation, Percentage",
        "terseLabel": "Defer payment and taxation, bonus and other eligible cash compensation, percentage (up to)"
       }
      }
     },
     "localname": "DefinedBenefitPlanDeferPaymentAndTaxationBonusAndOtherCompensationPercentage",
     "nsuri": "http://integralife.com/20230331",
     "presentation": [
      "http://integralife.com/role/RETIREMENTPLANSNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [],
     "calculation": {
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Definite And Indefinite Lived Intangible Assets Net Excluding Goodwill.",
        "label": "Definite And Indefinite Lived Intangible Assets Net Excluding Goodwill",
        "totalLabel": "Net"
       }
      }
     },
     "localname": "DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://integralife.com/20230331",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_DerivativeNotionalAmountTerminated": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative, Notional Amount, Terminated",
        "label": "Derivative, Notional Amount, Terminated",
        "terseLabel": "Terminated notional amount"
       }
      }
     },
     "localname": "DerivativeNotionalAmountTerminated",
     "nsuri": "http://integralife.com/20230331",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_DermaSciencesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derma Sciences [Member]",
        "label": "Derma Sciences [Member]",
        "terseLabel": "Derma Sciences"
       }
      }
     },
     "localname": "DermaSciencesMember",
     "nsuri": "http://integralife.com/20230331",
     "presentation": [
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails",
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_DirectorsandCertainExecutiveOfficersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Directors and Certain Executive Officers [Member]",
        "label": "Directors and Certain Executive Officers [Member]",
        "terseLabel": "Directors and Certain Executive Officers"
       }
      }
     },
     "localname": "DirectorsandCertainExecutiveOfficersMember",
     "nsuri": "http://integralife.com/20230331",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_DiscontinuedOperationContinuingInvolvementPrepaidAsset": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discontinued Operation, Continuing Involvement, Prepaid Asset",
        "label": "Discontinued Operation, Continuing Involvement, Prepaid Asset",
        "terseLabel": "Discontinued operation, continuing involvement, prepaid asset"
       }
      }
     },
     "localname": "DiscontinuedOperationContinuingInvolvementPrepaidAsset",
     "nsuri": "http://integralife.com/20230331",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESDivestituresNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_DiscontinuedOperationContinuingInvolvementPrepaidAssetsCurrent": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discontinued Operation, Continuing Involvement, Prepaid Expenses, Current Assets",
        "label": "Discontinued Operation, Continuing Involvement, Prepaid Assets , Current",
        "terseLabel": "Inventory purchase, prepaid expenses and other current assets"
       }
      }
     },
     "localname": "DiscontinuedOperationContinuingInvolvementPrepaidAssetsCurrent",
     "nsuri": "http://integralife.com/20230331",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESDivestituresNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsideration": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Consideration, Contingent Consideration",
        "label": "Disposal Group, Including Discontinued Operation, Consideration, Contingent Consideration",
        "terseLabel": "Sale of business, contingent consideration"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsideration",
     "nsuri": "http://integralife.com/20230331",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESDivestituresNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsiderationPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Consideration, Contingent Consideration, Period",
        "label": "Disposal Group, Including Discontinued Operation, Consideration, Contingent Consideration, Period",
        "terseLabel": "Period for revenue based performance milestone"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationConsiderationContingentConsiderationPeriod",
     "nsuri": "http://integralife.com/20230331",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESDivestituresNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "iart_EmployeeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee [Member]",
        "label": "Employee [Member]",
        "terseLabel": "Employees"
       }
      }
     },
     "localname": "EmployeeMember",
     "nsuri": "http://integralife.com/20230331",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_ExciseTaxPayableOnShareRepurchases": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excise Tax Payable On Share Repurchases",
        "label": "Excise Tax Payable On Share Repurchases",
        "terseLabel": "Share repurchases, accrued excise tax"
       }
      }
     },
     "localname": "ExciseTaxPayableOnShareRepurchases",
     "nsuri": "http://integralife.com/20230331",
     "presentation": [
      "http://integralife.com/role/TREASURYSTOCKNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_FDAApprovalOfPremarketApprovalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "FDA Approval Of Premarket Approval",
        "label": "FDA Approval Of Premarket Approval [Member]",
        "terseLabel": "FDA Approval Of Premarket Approval"
       }
      }
     },
     "localname": "FDAApprovalOfPremarketApprovalMember",
     "nsuri": "http://integralife.com/20230331",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers From Long-Term to Current",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers From Long-Term to Current",
        "terseLabel": "Transfers"
       }
      }
     },
     "localname": "FairValueMeasurementwithUnobservableInputsReconciliationLiabilityTransfersFromLongTermtoCurrent",
     "nsuri": "http://integralife.com/20230331",
     "presentation": [
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_FiveYearOptionLeasePeriodOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Five-Year Option Lease Period One",
        "label": "Five Year Option Lease Period One [Member]",
        "terseLabel": "Five Year Option Lease From November 1, 2029 Through October 31, 2034"
       }
      }
     },
     "localname": "FiveYearOptionLeasePeriodOneMember",
     "nsuri": "http://integralife.com/20230331",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_FiveYearOptionLeasePeriodTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Five-Year Option Lease Period Two",
        "label": "Five Year Option Lease Period Two [Member]",
        "terseLabel": "Five Year Option Lease From November 1, 2034 Through October 31, 2039"
       }
      }
     },
     "localname": "FiveYearOptionLeasePeriodTwoMember",
     "nsuri": "http://integralife.com/20230331",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_InstrumentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instruments [Member]",
        "label": "Instruments [Member]",
        "terseLabel": "Instruments"
       }
      }
     },
     "localname": "InstrumentsMember",
     "nsuri": "http://integralife.com/20230331",
     "presentation": [
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofRevenuesDisaggregatedbyMajorSourceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_IntercompanyLoanQuarterlyPayment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intercompany Loan, Quarterly Payment",
        "label": "Intercompany Loan, Quarterly Payment",
        "terseLabel": "Intercompany loan quarterly payments"
       }
      }
     },
     "localname": "IntercompanyLoanQuarterlyPayment",
     "nsuri": "http://integralife.com/20230331",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_InterestPaymentsAfterYearThree": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Payments, After Year Three",
        "label": "Interest Payments, After Year Three",
        "terseLabel": "Interest payments, after year three"
       }
      }
     },
     "localname": "InterestPaymentsAfterYearThree",
     "nsuri": "http://integralife.com/20230331",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_InterestPaymentsReminderOfFiscalYear": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Payments, Reminder Of Fiscal Year",
        "label": "Interest Payments, Reminder Of Fiscal Year",
        "terseLabel": "Interest payments, remainder of fiscal year"
       }
      }
     },
     "localname": "InterestPaymentsReminderOfFiscalYear",
     "nsuri": "http://integralife.com/20230331",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_InterestPaymentsYearOne": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Payments, Year One",
        "label": "Interest Payments, Year One",
        "terseLabel": "Interest payments, year one"
       }
      }
     },
     "localname": "InterestPaymentsYearOne",
     "nsuri": "http://integralife.com/20230331",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_InterestPaymentsYearThree": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Payments, Year Three",
        "label": "Interest Payments, Year Three",
        "terseLabel": "Interest payments, year three"
       }
      }
     },
     "localname": "InterestPaymentsYearThree",
     "nsuri": "http://integralife.com/20230331",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_InterestPaymentsYearTwo": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Payments, Year Two",
        "label": "Interest Payments, Year Two",
        "terseLabel": "Interest payments, year two"
       }
      }
     },
     "localname": "InterestPaymentsYearTwo",
     "nsuri": "http://integralife.com/20230331",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_InterestRateSwapDesignatedDecember132017Tranche2Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Rate Swap Designated December 13, 2017 Tranche 2",
        "label": "Interest Rate Swap Designated December 13, 2017 Tranche 2 [Member]",
        "terseLabel": "Interest Rate Swap Designated December 13, 2017 Tranche 2"
       }
      }
     },
     "localname": "InterestRateSwapDesignatedDecember132017Tranche2Member",
     "nsuri": "http://integralife.com/20230331",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_InterestRateSwapDesignatedDecember132017Tranche3Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Rate Swap Designated December 13, 2017 Tranche 3 [Member]",
        "label": "Interest Rate Swap Designated December 13, 2017 Tranche 3 [Member]",
        "terseLabel": "Interest Rate Swap Designated December 13, 2017 Tranche 3"
       }
      }
     },
     "localname": "InterestRateSwapDesignatedDecember132017Tranche3Member",
     "nsuri": "http://integralife.com/20230331",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_InterestRateSwapDesignatedDecember152020Tranche1Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Rate Swap Designated December 15, 2020 Tranche 1",
        "label": "Interest Rate Swap Designated December 15, 2020 Tranche 1 [Member]",
        "terseLabel": "Interest Rate Swap Designated December 15, 2020 Tranche 1"
       }
      }
     },
     "localname": "InterestRateSwapDesignatedDecember152020Tranche1Member",
     "nsuri": "http://integralife.com/20230331",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_InterestRateSwapDesignatedDecember152020Tranche2Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Rate Swap Designated December 15, 2020 Tranche 2",
        "label": "Interest Rate Swap Designated December 15, 2020 Tranche 2 [Member]",
        "terseLabel": "Interest Rate Swap Designated December 15, 2020 Tranche 2"
       }
      }
     },
     "localname": "InterestRateSwapDesignatedDecember152020Tranche2Member",
     "nsuri": "http://integralife.com/20230331",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_InterestRateSwapDesignatedDecember182018Tranche1Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Rate Swap Designated December 18, 2018 Tranche 1 [Member]",
        "label": "Interest Rate Swap Designated December 18, 2018 Tranche 1 [Member]",
        "terseLabel": "Interest Rate Swap Designated December 18, 2018 Tranche 1"
       }
      }
     },
     "localname": "InterestRateSwapDesignatedDecember182018Tranche1Member",
     "nsuri": "http://integralife.com/20230331",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_InterestRateSwapDesignatedDecember182018Tranche2Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Rate Swap Designated December 18, 2018 Tranche 2 [Member]",
        "label": "Interest Rate Swap Designated December 18, 2018 Tranche 2 [Member]",
        "terseLabel": "Interest Rate Swap Designated December 18, 2018 Tranche 2"
       }
      }
     },
     "localname": "InterestRateSwapDesignatedDecember182018Tranche2Member",
     "nsuri": "http://integralife.com/20230331",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_InterestRateSwapDesignatedMarch312023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Rate Swap Designated March 31, 2023",
        "label": "Interest Rate Swap Designated March 31, 2023 [Member]",
        "terseLabel": "Interest Rate Swap Designated March 31, 2023"
       }
      }
     },
     "localname": "InterestRateSwapDesignatedMarch312023Member",
     "nsuri": "http://integralife.com/20230331",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_InterestRateSwapDesignatedOctober102018Tranche1Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Rate Swap Designated October 10, 2018 Tranche 1 [Member]",
        "label": "Interest Rate Swap Designated October 10, 2018 Tranche 1 [Member]",
        "terseLabel": "Interest Rate Swap Designated October 10, 2018 Tranche 1"
       }
      }
     },
     "localname": "InterestRateSwapDesignatedOctober102018Tranche1Member",
     "nsuri": "http://integralife.com/20230331",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_InterestRateSwapDesignatedOctober102018Tranche2Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Rate Swap Designated October 10, 2018 Tranche 2 [Member]",
        "label": "Interest Rate Swap Designated October 10, 2018 Tranche 2 [Member]",
        "terseLabel": "Interest Rate Swap Designated October 10, 2018 Tranche 2"
       }
      }
     },
     "localname": "InterestRateSwapDesignatedOctober102018Tranche2Member",
     "nsuri": "http://integralife.com/20230331",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_InterestRateSwapDesignatedOctober102018Tranche3Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Rate Swap Designated October 10, 2018 Tranche 3 [Member]",
        "label": "Interest Rate Swap Designated October 10, 2018 Tranche 3 [Member]",
        "terseLabel": "Interest Rate Swap Designated October 10, 2018 Tranche 3"
       }
      }
     },
     "localname": "InterestRateSwapDesignatedOctober102018Tranche3Member",
     "nsuri": "http://integralife.com/20230331",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_LesseeOperatingLeaseNumberOfRenewalOptions": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating Lease, Number Of Renewal Options",
        "label": "Lessee, Operating Lease, Number Of Renewal Options",
        "terseLabel": "Number of renewal options (or more)"
       }
      }
     },
     "localname": "LesseeOperatingLeaseNumberOfRenewalOptions",
     "nsuri": "http://integralife.com/20230331",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "iart_LongTermDebtMaturityAfterYearThree": {
     "auth_ref": [],
     "calculation": {
      "http://integralife.com/role/DEBTContractualMaturityTableDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-Term Debt, Maturity, after Year Three",
        "label": "Long-Term Debt, Maturity, after Year Three",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LongTermDebtMaturityAfterYearThree",
     "nsuri": "http://integralife.com/20230331",
     "presentation": [
      "http://integralife.com/role/DEBTContractualMaturityTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_MergersAcquisitionsAndDispositionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mergers, Acquisitions and Dispositions",
        "label": "Mergers, Acquisitions and Dispositions [Abstract]"
       }
      }
     },
     "localname": "MergersAcquisitionsAndDispositionsAbstract",
     "nsuri": "http://integralife.com/20230331",
     "xbrltype": "stringItemType"
    },
    "iart_MilestonePaymentOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Milestone Payment One [Member]",
        "label": "Milestone Payment One [Member]",
        "terseLabel": "Development Milestones"
       }
      }
     },
     "localname": "MilestonePaymentOneMember",
     "nsuri": "http://integralife.com/20230331",
     "presentation": [
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_MilestonePaymentTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Milestone Payment Two [Member]",
        "label": "Milestone Payment Two [Member]",
        "terseLabel": "Commercial Sales Milestones"
       }
      }
     },
     "localname": "MilestonePaymentTwoMember",
     "nsuri": "http://integralife.com/20230331",
     "presentation": [
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_NeurosurgeryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Neurosurgery [Member]",
        "label": "Neurosurgery [Member]",
        "terseLabel": "Neurosurgery"
       }
      }
     },
     "localname": "NeurosurgeryMember",
     "nsuri": "http://integralife.com/20230331",
     "presentation": [
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofRevenuesDisaggregatedbyMajorSourceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_NoncashLeaseExpense": {
     "auth_ref": [],
     "calculation": {
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncash Lease Expense",
        "label": "Noncash Lease Expense",
        "terseLabel": "Non-cash lease expense"
       }
      }
     },
     "localname": "NoncashLeaseExpense",
     "nsuri": "http://integralife.com/20230331",
     "presentation": [
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_PaymentsForOptionIndexToIssuersEquity": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments For Options Indexed to Issuer's Equity",
        "label": "Payments For Option Index To Issuers Equity",
        "terseLabel": "Cost of call transactions"
       }
      }
     },
     "localname": "PaymentsForOptionIndexToIssuersEquity",
     "nsuri": "http://integralife.com/20230331",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_PercentOfManufacturingFacilityOwnedByCorporationWhoseShareholdersAreTrustsWhoseBeneficiariesIncludeFamilyMembersOfCompanysFormerDirector": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percent Of Manufacturing Facility Owned By Corporation Whose Shareholders Are Trusts, Whose Beneficiaries Include Family Members Of Company's Former Director",
        "label": "Percent Of Manufacturing Facility Owned By Corporation Whose Shareholders Are Trusts, Whose Beneficiaries Include Family Members Of Company's Former Director",
        "terseLabel": "Percent of manufacturing facility owned by corporation whose shareholders are trusts whose beneficiaries include family members of company's former director"
       }
      }
     },
     "localname": "PercentOfManufacturingFacilityOwnedByCorporationWhoseShareholdersAreTrustsWhoseBeneficiariesIncludeFamilyMembersOfCompanysFormerDirector",
     "nsuri": "http://integralife.com/20230331",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "iart_PerformanceStockAndRestrictedStockAwardsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Performance Stock And Restricted Stock Awards [Member]",
        "label": "Performance Stock And Restricted Stock Awards [Member]",
        "terseLabel": "Performance Stock and Restricted Stock Awards"
       }
      }
     },
     "localname": "PerformanceStockAndRestrictedStockAwardsMember",
     "nsuri": "http://integralife.com/20230331",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_PrivateLabelMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Private Label [Member]",
        "label": "Private Label [Member]",
        "terseLabel": "Private Label"
       }
      }
     },
     "localname": "PrivateLabelMember",
     "nsuri": "http://integralife.com/20230331",
     "presentation": [
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofRevenuesDisaggregatedbyMajorSourceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_RegenerativeSkinAndWoundMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Regenerative Skin And Wound [Member]",
        "label": "Regenerative Skin And Wound [Member]",
        "terseLabel": "Wound Reconstruction and Care"
       }
      }
     },
     "localname": "RegenerativeSkinAndWoundMember",
     "nsuri": "http://integralife.com/20230331",
     "presentation": [
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofRevenuesDisaggregatedbyMajorSourceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_RelatedPartiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related Parties [Member]",
        "label": "Related Parties [Member]",
        "terseLabel": "Related Parties"
       }
      }
     },
     "localname": "RelatedPartiesMember",
     "nsuri": "http://integralife.com/20230331",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_RestOfWorldMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenues from rest of the world.",
        "label": "Rest Of World [Member]",
        "terseLabel": "Rest of World"
       }
      }
     },
     "localname": "RestOfWorldMember",
     "nsuri": "http://integralife.com/20230331",
     "presentation": [
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTotalRevenuebyMajorGeographicAreaDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_ReturnPolicyIssueOfCreditNumberOfDaysFromShipment": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Return Policy, Issue of Credit, Number of Days from Shipment",
        "label": "Return Policy, Issue Of Credit, Number Of Days From Shipment",
        "terseLabel": "Number of days from shipment to issue a credit"
       }
      }
     },
     "localname": "ReturnPolicyIssueOfCreditNumberOfDaysFromShipment",
     "nsuri": "http://integralife.com/20230331",
     "presentation": [
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "iart_RevenueBasedPerformanceMilestonesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue Based Performance Milestones",
        "label": "Revenue Based Performance Milestones [Member]",
        "terseLabel": "Revenue Based Performance Milestones"
       }
      }
     },
     "localname": "RevenueBasedPerformanceMilestonesMember",
     "nsuri": "http://integralife.com/20230331",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_RevenueProductWarrantyPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue, Product Warranty Period",
        "label": "Revenue, Product Warranty Period",
        "terseLabel": "Product warranty period (up to)"
       }
      }
     },
     "localname": "RevenueProductWarrantyPeriod",
     "nsuri": "http://integralife.com/20230331",
     "presentation": [
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "iart_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Right Of Use Asset Obtained In Exchange For Lease Liability [Abstract]",
        "label": "Right Of Use Asset Obtained In Exchange For Lease Liability [Abstract]",
        "terseLabel": "ROU assets obtained in exchange for lease liabilities:"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract",
     "nsuri": "http://integralife.com/20230331",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "iart_SecuredLongTermDebtSecuritizationProgram": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Secured Long-Term Debt, Securitization Program",
        "label": "Secured Long-Term Debt, Securitization Program",
        "terseLabel": "Secured long-term debt, securitization program"
       }
      }
     },
     "localname": "SecuredLongTermDebtSecuritizationProgram",
     "nsuri": "http://integralife.com/20230331",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_SecuredLongTermDebtSecuritizationProgramNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Secured Long-Term Debt, Securitization Program, Noncurrent",
        "label": "Secured Long-Term Debt, Securitization Program, Noncurrent",
        "terseLabel": "Long-term borrowings under securitization facility"
       }
      }
     },
     "localname": "SecuredLongTermDebtSecuritizationProgramNoncurrent",
     "nsuri": "http://integralife.com/20230331",
     "presentation": [
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_SecuritizationFacilityFairValueOfAmountOutstanding": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securitization Facility, Fair Value Of Amount Outstanding",
        "label": "Securitization Facility, Fair Value Of Amount Outstanding",
        "terseLabel": "Securitization facility, outstanding borrowings, fair value"
       }
      }
     },
     "localname": "SecuritizationFacilityFairValueOfAmountOutstanding",
     "nsuri": "http://integralife.com/20230331",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_SegmentReportingInformationNumberOfProductsOffered": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of products sold by a segment",
        "label": "Segment Reporting Information, Number Of Products Offered",
        "terseLabel": "Number of products offered (more than)"
       }
      }
     },
     "localname": "SegmentReportingInformationNumberOfProductsOffered",
     "nsuri": "http://integralife.com/20230331",
     "presentation": [
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "iart_SeniorCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Credit Facility.",
        "label": "Senior Credit Facility [Member]",
        "terseLabel": "Senior Credit Facility"
       }
      }
     },
     "localname": "SeniorCreditFacilityMember",
     "nsuri": "http://integralife.com/20230331",
     "presentation": [
      "http://integralife.com/role/DEBTMaximumTotalLeverageRatioTableDetails",
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_SupplierRelationShipsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Supplier Relation Ships [Member]",
        "label": "Supplier Relation Ships [Member]",
        "terseLabel": "Supplier relationships"
       }
      }
     },
     "localname": "SupplierRelationShipsMember",
     "nsuri": "http://integralife.com/20230331",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_SurgicalInnovationAssociatesIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Surgical Innovation Associates Inc",
        "label": "Surgical Innovation Associates Inc [Member]",
        "terseLabel": "Surgical Innovation Associates Inc"
       }
      }
     },
     "localname": "SurgicalInnovationAssociatesIncMember",
     "nsuri": "http://integralife.com/20230331",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationNarrativeDetails",
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails",
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails",
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesinCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_SwinglineLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Swingline Loan [Member]",
        "label": "Swingline Loan [Member]",
        "terseLabel": "Swingline Loans"
       }
      }
     },
     "localname": "SwinglineLoanMember",
     "nsuri": "http://integralife.com/20230331",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_TermLoanFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term Loan Facility [Member]",
        "label": "Term Loan Facility [Member]",
        "terseLabel": "Term Loan Facility"
       }
      }
     },
     "localname": "TermLoanFacilityMember",
     "nsuri": "http://integralife.com/20230331",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_ThirdPartiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Third Parties [Member]",
        "label": "Third Parties [Member]",
        "verboseLabel": "Third Parties"
       }
      }
     },
     "localname": "ThirdPartiesMember",
     "nsuri": "http://integralife.com/20230331",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_TissueTechnologiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Orthopedics and Tissue Technologies [Member]",
        "label": "Tissue Technologies [Member]",
        "terseLabel": "Tissue Technologies"
       }
      }
     },
     "localname": "TissueTechnologiesMember",
     "nsuri": "http://integralife.com/20230331",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesinCarryingAmountofGoodwillDetails",
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofRevenuesDisaggregatedbyMajorSourceDetails",
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_TrademarksBrandNamesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trademarks Brand Names.",
        "label": "Trademarks Brand Names [Member]",
        "terseLabel": "Trademarks/brand names"
       }
      }
     },
     "localname": "TrademarksBrandNamesMember",
     "nsuri": "http://integralife.com/20230331",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_TraditionalWoundCareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Traditional Wound Care",
        "label": "Traditional Wound Care [Member]",
        "terseLabel": "Traditional Wound Care"
       }
      }
     },
     "localname": "TraditionalWoundCareMember",
     "nsuri": "http://integralife.com/20230331",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESDivestituresNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iart_TransferorsInterestsInTransferredFinancialAssetsMaximumInvestmentLimit": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Transferor's Interests In Transferred Financial Assets, Maximum Investment Limit",
        "label": "Transferor's Interests In Transferred Financial Assets, Maximum Investment Limit",
        "terseLabel": "Securitization program outstanding borrowings, maximum limit"
       }
      }
     },
     "localname": "TransferorsInterestsInTransferredFinancialAssetsMaximumInvestmentLimit",
     "nsuri": "http://integralife.com/20230331",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iart_TwoThousandTwentyFiveSeniorConvertibleNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two Thousand Twenty Five Senior Convertible Notes [Member]",
        "label": "Two Thousand Twenty Five Senior Convertible Notes [Member]",
        "terseLabel": "2025 Notes"
       }
      }
     },
     "localname": "TwoThousandTwentyFiveSeniorConvertibleNotesMember",
     "nsuri": "http://integralife.com/20230331",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_AffiliatedEntityMember": {
     "auth_ref": [
      "r612",
      "r710",
      "r725",
      "r726",
      "r728"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Affiliated Entity [Member]",
        "terseLabel": "Affiliated Entity"
       }
      }
     },
     "localname": "AffiliatedEntityMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_AsiaPacificMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Asia Pacific [Member]",
        "terseLabel": "Asia Pacific"
       }
      }
     },
     "localname": "AsiaPacificMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTotalRevenuebyMajorGeographicAreaDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r252",
      "r286",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r304",
      "r308",
      "r354",
      "r355",
      "r356",
      "r357",
      "r359",
      "r360",
      "r362",
      "r364",
      "r365",
      "r702",
      "r703"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Axis]",
        "terseLabel": "Consolidation Items [Axis]"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [
      "r252",
      "r286",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r304",
      "r308",
      "r354",
      "r355",
      "r356",
      "r357",
      "r359",
      "r360",
      "r362",
      "r364",
      "r365",
      "r702",
      "r703"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Domain]",
        "terseLabel": "Operating Activities [Domain]"
       }
      }
     },
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CounterpartyNameAxis": {
     "auth_ref": [
      "r250",
      "r251",
      "r370",
      "r396",
      "r619",
      "r621"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Axis]",
        "terseLabel": "Counterparty Name [Axis]"
       }
      }
     },
     "localname": "CounterpartyNameAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_DirectorMember": {
     "auth_ref": [
      "r681"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Director [Member]",
        "terseLabel": "Directors"
       }
      }
     },
     "localname": "DirectorMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_EuropeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Europe [Member]",
        "terseLabel": "Europe"
       }
      }
     },
     "localname": "EuropeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTotalRevenuebyMajorGeographicAreaDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r349",
      "r350",
      "r351",
      "r352",
      "r451",
      "r561",
      "r588",
      "r613",
      "r614",
      "r633",
      "r648",
      "r656",
      "r704",
      "r731",
      "r732",
      "r733",
      "r734",
      "r735",
      "r736"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails",
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r349",
      "r350",
      "r351",
      "r352",
      "r451",
      "r561",
      "r588",
      "r613",
      "r614",
      "r633",
      "r648",
      "r656",
      "r704",
      "r731",
      "r732",
      "r733",
      "r734",
      "r735",
      "r736"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails",
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r310",
      "r562",
      "r635",
      "r654",
      "r699",
      "r700",
      "r708",
      "r737"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofRevenuesDisaggregatedbyMajorSourceDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r310",
      "r562",
      "r635",
      "r654",
      "r699",
      "r700",
      "r708",
      "r737"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofRevenuesDisaggregatedbyMajorSourceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r349",
      "r350",
      "r351",
      "r352",
      "r428",
      "r451",
      "r480",
      "r481",
      "r482",
      "r560",
      "r561",
      "r588",
      "r613",
      "r614",
      "r633",
      "r648",
      "r656",
      "r696",
      "r704",
      "r732",
      "r733",
      "r734",
      "r735",
      "r736"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails",
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r349",
      "r350",
      "r351",
      "r352",
      "r428",
      "r451",
      "r480",
      "r481",
      "r482",
      "r560",
      "r561",
      "r588",
      "r613",
      "r614",
      "r633",
      "r648",
      "r656",
      "r696",
      "r704",
      "r732",
      "r733",
      "r734",
      "r735",
      "r736"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails",
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "auth_ref": [
      "r250",
      "r251",
      "r370",
      "r396",
      "r620",
      "r621"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Domain]",
        "terseLabel": "Counterparty Name [Domain]"
       }
      }
     },
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r311",
      "r312",
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r636",
      "r655",
      "r708"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTotalRevenuebyMajorGeographicAreaDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r311",
      "r312",
      "r601",
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r636",
      "r655",
      "r708"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTotalRevenuebyMajorGeographicAreaDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualAxis": {
     "auth_ref": [
      "r681",
      "r727"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Axis]",
        "terseLabel": "Title of Individual [Axis]"
       }
      }
     },
     "localname": "TitleOfIndividualAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Domain]",
        "terseLabel": "Title of Individual [Domain]"
       }
      }
     },
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AOCIAttributableToParentNetOfTaxRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "AOCI Attributable to Parent, Net of Tax [Roll Forward]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Roll Forward]",
        "verboseLabel": "Accumulated Other Comprehensive Income (Loss) [Roll Forward]"
       }
      }
     },
     "localname": "AOCIAttributableToParentNetOfTaxRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt": {
     "auth_ref": [
      "r126"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash receipt from (payment to) bank; or stock received from (issuance to) bank in the settlement of the accelerated share repurchase agreement.",
        "label": "Accelerated Share Repurchases, Settlement (Payment) or Receipt",
        "terseLabel": "Accelerated share repurchase program, receipt (payment)"
       }
      }
     },
     "localname": "AcceleratedShareRepurchasesSettlementPaymentOrReceipt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/TREASURYSTOCKNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsPayableTradeCurrent": {
     "auth_ref": [
      "r15",
      "r30"
     ],
     "calculation": {
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Trade, Current",
        "terseLabel": "Accounts payable, trade"
       }
      }
     },
     "localname": "AccountsPayableTradeCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r316",
      "r317"
     ],
     "calculation": {
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Trade accounts receivable, net of allowances of $3,544 and $4,304"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r33"
     ],
     "calculation": {
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Accrued expenses and other current liabilities"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember": {
     "auth_ref": [
      "r45",
      "r50",
      "r154",
      "r666",
      "r667",
      "r668"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans attributable to the parent.",
        "label": "Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]",
        "terseLabel": "Defined Benefit Pension Items"
       }
      }
     },
     "localname": "AccumulatedDefinedBenefitPlansAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember": {
     "auth_ref": [
      "r230",
      "r238",
      "r239",
      "r517",
      "r622",
      "r666"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) from gain (loss) of derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent.",
        "label": "Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]",
        "terseLabel": "Gains and Losses on Derivatives"
       }
      }
     },
     "localname": "AccumulatedGainLossNetCashFlowHedgeParentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSNarrativeDetails",
      "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSNarrativeDetails",
      "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r48",
      "r49",
      "r50",
      "r223",
      "r583",
      "r593",
      "r594"
     ],
     "calculation": {
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
     "auth_ref": [
      "r237",
      "r238",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).",
        "label": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSNarrativeDetails",
      "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r47",
      "r50",
      "r154",
      "r554",
      "r589",
      "r590",
      "r666",
      "r667",
      "r668",
      "r675",
      "r676",
      "r677"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Total",
        "verboseLabel": "Accumulated Other Comprehensive Loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails",
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUNAUDITED",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedTranslationAdjustmentMember": {
     "auth_ref": [
      "r44",
      "r50",
      "r154",
      "r238",
      "r239",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r666"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.",
        "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]",
        "terseLabel": "Foreign Currency Items"
       }
      }
     },
     "localname": "AccumulatedTranslationAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Acquired Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Acquired Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": {
     "auth_ref": [
      "r91"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life",
        "terseLabel": "Weighted average life"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "auth_ref": [
      "r22"
     ],
     "calculation": {
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
        "label": "Additional Paid in Capital, Common Stock",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r488",
      "r489",
      "r490",
      "r675",
      "r676",
      "r677",
      "r717"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-In Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUNAUDITED"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r132",
      "r133",
      "r454"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net income to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "auth_ref": [
      "r224",
      "r318",
      "r321"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "terseLabel": "Trade accounts receivable, allowance"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITEDParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r76",
      "r89",
      "r95"
     ],
     "calculation": {
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED": {
       "order": 4.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "negatedTerseLabel": "Amortization",
        "terseLabel": "Intangible asset amortization"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED",
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r276"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Shares excluded from computation as their effect would be antidilutive (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/NETINCOMEPERSHARENarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r193",
      "r203",
      "r222",
      "r247",
      "r294",
      "r300",
      "r306",
      "r319",
      "r354",
      "r355",
      "r357",
      "r358",
      "r359",
      "r361",
      "r363",
      "r365",
      "r366",
      "r515",
      "r519",
      "r533",
      "r653",
      "r702",
      "r703",
      "r729"
     ],
     "calculation": {
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r216",
      "r226",
      "r247",
      "r319",
      "r354",
      "r355",
      "r357",
      "r358",
      "r359",
      "r361",
      "r363",
      "r365",
      "r366",
      "r515",
      "r519",
      "r533",
      "r653",
      "r702",
      "r703",
      "r729"
     ],
     "calculation": {
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails",
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r163",
      "r167"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails",
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis Of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/BASISOFPRESENTATIONPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BuildingMember": {
     "auth_ref": [
      "r102"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities.",
        "label": "Building [Member]",
        "terseLabel": "Leased facilities"
       }
      }
     },
     "localname": "BuildingMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r511",
      "r646",
      "r647"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationNarrativeDetails",
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails",
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails",
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails",
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesinCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r138",
      "r139",
      "r511",
      "r646",
      "r647"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationNarrativeDetails",
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails",
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails",
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails",
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesinCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationNarrativeDetails",
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1": {
     "auth_ref": [
      "r514",
      "r669"
     ],
     "calculation": {
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.",
        "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability",
        "verboseLabel": "Change in fair value of contingent consideration and others"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh": {
     "auth_ref": [
      "r148"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid.",
        "label": "Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High",
        "terseLabel": "Contingent consideration, maximum undiscounted payment amount"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationNarrativeDetails",
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiability": {
     "auth_ref": [
      "r145",
      "r146",
      "r513"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination.",
        "label": "Business Combination, Contingent Consideration, Liability",
        "verboseLabel": "Contingent consideration, estimated fair value"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationNarrativeDetails",
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent": {
     "auth_ref": [
      "r145",
      "r147"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled within one year or the normal operating cycle, if longer.",
        "label": "Business Combination, Contingent Consideration, Liability, Current",
        "terseLabel": "Contingent consideration, current"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationNarrativeDetails",
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent": {
     "auth_ref": [
      "r145",
      "r147"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled beyond one year or the normal operating cycle, if longer.",
        "label": "Business Combination, Contingent Consideration, Liability, Noncurrent",
        "terseLabel": "Contingent consideration, noncurrent"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": {
     "auth_ref": [
      "r141"
     ],
     "calculation": {
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents",
        "verboseLabel": "Cash"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability": {
     "auth_ref": [
      "r140",
      "r141"
     ],
     "calculation": {
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of liability arising from an inherited contingency (as defined) which has been recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Contingent Liability",
        "terseLabel": "Contingent consideration"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails",
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets": {
     "auth_ref": [
      "r141"
     ],
     "calculation": {
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails": {
       "order": 2.0,
       "parentTag": "iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets": {
     "auth_ref": [
      "r141"
     ],
     "calculation": {
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables": {
     "auth_ref": [
      "r141"
     ],
     "calculation": {
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables",
        "terseLabel": "Trade accounts receivable, net"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities": {
     "auth_ref": [
      "r141"
     ],
     "calculation": {
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable": {
     "auth_ref": [
      "r141"
     ],
     "calculation": {
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable",
        "terseLabel": "Accounts payable and accrued expenses"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities": {
     "auth_ref": [
      "r141"
     ],
     "calculation": {
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities",
        "terseLabel": "Deferred Tax Liability"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles": {
     "auth_ref": [
      "r140",
      "r141"
     ],
     "calculation": {
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails": {
       "order": 1.0,
       "parentTag": "iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of identifiable intangible assets recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles",
        "terseLabel": "Intangible assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory": {
     "auth_ref": [
      "r140",
      "r141"
     ],
     "calculation": {
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of inventory recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory",
        "terseLabel": "Inventories, net"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities": {
     "auth_ref": [
      "r141"
     ],
     "calculation": {
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities",
        "totalLabel": "Total liabilities assumed"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet": {
     "auth_ref": [
      "r141"
     ],
     "calculation": {
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net",
        "totalLabel": "Total liabilities assumed"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CallOptionMember": {
     "auth_ref": [
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r600"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial contract between two parties, the buyer and the seller of the option, where the buyer has the right but not the obligation to buy an agreed quantity of a particular commodity or financial instrument (the underlying instrument) from the seller of the option for a certain price (the strike price). Seller is obligated to sell the asset to the buyer, if the buyer exercises the option.",
        "label": "Call Option [Member]",
        "terseLabel": "Call Option"
       }
      }
     },
     "localname": "CallOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r78",
      "r218",
      "r615"
     ],
     "calculation": {
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r73",
      "r78",
      "r79"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "periodEndLabel": "Cash and cash equivalents at end of period",
        "periodStartLabel": "Cash and cash equivalents at beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r73",
      "r186"
     ],
     "calculation": {
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net decrease in cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashDivestedFromDeconsolidation": {
     "auth_ref": [
      "r66"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reduction in cash due to no longer including the former subsidiary's cash in the consolidated entity's cash.",
        "label": "Cash Divested from Deconsolidation",
        "terseLabel": "Cash divested from deconsolidation"
       }
      }
     },
     "localname": "CashDivestedFromDeconsolidation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESDivestituresNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowHedgingMember": {
     "auth_ref": [
      "r159"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk.",
        "label": "Cash Flow Hedging [Member]",
        "terseLabel": "Cash Flow Hedges"
       }
      }
     },
     "localname": "CashFlowHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "auth_ref": [
      "r397"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding.",
        "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights",
        "terseLabel": "Warrant strike price (in dollars per share)"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r107",
      "r346",
      "r347",
      "r602",
      "r701"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "COMMITMENTS AND CONTINGENCIES"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r675",
      "r676",
      "r717"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUNAUDITED"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r21"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITEDParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r21"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, authorized shares (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITEDParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r21"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, issued shares (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITEDParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r21",
      "r653"
     ],
     "calculation": {
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock; $0.01 par value; 240,000 authorized shares; 90,813 and 90,477 issued at March\u00a031, 2023 and December\u00a031, 2022, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CompensationAndRetirementDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retirement Benefits [Abstract]",
        "terseLabel": "Retirement Benefits [Abstract]"
       }
      }
     },
     "localname": "CompensationAndRetirementDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r51",
      "r234",
      "r236",
      "r242",
      "r579",
      "r585"
     ],
     "calculation": {
      "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSScheduleofComprehensiveIncomeDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "terseLabel": "Comprehensive income (See Note 14)",
        "totalLabel": "Comprehensive income, net"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSScheduleofComprehensiveIncomeDetails",
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNoteTextBlock": {
     "auth_ref": [
      "r62",
      "r241",
      "r578",
      "r584"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.",
        "label": "Comprehensive Income (Loss) Note [Text Block]",
        "terseLabel": "ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)"
       }
      }
     },
     "localname": "ComprehensiveIncomeNoteTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContingentConsiderationByTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of contingent consideration.",
        "label": "Contingent Consideration by Type [Axis]",
        "terseLabel": "Contingent Consideration by Type [Axis]"
       }
      }
     },
     "localname": "ContingentConsiderationByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationNarrativeDetails",
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ContingentConsiderationTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of contingent payment arrangement.",
        "label": "Contingent Consideration Type [Domain]",
        "terseLabel": "Contingent Consideration Type [Domain]"
       }
      }
     },
     "localname": "ContingentConsiderationTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationNarrativeDetails",
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock": {
     "auth_ref": [
      "r706"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.",
        "label": "Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]",
        "terseLabel": "Schedule of Changes in Contract Assets and Contract Liabilities"
       }
      }
     },
     "localname": "ContractWithCustomerAssetAndLiabilityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerAssetNet": {
     "auth_ref": [
      "r400",
      "r402",
      "r422"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.",
        "label": "Contract with Customer, Asset, after Allowance for Credit Loss",
        "periodEndLabel": "Contract asset, End of Period",
        "periodStartLabel": "Contract asset, Beginning of period"
       }
      }
     },
     "localname": "ContractWithCustomerAssetNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofChangesinContractAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerAssetReclassifiedToReceivable": {
     "auth_ref": [
      "r634"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time from transfer to receivable due to right to consideration becoming unconditional.",
        "label": "Contract with Customer, Asset, Reclassified to Receivable",
        "negatedTerseLabel": "Transferred to trade receivable from contract asset included in beginning of the year contract asset"
       }
      }
     },
     "localname": "ContractWithCustomerAssetReclassifiedToReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofChangesinContractAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiability": {
     "auth_ref": [
      "r400",
      "r401",
      "r422"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Contract with Customer, Liability",
        "periodEndLabel": "Contract liability, End of Period",
        "periodStartLabel": "Contract liability, Beginning of Period"
       }
      }
     },
     "localname": "ContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofChangesinContractAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "auth_ref": [
      "r400",
      "r401",
      "r422"
     ],
     "calculation": {
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Contract with Customer, Liability, Current",
        "terseLabel": "Contract liabilities",
        "verboseLabel": "Short-term portion of contract liability"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED",
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityNoncurrent": {
     "auth_ref": [
      "r400",
      "r401",
      "r422"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.",
        "label": "Contract with Customer, Liability, Noncurrent",
        "terseLabel": "Long-term portion of contract liability"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": {
     "auth_ref": [
      "r423"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.",
        "label": "Contract with Customer, Liability, Revenue Recognized",
        "negatedLabel": "Contract liability, net of revenue recognized on contracts during the period"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityRevenueRecognized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofChangesinContractAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConvertibleDebtMember": {
     "auth_ref": [
      "r114",
      "r367",
      "r368",
      "r379",
      "r380",
      "r381",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r628",
      "r629",
      "r630",
      "r631",
      "r632"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.",
        "label": "Convertible Debt [Member]",
        "terseLabel": "Convertible Debt"
       }
      }
     },
     "localname": "ConvertibleDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConvertibleDebtNoncurrent": {
     "auth_ref": [
      "r37"
     ],
     "calculation": {
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount of long-term convertible debt as of the balance sheet date, net of the amount due in the next twelve months or greater than the normal operating cycle, if longer. The debt is convertible into another form of financial instrument, typically the entity's common stock.",
        "label": "Convertible Debt, Noncurrent",
        "terseLabel": "Long-term convertible securities"
       }
      }
     },
     "localname": "ConvertibleDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CorporateNonSegmentMember": {
     "auth_ref": [
      "r84",
      "r299",
      "r300",
      "r301",
      "r302",
      "r308",
      "r680"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment.",
        "label": "Corporate, Non-Segment [Member]",
        "terseLabel": "Corporate and other"
       }
      }
     },
     "localname": "CorporateNonSegmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r56",
      "r562"
     ],
     "calculation": {
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "terseLabel": "Cost of goods sold"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing cost of sales.",
        "label": "Cost of Sales [Member]",
        "terseLabel": "Cost of Sales"
       }
      }
     },
     "localname": "CostOfSalesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostsAndExpenses": {
     "auth_ref": [
      "r55"
     ],
     "calculation": {
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total costs of sales and operating expenses for the period.",
        "label": "Costs and Expenses",
        "totalLabel": "Total costs and expenses"
       }
      }
     },
     "localname": "CostsAndExpenses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostsAndExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Costs and Expenses [Abstract]",
        "terseLabel": "Costs and expenses:"
       }
      }
     },
     "localname": "CostsAndExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CrossCurrencyInterestRateContractMember": {
     "auth_ref": [
      "r709",
      "r715"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument whose primary underlying risk is tied to interest rates and foreign exchange rates.",
        "label": "Cross Currency Interest Rate Contract [Member]",
        "terseLabel": "Cross-currency swap"
       }
      }
     },
     "localname": "CrossCurrencyInterestRateContractMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CurrencySwapMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Swap involving the exchange of principal and interest in one currency for another currency.",
        "label": "Currency Swap [Member]",
        "terseLabel": "Foreign currency swaps"
       }
      }
     },
     "localname": "CurrencySwapMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofDerivativesNotDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r144"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]",
        "verboseLabel": "Customer relationships"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r116",
      "r246",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r383",
      "r390",
      "r391",
      "r393"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "DEBT"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DEBT"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r17",
      "r18",
      "r19",
      "r194",
      "r195",
      "r202",
      "r252",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r373",
      "r379",
      "r380",
      "r381",
      "r382",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r542",
      "r628",
      "r629",
      "r630",
      "r631",
      "r632",
      "r671"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DEBTMaximumTotalLeverageRatioTableDetails",
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "Interest rates available"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentConvertibleConversionPrice1": {
     "auth_ref": [
      "r115",
      "r369"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The price per share of the conversion feature embedded in the debt instrument.",
        "label": "Debt Instrument, Convertible, Conversion Price",
        "terseLabel": "Initial conversion price (in dollars per share)"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleConversionPrice1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_DebtInstrumentConvertibleConversionRatio1": {
     "auth_ref": [
      "r36",
      "r120",
      "r121",
      "r123",
      "r369"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ratio applied to the conversion of debt instrument into equity with equity shares divided by debt principal amount.",
        "label": "Debt Instrument, Convertible, Conversion Ratio",
        "terseLabel": "Initial conversion rate"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleConversionRatio1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r188",
      "r190",
      "r367",
      "r542",
      "r629",
      "r630"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Convertible notes, maximum borrowing capacity"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFairValue": {
     "auth_ref": [
      "r381",
      "r532",
      "r629",
      "r630"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.",
        "label": "Debt Instrument, Fair Value Disclosure",
        "terseLabel": "Fair value"
       }
      }
     },
     "localname": "DebtInstrumentFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r35",
      "r368"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Convertible notes, interest rate"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DEBTMaximumTotalLeverageRatioTableDetails",
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r37",
      "r252",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r373",
      "r379",
      "r380",
      "r381",
      "r382",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r542",
      "r628",
      "r629",
      "r630",
      "r631",
      "r632",
      "r671"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DEBTMaximumTotalLeverageRatioTableDetails",
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPricePercentage": {
     "auth_ref": [
      "r200"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.",
        "label": "Debt Instrument, Redemption Price, Percentage",
        "terseLabel": "Redemption price, percentage"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPricePercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r37",
      "r120",
      "r122",
      "r123",
      "r124",
      "r187",
      "r188",
      "r190",
      "r201",
      "r252",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r373",
      "r379",
      "r380",
      "r381",
      "r382",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r392",
      "r542",
      "r628",
      "r629",
      "r630",
      "r631",
      "r632",
      "r671"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DEBTMaximumTotalLeverageRatioTableDetails",
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtWeightedAverageInterestRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average interest rate of debt outstanding.",
        "label": "Debt, Weighted Average Interest Rate",
        "terseLabel": "Weighted average interest rate on debt"
       }
      }
     },
     "localname": "DebtWeightedAverageInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DeferredCompensationPlanAssets": {
     "auth_ref": [
      "r663"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of assets held under deferred compensation agreements.",
        "label": "Deferred Compensation Plan Assets",
        "terseLabel": "Deferred compensation plan, fair value of assets"
       }
      }
     },
     "localname": "DeferredCompensationPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/RETIREMENTPLANSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFinanceCostsGross": {
     "auth_ref": [
      "r189"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Debt Issuance Costs, Gross",
        "terseLabel": "Incremental financing costs capitalized"
       }
      }
     },
     "localname": "DeferredFinanceCostsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFinanceCostsNet": {
     "auth_ref": [
      "r189",
      "r705"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Debt Issuance Costs, Net",
        "terseLabel": "Debt issuance costs capitalized"
       }
      }
     },
     "localname": "DeferredFinanceCostsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "auth_ref": [
      "r492",
      "r493"
     ],
     "calculation": {
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.",
        "label": "Deferred Income Tax Assets, Net",
        "terseLabel": "Deferred tax assets, net"
       }
      }
     },
     "localname": "DeferredIncomeTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r76",
      "r136",
      "r499",
      "r504",
      "r505",
      "r673"
     ],
     "calculation": {
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "terseLabel": "Deferred income tax provision"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r492",
      "r493"
     ],
     "calculation": {
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 6.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Deferred tax liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanFairValueOfPlanAssets": {
     "auth_ref": [
      "r427",
      "r429",
      "r431",
      "r432",
      "r642",
      "r643",
      "r644"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.",
        "label": "Defined Benefit Plan, Plan Assets, Amount",
        "terseLabel": "Estimated fair value of plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanFairValueOfPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/RETIREMENTPLANSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost": {
     "auth_ref": [
      "r437",
      "r446",
      "r644",
      "r645"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of net periodic benefit cost (credit) for defined benefit plan.",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit)",
        "terseLabel": "Net periodic benefit costs"
       }
      }
     },
     "localname": "DefinedBenefitPlanNetPeriodicBenefitCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/RETIREMENTPLANSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanServiceCost": {
     "auth_ref": [
      "r426",
      "r438",
      "r447",
      "r644",
      "r645"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.",
        "label": "Defined Benefit Plan, Service Cost",
        "verboseLabel": "Service cost component"
       }
      }
     },
     "localname": "DefinedBenefitPlanServiceCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/RETIREMENTPLANSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative Contract [Domain]",
        "verboseLabel": "Derivative, Name [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofDerivativeInstrumentsDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofDerivativesNotDesignatedasHedgingInstrumentsDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeAsset": {
     "auth_ref": [
      "r42",
      "r165",
      "r191",
      "r227",
      "r621"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.",
        "label": "Derivative Asset, Subject to Master Netting Arrangement, before Offset",
        "terseLabel": "Total derivatives designated as hedges \u2014 Assets"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeLiability": {
     "auth_ref": [
      "r42",
      "r165",
      "r191",
      "r227",
      "r621"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.",
        "label": "Derivative Liability, Subject to Master Netting Arrangement, before Offset",
        "terseLabel": "Total derivatives designated as hedges \u2014 Liabilities"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeNet": {
     "auth_ref": [
      "r532"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of the assets less the liabilities of a derivative or group of derivatives.",
        "label": "Derivative, Fair Value, Net",
        "terseLabel": "Fair Value Asset (Liability)",
        "verboseLabel": "Estimated Fair Value"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofDerivativeInstrumentsDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeFixedInterestRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fixed interest rate related to the interest rate derivative.",
        "label": "Derivative, Fixed Interest Rate",
        "terseLabel": "Fixed Interest Rate",
        "verboseLabel": "Fixed Rate"
       }
      }
     },
     "localname": "DerivativeFixedInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofDerivativeInstrumentsDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r164",
      "r166",
      "r170",
      "r172",
      "r621"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instrument [Axis]",
        "verboseLabel": "Derivative, by Nature [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofDerivativeInstrumentsDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofDerivativesNotDesignatedasHedgingInstrumentsDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r182",
      "r526"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.",
        "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]",
        "terseLabel": "DERIVATIVE INSTRUMENTS"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": {
     "auth_ref": [
      "r161",
      "r164",
      "r170"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of hedging relationship.",
        "label": "Hedging Relationship [Axis]",
        "terseLabel": "Hedging Relationship [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofDerivativeInstrumentsDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": {
     "auth_ref": [
      "r161",
      "r164",
      "r170",
      "r172",
      "r175",
      "r176",
      "r524"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table]",
        "terseLabel": "Derivative Instruments, Gain (Loss) by Hedging Relationship, by Income Statement Location, by Derivative Instrument Risk [Table]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofDerivativesNotDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative Instruments, Gain (Loss) [Line Items]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Line Items]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofDerivativesNotDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet": {
     "auth_ref": [
      "r169",
      "r714"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized and unrealized gain (loss) of derivative instruments not designated or qualifying as hedging instruments.",
        "label": "Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net",
        "terseLabel": "Derivative instruments not designated as hedging instruments, gain (loss), net"
       }
      }
     },
     "localname": "DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofDerivativesNotDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative [Line Items]",
        "terseLabel": "Derivative [Line Items]"
       }
      }
     },
     "localname": "DerivativeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofDerivativeInstrumentsDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeNotionalAmount": {
     "auth_ref": [
      "r712",
      "r713"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payment on derivative.",
        "label": "Derivative, Notional Amount",
        "netLabel": "Aggregate Notional Amount",
        "terseLabel": "Current notional amount",
        "verboseLabel": "Notional Amount"
       }
      }
     },
     "localname": "DerivativeNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofDerivativeInstrumentsDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeTable": {
     "auth_ref": [
      "r156",
      "r157",
      "r158",
      "r161",
      "r162",
      "r168",
      "r170",
      "r173",
      "r174",
      "r176",
      "r526"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Derivative [Table]",
        "terseLabel": "Derivative [Table]"
       }
      }
     },
     "localname": "DerivativeTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofDerivativeInstrumentsDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativesFairValueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivatives, Fair Value [Line Items]",
        "terseLabel": "Derivatives, Fair Value [Line Items]"
       }
      }
     },
     "localname": "DerivativesFairValueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DesignatedAsHedgingInstrumentMember": {
     "auth_ref": [
      "r161"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Designated as Hedging Instrument [Member]",
        "terseLabel": "Designated as Hedging Instrument"
       }
      }
     },
     "localname": "DesignatedAsHedgingInstrumentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofDerivativeInstrumentsDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DilutiveSecuritiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dilutive Securities, Effect on Basic Earnings Per Share [Abstract]",
        "terseLabel": "Effect of dilutive securities:"
       }
      }
     },
     "localname": "DilutiveSecuritiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/NETINCOMEPERSHAREBasicandDilutedNetIncomePerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofRevenuesDisaggregatedbyMajorSourceDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r421",
      "r635",
      "r636",
      "r637",
      "r638",
      "r639",
      "r640",
      "r641"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofRevenuesDisaggregatedbyMajorSourceDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r708"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Schedule of Disaggregation of Revenue"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r457",
      "r484",
      "r485",
      "r487",
      "r491",
      "r649"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement [Text Block]",
        "terseLabel": "STOCK-BASED COMPENSATION"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATION"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement [Abstract]",
        "terseLabel": "Share-based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationAxis": {
     "auth_ref": [
      "r214"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by disposal group classification.",
        "label": "Disposal Group Classification [Axis]",
        "terseLabel": "Disposal Group Classification [Axis]"
       }
      }
     },
     "localname": "DisposalGroupClassificationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESDivestituresNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations.",
        "label": "Disposal Group Classification [Domain]",
        "terseLabel": "Disposal Group Classification [Domain]"
       }
      }
     },
     "localname": "DisposalGroupClassificationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESDivestituresNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember": {
     "auth_ref": [
      "r100",
      "r105"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal group that has been sold. Excludes disposals classified as discontinued operations.",
        "label": "Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member]",
        "terseLabel": "Disposal Group, Disposed of by Sale, Not Discontinued Operations"
       }
      }
     },
     "localname": "DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESDivestituresNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable": {
     "auth_ref": [
      "r0",
      "r1",
      "r8",
      "r104"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as accounts payable attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Accounts Payable",
        "terseLabel": "Disposal group, payable recognized"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESDivestituresNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation.",
        "label": "Disposal Group, Including Discontinued Operation, Consideration",
        "terseLabel": "Sale of business, disposition price"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationConsideration",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESDivestituresNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": {
     "auth_ref": [
      "r646",
      "r647"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of disposal group.",
        "label": "Disposal Group Name [Domain]",
        "terseLabel": "Disposal Group Name [Domain]"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESDivestituresNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Earnings Per Share [Abstract]",
        "verboseLabel": "Net income per share"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r243",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r266",
      "r268",
      "r273",
      "r274",
      "r275",
      "r279",
      "r528",
      "r529",
      "r580",
      "r586",
      "r624"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Basic (in dollars per share)",
        "verboseLabel": "Basic net income per common share (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED",
      "http://integralife.com/role/NETINCOMEPERSHAREBasicandDilutedNetIncomePerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareBasicAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic [Abstract]",
        "terseLabel": "Basic net income per share:"
       }
      }
     },
     "localname": "EarningsPerShareBasicAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/NETINCOMEPERSHAREBasicandDilutedNetIncomePerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r243",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r268",
      "r273",
      "r274",
      "r275",
      "r279",
      "r528",
      "r529",
      "r580",
      "r586",
      "r624"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Diluted (in dollars per share)",
        "verboseLabel": "Diluted net income per common share (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED",
      "http://integralife.com/role/NETINCOMEPERSHAREBasicandDilutedNetIncomePerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Diluted [Abstract]",
        "terseLabel": "Diluted net income per share:"
       }
      }
     },
     "localname": "EarningsPerShareDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/NETINCOMEPERSHAREBasicandDilutedNetIncomePerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r276",
      "r277",
      "r278",
      "r280"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "NET INCOME PER SHARE"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/NETINCOMEPERSHARE"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r534"
     ],
     "calculation": {
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations",
        "terseLabel": "Effect of exchange rate changes on cash and cash equivalents"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r495"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Effective income tax rate",
        "verboseLabel": "Reported tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESNarrativeDetails",
      "http://integralife.com/role/INCOMETAXESSummaryofEffectiveTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r33"
     ],
     "calculation": {
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Accrued compensation"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "auth_ref": [
      "r486"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "terseLabel": "Total unrecognized compensation costs"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r486"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Weighted-average period for cost recognition"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-Based Payment Arrangement, Option [Member]",
        "terseLabel": "Stock Options"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]",
        "terseLabel": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r119",
      "r212",
      "r237",
      "r238",
      "r239",
      "r253",
      "r254",
      "r255",
      "r257",
      "r263",
      "r265",
      "r281",
      "r320",
      "r398",
      "r488",
      "r489",
      "r490",
      "r500",
      "r501",
      "r527",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r554",
      "r589",
      "r590",
      "r591"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSNarrativeDetails",
      "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails",
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUNAUDITED",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ExtendedProductWarrantyPolicy": {
     "auth_ref": [
      "r110"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for extended product warranties and other guarantee contracts including the methodology for measuring the liability.",
        "label": "Extended Product Warranty, Policy [Policy Text Block]",
        "terseLabel": "Product Warranties"
       }
      }
     },
     "localname": "ExtendedProductWarrantyPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/BASISOFPRESENTATIONPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r381",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r530",
      "r557",
      "r558",
      "r559",
      "r629",
      "r630",
      "r642",
      "r643",
      "r644"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails",
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails",
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByLiabilityClassAxis": {
     "auth_ref": [
      "r184",
      "r185"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by class of liability.",
        "label": "Liability Class [Axis]",
        "terseLabel": "Liability Class [Axis]"
       }
      }
     },
     "localname": "FairValueByLiabilityClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails",
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r381",
      "r431",
      "r436",
      "r530",
      "r558",
      "r629",
      "r630",
      "r642",
      "r643",
      "r644"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Fair Value, Inputs, Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r381",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r530",
      "r559",
      "r629",
      "r630",
      "r642",
      "r643",
      "r644"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Fair Value, Inputs, Level 3"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails",
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain": {
     "auth_ref": [
      "r183"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents classes of liabilities measured and disclosed at fair value.",
        "label": "Fair Value by Liability Class [Domain]",
        "terseLabel": "Fair Value by Liability Class [Domain]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails",
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]",
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]",
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable": {
     "auth_ref": [
      "r183",
      "r185"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of information required and determined to be provided for purposes of reconciling beginning and ending balances of fair value measurements of liabilities using significant unobservable inputs (level 3). Separately presenting changes during the period, attributable to: (1) total gains or losses for the period (realized and unrealized) and location reported in the statement of income (or activities); (2) purchases, sales, issuances, and settlements (net); (3) transfers in and/or out of Level 3.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]",
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": {
     "auth_ref": [
      "r183",
      "r185"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of Contingent Consideration"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings": {
     "auth_ref": [
      "r531"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings",
        "verboseLabel": "Change in fair value of contingent consideration liabilities"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": {
     "auth_ref": [
      "r183"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value",
        "periodEndLabel": "Balance, End of Period",
        "periodStartLabel": "Balance, Beginning of Period",
        "terseLabel": "Fair value"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails",
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r381",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r557",
      "r558",
      "r559",
      "r629",
      "r630",
      "r642",
      "r643",
      "r644"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails",
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails",
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable": {
     "auth_ref": [
      "r163",
      "r168",
      "r175"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that discloses the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.",
        "label": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]",
        "terseLabel": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]"
       }
      }
     },
     "localname": "FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FederalFundsEffectiveSwapRateMember": {
     "auth_ref": [
      "r716"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fixed rate on U.S. dollar, constant-notional interest rate swap having its variable-rate leg referenced to Federal Funds effective rate with no additional spread over Federal Funds effective rate on that variable-rate leg.",
        "label": "Fed Funds Effective Rate Overnight Index Swap Rate [Member]",
        "terseLabel": "Overnight Federal Funds"
       }
      }
     },
     "localname": "FederalFundsEffectiveSwapRateMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "terseLabel": "Weighted Average Life"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r220",
      "r338"
     ],
     "calculation": {
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails": {
       "order": 2.0,
       "parentTag": "iart_DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "negatedLabel": "Accumulated Amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, after Year Five",
        "terseLabel": "Expected annual amortization expense, thereafter"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r96"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "terseLabel": "Expected annual amortization expense, in 2023"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year",
        "terseLabel": "Expected annual amortization expense, remainder of 2022"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": {
     "auth_ref": [
      "r96"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five",
        "terseLabel": "Expected annual amortization expense, in 2027"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r96"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "terseLabel": "Expected annual amortization expense, in 2026"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r96"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "terseLabel": "Expected annual amortization expense, in 2025"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r96"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "terseLabel": "Expected annual amortization expense, in 2024"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r335",
      "r337",
      "r338",
      "r340",
      "r563",
      "r564"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r90",
      "r94"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignExchangeForwardMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foreign exchange forward traded on an exchange (examples include but are not limited to the International Securities Exchange, Philadelphia Stock Exchange, or the Chicago Mercantile Exchange) for options or future contracts to buy or sell a certain currency, at a specified date, at a fixed exercise exchange rate.",
        "label": "Foreign Exchange Forward [Member]",
        "terseLabel": "Foreign currency forward contracts"
       }
      }
     },
     "localname": "ForeignExchangeForwardMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofDerivativesNotDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainLossOnDerivativeInstrumentsNetPretax": {
     "auth_ref": [
      "r164"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate net gain (loss) on all derivative instruments recognized in earnings during the period, before tax effects.",
        "label": "Gain (Loss) on Derivative Instruments, Net, Pretax",
        "terseLabel": "Gain (loss) reclassified into other income"
       }
      }
     },
     "localname": "GainLossOnDerivativeInstrumentsNetPretax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnDispositionOfAssets": {
     "auth_ref": [
      "r670",
      "r694",
      "r695"
     ],
     "calculation": {
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property.",
        "label": "Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property",
        "negatedLabel": "Loss (gain) on disposal of property and equipment"
       }
      }
     },
     "localname": "GainLossOnDispositionOfAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnSaleOfBusiness": {
     "auth_ref": [
      "r518",
      "r670"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.",
        "label": "Gain (Loss) on Disposition of Business",
        "terseLabel": "Gain from sale of businesses"
       }
      }
     },
     "localname": "GainLossOnSaleOfBusiness",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESDivestituresNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r219",
      "r323",
      "r577",
      "r627",
      "r653",
      "r683",
      "r690"
     ],
     "calculation": {
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails": {
       "order": 3.0,
       "parentTag": "iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredIncludingGoodwill",
       "weight": 1.0
      },
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "End of Period",
        "periodStartLabel": "Beginning of Period",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails",
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED",
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesinCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r99"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "terseLabel": "GOODWILL AND OTHER INTANGIBLE ASSETS"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": {
     "auth_ref": [
      "r329"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Foreign Currency Translation Gain (Loss)",
        "terseLabel": "Foreign currency translation"
       }
      }
     },
     "localname": "GoodwillForeignCurrencyTranslationGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesinCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Goodwill [Line Items]",
        "terseLabel": "Goodwill [Line Items]"
       }
      }
     },
     "localname": "GoodwillLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesinCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillPurchaseAccountingAdjustments": {
     "auth_ref": [
      "r137",
      "r689"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Purchase Accounting Adjustments",
        "terseLabel": "SIA Acquisition Working Capital Adjustment"
       }
      }
     },
     "localname": "GoodwillPurchaseAccountingAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesinCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesinCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgingDesignationAxis": {
     "auth_ref": [
      "r161",
      "r524"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Axis]",
        "terseLabel": "Hedging Designation [Axis]"
       }
      }
     },
     "localname": "HedgingDesignationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofDerivativeInstrumentsDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgingDesignationDomain": {
     "auth_ref": [
      "r161"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Domain]",
        "terseLabel": "Hedging Designation [Domain]"
       }
      }
     },
     "localname": "HedgingDesignationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofDerivativeInstrumentsDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_HedgingRelationshipDomain": {
     "auth_ref": [
      "r161"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nature or intent of a hedge.",
        "label": "Hedging Relationship [Domain]",
        "terseLabel": "Hedging Relationship [Domain]"
       }
      }
     },
     "localname": "HedgingRelationshipDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofDerivativeInstrumentsDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r53",
      "r192",
      "r197",
      "r210",
      "r294",
      "r299",
      "r305",
      "r308",
      "r581",
      "r626"
     ],
     "calculation": {
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Income before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": {
     "auth_ref": [
      "r646",
      "r647"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of disposal group.",
        "label": "Disposal Group Name [Axis]",
        "terseLabel": "Disposal Group Name [Axis]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESDivestituresNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]",
        "terseLabel": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESDivestituresNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable": {
     "auth_ref": [
      "r1",
      "r2",
      "r3",
      "r4",
      "r5",
      "r6",
      "r7",
      "r9",
      "r10",
      "r11",
      "r12",
      "r105",
      "r106"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations [Table]",
        "terseLabel": "Disposal Groups, Including Discontinued Operations [Table]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESDivestituresNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r341",
      "r343"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSNarrativeDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r343"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSNarrativeDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r248",
      "r496",
      "r497",
      "r498",
      "r502",
      "r506",
      "r508",
      "r509",
      "r510"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "INCOME TAXES"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/INCOMETAXES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r249",
      "r264",
      "r265",
      "r292",
      "r494",
      "r503",
      "r507",
      "r587"
     ],
     "calculation": {
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Provision for income taxes"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r75"
     ],
     "calculation": {
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.",
        "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
        "terseLabel": "Accounts payable, accrued expenses and other current liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r75"
     ],
     "calculation": {
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r75"
     ],
     "calculation": {
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedLabel": "Inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in noncurrent operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Noncurrent Liabilities",
        "terseLabel": "Other non-current liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherNoncurrentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingAssets": {
     "auth_ref": [
      "r75"
     ],
     "calculation": {
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets",
        "negatedLabel": "Other non-current assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r75"
     ],
     "calculation": {
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUNAUDITED"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r269",
      "r270",
      "r271",
      "r275",
      "r456"
     ],
     "calculation": {
      "http://integralife.com/role/NETINCOMEPERSHAREBasicandDilutedNetIncomePerShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements",
        "terseLabel": "Stock options and restricted stock (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/NETINCOMEPERSHAREBasicandDilutedNetIncomePerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r336",
      "r339"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-Lived Intangible Assets [Axis]",
        "terseLabel": "Indefinite-lived Intangible Assets [Axis]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r92",
      "r97"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company.",
        "label": "Indefinite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Indefinite-lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r88",
      "r93"
     ],
     "calculation": {
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Intangible assets, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r189",
      "r199",
      "r240",
      "r288",
      "r541"
     ],
     "calculation": {
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedTerseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseMember": {
     "auth_ref": [
      "r171"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing interest expense.",
        "label": "Interest Expense [Member]",
        "terseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InterestIncomeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption in which reported facts about interest income have been included.",
        "label": "Interest Income [Member]",
        "terseLabel": "Interest income",
        "verboseLabel": "Interest income"
       }
      }
     },
     "localname": "InterestIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSNarrativeDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet": {
     "auth_ref": [
      "r177"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated net amount of unrealized gains or losses on interest rate cash flow hedges as of the balance sheet date expected to be reclassified to earnings within the next twelve months.",
        "label": "Interest Rate Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net",
        "terseLabel": "Gain expected to be reclassified to earnings in the next twelve months"
       }
      }
     },
     "localname": "InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateSwapMember": {
     "auth_ref": [
      "r651"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.",
        "label": "Interest Rate Swap [Member]",
        "verboseLabel": "Interest rate swap"
       }
      }
     },
     "localname": "InterestRateSwapMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InventoryDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory Disclosure [Abstract]"
       }
      }
     },
     "localname": "InventoryDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryDisclosureTextBlock": {
     "auth_ref": [
      "r322"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.",
        "label": "Inventory Disclosure [Text Block]",
        "terseLabel": "INVENTORIES"
       }
      }
     },
     "localname": "InventoryDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/INVENTORIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryFinishedGoodsNetOfReserves": {
     "auth_ref": [
      "r86",
      "r617"
     ],
     "calculation": {
      "http://integralife.com/role/INVENTORIESScheduleofNetInventoriesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.",
        "label": "Inventory, Finished Goods, Net of Reserves",
        "terseLabel": "Finished goods"
       }
      }
     },
     "localname": "InventoryFinishedGoodsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/INVENTORIESScheduleofNetInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r225",
      "r616",
      "r653"
     ],
     "calculation": {
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://integralife.com/role/INVENTORIESScheduleofNetInventoriesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventories, net",
        "totalLabel": "Inventories, net"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED",
      "http://integralife.com/role/INVENTORIESScheduleofNetInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryRawMaterialsAndPurchasedPartsNetOfReserves": {
     "auth_ref": [
      "r86",
      "r664"
     ],
     "calculation": {
      "http://integralife.com/role/INVENTORIESScheduleofNetInventoriesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of items purchased for use as components of a finished product or pieces of machinery and equipment plus any items in their natural and unrefined state. This element may be used when the reporting entity combines raw materials and purchased parts into an aggregate amount.",
        "label": "Inventory, Raw Materials and Purchased Parts, Net of Reserves",
        "terseLabel": "Raw materials"
       }
      }
     },
     "localname": "InventoryRawMaterialsAndPurchasedPartsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/INVENTORIESScheduleofNetInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcessNetOfReserves": {
     "auth_ref": [
      "r86",
      "r618"
     ],
     "calculation": {
      "http://integralife.com/role/INVENTORIESScheduleofNetInventoriesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.",
        "label": "Inventory, Work in Process, Net of Reserves",
        "terseLabel": "Work in process"
       }
      }
     },
     "localname": "InventoryWorkInProcessNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/INVENTORIESScheduleofNetInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeInterest": {
     "auth_ref": [
      "r59",
      "r287"
     ],
     "calculation": {
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.",
        "label": "Investment Income, Interest",
        "terseLabel": "Interest income"
       }
      }
     },
     "localname": "InvestmentIncomeInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseContractualTermAxis": {
     "auth_ref": [
      "r723"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by contractual term of lease arrangement.",
        "label": "Lease Contractual Term [Axis]",
        "terseLabel": "Lease Contractual Term [Axis]"
       }
      }
     },
     "localname": "LeaseContractualTermAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LeaseContractualTermDomain": {
     "auth_ref": [
      "r723"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual term of lease arrangement.",
        "label": "Lease Contractual Term [Domain]",
        "terseLabel": "Lease Contractual Term [Domain]"
       }
      }
     },
     "localname": "LeaseContractualTermDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]",
        "terseLabel": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Lessee, Lease, Description [Line Items]",
        "terseLabel": "Lessee, Lease, Description [Line Items]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "auth_ref": [
      "r547"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about lessee's leases.",
        "label": "Lessee, Lease, Description [Table]",
        "terseLabel": "Lessee, Lease, Description [Table]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r724"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Schedule of Operating Lease Maturities"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r552"
     ],
     "calculation": {
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total minimum lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r552"
     ],
     "calculation": {
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesDetails_1": {
       "order": 7.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r552"
     ],
     "calculation": {
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r552"
     ],
     "calculation": {
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesDetails_1": {
       "order": 6.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five",
        "terseLabel": "2028"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r552"
     ],
     "calculation": {
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesDetails_1": {
       "order": 5.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2027"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r552"
     ],
     "calculation": {
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesDetails_1": {
       "order": 4.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r552"
     ],
     "calculation": {
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesDetails_1": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": {
     "auth_ref": [
      "r724"
     ],
     "calculation": {
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year",
        "terseLabel": "Remainder of 2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r552"
     ],
     "calculation": {
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "terseLabel": "Less: Imputed interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseOptionToExtend": {
     "auth_ref": [
      "r546"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of terms and conditions of option to extend lessee's operating lease. Includes, but is not limited to, information about option recognized as part of right-of-use asset and lease liability.",
        "label": "Lessee, Operating Lease, Option to Extend",
        "terseLabel": "Period for extended lease"
       }
      }
     },
     "localname": "LesseeOperatingLeaseOptionToExtend",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeOperatingLeaseRenewalTerm": {
     "auth_ref": [
      "r722"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Renewal Term",
        "terseLabel": "Option to extend lease, years"
       }
      }
     },
     "localname": "LesseeOperatingLeaseRenewalTerm",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r553"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "LEASES AND RELATED PARTY LEASES"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LettersOfCreditOutstandingAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.",
        "label": "Letters of Credit Outstanding, Amount",
        "terseLabel": "Letters of credit outstanding"
       }
      }
     },
     "localname": "LettersOfCreditOutstandingAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r32",
      "r247",
      "r319",
      "r354",
      "r355",
      "r357",
      "r358",
      "r359",
      "r361",
      "r363",
      "r365",
      "r366",
      "r516",
      "r519",
      "r520",
      "r533",
      "r625",
      "r702",
      "r729",
      "r730"
     ],
     "calculation": {
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r26",
      "r196",
      "r207",
      "r653",
      "r672",
      "r682",
      "r718"
     ],
     "calculation": {
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and stockholders\u2019 equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r34",
      "r217",
      "r247",
      "r319",
      "r354",
      "r355",
      "r357",
      "r358",
      "r359",
      "r361",
      "r363",
      "r365",
      "r366",
      "r516",
      "r519",
      "r520",
      "r533",
      "r653",
      "r702",
      "r729",
      "r730"
     ],
     "calculation": {
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCredit": {
     "auth_ref": [
      "r19",
      "r195",
      "r202"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.",
        "label": "Long-Term Line of Credit",
        "terseLabel": "Line of credit facility outstanding"
       }
      }
     },
     "localname": "LineOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityCommitmentFeePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used.",
        "label": "Line of Credit Facility, Commitment Fee Percentage",
        "terseLabel": "Line of credit, commitment fee percentage"
       }
      }
     },
     "localname": "LineOfCreditFacilityCommitmentFeePercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding": {
     "auth_ref": [
      "r532"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of the amount outstanding under the credit facility.",
        "label": "Line of Credit Facility, Fair Value of Amount Outstanding",
        "terseLabel": "Line of credit facility, fair value of amount outstanding"
       }
      }
     },
     "localname": "LineOfCreditFacilityFairValueOfAmountOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r31"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Maximum borrowing capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates an ownership position in, or purchase of, a security.",
        "label": "Long [Member]",
        "terseLabel": "Long"
       }
      }
     },
     "localname": "LongMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r19",
      "r195",
      "r205",
      "r380",
      "r394",
      "r629",
      "r630"
     ],
     "calculation": {
      "http://integralife.com/role/DEBTContractualMaturityTableDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.",
        "label": "Long-Term Debt",
        "totalLabel": "Principal Repayment"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DEBTContractualMaturityTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": {
     "auth_ref": [
      "r112",
      "r252",
      "r385"
     ],
     "calculation": {
      "http://integralife.com/role/DEBTContractualMaturityTableDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year One",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DEBTContractualMaturityTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": {
     "auth_ref": [
      "r112",
      "r252",
      "r385"
     ],
     "calculation": {
      "http://integralife.com/role/DEBTContractualMaturityTableDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Three",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DEBTContractualMaturityTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": {
     "auth_ref": [
      "r112",
      "r252",
      "r385"
     ],
     "calculation": {
      "http://integralife.com/role/DEBTContractualMaturityTableDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Two",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DEBTContractualMaturityTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear": {
     "auth_ref": [
      "r674"
     ],
     "calculation": {
      "http://integralife.com/role/DEBTContractualMaturityTableDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in remainder of current fiscal year.",
        "label": "Long-Term Debt, Maturity, Remainder of Fiscal Year",
        "terseLabel": "Remainder of 2023"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DEBTContractualMaturityTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r37"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-Term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r37",
      "r113"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-Term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Loss Contingencies [Line Items]",
        "terseLabel": "Loss Contingencies [Line Items]"
       }
      }
     },
     "localname": "LossContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r108",
      "r109",
      "r348",
      "r349",
      "r350",
      "r697",
      "r698"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]",
        "terseLabel": "Loss Contingencies [Table]"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock": {
     "auth_ref": [
      "r13",
      "r149"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for business combinations, including leverage buyout transactions (as applicable), and divestitures. This may include a description of a business combination or divestiture (or series of individually immaterial business combinations or divestitures) completed during the period, including background, timing, and assets and liabilities recognized and reclassified or sold. This element does not include fixed asset sales and plant closings.",
        "label": "Mergers, Acquisitions and Dispositions Disclosures [Text Block]",
        "terseLabel": "ACQUISITIONS AND DIVESTITURES"
       }
      }
     },
     "localname": "MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r245"
     ],
     "calculation": {
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash used in financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "FINANCING ACTIVITIES:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r245"
     ],
     "calculation": {
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "INVESTING ACTIVITIES:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r73",
      "r74",
      "r77"
     ],
     "calculation": {
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "OPERATING ACTIVITIES:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r54",
      "r77",
      "r198",
      "r209",
      "r215",
      "r232",
      "r235",
      "r239",
      "r247",
      "r256",
      "r258",
      "r259",
      "r260",
      "r261",
      "r264",
      "r265",
      "r272",
      "r294",
      "r299",
      "r305",
      "r308",
      "r319",
      "r354",
      "r355",
      "r357",
      "r358",
      "r359",
      "r361",
      "r363",
      "r365",
      "r366",
      "r529",
      "r533",
      "r626",
      "r702"
     ],
     "calculation": {
      "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSScheduleofComprehensiveIncomeDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      },
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net income",
        "totalLabel": "Net income",
        "verboseLabel": "Net income"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSScheduleofComprehensiveIncomeDetails",
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED",
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUNAUDITED",
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED",
      "http://integralife.com/role/NETINCOMEPERSHAREBasicandDilutedNetIncomePerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetInvestmentHedgingMember": {
     "auth_ref": [
      "r160"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedges of a net investment in a foreign operation.",
        "label": "Net Investment Hedging [Member]",
        "terseLabel": "Net Investment Hedges"
       }
      }
     },
     "localname": "NetInvestmentHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recent Accounting Pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/BASISOFPRESENTATIONPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NondesignatedMember": {
     "auth_ref": [
      "r161"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Not Designated as Hedging Instrument [Member]",
        "terseLabel": "Not Designated as Hedging Instrument"
       }
      }
     },
     "localname": "NondesignatedMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NumberOfReportableSegments": {
     "auth_ref": [
      "r679"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.",
        "label": "Number of Reportable Segments",
        "terseLabel": "Number of reportable segments"
       }
      }
     },
     "localname": "NumberOfReportableSegments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent": {
     "auth_ref": [
      "r50",
      "r52"
     ],
     "calculation": {
      "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments, of other comprehensive income (loss), attributable to parent.",
        "label": "OCI, before Reclassifications, Net of Tax, Attributable to Parent",
        "terseLabel": "Other comprehensive gain (loss)"
       }
      }
     },
     "localname": "OciBeforeReclassificationsNetOfTaxAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r294",
      "r299",
      "r305",
      "r308",
      "r626"
     ],
     "calculation": {
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Operating income",
        "verboseLabel": "Operating income"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED",
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseExpense": {
     "auth_ref": [
      "r721"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating lease expense. Excludes sublease income.",
        "label": "Operating Lease, Expense",
        "terseLabel": "Operating lease expense"
       }
      }
     },
     "localname": "OperatingLeaseExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r544"
     ],
     "calculation": {
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "terseLabel": "Total lease liabilities",
        "totalLabel": "Total lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesDetails",
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r544"
     ],
     "calculation": {
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "netLabel": "Less: Current lease liabilities",
        "terseLabel": "Current lease liabilities",
        "verboseLabel": "Current portion of lease liability - operating leases"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED",
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesDetails",
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r544"
     ],
     "calculation": {
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 5.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      },
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "netLabel": "Long-term lease liabilities",
        "terseLabel": "Non-current lease liabilities",
        "verboseLabel": "Lease liability - operating leases"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED",
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesDetails",
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r545",
      "r548"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments",
        "terseLabel": "Operating cash flows from operating leases"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r543"
     ],
     "calculation": {
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "ROU assets",
        "verboseLabel": "Right of use asset - operating leases"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED",
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r551",
      "r652"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Weighted average discount rate"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r550",
      "r652"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Weighted average remaining lease term (in years)"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingLeasedAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Operating Leased Assets [Line Items]",
        "terseLabel": "Operating Leased Assets [Line Items]"
       }
      }
     },
     "localname": "OperatingLeasedAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesDetails",
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingSegmentsMember": {
     "auth_ref": [
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r308"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Operating Segments [Member]",
        "terseLabel": "Operating Segments"
       }
      }
     },
     "localname": "OperatingSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OptionIndexedToIssuersEquityEquityAxis": {
     "auth_ref": [
      "r118",
      "r178",
      "r179",
      "r181"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of options indexed to an issuer's equity.",
        "label": "Option Indexed to Issuer's Equity [Axis]",
        "terseLabel": "Option Indexed to Issuer's Equity [Axis]"
       }
      }
     },
     "localname": "OptionIndexedToIssuersEquityEquityAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OptionIndexedToIssuersEquityStrikePrice1": {
     "auth_ref": [
      "r117",
      "r180"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise or strike price stated in the contract for options indexed to the issuer's equity shares.",
        "label": "Option Indexed to Issuer's Equity, Strike Price",
        "terseLabel": "Initial strike price (in dollars per share)"
       }
      }
     },
     "localname": "OptionIndexedToIssuersEquityStrikePrice1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_OptionIndexedToIssuersEquityTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of the type of freestanding contract issued by a Company that is indexed to, and potentially settled in, a Company's own stock. Specifically, the pertinent rights and privileges of the securities outstanding.",
        "label": "Option Indexed to Issuer's Equity, Type [Domain]",
        "terseLabel": "Option Indexed to Issuer's Equity, Type [Domain]"
       }
      }
     },
     "localname": "OptionIndexedToIssuersEquityTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "auth_ref": [
      "r14",
      "r155"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]",
        "terseLabel": "BASIS OF PRESENTATION"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/BASISOFPRESENTATION"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAssetsMember": {
     "auth_ref": [
      "r163",
      "r175"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other assets.",
        "label": "Other Assets [Member]",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r221"
     ],
     "calculation": {
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r46",
      "r48",
      "r151",
      "r153"
     ],
     "calculation": {
      "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSScheduleofComprehensiveIncomeDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan, attributable to parent.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent",
        "negatedTerseLabel": "Pension liability adjustment, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSScheduleofComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r151",
      "r152",
      "r153"
     ],
     "calculation": {
      "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSScheduleofComprehensiveIncomeDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent",
        "terseLabel": "Foreign currency translation adjustment"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSScheduleofComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent": {
     "auth_ref": [
      "r229"
     ],
     "calculation": {
      "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSScheduleofComprehensiveIncomeDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax, Parent",
        "terseLabel": "Change in unrealized loss/(gain) on derivatives, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSScheduleofComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax": {
     "auth_ref": [
      "r228",
      "r229",
      "r521",
      "r522",
      "r525"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax",
        "terseLabel": "Gain (loss) recorded in AOCL, change in fair value",
        "verboseLabel": "Amount\u00a0of Gain (Loss) Recognized\u00a0in AOCL"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax": {
     "auth_ref": [
      "r229",
      "r231"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax",
        "terseLabel": "Amount\u00a0of\u00a0Gain (Loss) Reclassified from AOCL into Earnings"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax": {
     "auth_ref": [
      "r523"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative designated and qualifying as net investment hedge.",
        "label": "Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax",
        "negatedTerseLabel": "Gain (loss) recorded, net investment hedge, change in fair value"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r151",
      "r152",
      "r153",
      "r233",
      "r236"
     ],
     "calculation": {
      "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent",
        "terseLabel": "Other comprehensive income (loss), net of tax",
        "totalLabel": "Net current-period other comprehensive gain (loss)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails",
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other current liabilities.",
        "label": "Other Current Liabilities [Member]",
        "terseLabel": "Other Current Liabilities"
       }
      }
     },
     "localname": "OtherCurrentLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherDepreciationAndAmortization": {
     "auth_ref": [
      "r57",
      "r76",
      "r101"
     ],
     "calculation": {
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense charged against earnings to allocate the cost of tangible and intangible assets over their remaining economic lives, classified as other.",
        "label": "Other Depreciation and Amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "OtherDepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherExpenseMember": {
     "auth_ref": [
      "r171"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other expense.",
        "label": "Other Expense [Member]",
        "terseLabel": "Other income (expense)"
       }
      }
     },
     "localname": "OtherExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherLiabilitiesMember": {
     "auth_ref": [
      "r163",
      "r175"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other liabilities.",
        "label": "Other Liabilities [Member]",
        "terseLabel": "Other liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r38"
     ],
     "calculation": {
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 7.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other noncurrent liabilities.",
        "label": "Other Noncurrent Liabilities [Member]",
        "terseLabel": "Other Long-term Liabilities"
       }
      }
     },
     "localname": "OtherNoncurrentLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESFairValueContingentConsiderationBalanceInformationDetails",
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r61"
     ],
     "calculation": {
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "terseLabel": "Other income, net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other nonoperating income (expense).",
        "label": "Other Nonoperating Income (Expense) [Member]",
        "terseLabel": "Other income, net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities": {
     "auth_ref": [
      "r72"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability up to amount recognized at acquisition date, including, but not limited to, measurement period adjustment and less amount paid soon after acquisition date.",
        "label": "Payment for Contingent Consideration Liability, Financing Activities",
        "terseLabel": "Payment for contingent consideration"
       }
      }
     },
     "localname": "PaymentForContingentConsiderationLiabilityFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r69"
     ],
     "calculation": {
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedLabel": "Purchases of treasury stock"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDebtIssuanceCosts": {
     "auth_ref": [
      "r71"
     ],
     "calculation": {
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.",
        "label": "Payments of Debt Issuance Costs",
        "negatedTerseLabel": "Payment of debt issuance costs"
       }
      }
     },
     "localname": "PaymentsOfDebtIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [
      "r244"
     ],
     "calculation": {
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Payment, Tax Withholding, Share-Based Payment Arrangement",
        "negatedTerseLabel": "Cash taxes paid in net equity settlement"
       }
      }
     },
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesGross": {
     "auth_ref": [
      "r64",
      "r512"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.",
        "label": "Payments to Acquire Businesses, Gross",
        "terseLabel": "Payments to acquire businesses, gross"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment": {
     "auth_ref": [
      "r64"
     ],
     "calculation": {
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflows from the purchase of net carrying value allocated to in-process research and development costs and materials acquired in a business combination.",
        "label": "Payments to Acquire in Process Research and Development",
        "negatedLabel": "Acquired in-process research and development milestone"
       }
      }
     },
     "localname": "PaymentsToAcquireInProcessResearchAndDevelopment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r65"
     ],
     "calculation": {
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchases of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": {
     "auth_ref": [
      "r428",
      "r430",
      "r436",
      "r439",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r448",
      "r449",
      "r450",
      "r452",
      "r644"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for retirement benefits.",
        "label": "Retirement Benefits [Text Block]",
        "terseLabel": "RETIREMENT PLANS"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/RETIREMENTPLANS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PerformanceSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement awarded for meeting performance target.",
        "label": "Performance Shares [Member]",
        "terseLabel": "Performance Stock"
       }
      }
     },
     "localname": "PerformanceSharesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PositionAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by position taken for a security.",
        "label": "Position [Axis]",
        "terseLabel": "Position [Axis]"
       }
      }
     },
     "localname": "PositionAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PositionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates position taken for a security.",
        "label": "Position [Domain]",
        "terseLabel": "Position [Domain]"
       }
      }
     },
     "localname": "PositionDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r20",
      "r395"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITEDParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r20"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, authorized shares (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITEDParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r20"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred stock, outstanding shares (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITEDParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r20",
      "r653"
     ],
     "calculation": {
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock; no par value; 15,000 authorized shares; none outstanding"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r665"
     ],
     "calculation": {
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing prepaid expenses and other current assets.",
        "label": "Prepaid Expenses and Other Current Assets [Member]",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpensesAndOtherCurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSFairValueofDerivativeInstrumentsByBalanceSheetLocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProceedsFromDivestitureOfBusinesses": {
     "auth_ref": [
      "r63"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.",
        "label": "Proceeds from Divestiture of Businesses",
        "terseLabel": "Proceeds from sale of business"
       }
      }
     },
     "localname": "ProceedsFromDivestitureOfBusinesses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESDivestituresNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfSecuredDebt": {
     "auth_ref": [
      "r68"
     ],
     "calculation": {
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from amounts received from issuance of long-term debt that is wholly or partially secured by collateral. Excludes proceeds from tax exempt secured debt.",
        "label": "Proceeds from Issuance of Secured Debt",
        "terseLabel": "Proceeds from borrowings of long-term indebtedness"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfSecuredDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfWarrants": {
     "auth_ref": [
      "r67"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).",
        "label": "Proceeds from Issuance of Warrants",
        "verboseLabel": "Proceeds from warrant transactions"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfWarrants",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r67",
      "r131"
     ],
     "calculation": {
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds from Stock Options Exercised",
        "terseLabel": "Proceeds from exercised stock options"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r103"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Long-Lived Tangible Asset [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r103",
      "r208",
      "r582",
      "r653"
     ],
     "calculation": {
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property, plant and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r102"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Long-Lived Tangible Asset [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent": {
     "auth_ref": [
      "r50",
      "r52"
     ],
     "calculation": {
      "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss) attributable to parent.",
        "label": "Reclassification from AOCI, Current Period, Net of Tax, Attributable to Parent",
        "terseLabel": "Less: Amounts reclassified from accumulated other comprehensive income, net",
        "verboseLabel": "Gain (loss) reclassified from AOCI"
       }
      }
     },
     "localname": "ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSNarrativeDetails",
      "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyDomain": {
     "auth_ref": [
      "r440",
      "r555",
      "r556"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Domain]",
        "terseLabel": "Related Party [Domain]"
       }
      }
     },
     "localname": "RelatedPartyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "auth_ref": [
      "r440",
      "r555",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r728"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Axis]",
        "terseLabel": "Related Party [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RepaymentsOfSecuredDebt": {
     "auth_ref": [
      "r70"
     ],
     "calculation": {
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to repay long-term debt that is wholly or partially secured by collateral. Excludes repayments of tax exempt secured debt.",
        "label": "Repayments of Secured Debt",
        "negatedTerseLabel": "Payments on debt"
       }
      }
     },
     "localname": "RepaymentsOfSecuredDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost": {
     "auth_ref": [
      "r134"
     ],
     "calculation": {
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The costs incurred in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, excluding in-process research and development acquired in a business combination consummated during the period. Excludes software research and development, which has a separate concept.",
        "label": "Research and Development Expense (Excluding Acquired in Process Cost)",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockMember": {
     "auth_ref": [
      "r80"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.",
        "label": "Restricted Stock [Member]",
        "terseLabel": "Restricted Stock"
       }
      }
     },
     "localname": "RestrictedStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r23",
      "r125",
      "r206",
      "r592",
      "r594",
      "r653"
     ],
     "calculation": {
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 6.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r212",
      "r253",
      "r254",
      "r255",
      "r257",
      "r263",
      "r265",
      "r320",
      "r488",
      "r489",
      "r490",
      "r500",
      "r501",
      "r527",
      "r589",
      "r591"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUNAUDITED"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]",
        "terseLabel": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r285",
      "r286",
      "r298",
      "r303",
      "r304",
      "r310",
      "r311",
      "r314",
      "r420",
      "r421",
      "r562"
     ],
     "calculation": {
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Total Revenues",
        "verboseLabel": "Total revenue, net"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED",
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofRevenuesDisaggregatedbyMajorSourceDetails",
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails",
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTotalRevenuebyMajorGeographicAreaDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "auth_ref": [
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r425",
      "r623"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue from contract with customer.",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "terseLabel": "Summary of Accounting Policies on Revenue Recognition and Shipping and Handling Fees"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/BASISOFPRESENTATIONPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r410",
      "r411",
      "r424",
      "r425"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "REVENUES FROM CONTRACTS WITH CUSTOMERS"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]",
        "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeRevenueRemainingPerformanceObligationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1": {
     "auth_ref": [
      "r409"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period",
        "terseLabel": "Performance obligations expected to be satisfied, expected timing"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeRevenueRemainingPerformanceObligationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis": {
     "auth_ref": [
      "r409"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Start date of time band for expected timing of satisfaction of remaining performance obligation, in YYYY-MM-DD format.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]",
        "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeRevenueRemainingPerformanceObligationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about expected timing for satisfying remaining performance obligation.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]",
        "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeRevenueRemainingPerformanceObligationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationPercentage": {
     "auth_ref": [
      "r707"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of remaining performance obligation to total remaining performance obligation not recognized as revenue.",
        "label": "Revenue, Remaining Performance Obligation, Percentage",
        "terseLabel": "Expected performance obligation through 2021, percentage"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSNarrativeRevenueRemainingPerformanceObligationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_RevenueTransactionPriceMeasurementTaxExclusionPolicyTextBlock": {
     "auth_ref": [
      "r399"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for election to exclude from measurement of transaction price tax assessed by governmental authority that are both imposed on and concurrent with specific revenue-producing transaction, and collected from customer. Includes, but is not limited to, sales, use, value-added and excise tax.",
        "label": "Revenue, Transaction Price Measurement, Tax Exclusion [Policy Text Block]",
        "terseLabel": "Taxes Collected from Customers"
       }
      }
     },
     "localname": "RevenueTransactionPriceMeasurementTaxExclusionPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/BASISOFPRESENTATIONPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolving Credit Facility"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r549",
      "r652"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "terseLabel": "Operating leases"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r50",
      "r719",
      "r720"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Changes in Accumulated Other Comprehensive Loss by Component"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable": {
     "auth_ref": [
      "r90"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the major classes of acquired finite-lived intangible assets showing the amount, any significant residual value, weighted average amortization period, and other characteristics. A major class is composed of intangible assets that can be grouped together because they are similar, either by nature or by their use in the operations of the company.",
        "label": "Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]",
        "terseLabel": "Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r138",
      "r139",
      "r511"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationNarrativeDetails",
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESBusinessCombinationScheduleofPurchasePriceAllocationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r43"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of components of comprehensive income (loss). Includes, but is not limited to, foreign currency translation adjustments, foreign currency transactions designated as economic hedges of a net investment in foreign entity, gain (loss) and prior service cost (credit) for pension plans and other postretirement benefit plans.",
        "label": "Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "ScheduleOfComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtInstrumentsTextBlock": {
     "auth_ref": [
      "r37",
      "r120",
      "r122",
      "r123",
      "r124",
      "r187",
      "r188",
      "r190",
      "r201",
      "r629",
      "r631",
      "r674"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.",
        "label": "Schedule of Long-Term Debt Instruments [Table Text Block]",
        "terseLabel": "Schedule of Long-term Debt Maximum Leverage Ratios"
       }
      }
     },
     "localname": "ScheduleOfDebtInstrumentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DEBTTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock": {
     "auth_ref": [
      "r164",
      "r170",
      "r524"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table Text Block]",
        "terseLabel": "Effect of Derivative Instruments Designated as Cash Flow Hedges on Statements of Operations"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock": {
     "auth_ref": [
      "r168"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.",
        "label": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]",
        "terseLabel": "Schedule of Fair Value and Presentation of Derivatives"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsTextBlock": {
     "auth_ref": [
      "r156",
      "r157",
      "r158",
      "r161",
      "r162",
      "r168",
      "r170",
      "r173",
      "r174"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of pertinent information about a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Schedule of Derivative Instruments [Table Text Block]",
        "terseLabel": "Schedule of Derivative Instruments"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r678"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Basic and Diluted Net Income (Loss) Per Share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/NETINCOMEPERSHARETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "auth_ref": [
      "r135"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of Effective Income Tax Rate"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/INCOMETAXESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r90",
      "r94"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "auth_ref": [
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r627"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.",
        "label": "Schedule of Goodwill [Table]",
        "terseLabel": "Schedule of Goodwill [Table]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesinCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r627",
      "r683",
      "r684",
      "r685",
      "r686",
      "r687",
      "r688",
      "r689",
      "r690",
      "r691",
      "r692",
      "r693"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Schedule of Changes in Carrying Amount of Goodwill"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r97",
      "r98"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity, by either major class or business segment.",
        "label": "Schedule of Indefinite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Schedule of Indefinite-Lived Intangible Assets"
       }
      }
     },
     "localname": "ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r16",
      "r27",
      "r28",
      "r29"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "terseLabel": "Schedule of Inventories, Net"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/INVENTORIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": {
     "auth_ref": [
      "r112"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt.",
        "label": "Schedule of Maturities of Long-Term Debt [Table Text Block]",
        "terseLabel": "Schedule of Contractual Repayments of Long-Term Debt"
       }
      }
     },
     "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DEBTTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOperatingLeasedAssetsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of long-lived, depreciable assets that are subject to a operating lease agreements and are used in the normal conduct of business to produce goods and services. Examples may include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Schedule of Operating Leased Assets [Table]",
        "terseLabel": "Schedule of Operating Leased Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfOperatingLeasedAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESFutureMinimumLeasePaymentUnderOperatingLeasesDetails",
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock": {
     "auth_ref": [
      "r169",
      "r714"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of derivative instrument not designated or qualifying as hedging instrument.",
        "label": "Derivatives Not Designated as Hedging Instruments [Table Text Block]",
        "terseLabel": "Derivatives Not Designated as Hedging Instruments"
       }
      }
     },
     "localname": "ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": {
     "auth_ref": [
      "r142"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.",
        "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]",
        "terseLabel": "Schedule of Assets Acquired and Liabilities Assumed"
       }
      }
     },
     "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACQUISITIONSANDDIVESTITURESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r81",
      "r82",
      "r83",
      "r87"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNarrativeDetails",
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails",
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTotalRevenuebyMajorGeographicAreaDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r81",
      "r82",
      "r83",
      "r87"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Schedule of Geographic Revenue by Area",
        "verboseLabel": "Schedule of Net Sales and Profit by Segments"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r453",
      "r455",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SecuredDebtCurrent": {
     "auth_ref": [
      "r17",
      "r194",
      "r204"
     ],
     "calculation": {
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of the portion of long-term, collateralized debt obligations due within one year or the operating cycle, if longer. Such obligations include mortgage loans, chattel loans, and any other borrowings secured by assets of the borrower.",
        "label": "Secured Debt, Current",
        "terseLabel": "Current portion of borrowings under senior credit facility",
        "verboseLabel": "Term loan component of senior credit facility"
       }
      }
     },
     "localname": "SecuredDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED",
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SecuredDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collateralized debt obligation backed by, for example, but not limited to, pledge, mortgage or other lien on the entity's assets.",
        "label": "Secured Debt [Member]",
        "terseLabel": "Secured Debt"
       }
      }
     },
     "localname": "SecuredDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SecuredLongTermDebt": {
     "auth_ref": [
      "r37"
     ],
     "calculation": {
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount of collateralized debt obligations with maturities initially due after one year or beyond the operating cycle, if longer, excluding the current portion. Obligations include, but not limited to, mortgage loans, chattel loans, and other borrowings secured by assets.",
        "label": "Secured Long-Term Debt, Noncurrent",
        "terseLabel": "Long-term borrowings under senior credit facility"
       }
      }
     },
     "localname": "SecuredLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember": {
     "auth_ref": [
      "r716"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fixed rate on U.S. dollar, constant-notional interest rate swap that has its variable-rate leg referenced to Secured Overnight Financing Rate (SOFR) with no additional spread over SOFR on variable-rate leg.",
        "label": "Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member]",
        "terseLabel": "Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate"
       }
      }
     },
     "localname": "SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r282",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r308",
      "r314",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r344",
      "r345",
      "r627",
      "r737"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesinCarryingAmountofGoodwillDetails",
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofRevenuesDisaggregatedbyMajorSourceDetails",
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNarrativeDetails",
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r282",
      "r283",
      "r284",
      "r294",
      "r297",
      "r302",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r313",
      "r314",
      "r315"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "SEGMENT AND GEOGRAPHIC INFORMATION"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATION"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNarrativeDetails",
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails",
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTotalRevenuebyMajorGeographicAreaDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingInformationOperatingIncomeLossAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting Information, Operating Income (Loss) [Abstract]",
        "terseLabel": "Segment Net Sales"
       }
      }
     },
     "localname": "SegmentReportingInformationOperatingIncomeLossAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingInformationProfitLossAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting Information, Profit (Loss) [Abstract]",
        "terseLabel": "Segment Profit"
       }
      }
     },
     "localname": "SegmentReportingInformationProfitLossAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r58"
     ],
     "calculation": {
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED": {
       "order": 3.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "Selling, general and administrative"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r75"
     ],
     "calculation": {
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "terseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1": {
     "auth_ref": [
      "r649"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Estimated period over which an employee is required to provide service in exchange for the equity-based payment award, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Requisite Service Period",
        "terseLabel": "Requisite service periods of awards"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r649"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period",
        "terseLabel": "Stock options exercisable, vesting period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r472"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Awards granted during the period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r472"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Other than options, weighted average grant date fair value (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod": {
     "auth_ref": [
      "r711"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net number of share options (or share units) granted during the period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures",
        "terseLabel": "Grants in period, net of forfeitures (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r475"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Options, weighted average grant date fair value (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "auth_ref": [
      "r650"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period",
        "terseLabel": "Expiration period"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharesIssued": {
     "auth_ref": [
      "r119"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.",
        "label": "Shares, Issued",
        "periodEndLabel": "Balance End of Period, Shares (in shares)",
        "periodStartLabel": "Balance Beginning of Period, Shares (in shares)"
       }
      }
     },
     "localname": "SharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUNAUDITED"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShortMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates the sale of a borrowed security or written option.",
        "label": "Short [Member]",
        "terseLabel": "Short"
       }
      }
     },
     "localname": "ShortMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSNarrativeDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofCrossCurrencySwapDerivativesDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofNetInvestmentHedgesDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StandbyLettersOfCreditMember": {
     "auth_ref": [
      "r111",
      "r150",
      "r211",
      "r353"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An irrevocable undertaking (typically by a financial institution) to guarantee payment of a specified financial obligation.",
        "label": "Standby Letters of Credit [Member]",
        "terseLabel": "Standby Letters of Credit"
       }
      }
     },
     "localname": "StandbyLettersOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r213",
      "r282",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r308",
      "r314",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r342",
      "r344",
      "r345",
      "r627",
      "r737"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesinCarryingAmountofGoodwillDetails",
      "http://integralife.com/role/REVENUESFROMCONTRACTSWITHCUSTOMERSScheduleofRevenuesDisaggregatedbyMajorSourceDetails",
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNarrativeDetails",
      "http://integralife.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNetSalesandProfitbyReportableSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r40",
      "r119",
      "r212",
      "r237",
      "r238",
      "r239",
      "r253",
      "r254",
      "r255",
      "r257",
      "r263",
      "r265",
      "r281",
      "r320",
      "r398",
      "r488",
      "r489",
      "r490",
      "r500",
      "r501",
      "r527",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r554",
      "r589",
      "r590",
      "r591"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSNarrativeDetails",
      "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails",
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUNAUDITED",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUNAUDITED"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r253",
      "r254",
      "r255",
      "r281",
      "r562"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUNAUDITED"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": {
     "auth_ref": [
      "r20",
      "r21",
      "r119",
      "r125"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan.",
        "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans",
        "terseLabel": "Issuance of common stock through employee stock purchase plan (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUNAUDITED"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "auth_ref": [
      "r20",
      "r21",
      "r119",
      "r125"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture",
        "terseLabel": "Issuance of common stock for vesting of share based awards, net of shares withheld for taxes (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUNAUDITED"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan": {
     "auth_ref": [
      "r20",
      "r21",
      "r119",
      "r125"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.",
        "label": "Stock Issued During Period, Value, Employee Stock Purchase Plan",
        "terseLabel": "Issuance of common stock through employee stock purchase plan"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueEmployeeStockPurchasePlan",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "auth_ref": [
      "r20",
      "r21",
      "r125",
      "r130"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture",
        "terseLabel": "Issuance of common stock for vesting of share based awards, net of shares withheld for taxes"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodShares": {
     "auth_ref": [
      "r20",
      "r21",
      "r119",
      "r125"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Stock Repurchased During Period, Shares",
        "negatedLabel": "Accelerated shares repurchased (shares)"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodShares",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUNAUDITED"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodValue": {
     "auth_ref": [
      "r20",
      "r21",
      "r119",
      "r125"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Stock Repurchased During Period, Value",
        "negatedTerseLabel": "Accelerated shares repurchased"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r21",
      "r24",
      "r25",
      "r85",
      "r653",
      "r672",
      "r682",
      "r718"
     ],
     "calculation": {
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Balance, end of period",
        "periodStartLabel": "Balance, beginning of period",
        "totalLabel": "Total stockholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails",
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED",
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUNAUDITED",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSEffectofDerivativeInstrumentsDesignatedCashFlowHedgesonStatementsofOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders\u2019 equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TradeNamesMember": {
     "auth_ref": [
      "r143"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof.",
        "label": "Trade Names [Member]",
        "terseLabel": "Codman tradename"
       }
      }
     },
     "localname": "TradeNamesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/GOODWILLANDOTHERINTANGIBLEASSETSComponentsofCompanysIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockAcquiredAverageCostPerShare": {
     "auth_ref": [
      "r127"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total cost of shares repurchased divided by the total number of shares repurchased.",
        "label": "Treasury Stock Acquired, Average Cost Per Share",
        "terseLabel": "Treasury stock, average cost per share (in dollars per share)"
       }
      }
     },
     "localname": "TreasuryStockAcquiredAverageCostPerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/TREASURYSTOCKNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_TreasuryStockCommonShares": {
     "auth_ref": [
      "r127"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury.",
        "label": "Treasury Stock, Common, Shares",
        "terseLabel": "Treasury stock (in shares)"
       }
      }
     },
     "localname": "TreasuryStockCommonShares",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/TREASURYSTOCKNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockCommonValue": {
     "auth_ref": [
      "r41",
      "r127",
      "r128"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount allocated to previously issued common shares repurchased by the issuing entity and held in treasury.",
        "label": "Treasury Stock, Common, Value",
        "terseLabel": "Treasury stock"
       }
      }
     },
     "localname": "TreasuryStockCommonValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/TREASURYSTOCKNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TreasuryStockMember": {
     "auth_ref": [
      "r39",
      "r127"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Treasury Stock [Member]",
        "terseLabel": "Treasury Stock"
       }
      }
     },
     "localname": "TreasuryStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUNAUDITED"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockShares": {
     "auth_ref": [
      "r39",
      "r127"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.",
        "label": "Treasury Stock, Shares",
        "negatedPeriodEndLabel": "Balance, end of period, treasury stock, shares (in shares)",
        "negatedPeriodStartLabel": "Balance, beginning of period, treasury stock, shares (in shares)",
        "terseLabel": "Treasury stock, shares (in shares)"
       }
      }
     },
     "localname": "TreasuryStockShares",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITEDParenthetical",
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYUNAUDITED"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockTextBlock": {
     "auth_ref": [
      "r129"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.",
        "label": "Treasury Stock [Text Block]",
        "terseLabel": "TREASURY STOCK"
       }
      }
     },
     "localname": "TreasuryStockTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/TREASURYSTOCK"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_TreasuryStockValue": {
     "auth_ref": [
      "r39",
      "r127",
      "r128"
     ],
     "calculation": {
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.",
        "label": "Treasury Stock, Value",
        "negatedLabel": "Treasury stock, at cost; 8,918 shares and 6,823 shares at March\u00a031, 2023 and December\u00a031, 2022, respectively"
       }
      }
     },
     "localname": "TreasuryStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails",
      "http://integralife.com/role/DERIVATIVEINSTRUMENTSScheduleofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VehiclesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment used primarily for road transportation.",
        "label": "Vehicles [Member]",
        "terseLabel": "Leased vehicles"
       }
      }
     },
     "localname": "VehiclesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/LEASESANDRELATEDPARTYLEASESSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r267",
      "r275"
     ],
     "calculation": {
      "http://integralife.com/role/NETINCOMEPERSHAREBasicandDilutedNetIncomePerShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted (in shares)",
        "totalLabel": "Weighted average common shares for diluted earnings per share (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED",
      "http://integralife.com/role/NETINCOMEPERSHAREBasicandDilutedNetIncomePerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "terseLabel": "Weighted average common shares outstanding (See Note 13):"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r266",
      "r275"
     ],
     "calculation": {
      "http://integralife.com/role/NETINCOMEPERSHAREBasicandDilutedNetIncomePerShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic (in shares)",
        "verboseLabel": "Weighted average common shares outstanding - Basic (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED",
      "http://integralife.com/role/NETINCOMEPERSHAREBasicandDilutedNetIncomePerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WriteOffOfDeferredDebtIssuanceCost": {
     "auth_ref": [
      "r60"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Write-off of amounts previously capitalized as debt issuance cost in an extinguishment of debt.",
        "label": "Write off of Deferred Debt Issuance Cost",
        "terseLabel": "Write off of debt issuance costs"
       }
      }
     },
     "localname": "WriteOffOfDeferredDebtIssuanceCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://integralife.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    }
   },
   "unitCount": 11
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=d3e1107-107759",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2443-110228",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=SL51724579-110230",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "https://asc.fasb.org/topic&trid=2144648",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12053-110248",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721677-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=126907907&loc=d3e12803-110250",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=d3e1835-112601",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466302&loc=d3e4852-112606",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031898-161870",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "https://asc.fasb.org/topic&trid=2208564",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=109262807&loc=d3e22047-110879",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "63",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=126970277&loc=d3e23176-110880",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405686&loc=d3e22802-112653",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/subtopic&trid=2208821",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/subtopic&trid=2122178",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=SL79508275-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11149-113907",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11178-113907",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123586518&loc=d3e961-128460",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "https://asc.fasb.org/topic&trid=2122149",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "37",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123455525&loc=d3e2207-128464",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966325&loc=d3e6819-128478",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "b",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966325&loc=d3e6819-128478",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(3)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "https://asc.fasb.org/topic&trid=2303972",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116873149&loc=d3e923-111674",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569643-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "https://asc.fasb.org/topic&trid=2197479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(ii)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(iii)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41641-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41678-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "182",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=127000641&loc=SL5629052-113961",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=121549185&loc=d3e80748-113994",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90193-114008",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90198-114008",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "815",
   "URI": "https://asc.fasb.org/topic&trid=2229140",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=SL51823488-111719",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Subparagraph": "e",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(1))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=66023616&loc=SL35737432-115832",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(15))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(16))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e689-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1707-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1757-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1500-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "https://asc.fasb.org/topic&trid=2144383",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8844-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1474-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8981-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "https://asc.fasb.org/topic&trid=2134510",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "https://asc.fasb.org/topic&trid=2126998",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(5))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "32",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919569&loc=SL82860478-203043",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721659-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130531-203044",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130532-203044",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130533-203044",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.30)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130558-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130561-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130564-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226000-175313",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130549-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130549-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130550-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "https://asc.fasb.org/topic&trid=49130388",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e526-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(l)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b),(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(o)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(p)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(q)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=21916913&loc=d3e273930-122802",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=6414203&loc=d3e39689-114964",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i),(j),(k)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "70",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "715",
   "URI": "https://asc.fasb.org/topic&trid=2235017",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=SL116886442-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4534-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4549-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126962052&loc=d3e4991-113900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i-k)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(l)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "https://asc.fasb.org/topic&trid=2228938",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721663-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "https://asc.fasb.org/topic&trid=2144680",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(1)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(1)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e7008-128479",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4582445-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4CCC",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL109998896-113959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624181-113959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=121577181&loc=SL110061190-113977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/subtopic&trid=77888251",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "https://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.3)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(1)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(2)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(b))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13(Column B)(Footnote 1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611282-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13(Column C)(Footnote 1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611282-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13(Column D)(Footnote 1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611282-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13(Column E)(Footnote 1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611282-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13(Column F)(Footnote 1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611282-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721665-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13(Column G)(Footnote 1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611282-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 4))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "220",
   "URI": "https://asc.fasb.org/topic&trid=2134417",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226049-175313",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4587-114921",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r657": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r658": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r659": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r660": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r661": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r662": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r671": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r674": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r675": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r676": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r677": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r678": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r679": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8672-108599",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r680": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r681": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r682": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r683": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r684": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r685": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r686": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r687": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r688": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r689": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r690": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r691": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r692": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r693": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r694": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2443-110228",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r695": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r696": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r697": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r698": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r699": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721671-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r700": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r701": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "https://asc.fasb.org/topic&trid=2127136",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r702": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r703": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r704": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r705": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r706": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r707": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r708": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r709": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r710": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r711": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r712": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r713": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r714": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4CC",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL109998890-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r715": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(6)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r716": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=124256753&loc=SL5864739-113975",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r717": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r718": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r719": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r720": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r721": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r722": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r723": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r724": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r725": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r726": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r727": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r728": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r729": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r730": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r731": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r732": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r733": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r734": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r735": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r736": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r737": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8475-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b),(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "https://asc.fasb.org/topic&trid=2144416",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>95
<FILENAME>0000917520-23-000030-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000917520-23-000030-xbrl.zip
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MZ_CVF]P'J,0LTQ:*9?_?8DRD(L9,Q3OW0_)M85/*'=\ZOGW--YD+(TVKDJ.
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MZ.9;F@ZV74Y\V:9')9>\-([_(Z"4 X1L,5EVU9A@<B5ZIG0LZEATRRL BW&
M) I%!%-<((F13'24=!:^!>LO.A8U-J'1A@3"X@Q2RAD)8I06+61"+YUWHCBK
M55) +=A.JJ-21Z5&6"5C/=ALM<R1($3IHW!H#;!9DHF@!?L9=B6OK7*H%KFI
M8% %='1@)92$$8QGV&8K<@@EM< *=-!M%707IW5KZP+G9(S!$"@G@Z8"0I0@
MR14EJ/G0W1JFT0GM3QD>]9O?]F$ND7LQD7:W%KJCS<K11I--@JP(F"4[*SG&
MDB0K?4&F9.O;M-U:QY^./W_$G^7OBI* HH?B0\8,4MJ8:BFT<2!+X+!;-C\R
MZ#C6<>S.HY*H"P$:KU+*(*S$X$H6D5GDDBLB-]^U:RQX?I@IB\5JN%DF<6<T
M'#&*^7"55OW6S11>4UP_Z7P$:53P4H,!X2'XY'.IZ]U23*Y%KE_'KXY?[78-
MZ_2_#\Y"C@&D-=ZQ<RA=T?Q*(K2@@+/C8,?!QKF.Q9;HA;(6M8"<3*1@P#D!
ME(U5%Q4"C78=;R2K)Z/)=+?LXZ";U.R6Q"VF(8+2WF,PF7*"NFX[%&-*R<IB
M0FUUYQRN!))OWQ*TE%3+]PB]9#Z#\[9@AN!<$!@<9;(^&B9C:1$#.QO6/.9W
M=/MZ-PE=C(5@ZD;+V5!0B93WQ>F<8FC#"KJ.91W+EA!B&2N<$DEC3 J*U3YH
M8R!D(7(NUK5@%[T_-:DU/[GC3E<Z>ALM'HN,M7&W,2J"CBFX2"[$V?(@(1.M
MFL_7D:HC5;/<0 .&K$"MA%= ,:'PL:#4'I(NHK2@C7Y'O(YXS? ,=?(Q"2U0
MD(?LO8=2M-=>1./0J*[KS\TNXC.5-_]]Q@_GR>CD=#2LH+Y^+>LIG9V<#>K%
MS%OK\'EC.JZC5;C=@.=-\8+(.\M.CHY&6C"9@^^BK"N(,B;C36J1%]2PW3*6
M;U]M,9H$"6=C!@GD!167ZNX J TKB.;;UTXG+,.69$7$EJ3DFA17OJ[U$(P7
M!QP:.;+SE4FRR;:D*YUMM5MXEZ6S<G%]X7Q*R6@GP >0 CV$0 (#:6=T]/,:
M/W5I2E63]6['GXX_-_9MU,U]&[7 *21E#&3,QB)(:]$8KQP099^AQ(N-+#N.
M=1QK*\>NA7L+FT!R(7.<1U)SN"=C01&L4!1K+:R213??M6LL>+K2U[:5OB[.
M];,ZU1@[Z,(14P *N4 @0[: I]K=M#VN7\>OCE_M=@TA^D(^Z:2I-DI%7UQM
M^NA=*<46*LUW#3L.=AQLG.N(Y+TWA1U%K8 #KFBD8#^1?4DI+  VWW7L9FN[
MV=IF^(M>NSHU&Z(Q"#H'5!)<T,(8'2B'T")_L2-51ZH6.HF8)"04!EWR(%7P
M/F IV5K*.;,]:[Z3V!&O(UXS/,-HE(>"6I$,$,%[ET2(.F8IDY'!-M\S; 2@
M6U)GL#@O2"5G=<XVU'29*"X$R!"S\!*]S":VR MJ<NW1<N;GB)1'Z9TK$8)R
M/E/!*(-S!+E0;KY][73",FR)!:5D2BD'YX&4CAYL<$FC34A>SUO+2F&U:"IN
M;FC[+\S^(N=5_[9'-!KFSZ"^91LB;$^+1> E!NMTEAG @&,50]+)@%0\)7.Y
MEX(4H<-+R_$2%H,7QVI$Y5BB1<:+@2#9!I$VNM@@E8@MJG=>.'#^KJ.QG")G
MH9W*)D-R$LA:= 7JZZ(R..=$BYS(Q@ET*9XC1XU>>IMR2A:T$:%XJ1/81)Z?
M>FQ#E^S)>/IPKZXNGTNNOMW&C_V3LY-%J>[UNFC]X/R4KF-C\^1T,#HGVI^.
MTKO=TZJV5Y'SQ:'/65M+MM8 <L H@?5Y5"9'F60;E'C%Q$%_.J#=LC7,_??]
M?(:#+W#9Z(\I34?C#B^+P(L.(?MBL_?2@HC12T%$EB087U1K5,KOX&6VY_NE
M)#O +&1V@-6*4SX6+3BP$'5S'IE*B"2D5]:8%0#,I8:9X# _H?&4W?[-CY3.
MJONQ6TH_T?AO=ZWYEAWL#SL[N#@[R-&+4J$ZNH#6!VMUCJH898BB;8L=O!U7
MJ0D$Z& Z,[\QA0 E::AUYI"B2]9#R58!1$QMZF_Y.X+<(X[7^FE*>2;*512B
M339$H6PV+H/2%%V@&'-!"+7XN05[T2^3A+>S5P<4H4O)M6TED%)8K$T0+ F+
M*5";UN[_V H2@@^L%ST5(<"SFBPJ>)&54RJEA&UJ/_J5(&>6]@6-RVA\,MLQ
MN IR?9B_4IBS;WW/VK92M%J C4EJR38/F*%1VQ@4%*(DK1$MV(9J62;O5E0F
M.\@)7)"*6##@K5=9DG6FL DKMN3V,NWRXZMD.\;Q=UN/MH559\/^7(9C&M('
M'/PZFIF#S](Y(9R<C6FN<:Z?<SGBY2F7[^N0WT2)T%)Q[%\2,&DA&@PB$M4M
M#:1TD4R+YA1FLW>47_!3.3\8XW"":3:9]_C\ZI$OP=<Z1SZ#?CVP.;N159QA
MB%%YZ9.N2\:!U7-4_'_-BMD&$3B@;I$2:+AXEV)RJ2B5%4><MK;B\#(:[5VP
MRJ..&D4+(I47X[I2:'K^8L!FCKVE6OQS6L=X?/Y;A?_XK,^CMF:#0>>B+<:+
MHAR"+NA=#D$K2"YK_I.:WZBN>=)9X,[>IDZL@6*MJ$&H$-&$G$IV&DLITJT8
M=U[1<3]]OSU[4[B#25MP@FQ)$<#H&%R.3L>8R+ Q:\$.2\V3S@*Y(YW0.;)<
MA 15 &7(-AEF4\[6"FPN=ZIG\&1T5E<@G%9_80=/KL;O5UR)?FNX$BQFDXLF
M-![XCW<6V>:4)(4KC=[D[SO2.#CNCULF"R%)*W; A+491$D^>Z'9#]!HT?O8
M@D;/M^QGW_@ZGG,(^WEYT!D.#FA\<@4;3_OOZ9!P/$^5SDY^,1/3[K MS2=3
M*JQ(50(H'J1G/]Z'@""8O<66TH:I]PXTC8X/V652OF  #0&43IA12NVTRY:2
M<BWP<=L.K(,/HY9H(VN-LTHS4H*'+!PKH50J5(*U"DP;*BPZT#1:&W&H$&NQ
M#A@V>9Y"E%E:R,DI R6KR[D_!M:=(>PO/+>K#^..2O3 $6MQ"98(@B&^G:S9
MFS1@I+)PT4*CQL*]NPJ*_WSR^UKH^<?)[VNG_HWG)DQ)SI02-/M7H=@8')'W
MV0AIDM*742H_PP8\KNLZG25I%Z'3*:JD ^/&"F#2A;K^A^\_!@*,8"]UNK*]
M!CV*WVJJ+P_C.XR[>NK?J5) HTU$FZ.P$-&@4K$H#JYU-.B5N5C2*Z5JP..Z
MOCBUKEE?1&QBK?::\9(-JY\D TF,*=F<D &4[>6\('.U08_BMQ-N7Q[&=R;<
MKI[Z=VP<.;32)XLI BF'6B;AA6 C5XS6]G(QN((&/*ZOES4K6(3. 1L)3:$L
M!"C+46WQ(GARSI@D/5X@Y\+*W\F,\E] SDVM_ (7@X&/J1;/D"?05-#R?XDC
MN.CYMJ@%&U[^^17\ERMP=VAZM6DAL7].M]$LXE:2X2J(NO[:8'2)/3+O;0E&
MD0]%9';7<!4%MT&E/Z3\F(;\8EJG.";K^>W9O,-02^1&B1]D8<(%HX%#$>^$
M5\%&:;!DX_,JRFT6#<\7N;=.7J4VW_3%D80 X+S7R045 :1G\VK;5 /<?$VY
M_&R! DRR""-9UOQ2^<+QBQ<YJ2*M:M6FM8W7K\N7=I!:@ 3%D;F!(B!2*"F)
MG+.C[,-JD_N.M/+RI2QU%% B!F,)9$Q>*E=R8JDJJ;4SS9^/:+[FOI7) 2\,
M<4Q+8(3D.$4@6DJ H&WD=X%647#+\W$7.*F#'(?K( F H,@2K $7T/J$-J>X
MDH2[>Q]W@24!1:,A(]!HA-HR6Q.[0-$KZ<'& "MM!O^6IKSQ==U\&X/-.]DX
M9#G+Z8%1EJU08#*XXKPVA ISL<9K6]K0)F0E</:GFE:W!6F?UR]=7.FW%R[M
MSP]>CO%'*Y8^#W@Z'N6S]#L#7AR\R8!?A1X^H/-9RQ+K))E/()PO0MIB)'_6
M1BX\/INP[S*97#SDR96J@R>C?(+#_5-*?1Q,S_?/QF_Z"0>+Z$'Q9#2<C ;]
M/ /Z%E_)5QS<O=P4YO*R5@3PU_,64@G-6I2L<H!4,%'*"+-MIEUP;=H@K8-3
M(U;PA<0QLU;&@?48T5I?JQB\-9I=^A733@?]R>2,#B@=#T>#T9OO%WZW$DG+
M:6MBHZV80>?8_;/(Z@@TNA(594FB34M].R0M=T<9IT1!5D5&1=!915+2>,A2
M$QL[U8;HH8FR7(I6J%U$?3"D#$10POJ4K0]1944B1=D&=Z6)LEP*+RD59Z0V
M-B@%WFAO2P&G,!@H$+5;$5X^&8U/1RQ-VAD-+\2YBLPL(0:'F;2LK5Q!1B>,
M9[A@H @>V[!S7C.EN11N>DI P2>H._](HX()R-(%#A.+2KD-$YQ5FI\]KV<T
M>C/&T^,:[,T%FNI"SO'YPY?[J\5#DZ2,T6E)RD(BY1V&B!#)I")ELBWAX7(E
MMQ3."5="<,DX@QY,K&L DC?9>\RUWW$;NG%^1W+U\.99[32PBA8PN6(2E.P2
M$5B=JL(4Y&V.*2:.9MO/O#N3WW+VM_#1I)"2*%&"0,00/(K,H6((TF,;<E<W
MD-_ZI(\O,/$/I%4DH2DF.Z<S%2.@2.%34 *%#K(6Y%F_&B2\.R$NAXFL05F'
M)EF[#:2Z $P7I9-FY5I V;9$AG\@Q(OV+9/I;GD]XJ%6D8J(FKT9R"Z @<#:
M% FUUSZ@S<&*%;"'=RS%I7"Q)"Q! =7*N=IRDR/!E ([JAZ9>.B:O^[@*?;'
MKW!P1H_/G_<Q]@>U[F* D^OS@L.:;N.!:P* ?W4\2P!\/G]19197KN7SRY_Y
M[G"<CL^?TWL:7$\W?#YI:WAZ-IW,SM"+NIC'.)AWHR7ZH\*B^;YFT\MGL8"I
MB2\]^.;S(>OIWV?]2?_+[\]DLCY^UY\\[H_V4Y_X,B=;PW2_)8L_JI:+Q:/+
M7D&J/<.E 2]"H6RS@Q8LUFD2:6Z(TYW1,-T:5)M%W)7EC8L0977@!8&0,6!4
MB3B*CD(&94O'FXXWM\:;#1J?X"5I6D*8J"AB).3HB("RC-9[I:,VPF;+453S
M"?,=7?:$!G^[.JOCYO*XV12B:&.U0E"AA  14M!H8Q%:I2(S7NR2U&BB- F]
MS=+JS0YC+FM,MX;#T?OYQ4TFHU0;N%77K"7\43XQIF7(!3)8<*$(Y6U0R6!,
M-K6@WT>3^/.C:/^.0E?KG2()8VMG+I>@+N.P)J THB#$*$2;&N@VB4O-PG&S
M;='=I :6/_5  8IP@@"S!'0RQFRS068>> ^^HUIGMCJV+:[PQ;#C5SS*2 0Y
MV8BF2!7 Q$1U15G'MHYMK4_?+9]F)H9@LS9!HH3BHL<LC N*I-99^#:M_.V2
M?BO-Z%;2R]7VI9[CLIP%B(1>2 [41,K!U2V?V[3Y9),PWRP+TNSP[,[S',MG
M': J6M8.F527?644,KO@#0%_FD3'NL[2=,2[E96TR0@=2%@=(]0U)ZXXP:%;
M<18<AM#\7FM-XENSL-YL*W?G]4F+:WBGT6"T%K(7 DSMOYVSD8@,;X7N\QXM
M'6DZ(]7QYFH1>2PJFJQ+< )4S#$:(67R)LY6%)>.-QUOVIH8O!W"9 Q(D2*4
M!.25I]I@WLL@'*+)+=@*LTOQK30WFT*49(LOT0=7@@"V*!&9%J!TUG6G%"N;
M3Y0FH;=96KW98<PRBY(6N ,\H%/6&#"ZSMVZ$(I13G&40Y! =YY9I_T["GV'
M0EI[A11TTJ%N7.X36#9%6H@D32KS70MD5QK;1O@VVP3=>49 +JP8UNJ8E4>$
MVBS.9V80E9RTX6 G:T&E(TUG=SK>?",Q(/E_RA>%B2!&BLF$K*P'26R$0NIX
MT_%F!3)IBR-,W2B#C$I108%DLD<#-EG)_IJP1=KF$^8'S:0UBQ>WY @VAB7,
M"JU+TCYJ*#I[D4/((FHD80/HCB4-9<F/8L&:0A2'V9'3*2OM(6@=4^+XQ7H3
M@C4QR!8T-6LBC'\(9=^JZ&7YG>=\!DRV[N'J)*3LHW)4S1+J6KM6.JIU%J-C
MV^*6/P!D2U[4O51 ^X2%/4+PI>[/(;-.'=LZMK4^P[!\FJE<2L#:C"A*T,56
M_Q%5%J!%24ZWH2GN#QYQ-8M-S<E++)];QJ$U616R$<#HNHQ(1FV\ )>886W:
M,O 'Y=:/8BU;2J\LZUHA#[6?NY8^UE(AC#*#,:3]O 58DUG5)*C_$&:D53'8
MM:9?BRH.4C8B.WG.1XV0@XG*!TV^^.0P>^Q(T]F'CC??2OZ!9K\-==0^@(?(
M?Z40$$"8$$6"CC<=;]J:A;@5PA05HY+>Q&(-&YJ"7AF-:,F)E-G8-)\P/VC,
MTRQ>-">?<"LL 4P25'(*O84"UI, ;0MIY9((7G0L:2A+?A0+UA2BF!R2+:HP
M30@$$LK:E,?X;(I$D+.-)>IJ5!5:2I0[=HUEZ G74V$1ECY2"-[6N8,,F;R7
MR2@-,J JT2G3?-'\CM)X?'YP?DI7A+3=']!D.AK2"SRO/[$[_-[&LQTZLO,B
M>F.LT I018\E^%*L,)9\EJ7YZ%BX:&X=EP<?1BU!!T:TJO86P*@YEJY_)Z$T
M"A-%9(QTRSV;YA"T5*,M<'VE\DG7=2[>HP;M,!:R[+Z3)^V1P]OF^^P=9MN!
MV<6YSQATCL5 DA8A2(&HHP*K+4D!I$6G9]N+V=^-1.>@36E\1GGSXRE_D2;K
MP_QC39TM<EU] IDL,9,<),(8BO31>ZLD%J5MI_<[#JTFAQ:8QJG;MBM,A0!!
MU/ZN5D%4B%";O&!H47OEFP9G+*B-31P/1V?3B_!L@L.\3;E_S!';^5>'5F)"
M:?G=A+WE^+%H*TM*X$N*P6H3H@TIE2RE;KZ_TY09P;]E/\^&_;E !I?FX_/C
M/B&<G(UI?CN?#U^.<WGT\GT=Z)N"EBB"%BQ2)1R8)(((462+4F3^O&6=/!M@
M"%<!==<MCDQ1Z+K,GA!<#+$(B"+%;%,&4M0JKZT#R.)=DAQ(%JF-%2X!6/).
M\3_"D2=7V-.?+S47K&":"I ;3,'>=O>R:N%[5^[J;_!5): 4<LJ1 #2$NJ6\
M0<^Z'2(B-5^A-T <"^QG*H*QD(4'G\$F5ZUK3%'F4(+-)31??39 '']163WH
M?WPXILGH;,S:=/[VF##/KB?WWS_ZB?^Z($V1%&7,0F936_TA"L=_JE/D:C^
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MRUSZ_=6T+OG$T9&.W+$>GXV>)$[=RVM&/Z;2D2F/+]5SB@>F$1#(X'5D@L1
MKAT+D*YM'/C1+)K\(*_;Y<'>,-O_9FIY6>ID":FX-QW!XOS:]J!6:T2OP]%K
MDKN? ,@F\(FX<](=CR-2E6??<-!/!*QW7OA(QLZ+5CJ]=$36S[[8UF-=I'S>
M60S^_HRKOL&]L_A."EF"V3U_>-8K8]Z+?= I?DLR%7]@@M>G;Q@?=4=QQ/HT
M?MWORP;DR7@O<=:/?O\111\@?>=R5=.B3N'T^>'GUX^(88\9HR#UZ@,4NFAP
M4$> T@PQAA EB:5E_,SX64/\C)"EBYX>1CJIK8WX.=0)!!.D#!/%6_C;(FYB
ML/"%T4D$WO@MPPM:%9'G)*[!>2,QVOBX2 /3]<9A<3@<?!D?7;R\'@FN+\?F
M?.CVR\H=HP2JUP]M_E<_^?+$5=>N^>Z(6?T)TB-L +Y@W%=I]OK\1=B-JJ)<
M'U5P?#8:=\/YVHT>,U-_^'0P*6WR8NC3@?39SU4D_G[S5%XBP>\?T68TZ)V-
MYS_RJR+&DS^/AM\](8<>F*'7GX .\2AXH7M?(I=?^\_#5$]^6M6],%E79 F)
MR7Q=85)]<G9\$59_*4C6!;G98.]^\_%P<4B/[H+[7IMFN!51\' P/%_@@2O?
M5.*CG;[I23OC/KS?.]Y]?_!E]_V'XX/X'?$S+)4BBW\C.\=OO^YV#MG.MT^H
MW9F+P>Q]>+7#/AQOQO?'N7Q+Q*YW<G#L3MK']KR]W62[VY^^[7;>H6MRIU,_
M=<VY!)K15(\L!& "CW^D.B!!<(P]6=MXO?B\JE_H=%7L""Y@D'6/(;S9I#:_
M"W'"/Z>2?.PY5B\YNB!2<BX>5MX@->5GP<,/_];5.4;:B_CV$G?B;6R796['
M1UCJ10;GE(ZN!*KM3XRDR00O+:7)7Z<&T8I!W-(Y6+FD%QUT5K<,[ -QK_/7
MG9TY[L6)14)*D IF (JTBMS+:T IMC;($*!Q-RL#F\^VN@%2<[%7)H/0[4#H
M8AE?E:NX=>':RF!T+S"""P*,$!(^]<@%3@4+*(,!:(,"4 0A9K0(2N,J:E+?
M"QIN5\7Y<1S5X2<.X4;17>S'[H9%5X#EQ5\DQOU!>6]W-IHXDZ.*3;H<+*@'
M/1B6W]4[3U_^I1N_.GYMT8]3&R07\N?NJ"3:?=VW"0<B_4[EZ=*;4V,ZIX=N
M5*2\UJZ[+J& _*9_7^Q-+HHZWF7<-+?CP<^)N]YKC(Y\KW>QHXK?XCXI;Q>B
MO!9Z_*-H?E^_[BKJP(_J<A>U?$*;UFV%CY![7?BBCU1(Z[E0@""- =54 <6=
M!Q K1!U7ABCRRP,@W[+^^B;Z7EEG/]ZP/?!2=R*<],L\S 0NHQ05/[J F>\H
M]3__DAB)/T;%CW'U_X8IG/Y4#XO/*;J^40S.QN69DPX?73YG\W38[4WDA=FD
M:T\9(C*%AI=E9$9\8FH)7P+#9 AK/X*%<MQCQ;E2R-'@N9&:<J<L@4$:CMRT
MC3#%;"TBI^U&.W?T_ZVUVB\7A-.5,R@G4.8 C':_C_D'"'D1EP6XP1A,'QBY
M3*3H\5GPV4') ?N(;,0(IAE0T88%-% &XI;0P!(=7_#!J"#7-B1J*$@;T=J]
M0),+ 6^LS^O*S9K=BK5;!/T^Y_OIB[>FLP_$]4DK_V)T=A*1YR?@$L+28J(G
M(!?59UH[^<59I+C#]*XX'+UPN/[K4==TQW\\^@"+HV%"GG_=:']VRMO]B'9;
M";3ZX]'__D?_*D1@D91JT[WDUZT"'KTUP(UGLMW\?[<>99VLSQ_)SL,&DD1P
M68<3@+EM)(D4ZTS>K*/;K1*VX3I&-PM061W/XU.K)GFS9.,W\> K]6Q2!Z2B
ME.+KJYO]3('O=LC<1'J/>0C><WPW/P,1C.+<W.M,-FIKZIMXV6IOMK=:FZ^G
MOVZGAN?38V/N?+Q^4T]1+EE.4=9%I%U=5USLSI_=.<RP/K+$NY.\7Y_6?B61
M&8S]R61CHO7BY:7[M*P3>'(-B5M* ,,",E*62:V:LV?I7Y$^O4:Z&3KRYOGY
MYN&IND3\8#]=N\2?RO.H#';Z#AW)%MP]]9.OF92T2E[JH3^*'TOI7:FGT(F_
M3#(=QZ_W%QE75]I=%]-.U^5F7:45)"LWHU+(JRBJU9M1\=N[OCYSW:BSO^=#
M?H5Q.A_R>?/<:?-@?.TA_Z?NZ51]<O_(^WC03VZY5O>P3BNQ6H=UFE%Y6&][
MZ\N+SU65V^K-*)_<SP!\D5K;8/GDSIOG3BC!;FB>;^G14?&R-_@R>IY6>%JH
M%3O8V8I:X6EBJS>C?)8_$SCF^2S/F^=.FT?>]"PO,Q9&*5B^C.D\&O3BMXW^
M3]'\[UEW?/Y,#WBY<@>\7-4#7J[< 2_S ?]L,%KD SYOGKML'H)2Q9!Q'-)X
M4%R"17'-F9]C=)[9UI 95_+FN<OFD?)J>!]>CRR_KP]+Q+C,9-ONCNS9:)1R
MSQ*EW.SKWOFH6YH3WX$F(=$D&3N]9\^/SGJSP3T9@59X$Q&8(2COGCM=8B%\
M%8/(>O$VE5WHCLL\PQ).XB]Z%W]/:-0;C,Y2]NVF&9Q=]$4I]KJC3QEB5GF3
MT(PQ>?O<<?NPJQA#U\O\TV$47(DO;X8#ZUV"E P@J[P#,H#D[7/7[2,G>7M%
MJ[5>[';^:NX5=\W2RXEX>0?>80=B-).)]]H?1L.[/+O*5D3Y\%IIV5.4#Z^\
M?>ZV?>@/T+&Y7AK+Q<LXG<$PP\9*RSW#1MX^=]T^8N9RX%U_4NC.IXZ%^[HW
M*8 W#1VZTLXVV=3O1F6=IRD]R2"STKLD@TS>/G>M, %G/',[\0$17(*/F'+%
MV9\!9)5W0 :0O'WNNGVF%8H*ME[LEG7#6_U)<=KXR(P:JRSVC!IY^]QU^_"K
MM(.O%\W)'#+/6&F14YP1(V^?NVT?M;:QWWK5WNR\VVON9YA893G3G]9#NETC
MIAE(J4%%_9MW%$C5:BLHPW]]C_C*]F^%9?8??2Q+JZC_.(7E)V$3Z\5ED>,?
M(R=FU.7GNG3#;4O6'GW6I4EZ;;W<94R:KRU G2OG1NZ34,E,MG;;V\WV?G,[
MCKJ]O_NZM;W9B7_9[\3_[33;G?UB]V6Q^Z8YF<Y^[>>SV4XSV7FSU_PK3JOU
M3S.J9_Q[L_8#_^U=>_/==BLN_N\W["Y5/OCAA[^X6\5OVZD'Q;#,Q1\?#<[B
ML]RH4?BOUI^.4TO#28^I0I^D)H6CV\QQ[0EUOQ!X78J;M:FX5?<+M,Z1NM-C
M?_X:64:KCCA8?.,!+3 P+N38'Y14I@;O? HM1>0-;(I?MA11=6LI,CNKQ2U%
M.F6!CYU!6>"C^6.!CQNT3\F;XY;]9F[4FN-)[)S4/["J"=_ =[92"X>7KEJ/
MH*Y&VT^'PTA2')BNI+7>1].Y%GI\LPY+G<$X6FA#_]GW4W?.OA_/2NI7D[UV
MG_ZP#+"HU6(L!K5_+VGN?\PZ,>LTZ6O;K)Z-W$R/U3LU9/[>;!60BUZK9R-P
MJ/7IB[W)OGLY')R4>6EQ".^[XZ.MLU%<#C]L?K6]L[2,FZ.1C_^ZCOYZLP:L
MY)$;L+:[ZL2>O.SO'ENTVVD?M;_MG>Q\>QF_ZRT[..YUV]L'\$-GYWRG\_;+
MSG:+[7S;/']-]HX.3K[V=H][)SOXG^,/'8O:^)_>02=]MMT]Z'R"\;MH>[L7
MQ]$^^?!^!UY\)G[7V0?\CN^^/_CVX7V[U_[VCGQX_\]1^]7!I %LYVT<XR'<
M37/&'^)\]L).%WY]W6F.=_;AU]WM [ISW/P8K$.20PB4P1!0#BG0)@0@/'%:
M:J<9%&L;1,*&I'RN@>MB4E"-$J67;JE,/SM<?P7=LP=T1L&,@E,49#1XJ811
MFC@*29 !(HPT]]Z%@!PM41!?H"#.*%AW%/PVBX)&(X.T-D *)@ 5S &CO :8
M>.$ET5"G^R$B>(,3^811L+:,>^;J$.&?A"/,KV@H_[F5K;5"SZBM4%?9C-H:
MC,:3] __]305IAN]N(FKX+8LI,;/6(%M-Z-KM=IVBUE+VG;I"OQP,'"C=&:X
M:W<=OMW$%S+5I\S:*K==T]KOAE=IY3?[;M\//W>M'^U'&61R5A4Y:^_/FZC*
M$4EP)&?0.0DHPP(HR14@3 :KK,/(D+4-1$5#"79?<K88$I9JB-[TQ'_N"EVY
M&985^D$4>L[:$BA S90"D5IY0#4DP%"! 7=,&1*,$S DA<8-QE7M%7H%>%"=
MZ?=BV-CS(U]>XB8&[OQGWQN<IH"S.[&A!=-?.?!<@B=_(H&(G-O?U[\Y,8:^
M>[#L?\^Z0^]:_3(]?C1*F)O1M3)T7>31=UP()QR@*)(D*J$#FA(/)"$<.2<P
MHFAM _.&P+0B5U:-W/99X9?GM,X*7P>%GZ-3S$-NO&? 1NH$**<0&!X"@$A
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M6D*)B,<?5Q$I<20^< XJ?Z]/U$,.9+JS!B^!]&0-7IX&SW(=);EWB%J@&6:
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M6@/C P741Z-(6<$ "M(2RQTR'$;+B/(&0_.AU#G$8U54N2J6D57YH51YCF9
MK'6 ' $F66JZ2!S0DAB@ U<ZX/@OE$F590/+.JGR,W!DM/ICW3_LIGI3DWN6
M[+QXF$C1BV6?^%JCI=/\:GMG:>5>#0;N2[?7RYA463IQ9W.^\G($'0TQ)  B
MEO($E0<J4 ^X(I0%I)GFIO2\0MD0K$Y7P=F/44^&D97ZP95ZKKTS]M%<@!1
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M,+PG',V%*4C*$1,"*,T5H(AS(!W3P&+OB;(BVH<Z&H:R@7"=2N=76H#[Z='
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M&>0RR#TCD//*:6&5]((0:K!1,C([C2F5GB#C6 :YFH#<;(YQ1*E@I,2 2!L
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MC:%EVWM50=O[K/D9G[.4[H3/%?B>,C[7'Y_GW%;80 V]2,DYD "*H 3Q2);
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M@>&#.X_<?_J;B7"+YUM_#MY>46GI7P9C/^9A3&EJK8X)RBRUB#),D3"I0XG
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M8P=AFIU>D?COU]7?XOK]H3?1(S,6?WDY3YASIZ>[(P-+!W<N7;W+@053OKC
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M_N#K_&6P.[+062\N"C/=7UVNB/_SV'O:X.O#;S !3_Q1&;B!#2UWX/CPK=\
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MT*A\<_GS=OBI*CLS\UM*MQE-;OPYWL8W_G;;8S'?CHGXJ<?>_ELBZ.H'Z]>
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MC[L.2JT'OA)ZE8/V&--OS=3M%:47K*-2O38NG2?((9C^H:38]P7!UIKURH[
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M))B9-$.9 >HS#$1*"FJ\S 2H/V+[IA/+4^I/D9(R>[[4TTY3#D!9*&DM>3"
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M;?X,=4PW!*A6KI[YA3_HO2^6O0:JIP&J)6?38I48F0 RN<0H4,^H0D+%"6)
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MJ)RW?M0I(PO?=6,VA?V*%]T7_[A<<V#PSOCB$NO@]8[[5U\RD:4YI[H$9-R
M,?+W?O<BQ_1'1*X;[4]D$PSVG6V=V-/>TG\NEQ9HMH<W%WHE3^'BO/WT>A^;
M]<;&QR]KM4^;'S9VWF]NU-]O[-3^N_UI?;/^<:?V?OO+/]M?UAJ;V_4KRRDL
MRIO4MQLP],9V[6M][>OZ9F-C'89?7]^H[Y2?=K8_;:ZOY9\_;-;7ZN\WUS[5
M=AKPP]9&O;%3>W-^V=O:F_/J+V]KTXAC:DV9UU,C9KN_'[NUBZI(M;(LTGQ*
MQFRV0TQ-8-SQ$P#41*VFA6IL/(<R36(O>4Z(9@$Y1PSBFAIDC7=(\D@,T9%Z
M-MG9^*E6[T.U<E<5 F)[)$HAO:7("4L0CUP@G;A$*6ANO/<@N<AG6 BHD:O_
M= Z/.NT<>3?L0_T>?K'MTR(V6_W9@^6&H\W4+.KP-"^PQA;$\:RK_=RC>37G
M*TP^0E$:O*+XW7IB7_](A1^A>34<9/SY#)91^8P&RVXWH)=3FVBZKG<1<$&>
M9YV9:SJ!OYRUNV-=J5GT\,5>Y6_%EQB*6E-K,#!04XO/GYHI/M1,W*($T\N9
MT?>=WM7IDM7$73UQ:]X?'QZW[#DU'G9@;&?71YM7$WKUA-;'FH:\]'2%K &T
M(I!/K3\L%7=Z&\)YB/SRFREA;M-RG2YNE$_:$^TQH5Q8YH16VA&K<(C.87,+
M7?QJ#?QK+Z;C5F8DEYP5\!K^73CNGD;;?9Y:^< ]$0[KC7_WZ]^^,OB=;#6^
M'&[1KWSW;)-N-W[\WEI?([MG^X>[!_6?X^Z).MTE]6\;Y'O.6US_^KO^<??L
M>V/_8.M@5VRO;YQLK?][L/T1QD._3$U%8#9RQI-'D=#<F\T:Y("&0+NG6D7*
MG=*@RA,];KROY3F_E8"S^ 5<YK:?YEF]9=X@<JLX$4%M##3G14C.!396!R5)
MC$S*2/B-GLZF[?;?92EJ.ZT/++-%#?UKS;0?NYU>;^.W;QWGV7Q-3M(G0Z&)
M$!/K>" L.J2I!Q0BF"$GO$5&.L^53-BKPDE*L7R(()/'J_I2[JH*#BLXO.U+
MOWE"/+Q9T.J-J$ZC6E,%?P\(?Q,Q(LR'X"VV"#/L$9<T(>L)1T($;3 (TRIG
MDS%MENF4#IIO*]RK<._9X=Y3BX&W%P#KL5^)?X^)?VP<_P*E1EMF$>7&(FX<
M1RX9C!1.SCD5I*8F-Q!6RUPL<,F_$1!\Z?7^WA_W^IW#V*V5X7B==F^_>70W
M<\#-;_Z,K&"@J'!OF# L81ZQU5Y1Y4B4E/*HB:BL8/,'H"D)8B9'Z#+.4-(B
MHEQK!6F;<NE1JBSCG$F<JX[2![2"W3-OX*5*.-->[T4(,2)X3:WG/G+)$P]6
M..,U(X))3@.CE2WK>6+)A"T+A-2@:"+(,$\1T U%6LB E W):)FPHPRPQ+"I
MRMQ3EB"[@])6H=8+0*U93$[WA:W*Y+00*#5A<@*]V6DG&!(F>,2]QT@K1E 0
MWGAAF3<%2G&YC,VDO?WV)J<*H"J 6GBQJK(-+0Q03=B&:(@21"J,0*HJ:B5J
M9 W(5-&)F().1BB]M,K5,C'S+>AZ'^O/,PN/:G1MB(>V^[/W']>U[5#LI0<)
M!GG>UA] '&4U=0E3PXE/5C'&L(U$*V)]NDT^4F7]>5R(J;^?M/Y8S8)QBB"%
MG47 0R)R1$60A:+ RGB5,$ ,7: 8J)<JIDQ[O1<AIF I<6)",Y4,=YA8!M @
M"- 6YYPY7%E_GB>63%A_(HF>:AL0$88C;KE'3B6!A&=)>,6XEV)IU:AE(?A<
MBT<^O<>^ JU%>*]9C#_W1:W*^+,0(#59X#:%&"UAB/B(<[BE0(8(@2S15E*/
M<VO$I54FEJ44]P\WJO"IPJ?%%:HJV\_"X-2$[<<;;G!D N7&GX@+1I&3DB)B
M HE&TL0<X)0DRUK/MU'&:XK\Z02X1>[?$V+>1J\CYN<"&JI@C\HK<7-K%TFH
M3-(*&@WW3#IG9+!8$^]2D+8*]GB6'&IG2N*2E=H%09%AV8WJK$4N<8-T""'%
M$***=FF52-#WY]QOKO*EOD[4&G08KDAM<9;DI9+:4S/(2G5;&,8XF=(1"(E,
M:F2TU8CCY) SRB.=' W2J\0(73C&^-+]]CO'1T>MYH-D;;PHO[UT."4AB&+"
M<^&42S'WA4G!.1Z-HY7??OX8,Z5VB>=84R,8\EP%Q'6(R,!"(D5]@B5E4BFU
MM,IPY;>O3,QWE%-T3(YQ+8F6AD>'G9+$&:*LQC89QBI%_GEBR:0B#^HZL0+4
M=T,<XMQQ9#A6*"9B# E*IYA=8GB9DH?*0*W\8A5H/8[?_KZH5?GM%P*D)NN$
MX B2CB)(NJ 0ESXB[0E%(GA.F6;,>@Y*E5KFI/+;5_CTHH6JROBS,#@U8?QA
M,3B/<4#,8X&XB(!3SFID:7",$J>YS3A%E]6<.VB_(K_]6JM5Z^1N.:_#87^=
MN8<(I@BG2F*1.+742B>Y!$&?D, =3I6Y9_ZH,J5(A\268 58DHS#B+O(0?HQ
M$GD?K.'>>QX)H JIBG14;JD[2B8,8Y!'N!262$YT<%1RS*/5C@A*C*S,/<\3
M2R;,/<PZ99V.R#)F$"A/"K"$FUQUE@41%(LF+JW*94SOG:51N=(KS'I4:\]]
M0:NR]BP$1DU8>P((J2DF@2Q(I8C':."3QB@J%C2SA@F=EE;Y,IGB0*\*="S$
M-GZI\/34(E5E[%D8F)HP]CB0F;",'F$7*>*&".0HX4@ZE;02A/CH<^U^;29M
MTL\TSN<VO9_F<8];UKR=WA7^ZHJX+Q9T'W):7@18>\L=]T0Y%1R/*1B)B4R<
MZ<229[)JN/(<07M[2ID"FP()+!+$5.XX( )&6EN&%'% 1#Q@H;,M;5EALLPD
M>]B:V_?::(OLB:SP]37BZRRZ^GT!MM+5%P)/)W1U39+W.E#$C (AF'"+' D2
M42>=)QIS[L+2JC!T6>))B^)=.[A40%H!Z0L"TJ<65"NKPL( ZH150:=($HL,
MB11R1T#XI(6R2$8AK>#!N)#[DBX3K)>5>*CJ#W/#U<(B\9^^A6?!OZ'Y:_5_
MX:_A> ]M]T>S/1P6H;";!C\58Z'3(C'@SL7MSM^Y'+S/;>J/>O'=\,.?H=D[
M:MG3=\UVL2.+B_Z\_$1Q-#GV_+SR\)\GS=#?SWMX!9?[>&!:&3QY<'BE.#2V
M$N4QSE:49E<>QBODRF/7W9:0%6"]=[KM]8]4^&YWO6&PC,K7/E@A^*,,EMUN
M0#<8!F>,]7J:CNU7I7U/P[_S=Z+D-B^U>(WHUZ./ARYV:XPLUX#%TUG:TC^C
MY5O/Z-SMU9KM6G^_<PQW"K>*8'K0/O/S7.AOQ9<8_M=U_[.Z!@.S/V+Q.4?6
M/=1,W,8&_V)F-)MEJXF[P\2-&%1*:ARQJE03>H<)!6UJ%MA^]FGW[SN'1ZT(
MY%/K1[_?AH?^.+U/]O'#4L*\U?VI(=H.]#I*+'416VZ-=YS'J#@6@4;FF"M"
MM.DP1)L26H5H7VCM7T^WU__:W_JX>;)[X'G][/-9_>Q#$[1V_GW=X^W&W_M;
MC8VS^L'GWQ-:>V.3;WW<@.O^:L+S6'U]B\$[@M:^_Q/N([8.-WYO-;9H??U#
M;N0Z$:(MN/7:1H<H2P3Q* @RA%.D':7261Z9S&ZE!:JD__!MI!\'61>_D_0\
MWWN6AD%$DDBCBP83KA.S)DDG'0_4X. B+RR' T"I7-S/!XLF7-R449YBU,@R
M!UBDC$;9:)C+\4L?/>%&YPI$RQ3S94;O'9OT>&VESS=6A8L5+CZ>:_J^P%BY
MIA<"!R>+_0-)\^0!_2B1B$O-<I9+1,P3BJ50Q*>TM,H47C;R/IT>*P"L '#A
M /"I!</*I;PP0#A9E8"H8(M,OR04XL$39"V@H62)>4=3P,HLK6K&EIFX=V/N
MIT+#EUZVX/UQ#][V04I6OJ@:!@8T&(:=CP13N-HZ:YFE6'">3&(R50:R^6/0
ME!H&(E%JK2'( [<!#"(,&2,9$E:!,*:=-"&WW:9/5\/@PB4\V]:9*O8\9_YO
M$Q$16RJ 1W#BL:-.!^IXC#A1)4AE&'J>>W#",(2CH-X(CT0T'G%B G),4L04
ME=DJY*7(U8D,6\;ZWK4>[Y6R=C?%YU5O^%DL'O?=\97%8R$V^*3%0QAB*8V(
ML600CY@BHS5'UDG*HA8$MC]L<,Z7,<?S2IVO]O;",_-*F5^8/3ZAS!OO,&QC
M@AR.P,2Q$<@1K1$+GG*J@U4N+JUR UM\D7CX2P]U:>2V@(>V^[/W']>U[5!L
MIZK#1%/RH"TQ7%,NN&5"2Z^X-H8EPA7WLE+7YXXR]?=3U'7FDM(<) E"%>+4
MA=QA@J-@2/[%)HGQTBI]PGB66W'XVQ9&?LX<G@>2:[>IJ'W@P%6MX]SYE)AQ
M3C,N*G7]>>[!"77=Z22HT@9%E?V70G%D N"DU=83;22Q@BZM&K5,IS0K?\IB
MPH_BIGS9^WT6;?V^&[[2UA=B?T]HZSA$S), IFHE1USYG#HO")):B4 $H][G
M^ 2^+-4#9,Y76_N%LO)*65^8+3ZAK/N I4[.HZB# S':*N0<\X@0H10%4=IF
M95W296'FVUSIE?G6.P%N4>MGG3WOI-?A5;] A\J=^IB@+K0B443,O.!22:N-
M%O";XC$P2F.EGSU'<-^9XD[U.B6O<2YX1$ _HP(982U*(B3KL":!Y9 &*9>E
MN7<AN<KE\K0;?@[=XZM56GA8KF3MA8'C"5D;"ZXH-Q%9R13BF 9D<?Y$B?;2
M>YN(7D0X?NF>L:KW^G3/F#*!!2*,ICDECRKK3 R:,8ZEH\'3RC,V?YB9ENEM
M6%0J9(,=!97>"()T8 [9B 63!BN76Y$^9>_URIQVGLBB*<<DXF@<%R0XDPCS
M6@3%X0=7!;(^TSTX6<1;>&NUX$A''1 /42!KO$5:86.)3YI+O! ]RROS^2-G
M[MYOPU>>L878WY,-H'0DUGF*L)06&&VTN7B!0A)'9J2W)DA9M/LFZCYAK-76
M?MFLO-+6%V:+3VCKD42=J /=1@N)N%41&4,Q\A(X>^+<$)>+E+"'"&.M/&-5
ML^S9]7/NLO-6A)1;PX!:[FRB&!1U)FV0PI-*/Y\_L$Q)-'62:ILE!NLQ!MU
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M#OPS>.TO\? &=WL5 3],1=\\W5K;BX&PD%3N$NTLXMYII*TU"!#"!.VEQ]R
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MWANYOGK1-:4<[V B<G+@"RA#L@9O?U7AD?;T:;ZMZM'L%=E$<)LB^Z*690I
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M$UY:-?IJZAN2TP@5GA<7'Z.: 5W:85?TD3[L ^S,X1_M;)8!BF5O1QTE61@
M0BN]1.>&X6P3SKZ^/_.Q-[R@\=SHHBPW#'KV45'$.--ZNU>.'+B^!^EEV'=@
M:D]9>-'A^'ME&X-F>6G\W2RJZ1:*^*"GQK"<\JBTU"Y>SN93CEO]B<.7JR+#
MF:U.WJ^Q>_A,W!0W6>Z'97-K9IKEOM 7BD4?3-V'HH_ESO'14:OPM@&6; XI
M83B]G6X3WC:#TM G5RN+^9<%%,=]!< R^R>9:XX^.*_+>UA*9]L_EVOUE;65
MY7PY  :L*@B5/SI PNTA=H[W01[U6(W::$9;"3>[V7/EK0-Y(+;* +?,]^$E
M8JL)BF)!C=-N?E3@99:/]SL=H+JC_=->49VY%_O]<EKR'BC,/!=;;7*3%06@
M"Q+O7=HS^;0PL&#>..=YHC++&*?S_'08N<OOD1^_<S&V',%EKQU:200[Y]NS
M+(-5*STGY;@+PZR+@W<N8*%0%V;C3B"LE;=I=V!GG0SK><]B$:-&)AHBIY1&
M'D,PTJ5<L9=8JYV0M!31@=[-[1G2R,1=S-N'3K=H+G(^;UN@;10253$#F^WW
M\/X@*YWGO,WB:'IUTO[Z3UP_^W&R=;!U5C_[2;9!\K>8P[08%+!RB*<4D$XQ
M(9R;*5-0V(W*=2&F1BF_!##^;Z<5!L7/\RX9\7_L ^<N?>WY]+R[NR#&-;N7
M\*G\>6C++C9YJ;_GYO%YPU\.PV@.O3%V?EK*=.7X2PSQL,#80@>IG"6YF_4:
MSF7))>8"E VDE 3=V%F'' <%F6IIG,!646UAATS9'W]<K/HX*B^7L38%T_6^
MFQWUF:<<MXL F*%?;;EV?#0(^"@X5C>V2W78UM)Q.]@!7P+::X.$^>8:>;%6
MVJHSY^Y<$/K;R\RY('L@ETX9BU,0>Q%_#F/OQDS?8^I4(3MFFM\?[**3_<ZY
MSC]*[E.ZPP]#C"9?9""!=@?*5^Y948[Y<) 2..#3W1%30@#I 9YZFKMQC&[/
M8J[:G?[ C- ]I_*7@%U3G5^Q"/RP;3]%P[A&S/09L2ZI 9D>3VP7?NI?.K"<
M%P6F!-ZG?*9-J=EJ%HD+@R<.#8)#7.Q.-27F[UF^H_C/_1B @(]LSBZ!7=+N
M]XH#Y,\!A>;.[N?J_,1(9VU^1JW6EL4HE)'<2*.]LAI+3[&SB5%S Y:.!4H.
M R1!4MDN2"N+B;\;G<T<?]/M;< VZI]6#K[I"%NTJ;;)2:8L0XP[D$%P2$AK
MYI (F&EE!7'.983EUWGXAKUMKM(\NJ!R 43,YOA],$H9,MU_NAT?8^A]Z'8.
M-P?[=#M]*[=9Y0:^BDH*294R6 #'$+98(2X51S9IA;P'GLQR8^!LH^;71M("
MA!P-5J"68 D*BID&<E>2TR3Z--LY%#/W#BK1KK!L%_+?T>!6PP=-HMSRL!?4
M]$&<W[I7VH\OWW? %2?O.H#EVC[PBFR;[W>;/^/ CEEH>H7E\SS^8O2FY4L.
M\?O2E7>'WRO<//?<7%-$VA'\C6$,@7>*=WGE[IZB5>[)'DLL6>=(=O=0Q ,&
MP*4>(TRL2A$#Z@9[E;OGLFNQW6^BT&P=%VM^X6CLY9.R,2B3$<@)PRYH!<EV
MBF9J4W?7=80W=8?<E?8>S,7X/MLISQ%\N_LERV<;OT%]:O;BP-\SA/?!T=YK
MIK]- @P_!>4#$QB!.IN[O*L<T4,Y\@;;1.! TMFI0]@*XY-@/@G-EVC2 PV"
M;-T]O9HZ'U/XGWL#DK7^>73&/)22Y]+B='G S;K=T\+I<LE8>MX7L78RS[F<
M4:\!O-+!4\U9HIQFWQ3#&#1>QX2UBE[19GQ:F.)5T?NO5 +-11VVU_9@,CF7
M5B%&<?9%IX ,3P*%%)GQ2;LBGNF* /V%W 2C#=7&&A^/^^2F-B\N^.\\=\@B
M;(]!A^!7O#L\WCK9(R XN5STC@I/@*F#DN9X\$AHR43@F,$?V!V2K$P*E0NY
M.2[:#<Z3P@%^^YWNP&]Y*9@=Y-]F*"QX)_NQ78L@C1P.;+PW[>;S_,EL%0&V
M-^A^.VCE.VB""V)6B$#1W?)P"1*MHNWPU(B7D0$!*I3]B<DSL;/.F%=X11[K
M\WC7FVS*%!-]C:78EBD:18!H:50;9(%<FI+SM-\RW>B*"5MZ"X"=*YJ48:73
M[IN[$@]<!:%SF(G<%\IE,S1MMSD,O>VTBG#8;.MO([BZ<]P%+=/97K.PD]@R
MZJ4T21]E!33W=LZC&QB@=_[9&%J<EP>#:>8 E1P)T3T^ZOM3N.MA)T?69C+/
MM9.*X(KSD9R.12FNU-:*/!;8CKE]]GG7[7-+.#RQ&'J[T[_<>KP'4]1+I1OC
MZ@#BPKM8.CB: W5[.",KM0^%Q2E'!66%NTBC'C[RT)X.,B%@UHZOF/.!_>@B
MR;C(*#]?TF%XLSO-#LY687^"<5QUNQ(X+@3LZS.;KTH1'\0ZY<BCXLURB%WS
ML%E62"JEDL>OD3 >P-#(MH@4NP#0PX0S^##\]3S3!PAOK5C\0<S=9OM7+%71
M3_D5*K/O5+&B\8/E4AI*1B8I1D;D/K)P%Z2)BPA;(G4* A8-YW25ZVIIE!1X
M%66=%S&HO1G'J?-# %27@Y^NK&0 1 98U3L'+0^7M6T9*1^*&+9A<! PR&R+
MJ*VUQ[V[@V/Y<XC)YA"Y(IA@XNH!>A8I;U<-O=CR/YJ_<B!#[SQ<K QJ.,\M
M.,[4FVW(143#\#FQO/-PXU\;$SB*35DK:);ET$"3OI3)=WDZ1@()ITQ-;=^&
MX=2$9R)(W!3YMP6+074Q:>0&)@N+%TJR+%AH<25<55L;'@"B/"_V,)T:2TX&
MKQ^+AIN33O3"-W$>C4C+U229!D8&RLO],SD X,@P.9F#78H0&(_=ZW>R<S_'
M(CB ZW;L ='77L!R7@<J61XNB_L5F0^%1R)/ZZ?-O[:_P$::KD[G/3%<C4N'
MZ&5:R1OCR2L"[91L?[2&Z.6W_Z?;^=&UAQ4[F]XB>XUNK>_N:4F$40DC&B.H
MR00^.24TLB'B9")SA,?L[*;7^3%GK0B%1<*1BJ2<4*"3$Z,LB2HHX0.-C+!B
M_2FAU?H_[OHWMO8P9XZG:'-""\@S/O?@X@HC1:B-3EOK'2V#'::D6@W6?WD8
M<PQ</6L75PO5I7R0>?QU<G6MA+FLN ^R%2X5)(7[#PK2SA2R>#?081,1PM\&
M@QMDJHQ6=LB*SN47>[WABD!@;.LLUQX,7H7DD;92(VY"+CQI &6B$91':Z@1
M2ZMB95K.2L:5V1;Y;LA2+?*]%MGO)1HT5HFB)(5"7#,#>!)@S9FBCBHBO&5Y
MD:<$I5X&CZ*$QMI1M]D:R/$GL90\!^+BN=)?!CJW+ CSA0Q3BO2Y;!P:BC=#
MT+C*G3 5HVX286V_Q)XIXE+Y#92-V=7_Q+0C."023>1>.0="ES:>&ZI%9(G=
M7B Z'_)PQ.<.@>U4NLVV+UZ[8HU7$'6NT;Z7?(I1&HF$E#:7I0&E/]* J%3P
MCU8B&EJ*1E?' 1:TUQNEOAZ0=#?"*I8*9FFW.NZ5F7:AV2N5WU#&[:=6YZ1V
MV FQ-5FD>V ='Z_5/6J[NV0 + ?2;!\=]P<Y;9GF79%Q5PRBXT#Q*"UN@WN#
M3F:+^(9AP,S0$=T<9,T5I2#AA$L)<GDG@KI=6MSI<$.-[+_])H J;!\8U/"D
MP;#.$_F'/Q1NACS8D<$- RX* V:V1)R[QY=KL9F'!//8!41I%69)@(/!MXLJ
M!YWBK"+XS!;(,WSCD<<T%](+-#(M,/,Y90UPI8PE@:D?.$X&'I,\4<T<<5\D
MI@WMO9=6L:H[<T/=F?'&>B-_Y^$6P"@ MQUQ 9,@./',VMQ]"R1H^,=CKO>$
M7JJ*U53%:JXI5G-;@Q.A\[$X39\@M7))$1OTU1A3NPP(XC1AX3GF/&+#<\?0
MX'* M$J6%&&U#!-,T(6,,Q[AT&W^*B#F(LZAM]8._XT!YN7'6D;P LW6@7VV
M.KWC;FS \_]J=?S/^<HN9/O]4';Y<;*]#L<.04Y9][^W#CZ?[C9"<[NQ]7NK
ML?\3Y!/X[?O/[?7=2=EE?8W#.$YWZ0;.]Z^O_[U?IYMBZVSC]_;'S_Q[ WX[
M_,SK!P/9!=1Z:R3CBFNDDP.U7A*.K%8$R("'H",3.IE2!BV(<BV+@%3::# (
M/,X8K@.S/G&<' @Z6!%G[%(M@D1XE#=H]S@NK:YO?-G\%W;ROQNUS?I.X\O7
MDNPGNJQ<(O>I59EN?O+ED3H16,1!!J,M]XQ8(9/)1=B(8U$8O<!5G&;T[)^7
MU\Z:9VU \"_$5CUNE[]LY.DV>S_+-,%8^,R_KNRLU$*9@PXR3:?T" 40*;M-
M.ZA6-7+YA='I<M[-<2^./ZEW8H_@ED.,@:/G(),?#.^:35#1%MZV4NZ]$,[C
M[Z,"< :U(XIZ?MF),<P=;+;')/0+07Q\#+W<6*>5G=BI.:J_#HQ>[8GTW9$2
M1.?M>2YIP*.3<$5VWJ#L=K;V7_A1!JK#])K=ETW_0^4\V_0N#[B8AE(WA_M=
MH9EOMD=&<)T#:A \4:S52=8Z+IT[R*;JU;(EN"P>GY?I".2IBR&,9((6$YDZ
MH*$5D0+%Y$^.=Z4V@5V/R.5V_'X,QRW0TZ?RNU?-T0Z^[C&*?8[90YH$#-HX
M]B V$XM2\%AR[#G\F> 3-KE@A>)<)2XU-]@30X4/N>4%-7*<HSU[+*WMQU88
M*VLV%6BN<IQ?X_*KO1F@[[ <7Y$TTSF&H8?>VW>W9$J% #LNT [:O:'<*/(=
M+[2<X4_=\L6+WR;T@O*7,JO\'3)%P\M^&?XUU#R+)G,^#_RH%]\-/_P9FKVC
MECU]UVP7\UE<].?ED>8GCC68*QY7'AZH84:N*,VR)C;H]SEX\$!)6RF4M+&&
M>8-C8D5*=>5AO$+N>$P(<=LKIS06'4Y,#H6XTYFWGP"\HAE[A D !'X>$T!7
M))?SG8!JL',?K%F1]-8[=MX3RU>XI'/;73<T5IZA?_(,I]X;$*YY_)1FR0/.
M-L9Y#ILAM.)#"QCZ)BL//D^AJXUGSUW7G/I2X]>KN[O.>?(?EDRJ4U\V43\J
M<LW2#'FQYS6;J$!IW^S'PUM,ZER00#[2M#].\_;;37N]D\TZMC4HS_B@]/QR
MB',]]F (I>%Y';3AAZ70ES-/&RF5 3G5+%TS2XV1#(%JGJZ>IP^%-?N2)Z.:
MJBLV7IDT"].5P[9J1=S6I;EZ"#EB\=6C*U]CEG=XD)L\Z=L]WB)5CWSJ1SXO
M\;%(!ZV]^30,I'L["^@\QAZISJS.?&YGWL2;)T)'O8\QI>N0(CO$YB.?3+@:
M"YP@Z!#.V1]QLW_JV/9M3((WO?R3\F(ZVZ+@VI2E*1R3B[0V,Z0;2(F#<4Q3
MEA1GSCAGF.7>$"\Q,5)=D6[ K@[,&]H?9FEWP)YG),/^[N'OUO;!Y[/O!]^;
M];.?<,XNWCWXTMHZ^]+\_O'S[_K9%MEN[/[>7M\\@>?CX37PK./O]*NLK]</
MZX>;;+NQ\;M^\*59__CUK/[Q[Y_?US?8UME743_8X%L':_"N7U+]/<:?&AO]
MK1W\.Y?]VCK8V*-$6DZP1#)9BKC7#&G!&?*). Z?9&*J*$$PM4O"(&)S;,O.
MB%'%AL"WWP[/!AGN!]?S5"BG@\)Y+CUAV=)-U!-A]<N8O;^/6Z>UPD5 3#5Q
M,TU<.]98V>V+/^K,O2Y6/C7G]6[<?$H=P2$S+PQVHRFO"Y/@^EQX]N_\I^#;
MC1\4[OE[+T1F1& 2><,\XH$3I"VV*,@HL4W4:V>75ND*S\[(16#9<R#[/^:-
M%+>SYCQS#'D*=6 DZ7A$1XB58O"P(-,< YE<\%0:+E#2VB%.E$4Z*HT,<]X2
M[8FQ>FF5+V,ZF;%\-Y"YM?WS 36&)[;2#!)\7Z>59NSE%\9*,V517APL)X,M
M%L%SJA4(#(#'5CD<J ]44\ZN*@I166F>'HQW)JTTP1+J*"7($\P1MR0BFX1'
MFN2B$C80. P"'WX0*\UTC'I4*\T\D>%^<+UXZO+#6&EF7Y&7,7M_VW;12KHT
MU.AJ[NY">8-(V+L9:VX[>Z^+HT\UUMR-J5?&FD=DW9/&FB1H4(X;9(U-H$=9
MA;2Q I0I$;BE-L:HL[&&D7L;:QZ&<S\;8TV%%/.2_2N3S)- R;A)QEKE<TM0
MI)(AB >CD?-!(,D)Q<P+S+%86I7+BDT6P%PT): *CZG"8UZ>3VU*>7*-HZ8X
M$"T,M\XYG&MXJ&BE-\HQ7AE>%@9RFY.&E^B%MCY9Q#$QB#-'D,Z5L @5(:7
M=?)A:56)*CKFU4?';/M^IS"[X'N8#EYOC,<P.(;B:N+N&!PCYNWR?D&,?'K5
M_SOQ\LK>\H@<>]+>0B-)C@./SB$'B#LC$'Q-"!;<24>)4[G2-ENA=$$X]K.Q
MMU1(,2^1O[*W/ F4C-M;2"0T"9R0<0:@1!N--)$:B1 5(5)Z*0PHZLN,FL6
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M[<4;1W ,'(EH,+#NY)'V\!<+'MODDM0R%K87S!>#<3\;VTN%%?.2_2O;R].
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M"]W"N?W&YG\.&W0;T&SKQ^[[CQP0\*QQ]!%0ZX\$J"?@?MSX]OD,QG+6^'C
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MT_J4)U'C&#DRF%'$F9<(UM"A))VQH#)3JOC*^O \\\([3PLWWY>;':/4!6.
MD1G')MFH8S1!<%"FC,3Z\12JPLWWYN8I72HY8SBE":7@$^)>!*1Y%"A*&87U
MW ?C7@XW+X$R5:*G%G";8E':6 +Z+L9"42]NY8'E@4NKDXA*<R:<-C''YQL;
M"4X27U4NI_AKGEG'^#AM,9 475!)(!F"03Q@AC0H'2@1)72N@Y2875FGJX8_
MV%U3[(6%96CCC5(X4D4YY3)PX[!@8#[PY*RCQ!4'[*(R])31H,#,CU9Y1#07
MB&/'D0LAH&0P)B0Z'X->66>KC#QX1Z68#(^[3?^HF#$[%]Y^IV];-^3_GLJ(
M]QC&PDW/W2[;XW(F4;CEV)=%.(GD$PN.1L8B%T0ZIT)41C'FL,<!%VUS,873
MYVEM4S'0-95@2%$M$3=>(6U!0DEJO;/<PA++E75)5P6?UW[_K=/"/D4DP,V=
M*3A8</ *'+3$,96BMU9CSI2P09&@HG ^A&@8*TKZHN+@E))N5; R:8X2)B[7
MNDW(J9B0YAP;R9BQ J^L*[E*U(//.#PC#BZL_CZZ9<2*?% I9J%CEJ]L8VQE
M&2Q?Z)SD@C?72I6E:WYA*6UI+<5;9TW_T+2NV6KF8JKW2YW^<K>$RK;237ZB
M!3]!MN%]]R1>FSJ]]9.\RT&<<A!G28("YG+&[.6";@'N:X"[G#%[N6?,;D#H
M!V^"OER?TJP1+HOG2!%#A#(\21&X-\1YK'74W%B1O#+S"NX>:?IGQ4%T%P?1
MMXUI1[DE'DMM/8HYX).GJ)#61",JC @X>)&"R ZB)4QI4S!H.3%(4ARY"M@E
MS9V/6AC'G W4$IFDGE>2]#$,*F'I<\&F*>>U#D$8YB28#M$BCB5!3H>(;,)&
M)NLM$::$I2^(!?H:PG;+,>M;;B!&3VF@.GION%?$44>HQ4P[)1V/?/YJ8-E$
MG!<.STJ>$)+D-@'P8LP0Y\K#)V?SGB*3AC-!M<RIE?'#(_U*[H2%96ICI,/1
M2LX9Y\1S:VTB+E#N/78Q/K)>59CZ84P]I5PY;:0$11GQ"!H6#R8@9TE DK.4
M6/02YW2F;!68>^&9>@E4JY=Z(NI=IPM?V]6%<@5,>VJ[H<:.3"^/NUGUVL]3
M>!DL\SXY8QD@L@,@=EQ1BKV,W*1Y%2PL#K?[X>[.F#+U733.-]A!@E72@3 4
MG8B@3 6-M, &+%M!6;(T.0>X*Y>YZ,P]VK@]1P #$)%<DLPZGK@$M85P+A31
M7LMP64WYT6N^:3=;_V^EWSV)]V>)P@BW8(0+!>3;QOG._I<?!]*()*DQB(:<
M?ED+L"HL-PACP#)#?6269^J98(-%D.YED[^<_"\[_:]*SRTG_Y]6L<58@8C&
M-K% .8G)IF"3T9H+0[A,\ZJ;4G9Q'D_A'3H:\A$Z+CE%@0=0>*VAR,AHD+=4
M"F>#$>$%)1<J''WOTY761L$TBT(;'@G5-/BHI#?2,!E8V9==5(Z><AT:*:P/
MT0$?>PN:NV((K"R%.+,^RJ1QDB\H^=\2*%77& T+'O<^J)SRT-#VEZO1%ZO@
M1JO@Q5J]I7Q*.;51RJ<L7VA["1BX9:5$;G3P,B10^[D%U=\%[I2,*C!&O2M1
M0 NL]7^9MN,-SSLI(J+H28X"LA&9I#6"I<2.FJ@( 3N>K&*]^/46"E/?EZFE
MB909FIA,G(/A;I6P\ O12EJ!J2I6_(+R\Y05CP/P,=<,$6_ BL^U4RPW%#D>
ML?."&Z'TW*SX$@)4MD:*(W4^$$P<%89QQ5/0'#NKJ2&@:V'*&</&L*)7+2X.
M^VF]*E&6DVQA1 "1<QY5C&"!.7P5%@L2A).@5ZE5HI;P#%YAZE%9)*^\)D+!
M_R*//H"V':3U$NPDX'?B2W3U(C/UE'+%E21:$(FT2QQQ)RTR7BB88*D%URKK
M7BOK>E6Q!T=7EPV2$E55HJK*_DDQ'8J6<:.6D83B-N(4G>4B*1.)=5$X%3T+
M6,^KGDK1,AY!R_@^XV"FB9XH8A$3"4P'30ER!F>_K".1Q6AI7=4:K\IB.RPQ
M5_L0;.3.$6DE#]%JHK3"24E&/>61%MMAD;EZRG80^= * X;&R5#$%2=(!\&1
M]BHEZ[@31 RX&A?C8<%W\!\5..926>7#X\9>W?3<,"OS@)2F$C.7H@,/G)EE
M$7%/5)JEB+CYB[CS&5GG=)3.2H81?#"(LPB**Z;P26JM'4^:D)Q\@*TJ*>=;
MEN!![/2TQ5ONW=6"P06#7VY9F(+!CX+!4V8&,<ZYZ GBF"KX1Q-D<*"()2L\
M==@FX0&#Z:I6?&DQ>$'-D]_Z%J9E%)TZ%@9\9+M?F^U1$9/1Q RB@B<<O=].
M>OUF.AO\U&R'V.Z_06;^@<.WB=6E#XC5);]6CQ)C?",^TMJ:.HS5V\X1O/BL
M\BW;ZS53LS:I1G %)E4N35D7;!@[QY(MK5'EACR84 &X]J$QGT\%I%;GM%<7
M>_#9*NMW*A>K9KM^(%2GS?YA<W!WZK3@5ECBBM !SQU!EP][:Y?CEZ<I9,AC
MA+X2*OD9T?T,1%)M]*L=V_6'@R5B9+7*YDA-$YO1QR,7NY<NT=5Z=?NUJ=[N
MY '#!WL$F FD5 ]]0!;]G^17&^SJ]Q[0R60,?J\ZA5\J6//#ZE]WL:JDYC)(
M1H*+W#BB'596"NY4)#[R<(55I:^6Z(WA6#;JH=Q.@IN7*<%;\<]/9W__%8X=
MY1*D,(=^G'VA6SBWW]C\SV&#;HN=\ZT?N^\_\K_WX;>CC[SQ[8^TL[]!=S:_
M'%">A+!.(QRQ1UP(@FR2#E$B G>64:K\W79WN*&),Z>X)#QYZ[C0L)1!XF!,
M\E?Y@<MRSF4YHXR!4451)#KEY>3(&LF05E@D%PD.6*^LDS4Q(Z7-Q \52)$6
M?%@%*.AE&0%+T3J;P/SA0XV3(U@N/_B>R:'9/K&#9L>DPA"N.!T<!YU&V=-F
MZ!^.;(*Q!X=R!/]\Q#K0S$[Z5S\R)EU\S%@U;UE"\*U0F9*)"1O[]_"B,M^Q
M_1J1ZT;[';@/.OO&MD[M66_EM\M2%43JL'&AU_(4+L[HI]S ]>BW&_M;[S]M
M5!^VWVWMO=W>:KS=VJO^W/VPN=UXOU>]W?WTW]U/&_O;NXTK-8E%&4EC=Q^Z
MOK];?6YL?-[<WM_:A.XW-K<:>X-/>[L?MC<W\L_OMAL;C;?;&Q^JO7WX86>K
ML;]7_7+QV*_5+T,&B>&G4CE.%A,L-  RK34)U":5J.,Z.<>],5(0Y5S@D:8+
MC!ZRXL3FG%$\T(2%YYCSB VW3-'@G#5:)4L.-FL92S!!/X7M93S>\X<QG+0N
M6<G;[5Z_>Y(#?WKO;;/]H=/K;;?W^J 1Y-]VT[MFV[9]T[;^&[LU:K=]W(=.
M_='J^.^O#Z'A[_>#J+WVE$:45 "SET2,M&$,$9)P-%(%(^U*%4&.'<=A3KCK
M5.M,O6/VF)BI6#\3]NU?LAV.08QD2JG5R9@22)2JD\:-F.9/<IK8+KJP5T8;
M1UFI;<<^/'(1>C:\,K1PK/<#C36_&G@AY(IV=4+0VJ2O&^Z-*#7WHW,<!]%M
M\.Z3;GZJ5HX/NS%6 W.GBM!*N%+'SFK-F[M81&/+EK_#(M4&]T^A5WLB8+%:
MH%S'-Z,/OX\,]F:[GO+ZH=\OMS_#3*FI8G#YI]A8PP/1,=R)'+YY>'FMOC3A
M5AE<8WC-$'7E9;Q&KKQV7;.$0+-7/WI=L]=?8YH_1F<9E2^ELW0-B_LMV--W
M5J]1\6(F5JX)<[N)O6'/_XY;^X_CK]>W\M=O9BCJ9B<  &3G!%H*M]FWOV:$
M ]UN<HQ'S1!:\;''.#N"X0_;RNK* .B;[<'?C=VW'_[MNK^M_Q$!;=M92G12
M_</'$]N%$=QA%FX1%/RB)FQ@G@_F:3@I62FL?LEJX:_U]T_1=[ZVH<DPFM;Z
MYWI6R\0-)F[P=\;,C?R^H4K=SM'%Q&5/7*?^MF6[F2+OPHG+-I77,^U6+F><
MJL*J'SI^:%H.&/#"9.M=8M_="Y7XTEP]46'5I]F0OB)\K5;[=P9J_]9/M;\:
M:?P/.2!PY1;C=>$3<XU5+ITLG7QH)Y\^/^#C(.9")%A[N>?62AO/W<8SY#E\
M/DZ\+OG;?<X9W#IB\#F'_,@E=9]S:'?86-8Q&J6(<T9$3A4Q+"9H-!D25:(X
MWC;R;Z_?\=\/.RU \-[6_YZ\CAB_HVW\Y:]/WZ%MT=C?P="'T[^/<GQ? Y[[
M3+Z<;^&=;Y_)[N;&V62,WY=OGP[_?@^_[7\G.^<?3QN;?QS]_=?V^0[=AK;^
MY]O._L>SQOYGOK/YG[1S-HSOV\,_X/U\Y]O60231T2 -\LX:Q!U+R'#L$!=$
M6R>]$$*OK NYJLCSG@^\X(-Y*F$%C%X.&/UR!S1B47H<)38V$&Y<<"YY(K3#
M4:0@M9VYHWH9EO(&%WR:Q*<Z&W4.M^K&P]CNU=NLOG,4LS,H*YM9UZQ5S=&6
MZQ\1X"O^]! -;/N-=MBW/PJTS1':SB>A#1.31*0!)2,\XGE#UWH!T!:3HDI+
MA95=62=X5;#IZ.5?"ZHM#NLO,:H]+:@]$,NF4"Q'0Q4<FR^.D4D<T\)83A-&
MS'F&>/("F>@,"B%X('9K;+1U&5[\X*RZ!<L*ECU-/@H>G>9)FV #)T0ZGZO2
M"L5),E9R<MO#NL5<?%0L8I-8Q#7!8,YC1($T<UUPC PVJ4XGXQ312ED@/DY7
MI7K>Q!./ D:/N)^V$$Z[?-JHW8L/VT]\>"*]YYR+NZ0;>[1$[R_%S'8L16Z%
MIMX'CB6Q1J6 '8"Z\BKA<+73[PKKNL#YX\'YQ>G>,3A/1EIC>$026S"1C8P(
MY+% -I=H8Q(GS5*=1X@J\@ 3^4&IW>^'Y,]>K.&%*&)$:<>)H$83Q@7'FAOM
M=4@N1NZ=5X]O5!8'V1-Q_Y2#C*3DJ:%@20JP*7E0H,<QK)$SU";*A>=6 O>O
M$C/-_$]9W*$@P*-*\3E P+R<Y<7!] 0X,.5@HCHY[(U!@C"'N,,IYR2'3S@H
MGTLY$9L&#J:'^,D+!"PN!.1" MHHR8,SG$BAE?.1J,3@$['\FCIL19%_#A:>
M\LM([+#4*B"&+45<$H6<<Q;%*(T1/& 6@(4)7Q5J.EO:4O#P_--S/B?S#HH>
M-VMIN9K/4CY&C/=+\<F\ _L ^E"]'7EEX(=3VPW56W@T$_&]/#0+F/;YYI.[
M=S7ODDQ.8RJE99@'+UP$-% *\QB$I,-L[G,(RUJVJGM/!>5[8SZ9_:_0G\\'
MSDIK4N3(Z>R3L88@RRU#0F*M/>'8:#6WHGLE9?L3\^Z=M#+*M+9&A!C %&=
M"DF(E *5UELFV<)$,16.OPO'GU_B^&\[!]'0$$DNZN:IS#4:.+(AYWNB 50Z
M8KS%>&5=FN<*4BI\_J@R6A,0P5QIF6S@1BF#K5$QEP%S C@^+4I<3Y'Q]^5X
M<HGCS[<.>"+ UC2@0+4#/C<: ;@'Q(D25G%JN31%QC^ ]U^*XX4ZEH3D1I
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MVD7_2@7GW>=V1Y#LG"O3?:XC:(.]Z=.2;)#;%[X0.8*P!K8&,_SZN[)*8I+
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M8V"/LS2AR<!6,S/,!L= -[%5LD;H_P!:+!_E6S&&]*Z0V3 \":&; 8Q>#L
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MHR?78J)A4=T[/^J?@(8Q"-TW)EOJS:]X/P]$1LHQ4M(SQ(T.R%"K$.<Z2BQ
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MEC*5*7=(%V)$,R,4\YZY%(NT-HT)BV#TWKFQE:T[<]=/ZU_VL;'.Y18C1D5
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M">A@C5<V.9SR"CPJG_$K\1F_K13CF5C]$%]RA=4OAM6U:45/<IK30'*$(Q&
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M,C*B$+2/N5 :FU2P=^W6>KW3EL5#K KZ%%:%DY(I!K:$%X;GCNA C'5.>F?
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MR YZL*W=(KI]-8,%/LR^KNVL%6,",D+IC]4BV0!&G3(^@2W;9R#LW"A%!*7
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MKRZH$@5+3I:KC"8LJ->4X[IZ^\4R%-40TJI?A'1=O",A_P0NOJ;-\-G.L*Q
MO'WU)8 !L*<3A6.\?JVR8/2D$+M):>YERP5 RZOY6&7U1F>.4_'R(D:SZUO%
M=\ <ZMZOMMM;;@LA;F\+\8 X.WD19U?UDJAZ2<R@J&4(OV1/'GZY.<;&28F.
M18F2J[<F94 /!#P7WI'L)-]J;'PYKS=W1>V\!C:2/]P]A^\?M0_KY]]/;MI6
M19PS_7)22QV-Z!:O;]1(_>C[>>U\_;1./QZ!C44;WS99H_EG;#1W3_>%(9JH
MF#+MHD/<*(T4<0Z!B>NCI30/RMV,O)2I]GT43'*%N996$T,595K#1N36R9LQ
M=?7-9C:.OOR\N9WM_&=]>_,7(C!_^MIGC,"\04)_@F7@UKM^HY7DC5^HX,L7
M("NZ[S@UU/B \L DXCB%7N:Y0E[K&+W&D3NVA*&7Q3X7NHXO=[I(>AYKB9?E
MJ%+>B!F,@S0';R7*,F=K1/Y:..2=@8MDC>=L6:(LTV#O_=CE.;]X"X%T591E
M11P;"4_[@[*$2&\$S_-@W"8O[O'5>H.FD_+_[M6K]36%%E8QF55,YE+&9,[:
MF')8/KAQ)[5WA?\QW371\V;I=N\>$S\U-][XY0"M9QSD*Z#GY6LL7K\DV<?T
M!)X96K=H<_V?1\UPH2.=GK&,U518 I!0&9#P=V]PSZ)5+]S[^U=='..(07A'
MY^-AG7YAN\T#OM?</MS;:,-8/[9KS</6[A&\_UN-PM^'4Q&#W_[JP)C8WH8_
M;&P<MNN?/GYO?-LZW?WV];3QZ:\6S!7FL@M_?XRUL^EH9^&P%)CF2&$A$?>*
M(^6"3S4#G,M321Q#4]/H54H?'>\\Q\[?OPB?-V5&!4BO$I >&295 =+S =)4
M"+/(G;",>F19JL.@@D)6P49I%J)F7OOH_,I[1E?UC-KLBP9(KT !_36#ZB6!
MXMMTIX:RZ,RX'MAE%Y?'),"]HC20V3VKYJW43;9EW*&@7L2W-F)9VJEQN2F%
MX5MA[+PPMOYA6ND+E' CBQA6DR,>HT<Z5;1VE@3&<X[SA+&*K*K\T1@[&S^>
M5.F;8ZK8:^?RN6M*%9>_%)=/:5)4$>NE$RA08Q$GBB 5(D<XI%97E*FH.' Y
M6Y5LNI+QHG'YPFI2-X(&"2]/S.=CG[[R9RSLIKYF]7CFP<)5%?DQ3/_*G"2S
M9KB<TO_VMF2/5/2GVI+-#$Q;F!YD2R',9U2E@$T"-1U[9#61B%L;D"4Q(A$9
MY3)7V'F7BKFRZ<+%BR;*'ZRP5P#TJ@'HD39(!4!/ 4!3UD3. H[,>B0%28VT
M24#:!XVL@!V3DL->L0* ICNI+AH +:S:6=D2E2WQ&F*7-NZ(3']4]-*B!"B]
M+;K\M1BD%ZMS6 4@O;7S_BH :3GTRL;.C+,H*81U'B/L4[NGE*&E8<M2P7Q%
M6;1*&5$%(%6 ]/)3JP*07B,@31FZ*FJG,-8H)[E&/.0.*><9<B!-&#;<2T^J
M *27-767UQRH3(IE-"GN'U)6]+8F](^L\#K^4H#9?47_\@C(*L#L%<O0VEA^
M%G*T>4!3&^U]I@UUF"F$A56(>V>1L0(CYQ1CP" 8$S&O"+/%T^HK-J\BS%XE
MFY_=8'/AB0\\ETASQ1$W+B*;>MP%'0)5F$;K_;Q"S-ZNKOP*3A!F(\GFN!IF
M+&O9I,*7@^!&_=:P%0;50<%+WSDGK;Y@T;RLI;BHE+A3U$+N'9>E)\LRNJFF
M9M'GNRB47*GRSZC*;Z52QZDHJ&E_*"RM4KJO7ZF?VNQ-@CN"_VS.TLWK_7XJ
MSUN44JYD^X-D>VU:A5=265#1<F1$ -F.):CP"C1ZBDV@@1*%<T *+A9?L%?Z
M^R+I[Q5O/S]OW]3;G:**YYPBRZ('WO8*:>P)LC9W@5L=:3ITDYPO/&^_ JUI
MR93VG_A"4^WP267*BQ+@%]$_<V@Y.5T5Z-5C\'.Y2L=Q6U.NE,J+,C\T_C*M
M:5%-;/#,(RHX0YP3C4#%RH'PE)8N2A:96WFOZ"JC<^[;]A->6J)$W;<+#L_E
M8*W X5G X::JI@F3S@>&J(D*P,%'I'+F$/$ "SJ E<8I@ -?I?F<&](^*S@L
MK!Y7Q>17,?E+E=][2_!]E>%[[QDNIW+P<AF^8XJK4NP>).MWIPT!'22.F$:D
M>0ZRGFF!;,P=8HPY(S017.*48T<7/\>N2O*M,.@YDWPK#/I%#)IR#6L:9) <
M*<,"8!#U"#Z)2-K@I<X##;S*\WV>1NR/;[K[:#RX9U.B#V/ELCQ%CYDY/N[W
M3ENI.V3[[/8>US/]&813&X*5'-05KH*VQ!/)O<LI8 BH,6-M!0!BMK-3W(2*
M]>ZP-8DOV;D(+]D\+1I+^H_]7B>URQP-BS36Z<9:ZT6CC?MY.>1RHLXO-]JJ
M-3?9/C>>YH90I"P1B!/,D.(JG2TIY;W#S.(2,:8 (P-2;)>M?B>H<95Z7[)E
M=$'6=[1GGTFZD@-*&A&#QYA32;6."FL5\EP(1Y09"[DQZ4Z[XBK2?4[2W<+[
M(,\D%DHC9BE#G$:-=,08">N-%[F'A])"X;Z==,?'7F8XNP5R"B5*>UTT@9]%
MY,]%RQ<-Z+/A(0RV:"@^&(S*5L2'P&4'AUDX#7W7&H1;(O*RD]3X-S5Q'G?E
M]663HN((<$*%%]^]K3.=#<Z,4@-Q&%Y_TA#[Y+);-H!_ H1A"TV&<*_>O?=L
M4*M7WM_:!.^E^X[R)^\[FM"B'PY#=P#+6B84UGO#A>D3V=@98P HP+6CKW2O
M"9\W?6>WN9W^%K7.)F# )MF#_T!Y)>E[-S%@]]O66;VYUX8QB#K=.ZQ_2G]_
M/X,QGM::_X "_?6T?O0/C'$[UC<VS_>--X$Y)9#PP/X<&X&4M!AQS;$6GC&#
MZ<WVHR&GS 6E F@D/ #.@ZHBF8Q8ZZ2EY#?[2JY_^/"U]O7OHH5NH_F?S>WL
M0Z/V>7OS/YOUG:U_-B>M27_[N[&S\_LO]"7]Z7B>KR_I#!)+.:L+U8_T!>B,
M[&OEJ!)*(4>" NK*&;)26)0+R;RAAOM EK ?Z;7]GJ!]"@))<F%8- 8$TR U
M!@S7&P,6 O)"/K[5AJ5DC5 Z_QZ@=(UK^4N/?8&&I6FPZKZ/71X[_Q7UI*P:
MEE;$,>NH<4:KTJHA:=60]%X+5S4D7<3HWE\IGO:0KIVO]_CN_M-?VK.]JNS:
MO$S)\ISOJ':Z^^V?SE[GK^_U#1C'QO;WVJ=ZJ][9Y(V- USK;)'2%;I^=O.<
MKW;^\7#OVUYGM_,%UX[6<?W3EY-=ND73>6%CX\O9;C(]DRMTXZ]8FU%/W'J;
MLRARY#RUB"NCD>&8(I]'[*QAD2@WK[)K#V60!8]$J'#NC>%<5<UM:7!NJIH;
MEHH&IW(4,=.(:V*1IM@C9JPAE@3"I)U7-;>7Q;E7H"LO656PC[T^_-G-W*C?
M#UUWE@W[\+!VZ9<W/H5DI'S5JG+ <^F/C>%AZ,\X@!AOU(?Q/C73-I7#6^_Z
MYN6FK5_L&2!T(S;-Z>=>O[AP+3GYLX''W/-8O<+M>^#VC+[D3L40:&I$;GC*
M4)8<&><4(CHRG8=HM-4K[_DJ?GS62U5_X'D1XK?G5;T&,%_XK<**UX(54SH>
M$UA@8QAB.#>(1\J0QLHF'<\:"T@"YNS*>[$JU70(VN^+ Q.O0(%;,F?GA\-4
M4R0=7XRZ_0"#.0\^:X--]N_?#DRK^WL&X 2J?.N'26%(@]4BH*D7LZ$Y?5NM
MPQ\"V7/0ZAX(V<F*_F &AQ_;O9/_!'\0/L'FI0_7XS#TMX-KF\&@%6$M)S .
M8%WA\EQQ>6:;<>VC$=(@SRGH<#H$I"C-D786J$)B2K18>9^OLCQ_!"XO7BK3
MZ\:"EW2<50BPT @PI9EQ9C7L?$0*YSGB#JPX2Z)&BCDC#5/8IS+05*\J6K4@
MKQQL-Z'F<^)Q@)AVR]A6NS4\N^)5>[0RMK3V\T+K8ALAPH#]GZ$+OPP_MV&:
M#[24*\B]/^3.Z*>EJ94\XH"8-!IQFVND4V>M0"4+%CZD)E]Y3_"C*TE5;K/%
MM<&>3?&JV/UYV7U*PXHA&.NQ1(P&AK@G!FEK&,)@7EDA*!.<K+R?SM6N_%YO
MV>\U(V>CT*=^\:A[G"S!@"Q\;Y12+R93J&)EYK4^"RV;7O+0=U9.XUCP5,;]
MW$3/C!!"[[AD3CL4\SPU?Z$8:1E):O0D(HZ$NYR"<4]6,57S#:V9 S\M1XQA
M!:P5L+Z8SE\!Z_, ZY1.+V, 6*4,42=ST.D5 &M@H-B#/*1&:1\\6WDO\E7,
MYARSN'# NJ"VP=TEG)XKU7[=N5%GU#;#X.\Z&'G3J?>U\^_G^Y%&[02U2%J<
M:IH9C"P!<UE)18*WQD01'I-ZOT"%N(J(AB(CTUQ21]9+Y%%4:9E*U;=GQ>=
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M0)2XD/N4@TI)59%Q*5E]0<I[54S_TDP_Y=00SFGJJ4-.,(*XT10I9B425(3
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M,HI]?L#0[C&SQ\P>,^_2<9%RHU7,0DV()B8T+$U(QGA*)4^5%-=HFGWCH(=
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M\WP;&*BJ-B;=!)T=6L!K(X&=PTG.ZOB\WP2IFU/'=\"\R-Q2+XKANA?0VC6
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MH,QGYG!V^$L'.1SN;9#<L( Z"WCVV3O8)2S$IZ!/=F'ZHH&U&?[]U5^>]J#
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M4O7*PKV_4A+/[6A$,_V5U!/9F1Z#R:$9*=4 GY15.* XE _*G7C\ _-%[\'
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MZCX171&T2,+JXK#S8*BY59:+FZZV,N&IX9[;4*EM7"JS=O8C/KNP? @6PLZ
M\4\/FO."/26,ERW4H#ZS@>8&0*)S*L0F75KJ0\KR0(K2#F,>0^/;%!-9<K_E
M(I=>L6TR4S+3'<OQA!1JH'@0[4R\I1KB^/=>>&:;$% +T4#KLIT\:PQH[ZE]
M"MUPN?RWI>X,LC70O<X#6&8XCX)E]C"G0-RH(Z>90YOW+@!?A(@=R)]'=X#O
M='X3KU*IS'@)F56)<CAD14'R[7;'?!9RF[28'R*W$966R";9;@CNO9>0B:6V
M5=-ED$RP/Q,*'^LK3)=BLL@)0]<_2OI_X&@DX%, F&D6!"]^WET:"XIK&'&?
M#>P$#,,Z]DJ,;LFCPK72<[3\LSJUSW"-^-QN+Z,'O#Q9[,H*%A\0"=B'#*5'
MWG3T&?/5ZPYN:WE"/>Q7KX2[=4ET0QZYTR-5.0:U$9Q@5<CO7*9,T1\7?R:@
M5KR#<[R?://!EO3<!T*<BY3,^_#HJ<@GA#>)/@ASTA1?.6KZ@V6C!I]'&TTG
MZ"KQVT:S5A-'T4G@HI$;9T3[LP$;>S*!Y9 I3RO? ]_&$5ZN4:9+O#"#A:M*
MX7+-CF>^4&%]ELF(0.'P?W032F-(3ZM2]ZX^HRXZGM) 1,I.E%HZ480]W]3"
M[*P"[ CP;5;MB&6H[.?RND#XKY4,'B54P%WB2(DUP()\-WJ&.)EKO>M/-R<N
M#.41576:7$?+CN8RWV;T8$^6A=RR,P>*<>; J\&/[%B/<I%Y#OE=02B=A>^.
M$)R3WZQ9%$BF-0C,8^J\Y(8(O:#(Y0G]3AWP\G<2=M%A$0@J>;*+3K V6<H%
M>Y)#CCB'#MA)?EZRYP&7"I=[>L):VIG7IG&F]<6FI?WVNM4Z4ZH \%0T7*(5
M'?M ]8.$?E.UBYIDN5#18/[;G)H3.F!>R7&M1)X"5TU,"5S+ [M0PHDO_%%E
M-8E% =,YJ62O,DI57=')4:BL0C&QE.'$]BR$+.Y"),8"&5_@):Y[]WJV%<SL
MX/=D#3@775_=WEQ_Z=$=V;>;Z_.+CW@M5@[?<N4P+_ X:,O-_!%.$!ZW 92D
M&7C<1GQ+S[BE&O+3)WHG&_! ';!RJ$]S<KF1D2AQJNB>)2'3P3,)*?.9?I'?
M4)3H*8_JXJ49NBV]$NH.8A'H0I@3#^XR1\^JQ^G@ZHW169#!7OXT<\C0R.(*
M;EJ^.J)[-7?H9KR1O8OSU(:%B61NQ<[*K'VD=$T&H]P0\.YF,$C&";>)Y#@$
MXW'B@X.L9"5DX0[UWC3@"9(B"1),_2 A+<MSFD(QX_+[+/0MOM?13BH7CJ05
MZ5*!AHHE &&,$1T7,MV53GJVQH8JX$O66P=' (_*&-H=P1NH-E6Z])2)Q6^W
M'$SL]E-)"'P*QR\0![S-&(Q<EM9\Q]9"YL@>: $Y[SSVPVM*IS$CDH),>/!$
M B=VT/)_),Z=/+8PL8=%\UB-YD3 C\5E,,S,R)U@3\##BRC7<LGP#? HTK=C
M^D0Z=%S$=;;+$YMC@]FH$%"JVFK4*AJD8O3E!6.9"F7(NXIR[$_S5O0&+!MW
MW\RZ?6*>O>F_%<5EB'TA#%U2:3%=G:4^D*Z0"D7)!*D3(IF,3R<YROW &R\T
M5>J!=D^&3]*]RA,CH7?24Q=J9L4D*=U90U$_>?8DSCLZ.J@3])-#PNX(\'9*
M\[1&9^E@O<:Y634_Y,,LLD''$.@^S^(S%//&P(5PV;7K>YCG[&QX(V].2WC3
M :LNDE/5B%3*B.-SA _W&W#4F;QE]\5OR(L9RJCFG&88OE5VO:I$W@H1'5
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MC>57LZ?]P)G"?T;QV/OE_P-02P,$%     @ 0H.:5E8-2^S.%P  A@,! !$
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MN56JT*;MYR9AWE(W;H)+J](&I<K<RM%I?=6JK@GC)U@J'1B2\E:G!L*THE6
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M,6**4'A]2T:F-S*_ WTK9W+SR]6'(O_:&XKJ8TP"IN<E_OK3_P%02P,$%
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MVX/%M<U7\ZP29$T4^LUH)J'$1_A=0K:-R#PF4QM6-P@8LN-M5(003<"P)&(
MF5,FUCL,+*+BJ"<5HJ;?J^/]O.[IZAB\:[J'H?_*D202>F$D7L,,\F0Q1EL0
M4$R4".< O62326 1K5)VU":N=0JB%S#>(650Z83:2%I/\/VED;+,E);LB//.
M(Q4B$<=T)D+Q['F.DE*WT332:CSMYU_G\U0^]0B:CY,([=%\FL:2&0T*,N&"
M*R(Q&B0N*T5$ !5XLJ"J6]J'J1F2H5P+!_>ERBHHH!K(#Z$%_)@3)&8;/L)T
M_J'$<1>L?DWIQO\]FS20=F8'S1SI;0L;8R935L&B'+061#J&#IFFCC 4D(5$
MDZJ>5EV#W"%%\E4AM2D55L/<$71[_*]HW!L_1;*WTNED-FD7Q5OX>.69!VJ,
M4#J08OK/LP=($B/&<XZR82+RVEF@Y2A[8CS__2"I!\54 \W6Z;Q93/ZOD\E^
M1O_0S]Y/PA3*:=.B'1M@1E+GB,C(L73<$)LY)8RI;)UV0:G:,=3C% TI-*\*
MDHJ*N 6.?[ZZ+:M=_+EFH</KK=VMO3>CH]]&H^.C^I4,#WQ\7Z4*RW!3J19A
M=^+#9#I93*!]<]8TN+^,)1<&I N$9HE;1X!(G+&"!-PU;$I"9E6[%.$N%>MO
M1?$,-\5M"(M+OHP H-P98J <A'+K2 C,X ()243#4_"U^;I+Q9#\WS5U?W>3
M64OD]7*]E_G 7? M7#+YY8HFFVBD41+ -4^D31&Y2Y8X2 FD$:C$W-=YYKT4
M#<E_K0R)BJJHYV_$.#^;+=H#_\7C[G;<^ 27!&6;?;(Y$6.S(S(B50&\)\88
MSI@SE/+:9]V/D#,D=[0R,&HIH6).Z&[ATQV\JJRTHLBG,%:74II$O$0G62&(
MM>#H8.G:.\@R= W)(ZV,D^IJJ0:8$3J3\R^ ?NNTU%/?P[?"/2_)K(E+21*9
M<R:69D7 4:&"$]2QVEF4;Q*U#%34]PF5N@JIN=TT9_>2DT7T.4$@V>">)T7
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M3LE3(CEZD7.,F;G:/O&WJ1I2,%T9&)554@TJQPWZZF?-EVN0138B^N*<*&Z
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M%K)(@E)+8KFC+[WB)*2@"(_61L^$3K3VF=R#I6J#*>E:'PF/U'D]2>1]'KJ
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M4C&@7PBE94/O$+I&T%*91_K#@V=5%?6(FHNF#I<IC'N;.V!@X91(+I"LJ<?
M @)Z#Q$-9I%!Z4F>?&W_;C5*E\+9<Q\]]H^SZDKM$8 =25]%<DZ;=BAOR1EA
MAO'27B$0*XTCU"7ADV<AR]KEDLM1MA3 GOO,L7^ K:VT#7A4%^,K2QK_SI2Q
ML5205(Z6>!%3.16-Q%E?!BQ "M;RH$3]EE&K4+H4X'ZP?/H&=-JW0?MZW^HZ
MA:"U,I0+(B"B4(QGQ%M)B5.!"<$@9;XALW8O?4MA[0?+R?>FOWI-Z5$*M]HR
M'D*[:"9Q >FB;>/-%ZZ]\P":R3S=9?+BDO?H<^P"YT._@%'.$!=C, (7B[$D
MHS$O5KQKK&V($C93PZ2)NO9I]&8YW&!MBXR.NJA9 4C&R- I$B(Z^A&D8BXR
MYL)0:EN>MQIDP!B_IZ*D#_4_1S&MHRHQGAC1.6 (*D.I:#"1!*N#2E8%M)T#
M*:9]WA*4[Q^>ZZJ_;WC>5P"?##@A<R*I]*216EABJ0(,+Y3(5/ND=>WV9JO>
M1W[>,I?O'Y[KJK_>Y/B.Q?U\G>W]V5H"'J>@@7*92>;E3H4/E-A@*?YH%<ME
M3'#U1N8]L#&D>IWO"/#/#:@^.WALO?E_[W:.=HYW]O>.MO:VMW?^&!T=[QR_
M.QP=W7.*=Q1/()U-89X/+BY0'B![L#7M5B6^8;L,7YBV-RE?KLE'3Y14Z .R
M"1E5:A5R#SV'$.?O9Y/_0QN=$'J3//%7S<(N[A\DA.KUIJLM+F*$[-W@.64F
M>>*,T*R!2 :26,$U89%E@QZR9*)V8-DO1SV41U2D[E;*;,Q,8)XQ3A)(CN(W
M AV]B-H SI5,.J,U^Z[$?XO!(86S UI)2Y17# 1T?98=K<SB=;%[)5563G;W
MM(A4$(EGVA-/4>Q<!*-E[7BD)U:&).'+0\J;0X['SAEOI<X$N$2?RY7Y?E9X
M=+P _?X$UM':J;/^N?I1;=2JJZ1/XU0!5X.T2%\KVZZ*V<9:,0 N#$DY!B)M
M3!@J2X$0S][(:"FEM>LS>F9I2-F_'WVEK(NH82Z3NVZ3H]YE;WT9751.[ZPB
M3D1#+-<Z&>^LM;5[)FPR 'G>'.0/OTC6P].0U\AE/5@&96,L=P)H(E+(3(+/
MDG A&5/:62-JM_3IC9DA2?EJD-I8<?0W!#H;W)4"*:$%<88%C-ML@$R3U#!D
M W3%R(_JQJZ^'OJT/*OA9Y@&YSRS?3V7;1.SE">)II,9(C/GQ"43B-*@%$=Y
M9SKHM-0=CGY4SW68BV--1 USE5R7]&-#%\>9:Y\BL\0;7_J9 "<!F234"YV9
M$%&*VCV:GH71']71'>B:Z@5_PU]J7Z]T=;7L-LE0AF.(4DLL<*N-9:NU%%*4
M+.=!YWH?XFM(A_A_LX6T*KKJ-&I8D2U_'ULWWW)5.'$U7XA'7GJ4)@(<;8$4
M%*V"]QC!9V.H%BXH?FM7>J !Q :)'I)1^CJ5JQVSP*.QBA*KK";22T]*VH$P
MF:V.OLQMJMV^N2=6AA T#GHI]!M#K@:IX6_:XR#0!Y$"D D7RF&X(('%1&BF
MSH/0FK'O9J<>0NSXMUTCJ\.J_M3#F&(TB:-/G;S &-9F8G&E$F=9 *E#8+YV
M6[^G3#WL.];ZKC"XDM*>V[!>$GWO2BC3 <%8EZW*&-5QBQ(Q0*QPF;@,U(<R
M\IP-)%?]+5:^&[]98C @*54$HHA$!NJ(,XD2H8WQPDG)4ABVW_Q='@5470HW
MNK<-%3S/;7R^>>B;$=("I"4^E?@8<B(V4D$L@,'-5[$0:T]_WDBEW3.WJ!_2
M AD2A/J\([&S]\=H[WC_<&=T]+6XO^M*?M4*:(U[#T_X] IW&5;EI=+]A*N#
MT((YJ5SBC%.BE6.H7^I)*"UL),*-49\8[:'#U=?GK]\VXN*SWDYFD_;D?)&5
ML<S[N<QQ:#Z6,1$R"K3;DH1RR"ME+(T&LD$^=1364J=8[0L32Y UI!U_943<
M[0)15QT5VXM<$/;GO/GK:M3'3<+ <(,V01&5/<50%4U=,%R1Q+40/@=A9&\X
M>9BL(>0R^L-))774Q\FA__2[7T S\=/2)?KR&EDZP+WC%J%(FL -&W='VG7
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MJX/MCM28HXP^1@(^<UP5TA'OG2!)"!VT56B%G\NTW2!T&="9OR/H5E=GGXG
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MDCYTL80U6Q_RK8'T[7B0D)\+99SRM< XK750C27P7$=(0CMF.=G(I=]PSWO
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MP[6XJVDTV5NW-X8I#*19CR(K+VU$H;D*T:*.D<EXOLW VR[EBT=_.]]-WJ1
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MB:SLY3E%V^%I=58\N8;Q^CKLN)0@I:N-H7R,H!S+X%PH@"@4\S&;T&/%T26
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MM6,_S3;SXN3[<8A%@Z3-9AM;'F>T%U<_*G]'+[((WJ&&#:&,?!2>$3 "S<9
M=>*HO9:AP4_E$-R[P]\GX_$(4(L\UUV)??9M$1;X _]P/GN[?NR(UI0J$B'A
MRX:[H0P,H1*B359P*JRGM>.'=7?PXL3]@ +0H"*T[F[^E4:?OY1#_CU-W>>T
M^.5K-T_7X\8OJ+7*:K1+>,0G3G@DNB-:EE%[UBB5E*T^>WW@+?X^$(](A!JD
MG^]GJW],_W,UFHWFZ]=R;;1[IK1*5D(FTB$#E <?HP?'8TYHN4?E^&,Y%]LV
M\EOZ!Q>'NS*N#B;CRW3B&_D1BQ3@\R]N?/_KQQD74GH#1*$*)[1+X+7UH+EC
M!/>HT3!Z+&+?<V^_3\)C$)J[AT,_E</Q\$NH5<3'T*.RF!7JCDH&)(0K/C-F
MF%,$'\G:L<Y'L_G?Q^M)B-W=\V?V/G^K+/^S_"!)9IMHLDRSDXEGR5F"C(\M
MB!0\&(D7":&X11-\\KJZTE4+_%"YN8>6^H,P^]!IN;/I_.)CV=>RI;RB7KKD
M0*480$A.T.#)&KC52$ =G ^=?$3XJ3=$=+;,=5B*YR\+'BK!]D"\GNQ+\XI!
MJ&L0ZX8.'6#TR8GM(@+U4Y@>3GO=@_BWV;<'Y1HR4@;IF2V=.3P-Q: KMZ&P
M( W+-B0:J.]DZ!R:@1L24^OSKP_!*O/M/5+JZ]77%9!,O(V,<-R"P-<K6X>F
M>,I M=:1(1+%.V4C/<"Y7Q8=3KG=B^R3&C2KF(*R .+^O@$D!*8$DP2\X"47
MAJ/J$:T%0WE(7!KB72<+Z2'FW5ST"3)O9YJUJ.1?/./XQXNKA N5O6 $(B\-
MSZSQX*6)D!UC-I*$MD;M9F*_ 'B9NM#^O&B0J+ [(7YN8QP_7+KQJ?MZ/6:C
MPYX:%1VUV,]ABI7V$).^3HZA>-S@8FNR-V&9=H$Q4)HX$,%(<,)GT%1;M*PM
MC6SP_(%'([</5%$]<K'MP]J6>9#S2?COI:=P7?1CK,HI)M3I9$8%P3!P$A5]
M%@RCG$C*3&VWV48PC] -W)S7F_*O]F)4@TSPCVDVGX["/,4%M'4+6RF<I(I"
M)&5 8N*HCS@N(*ILC ]&$5*[NN->(+\EIP*#*MX[I?CJXD.:YLGTJQN'I3CC
M?F^!7.8/KIT\3*%X>]SW(E^<!11P&_!;17EF2C)/;_7RNEOBM<.Z+UAT6G.I
M@=UP$VTAT1H6]31FDBDDJ@D(PQ383"5P$HC)+D6I:N<>;(#R@N6I)I,J9OL6
MK\CY:%[L[[?C./H^BE?N<NG;7+2LLQ(28Q(WF0+X7,;0H" 3XZW)OH8[\-[%
M7Z8SH@XO6@O'OT;S+S=[OYQ/3L;ST?S'>K9W!Z@5 SD]X0T?[*G T&WBT8 ;
ME8,,?2%+ZT2F7J,&;\I,*IW D-)S@>0L/*6!JDXEO4]!<+8$F0XK-WV84%E>
M7H^F*>"OU]W>B3!1T0!E>AV^BXZ"8<Y 9JBJ<Y:-LC7$X==5AXUL-&7.I IE
M*QK-"\5Z;<JO[7=!@T5V0!G5 4)FW)M  3<QN\A$YCSJ3N;-KY_[_-BX+_%J
MF[%KD9JY<3Q.TSGNZ^3O%*Y*FXVSG$<A3=<*KHB"DL!U\3/B)CD*GN%XDSDE
M8BZM;YU3G7C<?<UGRO]&1-]HD=;L8//NY.C3R:>CT]<?3]X=G9^\_G#T\?P_
MES^LT<:FS\?OW\MFY\W<:FB#%RWCP5+M+1?*2:>=85;3:))FU+F+/@OM.?AJ
M/6CI72J&S=%LEN8W.I-J'JD6+D)4B8$0W( -/ ))"E\1QKCIIISU<"5L1[37
M[?4NX8>E7Q<XO2H'YRQ_3./TE[M<90Y?,))2)!HU+3PR:,\YBY<L?DL,?B6*
MVVA,I]NK^YK#.TLJ,O^7"ZL1G5O,??L%XVK,V(713,6(3ZJF09=N'1%<TA:8
MH5:'Z'-*M3WY]P)Y%A)1C]0-?/(AC>=G^;T;7V47YE=3A/?&A=$EOMIG?XU3
M?/7C>#+]-EFV<?G7E\ELZ<3[,KG$]6='TW0^O9K-9XO?O$+)QL<8/WJ49F_'
MX?(JIC?NZ^CRQ_)QGIWEXEMRXQ^S-Y/IUS1=O^OX:C-FK!3 M"Q#2R02@68!
M1E&=J'5<)]+ILGDL.WH6@ONH*-I+1BK&&A9$.!J/4;W]Z.:H;B[H>_1YFA9>
MT0NJ-?%9>Q"( 83S"A5.8X!'80*1S@CF.XGNYC6>CS!5HF.#YA_WO=BKE_H\
M3;]>H&K*\9K.H++%M]IX#\Y'"I++J,OP3:5KZX$/0'H64M&"_ UZ:=P';ZG
MH8F[,&TN,AHP2A"""*7$W5,%EJ,=FI*4 I4\$PT=0$!^1?7L960/)K1H('$=
M3;N7#,M F3-&<:]+HUZJRY0V#S:C*#O-\0:,V:E4/:^O ZZAJ@X;"DAU\A^Z
M6/!G-L]BZ-H'?$)_G$_=>(9J6#$>7_VX^9M%O$1KI2EN PA:CGA14@_>E3+>
MJ).1VGJ\-:OG8'5%=_@H=RW!N)-NU81!#7(_;^*Y[B'^,*)&B?)WT1PFS;T5
M_[:(R1[$'T8L2$PQ>"^!$*;0WA(2O'4!C% V2>*]8[6G:0XE#@]DCQ].&OK0
MO'(4^BAGM.@+H&7,9IVE10QUT9/2O101,<FAA-R+M](&D:DUMM-[\D T^O[5
MAU=?]^7)I"I!&_A[%^_>>I#$U=*Z6D@R<S*C>DP@AU+9JT(&G[,'M+QI"IQF
MZGQU^^5^+,]63:A"_ 9YM/?A6DE_%V2-E(/-J ZC)-3A7@>1V(/T#52#+0@U
ME<HXZR 1G4%(4ZJ2-1X(R1WG(D@B:N=9#RT4#Z@*0\M$'XK7CA:]&7U/_YG<
M=.ES68!<]I4Z&Z\S<P+763N"UGND$D0,'!RW"4@4O-0K47Z[[=(&9_C#:PVO
M&]1BRZ0=36MGK6V$=_[79)U4YS,+-GF@9=?"$0>&9 $J*F.D()[F!Y-8.J[U
MS%F^&TT'&<.U)1WGT]6W;TMWE[M\Y2Z791XIS=^.%U4?9>$VZ4T]%FZ:^+0K
M 6ZE1%$9%)'!)Z:),"PZ%:Q,)GJGHT@A;TN)Z@&A1AQD(;.OTRQ,1]]6E%QY
M;X-()J7@@#-2A@8Z LX* UH9%0U3B5:O'WX 4MW\F(^E@>)9_G.6%B;!14K1
M^E+OXCT3:-'Q4H:K* 2F(F7*!$UJ^_*W CK$#5E/(K8GS.Q#^^:)4^]&SB\2
M(I9#%><707-G?8R@%]D*Q(O2(]$!VO<R<ZJ9)[*I9-Q&])Q%8R_J-S"9-J [
MG8S#"J"7SDIO#"CB.0AMRG15:H$DP7GPC"I>.TSS(*@7(2$[\J"!TV4#P O4
M?;2UN-_2LZ34Q98,]FSPFHM:<VE$M+7[8FV \B($HA>]&R0>_0KK5HOFCZF0
M;?W+8GW0"V.2, 8WK0(E: ]:"B[2#-$KR[16+NO:CMJ^&)^SX%3F4(-DI:UX
M7X]F87(UGI<<O%5JYP7/B5KE.!"D2:F92>#PC430L6Q%62':/D8/8WQ!$K4O
MAQKD-=U/BV4\1 3C,[$,TB(SCVH+QB4+,1##N2?9J]HFT!8X0V4QM92.6M1^
M+-E+'Z83E/?YC])39'XT7DPM^+;L+_^S15NDG%'#(*1%::#-X'(N11%9,((&
MG=*UKZ .L X5B*PF ;=;L53F1 /3:2/$ G#=];$#Q$8QR0[P#A.<K,[:KJ*S
M)U\.)$+2\&#+,RI\Z5Z51 #'C80@0D*MWQ@MV7,1G0="F(]!<OJPHX'$O+H:
M7494QU;A%V.CRREJL)284J<NP8CD<<O4)DL95:;V),M?$0RO[59GTJ0:A1OX
M;O^9OHS"Y74G,BM0C68Z@K0LHKW&&5C!.61+$N=662YJ#Z[^%<'SX_<>%#YT
M0//-U?QJFE93#Y;AV66SLS_'B.97TVW6)K2Y$X2F0<[]B7(KW,E--DJ93(23
M DTBJZ,16GHG<ZE[WQKNW E,TRX10O"(;V$ &4D D74N'A^\U+C0VFEI8ZR=
M*]VF2\2V6JMKE^F*VK.E[ZN0/+\9S8*[+&D-%UI&'30-D%/IZQ@E7AN!A^*Z
M,#PFQ:VKK5KMCO;1%<CUD:0N!7(-F-8D*[D#\M=7Z11OD?._TN7W]'XRGG^9
M762A$C': --H$N/-(< Y&\%ZQ=!(UGC)U,] W WKRQ.U?1G6))FU&^YR*,[_
MFEQP$C2S4@%)^$5(P<%8HX#)0#V^9@2?\P/)UPKBBQ2K7=C3)&^^!UP4CW0A
M6 J>NU(NH"F*/\E@@\J%.%SA78LGH[:BT!ODRY6HWBP:J!'%)L!O)E?3"\&]
M5\(9,"KB&;",@ ^+K 8G@[,JTEB_<*<?QA<K4;T9-%#OBHUX1]_31<Y.Y'*+
MEASF8JPC78Q#6DF1$E4,Q6&(5B?;,+Y<@>K+H&;1X(?Q'N5YFEZ#]H+JTL(%
MN(JE,:<KT6N\5IG2AI=T=Z9J)T3N!/1%BM;NK+HK7VHH^;I@U"@CM =#2STM
M+68$-QQ4"$IXEYFT;5(/'L;V(J6H%T/N"HYN*CA_CN,JL2;%D[\#_NG1U_+=
MA25!!8L7*<MXD0K.D3(V<]"94V]BC,3%(:5H$]"7(U)56'57ODRKC%U-DRH.
M-& N180E*'@O!5!&2Y-CZX/4E27HT63L-I21&N2^*P6V<>$'M3I3ZS18$TNJ
M7IFQ%@G*J+"!914EI<^]\&-XF=B%^/=X%UL5!=TH.HC*QLRR .)+98KC99(6
MOI/<>.<RR<Q4;Q/X" L_AI>0'5EPCY#L/RVX2YL18R(J33( $TH5&X^#7]AX
ME%OC19)<U^[ _82Z!.XC(-7)?^@\V])LZ'BA+4V_E;Y%96[?(FO+14FT1 (9
MU)*02L&!4T$",]H[6Q)N8J?@Q0.]F^Y;^U&W\.G%W$E%(E=NV?4Q?;N:AB_N
M1AOEVQ!7J3Q=0%:<4=<9V/#3Z?;GX60H!AQ,6JS)I+2I0;4IEEFN&A5L)<O,
M-6.=-%0GURE(];BE9,LHN@,)21^ZUV[N<Z/QW>@Z;8]39J16 ;(O]K8I\\9=
M(!"U)YIQ;[+H-@/FOD\?=E95(RY,:I*P=O>>\R^CZ2TXTF:&FA(#W"(!$8C&
MS:$>Y2SB]%HRRU@GCM[][&?'SSW)-T@>Z]'Q\9_O_UPD2)Z=_^/DX_'9^P\?
M3_YQ<OKI[3]/WI[BMR?OSCY]6JM%DWS\I<SSG8W&1R%<?;U:2.S9_$N:EJD;
MT_2EW([?T]LQKI#\C_+#R1AINT>>Z] 0]\^#/2A1;^7))E+,44^MCE0HH0R:
M/IH1F4(9B)KTQ=!@][-].ZSY;C*[8>FY,CJ:9@F*E0GS(1APN'<@3!,5%15!
MU$Z8Z8MQ7W_ T=GQVZ/Y?#KR5_-BGYQ/\-)!BI^F^5D^=W]_G%Q>OIE,RZCM
M"T=5HM%XB%'C<Y)] %^HXPU:+<P*1W)MMT />,,[DIK*TVW/02M&-4BH_32?
MA/]>#6 JM1WS'Q="4^%=]&!2H&CUI@A>F PRJ.!Y"C:1ZAZE.R@.("&MF';;
MK;0?Q5MT(0JC5RE/IJA-A$LWFXWR*"Q'LZ[W?A]=+O"1*2WH&-K1HFBL.8&A
MF>.79)(6+E!9.QZZ&]+G*TL#<*Y!-NQML&^0?D>3,%H%9Y9-+K=N(!&;A->\
MI)NXTAM=@+$1[^IH+:&4:$=K%U[N#?KY2N&P_&S16FF+1K#&_6$R77#K7O@"
MSPQ3%"B5M'1=T6!DSL D2UYKZ16M/@5U/\C/5QB'Y&6#)-Q[M .6+#%!FH*#
M(S4H!<,Y ^F\"2Q;HJM7F3^DCS6SYY9Q%ZXB<X)["*XD0BO#P!&6P3K.M4PJ
ML5 [-:(/OJ%BF\/:+*T8=.BHYT^9QKV5#UH*]+6_8K9TV@L5DHQ(L*"1=%25
M6'\(D D/WEA!9*Q='[@5T*'BHNW$X(X95(L=#2RB6YC6L;D.H!JU$[H7T&$:
M"%5DW*05U0<3B<Q1_C550%T.('RI :-"@#-1*T:\BKEV3=6 HO! 0Z"A):$/
ML1M(0(>K<17]\=I)+KT!7IY@X;@#YUD":I+UJO0.]K4+HSJ#&U[SK\#,_KK*
M#IQHX%V] ?0/W/3*!CEVLR]O+B=__2/%SVEI=JS@9J^\S")"IL7PH3'BZ3$:
MK1\TB*0,E.:&08PN$!^EYWX79F\6J>J<:GL7O2X\2/%5&N,_YJ5/T^PH_M?5
M;/[U)]H0'"-.:\C"IC(GILR@*91)D3!K:+*QX874 >$+$*O:?&K@F+V!=C'.
M]'+ASKN#DCO)LO<"HL(#('P*8+WTD)/RB4C\-:G=N*<;LA<@1;7XLM&+>H"D
MDU,W+1FXWU/[Y)$[2PV6!+)]D[>;G@G/F;54^FA$9M(EG;E/$=E(BB;=-9GC
MSJ(#)V50!$ZYEQ BRR!BZ42N&%YJG"I"2V135L]"&#@I8__@AV<1Q3AK4-Y:
M$(4^/F8.-@?A1#12Z_KSLY]>,*NE[-6/:/5A:EO#XV$W7C0IXR.4P&EE2G.D
M!)9I JAYI,"(<-35]GT^"W?[/A+6C$&/Q=V^W,.UB^C=9'F2EEVB&3722PI!
MBM+HQJ'9SW4$(@RG1!#!4^T^NEO@/ E7>R\1F+1A10,[=@.T=9_X#N :.=RW
M CN,X[T:&[N)QQX\&%Q0K-;<<CP85*5R$], +J-Q112E,1,N'0M/7T ><,<?
M1C[ZD+Y%[F*Y.4_^_H8TNIZ#38F227#D66G[X%0&C\8P!!^CX-[@O5E]+MX=
M%,,KR!79=%]*S>XT;J#>OBWU.VDV_]7#(K@E6DN(2B54N:, [Y0#A0(>&+76
M^-K=5>[#\9PXOS>=&YSX[5%'%BSW+J&>Q#3:704F7GP:.(M&6]36F:C=ZNOI
MYW'LHUS68T<#A_;]H<<NH%YZ'D<OQG6*WN]"]<'R.)0(1G@70)#(2L6G L](
M@*(;,:*LMK*V OE4\CCJ2T(?8K>-G78*]5))N$@T0\I&HJXC,Z"^$R%[J;V2
M,B97NQ/3HP_*5V#LG@'X/ES9J('6#'9].OGC_<GI^='IZS].SO[X>/3A'V^/
MWYZ^.?OX_NC\[=EIC2!7WR7V#V[MM:G;0:U$;.!2*^F2H%2;S%T41*-^X;Q6
M[J+O8GOJD4L_Y\?TK50#C#^_'>?)]*O[=3PK3<0YQ@7$HC(+E&NP*J/Q++R7
M$C5>O %KJY,=<.U[!9Y>E3-TEI>+%!UPM>KLPBHILM495)2R[%B"#Q&MA^1%
M)E0K96H']S>C&?YBJRX5M^^Y2J2OW0)DR[[7B#],)_$JS&=G.:-1&"\4=8$(
M$T%'RDO1%@//+=J!)B7AB&:4BH=NM!W7?D9R,03U6UCAU_W3MF!_]6/URZ69
M:;VWGN*3'6)&^;:H1#J#-#(^"ZFR"C96OTS[PQPJW-C\IFG-HL<2:;PV7UY=
MS9!PL]GZ0EV8+S1H0Q+18!,>%B&T >]U *Y="C;;TKJ^E4/H/D"';WC82!HV
M^87VYDJ+VVN)966V= '3R!_T"Y #^X'V9]1M$=B;RLU9CV9C#HY3H)*7<88V
M@2LMXU/63FF;DZF>>S4 R[OZ>QISO ]Q:[<I/)[$KV[\Z5L*(W<Y__'I:OIY
M%-SERGE 1$C<)('ZM2ACI7,":TI==4PL!\43O=V(?X/JNG69@VFIN]!_TH1X
MC\+SDN:?W&6:N7%$)3J/YO[''>.KH5.FQ^KM_36[DN*V*\=YZQB:&M(JP:DP
MR4ANHU2I],X7XD%73@\< WAYDLN.<XEFE"Z-WI-V8"WCX*BG+);F)*SV\,XA
MO#Q;UKAN>OTS%'CD9_.I"_,+Y" >\*! !OPB3"A5W<J#LT*(H+0WL78<?3>D
MC]0+T$>:-CR@+5G6(!WC8_J>QE>I9$D?HXU7(/UK-/]R?#6;(]+IR=_A\BHB
M\M);'?\?S]W?%U(&Z0CA($WP(%@L[:<TA:BCIH0IR5/MRND=8#XJ$:LF 7>R
MW=NRKYT6?Q^5E@_*+\1AI4L%8P0H5640D"1@/==H&U'.O8A"UG<\]0'XJ*2L
M^46V)X-:)!'>/5@7G$<345V&$#4>J*0X6*(4,,M=9"X(X6LG$MT#XU%)QKZ,
MVS2 9T>JMT@-^%HV_>_E;9O?CN=N_'F$*NER*,A%4LD(G21N3X9R(&*Y9"-H
MBJ:/=E*Y4#NS=#NB1R4>=2Z.BBQHD%"VBQ>5!A=+/P#P^!27LEP#/C(+'FTH
MKWR4N7IGZJ<>]MCKY6G,HJ<1]I!4,R&Y!&X<P1U)!X[Q -H(RDO:5JC>2>39
MA#UZ24.OL$<?KC3W?7<!\U+#'KT8M=4)O@N5V[.>)Z$5OIW,E'Z[CFIPVGF(
M*/6,99M(J&U\/_:P1T6.]R#NL&$/3Y*53NABI9=Y=FBO6TLT4.&%UE0E?KO)
MY5,,>_2B?_>P1Q_B51_0-)K-KM)Y"E_&D\O)YY]SAKS5UC@=H,P; D&D!$,I
M \J585XJJ[CJQ-%-*SQ99E8A6>7)>L>3\6QR.8H+I6.AZ2ZN'L,X(ZITXJ=D
M@8B#MS*#LBXKJGU*HI-9^>#XS?M6?^Z*626Z5[0E[T>TDO<NF"H.X-R$XQ#S
M-O?GT5:6[T'@YM? NGY",<,75=JQ],3D&;')F)!EE#'AN<RI4]_S1\7TK>,S
MA^%Y'[JV="^O%<[52\2<%<$57Y9Q"??)&#AJ)% 5LW(A6&:JCXVX'\JP(QGK
M\&F3-WD/(C<(C1Y/IOBLH>%Q.AFOD*T[B+(R1Q[U$%]ZWPKF-7AF-22N!3<T
M\$QJ!Q@V@GD&_*]#Z$%F<3Z0'',^F;O+54S6_WCO_FLR_2--\%.^?1F%HVER
M[9*5.B_=/%-I-R+<2E/21C&'9U_X'-"VQYO 1NT$#5*QI )]*$VI,X@!<I18
MX,HI82%91O >HZ3,Q,&C8ICFT60?2.W8TQ Y2COE'N1H;#1H"69;+'$>P7.G
M0"=EHHVH)KC:"4I//75D-SFJDBC2@UDMYEON8&:&2%G6)=RD4QG_S!+8S/'I
M,!:?(:T%D[_KE.I)56L6'3I@5U2>:]_SS_?#72Z,G2RE6G2#3I&7Z5Z6@%52
MH;'CA9/X2RXZ=9YXP.;;". I^7]Z<7U2F_J5O0"KG=V$M!Z-T0%411_01B##
M.X$J,6K2BLJ#B0 30CB7\2K-K"1 1'PULPN08Y32*!\CZ12@>URLW^(*&I+S
M?8A;D>-A<H4ZTX^+/S^A2<H2*6.>HW$11"CY+9(:4($8%GDIH]A6<#!+X3\^
M3[[_W]4G+CF\^N8G@W^N-ZQY7XGPD[VH5E&5+'LZN9I.OJT;X!$KE$"Q++UF
M @B;)#B.#Q(+F<MLT<),-9[LFVL^90[N1;_*-^[1;.0^N% :NZ_ .":XIS:#
MR8N1*PC+96;!,I2I*'G(J5._DP>8>6?AI\[1_2A9,9RVB/9^3+/Y6?[7!/7W
M-9IDDHU90Z*T6"1,@&,9=44=O"6>.>]N3<W=$!F_\]%/F7,5B#7(Y)CCL_?O
MWYX7W]RGH]/7QV>GYV]/_S@Y/7Y[\NF-&TW_Z2ZO4G%!H+F Q"D.Y5%<^/_1
M9G"7;AS2#2MB#W]I$QS[.T_;D^=VP:?$Q]7;*)2F@C)A58[<>D54ID[F<-$$
MT7ZNG^MUWXV<'UTBE4L.B)M=35,\&W],X6HZ13BOW&PT^W,\\;,T_5[,S+?C
M;U=HC8;)..!_=<O10922:(-&2'C$\))CJ(.0R$$[Q2*QJDR"J^P;:K&/?=UJ
M%3$=N\MPM9QH=7,&?!36$:\-I)!++T$; /5] E(YK[5"@T#6GA'1?%/#NX0/
M?@9N._L>E^ T<#A?;W"UJ_)X%R?YG<W,?MW-[->]K\GS8_%9%\70E2IQ8)E(
M?*#1"'9Q$<-D)G!5DI]JIPHTV<B3/@$U!&[3<3B8M-3.0+YO1W]UV-'U%A83
M#G.:SDJ8Z=UD_/D\3;_.)ZO16Q="RABS1VM1VT4[8@L>U5?@W";*LG<FRDYZ
M?6.@OR7]D0I%@ZK 74_QAD.\[G_\=ESBJ2F^'9^XZ1C_;'8AE->4*0**E_PX
M+9 #%JTU2F)P+"4C3.T^Y8-M[O>)>0I2M='\?VPJD[:>ZM*<0O,RH;M,.[)!
M>[ Y>AN,T"381W)4>JA,!S75EE%8'70(PBYZNSL0B7@PO-3%V.1IR-EJ77M<
M9.T]#)4[\9S-K_["<.A$C#41UO5_1^%_KD:S)>-+I#$)%JE0 HCS90R.=6!H
M"B 3WN T<&YL;2-K Y1#)64<5CPF]=G4()O_/ECEG].45H[Y+@ ;%58_".XP
MQ=956-E!//;GPT$$)@NNB%%XHP=*"U T7RR>%VJEC39*:7GMA,,#"<H#)=J'
MD9,^Y*_M+CF:_O=H]FHT^11&:1Q2T<[_8Q64,YI&3VR$K!.^\YI:,)DI5&"%
MMEII(V_/L=S@Z=B\QO F5V5N3.J3LG;M]NLT_>K6F%9XA'?1*EJZ&%&/>!@!
MIW"/^""*P$D.6G<;G7'/AS\KGNY+O.K']3A=KAL"R$P-\6@KZZ1UF78E &\C
M!CR%I(@0WKIN3+SQH<^*>;L2JW9RR+J1P]OQ>/)].1-Y-IL$U%,7E\3ZCJ"6
MY1@M<&89")$,.!XI\DL6>=/<,M>)G9V6>U:,KD_@EEZF5S^N'2S'EVZVZGKO
MT$ZA.4,TI:FY8!0<$Q)L\)P'1>2- =FUG1KW ?IM 59E64NG__Z4NKV]]<2,
M#AML9$<VW]QA[-"* M7.L591&AI8L^TWRH@(!/]7QN )O#$<+V,K&+A LI!>
M%._];W'O8$T_96GO(P3UFZC=FZ=XC7.=QIXHT])S,,HB1,XDOFP(EG(2A J!
MJM M$Z';>D\Z/%J#RY.V+&J9"_;JQ_4__S%"K-/PY<>[]#TM*YR42:5'/X7L
M70;A8REPU 1"0A5)1:^<;)93NA79;R6T#1,'BJ'/[N)=-UKI +:U9MD%Z,&U
MQ&H<[Y#;49==+56_3J"3=I[+11$0MR!<9."%,>"=25PEO-GI$"FK \M6=Y7L
M<8A6'RZU%*EE6LR" GS=N8M:JV168 SA13D0X!0U0*FCBM.(EW?M!EE;X!Q0
M_:K/R$TBLR<7&JA0J^*@3U]2FK\K?[T."5+GI"7<@"(>CPAU!ES4'F0R>$AB
M,(355IHV8?FM)M5BU%T!$BT$Z-JC\C"R5GD:&U$=*$&C"O<ZB,0>I&^1FK$%
M(964>N] >9% :,_*5:HA1*ZCC"(9TZD7ZR,6BH>2,8:6B1X4;]&E=?XE35<%
M!;]<J(MGT";"$A4$];"2(EU:4UKB%].I3/82T59W2FX%=(#X827.W>[;6HWL
M#;2/!;A3?"<WX?-4"A+P  2%( 6S%JQ&E=T$F@.+EA-3>\S.0YB>EV34(OX@
MC5VW%,&?NFEQ47Y/;9H1W/GXICT&MF_F=A-6G4Q0B1.BA,@\XBE+02E/>!+<
M>[6M=<"=A?8[SJ7\Y=IS'%"0WETGU0=!DW)9@ RE>8E@:/ (+8$K;XFF*<98
M>R+.9C2U,DZ/)U_]:+RL3WK 87ZQR/PP2H$(<7'31O"H?X&)CGL20XY;6U+M
MDX/: ^;PEULEF=F4E=J*12U,\;N0BQ'Y>3SZ=XIO(^(>Y9&['M6X2BZ*1^-X
MX^K&WUU]3?'G7G]NCV=/F @4I%GT$ T13,X>B!;6V$Q)MK4['#?>TG.6UH.Q
M?B#']OX%B-F(H#VQ0)G"XVJ5!CRE"70FVBAIA:C>X/^9]&QH),6'9W.#-+0/
M[D?9QYO)]*'WXPV>7-S4^/-10)5J<20OM!9)6:DARS+4+"-NPV@&Z74@T>F4
MJK>ZW@OPLY'%X=A6,=B\2+WHKKF<7A72GN4;;\ %"PJ)%C4P+S0(KPQ8/" @
M'=&>6F5=X _90?O#>/)B-# G6OCE.X,_0AL0?[H(?WTL_SK+9U?S,C)^MHJ$
M??YR$0.-W!("/)N,M[ +@#NRH)S5TKB4K*J=OUUW!T]>)!\!8^^*J3R *;UN
M2F.B2IZ2!-Z0B)<T1R*Z,JJ>*,F%2%J(ZA'*G=&^0/';BV%W14WM*VIW"+(,
MRKH4 _<9K^C($%5,!*U^G< 1BD93])RJVH&H^Y$,U32CD6!4(.]C;V"ALPE<
M. /$E;0AK0.:T91!5I+Z(MQ!NT8WSB-I8%&#R1W;4/0A]D&Z"G0!^+L-16]6
M]FXOL L?#B(P40GOLRCCE7.9M6T(6!T#$).--RX8$6O/57M:;2C:RDD?\@_8
MAD)SP2QW!$A2'K4B2L'3Q$!)D;S.U)ET*_/A6;2AZ,6-CFTH^I!RB#84.0=.
M:>F((;,$X0GBX=R"HUFS)(PP7G5B[1-I0[$S3_<E7I,V%#\KZR6+1$CO2^XO
M1[78*[ )=6,5/8V1&Q9<MTJT7S_W6;%P#Y(U\-IO&H7PXQP_8-GRB*$UHS/!
M%R;H$E8@"#65-!<T= )QQ+-.<VEZ/,8/@GI&6GU=!@PG(07>.N._ \!&^OV#
MX ZCWU=F:C>1V9,C#33]AX%&9K0TUH,WRN MBO]R1&6(E"OKK.;6U,YV.I#(
M/*#I'UIB^C"BMA+Q?G299O/).*UBD6?C]8"V1'%984LO %/:J5L&UN ]:ZAF
MGE(;Y>T.OQOTB8U+#*]:5.;%I#HA:RO\MU&=_S59-V)B)$1-)&CK:&G$5/H\
M.0%>I4@(<3%U;%RV<8EGS=[="%G[]**%^;HT<)]<S5>X9FX<WZ<X^H)0?]SZ
MU0IP9-(;)A20G(K&%!BXY"SBIT&J'*D@W3B_R^K/2BB:D[^!2KFQH(=Q&='H
M49#E(DM?12C!532&J%*&9TY$[4RUQU9+V2)P4(/<#5I%;"G7Z(+LI5=$]N)>
M]^JW74@_;$4D8I VX!O'B>1X5Q)\Z#C3X(,GDAEKN:Y>(?!$*B(;R40?BK>J
MB-Q6@&5*W^W((P16;D>6.!B=)'"MC3<QE_DV+[GZK1?_^E:_]2%^;=OB*(3I
M58HG?W_#DY-F1^.XO8Q3Y9QYR!ZHHXA51 /.\8S:<M"1!=P!Z=9;M^?"3UX:
MFE.[937%]AXW(I8T4V:!YJ)Z\TC >:6 )L>C-#D'WZP_T*/L>M9 !6W B@:I
MP/T:W70!^[MW64V.[]5@:A=V';QWF0[!B)0H0B5E;)_*8(C#;X5-GD5EJ1QB
MS.*3[%TVG&CUX=+ O<LHEYSJG$!S&D 8[L$FZ2$IQYS+/OOXNW?9;HSLT;NL
M#Q?:MG^]I_^RM]DZ&3AHME '740M37O0.1+%=#:9UBZ]>Y03!]JJ/7L2OD%%
M2?NNRETV^'MN0+VY ;T$:O!.ZKM(PY.<&Q $(UQ8 7AS9-RH5V!X2""M(5ZB
MN1UY[?3E)RKN>\T->-S2WD<(#C0W@'J*_R'/$'-IX\)< AL#*1 S,T8S';IE
MW;[<N0&]N+S#W( ^+-JH.&[H++;Z<?GBW2S]O__SOU!+ P04    " !"@YI6
M*/,Z =4= 0"3J L %0   &EA<G0M,C R,S S,S%?;&%B+GAM;-2]:7/D.)8E
M^KU_!5ZUV726F5#)!23!FNX>4VQ581,9"HM054Z]M&=N6"5VND@UZ5*$ZM<_
M@(N[2[X!<)#B3-MD*202N/> /,1R[[G__K]^W"W!HZB;HBK_XP_AGX(_ %&R
MBA?ES7_\X6_7'R#^P__ZSW_YEW__?R#\/V^^?@+O*O9P)\H5>%L+LA(<?"]6
MM^!7+IK?@:RK._!K5?]>/!((_[.]Z6UU_U07-[<K$ 51_/*O]9\#$3..)89)
M%'"(LIA DO,0ABF5-!0LXVEZ<?/GB,8R".(<HA!E$*6,04SS!!*&<Q92J5K@
M;:/+HOS]S_H_E#0"*.?*IOWG?_SA=K6Z__///W___OU//VB]_%-5W_P<J39_
M'J[^0W_YCYWKO\?MU6&>YS^W?UU?VA3[+E3-AC__GU\^?6.WXH[ HFQ6I&2Z
M@Z;X<]/^\E/%R*K%_*1=X. 5^E]PN SJ7\$P@G'XIQ\-_\-__@L '1QUM11?
MA03Z?__V]>/!+O.?]14_E^)&C^P741<5_[8B]>H3H6*IK&];6SW=B__X0U/<
MW2_%\+O;6LC]S2[K^EFKVLI<6QFFVLI_/=39SV>8[\G>U:ZM'HQKW?WLR\9C
MF'[V9NZUX@<QOL%;W9QM<O= O2_Y5,_NNJNS31_?8E^/1;4BRPD>BTTW6R8O
M]2\^J9_Z;G1#1\BT[:>G[BU3Q8^5*+GHV/)9TZ#@__$']=/BH8$WA-POWCPT
M12F:YI+]]T/1%)J\+W\4S8+E09I%(84X#=7W"24"$DEB2"*:YC(,>$KI8K5^
MM!>BA'_[-EC1=F74SQ\L_%P=>%]KT50/-=M\Z>Z6^SY?ZLNEOW7XYY+<B>:>
M]#<H8_6DH+/_/P<SP9:=X#=MZ?_W[S]O?'/'=3D56LOY 56Q9^8L]62AJE_"
M4#%3&#;O8*,\:#&0I*&M$WT3"I H^EDL5\WP&ZA_T[Z(IWKY>6>4+^O! U*S
M$X/07_$SJ]0<Z7X%GXV'GE-:N;JJK!Z0#F!EPA] 57-1JSGP'G=V'MJ/)5/S
MWT:\$]W_?BR_K2KV^VVU5&TT[U57JZ>OU7+YH:J_DYHO,(HD3J(8YDF.(2(4
M*[H0$H8X2'& \H"+W(8D+/N?&WD,YH.?!@?^"(H2;/OP;Z#S ORF_0"](Y;<
M8CM,9IPS(O@C<]$(N%M3E2-ZGBC,MO=)J<T1FI>4Y]J,&Q5^4N0JQ-6]J-6"
MMKSYI'O\5!!:+%4W7\B3WBUHWCV(!>59AE 80($3!I$,),09"6""6932/ NB
M+%VLUI.]DZ^A:<=6Y'=@2NOS)6SGL^"N*(N[ASNP;-_'^]Y<.WHSAMZ,U\8
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M;\'$$6C.$.U&IKDWY9")<%TTS8.X%NRVK);532&:_H.<!9)'2$U?0D0"B*C
MD"9I"%G,$I%S$N!8&F<?'.IE;J37V0FV#;6(BC^(Y7&R\H;0R'2T!QR7W(&#
M*%GD"_A :Z(<@:MZ=5O="UZP+G#("46[;(%3Z!S-$#AX\W19 :?L?Y8)</)B
MQXWM9]FLOXKBYG8E^.6C^NV-T &:U4.YTJO'+T(]*/J@+XL"GA(&N92*+Q,4
MP+8,=93%,H]%$F,<6&UT6QHP-RH=+ :D,QGPWN9V:\IRY]MV, QWPD>$>.R=
M\9=I\&NX>_/!8'^[074!>A<\;I<[@N=K^]RV^VFWTQW!V=E>=VW'QW;[L)>L
MV]?;'(+WO:B^%R@)PT!KT"5:+AY))"!-XP!F6D)>A.J7=N=ZYEW/C>C>5J4:
MCU6[*BNKE1:F+;9WX<_9>C\Z!"Z;[[Z G7K[?7VNT;%99SK8V#[6#KP)7J/L
MP1_M^!5WX4T .;X/;]3"N=)Z[T1=/"KF?!2;CIN_J+7RIZII/I9MO_IW5_)#
M49*2%62IK&AET!4H&R4WQF4<:)6](%=<AW35-DPQARGG0<(1C]5_W43W/%DX
M-S9\+Z5@*QU#NG%PZTUNU*^;XJ9L7U_2@+>DN04?EM5W\%?!;]12J"K!VO5&
M-]-_ HT%E,9[%LSX]E5'>'1:WC>D%T [!7[2;OUQ(I$_S]AZE__S9=\K"0-Z
MAO>P9*#OCASGO>N$RRNY'3;\52PU4;VMFE73UF>B:A;.AQ"[=:)Z2@,IHQC#
M*,(4(DIRF"?JFY&1-,TREDB9V*7VGF7.W+X(K:6P-17TMH++NM;G?;UVL9MT
MP)F#9CA[GFPHQCZG;D?AS3FC8#^5]@*>K^GU><9,.^7V MS.--Q/JVX4>\EY
MH3M3_$T*_K%\2^Z+%5DJ.^ZJLBV MV TC=6P82C#5 O<BP02(@5$4N8TRM(@
MBJD-C9[N<FY4N;$8Z 0YJ&95K#/:CAH-P#:C/[\0CDQQ6^AI:W5R0V_O!>@L
M[NI@^B,X<W@\D9A!AY,2E3D +\G(XDY'K= ]HJ2="NEU]?['2I1\D29$I @S
MR)&0.F OA#BE'&9Y%DF)B<QE;*40>K++N1%.7_9%S:>!: U4LX.E-MM2%O0T
MUF9\XQ?!D?GFH"1Q9['.L^IL]BC\:8R/+[G/TQU.*_)I#,".M*?YG:XGQKHQ
M';[S0_#KZJ,^EJZ;]__]4*R>NO^VU6<$8SRA$BFLA0XUS#FD:9)#&02<Y%G"
M);;:433K=F[$T[\BO=GZ5>D,_[<&=$8[%?LQ' +3TV'?P(Y^)GPFI@YGP#80
M>3OY->ITXO->&R!V3WFM[G96QBA*P=^(4OVPT@GQGT5?KZQ@_6_U$G"1J8D/
MB7$*>8;4XHM0"4E. B@XQR$-><2PU:S(M..Y492R$MSW9@+:V0F87B1;ZV*8
M 6]ZGNL?SM&/#5J306]=JY)Q 32^@]WK/VG+P4^= /?ABB0N$AI6H/D3TS#K
M=FI9#2LP]@ALV-WO(I ^R/!MY=1\+U:W?RLKVHCZ49\Q?2SO'U:-EB0JM5)[
MNY<U* \]7=>D;*2BB0_*_Z$R^:KJ=8@6,@]2@<,44IGE:NF'"*0!1S )HR@B
M6%=3,\H7G<+8N1'CVEH;P?"1Q_,X=\YME$;FVXV4Z,6SG#3M+=AV%W3^@N<.
M7ZS%ZYXNP-IIH+T&VFVH_=;3R][S&3T&-I+S\WD<IE*KG\EC82E]/\TX'5?-
M']F&"07WIT'SN5;_1'TZ3#/>W]TOJR<Q)"$G7"01I1SR-&8095$&<9)ED/(H
MY2F+DB@SVIO9T_;</N*#=38?\1=H&7QSW3$8^1,Y&.:2P/0"!HMOCCL<$WTB
MS&&Q(_']CA_EW!>W3$>1^VU]QF@'+G';F'E;E>T!^Z^*$M\^-*OJKM="56RH
M\SP+6>A=(?4O4;1<N8AE(F0:(RA$'D&4\A#2,&20Y(+$C%(F4#9H"EZ;;]18
M&V+T #]7%KR><'U2=YN@RB<N0+VV&NCQ!JQWMI,Z!47)E@^\E20$5-P49:G/
M<RH)5K<"/ E2O[C!;@O(?HC-]H+&&;%I&'BPO9M^#M9?=(GMK=;VV@,]BAL?
M_.T*.</G:7O(OO])]XF<X7FY8>3>D!NC?A6/HGP07X5.CE?O\5;$Z!5=%C?M
M1U2K3S/-2,6=NN1*?M,Z+E)9J4\$VW<P(#)(PB2&B.F*+3EI:397/^4X2#(N
M8CM1$#]FS6TBV7NEW]C>+[#E&-AX=@$&WT#GG*;7;??ZT''+,S]/@VU&N-,/
MX<@L/.'H6=.S7[ ]<;8GHR8E<K] OF1WSZV[4?YGL>I*>NF\@460I%0D*(,Y
MUN7Y\IC /"08JF5\&*1I1,(,+U;5BBS-F/M9ZU8$O.YCW'/*HK7.CCB?0\:R
MD*5(YE#02$*4$:D@RU.894B0+,Z3G%D):+I#-M'1[OF0)6F2A''&81 F"*(D
MQ5"!%,%(K<4($9S* "\>14VKT4';[F7NL)E]:9VA&/F#J3'HBSGV"6^7JU5=
MT(=5N[94*Y4OQ,_N]U$D/'W-GK<]Z4=IKULOORW[+SHG(+B-^WLG&E87]YO9
M'Y(9)PP3&(<4Z2H- F(>()A2$M H9R1E5E/](WW-C0N'*-8^=G7+7+?Y^#&8
MS5Y]3^"-3 1GX.88]GL4$:_QOOM[>H5 WZ,N[X_P/7Z+BT)>OYU8U<T@7:!^
MV-ID7&>F#@I]/XJ[A[N/Y:.Z4N_9?U)SWM6"\S1!- I@*!)=""%3LU,==I)%
M$>%)('@LS2-._-@T-RKZ)MA#70S2\>"^KFYJ<@>JAU6S(B77BTY:U77U7?W4
M7("[SBFPU+[8"-#Y&5"#XZ_IAVEDTMLX]&_-6I-%_P2V-]W77FVIE'9#M?$,
M?'J=4;,1&9Q\]"8ZY9ML%"UE"[WB?5SDT$]7$THB>L7FN8"BWZ8=E7O$C6[J
MJ[C7M4/*FX]ENX?4UFZK*UFL] )@G;NOPS&BE&00(T(@PHQ *I%:>2>!3&@2
MA-QNL\*J]_E]-5OC06>II4B.%>QFT_?1P!SYVS;@N#8<;%E^T<.[5KD902[!
M"3A?RC56?4^K2N,"RX[BC%,CCE('Y:K@Q?)!J]H,4UK1O/_111CH&#:MOO#0
M?>6OY'M2ZVWSYHNH6_6%RSLMZKB@<9[I343%<8K9$(U#2*B,84"$B&,:L@!9
MB<IXL6IVW*=-:X#HO1A".]9^:(FQU:TH:B Z7;+OU<.2 ZI+;6_@ #\5)6C:
MI@[GG(PXU&:\.OD CLRWV_Z C4/@_;/!W/))GS@.7NE32M#Z=0$ZSSRJ.O@$
MVI?P@Q>;IM6&\ GCCGR$U\;= _=4H^JSHGYJ"M[K%+YYNE;MM8G&/,YD)),0
MHI#D$,5<<3BB!)(HR .)U)^)E:+-R1[GQL\;@\$SBP%] MIFIRSOT[B;$:I7
M-$<FRW.!=(J-,P+'8RS<\?XFCWTS<G]?K)O9C>=*W/Y"5CWM7<DA*4(K[;8;
MWAO5THSQD&0HABG*)$1<8$A")B!G:GZI%LH9E59U"6P-F!LE#?;KV<00F/A
MEGK9-Q3(5G_9)#1ICUR59PV'R'!=/2+P8R^MMS#?&+^+\T3BL7;X>=>&->S^
ME:1?[< YK.QJV8X;&WX0FF"7'QY*WG3*TWH^^)W<:W'Q(:E+$6# 101)1M1"
M&C$&:103& >Y"+A$01AF-@1HT.?<.._J4:CY[\WM"O3&@]9Z.UHSP=J,R3PC
M.#)Y?=!G(=I4L+:UK4( -JBVTBU >]#]Q5_VE -DGOC*I,=)*<H"@I>L9'.K
M/[7!=?[J(*7Z[D%<2O6^_T.0^H.R8"$%3L-<")@$!$.$HUPM#:,8QEG(PIA%
M.,C0N0*$)ZV8&UE=WXI:$&WA^2*$IX? C+%&!W9D#CLH5;B5TK^J]+ZH5N.\
M "W\0#L"M"?C"A@: SFBIN%I&UY=YM 8)A/E0_/&W/BPDRW3>W!5J9KOB_9R
MKA:B09K!,,@R?::10"H0@7D4!GDB. U8;L-W>WN9&Y_UVGMK*QV+).]'U(R^
MSL9I9'JRA\B:>(Y"X(E8]O<Q*7$<=?,E,1R_V+7Z>A="HA-^RF98%S!*."%!
M#'G$.40122&->0 ER_*$8C4/"JP.,_?V,K<7?UVS3'16VA9%WP>DV?M^-CPC
MO^]K9'H#1U@P'87 6UGR?7U,7'C\B)N[I<6/7>P:N,4>:L'USD[_B*91(,,T
M#F%,60P1R1.8LQQ!@1G.N1!4)E8?^9T>YO:>]P:Z[!3O@&>X%7P.)&/O]6ZA
M,<)[?=!U;X%0+]N?.-CI@'N[ 4V'+O11^O6KX.+NOHN.*MA07587'<68(IRD
MZNW.:*K>;AZKMYL0R*E(421DE$1GU'T]V._<WOF-H>!>6WJAI8)/U2(]"W@S
M9A@!SI'Y8J?4ZQ:T7SIHQR_S>A*H46J\'N[U%0N\GH3B>'77T[<[!E4RM5CI
M@M&+E?A4/ JNIC/J0=)UE[O ]$]%*3ZNQ%VSX 21).=JSL'C "*$ YB'40I3
MSH(XX#A/,VD5.VG1^=R8:K ==,;#UGJP,;_/[@"_:0] ZX+ESH35T)C1V%B
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ML,AA'D82)I@$.(@YB;+42L33IW5S(U%M,_AIJ:S^(Z@%TZ.FYW;@\NKMIPO
M;G6A3/UOJ<6>'K4:D*4"J->AY5D>X%2&:L6<J4\ASXF:?#,&$Y'PA";J%VEB
M5Z7@U09WFJ($EW=:X>-__&N8!O^SDJ ;[4_M:&_.5[L_]X/^FL-K]IE]M2$;
M^=O;^@6>.38L%;HAZXL-:/] Z^#%]H!>J*^R]A.\=+3=.52N>I2>'6,$?"G5
M>K5M6F';,6#=T<$=I1/')5%5WER+^DX?XOY"5@]U&\;Q50PI3U?R2UV4K+@G
MRX]EFUZA'A*Q0'F>1'F8P)2R%"*"U5<@%0@&*4:AC"7*(RM!)S<SYO8E5V]"
M:KD<<H/?<#$T.JAC+X64 U![ +0+.H6A=>)IR)C2YGI<]IP%EZ]%CYL1TRYY
MS@)J9\%S7FMNM/=W<5NPY3J%&TL<$*K#R+B6)!"<0<H#"J.8*4+3/R*KH@//
MFY\;3?72^(^]D7:,]0(Y,R9RQV-DAAD,&T$39;_/GFCB1>.3OO[['7OY6A^X
MRCYBXU+*8EF0E>#=05/_X*E7D^ 44QCS0"U&XXA"F@0YE&&&B21AFN1&,Y##
M7<SMM=U8"3HSS0,T#F!X_.7U@\S(+_ .*![?Y-, G!&5<:#AR4(RCCNV'8]Q
MXLHS1"9:1:+OY/Z=:(J;4O?P3K"V]3".@C"[KDG);D7</ZZ4Y22.A8",B41]
MJF,$\XA',$DCE@<IBSDW2C@\PX:Y<<):3* 5]FHEOC:.@,$3$,870#L#>F]
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M.=G?M+QBZOX.MQC?Z,8O@P3:5?F-:!V=-P]-4:I5[0(G89YF.(91%.L$B)Q
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M:6I]H)-)9\_''7TY03YQM8>D[W5UCT=1DYMV$W8=P"#4K#C-A8!9*C*((IQ
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M"YM\W!2]7L <I.SU&V74OC]'&T:\J^OY[/YBOU;FC"0FR;31D":IM;0$PK#
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M#&:,<2&9M+_RZMQP./3D6*^1SM/[?@2K\UZ-_@@,34*-8!%O)4_K>X%;XM6
MH_D>CBNRZV X\8F^F;Z\U.^6B_6*R_4S?W2MH*K+JR3)BUP:#&7F6KAE&MG7
MD:8P5<8DJ53,A!55/#71U%[.2DZP(RBHNI+UN2\\B:V?U1$#L8%?YGY@]<C
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M4S,J&\DWA7FVU1:!;*[4^]16#5@+/]X;!N&!^:X%]\,NN'6)UM9?,5BIUG#
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M8)B]Q7RH$I>JI1QW^0+LS7$69113=$^5C2WZL7Z3/M5ODE7I"C1*#5[T-!+
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MPSI*<^8C&/M185SD!N:[PZ;-/^W("QJ!3]^-7MS!^30Z W5S/C+AFW9V/@W
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MT6,=_ Y(PZ([,*>X)L%.>M"*#\0+^,EI .:+O^P4B-UJ,4@YB_X@QNK?&2[
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M(DP_,:9&)8V88%?.7NE-/5?%]\9H:*P')J(^,%]0G;T/2M$KM@<)\495W/L
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MLZ8T/6X\ ZG*:.:J(9,TM7M0IJS=JKB"*$N0D:1@W,]N[2_"U#:A[E8-C2(
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M9I/3R</$./)7?K%\2[^1N2%N- 2_O#R#Y=S%DA)TZ"UX]KT&M&.B;M0"C5[
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M6QZW[8X9%DI@6<!8F921*2*0)'D*8X%T'X1':6:5ZOD"&89&(T;Z.C6D,BG
MGN8S4!JMS%49,,E\FK2"U4T98-7U"ZVR^ZPOU>I+M*H _:.<BNK-)?UYT16;
MQ^!:&@JZ';(^+LM*4,L_JN_$RM'QN['MO&!U<;#-+5A ZX _GJ%L AX2]&L)
M\(?HX/Q_05.>^6*:+=RMJFB\88O*66*L-U=YE.04$EXPB&AF\L1("54AJ,J3
M6!4R7P7TW3NDBSG=I=54W WFN^^!1%=S3I.A,)N-R8I4/?(HM@%N1W&7XM</
ME:V/=AJT>H>V NVZ%33WM##GX0B5#J:EIW[3P)Q7^2#]B\4KGL$_=7+QV<,7
M$_SW94+99#I9OHU%D<8H3RFDA5 0%:R F&0%S!4N2!IAE25.+DTG^AG:AJMV
M<)Q64:S31LB)JW_C*4P5RDFJ=[F08.,MFIJ$N!E+(,\2CC+.:9)&+MZB(3#M
MS6FT(TSM2#< 4AT3[EI"4(DX FLA P8+M:,0*N;G1"_]ANZTJWH0@7/F<<]#
M\%ZI[V-Q=@6.B"2:9]/41$A&5$",LPCFDB6"IIBIV*F4MD6?0^/<NT^_??WT
M[1Y<??L(?OMT^]N/J^]_N;D&-]\^W_[XZA$+:0.[Y7$T+)A='S]K:<%:W.[#
M#QT "G6>M.BQW_.C/00'YT6'5_T8Z/3]<WGU9#K]Y[K*P*R4_R/IXOZ/^1BC
M5#&*$YB9/ U5S356% E,N-X54DXU20D73O*28F@LM2[F06>S%[V?H5N2K^)@
M1L:Y67^RR(VP_$;)CL(ZQ[YC4FOUKMDJL;*MS @8/8!6)!S3781C(.[SDZ%7
M-KP(IGU^O*PQSS2HFP/*U4Q4%KW'^52_7YJ4J\NW*U8N%Y0OQR+!<4&9@E&J
M_]",&4,2Y^: G%!)XUS1U"U)JF7'0^/%+S=7'VZ^W-S??+JK=G!W][?7__V7
MVR\?/_VX^_=_PTE<_!E\^G]_O;G_'\=$J[8#8<>#7<#;,?5MB5R'%E:"@M]7
MHH9,W.J(3JBTKK;=]IOTU1&,@Y2PKN][6NY6!7P7\E'SGV;).A']Y_E"3AYF
MUR^+A9SQM_L%G95UP2A3!=C\:UK'THC_?2F79@/Z32YOU3W]^=UPJO[%<KF8
ML)>E\4J\GW^GNIGE&,69R"2/H2@DARA6"<0B(I!PF:3Z#,M$YN3'T:OT0^/,
M1DG &RW!<J,8H&O-'"UDO7X/EG:WH8YRU]:\=>WUM>*KPAR_?)F7Y:\CL/H&
M5AB +1 JNM^" 6QP6 =-:BQ&H$$#;,-A*D;6@ 2T'+['.(:R1_8J>[]6SO<8
ME@/;Z;L(X5_DX%XNGLPMVE>Z-%GT]"K]0SZO[]>^+R8S/GFFT[HNHV[:9%TJ
M.9V:\\68)#1G1$5ZKU]$$ F:08:)_D-F@BFI$DF4:VF$2P0:VLJV%M)0E''
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M>S.[EOK;BSEIMK/W<GO3SYA]Q74K"RE:J@7M74_]M93J9?IEHN0X$5G!>9K
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MU1EC<]Y2)!=9'A%8*)GJ760N(,XC 7FL9$88,[EV@P6.')=A:+RV?5+;"W\
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ME2@\B+^:EKD?BAV1VE@2^LT_5-]SO*WJ!QFF2RK?/-^KG)'^QN/;4X0X*8H
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M./N41J,;ZK5QW'HB(8:,$DG!@K'"@_/!,!N(2<G4,!/WWKD:&AK><]Q2C$V
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ME$2CE&4H)%KFXVE96/6EDTQ@7A.A[",\OM D:I.W]SSKJQ4,[D9[?<.S-&5
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M+,H!RPG1Z<&O!T=GBY/TLG(_'I]M>!EMM4?7N9BV 1O=Y#($G0:&L0D(IJ"
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MZ+(#@LDI4T(U$*[*N,?2,#IB3):,#]&YJ%.NW2CY3:+ZA6E5"*P.KPWTT1K
MKK_ !9G??3MSHW0TF3^_3I?M,8)V25)#@1*>0#!GD%<J@$7\;^8^T^KCL+>A
MMUE8;@*=UX#9I1X;P&SW?NAZ\!837$A;1HT7J;ALT0WQ $HD[LK] %:]E_)N
M..OWL/Y[B"(:1%@#ZVXM!H_<Y4V3)NDM44*5N9P2V51$@C.*@?:&66Z==*SV
MO)H-2?W1X^OU4?>:F^D( GW7\)]/W8VD_YA<C>,^*F_I* FU6F43P)!(0<2
M-D5' =JBV[9"4$X?!=LO[ ^]_(Z&@I2N]#NI+^P&K&/WJ_=N^UU[3=&7)>!Y
M<6JO/=B<<44;:;S0F=%<N[AIA^SU>Z'I_\8GFV.M@67X@,O7F7S0/'[@HQ..
M9^33Z])C0A&PH8SW3BGBCXQ,L=/=OC5H_='#E W!]UJLTA42&D#\R702D++9
M!]34O9.UN]:6:3;@(5,:8@:V8"DE#BX9!]$3IS'#1X-3NW/<"F3]Z(EH'1S7
MUF_?\?6FZ_*%J1\#;K(561#(/I/".^8S%H/%S%1DT@@E5QS67)FP'SV,V0[=
MO4/A!UL&)VDZG,2!1J:%C*6>*^0RBIV#E=2 %%I$+A1/CZ_"[F8Q7)/7[_7O
M?\0EL0$L&@AI2K_2:U>7XL+M)>1^-AD-X_4Z-Q1#,\X$Q'+)202KP;'DP,L@
M;43'YZM7\KU!4K\WM5M'=A=Z;0"FO[CA^.-D-CL>EU.VNX!LP!4SAGH"DI3!
M8U0IL%084(1'35QFY'%(LGTWF!=HZ??*V/<"S"J:;""B>-9)E.^@_ ['7R:C
M+PL]++OY+8IM!YDAB^@>@+K"HJ1EFGW0X(-,Q@A?"GU7#1DV>'^_%[=:!^BN
M%/M]8G=V,^DQ:,:C<;:<%3 0G@;PC%M<ICE9%U+IGM<AAF_HZ/?RU0^,Y8T4
MW4"$L$8T_[ACALG<T"!):?T80)"2RW(607')4[3!(O/][4=OTFVELUM7K0-_
MQVAH]-[+Z<'?#HY^/SC[<'K\V_[QT?GIWO[YV1^'Y[_N_WYV?OS;P>E9C2LO
M&[REQFV7;9G;\J++#<).TY>$."JY5;&IY>; '\/YI_VKV1Q7R/2NE8D)V@B6
M("*N0!A.P&=/P5-A(Y?&2EG[ 'E%TK:*(D[3_&HZ/L&$,GP[G,VN,)+?1_ /
MYT=7I:3@.+]WWQ;[Z&>?AI^+J1AX;E/6R+[)Y?ZCYPJ,,QZ(R5HH2B(ZFY4"
MA[5?W>\A7A= >>#GNU5% Z[].;$]F4 >!'4R6@(J,!1?PCC<!ZTA4)>25Q$9
MJUTAO0I=_1Z\=8F]SK33Q RD5[DZFHS##6/$9YETZ9ULD3%.;4GZ'/(IN7,V
M8YB\4]C=D=;OH5COR-M01WUGYTNYG4PG\0HY*Y',>/YM>;80<O"ZS \K>V7(
MB)'@>;F<[9BTC%E*'_<2>M&%OOR6?D^.=N M*PGX^X_]EZ(X3:6P%-,C%$*>
M3"]+1G?L1\.+ZQLS.TD0UB)EQUG$YF+:<:HAE7=<<(;^E5A<$\&!X]J (S[$
MR#W)N7;U?\>IQJ/7O*Z",C$GS%,\'U[BKQSG,_SN+./;AS>CA;VQF<? T/+K
M4K1 -#C'$P:_M*SO&#BKW;VZ#N7?1P:S#OX>^_(>--Q 9K,UUV=SM+KOW3Q=
MWS<I.V76E5TKY3"O$QR,EQH8S5QIY6D@M6\HU^6@"9SO%(.UE\'F@/@1EL/=
MYK$(3$4A% 3ET2!QS8H2,)PSUC)'=60NMK84/JYU+:/K38/O>AEL!H3O90G@
M-T-!Q$4:")VI9.4R"U>8IVC#P09%@7"A@]:6\]31]O*J)'[G-GU#)&T"Z W5
M^KV@]C4I7^??=!"-XYD'C!ES4F4H7P ?F #M79(9$W 5:G?'K$7[=VZT=XCS
MVD#XQ]J)&3PZ?>YU+V9 6]Z->2RJV_V8GSM3Z5GXE.+5*$WR_B<WODBSX?@F
M9[XNKWDXC*S3W;4-:=F-0FL(:M?[:X*12,HHG5@Z6 OMP7F103L1G&$8U3X^
MP6Y]?VVQ(WXM_\/QLR\HJCB=C$8?)M,_W30.G,J&:,. VT6K !X G8+'."6E
M0KW*4;V%W+7?VD0(614>#XXD.E-  Y'ABSR5EMA**TP"36G#95%BDI2[,H:
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M70?.9$=>UV@-*N$D,*?HL"[&D)IT@<1L8BRA=LV)<4?D8CX8P4GK1Z?&ENH
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MLECB1TP78;6:E=GU!<@\G]'BO9<BFSKZCM<65Z%I\25*X,QHCR&$V#R<;KJ
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MVDW^M7H8!R%AZQ[&(6;I %^/CR75CL?(102C BU";8IR>0'.LL.(M"M3:Q:
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M7*< O"FQEYH9(S7PG#=DG0@NR00E(M."(M?0O"3D:6DF'G?1Q-I;0&@'U7<
MHM^7^"7,\IMO7W"^PEKK<K+^A,NKUXSUJ]4*UZMK_YR,YKXD#SQ2**%L)=*S
MZ(%6E!3Y:,I<6K\K;2]=?R#;!0_W.^'&,4X'L-NLXZ<%J*BE1R] .T;;4:@,
M@5%T$7E244A34FS]"OY B&DO(D8"T7ZJGKJE_U5*RTM\:@N\GX4XN]A4Y-W0
M%3!G*"JE<"!'"4J6",XS!CEE-%$S=/)>5<X37?T#/SSM+41CZ(RN^5X\T,-5
M6*Z,#"&#"T+0*FI4X&F#2"6<,X8ICZTIXA^79-K0?4Q?M)_2.X#.G6SF-L5Y
M?]OY44J0TM4Y,CY&4-7%.E<S%12*\N1L@FQ- _"L0--V=W:: [8S85=X?+1?
M:'/VGP=CN-.:0REI,X[/@<O(@3D==92<.SYB[^B3<O7R*+TW#(;U< VW2?\X
MN_'KW\\9I<XJ90TH; &%NK9PAU3K*[/7UIKD6Y,.;BM;+R6(!\;;;K;I"G/W
M^FHE>?A8=(8B*>94;M-@*2)PI0NWFG-FQ^L%V:&3^0#%A^-A:@_='U/WZ9M2
M,*V?Z*[\\81QMS@$5XOY*4F#F[^S*"=?<'E51]"Z*744X4;K51U?E1VTL%*4
M*4T)6 GVZS-K*A B_58+E[W7L; TWCDWX32U;2OX?OG^;DXPP5NK/A;L_]PP
M=!7:6V,,.E*GM2E7TLG:,:0,)81,U^F,VKKQ^+#'7ETO(>^X>-^_$O@@Z.D@
MQ'FBAL.B-%XF!)E#36^%!3JO,V3%G C:"Y0=%5AU5#=\&-QL5W UQ(A=0O'F
MT@]#3M(&VNJ:PL@H.'@N&6#EL"FF)"M:L[X<5<'5(#MO6W U1.D=@&>;&A^K
M,H\L, BY4.; >:031%'ZP!47Z+5*_-\%5SO9?X>"JR'&Z )?S_28DW*2<UI"
MM+R&)DB_<B6"CKYXC+$D&0\0,0ZBACC -5/79V8S@W;1GOUL$ZC,3M Y$"&E
MQ$#E$B D8>JX*YMS$B6S\<B.CHHL8I#=AY!%##%!%X!Z@K? )!LY:@/%*%)0
M8A1J)%> %::5ESHSV[J\].CH(@;9>CNZB"%J[P(^V[(22&M=\,F"+)8T5(JJ
M%1Q8Q^5J+YDO1K=^&#Q^NHA] #:&83H(SY[E*E!:9HH&& A7.;\%+2-H78DQ
MHV7(T;/4G*/N..DB]D%6,Q-T *<=^\6MBVBR+)0S%5?G P9P*G)@7-4X%:,8
MH:-G-+J( T#PZ#*$QB#H .K/=" '\O/.9$!I:"$L<*"$'<&5.C'7">YBZVK$
MOQ9]Q" D;$\?,< L'>#K<3(#'FD-6.LXK2]T'M!RHB@)A I,:DL!+FN=1QP7
M?<00(V]%'S%$XQW YAD* ^&XE=I0:E['R]=K1 B^6%!U[A,31CO9NOCF".DC
M]@!0(]UW@*(GHH:-=T8O#:7-"A(W%.&B3Q!]3L!DTHG"48>E]:W8,^+T,E2O
MZXBLE3G[1>;U[C4D5/%:@DDB@0K.4;ID--B89(DR9J%;N[AG!9KVF&QF]NW@
MM(,-N@#4U5W.=<O4M;_V(FF+2D)2-025RD&,5@-S@F53*/O&UAGIHX)T":!=
M#/W$?>WN6N\ .IO&J ^+^>*JYK$^UE9]_;PF(P-3KDC0OA)^.ET@"$M!9)%2
M:%68\:UO:K>1:]KX:SQ@-;=)!SA[O5BM3\IIN+CMO8N!TI*<&" +@C3$)3CZ
M[RB<#"6XK#'[UNUJ#X28]BYL/ 3MI^T.X'+C6Z]4=,L[K)V37H#-N=+B:7*M
MM6_34@8BO=22\];%N8_),6VX/OYYMK/..\#-K5[>_/?E;/W]]>+SE\5\4VA<
M \8L".M>B4I382O14P!G0P+AA?=HDQ'-V=N>%:B7^:==)W[M3-H!/N^MX7K7
M9L9<%BCH\':%5F+H+&<\@E!.I:)M+,V'8SXJR+21>D-#+UIKO0/HO$KI\O/E
M1:VLO.+#H.4L\1.%A)M-=\=GHW:<J2@@*U*0PD*J\I21Z"QJDEQ$9JV[@[86
M;EJ(-0#"XA!6Z:*.Y]GSX?UMHZ=D/O*L(A3RZZ"\,^ P2^#:&%8<IB3'Z^]_
M3K*MH&;^Q4_7$8S<@Z\\>?WNU7J]G,7+=571V>+WC=$^(*5%9^';Q\7%Q761
MRGE"%(YK"XR7#1V?A%!0@M"E8 BDO=*ZW6F >!T_?N^(COL.="13=8#"T_4B
M_?/3XH)LM+HZ><Z=R-QEGB XRJ24E0)"\ Q*$%&X8KVTK9WE0RFFQ=1H!G^0
M-^RE_9WQ\X7VS"*3$U^V&8W^5%A1M^!/7>RWAPN6Q1(_8KH(J]6LS*Y?3.:9
ME'NN.7I1R4>-UYPT:K%>3SOP&IVP4JH26[>K-%W M'>^A\+N=#;O(O(<O/P'
M"R_DQ>O2K1+H/!9PTE#JZ&(!3_B$%+FT,NGH1>N'_F;"3WLYW2W4F]BZS^B
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M&K,#^#[AZ:_W^@.'?UZ"#2KE IO 5V63(2IK:N8<3-%)9-$ZM!LHXK2G\DC
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ME/9A=&,(AKI.V.195);*8]0ZO^Y!0YT0<M"@H2[J:@F+SXRUH5QRJG,"S6D
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M'_U8'/\KK4525FK(,J(%S,BG832#]#J0Z'1*LG;&ZR""&WM/JH/CXZEPZ+3
M[O[9I]L2<9[G7VS5%0L*A1PU,"\P+O'*@,7#"!C9EK<495UXY%AOJCL\A(S&
MDK*'0?#(6FG@OMR=V9/IU.&_7;RK?"E_.\_GM_,P^99FJR>6ZZ]7,=#(+2'
ML\EH+5P E( %Y4IQE4O)JMIS/.MRT%CRX=AQ8'4EORJ(_\PBKN:[F=(/3DD"
M;TA$8\)1Z$Y%T$1)+D320E3?M[$WM3M!5_^VT#U(>=5@NG&XT>H'Y0_O9NF_
M_^/_ 5!+ P04    " !"@YI6A*57[GC[ 0"S-!, &    &EA<G0M,C R,S S
M,S%X97AX,3 T+FAT;>R]:7?B2/8G_'X^1?RKIGOL\Y N8^=>U74.B7$VTT[;
MQW96=;^:(Z0 U"DD6HN=]*=_[A(1"H' .!<09,Q2G08AA2+NOOSN;_]S=M6]
M^]=U3XSS222N/[Z[Z'?%3\]^^>7/T^XOOYS=G8F_WWVX$,^/CMOB+O7B+,S#
M)/:B7W[I7?XD?AKG^?3M+[\\/#P</9P>)>GHE[N;7_!6SW^)DB231T$>_/3[
M;_@)_%=ZP>__Z[?_>?9,G"5^,9%Q+OQ4>KD,1)&%\4C\&<CLDWCV3%W53::S
M-!R-<W%R?'(J_DS23^&]Q]_G81[)W_5]?ON%__[M%WK(;X,DF/W^6Q#>BS#X
MVT_AR9O@5,I7KX^?MU\\/W[Y^LWSX+CMOWP]?'ERX@?#]O][\1I6^0M<SS_*
M\EDD__;3)(R?C24NX.VKDVG^ZT,8Y..W[>/CO_Q4N2Z7G_-G7A2.XK>T7/AV
MF,#+J:_])$K2MS\?T__Y%;]Y-O0F831[^W_NPHG,Q*5\$#?)Q(O_3RN#+7Z6
MR30<\H59^%_YMHT/IS\?U&K@/E$82[TZ7E+O\S@<A+EH'Q\]_^T7O%Z_T\*;
M62OV8?MDNJ4E=S[T+L_@_]^)RZLC\5S<78F;7K?7_Z/S[J)W*\[[EYW+;O_R
MO>B\O^GU\,+JBS7QE2[/EJYQXJ4CH*E!DN?)Y&W[-=RP&<OF90323U(/&?QM
M$0<RQ:M^^OVFUSD_[]]\Z-SUKR[%U;FX[MV<7\'?E]V>>/^Q<].YO/N76/>=
M3ZKO_.\BR\/AC#\*X:%Q_O;TY?3[L]#SVL.[&X>9>#I1"CATL=X^'>3XB+_^
M_/KDY/A7O6F;?]55!]X!B1JP5-W6\G[ZG7:H_>MA2P2D(+Q,)$/1F:9A)-JO
M6JP18">)9^#[,,X3,9@)+X9K)PDHD_[E7>_]3:=R=A<777'0Z,WOP_N,4J\9
M6P^;/DC2-'F0J: UBGPLQ8WT)>CA002// ]C+_91=W=&J92DTP_@9X$<PGT#
M,9!1\G H#L)89(4_%KXW]?PPG[5$GHPDW"T5#V$^%F&>X06^S+(DS>@4IS*=
MA#F??0:R(A,U-X'E-/HXWZGM:\9Y:I:XZ)_W;KO]'DBF6W';V2G.$+<>$%XS
M]M-#F@2+V(L$W.L^])_&)S\J4]RJO6K&(5Y?=L6[SN4_6N*25'?G0G1N;Z^Z
M?5;DS68*6'PS=A%8P0O 80JS'%=Y+X4W0B)W[/"XO57=M\ZH,:87'JKPDXG:
MXTC286[_2+UF'VC7[-@%[5A##C,F*WJ4)L54,><PX7-$$?B>/G=G^\C9\C8U
MB4=A7_&\[KTT3 KPDN@$F/!XUZTE9V*8)A.1PU+@M/A_IUZ:S^BOQT]=49'_
M*4X>(AF,\"3Q _P^$.R!(3%U.]?].U"D'SHW_^C=D75)T@2$7.'G18HW91+\
M8:7^K;45#2,G<*M3Z0V'83I!%PYVDTXBE=E4^CD><T.W%%8''XEV>YM[*8!T
M93)<XFW]_>KBK'_Y_E9TKVZNKVYVP<;4CM??DR@ :FV.[P5R #08W-.78E1X
MJ1?GH-!^6(ER;6W'>[T=33BLHR\,#F\H(%Z_^'>=[C_>WUQ]7#^<W^S0]I]_
M[]WT.K=,QSHLQ7]I?YS_ C+*DGB%I8#R#3X"!K2M#/C3-C3X7G6N#>F8ELB2
M2$:S!<UB9/CQ4?N8GX6RE)8YKS%;U>CO6O:+'4T^@XLG Q +)VT,*+=?4^C2
MP_"WA!7"JG*\&M9:3*<1W0!^"R*&;*R',)-BD@3A,(1/IV!]I=J*PH<(>^F-
MEAM7:0AD[$6/;5X#1,E??W[QYE=-;NJ@T.:DI(K)6^@+)MY,#*08%BD)_R\[
MV 4VV($3;?Y!'M))[J%DK57"BW*JYK+92JGTP])RW4XU@8#10AQZ][C10Q-<
M\<"JG.;*:5JF (T0VT/R1Q,AA'LK&P'(;XRT5B%;NG!=I2.F19H5<.A:MP(C
M3=CB\),XH'(D,.<E!;/ E, 'A_&76IP-V]K+JS];X@[W]_SJIM="DH.7SD)@
M#N(3%!>X)_#J<I104 7V9:B97XR2A ,T]UY4X!97?\Y'EN(!3%EI9@5X_7XH
M8W^&]WX8A^ ">2D;,YA=MR(_M0>NK\/C0X88)E&4/&1 \J_W1-K?]KKDL[>/
MMB@OIUZ KOBS2 [SMV^.>#O.,.?.#'$D1->;ACGLX'\Q,$<\4V0HF(I<Q$EN
M$O1 4G/&4S;VHDB,/1!7>, 3Z<7H]2O/F,-\\,6$?_JHR;TGK*B/_:1QQVY.
M+L.365>N H7TAD-TMNZE,CSF/!<E$ ;_5IX9?IV!W,B&GF\+'TL,3U&6!$1$
M1B #E333L-">YO.M!@N7<H==>#I-N.[V;2HC,B26EJ(J9CHN?^(-P-,N\N4_
M:4K I;VP%6NOHY.&7K3DZ:_7>_C)Z?-7Q^V7)W_]^<W)KW\\JRV@Y?^.4[VB
MJ3>2SP:I]#X]\X:P<6^]Z,&;93\]J8B87_+WWP;I[X\4[:XE+[=T>':P8VW3
M+LR,O:!<>0PK!>2]!#*2((HH!HMO:?GSL<30K9=2T@JD#[H'RQ]\7:3^V,ND
M]5PES#SS@9?GGC_FN% SA96N[>YL4UCMF2H_;9PJOY&@03/8'CK_K"7^]%)T
M>-' 1FW<0UKWI3<(HS"?H0H'LM5Z6,=T3498AW4UDZ7Z[GRS![YWIMFA/E:+
MWU02R/KN*O;+12+3:13ZR&^M);;$?)@WS#,9#5O[Z2(<>(=-H:R3DZ-7N _L
MZ%6HRR8")# X)1 P($]S3WL&VD1ZB>T_>+GUP<G"R:MC?TSJHSN9IX54/GR:
M(DG P]#KF #)H"[7I)*)@R*&&V6L"!YY [5VX9G[ )>(_Q3PO^#5*I<7OF>W
MU@>ET%KKONP1#6J634HID(<"]D2%@.H,:>"Q<5*,QG1Q]5IZ/EW\A!>EB+<,
M4^78I7(H*??@Q4)ZH#'@+[SEW,OB;V8K7F9+9_!=CH#N:>_%G@7=#@9-$C''
M)[@1!^$AD;[\+/V"Q 2>!QARH$[ 6 .B!?E"[&''&\H*)CN=3\((3G( FZ\H
M0I>F+61ZUA4ZJ(. \NB^Z<B+P_]ZW,PHIJ@WF>8H[C&0,A9!$8%A6@#GIA1$
M03,5:+"T/K4;S+?$0!C=X2"D??CB9>+-[H'H.'(7R1$\%78/: ZOM78$TY_*
M'H@D<:\/3!'0_I&^91FAV!AU.HF+/;/BGC?.BNN6 9%K'1 !6^T.64.'7&*4
MIPN\@![1(Q$7)$$3]47#"8FB+@3C[*GO:4_=+3&8[>@I!=;OT:L4PP)YF 6C
M1-U58*"%1,8"$2SGS^T?1_MDJ[H''K]"]UQ?<I'IBL(3K&>?K\[65L.<I_,U
MQ=$+IG$M5< G0ZD\NT2EQY P,E ];.-,O1G)=G*8K,=3)[Z2";H%GN_#&:)8
MF>E*"U1$#(J1=$6Y2AC[48$[W-)? ]61;(KO$W G@Q8NBV^%RB6<#(HT8_6E
MY)-Y*_EY*N,,_C@P=\7*T@R4+KX6F0=J^9BS+O)GR?#9-/$_8?08;M(2_A@$
ME;I;$&;F420\D8W C3R$>_ZG"%-5@8PYJ3"H+"YXY*U+O4W%RYPY$1^\%!:2
MF>+EA?JCIQ!$O5Q(@+@I'P]OBZW!V\[%(X.MTQDLSJ7<WA*K27AP>IAOA$0W
M X_W/!R"TW$'/E>&)WL&BM(#^^[@?[\X;L'"#EO*_:B\CSHB,**TBP&D-,^)
M2;Q .ZC:*XQ"OL<2SB8"P/S;#$B<S,R2K:I!'"0=BLVD$L25X3D=NS3"157E
M3=-D,LU!R1136*/.Z6I/2#UD/=7RXKE1+35AZ9TU(OS&&1&7B>C=*[EY)H=>
M$9%,_1B#ZUR@.)O_EGLH[-2:#LB\P0C->@&8BBQ*?+](4]7&,:!D7A[&!?Q@
MS]R$%XUS$TJ#CWV#536YZ\5F6W.!62RS=9T;7]"YL;20KU4M<,G'7LZABS2Y
M#S,3N'K,S5.:!F3XNHU7]9%%S !\QHJSE>6P3\S*@;[Q0HJW@/$5ZQ8OK'8K
MT+;#@(/UDD2\\SZL5VNA+I<H/URN^\3ENI^2ZWZY$RKF9>-43+>,,V2+C*K2
MZ28J0;;T3,0%51\K_TK_O"6DRC6RZ?PP!MLU2\I?FPA]@')$NV(>^EU*\)"?
MS>$KZQZY]PG_JSNT^#98IIB'.=P87203/LU QI5I>WBC,QU<)A^N/L"BS'00
MBT//ST+8>FG*HX6,0(:E21SZ5.AF)1K(F<"@C5TE%52?IU]M26QG71-J-\C[
M5?/(VYOJ:D<TH!#ZCRH5E:)41D6= L8X.^EL5)BJ$PGC/4!WH+2Q_I52$)18
MHS^H%HY( YTW*JB?M50190OC'.3JI2(*T5E#-E*+X P=Q1Z,B?"$D-\N$LKK
MQA'*[2/=GHJ U%DM,== )N@D#/K8+8LFP&-*I;;D!F#U#2G3]7BOG;/KFV'7
M:PU339<]UB2\7VS[IGEL*T'7EL5.G7A62M$:-F6C(L0<6$+5<MP'5<3S:5*X
MS[^+-,R"D*F3F)A3!PG'R^RO6\CYL%YC!U3#XCK$IA\:<JC9>BJMGQ@V*2B,
MCLE=8!40)%R6@_X6_F6I"$VQ9#/!>M=ZQ-)W(Z5E'BPY-JZP?.S-T4]16ZSN
MQY:2?=?](OSV<6,H_U11_OL$*)]HXL)[("+XO_;VL[J:MR@>#R+,*XV1>4SD
M/;3FJ)Z!770F3.';X9/@N2@6N5@A!K$_1<E?VTM"58?&ALI$.)RCL4R 9I1?
MWK_U>C<HK#G-0IK";D  Z8(L/-0:M2@E"EUT]L4HO$<J81G( G"NAJ<L2U@D
MR]IF5Q9,+/R61I>,YU>OM75A*[V+RK<P;DVVHLNVBF"4E5&\VLO'7J:CXBH4
M9EQ4^FSYVFLJ<K"VYY$BG*:$J/[Z\YOVKS>]#YW^Y5GOAO",.^][!&ISR3")
M%_\2%[WS._'NHG/Y#[C\]#N5FZQ.0OUPL</3'8D=KH^^_[+]TW<*.-:<G8W0
M__1(Y.EQHQ5._U+\V;^[[-W>"FK+OCJO[]+%U)^)6"WJ;/:$Y@L@$^P-ICK)
M:BX"Y&T&DGH QH1X2-%#6J&_JXG0=KV%N"7H_B6(X=MT75MKBE2BRV;L;?V+
MJ *K>3SLAM+'$DBH&155BH8&6_[Z<_OE\:]U_WW^ZM>,_BL^>#FPNRQ$I\A@
M 1,9RG3Y[^K_NY-G=^E-))]>,P_O^Y[,C@F+.QSFLY.\=H?EC47Z]*/;,R9<
MK6#KYP_L@IZEVS5CBU?J6=/[N2\B0>M>#49Z$0[E+2'5P#.Z*@;%S64([YE$
MB%R"B>R&,XJS-'97R#E+8^?%BK,TOB43-C9@]WW&,A[KHZ4[OB6X+7\-HBMC
M+9<)#IC+$W%SWA$'2K<=-CXV?/NL_4WB?L]W*^ZG"9YN]?;D1:,0>#KS0QD<
MA/_7%XS41CI5C),CGJ0[MBZ"%46V-Q%Y?H)K5S?L8*M>WA>Y0Q:[;]>I6PGP
MOTI9.&>F <[,DYF[,0=8>C1-/<.MG,]:F4'GUSR1[<3&')OO&G5P/M#>^T G
MRWV@YKDSS0C"U-N.JR>P[D):H/%QKA6P*#L99&VX32ELX[&7AKYXEQ9QLA.:
M:XO694,/LP$'N&/B9G?-SUL9(T;0'UCK?IU*'):!6&H_!'\Z[;Q=[;P2?:SA
MM./4]-Z( :>FG9INRJ$Z->W4=&/8I18^M.'$XO3RWO"]T\M.+S?E4)NEE[^V
M5L<E:_8^67.Z2\F:G:\](XPVQH";?745U0Y4/Q%L>.>Z?P=6]X?.S3]Z=]OO
M:-GM6J<%L/7FE\DXH_I)W-N8<VM\PX8[K;VPC3]XL3=">786XN2R9(L5A*L-
MWLW^S)G7>V!>?QL<F%<[TP\R#SSV?0CJ:R61F1J,)%5/95\(M+95<NM>79Y?
MW7SHG5606L[[EYW+;O_RO>B\O^GU/O0N[QHE<[:Z90OSH_<&/.K5\9:$QF9]
MS"]E\Z=)-5R)^BA/IF_;SX^WPO;U3O:7,OMJ\+FMLN69QW#"/./')\ "<=)N
MB9/C]NM=?*&!PE><)/&H06;+WN%]->C05TDFH&P#?]YX<KC[>T]<]VYNKRY!
MOMQ<?1!W_0\]<7?%_WO=N;G[ET!0O;LK1R%/#^HI^'H];;.";]]XTMC]XHH&
MD<,C J-V)D+C*607H:UV@AR %G)P/,K!&5\QDK*I;QD'#3JCIWH?C<M]K5KL
MVEFQE]OQ?+Z 0=;/E'WWJ,=WB274R]L>6)7I_XB/,6:>8S-&&M'GIQ('XL;>
M9'[>[1<&&$Z_08"AW7Y]=/QZ19#A,9C!%T>O7BSD:=6'S9 18$"C"X5(\=TK
M0HF_79/73K[T;;<7C@&Q!Q2P)+CR^V\YCU/1#)0"OS[S<0KU-)-O]3]^#<)L
M&GFSMV%,MZ<?_5K=&GSA>Z#GT/<B]=+T_OQU24U'QTQ1.>C&/-!/5E\?T5>_
MY,'B=\]?')T>+__Z^*B]]+M5MWUQ<O1BS=O^0DOF9</.9%,O_MM/IS_-U7B\
M/19M*DG0]UMQZ<GT,UYL$PH2U?P^\A96N;!:%%A'A/SA,II[#?_W.YIROWEB
MG,KAWW[Z>0VQ]?*GS2YO04W%"<V,O[GK=T$L],59[[Q_V4>'"02#-Y]O>0(M
MN -NT@&;(3='QSCFICS8-:5R%TYKD(;+5M;>R,9]EV4MV;#E:?Q']LX1W\)>
M=H'E<8#0&4WB#,0=#M=9(ET:*U2^<P#@V_/&]S_7MM,0^\.DEH8X<1K":8B-
M$M\53:_LTTSN5.8<5$:\.)DZ1;'[BN+TS==I"N=7[BA?&[^R+^YZ-Q]N,>Z$
M&=R+JX[S+_?IH+7U<.+\2V<];)KX+A(O%N>>3P.VG;GPPYL+3C4TB3LMU> <
M2Z<:-DM\'[Q/F')'#9']]><7;WX5-W+JS2@+G0SY<Z<Q=EYC/#]V&F-_F-;2
M&*=.8SB-L5'BHR"DQ%GI<2#.I73J80_4PXE3#_O#H99Z>.[4@U,/&R6^&_P@
MR)SSX+1# T[3,>@J[?#":0>G'39+?#)2LU%!/QA/XL;+G1NQ#XKBU"F*/>+5
M4E&\=(K"*8J-$M^9''I%E%-N@GONG7[XX?6#*W/;46XNR]SZXK9W=W=!6$?B
M^N:JVSO[>-.[%9W+,W'=^9?^^(_^K>NPVB\:T.;$J:N <^;$YOW./(\D535<
MIXDO@R)U'N<^6!3/G8K8(RXM582KA',J8K/$=\U5;XSMUDTFTR*GK[.6Z.6^
MTQ6[KRM>.>]SZP>_5>_S#]&_[-[T.K>],]&]NKV[Y8K7\X^79PC">W%U>]M3
MG]UU_JG_V;^XZ+WO7/3O_D5>*BBICS?X!X+E@>MZYRR0_2$5;8$\=TZJLT V
M37S]V$^EETDT/[+<N:?.Y'#*H4G\:2D'YYXZY;!9XCLOXH [M;+,A2[W03>X
M)MX]8D]+-[B6+*<;-DM\=]YGIQ*<2G JH5%<::D$UX;E5,)FB:^;Q,,DG:#'
MT!U[\0@>=T,S$N"#/"&$67%[=7XCDE2<>; HT?Y 'S@ULO-JY(4KP]\C3K;4
MB.O7<FIDP\0G_2(-\YGIU7+J8??5@ZN9VR<.+=6#Z])RZF&SQ(>-N^)C[&4^
M3[# V4^J:":*Y,A#O%'^^YV,_?'$2S\AOESD^5R+C679P/M'3JOLOE9YX;3*
M_C"VI55>.:WBM,I&B:]>5UPF>3@$28 7.GVQ^_IB96G4+S1&4G^^R>FOM4?>
M/N+#W>Q$S#=OCEZ^>H/K>O) S-.CYZ>G2[_^TH&8;XY>GYY\\[O28E^L==NM
M5>KGR?3+)$)#IB__]/NS\-F3)69E'^OY<H>&)7_'N<=?,O9W1X8<-_C5Z@G]
MP(=+PKB0P:&;W+P1/=5VDYL;8F<Z9V)I\]<?*.K.>' S9L![PR$BT=W+6&:J
MY_.F!]^+WC]!(#KTD3TC QW0>.$:NUQ 8PO%. &YG9FX3J4O S1;:V50/I:B
M'\.U7B2ZJ81?B=[G7,:9"WKL1=#CM=,I^\/6EDYQ_6!.IS1#IW2B1<WA>@.<
MZG"JHTG<:ZD.UR[F5$=S5,>-C!""PFF,/= 87]E-YD*>.\K?)N39%S>]ZYO>
M;>_RKL.!3P2P^K-S<].YO.OW7(!SCPY=6Q0O78#3612;)KX;.4UE!F8$(V92
M*/-/+TV]. \ES8+#P.:[)$V3!YDZVV+G;8N7;I[T'K&OI3M<(-/ICB;JCEN9
MWH>^TQW[H#N^LE/$^:4[RNFE7]H7W:L_>I<=*CQT=L2^'+"V(UXY']39$9N/
M:M_+V,,!#L[=W#N3P0&C[1&G6FK"N9M.36Q933C/<F_4Q"M7([-'G&JI"5<C
MX]3$AHE/3KT4T6UZG\,LE[$OG5NQ=_KBM4-"VR>6+?6%PUMV^F*SQ'<>@E/A
M4]N6<C"<?MA]_> FAF[_X+><J>J+SMF'_F7_]NZ&:BBIA+)[=7&AM,W5N;CI
M=7O]/Q!1PV6S]H@(M#WQVF6SG#VQ<0DTG29AG!/ D0M4[IUAX0*5>\2KEJ)P
M^2RG*#9+?&>%*Y/<3QWA:A[VB$TM'>&264Y';);XNDD4(=!4$HN.[R<%[%H'
M"^Q'A*SM>KUW7UF\<?U8>\2OEK)PF2RG+#9+?#T<'*IF+MS@Q4X_[(%^:#O]
ML#\L:ND'-Q+4Z8?-$M^-S*9)G(6#, H=NL-^:HL3IRWVAV$M;>$FA#IML6'B
MHX0$<*\XE]*IAMU7#:>N)&[K![_-DKC^/T7O#YP8A95O9[WSSL>+.S?)STWR
M<Y/\-J4VGH5NE)\;Y6?VTHWR<Z/\W"@_%YW84;M21R?>N"I[%YW8>*[S7BHD
MD#,Y](K(->VY"(6+4.PH,^L(Q3_%W=][E:Z]/^#/]V :NZS&_IRVMAO:Q\YP
M<(;#QF5-D8^3-/PO?4:0U1VJKW7VP^[;#U_9]._41),8U583KCG/J8D-JXE@
M$L9AEJ>4U!*=$;B;?_WY]4G[U:\9CMH+O=B7+='+?:<XG.)PBJ-!K&LK#M>Q
MYQ3']A4'NQG#80AJ(W<36IW&<!JC43QK:PS7MN<TQF:IKQ\'<A*'0^![BDDE
M0U&G1)S6V'VMX<"C]HAO;:WAFOF<UM@L]9W)2(Z,PF L*:<BG(IP*J)!3&JK
M"-?!YU3$AD-1#!R5I*(?>_SOP<SY%DYQ-.PT'>NN5!ROG.)PBF.CU'>9 ,O3
MV*R%,NN__OSBS:^J9,II$Z=-FG>:CI]7:I/73ILX;;)A;1(_TQ53 H%LEV7(
MK_*Q3,6UE[I8UGXH$8>#OD=L;"N1-TZ)."6R6>HK?%]F69(ZC\,IBX:=IF/7
M5<H"_I]3%DY9;)3Z\K3P\R)%\$*G'YQ^</JA<1QJZ0?7 ^[TPV:I#T'L8ID4
MF;CV9A.G'_9!/\!7#CUFZR>_5?28/L''O+^Y^GC-J#%NJ/L>';,Q&=H.-L:9
M#!L7,@XV9G\M!S=B:X\XU=83#C?&Z8G-4M_[-"FF#B[&*8R&'J=CV94*P^'%
M.(6Q-87A8&+V3U.X>8Q[Q*NVIG X,4Y3;);Z:G!B+.7AU(53%TY=-(IA;77A
M &*<NM@L]3F &*<C&G:<CDM7Z@B'$.-TQ&:I;T6COU,5^ZXJW'QO-]_;S??^
MQO.]W8!O-^#;[*4;\.T&?+L!W\XWW5'OP/9-'0B=\TTW[9M688/F"R4<6M"^
M>:M?.?[;*8\FL:^M/!SFG%,>&Z8^ Q=DJ0VG))R2<$JB46QJ*0F'*>>4Q&:I
M;XEWX=2$4Q,.#&)'>;ICP"#ZHG]YUOMPV3_O=SNH99SAL#_'; R'$P<&X0R'
M35.?JL3'P"/.P,C'4KQ+TC1YD*DS'ISQX%1%DYC55A4.#\*IBJVH"M.TI=3%
MK4SO0]^IB[U0%Z^<K[GUD]^RK]D7'_JWW=[%1>>R=_71X0[NT2D;^^'4N9K.
M?MBXC)G(., "W,RA1^V+O>!F*^X1@]KJP;F73CULEOJX@<_IAKW1#6[*R1YQ
MIZT;'+*@TPT;=AVR#'C=&X11F,_4W'9@9XT(<@&.A4PS_N)&3I)[+[(^=]K$
M:1.G39K$S[8V<>B#3IMLEOJZ299GU'C5^SR5<>9ZKO9!0[1=J<,>\:BM(1S@
MH-,0FXY%B>LT\:5$%E9^Q44X"7,%0ACK:8M.<SC-X31'HWC7UAP.AM!ICDW[
M%O$P#$ SA![&JIQZV /U\-RIA_UA4%L]."0@IQXV2WWOK_[HW5SV+]^+B\Z?
M3CGL@7)XZ93#_K"GK1P<TH]3#INEOMYGZ1<48 ICT4T*Q$2=>JD+,CE%X11%
MLUC55A0.[<<IBLU27Q\TPX@_X=S$NS!&;A:]X5#Z.7]V6Z3WH2J$NI/I)(SI
M!TZ7.%WB=$F3N-G2)>UCITN<+MELPN+J\K9W>2?NKL3__7C3OSWK=U<@3#56
MKC@UX=3$?C.JK29<\[93$YNEOC\[_3]Z-S@ "+3$O\3=3;]SX73$'NB(KT1\
M<3JB25QJZPC7P>UTQ&:I[\;C,6*N-M;IAP8<I^/0E?K!=7$[_;!9ZK,[*(;B
M(E3]W$Y-.#7AU$23&-56$ZX]VZF)S5(?9K=AIT!%(+RPFXJY/TIB)5K@PJ1X
MO6AUYU<T=#O)"/7E;2HCN/>]7#IA7<VC/BY_X@VR)"KRY3^IG'G[B$]WLY.Q
MW[PY>OGJ#:[KR8.Q3X^>GYXN_?I+!V._.7I]>O+-[TJ+?;'6;;>&/)TGTR\3
M"8T9;/\LO'_V9)E9V<AZQES[;3IIZ$5+WN'UW"O4#ZWOI6F2_H_X&'^*DX=8
M!(E?8&A)3--D"L<U$[$WD4=U8^WYO^.T?+^1?#9(I??IF3>$,WGK10_>+*L>
M\03853^__?KH&!>YEK1X44<.+[9%#O5[>==Y=]'##$[WZO*N=WEW6]VVW7BU
M>DH_\.&2,"YD<+CTI:K2^.3$>J>GO"=]OJ43O 8:KJ-U^L]F%14LZ.B8>>+)
MFNK%T>GQ\J^_5*>\.#EZL>9MG5.Z@VZ![90Z1!CGE&Z6^C[>=L 5S=,PR47'
M=X-5]]X==>IAMQC45@\.]L6IA\U2WPU>@"'+6YDGPZ%3#TX]./70) :UU8.#
M?7'J8</4)X'K7;G#_N@&AT:_3]QIZ0:'^N)TPV:I[T.1%UX$CQ@E>4A?N&('
MIR*<BF@4D]HJPN&].!6Q6>KK>E/2"S2SI)LF629NY%"F,O9=9=S^*XLE!3B_
M_S9(?U\H=UCU77TI!*[\IW5^Y@KQ7"&>*\3[DD(\5X?GZO!<'=Z/4(?WJ(K=
MLL%1X$14O IX^I]_[[_KUY#?=FA'+4=TEGD.R__[^J3=7OKU>9).J-\P\6(P
MF_]3R"QOV"N_^TZO?".#PJ=^2QZNWK#7[C[]M5>_+X\))L6$GE+']^4T]\!)
M$IU1*B5^T; M./M.)P\[44S(:6SLJ_>^\:MW4QF$?/!=\ 8D$SZ-<0N*%/WD
M1KW^^7<Z^7X\A']QE_6UYW]:4%5;?_/WW^G-N\ED&H7$[EWT((;@0^1->_F_
M?VNJC\"KCD?B@YR BH^#8K*NX?5\:R$:O1?];RW_L7,T#2>@]Z9)NBCO=L@V
MN^W^O7?V\:+7%.-,K^=+SFPU_2:329@KN*"&O>J*=UWY3A>)_^G9N^2SS%JV
M*@)S!&<Z9/,J2GTNWGGQIP9NPI?N IN<HA,$H'RSQNC?\LW^^,(7ZWWVHR*0
M@;@:@">:I'R@5^"0(L0Z_+VFX'GSTL5=7=S5Q5V_9]PU_-$#KWA\8?"WG]9*
MAGU]M)9DU+QX^:)TU1I6FTUG_RXRL/AG_%$8XP36MZ<OMV;BWHW#3-STNKW^
M'QCMO17G_<O.91<'_W7>W_1Z'Q!R_< #U0&G";JD)4!)YN"NP+^R8CJ-R&,'
M'9.D(LG',GT(,RDF20!>#7PZ3).)R&'!(D_H?ULBQR>BYCK!'#OO9+-LVH5
MQ#8.AG:H_>NA@-TBT02[&<:PBW 6X$&<25].!C(5)^V6.#ENOQ:#&:EW;Y*
MEX6 -$-0><D#^EQ3AJ;YZ\\O7O_Z!&>C&NY&(FTP(1^$A\OLH/[E7>_]3:="
MYA<7W9;P8!LC[\%+I8@0\@VV.-)@;R!Y)R!X9RW<\'<)2+<'V.V#/!E))'/Q
M$.9C$8*1G!6^#W:C-J\\"NUE+3J"1I.Y?JDF4#E- MI?TEQ.FX0<)=,,BV86
MA"4Q[DP N4EF_ N4P8;0Q/LT*::B,T*G=-]W</D67E]VQ;O.Y3]:XK*#M6^=
M"]&YO;WJ]NDO<=!H)H3%-X'_FKDYK6UN#3)8)P"3,<SRE#Q8YK0]9[3[1]7H
M1?^\=]OM]RZ[H$=O.T_4IF%,6A/GP-V' 1:4^][4\_&:9G.JFF4G;KVHC!%M
MU3)46@ H- ?O3<#M[D,?C1388[!*QF9GP1A9TVP1-3]MNAUSJ]Z["6?"$PUA
M0_=60"R7#ZB'NYWK_ATHX ^=FW_T[HQ@N)9QG,VB>R\.O4=,[=L\+?R\2-%O
M(7E[])2M;$I Y_JF=]'_ *[TS;_$[5WGCOSHY?53.Q8RD*5#-,;0@/^?(DPQ
M(H"2Y"&,(OU1G?]_ YYK>(^!*FWQPOW*H/1!=BBF19H5'KP9_@@-Y"+UX4&2
M[H_RMZP5.!)B83TIU\X B>5C+Z<[:,-YXGV25&!39VVKI^E[M402TP= 1I.,
M7RXK!O^6OEF8GX :XXKW3.;@<:<@7=%<#^,6?.(7Z+4/D+#)*Z< "09 XI%R
M$*W-^%(Z;QAU]&/<E2R$[38(ZOBF$^X>\_3!P09,T^0^S$R_@)_<R]C#O!,6
MYWEPY\#L)=XA*X;#T ]E[,_PI@_C$/14F-$U&/SP,?(8R6"$E(@_4&$/XS_A
MHU'$<&#DZ>&0IM1E=F[N^MV+GFAO1N/5+:*JLUX?*8+#X"C\_[/>>?^RC][7
MGH@\TU5U=.P=;=$*JEH*L!JJC< B$F 7,+^'Q#0X1#D#P=C)1)%1V)"#KD9H
MMN;B@R3@1#;V0'*//7!TJE]/).AM$%GB@$Q#\R?PU$ *$+;P.^"_Z30*?<K!
MX1<@ZYAKX=(B\E)B\6E4I" $L/ GTX*!'Q[PV@^_ABD;1C2--IIU+K\+]TB3
M:+'X;HM6-%%8)J0'Q.:5- MDC(2C]7#&!9,9O%HV]'PP'69:+=>Y[2TK,EYJ
M>/SKMO2;AA85'[:6WHL]IF6E$2TQ DV6QJ%Z&A.XHG;*ALNZLHJ,K96#\) 5
M8R"SY0L@-\Y79X=_A&RJ*-[43_O8[0I<"_T12$JP@Z)4S[.,&6)LL]?T?ABU
MQ*0".HO* IIX,Q$G.7)]K@:U<^;'QZ.(R-9YY"UIAVC%2<&FV4,:YKEDJ\&"
MTZ]];7A4,86;Q8D BXEV#/S5\#,&#UX>'\(Z(C#T0-@$WBRCZHA7O\)NAO [
M_9B8JSU64PKO?.:!48CO#._[C=)?>V+D-5NT!;A;L/N78)+;WL9U LSRSHN0
M6)LCYH""03(A:Y F14HY\ Z) %>]@ #"+4 E#_A28%V@RA2Y!R4(R;6I]*FV
M%+7SC<3P$&S*61@5S)#\4,/J_Y5ILIP\OWMISPZ5*KBJ@SV7'XLZH3GBXOJR
M:X+H)G+NL<^<@AF$(B254U!3L&Q^ [":2""HQ@,UJ(8#&EX\*T/!>!6YRO-1
M8#2+DI 4G1V;:>CY87$8>"'_1*5\J\R/]NG1\>G!:(N)KI]^=\I_$\P+YBZ8
M8-W("R?-X5ID,] UL+1Q.,4Z'HEV))G.N% PK9,T'X$V:8&9CN8D&,$I''L+
M7&:,:+5$%$H=4T2&U+=HB?%LBI:G3UO1$OX8:$D:>U3(&+3;("63 3XT-_!2
M^&S$YCX\#1<(YGR1@D$.;DB6(!!@"_[-::-[4-H@3E+8)[Q+&-L?C$#(Q"B4
ML-P8O(^6&(!MCXZ"#O7G28N>8.*EF*["."[*G#"/T&/ 65K(J=;"2A'EF8:Y
M5NG'V&^0@D. $6+<%S34X1<M_'3LW6L_3 Z'Z.TD0VL;]?V'(7HO0_!H8A^O
M)QM?WYDW4CD.:J^4EP*B58X2_,6!WJJ$+A4>G5C].80@KLE>([]!?@9E R3"
M[A!Y"_KN(=#52"650O2[\$E$[5F>)"J^7;L<=):]>WSZD/:!-U =Q5+_ZD"K
MBH&,Y3 TSMBM"F4KU7&H8D7XGNBVP1&"28>6;(7]G+S;B+P+,ZN4?YNB;JS\
M9AV$*%,B0(W-W#[;/'AYX#OS8-_9A70 2C*JN6L"UUC!3LM G[7XH^LT&:7>
M1-P64VP5Q+\Q-)BJKR_"_Q1A@)JL#$S2%RRXPQ3C55,D<I3Q0U0HH';V)=?8
M=%+CW6X,D7%@,R&#@>F?LBT4;BH_(Z,"K*PP!;+1YI[^JX6V2QB;T#-:%V&F
M_U018/Q%QF8*EG9,DK@2JF;74CT,KL40UL,XP=]XZK$)F5$)YGMERHNDL!90
M]?R/0_[86G\@,S\-!YSX:B9M@-%?@)4$&[]-X@ 9\AF!)]2)JQ2"CV8T["A+
M)##8"Q!)7#_1*D6(L@"1KNA7XR2""[!X WZ*L8FN-PUS,/-O\\3_A"<UH7Z%
MBO^3F5 [/91#[4="G,/ETR(%,U^JQ$FH,H2A<G(,^5%Q$1W[W(*FG.!A>K*)
MN'1JE*4N/\O4#S,9:$+[?(A<<I_ 6YZ\^ NM'>QJ;0LKWX$*"]BY2%+P>KQT
MAC^A=@NJ1-&FM-09$/B]INZ,;NK%X/"E61U5SV@)Y>)]HA?*XM!G=F$%W<:D
M;:9)A$42\W>EXY4AO3=MMMZ$@>V8XF_,Z[5,3(E*-3[/*DD.IT(VT8@T G\.
MN4UQ4Y-4"3N>VET-I,X($H,B87IF]4F18[868P-&+B#K K^:CH:<J=4ER39-
M6GTEC'>4MCS?3PN,]X#L*^*I%P;FC73]'M?[.8)S395K12KPBV;NX325WF00
M;=6CX,H)NYK,<<\&N"<"D19SJ+9;I BH/6L"(UG!"Y"OO2)-2!"_?W?MJ&(#
M5!'GX;,[B>4,8381%]Y#(^+ 9<JK4]:$PN*X+(S2,0D6D*EEFZP+J/;4"[#N
M*O:YJ'[*T2^N#P?_$2@G0<<DG& P[*\_/W_UJ_Q,<3%XC(PSNLDDB>5,@(>-
M&\7^F1A@0""=E0DEL!Z*2!D4!!5#61+E7 &3P9,G133B2J\PRPJ5JT'0.G\N
M#4YV1/55T8C!-@@+-V&^7"R5T\CS79'8EEBG<ER-X9H61\A4T+8:K&M19 +)
MRFJ< *D;>0\M2E@6.<)K8&)QUBKS<IK$B<O@@K2(\+]5^C=?2NK;X40KVM!I
MZ/-%4S3!<PP92;\@%E%LXY<0AIB;]6EA+8N5*)@7<&T:OLU[JH[%1X ;V"GR
M<9*J$A.K?GPN(*)RG!A8,E5:5+DVXQWY=Q&,5%=)&/^[4/)#L3;N*CPBH^6!
MT:(Z'A^\-#!N@9\4J4(\\])!B&E1#-. .3A%8$X94,4[KD2))OB&.U#LE5((
MDYOV$PJM\"5UJX=+!PD0I IWD5-SGX0!)^K!Z4F* 6SW>>>NVU&QK6JJ5;%7
ME9 U,6'PB2AE/HKFK+9-"IGU87ZW+GFH#K6Z7J]<;UD:7L&BP;8KP<B(J-5T
ME!ANU0-B"9$H>0^D;#&CS%^LBK0SL90<-P8JUY3>T9,O!R!TM;%?7AN[I=.V
M,%R(Z59T)<1HB@ZUCE9-CF4OBVV26JII@1-5GL5/P.+4VFK!J6]Q#2AUV2"Z
M0#33!48$8-M,>=O[/ Y!=XNM0JJH=E.G7S>B7Y>"QS<VO-C,K:S628>N$&K?
M60=V,,4X23?)\D9%C0)52(QN&G@P0\F9:*H6D)^G,LZ4 Q>$V0!4'J,):.<2
MG&$Q#%%)F<+;SQ0Z)1</?ANQ:0MW7O@]E2585SHZW  =WGMA1-[KG8R3)F#X
M6+52BJ8"RF'/Y2$5UDDU6$,%W&,9/_,I1I^+=S+VQT MG^A^98B###DRS\P5
M5(8%)AAV[XO;J_,;).$S#POLVQ_H P0DD>*@?8@ASGS,P4RLGJ*P ZY-I!2%
MH>0I;B?% >8?DU!5UA3N%>?<\9,,#[F4/%2%*=3R2M@!> /]WKJ0/I+Q*!_S
M[I2]#. >A$DPA]UBFY1J1VDYM*6X?"S L1H'ABM"(>5;)0M[IU=/FY_*27)O
M JO4^:Q+A_"GBA],EOB:%JY/O_G]35I5/\>2Y> 0(=N<MMYO*8E-\VDQS7W4
MUT%S*DH99""F'I];;)G)A+74&TGN8H>:;D3[S:O7(+S:XN/1[5'W2"!HV*M?
M1?NX#7H=7D/^Y^BP965,7%YD.Y2627'3K*KEH4H !%[9L&5"C6(8(5X<YQ6-
M,D(]^+W%-]WQ+1:SA?X:+P7Z$58>%UOM2D3^XF3"0%)%*/?$U<"T<00I+4M]
M$00C)\,YIQ49M((J_,!^@XRWMXF46QUK<7)T?((;07@KRD(U]&\=K;8 B7LR
ML&\&0*^(UQ3'X.;4)J UC(N5DK/#E%A,#1Y360N.(*2Y ?5/]<1W6I;F9?B1
M^GZ:XB.L[^9LXR,A;G'!7WH[M ,QXO+$EQAX:.\2O,R]!Q9AD0F&%<JLUE8[
MVV=2%^2<LDLJ,XS,8C=KD<8M 4^2"'@%HC9.)J%O P;B]>RAFL>0\ZM NW!+
M1/GNU'Y/APGORRVJ&+^-$DX:$[,JNQTOP!N@R3Q(. $[D%'RH%!^S+EK9X$>
MBH9X+!$'@)MZR=!/'HPPY;[B0*>D?6!,6$"Z_X"G)\UC>4^ 1!ZBQ^53U^[Q
MT8OCOQPZ?5>G[X@#B)C1/,W%%4%SP16,1'5><%DZFCS.OMR@?4E5V8TQ,D'6
MTMCE@?32BB&INO+-LAV-;(!&=%BG,>31TB#KD0)$+X-T1,LJ:L71.O/QG%W#
MJK*96ZX0!X-M[GA+1?&PIZ^,[-VE<$N.W?7N4=MA<BWQ*<#ZM  L?JZ-1O/Q
M8CC#LA?+5=QPL2:%,=5C,*\0<^_D?#32OIH!J56I)UW'>(0#<S695[L5=G3Q
MQA]$ MNDW"!I7%<DNUQD*+CC,$5];C52+'3]<)DJ^TK$USZ9!"8!4@*<UJ+G
MF.3%8Q+DC)S5O0$Z/FBO'&^5%1,=%Q('G4.M)</)%#:(\UJ4R'JG8"M1?3*&
MY^1+QNTT>)].UM@GVB*B(D6I<EY5$&6B6AE(4&@9]9<_0IFZL*PL%AN%U+H>
M%'(.KA_A1S\S'D16MJYCNP)".2"ZKLZC>5JO$4W/+5*QPD3Z8R^F+H^Y1"+'
M(OABM?0;>-X]ZL!*A?B[))CIGGA<E;Q/(M5VSZI^FDI,(A-2.3Q?$B;5O4(3
MFW^L-[]0%6=94._U5@3=#Q,8(L"!PBG(3PSL,!!R-@-?TJ=_^HSD,O1\G'""
M[?AVOVF%WC56<KVHF&,$5R9KN.G4E<G^N!"RN^/+D-BM96TOLPV+YCL &K1F
MFP%1$]%[2(HH0-NLQ(''G3Z/DD3!^M=O.DTG(I,._@[4" OS2V/"+>^;,;J4
M8_=D:W)/D#A34L#!:VW+1;'49<.]%=OBT(-0ZBT.^C60]\?8T\#VM>^NAB0A
M1D @/+,/+<9>RL<)%W/Y7N07J@VWSB2KN<%!);WD";85.+$4(PH'_OO>BPKZ
M!''D#S=@I';6-%*_QXYH,3%WBG-A(#JY.8?PL5-<TQ9^]VULX1W;FV]B?#OA
MO"WA?-:DLB+$&M1%J.23K1?DT;GVH%(8@_-HJ/[%&"+2@ZW !!*(*HI6EQ#-
M>JR6O*?"\_5#V J?;C_H%\N8YQ 'FTG+VNS=9ND/F+T@^IJY/]OV!Q1?U=9X
MKX@):V&@2P-2._:F*_[9%<""*5%!A.?/C)$1(BK(A/\T)3L!U]:'<27:PW?6
MV &D $LI4UO:?F!<$GAF-D;]9JKWR_%^LE35C'K&5?V(VN#AI0;(E;=)PM\^
M N83(*SRF.N>S&- %ML%T,M:;&&H-B(H(%@NK,*.B4J/ DC.N>:/;,G;+UD#
M!\3*GI$=EX<G.R8/3W>>[8D7OUCM(T+0%/F*-?JWEQN/!'QWBKI709Q\E1C!
MFRZ<^F*NC0]],?A#TTY--<%.\9^S1YIICZS.35-],84/F>@4*\QYPN0:$-X8
M^PAEIEK;% M/P;I\VVM84[=^J67AO.A->M'S:JPQ7G2KAI:Q274.,WW>Z5V,
MB3[B]>X'M:THE/">:B_PG 7\AZ1B<"U$OJ<WH5H'N ]8Q]2J3\20+SD6A'%(
M"I?^W%TWH[7*B7(UG>OD05OSP\TX=KR$TEN\]=R48@VGK!(:$2#3%ZPBC(L*
MB1'X:/78O\"YW!.IL[SLZ$NDCK<,P%%-P_AWD899$*J<C!X^7N]4<9Z D"AQ
M?'M63'$6>V8E8K^G/./GG\N >K34A&3Q+O'28,E7V#$":\"#^5="H X(@) E
MT3T",O/ FM!38V[J-Z+Z0DOP&:I$B6W1J"L3-;G9,UO^C9]#^)8,A<F@FZ[<
MR'#1<U=N] .A\F'&5/-7%L(#O+3"Z&D]/WXEERO4/@92( 6WK@B<9^3],\-6
M66$M_4[!ELR-C6[E-S%M]B=N?OI-K9OM6B2L@+^5?57OK^T.QWLI9M9S-;]8
M5_-(/QR&B%I0T+1J"KD38V('^X PS*<@G''W<"OV)%#UW0+HWN-)DW7#YZLC
MG]37]T2&+..>7/6YLO>/II"LBH&Z$.@.AT _QAZ?)M9TS11H6V/BH$Q$C(!W
M$!)LX"'UT0PD4 )7VUDV"<]M7]$=5J7T<-BJE+"UT%)9H]WTD3Z6RH  )&H>
MV<J3U/A?L]H"9^0*SX?S8DE$C-A,^IG#RMMNX;J:5R$9<6)M>G!'VM0C=1I@
M QI 58,W0=0OX'H;8W0GQ@8N0K(ZYODQF$?TX;-)S+3:F8!3V S,[UT&RC\Y
M.FYO>8"[8Z$ML= U#DUQ#.08R#'0^@QT-8"]HZ\;H7M4%Q!5\E*XD+PD%57$
M,QWD,HAEEF%$,9R841$B*=^C9:%X1B'')D(UGL*Z3!R,DX<LD1BL]0DI-X!?
MIF&FVNHD)A&P]!=30)+NQN,35:*#_HUHGIPK%83@CUF(D6[9"[CWDMJ9:; 3
M?'"H:X+,":B87)?[XTB(M<1R 8>O03-6%?YRAQ!E\5LUCU*_ KN6M%9<6*PX
M7/7X5;JGU:V6-T]KY)"\_"ZCMY63*0-EH%O+U4\Y_Y-/@:NRU>P0+C!+"AP,
M.PESE>C!"[K>%"$LZ2>U@^+YLG,S)A+^X-5Z;#?5[K7: KQ);4<X]M#RP8:Q
MB5G"\=1.-VD1^=%1^(J $C7-Y"',Y*&%1UO_GAJ]L$7WMVC4IDF..?A^"JNG
M5# '.JE_MFS;Q,/JEXG/:S,,L[:"S]#2 0(08SR6:JGUNV._<$(8TG"1@KCU
M(R^<\+ QPD;3]W?AU0W*9@-E? GVPY]H/S1&0E/DDT9_J&1N90H+5> P8Y:
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M@KM]S< 5D7ER@GA686#*Z#I9)G-X'_\3OE!95WGM@56$D%>CU--Q#-3+5\1
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M>I+YB^4@7V@":V/3-NI;!MM6U4T*6C\VV*A1KPN6"0=9* C($M#X!#6S%:L
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MCZ[?/5R_[]UBV^0],3?Z".,&L'L7K> !'EW:"[1'6] 2TE$O[$ O-&# Y,/
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MP29]<W(VF&U)LO/'P>5!\%IAT>126.L_(]-F4]K([,?Y/&5!>E.4<+L\.&$
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M &[MTOOV'8N1,+I1^DA$DB8&DV5X #J(52O)>U]Q_W>IKFABF-.*ZWOPV!2
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M1 .GBBR9]A(R3^<VM^8,1$KP>A_O6$$S1"*_)C.PJO7-I'I",ARTX_&6.LF
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M6%FW00"WM#+TF\'LP-0A'HUF=0-N?14&6Z#O3'&4M:8,Y5NN(EJ0(ZJ6AT&
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M#TU3OB)\3?!RP;YI)$R=("HI45A(F7W[F4DZUZ'EF:IOE-+@Q'6W;=(81N1
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MFSA1^@$+_4XQ=;M*R\C-O&W>IIR=-5^/R$#WA;\IE8-[@\0:V%\HI8<:G%&
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MU!!<*Q3)Y)&U<K\\.-R1(;@)T0SKR&!X%0&>N.&BT-<!#!F>Z02=GY-'PUW
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M94-.6F\5ND=06PN4II=CZ8[F\5%[GD_&"!L%PW"Q_8/32P2+=IK^HM=^DDP
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MTZ[BL3MHA>BG\6.(HJP&CR?A!7>/1%LN]*6GG"R+?RMCK_1&9K,(00AN*VO
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M)&YQ;JHDMFTXB*'P5CI""J12R9$2'1^[*ZK=#-@CRAQ-&/;SFT&BPU&:9!.
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M->P"8#K(%@3):< KUBQR-JPQN*?$7Z29.6KW$?J$A)-<%02@>'NOX:8CP&9
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M:1-GN5% "C&C[*!%H=/J%FX44^P1@0J#XC<CPOQ@6:?$9X.;*+A3'FUJX^'
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M)#?[ IST0]M6:GYX C-1@8&SA?V@9B.RID@8Q _G8*5=,SADLWO) .4+($-
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M$/.+.4=LJQ:1>U*#%D @Q=!#E+T6AF1+N,A/<)46L6;:3/YQG2'A3(<EKUS
M I$\8>;B[?5Q:S,!@Q5V"C:[3]&-_L/H8(O0U8/K/*XLKUSW'7?IU'60C\?3
MNYEJ"<6V;DX9YSV436!8C-ND93?QPM.$VA]WI]T(>ZUL=.B^*H@Q:_[W^)\,
M;'5SZ6Z#A>6=\YNZ]QECR-QK,2@VX2E^I]TP.>RM3[T7DNP]8ESNICPR:03C
MS61+H&],7>PSU\6F5.?DD]%"NK%(CCJ])N\A8$7?SQCXP1S<"V_-T2G(P1RV
MD-HEZJC.86)E 0%6(^!VB>"TAIAB!,GA5C"GW#V0:MUXZ96SOY/44((8*!BG
M+_-:HZDYGZ>7:;KQ<>[#T]#[[IQ< BW,P.:FHFBD3Q/1X=R2BQ9OY D@@KUT
M'09?SL^81UM%)3<.? XZF*WHE#$%0HN^2^K/5&@3<$J(J:%T7<HDSM#WX9RV
M$458#;L&>#\OQROX1T>'23T+TY_0N<Z]MN2,B\>XF2X>XYW4*22?,56+1%2E
MA!(VA97A7:A?F0MA>8W[BR2:R>+4M;OB7=CJG@:%7?U9GIZGA32=JPA&;1%C
MO8M9VN:-))L#*A\>*_:AOO[JYT-]_4]47[<E%@.3#F./ZM+##NVQSRW3LN[<
M>SY?1@U5)]OW:6(? ?YAAXXE8X-WJ*"WR1TY%*P>42&O"W;H [>V*-'QQ#F$
MT/5-T,_;Y#'GT9RZW##GG9OF\NK*W:A9FC./M$O%X@)T8BFEIXA"SN:0TZT0
M,H=V5MO&^Q#,X4%%+M@#O^'<7[I28:;<N\7@V6())J6:ZOZ/;R"]@T&LP.3P
M?#458/05@K#^;DTX,F]&,OLRP\8"Q3,LQ82*Q5]3(>Z"]9G\'=;Q'6=?DQ&W
M38@D-APXB5U!PII_KX9P1"LX52-(B!2,9Y%K EY]$\U.1Z_/!@R>8^R"CO4\
MZJ?,R2QA+IU7KA>4.L$JQ-M9I0 (F 'X)S8_^NWCW++.*2F,>9<I1[2DO4U[
M&2<1D_*<%ZQU7C.95Y-C<VJIGF;S"O6[*9N/X@Q:5_"JP/2+57Q55CMS@4<H
M3TB@,(LC]M"S<[R0AM<P3::C+C8F4IZ$^%(:- =HYY$*DO/VDNG@U]!_UF\;
MW3[-G#Z2:K"=\QU:S41*ZSO'7.\<=(CLO),-%?A='Q5.Z]"9WH@E&PGEPTD5
M2:%*2RP>52)66VMSN%V[MV$ G!L94'M_:BSD._2X\U[:S"P'XF2@5?_$K/K,
MF(ZA"YK6ML%MX96*/LN18HR3GS\.X^)"4\]E2,9#8F40/Z/)JNU&YZG(XVM<
MZ^DFKE(!E[,<YDY0U Z>7?/(PC7AD%(0KO(*#8"C"-@E,M73F?)PU 84&T@B
MW SY.X(_Q0G-L[1EQBWWI_9+D8-K9 U&O^]!?I5&P47P-6]YU[*1M[E[$F7*
M'/ED'K=42V6.4W]+PJ.0 ITK!^U/EJUD(J>L6X)!OXHHR+IMM"% Z> *N4;7
M"E\S_)+6F4\$ 8\^*'^6YK4IS SV$7,V5971 LV &!EP@0I91EW:$YJ9V'4P
M(VI$QH7E?8ADB3$>J/I7\X'88M>3A$,8S%G*V::4DA"\$I-T(9.5WJ !2VM*
M VNG]<I!!(=>%(MT9U0,*U*'KWMP>J)OJZ@]H@A\LE0NO[45&:'CNFXKS#/6
MW/5K(W.BRH87]U\=HA_=?K1 1P<4/E9FP6GI5/W'__(.?;2LBZTU_9P1UT_1
M2:O['H&)$C!G:B(%TTA& $QVS(ZRE3T4YYZ?%C-%BA3 ''<-OV/-CW3^F3!$
M?R+.F31P]QP\$M^1B"2:*6GMX D3=GVC;_?ASU$0**2+>0<J7!X_3&K!\=4W
MQ 3\:JIE)N2>$H6%OBQ>@VH]<*%DG2;8-_AUJD5P3O\C1(F!Y/@DU=XY>WMK
MTR+B(BN((>]J=U_D$$F$MX!W+-I;'"#&L@5\Q-IBX\3;X"Q1)/T#J.=YVPX8
M8X&;5>UI+<IK&C[4_WS5JY>'ZM4T6-2G<MI/2V^O<]H[Q_R@I="@)AQ1#Y@Y
MCLA[9HX_ID8'YW-LW.AR2?5HI+K9BR@(1O5H);H\.<X8FHL ,=5>@2JI8&XN
MRJ9D9)XKIEXF+L#(.PP-B0PVI63+C"J>'+[WIE7B6XN8YTS*HZ7:GI967V>+
M&."X8;T@Z+:RKCJYCAPI*-71:J@'"8EHX&/-?MGD0:/%/9L;UB+-+02LCW85
M3$O"KK,*#);9>4NLP)272PF8&9O '.@0EV\P-$?)9BR1HB&1FB;VBG<R7X'@
MR:GGL=#S4,G%;2>WSAL7D"7+2)D:_MQ!/_9CDZ 7?\?NN('4JS&Z4A?1A&/I
MQ&X["Q3LK[)G'\A7N65.%I*3US*W7?2K_=+T_$C33.WHFADU+^/5"X6^@4+X
MW12F&.+,R@U\3ILEV#9=P_?K58RLC-O=(/;:%+<QQ>RL;JXR2#+<4##NN;)B
MX5A .W^OJ<IGHP+CI\OMZZ8%'&;?D:%!'Y"Q+UB@.%ZAK9.SW4M.2+8#K&>5
MN-2C 0%R^:J]EGC!1&BP%$\6V2MXI\GNBAS\!KF=%7+-1RJI^9G=9US3RRT/
M=F!RC1GGYFQ3IA[ZNN4MT1J+R\3!)0#+7[8U&],;4:=W$5-*RVR##R\-@?@X
M1!?2%@(W[]-<[GJ@_B3XE0IS1SD":8C.@]SG=O_Y]:C8\PF3 1Z#A_3D=]A>
MV]G[F#Z']_77O_S\^E="RG#M 18"O.F$:GDS2TP_);R@6<F+E#KSX]D9#!$'
MCPE3HK\A.P+#YX/QE%S#:)9FDMXS+A\W^U/"#E;C^477C$1\LZ-X;DN.0@P+
MD73*M6GO_B<()6/O4+V_$KY9UW3R+F'!ELE6<Y2(8J-28N\!\,=769F;+4-&
M"U_@EQ0335F]QC?$Q:6CQ1P5*URE!R%$B#@U667^V(72@&H)67&5:I,(_]"3
MCN.K$#XE^)#?./+E?)86Y[%584W2F,O@W8& P;S(%IDXD.&+DF1Q,I\IFDJT
MT$WKM/3N668!S*^T1%+CT%[@/$3B2:<"MK1S5+++?)41:5]&V)?( D8="&8T
MN#*^=M)D)S!S$SRDL.'"/864K/M\SE:192 DCWA]B(GBZU6;Z_-LP\#<GO!#
M;U@#K$ZF!H50T-6PT]_MBG3/6E-9Z JO?4Y1:EM(>XQ\!G'0=D>#)SO. 4V8
M=Q3^R'7BP8J'5XG*8%?!Q?.(2OB3I?;IU:6^Q#>44VHGA9JG12QB1#%XNB4X
MI$_@3$LYI@/?DI(4N%?^*,AL4EZ,J/YQA1TY*+)U&A>2&5 >CM>OGSV'8^_H
MQ;.YNMLG99)R2"\61?5=D$,.+H;$J48BU%SH^<\_OW*O,(S^I[R<:3/S$W0+
M3<4X_>O@G"+-M#R#)17,YJ)5VE O:^)!YS'M*X*B258S4#]-F+5NJ]*BX:GY
MX^G94W".TKAN868_$P4^C>^O?WG^ZO6OLQ?/GC_%:7OR@F!T]/55FE!Z6T[<
M!I:2J#^0A2#$.[DQVHM;U^4R$]\_ON$.SYI@;YS4RM0X,/\]5OC176-_I8!7
M>Y%MAG^YS[@>"SY]JO;E-_@W5F<:F'Z&!4W*KIC]^(UHL]W\#4;0@9I,FSK-
M5X303:MS5)G(L.0M7G)=YAG)V9,'0GXUGIK\QZL4HW A_(QFA.(;8B@#DW>1
M:@2 689#Z=R4SE\=2N=_HL9/)["20#6>X:5$L\@)NYA1@?C\7)%%^M"+@\W>
M@E<X8S>D9-004S3'2Z9?FEMN/N/ITBEHC0#&*B0/A/(=="4)^/07;B=<![9L
M5=0UU*WK5MS^TF'<.HDW2.@&/E&YO#1H*?X)7Q_IHKQF"AH9G9:.W]-K:!F.
MA<BD#<.J*;QJR(+!E<'&'CU_UN$Z5A18L-%ND2(F"$.,,!-.SZTM!(BJU1H)
M4/37(AZ\^QJWE=T<;RU;;^*L\FUSQ?$>W@XK":%R_ Z4]!TU[,7KPW5>MC6L
MK756PVPGE 1COP_\)2Y!("<:=@/6&>R^F+M)Y\AN3#&DS(:3E(71<T*#PEAY
M([<1 >$?/7V 'BZ16@FI-D.+"#8:>G "$7=N[_102CB+1QYXM<37A'=-G%3W
M(PHBI\L:!N<61F9F@8[MX_WC>_IR32\P-=W<7<K$<*>)W\KMLA=&REU8I5?E
M9:"U.[C7!_3HQ$@8SL!N(<E"41W01^PP"LE5A4NPUF85=_[$S+QSA.S>BMB=
MFIDCS\YTK$IO+"<L>;:4PM=OG@+G>T0#8*MRIBQ.F VC4TE7WOTR^XQ;3)TN
MS=AGI+C*J%%619=&WO&/%:LTM18.(=P]B,KMBV%9I'EY/7!H"//4\1SG$]P:
MCN:G.9\0S8"%'5>?ST8MZW2]D/2?B5E(IQ:SD\]^A4?($0I9DL@9E]HHRU)0
MH(:N95QCA$(<ZU1@6LEQR5I8G!V,2(R6NHKA:';?$<\&_>!MNFC@BV_G$,WP
MY>/DRA1)1+L&8K73N12O\..\C(O:^2[71E;L(YB:E3RL@6] X$F^\)H9/)*T
M7E;98LI$U[P+:USCX^I]2,5[FK,$:V-D&\5L5JNT$F@=^&SBVDUSQB;F@(BO
M>S?G\R&Y(5/K+3FS22D"Q!N8<.WD#29N%3E]-SGG!%&J5+H/[#'DQD,A,),[
M"GTGKH3ZBR2#I/J@K:NFHT]9K*\IU:=^4'@DR[AV]"D=:ED^FNGCN:IGPM(H
MD8Z,BJ$?RH;Q"'TNS#2K%/&'H3^K#A"$^TU@'.I1$.@WMNX$7'Q%>$G8V4P$
M1$2\N/K6V+(*H\BWFJYD F/[,2>+SS.2=>?TE6W3#(;''V!Q_X,7-\,\A+PL
M5A86H?W7C.\QN0J/UBQ-NI]GYT9BN>[6)%+(3R01,G#\2)]5V.;J!Q!KG6D7
M'#(ACVK0>NUP!QGZ6SWCL H]@Z>W O8C8*5:P&U@1?LLZ]8^SLD^[C1T^/6>
MG#I"-XHU]44F_;\Z/4N>YOHB_4Z:ZR/CK"=,\OV1:E!:N9L2MJ.39<FZX%N#
M('9*K-0XY@)Q<3FEZPWW_DHOUP!=$5,*$PJ+^/E:"N:5UM65AL.4@:(O+S-T
M.0P0S/L%+&>IZ&)F@.K/P@I*.8246X[@0DN"<!*9ZR(N+N%3K9Z*/"2F&")3
MRCM7+7,D,+Q9TARL9JL,=BF!SLJV9B:(''8\.%S_S_.7$;P[GY=U-Z_(@"=F
MBM;2DD7<M@:^YV!&.T#MKN+K/>_M<:MZ4^46_8.!1&Z;^_%5G.6NV.@4^@0'
M%+@V".1F(*9]@'CH 9@R\3*U<8;L%ANJ,!,ES(AV_5G+PHT_6]7L(V %\B-+
M3!KL=S5 <!4)&:SF(UFO;Z/Z6VLN!J@S$MC_E4)"VF(39XG#\CD8, D_,5R.
M[YN#N<CI4Z91O1T]^><#E;T^@,K& )7Y!=LQ?;2IFO'A),+TC':'"']'_H/=
MH_M/?TS<69@L%^2GLFZ>G.0E"6,<\VD[[OIZK$FOJ4$"CCD<(9I&Z==8J3"L
M+HBW<>.Q.:\PY7KTL@/YE!]2YFMC4F.6+3G-P6.ZB8V@0D5M<5PO/7GS[O^+
M9N^*Y=/;*3<&V1D$2^AEK%UNJ5ZDDSG\Y)B_IB^'E&TC1_WAR )^*U)WXO]B
MWRU)5_3 HFPF&8\T<7BJ(N3Z8;W=QOOX%)9KAKZM]R$'>"=E@?Y1)60J:$A=
M 2E2E!)EW@@F"-<\NH,[OP;#_U*BG?V<DKYL'?G(5$)\45D1<9U4IJ:J@?N,
MB[8AJY_>(&,W(E7SC&Z-Z2&R+](\^P9E2#"\EC9&^%]A!=Z\Q\,@$?\+@WVM
MZXM<"5\,P]"3N54)Q1)#OFQM1ZH]?%BQN$X[;/_4BKK*E4Y[E1'2NKY]S1XY
ML+F)6G(%U!H9\FG45MEAV#!'J/@+F#)!*@<D%B6LOF&:3#'/"-:!Y6%PPVJ\
M$V"#<>FK X]ON& IP*"6'.Q"%$BI0Y_=LP^=E*=H*X?N0,6<N#%!7A 3[P2C
M0W;,N$ILR^)\V-$"_XD [;D*N"P4LXJ:,>]+&,9GIJO!"+;)\N'1NY1'$54
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M482W$+TSYT]L?U7)SX30!(S?L*.B$4P\^UW7J6KMG)(S<R!;L?"@OQW@0=.
M!TW%T$TKD;)3F-P5T/K.@Z8K_B=2H63+_:S?F,:74)U6^:P#S/>5QVPY$EOU
MT&#&MG<8JY#\5PXV$<<3EE3S4Y.>"R*YR& XWAG:5OL2T+<A-@=7T+5;U"/-
MY7Y_X1')"C#1X/MR>?GD37DS5Z8"-TG*-Q=ZV([VF3)_X0&&LF1&U=P=0">]
MBN$R2PX,3- ^4_)H/:B7#\:P?$")NVEHK![OEO:S?-CNVO4+ XXZE;=+/46_
MR&^] 5?-U;+R P:Y$:><-<UDN1M0\CBLRH?T#YJE\L-XRE_Q=6L3<=^##-U#
MVA^O'LS^.#$K34QN+$6)8]OZ\JF$DW([]N[QMH722V(';87]D[$[>@Y.L(Y]
M7L787M!LA0B23R#S9!MZLJX&G*\B:@+DX.\Z8G;,3('M9GEZ94HUM]+GWC&B
M/\H:2?32FZR;LDSXUH[QD#O#W!>L=\SA5F? \E"U:;;K(6NZ125A;]!I446[
M%2G$6IF@QRO[\?K!;&Z;2_ZD,DUHD,_B//4X8B29ZN97]_B!I 6ZR+<];P5N
MU)WNYO2O]K_]=<V<#VG1_?)@%ETO4<-'S$2D$$>8O=VL8ER"#"*_3*A6F'T,
MUGO4W@%[&,K+]=6A%6@9S3#I$PO[BTD!H8R;*0J9"BFV=V=N5M$[N"?ZYESV
MF&L1UK6"2]3(XAW#)T1&3Q;+"7/'?)>?,!&;@/D=,2[:-<.CBD#=,^QD3/Z-
MJ3(PGUA6APD)9?@(E*1D(I<+HK&TS!1$=(F, ;.D)<92BJ^1Y8^HX.$CP\$I
M/1[GZ*);!!E2=20E#!\,^P[.#O@A,E[LC.?Q!I:\(!?\&$.I6C!,Q-X$ U86
M#8]"8S=9A__56B^1$OZD<:J<6J:A ,#>]7N5=KZ"F./%:!MPNOO/-%I2+O1]
M?#V]#4C=25L>(*[M8TM>A^/U5-Z%"*L6%<3^$I6+36=5CGLR3)8U_3=&J@I8
MSFUFX[X^EB=D4^AD*B:W>.^_ ZL//2>+Z\+>]^J6TK0L.^!.L>@KX/!]\'MH
M,B)*V0DIGO[%I*UQ^Q7(6BB-+E5ZWF(GMSE\P+^NI&83:H^+7'V$.^"9*>3R
M)2_C<X5ENYB=*X:$$=TF\5:G<NZB$*<AA"1>H 7>>=D(\1OESLKRDN>\PO6>
MU%YW0/ %F>#(OANNV%WAR<[OCD!UM;!S483E\%*:R=>\GJ3EF,H2GX#2^;AZ
M^L.C-O^3^2S)ZF4+LP]+BT2U;AMV%%Y4JGS5?>LP9%JW> 098G/\MDWU[)+_
M<6T_]AT2/;*>%1;W*P!<&!Q7(4O\)Z9?RVW*,XW6>).2289I6L !TTTG>S-Z
MI)UUG'+M+I/NUY'66;ZARYOYWGER,42>XYF#?T#L1)XFY_2:Z%LZ]2(^-/>#
M3:W8T(AJY2&=IE4W^K[CJOO&B_+J-D,3W6ZHJ-+^-9VZ8JB$VX*Z.OHK3G?_
M =QDDN[/#N"F,92D1GK=<9MD:*E5JM'1I@L>[TY\&\.FOLI@&$H7V3O>]G:1
MNB?9H=U[;][C#AG!(O7:VJHT6R_:2D1+@F]T11P#F%P!7^OH^5Q[S>C53E_]
MV:K93^"X4R!)<YWF5^F3=8FR#F"XLA+U#TDN+-!'?DLWQ;T&PJ_&Y$V]FFQG
MGJ.,[OO9?:C<],+?V&'!C@SXCCX3U![Y\*I7L'&>-6B125\F@!'$N-2  \.Q
MIS\4DRT="G]8B\5+]Z)N-W4CNKJI C=, G$Y,N\$H^YR5J>J-$SW=R](U^%3
MQQ;-NO&$Q.X6Q%'#0[];B4+,+9/H!99&_[5*[;-(U\DP !1,A=NJGAGE\3)/
M! +BJL56L-]-%+I(BW25[>2UYQNZ<@.==,59NF30@.KF< #,A51MX[2<2LI5
M%^12\K35YIC4SZ2K>07;L%95H_ZJ"S-W.TJ-_'L'-.I.^-#JZ(7.V@).#KL(
M!PU@97D1.&/G-0Q;"RY*-GZORX2XA**=DQC-CF[F=H/0R\* ?956[G#$T8HW
MN+(K5.909&WJZ2W9\6/(NYU;R\%*5/P;^&I1SO*R.$\K?3 KJ^&^//WL]G>H
M3<?<8FO$A0+2FUW"!A^S98>(*EQP5.:^W++9@V9B;"=B>$=T\V[>[=S]L,4S
M6N<S<G(A]G[AE4NN5IPD81-[1#8V",0.?I]D8>B%8\I)M.M&K7?O.F7/EA=I
MTL)+>O=N5%^MIY06:1$CZ"%?Q,X)9"$B7(-+!%)!*<F.D$R\-'DF*PT4%SO$
M:([8[#NB;MP).Q_@Y=PS:C.I$D>3:& U[5BUC4#%TAUK$5/PQ 9VI^5MQ(3\
M1,\>XBSWZAR_&).VXFJZO!6G*)]3"Z;]V 6M=P_7D7UC5!O=-,1,UZ@"*I\J
MPI$WS?E5>IE?GC[[:>RT0N"8!I=>07.)2K\NM\KPBEN:!%O966X; [X0I=:0
M("UCM>'-&!!Y9R6I:VD9 2"T6%JIK\&R,8O XAJ-]%[4!)Y=L597J!6;SWW2
MBRT#,#FU5V2NX^6 2QJK8HPDKC$ZR=E+0WV9K59AI#><*N0").F.I[9U>%MP
MB.!'JH1D75CTQS/D4>B0&94+4I&A*"-S,;WZ$+5YK,$:$SF8W:=P@0+#>#N+
M>=,DX'E<64*D[LO6N*,WTX\& Y#=3-2VV[Z4V][DY/(>_B;R]\YW7YI8V^33
MYAI=-&43*EQ:]2[^Y0[@EX&(B0OAG@WS@<%[/3.6-;_*VS*S$50KA$$;G+4E
M@?+;[/898^@8,F*;GL1FNV'*\%N?>B\ R'LL35>/! TW57OSQF0!/W,6<')F
MQ6(\,1./I-WD[<;^VJ$CF+'WV*=FEYI#AXF1G !-J1:#^O%-:M*?*=:1N-TS
MF*3JF1S=0.F5LT^3U#1;&R0&YTMR0[\_Y\.<].YZ,%8MLL*^HQ1MI .,R,*V
MY/O%&QE4DM67K@/B0J(<4^>)S\8)^#!D3:W2G-FEZ&3!*'HSX,RCR1<GX.10
M6VOI)HN2.,-C@/-B*G:G0A@A>X[W\_)$@B@B-]9@7NCG!E[<N<Z.KKL_'V3@
M^0$R, 9D8$+N[<U44Q?O)%LN&-<)GCD</9JL/L:0ZQCE#IEEGTZ6NG;-H(L.
MW//@X'AREJ?@\0B<3K4#ZIFCH=RYF"6UW4@6,R# ^/U4/L>M5M],-A]G8S:I
M6R-6VS*NP++0NN_T%CH&,4=6^=:I^V"@<-8NGI@?8-H[3A+T1S9YS(DD)P<]
M3&3C)FV\&HJ)GFQ DI%;Y<\>);*T<L[Q(3EY6FUUJ .UZ[ /$Q@>2>16*[G[
MR+IPW/$$T^'>+0:W"^)"T4K:_YDC19T,!C]24<9];DH<"" /(BZ[18_(O [)
M#<NT&@QMK!I8O6K(UY1 NG R#KEAL=YI]DT,>]M\2#SLE$OMJA'FX\=3?;B9
M;O6!RJX80Y%>!D0[T>RT68XXV/_X7R'+%O4SP&1M,#7,:].+B9Q8"2*XK-(:
MGI$_[@1JW/#(R8J"M,HYH,JJNN'=BE.$.69.,=4Z:YG,FLF^.(T.VI6X1)*'
M%7)O4W(Z%\U8W#\^[QE6(>.KLMJ9)#J"9UVD,"<KBZGQD"1SO+,&=S!+!JH?
M&QLH#T(][0WN=[3>I&Y"66@)G1G6V'_4;QO=/LTY/A9@L#WG'9I%2KV7MXRY
MWCGH$"-M&$#21TC1,G2FERHD4J?FD%YR:]+BA&<1GSQQK;U^=NG>UH_OW,@
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M\J&C(YMR772698&:]G$0LC<,3!K:"><QBPB.HS(E&\,H<=\*;]VM3O>>1L@
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M%&1:<B5X'L6)H6%?Y<SDA4;M76=)@G7775T_+Y_+^H'5(4?1FI,N=QQVOZO
MR\\1 FX<KN+K\U(4?0>^,&=39,6:15I^TW(+>LJ2C1-U\6F;F^-1J:A-0K@O
MS9G2W"_[TMSW+\UM8O2VM  8,H2=YX0:Y/0[V0GJXZ,]+2R3="8UE"<;NZQY
MZ3U*9R.43OKPF0U!>V>&5KG,\85-[QW[C!DPB#WO\J#WLA]\$"&P$X#H&(_2
MBM8E;/+W.#S<F:D]AOS=_SB.YV,>R79^=MKW>/6<? \=K+NN!AW%F&AD71G/
MU]#8<&YNT$=9VSF6,4T*3RHN#ISYVSMKPUJC<2%=OEB3\_%#P%4J,GV( ?9V
M_S[5P.:01$&D&JAZ1;=J?\M5-W>7-DX]0FUS,8O =4NX_KUB^U,R[D-?ZW#3
M^U([^ :0@,F$,^F4_R&;0MZ?G9-)/;)!F,A>ILMJ6<M+.;P0-I9] NVK:V<&
MB\6:HA?7)!?]H:*'2E4"HV\\A37^4,77ZO=)%BL#!-W"9%CYKU(ML!\89IR7
M6+B/K#1E]S.R;M;1TUHV:I9]&]A&;O:6CFK,YE*&6'@/6@H-.[T2WCRGE="#
M./=!I%)TO %!!1E7/ =$.Q=Z=QA84UIN$7-Y[NH;?_N<WKB<W[A1.:\&0'3F
MOK7:/:QBT^>JF-R ,PLV *!.+LB;UX#N0_ZUBH!"W;U$\_,G90+I!%JO46FK
MEC=J"_TG*5=$%QLF@-*B2&[S";D(Q,.YXJI12=Q4:OZ*++E7L_0"Z"GH;)]6
MT%M,D=@4"1C(/^%RK/D.CQ]:4KG(AWL>B^Y+T%2MA<R2,XLLGE!$JE8+:/SB
M_FV=A@N=TIHTT@$YKQ: A7Q)(S!'1ZP^:_I3O^\:RA4M8*&T#SF=WO[@T*A(
M?5-U(K1=:/NA92L"OB8OW$XEV)XFY2V_@',50%K1S&["(C].1N2=/36X-0XM
MBR+4_57$6&)-2@,ES2! A/SAL&=1UT 2$.XHRT!H6$J[,&(B8R%8@HF]&DN[
M7L-O%J2ET[$:_P'S[[\,PQ>!9@%XI^X)DJWKWM2A2KZ^:=*7!C2UEF(5$[*.
M=YK=*H,5VSJR2]#\IL>A>K(%#ESQ;! JJ&]SL'"G?+,R!W;JW85/_FPFU.3"
MOJ<)=1J5/+/&G^Y-J->$&CSYWH3^"!.ZKVJ)=7Q_N*]J_5P-9\_+=^@&ABOI
M3""N0?472;D F@4TA!;'BWCC.X7HDL.*T+J-,RMS#S<?!MXT[ O!&E=-P!.S
MUCLW2MZ'-C=#SK01=C^]MTS!?\<RA)H_<?:FID$:-HVOB[X,;I3+1EP!Z@RS
M =.ZM<?@-33N>67=T>F29X()YHK"M>+V<#."O-Y(!$-"OD\&1NMIQ;P./HIM
M+KCOO@\@%F42U*. AX1XO.AK4MKN$/9;8G<;?J1!6-ZFG?::D'H*$&72'K)F
MS 3R+^7W&(?%FH(T<6C%7*-']2UQ,7QMHK9_9\PH7@5O-0=_@R](RT6O.OT=
M'Y&?RYAGO$)ZD58&;6E85'<IU>4V/7*@Y@17+L+<!I)KGV^""EU,^U0/_'@C
MZ2_#.=9C% &DF5]0 +&TJJZY5&.A^$=A71PMHQ<(J"[1GX^NK882.Q0*]7Z?
M1(MH@A5+/STT:KEX+SZM,G;R+1CZN%KBUD02#5IB0*J@EBPWGZ;9HEIBF #7
M"Z#T6&A!U/HV:M+8T%Y2HU##@E]!+S4T](Q1EU1< KBT1LM'EA$R(9NOBNN[
M'<[3&$SX,D5N"FU([X!\ UZX.W%&_D8/Q3]K*NR=X?*()J3LX;PE%1N-F@9'
M]X+[KNCML0)[IUY"35H$SPP=TZ[M+]:T+DU$B'*/J7FE)R&2#J522@.H"=?(
MP6?4./=JVY(RN^>N3KOCKJH3!3W'2^F2#SXF3TNFL&7?]-+LQF[N,]% &6^U
M+U4=QK/\KMUR.N=F, 5 #ORMVWS=]IKN F%W .FMF4A=_E_?>T'B%?^>+M7F
MG&PPR@6Z1%DUW^HZ?&;+"B1"N[&VA ,\ N6%B 5,HVL!M9U72YU<_A#-;-KP
M>N1&P@]%A3@^ZUDM;4.)!=$AJO& 4@"\E#8>C?8C]^C9<(!VQ?_9K0"R%H)A
M+"BM6QM2ZI@+R![4RQ(^NH9D U;G3$X)PQ_BK9U$LTE%62*[Z-'--6CTT;9J
MDTE86J>.HHS()S/*9O'$0@(FG:8&;>M!'2/C4RZZST='Z@R4X%0;*ILXN1F!
MJ0B;N-#&HB7=O$M+@JHFF%!+++9HX#QG@>=??LRB>;C \_"WX=G597#^,3@9
M?AQ\.;W:N0BO@Q+.6$XOK7HZ9%:F=L+3M,XD]%U6Y<FZ[8_5<0*=\,;H2$*\
M@].8O@U[T%Y.?W[A? _/G_N:;@;--O2-V;E\=2;D*#'%!8ZDF ,'H%HN$7,4
M&P68Q[$8]RQ"0)V2A&%41<)PGKN\FL6F%23QLGS2[;NYO<0'V3)Q%KR-;DX0
MTEAO=VJ8_KR;\R.!%* ,M^S),AS0WJ9A3:2*(U<H!V%)8!I,Z%M2!P*8&F#*
M"N"+!W>7&M-2L$.]5X=]B#"2+(X*IHSW71W: QU; 4 _<\=Q@B3<"&3L1:51
M.UC9R=;7K6P-72'N""XU_[FK>N]%0:J;1E2N0O^<G6FT:2DB$Y<L;@GU6)8?
M@B'79I<CAM46&QL$G6JT)@(IA%S+YO<@"-DJH[U'D&D$V5%C+O8(LAU&D+5[
M*W73M\ZF>?OK>U4&3,\-\V5!;WP>SC,J>.(Y=;/M<XK$,7Q8A*:J+IUJ6>Y+
MACQ"J]9&WB#:B2'IU"2,6HTVFYRFWX3-"7 C"BJUH_V,7OT[%2MWPI.SA6P>
MUC';]0PP+ V-DM=PKKNHP,9 .M[QT$<Y'CGM&QY-3X(S#U(NGTYAZ9=]]A#R
MEI3@ X,]_D::81911D[ &XMHUS=:%U[_L/N&=:B\V9=IIA8S\E)AQ^6RJ!(#
M^B4:;XV,0^_*-[OX3QY\2)@HK\^*!I^W^).XJZ%SR=5GT3151[YZ@-[1F[J#
M[5(()I':TM2;@QP<=<?3:*"37()6;=?: 3P>\:7;AJ\OU'2IF]ZN>^VGWM/;
M[]]RVPQK1&VNJR^T]+A'S$[Z'$W^A(*E^C%,79'.@PO:6>U[IQG,N8+)&_DS
M3?AHV[@>\'O[ 5RFJ%V0?_=;L%)T6S37WC68] ;'\@.M+J\>_B)Y,P9"BLCB
M!*'4;5\!"J8HP)X*JPLKH9)T6J#R(2/T('%(A#'-AU'K:1K=YL5*]:[Z8A P
MI6"1IZ GCL37,V6HQ%,:Q*"7J+XYB]+YDQ_XV]1$;HO[U63!A,RP-0 !1L07
M,UYB'8XEHL=(L3C)YZ!L3B^90<$QL-S8"M,(W!=$.*2 G4OJVUG7P)1#)!^Q
MKC*N. _1T 21Z4+4):MVE*F#4CFYDWL2@N2&.2E&IY+RQ6,0T\T1_,US/@@2
M>2G<8;PR#,25KFU=4BY&S0K$P]$3U+%[:^LKZM!-4MQL]4O7+&><EO.T9%Z@
M2ETNNF<S&L$V27/L7RW3K^"+O86L%[#V3RK<#,X!;?H<IE8F"1)CE5HJ&G]M
M#<6"4>.1KAR;>^X)I4S3E#1GTF0JTQ!:@IJZ>Q9^(BQ- -DOU/9(U#J:J/_-
M5?2"_AN9GC)5ZQ]WI'(=P6V:YH1"MPR+!7\.0#U!BLB2RJ@7?>R%TMP"NG57
MN7 +"$GPC,F+ZRA+_X-GCR/&I;NAO5.I(RRJU$MG:+>#+8RSDZW&V=_!$]OB
MT7Q+Y3%<&8S_(EL&IT[OE;M'/Z:EVJ;!)W75FU*#9=!IA@M(WN8"7A\O689M
M3/.J !LPP4SV:T R0K[B@_R0A4:55?3\N/>U;[=]7] N_HP6!6R3>AKP\_7E
MC][S]=$?OR=Z-ZV3 (TE />_2Y0=MG[T$G^$V8IC'I;R#W'5><:DK)CY[5OS
MTY0G$_P\(1*F1(P-IJM?2NWP*4QP[VT]5-ESAJ[C#.WFW$!SRU:S0AR/>R6/
MI3P[57OD*IG#45(  G24J:UUG8*7:[?X:.\$U3= P LAG!CR0H-2GEF=4H*5
MHT;CDK*[1GH;OC]+7?WQ)3914CW%L!<XUB3TVXG0MT]AUZ_9?JX<B3,C3V[>
MWVXS>78+V;/@F,2IU<.*ZDO=ZWC*!WZUS<S";8I/3(D%PBV7N):4B[:T'[LN
MYVTR9)246D48O%LN0/I5NP"U+@X-CHGNJ<"JSN!)NHBPR1K%W9)Y6LTI6<HQ
M;YZ)MPE^[HF*I2B-J%O_*#HKN6H;:UAX3WT-#VB(/B8W25S-2%J026&A83.%
M-Z/NRI7>$-DC9PF9WY!5,;6'#AHUGNI]/6UHJ&;V!6!= 'ZY+P#_1 5@2Q],
MQ9R31,+UG@N^;D6L] W%@H%TBZR92;W.U9E[K=Y(&)#A@\V8VV1(CA/ NLW*
M@&C3D!,<W+.;C?F^BY!@V5 ]2)59#X3.>(,RH;B@EGUO+Q5=JI@^C5/E,A'W
M@7K':5QA9HJJ1@XV/7Q:6RK:N+GESB UM+D>8^MS;*6?)9&Z$)1"[@.U<&;@
M)L6072S*H+=-@.G_>G,8JCO __6WZ,.KXZ_VPI[/<?6S[EIGVR+LW';LX';
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MG9&X03HGQ\9N<%!.J20)'5=*/0AX0%R-]=.JVUP-5/T,=4:S;5Y7S4&<JQ'
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M]Q*!)J8P_.?3!?M2O;ZM6TP-[>N1V'O_&4W@D=H K[<Y@][$>+-8P;EDZB0
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M<%HMC'?!:1N SU8%^!T"G^EA/@1\MFJ2?P3X;-6@-QGDLP&?Z6=X5LB8EQU
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MM%0FA-:5@)GH:@N"%_'=L"YF%E]MV8WOK57B*?)@\P>>XCT'5$7MB#2VFZB
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M +M@PT3UCVT9L%YP+=^.QXS3/\FA#%BFW*,CQ*%3DKD4PP;,H&-,7ZH!IE,
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M#K!: \8\QQ4-5I)JSH*UWP5:3\2;[3S[8=<X.NNO,<X3 MJ FL9,!:$4I0Y
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M'$PB6)O[/3/V'$8B-HR%IF,6$W%+3A@0V75G\3KS<J7&29GE5G:54!XPDJ#
M$78/L+?A 3'<B[@/&HN2?367YL);D N/Q=2F#U3=/UAS??\K'B4M^'_9BL?M
M^6AI49;""R#EM D-91.**$8K*+>POR3?3'<)*O.;B.6IVC-5>Z9JSW:J/8L*
MZ;B6T=BL/[9><1 Q8XU6H]HX4J9LLREKEMF4Y:C\.5&5/WDJ?[+J."DK?SJ8
MTK(0.06=V<Q8N1IDEJ]E^62I>9!E;,Y#:>W?@S^,&$%VKK4LV2R%GD.M[[-*
M5"!\W*ZV:^F7=ZWD;=(',S:;L9*7E^<B46[S%$ESLY7J%C$E0E!N(DLN>AQ?
M&F[@;/W]+<C'B1:&[>L ,T-A!=!\MK'0S"7FE87AVM20[\V0B]BH-I];# ;0
MM8A:Z'L^ZIL6.IL0:KSW:;RA6LX&XK$#\X[Z $^'L?4NE(!:[.]O\)4NV#(=
M4K!@\H3GI'8S"\WIRY\.+<*9)]7646'1XQZFC4"MQCG/T,-#C@R1%AXF#C$Y
M)LR]4J>&WZSHI&*'/R9/HM.-.965_91'4()UDALEPT\KUKC"\K]PZ-1V[C0V
MF_GQ$0,KGUE+W609@)#+&/PHI"&RXCS9,Y))O5FM-0]NY2IJPAI(45%W:\RM
MQ\,*RX8+LOKA <-?)WB>%X@=S_0JT0$669DS:T&_%>7=%F;J51CL!6T1&'Y<
M\4)H3%AZIW5+%P-/]\3:/90E;0XL65#59T$)5;BB+>M\K,1+!E-^F[[9.GXZ
M.QQ]!FY'.HJ&0K)X2?R!S;@2"MOA.;)5V Z9!DU:;(<=D!:D%_;:.TLA:84P
M\-8( SMNO0L] #V8T%? .@5RK=W#+@)K) \S]@4.<U4R2'HR2%?ENK]R7F-H
M!KYY!'PRZ5\.1^.,65NO^XK;T #R!@@PRSR::7=47%(YS[23TPJE#?QK_[](
MHQ?);/3S%_-;C6+6;*^W9<WN]Y"^M*Y8KU%1ND(V71&RJT4,RKJNR(/"T3J1
M:8)Q"&O=-IP4M.>"=!M&'/UP7[SZ07[ES,LSDF=&,4H1@T:=X9<*&7:F_=&P
M,R#4A(RZ??Q4*$9LCO*/@L8S):(F_XN7TH241<5+67>D5G#:"HZ?K<C[LFK5
MOOG&K+E;J=GVQ[*5()W6/R3\EBRQ55'X<U[RPA]OL<(L@NV5/N\VRJNJUU\W
MRBMYNM+TJC\!O^#FZS6X!:1S.>[UOO:&4SB]-!UUB)9AB8D3_G#&2B@D1: J
MSP],50"(BV6M?$_X4X)#8[E25B*Q/RYA#:'.=,\$;!M,/9)?JK%$7-+E'6 I
M(U++&F0[!E-)9_]:ZE>9).^+/MH'"83/LCVM>P,3.Q]-]P&E'ITD)4A[B,]R
MGA E@80/&21BRA2_Q^PL#=-Z[BR;"SJQ+V6<\:'D,PF&(F6RI\B[5+,^(G )
M1%W.U)^S3O?+Y7AT,\SLGTJ^"8_CA__4;-/R');LYB#0,Z2$(F&&1;072J(.
M)]K1160CHG(,J%Z@ +-*@P4P13P!=+"?GR>>A_N@S@I^<&^S]K;(6XH%G<H6
MM)44*,CM9T#5<.S!F8$B)0284LP:YLPJ:K1RCM:>\& ,1]\J9'K5&_<N1N,>
M6\!"47$"*<Z.H8'4G\-D(:\0)KTNAD[JU;1H6RK;U#(Q2!DIT.&%4'*N,%Z>
M94I1GK5EN<>9J'3#,:FB8]O*#?M+]B'AKA1OD7U+1P[O].NY<,<7:LM<SFP#
MX+H!$!*AN>- (W"K*)S:VCOFO7A0? AW,^T,7SG>[=\<XQLNA&H"'0-]&;J[
MYEI\ZT_X_7]Q<:%ZP'N=1/D)WPJ< 21#8!Y+4.F6)MD0F >7  <]#GI/E1+<
MR3<>X1%@WD@P!HZ?<2Y($;9VCZM!QF6U'_HN#_D1E_GK3!J\393!)N0 AMU:
M/LU2N)CVT2SM"9U2>=B3BB=/RF8(DWF#4DAT,E'MY";]D'C5O OR%Y\3),SD
MPJO1Q784[C<6*Q;69VI^)P8 B<=:0CH7.@A%9M(72K:YQG/ ( <@9H&AB9WH
M#N2=?L)O;*3ZC9FP1.*((9% (NZ*#(WJZ06+_7$3D7P"D+H->_YFK9(-IP2#
M_3S\Y&_8=7:584NP/5WI$$Q*X2(#8,!L[B'M"]S.L]HQ9A&"'=G(U_Q5^]NR
M@:(N#&APR,/#]-=7_D1-;(;^Q S\,\.&.)*3,,T/'A_8P1!MADXGQZ3R,B(Q
MYL. ?('>@[.?OWDT-E79.M4W@K)DP4(1[7C!^>S6W9GOT*3XHTEK)+[F,#*+
M^S,V#%J(]4\+N_XISBT*#9_?Y-#F4 +\YW?PS3?*(N7UL[W2_KGFPJ0T4TU*
M#P:63>-H@'9FT4VD)AQXC,<$I.M(9 UVV!3!2WJ'!A]P+_FW!3&9Y1/7Y]=T
M_E'%9R[]V_$$03P -\83%^"[6VWYP_96[NRI4B#SG'2IN#Q3\US5X[\7GB'L
MI6U8]KVV-/]?8/Q A.2>!V+I0K+F=+W.GF#YS<U_/%-G^V8Z'C/#T(67QQ9D
M\"57F+#<[@SZ+VT.=^&I;6C]X7=@5S7:N/98P907:VF0)T-C^TKXH&M/(:PS
M\!,=EZ!+"C]$+>;"L&? >[O2Z!0!]6$XP3O1#85)/X#.O*4Z&0F53.I],J/-
M34]828 /N]),W/'=>?-Y%</Y0FU%XT2X9:!:CJHQ;?7 ;8_CV3]AHP&==T.N
M1L;C@_VR$*WTPRK,"!9IP!72'W8'-^?]X24<])%Q__)J2J\/S\GYS;3?FY#1
M!5ZX[HSQ(QP&3D<5,KGJ# ;DK$<N1W_VQL/>.3G[JX+/=4?#R71\0[_I#TFG
MVQV-SSO#;H]\ZT^O\#21##K?_'8GT\ZT!Q^&O6_DK]'X"SD(WHCW9D*./M9;
MM3HVC_]LB,<O>\/>N#,@H[-!_[+#;J;-I[9>(6<W4WR5$?U[W+OLC,_)=$1;
M_HN,X*037O]BT.].\0VAJ>OQZ,_^!%O&H]#1Q2&>-45VK9 V 08T2)W 119.
MDS!^01%LY/!/PRTXS$-^^DX?3]_/XLH,_="C1J=[QG:?_/9@?PM/SQ[HO*;.
M=F)7X#W$'MM<1K;L;&_,&]3-NSOZ;F H^*O2!1=\&7U.](S16;-%&QR7PFDI
M]2SH4M/F%7+KN4BN[:>)K=T.*BK R(3M^W.7<IGACG*JI8(AD>3=A*ERF?>T
M":,&BIJ"86\R(=^8:D_.<8% 0)3P,1Z6,^TTUD?G6;2/D2AR_;15+0X#(8;I
M',J>UN+5## K^'^\]%4^I*!-L3T92E_)-=UGNYRN0(DOUT%#WF)A9'Z3;:EM
MQ'$IG7Z(E=PH[:"T@[S:0;95E4D5E$"EQ=(?2R/_2 EOH-="1V 80DO"J5.*
M3BDZI>A>4=%E!GIYQU&-4O-^ER"J\2;04B5"#Z/RRX_/56\5IWRVF6>.*9S-
M&$7@JK:9+*6F C75*K.:RH$-UOH@M6Z39F)PE+)>&5'*NK:AFRS;JVO-YSQ9
M\!I.ZG6/[G'D[E/*&57'=;79@Z&OGTKE1]I#!S6M9VHGEZ@B>^5.$LJA(MM*
M1>91D1=RJY/-0([]Y1W]%TO6N=9F/^@POX0.D4@[OIGBDA.%\N*]J"WZ>TIO
MY=%;EV766UUKL9J;R*/:!<+O.W.FN5E5E^1YA%.+\=#L2$WY@D)H-PJLA#>=
ME%&&;-4[SZ;]I@H_QKC[QBRX[[:>4'X@/KF@5!7[[^O)5K'_9AHTQ?[[EBM$
ML?\6-<UEP*#;CAC(<0&W @>RW'N_')9C!CH1T$!Z82& IEZEJ*;(?>!5C]P,
MSWMC9&@\QQJ8L[](MS>>]B^@*&9ZU9F^-+10@?U-1[KKTZ7+,IDAV=F L#8=
M_N^Q/SS;65CH/9D%Z3@.?;8V;..G:3P:>@BA35341ZJ_PQ4^K%AN:M/WXM )
MYSP\P0IU>=, SH,%?_AIIN'R974\B-O#ROX64%BW JD[;.= %S)U0^:&SM]-
M_*H;_)[#48*6 0A#!&5"9_8#J[=G6,\#'^F/F):.U7EV4%ZD\0 8N6.N#K6C
M6'J(W=F369!>>@WEBL8O3=0=.H! .+/-6YE!+((:RD:1IHI70^@F,T2ZZ<SF
MEF-4PDM@:1&(W]')? \8 &P7@,"*X,@@>,CR*3R1;6(@;A(K-XOA<B8!+M&O
MTS&7<!<8P"; \H88@+"4 5!!V+EG:P>:=MGK0FGMW0LL)FPS6E8BD#1"00I,
MJ:J( D$M!@DI^XP\*G1&WAISZ_'%L2,*5%SI%<%R3H0)3'YO;I!^L9I)+$->
M"^: 5\C64/+"9$OR6K.%N0<HE(EWZYBZJ=E0528()OBZMPVLEIV!!\0]>C4B
MZ2.R)\L1=?-1ZIH\]_<.J(@8IB,:/-#EL+VH$!--7@7V@8'6;');2JW(G($.
M YP$WP@RHQG%T5FWF)7P[.0VC!E1DT$/,JNK^^77?.?*[@F@8P'<1_MA+)$2
MB_Y+@%; N1NU[@P]EMZPAG@4F-GUE^-)=>G<U@6GCLAY GM9[A-8*<]2-Z<B
M2*9NP#FA=L>XMQ"\Q=\C,@_0YFYD"(%0%#HSCQ[!8*C"B'OZWX'[KE&C?V55
MRP62N">5Y^R\*!0_L"2R"VB"RRV]Y.5R4MQR62\?*KEDWZWM+S6H29[LJZ;<
MV5<2PP]-NE>]\YM!C_0!#:L[^GH]Z"-J%S_DZ':FF=/PY<YLJE<+5&=14/ V
M",'WJJ,991C=2UO:Z?LPYDO)J; %8G*[6FL<W!Y*@ID<)A"Z6<X!IS#M(+02
M.MG!$Q@!19B2(Y9T8LJ]>I[]L;<GIB 51\QLM+&&SQ:SH(\_$,P 8$F&ZY-Y
M3] 8&Y+I&N8% JX<>($O%+^D XFG'$N2I) JZ%W&HJA[1,/3E&R(NQ9@QYHL
MKW1J02[3P*#^/-T%D3&HY.@H^8-Y9WF,O [9"'X"3)DSHP__XVDV8,!&!ILM
MV_5UFW79MO-IKY207M9=X?&'++LUY2A<EALG(,^4.)7;49#%*Q!E&E=E+-/H
MSNDZI(;IJ[&@F]&E[BU45=D^J:NK<I]IY%!7]8925WG45;^,ZBJHAJ7O8"[(
MV%A9=M9"JK*IK.C;MS:-0QY,@6<T]$Z5:/_]*-$CI43S18++J$4#A,EUA)4_
M_L>%HLE@[=JZ87^D;S;75H[QN_C'9]UT5G/MZ7=SB>WC0Y^C?3ZB+_,3(GW4
M1>;=1@FPR\$,J=;8+''I\+NZ^&5^N8J7/KGZ^K5FN]JNIU^N5>NIUS8V6ZN>
M-%HOWFSCI%H_/L[4[">4!),&%;BSTI;_^Z'Y(38F&,^H5:F4"08SB)@X_+IK
MK1(O\WC([XW5+U*G5^'O5C4>08+6UT;/6A4T8Z'J#,L#_?G*99@NGFW=KT'G
M/V1I"9GMGB/IR$^]Y\'->QAR#46@V8=<"0V$UN65KB\GMV<O@/T0[%?ME[GP
M%B'*QHB(U<).T-IJ\:9OP$)(_VJI[B+&W^I'M0K]"?AOAZ4H_-)T8;VG.9EK
ML2K1A447 JYX2Q&^J[4^_/>_6NW/G?5E_@E=S^<EDBDDS6ATPZ]A>C^!KQ,5
M^,H7^"IEY&M@S7Y\/+-^&4XEC#C<877&3AR)F'^/R$/I8,21!)/6<;7>1&__
M;>-H)[5JJW6R2QBM14U$L_GR\:ZC:ONT\1K1N6;[2-(P6K/:;LMK1#<&#9(G
M?3'N6WG%*/2+I Y=>06[/C^E=_CD%O:'/V!]PUEZ9T&?GVD5,JQVJK*Z@+(+
MD]JDXV:CW6B>E-8#+*F(<SF!)UO2994[N-$=?#_^8*.N_,&<_J#D#F%*6,FB
MRLT@G%(O.^-,<FY^8;EDAVDI3+QT:J8Y1ARUKB( MX)B%TTP"V:F0TPI4BA(
M$%O O\O4E3K]BW2UQ<IS:'.:7L8^ !'<S' !91%:_#_#=HPG4CNA.K>,W>FX
M+E55U'3SRA[:N.4^/)')H^EDC [)U:&I,3=6#];2X!TZKIU^/&T>?SP^/3[-
MHP@E[F)OH9ESWCV7C5?5@?'Z][^.6Y]-IB_FYIU1G5E92Q\D4_YG>92_@)O=
M8^6?C-Q?QAXI&R!==Y0-D+P_N10^>8D>;HX62".8@VY6.P')MKS@.8F*XL5,
M1W&)+ANH1*1__2:U"1?FG?M .C^-I9=.I27+"U^;KNO<>O;]0X5<=TC]J-%8
MQUJ2[:7C>O[,-K4EF;C:<FX\2?_V<:5^T*HW#DG[^.1CHU9;#^')]OH7VLPQ
M:;O1US^I-3^VZZWTN9/%,Y' *MW"5*HZ;"JA55HM9\]W/V3!^C@XSVIG (J>
M43M<TUTA<C$PP\+-"<)N(,(MNTX ^Y;QW?"6-A!#4&&??H;[$"<7?K+",>:Q
M1?:D^"% ?4?ZEEM ,P*^%D0&N7V*_#RPP)!'&Q)WEP#!#X%#CM;#F@/.*E-
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MZIL#[#X(\%2@0@KAH:$E,W.'Z<,"*Z@Z7Z$+6DOE$)U"'V8*H[>LI)<%HZ*
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M@G.@[\)LF_S'K4KS[>]XW&W3T3]02P,$%     @ 0X.:5FMR8V/:!   TQ(
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ML#2__KK'73P=_@M02P$"% ,4    " !"@YI6'?Y$/'5J @ VT!L $0
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M,2YH=&U02P$"% ,4    " !#@YI6J]5VI!@(  !B*   &
M@ %\]08 :6%R="TR,#(S,#,S,7AE>'@S,3(N:'1M4$L! A0#%     @ 0X.:
M5F'B4+_.!   R!(  !@              ( !ROT& &EA<G0M,C R,S S,S%X
M97AX,S(Q+FAT;5!+ 0(4 Q0    ( $.#FE9K<F-CV@0  -,2   8
M      "  <X"!P!I87)T+3(P,C,P,S,Q>&5X>#,R,BYH=&U02P4&      L
,"P#H @  W@<'

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
